PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Yoshimoto, M; Kobayashi, K; Hiraishi, K				Yoshimoto, Miwa; Kobayashi, Koichi; Hiraishi, Kunihiko			Diagnosis of Stochastic Discrete Event Systems Based on N-gram Models	IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES			English	Article						stochastic discrete event systems; diagnosis; N-gram models	DYNAMIC-SYSTEMS; DIAGNOSABILITY; AUTOMATA	In this paper, we present a new method for diagnosis of stochastic discrete event system. The method is based on anomaly detection for sequences. We call the method sequence profiling (SP). SP does not require any system models and any system-specific knowledge. The only information necessary for SP is event logs from the target system. Using event logs from the system in the normal situation, N-gram models are learned, where the N-gram model is used as approximation of the system behavior. Based on the N-gram model, the diagnoser estimates what kind of faults has occurred in the system, or may conclude that no faults occurs. Effectiveness of the proposed method is demonstrated by application to diagnosis of a multi-processor system.	[Yoshimoto, Miwa; Kobayashi, Koichi; Hiraishi, Kunihiko] Japan Adv Inst Sci & Technol, Sch Informat Sci, Nomi Shi 9231292, Japan	Yoshimoto, M (reprint author), Japan Adv Inst Sci & Technol, Sch Informat Sci, Nomi Shi 9231292, Japan.	hira@jaist.ac.jp			MEXT [25330011]	This research is partly supported by Grant-in-Aid for Scientific Research of MEXT under Grant No. 25330011.	Thorsley D, 2005, IEEE T AUTOMAT CONTR, V50, P476, DOI 10.1109/TAC.2005.844722; Lamperti G, 2000, APPL INTELL, V12, P217, DOI 10.1023/A:1008319108717; Qiu WB, 2006, IEEE T SYST MAN CY A, V36, P384, DOI 10.1109/TSMCA.2005.853503; RICH SH, 1987, COMPUT CHEM ENG, V11, P111, DOI 10.1016/0098-1354(87)80012-1; SAMPATH M, 1995, IEEE T AUTOMAT CONTR, V40, P1555, DOI 10.1109/9.412626; Liu FC, 2008, IEEE T AUTOMAT CONTR, V53, P535, DOI 10.1109/TAC.2007.915172; van der Aalst W, 2004, IEEE T KNOWL DATA EN, V16, P1128, DOI 10.1109/TKDE.2004.47; WILLSKY AS, 1976, AUTOMATICA, V12, P601, DOI 10.1016/0005-1098(76)90041-8; Chandola V, 2008, IEEE DATA MINING, P743, DOI 10.1109/ICDM.2008.151; Sun P, 2006, SIAM PROC S, P94; Ron D, 1996, MACH LEARN, V25, P117, DOI 10.1023/A:1026490906255; SHANNON CE, 1948, AT&T TECH J, V27, P623; Chandola V, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1541880.1541882; Forrest S., 1999, P IEEE ISRSP IEEE CO, P133; FRANK PM, 1990, AUTOMATICA, V26, P459, DOI 10.1016/0005-1098(90)90018-D; Grastein A., 2007, P AAAI 07, V1, P305; Lee W., 1997, P AAAI97 WORKSH AI M, P50; Michael CC, 2000, 16TH ANNUAL COMPUTER SECURITY APPLICATIONS CONFERENCE, PROCEEDINGS, P21, DOI 10.1109/ACSAC.2000.898854; Nagao M., 1994, P 15 C COMP LING, V1, P611, DOI 10.3115/991886.991994; Ogawa H., 2007, P SICE SSI2007, P327; Wang Xi, 2004, 43 IEEE C DEC CONTR, P14	21	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1337			IEICE T FUND ELECTR	IEICE Trans. Fundam. Electron. Commun. Comput. Sci.	FEB	2015	E98A	2					618	625		10.1587/transfun.E98.A.618		8	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CO9AO	WOS:000359464400023		
J	Kobayashi, K; Nagami, T; Hiraishi, K				Kobayashi, Koichi; Nagami, Takuro; Hiraishi, Kunihiko			Optimal Control of Multi-Vehicle Systems with Temporal Logic Constraints	IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES			English	Article						mixed integer programming; multi-vehicle systems; optimal control; temporal logic constraints	OBSTACLE AVOIDANCE; DISCRETE	In this paper, optimal control of multi-vehicle systems is studied. In the case where collision avoidance between vehicles and obstacle avoidance are imposed, state discretization is effective as one of the simplified approaches. Furthermore, using state discretization, cooperative actions such as rendezvous can be easily specified by linear temporal logic (LTL) formulas. However, it is not necessary to discretize all states, and partial states (e.g., the position of vehicles) should be discretized. From this viewpoint, a new control method for multi-vehicle systems is proposed in this paper. First, the system in which partial states are discretized is formulated. Next, the optimal control problem with constraints described by LTL formulas is formulated, and its solution method is proposed. Finally, numerical simulations are presented. The proposed method provides us a useful method in control of multi-vehicle systems.	[Kobayashi, Koichi; Nagami, Takuro; Hiraishi, Kunihiko] Japan Adv Inst Sci & Technol, Nomi Shi 9231292, Japan	Kobayashi, K (reprint author), Japan Adv Inst Sci & Technol, Nomi Shi 9231292, Japan.	k-kobaya@jaist.ac.jp			 [26420412]	This work was partially supported by Grant-in-Aid for Scientific Research (C) 26420412.	Wongpiromsarn T, 2012, IEEE T AUTOMAT CONTR, V57, P2817, DOI 10.1109/TAC.2012.2195811; Fainekos GE, 2009, AUTOMATICA, V45, P343, DOI 10.1016/j.automatica.2008.08.008; Olfati-Saber R, 2007, P IEEE, V95, P215, DOI 10.1109/JPROC.2006.887293; Tabuada P, 2006, IEEE T AUTOMAT CONTR, V51, P1862, DOI 10.1109/TAC.2006.886494; Wang P, 2014, IEEE T AUTOMAT CONTR, V59, P1439, DOI 10.1109/TAC.2014.2304175; Ding XC, 2014, AUTOMATICA, V50, P399, DOI 10.1016/j.automatica.2013.11.030; Ding XC, 2014, IEEE T AUTOMAT CONTR, V59, P1244, DOI 10.1109/TAC.2014.2298143; Girard A, 2007, IEEE T AUTOMAT CONTR, V52, P782, DOI 10.1109/TAC.2007.895849; Belta C, 2007, IEEE ROBOT AUTOM MAG, V14, P61, DOI 10.1109/MRA.2007.339624; CAVALIER TM, 1990, COMPUT OPER RES, V17, P561, DOI 10.1016/0305-0548(90)90062-C; Earl M.G., 2007, COOPERATIVE CONTROL, P213; Frew E, 2004, IEEE DECIS CONTR P, P614, DOI 10.1109/CDC.2004.1428712; Gabbay D., 1994, TEMPORAL LOGIC; Rakovic SV, 2005, IEEE DECIS CONTR P, P981; Reinl C., 2007, P 1 INT C ROB COMM C; Tabuada P., 2009, VERIFICATION CONTROL; Tazaki Y, 2012, IEEE T AUTOMAT CONTR, V57, P550, DOI 10.1109/TAC.2011.2161789	17	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1337			IEICE T FUND ELECTR	IEICE Trans. Fundam. Electron. Commun. Comput. Sci.	FEB	2015	E98A	2					626	634		10.1587/transfun.E98.A.626		9	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CO9AO	WOS:000359464400024		
J	Toyoshima, I; Yamaguchi, S; Murakami, Y				Toyoshima, Ichiro; Yamaguchi, Shingo; Murakami, Yuki			Two Sufficient Conditions on Refactorizability of Acyclic Extended Free Choice Workflow Nets to Acyclic Well-Structured Workflow Nets and Their Application	IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES			English	Article						workflow net; extended free choice WF-net; well-structured WF-net; refactorizability; PT-handle; TP-handle	PETRI NETS	A workflow net (WF-net for short) is a Petri net which represents a workflow. There are two important subclasses of WF-nets: extended free choice (EFC for short) and well-structured (WS for short). It is known that most actual workflows can be modeled as EFC WF-nets; and acyclic WS is a subclass of acyclic EFC but has more analysis methods. A sound acyclic EFC WF-net may be transformed to an acyclic WS WF-net without changing the observable behavior of the net. Such a transformation is called refactoring. In this paper, we tackled a problem, named acyclic EFCWF-net refactorizability problem, that decides whether a given sound acyclic EFC WF-net is refactorable to an acyclic WS WF-net. We gave two sufficient conditions on the problem, and constructed refactoring procedures based on the conditions. Furthermore, we applied the procedures to a sample workflow, and confirmed usefulness of the procedures for the enhancement of the readability and the analysis power of acyclic EFC WF-nets.	[Toyoshima, Ichiro; Yamaguchi, Shingo; Murakami, Yuki] Yamaguchi Univ, Grad Sch Sci & Engn, Ube, Yamaguchi 7558611, Japan	Toyoshima, I (reprint author), Yamaguchi Univ, Grad Sch Sci & Engn, Ube, Yamaguchi 7558611, Japan.	p501we@yamaguchi-u.ac.jp; shingo@yamaguchi-u.ac.jp					Aalst W. v.d., 2002, WORKFLOW MANAGEMENT; Van der Aalst WMP, 1998, J CIRCUIT SYST COMP, V8, P21, DOI 10.1142/S0218126698000043; BEST E, 1983, LECT NOTES COMPUT SC, V159, P141; Desel J., 2005, FREE CHOICE PETRI NE; Esparza J., 1990, LECT NOTES COMPUTER, V483, P210; Kuroda Y., 2009, P ITC CSCC 2009, P875; Murakami Y, 2013, 2013 FIRST INTERNATIONAL SYMPOSIUM ON COMPUTING AND NETWORKING (CANDAR), P592, DOI 10.1109/CANDAR.2013.106; Murata T., 1989, IEEE, V77, P541, DOI DOI 10.1109/5.24143; Verbeek HMW, 2003, LECT NOTES COMPUT SC, V2679, P44; Yamaguchi S, 2012, IEICE T INF SYST, VE95D, P1375, DOI 10.1587/transinf.E95.D.1375; Yamaguchi S, 2014, IEICE T FUND ELECTR, VE97A, P468, DOI 10.1587/transfun.E97.A.468	11	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1337			IEICE T FUND ELECTR	IEICE Trans. Fundam. Electron. Commun. Comput. Sci.	FEB	2015	E98A	2					635	644		10.1587/transfun.E98.A.635		10	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CO9AO	WOS:000359464400025		
J	Amtade, S; Miyamoto, T				Amtade, Supacheep; Miyamoto, Toshiyuki			Cuckoo Search Algorithm for Job Scheduling in Cloud Systems	IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES			English	Article						Cloud systems; resource constraint; cuckoo search; job scheduling; optimization		A cloud system is defined as a large scale computer system that contains running high performance computers and responds to a large number of incoming tasks over the Internet. In this paper, we consider the problem to schedule computational jobs efficiently regarding system resource constraint and introduce a cuckoo search (CS) algorithm. Experimental results show that CS outperforms the genetic algorithm in terms of fitness value.	[Amtade, Supacheep] Osaka Univ, Sch Engn, Suita, Osaka 5650871, Japan; [Amtade, Supacheep] Kasetsart Univ, Fac Engn, Bangkok 10900, Thailand; [Miyamoto, Toshiyuki] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Amtade, S (reprint author), Osaka Univ, Sch Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	peehcapus@gmail.com; miyamoto@eei.eng.osaka-u.ac.jp					Gandomi AH, 2013, ENG COMPUT-GERMANY, V29, P17, DOI 10.1007/s00366-011-0241-y; Beloglazov A, 2012, CONCURR COMP-PRACT E, V24, P1397, DOI 10.1002/cpe.1867; Yang XS, 2009, WOR CONG NAT BIOL, P210, DOI 10.1109/NABIC.2009.5393690; Pandey S, 2010, INT CON ADV INFO NET, P400, DOI 10.1109/AINA.2010.31; Ouaarab A, 2014, NEURAL COMPUT APPL, V24, P1659, DOI 10.1007/s00521-013-1402-2; Burnwal S, 2013, INT J ADV MANUF TECH, V64, P951, DOI 10.1007/s00170-012-4061-z; Bitam Salim, 2012, P 2 INT C COMM INF T, P186; DEWDNEY AK, 1985, SCI AM, V253, P21; Dhivya M., 2011, INT J COMMUNICATIONS, V4, P249, DOI DOI 10.4236/IJCNS.2011.44030; Dhivya M, 2011, INT J MOB COMMUN, V9, P642, DOI 10.1504/IJMC.2011.042781; Fan W., 2013, INT J ADV COMP TECH, V5, P65; IZAKIAN H, 2009, P 3 INT C INF SYST T, V31, P100; Jang S., 2012, INT J CONTROL AUTOM, V5, P157; Li W., 2011, P IEEE 3 INT C CLOUD, P163; Mell P., 2011, 800145 NIST; Payne RB, 2005, CUCKOOS; Tein L. H., 2010, P 6 IMT GT C MATH ST, P395	17	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1337			IEICE T FUND ELECTR	IEICE Trans. Fundam. Electron. Commun. Comput. Sci.	FEB	2015	E98A	2					645	649		10.1587/transfun.E98.A.645		5	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CO9AO	WOS:000359464400026		
J	Yamamoto, T; Takai, S				Yamamoto, Takashi; Takai, Shigemasa			Online Synthesis of Conjunctive Decentralized Diagnosers for Discrete Event Systems	IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES			English	Article						discrete event system; failure diagnosis; conjunctive decentralized diagnoser; online synthesis		In this paper, we consider a decentralized failure diagnosis problem for discrete event systems. For a conjunctively codiagnosable system, there exists a conjunctive decentralized diagnoser that can detect the occurrence of any failure within a uniformly bounded number of steps. We present a method for synthesizing such a conjunctive decentralized diagnoser as an online diagnoser.	[Yamamoto, Takashi; Takai, Shigemasa] Osaka Univ, Div Elect Elect & Informat Engn, Suita, Osaka 5650871, Japan	Yamamoto, T (reprint author), Osaka Univ, Div Elect Elect & Informat Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takai@eei.eng.osaka-u.ac.jp			Okawa Foundation for Information and Telecommunications	This work was supported in part by the Okawa Foundation for Information and Telecommunications.	Cassez F, 2012, IEEE T AUTOMAT CONTR, V57, P1752, DOI 10.1109/TAC.2012.2183169; Wang Y, 2007, DISCRETE EVENT DYN S, V17, P233, DOI 10.1007/s10626-006-0006-8; Qiu WB, 2006, IEEE T SYST MAN CY A, V36, P384, DOI 10.1109/TSMCA.2005.853503; SAMPATH M, 1995, IEEE T AUTOMAT CONTR, V40, P1555, DOI 10.1109/9.412626; Cassandras C. G., 2008, INTRO DISCRETE EVENT; Hopcroft JE, 1979, INTRO AUTOMATA THEOR; Yamamoto T, 2014, IEICE T FUND ELECTR, VE97A, P1605, DOI 10.1587/transfun.E97.A.1605; Yamamoto T., 2013, P 4 IFAC WORKSH DEP, P67	8	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1337			IEICE T FUND ELECTR	IEICE Trans. Fundam. Electron. Commun. Comput. Sci.	FEB	2015	E98A	2					650	653		10.1587/transfun.E98.A.650		4	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CO9AO	WOS:000359464400027		
J	Oshima, T; Yamawaki, T				Oshima, Takashi; Yamawaki, Taizo			Reference-Free Deterministic Calibration of Pipelined ADC	IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES			English	Article						deterministic calibration; dither; LMS algorithm; pipelined ADC; multi-bit/stage MDAC	DIGITAL BACKGROUND-CALIBRATION; A/D CONVERTERS; SPLIT ADC; ARCHITECTURE	Novel deterministic digital calibration of pipelined ADC has been proposed and analyzed theoretically. Each MDAC is dithered exploiting its inherent redundancy during the calibration. The dither enables fast accurate convergence of calibration without requiring any accurate reference signal and hence with minimum area and power overhead. The proposed calibration can be applied to both the 1.5-bit/stage MDAC and the multi-bit/stage MDAC. Due to its simple structure and algorithm, it can be modified to the background calibration easily. The effectiveness of the proposed calibration has been confirmed by both the extensive simulations and the measurement of the prototype 0.13-mu m-CMOS 50-MS/s pipelined ADC using the op-amps with only 37-dB gain. As expected, SNDR and SFDR have improved from 35.5 dB to 58.1 dB and from 37.4 dB to 70.4 dB, respectively by the proposed calibration.	[Oshima, Takashi; Yamawaki, Taizo] Hitachi Ltd, Cent Res Lab, Kokubunji, Tokyo 1858601, Japan	Oshima, T (reprint author), Hitachi Ltd, Cent Res Lab, Kokubunji, Tokyo 1858601, Japan.	takashi.oshima.yp@hitachi.com					Galton I, 2000, IEEE T CIRCUITS-II, V47, P185, DOI 10.1109/82.826744; Murmann B, 2003, IEEE J SOLID-ST CIRC, V38, P2040, DOI 10.1109/JSSC.2003.819167; KARANICOLAS AN, 1993, IEEE J SOLID-ST CIRC, V28, P1207, DOI 10.1109/4.261994; Grace CR, 2005, IEEE J SOLID-ST CIRC, V40, P1038, DOI 10.1109/JSSC.2005.845972; LEWIS SH, 1992, IEEE J SOLID-ST CIRC, V27, P351, DOI 10.1109/4.121557; Chiu Y, 2004, IEEE T CIRCUITS-I, V51, P38, DOI 10.1109/TCSI.2003.821306; Haykin S., 2002, ADAPTIVE FILTER THEO; Liu HC, 2004, ISSCC DIG TECH PAP I, V47, P454; Liu W., 2007, INT C ASIC OCT, P289; McNeill JA, 2009, IEEE T CIRCUITS-I, V56, P294, DOI 10.1109/TCSI.2008.2001830; McNeill J., 2005, 2005 IEEE International Solid-State Circuits Conference (IEEE Cat. No. 05CH37636); McNeill J, 2005, IEEE J SOLID-ST CIRC, V40, P2437, DOI 10.1109/JSSC.2005.856291; Moon UK, 1997, IEEE T CIRCUITS-II, V44, P102, DOI 10.1109/82.554434; Oshima T, 2008, MIDWEST SYMP CIRCUIT, P914, DOI 10.1109/MWSCAS.2008.4616949; Oshima Takashi, 2009, 2009 IEEE International Symposium on Circuits and Systems - ISCAS 2009, DOI 10.1109/ISCAS.2009.5117917; Tsang CY, 2008, IEEE CUST INTEGR CIR, P301; Verma Ashutosh, 2009, 2009 IEEE International Solid-State Circuits Conference (ISSCC 2009), DOI 10.1109/ISSCC.2009.4977319; Wang HY, 2009, IEEE J SOLID-ST CIRC, V44, P2780, DOI 10.1109/JSSC.2009.2028756	18	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1337			IEICE T FUND ELECTR	IEICE Trans. Fundam. Electron. Commun. Comput. Sci.	FEB	2015	E98A	2					665	675		10.1587/transfun.E98.A.665		11	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CO9AO	WOS:000359464400029		
J	Izawa, M; Torikai, H				Izawa, Masato; Torikai, Hiroyuki			Asynchronous Cellular Automaton Model of Spiral Ganglion Cell in the Mammalian Cochlea: Theoretical Analyses and FPGA Implementation	IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES			English	Article						asynchronous cellular automaton; nonlinear response; spiral ganglion cell; mammalian cochlea; FPGA	SPIKING NEURON; BASILAR-MEMBRANE; RESPONSES; BIFURCATIONS	The mammalian cochlear consists of highly nonlinear components: lymph (viscous fluid), a basilar membrane (vibrating membrane in the viscous fluid), outer hair cells (active dumpers for the basilar membrane), inner hair cells (neural transducers), and spiral ganglion cells (parallel spikes density modulators). In this paper, a novel spiral ganglion cell model, the dynamics of which is described by an asynchronous cellular automaton, is presented. It is shown that the model can reproduce typical nonlinear responses of the spiral ganglion cell in the mammalian cochlea, e.g., spontaneous spiking, parallel spike density modulation, and adaptation. Also, FPGA experiments validate reproductions of these nonlinear responses.	[Izawa, Masato] Osaka Univ, Grad Sch Engn Sci, Dept Syst Innovat, Toyonaka, Osaka 5608531, Japan; [Torikai, Hiroyuki] Kyoto Sangyo Univ, Dept Comp Sci, Kyoto 6038555, Japan	Izawa, M (reprint author), Osaka Univ, Grad Sch Engn Sci, Dept Syst Innovat, Toyonaka, Osaka 5608531, Japan.	izawa@hopf.sys.es.osaka-u.ac.jp; torikai@cse.kyoto-su.ac.jp			KAKENHI Grant [24700225]	The authors would like to thank Professor Toshimitsu Ushio of Osaka Univ. for valuable discussions. This work was partially supported by the KAKENHI Grant Number 24700225.	Stoop R, 2005, PHYSICA A, V351, P175, DOI 10.1016/j.physa.2004.12.019; Matsubara T, 2013, IEEE T NEUR NET LEAR, V24, P736, DOI 10.1109/TNNLS.2012.2230643; Matsubara T, 2011, IEEE T CIRCUITS-II, V58, P677, DOI 10.1109/TCSII.2011.2161705; Eguiluz VM, 2000, PHYS REV LETT, V84, P5232, DOI 10.1103/PhysRevLett.84.5232; Fletcher H, 1940, REV MOD PHYS, V12, P0047, DOI 10.1103/RevModPhys.12.47; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769; Chan V, 2007, IEEE T CIRCUITS-I, V54, P48, DOI [10.1109/TCSI.2006.887979, 10.1109/TCSI.2006.887977]; Bekesy G., 1960, EXPT HEARING; Chua LO, 1987, LINEAR NONLINEAR CIR; Galbraith C, 2007, IEEE RAD FREQ INTEGR, P219, DOI 10.1109/RFIC.2007.380869; Geisler C.D., 1997, SOUND SYNAPSE PHYSL; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; Hashimoto S, 2010, IEEE T CIRCUITS-I, V57, P2168, DOI 10.1109/TCSI.2010.2041507; Helmholtz H., 1954, SENSATION TONE PHILO; Izawa M., 2014, P IEEE INNS INT JOIN, P2483; Kern A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.128101; Matsubara T, 2012, IEICE T FUND ELECTR, VE95A, P1317, DOI 10.1587/transfun.E95.A.1317; Noguchi T, 2013, IEEE T CIRCUITS-II, V60, P111, DOI 10.1109/TCSII.2012.2235015; Pickles J. O., 2013, INTRO PHYSL HEARING; ROBLES L, 1991, NATURE, V349, P413, DOI 10.1038/349413a0; Ruggero M A, 1992, Curr Opin Neurobiol, V2, P449, DOI 10.1016/0959-4388(92)90179-O; Schouten J.F., 1970, FREQUENCY ANAL PERIO, P41; Sellami L, 1997, IEEE T CIRCUITS-I, V44, P174, DOI 10.1109/81.554339; Stoop R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268103; Tian G., 2005, P IEEE EMBS C, P5339; Torikai H, 2009, NEURAL NETWORKS, V22, P664, DOI 10.1016/j.neunet.2009.06.023; Torikai H, 2008, DISCRETE CONT DYN-B, V9, P183; van Schaik A., 1998, THESIS EPFL; Wang J, 1997, HEARING RES, V107, P67, DOI 10.1016/S0378-5955(97)00020-8; Watts L., 2012, LNCS, V7311, P47; Wever E.G., 1949, THEORY HEARING	31	1	1	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1337			IEICE T FUND ELECTR	IEICE Trans. Fundam. Electron. Commun. Comput. Sci.	FEB	2015	E98A	2					684	699		10.1587/transfun.E98.A.684		16	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CO9AO	WOS:000359464400031		
J	Koguma, Y; Aiyoshi, E				Koguma, Yuji; Aiyoshi, Eitaro			A New Framework with a Stability Theory for Multipoint-Type and Stochastic Meta-Heuristic Optimization Algorithms	IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES			English	Article						meta-heuristics; global optimization; stochastic optimization; normal distribution	DIFFERENTIAL EVOLUTION; MULTIAGENT ARCHITECTURE; POPULATION	In Recent years, a paradigm of optimization algorithms referred to as "meta-heuristics" have been gaining attention as a means of obtaining approximate solutions to optimization problems quickly without any special prior knowledge of the problems. Meta-heuristics are characterized by flexibility in implementation. In practical applications, we can make use of not only existing algorithms but also revised algorithms that reflect the prior knowledge of the problems. Most meta-heuristic algorithms lack mathematical grounds, however, and therefore generally require a process of trial and error for the algorithm design and its parameter adjustment. For one of the resolution of the problem, we propose an approach to design algorithms with mathematical grounds. The approach consists of first constructing a "framework" of which dynamic characteristics can be derived theoretically and then designing concrete algorithms within the framework. In this paper, we propose such a framework that employs two following basic strategies commonly used in existingmeta-heuristic algorithms, namely, (1) multipoint searching, and (2) stochastic searching with pseudo-random numbers. In the framework, the update-formula of search point positions is given by a linear combination of normally distributed random numbers and a fixed input term. We also present a stability theory of the search point distribution for the proposed framework, using the variance of the search point positions as the index of stability. This theory can be applied to any algorithm that is designed within the proposed framework, and the results can be used to obtain a control rule for the search point distribution of each algorithm. We also verify the stability theory and the optimization capability of an algorithm based on the proposed framework by numerical simulation.	[Koguma, Yuji] Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa 2238522, Japan; [Aiyoshi, Eitaro] Keio Univ, Fac Sci & Technol, Yokohama, Kanagawa 2238522, Japan	Koguma, Y (reprint author), Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa 2238522, Japan.	moltire@gmail.com					Aitchison J., 1957, LOGNORMAL DISTRIBUTI; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/ICNN.1995.488968; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Poli R, 2009, IEEE T EVOLUT COMPUT, V13, P712, DOI 10.1109/TEVC.2008.2011744; Hansen N, 2006, STUD FUZZ SOFT COMP, V192, P75; Campana EF, 2010, J GLOBAL OPTIM, V48, P347, DOI 10.1007/s10898-009-9493-0; Chen C. W., 2011, EVID-BASED COMPL ALT, V2011, P7; Clerc M., 2006, CSM460 U ESS DEP COM; Dasgupta S, 2009, AI COMMUN, V22, P1, DOI 10.3233/AIC-2009-0440; Fernandes FC, 2009, IEEE SYS MAN CYBERN, P3071, DOI 10.1109/ICSMC.2009.5345934; Ghosh S., 2011, IEEE T SYST MAN CY B, V42, P107; GLOVER F, 1986, COMPUT OPER RES, V13, P533, DOI 10.1016/0305-0548(86)90048-1; Goldberg D. E., 1989, GENETIC ALGORITHMS S; Hansen N., 1996, P 1996 IEEE INT C EV, P312, DOI DOI 10.1109/ICEC.1996.542381; Kenney J., 1962, MATH STAT 2, V2nd; Masuda K, 2011, IEEE C EVOL COMPUTAT, P2550; Milano M, 2004, IEEE T SYST MAN CY B, V34, P925, DOI 10.1109/TSMCB.2003.818432; Paul S., 1995, EVOLUTION OPTIMUM SE; Rastrigin L. A., 1974, SYSTEMS EXTREMAL CON; Zhang J, 2007, IEEE C EVOL COMPUTAT, P2220, DOI 10.1109/CEC.2007.4424747	20	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1337			IEICE T FUND ELECTR	IEICE Trans. Fundam. Electron. Commun. Comput. Sci.	FEB	2015	E98A	2					700	709		10.1587/transfun.E98.A.700		10	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CO9AO	WOS:000359464400032		
J	Zhou, YZ; Takahashi, R; Hikihara, T				Zhou, Yanzi; Takahashi, Ryo; Hikihara, Takashi			Realization of Autonomous Clock Synchronization for Power Packet Dispatching	IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES			English	Article						system modeling; CPPLL; clock synchronization; power packet		In this letter, we establish a model of a digital clock synchronization method for power packet dispatching. The first-order control is carried out to a specified model to achieve the clock synchronization. From the experimental results, it is confirmed that power packets were recognized under autonomous synchronization.	[Zhou, Yanzi; Takahashi, Ryo; Hikihara, Takashi] Kyoto Univ, Dept Elect Engn, Kyoto 6158510, Japan	Zhou, YZ (reprint author), Kyoto Univ, Dept Elect Engn, Kyoto 6158510, Japan.	y-zhou@dove.kuee.kyoto-u.ac.jp; takahashi.ryo.2n@kyoto-u.ac.jp; hikihara.takashi.2n@kyoto-u.ac.jp			Regional Innovation Cluster Program "Kyoto Enviromental Nanotechnology Cluster"; JST; Excellent Graduate Schools Program in Kyoto University; JSPS [26820144]	This research was partially supported by the Regional Innovation Cluster Program "Kyoto Enviromental Nanotechnology Cluster", JST supported Super Cluster Project of Kyoto, Consultation of a High-Efficiency Energy Utilization System Realising Clean and Low Enviromental Load Society, and the Excellent Graduate Schools Program in Kyoto University. The author (R.T.) was partially supported by the JSPS, Grant-in-Aid for Young Scientists (B), 26820144, 2014.	Gadelovits S, 2014, RENEW SUST ENERG REV, V31, P501, DOI 10.1016/j.rser.2013.12.039; Takuno T, 2011, ENERGIES, V4, P717, DOI 10.3390/en4050717; Lenzen M, 2010, ENERGIES, V3, P462, DOI 10.3390/en3030462; Fujii N., 2014, 2014 IEEE SICE INT S; Hikihara T., 2010, SANTA BARBARA SUMMIT, P12; Lee Kun-Seok, 2003, SOL STAT CIRC C EST, P525; Mishra B., 2011, INT J VLSI DES COMMU, V2, P97; Nawata S., 2014, IEICE INT S NONLIN T, P60; Saitoh H, 1997, ELECTR ENG JPN, V121, P28, DOI 10.1002/(SICI)1520-6416(199712)121:4<28::AID-EEJ4>3.0.CO;2-X; Takahashi R, 2012, ENERGIES, V5, P2141, DOI 10.3390/en5072141; Takuno T, 2010, 2010 IEEE 1ST INTERNATIONAL CONFERENCE ON SMART GRID COMMUNICATIONS (SMARTGRIDCOMM), P427, DOI 10.1109/SMARTGRID.2010.5622079; Tashiro K, 2012, 2012 IEEE THIRD INTERNATIONAL CONFERENCE ON SMART GRID COMMUNICATIONS (SMARTGRIDCOMM), P401, DOI 10.1109/SmartGridComm.2012.6486017; Wang X., 2014, APPL MECH MAT, V543, P558	13	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1337			IEICE T FUND ELECTR	IEICE Trans. Fundam. Electron. Commun. Comput. Sci.	FEB	2015	E98A	2					749	753		10.1587/transfun.E98.A.749		5	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CO9AO	WOS:000359464400038		
J	Yoshida, M; Fujiwara, T				Yoshida, Maki; Fujiwara, Toru			On the Impossibility of d-Multiplicative Non-perfect Secret Sharing	IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES			English	Article						secret sharing; multiplicative; non-perfect; impossibility	SCHEMES	A secret sharing scheme is said to be d-multiplicative if the scheme allows the players to multiply shared d secrets by locally converting their shares into an additive sharing of the product. In the previous work, the following negative result for perfect secret sharing has been shown: The d-multiplicative secret sharing for d players is impossible. This paper extends the impossibility result to non-perfect secret sharing. Our main result is a proof that d-multiplicative secret sharing for d players is impossible even if every player has partial information on the secret (e.g., all but one bit). This result means that there is no need to relax the privacy requirement with leakage of partial information only for the purpose of d-multiplication.	[Yoshida, Maki] Natl Inst Informat & Commun Technol, Koganei, Tokyo 1848795, Japan; [Fujiwara, Toru] Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan	Yoshida, M (reprint author), Natl Inst Informat & Commun Technol, 4-2-1 Nukuikitamachi, Koganei, Tokyo 1848795, Japan.	maki-yos@nict.go.jp; fujiwara@ist.osaka-u.ac.jp					SHAMIR A, 1979, COMMUN ACM, V22, P612, DOI 10.1145/359168.359176; Cramer R, 2000, LECT NOTES COMPUT SC, V1807, P316; Ishai Y, 2007, ACM S THEORY COMPUT, P21; Barkol O, 2010, J CRYPTOL, V23, P580, DOI 10.1007/s00145-010-9056-z; Blakley G., 1979, AFIPS P, V48, P313; Blakley G.R., 1985, LNCS, V196, P242; Chen H, 2006, LECT NOTES COMPUT SC, V4117, P521; Itoh M., 1987, IEEE GLOBECOM, P99; Kurosawa K., 1993, LECT NOTES COMPUT SC, V765, P126; Ogata W., 1993, LECT NOTES COMPUTER, V718, P56, DOI [10.1007/3-540-57220-1_52, DOI 10.1007/3-540-57220-1_52]; Yamamoto H., 1985, ELECTR COMMUN 1, VJ68-A, p[945, 46]; Zhang ZF, 2008, LECT NOTES COMPUT SC, V5350, P19	12	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1337			IEICE T FUND ELECTR	IEICE Trans. Fundam. Electron. Commun. Comput. Sci.	FEB	2015	E98A	2					767	770		10.1587/transfun.E98.A.767		4	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CO9AO	WOS:000359464400042		
J	Takanashi, M; Makido, S				Takanashi, Masaki; Makido, Satoshi			A Robust Wireless Image Transmission for ITS Broadcast Environment Using Compressed Sensing	IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES			English	Article						compressed sensing; ITS (Intelligent Transportation System); robust wireless image transmission; broadcast; packet erasure		Providing images captured by an on-board camera to surrounding vehicles is an effective method to achieve smooth road traffic and to avoid traffic accidents. We consider providing images using WiFi technology based on the IEEE802.11p standard for vehicle-to-vehicle (V2V) communication media. We want to compress images to suppress communication traffic, because the communication capacity of the V2V system is strictly limited. However, there are difficulties in image compression and transmission using wireless communication especially in a vehicular broadcast environment, due to transmission errors caused by fading, packet collision, etc. In this letter, we propose an image transmission technique based on compressed sensing. Through computer simulations, we show that our proposed technique can achieve stable image reconstruction despite frequent packet error.	[Takanashi, Masaki; Makido, Satoshi] Toyota Res & Dev Lab Inc, Nagakute, Aichi 4801192, Japan	Takanashi, M (reprint author), Toyota Res & Dev Lab Inc, Nagakute, Aichi 4801192, Japan.	m-takanashi@mosk.tytlabs.co.jp					Lustig M, 2008, IEEE SIGNAL PROC MAG, V25, P72, DOI 10.1109/MSP.2007.914728; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Pudlewski S, 2012, IEEE T MOBILE COMPUT, V11, P1060, DOI 10.1109/TMC.2011.175; Duarte MF, 2008, IEEE SIGNAL PROC MAG, V25, P83, DOI 10.1109/MSP.2007.914730; Bobin J, 2008, IEEE J-STSP, V2, P718, DOI 10.1109/JSTSP.2008.2005337; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Sabir MF, 2006, IEEE T IMAGE PROCESS, V15, P1349, DOI 10.1109/TIP.2006.871118; Sachs D., 2000, P SPIE, V3974; Zhang J., 2012, IEEE J EMERG SEL CIR, V2	10	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1337			IEICE T FUND ELECTR	IEICE Trans. Fundam. Electron. Commun. Comput. Sci.	FEB	2015	E98A	2					783	787		10.1587/transfun.E98.A.783		5	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CO9AO	WOS:000359464400045		
J	Taguchi, A; Hoshi, Y				Taguchi, Akira; Hoshi, Yoshikatsu			Color Image Enhancement in HSI Color Space without Gamut Problem	IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES			English	Article						color image processing; HSI color space; RGB color space; gamut		While emphasizing the intensity or saturation component for getting high-quality color images, keeping the hue component unchanged is important; thus, perceptual color models such as HSI and HSV have been used. Hue-Saturation-Intensity (HSI) is a public color model, and many color applications are commonly based on this model. However, the transformation from the HSI color space to the RGB color space after processing intensity/saturation in the HSI color space usually generates the gamut problem. In this study, we clear the relationship between the RGB gamut and the HSI gamut completely. According to the result, we can check whether the processing result is located inside or outside of the RGB gamut without transforming to the RGB color space. If the processing result is judged outside of the RGB gamut, we apply the effective way of hue preserving correction algorithm which is proposed in this study to the saturation component. Experimental results demonstrate that the proposed algorithm can correct the color distortion caused by the enhancement without reducing the visual effect and it is especially useful for images with rich colors and local high component values.	[Taguchi, Akira; Hoshi, Yoshikatsu] Tokyo City Univ, Dept Comp Sci, Tokyo 1588557, Japan	Taguchi, A (reprint author), Tokyo City Univ, Dept Comp Sci, Tokyo 1588557, Japan.	ataguchi@tcu.ac.jp					Naik SK, 2003, IEEE T IMAGE PROCESS, V12, P1591, DOI 10.1109/TIP.2003.819231; Shyu MS, 1998, PATTERN RECOGN, V31, P871, DOI 10.1016/S0031-3203(97)00073-3; Gao Li, 2010, Proceedings of the 2010 International Conference on Computer and Information Application (ICCIA 2010), DOI 10.1109/ICCIA.2010.6141522; Gonzalez RC, 2008, DIGITAL IMAGE PROCES; Hashem H.F., 2009, P INT TOP M MICR PHO, P1; Su C.-H., 2011, P INT C EL CONTR ENG, P5746; Ubong L.J., 2008, P INT S INF TECHN IT, V4, P1; WEEKS AR, 1995, J ELECTRON IMAGING, V4, P15, DOI 10.1117/12.191335; Yu D, 2007, PROCEEDINGS OF 2007 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-7, P1498; Zengwei J., 2013, P INT C INF COMM TEC, P135	10	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1337			IEICE T FUND ELECTR	IEICE Trans. Fundam. Electron. Commun. Comput. Sci.	FEB	2015	E98A	2					792	795		10.1587/transfun.E98.A.792		4	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CO9AO	WOS:000359464400047		
J	Bao, S; Tanaka, G				Bao, Shi; Tanaka, Go			Proposal of New Signed Color Distance for Color-to-Gray Conversion	IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES			English	Article						color-to-gray conversion; color distance; color image	REMOVAL	A new signed color distance for color-to-gray conversion is proposed. It is suited to reflect gradation and detailed color change in an input color image into an output monochrome image. Experiments show the effectiveness of the proposed distance.	[Bao, Shi; Tanaka, Go] Nagoya City Univ, Grad Sch Nat Sci, Nagoya, Aichi 4678501, Japan	Bao, S (reprint author), Nagoya City Univ, Grad Sch Nat Sci, Nagoya, Aichi 4678501, Japan.	tanakago@nsc.nagoya-cu.ac.jp					Grundland M, 2007, PATTERN RECOGN, V40, P2891, DOI 10.1016/j.patcog.2006.11.003; Smith K, 2008, COMPUT GRAPH FORUM, V27, P193, DOI 10.1111/j.1467-8659.2008.01116.x; Song ML, 2010, IEEE T PATTERN ANAL, V32, P1537, DOI 10.1109/TPAMI.2009.74; Gooch AA, 2005, ACM T GRAPHIC, V24, P634, DOI 10.1145/1073204.1073241; Bao S, 2014, OPT REV, V21, P127, DOI 10.1007/s10043-014-0020-2; Kim Y, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1618452.1618507; Lu C., 2012, P IEEE ICCP APR, P1; Tanaka G, 2009, OPT REV, V16, P601, DOI 10.1007/s10043-009-0118-0; Wu JL, 2012, VISUAL COMPUT, V28, P723, DOI 10.1007/s00371-012-0683-2; Wyszecki G., 2000, COLOR SCI CONCEPT ME	10	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1337			IEICE T FUND ELECTR	IEICE Trans. Fundam. Electron. Commun. Comput. Sci.	FEB	2015	E98A	2					796	800		10.1587/transfun.E98.A.796		5	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CO9AO	WOS:000359464400048		
J	Hossain, MI; Chisti, J; Yoshimatsu, S; Yasmin, R; Ahmed, T				Hossain, Md. Iqbal; Chisti, Jobayer; Yoshimatsu, Shoji; Yasmin, Rehana; Ahmed, Tahmeed			Features in Septic Children With or Without Severe Acute Malnutrition and the Risk Factors of Mortality	PEDIATRICS			English	Meeting Abstract	6th Annual Conference on Excellence in Pediatrics	DEC 04-06, 2014	Dubai, U ARAB EMIRATES	Excellence Pediat Inst					[Hossain, Md. Iqbal; Chisti, Jobayer; Yasmin, Rehana; Ahmed, Tahmeed] Icddr B, Dhaka, Bangladesh; [Yoshimatsu, Shoji] Univ Tsukuba, Tsukuba, Ibaraki 305, Japan								0	0	0	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	FEB	2015	135			1			S10	S10		10.1542/peds.2014-3330Q		1	Pediatrics	Pediatrics	CO2ON	WOS:000358996400014		
J	Hasegawa, T; Koshino, M; Kimura, H				Hasegawa, Tatsuhito; Koshino, Makoto; Kimura, Haruhiko			An experimental result of estimating an application volume by machine learning techniques	SPRINGERPLUS			English	Article						Smartphone; Machine learning; Context aware; Lifelog	CONTEXT-AWARENESS; PHONE	In this study, we improved the usability of smartphones by automating a user's operations. We developed an intelligent system using machine learning techniques that periodically detects a user's context on a smartphone. We selected the Android operating system because it has the largest market share and highest flexibility of its development environment. In this paper, we describe an application that automatically adjusts application volume. Adjusting the volume can be easily forgotten because users need to push the volume buttons to alter the volume depending on the given situation. Therefore, we developed an application that automatically adjusts the volume based on learned user settings. Application volume can be set differently from ringtone volume on Android devices, and these volume settings are associated with each specific application including games. Our application records a user's location, the volume setting, the foreground application name and other such attributes as learning data, thereby estimating whether the volume should be adjusted using machine learning techniques via Weka.	[Hasegawa, Tatsuhito; Kimura, Haruhiko] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Koshino, Makoto] Ishikawa Natl Coll Technol, Dept Elect & Informat Engn, Kitachujo, Tsubatamachi, Japan	Hasegawa, T (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Kakumamachi, Kanazawa, Ishikawa 9201192, Japan.	t-hasegawa@blitz.ec.t.kanazawa-u.ac.jp					Abowd GD, 1999, LECT NOTES COMPUT SC, V1707, P304; Adami AM, 2003, P 25 ANN INT C IEEE, V2, P1360; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Eyrolle H, 2000, APPL ERGON, V31, P537, DOI 10.1016/S0003-6870(00)00019-3; Lee YS, 2011, LECT NOTES ARTIF INT, V6678, P460; Chen ZY, 2013, INT CONF PER COMP, P145, DOI 10.4108/icst.pervasivehealth.2013.252148; Gellersen HW, 2002, MOBILE NETW APPL, V7, P341, DOI 10.1023/A:1016587515822; Sellen A, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P81; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cutrell E, 2001, C HUM COMP INT INT 2; Dekel A, 2009, 11 INT C HUM COMP IN, V43; Frank E., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98); Hao T, 2013, P 11 ACM C EMB NETW, P4; Ho J., 2005, P SIGCHI C HUM FACT, P909, DOI DOI 10.1145/1054972.1055100; Hori T, 2003, P 5 ACM SIGMM INT WO, P31, DOI 10.1145/973264.973270; Kang JH, 2004, 2 ACM INT WORKSH WIR, V9, P110; Khalil A, 2005, LECT NOTES ARTIF INT, V3554, P197; Kobayashi A, 2011, IEICE T INF SYST, VE94D, P1153, DOI 10.1587/transinf.E94.D.1153; Kwapisz J. R., 2010, SIGKDD EXPLORATIONS, V12, P74, DOI DOI 10.1145/1964897.1964918; Lewis D., 1998, LECT NOTES COMPUTER, V1398, P4, DOI DOI 10.1007/BFB0026666; Metsis V, 2006, 3 C EM ANT SPAM CEAS; Ouchi K., 2012, P ACM C UB COMP 2012, P600	22	0	0	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus	FEB 1	2015	4								39	10.1186/s40064-015-0791-3		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CO4UM	WOS:000359156200002		
J	Oda, K; Minata, M				Oda, Kosaku; Minata, Mutsuko			Drug free remission after steroid-dependent disappearance of lymphoproliferative disorder in rheumatoid arthritis patient treated with TNF-alpha blockade: case study	SPRINGERPLUS			English	Article						Rheumatoid arthritis; Complete remission; Lymphoproliferative disorder; Tumor necrosis factor alpha inhibitor	EPSTEIN-BARR-VIRUS; CD8(+) T-CELLS; METHOTREXATE; ADALIMUMAB; APOPTOSIS; DISEASES; THERAPY; RA	Introduction: TNF-alpha inhibitors plus MTX appear to have benefit in the longer-term reduction of RA. Boolean long-term remission under drug-free conditions is rare. The therapeutic mechanism and the factor of predicting response have not been clarified yet. Case description: A 24-year-old female rheumatoid arthritis (RA) patient, who once attained complete remission (CR) with the combination therapy with tumor necrosis factor alpha (TNF-alpha) inhibitor adalimumab (ADA) and methotrexate (MTX), showed the occurrence of Epstain-Barr virus (EBV)-associated lymphoproliferative disorder (LPD). Pulse treatment with methylprednisolone after the termination of anti TNF-alpha therapy resulted in the remission of EBV-associated LPD. The administration of prednisolone (PSL) was tapered off after the improvement of clinical symptoms and laboratory data. The patients achieved drug-free 12 months after urgent hospitalization and delivered healthy baby 2 years after hospital discharge. She has been complete drug-free Boolean remission for 5 years. Discussion and evaluation: The purpose of this brief case is report that we experienced the remission of LPD after CR with combined therapy with ADA and MTX. We believe this case report will be one of the paths for unveiling the pathogenesis and improving the treatment for RA. Conclusions: We believe this case report will be one of the paths for unveiling the pathogenesis and improving the treatment for RA.	[Oda, Kosaku] Takatsuki Red Cross Hosp, Dept Orthoped Surg, Takatsuki, Osaka 5691045, Japan; [Minata, Mutsuko] Ohio State Univ, Dept Neurol Surg, Columbus, OH 43210 USA	Minata, M (reprint author), Ohio State Univ, Dept Neurol Surg, 400 W Wiseman Hall 12th Ave, Columbus, OH 43210 USA.	mmtododon1@gmail.com					Wong M, 2008, CLIN IMMUNOL, V126, P121, DOI 10.1016/j.clim.2007.08.013; Wolfe F, 2004, ARTHRITIS RHEUM, V50, P1740, DOI 10.1002/art.20311; van den Broek M, 2013, CURR OPIN PHARMACOL, V13, P463, DOI 10.1016/j.coph.2013.03.006; Lunemann JD, 2008, J IMMUNOL, V181, P991; Shahouri SH, 2011, ARTHRITIS RHEUM-US, V63, P3204, DOI 10.1002/art.30524; Toussirot E, 2008, BEST PRACT RES CL RH, V22, P883, DOI 10.1016/j.berh.2008.09.007; Samuels J, 2005, J EXP MED, V201, P1659, DOI 10.1084/jem.20042321; Emery P, 2009, J RHEUMATOL, V36, P1429, DOI 10.3899/jrheum.081018; Shen C, 2006, INFLAMM BOWEL DIS, V12, P22, DOI 10.1097/01.MIB.0000194185.69800.07; Baran-Marszak F, 2006, CYTOKINE, V33, P337, DOI 10.1016/j.cyto.2006.03.005; Das H, 2004, CLIN RHEUMATOL, V23, P218, DOI 10.1007/s10067-003-0860-9; Tan LC, 2000, ARTHRITIS RES, V2, P154, DOI 10.1186/ar80; Tanaka Y, 2013, ANN RHEUM DIS, V72, P124, DOI 10.1136/annrheumdis-2012-202350; Upchurch KS, 2012, RHEUMATOLOGY, V51, P28, DOI 10.1093/rheumatology/kes278	14	0	0	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus	FEB 1	2015	4								41	10.1186/s40064-015-0798-9		5	Multidisciplinary Sciences	Science & Technology - Other Topics	CO4UM	WOS:000359156200004		
J	Sekine, A; Okamoto, M; Kanatani, Y; Sano, M; Shibata, K; Fukuwatari, T				Sekine, Airi; Okamoto, Misaki; Kanatani, Yuka; Sano, Mitsue; Shibata, Katsumi; Fukuwatari, Tsutomu			Amino acids inhibit kynurenic acid formation via suppression of kynurenine uptake or kynurenic acid synthesis in rat brain in vitro	SPRINGERPLUS			English	Article						Amino acids; Kynurenic acid; Kynurenine; alpha 7 nicotinic acetylcholine receptor; Dopamine; Neuropsychiatric disorders	PERFORMANCE LIQUID-CHROMATOGRAPHY; EXTRACELLULAR DOPAMINE LEVELS; AMINOTRANSFERASE-II; RELEASE; SCHIZOPHRENIA; TRANSPORTER; EXPRESSION; RECEPTORS; GLUTAMATE; STRIATUM	The tryptophan metabolite, kynurenic acid (KYNA), is a preferential antagonist of the alpha 7 nicotinic acetylcholine receptor at endogenous brain concentrations. Recent studies have suggested that increase of brain KYNA levels is involved in psychiatric disorders such as schizophrenia and depression. KYNA-producing enzymes have broad substrate specificity for amino acids, and brain uptake of kynurenine (KYN), the immediate precursor of KYNA, is via large neutral amino acid transporters (LAT). In the present study, to find out amino acids with the potential to suppress KYNA production, we comprehensively investigated the effects of proteinogenic amino acids on KYNA formation and KYN uptake in rat brain in vitro. Cortical slices of rat brain were incubated for 2 h in Krebs-Ringer buffer containing a physiological concentration of KYN with individual amino acids. Ten out of 19 amino acids (specifically, leucine, isoleucine, phenylalanine, methionine, tyrosine, alanine, cysteine, glutamine, glutamate, and aspartate) significantly reduced KYNA formation at 1 mmol/L. These amino acids showed inhibitory effects in a dose-dependent manner, and partially inhibited KYNA production at physiological concentrations. Leucine, isoleucine, methionine, phenylalanine, and tyrosine, all LAT substrates, also reduced tissue KYN concentrations in a dose-dependent manner, with their inhibitory rates for KYN uptake significantly correlated with KYNA formation. These results suggest that five LAT substrates inhibit KYNA formation via blockade of KYN transport, while the other amino acids act via blockade of the KYNA synthesis reaction in brain. Amino acids can be a good tool to modulate brain function by manipulation of KYNA formation in the brain. This approach may be useful in the treatment and prevention of neurological and psychiatric diseases associated with increased KYNA levels.	[Sekine, Airi; Okamoto, Misaki; Kanatani, Yuka; Sano, Mitsue; Shibata, Katsumi; Fukuwatari, Tsutomu] Univ Shiga Prefecture, Sch Human Cultures, Dept Nutr, Hikone, Shiga 5228533, Japan	Fukuwatari, T (reprint author), Univ Shiga Prefecture, Sch Human Cultures, Dept Nutr, 2500 Hassaka, Hikone, Shiga 5228533, Japan.	fukkie@shc.usp.ac.jp			JSPS KAKENHI [24614010]	This work was supported by JSPS KAKENHI (Grant No. 24614010).	Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Potter MC, 2010, NEUROPSYCHOPHARMACOL, V35, P1734, DOI 10.1038/npp.2010.39; Erhardt S, 2007, PHYSIOL BEHAV, V92, P203, DOI 10.1016/j.physbeh.2007.05.025; KESSLER M, 1989, J NEUROCHEM, V52, P1319, DOI 10.1111/j.1471-4159.1989.tb01881.x; Amori L, 2009, J NEUROCHEM, V109, P316, DOI 10.1111/j.1471-4159.2009.05893.x; Dounay AB, 2012, ACS MED CHEM LETT, V3, P187, DOI 10.1021/ml200204m; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; Hilmas C, 2001, J NEUROSCI, V21, P7463; Amori L, 2009, NEUROSCIENCE, V159, P196, DOI 10.1016/j.neuroscience.2008.11.055; Fernstrom JD, 2013, AMINO ACIDS, V45, P419, DOI 10.1007/s00726-012-1330-y; Chess AC, 2009, BEHAV BRAIN RES, V201, P325, DOI 10.1016/j.bbr.2009.03.013; Erhardt S, 2009, CNS DRUGS, V23, P91, DOI 10.2165/00023210-200923020-00001; Chess AC, 2006, BEHAV BRAIN RES, V170, P326, DOI 10.1016/j.bbr.2006.03.006; Kozak R, 2014, J NEUROSCI, V34, P10592, DOI 10.1523/JNEUROSCI.1107-14.2014; Schwarcz R, 2001, BIOL PSYCHIAT, V50, P521, DOI 10.1016/S0006-3223(01)01078-2; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Orosco M, 2004, BEHAV BRAIN RES, V148, P1, DOI 10.1016/S0166-4328(03)00153-0; Erhardt S, 2001, NEUROSCI LETT, V313, P96, DOI 10.1016/S0304-3940(01)02242-X; Carpenedo R, 2001, EUR J NEUROSCI, V13, P2141, DOI 10.1046/j.0953-816x.2001.01592.x; Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Erhardt S, 2004, BIOL PSYCHIAT, V56, P255, DOI 10.1016/j.physch.2004.06.006; Zarnowski T, 2012, J NEURAL TRANSM, V119, P679, DOI 10.1007/s00702-011-0750-2; Zmarowski A, 2009, EUR J NEUROSCI, V29, P529, DOI 10.1111/j.1460-9568.2008.06594.x; Choi SJ, 2009, PHYSIOL BEHAV, V98, P156, DOI 10.1016/j.physbeh.2009.05.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Chess AC, 2007, SCHIZOPHRENIA BULL, V33, P797, DOI 10.1093/schbul/sbl033; Asai Y, 2008, J NUTR SCI VITAMINOL, V54, P460, DOI 10.3177/jnsv.54.460; CARPENEDO R, 1994, NEUROSCIENCE, V61, P237, DOI 10.1016/0306-4522(94)90227-5; Guidetti P, 2007, J NEUROCHEM, V102, P103, DOI 10.1111/j.1471-4159.2007.04556.x; Han QA, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-19; Han Q, 2009, MOL CELL BIOL, V29, P784, DOI 10.1128/MCB.01272-08; HOLMES EW, 1988, ANAL BIOCHEM, V172, P518, DOI 10.1016/0003-2697(88)90478-2; Kocki T, 2003, NEUROSCI LETT, V346, P97, DOI 10.1016/S0304-3940(03)00579-2; Konradsson-Geuken A, 2010, NEUROSCIENCE, V169, P1848, DOI 10.1016/j.neuroscience.2010.05.052; Linderholm KR, 2010, SCHIZOPHR B, V38, P426; Okuno A, 2011, J NEUROCHEM, V118, P796, DOI 10.1111/j.1471-4159.2011.07369.x; OKUNO E, 1991, BRAIN RES, V542, P307, DOI 10.1016/0006-8993(91)91583-M; Rassoulpour A, 2005, J NEUROCHEM, V93, P762, DOI 10.1111/j.1471-4159.2005.03134.x; SHIBATA K, 1988, J CHROMATOGR-BIOMED, V430, P376, DOI 10.1016/S0378-4347(00)83173-4; SPECIALE C, 1989, J NEUROSCI, V9, P2066; SWARTZ KJ, 1990, J NEUROSCI, V10, P2965; TURSKI WA, 1989, J NEUROCHEM, V52, P1629, DOI 10.1111/j.1471-4159.1989.tb09218.x	45	0	0	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus	FEB 1	2015	4								48	10.1186/s40064-015-0826-9		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CO4UM	WOS:000359156200011		
J	Chung, YH; Zheng, LL; Xing, X; Zhang, LP; Bian, MY; Xiao, LX; Chen, ZJ; Qu, B; Gong, QH; Kido, JJ				Chung, Yaohsien; Zheng, Lingling; Xing, Xing; Zhang, Lipei; Bian, Mengying; Xiao, Lixin; Chen, Zhijian; Qu, Bo; Gong, Qihuang; Kido, Junji			The Effect of Electron-Withdrawing Groups on Electron Transporting Silane Derivatives with Wide Energy Gap for Green Electrophosphorescent Devices	ADVANCED ELECTRONIC MATERIALS			English	Article							LIGHT-EMITTING DEVICES; ORGANIC ELECTROLUMINESCENT DEVICES; PHOSPHORESCENT OLEDS; REORGANIZATION ENERGIES; QUANTUM EFFICIENCY; BLOCKING MATERIAL; CONTAINING HOLE; DIODES; COMPLEXES; MOBILITY	Silane derivatives with wide energy gap (approximate to 3.5 eV) containing different electron-withdrawing groups of quinoline and naphthyridine are synthesized and used as the electron transporting materials. The different electron transporting and hole/exciton blocking properties of the silane derivatives are investigated via multilayered structure of organic electrophosphorescent devices by using fac-tris(2-phenylpyridine) iridium (Ir(ppy)(3)) as the phosphorescent emitter. 15.4% of maximum external quantum efficiency (EQE) corresponding to 56.2 cd A(-1) of maximum current efficiency is obtained with a maximum power efficiency of 58.9 lm W-1 by employing di-(4-(1,8-naphthyridin-2-yl) phenyl) diphenylsilane (DNPS) as the electron transporting material, combining with 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline as the hole blocking layer, which is higher than the performance of conventional Alq(3) device. When changing naphthyridine of DNPS to the electron-withdrawing group of quinoline (di-(4-(isoquinolin-4-yl)phenyl) diphenylsilane), only 11.4% of maximum EQE with 41.4 cd A(-1) of maximum current efficiency and 32.5 lm W-1 of a maximum power efficiency is obtained. These indicate that the electron transporting ability increases while the electron-withdrawing group changes from quinoline to naphthyridine, which is also consistent with the calculated reorganization energy.	[Chung, Yaohsien; Zheng, Lingling; Xing, Xing; Zhang, Lipei; Bian, Mengying; Xiao, Lixin; Chen, Zhijian; Qu, Bo; Gong, Qihuang] Peking Univ, State Key Lab Mesoscop Phys, Beijing 100871, Peoples R China; [Chung, Yaohsien; Zheng, Lingling; Xing, Xing; Zhang, Lipei; Bian, Mengying; Xiao, Lixin; Chen, Zhijian; Qu, Bo; Gong, Qihuang] Peking Univ, Dept Phys, Beijing 100871, Peoples R China; [Xiao, Lixin; Chen, Zhijian; Qu, Bo] Ctr West Coast Taiwan Strait, New Display Device & Syst Integrat Collaborat Inn, Fuzhou 350002, Peoples R China; [Kido, Junji] Yamagata Univ, Dept Organ Device Engn, Yonezawa, Yamagata 9928510, Japan	Xiao, LX (reprint author), Peking Univ, State Key Lab Mesoscop Phys, Beijing 100871, Peoples R China.	xiao66@pku.edu.cn; kid@yz.yamagata-u.ac.jp			NSFC [61177020, 11121091]; National Basic Research Program of China [2009CB930504, 2013CB328704]; NEDO (Japan) through the "High Efficiency Organic Device" Project	Y.C. and L.Z. contributed equally to this work. This study was partly financially supported by the NSFC (Grant Nos. 61177020 and 11121091), National Basic Research Program of China (Grant Nos. 2009CB930504 and 2013CB328704), and NEDO (Japan) through the "High Efficiency Organic Device" Project.	Tanaka I, 2006, J APPL PHYS, V99, DOI 10.1063/1.2185835; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Su SJ, 2008, ORG LETT, V10, P941, DOI 10.1021/ol7030872; Kido J, 1998, APPL PHYS LETT, V73, P2866, DOI 10.1063/1.122612; Liu XM, 2005, ORG LETT, V7, P2829, DOI 10.1021/ol050687y; Wang CS, 2001, CHEM MATER, V13, P1167, DOI 10.1021/cm0010250; ANTONIADIS H, 1994, APPL PHYS LETT, V65, P2030, DOI 10.1063/1.112784; Xiao LX, 2011, ADV MATER, V23, P926, DOI 10.1002/adma.201003128; Xiao LX, 2013, ADV FUNCT MATER, V23, P1323, DOI 10.1002/adfm.201202194; Baldo MA, 2000, NATURE, V403, P750; Oda S, 2013, ANGEW CHEM INT EDIT, V52, P8165, DOI 10.1002/anie.201304225; Su SJ, 2009, ADV FUNCT MATER, V19, P1260, DOI 10.1002/adfm.200800809; Su SJ, 2010, ADV MATER, V22, P3311, DOI 10.1002/adma.200904249; ADACHI C, 1989, APPL PHYS LETT, V55, P1489, DOI 10.1063/1.101586; Su SJ, 2008, ADV MATER, V20, P2125, DOI 10.1002/adma.200701730; Baldo MA, 1998, NATURE, V395, P151; You YM, 2006, J MATER CHEM, V16, P4706, DOI 10.1039/b611288a; Duan JP, 2003, ADV MATER, V15, P224, DOI 10.1002/adma.200390051; Tanaka D, 2007, JPN J APPL PHYS 2, V46, pL10, DOI 10.1143/JJAP.46.L10; Xiao LX, 2009, ADV MATER, V21, P1271, DOI 10.1002/adma.200302034; Inomata H, 2004, CHEM MATER, V16, P1285, DOI 10.1021/cm034689t; Kang JW, 2007, J MATER CHEM, V17, P3714, DOI 10.1039/b705741e; Sasabe H, 2008, CHEM COMMUN, P5821, DOI 10.1039/b812270a; Lin BC, 2003, J PHYS CHEM A, V107, P5241, DOI 10.1021/jp0304529; Hutchison GR, 2005, J AM CHEM SOC, V127, P2339, DOI 10.1021/ja0461421; Kawamura Y, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1862777; Kido J., 1995, SCIENCE, V267, P332; Oda S., 2013, ANGEW CHEM, V125, P8323; Parthasarathy G, 2000, APPL PHYS LETT, V76, P2128, DOI 10.1063/1.126275; Piao MZ, 1996, J HETEROCYCLIC CHEM, V33, P389; TANG CW, 1987, APPL PHYS LETT, V51, P913, DOI 10.1063/1.98799; Thomas G. M., 1974, J ORG CHEM, V39, P720	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2199-160X			ADV ELECTRON MATER	Adv. Electron. Mater.	FEB	2015	1	1-2							1400034	10.1002/aelm.201400034		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CM4KI	WOS:000357653000007		
J	Eshita, Y; Ji, RC; Onishi, M; Kobayashi, T; Mizuno, M; Yoshida, J; Kubota, N; Onishi, Y				Eshita, Yuki; Ji, Rui-Cheng; Onishi, Masayasu; Kobayashi, Takashi; Mizuno, Masaaki; Yoshida, Jun; Kubota, Naoji; Onishi, Yasuhiko			Medicinal facilities to B16F10 melanoma cells for distant metastasis control with a supramolecular complex by DEAE-dextran-MMA copolymer/paclitaxel	DRUG DELIVERY AND TRANSLATIONAL RESEARCH			English	Article						DEAE-dextran-MMA copolymer; Paclitaxel; Melanoma cells; Metastatic spread; Lymphatic vessel density; M2 macrophages	METHACRYLATE GRAFT COPOLYMER; NONVIRAL GENE DELIVERY; METHYL-METHACRYLATE; MECHANISM; POLYMER; VECTOR; ACCUMULATION; PACLITAXEL; LIPOSOMES; RESPONSES	The resistance of cancer cells to chemotherapeutic drugs (MDR) is a major problem to be solved. A supramolecular DEAE-dextran-MMA copolymer (DDMC)/paclitaxel (PTX) complex was obtained by using PTX as the guest and DDMC as the host having 50-300 nm in diameter. The drug resistance of B16F10 melanoma cells to paclitaxel was observed, but there is no drug resistance of melanoma cells to the DDMC/PTX complex in vitro. The cell death rate was determined using Michaelis-Menten kinetics, as the DDMC/PTX complex promoted allosteric supramolecular reaction to tubulin. The DDMC/PTX complex showed a very superior anticancer activity to paclitaxel alone in vivo. The median survival time (MST) of the saline, PTX, DDMC/PTX4 (particle size, 50 nm), and DDMC/PTX5 (particle size, 290 nm) groups were 120 h (T/C, 1.0), 176 h (T/C, 1.46), 328 h (T/C, 2.73), and 280 h (T/C, 2.33), respectively. The supramolecular DDMC/PTX complex showed the twofold effectiveness of PTX alone (p<0.036). Histochemical analysis indicated that the administration of DDMC/PTX complex decreased distant metastasis and increased the survival of mice. A mouse of DDMC/PTX4 group in vivo was almost curing after small dermatorrhagia owing to its anti-angiogenesis, and it will be the hemorrhagic necrotic symptom of tumor by the release of "tumor necrosis factor alpha (TNF-alpha)" cytokine. As the result, the medicinal action of the DDMC/PTX complex will suppress the tumor-associated action of M2 macrophages and will control the metastasis of cancer cells.	[Eshita, Yuki; Kobayashi, Takashi] Oita Univ, Dept Infect Dis Control, Fac Med, Oita 8795593, Japan; [Ji, Rui-Cheng] Oita Univ, Dept Human Anat, Fac Med, Oita 8795593, Japan; [Mizuno, Masaaki] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Showa Ku, Nagoya, Aichi 4668560, Japan; [Yoshida, Jun] Chubu Rosai Hosp, Japan Labour Hlth & Welf Org, Nagoya, Aichi 4558530, Japan; [Kubota, Naoji] Oita Univ, Dept Chem, Fac Med, Oita 8795593, Japan; [Onishi, Masayasu; Onishi, Yasuhiko] Ryujyu Sci Corp, Seto, Aichi 4890842, Japan	Eshita, Y (reprint author), Oita Univ, Dept Infect Dis Control, Fac Med, 1-1 Idaigaoka,Hasama Machi, Oita 8795593, Japan.	yeshita@oita-u.ac.jp; ji@oita-u.ac.jp			Japanese Ministry of Health, Labor, and Welfare Scientific Research Grant [H26-Shinko Jitsuyoka-Ippan-007]; Japan Society for the Promotion of Science [25300053]	A portion of this research was carried out with the support of a Japanese Ministry of Health, Labor, and Welfare Scientific Research Grant (H26-Shinko Jitsuyoka-Ippan-007) and the Japan Society for the Promotion of Science Research Grant (Basic B 25300053).	ALLEN TM, 1987, FEBS LETT, V223, P42, DOI 10.1016/0014-5793(87)80506-9; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Zarogoulidis P, 2013, GENE THER, V20, P1022, DOI 10.1038/gt.2013.27; Onishi Y, 2014, BEILSTEIN J NANOTECH, V5, P2293, DOI 10.3762/bjnano.5.238; Evangelista AM, 2013, PHYSIOL GENOMICS, V45, P493, DOI 10.1152/physiolgenomics.00008.2013; Ji RC, 2012, CELL MOL LIFE SCI, V69, P897, DOI 10.1007/s00018-011-0848-6; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Wadsworth P, 2004, TRENDS CELL BIOL, V14, P413, DOI 10.1016/j.tcb.2004.07.004; Onishi Y, 2007, NANOMED-NANOTECHNOL, V3, P184, DOI 10.1016/j.nano.2007.07.002; Nakano T, 2001, J AM CHEM SOC, V123, P9182, DOI 10.1021/ja0111131; Shields JD, 2004, BRIT J CANCER, V90, P693, DOI 10.1038/sj.bjc.6601571; OKU N, 1992, BIOCHIM BIOPHYS ACTA, V1126, P255, DOI 10.1016/0005-2760(92)90238-Q; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Onishi Y, 2008, J GENE MED, V10, P472; Horlad H, 2013, MOL NUTR FOOD RES, V57, P1046, DOI 10.1002/mnfr.201200610; Okumura Y, 2000, POLYM ADVAN TECHNOL, V11, P815, DOI 10.1002/1099-1581(200008/12)11:8/12<815::AID-PAT30>3.0.CO;2-P; Minoura I, 2006, BIOPHYS J, V90, P3739, DOI 10.1529/biophysj.105.071324; Baliaka A, 2014, GENE THER, V21, P158, DOI 10.1038/gt.2013.68; ONISHI Y, 1979, KOBUNSHI RONBUNSHU, V36, P535; Shime H, 2012, P NATL ACAD SCI USA, V109, P2066, DOI 10.1073/pnas.1113099109; ONISHI Y, 1978, POLYMER, V19, P1325, DOI 10.1016/0032-3861(78)90316-6; Onishi Y, 2005, J APPL POLYM SCI, V98, P9, DOI 10.1002/app.21993; ONISHI Y, 1980, POLYMER, V21, P819, DOI 10.1016/0032-3861(80)90302-X; MATSUMURA Y, 1986, CANCER RES, V46, P6387; LEFFLER JE, 1955, J ORG CHEM, V20, P1202, DOI 10.1021/jo01126a009; DeVita VT, 1977, CANC PRINCIPLES PRAC, P333; Eshita Y, 2009, MOLECULES, V14, P2669, DOI 10.3390/molecules14072669; Eshita Y, 2011, J NANOMEDICINE NANOT, V2, P1, DOI [10.4172/2157-7439.1000105., DOI 10.4172/2157-7439.1000105]; Eshita Y, 2012, J NANOMED NANOTECHNO, V5, DOI [10.4172/2157-7439.S5-002, DOI 10.4172/2157-7439.S5-002]; Eshita Y, 2012, J NANOMED BIOTHER DI, V2, P109, DOI [10.4172/2155-983X.1000109, DOI 10.4172/2155-983X.1000109]; Hamblin MR, 2001, CANCER RES, V61, P7155; Hill A.V., 1910, J PHYSIOL-LONDON, V40, pIV; Lanni JS, 1997, P NATL ACAD SCI USA, V94, P9679, DOI 10.1073/pnas.94.18.9679; Lehn J.-M., 1988, ANGEW CHEM, V100, P91, DOI DOI 10.1002/ANGE.19881000110; Miyano S, 2011, CICSJ B, V29, P42; Nishiyama N, 2003, CANCER RES, V63, P7876; Onishi Y, 2014, PROCESS REP FAC ENG, V61, P17; Onishi Y, 2009, ADV NANOTECHNOLOGY, V3, P409; Onishi Y, 2013, POLYSACCHARIDE BASED, P205, DOI DOI 10.1007/978-3-642-36566-9_6; Onishi Y, 2014, J NANOMED BIOTHER DI, V4, pe127, DOI [10.4172/2155-983X.1000e127, DOI 10.4172/2155-983X.1000E127]; Onishi Y, 2010, POLYM RES J, V3, P415; Onishi Y, 2009, DELIVERY TECHNOLOGIE, P339, DOI DOI 10.1002/9780470688397.CH17; Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192; Tagaki W, 1986, KOBUNSHI, V35, P938, DOI DOI 10.1295/KOBUNSHI.35.938; Willstatter R, 1920, LIEBIGS ANN CHEM, V422, P1; Yu JL, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-25	47	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2190-393X	2190-3948		DRUG DELIV TRANSL RE	Drug Deliv. Transl. Res.	FEB	2015	5	1					38	50		10.1007/s13346-014-0213-z		13	Instruments & Instrumentation; Medicine, Research & Experimental; Pharmacology & Pharmacy	Instruments & Instrumentation; Research & Experimental Medicine; Pharmacology & Pharmacy	CM0MC	WOS:000357371100005		
J	Ohmukai, M; Nakagawa, T; Matsurnoto, A				Ohmukai, Masato; Nakagawa, Takuya; Matsurnoto, Ayumu			Oxygen Surplus to Zn in ZnO Films Deposited by Means of Direct Current Sputtering	JOURNAL OF NANOELECTRONICS AND OPTOELECTRONICS			English	Article						ZnO Film; DC Sputtering; Annealing; X-ray Analysis	MOLECULAR-BEAM EPITAXY; VAPOR-PHASE EPITAXY; P-TYPE ZNO; ZINC-OXIDE; THIN-FILMS; OPTICAL-PROPERTIES; SINGLE-CRYSTALS; BAND-GAP; GROWTH; SAPPHIRE	ZnO films were deposited on silicon wafers by means of a direct current (DC) sputtering technique. We investigated the physical properties of the films on the basis of X-ray diffraction measurements. We found that as-deposited films have shown c-axis orientation normal to the (100) silicon surface, together with the extension of c axis by 1.75% that is estimated from the amount of the peak shift in the X-ray diffraction pattern. Post-deposition annealing in air at higher than 400 degrees C eliminates the peak shift and sharpens the diffraction peak structure at the same time. We assume that excess oxygen was included during the deposition, and that the deposited film achieved stoichiometry by the post-deposition annealing.	[Ohmukai, Masato] Akashi Coll Technol, Dept Elect & Comp Engn, Akashi, Hyogo 6748501, Japan; [Nakagawa, Takuya] Akashi Coll Technol, Tech Educ Support Ctr, Akashi, Hyogo 6748501, Japan; [Matsurnoto, Ayumu] Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Kyoto 6158510, Japan	Ohmukai, M (reprint author), Akashi Coll Technol, Dept Elect & Comp Engn, Akashi, Hyogo 6748501, Japan.						Hong SK, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.115331; Ma Y, 2004, J APPL PHYS, V95, P6268, DOI 10.1063/1.1713040; Water W, 2002, MATER LETT, V55, P67, DOI 10.1016/S0167-577X(01)00621-8; Dietl T, 2000, SCIENCE, V287, P1019, DOI 10.1126/science.287.5455.1019; Zhang SB, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.075205; TIKU SK, 1980, APPL PHYS LETT, V36, P318, DOI 10.1063/1.91477; Janotti A, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126501; Oh BY, 2006, J APPL PHYS, V99, DOI 10.1063/1.2206417; Pearton SJ, 2004, SEMICOND SCI TECH, V19, pR59, DOI 10.1088/0268-1242/19/10/R01; Choopun S, 1999, APPL PHYS LETT, V75, P3947, DOI 10.1063/1.125503; Johnson MAL, 1996, J ELECTRON MATER, V25, P855, DOI 10.1007/BF02666649; Maksimov O, 2010, REV ADV MATER SCI, V24, P26; Look DC, 1999, PHYS REV LETT, V82, P2552, DOI 10.1103/PhysRevLett.82.2552; Fan JC, 2013, PROG MATER SCI, V58, P874, DOI 10.1016/j.pmatsci.2013.03.002; Jeong SH, 2003, APPL PHYS LETT, V82, P2625, DOI 10.1063/1.1568543; Vlasenko LS, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.125210; Janotti A, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2053360; Look DC, 2005, SEMICOND SCI TECH, V20, pS55, DOI 10.1088/0268-1242/20/4/007; Shan FK, 2004, J EUR CERAM SOC, V24, P1869, DOI 10.1016/S0955-2219(03)00490-4; Srikant V, 1998, J APPL PHYS, V83, P5447, DOI 10.1063/1.367375; Cooray N. F., 1999, JPN J APPL PHYS, V38, P6231; GALLI G, 1970, APPL PHYS LETT, V16, P439, DOI 10.1063/1.1653058; Guilio M. D., 1983, MATER CHEM PHYS, V9, P197; Hiramatsu T, 2007, JPN J APPL PHYS 1, V46, P3319, DOI 10.1143/JJAP.46.3319; Izyumskaya N, 2004, J CRYST GROWTH, V269, P356, DOI 10.1016/j.jcrysgro.2004.04.120; Kawamoto N, 2003, JPN J APPL PHYS 1, V42, P7209, DOI 10.1143/JJAP.42.7209; Kim HW, 2003, MAT SCI ENG B-SOLID, V103, P297, DOI 10.1016/S0921-5107(03)00281-2; Kim IW, 2007, JPN J APPL PHYS 1, V46, P3556, DOI 10.1143/JJAP.46.3556; LAD RJ, 1980, J VAC SCI TECHNOL, V17, P808, DOI 10.1116/1.570565; Li XH, 2003, MATER LETT, V57, P4655, DOI 10.1016/S0167-577X(03)00379-3; Lin W, 2007, SOL ENERG MAT SOL C, V91, P1902, DOI 10.1016/j.solmat.2007.07.008; MATSUMOTO K, 1990, J CRYST GROWTH, V102, P137, DOI 10.1016/0022-0248(90)90894-Q; Ozaki K, 2002, JPN J APPL PHYS 1, V41, P5614, DOI 10.1143/JJAP.41.5614; Ozgur U, 2005, J APPL PHYS, V98, DOI 10.1063/1.1992666; Pearton SJ, 2004, J PHYS-CONDENS MAT, V16, pR209, DOI 10.1088/0953-8984/16/7/R03; Sang BS, 1999, JPN J APPL PHYS 1, V38, P4983, DOI 10.1143/JJAP.38.4983; SANKUR H, 1983, J VAC SCI TECHNOL A, V1, P1806, DOI 10.1116/1.572219; Sekiguchi T, 2000, J CRYST GROWTH, V214, P72, DOI 10.1016/S0022-0248(00)00065-8; SHILOH M, 1971, J CRYST GROWTH, V11, P105, DOI 10.1016/0022-0248(71)90172-2; Singh A. V., 2001, J APPL PHYS, V90; Takahashi N, 1999, JPN J APPL PHYS 2, V38, pL454, DOI 10.1143/JJAP.38.L454	41	0	0	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1555-130X	1555-1318		J NANOELECTRON OPTOE	J. Nanoelectron. Optoelectron.	FEB	2015	10	1					65	68		10.1166/jno.2015.1696		4	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	CL6GS	WOS:000357066200012		
J	Saito, D; Fukuoka, H				Saito, Daisuke; Fukuoka, Hiroshi			High-Pressure Synthesis, Structures, and Properties of New Germanides, Na3Pt4Ge13 and Na3Pt2Ge14	JOURNAL OF NANOELECTRONICS AND OPTOELECTRONICS			English	Article						High-Pressure Synthesis; Zintl Phase; Germanide; Clathrate; Platinum Germanide	CLATHRATE; SUPERCONDUCTIVITY	Two new ternary platinum germanides, Na3Pt4Ge13 and Na3Pt2Ge14, were prepared from NaGe, Pt, and Ge mixtures by high-pressure and high-temperature reactions. Single crystal structure analysis revealed that Na3Pt4Ge13 has a Pr3Pt4Ge13 related structure containing disordered Ge sites. It crystallizes in the cubic Pm-3n (No. 223) space group with a = 9.0002 (9) angstrom and V = 729.06 (2) angstrom(3). Na3Pt2Ge14 crystallizes in the tetragonal P4(2)Imnm (No. 136) space group with a = 8.2429 (5) angstrom, c = 10.7414 (9) angstrom, and V = 729.83 (9) angstrom(3). Na3Pt2Ge14 has a clathrate structure with a very large cage composed of 40 atoms (6 Pt and 34 Ge). The cage has a shape of long tube closed at the ends, and encapsulates three Na ions. According to the band structure calculations, Na3Pt2Ge14 is expected to be a metal having Pt 5d-Ge 4p hybridized conduction bands.	[Saito, Daisuke; Fukuoka, Hiroshi] Hiroshima Univ, Fac Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan	Fukuoka, H (reprint author), Hiroshima Univ, Fac Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan.		Fukuoka, Hiroshi/J-2103-2015		Ministry of Education, Science, and Culture of Japan [20550178, 24550233]	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan, Grant Nos. 20550178, and 24550233.	Gumeniuk R, 2012, DALTON T, V41, P6299, DOI 10.1039/c2dt30339f; [Anonymous], 2001, CRYSTALSTRUCTURE 2 0; Fukuoka H, 2003, INORG CHEM, V42, P2933, DOI 10.1021/ic020676q; Kim SJ, 2000, J SOLID STATE CHEM, V153, P321, DOI 10.1006/jssc.2000.8777; Gumeniuk R, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.017002; Bauer E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.217001; Yamanaka S, 2000, INORG CHEM, V39, P56, DOI 10.1021/ic990778p; Blaha P, 2001, WIEN2K AUGMENTED PLA; BLAHA P, 1990, COMPUT PHYS COMMUN, V59, P399, DOI 10.1016/0010-4655(90)90187-6; Carrillo-Cabrera W, 2000, Z KRIST-NEW CRYST ST, V215, P207; Fukuoka H, 2000, J SOLID STATE CHEM, V151, P117, DOI 10.1006/jssc.2000.8632; Fukuoka H, 2005, INORG CHEM, V44, P1460, DOI 10.1021/ic0485615; Fukuoka H, 2011, INORG CHEM, V50, P6372, DOI 10.1021/ic200826d; Fukuoka H, 2010, B CHEM SOC JPN, V83, P323, DOI 10.1246/bcsj.20090310; Fukuoka H, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.094501; Fukuoka H, 2000, J ORGANOMET CHEM, V611, P543, DOI 10.1016/S0022-328X(00)00404-6; Fukuoka H, 2009, J SOLID STATE CHEM, V182, P2024, DOI 10.1016/j.jssc.2009.05.018; Fukuoka H, 2011, INORG CHEM, V50, P3901, DOI 10.1021/ic102077k; MIRAGLIA S, 1986, J SOLID STATE CHEM, V63, P358, DOI 10.1016/0022-4596(86)90192-1; Rachi T, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.144504; Sheldrick G. M., 1997, SHELXS 97	21	0	0	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1555-130X	1555-1318		J NANOELECTRON OPTOE	J. Nanoelectron. Optoelectron.	FEB	2015	10	1					147	150		10.1166/jno.2015.1704		4	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	CL6GS	WOS:000357066200027		
J	Morohoshi, S; Matsuura, K; Haruta, S				Morohoshi, Sho; Matsuura, Katsumi; Haruta, Shin			Secreted protease mediates interspecies interaction and promotes cell aggregation of the photosynthetic bacterium Chloroflexus aggregans	FEMS MICROBIOLOGY LETTERS			English	Article						interspecies interaction; extracellular protease; cell aggregation; gliding motility	MICROBIAL MATS; DIVERSITY; MOTILITY	Interspecies interactions were studied in hot spring microbial mats where diverse species of bacterial cells are densely packed. The anoxygenic photosynthetic bacterium, Chloroflexus aggregans, has been widely found in the microbial mats as a major component in terrestrial hot springs in Japan at the temperature from 50 to 70 degrees C. C. aggregans shows cellular motility to form a microbial mat-like dense cell aggregate. The aggregating ability of C. aggregans was affected by another bacterial species, strain BL55a (related to Bacillus licheniformis) isolated from the microbial mats containing C. aggregans. Cell aggregation rate of C. aggregans was promoted by the addition of culture supernatants of strain BL55a. Similar effects were also detected from other bacterial isolates, specifically Geobacillus sp. and Aeribacillus sp. Protease activity was detected from the culture supernatants from all of these isolates. The promoting effect of strain BL55a was suppressed by a serine protease inhibitor, phenylmethylsulfonyl fluoride. A purified serine protease, subtilisin obtained from B. licheniformis, showed a promoting effect on the cell aggregation. These results suggest that an extracellular protease, secreted from co-existing bacterial species promoted the aggregating motility of C. aggregans. This is the first report that exogenous protease affects bacterial cellular motility.	[Morohoshi, Sho; Matsuura, Katsumi; Haruta, Shin] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan	Haruta, S (reprint author), Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Biol Sci, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	sharuta@tmu.ac.jp			Ministry of Education, Culture, Sports Science and Technology of Japan [20370013, 25117518]	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports Science and Technology of Japan to K. M. (20370013) and to S. H. (25117518).	Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Everroad RC, 2012, MICROBES ENVIRON, V27, P374; STAHL DA, 1988, APPL ENVIRON MICROB, V54, P1079; Secades P, 1999, APPL ENVIRON MICROB, V65, P3969; Connelly MB, 2004, J BACTERIOL, V186, P4159, DOI 10.1128/JB.186.13.4159-4167.2004; Spormann AM, 1999, MICROBIOL MOL BIOL R, V63, P621; [Anonymous], 2007, MICROBE; Ferrero MA, 1996, APPL MICROBIOL BIOT, V45, P327, DOI 10.1007/s002530050691; Schauder S, 2001, GENE DEV, V15, P1468, DOI 10.1101/gad.899601; Kubo K, 2011, SYST APPL MICROBIOL, V34, P293, DOI 10.1016/j.syapm.2010.12.002; Federle MJ, 2003, J CLIN INVEST, V112, P1291, DOI 10.1172/JCI200320195; Shank EA, 2009, CURR OPIN MICROBIOL, V12, P205, DOI 10.1016/j.mib.2009.01.003; Broderick NA, 2006, P NATL ACAD SCI USA, V103, P15196, DOI 10.1073/pnas.0604865103; Otaki H, 2012, MICROBES ENVIRON, V27, P293, DOI 10.1264/jsme2.ME11348; HANADA S, 1995, INT J SYST BACTERIOL, V45, P676; Kreth J, 2005, J BACTERIOL, V187, P7193, DOI 10.1128/JB.187.21.7193-7203.2005; Nakagawa T, 2002, J GEN APPL MICROBIOL, V48, P211, DOI 10.2323/jgam.48.211; Cihan AC, 2011, WORLD J MICROB BIOT, V27, P2683, DOI 10.1007/s11274-011-0742-2; Hanada S, 2002, FEMS MICROBIOL LETT, V208, P275, DOI 10.1016/S0378-1097(02)00480-9; HANADA S, 1995, J GEN APPL MICROBIOL, V41, P119, DOI 10.2323/jgam.41.119; Hanada S., 2006, PROKARYOTES, V7, P815, DOI DOI 10.1007/0-387-30747-8_33; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115; Pierson BK, 2001, BERGEYS MANUAL SYSTE, V1, P429; Yeo IC, 2012, APPL BIOCHEM BIOTECH, V166, P700, DOI 10.1007/s12010-011-9459-9	25	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0378-1097	1574-6968		FEMS MICROBIOL LETT	FEMS Microbiol. Lett.	FEB	2015	362	3								10.1093/femsle/fnu046		5	Microbiology	Microbiology	CL3XF	WOS:000356884600006		
J	Kubota, T; Tanaka, Y; Takemoto, N; Hiraga, K; Yukawa, H; Inui, M				Kubota, Takeshi; Tanaka, Yuya; Takemoto, Norihiko; Hiraga, Kazumi; Yukawa, Hideaki; Inui, Masayuki			Identification and expression analysis of a gene encoding a shikimate transporter of Corynebacterium glutamicum	MICROBIOLOGY-SGM			English	Article							MAJOR FACILITATOR SUPERFAMILY; OXYGEN DEPRIVATION CONDITIONS; ESCHERICHIA-COLI; AMINO-ACIDS; PROTEINS; QUINATE; CLUSTER; DEHYDROGENASE; BIOSYNTHESIS; METABOLITES	Shikimate can be utilized as the sole source of carbon and energy of Cotynebacterium glutamicum. Although biosynthesis and degradation of shikimate are well characterized in a glutamicum, the transport of shikimate has hardly been studied. A mutant strain deficient in cgR_2523 loses the ability to grow on shikimate as well as to consume extracellular shikimate, indicating that the gene is involved in shikimate utilization (designated shiA). The hydropathy profile of the deduced amino acid sequence indicates that ShiA belongs to the metabolite/proton symporter family, which is a member of the major facilitator superfamily. An accumulation assay showed that the uptake of shikimate was hardly detected in the shiA-deficient strain, but was markedly enhanced in a shiA-expressing strain. These results suggested that the uptake of shikimate was mainly mediated by the shikimate transporter encoded by shiA. The level of shiA mRNA induction by shikimate was significantly decreased by the disruption of cgR_2524 (designated shiR), which is located immediately upstream of shiA and encodes a LysR-type transcriptional regulator, suggesting that ShiR acts as an activator of shiA. To our knowledge, this is the first report in Gram-positive bacteria of a shikimate transporter and its regulation.	[Kubota, Takeshi; Tanaka, Yuya; Takemoto, Norihiko; Hiraga, Kazumi; Yukawa, Hideaki; Inui, Masayuki] Res Inst Innovat Technol Earth, Kyoto 6190292, Japan; [Inui, Masayuki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Inui, M (reprint author), Res Inst Innovat Technol Earth, 9-2 Kizugawadai, Kyoto 6190292, Japan.	mmg-lab@rite.or.jp					Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Teramoto H, 2009, APPL ENVIRON MICROB, V75, P3461, DOI 10.1128/AEM.00163-09; Prevost K, 2007, MOL MICROBIOL, V64, P1260, DOI 10.1111/j.1365-2958.2007.05733.x; SEOL W, 1991, P NATL ACAD SCI USA, V88, P3802, DOI 10.1073/pnas.88.9.3802; Yamamoto S, 2012, APPL ENVIRON MICROB, V78, P4447, DOI 10.1128/AEM.07998-11; Youn JW, 2009, J BACTERIOL, V191, P5480, DOI 10.1128/JB.00640-09; Youn JW, 2008, J BACTERIOL, V190, P6458, DOI 10.1128/JB.00780-08; Vogl C, 2007, J BACTERIOL, V189, P7367, DOI 10.1128/JB.00590-07; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Inui M, 2004, J MOL MICROB BIOTECH, V7, P182, DOI 10.1159/000079827; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Knaggs AR, 2003, NAT PROD REP, V20, P119, DOI 10.1039/b100399m; Suzuki H, 2006, J BIOL CHEM, V281, P36944, DOI 10.1074/jbc.M608103200; Wendisch VF, 2000, J BACTERIOL, V182, P3088, DOI 10.1128/JB.182.11.3088-3096.2000; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Nandineni MR, 2004, J BACTERIOL, V186, P3539, DOI 10.1128/JB.186.11.3539-3546.2004; Tsuge Y, 2008, J BACTERIOL, V190, P8204, DOI 10.1128/JB.00752-08; Hermann T, 2003, J BIOTECHNOL, V104, P155, DOI 10.1016/S0168-1656(03)00149-4; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; Kawaguchi H, 2009, APPL ENVIRON MICROB, V75, P3419, DOI 10.1128/AEM.02912-08; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Bongaerts J, 2001, METAB ENG, V3, P289, DOI 10.1006/mben.2001.0196; ELSEMORE DA, 1994, J BACTERIOL, V176, P7659; Görke Boris, 2008, Nat Rev Microbiol, V6, P613, DOI 10.1038/nrmicro1932; HAWKINS AR, 1993, J GEN MICROBIOL, V139, P2891; Kubota Takeshi, 2014, New Zealand Journal of Zoology, V41, P356, DOI 10.1111/mmi.12560; Kubota T, 2013, APPL MICROBIOL BIOT, V97, P8139, DOI 10.1007/s00253-012-4659-y; Merkens H, 2005, CURR MICROBIOL, V51, P59, DOI 10.1007/s00284-005-4531-8; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Saint CP, 1996, MICROBIOL-UK, V142, P2407; Suzuki N, 2006, APPL ENVIRON MICROB, V72, P3750, DOI 10.1128/AEM.72.5.3750-3755.2006; Teramoto H, 2008, APPL ENVIRON MICROB, V74, P5290, DOI 10.1128/AEM.00832-08; Tsuchida Y, 2010, APPL MICROBIOL BIOT, V87, P1855, DOI 10.1007/s00253-010-2701-5; VANDERREST ME, 1990, EUR J BIOCHEM, V189, P401; Whipp MJ, 1998, GENE, V209, P185, DOI 10.1016/S0378-1119(98)00043-2; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038701; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0	38	0	0	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	1350-0872			MICROBIOL-SGM	Microbiology-(UK)	FEB	2015	161		2				254	263		10.1099/mic.0.083733-0		10	Microbiology	Microbiology	CL0QR	WOS:000356647800003		
J	Yamamoto, R; Noiri, Y; Yamaguchi, M; Asahi, Y; Maezono, H; Ebisu, S; Hayashi, M				Yamamoto, Reiko; Noiri, Yuichiro; Yamaguchi, Mikiyo; Asahi, Yoko; Maezono, Hazuki; Ebisu, Shigeyuki; Hayashi, Mikako			Inhibition of polysaccharide synthesis by the sinR orthologue PGN_0088 is indirectly associated with the penetration of Porphyromonas gingivalis biofilms by macrolide antibiotics	MICROBIOLOGY-SGM			English	Article							HUMAN PERIODONTAL POCKETS; BACTERIAL BIOFILMS; BACILLUS-SUBTILIS; IN-VITRO; RESISTANCE; GENE; LOCALIZATION; AZITHROMYCIN; CHLORHEXIDINE; EXPRESSION	Microbes commonly adhere to surfaces, aggregate in self-produced extracellular polymeric substances (EPS) and live in biofilms. Periodontitis is a serious oral infection that is initiated by the formation of biofilms by Porphyromonas gingivalis. EPS act as a barrier that protects biofilmforming cells against sources of stress, including those induced by host immune cells and antimicrobial agents. Therefore, drugs intended to kill such micro-organisms cannot be used for the treatment of biofilm infections. Our previous studies revealed that subminimal inhibitory concentrations (subMIC) of two macrolide antibiotics (azithromycin, AZM and erythromycin, ERY) reduced P. gingivalis biofilms. Furthermore, we demonstrated that the Bacillus subtilis sinR orthologue (PGN_0088) inhibits the synthesis of carbohydrates that are components of EPS in P. gingivalis biofilms. Here, we constructed a novel sinR mutant from P. gingivalis ATCC 33277 and reveal that the increased abundance of carbohydrate in EPS of the mutant led to a reduced infiltration rate of AZM and FRY through EPS, and consequently elevated biofilm resistance to these macrolides. Detailed elucidation of the interaction between the product of the sinR gene and EPS will assist in the development of novel approaches that target EPS to prevent and inhibit the formation of biofilms.	[Yamamoto, Reiko; Noiri, Yuichiro; Yamaguchi, Mikiyo; Asahi, Yoko; Maezono, Hazuki; Ebisu, Shigeyuki; Hayashi, Mikako] Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, Suita, Osaka 5650871, Japan	Noiri, Y (reprint author), Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	noiri@dent.osaka-u.ac.jp			Japan Society for the Promotion of Science [24390425, 24390424, 24890118, 26861593]	We thank Masae Kuboniwa (Department of Preventive Dentistry, Osaka University Graduate School of Dentistry), Koji Nakayama (Department of Microbiology and Oral Infection, Nagasaki University Graduate School of Biomedical Sciences) and his colleagues, Keiko Sato and Hideharu Yukitake for support with the construction of the sinR mutant (Delta sinR: : cat). This study was supported by the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (24390425, 24390424, 24890118 and 26861593).	Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; Noiri Y, 2002, J ENDODONT, V28, P679, DOI 10.1097/00004770-200210000-00001; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Yamaguchi M, 2013, EUR J ORAL SCI, V121, P162, DOI 10.1111/eos.12050; BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777; Winkelman JT, 2009, J BACTERIOL, V191, P3981, DOI 10.1128/JB.00278-09; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Chu F, 2008, MOL MICROBIOL, V68, P1117, DOI 10.1111/j.1365-2958.2008.06201.x; Noguchi N, 2005, APPL ENVIRON MICROB, V71, P8738, DOI 10.1128/AEM.71.12.8738-8743.2005; Starner TD, 2008, ANTIMICROB AGENTS CH, V52, P137, DOI 10.1128/AAC.00607-07; Samaranayake YH, 2005, J CLIN MICROBIOL, V43, P818, DOI 10.1128/JCM.43.2.818-825.2005; COSTERTON JW, 1981, ANNU REV MICROBIOL, V35, P299, DOI 10.1146/annurev.mi.35.100181.001503; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Yamaguchi M, 2010, INFECT IMMUN, V78, P3801, DOI 10.1128/IAI.00071-10; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; Li YH, 2002, J BACTERIOL, V184, P2699, DOI 10.1128/JB.184.10.2699-2708.2002; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435; Ichimiya T, 1996, CHEMOTHERAPY, V42, P186; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Characklis W. G., 1990, BIOFILMS, P585; CLOSE TJ, 1982, GENE, V20, P305, DOI 10.1016/0378-1119(82)90048-8; Lynch SV, 2007, ANTIMICROB AGENTS CH, V51, P3650, DOI 10.1128/AAC.00601-07; Maezono H, 2011, ANTIMICROB AGENTS CH, V55, P5887, DOI 10.1128/AAC.05169-11; Noiri Y, 2003, J PERIODONTOL, V74, P1647, DOI 10.1902/jop.2003.74.11.1647; Noiri Y, 1997, J PERIODONTAL RES, V32, P598, DOI 10.1111/j.1600-0765.1997.tb00937.x; Noiri Y, 2004, J DENT RES, V83, P941; Yamamoto R, 2011, APPL ENVIRON MICROB, V77, P6733, DOI 10.1128/AEM.00746-11; Yamamoto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056017	33	0	0	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	1350-0872			MICROBIOL-SGM	Microbiology-(UK)	FEB	2015	161		2				422	429		10.1099/mic.0.000013		8	Microbiology	Microbiology	CL0QR	WOS:000356647800018		
J	Hironaka, T				Hironaka, Tetsuo			Special Section on Reconfigurable Systems FOREWORD	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Editorial Material										Hironaka, T (reprint author), Hiroshima City Univ, Dept Comp & Network Engn, Hiroshima, Japan.							0	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1361			IEICE T INF SYST	IEICE Trans. Inf. Syst.	FEB	2015	E98D	2					219	219				1	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CK9WB	WOS:000356589100001		
J	Kinoshita, K; Yamaguchi, Y; Takano, D; Okamura, T; Yao, T				Kinoshita, Kei; Yamaguchi, Yoshiki; Takano, Daisuke; Okamura, Tomoyuki; Yao, Tetsuhiko			Energy Efficiency Improvement by Dynamic Reconfiguration for Embedded Systems	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						dynamic reconfiguration; power performance; video processing; image recognition; object tracking; embedded / wearable computing	POWER	This paper seeks to improve power-performance efficiency of embedded systems by the use of dynamic reconfiguration. Programmable logic devices (PLDs) have the competence to optimize the power consumption by the use of partial and/or dynamic reconfiguration. It is a non-exclusive approach, which can use other power-reduction techniques simultaneous, and thus it is applicable to a myriad of systems. The power-performance improvement by dynamic reconfiguration was evaluated through an augmented reality system that translates Japanese into English. It is a wearable and mobile system with a head-mounted display (HMD). In the system, the computing core detects a Japanese word from an input video frame and the translated term will be output to the HMD. It includes various image processing approaches such as pattern recognition and object tracking, and these functions run sequentially. The system does not need to prepare all functions simultaneously, which provides a function by reconfiguration only when it is needed. In other words, by dynamic reconfiguration, the spatiotemporal module-based pipeline can introduce the reduction of its circuit amount and power consumption compared to the naive approach. The approach achieved marked improvements; the computational speed was the same but the power consumption was reduced to around 1/6.	[Kinoshita, Kei; Takano, Daisuke; Okamura, Tomoyuki; Yao, Tetsuhiko] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3058573, Japan; [Yamaguchi, Yoshiki] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki 3058573, Japan	Kinoshita, K (reprint author), Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3058573, Japan.	yoshiki@cs.tsukuba.ac.jp			TOKYO KEIKI Inc.	This research was partially supported by TOKYO KEIKI Inc. and we would like to thank Mr. Watanabe for his helpful discussion.	Altera Corp, 2008, STRAT 2 VIRT 4 POW C; Altera Corp, 2008, STRAT 2 90 NM SIL PO; Venkatesh G, 2010, ACM SIGPLAN NOTICES, V45, P205; Fan XB, 2007, CONF PROC INT SYMP C, P13; DAVARI B, 1995, P IEEE, V83, P595, DOI 10.1109/5.371968; Esmaeilzadeh H, 2011, ISCA 2011: PROCEEDINGS OF THE 38TH ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE, P365; SHI JB, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P593; Dally B., 2011, Proceedings of the 25th IEEE International Parallel & Distributed Processing Symposium (IPDPS 2011), DOI 10.1109/IPDPS.2011.420; Goulding-Hotta N, 2012, ASIA S PACIF DES AUT, P100, DOI 10.1109/ASPDAC.2012.6164926; Hu Z., 2004, LOW POW EL DES INT S, P32; Huda S, 2009, I C FIELD PROG LOGIC, P112; Kinoshita K., 2012, ACM SIGARCH COMP ARC, V40, P16; Kinoshita K., 2013, IEEE 7 INT S EMB MUL, P97; Kissler D, 2011, IEEE Embedded Systems Letters, V3, DOI 10.1109/LES.2011.2124438; Lari V., 2013, ACM T DES AUTOMAT EL, V18, P1; Lucas B. D., 1981, INT JOINT C ART INT, V2, P674; Luk W., 1999, Seventh Annual IEEE Symposium on Field-Programmable Custom Computing Machines (Cat. No.PR00375), DOI 10.1109/FPGA.1999.803675; Moore G, 1965, ELECTRONICS, V38, P114; Nakada H., 1999, Parallel and Distributed Processing. 11th IPPS/SPDP'99 Workshops Held in Conjunction with the 13th International Parallel Processing Symposium and 10th Symposium on Parallel and Distributed Processing. Proceedings; Niyonkuru A, 2002, LECT NOTES COMPUT SC, V2438, P1160; Oja E., 1983, SUBSPACE METHODS PAT; SugiwaraIde T., 2004, IEICE T INF SYST, VE87-D, P1997; Tatas K., 2007, FINE COARSE GRAIN RE; Tau E., 1995, 3 CAN WORKSH FIELD P, P138; Theeuwen F., 1996, LOGIC ARCHITECTURE S, P184; Theodoridis G., 2007, FINE COARSE GRAIN RE; Toledo J., 2010, AUGMENTED REALITY; Watanabe S., 1967, COMPUTER INFORMATION, P91	28	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1361			IEICE T INF SYST	IEICE Trans. Inf. Syst.	FEB	2015	E98D	2					220	229		10.1587/transinf.2014RCP0015		10	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CK9WB	WOS:000356589100002		
J	Amagasaki, M; Zhao, Q; Iida, M; Kuga, M; Sueyoshi, T				Amagasaki, Motoki; Zhao, Qian; Iida, Masahiro; Kuga, Morihiro; Sueyoshi, Toshinori			Fault-Tolerant FPGA: Architectures and Design for Programmable Logic Intellectual Property Core in SoC	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						fault tolerant; FPGA; IP-core	FRAMEWORK	In this paper, we propose fault-tolerant field-programmable gate array (FPGA) architectures and their design framework for intellectual property (IP) cores in system-on-chip (SoC). Unlike discrete FPGAs, in which the integration scale can be made relatively large, programmable IP cores must correspond to arrays of various sizes. The key features of our architectures are a regular tile structure, spare modules and bypass wires for fault avoidance, and a configuration mechanism for single-cycle reconfiguration. In addition, we utilize routing tools, namely Easy-Router for proposed architecture. This tool can handle various array sizes corresponding to developed programmable IP cores. In this evaluation, we compared the performances of conventional FPGAs and the proposed fault-tolerant FPGA architectures. On average, our architectures have less than 1.82 times the area and 1.11 times the delay compared with traditional island-style FPGAs. At the same time, our FPGA shows a higher fault tolerant performance.	[Amagasaki, Motoki; Zhao, Qian; Iida, Masahiro; Kuga, Morihiro; Sueyoshi, Toshinori] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan	Amagasaki, M (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.	amagasaki@cs.kumamoto-u.ac.jp			VLSI Design and Education Center (VDEC); University of Tokyo; Synopsys, Inc.; Cadence Design Systems, Inc.	This work is supported by VLSI Design and Education Center (VDEC), the University of Tokyo in collaboration with Synopsys, Inc. and Cadence Design Systems, Inc.	Ahmed E., 2000, P ACM INT S FIELD PR, P3, DOI 10.1145/329166.329171; Amagasaki M., 2013, P 23 INT C FIELD PRO; [Anonymous], 2009, ABC SYST SEQ SYNTH V; Cheatham JA, 2006, ACM T DES AUTOMAT EL, V11, P501, DOI 10.1145/1142155.1142167; Doumar A, 2000, IEICE T INF SYST, VE83D, P1104; Durand S., 1994, P ACM INT WORKSH FIE, P1; Easton M., 2004, CROSS PLATFORM DEV U; Ichinomiya Y, 2012, IEICE T FUND ELECTR, VE95A, P2347, DOI 10.1587/transfun.E95.A.2347; Inoue K, 2012, IEICE T INF SYST, VE95D, P303, DOI 10.1587/transinf.E95.D.303; Jamieson P., 2010, IEEE ANN INT S FIELD, P149; Kastensmidt F.L., 2006, FRONTIERS ELECT TEST, P180; Kelly J.L., 1994, PACIFIC TELECOMM DEC, P1; Lemieux GG, 2002, LECT NOTES COMPUT SC, V2438, P122; Luu J., 2009, P ACM SIGDA INT S FI, P133, DOI 10.1145/1508128.1508150; Marquardt A. S., 1999, P 1999 ACM SIGDA 7 I, P37, DOI 10.1145/296399.296426; McElvain K., 1993, MCNC INT WORKSH LOG; mentra Inc, EFPGA OV; Nishitani Y., 2012, P INT C REC COMP FPG, P1; Sterpone L., 2008, ELECT SYSTEM DESIGN; Vijay L., 2000, P ACM SIGDA INT S FI, P187; Wilton S.J.E., 2008, ACM T RECONFIG TECHN, V1; Xilinx Inc, ZYNQ 7000 ALL PROGR; Zhao Q, 2013, IEICE T INF SYST, VE96D, P1602, DOI 10.1587/transinf.E96.D.1602	23	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1361			IEICE T INF SYST	IEICE Trans. Inf. Syst.	FEB	2015	E98D	2					252	261		10.1587/transinf.2014RCP0009		10	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CK9WB	WOS:000356589100005		
J	Nakahara, H; Sasao, T; Matsuura, M; Iwamoto, H; Terao, Y				Nakahara, Hiroki; Sasao, Tsutomu; Matsuura, Munehiro; Iwamoto, Hisashi; Terao, Yasuhiro			A Memory-Based IPv6 Lookup Architecture Using Parallel Index Generation Units	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						CAM; IP lookup; index generation unit; FPGA		In the era of IPv6, since the number of IPv6 addresses rapidly increases and the required speed is more than Giga lookups per second (GLPS), an area-efficient and high-speed IP lookup architecture is desired. This paper shows a parallel index generation unit (IGU) for memory-based IPv6 lookup architecture. To reduce the size of memory in the IGU, we use a linear transformation and a row-shift decomposition. A single-memory realization requires O(2(l) log k) memory size, where l denotes the length of prefix, while the realization using IGU requires O(kl) memory size, where k denotes the number of prefixes. In IPv6 prefix lookup, since l is at most 64 and k is about 340 K, the IGU drastically reduces the memory size. Also, to reduce the cost, we realize the parallel IGU by using both on-chip and off-chip memories. We show a design algorithm for the parallel IGU to store given off-chip and on-chip memories. The parallel IGU has a simple architecture and performs lookup by using complete pipelines those insert the pipeline registers in all the paths. We loaded more than 340 K IPv6 pseudo prefixes on the Xilinx Virtex 6 FPGA with off-chip DDRII+ Static RAMs (SRAMs). Its lookup speed is 1.100 giga lookups per second (GLPS) which is sufficient for the required speed for a next generation 400 Gbps link throughput. As for the normalized area and lookup speed, our implementation outperforms existing FPGA implementations.	[Nakahara, Hiroki] Ehime Univ, Dept Elect & Elect Engn & Comp Sci, Matsuyama, Ehime 7908577, Japan; [Sasao, Tsutomu] Meiji Univ, Dept Comp Sci, Kawasaki, Kanagawa 2148571, Japan; [Matsuura, Munehiro] Kyushu Inst Technol, Dept Comp Sci & Elect, Iizuka, Fukuoka 8208502, Japan; [Iwamoto, Hisashi; Terao, Yasuhiro] REVSONIC Corp, Yokohama, Kanagawa 2200012, Japan	Nakahara, H (reprint author), Ehime Univ, Dept Elect & Elect Engn & Comp Sci, Matsuyama, Ehime 7908577, Japan.	nakahara@cs.ehime-u.ac.jp; sasao@cs.meiji.ac.jp; matsuura@cse.kyutech.ac.jp; hisashi-iwamoto@revsonic.com; yasuhiro-terao@revsonic.com			JSPS; Adaptable and Seamless Technology Transfer Program through target-driven RD of JST	This research is supported in part by the Grants in Aid for Scientific Research of JSPS, and the Adaptable and Seamless Technology Transfer Program through target-driven R&D of JST. Reviewer's comments were quite useful to improve the presentation.	Luo LY, 2012, 2012 PROCEEDINGS IEEE INFOCOM, P2435; Ravikumar VC, 2004, IEEE MICRO, V24, P60, DOI 10.1109/MM.2004.1289292; TARJAN RE, 1979, COMMUN ACM, V22, P606, DOI 10.1145/359168.359175; Bando M, 2012, IEEE ACM T NETWORK, V20, P1262, DOI 10.1109/TNET.2012.2188643; Song HY, 2009, IEEE INFOCOM SER, P2518, DOI 10.1109/INFCOM.2009.5062180; Pong F, 2012, IEEE ACM T NETWORK, V20, P729, DOI 10.1109/TNET.2011.2167158; Baboescu F, 2005, CONF PROC INT SYMP C, P123, DOI 10.1109/ISCA.2005.7; Chao H. J., 2007, HIGH PERFORMANCE SWI; Cypress Inc, DDR 2 STAT RAM SRAM; Fadishei H., 2005, NOVEL RECONFIGURABLE, P81; Kumar S., 2006, CAMP FAST EFFICIENT, P51; LE H, 2009, SCALABLE HIGH THROUG, P167; Le H, 2012, IEEE T COMPUT, V61, P1026, DOI 10.1109/TC.2011.130; Le H, 2011, FPGA 11: PROCEEDINGS OF THE 2011 ACM/SIGDA INTERNATIONAL SYMPOSIUM ON FIELD PROGRAMMABLE GATE ARRAYS, P257; Nakahara H, 2013, LECT NOTES COMPUT SC, V7806, P59, DOI 10.1007/978-3-642-36812-7_6; Sangireddy R., 2006, IEEE J SEL AREA COMM, V21, P512; Sangireddy R, 2005, IEEE ACM T NETWORK, V13, P802, DOI 10.1109/TNET.2005.852878; Sasao T., 2010, INT WORKSH LOG SYNTH, P201; Sasao T, 2006, INT SYM MVL, P1; Sasao T., 2012, DATE2012, P1585; Sasao T, 2012, ASIA S PACIF DES AUT, P781, DOI 10.1109/ASPDAC.2012.6165060; Sasao T, 2011, MEMORY-BASED LOGIC SYNTHESIS, P1, DOI 10.1007/978-1-4419-8104-2; Tucker R., 2008, OPT FIB COMM C EXP N, P1; Wang M., 2004, HOTI 04, P35; Xilinx Inc, SPART 6 FPGA CONF LO	25	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1361			IEICE T INF SYST	IEICE Trans. Inf. Syst.	FEB	2015	E98D	2					262	271		10.1587/transinf.2014RCP0006		10	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CK9WB	WOS:000356589100006		
J	Denholm, S; Inoue, H; Takenaka, T; Becker, T; Luk, W				Denholm, Stewart; Inoue, Hiroaki; Takenaka, Takashi; Becker, Tobias; Luk, Wayne			Network-Level FPGA Acceleration of Low Latency Market Data Feed Arbitration	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						data feed arbitration; acceleration; FPGA; low latency; finance		Financial exchanges provide market data feeds to update their members about changes in the market. Feed messages are often used in time-critical automated trading applications, and two identical feeds (A and B feeds) are provided in order to reduce message loss. A key challenge is to support A/B line arbitration efficiently to compensate for missing packets, while offering flexibility for various operational modes such as prioritising for low latency or for high data reliability. This paper presents a reconfigurable acceleration approach for A/B arbitration operating at the network level, capable of supporting any messaging protocol. Two modes of operation are provided simultaneously: one prioritising low latency, and one prioritising high reliability with three dynamically configurable windowing methods. We also present a model for message feed processing latencies that is useful for evaluating scalability in future applications. We outline a new low latency, high throughput architecture and demonstrate a cycle-accurate testing framework to measure the actual latency of packets within the FPGA. We implement and compare the performance of the NAS-DAQ TotalView-ITCH, OPRA and ARCA market data feed protocols using a Xilinx Virtex-6 FPGA. For high reliability messages we achieve latencies of 42ns for TotalView-ITCH and 36.75ns for OPRA and ARCA. 6ns and 5.25ns are obtained for low latency messages. The most resource intensive protocol, TotalView-ITCH, is also implemented in a Xilinx Virtex5 FPGA within a network interface card; it is used to validate our approach with real market data. We offer latencies 10 times lower than an FPGA-based commercial design and 4.1 times lower than the hardware-accelerated IBM PowerEN processor, with throughputs more than double the required 10Gbps line rate.	[Denholm, Stewart; Becker, Tobias] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London SW7 2AZ, England; [Luk, Wayne] Univ London Imperial Coll Sci Technol & Med, Comp Engn, London SW7 2AZ, England; [Inoue, Hiroaki; Takenaka, Takashi] NEC Corp Ltd, Kawasaki, Kanagawa 2118666, Japan	Denholm, S (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Comp, London SW7 2AZ, England.	tbecker@doc.ic.ac.uk					[Anonymous], 2013, NYSE ARCA EUROPE EXC; [Anonymous], 2011, OPRA PARTICIPANT INT; [Anonymous], 2009, MOLDUDP64 PROTOCOL; Cisco, NEXT GEN TRADINFR; Denholm S., 2013, FIELD PROGRAMMABLE T, P322; Kodama Yuetsu, 2007, Systems and Computers in Japan, V38, DOI 10.1002/scj.20807; Leber C., 2011, FIELD PROGR LOG APPL, P317; Lockwood J.W., 2012, HIGH PERFORMANCE INT, P9; Morris G., 2009, 17 IEEE S HIGH PERF; Pasetto Davide, 2011, Computer Science - Research and Development, V26, DOI 10.1007/s00450-011-0166-0; Pottathuparambil R., 2011, FIELD PROGRAMMABLE C, P93; RAMANATHAN P, 1992, ACM T COMPUT SYST, V10, P144, DOI 10.1145/128899.128902; Solarflare, 2013, SOL AOE LIN ARB BRIE	13	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1361			IEICE T INF SYST	IEICE Trans. Inf. Syst.	FEB	2015	E98D	2					288	297		10.1587/transinf.2014RCP0011		10	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CK9WB	WOS:000356589100009		
J	Dohi, K; Okina, K; Soejima, R; Shibata, Y; Oguri, K				Dohi, Keisuke; Okina, Koji; Soejima, Rie; Shibata, Yuichiro; Oguri, Kiyoshi			Performance Modeling of Stencil Computing on a Stream-Based FPGA Accelerator for Efficient Design Space Exploration	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						high-level synthesis; FPGA; stencil computation; heat conduction simulation		In this paper, we discuss performance modeling of 3-D stencil computing on an FPGA accelerator with a high-level synthesis environment, aiming for efficient exploration of user-space design parameters. First, we analyze resource utilization and performance to formulate these relationships as mathematical models. Then, in order to evaluate our proposed models, we implement heat conduction simulations as a benchmark application, by using MaxCompiler, which is a high-level synthesis tool for FPGAs, and MaxGenFD, which is a domain specific framework of the MaxCompiler for finite-difference equation solvers. The experimental results with various settings of architectural design parameters show the best combination of design parameters for pipeline structure can be systematically found by using our models. The effects of changing arithmetic accuracy and using data stream compression are also discussed.	[Dohi, Keisuke; Okina, Koji; Soejima, Rie; Shibata, Yuichiro; Oguri, Kiyoshi] Nagasaki Univ, Grad Sch Engn, Nagasaki 8528521, Japan	Dohi, K (reprint author), Nagasaki Univ, Grad Sch Engn, Nagasaki 8528521, Japan.	shibata@cis.nagasaki-u.ac.jp					Accellera Systems Inititaive, SYST C; Datta K, 2008, P 2008 ACM IEEE C SU, P4; Dohi K., 2013, RECONFIG, P1; Giefers H., 2013, P 4 INT S HIGHL EFF, P33; Impulse Accelerated Technologies, IMP C; Jiayuan M., 2010, INT J PARALLEL PROG, V39, P115; Kobori T, 2003, LECT NOTES COMPUT SC, V2778, P755; Lim AW, 2001, ACM SIGPLAN NOTICES, V36, P103, DOI 10.1145/568014.379586; Maxeler Technologies, 2013, MAXGENFD TUT VERS 20; Maxeler Technologies, MAXCOMPILER; Pell O., 2013, HIGH PERFORMANCE COM, P747; Rivera G., 2000, P 2000 ACM IEEE C SU, P1; Sano K., 2013, HIGH PERFORMANCE COM, P279; Sato Y., 2012, P INT C RECONFIGURAB, P1; Vanderbauwhede W, 2013, HIGH PERFORMANCE COM; Xilinx, VIV HSL DES	16	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1361			IEICE T INF SYST	IEICE Trans. Inf. Syst.	FEB	2015	E98D	2					298	308		10.1587/transinf.2014RCP0013		11	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CK9WB	WOS:000356589100010		
J	Ukawa, H; Narumi, T				Ukawa, Hitoshi; Narumi, Tetsu			Acceleration of the Fast Multipole Method on FPGA Devices	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						FPGA; fast multipole method; special-purpose pipeline; N-body simulation		The fast multipole method (FMM) for N-body simulations is attracting much attention since it requires minimal communication between computing nodes. We implemented hardware pipelines specialized for the FMM on an FPGA device, the GRAPE-9. An N-body simulation with 1.6 x 10(7) particles ran 16 times faster than that on a CPU. Moreover the particle-to-particle stage of the FMM on the GRAPE-9 executed 2.5 times faster than on a GPU in a limited case.	[Ukawa, Hitoshi] Univ Tsukuba, Tsukuba, Ibaraki 3058577, Japan; [Narumi, Tetsu] Univ Electrocommun, Chofu, Tokyo 1828585, Japan	Ukawa, H (reprint author), Univ Tsukuba, Tsukuba, Ibaraki 3058577, Japan.	ukawa@hpcs.cs.tsukuba.ac.jp; narumi@cs.uec.ac.jp					Arnold A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.063308; Fukushige T., GRAPE 9 MODEL800; Fukushige T., PIPELINE DESIGNING U; Greengard L, 1997, J COMPUT PHYS, V135, P280, DOI 10.1006/jcph.1997.5706; Hamada T, 2005, PUBL ASTRON SOC JPN, V57, P799; Rokhlin V., 1985, COMPUT PHYS, V60, P187; Yokota R., 2013, ALGORITHM COMP TECH, V7, P301; Yokota R., GEMSFMM; Yokota R, 2013, COMPUT PHYS COMMUN, V184, P445, DOI 10.1016/j.cpc.2012.09.011	9	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1361			IEICE T INF SYST	IEICE Trans. Inf. Syst.	FEB	2015	E98D	2					309	312		10.1587/transinf.2014RCL0002		4	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CK9WB	WOS:000356589100011		
J	Li, J; Atsumari, Y; Kubo, H; Ogishima, Y; Yokota, S; Tamukoh, H; Sekine, M				Li, Jiang; Atsumari, Yusuke; Kubo, Hiromasa; Ogishima, Yuichi; Yokota, Satoru; Tamukoh, Hakaru; Sekine, Masatoshi			A Multidimensional Configurable Processor Array - Vocalise	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						FPGA array; scalable; hw/sw complex; poisson equation; distributed computing; HPC		A processing system with multiple field programmable gate array (FPGA) cards is described. Each FPGA card can interconnect using six I/O (up, down, left, right, front, and back) terminals. The communication network among FPGAs is scalable according to user design. When the system operates multi-dimensional applications, transmission efficiency among FPGA improved through user-adjusted dimensionality and network topologies for different applications. We provide a fast and flexible circuit configuration method for FPGAs of a multi-dimensional FPGA array. To demonstrate the effectiveness of the proposed method, we assess performance and power consumption of a circuit that calculated 3D Poisson equations using the finite difference method.	[Li, Jiang; Atsumari, Yusuke; Kubo, Hiromasa; Ogishima, Yuichi; Yokota, Satoru; Sekine, Masatoshi] Tokyo Univ Agr & Technol, Koganei, Tokyo 1848588, Japan; [Tamukoh, Hakaru] Kyushu Inst Technol, Kitakyushu, Fukuoka 8048550, Japan	Li, J (reprint author), Tokyo Univ Agr & Technol, Koganei, Tokyo 1848588, Japan.	ff8ff7123@gmail.com; atsumari@sekine-lab.ei.tuat.ac.jp; kubo@sekine-lab.ei.tuat.ac.jp; ogishima@sekine-lab.ei.tuat.ac.jp; yokota@sekine-lab.ei.tuat.ac.jp; tamukoh@brain.kyutech.ac.jp; sekinem@cc.tuat.ac.jp					Mencer O, 2009, 2009 5TH SOUTHERN CONFERENCE ON PROGRAMMABLE LOGIC, PROCEEDINGS, P51, DOI 10.1109/SPL.2009.4914907; Vuillemin JE, 1996, IEEE T VLSI SYST, V4, P56, DOI 10.1109/92.486081; Balaji Pavan, 2011, Computer Science - Research and Development, V26, DOI 10.1007/s00450-011-0168-y; Baxter R., 2007, P 2 NASA ESA C AD HA, P287; Chen W., 2004, P 2004 ACM SIGDA 12, P213, DOI 10.1145/968280.968311; Davis J.D., 2009, MSRTR200945; Durbano J.P., 2004, P 12 ANN IEEE S FIEL, V1, P156; Herbordt MC, 2007, COMPUTER, V40, P50, DOI 10.1109/MC.2007.79; HWANG YS, 1995, IEEE COMPUT SCI ENG, V2, P18, DOI 10.1109/99.388949; Kindratenko V, 2006, ANN IEEE SYM FIELD P, P13; Kudo K, 2004, IEICE T FUND ELECTR, VE87A, P547; Kumar S., 2006, P IEEE INT PAR DISTR, P25; Makino J., 2007, P 2007 ACM IEEE C SU, P1, DOI 10.1145/1362622.1362647; Mencer O, 2006, IEEE T COMPUT AID D, V25, P1603, DOI 10.1109/TCAD.2005.857377; Morishita H., 2010, ACM SIGARCH COMPUTER, V38, P8; Sano K., 2010, ACM SIGARCH COMPUTER, V38; Sekine M, 2012, PROCEDIA ENGINEER, V50, P253, DOI 10.1016/j.proeng.2012.10.030	17	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1361			IEICE T INF SYST	IEICE Trans. Inf. Syst.	FEB	2015	E98D	2					313	324		10.1587/transinf.2014EDP7219		12	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CK9WB	WOS:000356589100012		
J	Choi, E; Yoshida, N; Higo, Y; Inoue, K				Choi, Eunjong; Yoshida, Norihiro; Higo, Yoshiki; Inoue, Katsuro			Proposing and Evaluating Clone Detection Approaches with Preprocessing Input Source Files	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						code clone; hash function; source code transformation	SOURCE-CODE; CCFINDER; SYSTEM	So far, many approaches for detecting code clones have been proposed based on the different degrees of normalizations (e.g. removal of white spaces, tokenization, and regularization of identifiers). Different degrees of normalizations lead to different granularities of source code to be detect as code clones. To investigate how the normalizations impact the code clone detection, this study proposes six approaches for detecting code clones with preprocessing input source files using different degrees of normalizations. More precisely, each normalization is applied to the input source files and then equivalence class partitioning is performed to the files in the preprocessing. After that, code clones are detected from a set of files that are representatives of each equivalence class using a token-based code clone detection tool named CCFinder. The proposed approaches can be categorized into two types, approaches with non-normalization and normalization. The former is the detection of only identical files without any normalization. Meanwhile, the latter category is the detection of identical files with different degrees of normalizations such as removal of all lines containing macros. From the case study, we observed that our proposed approaches detect code clones faster than the approach that uses only CCFinder. We also found the approach with non-normalization is the fastest among the proposed approaches in many cases.	[Choi, Eunjong; Higo, Yoshiki; Inoue, Katsuro] Osaka Univ, Suita, Osaka 5650871, Japan; [Yoshida, Norihiro] Nagoya Univ, Nagoya, Aichi 4648601, Japan	Choi, E (reprint author), Osaka Univ, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ejchoi@ist.osaka-u.ac.jp					Bosch J, 2010, J SYST SOFTWARE, V83, P67, DOI 10.1016/j.jss.2009.06.051; Bettenburg N, 2009, WORK CONF REVERSE EN, P85, DOI 10.1109/WCRE.2009.51; Weissgerber P, 2006, IEEE INT CONF AUTOM, P231; Bellon S, 2007, IEEE T SOFTWARE ENG, V33, P577, DOI 10.1109/TSE.2007.70725; Roy CK, 2009, SCI COMPUT PROGRAM, V74, P470, DOI 10.1016/j.scico.2009.02.007; Baker B. S., 1995, Proceedings. Second Working Conference on Reverse Engineering (Cat. No.95TB8101), DOI 10.1109/WCRE.1995.514697; Barbour L, 2013, J SOFTW-EVOL PROC, V25, P1139, DOI 10.1002/smr.1597; Ducasse S, 2006, J SOFTW MAINT EVOL-R, V18, P37, DOI 10.1002/smr.317; Faust D, 2003, SOFTWARE PRACT EXPER, V33, P933, DOI 10.1002/spe.530; Gusfield D., 1997, ALGORITHMS STRINGS T; Hummel B, 2010, P 26 IEEE INT C SOFT, P1; Kamiya T, 2002, IEEE T SOFTWARE ENG, V28, P654, DOI 10.1109/TSE.2002.1019480; Kim M., 2005, P FDN SOFTW ENG ESEC, V30, P187; Koschke R, 2014, J SOFTW-EVOL PROC, V26, P747, DOI 10.1002/smr.1592; Li JY, 2012, PROC INT CONF SOFTW, P310; Li ZM, 2006, IEEE T SOFTWARE ENG, V32, P176, DOI 10.1109/TSE.2006.28; Livieri S, 2007, PROC INT CONF SOFTW, P106; Nguyen TT, 2009, IEEE INT CONF AUTOM, P123, DOI 10.1109/ASE.2009.90; Runeson P, 2003, J SOFTW MAINT EVOL-R, V15, P41, DOI 10.1002/smr.265; Sasaki Y, 2010, Proceedings of the 2010 7th IEEE Working Conference on Mining Software Repositories (MSR 2010), DOI 10.1109/MSR.2010.5463293	20	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1361			IEICE T INF SYST	IEICE Trans. Inf. Syst.	FEB	2015	E98D	2					325	333		10.1587/transinf.2014EDP7292		9	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CK9WB	WOS:000356589100013		
J	Yamashita, N; Numao, M; Ichise, R				Yamashita, Nagayoshi; Numao, Masayuki; Ichise, Ryutaro			Predicting Research Trends Identified by Research Histories via Breakthrough Researches	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						scientometrics; data mining; grant application analysis		Since it is difficult to understand or predict research trends, we proposed methodologies for understanding and predicting research trends in the sciences, focusing on the structures of grants in the Japan Society for the Promotion of Science (JSPS), a Japanese funding agency. Grant applications are suitable for predicting research trends because these are research plans for the future, different from papers, which report research outcomes in the past. We investigated research trends in science focusing on research histories identified in grant application data of JSPS. Then we proposed a model for predicting research trends, assuming that breakthrough research encourages researchers to change from their current research field to an entirely new research field. Using breakthrough research, we aim to obtain higher precision in the prediction results. In our experimental results, we found that research fields in Informatics correlate well with actual scientific research trends. We also demonstrated that our prediction models are effective in actively interacting research areas, which include Informatics and Social Sciences.	[Yamashita, Nagayoshi] Japan Soc Promot Sci, Tokyo 1020083, Japan; [Numao, Masayuki] Osaka Univ, Inst Sci & Ind Res, Ibaraki 5670047, Japan; [Ichise, Ryutaro] Natl Inst Informat, Principles Informat Res Div, Tokyo 1018430, Japan	Yamashita, N (reprint author), Japan Soc Promot Sci, Tokyo 1020083, Japan.	nagayoshi3@gmail.com					Abercrombie R.K., 2012, SCIENTOMETRICS, P1; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Herr Bruce William  II, 2009, Proceedings 2009 13th International Conference Information Visualisation, IV, DOI 10.1109/IV.2009.105; Small H, 2006, SCIENTOMETRICS, V68, P595, DOI 10.1007/s11192-006-0132-y; Chen CM, 2001, COMPUTER, V34, P65; Boyack KW, 2009, SCIENTOMETRICS, V79, P45, DOI 10.1007/s11192-009-0403-5; Chen CM, 2009, PRO INT CONF SCI INF, V2, P874; Frizo J., 2008, SCIENTOMETRICS, P607; Google Inc, GOOGL TRENDS; Information Processing Society of Japan, SPEC INT GROUPS BIOI; Japan Society for the Promotion of Science, 2011, APPL PROC GRANTS IN; Jian Zhang, 2009, IEEE Transactions on Visualization and Computer Graphics, V15, DOI 10.1109/TVCG.2009.202; Nakakoji K., INTERFACES INTERACTI; Okuoka S., 2009, P KNOWL BAS SYST, P21; Pham M.C., 2011, CORR, V1, P321; Saka A., 2010, 110 NISTEP; Satoh K., 2009, P 25 FUZZ SYST S; Woo L., 2008, SCIENTOMETRICS, P503; Yamashita N., 2010, IPSJ SIG TECHNICAL R	19	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1361			IEICE T INF SYST	IEICE Trans. Inf. Syst.	FEB	2015	E98D	2					355	362		10.1587/transinf.2013EDP7435		8	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CK9WB	WOS:000356589100016		
J	Jiang, Z; Wen, JH; Zeng, J; Zhang, YH; Wang, XB; Hirokawa, S				Jiang, Zhuo; Wen, Junhao; Zeng, Jun; Zhang, Yihao; Wang, Xibin; Hirokawa, Sachio			Dynamic Macro-Based Heuristic Planning through Action Relationship Analysis	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						AI planning; heuristic planning; macro; action relationship; dynamic heuristic	SEARCH	The success of heuristic search in AI planning largely depends on the design of the heuristic. On the other hand, previous experience contains potential domain information that can assist the planning process. In this context, we have studied dynamic macro-based heuristic planning through action relationship analysis. We present an approach for analyzing the action relationship and design an algorithm that learns macros in solved cases. We then propose a dynamic macro-based heuristic that appropriately reuses the macros rather than immediately assigning them to domains. The above ideas are incorporated into a working planning system called Dynamic Macro-based Fast Forward planner. Finally, we evaluate our method in a series of experiments. Our method effectively optimizes planning since it reduces the result length by an average of 10% relative to the FF, in a time-economic manner. The efficiency is especially improved when invoking an action consumes time.	[Jiang, Zhuo; Zhang, Yihao; Wang, Xibin] Chongqing Univ, Coll Comp Sci, Chongqing 400044, Peoples R China; [Wen, Junhao; Zeng, Jun] Chongqing Univ, Sch Software Engn, Chongqing 400044, Peoples R China; [Hirokawa, Sachio] Kyushu Univ, Res Inst Informat Technol, Fukuoka 8128581, Japan	Jiang, Z (reprint author), Chongqing Univ, Coll Comp Sci, Chongqing 400044, Peoples R China.	wjhcqu@cqu.edu.cn			National Science Foundations of China [61379158, 71301177]; Ph.D. Programs Foundation of Ministry of Education of China [20120191110028]; Chongqing Science and Technology Commission, China [cstc2013jcyjA40011]	The authors would like to thank the anonymous reviewers for their valuable comments and suggestions to significantly improve the quality of this paper. The research reported in this paper has been partially supported by the National Science Foundations of China (Grant No. 61379158 and 71301177), the Ph.D. Programs Foundation of Ministry of Education of China (Grant No. 20120191110028), the Chongqing Science and Technology Commission, China (Grant No. cstc2013jcyjA40011).	WARSHALL S, 1962, J ACM, V9, P11, DOI 10.1145/321105.321107; Botea A, 2005, J ARTIF INTELL RES, V24, P581; Bonet B, 2001, ARTIF INTELL, V129, P5, DOI 10.1016/S0004-3702(01)00108-4; Betz C, 2009, LECT NOTES ARTIF INT, V5803, P9, DOI 10.1007/978-3-642-04617-9_2; Bonnet B., 1998, AI MAGAZINE; BYLANDER T, 1994, ARTIF INTELL, V69, P165, DOI 10.1016/0004-3702(94)90081-7; Cai D., 2008, 23 AAAI C ART INT 20, P1780; Chrpa L., 2012, 22 INT C AUT PLANN S, P338; Chrpa L., 2008, 21 INT FLOR ART INT, P531; Coles A, 2007, J ARTIF INTELL RES, V28, P119; Dulac Adrien, 2013, 2013 IEEE 25th International Conference on Tools with Artificial Intelligence (ICTAI), DOI 10.1109/ICTAI.2013.123; Ghallab M, 2004, AUTOMATED PLANNING T; Haslum P., 2012, 22 INT C AUT PLANN S, P353; Haslum P., 2005, 20 NAT C ART INT C, P1163; Helmert M., 2009, 19 INT C AUT PLANN S, P162; Hoffmann J., 2001, J ARTIFICIAL INTELLI, V14, P2001; Hoffman J, 2004, J ARTIF INTELL RES, V22, P215; Jimenez S, 2012, KNOWL ENG REV, V27, P433, DOI 10.1017/S026988891200001X; Karpas E, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P1728; Newton M.A.H., 2007, 17 INT C AUT PLANN S, P256; Pommerening F., 2012, 22 INT C AUT PLANN S, P363	21	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1361			IEICE T INF SYST	IEICE Trans. Inf. Syst.	FEB	2015	E98D	2					363	371		10.1587/transinf.2014EDP7170		9	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CK9WB	WOS:000356589100017		
J	Taguchi, K; Finch, A; Yamamoto, S; Sumita, E				Taguchi, Keiko; Finch, Andrew; Yamamoto, Seiichi; Sumita, Eiichiro			Automatic Induction of Romanization Systems from Bilingual Corpora	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						romanization; transliteration; input method		In this article we present a novel corpus-based method for inducing romanization systems for languages through a bilingual alignment of transliteration word pairs. First, the word pairs are aligned using a non-parametric Bayesian approach, and then for each grapheme sequence to be romanized, a particular romanization is selected according to a user-specified criterion. As far as we are aware, this paper is the only one to describe a method for automatically deriving complete romanization systems. Unlike existing human-derived romanization systems, the proposed method is able to discover induced romanization systems tailored for specific purposes, for example, for use in data mining, or efficient user input methods. Our experiments study the romanization of four totally different languages: Russian, Japanese, Hindi and Myanmar. The first two languages already have standard romanization systems in regular use, Hindi has a large number of diverse systems, and Myanmar has no standard system for romanization. We compare our induced romanization system to existing systems for Russian and Japanese. We find that the systems so induced are almost identical to Russian, and 69% identical to Japanese. We applied our approach to the task of transliteration mining, and used Levenshtein distance as the romanization selection criterion. Our experiments show that our induced romanization system was able to match the performance of the human created system for Russian, and offer substantially improved mining performance for Japanese. We provide an analysis of the mechanism our approach uses to improve mining performance, and also analyse the differences in characteristics between the induced system for Japanese and the official Japanese Nihon-shiki system. In order to investigate the limits of our approach, we studied the romanization of Myanmar, a low-resource language with a large vocabulary of graphemes. We estimate the approximate corpus size required to effectively romanize the most frequency k graphemes in the language for all values of k up to 1800.	[Taguchi, Keiko; Yamamoto, Seiichi] Doshisha Univ, Kyotanabe 6100394, Japan; [Finch, Andrew; Sumita, Eiichiro] NICT, Kyoto 6190289, Japan	Taguchi, K (reprint author), Doshisha Univ, Kyotanabe 6100394, Japan.	buji1077@gmail.com; andrew.finch@nict.go.jp; seyamamo@mail.doshisha.ac.jp; eiichiro.sumita@nict.go.jp					WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.2307/3001968; HANLEY JA, 1982, RADIOLOGY, V143, P29; Aransa W., 2012, P IWSLT 2012, P185; Bright W., 1996, WORLDS WRITING SYSTE, P384; Corder GW, 2009, NONPARAMETRIC STAT N; Finch A., 2010, P 7 INT WORKSH SPOK, P259; Fukunishi T., 2011, 2011 NAM ENT WORKSH, P49; Htun O., 2012, INT J COMPUTER APPL, V58, P12; Jiampojamarn S., 2010, P 2010 NAM ENT WORKS, P39; Kumaran A., 2010, P 2010 NAM ENT WORKS, P21; Oo H.M., 2009, P 7 INT C COMP APPL, P233; Oo N.P., 2011, IT CONVERGENCE SERVI, P661; Russell R., 1918, SOUNDEX INDEXING SYS; Siegel S, 1956, NONPARAMETRIC STAT B; Taguchi K., 2013, P MACH TRANSL SUMM 1, P19; Taguchi K., 2013, ASS NATURAL LANGUAGE, P208	16	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1361			IEICE T INF SYST	IEICE Trans. Inf. Syst.	FEB	2015	E98D	2					381	393		10.1587/transinf.2014EDP7236		13	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CK9WB	WOS:000356589100019		
J	Xing, XX; Dobashi, Y; Yamamoto, T; Katsura, Y; Anjyo, K				Xing, Xiaoxiong; Dobashi, Yoshinori; Yamamoto, Tsuyoshi; Katsura, Yosuke; Anjyo, Ken			Efficient Hair Rendering under Dynamic, Low-Frequency Environmental Light Using Spherical Harmonics	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						hair rendering; spherical harmonics; environmental light; voxelization	MAPS	We present an algorithm for efficient rendering of animated hair under a dynamic, low-frequency lighting environment. We use spherical harmonics (SH) to represent the environmental light. The transmittances between a point on a hair strand and the light sources are also represented by SH functions. Then, a convolution of SH functions and the scattering function of a hair strand is precomputed. This allows us to efficiently compute the intensity at a point on the hair. However, the computation of the transmittance is very time-consuming. We address this problem by using a voxel-based approach: the transmittance is computed by using a voxelized hair model. We further accelerate the computation by sampling the voxels. By using our method, we can render a hair model consisting of tens of thousands of hair strands at interactive frame rates.	[Xing, Xiaoxiong; Dobashi, Yoshinori; Yamamoto, Tsuyoshi] Hokkaido Univ, Sapporo, Hokkaido 0600808, Japan; [Dobashi, Yoshinori; Anjyo, Ken] JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Katsura, Yosuke; Anjyo, Ken] OLM Digital, Tokyo 1540023, Japan	Xing, XX (reprint author), Hokkaido Univ, Sapporo, Hokkaido 0600808, Japan.	doba@ime.ist.hokudai.ac.jp					Kim TY, 2001, SPRING EUROGRAP, P177; Marschner SR, 2003, ACM T GRAPHIC, V22, P780, DOI 10.1145/882262.882345; Tsai YT, 2006, ACM T GRAPHIC, V25, P967, DOI 10.1145/1141911.1141981; BRESENHAM JE, 1965, IBM SYST J, V4, P25; Yuksel C, 2008, COMPUT GRAPH FORUM, V27, P675, DOI 10.1111/j.1467-8659.2008.01165.x; Sintorn E, 2008, I3D 2008: SYMPOSIUM ON INTERACTIVE 3D GRAPHICS AND GAMES, PROCEEDINGS, P157; Jarosz W, 2008, COMPUT GRAPH FORUM, V27, P1087, DOI 10.1111/j.1467-8659.2008.01246.x; Kajiya J. T., 1989, P SIGGRAPH 89, V23, P271; King G., 2005, GPU GEMS 2; Mehta SU, 2012, COMPUT GRAPH FORUM, V31, P1501, DOI 10.1111/j.1467-8659.2012.03146.x; Moon J. T., 2008, ACM SIGGRAPH 2008 PA; Ren Z., 2010, ACM SIGGRAPH 2010 PA; Sintorn E, 2009, P 2009 S INT 3D GRAP, P67, DOI 10.1145/1507149.1507160; Xu K., 2011, P 2011 SIGGRAPH AS C; Yu X., 2012, P ACM SIGGRAPH S INT, P111; Zinke A., 2008, ACM T GRAPHIC, V27	16	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1361			IEICE T INF SYST	IEICE Trans. Inf. Syst.	FEB	2015	E98D	2					404	411		10.1587/transinf.2014EDP7203		8	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CK9WB	WOS:000356589100021		
J	Guo, HY; Guo, CY; Cheng, YZ; Tamura, S				Guo, Haoyan; Guo, Changyong; Cheng, Yuanzhi; Tamura, Shinichi			A Novel Method for Boundary Detection and Thickness Measurement of Two Adjacent Thin Structures from 3-D MR Images	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						boundary detection; cartilage; magnetic resonance imaging; osteoarthritis; segmentation	ARTICULAR-CARTILAGE THICKNESS; HIP-JOINT; VALIDATION; ACCURACY; ARTHROGRAPHY; VOLUME; LIMITS; MODEL	To determine the thickness from MR images, segmentation, that is, boundary detection, of the two adjacent thin structures (e.g., femoral cartilage and acetabular cartilage in the hip joint) is needed before thickness determination. Traditional techniques such as zero-crossings of the second derivatives are not suitable for the detection of these boundaries. A theoretical simulation analysis reveals that the zero-crossing method yields considerable biases in boundary detection and thickness measurement of the two adjacent thin structures from MR images. This paper studies the accurate detection of hip cartilage boundaries in the image plane, and a new method based on a model of the MR imaging process is proposed for this application. Based on the newly developed model, a hip cartilage boundary detection algorithm is developed. The in-plane thickness is computed based on the boundaries detected using the proposed algorithm. In order to correct the image plane thickness for overestimation due to oblique slicing, a three-dimensional (3-D) thickness computation approach is introduced. Experimental results show that the thickness measurement obtained by the new thickness computation approach is more accurate than that obtained by the existing thickness computation approaches.	[Guo, Haoyan; Guo, Changyong; Cheng, Yuanzhi] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150001, Peoples R China; [Tamura, Shinichi] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan	Guo, HY (reprint author), Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150001, Peoples R China.	yzcheng@hitwh.edu.cn			Fundamental Research Funds for the Central Universities [HIT. IBRSEM. 201328]; Scientific Research Personnel Project of Heilongjiang Provincial Education Department [12541164]	The authors would like to thank the anonymous reviewers for their valuable comments and help suggestions that greatly improved the paper's quality. This work is supported by the Fundamental Research Funds for the Central Universities under Grant No. HIT. IBRSEM. 201328, and the Scientific Research Personnel Project of Heilongjiang Provincial Education Department (No. 12541164).	Al-Ali D, 2002, J ORTHOPAED RES, V20, P249, DOI 10.1016/S0736-0266(01)00098-5; Graichen H, 2003, OSTEOARTHR CARTILAGE, V11, P475, DOI 10.1016/S1063-4584(03)00077-3; Kauffmann C, 2003, IEEE T BIO-MED ENG, V50, P978, DOI 10.1109/TBME.2003.814539; Schmid MR, 2003, RADIOLOGY, V226, P382, DOI 10.1148/radiol.2262020019; HARALICK RM, 1984, IEEE T PATTERN ANAL, V6, P58; Hoogeveen RM, 1998, JMRI-J MAGN RESON IM, V8, P1228, DOI 10.1002/jmri.1880080608; Cohen ZA, 1999, OSTEOARTHR CARTILAGE, V7, P95, DOI 10.1053/joca.1998.0165; Nishii T, 2004, OSTEOARTHR CARTILAGE, V12, P650, DOI 10.1016/j.joca.2004.04.009; Naish JH, 2006, OSTEOARTHR CARTILAGE, V14, P967, DOI 10.1016/j.joca.2006.03.017; Wyler A, 2009, OSTEOARTHR CARTILAGE, V17, P19, DOI 10.1016/j.joca.2008.05.015; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679; Chan RC, 2000, IEEE T MED IMAGING, V19, P243, DOI 10.1109/42.845182; Cheng YZ, 2013, IEEE T BIO-MED ENG, V60, P517, DOI 10.1109/TBME.2012.2230002; Cheng YZ, 2011, J MAGN RESON IMAGING, V34, P136, DOI 10.1002/jmri.22618; Graichen H, 2000, OSTEOARTHR CARTILAGE, V8, P106, DOI 10.1053/joca.1999.0278; McGibbon CA, 2003, J MAGN RESON IMAGING, V17, P703, DOI 10.1002/jmr.10309; Nishii T, 1998, MAGN RESON IMAGING, V16, P871, DOI 10.1016/S0730-725X(98)00009-5	17	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1361			IEICE T INF SYST	IEICE Trans. Inf. Syst.	FEB	2015	E98D	2					412	428		10.1587/transinf.2014EDP7205		17	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CK9WB	WOS:000356589100022		
J	Iwamoto, C; Matsui, Y				Iwamoto, Chuzo; Matsui, Yuta			Computational Complexity of Generalized Forty Thieves	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						computational complexity; NP-completeness; puzzle		Forty Thieves is a solitaire game with two 52-card decks. The object is to move all cards from ten tableau piles of four cards to eight foundations. Each foundation is built up by suit from ace to king of the same suit, and each tableau pile is built down by suit. You may move the top card from any tableau pile to a tableau or foundation pile, and from the stock to a foundation pile. We prove that the generalized version of Forty Thieves is NP-complete.	[Iwamoto, Chuzo; Matsui, Yuta] Hiroshima Univ, Grad Sch Engn, Higashihiroshima 7398527, Japan	Iwamoto, C (reprint author), Hiroshima Univ, Grad Sch Engn, Higashihiroshima 7398527, Japan.	chuzo@hiroshima-u.ac.jp	Iwamoto, Chuzo/D-6380-2011				Cerioli MR, 2008, DISCRETE APPL MATH, V156, P2270, DOI 10.1016/j.dam.2007.10.015; Garey M.R., 1979, COMPUTERS INTRACTABI; Haraguchi K, 2013, IEICE T INF SYST, VE96D, P481, DOI 10.1587/transinf.E96.D.481; Hearn R.A., 2009, GAMES PUZZLES COMPUT; Houston R, 2012, INFORM PROCESS LETT, V112, P106, DOI 10.1016/j.ipl.2011.10.016; Iwamoto C., 2012, ALGORITHMS, V5, P261; Iwamoto C., 2014, J INF PROCESS, V22, P1; Iwamoto C, 2013, IEICE T INF SYST, VE96D, P502, DOI 10.1587/transinf.E96.D.502; Iwamoto C, 2013, IEICE T INF SYST, VE96D, P2462, DOI 10.1587/transinf.E96.D.2462; Uejima A., 2013, J INF PROCESS, V21, P405	10	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1361			IEICE T INF SYST	IEICE Trans. Inf. Syst.	FEB	2015	E98D	2					429	432		10.1587/transinf.2014EDL8154		4	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CK9WB	WOS:000356589100023		
J	He, LF; Yao, B; Zhao, X; Yang, Y; Chao, YY; Ohta, A				He, Lifeng; Yao, Bin; Zhao, Xiao; Yang, Yun; Chao, Yuyan; Ohta, Atsushi			A Graph-Theory-Based Algorithm for Euler Number Computing	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						Euler number; topological property; graph theory; computer vision; pattern recognition; image analysis	BINARY IMAGES	This paper proposes a graph-theory-based Euler number computing algorithm. According to the graph theory and the analysis of a mask's configuration, the Euler number of a binary image in our algorithm is calculated by counting four patterns of the mask. Unlike most conventional Euler number computing algorithms, we do not need to do any processing of the background pixels. Experimental results demonstrated that our algorithm is much more efficient than conventional Euler number computing algorithms.	[He, Lifeng; Yao, Bin; Zhao, Xiao; Yang, Yun] Shaanxi Univ Sci & Technol, Coll Elect & Informat Engn, Artificial Intelligence Inst, Xian 710021, Shaanxi, Peoples R China; [He, Lifeng; Ohta, Atsushi] Aichi Prefectural Univ, Grad Sch Informat Sci & Technol, Nagakute, Aichi 4801198, Japan; [Chao, Yuyan] Nagoya Sangyo Univ, Grad Sch Environm Management, Owariasa 4888711, Japan	Yang, Y (reprint author), Shaanxi Univ Sci & Technol, Coll Elect & Informat Engn, Artificial Intelligence Inst, Xian 710021, Shaanxi, Peoples R China.	helifeng@ist.aichi-pu.ac.jp			National Natural Science Foundation of China [61471227]; Ministry of Education, Science, Sports and Culture of Japan [26330200]	We thank the anonymous referee for their valuable comments that improved this paper greatly. We are grateful to the associate editor Prof. Hitoshi Habe for his kind cooperation. This work was supported in part by the National Natural Science Foundation of China under Grant No. 61471227 and the Grant-in-Aid for Scientific Research (C) of the Ministry of Education, Science, Sports and Culture of Japan under Grant No. 26330200.	He LF, 2013, J COMPUT SCI TECH-CH, V28, P468, DOI 10.1007/s11390-013-1348-y; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62; He LF, 2010, PATTERN RECOGN LETT, V31, P28, DOI 10.1016/j.patrec.2009.08.012; CHEN MH, 1988, PATTERN RECOGN LETT, V8, P295, DOI 10.1016/0167-8655(88)90078-5; Douglas B.M., 2001, WINTRODUCTION GRAPH, VSecond; Gonzalez RC, 2008, DIGITAL IMAGE PROCES; GRAY SB, 1971, IEEE T COMPUT, VC 20, P551, DOI 10.1109/T-C.1971.223289; Hashizume A., 1990, BIOMEDICAL ENG, V28, P25; Horn B., 1986, ROBOT VISION, P73; Juan L.D.S., 1996, PATTERN RECOGN, V29, P471; Karnaugh M., 1953, Transactions of the American Institute of Electrical Engineers, Part I (Communications and Electronics), V72; Nayar SK, 1996, INT J COMPUT VISION, V17, P219, DOI 10.1007/BF00128232; Rosin P. L., 1995, P 1995 BRIT C MACH V, V1, P347; Srihari S.N., 1986, P IEEE COMP SOC FALL, P87; Yao B, 2014, IEICE T INF SYST, VE97D, P1374, DOI 10.1587/transinf.E97.D.1374; Zenzo S. D., 1996, IEEE T PAMI, V18, P83	16	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1361			IEICE T INF SYST	IEICE Trans. Inf. Syst.	FEB	2015	E98D	2					457	461		10.1587/transinf.2014EDL8155		5	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CK9WB	WOS:000356589100030		
J	Turcotte, M; Sakai, S				Turcotte, Melissa; Sakai, Satoko			Separation of Lactulose and Epilactose	LC GC NORTH AMERICA			English	Article									[Turcotte, Melissa] Showa Denko Amer Inc, New York, NY USA; [Sakai, Satoko] Showa Denko Co Ltd, Minato, Japan	Turcotte, M (reprint author), Showa Denko Amer Inc, New York, NY USA.							0	0	0	ADVANSTAR COMMUNICATIONS INC	DULUTH	131 W 1ST STREET, DULUTH, MN 55802 USA	1527-5949	1939-1889		LC GC N AM	LC GC N. AM.	FEB	2015				S			22	22				1	Chemistry, Analytical	Chemistry	CB8MJ	WOS:000349883400012		
J	Gauchan, P; Sasaki, E; Nakagomi, T; Do, LP; Doan, YH; Mochizuki, M; Nakagomi, O				Gauchan, Punita; Sasaki, Eriko; Nakagomi, Toyoko; Loan Phuong Do; Doan, Yen Hai; Mochizuki, Masami; Nakagomi, Osamu			Whole genotype constellation of prototype feline rotavirus strains FRV-1 and FRV64 and their phylogenetic relationships with feline-like human rotavirus strains	JOURNAL OF GENERAL VIROLOGY			English	Article							SEQUENCE; CANINE; CLASSIFICATION; TRANSMISSION; ORIGIN	Feline rotaviruses, members of the species Rota virus A, are an infrequent source of zoonotic infections, and were previously shown by RNA-RNA hybridization assays to possess two distinct genomic RNA constellations, represented by strains FRV-1 and FRV64. Due to the lack of whole genome sequence information for FRV-1, human rotavirus strain AU-1 has been used as a surrogate for the genotype constellation of feline rotaviruses. The aim of this study was to determine the whole genome sequence of FRV-1 and FRV64 to help understand the genetic relationships among existing feline rotaviruses from the evolutionary perspective. The genotype constellations of FRV-1 and FRV64 were G3-P[9]-I3-R3-C3-M3-A3-N3-T3-E3-H3 and G3P[3]-l3-R3-C2-M3-A9-N2-T3-E3-H6, respectively. FRV-1 has a genotype constellation identical to that of the AU-1 strain. Although for individual genes they shared lineages, with the exception of genes encoding VP2, VP6 and VP7, the sequence identity between FRV-1 and AU-1 was considered to be sufficiently high for the AU-1 to be regarded as an example of the direct transmission of a feline rotavirus to a child. On the other hand, the FRV64 strain was not only similar in all the 11 genome segments to another feline rotavirus strain, Cat97, but also to canine rotavirus strains (K9 and CU-1) and feline/canine-like human rotavirus strains (Rol 845 and HCR3A). In conclusion, this study revealed intermingled sharing of genotypes and lineages among feline rotaviruses, suggesting the occurrence of frequent reassortment events over the course of evolution to emerge in four genotype constellations represented by FRV-1, FRV64/Cat97, Cat2 and BA222 strains.	[Gauchan, Punita; Sasaki, Eriko; Nakagomi, Toyoko; Loan Phuong Do; Doan, Yen Hai; Nakagomi, Osamu] Nagasaki Univ, Dept Hyg & Mol Epidemiol, Nagasaki 852, Japan; [Mochizuki, Masami] Kagoshima Univ, Joint Fac Vet Med, Lab Infect Dis, Kagoshima 890, Japan	Nakagomi, O (reprint author), Nagasaki Univ, Dept Hyg & Mol Epidemiol, Nagasaki 852, Japan.	onakagom@nagasaki-u.ac.jp			Global Centre of Excellence Program on Integrated Global Control Strategy for Tropical and Emerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported in part by the Global Centre of Excellence Program on Integrated Global Control Strategy for Tropical and Emerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors declare no conflict of interest.	ISEGAWA Y, 1992, J GEN VIROL, V73, P1939, DOI 10.1099/0022-1317-73-8-1939; NAKAGOMI T, 1989, J VIROL, V63, P1431; Matthijnssens J, 2011, INFECT GENET EVOL, V11, P1396, DOI 10.1016/j.meegid.2011.05.007; Tsugawa T, 2008, VIROLOGY, V380, P344, DOI 10.1016/j.virol.2008.07.041; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Martella V, 2011, J GEN VIROL, V92, P1214, DOI 10.1099/vir.0.027425-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Horie Y, 1997, J GEN VIROL, V78, P2341; De Grazia S, 2010, EMERG INFECT DIS, V16, P859, DOI 10.3201/eid1605.091826; Fredj MB, 2013, EMERG INFECT DIS, V19, P630, DOI 10.3201/eid1904.121383; Greene C. E, 2006, INFECT DIS DOG CAT, P103; ISEGAWA Y, 1993, RES VIROLOGY, V144, P371, DOI 10.1016/S0923-2516(06)80052-X; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; MOCHIZUKI M, 1992, ARCH VIROL, V122, P373, DOI 10.1007/BF01317199; MOCHIZUKI M, 1994, MICROBIOL IMMUNOL, V38, P229; MOCHIZUKI M, 1995, RES VIROLOGY, V146, P371, DOI 10.1016/0923-2516(96)80600-5; NAKAGOMI O, 1987, J CLIN MICROBIOL, V25, P1159; Nakagomi T, 2000, ARCH VIROL, V145, P2403, DOI 10.1007/s007050070029; Yamamoto D, 2011, VIRUS GENES, V43, P215, DOI 10.1007/s11262-011-0624-6	19	0	0	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	0022-1317	1465-2099		J GEN VIROL	J. Gen. Virol.	FEB	2015	96		2				338	350		10.1099/vir.0.070771-0		13	Biotechnology & Applied Microbiology; Virology	Biotechnology & Applied Microbiology; Virology	CJ8WR	WOS:000355784700012		
J	Orba, Y; Sasaki, M; Yamaguchi, H; Ishii, A; Thomas, Y; Ogawa, H; Hang'ombe, BM; Mweene, AS; Morikawa, S; Saijo, M; Sawa, H				Orba, Yasuko; Sasaki, Michihito; Yamaguchi, Hiroki; Ishii, Akihiro; Thomas, Yuka; Ogawa, Hirohito; Hang'ombe, Bernard M.; Mweene, Aaron S.; Morikawa, Shigeru; Saijo, Masayuki; Sawa, Hirofumi			Orthopoxvirus infection among wildlife in Zambia	JOURNAL OF GENERAL VIROLOGY			English	Article							HUMAN MONKEYPOX; VIRUS; CONGO; SMALLPOX; OUTBREAK; POXVIRUSES; VACCINE; AFRICA; ASSAYS; LC16M8	Human monkeypox is a viral zoonosis caused by monkeypox virus, an orthopoxvirus (OPXV). The majority of human monkeypox cases have been reported in moist forested regions in West and Central Africa, particularly in the Democratic Republic of the Congo (DRC). In this study we investigated zoonotic OPXV infection among wild animals in Zambia, which shares a border with DRC, to assess the geographical distribution of OPXV. We screened for OPXV antibodies in sera from non-human primates (NHPs), rodents and shrews by ELISA, and performed real-time PCR to detect OPXV DNA in spleen samples. Serological analysis indicated that 38 of 259 (14.7 %) rodents, 14 of 42 (33.3%) shrews and 4 of 188 (2.1 %) NHPs had antibodies against OPXV. The OPXV DNA could not be detected in spleens from any animals tested. Our results indicated that wild animals living in rural human habitation areas of Zambia have been infected with OPXV.	[Orba, Yasuko; Sasaki, Michihito; Yamaguchi, Hiroki; Sawa, Hirofumi] Hokkaido Univ, Div Mol Pathobiol, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Ishii, Akihiro; Thomas, Yuka; Ogawa, Hirohito] Hokudai Ctr Zoonosis Control Zambia, Lusaka, Zambia; [Hang'ombe, Bernard M.] Univ Zambia, Sch Vet Med, Dept Paraclin Studies, Lusaka, Zambia; [Mweene, Aaron S.] Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka, Zambia; [Morikawa, Shigeru] Natl Inst Infect Dis, Dept Vet Sci, Shinjyuku Ku, Tokyo 1628640, Japan; [Saijo, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Shinjyuku Ku, Tokyo 1628640, Japan; [Sawa, Hirofumi] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Kita Ku, Sapporo, Hokkaido 0010020, Japan	Sawa, H (reprint author), Hokkaido Univ, Div Mol Pathobiol, Res Ctr Zoonosis Control, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan.	h-sawa@czc.hokudai.ac.jp	Ogawa, Hirohito/F-6918-2012		Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [24405043]; Ministry of Health, Labour, and Welfare of Japan; Japan Initiative for Global Research Network of Infectious Diseases, MEXT, Japan	We would like to thank Mr Ladslav Moonga and Mr Evans Mulenga for assistance in collection of animal samples. This study was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT; 24405043) and the Ministry of Health, Labour, and Welfare of Japan; and from the Japan Initiative for Global Research Network of Infectious Diseases, MEXT, Japan.	Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026; Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005; Learned LA, 2005, AM J TROP MED HYG, V73, P428; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; Li Y, 2010, J CLIN MICROBIOL, V48, P268, DOI 10.1128/JCM.01697-09; Nakazawa Y, 2013, EMERG INFECT DIS, V19, P237, DOI 10.3201/eid1902.121220; Orba Y, 2011, J GEN VIROL, V92, P789, DOI 10.1099/vir.0.027854-0; Parker S, 2007, FUTURE MICROBIOL, V2, P17, DOI 10.2217/17460913.2.1.17; Saijo M, 2006, J VIROL, V80, P5179, DOI 10.1128/JVI.02642-05; Ellis CK, 2012, J WILDLIFE DIS, V48, P335; Kulesh DA, 2004, J CLIN MICROBIOL, V42, P601, DOI 10.1128/JCM.42.2.601-609.2004; LOURIE B, 1975, J INFECT DIS, V132, P677; KHODAKEVICH L, 1986, LANCET, V1, P98; Scaramozzino N, 2007, CLIN CHEM, V53, P606, DOI 10.1373/clinchem.2006.068635; Hutin YJF, 2001, EMERG INFECT DIS, V7, P434; Haller SL, 2014, INFECT GENET EVOL, V21, P15, DOI 10.1016/j.meegid.2013.10.014; Formenty P, 2010, EMERG INFECT DIS, V16, P1539, DOI 10.3201/eid1610.100713; Levine RS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000176; Sasaki M., 2013, EMERG INFECT DIS, V19, P9; Tryland M, 1998, J WILDLIFE DIS, V34, P240	20	2	2	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	0022-1317	1465-2099		J GEN VIROL	J. Gen. Virol.	FEB	2015	96		2				390	394		10.1099/vir.0.070219-0		5	Biotechnology & Applied Microbiology; Virology	Biotechnology & Applied Microbiology; Virology	CJ8WR	WOS:000355784700016		
J	Atsumi, G; Tomita, R; Yamashita, T; Sekine, KT				Atsumi, Go; Tomita, Reiko; Yamashita, Tetsuro; Sekine, Ken-Taro			A novel virus transmitted through pollination causes ring-spot disease on gentian (Gentiana triflora) ovaries	JOURNAL OF GENERAL VIROLOGY			English	Article							PEANUT CLUMP VIRUS; BEET VIRUS; PROTEIN; SUPPRESSION; ALIGNMENT; EXPRESSION; FAMILIES; SEQUENCE; DISTANCE; DOMAINS	In this study, we identified a novel virus from gentian (Gentiana triflora) that causes ring-spots on ovaries. Furthermore, the virus causes unusual symptoms, ring-spots that appear specifically on the outer surface of the ovarian wall after pollination. Pollen grains carrying the virus were used to infect host plants by hand-pollination. RNA extracted from purified virions indicated that the virus had two segments, RNA1 and RNA2. The full-length cDNA sequence indicated that RNA1 had two ORFs: ORF1 had methyltransferase and helicase motifs, and ORF2 had an RNA-dependent RNA polymerase motif. RNA2 had five ORFs encoding a coat protein, triple gene block proteins 1-3 and a cysteine-rich protein. The length of RNA1 was 5519 bases and that of RNA2 was 3810 bases not including a polyU/polyA region between the first and second ORFs. Viral RNA does not have a polyA tail at the 3' end. Sequence similarity and phylogenetic analysis suggested that the virus is closely related to members of the genera Pecluvirus and Hordeivirus but distinct from them. These combined results suggest that the causal agent inducing ring-spot symptoms on gentian ovaries is a new virus belonging to the family Virgaviridae but not to any presently known genus. We tentatively name the virus gentian ovary ring-spot virus.	[Atsumi, Go; Tomita, Reiko; Sekine, Ken-Taro] Iwate Biotechnol Res Ctr, Kitakami, Iwate 0240003, Japan; [Yamashita, Tetsuro] Iwate Univ, Morioka, Iwate 0208550, Japan	Sekine, KT (reprint author), Iwate Biotechnol Res Ctr, Kitakami, Iwate 0240003, Japan.	k-sekine@ibrc.or.jp			Iwate Prefecture Government	We thank Kazue Obara and Yukari Takahashi for technical assistance; we also thank Kazumichi Fujiwara and Nobue Hoshi for collecting gentian samples and conducting the hand-pollination experiment, and Tsuyoshi Nakagawa for providing pGWB614 containing the bar gene identified by Meiji Seika Kaisha, Ltd. This study was supported by the Iwate Prefecture Government.	Sekine KT, 2012, MOL PLANT MICROBE IN, V25, P1219, DOI 10.1094/MPMI-11-11-0289; Atsumi G, 2013, ARCH VIROL, V158, P1549, DOI 10.1007/s00705-013-1625-7; Card SD, 2007, AUSTRALAS PLANT PATH, V36, P455, DOI 10.1071/AP07050; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Adams MJ, 2009, ARCH VIROL, V154, P1967, DOI 10.1007/s00705-009-0506-6; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Martin-Hernandez AM, 2008, J VIROL, V82, P4064, DOI 10.1128/JVI.02438-07; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Hamada M, 2009, BIOINFORMATICS, V25, P465, DOI 10.1093/bioinformatics/btn601; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Koenig R, 1998, J GEN VIROL, V79, P2027; Atsumi G, 2012, ARCH VIROL, V157, P1019, DOI 10.1007/s00705-012-1281-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Crutzen F, 2009, J GEN VIROL, V90, P754, DOI 10.1099/vir.0.008029-0; DALPALU A, 2010, P 16 INT C PRINC PRA, V6308, P167; Dunoyer P, 2002, PLANT J, V29, P555, DOI 10.1046/j.0960-7412.2001.01242.x; Hull R, 2013, PLANT VIROLOGY; Imamura T, 2014, PLANT BIOTECHNOL-NAR, V31, P97, DOI 10.5511/plantbiotechnology.13.1211a; Kobayashi K, 2009, J GEN PLANT PATHOL, V75, P87, DOI 10.1007/s10327-009-0155-3; Kobayashi K, 2013, J GEN PLANT PATHOL, V79, P56, DOI 10.1007/s10327-012-0423-5; Kobayashi YO, 2005, PHYTOPATHOLOGY, V95, P192, DOI 10.1094/PHYTO-95-0192; MANOHAR SK, 1993, VIROLOGY, V195, P33, DOI 10.1006/viro.1993.1343; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Sorescu DA, 2012, NUCLEIC ACIDS RES, V40, pW49, DOI 10.1093/nar/gks491; Yambao MLM, 2008, ARCH VIROL, V153, P105, DOI 10.1007/s00705-007-1073-3; Yelina NE, 2002, J VIROL, V76, P12981, DOI 10.1128/JVI.76.24.12981-12991.2002	27	0	0	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	0022-1317	1465-2099		J GEN VIROL	J. Gen. Virol.	FEB	2015	96		2				431	439		10.1099/vir.0.071498-0		9	Biotechnology & Applied Microbiology; Virology	Biotechnology & Applied Microbiology; Virology	CJ8WR	WOS:000355784700020		
J	Sasaki, M; Orba, Y; Ueno, K; Ishii, A; Moonga, L; Hang'ombe, BM; Mweene, AS; Ito, K; Sawa, H				Sasaki, Michihito; Orba, Yasuko; Ueno, Keisuke; Ishii, Akihiro; Moonga, Ladslav; Hang'ombe, Bernard M.; Mweene, Aaron S.; Ito, Kimihito; Sawa, Hirofumi			Metagenomic analysis of the shrew enteric virome reveals novel viruses related to human stool-associated viruses	JOURNAL OF GENERAL VIROLOGY			English	Article							FAMILY PICORNAVIRIDAE; MELEAGRIS-GALLOPAVO; GENETIC DIVERSITY; MAMMALIAN VIRUSES; DISEASE VIRUS; FECAL VIROME; RNA VIRUSES; VIRAL FLORA; GENUS; GENOMES	Shrews are small insectivorous mammals that are distributed worldwide. Similar to rodents, shrews live on the ground and are commonly found near human residences. In this study, we investigated the enteric virome of wild shrews in the genus Crocidura using a sequence-independent viral metagenomics approach. A large portion of the shrew enteric virome was composed of insect viruses, whilst novel viruses including cyclovirus, picornavirus and picorna-like virus were also identified. Several cycloviruses, including variants of human cycloviruses detected in cerebrospinal fluid and stools, were detected in wild shrews at a high prevalence rate. The identified picornavirus was distantly related to human parechovirus, inferring the presence of a new genus in this family. The identified picorna-like viruses were characterized as different species of calhevirus 1, which was discovered previously in human stools. Complete or nearly complete genome sequences of these novel viruses were determined in this study and then were subjected to further genetic characterization. Our study provides an initial view of the diversity and distinctiveness of the shrew enteric virome and highlights unique novel viruses related to human stool-associated viruses.	[Sasaki, Michihito; Orba, Yasuko; Sawa, Hirofumi] Hokkaido Univ, Div Mol Pathobiol, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Ueno, Keisuke; Ito, Kimihito] Hokkaido Univ, Div Bioinformat, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Ishii, Akihiro] Hokudai Ctr Zoonosis Control Zambia, Lusaka, Zambia; [Moonga, Ladslav; Hang'ombe, Bernard M.] Univ Zambia, Sch Vet & Med, Dept Paraclin Studies, Lusaka, Zambia; [Mweene, Aaron S.] Univ Zambia, Sch Vet & Med, Dept Dis Control, Lusaka, Zambia; [Sawa, Hirofumi] Hokkaido Univ, Global Inst Collaborat Res & Educ, Kita Ku, Sapporo, Hokkaido 0010020, Japan	Sawa, H (reprint author), Hokkaido Univ, Div Mol Pathobiol, Res Ctr Zoonosis Control, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan.	h-sawa@czc.hokudai.ac.jp	Sawa, Hirofumi/F-6954-2012		Zambia Wildlife Authority; Japan Initiative for Global Research Network of Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Japan Society for the Promotion of Science (JSPS) KAKENHI [24405043]	We thank the Zambia Wildlife Authority for their support of this research. This study was supported by the Japan Initiative for Global Research Network of Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan, and Japan Society for the Promotion of Science (JSPS) KAKENHI grant no. 24405043.	Li Z, 2005, J VIROL METHODS, V130, P154, DOI 10.1016/j.jviromet.2005.06.022; Williams CH, 2009, J GEN VIROL, V90, P1702, DOI 10.1099/vir.0.008813-0; Sauvage V, 2012, J VIROL, V86, P10036, DOI 10.1128/JVI.00046-12; Sweeney TR, 2010, J BIOL CHEM, V285, P24347, DOI 10.1074/jbc.M110.129940; Phan TG, 2014, J GEN VIROL, V95, P922, DOI 10.1099/vir.0.061143-0; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Nakashima N, 2009, VIRUS RES, V139, P137, DOI 10.1016/j.virusres.2008.06.006; Blom N, 1996, PROTEIN SCI, V5, P2203; Delwart E, 2012, VIRUS RES, V164, P114, DOI 10.1016/j.virusres.2011.11.021; Boros A, 2013, J GEN VIROL, V94, P1496, DOI 10.1099/vir.0.051797-0; van den Brand JMA, 2012, J VIROL, V86, P2360, DOI 10.1128/JVI.06373-11; Goodfellow I, 2011, CURR OPIN VIROL, V1, P355, DOI 10.1016/j.coviro.2011.09.003; Sasaki M, 2014, J GEN VIROL, V95, P325, DOI 10.1099/vir.0.058404-0; Dacheux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087194; Bonning BC, 2010, ANNU REV ENTOMOL, V55, P129, DOI 10.1146/annurev-ento-112408-085457; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Rosario K, 2012, ARCH VIROL, V157, P1851, DOI 10.1007/s00705-012-1391-y; Honkavuori KS, 2011, EMERG INFECT DIS, V17, P480, DOI 10.3201/eid1703.101410; Bodewes R, 2013, J VIROL, V87, P7758, DOI 10.1128/JVI.00568-13; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Kapoor A, 2010, J VIROL, V84, P10322, DOI 10.1128/JVI.00601-10; KAMER G, 1984, NUCLEIC ACIDS RES, V12, P7269, DOI 10.1093/nar/12.18.7269; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Li LL, 2009, J VIROL, V83, P12002, DOI 10.1128/JVI.01241-09; Baker KS, 2013, VIROLOGY, V441, P95, DOI 10.1016/j.virol.2013.03.014; Boros A, 2012, J GEN VIROL, V93, P2171, DOI 10.1099/vir.0.043224-0; Woo PCY, 2010, J GEN VIROL, V91, P2433, DOI 10.1099/vir.0.021717-0; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Luke GA, 2008, J GEN VIROL, V89, P1036, DOI 10.1099/vir.0.83428-0; Esposito S, 2014, J CLIN VIROL, V60, P84, DOI 10.1016/j.jcv.2014.03.003; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Smith I, 2013, CURR OPIN VIROL, V3, P84, DOI 10.1016/j.coviro.2012.11.006; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Ng TFF, 2014, VET MICROBIOL, V171, P102, DOI 10.1016/j.vetmic.2014.04.005; Woo PCY, 2012, J VIROL, V86, P2797, DOI 10.1128/JVI.05481-11; Yanagihara R, 2014, VIRUS RES, V187, P6, DOI 10.1016/j.virusres.2013.12.038; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Firth C, 2013, ANNU REV GENOM HUM G, V14, P281, DOI 10.1146/annurev-genom-091212-153446; Lole KS, 1999, J VIROL, V73, P152; Wu ZQ, 2012, J VIROL, V86, P10999, DOI 10.1128/JVI.01394-12; Adams MJ, 2013, ARCH VIROL, V158, P2023, DOI 10.1007/s00705-013-1688-5; Kapoor A, 2008, P NATL ACAD SCI USA, V105, P20482, DOI 10.1073/pnas.0807979105; Reuter G, 2012, J VIROL, V86, P13295, DOI 10.1128/JVI.01142-12; GORBALENYA AE, 1989, FEBS LETT, V243, P103, DOI 10.1016/0014-5793(89)80109-7; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; Le Gall O, 2008, ARCH VIROL, V153, P715, DOI 10.1007/s00705-008-0041-x; Li LL, 2011, J GEN VIROL, V92, P768, DOI 10.1099/vir.0.028704-0; Kapoor A, 2008, J VIROL, V82, P311, DOI 10.1128/JVI.01240-07; Rosario K, 2011, J GEN VIROL, V92, P1302, DOI 10.1099/vir.0.030338-0; Anthony SJ, 2013, MBIO, V4; Dayaram A, 2013, J GEN VIROL, V94, P1827, DOI 10.1099/vir.0.052654-0; Delwart E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003146; Diirrwald R., 2014, PLOS ONE, V9; Dubey S, 2007, ZOOLOGY, V110, P48, DOI 10.1016/j.zool.2006.05.003; Ge XY, 2011, J GEN VIROL, V92, P2646, DOI 10.1099/vir.0.034108-0; Guo WP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003159; Hilbe M, 2006, EMERG INFECT DIS, V12, P675; Joffre ML, 2013, J GEN VIROL, V94, P1547, DOI 10.1099/vir.0.053157-0; King A. M. Q., 2012, VIRUS TAXONOMY CLASS; Lim ES, 2014, VIROLOGY, V454, P25, DOI 10.1016/j.virol.2014.01.018; Malboeuf CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks794; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Ng Terry Fei Fan, 2012, J Virol, V86, P12161, DOI 10.1128/JVI.00869-12; Niklasson B, 1999, VIROLOGY, V255, P86, DOI 10.1006/viro.1998.9557; Padilla-Rodriguez M, 2013, ARCH VIROL, V158, P1389, DOI 10.1007/s00705-013-1606-x; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Phan TG, 2013, VIRUS GENES, V47, P556, DOI 10.1007/s11262-013-0968-1; Phan TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072787; Shirai Y, 2006, J MAR BIOL ASSOC UK, V86, P475, DOI 10.1017/S0025315406013373; Simmonds Peter, 2012, BMC Res Notes, V5, P50, DOI 10.1186/1756-0500-5-50; Smits S. L, 2013, EMERG INFECT DIS, V19, P19, DOI DOI 10.3201/EID1912.130265; Smits SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071595; Takao Y, 2006, J GEN VIROL, V87, P723, DOI 10.1099/vir.0.81204-0; Tan V., 2013, MBIO, V4; Trujillo-Ortiz A., 2004, RAFISHER2CDA CANONIC; Witkowski PT, 2014, VIRUS RES, V187, P34, DOI 10.1016/j.virusres.2013.12.039; Yu JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070137; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3703.1.1	83	3	3	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	0022-1317	1465-2099		J GEN VIROL	J. Gen. Virol.	FEB	2015	96		2				440	452		10.1099/vir.0.071209-0		13	Biotechnology & Applied Microbiology; Virology	Biotechnology & Applied Microbiology; Virology	CJ8WR	WOS:000355784700021		
J	Hirabayashi, M				Hirabayashi, Mikihito			A GENERALIZATION OF JAKUBEC'S FORMULA	MATHEMATICA SLOVACA			English	Article						cyclotomic field; relative class number; determinant; class number formula		In 2009 Jakubec gave two determinantal formulas for the relative class number of the pth cyclotomic field, p an odd prime. We generalize one of the formulas to an arbitrary cyclotomic field and also determine the sign of the formula, which he had not given. (C)2015 Mathematical Institute Slovak Academy of Sciences	Kanazawa Inst Technol, Nonoichi, Ishikawa 921, Japan	Hirabayashi, M (reprint author), Kanazawa Inst Technol, 7-1 Ogigaoka, Nonoichi, Ishikawa 921, Japan.	hira@neptune.kanazawa-it.ac.jp			Japan Society for the Promotion of Science [23540010]	This work was supported by Grand-in-Aid for Scientific Research ((C), No. 23540010), Japan Society for the Promotion of Science.	HIRABAYASHI M., 1997, P C AN EL NUMB THEOR, P81; Jakubec S, 2009, ACTA ARITH, V137, P43, DOI 10.4064/aa137-1-2; METANKYLA T., 1997, TATRA MT MATH PUBL, V11, P59; WANG K, 1984, J NUMBER THEORY, V18, P306, DOI 10.1016/0022-314X(84)90064-7; Washington L.C., 1997, INTRO CYCLOTOMIC FIE	5	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0139-9918	1337-2211		MATH SLOVACA	Math. Slovaca	FEB	2015	65	1					215	227		10.1515/ms-2015-0018		13	Mathematics	Mathematics	CJ6DH	WOS:000355583100018		
J	Inoue, Y; Hiro, J; Kawamoto, A; Okugawa, Y; Okita, Y; Toiyama, Y; Araki, T; Tanaka, K; Mohri, Y; Kusunoki, M				Inoue, Yasuhiro; Hiro, Junichiro; Kawamoto, Aya; Okugawa, Yoshinaga; Okita, Yoshiki; Toiyama, Yuji; Araki, Toshimitsu; Tanaka, Koji; Mohri, Yasuhiko; Kusunoki, Masato			Comparison of Reduced-port and Conventional Laparoscopic Total Proctocolectomy with Ileal J-pouch-anal Anastomosis	AMERICAN SURGEON			English	Article									[Inoue, Yasuhiro; Hiro, Junichiro; Kawamoto, Aya; Okugawa, Yoshinaga; Okita, Yoshiki; Toiyama, Yuji; Araki, Toshimitsu; Tanaka, Koji; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, Div Reparat Med,Inst Life Sci, Tsu, Mie 5148507, Japan	Inoue, Y (reprint author), Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, Div Reparat Med,Inst Life Sci, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	yasinoue@clin.medic.mie-u.ac.jp					Buskens CJ, 2014, BEST PRACT RES CL GA, V28, P19, DOI 10.1016/j.bpg.2013.11.007; Beyer-Berjot L, 2013, ANN SURG, V258, P275, DOI 10.1097/SLA.0b013e3182813741; Duepree HJ, 2003, J AM COLL SURGEONS, V197, P177, DOI 10.1016/S1072-7515(03)00232-1; Kusunoki M, 1999, DIS COLON RECTUM, V42, P1349, DOI 10.1007/BF02234229	4	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	FEB	2015	81	2					E70	E72				3	Surgery	Surgery	CI6TK	WOS:000354894700011		
J	Hattori, K; Sakuma, E; Nakayama, M; Kozaki, A; Wada, I; Otsuka, T				Hattori, K.; Sakuma, E.; Nakayama, M.; Kozaki, A.; Wada, I.; Otsuka, T.			An anatomic study of the accessory anterolateral talar facet	FOLIA MORPHOLOGICA			English	Article						talus; anatomy; cadaver; variation; facet	SYMPTOMATIC FLATFOOT; TALOCALCANEAL; JOINT; ADULTS	Background: A small accessory facet with articular surface morphology is occasionally seen on the talus, bordering on the lateral end of the sinus tarsi. This facet has been named the accessory anterolateral talar facet. However, few anatomical studies have addressed this facet. Here we present the precise morphology of accessory anterolateral talar facet with emphasis on anatomical correlation between the presence of this facet and the angle of the infero-lateral surface of the talus (talar infero-lateral surface - TILS angle). Materials and methods: A total of 22 (11 male, 11 female) adult cadavers with no known pathological conditions in the talocalcaneal joints were examined during educational dissection at Nagoya City University Medical School in 2013. After exclusion of 1 joint due to the poor condition of the talus, 43 talus (22 right, 21 left) were analysed. We judged the presence of the accessory anterolateral talar facet and measured TILS angle. We performed statistical analysis on the point of laterality, gender difference and the difference in the TILS angles in tali with or without the accessory anterolateral talar facets. Results: An accessory anterolateral talar facet was identified in 11 (26%) of the 43 specimens. Of the 21 cadavers with paired talar specimens, 5 displayed the facet bilaterally. Conclusions: There was no sex difference and no significant laterality, however we found that TILS angle was significantly larger in accessory anterolateral talar facet positive samples than in negative ones.	[Hattori, K.; Wada, I.; Otsuka, T.] Nagoya City Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Nagoya, Aichi 4678601, Japan; [Sakuma, E.; Nakayama, M.; Kozaki, A.] Nagoya City Univ, Grad Sch Med Sci, Dept Funct Anat, Nagoya, Aichi 4678601, Japan	Sakuma, E (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Funct Anat, Nagoya, Aichi 4678601, Japan.	esakuma@med.nagoya-cu.ac.jp					Ananthakrisnan D, 1999, J BONE JOINT SURG AM, V81A, P1147; Malicky ES, 2002, J BONE JOINT SURG AM, V84A, P2005; Martus JE, 2008, J BONE JOINT SURG AM, V90A, P2452, DOI 10.2106/JBJS.G.01230; BLOCKEY NJ, 1955, J BONE JOINT SURG BR, V37, P191; Jones R, 1897, LIVERPOOL MED CHIR J, V17, P442; Kelikian AS, 2011, DESCRIPTIVE TOPOGRAP, V3rd, P48; Knudson GA, 1997, ACTA ORTHOP SCAND, V68, P442, DOI 10.3109/17453679708996259; Martus Jeffrey E, 2008, Iowa Orthop J, V28, P1; Ozeki S, 2006, FOOT ANKLE INT, V27, P965; Sewell RBS, 1904, J ANAT PHYSIOL, V38, P423	10	0	0	VIA MEDICA	GDANSK	UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND	0015-5659	1644-3284		FOLIA MORPHOL	Folia Morphol.	FEB	2015	74	1					61	64		10.5603/FM.2015.0010		4	Anatomy & Morphology	Anatomy & Morphology	CJ0XH	WOS:000355203000009		
J	Teramoto, M; Yagyu, K; Nishijima, M				Teramoto, Maki; Yagyu, Ken-ichi; Nishijima, Miyuki			Perspicuibacter marinus gen. nov., sp nov., a semi-transparent bacterium isolated from surface seawater, and description of Arenicellaceae fam. nov and Arenicellales ord. nov.	INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY			English	Article							PETROLEUM ALIPHATIC-HYDROCARBONS; DEOXYRIBONUCLEIC-ACID; LIQUID-CHROMATOGRAPHY; MICROORGANISMS; ENVIRONMENT; STRAINS; TREES	A Gram-stain-negative, non-motile, mesophilic, aerobic, rod-shaped bacterium, strain 2-9(T), was isolated from surface seawater at Muroto city, Kochi prefecture, Japan. The strain was transparent on 1/5 strength marine broth plate but became easily visible when the plate was supplemented with pyruvate. Phylogenetic analyses based on the 16S rRNA gene sequence showed that the strain fell within the class Gammaproteobacteria and was most closely related to the genus Arenicella (92.7-93.0% 16S rRNA gene sequence similarities to type strains of species of this genus) of an unclassified order within this class. The DNA G +C content of strain 2-9(T) was 41.7 mol%. The major fatty acids were C-18:1 omega 7c (37.6%), C-16:1 omega 7c and/or iso-C-15:0 2-OH (summed feature 3; 19.1 %), C-18:0 (10.8%), C-16:0 (10.2 %) and an unidentified fatty acid with an equivalent chain-length value of 11.799 (9.5 %). The major polar lipids were phosphatidylglycerol, phosphatidylethanolamine and three unidentified lipids. Ubiquinone-8 (Q-8) was detected as the sole isoprenoid qui-none. From these taxonomic data, it is proposed that strain 2-9(T) represents a novel species of a new genus, Perspicuibacter marinus gen. nov., sp. nov. The type strain of the type species is 2-9(T) (=NBRC 110144(T)=KCTC 42196(T)). A new family, Arenicellaceae fam. nov. (type genus Arenicella), and order, Arenicellales ord. nov., of the class Gammaproteobacteria are proposed to accommodate the novel taxon.	[Teramoto, Maki] Kochi Univ, Oceanog Sect, Nankoku, Kochi 7838505, Japan; [Yagyu, Ken-ichi] Kochi Univ, Facil Res Instruments, Nankoku, Kochi 7838505, Japan; [Nishijima, Miyuki] TechnoSuruga Lab Co Ltd, Shimizu Ku, Shizuoka 4240065, Japan	Teramoto, M (reprint author), Kochi Univ, Oceanog Sect, Nankoku, Kochi 7838505, Japan.	makiiteramoto@kochi-u.ac.jp					C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; MARMUR J, 1961, J MOL BIOL, V3, P208; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Teramoto M, 2011, INT J SYST EVOL MICR, V61, P375, DOI 10.1099/ijs.0.018671-0; LEIFSON E, 1963, J BACTERIOL, V85, P1183; DYKSTERHOUSE SE, 1995, INT J SYST BACTERIOL, V45, P116; TAKAICHI S, 1992, METHOD ENZYMOL, V213, P374; Nishijima M, 1997, J MICROBIOL METH, V28, P113, DOI 10.1016/S0167-7012(96)00972-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; SAITO H, 1963, BIOCHIM BIOPHYS ACTA, V72, P619, DOI 10.1016/0926-6550(63)90386-4; Hansman RL, 2009, P NATL ACAD SCI USA, V106, P6513, DOI 10.1073/pnas.0810871106; Barrow G. I., 1993, COWAN STEELS MANUAL; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; KATAYAMAFUJIMURA Y, 1984, AGR BIOL CHEM TOKYO, V48, P3169; Nedashkovskaya OI, 2013, INT J SYST EVOL MICR, V63, P4124, DOI 10.1099/ijs.0.051599-0; Romanenko LA, 2010, INT J SYST EVOL MICR, V60, P1832, DOI 10.1099/ijs.0.017194-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Teralmoto M, 2009, MICROBIOL-SGM, V155, P3362, DOI 10.1099/mic.0.030411-0	22	0	0	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	1466-5026	1466-5034		INT J SYST EVOL MICR	Int. J. Syst. Evol. Microbiol.	FEB	2015	65		2				353	358		10.1099/ijs.0.064683-0		6	Microbiology	Microbiology	CJ3CE	WOS:000355360200005		
J	Nomoto, R; Maruyama, F; Ishida, S; Tohya, M; Sekizaki, T; Osawa, R				Nomoto, R.; Maruyama, F.; Ishida, S.; Tohya, M.; Sekizaki, T.; Osawa, Ro			Reappraisal of the taxonomy of Streptococcus suis serotypes 20, 22 and 26: Streptococcus parasuis sp nov.	INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY			English	Article							CAPSULAR TYPES; IDENTIFICATION; CLASSIFICATION	In order to clarify the taxonomic position of serotypes 20, 22 and 26 of Streptococcus suis, biochemical and molecular genetic studies were performed on isolates (SUT-7, SUT-286(T), SUT-319, SUT-328 and SUT-380) reacted with specific antisera of serotypes 20, 22 or 26 from the saliva of healthy pigs as well as reference strains of serotypes 20, 22 and 26. Comparative recN gene sequencing showed high genetic relatedness among our isolates, but marked differences from the type strain S. suis NCTC 10234(T), i.e. 74.8-75.7% sequence similarity. The genomic relatedness between the isolates and other strains of species of the genus Streptococcus, including S. suis, was calculated using the average nucleotide identity values of whole genome sequences, which indicated that serotypes 20, 22 and 26 should be removed taxonomically from S. suis and treated as a novel genomic species. Comparative sequence analysis revealed 99.0-100 % sequence similarities for the 16S rRNA genes between the reference strains of serotypes 20, 22 and 26, and our isolates. Isolate STU-286(T) had relatively high 16S rRNA gene sequence similarity with S. suis NCTC 10234(T) (98.8%). SUT-286(T) could be distinguished from S. suis and other closely related species of the genus Streptococcus using biochemical tests. Due to its phylogenetic and phenotypic similarities to S. suis we propose naming the novel species Streptococcus parasuis sp. nov., with SUT-286(T) (=JCM 30273(T)=DSM 29126(T)) as the type strain.	[Nomoto, R.] Kobe Univ, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Maruyama, F.] Tokyo Med & Dent Univ, Sect Bacterial Phathogenesis, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138510, Japan; [Ishida, S.; Tohya, M.; Sekizaki, T.] Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Bunkyo Ku, Tokyo 1138657, Japan; [Osawa, Ro] Kobe Univ, Grad Sch Agr Sci, Dept Bioresource Sci, Nada Ku, Kobe, Hyogo 6578501, Japan	Nomoto, R (reprint author), Kobe Univ, Org Adv Sci & Technol, Nada Ku, Rokko Dai 1-1, Kobe, Hyogo 6578501, Japan.	nomotsu@people.kobe-u.ac.jp			Kieikai Research Foundation, Japan	The serotype reference strains used in the present study were generously gifted from the National Institute of Animal Health, Japan. This work was supported by a Grant-in-Aid from Kieikai Research Foundation, Japan.	HIGGINS R, 1995, J VET DIAGN INVEST, V7, P405; Vela AI, 2011, INT J SYST EVOL MICR, V61, P1585, DOI 10.1099/ijs.0.022657-0; KILPPERBALZ R, 1987, INT J SYST BACTERIOL, V37, P160; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Chatellier S, 1998, INT J SYST BACTERIOL, V48, P581; Collins MD, 2001, INT J SYST EVOL MICR, V51, P1147; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Brousseau R, 2001, APPL ENVIRON MICROB, V67, P4828, DOI 10.1128/AEM.67.10.4828-4833.2001; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; GOTTSCHALK M, 1989, J CLIN MICROBIOL, V27, P2633; Glazunova OO, 2010, INT J SYST EVOL MICR, V60, P2140, DOI 10.1099/ijs.0.018176-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; FACKLAM R, 1995, CLIN MICROBIOL REV, V8, P479; GARVIE EI, 1979, J APPL BACTERIOL, V46, P295, DOI 10.1111/j.1365-2672.1979.tb00824.x; Gottschalk M., 2010, Clinical Microbiology Newsletter, V32, P89; GOTTSCHALK M, 1991, J CLIN MICROBIOL, V29, P2590; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Higgins R, 1990, J Vet Diagn Invest, V2, P249; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Tien LHT, 2013, VET MICROBIOL, V162, P842; Vela AI, 2011, INT J SYST EVOL MICR, V61, P1989, DOI 10.1099/ijs.0.026187-0	24	5	5	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	1466-5026	1466-5034		INT J SYST EVOL MICR	Int. J. Syst. Evol. Microbiol.	FEB	2015	65		2				438	443		10.1099/ijs.0.067116-0		6	Microbiology	Microbiology	CJ3CE	WOS:000355360200019		
J	Sakai, M; Deguchi, D; Hosoda, A; Kawauchi, T; Ikenaga, M				Sakai, Masao; Deguchi, Daigo; Hosoda, Akifumi; Kawauchi, Tomohiro; Ikenaga, Makoto			Ammoniibacillus agariperforans gen. nov., sp nov., a thermophilic, agar-degrading bacterium isolated from compost	INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY			English	Article							XYLANOLYTIC BACTERIUM; STRUCTURAL-ANALYSIS; MAXIMUM-LIKELIHOOD; BASE COMPOSITION; ROOT-NODULES; ZEA-MAYS; SATIVA-L; COHNELLA; SOIL; PAENIBACILLUS	A thermophilic, agar-degrading bacterium, strain FAB2(T), was isolated from sewage sludge compost. According to phylogenetic analysis based on 16S rRNA gene sequences, strain FAB2(T) belonged to the family Paenibacillaceae within the phylum Firmicutes. However, FAB2(T) was different enough at the genus level from closely related species. The percentages of 16S rRNA gene sequence similarity with related organisms were 90.4 % for Thermobacillus xylanilyticus, 91.8% for Paenibacillus barengoltzii, 89.4% for Cohnella lupini, 90.1 % for Fontibacillus aquaticus, and 89.0% for Saccharibacillus sacchari. Morphological and physiological analyses revealed that the strain was motile, rod-shaped, Gram-stain-positive, aerobic and able to form oval endospores in swollen sporangia. Ammonium was required as a nitrogen source while nitrate, nitrite, urea and glutamate were not utilized. Catalase and oxidase activities were weakly positive and positive, respectively. The bacterium grew in the temperature range of 50-65 degrees C and in media with pH 7.5 to 9.0. Optimal growth occurred at 60 degrees C and pH 8.0-8.6. Growth was inhibited at pH <= 7.0 and NaCI concentrations >= 2.5% (w/v). In chemotaxonomic characterization, MK-7 was identified as the dominant menaquinone. Major fatty acids were iso-C-16:0 and C-16:0. Dominant polar lipids were diphosphatidylglycerol, phosphatidylglycerol and phosphatidylethanolamine. Phosphatidylcholine was present in a moderate amount. The diamino acid in the cell wall was meso-diaminopimelic acid. The G+C content of the genomic DNA was 49.5 mol% in a nucleic acid study. On the basis of genetic and phenotypic characteristics, strain FAB2(T) (=NBRC 109510(T)=KCTC 33130(T)) showed characteristics suitable for classification as the type strain of a novel species of a new genus in the family Paenibacillaceae, for which the name Ammoniibacillus agariperforans gen. nov., sp. nov. is proposed.	[Sakai, Masao; Ikenaga, Makoto] Kagoshima Univ, Fac Agr, Kagoshima 8900065, Japan; [Deguchi, Daigo] Kagoshima Univ, Grad Sch Agr, Kagoshima 8900065, Japan; [Hosoda, Akifumi] Meijo Univ, Sch Agr, Tenpaku Ku, Nagoya, Aichi 4688502, Japan; [Kawauchi, Tomohiro] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 8900065, Japan	Ikenaga, M (reprint author), Kagoshima Univ, Fac Agr, 1-21-24 Korimoto, Kagoshima 8900065, Japan.	ikenaga@agri.kagoshima-u.ac.jp			JSPS KAKENHI [20225775]	We appreciate our laboratory students at Kagoshima University for assisting us in this ongoing study. This research was partially supported by a Grant-in-Aid for Scientific Research from JSPS KAKENHI (20225775).	AGBO JAC, 1979, J GEN MICROBIOL, V115, P355; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; Logan NA, 2009, INT J SYST EVOL MICR, V59, P2114, DOI 10.1099/ijs.0.013649-0; Hameed A, 2013, INT J SYST EVOL MICR, V63, P2806, DOI 10.1099/ijs.0.045831-0; Khianngam S, 2012, INT J SYST EVOL MICR, V62, P1921, DOI 10.1099/ijs.0.032607-0; Cai F, 2010, INT J SYST EVOL MICR, V60, P1605, DOI 10.1099/ijs.0.016790-0; Flores-Felix JD, 2014, INT J SYST EVOL MICR, V64, P83, DOI 10.1099/ijs.0.050849-0; Yoon JH, 2005, INT J SYST EVOL MICR, V55, P2339, DOI 10.1099/ijs.0.63771-0; Pettersson B, 1999, INT J SYST BACTERIOL, V49, P531; Khianngam S, 2010, INT J SYST EVOL MICR, V60, P2913, DOI 10.1099/ijs.0.017855-0; Shiratori H, 2010, INT J SYST EVOL MICR, V60, P1344, DOI 10.1099/ijs.0.014605-0; Lee JC, 2008, INT J SYST EVOL MICR, V58, P612, DOI 10.1099/ijs.0.65350-0; Khianngam S, 2010, INT J SYST EVOL MICR, V60, P2284, DOI 10.1099/ijs.0.015859-0; Cho EA, 2007, INT J SYST EVOL MICR, V57, P2902, DOI 10.1099/ijs.0.64844-0; Kampfer P, 2014, INT J SYST EVOL MICR, V64, P1811, DOI 10.1099/ijs.0.060814-0; Jiang F, 2012, INT J SYST EVOL MICR, V62, P817, DOI 10.1099/ijs.0.030247-0; KOMAGATA K, 1987, METHOD MICROBIOL, V19, P161; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Garcia-Fraile P, 2008, INT J SYST EVOL MICR, V58, P1855, DOI 10.1099/ijs.0.65468-0; Hosoda A, 2003, BIOSCI BIOTECH BIOCH, V67, P1048, DOI 10.1271/bbb.67.1048; Yoon JH, 2003, INT J SYST EVOL MICR, V53, P53, DOI 10.1099/ijs.0.02342-0; Zhou Y, 2012, ANTON LEEUW INT J G, V102, P601, DOI 10.1007/s10482-012-9755-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Knee EM, 2001, MOL PLANT MICROBE IN, V14, P775, DOI 10.1094/MPMI.2001.14.6.775; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Rivas R, 2008, INT J SYST EVOL MICR, V58, P1850, DOI [10.1099/ijs.0.65499-0, 10.1099/ijs.0.655499-0]; Kampfer P, 2006, INT J SYST EVOL MICR, V56, P781, DOI 10.1099/ijs.0.63985-0; BACIC A, 1986, PLANT PHYSIOL, V80, P771, DOI 10.1104/pp.80.3.771; Bannikova GE, 2008, APPL BIOCHEM MICRO+, V44, P366, DOI 10.1134/S0003683808040054; CHABOUD A, 1984, J PLANT PHYSIOL, V116, P323, DOI 10.1016/S0176-1617(84)80111-X; De Vos P., 2009, BERGEYS MANUAL SYSTE, V3, P20; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Hiraishi A, 1996, SYST APPL MICROBIOL, V19, P168; Hosoda A, 2006, BIOSCI BIOTECH BIOCH, V70, P722, DOI 10.1271/bbb.70.722; HUNGER W, 1978, A VAN LEEUW J MICROB, V44, P105, DOI 10.1007/BF00400080; KATAYAMAFUJIMURA Y, 1984, AGR BIOL CHEM TOKYO, V48, P3169; Kim SJ, 2010, INT J SYST EVOL MICR, V60, P526, DOI 10.1099/ijs.0.013581-0; Lee JS, 2002, INT J SYST EVOL MICR, V52, P2107, DOI 10.1099/ijs.0.02096-0; Miyazaki M, 2008, INT J SYST EVOL MICR, V58, P1128, DOI 10.1099/ijs.0.65507-0; MOODY SF, 1988, PHYTOCHEMISTRY, V27, P2857, DOI 10.1016/0031-9422(88)80676-9; NAKAMURA LK, 1987, INT J SYST BACTERIOL, V37, P391; Ohta Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1073, DOI 10.1271/bbb.68.1073; Priest FG, 2009, BERGEYS MANUAL SYSTE, V2, P269; Roux V, 2004, INT J SYST EVOL MICR, V54, P1049, DOI 10.1099/ijs.0.02954-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Smibert Robert M., 1994, P607; Stanier RY, 1942, J BACTERIOL, V44, P555; Touzel JP, 2000, INT J SYST EVOL MICR, V50, P315; VANDERME.HJ, 1974, A VAN LEEUW J MICROB, V40, P329; Watanabe K, 2007, INT J SYST EVOL MICR, V57, P1473, DOI 10.1099/ijs.0.64672-0; Yang SY, 2009, INT J SYST EVOL MICR, V59, P953, DOI 10.1099/ijs.0.005199-0; Zhilina TN, 1996, INT J SYST BACTERIOL, V46, P305	53	0	0	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	1466-5026	1466-5034		INT J SYST EVOL MICR	Int. J. Syst. Evol. Microbiol.	FEB	2015	65		2				570	577		10.1099/ijs.0.067843-0		8	Microbiology	Microbiology	CJ3CE	WOS:000355360200040		
J	Pramono, AK; Sakamoto, M; Iino, T; Hongoh, Y; Ohkuma, M				Pramono, Ajeng K.; Sakamoto, Mitsuo; Iino, Takao; Hongoh, Yuichi; Ohkuma, Moriya			Dysgonomonas termitidis sp nov., isolated from the gut of the subterranean termite Reticulitermes speratus	INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY			English	Article							ACIDS	A facultatively anaerobic, Gram-stain-negative, non-motile and rod-shaped bacterium, strain N-10(T), was isolated from the gut of the termite Reticulitermes speratus. Strain N-10(T) was closely related to Dysgonomonas gadei JCM 16698(T) according to 16S rRNA gene sequence similarity analysis (98%) and DNA-DNA relatedness value (<= 61.3%). The optimum growth temperature of strain N-10(T) was 30 degrees C, which was distinct from that (37 degrees C) of known species of the genus Dysgonomonas. Growth of strain N-10(T) was inhibited on medium containing 5 or 20% bile, unlike other species of the genus Dysgonomonas. In addition, acid production in the API 20A system and enzymic reactions in the Rapid ID 32A system of strain N-10(T) differed from those of other species of the genus Dysgonomonas. Based on these characteristics, strain N-10(T) represents a novel species of the genus Dysgonomonas, for which the name Dysgonomonas termitidis sp. nov. is proposed. The type strain is N-10(T) (=JCM 30204(T)=CCUG 66188(T)).	[Pramono, Ajeng K.; Hongoh, Yuichi] Tokyo Inst Technol, Dept Biol Sci, Tokyo 152, Japan; [Pramono, Ajeng K.; Sakamoto, Mitsuo; Iino, Takao; Hongoh, Yuichi; Ohkuma, Moriya] RIKEN BioResource Ctr, Microbe Div, Japan Collect Microorganisms, Tsukuba, Ibaraki 3050074, Japan	Sakamoto, M (reprint author), RIKEN BioResource Ctr, Microbe Div, Japan Collect Microorganisms, Tsukuba, Ibaraki 3050074, Japan.	sakamoto@jcm.riken.jp	Ohkuma, Moriya/A-8100-2011				Hofstad T, 2000, INT J SYST EVOL MICR, V50, P2189; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224; Hongoh Y, 2011, CELL MOL LIFE SCI, V68, P1311, DOI 10.1007/s00018-011-0648-z; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Yang YJ, 2014, INT J SYST EVOL MICR, V64, P2956, DOI 10.1099/ijs.0.061739-0; Nakajima H, 2005, FEMS MICROBIOL ECOL, V54, P247, DOI 10.1016/j.femsec.2005.03.010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Holdeman L.V., 1977, ANAEROBE LAB MANUAL; Inoue T, 1997, J INSECT PHYSIOL, V43, P235, DOI 10.1016/S0022-1910(96)00097-2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KUYKENDALL LD, 1988, INT J SYST BACTERIOL, V38, P358; McClung L. S., 1957, MANUAL MICROBIOLOGIC, P120; MILLER LT, 1982, J CLIN MICROBIOL, V16, P584; Ohkuma M, 2002, BIOSCI BIOTECH BIOCH, V66, P78, DOI 10.1271/bbb.66.78; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Shah H. N, 1992, PROKARYOTES, V2nd, P3593; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; TAMAOKA J, 1984, FEMS MICROBIOL LETT, V25, P125, DOI 10.1111/j.1574-6968.1984.tb01388.x	20	2	2	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	1466-5026	1466-5034		INT J SYST EVOL MICR	Int. J. Syst. Evol. Microbiol.	FEB	2015	65		2				681	685		10.1099/ijs.0.070391-0		5	Microbiology	Microbiology	CJ3CE	WOS:000355360200056		
J	Nakano, C; Takahashi, N; Tanaka, N; Okada, S				Nakano, Chisa; Takahashi, Naoto; Tanaka, Naoto; Okada, Sanae			Alicyclobacillus dauci sp nov., a slightly thermophilic, acidophilic bacterium isolated from a spoiled mixed vegetable and fruit juice product	INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY			English	Article							CYCLOHEPTANE FATTY-ACIDS; GENUS ALICYCLOBACILLUS; BACILLUS-CYCLOHEPTANICUS; DEOXYRIBONUCLEIC-ACID; OXIDIZING BACTERIUM; EMENDED DESCRIPTION; FORMING BACTERIUM; SOIL; ACIDOTERRESTRIS; IDENTIFICATION	A novel, moderately thermophilic, acidophilic, Gram-variable, rod-shaped, endospore-forming bacterium was isolated from a spoiled mixed vegetable and fruit juice product that had the off-flavour of guaiacol. The bacterium, strain 4F(T), grew aerobically at 20-50 degrees C (optimum 40 degrees C) and pH 3.0-6.0 (optimum pH 4.0) and produced acid from glycerol, D-galactose and D-glucose. It contained menaquinone-7 (MK-7) as the major isoprenoid quinone and the DNA G+C content was 49.6 mol%. The predominant cellular fatty acids of strain 4F(T) were omega-alicyclic (omega-cyclohexane fatty acids), which are characteristic of the genus Alicyclobacillus. Phylogenetic analyses based on 16S rRNA gene sequences showed that the strain belongs to the Alicyclobacillus cluster, and is related most closely to the type strains of Alicyclobacillus acidoterrestris (97.4% similarity) and Alicyclobacillus fastidiosus (97.3%). Strain 4F(T) produced guaiacol from vanillic acid. It can be distinguished from related species by its acid production type and guaiacol production. On the basis of phenotypic characteristics, phylogenetic analysis and DNA-DNA relatedness values, it can be concluded that the strain represents a novel species of the genus Alicyclobacillus, for which the name Alicyclobacillus dauci sp. nov. is proposed; the type strain is 4F(T) (=DSM 28700(T)=NBRC 108949(T)=NRIC 0938(T)).	[Nakano, Chisa; Takahashi, Naoto] Kagome Co Ltd, Res & Dev Div, Nasushiobarashi, Tochigi 3292762, Japan; [Tanaka, Naoto] Tokyo Univ Agr, NODAI Culture Collect Ctr NRIC, Setagaya Ku, Tokyo 1568502, Japan; [Okada, Sanae] Tokyo Univ Agr, Fac Appl Biosci, Dept Appl Biol & Chem, Setagaya Ku, Tokyo 1568502, Japan	Nakano, C (reprint author), Kagome Co Ltd, Res & Dev Div, 17 Nishitomoyama, Nasushiobarashi, Tochigi 3292762, Japan.	chisa_nakano@kagome.co.jp					MARMUR J, 1961, J MOL BIOL, V3, P208; TAMURA K, 1993, MOL BIOL EVOL, V10, P512; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224; Goto K, 2007, INT J SYST EVOL MICR, V57, P1276, DOI 10.1099/ijs.0.64692-0; Goto K, 2002, J GEN APPL MICROBIOL, V48, P243, DOI 10.2323/jgam.48.243; Yamazaki K, 1996, BIOSCI BIOTECH BIOCH, V60, P543; Matsubara H, 2002, INT J SYST EVOL MICR, V52, P1681, DOI 10.1099/ijs.0.02169-0; DARLAND G, 1971, J GEN MICROBIOL, V67, P9; WISOTZKEY JD, 1992, INT J SYST BACTERIOL, V42, P263; HIPPCHEN B, 1981, ARCH MICROBIOL, V129, P53, DOI 10.1007/BF00417180; Albuquerque L, 2000, INT J SYST EVOL MICR, V50, P451; Goto K, 2002, INT J SYST EVOL MICR, V52, P109; Goto K, 2008, LETT APPL MICROBIOL, V46, P289, DOI 10.1111/j.1472-765X.2007.02307.x; Tsuruoka N, 2003, INT J SYST EVOL MICR, V53, P1081, DOI 10.1099/ijs.0.02409-0; DEINHARD G, 1987, SYST APPL MICROBIOL, V10, P68; Goto K, 2003, INT J SYST EVOL MICR, V53, P1537, DOI 10.1099/ijs.0.02546-0; Karavaiko GI, 2005, INT J SYST EVOL MICR, V55, P941, DOI 10.1099/ijs.0.63300-0; Guo X, 2009, INT J SYST EVOL MICR, V59, P2415, DOI 10.1099/ijs.0.008870-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; DEINHARD G, 1987, SYST APPL MICROBIOL, V10, P47; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Jiang CY, 2008, INT J SYST EVOL MICR, V58, P2898, DOI 10.1099/ijs.0.2008/000562-0; KATAYAMAFUJIMURA Y, 1984, AGR BIOL CHEM TOKYO, V48, P3169; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kusube M, 2014, INT J SYST EVOL MICR, V64, P2257, DOI 10.1099/ijs.0.061440-0; LAKE JA, 1987, MOL BIOL EVOL, V4, P167; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Simbahan J, 2004, INT J SYST EVOL MICR, V54, P1703, DOI 10.1099/ijs.0.03012-0; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463	30	0	0	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	1466-5026	1466-5034		INT J SYST EVOL MICR	Int. J. Syst. Evol. Microbiol.	FEB	2015	65		2				716	722		10.1099/ijs.0.068957-0		7	Microbiology	Microbiology	CJ3CE	WOS:000355360200062		
J	Harasawa, R; Fujita, H; Kadosaka, T; Ando, S; Rikihisa, Y				Harasawa, Ryo; Fujita, Hiromi; Kadosaka, Teruki; Ando, Shuji; Rikihisa, Yasuko			Proposal for 'Candidatus Mycoplasma haemomuris subsp musculi' in mice, and 'Candidatus Mycoplasma haemomuris subsp ratti' in rats	INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY			English	Article							PHYLOGENETIC ANALYSIS; BARTONELLA MURIS; GENUS MYCOPLASMA; P RNA; SEQUENCES; EPERYTHROZOON; HEMOPLASMA; HAEMOBARTONELLA; SUBSTITUTIONS; ANEMIA	Mycoplasma haemomuris is causative of infectious anaemia or splenomegaly in rodents. We examined the nucleotide sequences of the non-ribosomal genes, rnpB and dnaK, in strains of the species M. haemomuris detected in small field mice and black rats. rnpB nucleotide sequences in strains of the species M. haemomuris isolated from small field mice and black rats had only 89% sequence similarity, suggesting their separation into two distinct subgroups. dnaK had a nucleotide sequence similarity of 84% between the subgroups. These results support the classification of M. haemomuris into two genetically distinct subgroups. Here we propose the establishment of these subgroups as 'Candidatus Mycoplasma haemomuris subsp. musculi', detected in small field mice (Apodemus argenteus), and 'Candidatus Mycoplasma haemomuris subsp. ratti', detected in black rats (Rattus rattus).	[Harasawa, Ryo] Iwate Res Ctr Wildlife Dis, Morioka, Iwate 0200816, Japan; [Fujita, Hiromi] Mahara Inst Med Acarol, Anan 7791510, Japan; [Kadosaka, Teruki] Aichi Med Univ, Dept Microbiol & Immunol, Nagakute, Aichi 4801195, Japan; [Ando, Shuji] Natl Inst Infect Dis, Dept Virol 1, Tokyo 1628640, Japan; [Rikihisa, Yasuko] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA	Harasawa, R (reprint author), Iwate Res Ctr Wildlife Dis, Morioka, Iwate 0200816, Japan.	harasawa-tky@umin.ac.jp					Peters IR, 2008, J CLIN MICROBIOL, V46, P1873, DOI 10.1128/JCM.01859-07; Steer JA, 2011, CLIN INFECT DIS, V53, pE147, DOI 10.1093/cid/cir666; Neimark H, 2005, INT J SYST EVOL MICR, V55, P1385, DOI 10.1099/ijs.0.63437-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Rikihisa Y, 1997, J CLIN MICROBIOL, V35, P823; Neimark H, 2001, INT J SYST EVOL MICR, V51, P891; Messick JB, 2004, VET CLIN PATH, V33, P2, DOI 10.1111/j.1939-165X.2004.tb00342.x; Ford WW, 1928, J EXP MED, V48, P475, DOI 10.1084/jem.48.4.475; Hicks CAE, 2014, INFECT GENET EVOL, V23, P99, DOI 10.1016/j.meegid.2014.02.001; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Mayer M, 1921, ARCH SCHIFFS TROP, V25, P150; Neimark H, 2002, INT J SYST EVOL MICR, V52, P683, DOI 10.1099/ijs.0.02283-0; Noguchi H, 1928, J EXP MED, V47, P235, DOI 10.1084/jem.47.2.235; Regendanz P, 1928, CR SOC BIOL, V98, P1578; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sasaoka F, 2011, J VET MED SCI, V73, P1517; Sashida H, 2013, J VET MED SCI, V75, P643, DOI 10.1292/jvms.12-0472; Schilling V, 1929, KLIN WOCHENSCHR, V8, P55, DOI 10.1007/BF01739366; Tasker S, 2003, J CLIN MICROBIOL, V41, P3877, DOI 10.1128/JCM.41.8.3877-3880.2003; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	20	0	0	SOC GENERAL MICROBIOLOGY	READING	MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG, BERKS, ENGLAND	1466-5026	1466-5034		INT J SYST EVOL MICR	Int. J. Syst. Evol. Microbiol.	FEB	2015	65		2				734	737		10.1099/ijs.0.069856-0		4	Microbiology	Microbiology	CJ3CE	WOS:000355360200065		
J	Danisi, RM; Armbruster, T; Nagashima, M				Danisi, Rosa Micaela; Armbruster, Thomas; Nagashima, Mariko			Structural intergrowth of merlinoite/phillipsite and its temperature-dependent dehydration behaviour: a single-crystal X-ray study	MINERALOGICAL MAGAZINE			English	Article						zeolite; merlinoite; phillipsite; chabazite; crystal structure; dehydration; intergrowth	ZEOLITE; PHILLIPSITE; MERLINOITE; CHABAZITE	Supposed 'merlinoite' crystals from Monte Somma, Vesuvius (Italy) and Fosso Attici, north of Rome (Italy) represent highly twinned coherent intergrowths between merlinoite and phillipsite on a submicroscopic level. The MER (Immm, a approximate to 14.1, b approximate to 14.2, c approximate to 9.9 angstrom) and PHI (P2(1)/m, a approximate to 9.9, b approximate to 14.3, c approximate to 8.7 angstrom, beta = 124.8 degrees) frameworks of similar composition are assembled from identical tetrahedral units, though with a different connectivity. Coherent intergrowth and twinning of the two frameworks lead to P4(2)/mnm pseudosymmetry, which is diagnostic of the intergrowth. Under ambient conditions merlinoite has Immm symmetry or I4/mmm if twinned. A low-symmetry model of space group P12(1)/m1 (a approximate to 14.2, b approximate to 14.2, c approximate to 10 angstrom, beta = 90 degrees) allows structure refinement and quantification of the two frameworks. Upon in situ dehydration to 250 degrees C the evolution of the unit-cell volume of the Monte Somma merlinoite/phillipsite intergrowth displays an intermediate trend between previously studied pure merlinoite from the Khibiny massif (Russia) and Ba-rich phillipsite. The Monte Somma crystal studied by temperature-dependent single-crystal X-ray diffraction methods also contained a subordinate chabazite inclusion with no coherent structural relationship to the merlinoite/phillipsite framework. Thus, the modification of the chabazite framework on dehydration could also be studied.	[Danisi, Rosa Micaela; Armbruster, Thomas] Univ Bern, Inst Geol Sci, Mineral Crystallog, CH-3012 Bern, Switzerland; [Nagashima, Mariko] Yamaguchi Univ, Grad Sch Sci & Engn, Yamaguchi 7538512, Japan	Danisi, RM (reprint author), Univ Bern, Inst Geol Sci, Mineral Crystallog, Freiestr 3, CH-3012 Bern, Switzerland.	rosamicaela.danisi@libero.it					Bieniok A, 1996, J MATER CHEM, V6, P271, DOI 10.1039/jm9960600271; Gatta GD, 2009, AM MINERAL, V94, P190, DOI 10.2138/am.2009.3032; RINALDI R, 1974, ACTA CRYSTALLOGR B, V30, P2426, DOI 10.1107/S0567740874007242; Bruker, 1999, SMART SAINT PLUS VER; Della Ventura G., 1993, RENDICONTI LINCE SFN, V9, P303; Galli E., 1979, MONATSHEFTE, V1979, P1; Pakhomova AS, 2014, EUR J MINERAL, V26, P371, DOI 10.1127/0935-1221/2014/0026-2380; Passaglia E., 1977, MONATSHEFTE, V1977, P355; Russo M., 2011, MERLINOITE MONTE SOM, V2, P64; Sani A, 2002, PHYS CHEM MINER, V29, P351, DOI 10.1007/s00269-002-0247-5; SATO M, 1982, Z KRISTALLOGR, V161, P187, DOI 10.1524/zkri.1982.161.3-4.187; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sherman J.D., 1977, S SERIES AM CHEM SOC, VII, P30; Skofteland BM, 2001, MICROPOR MESOPOR MAT, V43, P61, DOI 10.1016/S1387-1811(00)00347-4; Smith J. V., 1962, MINERAL MAG GB, V33, P202, DOI 10.1180/minmag.1962.033.258.03; Smith J.V., 1968, MINERAL MAG, V38, P640; STEINFINK H, 1962, ACTA CRYSTALLOGR, V15, P644, DOI 10.1107/S0365110X62001802; Tschernich R. W., 1992, ZEOLITES WORLD; Yakubovich OV, 2005, CRYSTALLOGR REP+, V50, P544, DOI 10.1134/1.1996728; Zema M, 2008, CHEM MATER, V20, P5876, DOI 10.1021/cm800781t	20	0	0	MINERALOGICAL SOC	TWICKENHAM	12 BAYLIS MEWS, AMYAND PARK ROAD,, TWICKENHAM TW1 3HQ, MIDDLESEX, ENGLAND	0026-461X	1471-8022		MINERAL MAG	Mineral. Mag.	FEB	2015	79	1					191	203		10.1180/minmag.2015.079.1.15		13	Mineralogy	Mineralogy	CJ2JK	WOS:000355310100014		
J	Takebayashi, T; Amano, S; Hanada, K; Umeji, A; Takahashi, K; Marumoto, K; Kodama, N; Koyama, T; Domen, K				Takebayashi, Takashi; Amano, Satoru; Hanada, Keisuke; Umeji, Atsushi; Takahashi, Kayoko; Marumoto, Kohei; Kodama, Norihiko; Koyama, Tetsuo; Domen, Kazuhisa			A one-year follow-up after modified constraint-induced movement therapy for chronic stroke patients with paretic arm: a prospective case series study	TOPICS IN STROKE REHABILITATION			English	Article						Constraint-induced movement therapy; Stroke rehabilitation; Chronic-phase stroke	UPPER-EXTREMITY; CONTROLLED-TRIAL; TRANSFER PACKAGE	Background: Despite the confirmed short-term effects of constraint-induced movement therapy, the long-term effects have not been sufficiently verified in terms of functional improvement of the affected arm. Objective: To evaluate the long-term effects and relationship between arm use in activities of daily living and arm improvement with modified constraint-induced movement therapy in chronic stroke patients. Methods: At 1 year after completing modified constraint-induced movement therapy, arm function (Fugl-Meyer Assessment) and amount of daily arm use (motor activity log) were assessed. Results: Fourteen post-stroke patients with mild to moderate impairment of arm function were analyzed. One year after completing modified constraint-induced movement therapy, participants consistently showed improvements in arm function and amount of daily arm use (analysis of variance: Fugl-Meyer Assessment, P<0.001; Motor Activity Log, P<0.001). For the Fugl-Meyer Assessment, post-hoc tests detected significant improvements (pre versus post, P=0.009; pre versus 1 year, P<0.0001; post versus 1 year, P<0.036). For the Motor Activity Log, post-hoc tests also detected significant improvements (pre versus post, P=0.0001; pre versus 1 year, P<0.0001; post versus 1 year, P=0.0014). The magnitude of the change in Fugl-Meyer Assessment score correlated significantly with the change in Motor Activity Log score (R=0.778, P=0.001). Conclusions: Among post-stroke patients with mild to moderate impairments of arm function, modified constraint-induced movement therapy without any other rehabilitation after intervention may improve arm function and increase arm use for 1 year. In addition, increasing arm use may represent an important factor in improving arm function, and vice versa.	[Takebayashi, Takashi; Amano, Satoru; Hanada, Keisuke; Umeji, Atsushi] Hosp Hyogo Coll Med, Dept Rehabil, Nishinomiya, Hyogo 6638501, Japan; [Takahashi, Kayoko; Domen, Kazuhisa] Kitasato Univ, Dept Rehabil, Sagamihara, Kanagawa, Japan; [Marumoto, Kohei] Hyogo Coll Med, Dept Rehabil Med, Kobe, Hyogo, Japan; [Kodama, Norihiko] Hyogo Prefectural Rehabil Ctr Nishi Harima, Dept Rehabil Med, Nishi Harima, Hyogo, Japan; [Koyama, Tetsuo] Nishinomiya Kyoritsu Neurosurg Hosp, Dept Rehabil Med, Nishinomiya, Hyogo, Japan	Amano, S (reprint author), Hosp Hyogo Coll Med, Dept Rehabil, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	satoru@hyo-med.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [26282158]	Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (KAKENHI [26282158]).	Takebayashi T, 2013, CLIN REHABIL, V27, P418, DOI 10.1177/0269215512460779; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; Taub E, 2013, STROKE, V44, P1383, DOI 10.1161/STROKEAHA.111.000559; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Gauthier LV, 2008, STROKE, V39, P1520, DOI 10.1161/STROKEAHA.107.502229; Taub E, 2002, NAT REV NEUROSCI, V3, P228, DOI 10.1038/nrn754; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Taub E, 2006, STROKE, V37, P1045, DOI 10.1161/01.STR.0000206463.66461.97; Brogardh C, 2010, ARCH PHYS MED REHAB, V91, P460, DOI 10.1016/j.apmr.2009.11.009; Morris D M, 2006, Eura Medicophys, V42, P257; Ostendorf OG, 1981, PHYS THER, V61, P1022; Sirtori V, 2009, COCHRANE DB SYST REV, V4, P1; TAUB E, 1980, NEUROSCIENCE, V5, P389, DOI 10.1016/0306-4522(80)90114-1; Uswatte G, 2006, NEUROREHABILITATION, V21, P147	17	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1074-9357	1945-5119		TOP STROKE REHABIL	Top. Stroke Rehabil.	FEB	2015	22	1					18	25		10.1179/1074935714Z.0000000028		8	Rehabilitation	Rehabilitation	CI8IH	WOS:000355015400007		
J	Li, RM; Kido, A; Wang, S				Li, Ruimin; Kido, Ai; Wang, Shi			Evaluation Index Development for Intelligent Transportation System in Smart Community Based on Big Data	ADVANCES IN MECHANICAL ENGINEERING			English	Article							SUSTAINABILITY; INDICATORS	A scientific evaluation index system for intelligent transportation system (ITS) can play an important role in guiding the development of ITS for decision makers in smart communities. This study aims to develop a set of performance indicators for the effective evaluation of the transportation systemin a smart community in China. The main goals of the developed evaluation index are determined after a careful review of the various index systems implemented by various agencies worldwide. A set of indicators divided into the following six categories are then presented: transport structure, traffic information service, traffic efficiency, traffic safety, energy and pollution reduction, and social inclusion. To further discuss the practical application of the index system, a number of indicators are defined in detail and applied in arterial and public transportation efficiency evaluations based on the available dataset. Results from the index calculation show that the index proposed in this study can be adopted in evaluating the transportation system performance in smart communities based on big data.	[Li, Ruimin] Tsinghua Univ, Dept Civil Engn, Inst Transportat Engn, Beijing 100084, Peoples R China; [Kido, Ai] Toshiba Solutions Corp, IT Res & Dev Ctr, Tokyo 1838512, Japan; [Wang, Shi] Tsinghua Univ, Dept Civil Engn, Beijing 100084, Peoples R China	Li, RM (reprint author), Tsinghua Univ, Dept Civil Engn, Inst Transportat Engn, Beijing 100084, Peoples R China.	lrmin@tsinghua.edu.cn			Tsinghua-Toshiba Energy and Environment Research Center; Qinhuangdao Traffic Management Bureau; Professor Nigel H. M. Wilson of Massachusetts Institute of Technology; Collaborative Innovation Center for Capital World City's Smooth Traffic Construction	This project is funded by Tsinghua-Toshiba Energy and Environment Research Center. The authors would like to thank Mr. Yoshiyuki Sakamoto in Toshiba Corporation, Mr. Satoshi Sekine, Dr. Junichi Yamamoto, Dr. Makoto Kano, and Mr. Ryoya Mori in Toshiba Solutions Corporation for their valuable discussion. The authors would also like to thank the Qinhuangdao Traffic Management Bureau and Professor Nigel H. M. Wilson of Massachusetts Institute of Technology for their support on data collection. The authors would also like to thank the Collaborative Innovation Center for Capital World City's Smooth Traffic Construction for its support.	Reddy S, 2010, ACM T SENSOR NETWORK, V6, DOI 10.1145/1689239.1689243; [Anonymous], 2012, EV IND SYST URB ROAD; Black JA, 2002, J URBAN PLAN D-ASCE, V128, P184, DOI 10.1061/(ASCE)0733-9488(2002)128:4(184); Jeon CM, 2005, J INFRASTRUCT SYST, V11, P31, DOI 10.1061/(ASCE)1076-0342(2005)11:1(31); Castillo H, 2010, TRANSPORT RES D-TR E, V15, P179, DOI 10.1016/j.trd.2009.09.002; Haghshenas H, 2012, ECOL INDIC, V15, P115, DOI 10.1016/j.ecolind.2011.09.010; Fei X, 2013, J TRANSP ENG, V139, P1058, DOI 10.1061/(ASCE)TE.1943-5436.0000538; Harris G. A., 2009, ESTABLISHING PERFORM; Ibm Big Data and Analytics, 2013, BIG DAT AN TRAV TRAN; Incorporated C. S., 2000, GUID PERF BAS TRANSP; Jeon CM, 2010, INT J SUSTAIN TRANSP, V4, P227, DOI 10.1080/15568310902940209; Jeon CM, 2013, TRANSPORT POLICY, V25, P10, DOI 10.1016/j.tranpol.2012.10.004; Jeon M. C., 2007, THESIS GEORGIA I TEC; Kaparias I., 2011, KEY PERFORMANCE INDI; Komninos N., 2009, INT J INNOVATION REG, V1, P337; Kristensen P., 2005, EEA CORE SET INDICAT; Li R., 2013, EFFECTIVE EVALUATION; Litman T., 2008, WELL MEASURED DEV IN; Litman T. A., 2007, TRANSPORT RES REC, V2017, P10, DOI 10.3141/2017-02; MOHURD, 2012, NAT SMAR CIT DISTR T; Rakha H, 2010, J INTELL TRANSPORT S, V14, P232, DOI 10.1080/15472450.2010.517477; Ramani T., 2009, DEV SUSTAINABLE TRAN; Reed M. F., 1993, MEASURING STATE TRAN; Renne J. L., 2005, TRANSIT ORIENTED DEV; Sisiopiku V. P., 2012, INT J ENG RES DEV, V3, P83; Smith TW, 2013, TRANSPORT POLICY, V30, P308, DOI 10.1016/j.tranpol.2013.09.019; U.S. Environmental Protection Agency, 2011, GUID SUST TRANSP PER; Xiong Z, 2012, SCI CHINA INFORM SCI, V55, P2908, DOI 10.1007/s11432-012-4725-1; Zegras C., 2006, P BIANN C EXH CLEAN; Zietsman J., 2006, INT J MANAGEMENT DEC, V7, P254, DOI 10.1504/IJMDM.2006.009147; Zietsman J., 2011, GUIDEBOOK SUSTAINABI	31	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1687-8132	1687-8140		ADV MECH ENG	Adv. Mech. Eng.	FEB	2015	7	2							541651	10.1155/2014/541651		8	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CH5NW	WOS:000354083600022		
J	Yu, B; Zakin, JL; Kawaguchi, Y; Wei, JJ; Li, FC; Wang, Y				Yu, Bo; Zakin, Jacques L.; Kawaguchi, Yasuo; Wei, Jinjia; Li, Fengchen; Wang, Yi			Advances in Turbulent Drag Reduction	ADVANCES IN MECHANICAL ENGINEERING			English	Editorial Material									[Yu, Bo; Wang, Yi] China Univ Petr, Beijing Key Lab Urban Oil & Gas Distribut Technol, Natl Engn Lab Pipeline Safety, Beijing 102249, Peoples R China; [Zakin, Jacques L.] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Kawaguchi, Yasuo] Tokyo Univ Sci, Dept Mech Engn, Noda, Chiba 278, Japan; [Wei, Jinjia] Xi An Jiao Tong Univ, State Key Lab Multiphase Flow Power Engn, Xian 710049, Peoples R China; [Li, Fengchen] Harbin Inst Technol, Sch Energy Sci & Engn, Harbin 150001, Peoples R China	Yu, B (reprint author), China Univ Petr, Beijing Key Lab Urban Oil & Gas Distribut Technol, Natl Engn Lab Pipeline Safety, Beijing 102249, Peoples R China.	yubobox@vip.163.com						0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1687-8132	1687-8140		ADV MECH ENG	Adv. Mech. Eng.	FEB	2015	7	2							862424	10.1155/2014/862424		2	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CH5NW	WOS:000354083600071		
J	Ohno, N; Okabe, S				Ohno, Nobuhiko; Okabe, Shigeo			For Microscopy special issue on 'connectome'	MICROSCOPY			English	Editorial Material									[Ohno, Nobuhiko] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Anat & Mol Histol, Chuo Ku, Yamanashi 4093898, Japan; [Ohno, Nobuhiko] Natl Inst Physiol Sci, Ctr Multidisciplinary Brain Res, Okazaki, Aichi 4448787, Japan; [Okabe, Shigeo] Univ Tokyo, Grad Sch Med, Dept Cellular Neurobiol, Bunkyo Ku, Tokyo 1130033, Japan	Ohno, N (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Anat & Mol Histol, Chuo Ku, Yamanashi 4093898, Japan.							0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	FEB	2015	64	1			SI		1	1		10.1093/jmicro/dfu105		1	Microscopy	Microscopy	CI4JW	WOS:000354715500001		
J	Okabe, S				Okabe, Shigeo			Brain/MINDS - a new program for comprehensive analyses of the brain	MICROSCOPY			English	Editorial Material									[Okabe, Shigeo] Univ Tokyo, Brain MINDS, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Okabe, Shigeo] Univ Tokyo, Dept Cellular Neurobiol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan	Okabe, S (reprint author), Univ Tokyo, Brain MINDS, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan.						Cyranoski D, 2014, NATURE, V514, P151, DOI 10.1038/514151a	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	FEB	2015	64	1			SI		3	4		10.1093/jmicro/dfu106		2	Microscopy	Microscopy	CI4JW	WOS:000354715500002		
J	Miyawaki, A				Miyawaki, Atsushi			Brain clearing for connectomics	MICROSCOPY			English	Review						fluorescence microscopy; optical clearing; large-scale 3D reconstruction	SINGLE-CELL RESOLUTION; NEURAL CIRCUITS; MOUSE-BRAIN; RECONSTRUCTION; TISSUE; BODY	The article reflects on the development of tissue clearing methods in the last decade. This technological innovation has been achieved in the neuroscience community thanks to the combined efforts of molecular biologists, brain anatomists and light microscopists. Although this technology is becoming increasingly diversified, it mostly aims at the large-scale, three-dimensional reconstruction of brain structures.	[Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Lab Cell Funct Dynam, Wako, Saitama 3510198, Japan; [Miyawaki, Atsushi] RIKEN, Ctr Adv Photon, Biotechnol Opt Res Team, Wako, Saitama 3510198, Japan	Miyawaki, A (reprint author), RIKEN, Brain Sci Inst, Lab Cell Funct Dynam, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsushi@brain.riken.go.jp			Brain/MINDS (Mapping by Integrated Neurotechnologies for Disease Studies)	This work was partly supported by the Brain/MINDS (Mapping by Integrated Neurotechnologies for Disease Studies).	Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Chiang AS, 2002, P NATL ACAD SCI USA, V99, P37, DOI 10.1073/pnas.012318899; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Cai D, 2013, NAT METHODS, V10, P540, DOI 10.1038/NMETH.2450; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Hayworth KJ, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00068; Jahrling N., 2009, ORGANOGENESIS, V5, P145; Lightman J W, 2014, NAT NEUROSCI, V17, P1448; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Liu YC, 2003, METHODS, V30, P86, DOI 10.1016/S1046-2023(03)00010-0; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034	23	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	FEB	2015	64	1			SI		5	8		10.1093/jmicro/dfu108		4	Microscopy	Microscopy	CI4JW	WOS:000354715500003		
J	Nemoto, T; Kawakami, R; Hibi, T; Iijima, K; Otomo, K				Nemoto, Tomomi; Kawakami, Ryosuke; Hibi, Terumasa; Iijima, Koichiro; Otomo, Kohei			Two-photon excitation fluorescence microscopy and its application in functional connectomics	MICROSCOPY			English	Review						non-linear optics; ultrashort pulse laser; in vivo imaging; neuronal activity	NONLINEAR-MICROSCOPY; DENDRITIC SPINES; BRAIN; NEURONS; TISSUE; LASER; RECONSTRUCTION; EXOCYTOSIS; DYNAMICS; MODELS	Two-photon excitation fluorescence microscopy has become widely used in various life science fields in this decade. In the field of neuroscience in particular, in vivo two-photon microscopy has provided vital information on neural activity and brain function. In the current era of connectomics, visualization of the morphology and activity of numerous neurons in ever larger regions of the living brain are required within short periods. Based on this viewpoint, we discuss the fundamentals, advantages and potential of two-photon excitation fluorescence microscopy for the investigation of neural circuit functions.	[Nemoto, Tomomi; Kawakami, Ryosuke; Hibi, Terumasa; Iijima, Koichiro; Otomo, Kohei] Hokkaido Univ, Res Inst Elect Sci, Lab Mol & Cellular Biophys, Kita Ku, Sapporo, Hokkaido 0010020, Japan	Nemoto, T (reprint author), Hokkaido Univ, Res Inst Elect Sci, Lab Mol & Cellular Biophys, Kita Ku, Kita 20 Nishi 10, Sapporo, Hokkaido 0010020, Japan.	tn@es.hokudai.ac.jp	Nemoto, Tomomi /B-4412-2012		JSPS KAKENHI grants of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22113005, 26242082]; Nano-Macro Materials, Devices and System Research Alliance (MEXT); Network Joint Research Center for Materials and Devices (MEXT); CREST, Japan Science and Technology Agency (JST)	Our studies in the manuscript were supported by JSPS KAKENHI grants (Nos. 22113005 and 26242082) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; the Nano-Macro Materials, Devices and System Research Alliance (MEXT) and the Network Joint Research Center for Materials and Devices (MEXT); CREST, Japan Science and Technology Agency (JST).	Yokoyama H, 2008, OPT EXPRESS, V16, P17752, DOI 10.1364/OE.16.017752; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Deisseroth K, 2013, NEURON, V80, P568, DOI 10.1016/j.neuron.2013.10.032; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; DeFelipe J, 2010, SCIENCE, V330, P1198, DOI 10.1126/science.1193378; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Masamizu Y, 2014, NAT NEUROSCI, V17, P987, DOI 10.1038/nn.3739; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Olarte OE, 2012, BIOMED OPT EXPRESS, V3, P1492, DOI 10.1364/BOE.3.001492; Shimozawa T, 2013, P NATL ACAD SCI USA, V110, P3399, DOI 10.1073/pnas.1216696110; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Hayakawa Y, 2005, CELL CALCIUM, V37, P359, DOI 10.1016/j.ceca.2004.11.005; KAISER W, 1961, PHYS REV LETT, V7, P229, DOI 10.1103/PhysRevLett.7.229; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Takatsuru Y, 2009, J NEUROSCI, V29, P10081, DOI 10.1523/JNEUROSCI.1638-09.2009; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Cyranoski D, 2014, NATURE, V514, P151, DOI 10.1038/514151a; Goppert-Mayer V M, 1931, ANN PHYS, V9, P273; Gustafsson M G, 2005, P NATL ACAD SCI USA, V2102, P13081; Kawakami R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01014; Kishimoto T, 2006, EMBO J, V25, P673, DOI 10.1038/sj.emboj.7600983; Kobat D, 2009, OPT EXPRESS, V17, P13354, DOI 10.1364/OE.17.013354; Koga S, 2014, CANCER SCI, V105, P1299, DOI 10.1111/cas.12500; Matsui T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00143; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; Ogata S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037048; Sawada M, 2011, J NEUROSCI, V31, P11587, DOI 10.1523/JNEUROSCI.0614-11.2011; Sporns O, 2005, PLOS COMPUT BIOL, V1, P246	44	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	FEB	2015	64	1			SI		9	15		10.1093/jmicro/dfu110		7	Microscopy	Microscopy	CI4JW	WOS:000354715500004		
J	Ohno, N; Katoh, M; Saitoh, Y; Saitoh, S; Ohno, S				Ohno, Nobuhiko; Katoh, Mitsuhiko; Saitoh, Yurika; Saitoh, Sei; Ohno, Shinichi			Three-dimensional volume imaging with electron microscopy toward connectome	MICROSCOPY			English	Review						connectome; scanning electron microscopy; three-dimensional reconstruction; serial sectioning; neuron; synapse	NEMATODE CAENORHABDITIS-ELEGANS; CORRELATIVE MICROSCOPY; DIRECTION-SELECTIVITY; WIRING SPECIFICITY; DENDRITIC SPINES; SERIAL SECTIONS; NERVOUS-SYSTEM; TOMOGRAPHY; CELLS; RECONSTRUCTION	Ultrastructural analyses with electron microscopy have provided indispensable information to understand physiology and pathology of the nervous system. Recent advancement in imaging methodology paved the way for complete reconstruction of the neuronal connection map in the central nervous system, which is termed 'connectome' and would provide key insights to understand the functions of the brain. The critical advancement includes serial ultrastructural observation with scanning electron microscopy (SEM) instead of conventional serial sectioning transmission electron microscopy along with specific tissue preparation methods to increase heavy metal deposition for efficient SEM imaging. The advanced imaging methods using SEM have distinct advantages and disadvantages in multiple aspects, such as resolution and imaging speed, and should be selected depending on the observation conditions, such as target tissue sizes, required spatial resolution and necessity for re-observation. Dealing with the huge dataset remained to be a major obstacle, and automation in segmentation and 3D reconstruction would be critical to understand neuronal circuits in a larger volume of the brain. Future improvement in acquisition and analyses of the morphological data obtained with the advanced SEM imaging is awaited to elucidate the significance of whole connectome as the structural basis of the consciousness, intelligence and memory of a subject.	[Ohno, Nobuhiko; Katoh, Mitsuhiko; Saitoh, Yurika; Saitoh, Sei; Ohno, Shinichi] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Anat & Mol Histol, Chuo City, Yamanashi 4093898, Japan	Ohno, N (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Anat & Mol Histol, 1110 Shimokato, Chuo City, Yamanashi 4093898, Japan.	nohno@yamanashi.ac.jp			JSPS KAKENHI [26860129]; National Institute for Physiological Sciences	This work was supported by JSPS KAKENHI (grant number 26860129) and The Cooperative Study Program of National Institute for Physiological Sciences.	Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Mikula S, 2012, NAT METHODS, V9, P1198, DOI [10.1038/nmeth.2213, 10.1038/NMETH.2213]; GRAY EG, 1959, J ANAT, V93, P420; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Grabenbauer M, 2005, NAT METHODS, V2, P857, DOI 10.1038/nmeth806; SELIGMAN AM, 1966, J CELL BIOL, V30, P424, DOI 10.1083/jcb.30.2.424; Sartori A, 2007, J STRUCT BIOL, V160, P135, DOI 10.1016/j.jsb.2007.07.011; Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Ohno N, 2011, J NEUROSCI, V31, P7249, DOI 10.1523/JNEUROSCI.0095-11.2011; WALTON J, 1979, J HISTOCHEM CYTOCHEM, V27, P1337; Young RD, 2014, P NATL ACAD SCI USA, V111, P687, DOI 10.1073/pnas.1313561110; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; WARE RW, 1975, INT REV CYTOL, V40, P325, DOI 10.1016/S0074-7696(08)60956-0; Terasaki M, 2013, CELL, V154, P285, DOI 10.1016/j.cell.2013.06.031; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; SANDELL JH, 1988, J HISTOCHEM CYTOCHEM, V36, P555; Denk W, 2012, NAT REV NEUROSCI, V13, P351, DOI 10.1038/nrn3169; Ohno N, 2014, P NATL ACAD SCI USA, V111, P9953, DOI 10.1073/pnas.1401155111; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; McCulloch D, 2003, EXP GERONTOL, V38, P129, DOI 10.1016/S0531-5565(02)00147-X; BUHL EH, 1987, ACTA NEUROPATHOL, V75, P140; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Tonnesen J, 2013, EXP NEUROL, V242, P33, DOI 10.1016/j.expneurol.2012.10.004; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Xu-Friedman MA, 2004, PHYSIOL REV, V84, P69, DOI 10.1152/physrev.00016.2003; Baumeister W, 2002, CURR OPIN STRUC BIOL, V12, P679, DOI 10.1016/S0959-440X(02)00378-0; Briggman K L, 2011, CURR OPIN NEUROBIOL, V22, P154, DOI DOI 10.1016/J.C0NB.2011.10.022; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; Catani M, 2013, NEUROIMAGE, V80, P2, DOI 10.1016/j.neuroimage.2013.05.109; COLONNIER MARC, 1968, BRAIN RES, V9, P268, DOI 10.1016/0006-8993(68)90234-5; De Bruijn W C, 1968, 4TH P EUR C EL MICR, P65; Deerinck T. J., 2010, MICROSC MICROANAL, V16, P1138, DOI DOI 10.1017/S1431927610055170; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Goldstein J., 2003, SCANNING ELECT MICRO; Harris KM, 2006, J NEUROSCI, V26, P12101, DOI 10.1523/JNEUROSCI.3994-06.2006; Hayat MA., 1989, PRINCIPLES TECHNIQUE; Hayworth K J, 2006, MICROSC MICROANAL, V12, P86; Hennig P, 2007, J APPL PHYS, V102, DOI 10.1063/1.2817591; HOPPE W, 1981, ANNU REV BIOPHYS BIO, V10, P563, DOI 10.1146/annurev.bb.10.060181.003023; Karnovsky M J, 1971, 11TH ANN M AM SOC CE, P146; Kreshuk A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024899; Kuwajima M, 2013, NEUROSCIENCE, V251, P75, DOI 10.1016/j.neuroscience.2012.04.061; Leighton SB, 1981, SCAN ELECT MICROSC, V2, P73; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; LUBKE J, 1993, MICROSC RES TECHNIQ, V24, P2, DOI 10.1002/jemt.1070240103; Oberti D, 2011, FRONT NEUROSCI, V5, P50; RICHARDS RG, 1995, J MICROSC-OXFORD, V177, P43; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; STEVENS JK, 1980, BRAIN RES REV, V2, P265, DOI 10.1016/0165-0173(80)90010-7; Wergin W P, 1997, Scanning, V19, P386; WHITE JG, 1986, PHILOS T ROY SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477	61	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	FEB	2015	64	1			SI		17	26		10.1093/jmicro/dfu112		10	Microscopy	Microscopy	CI4JW	WOS:000354715500005		
J	Kubota, Y				Kubota, Yoshiyuki			New developments in electron microscopy for serial image acquisition of neuronal profiles	MICROSCOPY			English	Review						3D reconstruction; SBEM; ATUM; FIB-SEM; neuron	INHIBITORY SYNAPSES; DENDRITIC SPINES; RECONSTRUCTION; BRAIN; NEOCORTEX; SECTIONS; AXONS; SEM	Recent developments in electron microscopy largely automate the continuous acquisition of serial electron micrographs (EMGs), previously achieved by laborious manual serial ultrathin sectioning using an ultramicrotome and ultrastructural image capture process with transmission electron microscopy. The new systems cut thin sections and capture serial EMGs automatically, allowing for acquisition of large data sets in a reasonably short time. The new methods are focused ion beam/scanning electron microscopy, ultramicrotome/serial block-face scanning electron microscopy, automated tape-collection ultramicrotome/scanning electron microscopy and transmission electron microscope camera array. In this review, their positive and negative aspects are discussed.	[Kubota, Yoshiyuki] Natl Inst Physiol Sci, Div Cerebral Circuitry, Okazaki, Aichi 4448787, Japan; [Kubota, Yoshiyuki] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Okazaki, Aichi, Japan; [Kubota, Yoshiyuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan	Kubota, Y (reprint author), Natl Inst Physiol Sci, Div Cerebral Circuitry, 5-1 Myodaiji Higashiyama, Okazaki, Aichi 4448787, Japan.	yoshiy@nips.ac.jp			MEXT of Japan [25290012, 24120718, 26112006]; Imaging Science Program of National Institutes of Natural Sciences (NINS)	This work was supported by Grant-in-Aid for Scientific Research (B) (25290012), Grant-in-Aid for Scientific Research on Innovative Areas "Neural creativity for communication (No. 4103)" (24120718) and "Adaptive circuit shift (No. 3603)" (26112006) from the MEXT of Japan; The Imaging Science Program of National Institutes of Natural Sciences (NINS).	Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Mikula S, 2012, NAT METHODS, V9, P1198, DOI [10.1038/nmeth.2213, 10.1038/NMETH.2213]; Langford RM, 2006, MICROSC RES TECHNIQ, V69, P538, DOI 10.1002/jemt.20324; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Egerton RF, 2004, MICRON, V35, P399, DOI 10.1016/j.micron.2004.02.003; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Chen JL, 2011, NAT NEUROSCI, V14, P587, DOI 10.1038/nn.2799; Ohno N, 2014, P NATL ACAD SCI USA, V111, P9953, DOI 10.1073/pnas.1401155111; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; WILLINGHAM MC, 1984, J HISTOCHEM CYTOCHEM, V32, P455; Kubota Y, 2007, J NEUROSCI, V27, P1139, DOI 10.1523/JNEUROSCI.3846-06.2007; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Kubota Y, 2000, J NEUROSCI, V20, P375; Deerinck T. J., 2010, MICROSC MICROANAL, V16, P1138, DOI DOI 10.1017/S1431927610055170; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Harris KM, 2006, J NEUROSCI, V26, P12101, DOI 10.1523/JNEUROSCI.3994-06.2006; Hayworth KJ, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00068; Kubota Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00089; Kubota Y, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.004.2009; LEIGHTON SB, 1981, SCAN ELECTRON MICROS, P73; Merchan-Perez A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.018.2009; Sonomura T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00026; Titze B, 2013, J MICROSC-OXFORD, V250, P101, DOI 10.1111/jmi.12023; WHITE EL, 1980, J NEUROCYTOL, V9, P615, DOI 10.1007/BF01205029; WHITE EL, 1994, J COMP NEUROL, V342, P1, DOI 10.1002/cne.903420102	27	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	FEB	2015	64	1			SI		27	36		10.1093/jmicro/dfu111		10	Microscopy	Microscopy	CI4JW	WOS:000354715500006		
J	Shibata, S; Komaki, Y; Seki, F; Inouye, MO; Nagai, T; Okano, H				Shibata, Shinsuke; Komaki, Yuji; Seki, Fumiko; Inouye, Michiko O.; Nagai, Toshihiro; Okano, Hideyuki			Connectomics: comprehensive approaches for whole-brain mapping	MICROSCOPY			English	Review						connectomics; connectome; brain mapping; magnetic resonance imaging; electron microscope; serial EM	NEMATODE CAENORHABDITIS-ELEGANS; NEURAL STEM/PROGENITOR CELLS; SCANNING-ELECTRON-MICROSCOPY; NERVOUS-SYSTEM; SPINAL-CORD; SERIAL RECONSTRUCTION; SYNAPSE ELIMINATION; HUMAN GENOME; MRI DATA; TRACTOGRAPHY	The aim of connectomics analysis is to understand whole-brain neural connections. This is accomplished using new biotechnologies. Here, we provide an overview of the recent progress in connectomics analysis. The entire neural network of an organism was revealed for the first time in the nematode. Caenorhabditis elegans (C. elegans) have an advantage of their limited number of neurons and their transparency, allowing the neural network to be visualized using light and electron microscopes (EMs). It is practically impossible to adopt the same approach for mammals because of the large number of neural cells and the opacity of the central nervous system. A variety of new technologies are being developed to perform computer-assisted high-throughput image acquisition and analysis to obtain whole-brain maps for higher species, including mammals. Diffusion tensor magnetic resonance imaging and tractography and three-dimensional imaging with the EM are examples of novel approaches to connectomics. These new technologies will soon be applied not only to Drosophila, Caenorhabditis elegans and rodent research, but also to comprehensive connectomics analysis in a wide range of species including humans and primates. In the near future, results from connectomics analysis will reveal the neural circuitry of the whole brain and enhance our understanding of the human mind and neuropsychiatric diseases.	[Shibata, Shinsuke; Komaki, Yuji; Seki, Fumiko; Inouye, Michiko O.; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; [Komaki, Yuji] Cent Inst Expt Anim, Kawasaki Ku, Kawasaki, Kanagawa 2100821, Japan; [Nagai, Toshihiro] Keio Univ, Sch Med, Electron Microscopy Lab, Shinjuku Ku, Tokyo 1608582, Japan; [Okano, Hideyuki] RIKEN, Brain Sci Inst, Lab Marmoset Neural Architecture, Wako, Saitama 3510198, Japan	Shibata, S (reprint author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	shibata@2001.jukuin.keio.ac.jp; hidokano@a2.keio.jp	Okano, Hideyuki/J-5973-2013		Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japanese Government Scholarship program; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) - MEXT	This work was supported by a grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (to S.S.), a grant from Japanese Government Scholarship program (to M.O.I.) and a grant from Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) supported by MEXT (to S.S. and H.O.).	Aggaarwal M, 2014, CEREB CORTEX, DOI [10.1093/ cercor/ bhu006, DOI 10.1093/CERC0R/BHU006]; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI [10.1038/nmeth.1567, 10.1038/NMETH.1567]; Takaku Y, 2013, P NATL ACAD SCI USA, V110, P7631, DOI 10.1073/pnas.1221341110; Stahnisch FW, 2002, TRENDS NEUROSCI, V25, P589, DOI 10.1016/S0166-2236(02)02251-8; Marx V, 2013, NATURE, V503, P147, DOI 10.1038/503147a; HALL DH, 1991, J NEUROSCI, V11, P1; Numasawa-Kuroiwa Y, 2014, STEM CELL REP, V2, P648, DOI 10.1016/j.stemcr.2014.03.007; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; Loulier K, 2014, NEURON, V81, P505, DOI 10.1016/j.neuron.2013.12.016; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; WHITE JG, 1976, PHILOS T ROY SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Irimia A, 2012, NEUROIMAGE, V60, P1340, DOI 10.1016/j.neuroimage.2012.01.107; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Terasaki M, 2013, CELL, V154, P285, DOI 10.1016/j.cell.2013.06.031; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; Yasuda A, 2011, STEM CELLS, V29, P1983, DOI 10.1002/stem.767; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Nagoshi N, 2011, GLIA, V59, P771, DOI 10.1002/glia.21150; Murai T, 2011, J BIOL CHEM, V286, P1999, DOI 10.1074/jbc.M110.184010; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; HARRIS KM, 1988, J NEUROSCI, V8, P4455; Tada H, 2010, J BIOL CHEM, V285, P3840, DOI 10.1074/jbc.M109.046284; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Hampel S, 2011, NAT METHODS, V8, P253, DOI [10.1038/nmeth.1566, 10.1038/NMETH.1566]; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Tabansky I, 2013, CURR BIOL, V23, P21, DOI 10.1016/j.cub.2012.10.054; Lichtman JW, 2003, J NEUROCYTOL, V32, P767, DOI 10.1023/B:NEUR.0000020622.58471.37; Cyranoski D, 2014, NATURE, V514, P151, DOI 10.1038/514151a; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Hagmann P, 2005, THESIS I TRAIT SIGN, P1; Hagmann P., 2009, PLOS BIOL, pe159; Hayworth KJ, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00068; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Irimia Andrei, 2012, Front Neurol, V3, P10, DOI 10.3389/fneur.2012.00010; Ishigaki Y, 2012, PLOS ONE, V7; Jansons Kalvis M, 2003, Inf Process Med Imaging, V18, P672; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Kumagai G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007706; Kuwajima M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059573; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Murota Y, 2014, CELL REP, V8, P103, DOI 10.1016/j.celrep.2014.05.043; Nishimoto Y, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-31; Okano H, 2015, NEUROSCI RES, V93, P3, DOI 10.1016/j.neures.2014.08.014; Pan Y A, 2011, COLD SPRING HARB PRO; Sato C, 2012, BIOCHEM BIOPH RES CO, V417, P1213, DOI 10.1016/j.bbrc.2011.12.111; Schalek R, 2011, MICROSC MICROANAL, V17, P2; Shibata S, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-31; STEVENS JK, 1980, BRAIN RES REV, V2, P265, DOI 10.1016/0165-0173(80)90010-7; STEVENS JK, 1980, SCIENCE, V207, P317, DOI 10.1126/science.7350663; STEVENS JK, 1986, ANAL QUANT CYTOL, V8, P102; Suga M, 2011, ULTRAMICROSCOPY, V111, P1650, DOI 10.1016/j.ultramic.2011.08.001; Takano M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-40; Takano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052904; WHITE JG, 1986, PHILOS T ROY SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhang L, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-14	65	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	FEB	2015	64	1			SI		57	67		10.1093/jmicro/dfu103		11	Microscopy	Microscopy	CI4JW	WOS:000354715500009		
J	Horie, M; Stowe, M; Tabei, M; Kuroda, E				Horie, Masanori; Stowe, Mayumi; Tabei, Miki; Kuroda, Etsushi			Pharyngeal aspiration of metal oxide nanoparticles showed potential of allergy aggravation effect to inhaled ovalbumin	INHALATION TOXICOLOGY			English	Article						Allergy aggravation; nanoparticle; ovalbumin; zinc oxide	ASIAN SAND DUST; ACUTE OXIDATIVE STRESS; IN-VITRO; INTRATRACHEAL INSTILLATION; PARTICULATE MATTER; ZNO NANOPARTICLES; SURFACE-AREA; ION RELEASE; MURINE LUNG; RAT LUNG	The inhalation of manufactured metal oxide nanoparticles may lead to pulmonary toxicity. For instance, ZnO nanoparticles are known to induce pulmonary oxidative stress and inflammation. On the other hand, the pulmonary toxicity of TiO2 nanoparticles is less than that of ZnO nanoparticles. Although, there have been some investigations concerning the induction of pulmonary oxidative stress and inflammation caused by manufactured metal oxide nanoparticles. And, although, it has reported that some nanoparticles cause aggravation of allergic reactions, there have so far been no reports regarding allergy aggravation effects of manufactured metal oxide nanoparticles. In this study, three types of nanoparticles, TiO2, ZnO and SiO2, were administered to mouse lungs by pharyngeal aspiration. Subsequently, the mice inhaled ovalbumin (OVA) a total of eight times over 3 weeks. After inhalation of OVA, the concentrations of total IgE, OVA-specific IgE and OVA-specific IgG(1) in serum increased in the mice treated with ZnO. TiO2 and SiO2 nanoparticles did not affect the OVA-specific IgE and IgG(1) levels. These results suggest that ZnO nanoparticles have the potential to aggravate allergic reactions. The results also suggest that Zn2+ release from ZnO nanoparticles is involved in the aggravation potential of allergies. However, pharyngeal aspiration of ZnCl2 solution was not able to aggravate allergic reactions. Continuous Zn2+ release from ZnO nanoparticles to the lung is necessary for the aggravation of allergic reactions.	[Horie, Masanori] Natl Inst Adv Ind Sci & Technol, HRI, Takamatsu, Kagawa 7610395, Japan; [Horie, Masanori; Stowe, Mayumi; Tabei, Miki] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Yahata Nishi Ku, Kitakyushu, Fukuoka, Japan; [Kuroda, Etsushi] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Vaccine Sci, Suita, Osaka, Japan	Horie, M (reprint author), Natl Inst Adv Ind Sci & Technol, HRI, 2217-14 Hayashi Cho, Takamatsu, Kagawa 7610395, Japan.	masa-horie@aist.go.jp			JSPS KAKENHI [25871005]	This work was funded by JSPS KAKENHI Grant Number 25871005. The authors report no declarations of interest.	Chuang HC, 2013, INT J NANOMED, V8, P4495, DOI 10.2147/IJN.S52239; Karlsson HL, 2009, TOXICOL LETT, V188, P112, DOI 10.1016/j.toxlet.2009.03.014; Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j; Horie M, 2009, CHEM RES TOXICOL, V22, P543, DOI 10.1021/tx800289z; Ichinose T, 2008, ARCH ENVIRON CON TOX, V55, P348, DOI 10.1007/s00244-007-9128-8; Fukui H, 2012, CHEM-BIOL INTERACT, V198, P29, DOI 10.1016/j.cbi.2012.04.007; Gilbert B, 2012, ACS NANO, V6, P4921, DOI 10.1021/nn300425a; Kao YY, 2012, TOXICOL SCI, V125, P462, DOI 10.1093/toxsci/kfr319; De Angelis I, 2013, NANOTOXICOLOGY, V7, P1361, DOI 10.3109/17435390.2012.741724; Ramasamy M, 2014, INT J NANOMED, V9, P3707, DOI 10.2147/IJN.S65086; Mimura T, 2014, SCI TOTAL ENVIRON, V487, P493, DOI 10.1016/j.scitotenv.2014.04.057; Ho M, 2011, INHAL TOXICOL, V23, P947, DOI 10.3109/08958378.2011.629235; Monopoli MP, 2011, J AM CHEM SOC, V133, P2525, DOI 10.1021/ja107583h; Altunbek M, 2014, COLLOID SURFACE B, V121, P106, DOI 10.1016/j.colsurfb.2014.05.034; Ichinose T, 2008, INHAL TOXICOL, V20, P685, DOI 10.1080/08958370801935133 ; Cai L, 1998, CHEM-BIOL INTERACT, V115, P141, DOI 10.1016/S0009-2797(98)00069-6; Garcia GJM, 2009, INHAL TOXICOL, V21, P1165, DOI 10.3109/08958370902882713; Horie M, 2012, METALLOMICS, V4, P350, DOI 10.1039/c2mt20016c; Sarkar A, 2014, J NANOSCI NANOTECHNO, V14, P730, DOI 10.1166/jnn.2014.8752; Horie M, 2012, CHEM RES TOXICOL, V25, P605, DOI 10.1021/tx200470e; Horie M, 2009, CHEM RES TOXICOL, V22, P1415, DOI 10.1021/tx900171n; Triboulet S, 2014, NANOSCALE, V6, P6102, DOI 10.1039/c4nr00319e; Nikasinovic L, 2006, J ALLERGY CLIN IMMUN, V117, P1382, DOI 10.1016/j.jaci.2006.03.023; He M, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-19; Horie M, 2011, J OCCUP HEALTH, V53, P64, DOI 10.1539/joh.L10121; Horie M, 2012, INHAL TOXICOL, V24, P391, DOI 10.3109/08958378.2012.682321; Ichinose T, 2009, INHAL TOXICOL, V21, P985, DOI 10.1080/08958370802672883; Johnson BM, 2014, NANOTOXICOLOGY, V7, P1; Karlsson HL, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0041-9; Lefebvre DE, 2014, TOXICOL SCI, V138, P322, DOI 10.1093/toxsci/kfu010; Mizuguchi Y, 2013, INHAL TOXICOL, V25, P29, DOI 10.3109/08958378.2012.751470; Morishita M, 2004, INHAL TOXICOL, V16, P663, DOI 10.1080/08958370490476550; Riedl MA, 2012, RES REP HLTH EFF I, V165, P5; Saito Y, 2002, EXP LUNG RES, V28, P493, DOI 10.1080/01902140290096764; Syama S, 2014, TOXICOL MECH METHOD, V24, P644, DOI 10.3109/15376516.2014.956914; Takano H, 1998, IMMUNOPHARM IMMUNOT, V20, P329, DOI 10.3109/08923979809038548	36	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0895-8378	1091-7691		INHAL TOXICOL	Inhal. Toxicol.	FEB	2015	27	3					181	190		10.3109/08958378.2015.1026618		10	Toxicology	Toxicology	CI0DK	WOS:000354406000007		
J	Kusama, K; Yoshie, M; Tamura, K; Imakawa, K; Tachikawa, E				Kusama, Kazuya; Yoshie, Mikihiro; Tamura, Kazuhiro; Imakawa, Kazuhiko; Tachikawa, Eiichi			EPAC2-mediated calreticulin regulates LIF and COX2 expression in human endometrial glandular cells	JOURNAL OF MOLECULAR ENDOCRINOLOGY			English	Article						exchange protein directly activated by cAMP (EPAC); calreticulin (CALR); leukemia inhibitory factor (LIF); cyclooxygenase 2 (COX2, PTGS2); prostaglandin E2 (PGE2); endometrial glandular epithelial cell	LEUKEMIA INHIBITORY FACTOR; CYCLIC-AMP EPAC; EMBRYO IMPLANTATION; STROMAL CELLS; MENSTRUAL-CYCLE; PROTEIN; RAP1; DECIDUALIZATION; MOUSE; LOCALIZATION	The proper production of the implantation-related factors, leukemia inhibitory factor (LIF), cyclooxygenase 2 (COX2, PTGS2), and prostaglandin E2 (PGE2) in the uterine glands is essential for embryo implantation and the establishment of endometrial receptivity. It has been shown that cAMP-mediated protein kinase A (PKA) signaling regulates the production of these factors. We have previously reported that exchange protein directly activated by cAMP 2 (EPAC2, RAPGEF4), another cAMP mediator, is involved in the differentiation of endometrial stromal cells through the regulation of the expression of calreticulin (CALR). To address whether EPAC2-CALR signaling is involved in the expression of implantation-related factors, we examined the effect of EPAC2 and CALR knockdown on their expression in cultured human endometrial glandular epithelial EM1 cells, treated with forskolin, an adenylyl cyclase activator, an EPAC-selective cAMP analog (8-(4-chlorophenylthio)-2'-O-methyl cAMP (CPT)), or a PKA-selective cAMP analog (N-6-phenyl-cAMP (Phe)). In addition, the status of cell senescence was examined. EPAC2 knockdown suppressed the expression of CALR protein and mRNA in EM1 cells. Forskolin- or Phe-, but not CPT-, induced expression of LIF or PTGS2 and secretion of PGE2 was inhibited in EPAC2- or CALR-silenced EM1 cells. In addition, knockdown of EPAC2 or CALR increased senescence-associated beta galactosidase activity and expression of p21 but decreased expression of p53. These findings indicate that expression of CALR regulated by EPAC2 in endometrial glandular epithelial cells is critical for the expression of LIF and PTGS2-mediated production of PGE2 through cAMP signaling. Furthermore, EPAC2 and CALR could play a role in the maintenance of gland function.	[Kusama, Kazuya; Yoshie, Mikihiro; Tamura, Kazuhiro; Tachikawa, Eiichi] Tokyo Univ Pharm & Life Sci, Dept Endocrine & Neural Pharmacol, Hachioji, Tokyo 1920392, Japan; [Kusama, Kazuya; Imakawa, Kazuhiko] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Theriogenol & Anim Breeding, Bunkyo Ku, Tokyo 1138657, Japan	Tamura, K (reprint author), Tokyo Univ Pharm & Life Sci, Dept Endocrine & Neural Pharmacol, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	hiro@toyaku.ac.jp			KAKENHI from the Japan Society for the Promotion of Science [25861511]	This work was supported by KAKENHI (Grant-in-Aid for Young Scientists (B), 25861511 to M Y) from the Japan Society for the Promotion of Science.	Ahn YH, 2006, J CELL PHYSIOL, V209, P1039, DOI 10.1002/jcp.20821; Yoshie M, 2010, HUM REPROD, V25, P2229, DOI 10.1093/humrep/deq190; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Lim HJ, 2010, J CLIN INVEST, V120, P1004, DOI 10.1172/JCI41210; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; de Rooij J, 1998, NATURE, V396, P474; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Zhang CL, 2009, SCIENCE, V325, P607, DOI 10.1126/science.1172256; Tinel H, 2000, MOL HUM REPROD, V6, P1119, DOI 10.1093/molehr/6.12.1119; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Matsumoto H, 2002, J BIOL CHEM, V277, P29260, DOI 10.1074/jbc.M203996200; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Kusama K, 2014, ENDOCRINOLOGY, V155, P240, DOI 10.1210/en.2013-1478; Zhou XL, 1999, J CLIN ENDOCR METAB, V84, P3364, DOI 10.1210/jc.84.9.3364; Kyo S, 2003, AM J PATHOL, V163, P2259, DOI 10.1016/S0002-9440(10)63583-3; Ruan YC, 2012, NAT MED, V18, P1112, DOI 10.1038/nm.2771; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Senturk LM, 1998, AM J REPROD IMMUNOL, V39, P144; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Liu XM, 2012, J CLIN ENDOCR METAB, V97, P3672, DOI 10.1210/jc.2012-2075; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P9761, DOI 10.1073/pnas.0904280106; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Cheng Z, 2007, REPRODUCTION, V133, P1017, DOI 10.1530/REP-06-0220; Kusama K, 2014, REPRODUCTION, V147, P897, DOI 10.1530/REP-13-0654; Kusama K, 2013, PLACENTA, V34, P212, DOI 10.1016/j.placenta.2012.12.017; Kutsukake M, 2010, MOL REPROD DEV, V77, P265, DOI 10.1002/mrd.21143; Marions L, 1999, MOL HUM REPROD, V5, P961, DOI 10.1093/molehr/5.10.961; Mesaeli N, 2004, MOL BIOL CELL, V15, P1862, DOI 10.1091/mbc.E03-04-0251; Milne SA, 2001, J CLIN ENDOCR METAB, V86, P4453, DOI 10.1210/jc.86.9.4453; Parmar T, 2009, FERTIL STERIL, V92, P1091, DOI 10.1016/j.fertnstert.2008.07.1734; Parmar T, 2009, HUM REPROD, V24, P2205, DOI 10.1093/humrep/dep187	34	2	2	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0952-5041			J MOL ENDOCRINOL	J. Mol. Endocrinol.	FEB	2015	54	1					17	24		10.1530/JME-14-0162		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CI3EE	WOS:000354629600004		
J	Nuida, K; Abe, T; Kaji, S; Maeno, T; Numata, Y				Nuida, Koji; Abe, Takuro; Kaji, Shizuo; Maeno, Toshiaki; Numata, Yasuhide			A Mathematical Problem for Security Analysis of Hash Functions and Pseudorandom Generators	INTERNATIONAL JOURNAL OF FOUNDATIONS OF COMPUTER SCIENCE			English	Article						Function density problem; hash function; pseudorandom generator; security evaluation		In this paper, we specify a class of mathematical problems, which we refer to as "Function Density Problems" (FDPs, in short), and point out novel connections of FDPs to the following two cryptographic topics; theoretical security evaluations of keyless hash functions (such as SHA-1.), and constructions of provably secure pseudorandom generators (PRGs) with some enhanced security property introduced by Dubrov and Ishai (STOC 2006). Our argument aims at proposing new theoretical frameworks for these topics (especially for the former) based on FDPs, rather than providing some concrete and practical results on the topics. We also give some examples of mathematical discussions on FDFs, which would be of independent interest from mathematical viewpoints. Finally, we discuss possible directions of future research on other cryptographic applications of FDPs and on mathematical studies on FDPs themselves.	[Nuida, Koji] Natl Inst Sci & Technol AIST, Res Inst Secure Syst RISEC, Tsukuba, Ibaraki 3058568, Japan; [Abe, Takuro] Kyoto Univ, Dept Mech Engn & Sci, Kyoto 6068501, Japan; [Kaji, Shizuo] Yamaguchi Univ, Fac Sci, Dept Math Sci, Yamaguchi 7538512, Japan; [Maeno, Toshiaki] Meijo Univ, Dept Math, Nagoya, Aichi 4688502, Japan; [Numata, Yasuhide] Shinshu Univ, Dept Math Sci, Nagano 3908621, Japan	Nuida, K (reprint author), Natl Inst Sci & Technol AIST, Res Inst Secure Syst RISEC, AIST Tsukuba Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	k.nuida@aist.go.jp; abe.takuro.4c@kyoto-u.ac.jp; skaji@yamaguchi-u.ac.jp; tmaeno@meijo-u.ac.jp; nu@math.shinshu-u.ac.jp					BLUM L, 1986, SIAM J COMPUT, V15, P364, DOI 10.1137/0215025; RIVEST RL, 1978, COMMUN ACM, V21, P120, DOI 10.1145/359340.359342; Blais E., 2014, P ICALP 2014 1, P235; Carter J. L., 1977, P STOC 1977, V1977, P106; Dubrov B., 2006, P STOC 2006, V2006, P711; Farashahi R. R., 2007, P PKC 2007, V2007, P426; Henshall K., 2010, CHIC J THEORET COMPU, P1; Matsumoto T., 1988, P EUROCRYPT 1988, V1988, P419; Nuida K., 2011, P IWSEC 2011, V2011, P144; Nuida K, 2013, IEEE T INFORM THEORY, V59, P635, DOI 10.1109/TIT.2012.2216978; Rogaway P., 2006, P VIETCRYPT 2006, V2006, P211; Wang ., 2005, P CRYPTO 2005, V2005, P17	12	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0129-0541	1793-6373		INT J FOUND COMPUT S	Int. J. Found. Comput. Sci.	FEB	2015	26	2					169	194		10.1142/S0129054115500100		26	Computer Science, Theory & Methods	Computer Science	CH5BL	WOS:000354049200001		
J	Blokhin, IS; Gavrilkin, SY; Gorshunov, BP; Dravin, VA; Zhukova, ES; Ivanenko, OM; Iida, K; Krasnosvobodtsev, SI; Kurth, F; Mitsen, KV; Tsvetkov, AY				Blokhin, I. S.; Gavrilkin, S. Yu.; Gorshunov, B. P.; Dravin, V. A.; Zhukova, E. S.; Ivanenko, O. M.; Iida, K.; Krasnosvobodtsev, S. I.; Kurth, F.; Mitsen, K. V.; Tsvetkov, A. Yu.			Effect of radiation defects on the magnetotransport properties of Ba(Fe1-x Co (x) As)(2) high-temperature superconductor	JETP LETTERS			English	Article							IMPURITIES	The effect of 200-keV He+ ion irradiation on the transport properties of films of the iron-based Ba(Fe1 - x Co (x) As)(2) superconductor has been studied. Contributions to the resistivity and magnetoresistance of irradiated samples from scattering by magnetic and nonmagnetic defects have been separated. It has been shown that mainly nonmagnetic defects are generated in the sample under the corresponding irradiation conditions. This result is important in view of the use of the radiation technique for the study of the effect of defects on the properties of iron-based superconductors.	[Blokhin, I. S.; Gavrilkin, S. Yu.; Dravin, V. A.; Ivanenko, O. M.; Krasnosvobodtsev, S. I.; Mitsen, K. V.; Tsvetkov, A. Yu.] Russian Acad Sci, Lebedev Phys Inst, Moscow 119991, Russia; [Gorshunov, B. P.; Zhukova, E. S.] Russian Acad Sci, Prokhorov Gen Phys Inst, Moscow 119991, Russia; [Gorshunov, B. P.; Zhukova, E. S.] Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Moscow Region, Russia; [Iida, K.; Kurth, F.] Leibniz Inst Solid State & Mat Res Dresden, D-01069 Dresden, Germany; [Iida, K.] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan	Blokhin, IS (reprint author), Russian Acad Sci, Lebedev Phys Inst, Leninskii Pr 53, Moscow 119991, Russia.	mitsen@sci.lebedev.ru	Iida, Kazumasa/C-5702-2013; Ivanenko, Olga/M-3595-2015; Mitsen, Kirill/M-3729-2015; Gavrilkin, Sergey/M-3765-2015; Tsvetkov, Alexey/M-3827-2015; Blokhin, Ilya/M-4143-2015; Dravin, Valeri/M-7266-2015; Krasnosvobodtsev, Sergei/M-7977-2015; Gorshunov, Boris/J-3928-2013; Zhukova, Elena/M-6761-2013	Iida, Kazumasa/0000-0003-1038-9630; 	Russian Academy of Sciences [20]; Russian Foundation for Basic Research [14-02-00785]; Ministry of Education and Science of the Russian Federation [5top100]	We are grateful to O.V. Dolgov, I.M. Eremin, D.V. Efremov, M.M. Korshunov, M. Dressel, and S. Zapf for useful discussion of the results. This work was supported by the Russian Academy of Sciences (program no. 20), by the Russian Foundation for Basic Research (project no. 14-02-00785), and by the Ministry of Education and Science of the Russian Federation (program 5top100).	ABRIKOSOV AA, 1961, SOV PHYS JETP-USSR, V12, P1243; Openov LA, 1998, PHYS REV B, V58, P9468, DOI 10.1103/PhysRevB.58.9468; Mazin II, 2010, NATURE, V464, P183, DOI 10.1038/nature08914; BORKOWSKI LS, 1994, PHYS REV B, V49, P15404, DOI 10.1103/PhysRevB.49.15404; Efremov DV, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.180512; Tarantini C, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.087002; Mizukami Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6657; Rullier-Albenque F, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.045105	8	1	1	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0021-3640	1090-6487		JETP LETT+	Jetp Lett.	FEB	2015	101	4					247	250		10.1134/S0021364015040050		4	Physics, Multidisciplinary	Physics	CH5ST	WOS:000354096300007		
J	Nakahira, R; Michishita, M; Yoshimura, H; Hatakeyama, H; Takahashi, K				Nakahira, R.; Michishita, M.; Yoshimura, H.; Hatakeyama, H.; Takahashi, K.			Neuroendocrine Carcinoma of the Mammary Gland in a Dog	JOURNAL OF COMPARATIVE PATHOLOGY			English	Article						dog; mammary gland; neuroendocrine carcinoma	MERKEL CELL-CARCINOMA; MUCINOUS CARCINOMA	A 10-year-old female border collie was presented with a mass (2 cm diameter) in the fifth mammary gland. The mass was located in the subcutis and the cut surface was grey white in colour. Microscopically, the mass was composed of tumour cells arranged in nests of various sizes separated by delicate fibrovascular stroma. The tumour cells had small, round hypochromatic nuclei and abundant cytoplasm. Metastases were observed in the inguinal lymph node. Immunohistochemically, most tumour cells expressed cytokeratin (CK) 20, chromogranin A, neuron-specific enolase, synaptophysin and oestrogen receptor-beta, but not low molecular weight CK (CAM5.2), p63 and insulin. Ultrastructurally, the tumour cells contained a large number of electron-dense granules corresponding to neuroendocrine granules. Based on these findings, this case was diagnosed as a neuroendocrine carcinoma of the mammary gland. (C) 2014 Elsevier Ltd. All rights reserved.	[Nakahira, R.; Michishita, M.; Takahashi, K.] Nippon Vet & Life Sci Univ, Sch Vet Med, Dept Vet Pathol, Tokyo, Japan; [Yoshimura, H.] Nippon Vet & Life Sci Univ, Sch Vet Nursing & Technol, Dept Appl Sci, Tokyo, Japan; [Hatakeyama, H.] Nippon Vet & Life Sci Univ, Dept Comparat Cellular Biol, Tokyo, Japan	Michishita, M (reprint author), Nippon Vet & Life Sci Univ, Sch Vet Med, Dept Vet Pathol, Tokyo, Japan.	michishita@nvlu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) [26292161]	We thank Dr. T. Ishiwata from Department of Integrated Diagnostic Pathology, Graduate School of Medicine, Nippon Medical School for helpful discussions and Dr. M. Namiki for providing this specimen. This work was supported in part by Grants-in-Aid for Scientific Research (26292161) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT).	Joiner KS, 2010, VET PATHOL, V47, P1090, DOI 10.1177/0300985810375945; Ozaki K, 2009, J VET MED SCI, V71, P1093, DOI 10.1292/jvms.71.1093; Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; Brunetti B, 2003, J COMP PATHOL, V129, P131, DOI 10.1016/S0021-9975(03)00020-3; Bussolati G, 2012, WHO CLASSIFICATION T, P62; Espinosa de los Monteros A, 1999, VET PATHOL, V36, P179; Gil da Costa RM, 2009, VET DERMATOL, V21, P198; Kohler S, 2006, WHO CLASSIFICATION T, P272; Konno A, 1998, VET PATHOL, V35, P538; Martin de las Mulas J, 2004, VET PATHOL, V41, P269; Misdorp W., 1999, HISTOLOGICAL CLASSIF; SCOPSI L, 1994, AM J SURG PATHOL, V18, P702, DOI 10.1097/00000478-199407000-00006; Sorenmo K.U., 2013, SMALL ANIMAL CLIN ON, VFifth, P538	13	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9975	1532-3129		J COMP PATHOL	J. Comp. Pathol.	FEB-APR	2015	152	2-3					188	191		10.1016/j.jcpa.2014.12.009		4	Pathology; Veterinary Sciences	Pathology; Veterinary Sciences	CH4KH	WOS:000354001900015		
J	Mwase, M; Shimada, K; Mumba, C; Yabe, J; Squarre, D; Madarame, H				Mwase, M.; Shimada, K.; Mumba, C.; Yabe, J.; Squarre, D.; Madarame, H.			Positive Immunolabelling for Feline Infectious Peritonitis in an African Lion (Panthera leo) with Bilateral Panuveitis	JOURNAL OF COMPARATIVE PATHOLOGY			English	Article						African lion (Panthera leo); feline infectious peritonitis; immunohistochemistry; panuveitis	CORONAVIRUS INFECTION; DIAGNOSIS	A 15-year-old male African lion (Panthera leo) was presented with blindness due to bilateral panuveitis with retinal detachment. Feline coronavirus (FCoV) antigen was identified immunohistochemically in ocular macrophages, consistent with a diagnosis of feline infectious peritonitis (FIP) infection. This is the first report of FIP in an African lion and the first report of ocular FIP in a non-domestic felid. (C) 2014 Elsevier Ltd. All rights reserved.	[Mwase, M.; Mumba, C.; Yabe, J.] Univ Zambia, Sch Vet Med, Dept Paraclin Studies, Lusaka, Zambia; [Squarre, D.] Zambia Wildlife Author ZAWA, Chilanga, Zambia; [Shimada, K.; Madarame, H.] Azabu Univ, Vet Teaching Hosp, Lab Small Anim Clin, Chuo Ku, Sagamihara, Kanagawa, Japan	Madarame, H (reprint author), Azabu Univ, Vet Teaching Hosp, Lab Small Anim Clin, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa, Japan.	madarame@azabu-u.ac.jp					Kipar A, 2014, VET PATHOL, V51, P505, DOI 10.1177/0300985814522077; Bailey EL, 2012, BRAIN PATHOL, V22, P583, DOI 10.1111/j.1750-3639.2012.00575.x; DOHERTY MJ, 1971, J AM VET MED ASSOC, V159, P417; Bauer BS, 2013, VET OPHTHALMOL, V16, P160, DOI 10.1111/vop.12044; COLBY ED, 1970, VET MED SM ANIM CLIN, V65, P783; Colby ED, 1970, COMP PATH B, V2, P4; Drechsler Y, 2011, VET CLIN N AM-SMALL, V41, P1133, DOI 10.1016/j.cvsm.2011.08.004; Dubielzig RR, 2010, VET OCULAR PATHOLOGY, P245, DOI 10.1016/B978-0-7020-2797-0.00009-6; Foley JE, 2001, J VET INTERN MED, V15, P438, DOI 10.1892/0891-6640(2001)015<0438:AROCII>2.3.CO;2; Giori L, 2011, J SMALL ANIM PRACT, V52, P152, DOI 10.1111/j.1748-5827.2011.01042.x; HOHDATSU T, 1991, VET MICROBIOL, V28, P13, DOI 10.1016/0378-1135(91)90096-X; Kennedy M, 2003, J WILDLIFE DIS, V39, P529; McReynolds C, 1997, COMP CONT EDUC PRACT, V19, P1007; ROBISON RL, 1971, J AM VET MED ASSOC, V158, P981; Stephenson N, 2013, J WILDLIFE DIS, V49, P408, DOI 10.7589/2012-08-210; Vandevelde M, 2012, VET NEUROPATHOLOGY E, P44	16	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9975	1532-3129		J COMP PATHOL	J. Comp. Pathol.	FEB-APR	2015	152	2-3					265	268		10.1016/j.jcpa.2014.12.006		4	Pathology; Veterinary Sciences	Pathology; Veterinary Sciences	CH4KH	WOS:000354001900026		
J	Aoyama, N; Suzuki, Y; Nishino, H; Kobayashi, K; Hirai, F; Watanabe, K; Naganuma, M; Hibi, T				Aoyama, N.; Suzuki, Y.; Nishino, H.; Kobayashi, K.; Hirai, F.; Watanabe, K.; Naganuma, M.; Hibi, T.			Twice-daily budesonide rectal foam induces complete mucosal healing in Japanese patients with mild to moderate ulcerative colitis: Results of multicenter, randomized, double-blind, placebo-controlled trial	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Aoyama, N.] GI Endoscopy & IBD Ctr, Aoyama Med Clin, Kobe, Hyogo, Japan; [Suzuki, Y.] Toho Univ, Dept Internal Med, Sakura Med Ctr, Sakura, Japan; [Nishino, H.] Matsushima Clin, Coloproctol Ctr, Yokohama, Kanagawa 228, Japan; [Kobayashi, K.] Kitasato Univ, Dept Res & Dev, Ctr New Med Frontiers, Sagamihara, Kanagawa 228, Japan; [Hirai, F.] Fukuoka Univ, Chikushi Hosp, Dept Gastroenterol, Chikushino, Japan; [Watanabe, K.] Osaka City Gen Hosp, Dept Gastroenterol, Osaka, Japan; [Naganuma, M.] Keio Univ, Sch Med, Ctr Diagnost & Therapeut Endoscopy, Tokyo, Japan; [Hibi, T.] Kitasato Univ, Ctr Adv IBD Res & Treatment, Kitasato Inst Hosp, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P558	S359	S359				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200673		
J	Araki, M; Shinzaki, S; Iijima, H; Yamaguchi, T; Kawai, S; Hiyama, S; Inoue, T; Hayashi, Y; Watabe, K; Tsujii, M; Miyoshi, E; Takehara, T				Araki, M.; Shinzaki, S.; Iijima, H.; Yamaguchi, T.; Kawai, S.; Hiyama, S.; Inoue, T.; Hayashi, Y.; Watabe, K.; Tsujii, M.; Miyoshi, E.; Takehara, T.			Agalactosyl IgG predicts therapeutic effect of anti-TNF agents in patients with Crohn's Disease	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Araki, M.; Shinzaki, S.; Iijima, H.; Yamaguchi, T.; Kawai, S.; Hiyama, S.; Inoue, T.; Hayashi, Y.; Watabe, K.; Tsujii, M.; Takehara, T.] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan; [Miyoshi, E.] Osaka Univ, Dept Mol Biochem & Clin Invest, Grad Sch Med, Suita, Osaka 565, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P362	S259	S260				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200478		
J	Araki, M; Shinzaki, S; Iijima, H; Hiyama, S; Yamada, T; Arimitsu, S; Komori, M; Ito, M; Mukai, A; Nakajima, S; Terabe, F; Kinoshita, K; Kitamura, S; Murayama, Y; Ogawa, H; Yasunaga, Y; Oshita, M; Masuda, E; Tsujii, M; Takehara, T				Araki, M.; Shinzaki, S.; Iijima, H.; Hiyama, S.; Yamada, T.; Arimitsu, S.; Komori, M.; Ito, M.; Mukai, A.; Nakajima, S.; Terabe, F.; Kinoshita, K.; Kitamura, S.; Murayama, Y.; Ogawa, H.; Yasunaga, Y.; Oshita, M.; Masuda, E.; Tsujii, M.; Takehara, T.			Age of onset is associated with disease seasonality in inflammatory bowel disease: A multi-center observational study by the Osaka Gut Forum	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Araki, M.; Shinzaki, S.; Iijima, H.; Hiyama, S.; Tsujii, M.; Takehara, T.] Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Suita, Osaka, Japan; [Yamada, T.] Natl Hosp Org, Osaka Med Ctr, Dept Gastroenterol, Chuo Ku, Osaka, Japan; [Arimitsu, S.] Infus Clin, Osaka, Japan; [Komori, M.] Osaka Rosai Hosp, Dept Gastroenterol, Kita Ku, Sakai, Osaka, Japan; [Ito, M.] NTT West Hosp, Dept Gastroenterol, Tennoji Ku, Osaka, Japan; [Mukai, A.] Sumitomo Hosp, Dept Gastroenterol, Kita Ku, Osaka, Japan; [Nakajima, S.] Toyonaka City Hosp, Dept Gastroenterol, Toyonaka, Osaka, Japan; [Terabe, F.] Yao Municipal Hosp, Dept Gastroenterol, Yao, Osaka, Japan; [Kinoshita, K.] Otemae Hosp, Dept Gastroenterol, Chuo Ku, Osaka, Japan; [Kitamura, S.] Sakai City Hosp, Dept Gastroenterol, Sakai Ku, Sakai, Osaka, Japan; [Murayama, Y.] Itami City Hosp, Dept Gastroenterol, Itami, Hyogo, Japan; [Ogawa, H.] Nishinomiya Municipal Cent Hosp, Dept Gastroenterol, Nishinomiya, Hyogo, Japan; [Yasunaga, Y.] Hyogo Prefectural Nishinomiya Hosp, Dept Gastroenterol, Nishinomiya, Hyogo, Japan; [Oshita, M.] Osaka Police Hosp, Dept Gastroenterol, Tennoji Ku, Osaka, Japan; [Masuda, E.] Natl Hosp Org, Osaka Minami Med Ctr, Dept Gastroenterol, Kawachi Nagano, Osaka, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P650	S407	S407				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200765		
J	Haga, K; Chiba, A; Shibuya, T; Osada, T; Ishikawa, D; Kodani, T; Nomura, O; Watanabe, S; Miyake, S				Haga, K.; Chiba, A.; Shibuya, T.; Osada, T.; Ishikawa, D.; Kodani, T.; Nomura, O.; Watanabe, S.; Miyake, S.			Analysis of Innate-like Lymphocyte Subsets in Ulcerative Colitis	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Haga, K.; Shibuya, T.; Osada, T.; Ishikawa, D.; Kodani, T.; Nomura, O.; Watanabe, S.] Juntendo Univ, Dept Gastroenterol, Tokyo, Japan; [Chiba, A.; Miyake, S.] Juntendo Univ, Dept Immunol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P011	S82	S82				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200128		
J	Hayashi, R; Tsuchiya, K; Hibiya, S; Fukushima, K; Horita, N; Okada, E; Araki, A; Ohtsuka, K; Watanabe, M				Hayashi, R.; Tsuchiya, K.; Hibiya, S.; Fukushima, K.; Horita, N.; Okada, E.; Araki, A.; Ohtsuka, K.; Watanabe, M.			Human alpha-Defensin 6 regulated by both Atoh1 and beta-catenin might be the pathogenesis of Japanese Crohn's Disease	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Hayashi, R.] Hiroshima Univ Hosp, Gastroenterol & Metab, Hiroshima, Japan; [Tsuchiya, K.] Tokyo Med & Dent Univ, Adv Therapeut Gastrointestinal Dis, Tokyo, Japan; [Hibiya, S.; Fukushima, K.; Horita, N.; Okada, E.; Araki, A.; Ohtsuka, K.; Watanabe, M.] Tokyo Med & Dent Univ, Gastroenterol & Hepatol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P059	S106	S107				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200176		
J	Hibiya, S; Tsuchiya, K; Fukushima, K; Hayashi, R; Horita, N; Oshima, S; Okamoto, R; Nakamura, T; Watanabe, M				Hibiya, S.; Tsuchiya, K.; Fukushima, K.; Hayashi, R.; Horita, N.; Oshima, S.; Okamoto, R.; Nakamura, T.; Watanabe, M.			Long-term stimulation with cytokines acquires irreversible accumulation of NF-kappa B signaling in colonic epithelial cells	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Hibiya, S.; Fukushima, K.; Horita, N.; Oshima, S.; Watanabe, M.] Tokyo Med & Dent Univ, Gastroenterol & Hepatol, Tokyo, Japan; [Tsuchiya, K.; Okamoto, R.; Nakamura, T.] Tokyo Med & Dent Univ, Adv Therapeut Gastrointestinal Dis, Tokyo, Japan; [Hayashi, R.] Hiroshima Univ Hosp, Gastroenterol & Metab, Hiroshima, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P017	S85	S85				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200134		
J	Hirano, A; Umeno, J; Asano, K; Esaki, M; Matsumoto, T				Hirano, A.; Umeno, J.; Asano, K.; Esaki, M.; Matsumoto, T.			A functional variant of SLC26A3 in association with Ulcerative Colitis down regulates SLC26A3 expression	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Hirano, A.; Umeno, J.; Asano, K.; Esaki, M.] Kyushu Univ, Dept Med & Clin Sci, Fukuoka 812, Japan; [Hirano, A.] Yamaguchi Red Cross Hosp, Dept Internal Med, Yamaguchi, Japan; [Matsumoto, T.] Iwate Med Univ, Dept Internal Med, Div Gastroenterol, Morioka, Iwate 020, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P694	S428	S428				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200809		
J	Hirayama, Y; Watanabe, O; Nakamura, M; Yamamura, T; Goto, H				Hirayama, Y.; Watanabe, O.; Nakamura, M.; Yamamura, T.; Goto, H.			Sequential Change of Endoscopic Findings and Therapeutic Efficacy of Anti-TNF alpha therapy for Patients with Intestinal Behcet's Disease	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Hirayama, Y.; Watanabe, O.; Nakamura, M.; Yamamura, T.; Goto, H.] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan; [Hirayama, Y.] Tokai Cent Hosp, Dept Endoscopy, Kakamigahara, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P583	S372	S372				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200698		
J	Ishige, T; Tomomasa, T; Hatori, R; Tatsuki, M; Igarashi, Y; Arai, K; Arakawa, H				Ishige, T.; Tomomasa, T.; Hatori, R.; Tatsuki, M.; Igarashi, Y.; Arai, K.; Arakawa, H.			Increasing prevalence of paediatric Inflammatory Bowel Disease in Japan: Direct comparison with adult disease using national registry data	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Ishige, T.; Tomomasa, T.; Hatori, R.; Tatsuki, M.; Igarashi, Y.; Arakawa, H.] Gunma Univ, Dept Pediat, Maebashi, Gumma 371, Japan; [Arai, K.] Natl Ctr Child Hlth & Dev, Div Gastroenterol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P653	S408	S409				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200768		
J	Ishihara, S; Kawashima, K; Sonoyama, H; Tada, Y; Oka, A; Kusunoki, R; Fukuba, N; Oshima, N; Moriyama, I; Yuki, T; Maegawa, H; Kashiwagi, N; Kinoshita, Y				Ishihara, S.; Kawashima, K.; Sonoyama, H.; Tada, Y.; Oka, A.; Kusunoki, R.; Fukuba, N.; Oshima, N.; Moriyama, I.; Yuki, T.; Maegawa, H.; Kashiwagi, N.; Kinoshita, Y.			Apoptotic neutrophils ameliorate intestinal inflammation - possible mechanism of granulocyte/monocyte apheresis	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Ishihara, S.; Kawashima, K.; Sonoyama, H.; Tada, Y.; Oka, A.; Kusunoki, R.; Fukuba, N.; Oshima, N.; Kinoshita, Y.] Shimane Univ, Fac Med, Internal Med 2, Izumo, Shimane, Japan; [Moriyama, I.] Shimane Univ Hosp, Ctr Canc, Izumo, Shimane, Japan; [Yuki, T.] Shimane Univ Hosp, Gastrointestinal Endoscopy, Izumo, Shimane, Japan; [Maegawa, H.; Kashiwagi, N.] JIMRO Co Ltd, Div Res, Takasaki, Gumma, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P036	S95	S95				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200153		
J	Ishii, H; Hata, K; Nishikawa, T; Tanaka, T; Kiyomatsu, T; Kawai, K; Nozawa, H; Kazama, S; Yamaguchi, H; Ishihara, S; Sunami, E; Kitayama, J; Watanabe, T				Ishii, H.; Hata, K.; Nishikawa, T.; Tanaka, T.; Kiyomatsu, T.; Kawai, K.; Nozawa, H.; Kazama, S.; Yamaguchi, H.; Ishihara, S.; Sunami, E.; Kitayama, J.; Watanabe, T.			Risk factors of pouchitis after ileal pouch-anal anastomosis in ulcerative colitis: Multivariate analysis	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Ishii, H.; Hata, K.; Nishikawa, T.; Tanaka, T.; Kiyomatsu, T.; Kawai, K.; Nozawa, H.; Kazama, S.; Yamaguchi, H.; Ishihara, S.; Sunami, E.; Kitayama, J.; Watanabe, T.] Univ Tokyo, Surg Oncol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		DOP053	S54	S55				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200082		
J	Ishii, M; Tarumi, KI; Kamada, T; Fujita, M; Matsumoto, H; Murao, T; Nakato, R; Osawa, M; Hirai, S; Fukushima, S; Manabe, N; Kusunoki, H; Shiotani, A; Hata, J; Haruma, K				Ishii, M.; Tarumi, K. -I.; Kamada, T.; Fujita, M.; Matsumoto, H.; Murao, T.; Nakato, R.; Osawa, M.; Hirai, S.; Fukushima, S.; Manabe, N.; Kusunoki, H.; Shiotani, A.; Hata, J.; Haruma, K.			Early intervention of infliximab prevent reoperation for the recurrence of Crohn's disease	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Ishii, M.; Tarumi, K. -I.; Kamada, T.; Fujita, M.; Matsumoto, H.; Murao, T.; Nakato, R.; Osawa, M.; Hirai, S.; Fukushima, S.; Shiotani, A.; Haruma, K.] Kawasaki Med Univ, Div Gastroenterol, Dept Internal Med, Kurashiki, Okayama, Japan; [Manabe, N.; Hata, J.] Kawasaki Med Univ, Clin Pathol & Lab Med, Kurashiki, Okayama, Japan; [Kusunoki, H.] Kawasaki Med Univ, Genaral Med, Kurashiki, Okayama, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P548	S353	S353				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200663		
J	Ishikawa, D; Osada, T; Sasaki, T; Kuwahara-Arai, K; Haga, K; Shibuya, T; Kodani, T; Hiramatsu, K; Watanabe, S				Ishikawa, D.; Osada, T.; Sasaki, T.; Kuwahara-Arai, K.; Haga, K.; Shibuya, T.; Kodani, T.; Hiramatsu, K.; Watanabe, S.			Alterations of Intestinal Microbiota in Ulcerative Colitis Patients Treated with Sequential Antibiotic Combination and Faecal Microbiota Transplantation	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Ishikawa, D.; Osada, T.; Haga, K.; Shibuya, T.; Kodani, T.; Watanabe, S.] Juntendo Univ, Dept Gastroenterol, Tokyo, Japan; [Sasaki, T.; Kuwahara-Arai, K.; Hiramatsu, K.] Juntendo Univ, Dept Bacteriol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P568	S364	S365				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200683		
J	Ito, A; Kuriyama, T; Omori, T; Yonezawa, M; Iizuka, N; Shiratori, K				Ito, A.; Kuriyama, T.; Omori, T.; Yonezawa, M.; Iizuka, N.; Shiratori, K.			An endoscopic therapeutic goal to maintain remission with tacrolimus in refractory ulcerative colitis	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Ito, A.; Kuriyama, T.; Omori, T.; Yonezawa, M.; Iizuka, N.; Shiratori, K.] Tokyo Womens Med Univ, Dept Gastroenterol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P098	S126	S126				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200214		
J	Kawaguchi, T; Tanaka, R; Sako, M; Yoshimura, N; Takazoe, M				Kawaguchi, T.; Tanaka, R.; Sako, M.; Yoshimura, N.; Takazoe, M.			Efficacy of cyclosporine therapy in intestinal Behcet's disease	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Kawaguchi, T.; Tanaka, R.; Sako, M.; Yoshimura, N.; Takazoe, M.] Tokyo Yamate Med Ctr, Dept IBD, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P523	S340	S341				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200638		
J	Kawakami, A; Tanaka, M; Yamamoto-Mitani, N; Yoshimura, N; Suzuki, R; Maeda, S; Kunisaki, R				Kawakami, A.; Tanaka, M.; Yamamoto-Mitani, N.; Yoshimura, N.; Suzuki, R.; Maeda, S.; Kunisaki, R.			Application of a Japanese version of the morisky medication adherence scale and related factors to low medication adherence in patient with Ulcerative Colitis	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Kawakami, A.; Kunisaki, R.] Yokohama City Univ, Ctr Inflammatory Bowel Dis, Med Ctr, Yokohama, Kanagawa 232, Japan; [Tanaka, M.] Mahidol Univ, Fac Med, Ramatibodi Hosp, Ramatibodi Sch Nursing, Bangkok 10700, Thailand; [Yamamoto-Mitani, N.] Univ Tokyo, Sch Hlth Sci & Nursing, Tokyo, Japan; [Yoshimura, N.] Social Insurance Cent Gen Hosp, Ctr Inflammatory Bowel Dis, Tokyo, Japan; [Suzuki, R.] Div Gastroenterol, Kannai Suzuki Clin, Yokohama, Kanagawa, Japan; [Maeda, S.] Yokohama City Univ, Dept Gastroenterol, Grad Sch Med, Yokohama, Kanagawa 232, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		NO001	S444	S444				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200841		
J	Kawashima, K; Ishihara, S; Sonoyama, H; Tada, Y; Oka, A; Kusunoki, R; Fukuba, N; Oshima, N; Moriyama, I; Yuki, T; Kinoshita, Y				Kawashima, K.; Ishihara, S.; Sonoyama, H.; Tada, Y.; Oka, A.; Kusunoki, R.; Fukuba, N.; Oshima, N.; Moriyama, I.; Yuki, T.; Kinoshita, Y.			Serum Matrix Metalloproteinase-3 Concentration Correlates with Clinical and Endoscopic Evidence of Ulcerative Colitis	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Kawashima, K.; Ishihara, S.; Sonoyama, H.; Tada, Y.; Oka, A.; Kusunoki, R.; Fukuba, N.; Oshima, N.; Moriyama, I.; Kinoshita, Y.] Shimane Univ, Sch Med, Internal Med 2, Izumo, Shimane, Japan; [Yuki, T.] Shimane Univ Hosp, Gastrointestinal Endoscopy, Izumo, Shimane, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P088	S122	S122				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200205		
J	Kobayashi, T; Takeuchi, O; Kuronuma, S; Nakano, M; Umeda, S; Serizawa, H; Watanabe, N; Hibi, T				Kobayashi, T.; Takeuchi, O.; Kuronuma, S.; Nakano, M.; Umeda, S.; Serizawa, H.; Watanabe, N.; Hibi, T.			Usefulness of fecal S100A12 in defining mucosal healing in Ulcerative Colitis	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Kobayashi, T.; Takeuchi, O.; Kuronuma, S.; Nakano, M.; Umeda, S.; Serizawa, H.; Watanabe, N.; Hibi, T.] Kitasato Univ Kitasato Inst Hosp, Ctr Adv IBD Res & Treatment, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P147	S150	S150				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200854		
J	Matsuoka, K; Saito, E; Fujii, T; Takenaka, K; Nagahori, M; Ohtsuka, K; Watanabe, M				Matsuoka, K.; Saito, E.; Fujii, T.; Takenaka, K.; Nagahori, M.; Ohtsuka, K.; Watanabe, M.			The Ulcerative Colitis Endoscopic Index of Severity (UCEIS) is useful to evaluate endoscopic improvement and to predict medium-term prognosis in ulcerative colitis patients treated with tacrolimus.	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Matsuoka, K.; Saito, E.; Fujii, T.; Takenaka, K.; Nagahori, M.; Ohtsuka, K.; Watanabe, M.] Tokyo Med & Dent Univ, Gastroenterol & Hepatol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P224	S187	S187				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200338		
J	Miyamura, M; Takeuchi, K; Arai, T; Kasai, R; Yamada, A; Suzuki, Y				Miyamura, M.; Takeuchi, K.; Arai, T.; Kasai, R.; Yamada, A.; Suzuki, Y.			The Usefulness of Ultra-low Dose CT colonography for Assessing Mucosal Inflammation in Patients with Ulcerative Colitis	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Miyamura, M.; Takeuchi, K.; Arai, T.; Yamada, A.; Suzuki, Y.] Toho Univ, Sakura Med Ctr, Div Gastroenterol, Dept Internal Med, Sakura, Chiba, Japan; [Kasai, R.] Toho Univ, Sakura Med Ctr, Radiol, Sakura, Chiba, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P143	S148	S148				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200259		
J	Mizukami, K; Sonoda, A; Okimoto, T; Kodama, M; Murakami, K				Mizukami, K.; Sonoda, A.; Okimoto, T.; Kodama, M.; Murakami, K.			An Open-label Prospective Randomized Multicentre Study of Daily Granulocyte and Monocyte Adsorptive Apheresis as Compared with Intensive Treatment in Patients with Active Ulcerative Colitis	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Mizukami, K.; Sonoda, A.; Okimoto, T.; Kodama, M.; Murakami, K.] Oita Univ, Gastroenterol, Oita 87011, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P545	S352	S352				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200660		
J	Motoya, S; Tanaka, H; Miyakawa, M; Sakemi, R; Nasuno, M; Imamura, A				Motoya, S.; Tanaka, H.; Miyakawa, M.; Sakemi, R.; Nasuno, M.; Imamura, A.			Efficacy of switching to pH-dependent release formulation of mesalazine at 3.6 g/day from time-dependent release formulation of mesalazine at 4.0 g/day in patients with Ulcerative Colitis	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Motoya, S.; Tanaka, H.; Miyakawa, M.; Sakemi, R.; Nasuno, M.; Imamura, A.] Sapporo Kosei Gen Hosp, IBD Ctr, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P480	S319	S320				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200595		
J	Naganuma, M; Iwao, Y; Hisamatsu, T; Ogata, H; Kanai, T				Naganuma, M.; Iwao, Y.; Hisamatsu, T.; Ogata, H.; Kanai, T.			Usefulness of magnifying endoscopy for diagnosis of colitis-associated intraepithelial neoplasia in patients with ulcerative colitis	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Naganuma, M.; Ogata, H.] Keio Univ, Ctr Diagnost & Therapeut Endoscopy, Tokyo, Japan; [Iwao, Y.] Keio Univ, Sch Med, Ctr Prevent Med, Tokyo, Japan; [Hisamatsu, T.; Kanai, T.] Keio Univ, Gastroenterol & Hepatol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P110	S131	S131				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200226		
J	Naito, T; Kakuta, Y; Onodera, M; Kimura, T; Kuroha, M; Shiga, H; Endo, K; Negoro, K; Kinouchi, Y; Shimosegawa, T				Naito, T.; Kakuta, Y.; Onodera, M.; Kimura, T.; Kuroha, M.; Shiga, H.; Endo, K.; Negoro, K.; Kinouchi, Y.; Shimosegawa, T.			Thiopurine-induced leucopenia and hair loss were inevitable in Japanese IBD patients homozygous for NUDT15 R139C: a case series	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Naito, T.; Kakuta, Y.; Onodera, M.; Kimura, T.; Kuroha, M.; Shiga, H.; Endo, K.; Negoro, K.; Kinouchi, Y.; Shimosegawa, T.] Tohoku Univ, Grad Sch Med, Gastroenterol, Sendai, Miyagi 980, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P693	S428	S428				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200808		
J	Nasuno, M; Miyakawa, M; Sakemi, R; Tanaka, H; Motoya, S; Imamura, A				Nasuno, M.; Miyakawa, M.; Sakemi, R.; Tanaka, H.; Motoya, S.; Imamura, A.			Short- and long-term outcomes of infliximab treatment for refractory ulcerative colitis and associated prognostic factors: a Japanese single-center study	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Nasuno, M.; Miyakawa, M.; Sakemi, R.; Tanaka, H.; Motoya, S.; Imamura, A.] Sapporo Kosei Gen Hosp, IBD Ctr, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P399	S278	S279				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200515		
J	Nomura, O; Osada, T; Shibuya, T; Ishikawa, D; Haga, K; Sakamoto, N; Ogihara, T; Watanabe, S				Nomura, O.; Osada, T.; Shibuya, T.; Ishikawa, D.; Haga, K.; Sakamoto, N.; Ogihara, T.; Watanabe, S.			Efficacy of cytapheresis for remission induction therapy and dermatological manifestations of active ulcerative colitis	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Nomura, O.; Osada, T.; Shibuya, T.; Ishikawa, D.; Haga, K.; Sakamoto, N.; Ogihara, T.; Watanabe, S.] Juntendo Univ, Gastroenterol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P609	S385	S385				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200724		
J	Ogashiwa, T; Kunisaki, R; Yasuhara, H; Tsuda, S; Koh, R; Yazawa, K; Goto, K; Kimura, H; Sugita, A; Mori, M; Tanaka, M; Kanegane, H; Maeda, S				Ogashiwa, T.; Kunisaki, R.; Yasuhara, H.; Tsuda, S.; Koh, R.; Yazawa, K.; Goto, K.; Kimura, H.; Sugita, A.; Mori, M.; Tanaka, M.; Kanegane, H.; Maeda, S.			Clinical, Morphological and Histological Features of X-linked Lymphoproliferative Syndrome Type 2 Enteritis Diagnosed in three Cases with Childhood Onset Inflammatory Bowel Disease	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Ogashiwa, T.; Kunisaki, R.; Yasuhara, H.; Tsuda, S.; Koh, R.; Yazawa, K.; Goto, K.; Kimura, H.] Yokohama City Univ, Med Ctr, Ctr Inflammatory Bowel Dis, Yokohama, Kanagawa 232, Japan; [Sugita, A.] Yokohama Municipal Citizens Hosp, Dept Inflammatory Bowel Dis, Yokohama, Kanagawa, Japan; [Mori, M.] Yokohama City Univ, Dept Pediat, Med Ctr, Yokohama, Kanagawa 232, Japan; [Tanaka, M.] Hirosaki City Hosp, Dept Pathol & Lab Med, Hirosaki, Aomori, Japan; [Kanegane, H.] Toyama Univ, Dept Pediat, Grad Sch Med, Toyama 930, Japan; [Maeda, S.] Yokohama City Univ, Grad Sch Med, Dept Gastroenterol, Yokohama, Kanagawa 232, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P134	S143	S143				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200250		
J	Okita, Y; Araki, T; Kawamura, M; Nagano, Y; Kondo, S; Inoue, M; Toiyama, Y; Tanaka, K; Inoue, Y; Uchida, K; Mohri, Y; Kusunoki, M				Okita, Y.; Araki, T.; Kawamura, M.; Nagano, Y.; Kondo, S.; Inoue, M.; Toiyama, Y.; Tanaka, K.; Inoue, Y.; Uchida, K.; Mohri, Y.; Kusunoki, M.			The relationship between onset days and clinical characteristics of pouchitis after ileal pouch-anal anastomosis in Ulcerative Colitis	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Okita, Y.; Araki, T.; Kawamura, M.; Nagano, Y.; Kondo, S.; Inoue, M.; Toiyama, Y.; Tanaka, K.; Inoue, Y.; Uchida, K.; Mohri, Y.; Kusunoki, M.] Mie Univ, Grad Sch Med Gastrointestinal & Pediat Surg, Tsu, Mie 514, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P082	S119	S119				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200199		
J	Sagami, S				Sagami, S.			Significance of non-alchoholic fatty liver disease in patients with Crohn's disease.	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Sagami, S.] Hiroshima Univ, Dept Med & Mol Sci, Hiroshima, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P445	S303	S303				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200561		
J	Suzuki, Y; Motoya, S; Hirai, F; Ogata, H; Ito, H; Sato, N; Ozaki, K; Watanabe, M; Hibi, T				Suzuki, Y.; Motoya, S.; Hirai, F.; Ogata, H.; Ito, H.; Sato, N.; Ozaki, K.; Watanabe, M.; Hibi, T.			Infliximab therapy for Japanese patients with ulcerative colitis: Efficacy, safety, and association between serum infliximab levels and early response in a randomized, double-blind, placebo-controlled study	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Suzuki, Y.] Toho Univ, Sakura Med Ctr, Dept Internal Med, Sakura, Japan; [Motoya, S.] Sapporo Kosei Gen Hosp, Ctr Inflammatory Bowel Dis, Sapporo, Hokkaido, Japan; [Hirai, F.] Fukuoka Univ, Chikushi Hosp, Dept Gastroenterol, Chikushino, Japan; [Ogata, H.] Keio Univ, Sch Med, Ctr Diagnost & Therapeut Endoscopy, Tokyo, Japan; [Ito, H.] Kitano Hosp, Tazuke Kofukai Med Res Inst, Ctr Digest Dis, Osaka, Japan; [Sato, N.] Mitsubishi Tanabe Pharma Corp, Pharmacovigilance & Qual Assurance Div, Osaka, Japan; [Ozaki, K.] Mitsubishi Tanabe Pharma Corp, Dev Div, Tokyo, Japan; [Watanabe, M.] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Hibi, T.] Kitasato Univ, Kitasato Inst Hosp, Ctr Adv IBD Res & Treatment, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P584	S372	S373				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200699		
J	Tada, Y; Ishihara, S; Sonoyama, H; Oka, A; Fukuba, N; Oshima, N; Moriyama, I; Yuki, T; Kawashima, K; Kinoshita, Y				Tada, Y.; Ishihara, S.; Sonoyama, H.; Oka, A.; Fukuba, N.; Oshima, N.; Moriyama, I.; Yuki, T.; Kawashima, K.; Kinoshita, Y.			Serum amyloid A level correlated with endoscopic findings in patients with Crohn's disease - possible biomarker for evaluating mucosal healing	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Tada, Y.; Ishihara, S.; Sonoyama, H.; Oka, A.; Fukuba, N.; Oshima, N.; Moriyama, I.; Kawashima, K.; Kinoshita, Y.] Shimane Univ, Sch Med, Internal Med 2, Izumo, Shimane, Japan; [Yuki, T.] Shimane Univ, Sch Med, Gastrointestinal Endoscopy, Izumo, Shimane, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P179	S166	S166				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200293		
J	Takagi, T; Yoshino, T; Bamba, S; Uchiyama, K; Naito, Y; Matsuura, M; Nakase, H; Tsujikawa, T; Andoh, A; Kogawa, T				Takagi, T.; Yoshino, T.; Bamba, S.; Uchiyama, K.; Naito, Y.; Matsuura, M.; Nakase, H.; Tsujikawa, T.; Andoh, A.; Kogawa, T.			Identification of risk factors of colitis-associated carcinoma in Japanese patients with Ulcerative Colitis: Results from a retrospective multicenter study in a Kyoto-Shiga cohort	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Takagi, T.; Uchiyama, K.; Naito, Y.] Kyoto Prefectural Univ Med, Mol Gastroenterol & Hepatol, Kyoto, Japan; [Yoshino, T.; Matsuura, M.; Nakase, H.] Kyoto Univ Hosp, Dept Gastroenterol & Hepatol, Kyoto 606, Japan; [Bamba, S.; Tsujikawa, T.; Andoh, A.] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan; [Kogawa, T.] Kogawa Internal Med Clin, Internal Med Clin, Kyoto, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P199	S175	S175				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200313		
J	Tamaki, H; Shibatoge, M; Nakase, H				Tamaki, H.; Shibatoge, M.; Nakase, H.			Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: a randomized, double-blinded, placebo-controlled multicenter trial	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Tamaki, H.; Shibatoge, M.] Takamatsu Red Cross Hosp, Gastroenterol, Takamatsu, Kagawa, Japan; [Nakase, H.] Kyoto Univ, Gastroenterol & Hepatol, Kyoto, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P534	S347	S347				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200649		
J	Tanaka, H; Miyakawa, M; Sakemi, R; Nasuno, M; Motoya, S; Imamura, A				Tanaka, H.; Miyakawa, M.; Sakemi, R.; Nasuno, M.; Motoya, S.; Imamura, A.			Long-term operation rate and related prognostic factors in patients with Crohn's Disease treated by infliximab maintenance treatment	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Tanaka, H.; Miyakawa, M.; Sakemi, R.; Nasuno, M.; Motoya, S.; Imamura, A.] Sapporo Kosei Gen Hosp, IBD Ctr, Sapporo, Hokkaido, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P571	S365	S366				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200686		
J	Tanaka, M; Hotta, Y; Uchiyama, K; Takagi, T; Naito, Y				Tanaka, M.; Hotta, Y.; Uchiyama, K.; Takagi, T.; Naito, Y.			Lower serum albumin level on admission is a predictive factor of colectomy in patients with moderate to severe ulcerative colitis	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Tanaka, M.; Hotta, Y.; Uchiyama, K.; Takagi, T.; Naito, Y.] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kamigyo Ku, Kyoto 6028566, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P227	S188	S189				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200341		
J	Toya, Y; Yanai, S; Matsumoto, T				Toya, Y.; Yanai, S.; Matsumoto, T.			Assessment of QOL using internet web system in Japanese patients with Inflammatory Bowel Disease: The 3I survey	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Toya, Y.; Yanai, S.; Matsumoto, T.] Iwate Med Univ, Div Gastroenterol, Dept Internal Med, Morioka, Iwate 020, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P103	S128	S128				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200219		
J	Tsuchiya, K; Fukushima, K; Hayashi, R; Hibiya, S; Horita, N; Watanabe, M				Tsuchiya, K.; Fukushima, K.; Hayashi, R.; Hibiya, S.; Horita, N.; Watanabe, M.			The acquisition of cancer stemness by Atoh1 in colitis associated cancer	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Tsuchiya, K.] Tokyo Med & Dent Univ, Adv Therapeut Gastrointestinal Dis, Tokyo, Japan; [Fukushima, K.; Hayashi, R.; Hibiya, S.; Horita, N.; Watanabe, M.] Tokyo Med & Dent Univ, Gastroenterol & Hepatol, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P077	S115	S115				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200194		
J	Tsuda, S; Kunisaki, R; Ogashiwa, T; Yasuhara, H; Koh, R; Tsunoda, S; Yamamoto, S; Kawashima, N; Kubota, R; Yazawa, K; Goto, K; Kimura, H; Maeda, S				Tsuda, S.; Kunisaki, R.; Ogashiwa, T.; Yasuhara, H.; Koh, R.; Tsunoda, S.; Yamamoto, S.; Kawashima, N.; Kubota, R.; Yazawa, K.; Goto, K.; Kimura, H.; Maeda, S.			Efficacy and Nephrotoxicity of Long-term Maintenance Therapy with Tacrolimus in Patients with Ulcerative Colitis	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Tsuda, S.; Kunisaki, R.; Ogashiwa, T.; Yasuhara, H.; Koh, R.; Tsunoda, S.; Yamamoto, S.; Kawashima, N.; Kubota, R.; Yazawa, K.; Goto, K.; Kimura, H.] Yokohama City Univ, Med Ctr, Ctr Inflammatory Bowel Dis, Yokohama, Kanagawa 232, Japan; [Maeda, S.] Yokohama City Univ, Grad Sch Med, Gastroenterol, Yokohama, Kanagawa 232, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P596	S379	S379				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200711		
J	Ueno, F; Nakayama, Y; Hagiwara, E; Mikami, O; Inamine-Sasaki, A; Hibi, T				Ueno, F.; Nakayama, Y.; Hagiwara, E.; Mikami, O.; Inamine-Sasaki, A.; Hibi, T.			Impact of Inflammatory Bowel Disease on Japanese patients' lives: International comparison of patients' views	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Ueno, F.] Ofuna Chuo Hosp, Dept Med, Kamakura, Kanagawa, Japan; [Nakayama, Y.; Hagiwara, E.] IBD Network, Sapporo, Hokkaido, Japan; [Mikami, O.; Inamine-Sasaki, A.] AbbVie GK, Med Affiars, Med, Tokyo, Japan; [Hibi, T.] Kitasato Univ, Kitasato Inst Hosp, Ctr Adv IBD Res & Treatment, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P332	S245	S245				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200448		
J	Watanabe, K; Noguchi, A; MIyazaki, T; Morimoto, K; Hosomi, S; Yukawa, T; Kamata, N; Yamgami, H; Nakamura, S; Arakawa, T				Watanabe, K.; Noguchi, A.; MIyazaki, T.; Morimoto, K.; Hosomi, S.; Yukawa, T.; Kamata, N.; Yamgami, H.; Nakamura, S.; Arakawa, T.			Developments of novel diagnostic findings on capsule endoscopy in the small bowel of patients with Crohn's disease	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Watanabe, K.] Osaka City Gen Hosp, Gastroenterol, Osaka, Japan; [Noguchi, A.; Morimoto, K.; Hosomi, S.; Yukawa, T.; Kamata, N.; Yamgami, H.; Arakawa, T.] Osaka City Univ, Gastroenterol, Osaka 558, Japan; [MIyazaki, T.; Nakamura, S.] Hyogo Coll Med, Inflammatory Bowel Dis, Nishinomiya, Hyogo 6638501, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P125	S139	S139				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200241		
J	Yamada, A; Iwashita, H; Sasaki, T; Katsumata, M; Miyamura, M; Kikuchi, H; Arai, T; Iwasa, R; Furukawa, R; Sono, K; Osamura, A; Nakamura, K; Aoki, H; Yoshimatsu, Y; Tsuda, Y; Takeuchi, K; Takada, N; Suzuki, Y				Yamada, A.; Iwashita, H.; Sasaki, T.; Katsumata, M.; Miyamura, M.; Kikuchi, H.; Arai, T.; Iwasa, R.; Furukawa, R.; Sono, K.; Osamura, A.; Nakamura, K.; Aoki, H.; Yoshimatsu, Y.; Tsuda, Y.; Takeuchi, K.; Takada, N.; Suzuki, Y.			Improved mucosal healing during scheduled adalimumab maintenance therapy in patients with Crohn's disease initiated following surgical resection of active lesions	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Yamada, A.; Iwashita, H.; Sasaki, T.; Katsumata, M.; Miyamura, M.; Kikuchi, H.; Arai, T.; Iwasa, R.; Furukawa, R.; Sono, K.; Osamura, A.; Nakamura, K.; Aoki, H.; Yoshimatsu, Y.; Tsuda, Y.; Takeuchi, K.; Takada, N.; Suzuki, Y.] Toho Univ, Sakura Med Ctr, Div Gastroenterol, Dept Internal Med, Sakura, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P557	S358	S359				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200672		
J	Yamada, A; Iwashita, H; Sasaki, T; Katsumata, M; Miyamura, M; Arai, T; Kikuchi, H; Iwasa, R; Furukawa, R; Sono, K; Osamura, A; Nakamura, K; Aoki, H; Yoshimatsu, Y; Tsuda, Y; Takeuchi, K; Takada, N; Suzuki, Y				Yamada, A.; Iwashita, H.; Sasaki, T.; Katsumata, M.; Miyamura, M.; Arai, T.; Kikuchi, H.; Iwasa, R.; Furukawa, R.; Sono, K.; Osamura, A.; Nakamura, K.; Aoki, H.; Yoshimatsu, Y.; Tsuda, Y.; Takeuchi, K.; Takada, N.; Suzuki, Y.			Remission induction therapy in patients with remitting-relapsing ulcerative colitis dependent and refractory to corticosteroids or intolerant to thiopurines	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Yamada, A.; Iwashita, H.; Sasaki, T.; Katsumata, M.; Miyamura, M.; Arai, T.; Kikuchi, H.; Iwasa, R.; Furukawa, R.; Sono, K.; Osamura, A.; Nakamura, K.; Aoki, H.; Yoshimatsu, Y.; Tsuda, Y.; Takeuchi, K.; Takada, N.; Suzuki, Y.] Toho Univ, Sakura Med Ctr, Div Gastroenterol, Dept Internal Med, Sakura, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P315	S235	S235				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200430		
J	Yamakawa, K; Yoshino, T; Nishimura, S; Watanabe, K; Yazumi, S				Yamakawa, K.; Yoshino, T.; Nishimura, S.; Watanabe, K.; Yazumi, S.			The predictive factor for relapse of ulcerative colitis in patients with endoscopic mucosal healing	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Yamakawa, K.; Nishimura, S.; Watanabe, K.; Yazumi, S.] Kitano Hosp, Gastroenterol, Osaka, Japan; [Yoshino, T.] Kyoto Univ, Gastroenterol & Hepatol, Grad Sch Med, Kyoto, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		DOP065	S61	S61				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200093		
J	Yamamoto, T; Shimoyama, T; Matsumoto, K				Yamamoto, T.; Shimoyama, T.; Matsumoto, K.			The effects of preoperative adsorptive leukocytapheresis on inflammatory cytokines and septic complications after restorative proctocolectomy for ulcerative colitis: a prospective randomized study	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Yamamoto, T.; Shimoyama, T.; Matsumoto, K.] Yokkaichi Hazu Med Ctr, Ctr Inflammatory Bowel Dis, Yokaichi, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P309	S232	S232				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200424		
J	Yamamoto, T; Nakahigashi, M; Shimoyama, T; Matsumoto, K				Yamamoto, T.; Nakahigashi, M.; Shimoyama, T.; Matsumoto, K.			The long-term efficacy of concomitant enteral nutritional therapy during maintenance infliximab in patients with Crohn's disease: a prospective observational trial	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Yamamoto, T.; Nakahigashi, M.; Shimoyama, T.; Matsumoto, K.] Ctr Inflammatory Bowel Dis, Yokkaichi Hazu Med Ctr, Yokaichi, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P567	S364	S364				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200682		
J	Yamamoto, T; Shimoyama, T; Matsumoto, K				Yamamoto, T.; Shimoyama, T.; Matsumoto, K.			Systemic and peritoneal inflammatory response after laparoscopic vs open emergency colectomy for acute severe ulcerative colitis	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Yamamoto, T.; Shimoyama, T.; Matsumoto, K.] Ctr Inflammatory Bowel Dis, Yokkaichi Hazu Med Ctr, Yokaichi, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P569	S365	S365				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200684		
J	Yasuhara, H; Kunisaki, R; Tsunoda, S; Kawashima, N; Yamamoto, S; Tsuda, S; Ogashiwa, T; Koh, R; Goto, K; Kimura, H; Numata, K; Maeda, S				Yasuhara, H.; Kunisaki, R.; Tsunoda, S.; Kawashima, N.; Yamamoto, S.; Tsuda, S.; Ogashiwa, T.; Koh, R.; Goto, K.; Kimura, H.; Numata, K.; Maeda, S.			Early transabdominal ultrasonography to assess intestinal wall thickness and vascularity appears to predict long-term outcome in Crohn's disease patients undergoing infliximab therapy: A prospective study	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Yasuhara, H.; Kunisaki, R.; Tsunoda, S.; Kawashima, N.; Yamamoto, S.; Tsuda, S.; Ogashiwa, T.; Koh, R.; Goto, K.; Kimura, H.; Numata, K.] Yokohama City Univ, Med Ctr, Ctr Inflammatory Bowel Dis, Yokohama, Kanagawa 232, Japan; [Maeda, S.] Yokohama City Univ, Grad Sch Med, Gastroenterol, Yokohama, Kanagawa 232, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		DOP004	S19	S20				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200033		
J	Yoshino, T; Matsuura, M; Nakase, H				Yoshino, T.; Matsuura, M.; Nakase, H.			IL-34 antibody ameliorates experimental Colitis by alternating IL-12p40 expression in macrophages	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Yoshino, T.; Matsuura, M.; Nakase, H.] Kyoto Univ, Grad Sch Med, Gastroenterol & Hepatol, Kyoto, Japan								0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	FEB	2015	9			1		P008	S80	S81				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH1VW	WOS:000353811200125		
J	Mizokami, F; Takahashi, Y; Nemoto, T; Nagai, Y; Tanaka, M; Utani, A; Furuta, K; Isogai, Z				Mizokami, Fumihiro; Takahashi, Yoshiko; Nemoto, Tetsuya; Nagai, Yayoi; Tanaka, Makiko; Utani, Atsushi; Furuta, Katsunori; Isogai, Zenzo			Wound fixation for pressure ulcers: A new therapeutic concept based on the physical properties of wounds	JOURNAL OF TISSUE VIABILITY			English	Article						Pressure ulcer; Undermining formation; Wound deformity; Wound fixation		A pressure ulcer is defined as damage to skin and other tissues over a bony prominence caused by excess pressure. Deep pressure ulcers that develop over specific bony prominences often exhibit wound deformity, defined as a change in the 3-dimensional shape of the wound. Subsequently, the wound deformity can result in undermining formation, which is a characteristic of deep pressure ulcers. However, to date, a concept with respect to alleviating wound deformity has yet to be defined and described. To clarify the issue, we propose a new concept called "wound fixation" based on the physical properties of deep pressure ulcers with wound deformity. Wound fixation is defined here as the alleviation of wound deformity by exogenous materials. The wound fixation methods are classified as traction, anchor, and insertion based on the relation between the wound and action point by the exogenous materials. A retrospective survey of a case series showed that wound fixation was preferentially used for deep pressure ulcers at specific locations such as the sacrum, coccyx, and greater trochanter. Moreover, the methods of wound fixation were dependent on the pressure ulcer location. In conclusion, our new concept of wound fixation will be useful for the practical treatment and care of pressure ulcers. Further discussion and validation by other experts will be required to establish this concept. (C) 2015 Tissue Viability Society. Published by Elsevier Ltd. All rights reserved.	[Mizokami, Fumihiro; Furuta, Katsunori] Natl Ctr Geriatr & Gerontol, Dept Pharm, Obu, Aichi, Japan; [Takahashi, Yoshiko] Aichi Prefectural Univ, Sch Nursing & Hlth, Dept Nursing & Hlth, Nagoya, Aichi, Japan; [Nemoto, Tetsuya] Natl Ctr Geriatr & Gerontol, Dept Gerontechnol, Obu, Aichi, Japan; [Nagai, Yayoi] Gunma Univ, Sch Med, Dept Dermatol, Maebashi, Gumma 371, Japan; [Tanaka, Makiko] Yamaguchi Prefectural Univ, Dept Nursing & Human Nutr, Grad Div Hlth & Welf, Yamaguchi, Japan; [Utani, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Dermatol, Nagasaki 852, Japan; [Furuta, Katsunori] Natl Ctr Geriatr & Gerontol, Dept Clin Res & Dev, Obu, Aichi, Japan; [Isogai, Zenzo] Natl Ctr Geriatr & Gerontol, Dept Adv Med, Div Dermatol & Connect Tissue Med, Obu, Aichi, Japan	Isogai, Z (reprint author), 35 Gengo,Morioka Cho, Obu, Aichi 4748511, Japan.	zenzo@ncgg.go.jp			National Center for Geriatrics and Gerontology (NCGG), Japan [23-13]	Funding for this study was provided by Research Funding for Longevity Sciences (23-13) (to ZI, TN, and KF) from the National Center for Geriatrics and Gerontology (NCGG), Japan.	Smith MEB, 2013, ANN INTERN MED, V159, P39, DOI 10.7326/0003-4819-159-1-201307020-00007; Mizokami F, 2014, INT WOUND J, V11, P106, DOI 10.1111/j.1742-481X.2012.01028.x; Mizokami F, 2013, INT WOUND J, V10, P606, DOI 10.1111/j.1742-481X.2012.01030.x; Ohura T, 2006, WOUNDS, V18, P329; Takahashi Y, 2014, INT J DERMA IN PRESS; Takahashi Y, 2013, J TISSUE VIABILITY, V22, P63, DOI 10.1016/j.jtv.2013.05.001	6	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0965-206X			J TISSUE VIABILITY	J. Viab.	FEB	2015	24	1					35	40		10.1016/j.jtv.2015.01.002		6	Dermatology; Nursing	Dermatology; Nursing	CG8XY	WOS:000353600200005		
J	Azizi, H; Zanjefili-Beiranvand, M; Asahara, Y				Azizi, Hossein; Zanjefili-Beiranvand, Mina; Asahara, Yoshihiro			Zircon U-Pb ages and petrogenesis of a tonalite-trondhjemite-granodiorite (TTG) complex in the northern Sanandaj-Sirjan zone, northwest Iran: Evidence for Late Jurassic arc-continent collision	LITHOS			English	Article						TTG; Adakite; Collision zone; Sr-Nd isotope ratios; Neotethys; Sanandaj-Sirjan zone	UNDERPLATED BASALTIC CRUST; TRACE-ELEMENT; EASTERN CHINA; NW IRAN; TECTONIC IMPLICATIONS; WESTERN-AUSTRALIA; VOLCANIC-ROCKS; GRANITIC-ROCKS; PARTIAL MELTS; HIGH-K	The Ghalaylan Igneous Complex is located in the northern part of the Sanandaj-Sirjan zone (SSZ) in northwest Iran. At the surface, the complex is ellipsoidal or ring-shaped. The igneous rocks, which are medium- to fine-grained, were intruded into a Jurassic metamorphic complex and are cut by younger dikes. Zircon U-Pb ages indicate that the crystallization of the main body occurred from 157.9 +/- 1.6 to 155.6 +/- 5.6 Ma. The igneous complex includes granodiorite, tonalite, and quartz monzonite, as well as subvolcanic to volcanic rocks such as dacite and rhyolite. The rocks have high concentrations of Al2O3 (15-19 wt.%), SiO2 (65-70 wt.%), and Sr (700-1100 ppm), high (La/Vb)(N) ratios (15-40), and very low concentrations of MgO (<0.83 wt.%), Ni (<7 ppm), and Cr (usually <50 ppm). There is a lack of negative Eu anomalies. These geochemical features show that the rocks are similar to high-silica adakites and Archaean tonalite-trondhjemite-granodiorite (TTG) rocks. The initial ratios of Sr-87/Sr-86 and N-143/Nd-144 vary from 0.70430 to 0.70476 and from 0.51240 to 0.51261, respectively, values that are similar to those of primitive mantle and the bulk Earth. The chemical compositions of the igneous rocks of the complex, and their isotope ratios, differ from those of neighboring granitic bodies in the northern SSZ. Based on our results, we suggest a new geodynamic model for the development of this complex, as follows. During the generation of the Songhor-Ghorveh island arc in the Neotethys Ocean, an extensional basin, such as a back-arc, developed between the island arc and the Sanandaj-Sirjan zone (SSZ). As a consequence, basaltic magma was injected from the asthenosphere without the development of a mature oceanic crust. During arc-continent collision in the Late Jurassic, hot basaltic rocks were present beneath the SSZ at depths of 30-50 km, and the partial melting of these rocks led to the development of TTG-type magmas, forming the source of the Ghalaylan Igneous Complex. (C) 2014 Elsevier B.V. All rights reserved.	[Azizi, Hossein] Univ Kurdistan, Min Dept, Fac Engn, Sanandaj, Iran; [Zanjefili-Beiranvand, Mina] Tarbiat Modares Univ, Fac Basic Sci, Dept Geol, Tehran, Iran; [Asahara, Yoshihiro] Nagoya Univ, Grad Sch Environm Studies, Dept Earth & Environm Sci, Nagoya, Aichi 4648601, Japan	Azizi, H (reprint author), Univ Kurdistan, Min Dept, Fac Engn, Sanandaj, Iran.	azizi1345@gmail.com			JSPS KAKENHI in Japan [25303029]; Nagoya University	This paper is part of the MSc thesis of M. Beiranvand, whose work was supported by JSPS KAKENHI grant no. 25303029 in Japan. H. Azizi would like to thank Nagoya University for providing support as a fellow researcher in the summer of 2013. The separation of zircon and the zircon age dating of sample GLG4 were performed by Sun-Lin Chung (National Taiwan University), who the authors would like to thank, along with M.H. Zarrinkoub, for supporting us in the age determination work. Special thanks are extended to K. Yamamoto and M. Shimizu from Nagoya University for supporting the XRF, ICP-MS, and LA-ICP-MS work, and to F. Nouri, M. Najari, and A. Khani for the help in the field and technical assistance. We are grateful to Nelson Eby, Chief Editor of the journal, and anonymous reviewers for their critical comments, and we give special thanks to Ayten Hadi from Baghdad University for improving the English of the first version, and to Stallared Scientific Editing for the editing of English in the revised version.	BEARD JS, 1991, J PETROL, V32, P365; Frost BR, 2001, J PETROL, V42, P2033, DOI 10.1093/petrology/42.11.2033; Moyen JF, 2009, LITHOS, V112, P556, DOI 10.1016/j.lithos.2009.04.001; Tsuchiya N, 2007, J VOLCANOL GEOTH RES, V167, P134, DOI 10.1016/j.jvolgeores.2007.07.002; Karsli O, 2010, LITHOS, V114, P109, DOI 10.1016/j.lithos.2009.08.003; Azizi H, 2011, CHEM ERDE-GEOCHEM, V71, P363, DOI 10.1016/j.chemer.2011.06.005; DEPAOLO DJ, 1976, GEOPHYS RES LETT, V3, P249, DOI 10.1029/GL003i005p00249; Cox RA, 2006, CHEM GEOL, V235, P21, DOI 10.1016/j.chemgeo.2006.06.002; Ge XY, 2002, CHINESE SCI BULL, V47, P962, DOI 10.1360/02tb9216; STACEY JS, 1975, EARTH PLANET SC LETT, V26, P207, DOI 10.1016/0012-821X(75)90088-6; Petford N, 2000, NATURE, V408, P669, DOI 10.1038/35047000; Golonka J, 2004, TECTONOPHYSICS, V381, P235, DOI 10.1016/j.tecto.2002.06.004; Rapp RP, 2003, NATURE, V425, P605, DOI 10.1038/nature02031; CASTRO A, 1991, EARTH-SCI REV, V31, P237, DOI 10.1016/0012-8252(91)90020-G; Kampunzu AB, 2003, LITHOS, V71, P431, DOI 10.1016/S00244937(03)00125-7; PEARCE JA, 1984, J PETROL, V25, P956; Naeraa T, 2014, LITHOS, V192, P291, DOI 10.1016/j.lithos.2014.02.013; Altunkaynak S, 2007, J GEOL, V115, P63, DOI 10.1086/509268; Robertson AHF, 2007, GEOL SOC SPEC PUBL, V272, P231, DOI 10.1144/GSL.SP.2007.272.01.14; EBY GN, 1992, GEOLOGY, V20, P641, DOI 10.1130/0091-7613(1992)020<0641:CSOTAT>2.3.CO;2; RUDNICK RL, 1995, REV GEOPHYS, V33, P267, DOI 10.1029/95RG01302; Mahmoudi S, 2011, J ASIAN EARTH SCI, V41, P238, DOI 10.1016/j.jseaes.2011.03.006; MUIR RJ, 1995, J GEOL SOC LONDON, V152, P689, DOI 10.1144/gsjgs.152.4.0689; Gu HO, 2013, LITHOS, V177, P352, DOI 10.1016/j.lithos.2013.07.011; Qian Q, 2013, CONTRIB MINERAL PETR, V165, P1195, DOI 10.1007/s00410-013-0854-9; Shahbazi H, 2010, J ASIAN EARTH SCI, V39, P668, DOI 10.1016/j.jseaes.2010.04.014; Plank T, 1998, CHEM GEOL, V145, P325, DOI 10.1016/S0009-2541(97)00150-2; Wang Q, 2005, GEOLOGY, V33, P465, DOI 10.1130/G21522.1; PEACOCK SM, 1990, SCIENCE, V248, P329, DOI 10.1126/science.248.4953.329; Hastie AR, 2010, GEOLOGY, V38, P495, DOI 10.1130/G30778.1; HILDRETH W, 1988, CONTRIB MINERAL PETR, V98, P455, DOI 10.1007/BF00372365; Martin H, 1999, LITHOS, V46, P411, DOI 10.1016/S0024-4937(98)00076-0; BEARD JS, 1989, SCIENCE, V244, P195, DOI 10.1126/science.244.4901.195; Sajona FG, 2000, LITHOS, V54, P173, DOI 10.1016/S0024-4937(00)00019-0; WIEDENBECK M, 1995, GEOSTANDARD NEWSLETT, V19, P1, DOI 10.1111/j.1751-908X.1995.tb00147.x; Chung SL, 2003, GEOLOGY, V31, P1021, DOI 10.1130/G19796.1; MANIAR PD, 1989, GEOL SOC AM BULL, V101, P635, DOI 10.1130/0016-7606(1989)101<0635:TDOG>2.3.CO;2; Smithies RH, 2000, EARTH PLANET SC LETT, V182, P115, DOI 10.1016/S0012-821X(00)00236-3; Zanchi A, 2009, GEOL SOC SPEC PUBL, V312, P31, DOI 10.1144/SP312.3; RAPP RP, 1995, J PETROL, V36, P891; DEFANT MJ, 1990, NATURE, V347, P662, DOI 10.1038/347662a0; Song BA, 1996, PRECAMBRIAN RES, V78, P79, DOI 10.1016/0301-9268(95)00070-4; SEN C, 1994, CONTRIB MINERAL PETR, V117, P394, DOI 10.1007/BF00307273; DEFANT MJ, 1991, J PETROL, V32, P1101; Mohajjel M, 2014, INT GEOL REV, V56, P263, DOI 10.1080/00206814.2013.853919; Guo ZF, 2007, LITHOS, V96, P205, DOI 10.1016/j.lithos.2006.09.011; SAJONA FG, 1993, GEOLOGY, V21, P1007, DOI 10.1130/0091-7613(1993)021<1007:IOSATG>2.3.CO;2; Yogodzinski GM, 2001, NATURE, V409, P500, DOI 10.1038/35054039; MARTIN H, 1986, GEOLOGY, V14, P753, DOI 10.1130/0091-7613(1986)14<753:EOSAGG>2.0.CO;2; KAY RW, 1993, TECTONOPHYSICS, V219, P177, DOI 10.1016/0040-1951(93)90295-U; Stern CR, 1996, CONTRIB MINERAL PETR, V123, P263, DOI 10.1007/s004100050155; Topuz G, 2005, CONTRIB MINERAL PETR, V150, P441, DOI 10.1007/s00410-005-0022-y; Xu JF, 2002, GEOLOGY, V30, P1111, DOI 10.1130/0091-7613(2002)030<1111:OOMAIR>2.0.CO;2; Hacker BR, 2011, EARTH PLANET SC LETT, V307, P501, DOI 10.1016/j.epsl.2011.05.024; Macpherson CG, 2006, EARTH PLANET SC LETT, V243, P581, DOI 10.1016/j.epsl.2005.12.034; TAYLOR SR, 1964, GEOCHIM COSMOCHIM AC, V28, P1273, DOI 10.1016/0016-7037(64)90129-2; Dilek Y, 2010, INT GEOL REV, V52, P536, DOI 10.1080/00206810903360422; Mohajjel M, 2003, J ASIAN EARTH SCI, V21, P397, DOI 10.1016/S1367-9120(02)00035-4; Martin H, 2005, LITHOS, V79, P1, DOI 10.1016/j.lithos.2004.04.048; Wang Q, 2006, LITHOS, V89, P424, DOI 10.1016/j.lithos.2005.12.010; Petford N, 1996, J PETROL, V37, P1491, DOI 10.1093/petrology/37.6.1491; Jahangiri A, 2007, J ASIAN EARTH SCI, V30, P433, DOI 10.1016/j.jseaes.2006.11.008; Foley SF, 2000, GEOCHIM COSMOCHIM AC, V64, P933, DOI 10.1016/S0016-7037(99)00355-5; Gao S, 2004, NATURE, V432, P892, DOI 10.1038/nature03162; Wen DR, 2008, LITHOS, V105, P1, DOI 10.1016/j.lithos.2008.02.005; Robertson AHF, 2006, J ASIAN EARTH SCI, V27, P108, DOI 10.1016/j.jseaes.2005.02.004; Drummond MS, 1996, T ROY SOC EDIN-EARTH, V87, P205; PECCERILLO A, 1976, CONTRIB MINERAL PETR, V58, P63, DOI 10.1007/BF00384745; Cluzel D, 2005, ISL ARC, V14, P254, DOI 10.1111/j.1440-1738.2005.00470.x; Nelson DR, 1997, PRECAMBRIAN RES, V83, P57, DOI 10.1016/S0301-9268(97)00005-3; Tanaka T, 2000, CHEM GEOL, V168, P279, DOI 10.1016/S0009-2541(00)00198-4; Azizi H, 2013, INT GEOL REV, V55, P1523, DOI 10.1080/00206814.2013.782959; ATHERTON MP, 1993, NATURE, V362, P144, DOI 10.1038/362144a0; Azizi H, 2014, CHEM ERDE-GEOCHEM, V74, P87, DOI 10.1016/j.chemer.2013.09.008; Berberian F., 1981, AM GEOPHYS UNION GEO, V3, P5; Boztug D, 2007, MINER PETROL, V91, P191, DOI 10.1007/s00710-007-0196-2; BROWN GC, 1973, NATURE-PHYS SCI, V241, P26; Castillo PR, 2006, CHINESE SCI BULL, V51, P257, DOI DOI 10.1007/S11434-006-0257-7; Cox K.G., 1979, INTERPRETATION IGNEO; Gutscher MA, 2000, TECTONICS, V19, P814, DOI 10.1029/1999TC001152; Gulmez F, 2013, GEOL SOC SPEC PUBL, V372, P107, DOI 10.1144/SP372.12; JAHN BM, 1981, GEOCHIM COSMOCHIM AC, V45, P1633; Johnson K, 1997, J PETROL, V38, P1585, DOI 10.1093/petrology/38.11.1585; Keskin M, 2008, LITHOS, V104, P267, DOI 10.1016/j.lithos.2007.12.011; KRUNER A, 1991, EARTH PLANET SC LETT, V103, P41, DOI 10.1016/0012-821X(91)90148-B; Ludwig K.R., 2003, ISOPLOT EX VERSION 3; Martin H., 1994, ARCHEAN CRUSTAL EVOL, V11, P205, DOI 10.1016/S0166-2635(08)70224-X; Mca L., 2014, LITHOS, V196, P321; Mensing T., 2005, ISOTOPES PRINCIPLES; Moinevaziri H., 2014, ARABIAN J GEOSCIENCE, P1; Peacock S.M., 1993, CHEM GEOL, V108, P43; Rahmati-Ilkhchi M, 2010, TECTONOPHYSICS, V494, P101, DOI 10.1016/j.tecto.2010.09.005; Rantakokko NE, 2014, GEOL SOC SPEC PUBL, V392, P107, DOI 10.1144/SP392.6; RAPP RP, 1991, PRECAMBRIAN RES, V51, P1, DOI 10.1016/0301-9268(91)90092-O; Rushmer T., 2008, EARTH SCI, V97, P325; Sengor A. M. C., 1984, GEOL SOC AM SPEC PAP, V195, P1; Shaikh Zakariaei S.J., 2010, JSIAU, V77, P203; Smithies RH, 2003, PRECAMBRIAN RES, V127, P89, DOI 10.1016/S0301-9268(03)00182-7; Stocklin J., 1974, GEOLOGY CONTINENTAL, P873, DOI DOI 10.1007/978-3-662-01141-6; Stocklin J., 1973, TECTONIC MAP OF IRAN; Sun SS, 1989, SPECIAL PUBLICATIONS, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Wilmsen M., 2009, CIMMERIAN OROGENY NO; Zhang XH, 2008, GEOL MAG, V145, P305, DOI 10.1017/S0016756807004311	103	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0024-4937	1872-6143		LITHOS	Lithos	FEB	2015	216						178	195		10.1016/j.lithos.2014.11.012		18	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CH2JK	WOS:000353851300013		
J	Abbou-Kebir, K; Arai, S; Ahmed, AH				Abbou-Kebir, Khadidja; Arai, Shoji; Ahmed, Ahmed Hassan			Spinel-free dunites as a proxy to komatiitic melt activity in the mantle	LITHOS			English	Article						Oman ophiolite; Spinel-free dunites; Komatiitic melt; Cumulate dunites; High-Ca boninites	NORTHERN OMAN OPHIOLITE; UPWELLING MANTLE; HIGH-PRESSURE; OLIVINE; CHROMITE; GEOCHEMISTRY; PETROGENESIS; PERIDOTITE; JAPAN; CRYSTALLIZATION	High-Mg dunites, which are spinel-free or spinel-poor, occur as veins that cut across a pod of chromitite within the mantle section deep below the Moho transition zone of the northern Oman ophiolite (Wadi Rajmi). Only thick (>50 cm) veins were considered in order to avoid the effects of subsolidus Mg-Fe2+ exchanges with the chromitite wall rock on the compositions of olivine. The spinel-free dunites contain especially high-Mg (Fo(>93)) olivines, whereas olivines in the spinel-poor dunites have lower Fo contents (Fo(91-93)). In addition, chromian spinels in the spinel-poor dunites display high values of Cr# up to 0.8 [Cr# = Cr/(Cr + Al) atomic ratio]. We found that these komatiitic dunites formed via an olivine fractional crystallization process, and not by replacement, and that the chromitites served as isolating capsules where melts were preserved from melt-rock reactions with peridotite minerals. The olivines show a continuous trend in their chemistry from the spinel-free dunites, through the spinel-bearing dunites, to the high-Ca boninites described from the northern Oman ophiolite (Fizh Block). This strongly suggests a genetic linkage between the high-Mg spinel-free or spinel-poor dunites and the high-Ca boninites, which respectively represent cumulates and the resultant fractionated melts of a primary komatiitic melt. In this paper, we challenge the prevalent models that rule out the genesis of komatiites in supra-subduction zones and shed light on the conditions of the mantle at an early stage of arc evolution. (C) 2015 Elsevier B.V. All rights reserved.	[Abbou-Kebir, Khadidja; Arai, Shoji] Kanazawa Univ, Dept Earth Sci, Kanazawa, Ishikawa 9201192, Japan; [Ahmed, Ahmed Hassan] King Abdulaziz Univ, Fac Earth Sci, Jeddah 21441, Saudi Arabia; [Ahmed, Ahmed Hassan] Helwan Univ, Fac Sci, Dept Geol, Cairo, Egypt	Abbou-Kebir, K (reprint author), Kanazawa Univ, Dept Earth Sci, T1-1 Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	kh_abboukebir@yahoo.fr; ultrasa@staff.kanazawa-u.ac.jp; ahmh2jp@yahoo.com					Abbou-Kebir K, 2011, J MINER PETROL SCI, V106, P235, DOI 10.2465/jmps.110301; SATO H, 1977, LITHOS, V10, P113, DOI 10.1016/0024-4937(77)90037-8; Libourel G, 1999, CONTRIB MINERAL PETR, V136, P63, DOI 10.1007/s004100050524; Falloon TJ, 2000, J PETROL, V41, P257, DOI 10.1093/petrology/41.2.257; Gaetani GA, 1998, CONTRIB MINERAL PETR, V131, P323, DOI 10.1007/s004100050396; EVANS BW, 1975, GEOCHIM COSMOCHIM AC, V39, P959, DOI 10.1016/0016-7037(75)90041-1; Kelemen PB, 1997, PHILOS T R SOC A, V355, P283; ARAI S, 1994, ECON GEOL BULL SOC, V89, P1279; KELEMEN PB, 1995, NATURE, V375, P747, DOI 10.1038/375747a0; Kubo K, 2002, J PETROL, V43, P423, DOI 10.1093/petrology/43.3.423; Ishikawa T, 2005, EARTH PLANET SC LETT, V240, P355, DOI 10.1016/j.epsl.2005.09.049; SIMKIN T, 1970, J GEOL, V78, P304; Arai S, 2006, J GEOL SOC LONDON, V163, P869, DOI 10.1144/0016-76492005-057; Suhr G, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000277; GREEN DH, 1975, GEOLOGY, V3, P11, DOI 10.1130/0091-7613(1975)3<11:EDOTEO>2.0.CO;2; ROEDER PL, 1970, CONTRIB MINERAL PETR, V29, P275, DOI 10.1007/BF00371276; Walter MJ, 1998, J PETROL, V39, P29, DOI 10.1093/petrology/39.1.29; Ishikawa T, 2002, GEOLOGY, V30, P899, DOI 10.1130/0091-7613(2002)030<0899:BVITOO>2.0.CO;2; SOBOLEV AV, 1994, J PETROL, V35, P1183; Kushiro I, 1998, GEOPHYS RES LETT, V25, P2337, DOI 10.1029/98GL01844; ROEDER PL, 1985, J PETROL, V26, P763; Arai S, 1996, P ODP SCI RESULTS, V147, P135, DOI DOI 10.2973/ODP.PROC.SR.147.008.1996; ARNDT N, 1980, GEOLOGY, V8, P155, DOI 10.1130/0091-7613(1980)8<155:K>2.0.CO;2; Arndt N, 2008, KOMATIITE, P1, DOI 10.1017/CBO9780511535550; Arndt N.T., 1976, CARNEGIE I WASHINGTO, V75, P555; AUGE T, 1987, MINER DEPOSITA, V22, P1; Barnes SJ, 1998, J PETROL, V39, P1689, DOI 10.1093/petrology/39.10.1689; BICKLE MJ, 1977, EARTH PLANET SC LETT, V37, P97, DOI 10.1016/0012-821X(77)90150-9; Borisova AY, 2012, J PETROL, V53, P2411, DOI 10.1093/petrology/egs054; BREARLEY M, 1986, J PETROL, V27, P1157; CASSARD D, 1981, ECON GEOL, V76, P805; Coleman R.G., 1977, OPHIOLITES ANCIENT O; Dobretsov N.L., 1977, PETROLOGY METAMORPHI; Dobretsov N.L, 1981, PETROLOGY MINERALOGY, P109; DONALDSON MJ, 1986, MINER DEPOSITA, V21, P296; ECHEVERRIA LM, 1980, CONTRIB MINERAL PETR, V73, P253, DOI 10.1007/BF00381444; EDWARDS SJ, 2000, GEOLOGICAL SOC AM SP, V349, P139; Irvine T.N., 1965, CAN J EARTH SCI, V2, P648, DOI DOI 10.1139/E65-046; Jackson E.D., 1969, EC GEOL MONOGR, V4, P41; Kanke N, 2014, GEOL SOC SPEC PUBL, V392, P229, DOI 10.1144/SP392.12; Khedr MZ, 2012, J ASIAN EARTH SCI, V43, P150, DOI 10.1016/j.jseaes.2011.08.017; LEBLANC M, 1991, LITHOS, V27, P231, DOI 10.1016/0024-4937(91)90002-3; Moores EM, 2000, GEOL S AM S, P3; MURCK BW, 1986, GEOCHIM COSMOCHIM AC, V50, P1871, DOI 10.1016/0016-7037(86)90245-0; Nicolas A., 2003, GEOLOGICAL SOC AM SP, V373, P137; Nicolas A., 1989, STRUCTURES OPHIOLITE; OZAWA K, 1983, CONTRIB MINERAL PETR, V82, P52, DOI 10.1007/BF00371175; Ozawa K., 1998, J MINERALOGICAL SOC, V27, P167; Rollinson H, 2008, CONTRIB MINERAL PETR, V156, P273, DOI 10.1007/s00410-008-0284-2; Suhr G, 1999, J PETROL, V40, P575, DOI 10.1093/petrology/40.4.575; Takahashi E., 1986, B VOLCANOL SOC JPN, V30, P17; Umino S., 1990, P TROOD 1987 S, P375	52	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0024-4937	1872-6143		LITHOS	Lithos	FEB	2015	216						315	323		10.1016/j.lithos.2014.12.022		9	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CH2JK	WOS:000353851300022		
J	Nagahama, M; Ochi, S; Oda, M; Miyamoto, K; Takehara, M; Kobayashi, K				Nagahama, Masahiro; Ochi, Sadayuki; Oda, Masataka; Miyamoto, Kazuaki; Takehara, Masaya; Kobayashi, Keiko			Recent Insights into Clostridium perfringens Beta-Toxin	TOXINS			English	Review							ENTERITIS NECROTICANS PIGBEL; PAPUA-NEW-GUINEA; INDUCED PLASMA EXTRAVASATION; ENDOTHELIAL-CELLS; NECROTIZING ENTERITIS; ACTIVE IMMUNIZATION; DIABETIC ADULT; ISOLATE CN3685; PORE FORMATION; ALPHA-TOXIN	Clostridium perfringens beta-toxin is a key mediator of necrotizing enterocolitis and enterotoxemia. It is a pore-forming toxin (PFT) that exerts cytotoxic effect. Experimental investigation using piglet and rabbit intestinal loop models and a mouse infection model apparently showed that beta-toxin is the important pathogenic factor of the organisms. The toxin caused the swelling and disruption of HL-60 cells and formed a functional pore in the lipid raft microdomains of sensitive cells. These findings represent significant progress in the characterization of the toxin with knowledge on its biological features, mechanism of action and structure-function having been accumulated. Our aims here are to review the current progresses in our comprehension of the virulence of C. perfringens type C and the character, biological feature and structure-function of beta-toxin.	[Nagahama, Masahiro; Miyamoto, Kazuaki; Takehara, Masaya; Kobayashi, Keiko] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Yamashiro, Tokushima 7708514, Japan; [Ochi, Sadayuki] Fujita Hlth Univ Sch Med, Dept Microbiol, Toyoake, Aichi 4701192, Japan; [Oda, Masataka] Niigata Univ Grad Sch Med & Dent Sci, Div Microbiol & Infect Dis, Chuo Ku, Niigata, Japan	Nagahama, M (reprint author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Yamashiro, Tokushima 7708514, Japan.	nagahama@ph.bunri-u.ac.jp; ochi@fujita-hu.ac.jp; masataka@dent.niigata-u.ac.jp; cfcdv305@jtw.zaq.ne.jp; mtakehara@ph.bunri-u.ac.jp; kobakei@ph.bunri-u.ac.jp					Sobel J, 2005, J AM COLL SURGEONS, V201, P48, DOI 10.1016/j.jamcollsurg.2005.02.029; Popescu F, 2011, VET MICROBIOL, V153, P173, DOI 10.1016/j.vetmic.2011.02.017; Li JH, 2013, MICROBIOL MOL BIOL R, V77, P208, DOI 10.1128/MMBR.00062-12; JOHNSON MW, 1992, VET MED-US, V87, P382; Sakurai J, 2006, TOXIN REV, V25, P89, DOI 10.1080/15569540500320979; SAKURAI J, 1981, MICROBIOL IMMUNOL, V25, P423; Sakurai J, 1997, J TOXICOL-TOXIN REV, V16, P195; Vidal JE, 2009, CELL MICROBIOL, V11, P1306, DOI 10.1111/j.1462-5822.2009.01332.x; Nagahama M, 2008, BRIT J PHARMACOL, V153, P1296, DOI 10.1038/bjp.2008.9; Shatursky O, 2000, INFECT IMMUN, V68, P5546, DOI 10.1128/IAI.68.10.5546-5551.2000; Gurtner C, 2010, INFECT IMMUN, V78, P2966, DOI 10.1128/IAI.01284-09; Geny B, 2006, BIOL CELL, V98, P667, DOI 10.1042/BC20050082; Ma ML, 2014, INFECT IMMUN, V82, P2958, DOI 10.1128/IAI.01848-14; HUNTER SEC, 1993, INFECT IMMUN, V61, P3958; Nagahama M, 1999, BBA-MOL BASIS DIS, V1454, P97, DOI 10.1016/S0925-4439(99)00026-5; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216; Popoff MR, 2009, FUTURE MICROBIOL, V4, P1021, DOI [10.2217/fmb.09.72, 10.2217/FMB.09.72]; Miclard J, 2009, VET MICROBIOL, V137, P320, DOI 10.1016/j.vetmic.2009.01.025; Sayeed S, 2010, INFECT IMMUN, V78, P495, DOI 10.1128/IAI.00838-09; Vidal JE, 2008, INFECT IMMUN, V76, P4396, DOI 10.1128/IAI.00547-08; Nagahama M, 2003, BRIT J PHARMACOL, V138, P23, DOI 10.1038/sj.bjp.0705022; Sayeed S, 2008, MOL MICROBIOL, V67, P15, DOI 10.1111/j.1365-2958.2007.06007.x; Tweten RK, 2001, VET MICROBIOL, V82, P1, DOI 10.1016/S0378-1135(01)00372-8; Nagahama M, 2003, J BIOL CHEM, V278, P36934, DOI 10.1074/jbc.M306562200; Uzal FA, 2011, VET MICROBIOL, V153, P37, DOI 10.1016/j.vetmic.2011.02.048; Miclard J, 2009, J MED MICROBIOL, V58, P826, DOI 10.1099/jmm.0.008060-0; Nagahama M, 2013, INFECT IMMUN, V81, P3703, DOI 10.1128/IAI.00579-13; SAKURAI J, 1987, TOXICON, V25, P1301, DOI 10.1016/0041-0101(87)90008-0; Autheman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064644; Bhatia B, 2014, PROTEIN EXPRES PURIF, V102, P38, DOI 10.1016/j.pep.2014.06.014; DAVIS M, 1982, LANCET, V2, P389; FITZGERALD GR, 1988, VET MED-US, V83, P80; Garcia JP, 2012, VET MICROBIOL, V157, P412, DOI 10.1016/j.vetmic.2012.01.005; Gibert M, 1997, SYST APPL MICROBIOL, V20, P337; GRINER LA, 1954, J AM VET MED ASSOC, V125, P125; GRINER LA, 1953, J AM VET MED ASSOC, V122, P99; Gui LZ, 2002, MODERN PATHOL, V15, P66, DOI 10.1038/modpathol.3880491; Gurjar A, 2010, INFECT IMMUN, V78, P4860, DOI 10.1128/IAI.00715-10; Johnson S., 1997, ENTEROTOXEMIC INFECT, P117; Katayama S, 1996, MOL GEN GENET, V251, P720, DOI 10.1007/s004380050222; LAWRENCE G, 1979, LANCET, V1, P227; LAWRENCE GW, 1990, LANCET, V336, P1165, DOI 10.1016/0140-6736(90)92776-E; MA M, 2011, MBIO, V2, P24969, DOI DOI 10.1128/MBI0.00338-10; Ma ML, 2012, INFECT IMMUN, V80, P4354, DOI 10.1128/IAI.00818-12; Matsuda T, 2007, PATHOL INT, V57, P622, DOI 10.1111/j.1440-1827.2007.02149.x; McClane B. A., 2004, ENTEROTOXIC CLOSTRID, P698; McDonel J. L., 1986, Pharmacology of bacterial toxins, P477; Milach A, 2012, ANAEROBE, V18, P363, DOI 10.1016/j.anaerobe.2012.01.004; MURRELL TGC, 1966, LANCET, V1, P217; Petrillo TM, 2000, NEW ENGL J MED, V342, P1250, DOI 10.1056/NEJM200004273421704; Popoff MR, 2014, ANAEROBE, V30, P220, DOI 10.1016/j.anaerobe.2014.05.014; Sakurai J., 1995, Reviews in Medical Microbiology, V6, P175; SAKURAI J, 1980, MICROBIOL IMMUNOL, V24, P595; SAKURAI J, 1984, MICROBIOL IMMUNOL, V28, P23; SAKURAI J, 1992, TOXICON, V30, P323, DOI 10.1016/0041-0101(92)90872-3; Salvarani FM, 2013, VACCINE, V31, P4152, DOI 10.1016/j.vaccine.2013.06.094; Schumacher VL, 2013, VET PATHOL, V50, P626, DOI 10.1177/0300985812461362; Springer S, 1999, FEMS IMMUNOL MED MIC, V24, P333; Steinthorsdottir V, 2000, MICROB PATHOGENESIS, V28, P45, DOI 10.1006/mpat.1999.0323; Steinthorsdottir V., 1998, FEMS MICROBIOL LETT, V158, P17, DOI [10.1111/j.1574-6968.1998.tb12794.x9453152, DOI 10.1111/J.1574-6968.1998.TB12794.X9453152]; Timoney J. F., 1988, MICROBIOLOGY INFECT; Uzal FA, 2009, INFECT IMMUN, V77, P5291, DOI 10.1128/IAI.00825-09; Vidal JE, 2012, MOL MICROBIOL, V83, P179, DOI 10.1111/j.1365-2958.2011.07925.x	63	2	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-6651			TOXINS	Toxins	FEB	2015	7	2					396	406		10.3390/toxins7020396		11	Toxicology	Toxicology	CH3YP	WOS:000353967500011		
J	Tamura, M; Mochizuki, N; Nagatomi, Y; Harayama, K; Toriba, A; Hayakawa, K				Tamura, Masayoshi; Mochizuki, Naoki; Nagatomi, Yasushi; Harayama, Koichi; Toriba, Akira; Hayakawa, Kazuichi			Identification and Quantification of Fumonisin A1, A2, and A3 in Corn by High-Resolution Liquid Chromatography-Orbitrap Mass Spectrometry	TOXINS			English	Article							TIME-OF-FLIGHT; FUSARIUM-VERTICILLIOIDES; MYCOTOXINS; PROLIFERATUM; MONILIFORME; CULTURES; ANALOGS	Three compounds, hypothesized as fumonisin A1 (FA1), fumonisin A2 (FA2), and fumonisin A3 (FA3), were detected in a corn sample contaminated with mycotoxins by high-resolution liquid chromatography-Orbitrap mass spectrometry (LC-Orbitrap MS). One of them has been identified as FA1 synthesized by the acetylation of fumonisin B1 (FB1), and established a method for its quantification. Herein, we identified the two remaining compounds as FA2 and FA3, which were acetylated fumonisin B2 (FB2) and fumonisin B3 (FB3), respectively. Moreover, we examined a method for the simultaneous analysis of FA1, FA2, FA3, FB1, FB2, and FB3. The corn samples were prepared by extraction using a QuEChERS kit and purification using a multifunctional cartridge. The linearity, recovery, repeatability, limit of detection, and limit of quantification of the method were >0.99, 82.9%-104.6%, 3.7%-9.5%, 0.02-0.60 mu g/kg, and 0.05-1.98 mu g/kg, respectively. The simultaneous analysis of the six fumonisins revealed that FA1, FA2, and FA3 were present in all corn samples contaminated with FB1, FB2, and FB3. The results suggested that corn marketed for consumption can be considered as being contaminated with both the fumonisin B-series and with fumonisin A-series. This report presents the first identification and quantification of FA1, FA2, and FA3 in corn samples.	[Tamura, Masayoshi; Nagatomi, Yasushi; Harayama, Koichi] Asahi Grp Holdings Ltd, Res Labs Food Safety Chem, Moriya, Ibaraki 3020106, Japan; [Tamura, Masayoshi] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Mochizuki, Naoki] Asahi Grp Holdings Ltd, Ctr Res & Dev, Moriya, Ibaraki 3020106, Japan; [Toriba, Akira; Hayakawa, Kazuichi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan	Mochizuki, N (reprint author), Asahi Grp Holdings Ltd, Ctr Res & Dev, 1-21,Midori 1 Chome, Moriya, Ibaraki 3020106, Japan.	masayoshi.tamura@asahigroup-holdings.com; naoki.mochizuki@asahigroup-holdings.com; yasushi.nagatomi@asahigroup-holdings.com; koichi.harayama@asahigroup-holdings.com; toriba@p.kanazawa-u.ac.jp; hayakawa@p.kanazawa-u.ac.jp					Fang LX, 2013, J SEP SCI, V36, P3115, DOI 10.1002/jssc.201300488; MUSSER SM, 1995, J NAT PRODUCTS, V58, P1392, DOI 10.1021/np50123a009; Rheeder JP, 2002, APPL ENVIRON MICROB, V68, P2101, DOI [10.1128/AEM.68.5.2101-2105.2002, 10.1128/AEM.68.5.2101-2105-2002]; Zachariasova M, 2012, J AGR FOOD CHEM, V60, P9280, DOI 10.1021/jf302069z; De Girolamo A, 2014, J MASS SPECTROM, V49, P297, DOI 10.1002/jms.3342; Nakagawa H, 2013, TOXINS, V5, P590, DOI 10.3390/toxins5030590; Musser SM, 1997, J AGR FOOD CHEM, V45, P1169, DOI 10.1021/jf960663t; Tamura M, 2014, J SEP SCI, V37, P1552, DOI 10.1002/jssc.201400099; Anastassiades M, 2003, J AOAC INT, V86, P412; Sewram V, 2005, J AGR FOOD CHEM, V53, P4861, DOI 10.1021/jf050307n; Lazzaro I, 2012, INT J FOOD MICROBIOL, V159, P93, DOI 10.1016/j.ijfoodmicro.2012.08.013; Hussein HS, 2001, TOXICOLOGY, V167, P101, DOI 10.1016/S0300-483X(01)00471-1; Bartok T, 2014, J CHROMATOGR SCI, V52, P508, DOI 10.1093/chromsci/bmt071; Bartok T, 2010, FOOD ADDIT CONTAM A, V27, P1714, DOI 10.1080/19440049.2010.521958; Lazzaro I., 2014, INT J FOOD MICROBIOL, V166, P21; NORRED WP, 1993, J TOXICOL ENV HEALTH, V38, P309; Tamura M, 2014, TOXINS, V6, P2580, DOI 10.3390/toxins6082580	17	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-6651			TOXINS	Toxins	FEB	2015	7	2					582	592		10.3390/toxins7020582		11	Toxicology	Toxicology	CH3YP	WOS:000353967500023		
J	Kosaka, A; Manickavelu, A; Kajihara, D; Nakagawa, H; Ban, T				Kosaka, Ayumi; Manickavelu, Alagu; Kajihara, Daniela; Nakagawa, Hiroyuki; Ban, Tomohiro			Altered Gene Expression Profiles of Wheat Genotypes against Fusarium Head Blight	TOXINS			English	Article							TRITICUM-AESTIVUM L.; DEFENSE RESPONSE GENES; MYCOTOXIN DEOXYNIVALENOL; UDP-GLUCOSYLTRANSFERASE; SPRING WHEAT; RESISTANCE; GRAMINEARUM; QTLS; INFECTION; SPIKES	Fusarium graminearum is responsible for Fusarium head blight (FHB), which is a destructive disease of wheat that makes its quality unsuitable for end use. To understand the temporal molecular response against this pathogen, microarray gene expression analysis was carried out at two time points on three wheat genotypes, the spikes of which were infected by Fusarium graminearum. The greatest number of genes was upregulated in Nobeokabouzu-komugi followed by Sumai 3, whereas the minimum expression in Gamenya was at three days after inoculation (dai). In Nobeokabouzu-komugi, high expression of detoxification genes, such as multidrug-resistant protein, multidrug resistance-associated protein, UDP-glycosyltransferase and ABC transporters, in addition to systemic defense-related genes, were identified at the early stage of infection. This early response of the highly-resistant genotype implies a different resistance response from the other resistant genotype, Sumai 3, primarily containing local defense-related genes, such as cell wall defense genes. In Gamenya, the expression of all three functional groups was minimal. The differences in these molecular responses with respect to the time points confirmed the variation in the genotypes. For the first time, we report the nature of gene expression in the FHB-highly resistant cv. Nobeokabouzu-komugi during the disease establishment stage and the possible underlying molecular response.	[Kosaka, Ayumi; Manickavelu, Alagu; Kajihara, Daniela; Ban, Tomohiro] Yokohama City Univ, Kihara Inst Biol Res, Yokohama, Kanagawa 2440813, Japan; [Kajihara, Daniela] Univ Sao Paulo, Heart Inst InCor, Sch Med, Vasc Biol Lab, BR-05403900 Sao Paulo, Brazil; [Nakagawa, Hiroyuki] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	Ban, T (reprint author), Yokohama City Univ, Kihara Inst Biol Res, Maioka 641-12, Yokohama, Kanagawa 2440813, Japan.	ayumikosaka25@hotmail.com; manicks@yokohama-cu.ac.jp; ka_danik@yahoo.com.br; hironkgw@affrc.go.jp; tban@yokohama-cu.ac.jp	Alagu, Manickavelu/M-8506-2015	Alagu, Manickavelu/0000-0003-2875-2290	JSPS (Japan Society for the Promotion of Science) [22580009]	This work was supported by the JSPS (Japan Society for the Promotion of Science) Grant in Aid for Scientific Research, Grant Number 22580009. We would also like to thank the three anonymous reviewers whose comments greatly improved the resulting manuscript.	Pritsch C, 2000, MOL PLANT MICROBE IN, V13, P159, DOI 10.1094/MPMI.2000.13.2.159; Buerstmayr H, 2002, THEOR APPL GENET, V104, P84, DOI 10.1007/s001220200009; Kawaura K, 2008, FUNCT INTEGR GENOMIC, V8, P277, DOI 10.1007/s10142-008-0076-9; Berthiller F, 2013, MOL NUTR FOOD RES, V57, P165, DOI 10.1002/mnfr.201100764; Yu JB, 2006, THEOR APPL GENET, V113, P308, DOI 10.1007/s00122-006-0297-z; Pritsch C, 2001, PHYSIOL MOL PLANT P, V58, P1, DOI 10.1006/pmpp.2000.0308; Buerstmayr H, 2003, THEOR APPL GENET, V107, P503, DOI 10.1007/s00122-003-1272-6; Schweiger W, 2013, MOL PLANT PATHOL, V14, P772, DOI 10.1111/mpp.12048; Jia HY, 2009, MOL PLANT MICROBE IN, V22, P1366, DOI 10.1094/MPMI-22-11-1366; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; SCHROEDER HW, 1963, PHYTOPATHOLOGY, V53, P831; Ban T, 2000, EUPHYTICA, V113, P87, DOI 10.1023/A:1003951509797; Foroud NA, 2012, PLANT DIS, V96, P1271, DOI 10.1094/PDIS-10-11-0863-RE; Steiner B, 2009, THEOR APPL GENET, V118, P753, DOI 10.1007/s00122-008-0935-8; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Desjardins AE, 2007, INT J FOOD MICROBIOL, V119, P47, DOI 10.1016/j.ijfoodmicro.2007.07.024; Desmond OJ, 2008, MOL PLANT PATHOL, V9, P435, DOI [10.1111/j.1364-3703.2008.00475.x, 10.1111/J.1364-3703.2008.00475.X]; Cuthbert PA, 2006, THEOR APPL GENET, V112, P1465, DOI 10.1007/s00122-006-0249-7; Bernardo A, 2007, FUNCT INTEGR GENOMIC, V7, P69, DOI 10.1007/s10142-006-0028-1; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Bai GH, 2001, MYCOPATHOLOGIA, V153, P91; Gardiner DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-289; Ghaffari Mohammad Reza, 2010, Iranian Journal of Biotechnology, V8, P112; Golkari S, 2009, GENOME, V52, P409, DOI [10.1139/g09-018, 10.1139/G09-018]; Gottwald S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-369; Gunnaiah R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040695; Handa H, 2008, MOL BREEDING, V22, P71, DOI 10.1007/s11032-008-9157-7; Ma LL, 2010, MOL BIOL REP, V37, P785, DOI 10.1007/s11033-009-9606-3; MILLER JD, 1986, CAN J PLANT PATHOL, V8, P147; Nakagawa H., 2014, J ANAL BIOANAL TEC S, pS6, DOI [10.4172/2155-9872. S6-002, DOI 10.4172/2155-9872.S6-002]; Shang Y, 2009, CHINESE SCI BULL, V54, P3249, DOI 10.1007/s11434-009-0553-0; Walter S, 2008, FUNCT INTEGR GENOMIC, V8, P421, DOI 10.1007/s10142-008-0089-4; Xiao J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-197	34	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-6651			TOXINS	Toxins	FEB	2015	7	2					604	620		10.3390/toxins7020604		17	Toxicology	Toxicology	CH3YP	WOS:000353967500025		
J	Battaglieri, M; Briscoe, BJ; Celentano, A; Chung, SU; D'Angelo, A; De Vita, R; Dring, M; Dudek, JJ; Eidelman, S; Fegan, S; Ferretti, J; Filippi, A; Fox, G; Galata, G; Garcia-Tecocoatzi, H; Glazier, DI; Grube, B; Hanhart, C; Hoferichter, M; Hughes, SM; Ireland, DG; Ketzer, B; Klein, FJ; Kubis, B; Liu, B; Masjuan, P; Mathieu, V; McKinnon, B; Mitchell, R; Nerling, F; Paul, S; Pelaez, JR; Rademacker, J; Rizzo, A; Salgado, C; Santopinto, E; Sarantsev, AV; Sato, T; Schluter, T; da Silva, MLL; Stankovic, I; Strakovsky, I; Szczepaniak, A; Vassallo, A; Walford, NK; Watts, DP; Zana, L				Battaglieri, M.; Briscoe, B. J.; Celentano, A.; Chung, S. -U.; D'Angelo, A.; De Vita, R.; Doering, M.; Dudek, J. J.; Eidelman, S.; Fegan, S.; Ferretti, J.; Filippi, A.; Fox, G.; Galata, G.; Garcia-Tecocoatzi, H.; Glazier, D. I.; Grube, B.; Hanhart, C.; Hoferichter, M.; Hughes, S. M.; Ireland, D. G.; Ketzer, B.; Klein, F. J.; Kubis, B.; Liu, B.; Masjuan, P.; Mathieu, V.; McKinnon, B.; Mitchell, R.; Nerling, F.; Paul, S.; Pelaez, J. R.; Rademacker, J.; Rizzo, A.; Salgado, C.; Santopinto, E.; Sarantsev, A. V.; Sato, T.; Schlueter, T.; da Silva, M. L. L.; Stankovic, I.; Strakovsky, I.; Szczepaniak, A.; Vassallo, A.; Walford, N. K.; Watts, D. P.; Zana, L.			ANALYSIS TOOLS FOR NEXT-GENERATION HADRON SPECTROSCOPY EXPERIMENTS	ACTA PHYSICA POLONICA B			English	Article							PI-PI SCATTERING; FINAL-STATE INTERACTIONS; PARTIAL-WAVE ANALYSIS; FINITE-VOLUME; DISPERSION-RELATIONS; ISOBAR-MODEL; SUM-RULE; ISOSPIN AMPLITUDES; HIGH STATISTICS; KEDR DETECTOR	The series of workshops on New Partial-Wave Analysis Tools for Next-Generation Hadron Spectroscopy Experiments was initiated with the ATHOS 2012 meeting, which took place in Camogli, Italy, June 20-22, 2012. It was followed by ATHOS 2013 in Kloster Seeon near Munich, Germany, May 21-24, 2013. The third, ATHOS3, meeting is planned for April 13-17, 2015 at The George Washington University Virginia Science and Technology Campus, USA. The workshops focus on the development of amplitude analysis tools for meson and baryon spectroscopy, and complement other programs in hadron spectroscopy organized in the recent past including the INT-JLab Workshop on Hadron Spectroscopy in Seattle in 2009, the International Workshop on Amplitude Analysis in Hadron Spectroscopy at the ECT*-Trento in 2011, the School on Amplitude Analysis in Modern Physics in Bad Honnef in 2011, the Jefferson Lab Advanced Study Institute Summer School in 2012, and the School on Concepts of Modern Amplitude Analysis Techniques in Flecken-Zechlin near Berlin in September 2013. The aim of this document is to summarize the discussions that took place at the ATHOS 2012 and ATHOS 2013 meetings. We do not attempt a comprehensive review of the field of amplitude analysis, but offer a collection of thoughts that we hope may lay the ground for such a document. The material presented in the article was edited by the following Editorial Board: Marco Battaglieri, Bill J. Briscoe, Su-Urk Chung, Michael Doring, Jozef Dudek, Geoffrey Fox, Christoph Hanhart, Martin Hoferichter, David G. Ireland, Bernhard Ketzer, Bastian Kubis, Vincent Mathieu, Ryan Mitchell, Jose R. Pelaez, Elena Santopinto, Adam Szczepaniak.	[Battaglieri, M.; Celentano, A.; De Vita, R.; Fegan, S.; Galata, G.; Garcia-Tecocoatzi, H.; Santopinto, E.; Vassallo, A.] Ist Nazl Fis Nucl, Sez Genova, I-16146 Genoa, Italy; [Briscoe, B. J.; Doering, M.; Strakovsky, I.] George Washington Univ, Washington, DC USA; [Chung, S. -U.; Grube, B.; Paul, S.] Tech Univ Munich, Dept Phys, Garching, Germany; [Chung, S. -U.] Pusan Natl Univ, Dept Phys, Busan, South Korea; [Chung, S. -U.] Brookhaven Natl Lab, Dept Phys, Upton, NY 11973 USA; [D'Angelo, A.; Rizzo, A.] Univ Roma Tor Vergata, Rome, Italy; [D'Angelo, A.; Rizzo, A.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, Rome, Italy; [Dudek, J. J.; Salgado, C.; Szczepaniak, A.] Thomas Jefferson Natl Accelerator Facil, Newport News, VA USA; [Dudek, J. J.] Old Dominion Univ, Dept Phys, Norfolk, VA 23529 USA; [Eidelman, S.] Budker Inst Nucl Phys, Novosibirsk 630090, Russia; [Eidelman, S.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Ferretti, J.] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Ferretti, J.] Univ Roma La Sapienza, Ist Nazl Fis Nucl, I-00185 Rome, Italy; [Filippi, A.; Fox, G.] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA; [Garcia-Tecocoatzi, H.] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico; [Glazier, D. I.; Ireland, D. G.; McKinnon, B.] Univ Glasgow, Sch Phys & Astron, SUPA, Glasgow G12 8QQ, Lanark, Scotland; [Hanhart, C.] Inst Adv Simulat, Inst Kernphys, Julich, Germany; [Hanhart, C.] Forschungszentrum Julich, Julich Ctr Hadron Phys, D-52425 Julich, Germany; [Hoferichter, M.] Univ Bern, Inst Theoret Phys, Albert Einstein Ctr Fundamental Phys, CH-3012 Bern, Switzerland; [Hoferichter, M.] Tech Univ Darmstadt, Inst Kernphys, Darmstadt, Germany; [Hoferichter, M.] GSI Helmholtzzentrum Schwerionenforsch GmbH, ExtreMe Matter Inst EMMI, Darmstadt, Germany; [Hughes, S. M.; Stankovic, I.; Watts, D. P.; Zana, L.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Ketzer, B.; Kubis, B.; Sarantsev, A. V.] Univ Bonn, Helmholtz Inst Strahlen & Kernphys, Bonn, Germany; [Klein, F. J.; Walford, N. K.] Catholic Univ Amer, Washington, DC 20064 USA; [Kubis, B.] Univ Bonn, Bethe Ctr Theor Phys, Bonn, Germany; [Liu, B.] Inst High Energy Phys, Beijing 100039, Peoples R China; [Masjuan, P.] Johannes Gutenberg Univ Mainz, PRISMA Cluster Excellence, D-55122 Mainz, Germany; [Masjuan, P.] Johannes Gutenberg Univ Mainz, Inst Kernphys, D-55122 Mainz, Germany; [Mathieu, V.; Mitchell, R.; Szczepaniak, A.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Mathieu, V.; Szczepaniak, A.] Indiana Univ, Ctr Explorat Energy & Matter, Bloomington, IN USA; [Nerling, F.] GSI Helmholtzzentrum Darmstadt, Helmholtz Inst Mainz, Darmstadt, Germany; [Pelaez, J. R.] Univ Complutense, Dept Fis Teor 2, E-28040 Madrid, Spain; [Rademacker, J.] Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England; [Salgado, C.] Norfolk State Univ, Norfolk, VA USA; [Sarantsev, A. V.] Petersburg Nucl Phys Inst, Gatchina, Russia; [Sato, T.] Osaka Univ, Dept Phys, Toyonaka, Osaka 560, Japan; [Schlueter, T.] Univ Munich, Munich, Germany; [Schlueter, T.] Tech Univ Munich, Excellence Cluster Universe, Garching, Germany; [da Silva, M. L. L.] Univ Fed Pelotas, Inst Fis & Matemat, Pelotas, RS, Brazil; Ist Nazl Fis Nucl, Sez Torino, I-10125 Turin, Italy	Mathieu, V (reprint author), Indiana Univ, Dept Phys, Bloomington, IN 47405 USA.	Vincent.MATHIEU@umons.ac.be	da Silva, Mario/K-6676-2012; Celentano, Andrea/J-6190-2012; D'Angelo, Annalisa/A-2439-2012; Pelaez, Jose/K-9767-2014; Paul, Stephan/F-7596-2015	D'Angelo, Annalisa/0000-0003-3050-4907; Celentano, Andrea/0000-0002-7104-2983; Paul, Stephan/0000-0002-8813-0437	SCOAP3	Funded by SCOAP<SUP>3</SUP> under Creative Commons License, CC-BY 3.0.	Aaij R., LHCBCONT2010013; AARON R, 1968, PHYS REV, V174, P2022, DOI 10.1103/PhysRev.174.2022; Abbas G, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.094018; Abbas G, 2010, EUR PHYS J A, V44, P175, DOI 10.1140/epja/i2010-10969-y; Abbon P., ARXIV14101797PHYSINS; Abbon P, 2007, NUCL INSTRUM METH A, V577, P455, DOI 10.1016/j.nima.2007.03.026; Adolph C., ARXIV14084286HEPEX C; AITCHISON IJR, 1979, PHYS REV D, V20, P1131, DOI 10.1103/PhysRevD.20.1131; AITCHISON IJR, 1979, PHYS LETT B, V84, P349, DOI 10.1016/0370-2693(79)90056-X; Akhmetshin RR, 2004, PHYS LETT B, V595, P101, DOI 10.1016/j.physletb.2004.05.056; Alves AA, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/08/S08005; Alwall J., 2011, JHEP, V1106, P128, DOI [DOI 10.1007/JHEP06(2011)128.ARXIV:1106.0522, DOI 10.1007/JHEP06(2011)128]; Ananthanarayan B, 2011, EUR PHYS J A, V47, DOI 10.1140/epja/i2011-11147-7; Ananthanarayan B, 2001, PHYS REP, V353, P207, DOI 10.1016/S0370-1573(01)00009-6; Anashin VV, 2010, PHYS LETT B, V685, P134, DOI 10.1016/j.physletb.2010.01.057; Anashin VV, 2010, PHYS LETT B, V686, P84, DOI 10.1016/j.physletb.2010.02.046; Anashin VV, 2011, PHYS LETT B, V703, P543, DOI 10.1016/j.physletb.2011.08.016; Anisovich AV, 2013, EUR PHYS J A, V49, DOI 10.1140/epja/i2013-13121-9; Anisovich A, 2005, EUR PHYS J A, V24, P111, DOI 10.1140/epja/i2004-10125-6; Anisovich AV, 2012, EUR PHYS J A, V48, DOI 10.1140/epja/i2012-12088-3; Anisovich AV, 2013, EUR PHYS J A, V49, DOI 10.1140/epja/i2013-13158-8; Anisovich AV, 2012, EUR PHYS J A, V48, DOI 10.1140/epja/i2012-12015-8; MARTIN A, 1963, PHYS REV, V129, P1432, DOI 10.1103/PhysRev.129.1432; Hoferichter M, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.116009; Edwards RG, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.054506; Aoki S, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.094505; Aznauryan IG, 2013, INT J MOD PHYS E, V22, DOI 10.1142/S0218301313300154; Lang CB, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.054503; [Anonymous], 2014, EXCITING BARYONS DES; CHEW GF, 1957, PHYS REV, V106, P1345, DOI 10.1103/PhysRev.106.1345; Dudek JJ, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.182001; Engel GP, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.074504; DOLEN R, 1968, PHYS REV, V166, P1768, DOI 10.1103/PhysRev.166.1768; GRAYER G, 1974, NUCL PHYS B, V75, P189, DOI 10.1016/0550-3213(74)90545-8; Jamin M, 2002, NUCL PHYS B, V622, P279, DOI 10.1016/S0550-3213(01)00605-8; Akhmetshin RR, 1999, PHYS LETT B, V466, P392, DOI 10.1016/S0370-2693(99)01080-1; WATSON KM, 1954, PHYS REV, V95, P228, DOI 10.1103/PhysRev.95.228; Feng X, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.094505; Pelaez JR, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.074016; Colangelo G, 2001, NUCL PHYS B, V603, P125, DOI 10.1016/S0550-3213(01)00147-X; Kambor J, 1996, NUCL PHYS B, V465, P215, DOI 10.1016/0550-3213(95)00676-1; Halzen F, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.074020; Workman RL, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.015202; Anashin VV, 2012, PHYS LETT B, V711, P292, DOI 10.1016/j.physletb.2012.04.019; Shklyar V, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.055206; Hanhart C, 2012, PHYS LETT B, V715, P170, DOI 10.1016/j.physletb.2012.07.038; Alexandrou C, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.034502; Chen Y, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.014516; Edwards KW, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.072003; Aaij R, 2013, NUCL PHYS B, V871, P1, DOI 10.1016/j.nuclphysb.2013.02.010; Garcia-Martin R, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.072001; AU KL, 1987, PHYS REV D, V35, P1633, DOI 10.1103/PhysRevD.35.1633; CHUNG SU, 1975, PHYS REV D, V11, P633, DOI 10.1103/PhysRevD.11.633; Kamano H, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.114019; ASTON D, 1988, NUCL PHYS B, V296, P493, DOI 10.1016/0550-3213(88)90028-4; DOLEN R, 1967, PHYS REV LETT, V19, P402, DOI 10.1103/PhysRevLett.19.402; Buttiker P, 2004, EUR PHYS J C, V33, P409, DOI 10.1140/epjc/s2004-01591-1; KHURI NN, 1960, PHYS REV, V119, P1115, DOI 10.1103/PhysRev.119.1115; Drechsel D, 2007, EUR PHYS J A, V34, P69, DOI 10.1140/epja/i2007-10490-6; Garcia-Martin R, 2010, EUR PHYS J C, V70, P155, DOI 10.1140/epjc/s10052-010-1471-7; Mahbub MS, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.011501; Durr S, 2008, SCIENCE, V322, P1224, DOI 10.1126/science.1163233; Christ NH, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.114506; [Anonymous], 2012, WORKSH SEC HADR BEAM; Dudek JJ, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.034505; Dudek JJ, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.094505; CHEW GF, 1957, PHYS REV, V106, P1337, DOI 10.1103/PhysRev.106.1337; Caprini I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.132001; Anisovich VV, 2003, EUR PHYS J A, V16, P229, DOI 10.1140/epja/i2002-10068-x; FROISSART M, 1961, PHYS REV, V123, P1053, DOI 10.1103/PhysRev.123.1053; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; Aaij R, 2010, PHYS LETT B, V694, P209, DOI 10.1016/j.physletb.2010.10.010; Huang F, 2009, EUR PHYS J A, V40, P77, DOI 10.1140/epja/i2008-10728-9; RUMMUKAINEN K, 1995, NUCL PHYS B, V450, P397, DOI 10.1016/0550-3213(95)00313-H; Pelissier C, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.014503; Alekseev MG, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.241803; Morningstar CJ, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.034509; Anashin VV, 2012, PHYS LETT B, V711, P280, DOI 10.1016/j.physletb.2012.04.009; Magalhaes PC, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.094001; Kamano H, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.035209; Tiator L, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.055203; Pelaez JR, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.114001; Edwards RG, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.074508; Arndt RA, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.045205; Descotes-Genon S, 2006, EUR PHYS J C, V48, P553, DOI 10.1140/epjc/s10052-006-0036-2; Aulchenko VM, 2003, PHYS LETT B, V573, P63, DOI 10.1016/j.physletb.2003.08.028; DONOGHUE JF, 1990, NUCL PHYS B, V343, P341, DOI 10.1016/0550-3213(90)90474-R; Stollenwerk F, 2012, PHYS LETT B, V707, P184, DOI 10.1016/j.physletb.2011.12.008; Moussallam B, 2000, EUR PHYS J C, V14, P111, DOI 10.1007/s100520000303; BARNES AV, 1978, NUCL PHYS B, V145, P45, DOI 10.1016/0550-3213(78)90412-1; Asner D. M., 2009, INT J MOD PHYS A, V24, pS1; Aznauryan IG, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.045201; Batinic M, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.038203; Berger N, 2010, J PHYS CONF SER, V219, DOI 10.1088/1742-6596/219/4/042031; Bernard V., 2011, JHEP, V1101; BJORKEN JD, 1973, PHYS REV D, V8, P1341, DOI 10.1103/PhysRevD.8.1341; Briceno RA, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.094507; Bulava JM, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.034505; Caprini I, 2012, EUR PHYS J C, V72, DOI 10.1140/epjc/s10052-012-1860-1; Ceci S, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.015205; Chung S. U., CERN7108; Colangelo G., 2009, POS CD, V09, P047; Collins P. D. B., 1971, Physics Reports. Physics Letters Section C, V1C, DOI 10.1016/0370-1573(71)90007-X; Collins P.D.B., 1977, INTRO REGGE THEORY H; Danilkin I. V., ARXIV14097708HEPPH; Daub J. T., 2013, J HIGH ENERGY PHYS, V1301, P179; Descotes-Genon S., 2001, JHEP, V0103, P002; Ditsche C., 2012, J HIGH ENERGY PHYS, V1206, P043; Doring M, 2012, EUR PHYS J A, V48, DOI 10.1140/epja/i2012-12114-6; Doring M, 2011, EUR PHYS J A, V47, DOI 10.1140/epja/i2011-11139-7; Doring M., 2013, J HIGH ENERGY PHYS, V1310; Dudek JJ, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.111502; Dudek JJ, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.054016; Dudek JJ, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.034508; Eidelman SI, 2011, NUCL PHYS B-PROC SUP, V218, P155, DOI 10.1016/j.nuclphysbps.2011.06.026; Fermi E, 2008, RIV NUOVO CIMENTO, V31, P1, DOI 10.1393/ncr/i2008-10028-x; FERMI E, 1955, NUOVO CIMENTO S, V2, P17, DOI 10.1007/BF02746078; Fox G. C., 2003, P JEFF LAB WORKSH GL; Frison J., 2010, P SCI LATTICE2010, V2010, P139; Garcia-Martin R, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.074004; Gasser J, 1999, EUR PHYS J C, V10, P159; Gerard JM, 1998, PHYS LETT B, V436, P363, DOI 10.1016/S0370-2693(98)00855-7; Gerard JM, 1999, EUR PHYS J C, V7, P1, DOI 10.1007/s100520050380; Gockeler M., 2008, POS LATTICE2008, V136; Gockeler M, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.094513; Goldberger M. L., 1965, COLLISION THEORY; Gorchtein M, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.015205; Guo P, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.094002; Guo P, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.014501; Guo P, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.056003; Gutz E, 2014, EUR PHYS J A, V50, DOI 10.1140/epja/i2014-14074-1; Hansen MT, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.016007; Hansen M. T., 2014, P SCI, P221; Hartmann J, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.062001; HITE GE, 1973, NUOVO CIMENTO A, VA 18, P237, DOI 10.1007/BF02722827; Hoferichter M., 2012, JHEP, V1206, P063; Hoferichter M, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-011-1743-x; Hoferichter M, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-3180-0; HOYER P, 1973, NUCL PHYS B, VB 60, P26, DOI 10.1016/0550-3213(73)90167-3; Kamano H, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.025206; Kaminiski R, 2003, PHYS LETT B, V551, P241, DOI 10.1016/S0370-2693(02)03021-6; Kim CH, 2005, NUCL PHYS B, V727, P218, DOI 10.1016/j.nuclphysb.2005.08.029; Kreuzer S, 2012, EUR PHYS J A, V48, DOI 10.1140/epja/i2012-12093-6; Lage M, 2009, PHYS LETT B, V681, P439, DOI 10.1016/j.physletb.2009.10.055; Lang CB, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.059903; Liu L., 2012, JHEP, V1207, P126, DOI DOI 10.1007/JHEP07(2012)126; Mandula J., 1970, ANN REV NUCL SCI, V20, P289, DOI 10.1146/annurev.ns.20.120170.001445; MANLEY DM, 1984, PHYS REV D, V30, P904, DOI 10.1103/PhysRevD.30.904; Martin A.D., 1970, ELEMENTARY PARTICLE; Moussallam B, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-011-1814-z; Muskhelishvili N. I., 1953, SINGULAR INTEGRAL EQ; Neubert S., 2012, THESIS TU MUNCHEN; Niecknig F, 2012, EUR PHYS J C, V72, DOI 10.1140/epjc/s10052-012-2014-1; Oller JA, 2008, PHYS LETT B, V659, P201, DOI 10.1016/j.physletb.2007.11.030; OMNES R, 1958, NUOVO CIMENTO, V8, P316; Perl M. L., 1975, HIGH ENERGY HADRON P; PHILLIPS RJ, 1974, REP PROG PHYS, V37, P1035, DOI 10.1088/0034-4885/37/8/002; Polejaeva K, 2012, EUR PHYS J A, V48, DOI 10.1140/epja/i2012-12067-8; Ronchen D, 2014, EUR PHYS J A, V50, DOI 10.1140/epja/i2014-14101-3; Ronchen D, 2013, EUR PHYS J A, V49, DOI 10.1140/epja/i2013-13044-5; ROY SM, 1971, PHYS LETT B, VB 36, P353, DOI 10.1016/0370-2693(71)90724-6; Ruiz de Elvira J., 2011, PHYS REV D, VD84, p[419, 418]; Salgado CW, 2014, PHYS REP, V537, P1, DOI 10.1016/j.physrep.2013.11.005; Sandorfi AM, 2011, J PHYS G NUCL PARTIC, V38, DOI 10.1088/0954-3899/38/5/053001; Schneider S. P., 2011, JHEP, V1102; SCHUTZ C, 1994, PHYS REV C, V49, P2671, DOI 10.1103/PhysRevC.49.2671; Shklyar V, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.015201; Shklyar V., ARXIV14097920NUCLTH; Shklyar V, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.019903; Shrestha M, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.055203; STEINER F, 1971, FORTSCHR PHYS, V19, P115, DOI 10.1002/prop.19710190302; Szczepaniak AP, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.036006; Tiator L., BLED WORKSHOPS PHYS, V13; Wanders G, 2000, EUR PHYS J C, V17, P323, DOI 10.1007/s100520000459; Williams M, 2010, J INSTRUM, V5, DOI 10.1088/1748-0221/5/09/P09004; Workman RL, 2011, EUR PHYS J A, V47, DOI 10.1140/epja/i2011-11143-y; WORKMAN RL, 1992, PHYS REV D, V45, P1789, DOI 10.1103/PhysRevD.45.1789; Wunderlich Y., ARXIV13120245NUCLTH	178	3	3	WYDAWNICTWO UNIWERSYTETU JAGIELLONSKIEGO	KRAKOW	UL GRODZKA 26, KRAKOW, 31044, POLAND	0587-4254	1509-5770		ACTA PHYS POL B	Acta Phys. Pol. B	FEB	2015	46	2					257	303		10.5506/APhysPolB.46.257		47	Physics, Multidisciplinary	Physics	CG8NM	WOS:000353564900004		
J	Fukushima, Y; Nakahara, I; Ohta, T; Matsumoto, S; Ishibashi, R; Gomi, M; Miyata, H; Nishi, H; Watanabe, S				Fukushima, Yutaka; Nakahara, Ichiro; Ohta, Tsuyoshi; Matsumoto, Shoji; Ishibashi, Ryota; Gomi, Masanori; Miyata, Haruka; Nishi, Hidehisa; Watanabe, Sadayoshi			Rare complication characterized by late-onset transient neurological symptoms without hyperperfusion after carotid artery stenting: A report of three cases	INTERVENTIONAL NEURORADIOLOGY			English	Article						Blood-brain barrier; carotid artery stenting; FLAIR MRI; reversible vasoparalysis	BRAIN-BARRIER DISRUPTION; POSTERIOR LEUKOENCEPHALOPATHY; COIL EMBOLIZATION; ISCHEMIA; ANEURYSM; MARKER	We experienced a rare complication after carotid artery stenting (CAS) characterized by transient neurological symptoms with no evidence of distal emboli or hyperperfusion. Using neuroimaging, we investigated the pathogenesis of the complication that occurred after CAS in three patients who developed neurological symptoms over a period of ten hours after CAS and improved within two days. None of the three patients showed signs of fresh infarctions on diffusion-weighted imaging or hyperperfusion on single-photon emission computed tomography. However, high signal intensity was observed in the leptomeningeal zone of the cerebral hemisphere on the stent side in all three patients and in the leptomeningeal zone of the contralateral anterior cerebral artery territory in one patient. These areas were assessed using fluid-attenuated inversion recovery (FLAIR) magnetic resonance imaging without gadolinium administration. The high signal intensity in the leptomeningeal zone disappeared as the symptoms improved. Based on the transient nature of the neurological disorders and the normalization of FLAIR imaging findings in these patients, the pathogenesis of this complication might have been vasogenic edema due to vasoparalysis of the local vessels caused by the hemodynamic changes occurring after CAS.	[Fukushima, Yutaka; Nakahara, Ichiro; Ohta, Tsuyoshi; Matsumoto, Shoji; Ishibashi, Ryota; Gomi, Masanori; Miyata, Haruka; Nishi, Hidehisa; Watanabe, Sadayoshi] Kokura Mem Hosp, Dept Neurosurg, Kokurakita Ku, Kitakyushu, Fukuoka 8020001, Japan	Fukushima, Y (reprint author), Kokura Mem Hosp, Dept Neurosurg, Kokurakita Ku, 3-2-1 Asano, Kitakyushu, Fukuoka 8020001, Japan.	yutaka471104@yahoo.co.jp		Nakahara, Ichiro/0000-0001-8909-2949			Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Jean WC, 1998, NEUROSURGERY, V43, P1382, DOI 10.1097/00006123-199812000-00076; Uchiyama Y, 2004, AM J NEURORADIOL, V25, P1783; Kohrmann M, 2012, STROKE, V43, P259, DOI 10.1161/STROKEAHA.111.632356; Yuan C, 2001, CIRCULATION, V104, P2051, DOI 10.1161/hc4201.097839; Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056/NEJM199602223340803; Ay H, 1998, NEUROLOGY, V51, P1369; Warach S, 2004, STROKE, V35, P2659, DOI 10.1161/01.STR.0000144051.32131.09; Bates ER, 2007, J AM COLL CARDIOL, V49, P126, DOI 10.1016/j.jacc.2006.10.021; SUNDT TM, 1981, MAYO CLIN PROC, V56, P533; Karapanayiotides T, 2009, STROKE, V25, P21; Martin AJ, 2005, AM J NEURORADIOL, V26, P531; Matsumoto S, 2009, NEUROLOGY, V72, P1512, DOI 10.1212/WNL.0b013e3181a2e846; Michel E, 2001, AM J NEURORADIOL, V22, P1590; Ogami R, 2011, CARDIOVASC INTER RAD, V34, P936, DOI 10.1007/s00270-010-0035-4; Shinoda J, 2004, NEUROL MED-CHIR, V44, P416, DOI 10.2176/nmc.44.416; Wilkinson ID, 2000, STROKE, V31, P848	17	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1591-0199	2385-2011		INTERV NEURORADIOL	Interv. Neuroradiol.	FEB	2015	21	1					72	79		10.15274/INR-2014-10099		8	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CH3BR	WOS:000353901600012		
J	Kanemaru, K; Yoshioka, H; Yagi, T; Wakai, T; Hashimoto, K; Fukumoto, Y; Suzuki, K; Tateoka, T; Kazama, H; Kinouchi, H				Kanemaru, Kazuya; Yoshioka, Hideyuki; Yagi, Takashi; Wakai, Takuma; Hashimoto, Koji; Fukumoto, Yuichiro; Suzuki, Keiko; Tateoka, Toru; Kazama, Hirofumi; Kinouchi, Hiroyuki			Hypoglossal canal dural arteriovenous fistula embolized under precise anatomical evaluation by selective intra-arterial injection computed tomography angiography	INTERVENTIONAL NEURORADIOLOGY			English	Article						Angiography; computed tomography; dural arteriovenous fistula; embolization; hypoglossal canal	ROW CT ANGIOGRAPHY; TRANSVENOUS EMBOLIZATION; INITIAL-EXPERIENCE; DIAGNOSIS; SYMPTOMS; TUMORS	Dural arteriovenous fistula (DAVF) involving the hypoglossal canal is rare but increasingly reported. To achieve complete obliteration without a procedure-related complication, understanding of the precise anatomy of this DAVF is essential. Here, we describe a 72-year-old man who underwent selective intra-arterial injection computed tomography angiography which allowed us to understand the detailed anatomy of the complex DAVF regarding access routes and the target regions for transvenous embolization (TVE). With the aid of this novel neuroimaging technique successful target TVE was achieved safely and completely.	[Kanemaru, Kazuya; Yoshioka, Hideyuki; Yagi, Takashi; Wakai, Takuma; Hashimoto, Koji; Fukumoto, Yuichiro; Suzuki, Keiko; Tateoka, Toru; Kazama, Hirofumi; Kinouchi, Hiroyuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Neurosurg, Chuo Ku, Yamanashi 4093898, Japan	Kanemaru, K (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Neurosurg, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	kanemaru@yamanashi.ac.jp					Hirai T, 2004, AM J NEURORADIOL, V25, P74; Miyachi S, 2008, INTERV NEURORADIOL, V14, P303; Ernst R, 1999, AM J NEURORADIOL, V20, P2016; Jung C, 2009, AM J NEURORADIOL, V30, P1173, DOI 10.3174/ajnr.A1528; Lee CW, 2010, RADIOLOGY, V256, P219, DOI 10.1148/radiol.10091835; Okahara M, 2007, INTERV NEURORADIOL, V13, P59; Kiyosue H, 2001, J NEUROSURG, V94, P630, DOI 10.3171/jns.2001.94.4.0630; Manabe S, 2008, NEURORADIOLOGY, V50, P715, DOI 10.1007/s00234-008-0393-7; Chen CJ, 2001, J COMPUT ASSIST TOMO, V25, P133, DOI 10.1097/00004728-200101000-00025; Choi JW, 2013, J NEUROSURG, V119, P955, DOI 10.3171/2013.4.JNS121974; Cyril C, 2013, J NEUROIMAGING, V23, P425, DOI 10.1111/j.1552-6569.2012.00718.x; Gandhi D, 2009, AM J NEURORADIOL, V30, P1054, DOI 10.3174/ajnr.A1438; Hirai T, 2005, CARDIOVASC INTER RAD, V28, P354, DOI 10.1007/s00270-003-0094-x; Hirai T, 2001, RADIOLOGY, V220, P499	14	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1591-0199	2385-2011		INTERV NEURORADIOL	Interv. Neuroradiol.	FEB	2015	21	1					88	93		10.15274/INR-2014-10104		6	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CH3BR	WOS:000353901600014		
J	Yamashita, Y; Nakamura, T; Otsuka-Kanazawa, S; Ichii, O; Kon, Y				Yamashita, Yuma; Nakamura, Teppei; Otsuka-Kanazawa, Saori; Ichii, Osamu; Kon, Yasuhiro			Morphological characteristics observed during early follicular development in perinatal MRL/MpJ mice	JAPANESE JOURNAL OF VETERINARY RESEARCH			English	Article						folliculogenesis; MRL/MpJ; nest breakdown; oocyte	GROWTH-DIFFERENTIATION FACTOR-9; METAPHASE-SPECIFIC APOPTOSIS; GERM-CELL; GENE-EXPRESSION; FETAL OOCYTES; MOUSE OVARY; DEATH; GONAD; FOLLICULOGENESIS; TESTIS	In perinatal mice, the ovary undergoes drastic morphological changes, as clusters of oocytes called nests break into smaller cysts and subsequently form individual follicles. We studied perinatal oocyte development in MRL/MpJ mice, and compared it to that observed in C57BL/6 mice between embryonic day 18.5 and postnatal day 4. Throughout the observation period, compared to C57BL/6 mice, MRL/MpJ mice displayed significantly fewer oocytes in their ovaries. Morphologically, there were no clear differences between the strains at embryonic day 18.5. However, the beginning of folliculogenesis, as evidenced by the expression of NOBOX. oogenesis homeobox (Nobox) transcript and protein, was more enhanced in MRL/MpJ mice than in C57BL/6 mice at embryonic day 18.5 and postnatal day 0. In addition, developed follicles were more frequently observed in MRL/MpJ mice than in C57BL/6 mice between postnatal days 0 and 4. In conclusion, the oocyte development during nest breakdown and folliculogenesis was accelerated in MRL/MpJ mice when compared to that observed in C57BL/6 mice.	[Yamashita, Yuma; Nakamura, Teppei; Otsuka-Kanazawa, Saori; Ichii, Osamu; Kon, Yasuhiro] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci,Lab Anat, Kita Ku, Sapporo, Hokkaido 0600818, Japan; [Nakamura, Teppei] Japan Food Res Labs, Chitose Lab, Sect Biol Safety Res, Bunkyo Ku, Chitose 0660052, Japan	Kon, Y (reprint author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci,Lab Anat, Kita Ku, Kita 18 Nishi 9, Sapporo, Hokkaido 0600818, Japan.	y-kon@vetmed.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [24380156]	The research described in this paper was chosen for the Encouragement Award (undergraduate section) at the 156th Japanese Association of Veterinary Anatomists in Iwate (20-22 September 2013). This work was supported by Grant-in-Aid for Scientific Research B (No. 24380156) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	De Felici M, 2008, AUTOPHAGY, V4, P240; Lechowska A, 2011, J ASSIST REPROD GEN, V28, P583, DOI 10.1007/s10815-011-9553-5; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; COUCOUVANIS EC, 1993, EXP CELL RES, V209, P238, DOI 10.1006/excr.1993.1307; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; BYSKOV AG, 1986, PHYSIOL REV, V66, P71; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Kon Y, 1999, CELL TISSUE RES, V296, P359, DOI 10.1007/s004410051296; Namiki Y, 2004, JPN J VET RES, V52, P125; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Kon Y, 2001, MOL REPROD DEV, V58, P216, DOI 10.1002/1098-2795(200102)58:2<216::AID-MRD11>3.0.CO;2-C; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Byskov AG, 1997, MOL HUM REPROD, V3, P795, DOI 10.1093/molehr/3.9.795; Otsuka S, 2010, MAMM GENOME, V21, P153, DOI 10.1007/s00335-010-9251-0; Pepling ME, 1998, DEVELOPMENT, V125, P3323; Kon Y, 2000, ANAT HISTOL EMBRYOL, V29, P313, DOI 10.1046/j.1439-0264.2000.00279.x; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Lobascio AM, 2007, REPRODUCTION, V134, P241, DOI 10.1530/REP-07-0141; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; PETERS H, 1969, ACTA ENDOCRINOL-COP, V62, P98; Ichii O, 2008, HISTOL HISTOPATHOL, V23, P411; Namiki Y, 2003, MOL REPROD DEV, V64, P179, DOI 10.1002/mrd.10208; Suzumori N, 2002, MECH DEVELOP, V111, P137, DOI 10.1016/S0925-4773(01)00620-7; Lee S, 2010, MAMM GENOME, V21, P162, DOI 10.1007/s00335-010-9254-x; McLaren A, 1984, Symp Soc Exp Biol, V38, P7; Nakamura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077246; Nicholas CR, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-2; PETERS H, 1970, PHILOS T ROY SOC B, V259, P91, DOI 10.1098/rstb.1970.0048; Raz E, 2000, GENOME BIOL, V1, DOI DOI 10.1186/GB-2000-1-3-REVIEWS1017; Takayama T, 2005, BIOL REPROD, V72, P1315, DOI 10.1095/biolreprod.104.038810; Tanaka H, 1997, INT J ANDROL, V20, P361	33	1	1	HOKKAIDO UNIV	SAPPORO	ED COMMITTEE JAPANESE JOURNAL VETERINARY RES, GRAD SCH VET MED, KITA 18 NISHI 9 KITAKU, SAPPORO, 060-0818, JAPAN	0047-1917			JPN J VET RES	Jpn. J. Vet. Res.	FEB	2015	63	1					25	36				12	Veterinary Sciences	Veterinary Sciences	CH0UI	WOS:000353737500003		
J	Kageyama, S; Hirayama, H; Moriyasu, S; Minamihashi, A				Kageyama, Soichi; Hirayama, Hiroki; Moriyasu, Satoru; Minamihashi, Akira			Genetic diagnosis of band 3 deficiency using a quenching probe (QProbe)-PCR assay in bovine embryos	JAPANESE JOURNAL OF VETERINARY RESEARCH			English	Article						Band 3; Cattle; Embryo; Preimplantation genetic diagnosis; quenching probe	JAPANESE BLACK CATTLE; PREIMPLANTATION EMBRYOS; FLUOROGENIC PROBES; DELETION MUTATION; SEX DETERMINATION; PCR; CELL	The present study was conducted to develop a simple and rapid procedure to determine the genotype of band 3 deficiency in bovine embryos by a novel real-time PCR method using a fluorescent quenching-based probe (QProbe-PCR). QProbe-PCR successfully distinguished wild type and R664X mutant alleles by melting curve analysis. Minimal amounts of DNA template were required for the detection of wild type/wild type alleles, mutant/mutant alleles, and wild type/mutant alleles; their amounts were 10 pg, 25 pg, and 50 pg, respectively. When 10 blastomeres were used as a DNA sample, accuracies of genotyping by QProbe-PCR were 100% and 89% in embryos homozygous for the wild type allele and heterozygous for the wild type and mutant alleles, respectively. QProbe-PCR takes approximately 2 h for genotyping and requires lesser time than the conventional method using PCR-RFLP, which requires digestion with a restriction enzyme and electrophoresis. Our data showed that QProbe-PCR is a useful method for rapid analysis of the genetic deficiency in preimplantation embryos. Reduction in the time required for genotyping enabled the transfer of genetically selected embryos to recipient cows on the day of embryo collection. These results suggest that determination of the genotype for the genetic deficiency in embryos is useful to select animals free from the genetic disease, and it also makes it possible to produce an animal model homozygous for the mutation.	[Kageyama, Soichi; Hirayama, Hiroki; Moriyasu, Satoru; Minamihashi, Akira] Hokkaido Res Org, Anim Res Ctr, Anim Biotechnol Grp, Shintoku, Hokkaido 0810038, Japan	Kageyama, S (reprint author), Hokkaido Res Org, Anim Res Ctr, Anim Biotechnol Grp, Shintoku, Hokkaido 0810038, Japan.	kageyama-soichi@hro.or.jp			Japan Science and Technology Agency (JST)	We thank Mr. Hidekazu Sogo, a J-BIO 21 corporation staff member, for his technical assistance in single-nucleotide-polymorphism genotyping, helpful discussions, and technical advice. This research was supported by the Japan Science and Technology Agency (JST).	LEE LG, 1993, NUCLEIC ACIDS RES, V21, P3761, DOI 10.1093/nar/21.16.3761; Hirano T, 2000, GENOME RES, V10, P659, DOI 10.1101/gr.10.5.659; Tani H, 2009, ANAL CHEM, V81, P5678, DOI 10.1021/ac900414u; Bauer TR, 2009, ILAR J, V50, P168; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Nomura T, 2001, J ANIM SCI, V79, P366; Hasler JF, 2002, THERIOGENOLOGY, V58, P1457, DOI 10.1016/S0093-691X(02)01044-0; Appa Rao K B, 1999, Theriogenology, V51, P785, DOI 10.1016/S0093-691X(99)00027-8; Ban A., 1999, Journal of the Japan Veterinary Medical Association, V52, P85; Chrenek P, 2001, THERIOGENOLOGY, V55, P1071, DOI 10.1016/S0093-691X(01)00467-8; Crockett AO, 2001, ANAL BIOCHEM, V290, P89, DOI 10.1006/abio.2000.4957; Garcia JF, 2001, THERIOGENOLOGY, V56, P1393, DOI 10.1016/S0093-691X(01)00642-2; Gregory TR, 2014, ANIMAL GENOME SIZE D; Hirano T, 2002, ANIM GENET, V33, P118, DOI 10.1046/j.1365-2052.2002.00844.x; Hirayama H, 2004, J REPROD DEVELOP, V50, P613, DOI 10.1262/jrd.50.613; Inaba M., SCHALMS VET HERMATOL, V5th, P1012; Inaba M, 1996, J CLIN INVEST, V97, P1804, DOI 10.1172/JCI118610; Kageyama S, 2006, J VET MED SCI, V68, P319, DOI 10.1292/jvms.68.319; Kageyama S, 2004, J VET MED SCI, V66, P509, DOI 10.1292/jvms.66.509; Komatsu M., 2014, BEEF CATTLE PRODUCTI, P143; Kurata S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.6.e34; Shea BF, 1999, THERIOGENOLOGY, V51, P841, DOI 10.1016/S0093-691X(99)00030-8; Sugimoto M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013817; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Ushijima H, 2008, J REPROD DEVELOP, V54, P239, DOI 10.1262/jrd.19128; Virta J, 2002, THERIOGENOLOGY, V57, P2229, DOI 10.1016/S0093-691X(02)00824-5; Watanabe T, 2000, J BIOL CHEM, V275, P21789, DOI 10.1074/jbc.C000230200; Yamakuchi H, 2000, ANIM GENET, V31, P13, DOI 10.1046/j.1365-2052.2000.00586.x	28	0	0	HOKKAIDO UNIV	SAPPORO	ED COMMITTEE JAPANESE JOURNAL VETERINARY RES, GRAD SCH VET MED, KITA 18 NISHI 9 KITAKU, SAPPORO, 060-0818, JAPAN	0047-1917			JPN J VET RES	Jpn. J. Vet. Res.	FEB	2015	63	1					45	51				7	Veterinary Sciences	Veterinary Sciences	CH0UI	WOS:000353737500005		
J	Miyamoto, M				Miyamoto, Masahiko			Pure exactness of the principal cover of vertex operator algebras	JOURNAL OF ALGEBRA			English	Article						Vertex operator algebra; Modules; Fusion product; Exact sequence; Principal cover	MODULES	Let V be a vertex operator algebra. The fusion products in this paper are defined by logarithmic intertwining operators. Under this setting, we prove the pure exactness of any extension of the V-module V. Namely, if 0 -> Q ->(is an element of) P ->(rho) V -> 0 is a short exact sequence of V-modules and W is a V-module, then 0 -> Q boxed times W ->(is an element of boxed times 1W) P boxed times W -> (rho boxed times 1W) V boxed times W -> 0 is also exact, where we view it as a sequence of g(V)-modules. (C) 2014 Published by Elsevier Inc.	Univ Tsukuba, Inst Math, Tsukuba, Ibaraki 305, Japan	Miyamoto, M (reprint author), Univ Tsukuba, Inst Math, Tsukuba, Ibaraki 305, Japan.	miyamoto@math.tsukuba.ac.jp			Ministry of Education, Science and Culture, Japan [26287001, 26610002]	Supported by the Grants-in-Aids for Scientific Research, No. 26287001 and No. 26610002, The Ministry of Education, Science and Culture, Japan.	Huang YZ, 2006, INT J MATH, V17, P975, DOI 10.1142/S0129167X06003758; TSUCHIYA A, 1986, PUBL RES I MATH SCI, V22, P259, DOI 10.2977/prims/1195178069; BORCHERDS RE, 1986, P NATL ACAD SCI USA, V83, P3068, DOI 10.1073/pnas.83.10.3068; Dong CY, 1997, J ALGEBRA, V188, P443, DOI 10.1006/jabr.1996.6862; Frenkel I. B., 1993, MEM AM MATH SOC, V104; Huang Y.-Z., 1995, SELECTA MATH, V1, P699, DOI 10.1007/BF01587908; Li H., 1994, THESIS RUTGERS STATE; Mikis A., 2002, CONT MATH, V297, P201; Miyamoto M., 2009, ARXIV09093665; Miyamoto M., 2011, MATH LECT PEKING U, P271	10	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-8693	1090-266X		J ALGEBRA	J. Algebra	FEB 1	2015	423						289	300		10.1016/j.jalgebra.2014.10.001		12	Mathematics	Mathematics	CG7ZH	WOS:000353525900013		
J	Kuroda, S				Kuroda, Shigeru			On the Karas type theorems for the multidegrees of polynomial automorphisms	JOURNAL OF ALGEBRA			English	Article						Polynomial automorphisms; Shestakov-Umirbaev theory; Karas type theorems	WILD AUTOMORPHISMS; TAME; C-3	To solve Nagata's conjecture, Shestakov-Umirbaev constructed a theory for deciding wildness of polynomial automorphisms in three variables. Recently, Karas and others studied multidegrees of polynomial automorphisms as an application of this theory. They give various necessary conditions for triples of positive integers to be multidegrees of tame automorphisms in three variables. In this paper, we prove a strong theorem unifying and generalizing these results using the generalized Shestakov-Umirbaev theory. (C) 2014 Elsevier Inc. All rights reserved.	Tokyo Metropolitan Univ, Dept Math & Informat Sci, Hachioji, Tokyo 1920397, Japan	Kuroda, S (reprint author), Tokyo Metropolitan Univ, Dept Math & Informat Sci, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	kuroda@tmu.ac.jp			Japan Society for the Promotion of Science [24740022]	Partly supported by the Grant-in-Aid for Young Scientists (B) 24740022, Japan Society for the Promotion of Science.	Kuroda S, 2010, TOHOKU MATH J, V62, P75; Edo E, 2013, TRANSFORM GROUPS, V18, P81, DOI 10.1007/s00031-013-9212-2; Jung H. W. E., 1942, J REINE ANGEW MATH, V184, P161; Kanehira T., 2012, THESIS TOKYO METROPO; Karas M., ARXIV11041061V1MATHA; Karas M, 2011, P AM MATH SOC, V139, P769, DOI 10.1090/S0002-9939-2010-10779-7; Karas M., 2011, B POL ACAD SCI MATH, V59, P27; Karas M, 2010, J PURE APPL ALGEBRA, V214, P2144, DOI 10.1016/j.jpaa.2010.02.017; Karas M, 2011, J PURE APPL ALGEBRA, V215, P2843, DOI 10.1016/j.jpaa.2011.04.003; Karas M, 2011, DISS MATH, P5, DOI 10.4064/dm477-0-1; Kuroda S., 2008, J MATH SOC JAPAN, V60, P405; Kuroda S., ARXIV11101466V1MATHA; Li J., ARXIV11126071V1MATHA; Li JT, 2013, PUBL MATH-DEBRECEN, V83, P697, DOI 10.5486/PMD.2013.5703; Matsianura H., 1989, CAMBRIDGE STUD ADV M, V8; Nagata M., 1972, KYOTO U LECT MATH, V5; Shestakov I., 2003, J AM MATH SOC, V17, P197; Shestakov I., 2003, J AM MATH SOC, V17, P181; Sun XS, 2012, PUBL RES I MATH SCI, V48, P129, DOI 10.2977/PRIMS/64	19	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-8693	1090-266X		J ALGEBRA	J. Algebra	FEB 1	2015	423						441	465		10.1016/j.jalgebra.2014.10.024		25	Mathematics	Mathematics	CG7ZH	WOS:000353525900019		
J	Matsuo, K; Shibata, R; Ohashi, K; Kambara, T; Uemura, Y; Hiramatsu-Ito, M; Enomoto, T; Yuasa, D; Joki, Y; Ito, M; Hayakawa, S; Ogawa, H; Kihara, S; Murohara, T; Ouchi, N				Matsuo, Kazuhiro; Shibata, Rei; Ohashi, Koji; Kambara, Takahiro; Uemura, Yusuke; Hiramatsu-Ito, Mizuho; Enomoto, Takashi; Yuasa, Daisuke; Joki, Yusuke; Ito, Masanori; Hayakawa, Satoko; Ogawa, Hayato; Kihara, Shinji; Murohara, Toyoaki; Ouchi, Noriyuki			Omentin functions to attenuate cardiac hypertrophic response	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY			English	Article						Omentin; Cardiac hypertrophy; Fibrosis; AMP-activated protein kinase	ACTIVATED PROTEIN-KINASE; ISCHEMIA-REPERFUSION INJURY; CORONARY-ARTERY-DISEASE; DEPENDENT MECHANISM; ASSOCIATION; HEART; ADIPOCYTOKINE; INFLAMMATION; MYOCYTE; TISSUE	Cardiac hypertrophy occurs in many obesity-related conditions. Omentin is an adipose-derived plasma protein that is downregulated under obese conditions. Here, we investigated whether omentin modulates cardiac hypertrophic responses in vivo and in vitro. Systemic administration of an adenoviral vector expressing human omentin (Ad-OMT) to wild-type (WT) mice led to the attenuation of cardiac hypertrophy, fibrosis and ERK phosphorylation induced by transverse aortic constriction (TAC) or angiotensin II infusion. In cultured cardiomyocytes, stimulation with phenylephrine (PE) led to an increase in myocyte size, which was prevented by pretreatment with human omentin protein. Pretreatment of cardiomyocytes with omentin protein also reduced ERK phosphorylation in response to PE stimulation. Ad-OMT enhanced phosphorylation of AMP-activated protein kinase (AMPK) in the heart of WT mice after TAC operation. Blockade of AMPK activation by transduction with dominant-negative mutant forms of AMPK reversed the inhibitory effect of omentin on myocyte hypertrophy and ERK phosphorylation following PE stimulation. Moreover, fat-specific transgenic mice expressing human omentin showed reduced cardiac hypertrophy and ERK phosphorylation following TAC surgery compared to littermate controls. These data suggest that omentin functions to attenuate the pathological process of myocardial hypertrophy via the activation of AMPK in the heart, suggesting that omentin may represent a target molecule for the treatment of cardiac hypertrophy. (C) 2014 Elsevier Ltd. All rights reserved.	[Matsuo, Kazuhiro; Shibata, Rei; Kambara, Takahiro; Uemura, Yusuke; Hiramatsu-Ito, Mizuho; Enomoto, Takashi; Yuasa, Daisuke; Joki, Yusuke; Ito, Masanori; Hayakawa, Satoko; Ogawa, Hayato; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Mol Cardiovasc Med, Nagoya, Aichi 4668550, Japan; [Kihara, Shinji] Osaka Univ, Grad Sch Med, Dept Biomed Informat, Osaka, Japan	Shibata, R (reprint author), Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	rshibata@med.nagoya-u.ac.jp; nouchi@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014		Takeda Science Foundation; Daiichi-Sankyo Foundation of Life Science; AstraZeneca Research & Development Grant; Novartis Foundation (Japan) for the Promotion of Science; Banyu Life Science Foundation International; Kanae Foundation	This work was supported by Grant-in-Aid for Scientific Research and grants from Takeda Science Foundation, Daiichi-Sankyo Foundation of Life Science, AstraZeneca Research & Development Grant, and the Novartis Foundation (Japan) for the Promotion of Science to N. Ouchi. R. Shibata was supported with the Grant-in-Aid for Scientific Research C, Banyu Life Science Foundation International and Kanae Foundation.	Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shibata R, 2007, CARDIOVASC RES, V74, P471, DOI 10.1016/j.cardiores.2007.02.010; Ilercil A, 2001, AM HEART J, V141, P992, DOI 10.1067/mhj.2001.115302; Maruyama S, 2012, J BIOL CHEM, V287, P408, DOI 10.1074/jbc.M111.261818; Shibata R, 2011, HYPERTENS RES, V34, P1309, DOI 10.1038/hr.2011.130; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Maruyama S, 2011, J BIOL CHEM, V286, P32790, DOI 10.1074/jbc.M111.245985; Shibata R, 2011, ATHEROSCLEROSIS, V219, P811, DOI 10.1016/j.atherosclerosis.2011.08.017; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Pan HY, 2010, DIABETES RES CLIN PR, V88, P29, DOI 10.1016/j.diabres.2010.01.013; Yue TL, 2000, J BIOL CHEM, V275, P37895, DOI 10.1074/jbc.M007037200; Yamawaki H, 2010, BIOCHEM BIOPH RES CO, V393, P668, DOI 10.1016/j.bbrc.2010.02.053; Kazama K, 2014, AM J PHYSIOL-HEART C, V306, pH1714, DOI 10.1152/ajpheart.00048.2014; Rutter MK, 2003, CIRCULATION, V107, P448, DOI 10.1161/01.CIR.0000045671.62860.98; Zhong X, 2011, ACTA PHARMACOL SIN, V32, P873, DOI 10.1038/aps.2011.26; Yamawaki H, 2011, BIOCHEM BIOPH RES CO, V408, P339, DOI 10.1016/j.bbrc.2011.04.039; Kataoka Y, 2014, J AM COLL CARDIOL, V63, P2722, DOI 10.1016/j.jacc.2014.03.032; de Souza Batista CM, 2007, DIABETES, V56, P1655, DOI DOI 10.2337/DB06-1506; Guerra F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016630; Kim J, 2001, J BIOL CHEM, V276, P19102, DOI 10.1074/jbc.M011579200; Li P, 2010, HYPERTENSION, V55, P69, DOI 10.1161/HYPERTENSIONAHA.109.141655; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Shibata R, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-37; Tanaki K, 2001, J AM COLL CARDIOL, V37, P676, DOI 10.1016/S0735-1097(00)01123-2; Yoo HJ, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-103	28	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2828	1095-8584		J MOL CELL CARDIOL	J. Mol. Cell. Cardiol.	FEB	2015	79						195	202		10.1016/j.yjmcc.2014.11.019		8	Cardiac & Cardiovascular Systems; Cell Biology	Cardiovascular System & Cardiology; Cell Biology	CG7ZG	WOS:000353525800020		
J	Tsuchiya, H; Homma, T				Tsuchiya, Hitoshi; Homma, Tetsuya			Laser beam scanning system for irradiation in an external quadrangular form for soldering of quad flat package IC	OPTICAL REVIEW			English	Article						Laser soldering; Laser beam scanning; Quad flat package (QFP); Yttrium aluminum garnet (YAG) laser; Galvano motor	DIODE-LASERS; ELECTRONIC COMPONENTS; JOINTS; STATE	We propose a new soldering process and a system for a quad flat package IC (QFP-IC). The incident line-formed laser beam converted by this system can realize an external quadrangular form line for the non-contact regional heating, to provide thin and light weight electronic packages as required. The laser beam pumped by an yttrium aluminum garnet (YAG) laser oscillator is split into four beams. Using a galvano motor, which can scan the reflection mirror with high frequencies, the laser beam can change the heating line. The soldering time for QFP-IC of 100 pins with the 0.65 mm pitch was 6 s. As the regional heating just only junctions, the temperature in the resin package was lower than 141 degrees C after solder fusion. From the experimental result, it is confirmed that this method is less damage to a resin package than a conventional whole heating method.	[Tsuchiya, Hitoshi; Homma, Tetsuya] Shibaura Inst Technol, Postgrad Course Funct Control Syst, Koto Ku, Tokyo 1358548, Japan; [Tsuchiya, Hitoshi] Toshiba Co Ltd, Corp Mfg Engn Ctr, Isogo Ku, Yokohama, Kanagawa 2350017, Japan	Tsuchiya, H (reprint author), Toshiba Co Ltd, Corp Mfg Engn Ctr, Isogo Ku, 33 Shin Isogo Cho, Yokohama, Kanagawa 2350017, Japan.	hitoshi.tsuchiya@toshiba.co.jp			Toshiba Corporate Manufacturing Center	This work was supported by Toshiba Corporate Manufacturing Center.	Amako J, 2001, APPL OPTICS, V40, P5643, DOI 10.1364/AO.40.005643; Bachmann F, 2003, APPL SURF SCI, V208, P125, DOI 10.1016/S0169-4332(02)01349-1; Beckett PM, 1995, OPT QUANT ELECTRON, V27, P1303; Brandner M, 2000, J LASER APPL, V12, P194; Chan YC, 2001, MICROELECTRON RELIAB, V41, P1867, DOI 10.1016/S0026-2714(01)00041-5; Fidan I., 1998, IEEE Transactions on Components, Packaging & Manufacturing Technology, Part C (Manufacturing), V21, DOI 10.1109/3476.670031; Flanagan A, 1996, J MATER PROCESS TECH, V56, P531, DOI 10.1016/0924-0136(95)01867-0; Han ZJ, 2008, T NONFERR METAL SOC, V18, P814, DOI 10.1016/S1003-6326(08)60141-7; Harsh KF, 1999, SENSOR ACTUAT A-PHYS, V77, P237, DOI 10.1016/S0924-4247(99)00220-4; Jagt JC, 1998, IEEE T COMPON PACK A, V21, P215, DOI 10.1109/95.705467; Jung JP, 1999, MET MATER INT, V5, P317; Kawakami H., 2002, T JPN SOC MECH ENG, V77, P3; Kawasumi H., 1981, Journal of the Japan Society of Precision Engineering, V47; Miura H., 1989, Review of Laser Engineering, V17; Murakami K., 1994, Journal of the Japan Society of Precision Engineering, V60; Suenaga N., 1988, Welding International, V2; Tian Y., 2002, IEEE 4 INT S EL MAT, P293	17	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	FEB	2015	22	1					1	8		10.1007/s10043-015-0032-6		8	Optics	Optics	CG9JE	WOS:000353630200001		
J	Sakita, K; Ohta, M; Shimano, T; Sakemoto, A				Sakita, Koichi; Ohta, Mitsuhiko; Shimano, Takeshi; Sakemoto, Akito			Aperture shape dependencies in extended depth of focus for imaging camera by wavefront coding	OPTICAL REVIEW			English	Article						Wavefront coding; EDOF; Aperture stop; PSF; OTF; MTF; De-convolution	PHOTOGRAPHY; FIELD	Optical transfer functions (OTFs) on various directional spatial frequency axes for cubic phase mask (CPM) with circular and square apertures are investigated. Although OTF has no zero points, it has a very close value to zero for a circular aperture at low frequencies on diagonal axis, which results in degradation of restored images. The reason for close-to-zero value in OTF is also analyzed in connection with point spread function profiles using Fourier slice theorem. To avoid close-to-zero condition, square aperture with CPM is indispensable in WFC. We optimized cubic coefficient a of CPM and coefficients of digital filter, and succeeded to get excellent de-blurred images at large depth of field.	[Sakita, Koichi; Ohta, Mitsuhiko; Shimano, Takeshi] Hitachi Ltd, Yokohama Res Lab, Yokohama, Kanagawa 2440817, Japan; [Sakemoto, Akito] Hitachi Maxell Ltd, Finetech Div, Watarai, Miyagi 9892383, Japan	Sakita, K (reprint author), Hitachi Ltd, Yokohama Res Lab, Yokohama, Kanagawa 2440817, Japan.	koichi.sakita.gb@hitachi.com					DOWSKI ER, 1995, APPL OPTICS, V34, P1859, DOI 10.1364/AO.34.001859; Zhao TY, 2012, OPT EXPRESS, V20, P2408, DOI 10.1364/OE.20.002408; Bagheri S, 2008, J OPT SOC AM A, V25, P1051, DOI 10.1364/JOSAA.25.001051; BRACEWELL RN, 1990, SCIENCE, V248, P697, DOI 10.1126/science.248.4956.697; Cossairt O, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778768; Goodman J. W., 1968, INTRO FOURIER OPTICS; Ishida I., 2012, 73 AUT M JAP SOC APP; Levoy M, 2010, IEEE COMPUT GRAPH, V30, P81, DOI 10.1109/MCG.2010.85; Raskar R, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360655	9	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	FEB	2015	22	1					9	18		10.1007/s10043-015-0038-0		10	Optics	Optics	CG9JE	WOS:000353630200002		
J	Nakamura, T; Horisaki, R; Tanida, J				Nakamura, Tomoya; Horisaki, Ryoichi; Tanida, Jun			Compact wide-field-of-view imager with a designed disordered medium	OPTICAL REVIEW			English	Article						Computational imaging; Wide field-of-view; Disordered medium; Lensless imaging	DEPTH	Disordered media have been exploited for realizing compact lensless imagers and spectroscopes. However, random scattering causes significant loss of the light energy acquirable by a sensor. Here, we present a compact, wide-field-of-view (wide-FOV) imager in which the usable light energy is increased using a designed disordered medium. The density of scattering air holes in a glass is spatially distributed so as to achieve an effective graded index, which guides light from a wide-FOV toward a sensor. Based on numerical experiments, we demonstrated brighter wide-FOV imaging than an imager using a conventional random medium.	[Nakamura, Tomoya; Horisaki, Ryoichi; Tanida, Jun] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Informat & Phys Sci, Suita, Osaka 5650871, Japan; [Nakamura, Tomoya] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1027472, Japan	Horisaki, R (reprint author), Osaka Univ, Grad Sch Informat Sci & Technol, Dept Informat & Phys Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	r.horisaki@ist.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS)	This research was supported by Grant-in-Aid for JSPS Fellows from the Japan Society for the Promotion of Science (JSPS).	Vellekoop IM, 2010, NAT PHOTONICS, V4, P320, DOI 10.1038/NPHOTON.2010.3; Popoff SM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.100601; Wang M, 2008, MAT SCI ENG R, V63, P1, DOI 10.1016/j.mser.2008.07.001; Nakamura T, 2012, OPT EXPRESS, V20, P27482, DOI 10.1364/OE.20.027482; Potuluri P, 2003, OPT EXPRESS, V11, P2134, DOI 10.1364/OE.11.002134; Choi Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.203901; Redding B, 2013, NAT PHOTONICS, V7, P746, DOI [10.1038/nphoton.2013.190, 10.1038/NPHOTON.2013.190]; Brady D.J., 2009, OPT EXPRESS, V17, P2026; Choi Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.023902; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Fergus R., 2006, 1 MIT CSAIL; Gill P. R., 2013, P IM APPL OPT; Goodman J. W., 1996, INTRO FOURIER OPTICS; Levin A, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.1239521; Liutkus A., 2014, SCI REP, V4, P5552; RICHARDS.WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055; Saleh B., 1991, FUNDAMENTALS PHOTONI; Vasic B, 2011, J APPL PHYS, V110, DOI 10.1063/1.3630116; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302	19	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	FEB	2015	22	1					19	24		10.1007/s10043-015-0060-2		6	Optics	Optics	CG9JE	WOS:000353630200003		
J	Morinaga, M				Morinaga, Makoto			Wave propagation through a set of slits	OPTICAL REVIEW			English	Article						Waveguides; Diffraction optics; Atom optics		Propagation of a wave through a set of identical slits is investigated using a scalar diffraction theory. The slits are aligned on a straight line with equal spacing. The asymptotic expansion of the matrix elements of the propagation operator is derived and compared with numerical calculations. And then the eigenmodes and eigen-values of the propagation operator are estimated. Our analysis should provide an insight into the properties of waveguides composed of opaque masks that have been proposed recently.	Univ Electrocommun, Inst Laser Sci, Chofu, Tokyo 1828585, Japan	Morinaga, M (reprint author), Univ Electrocommun, Inst Laser Sci, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	morinaga@ils.uec.ac.jp			Photon Frontier Network Program (MEXT)	This work was partly supported by the Photon Frontier Network Program (MEXT).	Kouznetsov D, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.013617; Kouznetsov D., 2012, J MOD PHYS, V3, P553; Kouznetsov D, 2005, OPT REV, V12, P363, DOI 10.1007/s10043-005-0363-9; Morinaga M., 2014, INT J PHYS SCI, V9, P444	4	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	FEB	2015	22	1					33	38		10.1007/s10043-015-0045-1		6	Optics	Optics	CG9JE	WOS:000353630200005		
J	Shibata, N; Ohashi, M; Maruyama, R; Kuwaki, N				Shibata, Nori; Ohashi, Masaharu; Maruyama, Ryo; Kuwaki, Nobuo			Measurements of differential group delay and chromatic dispersion for LP01 and LP11 modes of few-mode fibers with depressed claddings	OPTICAL REVIEW			English	Article						Few-mode fiber; Chromatic dispersion; Differential group delay; Modal interferometer method; White-light interferometric method	OPTICAL-FIBER; COMPENSATION	The chromatic dispersion of the LP11 mode in a few-mode fiber with low differential group delay is evaluated experimentally. A differential group delay of less than 100 ps/km around 1550 nm can be evaluated with the modal interferometer method. The white-light interferometric method confirms that the LP11 mode is behind the LP01 mode in the 1300-1600 nm wavelength region. The difference between the chromatic dispersion values of the two modes is less than 0.5 ps/km/nm, which means that the optical pulse spreading characteristics of the LP11 mode are similar to those of the LP01 mode for fibers with depressed claddings.	[Shibata, Nori] Nihon Univ, Coll Engn, Dept Elect & Elect Engn, Koriyama, Fukushima 9638642, Japan; [Ohashi, Masaharu] Osaka Prefecture Univ, Dept Elect & Elect Syst, Grad Sch Engn, Div Elect Engn & Informat Sci, Sakai, Osaka 5998531, Japan; [Maruyama, Ryo; Kuwaki, Nobuo] Fujikura Ltd, Sakura Ku, Chiba 2858550, Japan	Ohashi, M (reprint author), Osaka Prefecture Univ, Dept Elect & Elect Syst, Grad Sch Engn, Div Elect Engn & Informat Sci, Sakai, Osaka 5998531, Japan.	ohashi@eis.osakafu-u.ac.jp					Ryf R, 2012, J LIGHTWAVE TECHNOL, V30, P521, DOI 10.1109/JLT.2011.2174336; TATEDA M, 1981, IEEE J QUANTUM ELECT, V17, P404, DOI 10.1109/JQE.1981.1071115; Hamel P, 2007, OPT LETT, V32, P1029, DOI 10.1364/OL.32.001029; Dyott R.B., 1995, ELLIPTICAL FIBER WAV, P119; KITAYAMA K, 1979, IEEE J QUANTUM ELECT, V15, P6, DOI 10.1109/JQE.1979.1069881; POOLE CD, 1994, J LIGHTWAVE TECHNOL, V12, P1746, DOI 10.1109/50.337486; POOLE CD, 1992, OPT LETT, V17, P985, DOI 10.1364/OL.17.000985; Sakamoto T, 2011, OPT EXPRESS, V19, P478, DOI 10.1364/OE.19.00B478; Shibata N, 2009, J LIGHTWAVE TECHNOL, V27, P1269, DOI 10.1109/JLT.2009.2014886; Shibata N, 2005, J LIGHTWAVE TECHNOL, V23, P1244, DOI 10.1109/JLT.2005.843522; SHIBATA N, 1980, APPL OPTICS, V19, P1489, DOI 10.1364/AO.19.001489	11	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	FEB	2015	22	1					65	70		10.1007/s10043-015-0056-y		6	Optics	Optics	CG9JE	WOS:000353630200010		
J	Suzuki, M				Suzuki, Masahiro			Motion of half-occluded zones contributes to avoidance of interocular suppression in natural viewing situations	OPTICAL REVIEW			English	Article						Interocular suppression; Binocular rivalry; Half-occlusion; Half-occluded zones; Motion; Binocular vision; Stereopsis; Stereoscopic vision; Natural viewing situation	RIVALROUS-TEXTURE STEREOGRAMS; EXCLUSIVE BINOCULAR-RIVALRY; SPATIAL-FREQUENCY; PERCEIVED DEPTH; NEURAL THEORY; STEREOPSIS; VISION; FUSION; DISPARITY	This study examined the effect of motion on avoidance of interocular suppression in the half-occluded zones, which are non-fusible images projected onto the corresponding retinal areas in natural viewing situations. Six and seven adults participating in Experiments 1 and 2, respectively, measured the amount of suppression in the half-occluded zones. In the moving condition, motion of the occluded surface caused motion of the half-occluded zones in Experiment 1; motion of the occluder caused it in Experiment 2. In the static condition, the occluded surface, half-occluded zones, and occluder were static in Experiments 1 and 2. The results obtained from both experiments indicated that the half-occluded zones were less suppressed in the moving condition than in the static condition. These findings demonstrated that motion of the half-occluded zones contributes to the avoidance of interocular suppression in natural viewing situations.	Kanagawa Inst Technol, Human Media Res Ctr, Atsugi, Kanagawa 2430292, Japan	Suzuki, M (reprint author), Kanagawa Inst Technol, Human Media Res Ctr, 1030 Shimo Ogino, Atsugi, Kanagawa 2430292, Japan.	msuzuki@ctr.kanagawa-it.ac.jp					ANDERSON BL, 1994, PSYCHOL REV, V101, P414, DOI 10.1037/0033-295X.101.3.414; BLAKE R, 1985, PERCEPT PSYCHOPHYS, V37, P114, DOI 10.3758/BF03202845; WOLFE JM, 1986, PSYCHOL REV, V93, P269, DOI 10.1037/0033-295X.93.3.269; SHIMOJO S, 1990, VISION RES, V30, P69, DOI 10.1016/0042-6989(90)90128-8; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Abrams RA, 2003, PSYCHOL SCI, V14, P427, DOI 10.1111/1467-9280.01458; BLAKE R, 1991, VISION RES, V31, P1191, DOI 10.1016/0042-6989(91)90044-6; Bingushi K, 2005, JPN PSYCHOL RES, V47, P223, DOI 10.1111/j.1468-5884.2005.00291.x; Emoto M, 1998, J OPT SOC AM A, V15, P2257, DOI 10.1364/JOSAA.15.002257; FAHLE M, 1982, VISION RES, V22, P787, DOI 10.1016/0042-6989(82)90010-4; FRISBY JP, 1978, PERCEPTION, V7, P661, DOI 10.1068/p070661; Hayashi R, 2004, VISION RES, V44, P2367, DOI 10.1016/j.visres.2004.04.017; HOWARD IP, 1995, PERCEPTION, V24, P67, DOI 10.1068/p240067; JULESZ B, 1975, PERCEPTION, V4, P125, DOI 10.1068/p040125; LEVELT WJM, 1966, BRIT J PSYCHOL, V57, P225; LEVY MM, 1978, VISION RES, V18, P239, DOI 10.1016/0042-6989(78)90157-8; Mackworth N. H., 1965, PSYCHON SCI, V3, P67; Matsumiya K, 2006, OPT REV, V13, P39, DOI 10.1007/s10043-006-0039-0; Matsumiya K, 2007, PERCEPTION, V36, P990, DOI 10.1068/p5749; MAYHEW JEW, 1976, NATURE, V264, P53, DOI 10.1038/264053a0; ONO H, 1977, PERCEPT PSYCHOPHYS, V21, P513, DOI 10.3758/BF03198731; Ono H., 1974, SHINRIGAKU HYOURON, V17, P156; SHIMOJO S, 1994, VISION RES, V34, P1875, DOI 10.1016/0042-6989(94)90311-5; SPERLING G, 1970, AM J PSYCHOL, V83, P461, DOI 10.2307/1420686; Suzuki Masahiro, 2002, Shinrigaku Kenkyu, V73, P270; Suzuki M., 2001, SHINRIGAKU KENKYU, V71, P486; Suzuki M, 2014, OPT REV, V21, P298, DOI 10.1007/s10043-014-0045-6; Troxler D., 1804, OPHTHALMOLOGISCHE BI, V2, P1; Tsai J. J., 2000, VISION RES, V40, P33; Verhoeff FH, 1935, ARCH OPHTHALMOL-CHIC, V13, P151; WADE NJ, 1984, PERCEPT PSYCHOPHYS, V35, P111, DOI 10.3758/BF03203891; WADE NJ, 1986, PERCEPTION, V15, P435, DOI 10.1068/p150435	32	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	FEB	2015	22	1					71	78		10.1007/s10043-015-0050-4		8	Optics	Optics	CG9JE	WOS:000353630200011		
J	Bao, S; Tanaka, G; Tajima, J				Bao, Shi; Tanaka, Go; Tajima, Johji			Fundamental study of illumination transformation for color vision deficiencies	OPTICAL REVIEW			English	Article						Dichromacy; Illumination; Genetic algorithm	DICHROMATS; IMAGE; DEUTERANOPIA; PROTANOPIA	An object's color depends on its reflectance and illumination, and dichromats cannot distinguish specific color pairs. It is considered that there is an appropriate illumination under which a dichromat can distinguish confusing color pairs. In this study, a fundamental investigation of an illumination transformation to assist dichromats is carried out. Because the appropriate illumination depends on the object, we propose a search algorithm for the optimum light source spectrum for an object. In experiments, the effectiveness of the proposed method is examined using digital images and an sRGB display.	[Bao, Shi; Tanaka, Go; Tajima, Johji] Nagoya City Univ, Grad Sch Nat Sci, Nagoya, Aichi 4678501, Japan	Tanaka, G (reprint author), Nagoya City Univ, Grad Sch Nat Sci, Nagoya, Aichi 4678501, Japan.	shibao@nsc.nagoya-cu.ac.jp; tanakago@nsc.nagoya-cu.ac.jp; tajima@nsc.nagoya-cu.ac.jp					Anagnostopoulos C.-N., 2007, P 5 INT C COMP VIS S; MALONEY LT, 1986, J OPT SOC AM A, V3, P29, DOI 10.1364/JOSAA.3.000029; Kuhn GR, 2008, IEEE T VIS COMPUT GR, V14, P1747, DOI 10.1109/TVCG.2008.112; Rasche K, 2005, COMPUT GRAPH FORUM, V24, P423, DOI 10.1111/j.1467-8659.2005.00867.x; Vienot F, 1999, COLOR RES APPL, V24, P243; Flatla D. R., 2012, P 14 INT ACM SIGACCE, P167; Flatla D. R., 2013, P SIGCHI C HUM FACT, P2069; Goldberg D. E., 1989, GENETIC ALGORITHMS S; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES, V3rd, P71; Huang C.-R., 2010, PCM-PREM PERS COMPUT, V2011, P637; Huang J. B., 2009, P 2009 IEEE INT C AC, P1161; Huang J. B., 2007, IEEE SIGNAL PROCESS, V14, P711, DOI 10.1109/LSP.2007.898333; Hunt R. W. G., 2011, MEASURING COLOUR, V4th, P94; Iaccarino G., 2006, P 15 INT C WORLD WID, P919, DOI 10.1145/1135777.1135944; Ichikawa M., 2004, P IEEE INT C SYST MA, P36; Jefferson L., 2007, P SIGCHI, P1535, DOI 10.1145/1240624.1240855; Jeong J.-Y., 2012, P IEEE INT C CONS EL, P600; Nagai T., 2009, NIHON SHIKISAI GAKKA, V33, P76; Rasche K, 2005, IEEE COMPUT GRAPH, V25, P22, DOI 10.1109/MCG.2005.54; Tamura S., 2011, NIHON SHIKISAI GAKKI, V35, P106; Tamura S., 2012, NIHON SHIKISAI GAKKA, V36, P124; Tanaka G, 2010, OPT REV, V17, P14, DOI 10.1007/s10043-010-0004-9; Tanaka G, 2011, IEICE T FUND ELECTR, VE94A, P884, DOI 10.1587/transfun.E94.A.884; Wakita K, 2005, P 7 INT ACM SIGACCES, P158, DOI 10.1145/1090785.1090815; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd, P459	25	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	FEB	2015	22	1					79	92		10.1007/s10043-015-0055-z		14	Optics	Optics	CG9JE	WOS:000353630200012		
J	Ikeda, K; Watanabe, E				Ikeda, Kanami; Watanabe, Eriko			Reducing input data via image categorization to improve the speed of copyright content management systems	OPTICAL REVIEW			English	Article						Correlators; Copyright content management; Video identification; Optical disks; Holography	OPTICAL CORRELATOR	An optical correlator has the advantage of high data transfer speed and parallel operation. However, in copyright content management systems (CCMSs), the numerous video files that need to be downloaded from the Internet and input to the optical correlator constitute a bottleneck. This paper proposes an image categorization method for CCMSs that uses the difference in the color features between animation and live-action images to remove this bottleneck and increase the speed of CCMSs. The results of experiments conducted indicate that the proposed method achieves a live-action video true rejection rate of 86.7 % and an animation video false rejection rate of 13.3 %. This indicates that the proposed method can improve the overall speed of a CCMS more than twice the original speed.	[Ikeda, Kanami; Watanabe, Eriko] Univ Electrocommun, Chofu, Tokyo 1828585, Japan	Ikeda, K (reprint author), Univ Electrocommun, Chofu, Tokyo 1828585, Japan.	kanami@uec.ac.jp					Manzur T, 2012, APPL OPTICS, V51, P4976, DOI 10.1364/AO.51.004976; Zheng TX, 2013, APPL OPTICS, V52, P2841, DOI 10.1364/AO.52.002841; Watanabe E, 2012, PROC SPIE, V8498, DOI 10.1117/12.929690; Kutanov A, 1996, OPT REV, V3, P258, DOI 10.1007/s10043-996-0258-4; [Anonymous], REP RES FIELD SURV I; Zeng X, 2011, OPT EXPRESS, V19, P12594, DOI 10.1364/OE.19.012594; Watanabe E, 2008, JPN J APPL PHYS, V47, P5964, DOI 10.1143/JJAP.47.5964; WEAVER CS, 1966, APPL OPTICS, V5, P1248, DOI 10.1364/AO.5.001248; Wu XM, 2013, IEEE T CIRC SYST VID, V23, P1054, DOI 10.1109/TCSVT.2013.2248991; Horimai H, 2005, APPL OPTICS, V44, P2575, DOI 10.1364/AO.44.002575; Zeng X, 2011, OPT LETT, V36, P1383, DOI 10.1364/OL.36.001383; Lin L, 2011, IEEE MULTIMEDIA, V18, P32, DOI 10.1109/MMUL.2011.35; Kobayashi Y, 1996, OPT REV, V3, P403; Fukunaga K., 1990, INTRO STAT PATTERN R; Ikeda K., 2014, IMAGING APPL OPTICS; Kitabayashi L., 2011, J INTELLECT PROP ASS, V7, P43; Matsubara D., 2009, IEEE INT S MULT, P312; Sarkar A, 2008, P SOC PHOTO-OPT INS, V6820, pE8200, DOI 10.1117/12.766171; Sun Y., REC VIDEO RETRIEVAL; VANDERLUGT A, 1964, IEEE T INFORM THEORY, V10, P139	20	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	FEB	2015	22	1					93	98		10.1007/s10043-015-0034-4		6	Optics	Optics	CG9JE	WOS:000353630200013		
J	Koga, T; Suetake, N				Koga, Takanori; Suetake, Noriaki			Impulse noise removal using 1-D switching median filter with adaptive scanning order based on structural context of image	OPTICAL REVIEW			English	Article						Impulse noise removal; Salt-and-pepper noise; Switching median filter; Minimum spanning tree; Space-filling curve	SPACE-FILLING CURVE; ENHANCEMENT	This paper describes the detail-preserving impulse noise removal performance of a one-dimensional (1D) switching median filter (SMF) applied along an adaptive space-filling curve. Usually, a SMF with a two-dimensional (2-D) filter window is widely used for impulse noise removal while still preserving detailed parts in an input image. However, the noise detector of the 2-D filter does not always distinguish between the original pixels and the noise-corrupted ones perfectly. In particular, pixels constituting thin lines in an input image tend to be incorrectly detected as noise-corrupted pixels, and such pixels are filtered regardless of the necessity of the filtering. To cope with this problem, we propose a new impulse noise removal method based on a 1-D SMF and a space-filling curve which is adaptively drawn using a minimum spanning tree reflecting structural context of an input image.	[Koga, Takanori] Tokuyama Coll, Natl Inst Technol, Gakuendai, Shunan 7458585, Japan; [Suetake, Noriaki] Yamaguchi Univ, Yamaguchi 7538512, Japan	Koga, T (reprint author), Tokuyama Coll, Natl Inst Technol, Gakuendai, Shunan 7458585, Japan.	koga@tokuyama.ac.jp; suetake@sci.yamaguchi-u.ac.jp			Telecommunications Advancement Foundation (TAF)	We would like to express our sincere gratitude to the Telecommunications Advancement Foundation (TAF) for their financial support.	BROWNRIGG DRK, 1984, COMMUN ACM, V27, P807, DOI 10.1145/358198.358222; Wang Z, 1999, IEEE T CIRCUITS-II, V46, P78; BOVIK AC, 1983, IEEE T ACOUST SPEECH, V31, P1342, DOI 10.1109/TASSP.1983.1164247; Alajlan N, 2004, SIGNAL PROCESS-IMAGE, V19, P993, DOI 10.1016/j.image.2004.08.003; Lin TC, 2007, INFORM SCIENCES, V177, P1073, DOI 10.1016/j.ins.2006.07.030; Windyga PS, 2001, IEEE T IMAGE PROCESS, V10, P173, DOI 10.1109/83.892455; SUN T, 1994, PATTERN RECOGN LETT, V15, P341, DOI 10.1016/0167-8655(94)90082-5; KO SJ, 1991, IEEE T CIRCUITS SYST, V38, P984, DOI 10.1109/31.83870; Asano T, 1999, IEICE T FUND ELECTR, VE82A, P553; Celebi M. E., 2008, J ELECTRON IMAGING, V17, P9; Koga T, 2013, J VIS COMMUN IMAGE R, V24, P806, DOI 10.1016/j.jvcir.2013.05.008; Koga T., 2013, P 39 ANN C IEEE IND, P2436; Koga T., 2011, P IEEE INT C IM PROC, P1497; Kruskal J.B., 1956, P AM MATH SOC, V7, P48, DOI DOI 10.1090/S0002-9939-1956-0078686-7; Pratt W., 1978, DIGITAL IMAGE PROCES; Sagan H, 1994, SPACE FILLING CURVES; Tukey J., 1977, EXPLORATORY DATA ANA; Tukey J. W., 1974, EASCON 74, P673; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wilson R.J., 1996, INTRO GRAPH THEORY	20	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	FEB	2015	22	1					123	135		10.1007/s10043-015-0059-8		13	Optics	Optics	CG9JE	WOS:000353630200016		
J	Shoji, T; Tsuboi, Y				Shoji, Tatsuya; Tsuboi, Yasuyuki			Plasmonic optical trapping of soft nanomaterials such as polymer chains and DNA: micro-patterning formation	OPTICAL REVIEW			English	Article						Optical tweezers; Optical trapping; Localized surface plasmons; Thermoresponsive polymer chains; DNA; Fluorescence microspectroscopy	LOCALIZED SURFACE-PLASMON; FLUORESCENCE MICROSPECTROSCOPY; METALLIC-NANOSTRUCTURE; NANO-OBJECTS; TEMPERATURE; PARTICLES; NANOPARTICLES; MANIPULATION; PRESSURE; GRADIENT	Localized surface plasmons exert a strong radiation force on nanoparticles in the vicinity of noble metal nanostructures, resulting in optical trapping. Such plasmon-based optical trapping is one of the hot topics in the field of nanophotonics and can be applied to molecular manipulation techniques. In this review paper, we describe the plasmon-based optical trapping of polymer chains and DNA. In addition, we describe the future outlook for this trapping method.	[Shoji, Tatsuya; Tsuboi, Yasuyuki] Osaka City Univ, Grad Sch Sci, Div Mol Mat Sci, Sumiyo, Osaka 5588585, Japan	Shoji, T (reprint author), Osaka City Univ, Grad Sch Sci, Div Mol Mat Sci, 3-3-138 Sugimoto, Sumiyo, Osaka 5588585, Japan.	t-shoji@sci.osaka-cu.ac.jp; twoboys@sci.osaka-cu.ac.jp					Chen C, 2012, NANO LETT, V12, P125, DOI 10.1021/nl2031458; Ueno K, 2013, J PHOTOCH PHOTOBIO C, V15, P31, DOI 10.1016/j.jphotochemrev.2013.04.001; Toshimitsu M, 2012, J PHYS CHEM C, V116, P14610, DOI 10.1021/jp305247a; Shoji T, 2013, J AM CHEM SOC, V135, P6643, DOI 10.1021/ja401657j; Maeda YT, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.038301; ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653; Shoji T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.092001; Nagasawa F, 2014, J PHYS CHEM LETT, V5, P14, DOI 10.1021/jz402243a; Turner APF, 2013, CHEM SOC REV, V42, P3184, DOI 10.1039/c3cs35528d; Righini M, 2009, NANO LETT, V9, P3387, DOI 10.1021/nl803677x; Tanaka Y, 2013, NANO LETT, V13, P2146, DOI 10.1021/nl4005892; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; SVOBODA K, 1994, OPT LETT, V19, P930, DOI 10.1364/OL.19.000930; Grigorenko AN, 2008, NAT PHOTONICS, V2, P365, DOI 10.1038/nphoton.2008.78; Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; Shoji T, 2013, J PHYS CHEM C, V117, P2500, DOI 10.1021/jp306405j; Tsuboi Y, 2010, J PHYS CHEM LETT, V1, P2327, DOI 10.1021/jz100659x; Braun M, 2013, ACS NANO, V7, P11200, DOI 10.1021/nn404980k; Juan ML, 2009, NAT PHYS, V5, P915, DOI 10.1038/NPHYS1422; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Piazza R, 2008, SOFT MATTER, V4, P1740, DOI 10.1039/b805888c; Ito S, 2007, J PHYS CHEM B, V111, P2365, DOI 10.1021/jp0651561; Pang YJ, 2012, NANO LETT, V12, P402, DOI 10.1021/nl203719v; De Groot S.R., 1962, NONEQUILIBRIUM THERM; Heskins M., 1968, SCI CHEM A, V2, P1441; Hulteen J. C., 1995, FILM, V13, P1553; Kita R, 2005, MACROMOLECULES, V38, P4554, DOI 10.1021/ma050526+; Kitagawa F, 2002, B CHEM SOC JPN, V75, P705, DOI 10.1246/bcsj.75.705; Nagasawa F, 2011, CHEM COMMUN, V47, P4514, DOI 10.1039/c0cc05866a; Roxworthy BJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00660; Roxworthy B. J., 2014, NAT COMMUN, V5, P1; Wang K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1480; Yamauchi H, 2013, J PHYS CHEM C, V117, P8388, DOI 10.1021/jp311173j	35	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	FEB	2015	22	1					137	142		10.1007/s10043-015-0030-8		6	Optics	Optics	CG9JE	WOS:000353630200018		
J	Kumeta, A; Bond, C; Somiya, K				Kumeta, Ayaka; Bond, Charlotte; Somiya, Kentaro			Design study of the KAGRA output mode cleaner	OPTICAL REVIEW			English	Article						Interferometer; Simulation; Gravitational waves		Most second-generation gravitational-wave detectors employ an optical resonator called an output mode cleaner (OMC), which filters out junk light from the signal and the reference light, before it reaches the detection photodiode located at the asymmetric port of the large-scale interferometer. The optical parameters of the OMC should be carefully chosen to satisfy the requirements to filter out unwanted light whilst transmitting the gravitational-wave signal. We use the simulation program FINESSE and realistic mirror phase maps that have the same surface quality as the KAGRA test masses to find out a proper design of the KAGRA OMC.	[Kumeta, Ayaka; Somiya, Kentaro] Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan; [Bond, Charlotte] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England	Kumeta, A (reprint author), Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan.	kumeta@gw.phys.titech.ac.jp			Springer A. Advanced Research Networks of the Japan Society for the Promotion of Science (JSPS)	The authors would like to thank Daniel Brown and Andreas Freise for their kind help on the use of FINESSE, and Hiro Yamamoto for his kind support in creating realistic mirror maps. Special thanks also go to Jumpei Kato, Kazushiro Yano, Sho Atsuta, Yuu Kataoka for their kind support. This work is partially supported by the Specially Promoted Research and the Core-to-Core Program, Springer A. Advanced Research Networks of the Japan Society for the Promotion of Science (JSPS).	Hirose E, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.062003; Somiya K, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/12/124007; Fricke TT, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/6/065005; Aso Y, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.043007; MIZUNO J, 1993, PHYS LETT A, V175, P273, DOI 10.1016/0375-9601(93)90620-F; Maselli A, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.023007; Freise A, 2004, CLASSICAL QUANT GRAV, V21, pS1067, DOI 10.1088/0264-9381/21/5/102; Arai K., 2013, LIGOT10002765; Arai K., 2013, SEPT LVC M 2013; Einstein A., 1916, ANN PHYS-LEIPZIG, V49; Freise A., ARXIV13062973; Somiya K, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.122005; Waldman S., 2011, LIGOT10002764; Yamamoto H., COMMUNICATION	14	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	FEB	2015	22	1					149	152		10.1007/s10043-015-0028-2		4	Optics	Optics	CG9JE	WOS:000353630200020		
J	Ichihara, A; Matsuoka, L; Kurosaki, Y; Yokoyama, K				Ichihara, Akira; Matsuoka, Leo; Kurosaki, Yuzuru; Yokoyama, Keiichi			Quantum control of isotope-selective rovibrational excitation of diatomic molecules in the thermal distribution	OPTICAL REVIEW			English	Article						Quantum control; Isotope separation; Optical frequency comb; LiCl; Rotational excitation; Vibrational excitation; Close-coupling		We propose a new method to excite the rovibrational states of diatomic molecules in the gas-phase isotope-selectively by optical pulses. The proposed method uses an optical frequency comb to excite the rotational states of the selected isotope molecules, and the second pulse to excite the vibrational states via the fundamental transitions in the P-branch. We demonstrate its applicability by computer simulations for lithium chloride (LiCl) molecules in the thermal distribution at 70 K.	[Ichihara, Akira; Yokoyama, Keiichi] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Kyoto 6190215, Japan; [Matsuoka, Leo] Hiroshima Univ, Grad Sch Engn, Hiroshima 7398527, Japan; [Kurosaki, Yuzuru] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Tokai, Ibaraki 3191195, Japan	Ichihara, A (reprint author), Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Kyoto 6190215, Japan.	ichihara.akira@jaea.go.jp	Matsuoka, Leo/K-5744-2015		JSPS KAKENHI [26420875]	This work was supported by JSPS KAKENHI Grant No. 26420875.	LETOKHOV VS, 1979, NATURE, V277, P605, DOI 10.1038/277605a0; BLUMEL R, 1986, J CHEM PHYS, V84, P2604; Ichihara A., 2014, JPS C P, V1; Kurosaki Y, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4742059; Matsuoka L., 2011, P INT C FUK DAIICH A; Shapiro M, 2012, QUANTUM CONTROL MOL; WU CYR, 1978, REV SCI INSTRUM, V49, P380, DOI 10.1063/1.1135412; Yokoyama K., 2010, ADV INTENSE LASER SC, P113	8	1	1	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	FEB	2015	22	1					153	156		10.1007/s10043-015-0025-5		4	Optics	Optics	CG9JE	WOS:000353630200021		
J	Akiba, T; Kaneko, N; Suizu, K; Miyamoto, K; Omatsu, T				Akiba, Takuya; Kaneko, Naoya; Suizu, Koji; Miyamoto, Katsuhiko; Omatsu, Takashige			Real-time terahertz wave sensing via infrared detection interacted with evanescent terahertz waves	OPTICAL REVIEW			English	Article						Terahertz; Evanescent waves; Nonlinear wave mixing; Total internal reflection; Real-time sensing	TOTAL-REFLECTION SPECTROSCOPY; LASER	A novel sensing technique is developed that makes use of evanescent terahertz (THz) waves without directly detecting the THz wave. The technique is demonstrated for measuring changes in the electric field of near-infrared light, transcribed from changes in the electric field of THz waves. The method will enable sensing of various materials in the THz-frequency region, to provide knowledge about chemical reactions that require real-time tracking.	[Akiba, Takuya; Kaneko, Naoya; Suizu, Koji] Chiba Inst Technol, Narashino, Chiba 2750016, Japan; [Miyamoto, Katsuhiko; Omatsu, Takashige] Chiba Univ, Inage Ku, Chiba 2638522, Japan; [Omatsu, Takashige] CREST, Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020075, Japan	Akiba, T (reprint author), Chiba Inst Technol, Narashino, Chiba 2750016, Japan.	takuya.akiba@it-chiba.ac.jp	Miyamoto, Katsuhiko/E-6713-2015	Miyamoto, Katsuhiko/0000-0002-2611-882X	Industry-Academia Collaborative R&D from the Japan Science and Technology Agency, JST	This work is funded by the Industry-Academia Collaborative R&D from the Japan Science and Technology Agency, JST.	Akiba T, 2013, OPT LETT, V38, P3687, DOI 10.1364/OL.38.003687; Miyamoto K, 2013, APPL PHYS B-LASERS O, V110, P321, DOI 10.1007/s00340-013-5359-8; Nagai M, 2006, INT J INFRARED MILLI, V27, P505, DOI 10.1007/s10762-006-9098-3; Suizu K, 2009, OPT EXPRESS, V17, P6676, DOI 10.1364/OE.17.006676; Hishida M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.158102; Yamashita M, 2005, OPT EXPRESS, V13, P115, DOI 10.1364/OPEX.13.000115; Zhang S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.023901; Kawase K, 2003, OPT EXPRESS, V11, P2549, DOI 10.1364/OE.11.002549; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; Hirori H, 2004, JPN J APPL PHYS 2, V43, pL1287, DOI 10.1143/JJAP.43.L1287; Shibuya T, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.032302; Shiraga K, 2014, J INFRARED MILLIM TE, V35, P493, DOI 10.1007/s10762-014-0067-y; Koichi M, 2011, OPT EXPRESS, V19, P18523, DOI 10.1364/OE.19.018523; Ohno S, 2009, J EUR OPT SOC-RAPID, V4, DOI 10.2971/jeos.2009.09012	14	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	FEB	2015	22	1					166	169		10.1007/s10043-015-0022-8		4	Optics	Optics	CG9JE	WOS:000353630200024		
J	Otsu, T; Ando, T; Takiguchi, Y; Ohtake, Y; Toyoda, H; Itoh, H				Otsu, Tomoko; Ando, Taro; Takiguchi, Yu; Ohtake, Yoshiyuki; Toyoda, Haruyoshi; Itoh, Hiroyasu			Precise revolution control in three-dimensional off-axis trapping with single Laguerre-Gaussian beam	OPTICAL REVIEW			English	Article						Holographic optical tweezers; Optical vortices; Phase only spatial light modulator	ORBITAL ANGULAR-MOMENTUM; PARTICLES	We report the precise study of orbital angular momentum transfer from Laguerre-Gaussian (LG) beams to submicrometer-sized dielectric spheres. Stable three-dimensional off-axis trapping of the spheres was achieved and confirmed by the constant behavior of the sphere's revolution radius against the trapping LG-beam power. By measuring the revolutions of the sphere that was trapped and revolved in mid-water, we confirmed excellent linearity between the revolution rate and the trapping light free from the hydrodynamic coupling with walls of a sample chamber. This result suggests a torque source of precise controllability, which will contribute to the study of biological molecules, nonequilibrium statistical physics, and micromachines.	[Otsu, Tomoko; Ando, Taro; Takiguchi, Yu; Ohtake, Yoshiyuki; Toyoda, Haruyoshi] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka 4348601, Japan; [Itoh, Hiroyasu] Hamamatsu Photon KK, Cent Res Lab, Tsukuba Res Ctr, Tsukuba, Ibaraki 3002635, Japan	Otsu, T (reprint author), Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka 4348601, Japan.	t-otsu@crl.hpk.co.jp					Allen L., 2003, OPTICAL ANGULAR MOME; Simpson SH, 2009, J OPT SOC AM A, V26, P625, DOI 10.1364/JOSAA.26.000625; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Garces-Chavez V, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.063402; Garces-Chavez V, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.093602; Chen MZ, 2013, OPT LETT, V38, P4919, DOI 10.1364/OL.38.004919; BARNETT SM, 1994, OPT COMMUN, V110, P670, DOI 10.1016/0030-4018(94)90269-0; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; O'Neil AT, 2000, OPT COMMUN, V185, P139, DOI 10.1016/S0030-4018(00)00989-5; Maruo S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768631; Ando T, 2009, OPT LETT, V34, P34, DOI 10.1364/OL.34.000034; Simpson SH, 2010, J OPT SOC AM A, V27, P2061, DOI 10.1364/JOSAA.27.002061; Iketaki Y, 2007, OPT LETT, V32, P2357, DOI 10.1364/OL.32.002357; Otsu T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04579; Volpe G, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.210603	15	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	FEB	2015	22	1					170	173		10.1007/s10043-015-0024-6		4	Optics	Optics	CG9JE	WOS:000353630200025		
J	Sakamoto, M; Fukumoto, R; Murakami, N; Morita, R; Oka, K				Sakamoto, Moritsugu; Fukumoto, Ryohei; Murakami, Naoshi; Morita, Ryuji; Oka, Kazuhiko			Dispersion reduction in generation of high-order optical vortex using axially symmetric half-wave plates	OPTICAL REVIEW			English	Article						Optical vortex; Singular optics; Broadband optical vortex; Polarization; Achromatic optics		We present the topological-charge-dispersion reduction scheme in optical vortex generation using axially symmetric half-wave plates (AHPs). The topological-charge dispersion caused by retardation errors of AHPs and other waveplates is decreased by eliminating unwanted circular-polarization components.	[Sakamoto, Moritsugu; Fukumoto, Ryohei] Hokkaido Univ, Grad Sch Engn, Div Appl Phys, Sapporo, Hokkaido 0608628, Japan; [Murakami, Naoshi; Morita, Ryuji; Oka, Kazuhiko] Hokkaido Univ, Fac Engn, Div Appl Phys, Sapporo, Hokkaido 0608628, Japan; [Morita, Ryuji] CREST, JST, Chiyoda Ku, Tokyo 1020075, Japan	Sakamoto, M (reprint author), Hokkaido Univ, Grad Sch Engn, Div Appl Phys, Sapporo, Hokkaido 0608628, Japan.	m.sakamoto@eng.hokudai.ac.jp					Marrucci L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.163905; Marrucci L, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2207993; Mariyenko IG, 2005, OPT EXPRESS, V13, P7599, DOI 10.1364/OPEX.13.007599; Biener G, 2002, OPT LETT, V27, P1875, DOI 10.1364/OL.27.001875; Swartzlander GA, 2006, OPT LETT, V31, P2042, DOI 10.1364/OL.31.002042; Foo G, 2005, OPT LETT, V30, P3308, DOI 10.1364/OL.30.003308; Oka K., 2011, SPIE PHOT W, P7950; Tokizane Y, 2009, OPT EXPRESS, V17, P14517, DOI 10.1364/OE.17.014517	8	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	FEB	2015	22	1					174	178		10.1007/s10043-015-0026-4		5	Optics	Optics	CG9JE	WOS:000353630200026		
J	Suzuki, M; Yamane, K; Oka, K; Toda, Y; Morita, R				Suzuki, Masato; Yamane, Keisaku; Oka, Kazuhiko; Toda, Yasunori; Morita, Ryuji			Extended Stokes parameters for cylindrically polarized beams	OPTICAL REVIEW			English	Article						Extended Stokes parameters; Cylindrically polarized beam; Optical vortex; Poincare sphere; Pancharatnam-Berry phase	ORBITAL ANGULAR-MOMENTUM; VECTOR BEAMS; PHASE; PROPAGATION; FIBERS; LIGHT	The extended Stokes parameters for arbitrary cylindrically polarized beams are newly introduced to evaluate their quality. A set of the parameters, expressing a cylindrically polarized state, permits the definition of the degree of polarization that indicates the purity of the spatial symmetry of polarization of a light beam. In addition, the Pancharatnam-Berry phase related to the cylindrically polarized states is described by the new Stokes parameters.	[Suzuki, Masato; Yamane, Keisaku; Oka, Kazuhiko; Toda, Yasunori; Morita, Ryuji] Hokkaido Univ, Dept Appl Phys, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Yamane, Keisaku; Toda, Yasunori; Morita, Ryuji] CREST, JST, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Suzuki, M (reprint author), Hokkaido Univ, Dept Appl Phys, Kita Ku, Kita 13,Nishi 8, Sapporo, Hokkaido 0608628, Japan.	masato_suzuki@eng.hokudai.ac.jp					Marrucci L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.163905; Bozinovic N, 2013, SCIENCE, V340, P1545, DOI 10.1126/science.1237861; Ramachandran S, 2009, OPT LETT, V34, P2525, DOI 10.1364/OL.34.002525; ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; Holleczek A, 2011, OPT EXPRESS, V19, P9714, DOI 10.1364/OE.19.009714; Tovar AA, 1998, J OPT SOC AM A, V15, P2705, DOI 10.1364/JOSAA.15.002705; Suzuki M, 2014, OPT EXPRESS, V22, P16903, DOI 10.1364/OE.22.016903; BHANDARI R, 1988, PHYS REV LETT, V60, P1211, DOI 10.1103/PhysRevLett.60.1211; WOLF E, 1959, NUOVO CIMENTO, V13, P1165, DOI 10.1007/BF02725127; Zhan QW, 2009, ADV OPT PHOTONICS, V1, P1, DOI 10.1364/AOP.1.000001; Milione G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.053601; AHARONOV Y, 1987, PHYS REV LETT, V58, P1593, DOI 10.1103/PhysRevLett.58.1593; Milione G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.190401; Hnatovsky C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.123901; BERRY MV, 1984, P ROY SOC LOND A MAT, V392, P45, DOI 10.1098/rspa.1984.0023; Goldstein D. H., 2011, POLARIZED LIGHT, V3rd; Goodman J. W., 1985, STATISTICAL OPTICS; Hecht E, 2002, OPTICS; Maurer C, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/3/078; Pancharatnam S., 1956, Proceedings of the Indian Academy of Sciences, Section A, V43; Tokizane Y., 2010, OPT EXPRESS, V18, P2144	21	1	1	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	FEB	2015	22	1					179	183		10.1007/s10043-015-0023-7		5	Optics	Optics	CG9JE	WOS:000353630200027		
J	Anzaki, R; Fukushima, K; Hidaka, Y; Oka, T				Anzaki, Ryoji; Fukushima, Kenji; Hidaka, Yoshimasa; Oka, Takashi			Restricted phase-space approximation in real-time stochastic quantization	ANNALS OF PHYSICS			English	Article						Real-time dynamics; Numerical simulation; Scalar field theory; Stochastic quantization; Complex Langevin equation	COMPLEX LANGEVIN DYNAMICS; LATTICE QCD; PERTURBATION-THEORY; FINITE-DENSITY; FIELD-THEORY; TEMPERATURE; INSULATOR; EQUATION	We perform and extend real-time numerical simulation of a low-dimensional scalar field theory or a quantum mechanical system using stochastic quantization. After a brief review of the quantization method and the complex Langevin dynamics, we calculate the propagator and make a comparison with analytical results. This is a first step toward general applications, and we focus only on the vacuum properties of the theory; this enables us to handle the boundary condition with the i epsilon prescription in frequency space. While we can control stability of the numerical simulation for any coupling strength, our results turn out to flow into an unphysical fixed-point, which is qualitatively understood from the corresponding Fokker Planck equation. We propose a simple truncation scheme, "restricted phase-space approximation", to avoid the unphysical fixed-point. With this method, we obtain stable results at reasonably good accuracy. Finally we give a short discussion on the closed-time path formalism and demonstrate the direct computation of the vacuum expectation value not with the i epsilon prescription but from an explicit construction of the Feynman kernel. (C) 2014 Elsevier Inc. All rights reserved.	[Anzaki, Ryoji; Oka, Takashi] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Fukushima, Kenji] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Hidaka, Yoshimasa] RIKEN, Nishina Ctr, Theoret Res Div, Wako, Saitama 3510198, Japan	Fukushima, K (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	fukush@gmail.com			JSPS KAKENHI [24740169, 24740184, 23740260]; RIKEN iTHES Project	K.F. would like to thank Jurgen Berges, Jan Pawlowski, and Denes Sexty for useful conversations. K.F., Y.H., and T.O. were partially supported by JSPS KAKENHI Grant Nos. 24740169, 24740184, and 23740260, respectively. Y.H. was also supported by the RIKEN iTHES Project.	Aarts G, 2013, EUR PHYS J A, V49, DOI 10.1140/epja/i2013-13089-4; Aarts G, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-011-1756-5; Aarts G., 2012, P SCI LATTICE2012, VLATTICE2012, P017; Aarts G., 2013, J HIGH ENERGY PHYS, V1303; Muhlbacher L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.176403; Schollwock U, 2005, REV MOD PHYS, V77, P259, DOI 10.1103/RevModPhys.77.259; Nakamura A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.072305; WHITE SR, 1992, PHYS REV LETT, V69, P2863, DOI 10.1103/PhysRevLett.69.2863; Heller MP, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.201602; Berges J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.202003; Dusling K, 2011, NUCL PHYS A, V850, P69, DOI 10.1016/j.nuclphysa.2010.11.009; Cazalilla MA, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.256403; Bazavov A, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.054503; DAMGAARD PH, 1987, PHYS REP, V152, P227, DOI 10.1016/0370-1573(87)90144-X; Romatschke P, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.045011; Georges A, 1996, REV MOD PHYS, V68, P13, DOI 10.1103/RevModPhys.68.13; Aarts G, 2010, PHYS LETT B, V687, P154, DOI 10.1016/j.physletb.2010.03.012; Freericks JK, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266408; Amato A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.172001; Meyer HB, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.101701; Moeckel M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/055016; Werner P, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.035320; Khlebnikov SY, 1996, PHYS REV LETT, V77, P219, DOI 10.1103/PhysRevLett.77.219; Dusling K, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.085040; Aarts G, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.054508; SCHWINGER J, 1961, J MATH PHYS, V2, P407, DOI 10.1063/1.1703727; Fukushima K, 2012, NUCL PHYS A, V874, P108, DOI 10.1016/j.nuclphysa.2011.11.003; Gelis F, 2007, INT J MOD PHYS E, V16, P2595, DOI 10.1142/S0218301307008331; Avila K, 2011, SCIENCE, V333, P192, DOI 10.1126/science.1203223; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Ding HT, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.034504; Eckstein M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.115131; Muroya S, 2003, PROG THEOR PHYS, V110, P615, DOI 10.1143/PTP.110.615; Chesler PM, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.026006; Berges J, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.045007; D'Elia M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.072001; PARISI G, 1981, SCI SINICA, V24, P483; Aharony O, 2000, PHYS REP, V323, P183, DOI 10.1016/S0370-1573(99)00083-6; Karsch F, 2002, PHYS LETT B, V530, P147, DOI 10.1016/S0370-2693(02)01326-6; Borsanyi S, 2014, PHYS LETT B, V730, P99, DOI 10.1016/j.physletb.2014.01.007; Asakawa M, 2001, PROG PART NUCL PHYS, V46, P459, DOI 10.1016/S0146-6410(01)00150-8; Fukushima K, 2007, NUCL PHYS A, V786, P107, DOI 10.1016/j.nuclphysa.2007.01.086; Berges J, 2008, NUCL PHYS B, V799, P306, DOI 10.1016/j.nuclphysb.2008.01.018; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Romatschke P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.062302; LANDSMAN NP, 1987, PHYS REP, V145, P141, DOI 10.1016/0370-1573(87)90121-9; Epelbaum T, 2011, NUCL PHYS A, V872, P210, DOI 10.1016/j.nuclphysa.2011.09.019; Polarski D, 1996, CLASSICAL QUANT GRAV, V13, P377, DOI 10.1088/0264-9381/13/3/006; NELSON E, 1966, PHYS REV, V150, P1079, DOI 10.1103/PhysRev.150.1079; Aarts G, 2013, ANN PHYS-NEW YORK, V337, P238, DOI 10.1016/j.aop.2013.06.019; Nakahara Y, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.091503; Berges J, 2004, Phys Rev Lett, V93, P142002, DOI 10.1103/PhysRevLett.93.142002; Aarts G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.022002; HUFFEL H, 1984, PHYS LETT B, V148, P104, DOI 10.1016/0370-2693(84)91619-8; Meyer HB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.162001; Gelis F, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.125035; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; CORNWALL JM, 1974, PHYS REV D, V10, P2428, DOI 10.1103/PhysRevD.10.2428; PARISI G, 1983, PHYS LETT B, V131, P393, DOI 10.1016/0370-2693(83)90525-7; Aoki H., ARXIV13105329CONDMAT; Balasubramanian V, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.026010; Balasubramanian V, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.191601; Berges J., ARXIV13125216HEPPH; Berges J., ARXIV13035650HEPPH; Berges J., ARXIV13113005HEPPH; Brambilla N., ARXIV14043723HEPPH; Breuer H-P, 2002, THEORY OPEN QUANTUM; Chesler PM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.211601; Cristoforetti M., ARXIV14035637HEPLAT; Cristoforetti M, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.074506; Cristoforetti M., ARXIV13121052HEPLAT; Epelbaum T., ARXIV14020115HEPPH; Feynman R. P., 1965, INT SERIES PURE APPL; Fodor Z, 2012, REV MOD PHYS, V84, DOI 10.1103/RevModPhys.84.449; Fujii H., 2013, J HIGH ENERGY PHYS, V1310, P147; Fukushima K, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.024907; Fukushima K., ARXIV14034177HEPTH; GRIMUS W, 1983, Z PHYS C PART FIELDS, V18, P129, DOI 10.1007/BF01572474; Grumiller D., 2008, JHEP, V0808, P27; Gupta R., ARXIVHEPLAT9807028HE; Hashimoto K, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.066005; HUFFEL H, 1985, NUCL PHYS B, V260, P545, DOI 10.1016/0550-3213(85)90050-1; Kadanoff L., 1962, FRONTIERS PHYS; Kasper V., ARXIV14034849HEPPH; Keldy macr sh L.V., 1964, Zhurnal Eksperimental'noi i Teoreticheskoi Fiziki, V47; Mukherjee A., ARXIV14035680CONDMAT; Namiki M., 1993, PROG THEOR PHYS, V111, P1, DOI 10.1143/PTPS.111.1; Polkovnikov A, 2010, ANN PHYS-NEW YORK, V325, P1790, DOI 10.1016/j.aop.2010.02.006; Press W.H., 2007, NUMERICAL RECIPES AR; Rammer J., 1998, QUANTUM TRANSPORT TH; Rothe H. J., 2012, WORLD SCI LECT NOTES; Son D., ARXIVHEPPH9601377HEP; Vidal G., 2004, J STAT MECH-THEORY E; White S., 2004, PHYS REV LETT, V93, P1	94	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-4916	1096-035X		ANN PHYS-NEW YORK	Ann. Phys.	FEB	2015	353						107	128		10.1016/j.aop.2014.11.004		22	Physics, Multidisciplinary	Physics	CG1XT	WOS:000353070200009		
J	Hirota, Y; Yamashita, S; Kurihara, Y; Jin, XL; Aihara, M; Saigusa, T; Kang, DC; Kanki, T				Hirota, Yuko; Yamashita, Shun-ichi; Kurihara, Yusuke; Jin, Xiulian; Aihara, Masamune; Saigusa, Tetsu; Kang, Dongchon; Kanki, Tomotake			Mitophagy is primarily due to alternative autophagy and requires the MAPK1 and MAPK14 signaling pathways	AUTOPHAGY			English	Article						autophagy; alternative autophagy; Keima; mitochondria; mitogen-activated protein kinase; mitophagy	SELECTIVE AUTOPHAGY; UBIQUITIN LIGASE; MAMMALIAN-CELLS; PROTEIN; PARKIN; MITOCHONDRIA; DEGRADATION; STARVATION; YEAST; ATG32	In cultured cells, not many mitochondria are degraded by mitophagy induced by physiological cellular stress. We observed mitophagy in HeLa cells using a method that relies on the pH-sensitive fluorescent protein Keima. With this approach, we found that mitophagy was barely induced by carbonyl cyanide m-chlorophenyl hydrazone treatment, which is widely used as an inducer of PARK2/Parkin-related mitophagy, whereas a small but modest amount of mitochondria were degraded by mitophagy under conditions of starvation or hypoxia. Mitophagy induced by starvation or hypoxia was marginally suppressed by knockdown of ATG7 and ATG12, or MAP1LC3B, which are essential for conventional macroautophagy. In addition, mitophagy was efficiently induced in Atg5 knockout mouse embryonic fibroblasts. However, knockdown of RAB9A and RAB9B, which are essential for alternative autophagy, but not conventional macroautophagy, severely suppressed mitophagy. Finally, we found that the MAPKs MAPK1/ERK2 and MAPK14/p38 were required for mitophagy. Based on these findings, we conclude that mitophagy in mammalian cells predominantly occurs through an alternative autophagy pathway, requiring the MAPK1 and MAPK14 signaling pathways.	[Hirota, Yuko; Yamashita, Shun-ichi; Kurihara, Yusuke; Jin, Xiulian; Saigusa, Tetsu; Kanki, Tomotake] Niigata Univ, Grad Sch Med & Dent Sci, Lab Biosignaling, Niigata, Japan; [Hirota, Yuko; Kurihara, Yusuke; Aihara, Masamune; Kang, Dongchon] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Fukuoka 812, Japan; [Hirota, Yuko; Kurihara, Yusuke] Kyushu Univ, Grad Sch Pharmaceut Sci, Div Pharmaceut Cell Biol, Fukuoka 812, Japan	Kanki, T (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Lab Biosignaling, Niigata, Japan.	kanki@med.niigata-u.ac.jp	Kanki, Tomotake/H-7250-2012	Kanki, Tomotake/0000-0001-9646-5379	Ministry of Education, Culture, Sports, Science and Technology (MEXT) program "Promotion of Environmental Improvement for Independence of Young Researchers" under the Special Coordination Funds for Promoting Science and Technology; Japan Society for the Promotion of Science KAKENHI Grant [23689032, 25560414, 23790371]; MEXT KAKENHI Grant [25117714]; Uehara Memorial Foundation; Tokyo Biochemical Research Foundation; Suzuken Memorial Foundation	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) program "Promotion of Environmental Improvement for Independence of Young Researchers" under the Special Coordination Funds for Promoting Science and Technology (TK), the Japan Society for the Promotion of Science KAKENHI Grant Numbers 23689032 (TK), 25560414 (TK), and 23790371 (YH), MEXT KAKENHI Grant Number 25117714 (TK), the Uehara Memorial Foundation (TK), The Tokyo Biochemical Research Foundation (TK), and the Suzuken Memorial Foundation (TK).	Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Dagda RK, 2008, AUTOPHAGY, V4, P770; Mao K, 2011, J CELL BIOL, V193, P755, DOI 10.1083/jcb.201102092; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Kanki T, 2013, EMBO REP, V14, P788, DOI 10.1038/embor.2013.114; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Kristensen AR, 2008, MOL CELL PROTEOMICS, V7, P2419, DOI 10.1074/mcp.M800184-MCP200; Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Jia W, 2011, J IMMUNOL, V186, P5313, DOI 10.4049/jimmunol.1002404; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Lokireddy S, 2012, CELL METAB, V16, P613, DOI 10.1016/j.cmet.2012.10.005; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768; McAlpine F, 2013, AUTOPHAGY, V9, P361, DOI 10.4161/auto.23066; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; Fu M, 2013, MOL BIOL CELL, V24, P1153, DOI 10.1091/mbc.E12-08-0607; Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Ogawa M, 2011, CELL HOST MICROBE, V9, P376, DOI 10.1016/j.chom.2011.04.010; Carreira RS, 2010, AUTOPHAGY, V6, P462, DOI 10.4161/auto.6.4.11553; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Hirota Y, 2009, CELL MOL LIFE SCI, V66, P2913, DOI 10.1007/s00018-009-0080-9; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Violot S, 2009, J AM CHEM SOC, V131, P10356, DOI 10.1021/ja903695n; Chang TK, 2013, NAT CELL BIOL, V15, P1067, DOI 10.1038/ncb2804; Juenemann K, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/189794; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211	54	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1554-8627	1554-8635		AUTOPHAGY	Autophagy	FEB	2015	11	2					332	343		10.1080/15548627.2015.1023047		12	Cell Biology	Cell Biology	CF8AX	WOS:000352778700012		
J	Nakatogawa, H				Nakatogawa, Hitoshi			Hrr25: An emerging major player in selective autophagy regulation in Saccharomyces cerevisiae	AUTOPHAGY			English	Editorial Material						Ams1; Atg19; Atg34; Atg36; casein kinase 1; Cvt pathway; nitrogen starvation; pexophagy; selective autophagy; yeast		As with the case of the mechanism of autophagosome formation, studies in yeast have taken a leading role in elucidating the molecular basis of target recognition during selective autophagy. Degradation targets are recognized by receptor proteins, which also bind to Atg8 homologs on growing phagophore membranes, leading to the loading of the targets into autophagosomes. However, it remains to be elucidated how these processes are regulated. In yeast, receptors also interact with the scaffold/adaptor protein Atg11, which subsequently recruits core Atg proteins onto receptortarget complexes to initiate autophagosome formation. Recently, we found that Hrr25, a homolog of CSNK1D/casein kinase 1d, regulates 3 of 4 selective autophagy-related pathways in the budding yeast Saccharomyces cerevisiae by a uniform mechanism: phosphoregulation of the receptor-scaffold interaction.	Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan	Nakatogawa, H (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan.	hnakatogawa@bio.titech.ac.jp						0	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1554-8627	1554-8635		AUTOPHAGY	Autophagy	FEB	2015	11	2					432	433		10.1080/15548627.2015.1017195		2	Cell Biology	Cell Biology	CF8AX	WOS:000352778700024		
J	Hsueh, AJW; Kawamura, K; Cheng, Y; Fauser, BCJM				Hsueh, Aaron J. W.; Kawamura, Kazuhiro; Cheng, Yuan; Fauser, Bart C. J. M.			Intraovarian Control of Early Folliculogenesis	ENDOCRINE REVIEWS			English	Review							POLYCYSTIC-OVARY-SYNDROME; FOLLICLE-STIMULATING-HORMONE; ANTI-MULLERIAN HORMONE; GROWTH-DIFFERENTIATION FACTOR-9; BONE MORPHOGENETIC PROTEIN-15; NATRIURETIC PEPTIDE RECEPTOR; INCREASED OVULATION RATE; IN-VITRO FERTILIZATION; NORMAL MENSTRUAL-CYCLE; ORGAN SIZE CONTROL	Although hormonal regulation of ovarian follicle development has been extensively investigated, most studies concentrate on the development of early antral follicles to the preovulatory stage, leading to the successful use of exogenous FSH for infertility treatment. Accumulating data indicate that preantral follicles are under stringent regulation by FSH and local intraovarian factors, thus providing the possibility to develop new therapeutic approaches. Granulosa cell-derived C-type natriuretic factor not only suppresses the final maturation of oocytes to undergo germinal vesicle breakdown before ovulation but also promotes preantral and antral follicle growth. In addition, several oocyte- and granulosa cell-derived factors stimulate preantral follicle growth by acting through wingless, receptor tyrosine kinase, receptor serine kinase, and other signaling pathways. In contrast, the ovarian Hippo signaling pathway constrains follicle growth and disruption of Hippo signaling promotes the secretion of downstream CCN growth factors capable of promoting follicle growth. Although the exact hormonal factors involved in primordial follicle activation has yet to be elucidated, the protein kinase B (AKT) and mammalian target of rapamycin signaling pathways are important for the activation of dormant primordial follicles. Hippo signaling disruption after ovarian fragmentation, combined with treating ovarian fragments with phosphatase and tensin homolog (PTEN) inhibitors and phosphoinositide-3-kinase stimulators to augment AKT signaling, promote the growth of preantral follicles in patients with primary ovarian insufficiency, leading to a new infertility intervention for such patients. Elucidation of intraovarian mechanisms underlying early folliculogenesis may allow the development of novel therapeutic strategies for patients diagnosed with primary ovarian insufficiency, polycystic ovary syndrome, and poor ovarian response to FSH stimulation, as well as for infertile women of advanced reproductive age.	[Hsueh, Aaron J. W.; Cheng, Yuan] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Program Reprod & Stem Cell Biol, Stanford, CA 94305 USA; [Kawamura, Kazuhiro] St Mariana Univ, Sch Med, Dept Obstet & Gynecol, Kawasaki, Kanagawa 2168511, Japan; [Fauser, Bart C. J. M.] Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, NL-3584 CX Utrecht, Netherlands	Hsueh, AJW (reprint author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA.	aaron.hsueh@stanford.edu			National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (Specialized Cooperative Centers Program in Reproduction and Infertility Research) [U54 HD068158]; Japan Society for the Promotion of Science [24390376, 26114510]; Smoking Research Foundation; Takeda Science Foundation	This work was supported by National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54 HD068158 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research, to A.J.H.) and Grant-in-aid for Scientific Research Japan Society for the Promotion of Science (Research B: 24390376, and Innovative Areas, Mechanisms regulating gamete formation in animals: 26114510, to K.K.) and by research funds from the Smoking Research Foundation (to K.K.) and the Takeda Science Foundation (to K.K.).	ADASHI EY, 1994, HORM RES, V42, P44, DOI 10.1159/000184144; Adhikari D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039034; Adhikari D, 2010, CELL CYCLE, V9, P1673; Hansen KR, 2011, FERTIL STERIL, V95, P170, DOI 10.1016/j.fertnstert.2010.04.006; Macklon NS, 2006, ENDOCR REV, V27, P170, DOI 10.1210/er.2005-0015; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Xia YJ, 2012, MOL MED REP, V5, P1330, DOI 10.3892/mmr.2012.789; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Iliodromiti S, 2013, J CLIN ENDOCR METAB, V98, P3332, DOI 10.1210/jc.2013-1393; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Xu M, 2009, BIOL REPROD, V81, P587, DOI 10.1095/biolreprod.108.074732; Murray AA, 1998, J REPROD FERTIL, V113, P27; Parrott JA, 1999, ENDOCRINOLOGY, V140, P4262, DOI 10.1210/en.140.9.4262; SAUER MV, 1990, NEW ENGL J MED, V323, P1157, DOI 10.1056/NEJM199010253231702; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; SUGA S, 1992, J CLIN INVEST, V90, P1145, DOI 10.1172/JCI115933; Laissue P, 2006, EUR J ENDOCRINOL, V154, P739, DOI 10.1530/eje.1.02135; Zangmo R, 2014, REPROD BIOMED ONLINE, V28, P743, DOI 10.1016/j.rbmo.2014.01.019; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P653, DOI 10.1210/me.2003-0393; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Zeleznik AJ, 2003, ENDOCRINOLOGY, V144, P3985, DOI 10.1210/en.2003-0293; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; De Vos M, 2010, LANCET, V376, P911, DOI 10.1016/S0140-6736(10)60355-8; Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092; Pigny P, 2003, J CLIN ENDOCR METAB, V88, P5957, DOI 10.1210/jc.2003-030727; HSUEH AJW, 1984, ENDOCR REV, V5, P76; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; Fan HY, 2008, MOL ENDOCRINOL, V22, P2128, DOI 10.1210/me.2008-0095; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Suzuki N, 2012, HUM REPROD, V27, P2420, DOI 10.1093/humrep/des178; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Zheng WJ, 2014, HUM MOL GENET, V23, P920, DOI 10.1093/hmg/ddt486; Reddy P, 2010, TRENDS ENDOCRIN MET, V21, P96, DOI 10.1016/j.tem.2009.10.001; Schulz S, 2005, PEPTIDES, V26, P1024, DOI 10.1016/j.peptides.2004.08.027; Adhikari D, 2010, HUM MOL GENET, V19, P397, DOI 10.1093/hmg/ddp483; Donnez J, 2013, NAT REV ENDOCRINOL, V9, P735, DOI 10.1038/nrendo.2013.205; Zhang MJ, 2010, SCIENCE, V330, P366, DOI 10.1126/science.1193573; Broer SL, 2011, HUM REPROD UPDATE, V17, P46, DOI 10.1093/humupd/dmq034; Hoek A, 1997, ENDOCR REV, V18, P107, DOI 10.1210/er.18.1.107; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Adhikari D, 2009, MOL HUM REPROD, V15, P765, DOI 10.1093/molehr/gap092; McLaughlin M, 2014, MOL HUM REPROD, V20, P736, DOI 10.1093/molehr/gau037; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Kawamura K, 2013, P NATL ACAD SCI USA, V110, P17474, DOI 10.1073/pnas.1312830110; Woodruff TK, 2011, J ASSIST REPROD GEN, V28, P3, DOI 10.1007/s10815-010-9478-4; Baird DT, 1999, ENDOCRINOLOGY, V140, P462, DOI 10.1210/en.140.1.462; Solovyeva EV, 2000, BIOL REPROD, V63, P1214, DOI 10.1095/biolreprod63.4.1214; Weil S, 1999, J CLIN ENDOCR METAB, V84, P2951, DOI 10.1210/jc.84.8.2951; Lee WS, 2001, BIOL REPROD, V65, P994, DOI 10.1095/biolreprod65.4.994; Hannema SE, 2013, J CLIN ENDOCR METAB, V98, pE1988, DOI [10.1210/jc.2013-2358, 10.1210/jc.20130358]; Reddy P, 2005, DEV BIOL, V281, P160, DOI 10.1016/j.ydbio.2005.02.013; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Durlinger ALL, 2001, ENDOCRINOLOGY, V142, P4891, DOI 10.1210/en.142.11.4891; Kreeger PK, 2005, BIOL REPROD, V73, P942, DOI 10.1095/biolreprod.105.042390; Dewailly D, 2014, HUM REPROD UPDATE, V20, P334, DOI 10.1093/humupd/dmt061; Lee S, 2009, ENDOCRINOLOGY, V150, P3855, DOI 10.1210/en.2008-1774; Stein IF, 1935, AM J OBSTET GYNECOL, V29, P181; KOLLER KJ, 1991, SCIENCE, V252, P120, DOI 10.1126/science.1672777; Abel MH, 2000, ENDOCRINOLOGY, V141, P1795, DOI 10.1210/en.141.5.1795; Choi YS, 2007, BIOL REPROD, V77, P312, DOI 10.1095/biolreprod.107.060459; Tran ND, 2011, J CLIN ENDOCR METAB, V96, P3609, DOI 10.1210/jc.2011-0368; van Rooij IAJ, 2002, HUM REPROD, V17, P3065, DOI 10.1093/humrep/17.12.3065; Donnez J, 2011, ANN MED, V43, P437, DOI 10.3109/07853890.2010.546807; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; Hergovich A, 2012, BIOCHEM SOC T, V40, P124, DOI 10.1042/BST20110619; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Sunkara SK, 2012, HUM REPROD, V27, P637, DOI 10.1093/humrep/der464; Casson PR, 2000, HUM REPROD, V15, P2129, DOI 10.1093/humrep/15.10.2129; Zhang T, 2013, GENE, V524, P161, DOI 10.1016/j.gene.2013.04.040; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Sen A, 2010, MOL ENDOCRINOL, V24, P1393, DOI 10.1210/me.2010-0006; Ewens KG, 2010, J CLIN ENDOCR METAB, V95, P2306, DOI 10.1210/jc.2009-2703; Schuh-Huerta SM, 2012, HUM GENET, V131, P1709, DOI 10.1007/s00439-012-1184-0; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Kawamura K, 2011, HUM REPROD, V26, P3094, DOI 10.1093/humrep/der282; He CY, 2010, HUM GENET, V128, P515, DOI 10.1007/s00439-010-0878-4; BRENNER BM, 1990, PHYSIOL REV, V70, P665; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; HSUEH AJW, 1994, ENDOCR REV, V15, P707, DOI 10.1210/er.15.6.707; Vitt UA, 2000, ENDOCRINOLOGY, V141, P3814, DOI 10.1210/en.141.10.3814; Goswami D, 2005, HUM REPROD UPDATE, V11, P391, DOI 10.1093/humupd/dmi012; Campbell BK, 2012, ENDOCRINOLOGY, V153, P4533, DOI 10.1210/en.2012-1158; Otsuka F, 2000, J BIOL CHEM, V275, P39523, DOI 10.1074/jbc.M007428200; Urbanek M, 2007, J CLIN ENDOCR METAB, V92, P4191, DOI 10.1210/jc.2007-0761; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; John GB, 2008, DEV BIOL, V321, P197, DOI [10.1016/j.ydbio.2008.06.017, 10.1016/j.ydbio.2008.006.017]; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Baker SJ, 1999, HUM REPROD UPDATE, V5, P153, DOI 10.1093/humupd/5.2.153; Blank SK, 2009, J CLIN ENDOCR METAB, V94, P2360, DOI 10.1210/jc.2008-2606; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Weenen C, 2004, MOL HUM REPROD, V10, P77, DOI 10.1093/molehr/gah015; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Sato Y, 2012, MOL ENDOCRINOL, V26, P1158, DOI 10.1210/me.2012-1027; Louwers YV, 2013, J CLIN ENDOCR METAB, V98, P3848, DOI 10.1210/jc.2013-1976; Zhao H, 2013, MOL HUM REPROD, V19, P644, DOI 10.1093/molehr/gat040; Abu Hashim H, 2013, ARCH GYNECOL OBSTET, V288, P409, DOI 10.1007/s00404-013-2808-x; Santoro N, 2011, J CLIN ENDOCR METAB, V96, P3281, DOI 10.1210/jc.2011-1419; Peng J, 2013, P NATL ACAD SCI USA, V110, pE776, DOI 10.1073/pnas.1218020110; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; St John MAR, 1999, NAT GENET, V21, P182; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; MCGRATH SA, 1995, MOL ENDOCRINOL, V9, P131, DOI 10.1210/me.9.1.131; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Vitt UA, 2002, BIOL REPROD, V67, P473, DOI 10.1095/biolreprod67.2.473; Qin YY, 2007, AM J HUM GENET, V81, P576, DOI 10.1086/519496; TSAFRIRI A, 1986, CLIN ENDOCRINOL META, V15, P157, DOI 10.1016/S0300-595X(86)80047-0; Hutt KJ, 2006, BIOL REPROD, V75, P421, DOI 10.1095/biolreprod.106.051516; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Aaltonen J, 1999, J CLIN ENDOCR METAB, V84, P2744, DOI 10.1210/jc.84.8.2744; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Hatzirodos N, 2011, FASEB J, V25, P2256, DOI 10.1096/fj.11-181099; Nilsson E, 2001, MOL CELL ENDOCRINOL, V175, P123, DOI 10.1016/S0303-7207(01)00391-4; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Xu J, 2010, REPRODUCTION, V140, P685, DOI 10.1530/REP-10-0284; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Sen A, 2014, P NATL ACAD SCI USA, V111, P3008, DOI 10.1073/pnas.1318978111; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; Nilsson EE, 2002, MOL CELL ENDOCRINOL, V188, P65, DOI 10.1016/S0303-7207(01)00746-8; Dunaif A, 2013, J CLIN ENDOCR METAB, V98, P4325, DOI 10.1210/jc.2013-2040; McAllister JM, 2014, P NATL ACAD SCI USA, V111, pE1519, DOI 10.1073/pnas.1400574111; Roberts AE, 2007, BIOL REPROD, V76, P218, DOI 10.1095/biolreprod.106.050880; Broekmans FJ, 2006, BJOG-INT J OBSTET GY, V113, P1210, DOI 10.1111/j.1471-0528.2006.01008.x; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Ojeda SR, 2000, MOL CELL ENDOCRINOL, V163, P67, DOI 10.1016/S0303-7207(99)00242-7; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Kawwass JF, 2013, JAMA-J AM MED ASSOC, V310, P2426, DOI 10.1001/jama.2013.280924; RICHARDS JS, 1980, PHYSIOL REV, V60, P51; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; Gallardo TD, 2007, GENETICS, V177, P179, DOI 10.1534/genetics.107.074823; Garrido N, 2011, FERTIL STERIL, V96, P40, DOI 10.1016/j.fertnstert.2011.05.008; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; Aboura A, 2009, J CLIN ENDOCR METAB, V94, P4540, DOI 10.1210/jc.2009-0186; Danforth DR, 2003, BIOL REPROD, V68, P1736, DOI 10.1095/biolreprod.101.000679; Schuh-Huerta SM, 2012, HUM REPROD, V27, P594, DOI 10.1093/humrep/der391; Nagashima T, 2011, MOL ENDOCRINOL, V25, P1740, DOI 10.1210/me.2011-1045; Cortvrindt R, 1997, HUM REPROD, V12, P759, DOI 10.1093/humrep/12.4.759; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; West ER, 2007, BIOMATERIALS, V28, P4439, DOI 10.1016/j.biomaterials.2007.07.001; Oktay K, 1997, J CLIN ENDOCR METAB, V82, P3748, DOI 10.1210/jc.82.11.3748; Li T, 2012, J MED GENET, V49, P254, DOI 10.1136/jmedgenet-2011-100727; Tamura N, 2004, P NATL ACAD SCI USA, V101, P17300, DOI 10.1073/pnas.0407894101; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; ARMSTRONG DT, 1976, ENDOCRINOLOGY, V99, P1411; Barletta G, 1998, HYPERTENSION, V31, P802; Bayram N, 2004, BRIT MED J, V328, P192, DOI 10.1136/bmj.328.7433.192; Bell SM, 2003, MECH DEVELOP, V120, P597, DOI 10.1016/S0925-4773(03)00021-2; Bidet M, 2011, J CLIN ENDOCR METAB, V96, P3864, DOI 10.1210/jc.2011-1038; Broer SL, 2014, HUM REPROD UPDATE, V20, P688, DOI 10.1093/humupd/dmu020; Chaves RN, 2010, DOMEST ANIM ENDOCRIN, V39, P249, DOI 10.1016/j.domaniend.2010.06.006; Cheng Y, 2013, FASEB J, V27, P2175, DOI 10.1096/fj.12-223412; DAVIS GH, 1992, BIOL REPROD, V46, P636, DOI 10.1095/biolreprod46.4.636; Dewailly D, 2014, HUM REPROD UPDATE, V20, P804, DOI 10.1093/humupd/dmu043; Di Pasquale E, 2004, AM J HUM GENET, V75, P106, DOI 10.1086/422103; Dixit H, 2006, HUM GENET, V119, P408, DOI 10.1007/s00439-006-0150-0; Farquhar C., 2012, COCHRANE DB SYST REV, V6; Farquhar C, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001122.PUB3; Fauser BC, 2011, HUM REPROD UPDATE, V17, P829, DOI 10.1093/humupd/dmr033PMID: 21896560; Fauser BCJM, 1997, ENDOCR REV, V18, P71, DOI 10.1210/er.18.1.71; Fenichel P, 1997, HUM REPROD, V12, P2623, DOI 10.1093/humrep/12.12.2623; Gleicher N, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-67; GOODMAN AL, 1983, RECENT PROG HORM RES, V39, P1; Gutkowska J, 1999, BIOL REPROD, V61, P162, DOI 10.1095/biolreprod61.1.162; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; Hendriks ML, 2007, HUM REPROD UPDATE, V13, P249, DOI 10.1093/humupd/dm1058; HILLIER SG, 1981, ENDOCRINOLOGY, V109, P1303; Hobbs A, 2004, CIRCULATION, V110, P1231, DOI 10.1161/01.CIR.0000141802.29945.34; Hsueh AJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.099127; Huang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054052; Hughesdon P E, 1982, Obstet Gynecol Surv, V37, P59, DOI 10.1097/00006254-198202000-00001; Jankowski M, 1997, BIOL REPROD, V56, P59, DOI 10.1095/biolreprod56.1.59; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; JUDD HL, 1976, J CLIN ENDOCR METAB, V43, P347; Juengel JL, 2004, ANIM REPROD SCI, V82-3, P447, DOI 10.1016/j.anireprosci.2004.04.021; Kalous J, 2006, BIOL CELL, V98, P111, DOI 10.1042/BC20050020; Kezele P, 2005, BIOL REPROD, V73, P967, DOI 10.1095/bioreprod.105.043117; Kiyosu C, 2012, REPRODUCTION, V144, P187, DOI 10.1530/REP-12-0050; Lee J, 1999, ENDOCRINOLOGY, V140, P818, DOI 10.1210/en.140.2.818; Louwers YV, 2013, J CLIN ENDOCR METAB, V98, pE2006, DOI 10.1210/jc.2013-2495; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Matos MHT, 2007, REPROD FERT DEVELOP, V19, P677, DOI 10.1071/RD07021; McGee E, 1997, ENDOCRINOLOGY, V138, P2417, DOI 10.1210/en.138.6.2417; McGee EA, 1999, FERTIL STERIL, V71, P732, DOI 10.1016/S0015-0282(98)00547-0; McGee EA, 1997, BIOL REPROD, V57, P990, DOI 10.1095/biolreprod57.5.990; MCNATTY KP, 1976, J ENDOCRINOL, V71, P77, DOI 10.1677/joe.0.0710077; Modi D, 2006, REPRODUCTION, V132, P443, DOI 10.1530/rep.1.01178; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; NATRAJ U, 1993, ENDOCRINOLOGY, V133, P761, DOI 10.1210/en.133.2.761; Orisaka M, 2006, MOL ENDOCRINOL, V20, P2456, DOI 10.1210/me.2005-0357; PACHE TD, 1990, FERTIL STERIL, V54, P638; Persani L, 2014, HUM REPROD UPDATE; Pisarska MD, 2010, AM J PHYSIOL-ENDOC M, V299, pE101, DOI 10.1152/ajpendo.00534.2009; Qin Y, 2012, ORPHANET J RARE DIS, V7, P1; Reddy P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073763; Richards JS, 2002, RECENT PROG HORM RES, V57, P195, DOI 10.1210/rp.57.1.195; Robertson GG, 1940, P SOC EXP BIOL MED, V44, P302; RUSSELL WL, 1945, P NATL ACAD SCI USA, V31, P267, DOI 10.1073/pnas.31.9.267; SCHOOT DC, 1994, HUM REPROD, V9, P1237; Simpson CM, 2014, J CLIN ENDOCR METAB, V99, pE615, DOI 10.1210/jc.2013-3949; SLAGER HG, 1992, DIFFERENTIATION, V50, P47, DOI 10.1111/j.1432-0436.1992.tb00485.x; Spicer LJ, 2008, BIOL REPROD, V78, P243, DOI 10.1095/biolreprod.107.063446; STEVENS LC, 1957, TRANSPLAN B, V4, P106; Tanwar PS, 2008, ANIM REPROD SCI, V106, P232, DOI 10.1016/j.anireprosci.2007.04.015; Tarnawa ED, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105791; Tiotiu D, 2010, HUM REPROD, V25, P1581, DOI 10.1093/humrep/deq073; Tremblay J, 2002, MOL CELL BIOCHEM, V230, P31, DOI 10.1023/A:1014260204524; Urbanek M, 1999, P NATL ACAD SCI USA, V96, P8573, DOI 10.1073/pnas.96.15.8573; VANSANTBRINK EJP, 1995, FERTIL STERIL, V64, P37; Ventura SJ, 2008, NATL VITAL STAT REP, V56, P28; Ventura Stephanie J, 2008, Natl Vital Stat Rep, V56, P1; Vitt UA, 2000, BIOL REPROD, V62, P370, DOI 10.1095/biolreprod62.2.370; Walters KA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102012; Wang P, 2014, ENDOCRINOLOGY, V155, P1445, DOI 10.1210/en.2013-1764; Wright CS, 1999, HUM REPROD, V14, P1555, DOI 10.1093/humrep/14.6.1555; Xia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091770; Zeleznik AJ, 2001, BIOL REPROD, V65, P655, DOI 10.1095/biolreprod65.3.655; Zeleznik Anthony J, 2004, Reprod Biol Endocrinol, V2, P31, DOI 10.1186/1477-7827-2-31	231	8	8	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0163-769X	1945-7189		ENDOCR REV	Endocr. Rev.	FEB	2015	36	1					1	24		10.1210/er.2014-1020		24	Endocrinology & Metabolism	Endocrinology & Metabolism	CG2RK	WOS:000353122100001		
J	Kim, K; Oh, CM; Ohara-Imaizumi, M; Park, S; Namkung, J; Yadav, VK; Tamarina, NA; Roe, MW; Philipson, LH; Karsenty, G; Nagamatsu, S; German, MS; Kim, H				Kim, Kyuho; Oh, Chang-Myung; Ohara-Imaizumi, Mica; Park, Sangkyu; Namkung, Jun; Yadav, Vijay K.; Tamarina, Natalia A.; Roe, Michael W.; Philipson, Louis H.; Karsenty, Gerard; Nagamatsu, Shinya; German, Michael S.; Kim, Hail			Functional Role of Serotonin in Insulin Secretion in a Diet-Induced Insulin-Resistant State	ENDOCRINOLOGY			English	Article							PANCREATIC BETA-CELL; PREGNANCY; MECHANISMS; RECEPTOR; ISLETS; DETERMINANT; ADAPTATION; GROWTH; SUBSET; MOUSE	The physiological role of serotonin, or 5-hydroxytryptamine (5-HT), in pancreatic beta-cell function was previously elucidated using a pregnant mouse model. During pregnancy, 5-HT increases beta-cell proliferation and glucose-stimulated insulin secretion (GSIS) through the G alpha(q)-coupled 5-HT2b receptor (Htr2b) and the 5-HT3 receptor (Htr3), a ligand-gated cation channel, respectively. However, the role of 5-HT in beta-cell function in an insulin-resistant state has yet to be elucidated. Here, we characterized the metabolic phenotypes of beta-cell-specific Htr2b(-/-) (Htr2b beta KO), Htr3a(-/-) (Htr3a knock-out [KO]), and beta-cell-specific tryptophan hydroxylase 1 (Tph1)(-/-) (Tph1 beta KO) mice on a high-fat diet (HFD). Htr2b beta KO, Htr3a KO, and Tph1 beta KO mice exhibited normal glucose tolerance on a standard chow diet. After 6 weeks on an HFD, beginning at 4 weeks of age, both Htr3a KO and Tph1 beta KO mice developed glucose intolerance, but Htr2b beta KO mice remained normoglycemic. Pancreas perfusion assays revealed defective first-phase insulin secretion in Htr3a KO mice. GSIS was impaired in islets isolated from HFD-fed Htr3a KO and Tph1 beta KO mice, and 5-HT treatment improved insulin secretion from Tph1 beta KO islets but not from Htr3a KO islets. Tph1 and Htr3a gene expression in pancreatic islets was not affected by an HFD, and immunostaining could not detect 5-HT in pancreatic is lets from mice fed an HFD. Taken together, these results demonstrate that basal 5-HT levels in beta-cells play a role in GSIS through Htr3, which becomes more evident in a diet-induced insulin-resistant state.	[Kim, Kyuho; Oh, Chang-Myung; Park, Sangkyu; Namkung, Jun; Kim, Hail] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Ohara-Imaizumi, Mica; Nagamatsu, Shinya] Kyorin Univ, Sch Med, Dept Biochem, Mitaka, Tokyo 1818611, Japan; [Park, Sangkyu] Catholic Kwandong Univ, Coll Med, Dept Biochem, Kangnung 210701, Gangwondo, South Korea; [Namkung, Jun] Yonsei Univ, Wonju Coll Med, Dept Biochem, Wonju 220701, Gangwondo, South Korea; [Yadav, Vijay K.; Karsenty, Gerard] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA; [Tamarina, Natalia A.; Philipson, Louis H.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Roe, Michael W.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Roe, Michael W.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA; [German, Michael S.] Univ Calif San Francisco, Ctr Diabet, Hormone Res Inst, San Francisco, CA 94143 USA; [German, Michael S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Kim, H (reprint author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Biomed Res Ctr E7 8104,291 Daehak Ro, Taejon 305701, South Korea.	mgerman@diabetes.ucsf.edu; hailkim@kaist.edu			Korea Health Technology R&D Project through Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea [HI11C1964]; Bio & Medical Technology Development Program of the National Research Foundation - Ministry of Science, ICT and Future Planning [NRF-2012M3A9B2027974]; National Institutes of Health [P30 DK020595, R01 DK092616, P30 DK063720]; Juvenile Diabetes Research Foundation [16-2007-428, 10-2010-553]; Korean Diabetes Association	This work was supported by the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (Grant HI11C1964) (to H.K.); the Bio & Medical Technology Development Program of the National Research Foundation funded by the Ministry of Science, ICT and Future Planning (Grant NRF-2012M3A9B2027974) (to H.K.); National Institutes of Health Grants P30 DK020595 (to L.H.P.), R01 DK092616 (to M.W.R.), and P30 DK063720 (to M.S.G.); Juvenile Diabetes Research Foundation Grants 16-2007-428 (to M.S.G.) and 10-2010-553 (to H.K.); and the Korean Diabetes Association, 2013 (C.O.).	Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Zeitz KP, 2002, J NEUROSCI, V22, P1010; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Ohara-Imaizumi M, 2013, P NATL ACAD SCI USA, V110, P19420, DOI 10.1073/pnas.1310953110; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Cavaghan MK, 2000, J CLIN INVEST, V106, P329, DOI 10.1172/JCI10761; Sumara G, 2012, CELL METAB, V16, P588, DOI 10.1016/j.cmet.2012.09.014; Ohta Y, 2011, DIABETES, V60, P3208, DOI 10.2337/db10-1192; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Thompson AJ, 2006, CURR PHARM DESIGN, V12, P3615, DOI 10.2174/138161206778522029; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; EKHOLM R, 1971, DIABETOLOGIA, V7, P339, DOI 10.1007/BF01219468; Drews G, 2010, ADV EXP MED BIOL, V654, P115, DOI 10.1007/978-90-481-3271-3_7; CHEN C, 1994, J CLIN INVEST, V94, P399, DOI 10.1172/JCI117335; GERSHON MD, 1966, J PHYSIOL-LONDON, V186, P477; Gonzalez A, 2013, ENDOCRINOLOGY, V154, P3515, DOI 10.1210/en.2013-1424; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Szot GL, 2007, J VIS EXP, V7, P255; Tamarina NA, 2014, ISLETS, V6	25	3	3	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	FEB	2015	156	2					444	452		10.1210/en.2014-1687		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CG2UV	WOS:000353131800006		
J	Matsushita, M; Hasegawa, S; Kitoh, H; Mori, K; Ohkawara, B; Yasoda, A; Masuda, A; Ishiguro, N; Ohno, K				Matsushita, Masaki; Hasegawa, Satoru; Kitoh, Hiroshi; Mori, Kensaku; Ohkawara, Bisei; Yasoda, Akihiro; Masuda, Akio; Ishiguro, Naoki; Ohno, Kinji			Meclozine Promotes Longitudinal Skeletal Growth in Transgenic Mice with Achondroplasia Carrying a Gain-of-Function Mutation in the FGFR3 Gene	ENDOCRINOLOGY			English	Article							FACTOR RECEPTOR-3; THANATOPHORIC DYSPLASIA; DISTRACTION OSTEOGENESIS; LOWER-EXTREMITY; MOUSE MODEL; CHONDROCYTES; INHIBITOR; PEPTIDE; PATHWAY; CELLS	Achondroplasia (ACH) is one of the most common skeletal dysplasias causing short stature owing to a gain-of-function mutation in the FGFR3 gene, which encodes the fibroblast growth factor receptor 3. We found that meclozine, an over-the-counter drug for motion sickness, inhibited elevated FGFR3 signaling in chondrocytic cells. To examine the feasibility of meclozine administration in clinical settings, we investigated the effects of meclozine on ACH model mice carrying the heterozygous Fgfr3(ach) transgene. We quantified the effect of meclozine in bone explant cultures employing limb rudiments isolated from developing embryonic tibiae from Fgfr3(ach) mice. We found that meclozine significantly increased the full-length and cartilaginous primordia of embryonic tibiae isolated from Fgfr3(ach) mice. We next analyzed the skeletal phenotypes of growing Fgfr3(ach) mice and wild-type mice with or without meclozine treatment. In Fgfr3(ach) mice, meclozine significantly increased the body length after 2 weeks of administration. At skeletal maturity, the bone lengths including the cranium, radius, ulna, femur, tibia, and vertebrae were significantly longer in meclozine-treated Fgfr3(ach) mice than in untreated Fgfr3(ach) mice. Interestingly, meclozine also increased bone growth in wild-type mice. The plasma concentration of meclozine during treatment was within the range that has been used in clinical settings for motion sickness. Increased longitudinal bone growth in Fgfr3(ach) mice by oral administration of meclozine in a growth period suggests potential clinical feasibility of meclozine for the improvement of short stature in ACH.	[Matsushita, Masaki; Hasegawa, Satoru; Ohkawara, Bisei; Masuda, Akio; Ohno, Kinji] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi 4668550, Japan; [Matsushita, Masaki; Kitoh, Hiroshi; Ishiguro, Naoki] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4668550, Japan; [Mori, Kensaku] Nagoya Univ, Grad Sch Informat Sci, Dept Media Sci, Nagoya, Aichi 4668550, Japan; [Yasoda, Akihiro] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto 6068501, Japan	Ohno, K (reprint author), 65 Tsurumai,Showa Ku, Nagoya, Aichi 4668550, Japan.	ohnok@med.nagoya-u.ac.jp	Masuda, Akio/H-6323-2012		Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor and Welfare of Japan	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Ministry of Health, Labor and Welfare of Japan.	Naski MC, 1998, DEVELOPMENT, V125, P4977; Lorget F, 2012, AM J HUM GENET, V91, P1108, DOI 10.1016/j.ajhg.2012.10.014; Jin M, 2012, HUM MOL GENET, V21, P5443, DOI 10.1093/hmg/dds390; Yasoda A, 2009, ENDOCRINOLOGY, V150, P3138, DOI 10.1210/en.2008-1676; Yamashita A, 2014, NATURE, V513, P507, DOI 10.1038/nature13775; Noonan KJ, 1998, J BONE JOINT SURG AM, V80A, P793; HORTON WA, 1992, AM J MED GENET, V42, P667, DOI 10.1002/ajmg.1320420508; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Wang ZJ, 2012, J CLIN PHARMACOL, V52, P1343, DOI 10.1177/0091270011414575; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; Tavormina PL, 1999, AM J HUM GENET, V64, P722; WALLIN J, 1994, DEVELOPMENT, V120, P1109; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Kitoh H, 2007, J PEDIATR ORTHOPED, V27, P629; Toydemir RM, 2006, AM J HUM GENET, V79, P935, DOI 10.1086/508433; PRINOS P, 1995, HUM MOL GENET, V4, P2097, DOI 10.1093/hmg/4.11.2097; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Jonquoy A, 2012, HUM MOL GENET, V21, P841, DOI 10.1093/hmg/ddr514; Krejci P, 2010, J BIOL CHEM, V285, P20644, DOI 10.1074/jbc.M109.083626; Matsushita M, 2013, PLOS ONE, V8; Matsushita T, 2009, HUM MOL GENET, V18, P227, DOI 10.1093/hmg/ddn339; Mori K, 2003, PROC SPIE, V5031, P111, DOI 10.1117/12.480417; Waller DK, 2008, AM J MED GENET A, V146A, P2385, DOI 10.1002/ajmg.a.32485	24	2	2	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	FEB	2015	156	2					548	554		10.1210/en.2014-1914		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CG2UV	WOS:000353131800015		
J	Ikegami, K; Atsumi, Y; Yorinaga, E; Ono, H; Murayama, I; Nakane, Y; Ota, W; Arai, N; Tega, A; Iigo, M; Darras, VM; Tsutsui, K; Hayashi, Y; Yoshida, S; Yoshimura, T				Ikegami, Keisuke; Atsumi, Yusuke; Yorinaga, Eriko; Ono, Hiroko; Murayama, Itaru; Nakane, Yusuke; Ota, Wataru; Arai, Natsumi; Tega, Akinori; Iigo, Masayuki; Darras, Veerle M.; Tsutsui, Kazuyoshi; Hayashi, Yoshitaka; Yoshida, Shosei; Yoshimura, Takashi			Low Temperature-Induced Circulating Triiodothyronine Accelerates Seasonal Testicular Regression	ENDOCRINOLOGY			English	Article							DEEP BRAIN PHOTORECEPTOR; THYROID-HORMONE LEVELS; JAPANESE-QUAIL; IODOTHYRONINE DEIODINASE; ADAPTIVE THERMOGENESIS; PHOTOPERIODIC RESPONSE; COLD-ACCLIMATION; BODY-TEMPERATURE; SKELETAL-MUSCLE; EXPRESSION	In temperate zones, animals restrict breeding to specific seasons to maximize the survival of their offspring. Birds have evolved highly sophisticated mechanisms of seasonal regulation, and their testicular mass can change 100-fold within a few weeks. Recent studies on Japanese quail revealed that seasonal gonadal development is regulated by central thyroid hormone activation within the hypothalamus, depending on the photoperiodic changes. By contrast, the mechanisms underlying seasonal testicular regression remain unclear. Here we show the effects of short day and low temperature on testicular regression in quail. Low temperature stimulus accelerated short day-induced testicular regression by shutting down the hypothalamus-pituitary-gonadal axis and inducing meiotic arrest and germ cell apoptosis. Induction of T-3 coincided with the climax of testicular regression. Temporal gene expression analysis over the course of apoptosis revealed the suppression of LH response genes and activation of T-3 response genes involved in amphibian metamorphosis within the testis. Daily ip administration of T-3 mimicked the effects of low temperature stimulus on germ cell apoptosis and testicular mass. Although type 2 deiodinase, a thyroid hormone-activating enzyme, in the brown adipose tissue generates circulating T-3 under low-temperature conditions in mammals, there is no distinct brown adipose tissue in birds. In birds, type 2 deiodinase is induced by low temperature exclusively in the liver, which appears to be caused by increased food consumption. We conclude that birds use low temperature-induced circulating T-3 not only for adaptive thermoregulation but also to trigger apoptosis to accelerate seasonal testicular regression.	[Ikegami, Keisuke; Atsumi, Yusuke; Yorinaga, Eriko; Ono, Hiroko; Murayama, Itaru; Nakane, Yusuke; Ota, Wataru; Yoshimura, Takashi] Nagoya Univ, Physiol Anim Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Atsumi, Yusuke; Yoshimura, Takashi] Nagoya Univ, Avian Biosci Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Hayashi, Yoshitaka] Nagoya Univ, Grad Sch Bioagr Sci, Dept Genet, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Yoshimura, Takashi] Nagoya Univ, Environm Med Res Inst, Div Stress Adaptat & Recognit, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Yoshimura, Takashi] Nagoya Univ, Inst Transformat Biomol, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Arai, Natsumi; Tega, Akinori; Iigo, Masayuki] Utsunomiya Univ, Dept Appl Biochem, Utsunomiya, Tochigi 3218505, Japan; [Iigo, Masayuki] Utsunomiya Univ, Fac Agr, Ctr Biosci Res & Educ, Utsunomiya, Tochigi 3218505, Japan; [Iigo, Masayuki] Utsunomiya Univ, Ctr Opt Res & Educ, Utsunomiya, Tochigi 3218585, Japan; [Tsutsui, Kazuyoshi] Waseda Univ, Dept Biol, Tokyo 1628480, Japan; [Tsutsui, Kazuyoshi] Waseda Univ, Ctr Med Life Sci, Tokyo 1628480, Japan; [Yoshida, Shosei] Natl Inst Basic Biol, Div Germ Cell Biol, Okazaki, Aichi 4448787, Japan; [Yoshimura, Takashi] Natl Inst Basic Biol, Div Seasonal Biol, Okazaki, Aichi 4448585, Japan; [Darras, Veerle M.] Katholieke Univ Leuven, Dept Biol, Lab Comparat Endocrinol, Anim Physiol & Neurobiol Sect, B-3000 Leuven, Belgium	Yoshimura, T (reprint author), Nagoya Univ, Inst Transformat Bio Mol WPI ITbM, Lab Anim Physiol, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	takashiy@agr.nagoya-u.ac.jp			Funding Program for Next Generation World Leading Researchers (NEXT Program) [LS055]; Japan Society for the Promotion of Science KAKENHI Grant [26000013];  [21116504]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, "Regulatory Mechanism of Gamete Stem Cells" (Grant 21116504) and Funding Program for Next Generation World Leading Researchers (NEXT Program) initiated by the Council for Science and Technology Policy (Grant LS055), and Japan Society for the Promotion of Science KAKENHI Grant 26000013.	Abelenda M, 2003, J THERM BIOL, V28, P525, DOI 10.1016/S0306-4565(03)00053-6; Yamamura T, 2004, ENDOCRINOLOGY, V145, P4264, DOI 10.1210/en.2004-0366; Darras VM, 1996, GEN COMP ENDOCR, V104, P203, DOI 10.1006/gcen.1996.0163; Meddle SL, 1997, J NEUROSCI, V17, P8909; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; WADA M, 1993, GEN COMP ENDOCR, V90, P355, DOI 10.1006/gcen.1993.1091; Yasuo S, 2005, ENDOCRINOLOGY, V146, P2551, DOI 10.1210/en.2005-0057; Salvatore D, 1996, ENDOCRINOLOGY, V137, P3308, DOI 10.1210/en.137.8.3308; Yoshimura T, 2000, MOL BRAIN RES, V78, P207, DOI 10.1016/S0169-328X(00)00091-7; MROSOVSKY N, 1980, SCIENCE, V207, P837, DOI 10.1126/science.6928327; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; DANFORTH E, 1984, CLIN ENDOCRINOL META, V13, P581; YAOITA Y, 1990, GENE DEV, V4, P1917, DOI 10.1101/gad.4.11.1917; SILVA JE, 1985, J CLIN INVEST, V76, P2296, DOI 10.1172/JCI112239; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Bernal J, 2002, J ENDOCRINOL INVEST, V25, P268; Manna PR, 2001, ENDOCRINOLOGY, V142, P308, DOI 10.1210/en.142.1.308; Young KA, 2001, BIOL REPROD, V64, P706, DOI 10.1095/biolreprod64.2.706; SHIMIZU A, 1985, GEN COMP ENDOCR, V60, P361, DOI 10.1016/0016-6480(85)90069-3; Croteau W, 1996, J CLIN INVEST, V98, P405, DOI 10.1172/JCI118806; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117; Nandi S, 1999, BIOL REPROD, V61, P70, DOI 10.1095/biolreprod61.1.70; Nakane Y, 2014, CURR BIOL, V24, pR596, DOI 10.1016/j.cub.2014.05.038; Ikegami K, 2009, J COMP NEUROL, V517, P397, DOI 10.1002/cne.22165; Bicudo JEPW, 2001, BIOSCIENCE REP, V21, P181, DOI 10.1023/A:1013648208428; LIN M, 1990, J REPROD FERTIL, V88, P481; Toyomizu M, 2002, FEBS LETT, V529, P313, DOI 10.1016/S0014-5793(02)03395-1; Gereben B, 1999, J BIOL CHEM, V274, P13768, DOI 10.1074/jbc.274.20.13768; FOLLETT BK, 1978, J ENDOCRINOL, V78, P267, DOI 10.1677/joe.0.0780267; Lowell BB, 2000, NATURE, V404, P652; Young KA, 1999, ENDOCRINOLOGY, V140, P3133, DOI 10.1210/en.140.7.3133; Bates JM, 1999, ENDOCRINOLOGY, V140, P844, DOI 10.1210/en.140.2.844; Benistant C, 1998, AM J PHYSIOL-REG I, V275, pR683; Berry DL, 1998, DEV BIOL, V203, P12, DOI 10.1006/dbio.1998.8974; Bockmann J, 1997, ENDOCRINOLOGY, V138, P1019, DOI 10.1210/en.138.3.1019; CADOT M, 1969, FED PROC, V28, P1228; Chainier F, 2000, LIPIDS, V35, P1099, DOI 10.1007/s11745-000-0625-8; Collin A, 2003, GEN COMP ENDOCR, V130, P70, DOI 10.1016/S0016-6480(02)00571-3; Darras VM, 1998, ANN NY ACAD SCI, V839, P80, DOI 10.1111/j.1749-6632.1998.tb10736.x; Follett B. K., 1998, BIOL RHYTHMS PHOTOPE, P231; FOSTER RG, 1988, CELL TISSUE RES, V253, P327; Furlow J David, 2006, Trends Endocrinol Metab, V17, P40, DOI 10.1016/j.tem.2006.01.007; Hoch FL, 1974, HDB PHYSIOLOGY     7, V3, P391; Ikegami K, 2014, CELL REP, V9, P801, DOI 10.1016/j.celrep.2014.10.006; Jannini EA, 1990, ENDOCRINOLOGY, V126, P5; Kero J, 2000, J CLIN INVEST, V105, P633, DOI 10.1172/JCI7716; Lei ZM, 2004, BIOL REPROD, V71, P1605, DOI 10.1095/biolreprod.104.031161; Marin RH, 2004, POULTRY SCI, V83, P1028; Nakane Y, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00115; OISHI T, 1978, GEN COMP ENDOCR, V36, P250, DOI 10.1016/0016-6480(78)90031-X; SAARELA S, 1991, COMP BIOCHEM PHYS B, V100, P45, DOI 10.1016/0305-0491(91)90082-O; SINGH A, 1967, GEN COMP ENDOCR, V9, P353, DOI 10.1016/0016-6480(67)90030-5; Smith CA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-85; STGERMAIN DL, 1994, P NATL ACAD SCI USA, V91, P7767; STRAW JA, 1967, J APPL PHYSIOL, V23, P825; Underwood H, 1999, PHYSIOL BEHAV, V66, P137, DOI 10.1016/S0031-9384(98)00287-X; ValverdeR C, 1997, ENDOCRINOLOGY, V138, P642, DOI 10.1210/en.138.2.642; Wagner MS, 2008, J ENDOCRINOL, V199, P351, DOI 10.1677/JOE-08-0218; Yoda T, 2000, AM J PHYSIOL-REG I, V278, pR134	61	0	0	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	FEB	2015	156	2					647	659		10.1210/en.2014-1741		13	Endocrinology & Metabolism	Endocrinology & Metabolism	CG2UV	WOS:000353131800024		
J	Choi, JY; Suzuki, KT; Sakuma, T; Shewade, L; Yamamoto, T; Buchholz, DR				Choi, Jinyoung; Suzuki, Ken-ichi T.; Sakuma, Tetsushi; Shewade, Leena; Yamamoto, Takashi; Buchholz, Daniel R.			Unliganded Thyroid Hormone Receptor alpha Regulates Developmental Timing via Gene Repression in Xenopus tropicalis	ENDOCRINOLOGY			English	Article							AMPHIBIAN METAMORPHOSIS; TRANSCRIPTIONAL ACTIVATION; FROG METAMORPHOSIS; DUAL FUNCTIONS; LAEVIS; EXPRESSION; TRIIODOTHYRONINE; RECRUITMENT; COMPETENCE; COMPLEXES	Thyroid hormone (TH) receptor (TR) expression begins early in development in all vertebrates when circulating TH levels are absent or minimal, yet few developmental roles for unliganded TRs have been established. Unliganded TRs are expected to repress TH-response genes, increase tissue responsivity to TH, and regulate the timing of developmental events. Here we examined the role of unliganded TR alpha in gene repression and development in Xenopus tropicalis. We used transcription activator-like effector nuclease gene disruption technology to generate founder animals with mutations in the TR alpha gene and bred them to produce F1 offspring with a normal phenotype and a mutant phenotype, characterized by precocious hind limb development. Offspring with a normal phenotype had zero or one disrupted TR alpha alleles, and tadpoles with the mutant hind limb phenotype had two truncated TR alpha alleles with frame shift mutations between the two zinc fingers followed by 40-50 mutant amino acids and then an out-of-frame stop codon. We examined TH-response gene expression and early larval development with and without exogenous TH in F1 offspring. As hypothesized, mutant phenotype tadpoles had increased expression of TH-response genes in the absence of TH and impaired induction of these same genes after exogenous TH treatment, compared with normal phenotype animals. Also, mutant hind limb phenotype animals had reduced hind limb and gill responsivity to exogenous TH. Similar results in methimazole-treated tadpoles showed that increased TH-response gene expression and precocious development were not due to early production of TH. These results indicate that unliganded TR alpha delays developmental progression by repressing TH-response genes.	[Choi, Jinyoung; Shewade, Leena; Buchholz, Daniel R.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Suzuki, Ken-ichi T.; Sakuma, Tetsushi; Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Hiroshima 7398526, Japan	Buchholz, DR (reprint author), Univ Cincinnati, Dept Biol Sci, 312 Clifton Court, Cincinnati, OH 45221 USA.	buchhodr@ucmail.uc.edu			University of Cincinnati Chapter Sigma Xi	This work was supported by the University of Cincinnati Chapter Sigma Xi Grant-In-Aid of Research (to J.C.).	Mai W, 2004, P NATL ACAD SCI USA, V101, P10332, DOI 10.1073/pnas.0401843101; Buchholz DR, 2003, MOL CELL BIOL, V23, P6750, DOI 10.1128/MCB.23.6750.6758.2003; LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261; Shi YB, 1996, BIOESSAYS, V18, P391, DOI 10.1002/bies.950180509; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; Morte B, 2002, P NATL ACAD SCI USA, V99, P3985, DOI 10.1073/pnas.062413299; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Sato Y, 2007, MECH DEVELOP, V124, P476, DOI 10.1016/j.mod.2007.03.006; YAOITA Y, 1990, GENE DEV, V4, P1917, DOI 10.1101/gad.4.11.1917; Grimaldi A, 2013, BBA-GEN SUBJECTS, V1830, P3882, DOI 10.1016/j.bbagen.2012.04.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nakajima K, 2012, GENES CELLS, V17, P645, DOI 10.1111/j.1365-2443.2012.01614.x; Hoopfer ED, 2002, DEV GROWTH DIFFER, V44, P365; Sachs LM, 2000, COMP BIOCHEM PHYS B, V126, P199, DOI 10.1016/S0305-0491(00)00198-X; Hollar AR, 2011, GEN COMP ENDOCR, V173, P190, DOI 10.1016/j.ygcen.2011.05.013; STOLOW MA, 1995, NUCLEIC ACIDS RES, V23, P2555, DOI 10.1093/nar/23.13.2555; Winter H, 2007, HISTOCHEM CELL BIOL, V128, P65, DOI 10.1007/s00418-007-0294-6; Shi YB, 2009, THYROID, V19, P987, DOI 10.1089/thy.2009.0041; Bilesimo P, 2011, MOL ENDOCRINOL, V25, P225, DOI 10.1210/me.2010-0269; Furlow JD, 2004, J BIOL CHEM, V279, P26555, DOI 10.1074/jbc.M402847200; Buchholz DR, 2005, J BIOL CHEM, V280, P41222, DOI 10.1074/jbc.M509593200; Flamant F, 2002, MOL ENDOCRINOL, V16, P24, DOI 10.1210/me.16.1.24; Bernal J, 2013, BBA-GEN SUBJECTS, V1830, P3893, DOI 10.1016/j.bbagen.2012.04.014; Cai LQ, 2004, DEV BIOL, V266, P87, DOI 10.1016/j.ydbio.2003.10.005; KAWAHARA A, 1991, DEVELOPMENT, V112, P933; Buchholz DR, 2006, GEN COMP ENDOCR, V145, P1, DOI 10.1016/j.ygcen.2005.07.009; Chassande O, 2003, J MOL ENDOCRINOL, V31, P9, DOI 10.1677/jme.0.0310009; Chassande O, 1997, MOL ENDOCRINOL, V11, P1278, DOI 10.1210/me.11.9.1278; Faber J, 1994, NORMAL TABLE XENOPUS; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; LEE Y, 1993, J BIOL CHEM, V268, P2021; Mittag J, 2005, ENDOCRINOLOGY, V146, P3179, DOI 10.1210/en.2005-0114; Nagaya T, 1996, BIOCHEM BIOPH RES CO, V222, P524, DOI 10.1006/bbrc.1996.0777; Ocasio CA, 2006, ACS CHEM BIOL, V1, P585, DOI 10.1021/cb600311v; PATTERTON D, 1995, DEV BIOL, V167, P252, DOI 10.1006/dbio.1995.1021; PuzianowskaKuznicka M, 1997, MOL CELL BIOL, V17, P4738; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Sachs LM, 2002, MOL CELL BIOL, V22, P8527, DOI 10.1128/MCB.22.24.8527-8538.2002; Sakuma T, 2013, SCI REP, V3, P1; Sap J, 1989, NATURE, V340, P2422; Shi YB, 2013, CURR TOP DEV BIOL, V105, P275, DOI 10.1016/B978-0-12-396968-2.00010-5; Sive H. L., 1998, EARLY DEV XENOPUS LA; Suzuki KT, 2013, BIOL OPEN, V11, P1; TATA JR, 1968, DEV BIOL, V18, P415, DOI 10.1016/0012-1606(68)90050-X; YAOITA Y, 1990, P NATL ACAD SCI USA, V87, P7090, DOI 10.1073/pnas.87.18.7090	45	6	6	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	FEB	2015	156	2					735	744		10.1210/en.2014-1554		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CG2UV	WOS:000353131800031		
J	Mori, YH				Mori, Yasuhiko H.			On the Scale-up of Gas-Hydrate-Forming Reactors: The Case of Gas-Dispersion-Type Reactors	Energies			English	Article							UNSTIRRED GAS/LIQUID SYSTEM; LIQUID STIRRED TANKS; HEAT-TRANSFER; METHANE; WATER; FLOW; KINETICS; REGIME; HOLDUP; CO2	For establishing hydrate-based technologies for natural-gas storage/transport, CO2 capture from industrial flue gases, etc., we need appropriate guidelines for the scale-up of hydrate production/processing equipment from laboratory scales to industrial scales. This paper aims to provide technical remarks on the scale-up of hydrate-forming reactors, the central components of hydrate production/processing equipment, particularly focusing on such a reactor design that hydrate-forming gas is dispersed in an aqueous phase which is either stirred in a tank or forced to flow through a tube. Based on the principles of classical fluid mechanics and heat-transfer analysis, the paper derives semi-empirical formulas that show how the capacity for heat discharge from each reactor and the power for operating the reactor are required to change with an increase in its size. Consequently, it is concluded that the stirred-tank design is unfavorable for significant scale-up and that the scale-up of tubular reactors should be made without significantly increasing the in-tube flow velocity.	[Mori, Yasuhiko H.] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan; [Mori, Yasuhiko H.] BNE Mutsuura Lab, Yokohama, Kanagawa 2360031, Japan	Mori, YH (reprint author), Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 2238522, Japan.	yhmori@mech.keio.ac.jp					Ando N, 2012, ENERG FUEL, V26, P1798, DOI 10.1021/ef201865d; Ohmura R, 2002, ENERG FUEL, V16, P1141, DOI 10.1021/ef0200727; Watanabe K, 2005, CHEM ENG SCI, V60, P4846, DOI 10.1016/j.ces.2005.03.043; Brinchi L, 2014, J PETROL SCI ENG, V120, P187, DOI 10.1016/j.petrol.2014.06.015; Babu P, 2013, ENVIRON SCI TECHNOL, V47, P13191, DOI 10.1021/es403516f; RUSHTON JH, 1950, CHEM ENG PROG, V46, P467; Okutani K, 2008, CHEM ENG SCI, V63, P183, DOI 10.1016/j.ces.2007.09.012; Seo YT, 2005, ENVIRON SCI TECHNOL, V39, P2315, DOI 10.1021/es049269z; Yang D, 2008, ENERG FUEL, V22, P2649, DOI 10.1021/ef700749f; Linga P, 2012, CHEM ENG SCI, V68, P617, DOI 10.1016/j.ces.2011.10.030; TAITEL Y, 1976, AICHE J, V22, P47, DOI 10.1002/aic.690220105; RUSHTON JH, 1950, CHEM ENG PROG, V46, P395; DORSTEWITZ F, 1994, INT J HEAT MASS TRAN, V37, P2131, DOI 10.1016/0017-9310(94)90314-X; KUTERGIN OB, 1992, DOKL AKAD NAUK+, V323, P549; Linga P, 2010, INT J GREENH GAS CON, V4, P630, DOI 10.1016/j.ijggc.2009.12.014; BARDUHN AJ, 1967, CHEM ENG PROG, V63, P98; Fujita S, 2009, AICHE J, V55, P1056, DOI 10.1002/aic.11744; Gudmundsson JS, 2000, ANN NY ACAD SCI, V912, P851; Horiguchi K, 2011, P 7 INT C GAS HYDR E; Hutchinson A.J.L., 1944, U.S. Patent, Patent No. [US2356407, 235640722]; Ida H., 2004, JFE GIHO, V6, P76; Incropera F., 2011, FUNDAMENTALS HEAT MA; Iwasaki T., 2005, P 5 INT C GAS HYDR T; Lee BW, 2014, CHEM ENG SCI, V109, P264, DOI 10.1016/j.ces.2014.01.032; Matsuda S, 2006, AICHE J, V52, P2978, DOI 10.1002/aic.10890; Mori Y. H., 2003, J CHEM IND ENG S, V54, P1; Mueller SG, 2010, IND ENG CHEM RES, V49, P10744, DOI 10.1021/ie100542a; Murakami T, 2009, ENERG FUEL, V23, P1619, DOI 10.1021/ef800880f; Nauman E.B., 2008, CHEM REACTOR DESIGN; Nesterov A.N., 2001, Russian Patent, Patent No. [RU2166348 C1, 2166348]; Rogers R.E., 1996, P 2 INT C NAT GAS HY, P423; Sloan ED, 2008, CHEM IND-SER, V119, pXIX; Wichterle K., 1994, CHEM ENG SCI, V9, P1480; Yamamura K, 2011, CHEM ENG SCI, V66, P1844, DOI 10.1016/j.ces.2011.01.017; Yoshikawa K., 2003, U.S. Patent, Patent No. [US6653516 B1, 6653516]	35	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1996-1073			ENERGIES	Energies	FEB	2015	8	2					1317	1335		10.3390/en8021317		19	Energy & Fuels	Energy & Fuels	CG8OA	WOS:000353566400001		
J	Wang, LL; Watanabe, T; Xu, ZW				Wang, Lingling; Watanabe, Tsunemi; Xu, Zhiwei			Monetization of External Costs Using Lifecycle Analysis-A Comparative Case Study of Coal-Fired and Biomass Power Plants in Northeast China	Energies			English	Article							ELECTRICITY-GENERATION; UNITED-STATES; HEALTH; ENERGY; EMISSIONS; SECTOR; CONSEQUENCES; MORTALITY; TOXICITY; BENEFITS	In this study, the structures of external costs are built in line with coal-fired and biomass power plant life cycle activities in Northeast China. The external cost of coal-fired and biomass power plants was compared, using the lifecycle approach. In addition, the external costs of a biomass power plant are calculated for each stage for comparison with those of a coal-fired power plant. The results highlight that the external costs of a coal-fired plant are 0.072 US $/kWh, which are much higher than that of a biomass power plant, 0.00012 US$/kWh. The external cost of coal-fired power generation is as much as 90% of the current price of electricity generated by coal, while the external cost of a biomass power plant is 1/1000 of the current price of electricity generated by biomass. In addition, for a biomass power plant, the external cost associated with SO2, NOX, and PM2.5 are particularly lower than those of a coal-fired power plant. The prospect of establishing precise estimations for external cost mechanisms and sustainable energy policies is discussed to show a possible direction for future energy schemes in China. The paper has significant value for supporting the biomass power industry and taxing or regulating coal-fired power industry to optimize the energy structure in China.	[Wang, Lingling] Kochi Univ Technol, Grad Sch Engn, Kami City, Kochi 7820003, Japan; [Watanabe, Tsunemi] Kochi Univ Technol, Sch Management, Kami City, Kochi 7820003, Japan; [Xu, Zhiwei] State Grid Heilongjiang Elect Power Co Ltd, Harbin 150090, Peoples R China	Watanabe, T (reprint author), Kochi Univ Technol, Sch Management, Miyanokuchi 185,Tosayamada Cho, Kami City, Kochi 7820003, Japan.	goodwanglingling@gmail.com; watanabe.tsunemi@kochi-tech.ac.jp; zhiwei_x163@163.com			Kochi University of Technology, Tosayamada, Kami city, Kochi, Japan	This study was funded by Kochi University of Technology, Tosayamada, Kami city, Kochi, Japan. The authors are grateful to Lifeng Wang, at the National Bio Energy power plant, China, Yu Sun, at Wangkui Conunty office, China, Zhiwei Li, at Kochi University of Technology, Japan, for their advice, comments and encouragement. We are particularly very much thankful to the reviewers of this paper, whose comments and suggestions were very helpful in improving the manuscript.	Heller MC, 2004, RENEW ENERG, V29, P1023, DOI 10.1016/j.renene.2003.11.018; Faaij A, 1998, BIOMASS BIOENERG, V14, P125, DOI 10.1016/S0961-9534(97)10005-8; Cai WJ, 2007, ENERG POLICY, V35, P6445, DOI 10.1016/j.enpol.2007.08.026; [Anonymous], 2008, CHIN STAT YB 1991 20; Rentizelas A, 2014, ENERG POLICY, V65, P134, DOI 10.1016/j.enpol.2013.10.023; Trasande L, 2005, ENVIRON HEALTH PERSP, V113, P590, DOI 10.1289/ehp.7743; [Anonymous], 2007, EDITORIAL BOARD CHIN; Zuwala J, 2012, J CLEAN PROD, V35, P164, DOI 10.1016/j.jclepro.2012.06.001; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709; Palmer MA, 2010, SCIENCE, V327, P148, DOI 10.1126/science.1180543; [Anonymous], 2010, STAT MINISTRY ENV PR; Chen H, 2013, SAFETY SCI, V51, P217, DOI 10.1016/j.ssci.2012.06.025; Tunckaya Y, 2015, J ENERGY INST, V88, P11, DOI 10.1016/j.joei.2014.06.007; Ghose MK, 2007, ENVIRON MONIT ASSESS, V130, P35, DOI 10.1007/s10661-006-9451-y; Kimming M, 2011, BIOMASS BIOENERG, V35, P1572, DOI 10.1016/j.biombioe.2010.12.027; Epstein PR, 2011, ANN NY ACAD SCI, V1219, P73, DOI 10.1111/j.1749-6632.2010.05890.x; Rafaj P, 2007, ENERG POLICY, V35, P828, DOI 10.1016/j.enpol.2006.03.003; Hendryx M, 2009, PUBLIC HEALTH REP, V124, P541; Hendryx M, 2008, AM J PUBLIC HEALTH, V98, P669, DOI 10.2105/AJPH.2007.113472; [Anonymous], 2008, STAT YB COAL MIN IND; Levy JI, 2009, RISK ANAL, V29, P1000, DOI 10.1111/j.1539-6924.2009.01227.x; [Anonymous], 2013, CLIMATE CHANGE 2013, P711; Saez RM, 1998, BIOMASS BIOENERG, V14, P469, DOI 10.1016/S0961-9534(98)00016-6; [Anonymous], 2010, STAT YB HEILONGJIANG; Hendryx M, 2009, INT ARCH OCC ENV HEA, V82, P243, DOI 10.1007/s00420-008-0328-y; Bernow S., 1990, 90SB01 TELL I; Bickel P., 2005, EXTERNE EXTERNALITIE; Bjureby E., 2008, TRUE COST COAL PEOPL; Cai Hao, 2010, Acta Scientiarum Naturalium Universitatis Pekinensis, V46; Cai Q., 2005, OPENCAST MIN TECHNOL, V5, P50; Castelo Branco D.A., 2013, ENERG POLICY, V61, P221; Chen H., 2006, RES UNSAFE BEHAV CHI; China Electric Power Committee, 2013, CHIN EL POW YB 2013; China Industry Research Reports, 2008, CHINA IND RES REPORT; China Meteorological Administration, AN CAUS HAZ CHIN; COASE RH, 1960, J LAW ECON, V3, P1, DOI 10.1086/466560; Dan M., 2009, MOD AGR SCI, V16, P59; Dimitrijevic Z, 2011, ENERG POLICY, V39, P3036, DOI 10.1016/j.enpol.2011.03.068; Du L., 2013, ENERG ECON, V40, P845; European Commission, 2003, EXT COSTS RES RES SO; European Environment Agency, 2006, EMEP CORINAIR EM INV; Fankhauser S., 1992, 9229 CSERGE GEC; Fox JF, 2010, ENVIRON SCI TECHNOL, V44, P2144, DOI 10.1021/es903301j; Garg A., GUIDELINES NATL GREE, V2; Grausz S., 2011, SOCIAL COST COAL IMP; Hall D.C., 1990, CONTEMP ECON POLICY, V8, P282; Hohmeyer O., 1988, SOCIAL COSTS ENERGY; Houghton J. T., 2001, CLIMATE CHANGE 2001; Hu X.L., 2005, CHINESE ENERGY, V27, P10; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; Jacobs AJ, 2014, NY TIMES BK REV, V119, P20; Kathrin V., 2013, INT J GREENH GAS CON, V16, P91; Katzer J., 2007, FUTURE COAL OPTIONS; Levy JI, 2002, J AIR WASTE MANAGE, V52, P5; Lovins A.B., 2011, REINVENTING FIRE, P8; Mahapatra D, 2012, ENERG POLICY, V49, P253, DOI 10.1016/j.enpol.2012.06.014; MEP NDRC and NEA, 2008, NOT FURTH STRENGTH M; Mishra S.K., 2009, ESTIMATION EXTERNALI; National Bureau of Statistics of China (NBSC), 2010, CHIN ENV STAT YB 201; National Bureau of Statistics of China (NBSC), 2008, CHIN STAT YB 1991 20; National Research Council, 2009, HIDD COSTS EN UNPR C; NBSC, 2008, CHIN STAT YB 2008; Nkambule N.P., 2012, J ENERGY SOUTH AFR, V23, P86; Ottinger Richard L, 1990, ENV COSTS ELECT; Pigou A.C., 1920, EC WELFARE; Preiss P., 2008, REPORT PROCEDURE DAT; Pretorius K., 2009, COAL MINING COMBUSTI; Renfei P., 2010, THESIS U MINING BEIJ, P45; Research Center of Obligation and Labor Union, 2011, RES REP OCC DIS 2011; ROBERTO T, 2013, RENEW SUST ENERG REV, V28, P555; Schleisner L, 2000, ENERG POLICY, V28, P1127, DOI 10.1016/S0301-4215(00)00084-7; Sevenster M., 2008, REPORT EXTERNAL COST; Shafie SM, 2013, ENERGY, V57, P284, DOI 10.1016/j.energy.2013.06.002; Shindell D, 2008, ATMOS CHEM PHYS, V8, P7101; Spath P. L., 1999, LIFE CYCLE ASSESSMEN; Statistic Center of Railways Ministry, 2009, RAILW COND STAT; Stirling A, 1997, ENERG POLICY, V25, P517, DOI 10.1016/S0301-4215(97)00041-4; Sundqvist T., 2002, THESIS LULEA U TECHN; Trasande L, 2006, AM J IND MED, V49, P153, DOI 10.1002/ajim.20268; Viscusi W.K., ENV RESPONSIBLE ENER; Watson R.T., 2001, 3 ASSESSMENT REPORT, P21; Yardley J., 2008, NY TIMES; Zhao XG, 2011, RENEW SUST ENERG REV, V15, P4302, DOI 10.1016/j.rser.2011.07.120	83	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1996-1073			ENERGIES	Energies	FEB	2015	8	2					1440	1467		10.3390/en8021440		28	Energy & Fuels	Energy & Fuels	CG8PE	WOS:000353569900001		
J	Kiemeneij, F; Yoshimachi, F; Matsukage, T; Amoroso, G; Fraser, D; Claessen, BE; Saito, S				Kiemeneij, Ferdinand; Yoshimachi, Fuminobo; Matsukage, Takashi; Amoroso, Giovanni; Fraser, Douglas; Claessen, Bimmer E.; Saito, Shigeru			Focus on maximal miniaturisation of transradial coronary access materials and techniques by the Slender Club Japan and Europe: an overview and classification	EuroIntervention			English	Article						coronary angiography; coronary angioplasty; miniaturisation; radial artery occlusion; slender; transradial	BALLOON-ASSISTED TRACKING; CHRONIC TOTAL OCCLUSION; GUIDE CATHETER; VASCULAR COMPLICATIONS; 0.010-INCH GUIDEWIRE; RANDOMIZED-TRIAL; INTERVENTION; ANGIOPLASTY; ANGIOGRAPHY; SYSTEM	Aims: To create awareness of, to summarise and to classify "Slender TRI: any technique associated with less trauma to the radial artery compared to traditional, established or recommended procedures, predominantly by reduction of French (Fr) size. Methods and results: A literature search was conducted to identify publications on Slender transradial coronary interventions. Based on this search the following techniques will be described: miniaturisation of materials, sheathless coronary intervention, guideless coronary intervention and back-up-improving techniques. The European perspectives will be discussed. Conclusions: Slender TRI is a new challenge to maximise patient value by improving outcome and reducing costs during Till. Materials and techniques are continuously being refined and miniaturised to the highest standards. Whether outcome improves while reducing costs remains to be validated.	[Kiemeneij, Ferdinand; Claessen, Bimmer E.] Tergooi Hosp, Dept Cardiol, NL-1261 AN Blaricum, Netherlands; [Yoshimachi, Fuminobo] Tokai Univ, Sch Med, Tokyo 151, Japan; [Matsukage, Takashi] Tokai Univ, Hachioji Hosp, Tokyo 151, Japan; [Amoroso, Giovanni] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; [Fraser, Douglas] Manchester Heart Ctr, Manchester, Lancs, England; [Saito, Shigeru] Kamakura Gen Hosp, Kamakura, Kanagawa, Japan	Kiemeneij, F (reprint author), Tergooi Hosp, Back Off Intervent Cardiol, Rijksstr Weg 1, NL-1261 AN Blaricum, Netherlands.	ferdi@euronet.nl					Agostoni P, 2004, J AM COLL CARDIOL, V44, P349, DOI 10.1016/j.jacc.2004.04.034; Liang M, 2010, CATHETER CARDIO INTE, V75, P222, DOI 10.1002/ccd.22236; Gray HH, 2000, HEART, V83, P224; Aminian A, 2014, CATHETER CARDIO INTE, V84, P436, DOI 10.1002/ccd.25232; Chase AJ, 2008, HEART, V94, P1019, DOI 10.1136/hrt.2007.136390; Nagai S, 1999, AM J CARDIOL, V83, P180, DOI 10.1016/S0002-9149(98)00821-2; Patel T, 2013, CATHETER CARDIO INTE, V81, pE215, DOI 10.1002/ccd.24504; Matsukage T, 2010, CATHETER CARDIO INTE, V75, P1006, DOI 10.1002/ccd.22434; Mamas MA, 2008, CATHETER CARDIO INTE, V72, P357, DOI 10.1002/ccd.21637; Romagnoli E, 2012, J AM COLL CARDIOL, V60, P2481, DOI 10.1016/j.jacc.2012.06.017; Uhlemann M, 2012, JACC-CARDIOVASC INTE, V5, P36, DOI 10.1016/j.jcin.2011.08.011; Hamon M, 2013, EUROINTERVENTION, V8, P1242, DOI 10.4244/EIJV8I11A192; Takahashi S, 2004, CATHETER CARDIO INTE, V63, P452, DOI 10.1002/ccd.20223; Saito S, 1999, CATHETER CARDIO INTE, V46, P173, DOI 10.1002/(SICI)1522-726X(199902)46:2<173::AID-CCD12>3.0.CO;2-4; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Dahm JB, 2002, CATHETER CARDIO INTE, V57, P172, DOI 10.1002/ccd.10321; Cheaito R, 2014, CATHETER CARDIOVASC; Fujita S, 2003, CATHETER CARDIO INTE, V59, P482, DOI 10.1002/ccd.10551; Gobeil François, 2004, J Invasive Cardiol, V16, P353; Gwon Hyeon-Cheol, 2006, J Interv Cardiol, V19, P141, DOI 10.1111/j.1540-8183.2006.00121.x; Hamood Hatem, 2006, Acute Card Care, V8, P139, DOI 10.1080/17482940600885469; Harding SA, 2013, HEART LUNG CIRC, V22, P188, DOI 10.1016/j.hlc.2012.10.004; Honda T, 2013, POSTEP KARDIOL INTER, V9, P286, DOI 10.5114/pwki.2013.37511; Kajiya T, 2013, INT J CARDIOL, V168, P4287, DOI 10.1016/j.ijcard.2013.04.199; Matsukage T, 2009, EUROINTERVENTION, V5, P515, DOI 10.4244/EIJV5I4A82; Matsukage T, 2009, CATHETER CARDIO INTE, V73, P605, DOI 10.1002/ccd.21880; Matsukage Takashi, 2008, J Invasive Cardiol, V20, pE210; Metz D, 1997, AM HEART J, V134, P131, DOI 10.1016/S0002-8703(97)70117-0; Mitsudo K, 2008, J INVASIVE CARDIOL, V20, P571; Nakamura Reo, 2013, Cardiovasc Interv Ther, V28, P66, DOI 10.1007/s12928-012-0117-0; Patel T, 2014, CATHETER CARDIO INTE, V83, P211, DOI 10.1002/ccd.24959; Rakhit Roby D, 2002, J Invasive Cardiol, V14, P670; Rao SV, 2014, CATHETER CARDIO INTE, V83, P228, DOI 10.1002/ccd.25209; Saito S, 2010, CATHETER CARDIO INTE, V75, P690, DOI 10.1002/ccd.22316; Sakakura Kenichi, 2013, Cardiovasc Interv Ther, V28, P71, DOI 10.1007/s12928-012-0114-3; Takeshita S, 2010, CATHETER CARDIO INTE, V75, P735, DOI 10.1002/ccd.22308; Takeshita S, 2008, CATHETER CARDIO INTE, V72, P222, DOI 10.1002/ccd.21581; Tonomura D, 2014, CATHETER CARDIO INTE, V84, P426, DOI 10.1002/ccd.25357; Verouden NJ, 2014, CASE REP CARDIOL, V2014; YAZDANFAR S, 1993, CATHETER CARDIO DIAG, V28, P72, DOI 10.1002/ccd.1810280114; Yoshimachi Fuminobu, 2013, Cardiovasc Interv Ther, V28, P213, DOI 10.1007/s12928-012-0149-5; Yoshimachi Fuminobu, 2007, J Invasive Cardiol, V19, P519	42	1	1	EUROPA EDITION	TOULOUSE CEDEX 6	19 ALLEES JEAN JAURES B P 61508, TOULOUSE CEDEX 6, 31015, FRANCE	1774-024X	1969-6213		EUROINTERVENTION	EuroIntervention	FEB	2015	10	10					1178	1186		10.4244/EIJY14M09_09		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG5DH	WOS:000353310800009		
J	Kurokawa, T				Kurokawa, Takahide			A semi-group formula for the Riesz potentials	Hokkaido Mathematical Journal			English	Article						Riesz potentials; Lizorkin space; semi-group formula		The purpose of this article is to establish a semi-group formula for the Riesz potentials of L-p-functions. As preparations, we study the Lizorkin space Phi(R-n) and investigate integral estimates of the Riesz potentials of functions in the spaces L-p:r,L-s(R-n).	Kagoshima Univ, Grad Sch Sci & Technol, Dept Math & Comp Sci, Kagoshima 8900065, Japan	Kurokawa, T (reprint author), Kagoshima Univ, Grad Sch Sci & Technol, Dept Math & Comp Sci, Kagoshima 8900065, Japan.	kurokawa@sci.kagoshima-u.ac.jp					STEIN EM, 1958, J MATH MECH, V7, P503; Kurokawa T., 2006, ADV STUD PURE MATH, V44, P179; OKIKIOLU GO, 1970, GLASGOW MATH J, V11, P126; Samko S. G., 1993, THEORY APPL; Schwartz L., 1966, THEORIE DISTRIBUTION; Smako S.G., 2002, HYPERSINGULAR INTEGR; Stein E., 1970, SINGULAR INTEGRALS D	7	0	0	HOKKAIDO UNIV, DEPT MATHEMATICS	SAPPORO	NISHI-8-CHOME, KITA-10-JO, KITA-KU, SAPPORO, 060-810, JAPAN	0385-4035			HOKKAIDO MATH J	Hokkaido Math. J.	FEB	2015	44	1					1	27				27	Mathematics	Mathematics	CG6TT	WOS:000353436000001		
J	Garg, N; Kapono, CA; Lim, YW; Koyama, N; Vermeij, MJA; Conrad, D; Rohwer, F; Dorrestein, PC				Garg, Neha; Kapono, Clifford A.; Lim, Yan Wei; Koyama, Nobuhiro; Vermeij, Mark J. A.; Conrad, Douglas; Rohwer, Forest; Dorrestein, Pieter C.			Mass spectral similarity for untargeted metabolomics data analysis of complex mixtures	INTERNATIONAL JOURNAL OF MASS SPECTROMETRY			English	Article						Molecular networking; Mass spectrometry; Complex mixtures; Spectral matching; Cytoscape; Database search	DESORPTION ELECTROSPRAY-IONIZATION; PLATELET-ACTIVATING-FACTOR; MOLECULAR PROFILE DATA; SPECTROMETRY; IDENTIFICATION; VISUALIZATION; METABOLITES; NETWORKING; PROTEOMICS; METLIN	While in nucleotide sequencing, the analysis of DNA from complex mixtures of organisms is common, this is not yet true for mass spectrometric data analysis of complex mixtures. The comparative analyses of mass spectrometry data of microbial communities at the molecular level is difficult to perform, especially in the context of a host. The challenge does not lie in generating the mass spectrometry data, rather much of the difficulty falls in the realm of how to derive relevant information from this data. The informatics based techniques to visualize and organize datasets are well established for metagenome sequencing; however, due to the scarcity of informatics strategies in mass spectrometry, it is currently difficult to cross correlate two very different mass spectrometry data sets from microbial communities and their hosts. We highlight that molecular networking can be used as an organizational tool of tandem mass spectrometry data, automated database search for rapid identification of metabolites, and as a workflow to manage and compare mass spectrometry data from complex mixtures of organisms. To demonstrate this platform, we show data analysis from hard corals and a human lung associated with cystic fibrosis. (C) 2014 Elsevier B.V. All rights reserved.	[Garg, Neha; Koyama, Nobuhiro; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Kapono, Clifford A.; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Lim, Yan Wei; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Koyama, Nobuhiro] Kitasato Univ, Sch Pharm, Tokyo, Japan; [Vermeij, Mark J. A.] Univ Amsterdam, CARMABI, Dept Aquat Microbiol, Willemstad,Curacao, Amsterdam, Netherlands; [Conrad, Douglas] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Dorrestein, PC (reprint author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr,MC0751, La Jolla, CA 92093 USA.	pdorrestein@ucsd.edu			NIH [GM095384]; UCSD Clinical and Translational Research Institute Pilot award CIIPMDC; graduate student fellowship, Tribal Membership Initiative; UCSD; School of Pharmacy, Kitasato University, Tokya, Japan	We would like to acknowledge Tal Luzzatto Knaan for help with development of UPLC method, and Robert Quinn for his help with tissue homogenization and insights into this work. We acknowledge the Bruker Therapeutic Discovery Mass Spectrometry Center at UCSD Skaggs School of Pharmacy. This work was supported by the NIH as a metabolomics supplement to parent grant GM095384 and from the UCSD Clinical and Translational Research Institute Pilot award CIIPMDC. Clifford Kapono is supported by the graduate student fellowship, Tribal Membership Initiative, by UCSD. The visit by Nobuhiro Koyama is supported by School of Pharmacy, Kitasato University, Tokya, Japan.	Gross JH, 2014, ANAL BIOANAL CHEM, V406, P63, DOI 10.1007/s00216-013-7316-0; Niemi LM, 2013, ANAL CHEM, V85, P7279, DOI 10.1021/ac401170s; Broeckling CD, 2006, ANAL CHEM, V78, P4334, DOI 10.1021/ac0521596; Zhang AH, 2013, MOL BIOSYST, V9, P2259, DOI 10.1039/c3mb70171a; Zhang AH, 2012, ANALYST, V137, P293, DOI 10.1039/c1an15605e; Wang H, 2010, ANGEW CHEM INT EDIT, V49, P877, DOI 10.1002/anie.200906314; Kay RG, 2007, RAPID COMMUN MASS SP, V21, P2585, DOI 10.1002/rcm.3130; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Seeley EH, 2008, P NATL ACAD SCI USA, V105, P18126, DOI 10.1073/pnas.0801374105; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Makarov A, 2006, J AM SOC MASS SPECTR, V17, P977, DOI 10.1016/j.jasms.2006.03.006; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; McDonnell LA, 2007, MASS SPECTROM REV, V26, P606, DOI 10.1002/mas.20124; STEIN SE, 1995, J AM SOC MASS SPECTR, V6, P644, DOI 10.1016/1044-0305(95)00291-K; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Wilson ID, 2005, J PROTEOME RES, V4, P591, DOI 10.1021/pr049769r; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404; Yang JY, 2013, J NAT PROD, V76, P1686, DOI 10.1021/np400413s; Phelan VV, 2012, NAT CHEM BIOL, V8, P26, DOI 10.1038/nchembio.739; Guthals A, 2012, MOL BIOSYST, V8, P2535, DOI 10.1039/c2mb25085c; Nagele E, 2003, J CHROMATOGR A, V1009, P197, DOI 10.1016/S0021-9673(03)01034-3; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Watrous JD, 2011, NAT REV MICROBIOL, V9, P683, DOI 10.1038/nrmicro2634; Chen HW, 2006, RAPID COMMUN MASS SP, V20, P1577, DOI 10.1002/rcm.2474; Tautenhahn R, 2012, NAT BIOTECHNOL, V30, P826, DOI 10.1038/nbt.2348; Katajamaa M, 2006, BIOINFORMATICS, V22, P634, DOI 10.1093/bioinformatics/btk039; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Dudley E, 2010, ADV PROTEIN CHEM STR, V80, P45, DOI [10.1016/B978-0-12-381264-3.00002-3, 10.1016/S1876-1623(10)80002-1]; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109; Ponnusamy K, 2013, BIOSCI BIOTECH BIOCH, V77, P683, DOI 10.1271/bbb.120665; Frank AM, 2008, J PROTEOME RES, V7, P113, DOI 10.1021/pr070361e; Kind T, 2012, J CHROMATOGR A, V1244, P139, DOI 10.1016/j.chroma.2012.04.074; ARCHER CB, 1988, J INVEST DERMATOL, V91, P82, DOI 10.1111/1523-1747.ep12463296; Fernandez FM, 2006, CHEMMEDCHEM, V1, P702; Gaspari M, 2011, METHODS MOL BIOL, V790, P115, DOI 10.1007/978-1-61779-319-6_9; Korner R, 1996, J AM SOC MASS SPECTR, V7, P150, DOI 10.1016/1044-0305(95)00626-5; KRAMER RM, 1984, J BIOL CHEM, V259, P3316; Nunn Brook L., 2006, Briefings in Functional Genomics & Proteomics, V5, P154, DOI 10.1093/bfgp/ell024; OHNO M, 1985, CHEM PHARM BULL, V33, P572; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; de Bekker C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070609; Steinfath M, 2008, PHYSIOL PLANTARUM, V132, P150, DOI 10.1111/j.1399-3054.2007.01006.x	47	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1387-3806	1873-2798		INT J MASS SPECTROM	Int. J. Mass Spectrom.	FEB 1	2015	377				SI		719	727		10.1016/j.ijms.2014.06.005		9	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CG1BD	WOS:000353007100075		
J	Nakayamada, S; Iwata, S; Tanaka, Y				Nakayamada, Shingo; Iwata, Shigeru; Tanaka, Yoshiya			Relevance of lymphocyte subsets to B cell-targeted therapy in systemic lupus erythematosus	INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES			English	Article						B cell depletion therapy; B cells; rituximab; systemic lupus erythematosus; T cells	SPLEEN TYROSINE KINASE; HELPER T-CELLS; CENTRAL-NERVOUS-SYSTEM; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES; DOUBLE-BLIND; RITUXIMAB THERAPY; DEPLETION THERAPY; DOWN-REGULATION; SYK INHIBITOR	Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with heterogeneous clinical manifestations, and pathologically characterized by activation of autoreactive T cells and overproduction of autoantibodies by B cells. Although corticosteroids and immunosuppressants are widely used for the treatment, safer and more effective therapies are needed. B cells play a pivotal role in the pathogenesis of SLE not only by producing pathogenic autoantibodies but also by modulating immune responses via production of cytokines and chemokines. The potential efficacy of B-cell depletion therapy has been reported in SLE. Treatment with rituximab, an anti-CD20 antibody, results in reconstitution of B cells in the periphery, thereby inhibiting T cell activation and differentiation, which in turn leads to long-term remission of SLE. However, we have reported SLE recurrence driven by B cell- or T cell-memory activation after long-term remission, demonstrating pathological heterogeneity in SLE. Ideally, differential targeting therapies should be considered according to relevant lymphocyte subsets. Therefore, evaluation of peripheral blood lymphocyte subsets could be valuable for predicting the response to B cell-targeted therapy. A better understanding of B cell pathology should contribute to the development of novel specific therapies for SLE.	[Nakayamada, Shingo; Iwata, Shigeru; Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka 8078555, Japan	Tanaka, Y (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	tanaka@med.uoeh-u.ac.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; University of Occupational and Environmental Health, Japan	The authors thank all medical staff members at the associated institutions for helpful advice and encouragement. This work was supported in part by a Research Grant-In-Aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the University of Occupational and Environmental Health, Japan.	Emery P, 2006, ARTHRITIS RHEUM, V54, P1390, DOI 10.1002/art.21778; Wei C, 2007, J IMMUNOL, V178, P6624; Podolanczuk A, 2009, BLOOD, V113, P3154, DOI 10.1182/blood-2008-07-166439; Anolik JH, 2007, ARTHRITIS RHEUM, V56, P3044, DOI 10.1002/art.22810; Diaz-Lagares C, 2012, AUTOIMMUN REV, V11, P357, DOI 10.1016/j.autrev.2011.10.009; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; Tokunaga M, 2007, ANN RHEUM DIS, V66, P470, DOI 10.1136/ard.2006.057885; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; Nakayamada S, 2014, J IMMUNOL, V192, P2156, DOI 10.4049/jimmunol.1300675; Calabrese LH, 2008, ANN RHEUM DIS, V67, P64, DOI 10.1136/ard.2008.097972; Leandro MJ, 2002, ARTHRITIS RHEUM-US, V46, P2673, DOI 10.1002/art.10541; Vallerskog T, 2007, CLIN IMMUNOL, V122, P62, DOI 10.1016/j.clim.2006.08.016; Weinblatt ME, 2010, NEW ENGL J MED, V363, P1303, DOI 10.1056/NEJMoa1000500; Sfikakis PP, 2007, CLIN IMMUNOL, V123, P66, DOI 10.1016/j.clim.2006.12.006; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Cohen SB, 2006, ARTHRITIS RHEUM, V54, P2793, DOI 10.1002/art.22025; Meltzer EO, 2005, J ALLERGY CLIN IMMUN, V115, P791, DOI 10.1016/j.jaci.2005.01.040; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Crispin JC, 2007, ANN RHEUM DIS, V66, P65, DOI 10.1136/ard.2007.078493; Gunnarsson I, 2013, LUPUS, V22, P381, DOI 10.1177/0961203312471574; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Crow MK, 2008, NEW ENGL J MED, V358, P956, DOI 10.1056/NEJMe0800096; Jacobi AM, 2003, ARTHRITIS RHEUM, V48, P1332, DOI 10.1002/art.10949; Grammer AC, 2003, J CLIN INVEST, V112, P1506, DOI 10.1172/JCI200319301; Shin MS, 2011, CURR OPIN RHEUMATOL, V23, P444, DOI 10.1097/BOR.0b013e328349a255; Looney RJ, 2004, ARTHRITIS RHEUM, V50, P2580, DOI 10.1002/art.20430; Rastetter W, 2004, ANNU REV MED, V55, P477, DOI 10.1146/annurev.med.55.091902.104249; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Duxbury B, 2013, LUPUS, V22, P1489, DOI 10.1177/0961203313509295; Condon MB, 2013, ANN RHEUM DIS, V72, P1280, DOI 10.1136/annrheumdis-2012-202844; Bajpai M, 2009, IDRUGS, V12, P174; Weinblatt ME, 2008, ARTHRITIS RHEUM-US, V58, P3309, DOI 10.1002/art.23992; Satterthwaite AB, 1998, SEMIN IMMUNOL, V10, P309, DOI 10.1006/smim.1998.0123; Lo MS, 2012, ANN NY ACAD SCI, V1247, P138, DOI 10.1111/j.1749-6632.2011.06263.x; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; Bahjat FR, 2008, ARTHRITIS RHEUM, V58, P1433, DOI 10.1002/art.23428; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Kirou KA, 2005, ARTHRITIS RHEUM, V52, P1491, DOI 10.1002/art.21031; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Anolik JH, 2004, ARTHRITIS RHEUM, V50, P3580, DOI 10.1002/art.20592; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; DesaiMehta A, 1996, J CLIN INVEST, V97, P2063, DOI 10.1172/JCI118643; Kil LP, 2012, BLOOD, V119, P3744, DOI 10.1182/blood-2011-12-397919; Sanz I, 2010, NAT REV RHEUMATOL, V6, P326, DOI 10.1038/nrrheum.2010.68; Deng GM, 2010, ARTHRITIS RHEUM-US, V62, P2086, DOI 10.1002/art.27452; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Iwata S, 2011, J RHEUMATOL, V38, P633, DOI 10.3899/jrheum.100729; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Tokunaga M, 2005, RHEUMATOLOGY, V44, P176, DOI 10.1093/rheumatology/keh443; Rovin BH, 2012, ARTHRITIS RHEUM-US, V64, P1215, DOI 10.1002/art.34359; Lu TYT, 2009, ARTHRIT RHEUM-ARTHR, V61, P482, DOI 10.1002/art.24341; Nakayamada S, 2012, CURR OPIN IMMUNOL, V24, P297, DOI 10.1016/j.coi.2012.01.014; Avalos AM, 2010, AUTOIMMUNITY, V43, P76, DOI 10.3109/08916930903374618; Beaven MA, 1996, CURR OPIN IMMUNOL, V8, P766, DOI 10.1016/S0952-7915(96)80002-1; Bonelli M, 2010, ANN RHEUM DIS, V69, P65, DOI 10.1136/ard.2009.117135; Cobo-Ibanez T, 2014, SEMIN ARTHRITIS RHEU, V44, P175, DOI 10.1016/j.semarthrit.2014.04.002; Conley ME, 1998, CURR OPIN IMMUNOL, V10, P399, DOI 10.1016/S0952-7915(98)80112-X; Diaz-Lagares C, 2011, ARTHRITIS RES THER, V13, P13; DisPaolo J. A., 2011, NAT CHEM BIOL, V7, P41; Fernandez-Nebro A, 2012, LUPUS, V21, P1063, DOI 10.1177/0961203312446627; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Iwata S, 2012, ANN RHEUM DIS, V71, P1749, DOI 10.1136/annrheumdis-2012-201317; Iwata S, 2013, LUPUS, V22, P538, DOI 10.1177/0961203313477899; Iwata S, 2012, J ALLERGY CLIN IMMUN, V129, P1594, DOI 10.1016/j.jaci.2012.03.014; LesCoz C, 2013, PLOS ONE, V8; Marian V, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3917; Moroni G, 2014, RHEUMATOLOGY, V53, P1570, DOI 10.1093/rheumatology/ket462; Nakayamada S, 2007, ARTHRITIS RHEUM, V56, P1559, DOI 10.1002/art.22581; O'Shea JJ, 2013, NAT REV RHEUMATOL, V9, P173, DOI 10.1038/nrrheum.2013.7; Paz Z, 2013, CURR OPIN RHEUMATOL, V25, P297, DOI 10.1097/BOR.0b013e32835fd682; Reddy V, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3910; Rokosz LL, 2008, EXPERT OPIN THER TAR, V12, P883, DOI [10.1517/14728222.12.7.883 , 10.1517/14728220802198645]; Saito K, 2003, LUPUS, V12, P798, DOI 10.1191/0961203303lu450xx; Saito K, 2005, RHEUMATOLOGY, V44, P1462, DOI 10.1093/rheumatology/kei075; Tanaka Y, 2007, MOD RHEUMATOL, V17, P191, DOI [DOI 10.1007/S10165-007-0565-Z, 10.3109/s10165-007-0565-z]; Tanaka Y, 2013, MOD RHEUMATOL, V23, P415, DOI 10.1007/s10165-012-0799-2; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Wong WSF, 2004, BBA-PROTEINS PROTEOM, V1697, P53, DOI 10.1016/j.bbapap.2003.11.013	88	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1756-1841	1756-185X		INT J RHEUM DIS	Int. J. Rheum. Dis.	FEB	2015	18	2			SI		208	218		10.1111/1756-185X.12534		11	Rheumatology	Rheumatology	CG1VK	WOS:000353063100014		
J	Koike, T				Koike, Takao			Antiphospholipid syndrome: 30 years and our contribution	INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES			English	Article						antiphospholipid antibody syndrome; disease etiology and pathogenesis - human	SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACTIVATED PROTEIN-KINASE; AMINO-ACID-SEQUENCE; BETA(2)-GLYCOPROTEIN I DEFICIENCY; INTERNATIONAL CONSENSUS STATEMENT; ANTI-PROTHROMBIN ANTIBODIES; NECROSIS-FACTOR-ALPHA; TISSUE FACTOR; ANTICARDIOLIPIN ANTIBODIES; ENDOTHELIAL-CELLS	In 1983, Graham Hughes first described the concept of antiphospholipid syndrome (APS). In 1984, we described the enzyme-linked immunosorbent assay (ELISA) system which directly detected circulating aCL in patients with systemic lupus erythematosus (SLE) who revealed biological false positive serological test for syphilis. In 1990, three groups, including our group, independently reported the necessity of a cofactor for the binding of autoimmune anticardiolipin antibodies (aCL) to the solid phase phospholipids. 2-glycoprotein I (2GPI) was identified as this cofactor. In 1994,the epitope for aCL was shown to develop when 2GPI is adsorbed on polyoxygenated polystyrene plates. In 2000, we described antiprothrombin antibodies bind to prothrombin exposed to immobilized phosphatidylserine and established a phosphatidylserine dependent monoclonal antiprothrombin antibody. In 2004, a novel role of nicked 2GPI was identified in the negative feedback pathway of extrinsic fibrinolysis. Nicked 2GPI was found to bind angiostatin 4.5 and to attenuate its antiangiogenic property. In 2004, we demonstrated that the p38 MAPK pathway mediates induction of the TF gene in stimulated with human monoclonal anti- 2GPI antibodies. Very recently, 2GPI was identified as a complement regulator. The cross-link between complement activation and prothrombotic status in patients with APS has been drawn much attention. Genetic factors are hypothesized to play a role in the susceptibility to APS based on several family studies in patients with antiphospholipid antibodies (aPL) and/or clinical manifestations of APS. The genetics of 2GPI has been extensively studied. 247 Val/Leu polymorphism can affect the conformational change of 2-GPI and the exposure of the epitopes for aCL. We found that 247 Val was correlated with anti-2-GPI production in patients with primary APS, and 247 Val may be important for 2-GPI antigenicity. STAT4 SNP in Japanese patients with SLE and/or APS. T allele frequencies in SLE and APS were significantly elevated compared with that in healthy controls. When analyzed only in primary APS patients, T allele frequency was further higher. BANK1, BLK and SNP in 1q25.1 region were associated with not only SLE but also APS in Japanese population. These results suggest that APS and SLE, in part, share a common genetic background.	[Koike, Takao] Hokkaido Univ, Grad Sch Med, Dept Med 2, Sapporo, Hokkaido, Japan; [Koike, Takao] NTT Sapporo Med Ctr, Sapporo, Hokkaido 0600061, Japan	Koike, T (reprint author), NTT Sapporo Med Ctr, S-1 W-15, Sapporo, Hokkaido 0600061, Japan.	tkoike@med.hokudai.ac.jp					Raschi E, 2003, BLOOD, V101, P3495, DOI 10.1182/blood-2002-08-2349; Vega-Ostertag M, 2004, ARTHRITIS RHEUM, V50, P2911, DOI 10.1002/art.20434; Tedesco F, 1997, J EXP MED, V185, P1619, DOI 10.1084/jem.185.9.1619; Meroni PL, 2011, NAT REV RHEUMATOL, V7, P330, DOI 10.1038/nrrheum.2011.52; Ruiz-Irastorza G, 2010, LANCET, V376, P1498, DOI 10.1016/S0140-6736(10)60709-X; Pierangeli SS, 2005, ARTHRITIS RHEUM, V52, P2120, DOI 10.1002/art.21157; Fischetti F, 2005, BLOOD, V106, P2340, DOI 10.1182/blood-2005-03-1319; MATSUURA E, 1992, J IMMUNOL, V148, P3885; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Girardi G, 2004, NAT MED, V10, P1222, DOI 10.1038/1121; HARRIS EN, 1983, LANCET, V2, P1211; KATO H, 1991, BIOCHEMISTRY-US, V30, P11687, DOI 10.1021/bi00114a012; Sorice M, 2007, ARTHRITIS RHEUM, V56, P2687, DOI 10.1002/art.22802; Oku K, 2009, ANN RHEUM DIS, V68, P1030, DOI 10.1136/ard.2008.090670; Vega-Ostertag M, 2005, ARTHRITIS RHEUM, V52, P1545, DOI 10.1002/art.21009; HUGHES GRV, 1983, BRIT MED J, V287, P1088; Atsumi T, 2000, ARTHRITIS RHEUM, V43, P1982, DOI 10.1002/1529-0131(200009)43:9<1982::AID-ANR9>3.0.CO;2-2; Meroni PL, 2001, ARTHRITIS RHEUM, V44, P2870, DOI 10.1002/1529-0131(200112)44:12<2870::AID-ART475>3.0.CO;2-Y; Nakajima K, 2004, NEUROCHEM INT, V44, P205, DOI 10.1016/S0197-0186(03)00163-3; MATSUURA E, 1990, LANCET, V336, P177, DOI 10.1016/0140-6736(90)91697-9; Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F; MATSUURA E, 1994, J EXP MED, V179, P457, DOI 10.1084/jem.179.2.457; ASHERSON RA, 1992, ARTHRITIS RHEUM, V35, P124, DOI 10.1002/art.1780350119; Atsumi T, 2011, SYSTEMIC LUPUS ERYTHEMATOSUS, 5TH EDITION, P945; Bohgaki M, 2004, INT IMMUNOL, V16, P1633, DOI 10.1093/intimm/dxh166; CAMPS MT, 1995, LUPUS, V4, P51, DOI 10.1177/096120339500400111; Dunoyer-Geindre S, 2002, THROMB HAEMOSTASIS, V88, P851; Galli M, 1990, LANCET, V335, P952; Galli M, 1998, BLOOD, V91, P1999; Galli M, 1997, THROMB HAEMOSTASIS, V77, P486; Girardi G, 2010, CLIN REV ALLERG IMMU, V39, P160, DOI 10.1007/s12016-009-8187-1; Gushiken FC, 1999, ARTHRITIS RHEUM, V42, P1189, DOI 10.1002/1529-0131(199906)42:6<1189::AID-ANR15>3.0.CO;2-8; HARRIS EN, 1985, J CLIN LAB IMMUNOL, V16, P1; HASHIMOTO Y, 1992, J IMMUNOL, V149, P1063; Horita T, 2009, ANN RHEUM DIS, V68, P1366, DOI 10.1136/ard.2008.094367; Kasahara H, 2005, INT IMMUNOL, V17, P1533, DOI 10.1093/intimm/dxh330; KOIKE T, 1984, CLIN EXP IMMUNOL, V56, P193; Lopez-Pedrera C, 2006, ARTHRITIS RHEUM, V54, P301, DOI 10.1002/art.21549; LOZIER J, 1984, P NATL ACAD SCI-BIOL, V81, P3640, DOI 10.1073/pnas.81.12.3640; MATSUURA E, 1991, INT IMMUNOL, V3, P1217; MCHUGH NJ, 1989, ARTHRITIS RHEUM, V32, P1623, DOI 10.1002/anr.1780321222; MCNEIL HP, 1990, P NATL ACAD SCI USA, V87, P4120, DOI 10.1073/pnas.87.11.4120; Nakagawa H, 2009, BLOOD, V114, P2553, DOI 10.1182/blood-2008-12-190629; Pengo V, 1996, THROMB HAEMOSTASIS, V75, P721; Sakai Y, 2009, ARTHRITIS RHEUM, V60, P2457, DOI 10.1002/art.24708; Sanghera DK, 1997, HUM GENET, V100, P57, DOI 10.1007/s004390050465; Simmelink MJA, 2001, BRIT J HAEMATOL, V113, P621, DOI 10.1046/j.1365-2141.2001.02755.x; STEINKASSERER A, 1993, HUM GENET, V91, P401; STEINKASSERER A, 1991, BIOCHEM J, V277, P387; Takeuchi R, 2000, BLOOD, V96, P1594; WU JR, 1994, THROMB HAEMOSTASIS, V71, P596; Yasuda S, 2000, ATHEROSCLEROSIS, V152, P337, DOI 10.1016/S0021-9150(99)00496-7; Yasuda S, 2005, ARTHRITIS RHEUM, V52, P212, DOI 10.1002/art.20741; Yasuda S, 2004, BLOOD, V103, P3766, DOI 10.1182/blood-2003-08-2712; YOSHIDA H, 1987, AM J PATHOL, V129, P477	55	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1756-1841	1756-185X		INT J RHEUM DIS	Int. J. Rheum. Dis.	FEB	2015	18	2			SI		233	241		10.1111/1756-185X.12438		9	Rheumatology	Rheumatology	CG1VK	WOS:000353063100016		
J	Aoki, K; Kohmura, Y; Sakuma, K; Koshikawa, K; Naito, H				Aoki, Kazuhiro; Kohmura, Yoshimitsu; Sakuma, Kazuhiko; Koshikawa, Kazunori; Naito, Hisashi			Relationships Between Field Tests of Power and Athletic Performance in Track and Field Athletes Specializing in Power Events	International Journal of Sports Science & Coaching			English	Article						Jumping; IAAF Scoring Table; Sprinting; Throwing; Varsity Track and Field	SPRINT RUNNING PERFORMANCE; BODY-COMPOSITION; SOCCER PLAYERS; JUMP HEIGHT; STRENGTH; SPEED; SHOT; PARAMETERS; COMPETITION; PREDICTORS	We investigated the relationships between power event scores and power/strength tests using the International Association of Athletics Federations (IAAF) scoring table. We sought to identify tests suitable for evaluating the performance of athletes specialized in power events involving different techniques (jumping, sprinting, and throwing). Seventy-four male university-level track and field athletes participated in this study. Standing triple jump, standing quintuple jump, and backward medicine ball throwing were positively correlated with IAAF scores in sprinters (p < 0.05), while forward medicine ball throwing, backward medicine ball throwing, and clean lift (p < 0.05) were associated with IAAF scores in throwers. Standing long jump (p < 0.05), standing triple jump, standing quintuple jump, and anaerobic power (p < 0.001) were positively correlated with IAAF scores in all athletes. Our results demonstrated that standing triple jump and standing quintuple jump were effective indicators of performance in power events in university-level athletes.	[Aoki, Kazuhiro; Kohmura, Yoshimitsu; Koshikawa, Kazunori] Juntendo Univ, Sch Hlth & Sports Sci, Inzai, Chiba 2701695, Japan; [Sakuma, Kazuhiko; Naito, Hisashi] Juntendo Univ, Grad Sch Hlth & Sports Sci, Inzai, Chiba 2701695, Japan	Aoki, K (reprint author), Juntendo Univ, Sch Hlth & Sports Sci, 1-1 Hiraga Gakuendai, Inzai, Chiba 2701695, Japan.	k-aoki@juntendo.ac.jp					Hennessy L, 2001, J STRENGTH COND RES, V15, P326; Young WB, 2002, J SPORT MED PHYS FIT, V42, P282; Brechue WF, 2010, J STRENGTH COND RES, V24, P1169, DOI 10.1519/JSC.0b013e3181d68107; Kyriazis TA, 2009, J STRENGTH COND RES, V23, P1773, DOI 10.1519/JSC.0b013e3181b3f91e; Gonzalez-Badillo JJ, 2010, J STRENGTH COND RES, V24, P3443, DOI 10.1519/JSC.0b013e3181bac37d; Chelly SM, 2001, MED SCI SPORT EXER, V33, P326; Girard O, 2006, BRIT J SPORT MED, V40, P791, DOI 10.1136/bjsm.2006.027680; Delecluse C, 1997, SPORTS MED, V24, P147; Chamari K, 2004, BRIT J SPORT MED, V38, P191, DOI 10.1136/bjsm.2003.004374; Bret C, 2002, J SPORT MED PHYS FIT, V42, P274; Hudgins B, 2013, J STRENGTH COND RES, V27, P563, DOI 10.1519/JSC.0b013e31827e136f; Aoki k., 2007, JAPANESE J STUDIES A, V5, P12; Barr MJ, 2011, J STRENGTH COND RES, V25, P1976, DOI 10.1519/JSC.0b013e3181e4f7ba; Berthoin S, 2001, J STRENGTH COND RES, V15, P75; Bissas AI, 2008, J SPORT MED PHYS FIT, V48, P49; DELECLUSE C, 1995, MED SCI SPORT EXER, V27, P1203; Haugen TA, 2012, INT J SPORT PHYSIOL, V7, P340; Hirano Yuichi, 1994, Japanese Journal of Physical Fitness and Sports Medicine, V43, P113; Judge LW, 2012, INT J PERF ANAL SPOR, V12, P37; Kale M, 2009, J STRENGTH COND RES, V23, P2272, DOI 10.1519/JSC.0b013e3181b3e182; Kyriazis T, 2010, INT J SPORT PHYSIOL, V5, P417; Legaz-Arrese A, 2011, J STRENGTH COND RES, V25, P819, DOI 10.1519/JSC.0b013e3181c1fa71; Marcovic G, 2007, J Sports Med Phys Fitness, V47, P276; Markstrom JL, 2013, J STRENGTH COND RES, V27, P944, DOI 10.1519/JSC.0b013e318260edad; Mero A, 1981, SCAND J SPORTS SCI, V3, P16; Mikola M., 2007, ACTA AXADEMIAE OLYMP, V15, P9; Nakamura N., 1984, JAPANESE J SPORTS SC, V3, P834; RUSKO H, 1993, EUR J APPL PHYSIOL O, V66, P97, DOI 10.1007/BF01427048; Spiriev B, 2011, IAAF SCORING TABLES; Stockbrugger BA, 2001, J STRENGTH COND RES, V15, P431; Stockbrugger BA, 2003, J STRENGTH COND RES, V17, P768; Terzis G, 2012, INT J SPORT PHYSIOL, V7, P394; Visnapuu M, 2009, PERCEPT MOTOR SKILL, V108, P670, DOI 10.2466/PMS.108.3.670-676; YOUNG W, 1995, J SPORT MED PHYS FIT, V35, P13	34	0	0	MULTI-SCIENCE PUBL CO LTD	BRENTWOOD	5 WATES WAY, BRENTWOOD CM15 9TB, ESSEX, ENGLAND	1747-9541			INT J SPORTS SCI COA	Int. J. Sports Sci. Sci. Coach.	FEB	2015	10	1					133	144				12	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Sciences - Other Topics; Psychology	CG7IC	WOS:000353475300011		
J	Garg, M; Okamoto, R; Nagata, Y; Kanojia, D; Venkatesan, S; Anand, MT; Braunstein, GD; Said, JW; Doan, NB; Ho, Q; Akagi, T; Gery, S; Liu, LZ; Tan, KT; Chng, WJ; Yang, H; Ogawa, S; Koeffler, HP				Garg, Manoj; Okamoto, Ryoko; Nagata, Yasunobu; Kanojia, Deepika; Venkatesan, Subhashree; Anand, M. T.; Braunstein, Glenn D.; Said, Jonathan W.; Doan, Ngan B.; Quoc Ho; Akagi, Tadayuki; Gery, Sigal; Liu, Li-zhen; Tan, Kar Tong; Chng, Wee Joo; Yang, Henry; Ogawa, Seishi; Koeffler, H. Phillip			Establishment and Characterization of Novel Human Primary and Metastatic Anaplastic Thyroid Cancer Cell Lines and Their Genomic Evolution Over a Year as a Primagraft	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							CARCINOMA; MUTATIONS; LEUKEMIA; GROWTH; GENE; MICROARRAY; DROSOPHILA; MIGRATION; INVASION; POLARITY	Context: Anaplastic thyroid cancer (ATC) has no effective treatment, resulting in a high rate of mortality. We established cell lines from a primary ATC and its lymph node metastasis, and investigated the molecular factors and genomic changes associated with tumor growth. Objective: The aim of the study was to understand the molecular and genomic changes of highly aggressive ATC and its clonal evolution to develop rational therapies. Design: We established unique cell lines from primary (OGK-P) and metastatic (OGK-M) ATC specimen, as well as primagraft from the metastatic ATC, which was serially xeno-transplanted for more than 1 year in NOD scid gamma mice were established. These cell lines and primagraft were used as tools to examine gene expression, copy number changes, and somatic mutations using RNA array, SNP Chip, and whole exome sequencing. Results: Mice carrying sc (OGK-P and OGK-M) tumors developed splenomegaly and neutrophilia with high expression of cytokines including CSF1, CSF2, CSF3, IL-1 beta, and IL-6. Levels of HIF-1 alpha and its targeted genes were also elevated in these tumors. The treatment of tumor carrying mice with Bevacizumab effectively decreased tumor growth, macrophage infiltration, and peripheral WBCs. SNP chip analysis showed homozygous deletion of exons 3-22 of the PARD3 genein the cells. Forced expression of PARD3 decreased cell proliferation, motility, and invasiveness, restores cell-cell contacts and enhanced cell adhesion. Next generation exome sequencing identified the somatic changes present in the primary, metastatic, and primagraft tumors demonstrating evolution of the mutational signature over the year of passage in vivo. Conclusion: To our knowledge, we established the first paired human primary and metastatic ATC cell lines offering unique possibilities for comparative functional investigations in vitro and in vivo. Our exome sequencing also identified novel mutations, as well as clonal evolution in both the metastasis and primagraft.	[Garg, Manoj; Kanojia, Deepika; Venkatesan, Subhashree; Anand, M. T.; Liu, Li-zhen; Tan, Kar Tong; Chng, Wee Joo; Yang, Henry; Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst CSI Singapore, Singapore 117599, Singapore; [Okamoto, Ryoko; Quoc Ho; Akagi, Tadayuki; Gery, Sigal; Koeffler, H. Phillip] Cedars Sinai Med Ctr, Div Hematol Oncol, Los Angeles, CA 90048 USA; [Nagata, Yasunobu; Ogawa, Seishi] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Braunstein, Glenn D.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Said, Jonathan W.; Doan, Ngan B.] David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Koeffler, H. Phillip] Natl Univ Singapore Hosp, Natl Univ Canc Inst, Singapore 117599, Singapore	Garg, M (reprint author), Natl Univ Singapore, Canc Sci Inst CSI Singapore, 14 Med Dr, Singapore 117599, Singapore.	csimg@nus.edu.sg	Akagi, Tadayuki/E-1078-2011		Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award; NIH [2R01CA026038-35]; Thyroid Centre of Excellence, Cedars Sinai Medical Center	This work was funded by the Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award to H. Phillip Koeffler (National Research Foundation Singapore and the Singapore Ministry of Education under the Research Centres of Excellence initiative) and NIH Grant No. 2R01CA026038-35. Generous support also comes from the Thyroid Centre of Excellence, Cedars Sinai Medical Center.	Garg M, 2009, J CLIN ENDOCR METAB, V94, P4613, DOI 10.1210/jc.2009-0703; Borgstrom P, 1996, CANCER RES, V56, P4032; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Rothenberg SM, 2010, CANCER RES, V70, P2158, DOI 10.1158/0008-5472.CAN-09-3458; Smallridge RC, 2012, THYROID, V22, P1104, DOI 10.1089/thy.2012.0302; Bishop JA, 2011, HUM PATHOL, V42, P1873, DOI 10.1016/j.humpath.2011.02.004; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Duncavage EJ, 2011, J MOL DIAGN, V13, P325, DOI 10.1016/j.jmoldx.2011.01.006; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Okamoto R, 2010, HAEMATOL-HEMATOL J, V95, P1481, DOI 10.3324/haematol.2009.011114; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Chua SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl024; Neff RL, 2008, ENDOCRIN METAB CLIN, V37, P525, DOI 10.1016/j.ecl.2008.02.003; Rodrigues RF, 2007, BRIT J CANCER, V96, P1237, DOI 10.1038/sj.bjc.6603578; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; O'Neill JP, 2013, ORAL ONCOL, V49, P702, DOI 10.1016/j.oraloncology.2013.03.440; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; De Lellis R, 2004, WHO CLASSIFICATION T, V8, P49; Garg M, 2008, CANCER RES, V68, P8240, DOI 10.1158/0008-5472.CAN-08-1708; Garg M, 2014, J CLIN ENDOCR METAB, V99, pE62, DOI 10.1210/jc.2013-2994; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hayano T, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-17; Hebrant A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037807; HOANGVU C, 1992, EXP CLIN ENDOCRINOL, V100, P51; Lee JJ, 2007, THYROID, V17, P289, DOI 10.1089/thy.2006.0246; Paolini R, 1997, TUMORI, V83, P779; Ryder M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054302	32	3	3	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	FEB	2015	100	2					725	735		10.1210/jc.2014-2359		11	Endocrinology & Metabolism	Endocrinology & Metabolism	CG5RF	WOS:000353350900080		
J	Olney, RC; Prickett, TCR; Espiner, EA; Mackenzie, WG; Duker, AL; Ditro, C; Zabel, B; Hasegawa, T; Kitoh, H; Aylsworth, AS; Bober, MB				Olney, Robert C.; Prickett, Timothy C. R.; Espiner, Eric A.; Mackenzie, William G.; Duker, Angela L.; Ditro, Colleen; Zabel, Bernhard; Hasegawa, Tomonobu; Kitoh, Hiroshi; Aylsworth, Arthur S.; Bober, Michael B.			C-Type Natriuretic Peptide Plasma Levels Are Elevated in Subjects With Achondroplasia, Hypochondroplasia, and Thanatophoric Dysplasia	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR RECEPTOR-3; MUTATIONS; DOMAIN; CHONDROCYTES; PATHWAY	Context: C-type natriuretic peptide (CNP) is a crucial regulator of endochondral bone growth. In a previous report of a child with acromesomelic dysplasia, Maroteaux type (AMDM), caused by loss-of-function of the CNP receptor (natriuretic peptide receptor-B [NPR-B]), plasma levels of CNP were elevated. In vitro studies have shown that activation of the MAPK kinase (MEK)/ERK MAPK pathway causes functional inhibition of NPR-B. Achondroplasia, hypochondroplasia, and thanatophoric dysplasia are syndromes of short-limbed dwarfism caused by activating mutations of fibroblast growth factor receptor-3, which result in overactivation of the MEK/ERKMAPK pathway. Objective: The purpose of this study was to determine whether these syndromes exhibit evidence of CNP resistance as reflected by increases in plasma CNP and its amino-terminal propeptide (NTproCNP). Design: This was a prospective, observational study. Subjects: Participants were 63 children and 20 adults with achondroplasia, 6 children with hypochondroplasia, 2 children with thanatophoric dysplasia, and 4 children and 1 adult with AMDM. Results: Plasma levels of CNP and NTproCNP were higher in children with achondroplasia with CNP SD scores (SDSs) of 1.0 (0.3-1.4) (median [interquartile range]) and NTproCNP SDSs of 1.4 (0.4 -1.8; P < .0005). NTproCNP levels correlated with height velocity. Levels were also elevated in adults with achondroplasia (CNP SDSs of 1.5 [0.7-2.1] and NTproCNP SDSs of 0.5 [0.1-1.0], P < .005). In children with hypochondroplasia, CNP SDSs were 1.3 (0.7-1.5) (P < .08) and NTproCNP SDSs were 1.9 (1.82.3) (P < .05). In children with AMDM, CNP SDSs were 1.6 (1.4-3.3) and NTproCNP SDSs were 4.2 (2.7-6.2) (P < .01). Conclusions: In these skeletal dysplasias, elevated plasma levels of proCNP products suggest the presence of tissue resistance to CNP.	[Olney, Robert C.] Nemours Childrens Clin, Jacksonville, FL 32207 USA; [Prickett, Timothy C. R.; Espiner, Eric A.] Univ Otago, Christchurch 8011, New Zealand; [Mackenzie, William G.; Duker, Angela L.; Ditro, Colleen; Bober, Michael B.] Nemours Alfred I duPont Hosp Children, Wilmington, DE 19803 USA; [Zabel, Bernhard] Univ Hosp Freiburg, D-79106 Freiburg, Germany; [Hasegawa, Tomonobu] Keio Univ, Sch Med, Tokyo 1088345, Japan; [Kitoh, Hiroshi] Nagoya Univ, Sch Med, Nagoya, Aichi 4648601, Japan; [Aylsworth, Arthur S.] Univ N Carolina, Chapel Hill, NC 27599 USA	Olney, RC (reprint author), Nemours Childrens Clin, Jacksonville, FL 32207 USA.	rolney@nemours.org		Bober, Michael/0000-0002-6178-1264	Nemours	This work was supported by developmental funds from Nemours.	Krejci P, 2005, J CELL SCI, V118, P5089, DOI 10.1242/jcs.02618; Palmer SC, 2009, HYPERTENSION, V54, P612, DOI 10.1161/HYPERTENSIONAHA.109.135608; Hannema SE, 2013, J CLIN ENDOCR METAB, V98, pE1988, DOI [10.1210/jc.2013-2358, 10.1210/jc.20130358]; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Prickett TCR, 2013, CLIN ENDOCRINOL, V78, P783, DOI 10.1111/cen.12035; Hutchison MR, 2012, MOL ENDOCRINOL, V26, P1406, DOI 10.1210/me.2012-1063; BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Foldynova-Trantirkova S, 2012, HUM MUTAT, V33, P29, DOI 10.1002/humu.21636; HORTON WA, 1978, J PEDIATR-US, V93, P435; Hunter AGW, 1998, J MED GENET, V35, P705, DOI 10.1136/jmg.35.9.705; Miura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042180; National Center for Health Statistics, 2002, VITAL HLTH STAT, V11, P1; Olney RC, 2006, GROWTH HORM IGF RES, V16, pS6, DOI 10.1016/j.ghir.2006.03.016; Olney RC, 2012, CLIN ENDOCRINOL, V77, P416, DOI 10.1111/j.1365-2265.2012.04392.x; Ozasa A, 2005, BONE, V36, P1056, DOI 10.1016/j.bone.2005.03.006; Prickett TCR, 2012, HDB GROWTH GROWTH MO, V1, P2789	20	1	1	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	FEB	2015	100	2					E355	E359		10.1210/jc.2014-2814		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CG5RF	WOS:000353350900030		
J	Oryoji, D; Ueda, S; Yamamoto, K; Noh, JY; Okamura, K; Noda, M; Watanabe, N; Yoshihara, A; Ito, K; Sasazuki, T				Oryoji, Daisuke; Ueda, Sho; Yamamoto, Ken; Noh, Jaeduk Yoshimura; Okamura, Ken; Noda, Mitsuhiko; Watanabe, Natsuko; Yoshihara, Ai; Ito, Koichi; Sasazuki, Takehiko			Identification of a Hashimoto Thyroiditis Susceptibility Locus Via a Genome-wide Comparison With Graves' Disease	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							LYMPHOID TYROSINE PHOSPHATASE; CTLA-4 GENE POLYMORPHISM; AUTOIMMUNE HYPOTHYROIDISM; UNITED-KINGDOM; VAV FAMILY; T-CELLS; ASSOCIATION; POPULATION; RECEPTOR; REGION	Background: Hashimoto thyroiditis (HT) and Graves' disease (GD) share some immunological features. Determining the genetic basis that distinguishes HT from GD is key for a better understanding of the differences between these two related diseases. Aim: The aim of this study was to identify a non-HLA susceptibility locus that is specific to either HT or GD. Design: We performed a two-stagegenome-wide comparison between HT and GD in Japan. During the discovery stage, we performed a logistic regression analysis adjusting for sex using 727 413 single nucleotide polymorphisms (SNPs) for 265 HT and 261 GD patients. During the replication stage, 35 SNPs were analyzed for 181 HT and 286 GD cases. A combined meta-analysis was performed using the results from these two stages. An SNP showing a genome-wide significant level was further analyzed using 1363 healthy controls to determine the specificity of susceptibility. Results: A genome-wide direct comparison between HT and GD revealed an SNP at the VAV3 locus with genome-wide significant association signals (rs7537605: P-combined = 3.90 x 10(-8); odds ratio(combined =) 1.77; 95% confidence interval = 1.44-2.17). An association analysis using healthy controls showed that rs7537605 is significantly associated with HT (P = 1.24 x 10(-5); odds ratio = 1.60; 95% confidence interval = 1.30-1.97) but not with GD (P = .50), suggesting that the variant specifically affects susceptibility to HT. Conclusion: Agenome-wide direct comparison between HT and GD revealed an HT-specific variant within VAV3 in the Japanese. Considering physiological roles of VAV3, such as a guanine nucleotide exchange factor, our finding provides new insight into the molecular mechanism of HT.	[Oryoji, Daisuke; Ueda, Sho; Sasazuki, Takehiko] Kyushu Univ, Inst Adv Study, Higashi Ku, Fukuoka 8128582, Japan; [Yamamoto, Ken] Kurume Univ, Sch Med, Dept Med Chem, Kurume, Fukuoka 8300011, Japan; [Noh, Jaeduk Yoshimura; Watanabe, Natsuko; Yoshihara, Ai; Ito, Koichi] Ito Hosp, Shibuya Ku, Tokyo 1508308, Japan; [Ito, Koichi] Kyushu Univ, Grad Sch Med, Dept Med & Clin Sci, Higashi Ku, Fukuoka 8128582, Japan; [Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Dept Diabet Res, Shinjuku Ku, Tokyo 168655, Japan	Sasazuki, T (reprint author), Kyushu Univ, Inst Adv Study, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	sasazuki@bioreg.kyushu-u.ac.jp			Scientific Research on Innovative Areas, MEXT KAKENHI, in Japan [22133003, 22133009]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, MEXT KAKENHI Grants 22133003 and 22133009, in Japan.	Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Kotsa K, 1997, CLIN ENDOCRINOL, V46, P551, DOI 10.1046/j.1365-2265.1997.1710996.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Hiratani H, 2005, J CLIN ENDOCR METAB, V90, P2898, DOI 10.1210/jc.2004-2148; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Simmonds MJ, 2005, AM J HUM GENET, V76, P157, DOI 10.1086/426947; Tomer Y, 2010, THYROID, V20, P715, DOI 10.1089/thy.2010.1644; Brix TH, 2001, J CLIN ENDOCR METAB, V86, P930, DOI 10.1210/jc.86.2.930; Movilla N, 1999, MOL CELL BIOL, V19, P7870; YANAGAWA T, 1995, J CLIN ENDOCR METAB, V80, P41, DOI 10.1210/jc.80.1.41; Lambert AP, 2004, J CLIN ENDOCR METAB, V89, P4037, DOI 10.1210/jc.2003-032084; Shirasawa S, 2004, HUM MOL GENET, V13, P2221, DOI 10.1093/hmg/ddh245; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Donner H, 1997, J CLIN ENDOCR METAB, V82, P4130, DOI 10.1210/jc.82.12.4130; Einarsdottir E, 2003, EUR J HUM GENET, V11, P81, DOI 10.1038/sj.ejhg.5200903; Cooper JD, 2012, HUM MOL GENET, V21, P5202, DOI 10.1093/hmg/dds357; Dechairo BM, 2005, EUR J HUM GENET, V13, P1223, DOI 10.1038/sj.ejhg.5201485; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Ueda S, 2014, J CLIN ENDOCR METAB, V99, pE379, DOI 10.1210/jc.2013-2841; Barker JM, 2006, J CLIN ENDOCR METAB, V91, P1210, DOI 10.1210/jc.2005-1679; Gudmundsson J, 2012, NAT GENET, V44, P319, DOI 10.1038/ng.1046; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Fraser HI, 2010, J IMMUNOL, V184, P5075, DOI 10.4049/jimmunol.0903734; Furugaki K, 2004, J HUM GENET, V49, P166, DOI 10.1007/s10038-003-0120-5; Nithiyananthan R, 2002, THYROID, V12, P3, DOI 10.1089/105072502753451896; Carvajal-Gonzalez JM, 2009, MOL BIOL CELL, V20, P1715, DOI 10.1091/mbc.E08-05-0451; Chen QY, 1999, J CLIN ENDOCR METAB, V84, P3182, DOI 10.1210/jc.84.9.3182; Eriksson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034442; Gough SCL, 2007, CURR GENOMICS, V8, P453, DOI 10.2174/138920207783591690; Kwak SH, 2014, HUM MOL GENET, V23, P4433, DOI 10.1093/hmg/ddu145; Malhotra S, 2009, J BIOL CHEM, V284, P24088, DOI 10.1074/jbc.M109.014209; Pearce AC, 2004, J BIOL CHEM, V279, P53955, DOI 10.1074/jbc.M410355200; Simmonds MJ, 2011, BRIEF FUNCT GENOMICS, V10, P77, DOI 10.1093/bfgp/elq036; Sindrilaru A, 2009, BLOOD, V113, P5266, DOI 10.1182/blood-2008-07-166702; Vaidya B, 1999, HUM MOL GENET, V8, P1195, DOI 10.1093/hmg/8.7.1195; Zeitlin A, 2008, GENES IMMUN, V9, P358, DOI 10.1038/gene.2008.26	38	2	2	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	FEB	2015	100	2					E319	E324		10.1210/jc.2014-3431		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CG5RF	WOS:000353350900025		
J	Kinoshita, G; Sato, JJ; Meschersky, IG; Pishchulina, SL; Simakin, LV; Rozhnov, VV; Malyarchuk, BA; Derenko, MV; Denisova, GA; Frisman, LV; Kryukov, AP; Hosoda, T; Suzuki, H				Kinoshita, Gohta; Sato, Jun J.; Meschersky, Ilya G.; Pishchulina, Sofiko L.; Simakin, Leonid V.; Rozhnov, Vyacheslav V.; Malyarchuk, Boris A.; Derenko, Miroslava V.; Denisova, Galina A.; Frisman, Lyubov V.; Kryukov, Alexey P.; Hosoda, Tetsuji; Suzuki, Hitoshi			Colonization history of the sable Martes zibellina (Mammalia, Carnivora) on the marginal peninsula and islands of northeastern Eurasia	JOURNAL OF MAMMALOGY			English	Article						Hokkaido; mitochondrial DNA; Nd2; phylogeography; sable; Sakhalin	MITOCHONDRIAL-DNA VARIATION; BEAR URSUS-ARCTOS; RUSSIAN FAR-EAST; CYTOCHROME-B GENE; HARE LEPUS-TIMIDUS; COMPARATIVE PHYLOGEOGRAPHY; CONTROL REGION; PHYLOGENETIC-RELATIONSHIPS; CLIMATIC OSCILLATIONS; EVOLUTIONARY HISTORY	We examined the nucleotide sequences of the mitochondrial NADH dehydrogenase subunit 2 gene (976 base pairs) for 279 individuals of the sable Martes zibellina (Carnivora, Mustelidae), derived from diverse areas throughout the regions of the Ural Mountains to the Russian Far East on the Eurasian continent and the peripheral peninsula (Kamchatka) and islands (Sakhalin, Hokkaido, and southern Kurils). The demographic history of the sable and its migration history to the eastern peripheral peninsula and islands were inferred using phylogeographic approaches. The analyses confirmed the previously found major lineages for the examined sables and further identified novel sublineages. Our data also support that a lineage, which is endemic to the eastern marginal islands (Sakhalin, Hokkaido, and southern Kurils), was produced by the demographic expansion of an ancestral lineage in the Eurasian continent. The most recent common ancestor of the Sakhalin, Hokkaido, and southern Kuril sables was estimated to exist during the Late Pleistocene. We also determined that another lineage exists on Sakhalin and is shared by the Far East Primorsky population. Our results indicate multiple migration events onto Sakhalin from the continent and suggest the importance of the formation of several straits to the distribution of sable lineages. Meanwhile, Kamchatka is dominated by a sole lineage which would also have followed the demographic expansion on the Eurasian continent. The Russian Far East was indicated as the source area for lineage diversifications; in this region, genetic diversity was relatively high, which is consistent with previous studies.	[Kinoshita, Gohta; Suzuki, Hitoshi] Hokkaido Univ, Grad Sch Environm Earth Sci, Lab Ecol & Genet, Kita Ku, Sapporo, Hokkaido, Japan; [Sato, Jun J.] Fukuyama Univ, Fac Life Sci & Technol, Dept Biotechnol, Lab Anim Cell Technol, Fukuyama, Hiroshima 7290292, Japan; [Meschersky, Ilya G.; Pishchulina, Sofiko L.; Rozhnov, Vyacheslav V.] Russian Acad Sci, Severtsov Inst Ecol & Evolut, Moscow 119071, Russia; [Simakin, Leonid V.] Pechoro Ilychskii Biosphere Reserve, Yaksha 169436, Komi Republic, Russia; [Malyarchuk, Boris A.; Derenko, Miroslava V.; Denisova, Galina A.] Russian Acad Sci, Inst Biol Problems North, Genet Lab, Far East Branch, Magadan 685000, Russia; [Frisman, Lyubov V.] Russian Acad Sci, Far Eastern Branch, Inst Complex Anal Reg Problems, Birobidzhan 679016, Russia; [Kryukov, Alexey P.] Russian Acad Sci, Far East Branch, Inst Biol & Soil Sci, Lab Evolutionary Zool & Genet, Vladivostok 690022, Russia; [Hosoda, Tetsuji] Kansai Univ, Int Educ, Suita, Osaka 5650855, Japan	Kinoshita, G (reprint author), Hokkaido Univ, Grad Sch Environm Earth Sci, Lab Ecol & Genet, Kita Ku, N10W5, Sapporo, Hokkaido, Japan.	gohta_kinoshita@ees.hokudai.ac.jp	Suzuki, Hitoshi/F-8539-2012	Suzuki, Hitoshi/0000-0003-4426-385X	 [24005241]	We are grateful to N. A. Fadeev, A. R. Gruzdev, M. Hatanaka, H. Hirakawa, M. Kawabe, T. Kuwayama, K. Miyoshi, Y. Nishimura, K. Okazaki, O. V. Shpak, T. Sugimoto, and R. Takahashi for their help in collecting samples of the sables. We thank K. Anjo, K. Ishida, M. Nunome, K. Ogawa, and M. Tomozawa for valuable comments on this manuscript. This work was supported by the Grant-in-aid for Fellows of the Japan Society for the Promotion of Science (JSPS) to GK (24005241).	Aizawa M, 2009, J BIOGEOGR, V36, P996, DOI 10.1111/j.1365-2699.2008.02074.x; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Hope AG, 2010, J MAMMAL, V91, P1041, DOI 10.1644/09-MAMM-A-402.1; Yu L, 2006, GENETICA, V127, P65, DOI 10.1007/s10709-005-2482-4; Binney HA, 2009, QUATERNARY SCI REV, V28, P2445, DOI 10.1016/j.quascirev.2009.04.016; McKay BD, 2012, J BIOGEOGR, V39, P1134, DOI 10.1111/j.1365-2699.2011.02666.x; LI WH, 1977, GENETICS, V85, P331; Sato JJ, 2012, MOL PHYLOGENET EVOL, V63, P745, DOI 10.1016/j.ympev.2012.02.025; DOBSON M, 1994, MAMMAL REV, V24, P91, DOI 10.1111/j.1365-2907.1994.tb00137.x; Fedorov VB, 2008, MOL ECOL, V17, P598, DOI 10.1111/j.1365-294X.2007.03595.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Sakka H, 2010, BIOL J LINN SOC, V100, P797; Stebich M, 2009, GLOBAL PLANET CHANGE, V65, P56, DOI 10.1016/j.gloplacha.2008.10.010; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.2307/2410314; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Aizawa M, 2007, MOL ECOL, V16, P3393, DOI 10.1111/j.1365-294X.2007.03391.x; Fu YX, 1997, GENETICS, V147, P915; Fedorov VB, 2002, P ROY SOC B-BIOL SCI, V269, P2071, DOI 10.1098/rspb.2002.2126; Millien-Parra V, 1999, J BIOGEOGR, V26, P959, DOI 10.1046/j.1365-2699.1999.00346.x; Hewitt GM, 2004, PHILOS T ROY SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hirata D, 2013, MOL BIOL EVOL, V30, P1644, DOI 10.1093/molbev/mst077; Matsui M, 2008, MOL PHYLOGENET EVOL, V48, P84, DOI 10.1016/j.ympev.2008.04.010; TAJIMA F, 1989, GENETICS, V123, P585; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37; Kvist L, 2003, P ROY SOC B-BIOL SCI, V270, P1447, DOI 10.1098/rspb.2002.2321; Abbott RJ, 2003, MOL ECOL, V12, P299, DOI 10.1046/j.1365-294X.2003.01731.x; Polezhaeva MA, 2010, MOL ECOL, V19, P1239, DOI 10.1111/j.1365-294X.2010.04552.x; Serizawa K, 2002, BIOCHEM GENET, V40, P149, DOI 10.1023/A:1015841424598; Abramson Natalia I., 2012, Russian Journal of Theriology, V11, P137; Filatov DA, 2002, MOL ECOL NOTES, V2, P621, DOI 10.1046/j.1471-8286.2002.00313.x; Yu JN, 2012, ZOOL SCI, V29, P753, DOI 10.2108/zsj.29.753; Todisco V, 2012, J BIOGEOGR, V39, P1058, DOI 10.1111/j.1365-2699.2011.02675.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Kryukov A, 2012, ZOOL SCI, V29, P484, DOI 10.2108/zsj.29.484; Excoffier L, 2005, EVOL BIOINFORM, V1, P47; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Balmysheva N. P., 1999, RUSSIAN J GENETICS, V35, P1252; Balmysheva N. P., 1999, RUSSIAN J GENETICS, V35, P1681; Bannikova AA, 2010, BIOL J LINN SOC, V101, P721, DOI 10.1111/j.1095-8312.2010.01510.x; Davison J, 2011, QUATERNARY SCI REV, V30, P418, DOI 10.1016/j.quascirev.2010.11.023; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Goropashnaya AV, 2007, ANN ZOOL FENN, V44, P462; GROSSWALD MG, 1980, QUATERNARY RES, V13, P1, DOI 10.1016/0033-5894(80)90080-0; Grosswald MG, 1998, QUATERN INT, V45-6, P3, DOI 10.1016/S1040-6182(97)00002-5; Gus'kov VY, 2013, RUSS J GENET+, V49, P1213, DOI 10.1134/S1022795413110070; Harpending R. C., 1994, HUM BIOL, V66, P591; Hewitt G. M., 2000, NATURE, V405, P591; Hosoda Tetsuji, 1999, Mammal Study, V24, P25, DOI 10.3106/mammalstudy.24.25; Igarashi Y, 2011, QUATERN INT, V237, P24, DOI 10.1016/j.quaint.2011.01.005; Inoue T, 2010, MAMM STUDY, V35, P145, DOI 10.3106/041.035.0301; Inoue Takashi, 2007, Zoological Science (Tokyo), V24, P1178, DOI 10.2108/zsj.24.1178; Ishida K, 2013, ACTA THERIOL, V58, P13, DOI 10.1007/s13364-012-0103-z; Iwasa MA, 2000, ZOOL SCI, V17, P477, DOI 10.2108/0289-0003(2000)17[477:GPOCBA]2.0.CO;2; Iwasa MA, 2009, MAMM STUDY, V34, P123, DOI 10.3106/041.034.0301; Kawamura Yoshinari, 2007, Quaternary Research (Tokyo), V46, P171; Khatab IA, 2008, GENES GENET SYST, V83, P55, DOI 10.1266/ggs.83.55; Kinoshita G, 2012, ZOOL SCI, V29, P776, DOI 10.2108/zsj.29.776; Kito N, 2012, QUATERN INT, V254, P118, DOI 10.1016/j.quaint.2011.06.050; Koepfli Klaus-Peter, 2008, BMC Biology, V6, P1; Korsten M, 2009, MOL ECOL, V18, P1963, DOI 10.1111/j.1365-294X.2009.04163.x; Kvist L, 2001, J EVOLUTION BIOL, V14, P930, DOI 10.1046/j.1420-9101.2001.00354.x; Li B, 2013, ACTA THERIOL, V58, P139, DOI 10.1007/s13364-012-0100-2; Lister AM, 2004, PHILOS T R SOC B, V359, P221, DOI 10.1098/rstb.2003.1436; Malyarchuk B, 2013, MOL PHYLOGENET EVOL, V67, P348, DOI 10.1016/j.ympev.2013.02.004; Malyarchuk B. A., 2011, BIOL B REV, V1, P366; Malyarchuk BA, 2010, RUSS J GENET+, V46, P64, DOI 10.1134/S1022795410010102; Matsuhashi T, 2001, ZOOL SCI, V18, P1137, DOI 10.2108/zsj.18.1137; Matsuhashi T, 1999, MOL BIOL EVOL, V16, P676; Miyabe K., 1937, P IMPERIAL ACAD JAPA, V13, P24; Mokhova L, 2009, QUATERNARY SCI REV, V28, P2913, DOI 10.1016/j.quascirev.2009.07.018; Monakhov Vladimir G., 2011, Mammalian Species, P75, DOI 10.1644/876.1; Murakami T., 2009, WILD MAMMALS JAPAN, P196; Ohdachi SD, 2012, MAMM STUDY, V37, P281; Ohshima K., 1990, QUATERNARY RES, V29, P193, DOI DOI 10.4116/JAQUA.29.193; Ohshima K., 1991, J GEOGR, V100, P967; Ohshima K., 1992, CHISHITSU NEWS, V459, P40; Ono Y., 1990, QUATERNARY RES, V29, P183; Oshida T., 2005, MOL ECOL, V101, P219; Pavlenko MV, 1989, PRESENT DAY APPROACH, P61; Petrovskaya AV, 2007, RUSS J GENET+, V43, P424, DOI 10.1134/S1022795407040114; Position Information Database, 2010, HIGH PERF COMP SYST; Powell RA, 2012, BIOL CONSERVATION MA, P93; Poyarkov N. A., 2008, RUSSIAN J GENETICS, V44, P1089; Rambaut A., 2007, TRACER V1 4, V4; Rozhnov VV, 2013, RUSS J GENET+, V49, P220, DOI 10.1134/S1022795413020105; Rozhnov VV, 2010, RUSS J GENET+, V46, P488, DOI 10.1134/S1022795410040150; Sambrook J, 2001, MOL CLONING LAB MANU; Sato JJ, 2009, ZOOL SCI, V26, P457, DOI 10.2108/zsj.26.457; Sato Jun J., 2013, Animal Systematics Evolution and Diversity, V29, P99, DOI 10.5635/ASED.2013.29.2.99; Sato JJ, 2011, MAMM STUDY, V36, P209; Semerikov VL, 2007, RUSS J ECOL+, V38, P147, DOI 10.1134/S1067413607030010; Semerikova SA, 2011, J BIOGEOGR, V38, P326, DOI 10.1111/j.1365-2699.2010.02394.x; Tatewaki M, 1958, J FAC AGR HOKKAIDO U, V50, P371; Wolsan M, 2010, CLADISTICS, V26, P168, DOI 10.1111/j.1096-0031.2009.00281.x; Yamada F, 2002, GENES GENET SYST, V77, P107, DOI 10.1266/ggs.77.107	100	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-2372	1545-1542		J MAMMAL	J. Mammal.	FEB	2015	96	1					172	184		10.1093/jmammal/gyu021		13	Zoology	Zoology	CG5LV	WOS:000353334300021		
J	Rajendran, P; Rengarajan, T; Nandakumar, N; Divya, H; Nishigaki, I				Rajendran, Peramaiyan; Rengarajan, Thamaraiselvan; Nandakumar, Natarajan; Divya, H.; Nishigaki, Ikuo			Mangiferin in cancer chemoprevention and treatment: pharmacokinetics and molecular targets	JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION			English	Review						Cancer; chemoprevention; inflammation; mangiferin; polyphenol	INDUCED LUNG CARCINOGENESIS; CELL-CYCLE ARREST; INDICA L. EXTRACT; NATURALLY-OCCURRING GLUCOSYLXANTHONE; SWISS ALBINO MICE; FACTOR-KAPPA-B; BREAST-CANCER; MESENCHYMAL TRANSITION; POSTMENOPAUSAL WOMEN; ENDOTHELIAL FUNCTION	A variety of bioactive food components have been shown to modulate inflammatory responses and to attenuate carcinogenesis. Polyphenols isolated several years ago from various medicinal plants now seem to have a prominent role in the prevention and therapy of a variety of ailments. Mangiferin, a unique, important, and highly investigated polyphenol, has attracted much attention of late for its potential as a chemopreventive and chemotherapeutic agent against various types of cancer. Mangiferin has been shown to target multiple proinflammatory transcription factors, cell-cycle proteins, growth factors, kinases, cytokines, chemokines, adhesion molecules, and inflammatory enzymes. These targets can potentially mediate the chemopreventive and therapeutic effects of mangiferin by inhibiting the initiation, promotion, and metastasis of cancer. This review not only summarizes the diverse molecular targets of mangiferin, but also gives the results of various preclinical studies that have been performed in the last decade with this promising polyphenol.	[Rajendran, Peramaiyan; Rengarajan, Thamaraiselvan; Nishigaki, Ikuo] NPO Int Lab Biochem, Nakagawa Ku, Nagoya, Aichi 4540926, Japan; [Nandakumar, Natarajan] Ben Gurion Univ Negev, Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel; [Divya, H.] Univ Madras, Dept Biochem, Madras, Tamil Nadu, India	Nishigaki, I (reprint author), NPO Int Lab Biochem, Nakagawa Ku, 1-166 Uchide, Nagoya, Aichi 4540926, Japan.	nishigaki@se.starcat.ne.jp	Rajendran, Peramaiyan/I-3877-2012	Rajendran, Peramaiyan/0000-0001-6354-4388			Adami HO, 2002, TXB CANC EPIDEMIOLOG; Shanmugam MK, 2012, CANCER LETT, V320, P158, DOI 10.1016/j.canlet.2012.02.037; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Rajendran P, 2008, BASIC CLIN PHARMACOL, V103, P137, DOI 10.1111/j.1742-7843.2008.00254.x; Hodgson JM, 2006, J SCI FOOD AGR, V86, P2492, DOI 10.1002/jsfa.2675; Leiro J, 2004, INT IMMUNOPHARMACOL, V4, P763, DOI 10.1016/j.intimp.2004.03.002; Ludwig A, 2004, BIOCHEM BIOPH RES CO, V316, P659, DOI 10.1016/j.bbrc.2004.02.099; Sarkar A, 2004, J BIOL CHEM, V279, P33768, DOI 10.1074/jbc.M403424200; Rajendran P, 2008, BIOL PHARM BULL, V31, P1053, DOI 10.1248/bpb.31.1053; Rajendran P, 2008, ENVIRON TOXICOL PHAR, V26, P278, DOI 10.1016/j.etap.2008.05.005; Checkoway H, 2002, AM J EPIDEMIOL, V155, P732, DOI 10.1093/aje/155.8.732; Guha S, 1996, CHEMOTHERAPY, V42, P443; Schieber A, 2003, J AGR FOOD CHEM, V51, P5006, DOI 10.1021/jf030218f; Mantena SK, 2006, CARCINOGENESIS, V27, P1682, DOI 10.1093/carcin/bgl030; Das J, 2012, TOXICOL APPL PHARM, V260, P35, DOI 10.1016/j.taap.2012.01.015; RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649; Shanmugam MK, 2011, NUTR CANCER, V63, P161, DOI 10.1080/01635581.2011.523502; Bishayee A, 2011, FRONT BIOSCI-LANDMRK, V16, P980, DOI 10.2741/3730; Anila L, 2002, J ETHNOPHARMACOL, V79, P81, DOI 10.1016/S0378-8741(01)00361-0; Muruganandan S, 2002, TOXICOLOGY, V176, P165, DOI 10.1016/S0300-483X(02)00069-0; Joseph JA, 1999, J NEUROSCI, V19, P8114; Zern TL, 2005, J NUTR, V135, P1911; Hubbard GP, 2006, BRIT J NUTR, V96, P482, DOI 10.1079/BJN20061831; Johnson JJ, 2012, CARCINOGENESIS, V33, P413, DOI 10.1093/carcin/bgr291; Andreu GLP, 2005, ARCH BIOCHEM BIOPHYS, V439, P184, DOI 10.1016/j.abb.2005.05.015; Martinez G, 2000, PHYTOTHER RES, V14, P424, DOI 10.1002/1099-1573(200009)14:6<424::AID-PTR643>3.0.CO;2-8; Sanchez GM, 2000, PHARMACOL RES, V42, P565, DOI 10.1006/phrs.2000.0727; Li HZ, 2013, TOXICOL APPL PHARM, V272, P180, DOI 10.1016/j.taap.2013.05.011; Garcia-Rivera D, 2011, CANCER LETT, V305, P21, DOI 10.1016/j.canlet.2011.02.011; Piao M, 2006, ENDOTHELIUM-J ENDOTH, V13, P249, DOI 10.1080/10623320600903940; Manach C, 2004, AM J CLIN NUTR, V79, P727; Sethi G, 2012, BIOSCIENCE REP, V32, P1, DOI 10.1042/BSR20100136; SIDRANSKY D, 1992, NATURE, V355, P846, DOI 10.1038/355846a0; Yoshimi N, 2001, CANCER LETT, V163, P163, DOI 10.1016/S0304-3835(00)00678-9; Wang WQ, 2000, MOL CARCINOGEN, V28, P102; Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Middleton E, 2000, PHARMACOL REV, V52, P673; Schroeter H, 2001, BIOCHEM J, V358, P547, DOI 10.1042/0264-6021:3580547; Jeong YJ, 2005, BRIT J NUTR, V93, P581, DOI 10.1079/BJN20041397; Li JX, 2012, CANCER RES, V72, P260, DOI 10.1158/0008-5472.CAN-11-2596; THIBERVILLE L, 1995, CANCER RES, V55, P5133; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Califano J, 1996, CANCER RES, V56, P2488; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106; ARITOMI M, 1969, TETRAHEDRON LETT, P941; ARITOMI M, 1970, CHEM PHARM BULL, V18, P2224; Bairy Indira, 2002, Indian J Pathol Microbiol, V45, P307; Barathan M, 2013, CELL DEATH DIS, V27, pe697; BHATIA VK, 1968, TETRAHEDRON LETT, P1741; BHATIA VK, 1967, TETRAHEDRON, V23, P1363, DOI 10.1016/0040-4020(67)85090-7; Bikash Pal P, 2013, PLOS ONE, V2, P1; Cheng Peng, 2007, Zhong Yao Cai, V30, P306; DEVESA SS, 1995, J NATL CANCER I, V87, P175, DOI 10.1093/jnci/87.3.175; El Ansari MA, 1967, LEATHER SCI, V14, P247; ELSISSI HI, 1965, PLANTA MED, V13, P346; ELSISSI HI, 1966, PLANTA MED, V14, P171; Fabiani R, 2002, EUR J CANCER PREV, V11, P351, DOI 10.1097/00008469-200208000-00006; Fadzelly M, 2010, FOOD CHEM TOXI, V48, P1688; FRAHM AW, 1979, TETRAHEDRON, V35, P2035, DOI 10.1016/S0040-4020(01)88974-2; Fuhrman B, 2005, J NUTR, V135, P722; Garcia D, 2003, PHYTOTHER RES, V17, P1203, DOI 10.1002/ptr.1343; Ghosal S, 1971, PHYTOCHEMISTRY, V10, P2425; Ghosh M, 2002, FREE RADICAL RES, V46, P116; Gomez-Zaleta B, 2006, SPECTROCHIM ACTA A, V64, P1002, DOI 10.1016/j.saa.2005.09.009; Hallund J, 2006, BRIT J NUTR, V95, P1120, DOI 10.1079/BJN20061734; Haynes LJ, 1966, J CHEM SOC C, V1, P1685; HERATH P, 1970, PHYTOCHEMISTRY, V9, P1141, DOI 10.1016/S0031-9422(00)85240-1; Ho CK, 2002, PLANTA MED, V68, P975, DOI 10.1055/s-2002-35668; Hou SY, 2012, FOOD CHEM, V132, P289, DOI 10.1016/j.foodchem.2011.10.079; Hu XY, 2013, MED CHEM, V9, P1058; Huang H, 2002, CHIN J DIGEST, P06; Huayi H, 2002, CHI J DIGES, V6, P341; Kant singh S, 2009, BADANIA FITOCHEMICZN, V5, P126; Kelloff GJ, 2000, J NUTR, V130, P467; KISHIMOTO Y, 1995, J NATL CANCER I, V87, P1224, DOI 10.1093/jnci/87.16.1224; Li G, 2013, FRONT IMMUNOL, V4, P1; Li GB, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00080; Li JX, 2012, J CANCER RES THER, V8, P561, DOI 10.4103/0973-1482.106537; Makare N, 2001, J ETHNOPHARMACOL, V78, P133, DOI 10.1016/S0378-8741(01)00326-9; Mao MP, 1966, SCIENCE, V271, P659; NOTT PE, 1967, PHYTOCHEMISTRY, V6, P741, DOI 10.1016/S0031-9422(00)86015-X; Oliveria SA, 1997, P SOC EXP BIOL MED, V216, P142; Peng Zhi-Gang, 2004, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V12, P590; Plessis-Stoman DD, 2011, AFR J TRADIT COMPLEM, V8, P177; PROX A, 1968, TETRAHEDRON, V24, P3697, DOI 10.1016/S0040-4020(01)92002-2; Rajendran P, 2008, NAT PROD RES, V22, P672, DOI 10.1080/14786410701824973; Peramaiyan Rajendran, 2008, Asian Journal of Biochemistry, V3, P118; Rajendran Peramaiyan, 2013, Int J Biomed Sci, V9, P68; Ramanathan JD, 1969, CURR SCI, V29, P131; Rivera DG, 2011, J PHARM PHARMACOL, V63, P1336, DOI 10.1111/j.2042-7158.2011.01328.x; Roh T, 2012, TOXICOL LETT, V208, P232, DOI 10.1016/j.toxlet.2011.11.013; ROSIN MP, 1995, CANCER RES, V55, P5213; Sairam K, 2003, J ETHNOPHARMACOL, V84, P11, DOI 10.1016/S0378-8741(02)00250-7; SALEH NAM, 1975, PLANTA MED, V28, P124; Rao BSS, 2009, FOOD CHEM TOXICOL, V47, P592, DOI 10.1016/j.fct.2008.12.017; Severi JA, 2009, MOLECULES, V14, P1098, DOI 10.3390/molecules14031098; Shoji K, 2011, ARCH PHARM RES, V34, P469, DOI 10.1007/s12272-011-0316-8; Souza JRR, 2012, CYTOTOXICITY SCREEN; TANAKA T, 1984, CHEM PHARM BULL, V32, P2676; WHO Globacon, 2008, IARC 2010 NONC DIS A; Yao Yi-Bin, 2010, Zhong Yao Cai, V33, P81; Zhen L, 2013, J SIC U NATURAL SCI, V50, P159; Zhi-Gang P, 2007, CHINE TRAD HERB DRUG	107	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1079-9893	1532-4281		J RECEPT SIG TRANSD	J. Recept. Signal Transduct.	FEB	2015	35	1					76	84		10.3109/10799893.2014.931431		9	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CG5PM	WOS:000353345100010		
J	Di Sante, G; Wang, LP; Wang, CG; Jiao, XM; Casimiro, MC; Chen, K; Pestell, TG; Yaman, I; Di Rocco, A; Sun, X; Horio, Y; Powell, MJ; He, XH; McBurney, MW; Pestell, RG				Di Sante, Gabriele; Wang, Liping; Wang, Chenguang; Jiao, Xuanmiao; Casimiro, Mathew C.; Chen, Ke; Pestell, Timothy G.; Yaman, Ismail; Di Rocco, Agnese; Sun, Xin; Horio, Yoshiyuki; Powell, Michael J.; He, Xiaohong; McBurney, Michael W.; Pestell, Richard G.			Sirt1-Deficient Mice Have Hypogonadotropic Hypogonadism due to Defective GnRH Neuronal Migration	MOLECULAR ENDOCRINOLOGY			English	Article							GONADOTROPIN-RELEASING-HORMONE; HISTONE DEACETYLASE; CELL MOTILITY; CYCLIN D1; SIRT1 DEACETYLASE; MALE-FERTILITY; IN-VIVO; C-JUN; CORTACTIN; ACETYLATION	Hypogonadatropic hypogonadism (HH) can be acquired through energy restriction or may be inherited as congenital hypogonadotropic hypogonadism and its anosmia-associated form, Kallmann's syndrome. Congenital hypogonadotropic hypogonadism is associated with mutations in a group of genes that impact fibroblast growth factor 8 (FGF8) function. The Sirt1 gene encodes a nicotinamide adenine dinucleotide-dependent histone deacetylase that links intracellular metabolic stress to gene expression. Herein Sirt1(-/-) mice are shown to have HH due to failed GnRH neuronal migration. Sirtuin-1 (Sirt1) catalytic function induces GnRH neuronal migration via binding and deacetylating cortactin. Sirt1 colocalized with cortactin in GnRH neurons in vitro. Sirt1 colocalization with cortactin was regulated in an FGF8/ fibroblast growth factor receptor-1 dependent manner. The profound effect of Sirt1 on the hormonal status of Sirt1(-/-) mice, mediated via defective GnRH neuronal migration, links energy metabolism directly to the hypogonadal state. Sirt1-cortactin may serve as the distal transducer of neuronal migration mediated by the FGF8 synexpression group of genes that govern HH.	[Di Sante, Gabriele; Wang, Liping; Wang, Chenguang; Jiao, Xuanmiao; Casimiro, Mathew C.; Chen, Ke; Pestell, Timothy G.; Yaman, Ismail; Sun, Xin; Powell, Michael J.; Pestell, Richard G.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Di Sante, Gabriele; Wang, Liping; Wang, Chenguang; Jiao, Xuanmiao; Casimiro, Mathew C.; Chen, Ke; Pestell, Timothy G.; Yaman, Ismail; Sun, Xin; Powell, Michael J.] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Di Rocco, Agnese] Childrens Hosp, Translat Res Program Pediat Orthoped, Philadelphia Res Inst, Philadelphia, PA 19104 USA; [Horio, Yoshiyuki] Sapporo Med Univ, Dept Pharmacol, Sapporo, Hokkaido 0608556, Japan; [He, Xiaohong; McBurney, Michael W.] Univ Ottawa, Ottawa Hlth Res Inst, Dept Med & Biochem, Ottawa, ON K1Y 4E9, Canada; [He, Xiaohong; McBurney, Michael W.] Univ Ottawa, Ottawa Hlth Res Inst, Dept Microbiol & Immunol, Ottawa, ON K1Y 4E9, Canada	Pestell, RG (reprint author), Thomas Jefferson Univ, Dept Canc Biol, Sidney Kimmel Canc Ctr, 233 South 10th St, Philadelphia, PA 19107 USA.	richard.pestell@jefferson.edu			National Institutes of Health [R01CA70896, R01CA75503, R01CA86072]; Department of Defense Concept Award [W81XWH-1101-0303]; National Institutes of Health Cancer Center Core Grant [P30CA56036]; Dr Ralph and Marian C. Falk Medical Research Trust; Pennsylvania Department of Health; American-Italian Cancer Foundation Postdoctoral Research Fellowship	This work was supported in part by Grants R01CA70896, R01CA75503, and R01CA86072 (to R.G.P.) from the National Institutes of Health and the Department of Defense Concept Award W81XWH-1101-0303. The Sidney Kimmel Cancer Center was supported by the National Institutes of Health Cancer Center Core Grant P30CA56036 (to R.G.P). This project was also supported in part from the Dr Ralph and Marian C. Falk Medical Research Trust (to R.G.P.), grants from the Pennsylvania Department of Health (to R.G.P. and C.W.), and an American-Italian Cancer Foundation Postdoctoral Research Fellowship (to G.D.).	Akieda-Asai S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011755; Miraoui H, 2013, AM J HUM GENET, V92, P725, DOI 10.1016/j.ajhg.2013.04.008; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Byles V, 2012, ONCOGENE, V31, P4619, DOI 10.1038/onc.2011.612; Kong SY, 2012, IMMUNOL CELL BIOL, V90, P6, DOI 10.1038/icb.2011.102; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Hasegawa K, 2008, J NEUROSCI, V28, P8772, DOI 10.1523/JNEUROSCI.3052-08.2008; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Oliveira LMB, 2001, J CLIN ENDOCR METAB, V86, P1532, DOI 10.1210/jc.86.4.1532; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Zhang Y, 2009, ONCOGENE, V28, P445, DOI 10.1038/onc.2008.388; Ramadori G, 2011, CELL METAB, V14, P301, DOI 10.1016/j.cmet.2011.06.014; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Catarino T, 2013, J CELL SCI, V126, P149, DOI 10.1242/jcs.110742; KENDALL SK, 1995, GENE DEV, V9, P2007, DOI 10.1101/gad.9.16.2007; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Caronia LM, 2011, NEW ENGL J MED, V364, P215, DOI 10.1056/NEJMoa0911064; Sakamoto J, 2004, FEBS LETT, V556, P281, DOI 10.1016/S0014-5793(03)01444-3; Jiao XM, 2010, J BIOL CHEM, V285, P8218, DOI 10.1074/jbc.M110.100792; Nakane K, 2012, INT J UROL, V19, P71, DOI 10.1111/j.1442-2042.2011.02888.x; Falardeau J, 2008, J CLIN INVEST, V118, P2822, DOI 10.1172/JCI34538; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Tornberg J, 2011, P NATL ACAD SCI USA, V108, P11524, DOI 10.1073/pnas.1102284108; Liu MR, 2009, AM J PATHOL, V174, P1910, DOI 10.2353/ajpath.2009.080706; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Cariboni A, 2011, HUM MOL GENET, V20, P336, DOI 10.1093/hmg/ddq468; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Tucker KR, 2012, PHYSIOL BEHAV, V107, P424, DOI 10.1016/j.physbeh.2012.09.007; Wierman ME, 2011, FRONT NEUROENDOCRIN, V32, P43, DOI 10.1016/j.yfrne.2010.07.005; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Cariboni A, 2012, DEVELOPMENT, V139, P3326, DOI 10.1242/dev.079418; Cariboni A, 2005, DEVELOPMENT, V132, P4709, DOI 10.1242/dev.02033; Casimiro MC, 2012, J CLIN INVEST, V122, P833, DOI 10.1172/JCI60256; Chandrashekar V, 1999, ENDOCRINOLOGY, V140, P1082, DOI 10.1210/en.140.3.1082; Choi RY, 2011, INVEST OPHTH VIS SCI, V52, P364, DOI 10.1167/iovs.10-5347; Codocedo JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047073; Constantin S, 2011, J NEUROENDOCRINOL, V23, P542, DOI 10.1111/j.1365-2826.2011.02130.x; Janowski E, 2011, INT J BIOCHEM CELL B, V43, P1104, DOI 10.1016/j.biocel.2011.03.011; Kolthur-Seetharam U, 2009, BIOL REPROD, V80, P384, DOI 10.1095/biolreprod.108.070193; MELLON D, 1990, J COMP NEUROL, V296, P253, DOI 10.1002/cne.902960205; Meng H, 2011, CELL CYCLE, V10, P73, DOI 10.4161/cc.10.1.14243; RADOVICK S, 1991, P NATL ACAD SCI USA, V88, P3402, DOI 10.1073/pnas.88.8.3402; Seifert EL, 2012, FASEB J, V26, P555, DOI 10.1096/fj.11-193979; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Whittle JR, 2007, TRENDS ENDOCRIN MET, V18, P356, DOI 10.1016/j.tem.2007.07.007; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	50	0	1	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0888-8809			MOL ENDOCRINOL	Mol. Endocrinol.	FEB	2015	29	2					200	212		10.1210/me.2014-1228		13	Endocrinology & Metabolism	Endocrinology & Metabolism	CG4XD	WOS:000353291200005		
J	Liu, K; Orimoto, Y; Aoki, Y				Liu, Kai; Orimoto, Yuuichi; Aoki, Yuriko			Theoretical investigation of the pressure-induced insulator-to-metal-to-insulator transitions in one-dimensional bis(dimethylglyoximato) platinum(II), Pt(dmg)(2)	POLYHEDRON			English	Article						Pt(dmg)(2) system; Pressure-induced conductivity transition; DFT calculations; Natural charge analysis; Intra-molecular charge transfer (MLCT)	NONLINEAR-OPTICAL PROPERTIES; ULTRAFAST RELAXATION PROCESSES; RELAXED EXCITED-STATE; ELECTRONIC-STRUCTURE; MOTT-HUBBARD; BAND THEORY; COMPLEXES; DIMETHYLGLYOXIME; SPECTRA; VO2	The electrical resistivity of one-dimensional bis(dimethylglyoximato) platinum(II). Pt(dmg)(2), exhibits unexpected insulator-to-metal-to-insulator (I-M-I) transitions under the high pressure. The interesting but complicated nature of these pressure-induced I-M-I transitions is approached by the density functional theory calculations on a kind of stacking model. After optimization of one monomer, a set of stacking models with different intermolecular distances (metal-metal bond) are built from 8 units of monomers to simulate the various stages during pressure increasing in experiment. As the metal-metal bond lengths decrease, the calculated HOMO and LUMO energy gaps become narrow and reach the minimum value (0.27 eV) when the metal-metal bond length is 2.4 angstrom. If the metal-metal bond length is continually decreased for simulating even higher pressure, the energy gaps were found to be enlarged again, at the same time, the natural charge analysis of the models shows the intra-molecular charges transfer from Pt atom to N atoms rather than the inter-molecular one. The entire energy gap change of these stacking model systems is well consistent with the electrical resistivity change in experiment. This similar tendency also indicates that the change of metal-metal bond length and the following unique charge transfer may be the main reason to the pressure-induced I-M-I transitions of Pt(dmg)(2) complexes. (C) 2014 Elsevier Ltd. All rights reserved.	[Liu, Kai; Orimoto, Yuuichi; Aoki, Yuriko] Kyushu Univ, Fac Engn Sci, Dept Mat Sci, Kasuga, Fukuoka 8168580, Japan; [Aoki, Yuriko] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Aoki, Y (reprint author), Kyushu Univ, Fac Engn Sci, Dept Mat Sci, Kasuga, Fukuoka 8168580, Japan.	aoki.yuriko.397@m.kyushu-u.ac.jp			Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japan Society for the Promotion of Science (JSPS); Group, PRESTO	The calculations were mainly performed on the linux clusters of our laboratory provided by JST-CREST and also sometimes by the high performance computing system in Research Institute for Information Technology at Kyushu University. Besides JST-CREST, this work was partly supported by Group, PRESTO, Japan Science and Technology Agency (JST), a Grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan and the Japan Society for the Promotion of Science (JSPS).	Anderson B.M., 2009, EUR J INORG CHEM, V21, P3041; RICE TM, 1994, PHYS REV LETT, V73, P3042, DOI 10.1103/PhysRevLett.73.3042; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Gilbert DA, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4799651; HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI 10.1063/1.448975; IWASA Y, 1991, APPL PHYS LETT, V59, P2219, DOI 10.1063/1.106075; Ma YM, 2009, NATURE, V458, P182, DOI 10.1038/nature07786; Wysokinski R, 2006, J MOL STRUC-THEOCHEM, V758, P169, DOI 10.1016/j.theochem.2005.10.032; Savage N, 2012, NATURE, V483, pS30, DOI 10.1038/483S30a; Wysokinski R, 2001, J COMPUT CHEM, V22, P901, DOI 10.1002/jcc.1053; Gatti M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.216404; Adamo C, 1998, J CHEM PHYS, V108, P664, DOI 10.1063/1.475428; Eyert V, 2002, ANN PHYS-BERLIN, V11, P650, DOI 10.1002/1521-3889(200210)11:9<650::AID-ANDP650>3.0.CO;2-K; Chen AC, 2010, CHEM REV, V110, P3767, DOI 10.1021/cr9003902; EHLERS AW, 1993, CHEM PHYS LETT, V208, P111, DOI 10.1016/0009-2614(93)80086-5; Yamamoto K, 1998, ADV MATER, V10, P1018, DOI 10.1002/(SICI)1521-4095(199809)10:13<1018::AID-ADMA1018>3.3.CO;2-I; WENTZCOVITCH RM, 1994, PHYS REV LETT, V72, P3389, DOI 10.1103/PhysRevLett.72.3389; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Aetukuri NB, 2013, NAT PHYS, V9, P661, DOI 10.1038/NPHYS2733; Biermann S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026404; DIBELLA S, 1988, INORG CHEM, V27, P3993, DOI 10.1021/ic00295a020; Eyert V, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.016401; Frisch M J, 2010, GAUSSIAN 09 REVISION; Glendening ED, 2011, NBO 5 9; Hara Y., 1978, B CHEM SOC JPN, V51, P1982; HUSSAIN MS, 1979, ACTA CRYSTALLOGR B, V35, P628; Iwai S, 1999, J CHEM PHYS, V110, P8687, DOI 10.1063/1.478776; Iwai S, 1998, J LUMIN, V76-7, P226, DOI 10.1016/S0022-2313(97)00206-8; Iwai S, 1999, J CHEM PHYS, V111, P5402, DOI 10.1063/1.479800; IWAI S, 1998, ULTRAFAST PHENOME 11, V63, P502; Kamata T., 1993, J PHYS CHEM-US, V99, P13239; KAMATA T, 1994, CHEM PHYS LETT, V221, P194, DOI 10.1016/0009-2614(94)00268-1; KAMATA T, 1994, APPL PHYS LETT, V65, P1343, DOI 10.1063/1.112046; Kodzasa T, 1997, J SOL-GEL SCI TECHN, V8, P1029; KONNO M, 1989, ACTA CRYSTALLOGR B, V45, P142, DOI 10.1107/S0108768188012285; Kovacs A, 2007, J ORGANOMET CHEM, V692, P5383, DOI 10.1016/j.jorganchem.2007.08.024; OHASHI Y, 1970, INORG CHEM, V9, P2551; SHIROTANI I, 1981, J SOLID STATE CHEM, V40, P180, DOI 10.1016/0022-4596(81)90379-0; SHIROTANI I, 1988, CHEM PHYS LETT, V147, P231, DOI 10.1016/0009-2614(88)85090-5; SHIROTANI I, 1986, SOLID STATE COMMUN, V59, P533, DOI 10.1016/0038-1098(86)90052-9; Takeda K., 2000, CHEM MATER, V12, P912; VanKeuren E, 1997, SYNTHETIC MET, V86, P2149, DOI 10.1016/S0379-6779(97)81070-3; Yamamoto K, 1998, CHEM MATER, V10, P1343, DOI 10.1021/cm9707317; Yamamoto K, 1999, CHEM PHYS LETT, V302, P609, DOI 10.1016/S0009-2614(99)00151-7; ZAHNER JC, 1960, J CHEM PHYS, V33, P1625, DOI 10.1063/1.1731473	45	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-5387			POLYHEDRON	Polyhedron	FEB	2015	87						141	146		10.1016/j.poly.2014.11.013		6	Chemistry, Inorganic & Nuclear; Crystallography	Chemistry; Crystallography	CG5FP	WOS:000353316800018		
J	Nishijo, J; Yoshida, T; Enomoto, M				Nishijo, Junichi; Yoshida, Tomohiro; Enomoto, Masaya			Structures and intra-dimer ferromagnetic interactions of [MnX(2)Saloph(NCS)] (X = Cl, Br, I)	POLYHEDRON			English	Article; Proceedings Paper	14th International Conference on Molecule-Based Magnets (ICMM)	JUL 04-09, 2014	Saint Petersburg, RUSSIA			Manganese Schiff base complex; Ferromagnetic interaction; Molecular magnetism; Crystal structure; Magnetic susceptibility	SINGLE-MOLECULE-MAGNET; SCHIFF-BASE COMPLEXES; CRYSTAL-STRUCTURES; ANIONS	The preparation, structures and magnetic properties of the new magnetic materials [MnCl(2)Saloph(NCS)](PhCN) and [MnX(2)Saloph(NCS)] (X = Br and I) are reported. Regardless of the halogen employed, in the crystals, the complexes form dimers, in which two neighboring [MnX(2)Saloph(NCS)] molecules are connected through short intermolecular Mn-O contacts of 2.534(2), 2.537(4) and 2.532(4) angstrom for X = Cl, Br and I, respectively. The magnetic measurements revealed that the short contacts bring ferromagnetic intra-dimer interactions of 2J/k(B) = 6.3, 6.2 and 4.7 K for X = Cl, Br and I. respectively, while small inter-dimer overlaps lead to weak anti-ferromagnetic inter-dimer interactions. (C) 2014 Elsevier Ltd. All rights reserved.	[Nishijo, Junichi; Yoshida, Tomohiro] Meisei Univ, Sch Sci & Engn, Hino, Tokyo 1918506, Japan; [Enomoto, Masaya] Tokyo Univ Sci, Dept Chem, Fac Sci Div 1, Shinjyuku Ku, Tokyo 1628601, Japan	Nishijo, J (reprint author), Meisei Univ, Sch Sci & Engn, 2-1-1 Hodokubo, Hino, Tokyo 1918506, Japan.	jun-ichi.nishijo@meisei-u.ac.jp		Nishijo, Junichi/0000-0002-9779-5481			Ruiz E, 2008, J AM CHEM SOC, V130, P7420, DOI 10.1021/ja800092s; Lu ZL, 2006, INORG CHEM, V45, P3538, DOI 10.1021/ic051648l; Chilton NF, 2013, J COMPUT CHEM, V34, P1164, DOI 10.1002/jcc.23234; Miyasaka H, 2004, ANGEW CHEM INT EDIT, V43, P2801, DOI 10.1002/anie.200353563; Coronado E, 2000, NATURE, V408, P447, DOI 10.1038/35044035; Burla MC, 2005, J APPL CRYSTALLOGR, V38, P381, DOI 10.1107/S002188980403225X; Miller JS, 2014, MATER TODAY, V17, P224, DOI 10.1016/j.mattod.2014.04.023; Coomber AT, 1996, NATURE, V380, P144, DOI 10.1038/380144a0; Kaneko W, 2006, INORG CHEM, V45, P7191, DOI 10.1021/ic0606882; Biswas S, 2005, INORG CHIM ACTA, V358, P2473, DOI 10.1016/j.ica.2005.01.026; BOGGESS RK, 1980, INORG CHIM A-ARTICLE, V38, P183, DOI 10.1016/S0020-1693(00)91957-1; Ma X, 2013, INORG CHEM, V52, P11343, DOI 10.1021/ic401604q; Madalan AM, 2014, INORG CHEM, V53, P4275, DOI 10.1021/ic500285m; Miller JS., 2001, MAGNETISM MOL MAT; Miyasaka H., 2002, J CHEM SOC DA, V2002, P1528; Nishijo J, 2000, SOLID STATE COMMUN, V116, P661, DOI 10.1016/S0038-1098(00)00406-3; Nishijo J, 2009, POLYHEDRON, V28, P1664, DOI 10.1016/j.poly.2008.10.022; Nuida T, 2007, J SOLID STATE ELECTR, V11, P763, DOI 10.1007/s10008-006-0219-7; Shehlrick G.M., 2008, ACTA CRYSTALLOGR A, V64, P112; Wang S, 2006, POLYHEDRON, V25, P2583, DOI 10.1016/j.poly.2006.03.010	20	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-5387			POLYHEDRON	Polyhedron	FEB	2015	87						233	236		10.1016/j.poly.2014.11.015		4	Chemistry, Inorganic & Nuclear; Crystallography	Chemistry; Crystallography	CG5FP	WOS:000353316800030		
J	Nakamura, T; Ishida, T				Nakamura, Takeshi; Ishida, Takayuki			Strong exchange couplings in lanthanide complexes with an aliphatic nitroxide radical 1,1,3,3-tetramethylisoindolin-2-oxyl	POLYHEDRON			English	Article; Proceedings Paper	14th International Conference on Molecule-Based Magnets (ICMM)	JUL 04-09, 2014	Saint Petersburg, RUSSIA			Rare earth metal; Free radical; Aminoxyl; Exchange coupling; Magnetic property	SINGLE-MOLECULE MAGNET; EFFECTIVE IONIC-RADII; AB-INITIO; SUPEREXCHANGE; GD; GADOLINIUM(III); MAGNETIZATION; MECHANISM; CLUSTERS; FERROMAGNETISM	We prepared crystalline [REIII(hfac)(3)(TMIO)(2)] (RE = Gd, Y; abbreviated as RE-TMIO2), where TMIO and hfac stand for 1,1,3,3-tetramethylisoindolin-2-oxyl and 1,1,1,5,5,5-hexafluoropentane-2,4-dionate, respectively. Two compounds are isomorphous in a C2/c space group. The paramagnetic TMIO ligand serves as an O-donor, and there are two TMIO moieties related with twofold symmetry in each molecule. The discrete molecular system guarantees the three- or two-centered exchange-coupling model. Magnetic study clarified that Gd-TMIO2 behaved as a ground S-total = 5/2 species with the intramolecular exchange couplings 2J(Gd-TMIO)/k(B) = -12.5(4) K and 2J(TMIO-TMIO)/kB = -27(2) K from an isosceles triangle model. Superexchange interaction across the diamagnetic Y ion was characterized in Y-TMIO2 with 2J(TMIO-TMIO)/k(B) = -21.3(2) K from the singlettriplet model. DFT calculation on Y-TMIO2 and a series of model compounds involving Rb+, Sr2+, Y3+, and Zr4+ suggests a possible mechanism involving ligand-to-metal charge transfer interaction for the relatively strong radicalradical couplings. (C) 2014 Elsevier Ltd. All rights reserved.	[Nakamura, Takeshi; Ishida, Takayuki] Univ Electrocommun, Dept Engn Sci, Tokyo, Japan	Ishida, T (reprint author), Univ Electrocommun, Dept Engn Sci, Tokyo, Japan.	ishi@pc.uec.ac.jp	Ishida, Takayuki/F-6190-2012				Allen AD, 2001, J ORG CHEM, V66, P5759, DOI 10.1021/jo0102922; Mori F, 2006, J AM CHEM SOC, V128, P1440, DOI 10.1021/ja057183f; Murakami R, 2013, DALTON T, V42, P13968, DOI 10.1039/c3dt51784e; Ishikawa N, 2003, J AM CHEM SOC, V125, P8694, DOI 10.1021/ja029629n; Ishida T, 2013, POLYHEDRON, V66, P183, DOI 10.1016/j.poly.2013.04.004; GOODENOUGH JB, 1955, PHYS REV, V100, P564, DOI 10.1103/PhysRev.100.564; Neese F, 2004, J PHYS CHEM SOLIDS, V65, P781, DOI 10.1016/j.jpcs.2003.11.015; Winpenny REP, 1998, CHEM SOC REV, V27, P447; ANDRUH M, 1993, J AM CHEM SOC, V115, P1822, DOI 10.1021/ja00058a029; Costes JP, 2000, INORG CHEM, V39, P5994, DOI 10.1021/ic000666u; Cirera J, 2008, CR CHIM, V11, P1227, DOI 10.1016/j.crci.2008.04.012; KANAMORI J, 1959, J PHYS CHEM SOLIDS, V10, P87, DOI 10.1016/0022-3697(59)90061-7; Pointillart F, 2007, CHEM-EUR J, V13, P1602, DOI 10.1002/chem.200601194; Ruiz E, 1999, J COMPUT CHEM, V20, P1391, DOI 10.1002/(SICI)1096-987X(199910)20:13<1391::AID-JCC6>3.0.CO;2-J; MCCONNELL HM, 1963, J CHEM PHYS, V39, P1910, DOI 10.1063/1.1734562; Osa S, 2004, J AM CHEM SOC, V126, P420, DOI 10.1021/ja037365e; Bogani L, 2005, ANGEW CHEM INT EDIT, V44, P5817, DOI 10.1002/anie.200500464; Kanetomo T, 2014, INORG CHEM, V53, P10794, DOI 10.1021/ic501496a; Ramade I, 1997, INORG CHEM, V36, P930, DOI 10.1021/ic9607595; ANDERSON PW, 1959, PHYS REV, V115, P2, DOI 10.1103/PhysRev.115.2; [Anonymous], 2010, CRYST STRUCT VERS 4; Gupta T, 2014, PHYS CHEM CHEM PHYS, V16, P14568, DOI 10.1039/c4cp00214h; Ueki S, 2007, CHEM PHYS LETT, V440, P263, DOI 10.1016/j.cplett.2007.04.063; BLEANEY B, 1952, PROC R SOC LON SER-A, V214, P451, DOI 10.1098/rspa.1952.0181; Frisch M. J., 2004, GAUSSIAN 03 REVISION; Giamello E, 2009, ELECT PARAMAGNETIC R; GRIFFITHS PG, 1982, TETRAHEDRON LETT, V23, P1309, DOI 10.1016/S0040-4039(00)87091-4; Ikegaya N., 2014, CHEM LETT, V41, P82; Kahn O, 1993, MOL MAGNETISM; Kanetomo T, 2014, CHEM COMMUN, V50, P2529, DOI 10.1039/c3cc48326f; Lescop C, 1999, INORG CHEM, V38, P5472, DOI 10.1021/ic990996i; Lescop C, 2002, INORG CHEM, V41, P3375, DOI 10.1021/ic0200038; Micallef AS, 1999, J CHEM SOC PERK T 2, P65, DOI 10.1039/a806884d; Murakami R, 2014, DALTON T, V43, P5893, DOI 10.1039/c3dt53586j; Oshio H., 2005, CHEM-EUR J, V11, P5478; Paulovic J, 2004, J AM CHEM SOC, V126, P3321, DOI 10.1021/ja030628k; Pontillon Y, 2000, J MATER CHEM, V10, P1539, DOI 10.1039/b000691m; Rajaraman G, 2009, DALTON T, P3153, DOI 10.1039/b817540c; RICHARDS.MF, 1968, J INORG NUCL CHEM, V30, P1275, DOI 10.1016/0022-1902(68)80557-3; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; SHANNON RD, 1969, ACTA CRYSTALL B-STRU, VB 25, P925, DOI 10.1107/S0567740869003220; Yamaguchi K, 2002, INT J QUANTUM CHEM, V90, P370, DOI 10.1002/qua.979	42	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-5387			POLYHEDRON	Polyhedron	FEB	2015	87						302	306		10.1016/j.poly.2014.11.035		5	Chemistry, Inorganic & Nuclear; Crystallography	Chemistry; Crystallography	CG5FP	WOS:000353316800039		
J	Farrer, J				Farrer, James			The Multiple Contexts of Protest: Reflections on the Reception of the MIT Visualizing Cultures Project and the Anti-Right Japanese Demonstration in Shanghai	POSITIONS-ASIA CRITIQUE			English	Article						Sino-Japanese relations; protest movements; reception; Shanghai urban studies; nationalism	NATIONALISM	The MIT Visualizing Cultures controversy is linked to a series of anti-Japanese street protests in China during the previous year. As a comparative analysis of these two very different types of protests, this article produces a reading of protest through a series of linked contexts of reception, or interconnected interpretive communities. To elaborate this idea, this article focuses on one of these events, the anti-Japanese protest of April 2005, and in conclusion, compares the reception of this event to the reactions to Visualizing Cultures website. Both events followed a familiar twentieth-century pattern of Chinese youth reacting against perceived insults to China in the realm of international affairs, accusing the Chinese state of weakness in the face of foreign insults. Like the MIT webpage controversy, however, the Shanghai protest unfolded in the borderless context of global media coverage, and also in the particular local and transnational contexts of Shanghai, a rising global city with a large resident foreign population, including the largest Japanese population in any city in the world outside Japan. The interpretations of the protest thus developed across a series of interlinked contexts of reception in Shanghai, in Japan, and further afield. In particular, the article discusses reactions in the Japanese community in Shanghai, and subsequent reactions of Japanese public intellectuals writing about the protest from Japan. Finally, as the events of protest become embedded in opposing nationalist narratives, the article asks how they can be brought back into the classroom, and how the social space of the classroom can serve as an alternative interpretive community for the exploration of both historical memory and the meanings of protest.	Sophia Univ, Sociol & Global Studies, Tokyo 102, Japan	Farrer, J (reprint author), Sophia Univ, Sociol & Global Studies, Tokyo 102, Japan.						[Anonymous], 2005, SHANGHAI        0427; [Anonymous], 2006, MIT NEWS        0504; Jeans RB, 2005, J MILITARY HIST, V69, P149, DOI 10.1353/jmh.2005.0025; [Anonymous], 2005, SHANGHAI STAR   0428; [Anonymous], 2006, MIT FACULTY NEWSLETT, V18; [Anonymous], 2005, XINWEN CHENBAO SHANG; Callahan WA, 2004, ALTERNATIVES, V29, P199; [Anonymous], 2006, ASAHI SHIMBUN   0407; [Anonymous], 2005, XINMIN WANBAO X 0426; Zhou YM, 2005, CURR ANTHROPOL, V46, P779; DiMaggio P, 1997, ANNU REV SOCIOL, V23, P263, DOI 10.1146/annurev.soc.23.1.263; Diner Dan, 1995, HIST MEMORY, V7, P547; Dower John W., 1986, WAR MERCY RACE POWER; Farrer James, 2012, POLICY INNOVATIONS P; Farrer James, 2005, YALE GLOBAL ONL 0429; French Howard W., 2005, NY TIMES; Gries Peter Hays, CHINAS NEW NATL PRID, P35; Gries Peter Hays, 2005, SAIS REV, V25, P105, DOI 10.1353/sais.2005.0034; Griswold Wendy, 1986, RENAISSANCE REVIVALS; Griswold Wendy, 2008, CULTURES SOC CHANGIN, P73; He Yinan, 2007, HIST MEMORY, V19, P43, DOI 10.2979/HIS.2007.19.2.43; Hiroaki Yokoyama, 2005, ANTIJAPAN ANTICHINA, P72; Hironori Sasada, 2006, SAIS REV, V26, P112; Kazuko Mori, 2006, JAPAN CHINA RELATION, P196; Kokunimasa Utegawa, 1894, ILLUSTRATION DECAPIT; Mana Yoshimura, 2010, SAPIO, V22, P17; Monaghan Peter, 2006, CHRONICLE HIGHER ED; Moser John, 1940, JAPAN W ROAD WORLD W; Noburo Onuki, 2005, SEKAI SHUUHOU   0607, P18; Perez Hernaiz Hugo A., 2011, AGLOS J AREA BASED G, V2, P27; Perry EJ, 2008, POPULAR PROTEST CHIN, P205; Reilly James, 2006, CHINA INT J, V4, P189; Rorty Richard, 1989, CONTINGENCY IRONY SO; Rui Gao, 2008, AM SOC ASS ANN M BOS; Seichiro Aso, 2009, ANTIJAPAN RIOTS BUBB, P7; Shen Simon, 2007, PAC REV, V20, P475; Suler John, 2004, CYBERPSYCHOLOGY BEHA, V7, P325; Tatsumi Okabe, 2006, FUTURE JAPAN CHINA R, P213; Wasserstrom JN, 2005, WORLD POLICY J, V22, P59; Westad O. A., 2012, RESTLESS EMPIRE CHIN; Yang Guobin, 2009, POPULAR PROTEST CHIN, P126; Yoshikazu Shimizu, 2003, WHY CHINA BECAME ANT, P208; Yu ZY, 2006, SOC FORCES, V84, P1755, DOI 10.1353/sof.2006.0078; Zhao SS, 2005, WASH QUART, V29, P131	44	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	1067-9847	1527-8271		POSITIONS-ASIA CRIT	Positions-Asia Crit.	FEB	2015	23	1			SI		59	90		10.1215/10679847-2870486		32	Asian Studies	Asian Studies	CG5EF	WOS:000353313200005		
J	Mizumoto, M; Oshiro, Y; Ayuzawa, K; Miyamoto, T; Okumura, T; Fukushima, T; Fukushima, H; Ishikawa, H; Tsuboi, K; Sakurai, H				Mizumoto, Masashi; Oshiro, Yoshiko; Ayuzawa, Kaoru; Miyamoto, Toshio; Okumura, Toshiyuki; Fukushima, Takashi; Fukushima, Hiroko; Ishikawa, Hitoshi; Tsuboi, Koji; Sakurai, Hideyuki			Preparation of pediatric patients for treatment with proton beam therapy	RADIOTHERAPY AND ONCOLOGY			English	Article						Proton beam therapy; Pediatric; Preparation; Radiotherapy; Anesthesia	RADIATION-THERAPY; HEPATOCELLULAR-CARCINOMA; RADIOTHERAPY; ANESTHESIA; PHOTON; CANCER; MEDULLOBLASTOMA; CHILDREN	Purpose: Anesthesia is often used in proton beam therapy (PBT) for pediatric patients and this may prolong the treatment time. The aim of the study was to examine preparation of pediatric patients to allow smooth performance of PBT. Material and methods: Preparation was initiated 1-2 days before treatment planning CT and continued for 10 days. The patient first visited the facility to become familiar with the treatment room and staff. As the second step, the patient stayed in the treatment bed for a certain time with their mother, and then stayed on the treatment bed alone. Special fixtures painted with characters, music, and gifts were also prepared. Results: From 2010 to 2014, 111 pediatric patients underwent PBT. These patients were divided into 3 groups: 40 who could follow instructions well (group A, median age: 13.6 years old), 60 who could communicate, but found it difficult to stay alone for a long time (group B, median age: 4.6 years old), and 11 who could not follow instructions (group C, median age: 1.6 years old). Preparation was used for patients in group B. The mean treatment times in groups A, B and C were 13.6, 17.1, and 15.6 min, respectively, on PBT treatment days 2-6, and 11.8, 13.0, and 16.9 min, respectively, for the last 5 days of PBT treatment. The time reduction was significant in group B (p = 0.003). Conclusion: Preparation is useful for pediatric patients who can communicate. This approach allows PBT to be conducted more smoothly over a shorter treatment time. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Mizumoto, Masashi; Oshiro, Yoshiko; Okumura, Toshiyuki; Ishikawa, Hitoshi; Tsuboi, Koji; Sakurai, Hideyuki] Univ Tsukuba, Dept Radiat Oncol, Tsukuba, Ibaraki 3058575, Japan; [Mizumoto, Masashi; Ayuzawa, Kaoru; Miyamoto, Toshio] Univ Tsukuba, Proton Med Res Ctr, Tsukuba, Ibaraki 3058575, Japan; [Fukushima, Takashi; Fukushima, Hiroko] Univ Tsukuba, Dept Child Hlth, Tsukuba, Ibaraki 3058575, Japan	Mizumoto, M (reprint author), Univ Tsukuba, Proton Med Res Ctr, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	mizumoto1717@hotmail.com			Ministry of Education, Science, Sports and Culture of Japan [24390286, 24659556, 25861064, 24591832]	This work was supported in part by Grants-in-Aid for Scientific Research (B) (24390286); Challenging Exploratory Research (24659556), Young Scientists (B) (25861064); and Scientific Research (C) (24591832) from the Ministry of Education, Science, Sports and Culture of Japan. We wish to thank the members of the Tsukuba Critical Path Research and Education Integrated Leading Center (CREIL) at the University of Tsukuba for their critical advice in conducting the study and data management during the study period.	Anghelescu DL, 2008, INT J RADIAT ONCOL, V71, P491, DOI 10.1016/j.ijrobp.2007.09.044; Sethi RV, 2014, CANCER-AM CANCER SOC, V120, P126, DOI 10.1002/cncr.28387; Mizumoto M, 2010, INT J RADIAT ONCOL, V77, P98, DOI 10.1016/j.ijrobp.2009.04.054; Tsunashima Y, 2004, INT J RADIAT ONCOL, V60, P951, DOI 10.1016/j.ijrobp.2004.06.026; Paganetti H, 2002, INT J RADIAT ONCOL, V53, P407, DOI 10.1016/S0360-3016(02)02754-2; Brodin NP, 2011, ACTA ONCOL, V50, P806, DOI 10.3109/0284186X.2011.582514; Oshiro Y, 2012, J THORAC ONCOL, V7, P370, DOI 10.1097/JTO.0b013e31823c485f; Mizumoto M, 2011, INT J RADIAT ONCOL, V81, P1039, DOI 10.1016/j.ijrobp.2010.07.015; Owusu-Agyemang P, 2014, RADIOTHER ONCOL, V111, P30, DOI 10.1016/j.radonc.2014.01.016; Mizumoto M, 2008, INT J RADIAT ONCOL, V71, P462, DOI 10.1016/j.ijrobp.2007.09.056; Oshiro Y, 2013, ACTA ONCOL, V52, P600, DOI 10.3109/0284186X.2012.760849; Buchsbaum JC, 2013, INT J RADIAT ONCOL, V85, P1296, DOI 10.1016/j.ijrobp.2012.10.006; Fortney JT, 1999, INT J RADIAT ONCOL, V44, P587, DOI 10.1016/S0360-3016(99)00058-9; Haeberli S, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-17; Oshiro Y, 2011, ACTA ONCOL, V50, P470, DOI 10.3109/0284186X.2010.509106; Oshiro Y, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-142; Tsai YL, CHILDS NERV IN PRESS; Zabel-du Bois A, 2014, STRAHLENTHER ONKOL, V190, P582, DOI 10.1007/s00066-014-0619-z; Zhang R, 2014, RADIOTHER ONCOL, V113, P84, DOI 10.1016/j.radonc.2014.07.003	19	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-8140			RADIOTHER ONCOL	Radiother. Oncol.	FEB	2015	114	2					245	248		10.1016/j.radonc.2015.01.007		4	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CF9YD	WOS:000352922900018		
J	Ooi, L; Heng, LY; Mori, IC				Ooi, Lia; Heng, Lee Yook; Mori, Izumi C.			A High-Throughput Oxidative Stress Biosensor Based on Escherichia coli roGFP2 Cells Immobilized in a k-Carrageenan Matrix	SENSORS			English	Article							GREEN FLUORESCENT PROTEIN; TOXICITY; INDICATORS; AEQUOREA; METALS; MODEL	Biosensors fabricated with whole-cell bacteria appear to be suitable for detecting bioavailability and toxicity effects of the chemical(s) of concern, but they are usually reported to have drawbacks like long response times (ranging from hours to days), narrow dynamic range and instability during long term storage. Our aim is to fabricate a sensitive whole-cell oxidative stress biosensor which has improved properties that address the mentioned weaknesses. In this paper, we report a novel high-throughput whole-cell biosensor fabricated by immobilizing roGFP2 expressing Escherichia coli cells in a k-carrageenan matrix, for the detection of oxidative stress challenged by metalloid compounds. The E. coli roGFP2 oxidative stress biosensor shows high sensitivity towards arsenite and selenite, with wide linear range and low detection limit (arsenite: 1.0 x 10(-3)-1.0 x 10(1) mg center dot L-1, LOD: 2.0 x 10(-4) mg center dot L-1; selenite: 1.0 x 10(-5)-1.0 x 10(2) mg center dot L-1, LOD: 5.8 x 10(-6) mg center dot L-1), short response times (0-9 min), high stability and reproducibility. This research is expected to provide a new direction in performing high-throughput environmental toxicity screening with living bacterial cells which is capable of measuring the bioavailability and toxicity of environmental stressors in a friction of a second.	[Ooi, Lia; Heng, Lee Yook] Natl Univ Malaysia, Inst Environm & Dev LESTARI, Southeast Asia Disaster Prevent Res Initiat SEADP, Bangi 43600, Selangor, Malaysia; [Heng, Lee Yook] Natl Univ Malaysia, Fac Sci & Technol, Bangi 43600, Selangor, Malaysia; [Mori, Izumi C.] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan	Mori, IC (reprint author), Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan.	angelyn.ooi.lia@gmail.com; leeyookheng@yahoo.co.uk; imori@okayama-u.ac.jp			Kurita Water and Environment Foundation; Okayama Foundation for Science and Technology, Japan; National University of Malaysia [DIP-2015, DPP-2015]	This work is funded by Kurita Water and Environment Foundation and Okayama Foundation for Science and Technology, Japan; and DIP-2015, DPP-2015 and Dana Mobiliti Yayasan Canselor from The National University of Malaysia. We would also like to express our acknowledgement to JSPS Asia Core Program (ACP) for providing encouragement to this project.	Andreas J. M., 2010, ANTIOXID REDOX SIGN, V13, P621; Garelick H, 2008, REV ENVIRON CONTAM T, V197, P17, DOI 10.1007/978-0-387-79284-2_2; Chapman PM, 2000, ENVIRON TOXICOL CHEM, V19, P3, DOI 10.1897/1551-5028(2000)019<0003:WETTUL>2.3.CO;2; Poon HF, 2004, CLIN GERIATR MED, V20, P329, DOI 10.1016/j.cger.2004.02.005; Niwa H, 1996, P NATL ACAD SCI USA, V93, P13617, DOI 10.1073/pnas.93.24.13617; Chakraborti D, 2013, J HAZARD MATER, V262, P1048, DOI 10.1016/j.jhazmat.2012.10.002; Bjerketorp J, 2006, CURR OPIN BIOTECH, V17, P43, DOI 10.1016/j.copbio.2005.12.005; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Lei Y, 2006, ANAL CHIM ACTA, V568, P200, DOI 10.1016/j.aca.2005.11.065; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Schwarzlander M, 2008, J MICROSC-OXFORD, V231, P299, DOI 10.1111/j.1365-2818.2008.02030.x; Gupta R, 2007, BIOSENS BIOELECTRON, V22, P2387, DOI 10.1016/j.bios.2006.12.025; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; ROCHAS C, 1987, CARBOHYD POLYM, V7, P435, DOI 10.1016/0144-8617(87)90011-7; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Gebel T, 2000, TOXICOLOGY, V144, P155, DOI 10.1016/S0300-483X(99)00202-4; MORRIS ER, 1980, J MOL BIOL, V138, P349, DOI 10.1016/0022-2836(80)90291-0; Santore RC, 2001, ENVIRON TOXICOL CHEM, V20, P2397, DOI 10.1897/1551-5028(2001)020<2397:BLMOTA>2.0.CO;2; Arias-Barreiro CR, 2010, SENSORS-BASEL, V10, P6290, DOI 10.3390/s100706290; AZUR Environmental, 1998, MICR AC TOX BAS TEST, P1; Bhaskar A., 2014, PLOS PATHOG, P10, DOI [10.1371/journal.ppat.1003902, DOI 10.1371/J0URNAL.PPAT.1003902]; Cassidy MB, 2000, J MICROBIOL METH, V40, P135, DOI 10.1016/S0167-7012(99)00131-1; Durhan E. J., 1993, METHODS AQUATIC TOXI, P1; Dwivedi S., 2013, PLOS ONE, P8, DOI [10.1371/journal.pone.0057404, DOI 10.1371/J0URNAL.P0NE.0057404]; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Fujimoto H, 2006, APPL MICROBIOL BIOT, V73, P332, DOI 10.1007/s00253-006-0483-6; Gulrez S. K. H., 2011, PROGR MOL ENV BIOENG, P117; Heim Roger, 1996, Current Biology, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Henke KH, 2009, ARSENIC ENV CHEM HLT, P588; Kalcikova G, 2012, WATER SCI TECHNOL, V66, P903, DOI 10.2166/wst.2012.271; Lemly A. D., 2002, SELENIUM ASSESSMENT, P161; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Liu SQ, 1996, CURR EYE RES, V15, P726; Martins S. C. S., 2013, African Journal of Biotechnology, V12, P4412; McHugh D. J., 1987, PRODUCTION UTILIZATI; Mount D. I., 1993, METHODS AQUATIC TOXI, P1; Norberg-King T. J., 1991, METHODS AQUATIC TOXI, P1; Ooi L., 2015, J SENSORS IN PRESS; Rojkind M, 2002, CELL MOL LIFE SCI, V59, P1872, DOI 10.1007/PL00012511; Seko Y., 1989, SELENIUM BIOL MED, P70; SPALLHOLZ JE, 1994, FREE RADICAL BIO MED, V17, P45, DOI 10.1016/0891-5849(94)90007-8; Stolz J. F., 2002, International Microbiology, V5, P201	43	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1424-8220			SENSORS-BASEL	Sensors	FEB	2015	15	2					2354	2368		10.3390/s150202354		15	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	CE7BR	WOS:000351992500007		
J	Zhu, ZH; Liu, T; Li, GY; Li, T; Inoue, Y				Zhu, Zhihua; Liu, Tao; Li, Guangyi; Li, Tong; Inoue, Yoshio			Wearable Sensor Systems for Infants	SENSORS			English	Review							NEWBORN-INFANTS; MONITORING-SYSTEM; HEALTH-CARE; WIRELESS; CHALLENGES; TEXTILE; DESIGN; RHYTHM	Continuous health status monitoring of infants is achieved with the development and fusion of wearable sensing technologies, wireless communication techniques and a low energy-consumption microprocessor with high performance data processing algorithms. As a clinical tool applied in the constant monitoring of physiological parameters of infants, wearable sensor systems for infants are able to transmit the information obtained inside an infant's body to clinicians or parents. Moreover, such systems with integrated sensors can perceive external threats such as falling or drowning and warn parents immediately. Firstly, the paper reviews some available wearable sensor systems for infants; secondly, we introduce the different modules of the framework in the sensor systems; lastly, the methods and techniques applied in the wearable sensor systems are summarized and discussed. The latest research and achievements have been highlighted in this paper and the meaningful applications in healthcare and behavior analysis are also presented. Moreover, we give a lucid perspective of the development of wearable sensor systems for infants in the future.	[Zhu, Zhihua; Liu, Tao; Li, Guangyi; Li, Tong] Zhejiang Univ, Dept Mech Engeering, State Key Lab Fluid Power Transmiss & Control, Hangzhou 310027, Peoples R China; [Liu, Tao; Inoue, Yoshio] Kochi Univ Technol, Sch Syst Engn, Kochi 7808520, Japan	Liu, T (reprint author), Zhejiang Univ, Dept Mech Engeering, State Key Lab Fluid Power Transmiss & Control, Hangzhou 310027, Peoples R China.	zhihuaZhu@zju.edu.cn; liutao@zju.edu.cn; li_guangyi@zju.edu.cn; zjulitong@zju.edu.cn; inoue.yoshio@kochi-tech.ac.jp			NSFC [61428304]; China State Key Laboratory of Robotics and System (HIT) [SKLRS-2014-ZD-04]	This work was partly supported in part by the NSFC Grant No. 61428304 and the China State Key Laboratory of Robotics and System (HIT) SKLRS-2014-ZD-04.	ALzaidi A., 2013, P 2013 IEEE LONG ISL, P1; Guinovart T, 2014, ELECTROANAL, V26, P1345, DOI 10.1002/elan.201300558; Yu XG, 2008, 2008 10TH IEEE INTERNATIONAL CONFERENCE ON E-HEALTH NETWORKING, APPLICATIONS AND SERVICES, P42; Salman S, 2014, IEEE SENS J, V14, P2447, DOI 10.1109/JSEN.2014.2323896; Bouwstra S, 2009, SIXTH INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS, P162, DOI 10.1109/P3644.39; Tao WJ, 2012, SENSORS-BASEL, V12, P2255, DOI 10.3390/s120202255; Coosemans J, 2006, SENSOR ACTUAT A-PHYS, V130, P48, DOI 10.1016/j.sna.2005.10.052; Roundy S, 2004, LECT NOTES COMPUT SC, V2920, P1; Catrysse M, 2004, SENSOR ACTUAT A-PHYS, V114, P302, DOI 10.1016/j.sna.2003.10.071; Pantelopoulos A, 2010, IEEE T SYST MAN CY C, V40, P1, DOI 10.1109/TSMCC.2009.2032660; Rimet Y, 2007, P ANN INT IEEE EMBS, P4997, DOI 10.1109/IEMBS.2007.4353462; Baldemair R, 2013, IEEE VEH TECHNOL MAG, V8, P24, DOI 10.1109/MVT.2012.2234051; Als H, 2003, J DEV BEHAV PEDIATR, V24, P399, DOI 10.1097/00004703-200312000-00001; Liu T, 2014, MEASUREMENT, V47, P125, DOI 10.1016/j.measurement.2013.08.020; Liu T, 2012, IEEE SENS J, V12, P1461, DOI 10.1109/JSEN.2011.2173763; AL-Khalidi FQ, 2011, PEDIATR PULM, V46, P523, DOI 10.1002/ppul.21416; Paradiso R, 2005, IEEE T INF TECHNOL B, V9, P337, DOI 10.1109/TITB.2005.854512; Zhao P, 2014, SENSOR ACTUAT A-PHYS, V216, P158, DOI 10.1016/j.sna.2014.05.018; Chen W, 2009, J AMB INTEL SMART EN, V1, P185, DOI 10.3233/AIS-2009-0022; Chan M, 2012, ARTIF INTELL MED, V56, P137, DOI 10.1016/j.artmed.2012.09.003; Fernandes MS, 2013, SENSOR ACTUAT A-PHYS, V203, P316, DOI 10.1016/j.sna.2013.09.008; Zhen C, 2014, CLIN PEDIATR, V53, P1158, DOI 10.1177/0009922814536774; Chen W, 2008, ISSNIP 2008: PROCEEDINGS OF THE 2008 INTERNATIONAL CONFERENCE ON INTELLIGENT SENSORS, SENSOR NETWORKS, AND INFORMATION PROCESSING, P255; Pandian PS, 2008, MED ENG PHYS, V30, P466, DOI 10.1016/j.medengphy.2007.05.014; Yick J, 2008, COMPUT NETW, V52, P2292, DOI 10.1016/j.comnet.2008.04.002; Baker C.R., 2007, P 21 INT C ADV INF N, V2, P832; Cao H., 2007, P IEEE SENSORS 2007, P989; Cao H., 2007, P 2007 IEEE INT C RF, P134; Chen W., 2010, P 5 INT C BOD AR NET, P188; Chen W, 2010, IEEE T INF TECHNOL B, V14, P1468, DOI 10.1109/TITB.2010.2050592; Chen W, 2010, J HEALTHC ENG, V1, P535, DOI 10.1260/2040-2295.1.4.535; Chen Wei, 2009, Proceedings of the 2009 9th International Conference on Electronic Measurement & Instruments (ICEMI 2009), DOI 10.1109/ICEMI.2009.5274836; Corbishley P, 2008, IEEE T BIO-MED ENG, V55, P196, DOI 10.1109/TBME.2007.910679; Gilbert James M, 2008, International Journal of Automation and Computing, V5, DOI 10.1007/s11633-008-0334-2; Hsu C. H., 2005, BIOMED ENG APPL, V17, P126; Krenzel D, 2012, IEEE ENG MED BIO, P4042, DOI 10.1109/EMBC.2012.6346854; Linti C., 2006, P INT WORKSH WEAR IM, P3; Lorwongtragool P, 2013, INT NANOELECTR CONF, P291, DOI 10.1109/INEC.2013.6466026; Lun C. J., 2013, SENSOR ACTUAT B-CHEM, V183, P117; McAdams E, 2011, IEEE ENG MED BIO, P3648, DOI 10.1109/IEMBS.2011.6090614; Murković Ivana, 2003, Technol Health Care, V11, P399; Nemati E, 2012, IEEE COMMUN MAG, V50, P36, DOI 10.1109/MCOM.2012.6122530; Nishida Y., 2007, P IEEE SENSORS 2007, P1209; Orengo G, 2014, IEEE SENS J, V14, P2307, DOI 10.1109/JSEN.2014.2309997; Paradiso R, 2011, IEEE ENG MED BIO, P3274, DOI 10.1109/IEMBS.2011.6090889; Park C., 2006, P IEEE BIOM CIRC SYS, P241; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Pola T, 2007, PROCEEDINGS OF THE 2007 INTERNATIONAL CONFERENCE ON INTELLIGENT SENSORS, SENSOR NETWORKS AND INFORMATION PROCESSING, P635, DOI 10.1109/ISSNIP.2007.4496917; Saadatian E., 2011, P 2011 IEEE C HUM SO, P503; Sato S, 2010, NEONATOLOGY, V98, P179, DOI 10.1159/000283994; Schiavone G, 2010, IEEE ENG MED BIO, P1283, DOI 10.1109/IEMBS.2010.5626406; Seesaard T., 2014, P 2014 IEEE 9 INT C, P1; Taffoni F, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P3832, DOI 10.1109/IROS.2008.4651093; Tang SLP, 2007, T I MEAS CONTROL, V29, P283, DOI 10.1177/0142331207070389; Yamada T, 2013, PROC SICE ANN CONF, P259; Yamana Y, 2011, IEEE ENG MED BIO, P5323, DOI 10.1109/IEMBS.2011.6091317; Yang G. Z., 2014, BODY SENSOR NETWORKS, P580; Zhang LL, 2008, IFMBE PROC, V19, P580	58	2	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1424-8220			SENSORS-BASEL	Sensors	FEB	2015	15	2					3721	3749		10.3390/s150203721		29	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	CE7BT	WOS:000351992700023		
J	Ueda, H; Sugiura, T; Katano, K; Matsuhashi, M; Kato, S; Ito, K; Nagasaki, R; Kato, T; Tsuno, NH; Saitoh, S				Ueda, H.; Sugiura, T.; Katano, K.; Matsuhashi, M.; Kato, S.; Ito, K.; Nagasaki, R.; Kato, T.; Tsuno, N. H.; Saitoh, S.			Perinatal management of neonatal alloimmune thrombocytopenia associated with anti-group A antibody	TRANSFUSION MEDICINE			English	Article						anti-group A antibody; immunoglobulin; neonatal alloimmune thrombocytopenia; perinatal management		ObjectiveTo prevent neonatal alloimmune thrombocytopenia due to anti-group A antibody perinatal management was performed. BackgroundWe previously reported a case of severe intracranial haemorrhage associated with neonatal alloimmune thrombocytopenia due to anti-group A isoantibody. Material/MethodsA 40-year-old Japanese woman, gravida 4 para 1, was pregnant with her second baby. The previous sibling developed severe thrombocytopenia and died 10days after birth due to intracranial haemorrhage. He was diagnosed with neonatal alloimmune thrombocytopenia; the causative antibody was found to be the anti-group A antibody. Prednisone was started at 7weeks' gestational age. Intravenous immunoglobulin 1gkg(-1)week(-1) was started at 29weeks' gestational age and continued to delivery. Serological studies and genotyping were performed. ResultsThe second boy was delivered at 33weeks' gestational age by caesarean section. He was discharged without intracranial haemorrhage or thrombocytopenia. The anti-group A antibody titre in the maternal serum was 2048-4096 (normal range: 4-64). The anti-group A antibody titre in the newborn's serum was 4. Cross-matching between the maternal serum and the paternal platelets was positive. ConclusionOwing to the history of neonatal alloimmune thrombocytopenia causing intracranial haemorrhage and death of the previous sibling, strict follow-up of the subsequent pregnancy was conducted.	[Ueda, H.; Sugiura, T.; Kato, S.; Ito, K.; Nagasaki, R.; Kato, T.; Saitoh, S.] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Katano, K.] Nagoya City Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Nagoya, Aichi 4678601, Japan; [Matsuhashi, M.; Tsuno, N. H.] Univ Tokyo, Dept Transfus Med, Tokyo, Japan	Sugiura, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	tokio@med.nagoya-cu.ac.jp					Matsuhashi M, 2010, TRANSFUSION, V50, P1126, DOI 10.1111/j.1537-2995.2009.02537.x; Kjeldsen-Kragh J, 2007, BLOOD, V110, P833, DOI 10.1182/blood-2006-08-040121; Birchall JE, 2003, BRIT J HAEMATOL, V122, P275, DOI 10.1046/j.1365-2141.2003.04408.x; Porcelijn L, 2008, SEMIN FETAL NEONAT M, V13, P223, DOI 10.1016/j.siny.2008.02.008; Ohto H, 2004, TRANSFUSION MED, V14, P399, DOI 10.1111/j.1365-3148.2004.00535.x; Curtis BR, 2000, BLOOD, V96, P1574; Kato S, 2013, J PERINATOL, V33, P79, DOI 10.1038/jp.2011.204; Curtis BR, 2008, TRANSFUSION, V48, P358, DOI 10.1111/j.1537-2995.2007.01531.x; Berkowitz RL, 2006, OBSTET GYNECOL, V107, P91, DOI 10.1097/01.AOG.0000192404.25780.68; Espinoza J P, 2013, Rev Obstet Gynecol, V6, pe15	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0958-7578	1365-3148		TRANSFUSION MED	Transfus. Med.	FEB	2015	25	1					42	46		10.1111/tme.12178		5	Hematology	Hematology	CG5TM	WOS:000353358200009		
J	Li, W; Wan, XQ; Matsuoka, A; Zhang, SQ; Qu, HY; Tamura, T; Yoshino, K				Li Wei; Wan Xiaoqiao; Matsuoka, Atsushi; Zhang Shuqin; Qu Haiying; Tamura, Tsubasa; Yoshino, Kohei			Jurassic-Cretaceous Boundary Strata of the Somanakamura Group in NE Japan and their Correlation with Coeval Terrestrial Deposits in China	ACTA GEOLOGICA SINICA-ENGLISH EDITION			English	Review						Somanakamura Group; Jurassic-Cretaceous boundary; ammonites; spores and pollen; Tomizawa Formation; Koyamada Formation; Tuchengzi Formation	SOUTHERN TIBET; BASIN; AGE; STRATIGRAPHY; TETHYAN; TRANSITION; MONGOLIA; INTERVAL	Defining the Jurassic-Cretaceous boundary is a controversy in stratigraphic study of the world. It has been widely accepted that this boundary can be defined at the bottom of Berriasian in Tethys, with the appearance of the ammonite Berriasella jacobi dating to ca. 145 Ma. However, it is difficult for the widespread terrestrial deposits in China to correlate with the international standard of marine facies. The Somanakamura Group in Japan is represented by a succession of marine-continental transitional strata. It provides a bridge of marine and nonmarine stratigraphic correlation. The ammonite and radiolarian fossils preserved in this group suggest an age from Bajocian to early Valanginian. The J-K boundary was defined in or atop the Tomizawa Formation of the group according to the ammonite data. The present authors study the fossil spores and pollen newly found from the Tomizawa and Koyamada formations. Three assemblages have been recognized. They are Assemblage 1 (Cyathidites-Classopollis) from the upper part of the Tomizawa Formation, Assemblage 2 (Cyathidites-Jiaohepollis) from the lower part of the Koyamada Formation, and Assemblage 3 (Cyathidites-Spheripollenites-Ephedripites) from the middle to upper part of the Koyamada Formation. With the reference of ammonite evidence, the J-K boundary can be defined between Assemblage 1 and Assemblage 2. This palynological J-K boundary can be correlated with that of terrestrial sequence in China. However, local biostratigraphy imply that the continental J-K boundary in China is of 135 or 137 Ma age. It has a considerable discrepancy from the marine standard. Biogeographically, the distribution pattern of spores and pollen in southern China is in accordance with that in the Somanakamura Group, which parallels the Tuchengzi Formation in northeastern China. By the palynological correlation between the Somanakamura Group and the strata in southern China, and then with the sequence in northeastern China, it is suggested that the continental J-K boundary is located in the Tuchengzi Formation.	[Li Wei; Wan Xiaoqiao; Qu Haiying] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing 100083, Peoples R China; [Matsuoka, Atsushi; Tamura, Tsubasa; Yoshino, Kohei] Niigata Univ, Dept Geol, Niigata 9502181, Japan; [Zhang Shuqin] Jilin Univ, Res Ctr Paleontol & Stratig, Changchun 130026, Jilin, Peoples R China	Wan, XQ (reprint author), China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing 100083, Peoples R China.	wanxq@cugb.edu.cn			National Natural Science Foundation of China [41172037]; National Basic Research Program of China (973 Program) [2012CB822002]; China Geological Survey [1212011120142]	This study was supported by the National Natural Science Foundation of China (Project NO. 41172037), the National Basic Research Program of China (973 Program, NO. 2012CB822002) and the China Geological Survey (Project NO. 1212011120142). We are very grateful to Lu Yuanzheng (Research Institute of Petroleum Exploration and Development) for his guidance and help in palynological processing and identification, and to Ou Qiang (China University of Geosciences) for his amending and advices in English writing. Professor Deng shenghui (Research Institute of Petroleum Exploration and Development) and Wang Sien (Chinese Academy of Geological Sciences) gave us suggestions about some part of this article. Wang Daning (Chinese Academy of Geological Sciences) also helped us a lot in the identification of some difficult spores and pollen fossils. Li Jingjing (China University of Geosciences) guided us in the operation of microscope. Sincere appreciation goes to all of them mentioned above.	Adatte T., 1996, CRETACEOUS RES, V17, P67; Adatte T, 1994, GEOBIOS MEMOIRE SPEC, V17, P37, DOI [10.1016/s0016-6995(94)80124-x, DOI 10.1016/S0016-6995(94)80124-X]; All China Commission of Stratigraphy, 2002, ILL CHIN REG CHRON G, P72; Wan XQ, 2007, ACTA GEOL SIN-ENGL, V81, P957; Gradstein FM, 2004, EPISODES, V27, P83; Sha JG, 2009, SCI CHINA SER D, V52, P1873, DOI 10.1007/s11430-009-0173-1; Xu Huan, 2012, Palaeoworld, V21, P222, DOI 10.1016/j.palwor.2012.10.003; Mahoney JJ, 2005, GEOLOGY, V33, P185, DOI 10.1130/G21378.1; Arkell W. J., 1957, TREATISE INVERTEBR L, P80; Baumgartner Peter O., 1995, Memoires de Geologie (Lausanne), V23, P37; Boughdiri M, 2006, CR GEOSCI, V338, P1250, DOI 10.1016/j.crte.2006.09.015; Brogniart A.T., 1829, TABLEAU TERRAINES QU; Chen P., 2000, J STRATIGRAPHY, V24, P114; Cohen KM, 2013, EPISODES, V36, P199; Cope J.C.W., 2007, P GEOLOGISTS ASS, V119, P105; Davis G.A., 2005, EARTH SCI FRONTIERS, V12, P332; Fujita Y., 1984, GEOTECTONIC METALLOG, V8, P305; Gao Ruiqi, 1999, CRETACEOUS OIL STRAT, P1; Gradstein F.M., 2012, GEOLOGIC TIME SCALE, V2, P794; Gradstein F.M., 2004, GEOLOGICAL TIMESCALE, P344; Harland W.B., 1990, GEOLOGIC TIME SCALE, P1; Harland W.B., 1982, GEOLOGIC TIME SCALE, P1; Housa V, 2007, STRATIGR GEO CORREL+, V15, P297, DOI 10.1134/S0869593807030057; Isozaki Y., 2013, ACTA GEOL SINICA, V87, P299; Jahn B., 2013, ACTA GEOL SINICA, V87, P302; [季强 jI Qiang], 2006, [地质通报, Geological Bulletin of China], V25, P336; KIMURA T, 1988, Bulletin of the National Science Museum Series C (Geology and Paleontology), V14, P151; KIMURA T, 1988, Bulletin of the National Science Museum Series C (Geology and Paleontology), V14, P103; Kiyama O., 1998, J SEDIMENTOLOGICAL S, V47, P17; LEI Z-Q, 1981, Acta Botanica Sinica, V23, P235; Li JG, 2011, ISL ARC, V20, P35, DOI 10.1111/j.1440-1738.2010.00715.x; Li Peixian, 1994, ACTA GEOL SINICA, V7, P329; Li Wenben, 2001, ACTA PALAEONTOLOGICA, V40, P450; Li Zhenhong, 2013, ACTA GEOL SINICA, V87, P567; Liu Xianwen, 1993, WORLD GEOLOGY, V12, P1; Liu YQ, 2013, CRETACEOUS RES, V40, P90, DOI 10.1016/j.cretres.2012.05.010; [马文璞 Ma Wenpu], 2003, [地质通报, Geological Bulletin of China], V22, P192; Masatani K., 1959, JAPANESE J GEOLOGY G, V30, P245; MASATANI KIYOSHI, 1950, JOUR GEOL SOC JAPAN, V56, P499; Matsuoka A., 1989, FOSSIL, V46, P11; Michalik Jozef, 2011, Geoscience Frontiers, V2, P475; Mori K., 1963, Science Reports of the Tohoku University Ser 2 Geol, V35, P33; Morino Y., 1989, BENTHOS RES, V37, P83; OGG JG, 1991, CRETACEOUS RES, V12, P455, DOI 10.1016/0195-6671(91)90002-T; Ogg J.G., 2004, GEOLOGIC TIME SCALE, P344; PALFY J, 2000, CAN J EARTH SCI, V37, P923, DOI DOI 10.1139/CJES-37-6-923; POCOCK S A J, 1967, Review of Palaeobotany and Palynology, V5, P129, DOI 10.1016/0034-6667(67)90216-3; Pu Ronggan, 1982, B SHENYANG I GEOLOGY, V4, P169; Pu Ronggan, 1985, MESOZOIC STRATA PALE, P121; Remane J., 2000, 31 INT GEOL C RIO JA, P16; REMANE J, 1991, CRETACEOUS RES, V12, P447, DOI 10.1016/0195-6671(91)90001-S; Ruban Dmitry A., 2013, Geoscience Frontiers, V4, P87; Ruban D.A., 2014, GEOSCIENCE FRONTIERS; Sato T., 1992, JURASSIC CIRCUM PACI, P194; SATO TADASHI, 1961, JAPANESE JOUR GEOL AND GEOGR, V32, P543; Sato T., 2005, B FUKUSHIMA MUSEUM, P1; SATO TADASHI, 1962, MEM SOC GEOL FRANCE, V94, P1; Sato T., 2011, B FUKUSHIMA MUSEUM, V25, P25; SATO TADASHI, 1961, JAPANESE JOUR GEOL AND GEOGR, V32, P533; Sato T, 2008, PALEONTOL RES, V12, P261, DOI 10.2517/1342-8144-12.3.261; SATO T, 1991, NEWSL STRATIGR, V24, P81; Sha JG, 2009, SCI CHINA SER D, V52, P1871, DOI 10.1007/s11430-009-0205-x; Song Zhichen, 2000, FOSSIL SPORES POLLEN, P1; Song Zhichen, 1999, FOSSIL SPORES POLLEN, P1; Srivastava S.K., 1978, BIOL MEMOIRS, V3, P2; Sun Xiaomeng, 2007, Frontiers of Earth Science in China, V1, DOI 10.1007/s11707-007-0002-9; Taketani Y., 2013, B FUKUSHIMA MUSEUM, V27, P1; TOKUNAGA SHIGEYASU, 1930, JOUR GEOL SOC TOKYO, V37, P575; Wan Chuan-biao, 2002, Acta Micropalaeontologica Sinica, V19, P83; Wan CB, 2005, ACTA GEOL SIN-ENGL, V79, P459; Wan XQ, 2011, LETHAIA, V44, P231, DOI 10.1111/j.1502-3931.2010.00238.x; Wang LY, 2014, ACTA GEOL SIN-ENGL, V88, P46, DOI 10.1111/1755-6724.12182; Wang Qi-fei, 2005, Journal of Stratigraphy, V29, P114; Wang Xianzeng, 2000, ACTA GEOL SINICA, V74, P265; Wimbledon WAP, 2011, RIV ITAL PALEONTOL S, V117, P295; Wimbledon W.A.P., 2009, 8 INT S CRET SYST 6, P196; Wimbledon WAP, 2008, EPISODES, V31, P423; Yabe H., 1943, Proceedings of the Imperial Academy Tokyo, V19, P582; Yu Jingxian, 1989, TECTONIC MAGMATIC EV, P21; Zakharov Viktor A., 1996, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V66, P7; 张宏, 2008, [中国科学. D辑, 地球科学, Science in China. Series D, Earth Sciences], V38, P960; Zhang WP, 1989, TECTONIC MAGMATIC EV, P1; Zhang Yiyong, J STRATIGRAPHY, V24, P65; Zhao Chuanben, 1987, EARLY CRETACEOUS SPO, P1; Zhao Chuanben, 1985, PETROLEUM GEOLOGY OI, V4, P1; [郑玉龙 ZHENG Yulong], 2005, [地层学杂志, Journal of Stratigraphy], V29, P342; Zhou Zhong-he, 2009, Acta Palaeontologica Sinica, V48, P541	87	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1000-9515	1755-6724		ACTA GEOL SIN-ENGL	Acta Geol. Sin.-Engl. Ed.	FEB	2015	89	1					285	299				15	Geosciences, Multidisciplinary	Geology	CF8RD	WOS:000352828700023		
J	Komiya, K; Ishii, H; Kadota, J				Komiya, Kosaku; Ishii, Hiroshi; Kadota, Jun-ichi			Healthcare-associated Pneumonia and Aspiration Pneumonia	AGING AND DISEASE			English	Review						healthcare-associated pneumonia; aspiration pneumonia; elderly; diagnosis	COMMUNITY-ACQUIRED PNEUMONIA; PRIMARY LUNG ABSCESS; RISK-FACTORS; ELDERLY-PATIENTS; ANTIBIOTIC-THERAPY; CLINICAL-OUTCOMES; NURSING-HOME; HOSPITALIZED-PATIENTS; PROGNOSTIC-FACTORS; ADVANCED DEMENTIA	Healthcare-associated pneumonia (HCAP) is a new concept of pneumonia proposed by the American Thoracic Society/Infectious Diseases Society of America in 2005. This category is located between community-acquired pneumonia and hospital-acquired pneumonia with respect to the characteristics of the causative pathogens and mortality, and primarily targets elderly patients in healthcare facilities. Aspiration among such patients is recognized to be a primary mechanism for the development of pneumonia, particularly since the HCAP guidelines were published. However, it is difficult to manage patients with aspiration pneumonia because the definition of the condition is unclear, and the treatment is associated with ethical aspects. This review focused on the definition, prevalence and role of aspiration pneumonia as a prognostic factor in published studies of HCAP and attempted to identify problems associated with the concept of aspiration pneumonia.	[Komiya, Kosaku; Kadota, Jun-ichi] Oita Univ, Fac Med, Resp Med & Infect Dis, Oita 87011, Japan; [Komiya, Kosaku] Tenshindo Hetsugi Hosp, Clin Res Ctr Resp Med, Oita, Japan; [Ishii, Hiroshi] Fukuoka Univ Hosp, Dept Resp Med, Jonan Ku, Fukuoka, Japan	Komiya, K (reprint author), Oita Univ, Fac Med, Resp Med & Infect Dis, Oita 87011, Japan.	komiyakh1@oita-u.ac.jp					Allewelt M, 2004, CLIN MICROBIOL INFEC, V10, P163, DOI 10.1111/j.1469-0691.2004.00774.x; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bosch X, 2012, EUR J INTERN MED, V23, P720, DOI 10.1016/j.ejim.2012.08.006; Polverino E, 2009, SEMIN RESP CRIT CARE, V30, P36, DOI 10.1055/s-0028-1119807; Hsu JL, 2011, INT J INFECT DIS, V15, pE382, DOI 10.1016/j.ijid.2011.02.002; Ewig S, 2012, CURR OPIN INFECT DIS, V25, P166, DOI 10.1097/QCO.0b013e32835023fb; Chalmers JD, 2011, CLIN INFECT DIS, V53, P107, DOI 10.1093/cid/cir274; Yoneyama T, 2002, J AM GERIATR SOC, V50, P430, DOI 10.1046/j.1532-5415.2002.50106.x; Galvin S, 2012, J HOSP INFECT, V82, P143, DOI 10.1016/j.jhin.2012.06.015; Zissin R, 2001, EUR RADIOL, V11, P606, DOI 10.1007/s003300000619; Fukuyama H, 2013, J INFECT CHEMOTHER, V19, P719, DOI 10.1007/s10156-013-0557-1; Teramoto S, 2009, CHEST, V136, P1702, DOI 10.1378/chest.09-1204; Garcia-Vidal C, 2011, CLIN MICROBIOL INFEC, V17, P1659, DOI 10.1111/j.1469-0691.2011.03484.x; Attridge RT, 2011, AM J MED, V124, P689, DOI 10.1016/j.amjmed.2011.01.023; Grenier C, 2011, J ANTIMICROB CHEMOTH, V66, P1617, DOI 10.1093/jac/dkr176; SPICKARD A, 1994, ARCH INTERN MED, V154, P686, DOI 10.1001/archinte.154.6.686; Falcone M, 2012, INTERN EMERG MED, V7, P523, DOI 10.1007/s11739-012-0795-8; Komiya K, 2013, GERIATR GERONTOL INT, V13, P580, DOI 10.1111/j.1447-0594.2012.00940.x; Gleeson K, 1997, CHEST, V111, P1266, DOI 10.1378/chest.111.5.1266; Teramoto S, 2004, CHEST, V125, P801, DOI 10.1378/chest.125.2.801; Seymann GB, 2009, CLIN INFECT DIS, V49, P1868, DOI 10.1086/648429; KIKUCHI R, 1994, AM J RESP CRIT CARE, V150, P251; Ewig S, 2010, LANCET INFECT DIS, V10, P279, DOI 10.1016/S1473-3099(10)70032-3; Carrabba M, 2012, EUR RESPIR J, V40, P1201, DOI 10.1183/09031936.00187811; Dikensoy O, 2002, POSTGRAD MED J, V78, P399, DOI 10.1136/pmj.78.921.399; van der Maarel-Wierink CD, 2011, J AM MED DIR ASSOC, V12, P344, DOI 10.1016/j.jamda.2010.12.099; Carratala J, 2007, ARCH INTERN MED, V167, P1393, DOI 10.1001/archinte.167.13.1393; Jeong BH, 2013, CLIN INFECT DIS, V56, P625, DOI 10.1093/cid/cis970; Yamaya M, 2001, J AM GERIATR SOC, V49, P85, DOI 10.1046/j.1532-5415.2001.49015.x; Vergis EN, 2001, ARCH INTERN MED, V161, P2378, DOI 10.1001/archinte.161.19.2378; Falcone M, 2012, INTERN EMERG MED, V7, P415, DOI 10.1007/s11739-012-0796-7; Ishida T, 2012, INTERNAL MED, V51, P2537, DOI 10.2169/internalmedicine.51.7987; Quagliarello V, 2005, CLIN INFECT DIS, V40, P1, DOI 10.1086/426023; Falcone M, 2011, INTERN EMERG MED, V6, P431, DOI 10.1007/s11739-011-0521-y; Simonetti A, 2012, CLIN MICROBIOL INFEC, V18, P1149, DOI 10.1111/j.1469-0691.2011.03709.x; Parrilla C, 2008, CLIN NUCL MED, V33, P236, DOI 10.1097/RLU.0b013e31815969d2; Webb BJ, 2012, RESP MED, V106, P1606, DOI 10.1016/j.rmed.2012.08.003; Madaras-Kelly KJ, 2012, J HOSP MED, V7, P195, DOI 10.1002/jhm.942; Marik PE, 2003, CHEST, V124, P328, DOI 10.1378/chest.124.1.328; SOLOMON MZ, 1993, AM J PUBLIC HEALTH, V83, P14; Pae M, 2012, AGING DIS, V3, P91; Chroneou A, 2007, EXPERT OPIN PHARMACO, V8, P3117, DOI 10.1517/14656566.8.18.3117; Falcone M, 2011, INT J INFECT DIS, V15, pE545, DOI 10.1016/j.ijid.2011.04.005; Galovic M, 2013, STROKE, V44, P2760, DOI 10.1161/STROKEAHA.113.001690; Madaras-Kelly KJ, 2012, J GEN INTERN MED, V27, P845, DOI 10.1007/s11606-012-2011-y; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; El-Solh AA, 2003, AM J RESP CRIT CARE, V167, P1650, DOI 10.1164/rccm.200212-1543OC; Arai T, 1998, LANCET, V352, P115, DOI 10.1016/S0140-6736(98)85021-6; Fernandez-Sabe N, 2003, MEDICINE, V82, P159, DOI 10.1097/00005792-200305000-00002; HOLAS MA, 1994, ARCH NEUROL-CHICAGO, V51, P1051; Dobler CC, 2013, RESPIROLOGY, V18, P923, DOI 10.1111/resp.12132; Shindo Y, 2009, CHEST, V135, P633, DOI 10.1378/chest.08-1357; Bulow M, 2012, NESTLE NUTR WORKS SE, V72, P43, DOI 10.1159/000339980; Carratala J, 2008, CURR OPIN INFECT DIS, V21, P168, DOI 10.1097/QCO.0b013e3282f4f248; Craven DE, 2006, CURR OPIN INFECT DIS, V19, P153; Dharmarajan TS, 2001, AM J GASTROENTEROL, V96, P2556; Esayag Y, 2010, AM J MED, V123, pe81; Fraser NLM R. S., 1999, FRASER PARES DIAGNOS, VII; Fujitani S, 2006, EUR J CLIN MICROBIOL, V25, P627, DOI 10.1007/s10096-006-0197-9; Galicia-Castillo M, 2006, GERIATRICS, V61, P12; Giannella M, 2012, CLIN MICROBIOL INFEC, V18, P786, DOI 10.1111/j.1469-0691.2011.03757.x; Hazeldine J, 2013, AGEING RES IN PRESS; Hirose M, 2014, J PALLIAT M IN PRESS; Kadowaki M, 2005, CHEST, V127, P1276, DOI 10.1378/chest.127.4.1276; Kaku N, 2013, J INFECT CHEMOTHER, V19, P70, DOI 10.1007/s10156-012-0454-z; Kohno Shigeru, 2013, Respir Investig, V51, P103, DOI 10.1016/j.resinv.2012.11.001; Komiya K, 2012, J PALLIAT MED, V15, P561, DOI 10.1089/jpm.2011.0496; Komiya K, 2013, GERIATR GERONTOL INT, V13, P586, DOI 10.1111/j.1447-0594.2012.00941.x; Komiya K, 2013, EUR J INTERN MED, V24, pE88, DOI 10.1016/j.ejim.2013.06.009; Komiya K, 2013, GERIATR GERONTOL INT, V13, P388, DOI 10.1111/j.1447-0594.2012.00912.x; Komiya K, 2013, RESPIROLOGY, V18, P514, DOI 10.1111/resp.12029; Labelle A, 2012, CLIN CHEST MED, V32, P507; Lujan M, 2009, CURR OPIN CRIT CARE, V15, P419, DOI 10.1097/MCC.0b013e32832e9956; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Matsuse T, 1996, CHEST, V110, P1289, DOI 10.1378/chest.110.5.1289; Miyashita N, 2013, J INFECT CHEMOTHER, V19, P249, DOI 10.1007/s10156-012-0491-7; Miyashita N, 2012, INTERNAL MED, V51, P585, DOI 10.2169/internalmedicine.51.6475; Morrow LE, 2009, SEMIN RESP CRIT CARE, V30, P86, DOI 10.1055/s-0028-1119812; Mylotte JM, 2006, DRUG AGING, V23, P377, DOI 10.2165/00002512-200623050-00002; Nakagawa N, 2013, GERIATR GER IN PRESS; Nakagawa T, 2000, J INTERN MED, V247, P255, DOI 10.1046/j.1365-2796.2000.00599.x; Ohrui T, 2005, TOHOKU J EXP MED, V207, P3, DOI 10.1620/tjem.207.3; Oshitani Y, 2013, J INFECT CHEMOTHER, V19, P579, DOI 10.1007/s10156-012-0517-1; OTT DJ, 1993, AM J ROENTGENOL, V161, P507; Ott SR, 2008, INFECTION, V36, P23, DOI 10.1007/s15010-007-7043-6; Poch DS, 2009, SEMIN RESP CRIT CARE, V30, P26, DOI 10.1055/s-0028-1119806; Polverino E, 2009, SEMIN RESP CRIT CARE, V30, P239, DOI 10.1055/s-0029-1202940; Polverino E, 2013, RESPIROLOGY, V18, P263, DOI 10.1111/resp.12013; Restrepo MI, 2009, SEMIN RESP CRIT CARE, V30, P61, DOI 10.1055/s-0028-1119810; Riquelme R, 1996, AM J RESP CRIT CARE, V154, P1450; Robbins J, 1996, SEMIN NEUROL, V16, P309, DOI 10.1055/s-2008-1040989; Sasaki H, 1997, INTERNAL MED, V36, P851, DOI 10.2169/internalmedicine.36.851; Sekizawa K, 1998, LANCET, V352, P1069, DOI 10.1016/S0140-6736(05)60114-6; Steele CM, 2012, NESTLE NUTR WORKS SE, V72, P109, DOI 10.1159/000339999; Talaie Haleh, 2008, Acta Biomed, V79, P117; Teramoto S, 2008, J AM GERIATR SOC, V56, P1153, DOI 10.1111/j.1532-5415.2008.01703.x; Yoshino A, 2001, JAMA-J AM MED ASSOC, V286, P2235, DOI 10.1001/jama.286.18.2235	98	0	0	INT SOC AGING & DISEASE	FORT WORTH	EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA	2152-5250			AGING DIS	Aging Dis.	FEB	2015	6	1					27	37				11	Geriatrics & Gerontology	Geriatrics & Gerontology	CG1TQ	WOS:000353057700004		
J	Iwasaki, S; Yamasoba, T				Iwasaki, Shinichi; Yamasoba, Tatsuya			Dizziness and Imbalance in the Elderly: Age-related Decline in the Vestibular System	AGING AND DISEASE			English	Review						aging; vestibular; fall; rehabilitation	EVOKED MYOGENIC POTENTIALS; PAROXYSMAL POSITIONAL VERTIGO; CANALITH REPOSITIONING PROCEDURE; DEFINITE MENIERES-DISEASE; BONE CONDUCTED VIBRATION; HAIR CELL COUNTS; LONG-TERM SURVEY; HEARING-LOSS; VESTIBULOOCULAR RESPONSES; VIBROTACTILE FEEDBACK	Dizziness and imbalance are amongst the most common complaints in older people, and are a growing public health concern since they put older people at a significantly higher risk of falling. Although the causes of dizziness in older people are multifactorial, peripheral vestibular dysfunction is one of the most frequent causes. Benign paroxysmal positional vertigo is the most frequent form of vestibular dysfunction in the elderly, followed by Meniere's disease. Every factor associated with the maintenance of postural stability deteriorates during aging. Age-related deterioration of peripheral vestibular function has been demonstrated through quantitative measurements of the vestibulo-ocular reflex with rotational testing and of the vestibulo-collic reflex with testing of vestibular evoked myogenic potentials. Age-related decline of vestibular function has been shown to correlate with the age-related decrease in the number of vestibular hair cells and neurons. The mechanism of age-related cellular loss in the vestibular endorgan is unclear, but it is thought that genetic predisposition and cumulative effect of oxidative stress may both play an important role. Since the causes of dizziness in older people are multi-factorial, management of this disease should be customized according to the etiologies of each individual. Vestibular rehabilitation is found to be effective in treating both unilateral and bilateral vestibular dysfunction. Various prosthetic devices have also been developed to improve postural balance in older people. Although there have been no medical treatments improving age-related vestibular dysfunction, new medical treatments such as mitochondrial antioxidants or caloric restriction, which have been effective in preventing age-related hearing loss, should be ienvestigated in the future.	[Iwasaki, Shinichi; Yamasoba, Tatsuya] Univ Tokyo, Fac Med, Dept Otolaryngol, Bunkyo Ku, Tokyo 1138655, Japan	Iwasaki, S (reprint author), Univ Tokyo, Fac Med, Dept Otolaryngol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	iwashin-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [25293347]	We thank Dr. Chisato Fujimoto for critically reading the manuscript. This study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology (25293347).	Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Johkura K, 2008, J NEUROL NEUROSUR PS, V79, P1324, DOI 10.1136/jnnp.2008.147801; Baloh RW, 2001, ANN NY ACAD SCI, V942, P210; Brandt T, 1993, J Vestib Res, V3, P373; JOHNSSON LG, 1972, ANN OTO RHINOL LARYN, V81, P364; Semont A, 1988, Adv Otorhinolaryngol, V42, P290; BELAL A, 1986, J LARYNGOL OTOL, V100, P1037, DOI 10.1017/S0022215100100520; Neuhauser H, 2001, NEUROLOGY, V56, P436; Yardley L, 2004, ANN INTERN MED, V141, P598; COLLEDGE NR, 1994, AGE AGEING, V23, P117, DOI 10.1093/ageing/23.2.117; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Welgampola MS, 2005, NEUROLOGY, V64, P1682, DOI 10.1212/01.WNL.0000161876.20552.AA; Lawson J, 1999, J AM GERIATR SOC, V47, P12; Barin K, 2011, OTOLARYNG CLIN N AM, V44, P437, DOI 10.1016/j.otc.2011.01.013; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; Iwasaki S, 2007, NEUROLOGY, V68, P1227, DOI 10.1212/01.wnl.0000259064.80564.21; Neuhauser HK, 2007, CURR OPIN NEUROL, V20, P40, DOI 10.1097/WCO.0b013e328013f432; PARNES LS, 1992, LARYNGOSCOPE, V102, P988; Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; Lopez I, 2005, J NEUROSCI RES, V82, P421, DOI 10.1002/jnr.20652; Chihara Y, 2007, CLIN NEUROPHYSIOL, V118, P2745, DOI 10.1016/j.clinph.2007.08.005; Brantberg K, 2007, AUDIOL NEURO-OTOL, V12, P247, DOI 10.1159/000101332; OLOUGHLIN JL, 1994, J EPIDEMIOL COMMUN H, V48, P488, DOI 10.1136/jech.48.5.488; Curthoys IS, 2011, CLIN NEUROPHYSIOL, V122, P611, DOI 10.1016/j.clinph.2010.07.018; Rubenstein LZ, 2006, MED CLIN N AM, V90, P807, DOI 10.1016/j.mcna.2006.05.013; Le Prell CG, 2007, HEARING RES, V226, P22, DOI 10.1016/j.heares.2006.10.006; Ohlemiller KK, 2009, BRAIN RES, V1277, P70, DOI 10.1016/j.brainres.2009.02.079; Murofushi T, 2006, ACTA OTO-LARYNGOL, V126, P364, DOI 10.1080/00016480500417189; Fujimoto C, 2009, CLIN NEUROPHYSIOL, V120, P1408, DOI 10.1016/j.clinph.2009.05.002; Jonsson R, 2004, J VESTIBUL RES-EQUIL, V14, P47; Godemann F, 2005, J PSYCHIAT RES, V39, P529, DOI 10.1016/j.jpsychires.2004.12.006; Shojaku H, 2005, ORL J OTO-RHINO-LARY, V67, P305, DOI 10.1159/000089413; Yamasoba T, 2013, HEARING RES, V303, P30, DOI 10.1016/j.heares.2013.01.021; Iwasaki S, 2008, CLIN NEUROPHYSIOL, V119, P2135, DOI 10.1016/j.clinph.2008.05.028; KROENKE K, 1992, ANN INTERN MED, V117, P898; Delbaere K, 2004, AGE AGEING, V33, P368, DOI 10.1093/ageing/afh106; Rauch SD, 2001, ANN NY ACAD SCI, V942, P220; Agrawal Y, 2012, OTOL NEUROTOL, V33, P832, DOI 10.1097/MAO.0b013e3182545061; BALOH RW, 1993, EXP BRAIN RES, V95, P509; MUROFUSHI T, 1995, EXP BRAIN RES, V103, P174; Yardley L, 1998, BRIT J GEN PRACT, V48, P1136; BALOH RW, 1987, NEUROLOGY, V37, P371; Alrwaily M, 2011, OTOLARYNG CLIN N AM, V44, P473, DOI 10.1016/j.otc.2011.01.015; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Iwasaki S, 2009, CLIN NEUROPHYSIOL, V120, P588, DOI 10.1016/j.clinph.2008.12.036; Ballester M, 2002, OTOL NEUROTOL, V23, P73, DOI 10.1097/00129492-200201000-00017; BALOH RW, 1995, J AM GERIATR SOC, V43, P638; CAWTHORNE T, 1946, P ROY SOC MED, V39, P270; Cheng Alan G, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P343, DOI 10.1097/01.moo.0000186799.45377.63; Colledge NR, 1996, BRIT MED J, V313, P788; DAVIS LE, 1994, J AM GERIATR SOC, V42, P1184; DIX MR, 1952, P ROY SOC MED, V45, P341; EPLEY JM, 1992, OTOLARYNG HEAD NECK, V107, P399; Gopen Q, 2003, LARYNGOSCOPE, V113, P1132, DOI 10.1097/00005537-200307000-00007; Graafmans WC, 1996, AM J EPIDEMIOL, V143, P1129; Guilemany JM, 2004, ACTA OTO-LARYNGOL, V124, P49, DOI 10.1080/00016480310002122; IGARASHI M, 1993, ACTA OTO-LARYNGOL, P26; Iwasaki S, 2011, ACTA OTO-LARYNGOL, V131, P41, DOI 10.3109/00016489.2010.514008; KATSARKAS A, 1994, OTOLARYNG HEAD NECK, V110, P296, DOI 10.1016/S0194-5998(94)70772-3; Kushiro K, 2000, EXP BRAIN RES, V131, P406, DOI 10.1007/s002219900312; Li FZ, 2003, J GERONTOL B-PSYCHOL, V58, pP283; Merchant S N, 2000, Ann Otol Rhinol Laryngol Suppl, V181, P3; OKINAKA Y, 1993, ACTA OTO-LARYNGOL, P18; Paige G D, 1992, J Vestib Res, V2, P133; Peterka R J, 1990, J Vestib Res, V1, P49; RICHTER E, 1980, ACTA OTO-LARYNGOL, V90, P199, DOI 10.3109/00016488009131716; SCHUKNECHT H F, 1955, Laryngoscope, V65, P402; SEKITANI T, 1993, ACTA OTO-LARYNGOL, P9; Shiga A, 2005, AUDIOL NEURO-OTOL, V10, P97, DOI 10.1159/000083365; Shojaku H, 2009, ACTA OTO-LARYNGOL, V129, P155, DOI 10.1080/00016480802112587; SLOANE PD, 1994, J AM GERIATR SOC, V42, P847; Sloane PD, 2001, ANN INTERN MED, V134, P823; Stel VS, 2003, J AM GERIATR SOC, V51, P1356, DOI 10.1046/j.1532-5415.2003.51452.x; TEASDALE N, 1991, J GERONTOL, V46, pB238; Tinetti ME, 2000, ANN INTERN MED, V132, P337; Uchida Y, 2011, AURIS NASUS LARYNX, V38, P657, DOI 10.1016/j.anl.2011.02.005; Vuillerme N, 2009, INVEST OPHTH VIS SCI, V50, P476, DOI 10.1167/iovs.07-1595; Wall C, 2005, J VESTIBUL RES-EQUIL, V15, P313; Wall C, 2010, J NEUROL PHYS THER, V34, P98, DOI 10.1097/NPT.0b013e3181dde6f0; Whitney SL, 2002, LARYNGOSCOPE, V112, P1785, DOI 10.1097/00005537-200210000-00015; WLADISLAVOSKYWASERMAN P, 1984, LARYNGOSCOPE, V94, P1098; WOLFSON L, 1992, NEUROLOGY, V42, P2069	83	2	3	INT SOC AGING & DISEASE	FORT WORTH	EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA	2152-5250			AGING DIS	Aging Dis.	FEB	2015	6	1					38	47				10	Geriatrics & Gerontology	Geriatrics & Gerontology	CG1TQ	WOS:000353057700005		
J	Sato, M; Hasegawa, Y; Mishima, K; Takata, K				Sato, Miyako; Hasegawa, Yoichi; Mishima, Kentaro; Takata, Katsuhiko			ISOLATION AND CHARACTERIZATION OF 22 EST-SSR MARKERS FOR THE GENUS THUJOPSIS (CUPRESSACEAE)	APPLICATIONS IN PLANT SCIENCES			English	Article						Cupressaceae; expressed sequence tag; microsatellite; next-generation sequencing; Thujopsis	DNA	Premise of the study: Expressed sequence tag-simple sequence repeat (EST-SSR) markers were developed from Thujopsis dolabrata var. hondae (Cupressaceae) using Illumina sequencing to investigate the genetic diversity and population structure of the genus Thujopsis. Methods and Results: Twenty-two primer pairs were developed from ESTs of T. dolabrata var. hondae. The primers amplified di- and trinucleotide repeat-containing sequences. Polymorphisms were assessed in 81 individuals from two T. dolabrata var. hondae populations and one T. dolabrata population. The number of alleles ranged from one to 17 per locus. The observed and expected heterozygosities ranged from 0.000 to 1.000 and from 0.000 to 0.926, respectively. Conclusions: These new EST-SSR markers will be useful in analyses of the genetic diversity and population structure of the genus Thujopsis.	[Sato, Miyako; Hasegawa, Yoichi; Takata, Katsuhiko] Akita Prefectural Univ, Inst Wood Technol, Noshiro, Akita 0160876, Japan; [Mishima, Kentaro] Forest Tree Breeding Ctr, Forestry & Forest Prod Res Inst, Hitachi, Ibaraki 3191301, Japan	Takata, K (reprint author), Akita Prefectural Univ, Inst Wood Technol, 11-1 Kaieisaka, Noshiro, Akita 0160876, Japan.	katsu@iwt.akita-pu.ac.jp			Japan Society for Promotion of Science (JSPS) [25282069]	The authors thank S. Akiyama for assistance with the DNA extraction. This work was financially supported by a Grant-in-Aid for Scientific Research (B) (No. 25282069) of the Japan Society for Promotion of Science (JSPS).	Blacket MJ, 2012, MOL ECOL RESOUR, V12, P456, DOI 10.1111/j.1755-0998.2011.03104.x; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Pittermann J, 2012, P NATL ACAD SCI USA, V109, P9647, DOI 10.1073/pnas.1114378109; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Fageria MS, 2013, EVOL APPL, V6, P778, DOI 10.1111/eva.12064; Hayashi Y., 1960, TAXONOMICAL PHYTOGEO; Higuchi Y., 2012, Journal of the Japanese Forest Society, V94, P247, DOI 10.4005/jjfs.94.247; Inamori Yoshihiko, 2006, Biocontrol Science, V11, P49; Mishima K, 2012, AM J BOT, V99, pE317, DOI 10.3732/ajb.1200010; Rozen S, 2000, Methods Mol Biol, V132, P365; Uchiyama K, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200464; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407	17	0	0	BOTANICAL SOC AMER INC	ST LOUIS	PO BOX 299, ST LOUIS, MO 63166-0299 USA	2168-0450			APPL PLANT SCI	Appl. Plant Sci.	FEB	2015	3	2							1400101	10.3732/apps.1400101		4	Plant Sciences	Plant Sciences	CG1SC	WOS:000353053200004		
J	Ogura, K; Ishii, Y				Ogura, Kenichiro; Ishii, Yuji			Significance of non-cytochrome P450 (non-P450) enzymes in basic science, clinical field and drug development Preface	DRUG METABOLISM AND PHARMACOKINETICS			English	Editorial Material									[Ogura, Kenichiro] Tokyo Univ Pharm & Life Sci, Sch Pharm, Tokyo, Japan; [Ishii, Yuji] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan	Ogura, K (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Tokyo, Japan.						Hosokawa M, 2008, MOLECULES, V13, P412, DOI 10.3390/molecules13020412; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794	3	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	FEB	2015	30	1					1	2		10.1016/j.dmpk.2014.12.004		2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VM	WOS:000353285500001		
J	Naritomi, Y; Nakamori, F; Furukawa, T; Tabata, K				Naritomi, Yoichi; Nakamori, Fumihiro; Furukawa, Takako; Tabata, Kenji			Prediction of hepatic and intestinal glucuronidation using in vitro-in vivo extrapolation	DRUG METABOLISM AND PHARMACOKINETICS			English	Review						UDP-glucuronosyltransferase; Glucuronidation; In vitro-in vivo extrapolation; Liver; Intestine; Availability; Clearance; Prediction	HUMAN LIVER-MICROSOMES; HUMAN UDP-GLUCURONOSYLTRANSFERASES; HUMAN DRUG GLUCURONIDATION; MESSENGER-RNA EXPRESSION; TANDEM MASS-SPECTROMETRY; BOVINE SERUM-ALBUMIN; METABOLIC-CLEARANCE; QUANTITATIVE PREDICTION; 1ST-PASS METABOLISM; HUMAN KIDNEY	The accurate prediction of hepatic (F-h) and intestinal availability (F-g) is vital for determining human pharmacokinetics. To predict these PK parameters for cytochrome P450 (P450) metabolism, in vitro-in vivo extrapolation (IVIVE) using hepatic microsomes, hepatocytes, and intestinal microsomes has been actively investigated. However, IVIVE has not been sufficiently evaluated for non-P450 enzymes. UDP-glucuronosyltransferase (UGT) is a non-P450 enzyme that catalyzes glucuronidation, a major pathway for drugs possessing carboxylic acid, hydroxyl, and amine moieties. In drug metabolism, UGT is the most important enzyme after P450, and prediction of Fh for UGT substrates has mainly been attempted using hepatic models based on the clearance concepts. While various approaches for achieving improved prediction of clearance have been investigated-such as the addition of bovine serum albumin to microsomal incubation mixtures-optimized in vitro methods that utilize both hepatic microsomes and hepatocytes for more accurate prediction are still required. Although application of the simplified intestinal availability (SIA) model is effective in predicting the Fg of UGT substrates, this model is limited to compounds with high oral absorption. In this review, we discuss the current state, issues, and future directions of predicting Fh and F-g for glucuronidation. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Naritomi, Yoichi; Nakamori, Fumihiro; Furukawa, Takako; Tabata, Kenji] Astellas Pharma Inc, Anal & Pharmacokinet Res Labs, Tsukuba, Ibaraki 3058585, Japan	Naritomi, Y (reprint author), Astellas Pharma Inc, Anal & Pharmacokinet Res Labs, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	yoichi.naritomi@astellas.com					Akabane T, 2012, DRUG METAB PHARMACOK, V27, P181, DOI 10.2133/dmpk.DMPK-11-RG-097; Al-Jahdari WS, 2006, EUR J CLIN PHARMACOL, V62, P527, DOI 10.1007/s00228-006-0130-2; KOLARS JC, 1991, LANCET, V338, P1488, DOI 10.1016/0140-6736(91)92302-I; Di L, 2012, DRUG METAB DISPOS, V40, P1860, DOI 10.1124/dmd.112.046425; Cubitt HE, 2011, DRUG METAB DISPOS, V39, P864, DOI 10.1124/dmd.110.036566; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Ishiguro N, 2006, DRUG METAB DISPOS, V34, P1109, DOI 10.1124/dmd.105.009175; Obach RS, 2011, CURR TOP MED CHEM, V11, P334; Iwatsubo T, 1997, PHARMACOL THERAPEUT, V73, P147, DOI 10.1016/S0163-7258(96)00184-2; Shelby MK, 2003, DRUG METAB DISPOS, V31, P326, DOI 10.1124/dmd.31.3.326; Kilford PJ, 2009, DRUG METAB DISPOS, V37, P82, DOI 10.1124/dmd.108.023853; Ilett KF, 2002, DRUG METAB DISPOS, V30, P1005, DOI 10.1124/dmd.30.9.1005; Furukawa T, 2012, DRUG METAB PHARMACOK, V27, P171, DOI 10.2133/dmpk.DMPK-11-RG-088; Furukawa T, 2014, XENOBIOTICA, V44, P205, DOI 10.3109/00498254.2013.828362; Ritter JK, 2007, EXPERT OPIN DRUG MET, V3, P93, DOI 10.1517/17425255.3.1.93; Ohno S, 2009, DRUG METAB DISPOS, V37, P32, DOI 10.1124/dmd.108.023598; Gill KL, 2012, DRUG METAB DISPOS, V40, P825, DOI 10.1124/dmd.111.043984; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Harbourt DE, 2012, ANAL CHEM, V84, P98, DOI 10.1021/ac201704a; Fallon JK, 2013, J PROTEOME RES, V12, P4402, DOI 10.1021/pr4004213; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; RANE A, 1977, J PHARMACOL EXP THER, V200, P420; Nishimura M, 2009, DRUG METAB PHARMACOK, V24, P139; Rowland A, 2007, J PHARMACOL EXP THER, V321, P137, DOI 10.1121/jpet.106.118216; Fisher MB, 2000, DRUG METAB DISPOS, V28, P560; Rowland A, 2008, DRUG METAB DISPOS, V36, P1056, DOI 10.1124/dmd.108.021105; Yang JS, 2007, CURR DRUG METAB, V8, P676, DOI 10.2174/138920007782109733; Soars MG, 2002, J PHARMACOL EXP THER, V301, P382, DOI 10.1124/jpet.301.1.382; Miners JO, 2006, BIOCHEM PHARMACOL, V71, P1531, DOI 10.1016/j.bcp.2005.12.019; Lin JH, 2002, CURR DRUG METAB, V3, P623, DOI 10.2174/1389200023336992; Paine MF, 1996, CLIN PHARMACOL THER, V60, P14, DOI 10.1016/S0009-9236(96)90162-9; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; Kadono K, 2010, DRUG METAB DISPOS, V38, P1230, DOI 10.1124/dmd.109.029322; Mizuma T, 2009, INT J PHARMACEUT, V378, P140, DOI 10.1016/j.ijpharm.2009.05.044; Miners JO, 2010, DRUG METAB REV, V42, P196, DOI 10.3109/03602530903210716; Kumar S, 2002, J PHARMACOL EXP THER, V303, P969, DOI 10.1124/jpet.102.038992; Izumi T, 1997, J PHARMACOL EXP THER, V280, P1392; Gertz M, 2010, DRUG METAB DISPOS, V38, P1147, DOI 10.1124/dmd.110.032649; Soars MG, 2003, DRUG METAB DISPOS, V31, P762, DOI 10.1124/dmd.31.6.762; Manevski N, 2011, DRUG METAB DISPOS, V39, P2117, DOI 10.1124/dmd.111.041418; Sato Y, 2014, DRUG METAB DISPOS, V42, P885, DOI 10.1124/dmd.113.056291; BANHEGYI G, 1993, FEBS LETT, V328, P149, DOI 10.1016/0014-5793(93)80983-2; Boase S, 2002, BRIT J CLIN PHARMACO, V54, P493, DOI 10.1046/j.1365-2125.2002.01669.x; Bouska JJ, 1997, DRUG METAB DISPOS, V25, P1032; Engtrakul JJ, 2005, DRUG METAB DISPOS, V33, P1621, DOI 10.1124/dmd.105.005058; Furukawa T, 2012, XENOBIOTICA, V42, P980, DOI 10.3109/00498254.2012.680620; Gibson CR, 2013, XENOBIOTICA, V43, P1027, DOI 10.3109/00498254.2013.791761; Gill KL, 2013, DRUG METAB DISPOS, V41, P744, DOI 10.1124/dmd.112.050294; Houston JB, 2005, ARCH BIOCHEM BIOPHYS, V433, P351, DOI 10.1016/j.abb.2004.09.010; Komura H, 2011, DRUG METAB REV, V43, P476, DOI 10.3109/03602532.2011.597401; Kuester RK, 2007, DRUG METAB DISPOS, V35, P1910, DOI 10.1124/dmd.107.014787; Miners JO, 2004, ANNU REV PHARMACOL, V44, P1, DOI 10.1146/annurev.pharmtox.44.101802.121546; MISTRY M, 1987, DRUG METAB DISPOS, V15, P710; Nakamori F, 2012, DRUG METAB DISPOS, V40, P1771, DOI 10.1124/dmd.112.045476; Nakamori F, 2011, DRUG METAB PHARMACOK, V26, P465, DOI 10.2133/dmpk.DMPK-11-RG-018; Naritomi Y, 2001, DRUG METAB DISPOS, V29, P1316; Nishimuta H, 2011, DRUG METAB PHARMACOK, V26, P592, DOI 10.2133/dmpk.DMPK-11-RG-034; Pang K S, 1977, J Pharmacokinet Biopharm, V5, P625, DOI 10.1007/BF01059688; ROBERTS MS, 1986, J PHARM PHARMACOL, V38, P177; Rowland A, 2009, DRUG METAB DISPOS, V37, P1395, DOI 10.1124/dmd.109.027656; Tsoutsikos P, 2004, BIOCHEM PHARMACOL, V67, P191, DOI 10.1016/j.bcp.2003.08.025; Uno S, 2008, XENOBIOTICA, V38, P482, DOI 10.1080/00498250801935982 ; Wu BJ, 2013, CURR TOP MED CHEM, V13, P1343	63	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	FEB	2015	30	1					21	29		10.1016/j.dmpk.2014.10.001		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VM	WOS:000353285500003		
J	Oda, S; Fukami, T; Yokoi, T; Nakajima, M				Oda, Shingo; Fukami, Tatsuki; Yokoi, Tsuyoshi; Nakajima, Miki			A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development	DRUG METABOLISM AND PHARMACOKINETICS			English	Review						Carboxylesterase; Drug metabolism; Drug development; Enzyme induction; Enzyme inhibitors; Gene expression; Substrate; UDP-glucuronosyltransferase	ARYL-HYDROCARBON RECEPTOR; HUMAN LIVER-MICROSOMES; HUMAN ARYLACETAMIDE DEACETYLASE; TANDEM MASS-SPECTROMETRY; PREGNANE-X-RECEPTOR; HUMAN SERUM-ALBUMIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MESSENGER-RNA EXPRESSION; IN VIVO EXTRAPOLATION; CONSTITUTIVE ANDROSTANE RECEPTOR	UDP-glucuronosyltransferase (UGT) and esterases are recognized as the most important non-P450 enzymes because of their high contribution to drug metabolism. UGTs catalyze the transfer of glucuronic acid to hydroxyl, carboxyl, or amine groups of compounds, whereas esterases hydrolyze compounds that contain ester, amide, and thioester bonds. These enzymes, in most cases, convert hydrophobic compounds to water-soluble metabolites to facilitate the elimination of compounds from the body. Information about these enzymes is steadily increasing, although our knowledge is still behind our understanding of P450. This review gives an overview of recent findings in UGT and esterases studies focusing on tissue distribution, gene regulation, substrate and inhibitor specificity, and species differences. In particular, the absolute protein content of UGT isoforms and esterases in human tissues could be available. In the field of esterases, it is becoming clear that enzymes other than carboxylesterase are involved in drug hydrolysis. In addition, there is an interesting interplay between UGTs and esterases in the formation and hydrolytic deglucuronidation of acyl-glucuronide, which is considered to be a reactive metabolite. With the growing awareness of the importance of non-P450 enzymes in drug development, issues that should be resolved are discussed. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Oda, Shingo; Yokoi, Tsuyoshi] Nagoya Univ, Grad Sch Med, Dept Drug Safety Sci, Showa Ku, Nagoya, Aichi 4668550, Japan; [Fukami, Tatsuki; Nakajima, Miki] Kanazawa Univ, Fac Pharmaceut Sci, Drug Metab & Toxicol, Kanazawa, Ishikawa 9201192, Japan	Nakajima, M (reprint author), Kanazawa Univ, Fac Pharmaceut Sci, Drug Metab & Toxicol, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	nmiki@p.kanazawa-u.ac.jp	Nakajima, Miki/C-3990-2015				Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Wei YD, 2000, ARCH BIOCHEM BIOPHYS, V383, P99, DOI 10.1006/abbi.2000.2037; Sugatani J, 2004, BIOCHEM PHARMACOL, V67, P989, DOI 10.1016/j.bcp.2003.11.002; Parkinson EI, 2011, BIOORGAN MED CHEM, V19, P4635, DOI 10.1016/j.bmc.2011.06.012; Green MD, 1998, DRUG METAB DISPOS, V26, P507; Fallon JK, 2013, DRUG METAB DISPOS, V41, P2076, DOI 10.1124/dmd.113.053801; Achour B, 2014, DRUG METAB DISPOS, V42, P500, DOI 10.1124/dmd.113.055632; SMITH PC, 1992, DRUG METAB DISPOS, V20, P962; Takusagawa S, 2012, XENOBIOTICA, V42, P957, DOI 10.3109/00498254.2012.675095; Barbier O, 2003, GASTROENTEROLOGY, V124, P1926, DOI 10.1016/S0016-5085(03)00388-3; Uchaipichat V, 2006, DRUG METAB DISPOS, V34, P449, DOI 10.1124/dmd.105.007369; Prueksaritanont T, 2002, J PHARMACOL EXP THER, V301, P1042, DOI 10.1124/jpet.301.3.1042; Ohbuchi M, 2009, DRUG METAB DISPOS, V37, P97, DOI 10.1124/dmd.108.021964; Lankisch TO, 2008, ARCH TOXICOL, V82, P573, DOI 10.1007/s00204-008-0347-1; Quinney SK, 2005, J PHARMACOL EXP THER, V313, P1011, DOI 10.1124/jpet.104.081265; Holmes RS, 2010, MAMM GENOME, V21, P427, DOI 10.1007/s00335-010-9284-4; Kato Y, 2012, DRUG METAB DISPOS, V40, P240, DOI 10.1124/dmd.111.042150; He X, 2009, BRIT J CLIN PHARMACO, V68, P721, DOI 10.1111/j.1365-2125.2009.03519.x; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Hirohashi T, 2000, J BIOL CHEM, V275, P2905, DOI 10.1074/jbc.275.4.2905; Sawamura R, 2010, DRUG METAB DISPOS, V38, P1857, DOI 10.1124/dmd.110.034173; Buckley DB, 2007, DRUG METAB DISPOS, V35, P121, DOI 10.1124/dmd.106.012070; Pascussi JM, 2008, ANNU REV PHARMACOL, V48, P1, DOI 10.1146/annurev.pharmtox.47.120505.105349; Duysen EG, 2011, CHEM RES TOXICOL, V24, P1891, DOI 10.1021/tx200237a; PROBST MR, 1991, BIOCHEM BIOPH RES CO, V177, P453, DOI 10.1016/0006-291X(91)92005-5; Gardner-Stephen D, 2004, DRUG METAB DISPOS, V32, P340, DOI 10.1124/dmd.32.3.340; Xu CS, 2009, DRUG METAB DISPOS, V37, P1539, DOI 10.1124/dmd.109.026989; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Fukami T, 2010, DRUG METAB DISPOS, V38, P2173, DOI 10.1124/dmd.110.034454; Erichsen TJ, 2010, J HEPATOL, V52, P570, DOI 10.1016/j.jhep.2010.01.010; Riedmaier S, 2010, CLIN PHARMACOL THER, V87, P65, DOI 10.1038/clpt.2009.181; Rouguieg K, 2010, DRUG METAB DISPOS, V38, P40, DOI 10.1124/dmd.109.029546; SMITH PC, 1986, J CLIN INVEST, V77, P934, DOI 10.1172/JCI112392; Takai S, 1997, BIOL PHARM BULL, V20, P869; Thomsen R, 2014, DRUG METAB DISPOS, V42, P126, DOI 10.1124/dmd.113.053512; Watanabe A, 2009, DRUG METAB DISPOS, V37, P1513, DOI 10.1124/dmd.109.026567; Shelby MK, 2003, DRUG METAB DISPOS, V31, P326, DOI 10.1124/dmd.31.3.326; Gouedard C, 2003, MOL PHARMACOL, V63, P945, DOI 10.1124/mol.63.4.945; Tukey RH, 2001, MOL PHARMACOL, V59, P405; Wadkins RM, 2005, J MED CHEM, V48, P2906, DOI 10.1021/jm049011j; Picard N, 2005, DRUG METAB DISPOS, V33, P139, DOI 10.1124/dmd.104.001651; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kilford PJ, 2009, DRUG METAB DISPOS, V37, P82, DOI 10.1124/dmd.108.023853; Barbier O, 2003, J BIOL CHEM, V278, P32852, DOI 10.1074/jbc.M305361200; Kemp DC, 2002, DRUG METAB DISPOS, V30, P694, DOI 10.1124/dmd.30.6.694; Kalthoff S, 2010, J BIOL CHEM, V285, P5993, DOI 10.1074/jbc.M109.075770; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Ito K, 2005, PHARM RES, V22, P103, DOI 10.1007/s11095-004-9015-1; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001.0038; Shi DS, 2006, J PHARMACOL EXP THER, V319, P1477, DOI 10.1124/jpet.106.111807; Zhu LL, 2012, DRUG METAB DISPOS, V40, P529, DOI 10.1124/dmd.111.042192; Strassburg CP, 1999, BIOCHEM J, V338, P489, DOI 10.1042/0264-6021:3380489; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Phelan D, 1998, ARCH BIOCHEM BIOPHYS, V357, P155, DOI 10.1006/abbi.1998.0814; Watanabe A, 2010, DRUG METAB DISPOS, V38, P1532, DOI 10.1124/dmd.110.033720; Schaefer O, 2012, DRUG METAB DISPOS, V40, P93, DOI 10.1124/dmd.111.042275; Mano Y, 2007, DRUG METAB DISPOS, V35, P2040, DOI 10.1124/dmd.107.017269; Jinno N, 2013, BIOL PHARM BULL, V36, P1509; Wong NS, 2011, PHARMACOGENET GENOM, V21, P760, DOI 10.1097/FPC.0b013e32834a8639; Liu Y, 2010, DRUG METAB DISPOS, V38, P32, DOI 10.1124/dmd.109.029660; Ritter JK, 2007, EXPERT OPIN DRUG MET, V3, P93, DOI 10.1517/17425255.3.1.93; Humerickhouse R, 2000, CANCER RES, V60, P1189; Kobayashi Y, 2012, BIOCHEM PHARMACOL, V84, P1196, DOI 10.1016/j.bcp.2012.08.015; Ohno S, 2009, DRUG METAB DISPOS, V37, P32, DOI 10.1124/dmd.108.023598; Wilson W, 2004, GENOMICS, V84, P707, DOI 10.1016/j.ygeno.2004.06.011; Gouedard C, 2004, MOL CELL BIOL, V24, P5209, DOI 10.1128/MCB.24.12.5209-5222.2004; Zhang DL, 2005, DRUG METAB DISPOS, V33, P1729, DOI 10.1124/dmd.105.005447; Court MH, 2012, XENOBIOTICA, V42, P266, DOI 10.3109/00498254.2011.618954; Mojarrabi B, 1996, BIOCHEM BIOPH RES CO, V225, P785, DOI 10.1006/bbrc.1996.1251; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Miao YQ, 2010, CHEM REV, V110, P5216, DOI 10.1021/cr900214c; Harbourt DE, 2012, ANAL CHEM, V84, P98, DOI 10.1021/ac201704a; Williams ET, 2008, DRUG METAB DISPOS, V36, P1227, DOI 10.1124/dmd.107.020248; Walsky RL, 2012, DRUG METAB DISPOS, V40, P1051, DOI 10.1124/dmd.111.043117; Zhu HJ, 2009, BIOCHEM PHARMACOL, V77, P1266, DOI 10.1016/j.bcp.2008.12.017; Ciotti M, 1999, BIOCHEM BIOPH RES CO, V260, P199, DOI 10.1006/bbrc.1999.0453; DUBOISPRESLE N, 1995, MOL PHARMACOL, V47, P647; Morton CL, 2005, CANCER CHEMOTH PHARM, V56, P629, DOI 10.1007/s00280-005-1027-y; Kobayashi Y, 2012, DRUG METAB DISPOS, V40, P671, DOI 10.1124/dmd.111.043067; JIN CJ, 1993, BIOCHEM BIOPH RES CO, V194, P496, DOI 10.1006/bbrc.1993.1847; Strassburg CP, 2008, ARCH TOXICOL, V82, P415, DOI 10.1007/s00204-008-0314-x; Rae JM, 2001, J PHARMACOL EXP THER, V299, P849; Kaivosaari S, 2007, MOL PHARMACOL, V72, P761, DOI 10.1124/mol.107.037093; Miles KK, 2005, DRUG METAB DISPOS, V33, P1513, DOI 10.1124/dmd.105.004663; Fallon JK, 2013, J PROTEOME RES, V12, P4402, DOI 10.1021/pr4004213; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Miners JO, 2011, DRUG METAB DISPOS, V39, P644, DOI 10.1124/dmd.110.037036; Zhu HJ, 2009, DRUG METAB DISPOS, V37, P264, DOI 10.1124/dmd.108.024943; Court MH, 2002, DRUG METAB DISPOS, V30, P1257, DOI 10.1124/dmd.30.11.1257; Deakin S, 2003, ARTERIOSCL THROM VAS, V23, P2083, DOI 10.1161/01.ATV.0000096207.01487.36; Paine MF, 1997, J PHARMACOL EXP THER, V283, P1552; Shimizu M, 2014, DRUG METAB DISPOS, V42, P1103, DOI 10.1124/dmd.114.056994; Barbier O, 2009, MOL CELL BIOCHEM, V326, P3, DOI 10.1007/s11010-008-0001-5; Barbier O, 2000, BIOCHEMISTRY-US, V39, P11540, DOI 10.1021/bi000779p; Balliet RM, 2009, CANCER RES, V69, P2981, DOI 10.1158/0008-5472.CAN-08-4143; Fukami T, 2012, DRUG METAB PHARMACOK, V27, P466, DOI 10.2133/dmpk.DMPK-12-RV-042; Guillemette C, 2000, PHARMACOGENETICS, V10, P629, DOI 10.1097/00008571-200010000-00006; Chung JY, 2005, CLIN PHARMACOL THER, V77, P486, DOI 10.1016/j.clpt.2005.02.006; Rowland A, 2006, DRUG METAB DISPOS, V34, P1055, DOI 10.1124/dmd.106.009340; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Itaaho K, 2009, DRUG METAB DISPOS, V37, P768, DOI 10.1124/dmd.108.025692; Nishimura M, 2009, DRUG METAB PHARMACOK, V24, P139; Uchaipichat V, 2006, BRIT J CLIN PHARMACO, V61, P427, DOI 10.1111/j.1365-2125.2006.02588.x; Prueksaritanont T, 2002, DRUG METAB DISPOS, V30, P505, DOI 10.1124/dmd.30.5.505; Tang M, 2006, J PHARMACOL EXP THER, V319, P1467, DOI 10.1124/jpet.106.110577; Trottier J, 2006, HEPATOLOGY, V44, P1158, DOI 10.1002/hep.21362; Rowland A, 2007, J PHARMACOL EXP THER, V321, P137, DOI 10.1121/jpet.106.118216; SIDELL FR, 1975, CLIN CHEM, V21, P1393; Rowland A, 2013, INT J BIOCHEM CELL B, V45, P1121, DOI 10.1016/j.biocel.2013.02.019; Iwamura A, 2012, J BIOL CHEM, V287, P9240, DOI 10.1074/jbc.M111.271288; Shimizu M, 2012, DRUG METAB DISPOS, V40, P1183, DOI 10.1124/dmd.112.044883; Cubitt HE, 2009, PHARM RES-DORD, V26, P1073, DOI 10.1007/s11095-008-9823-9; Vogel A, 2001, GASTROENTEROLOGY, V121, P1136, DOI 10.1053/gast.2001.28655; Takahashi S, 2009, DRUG METAB DISPOS, V37, P956, DOI 10.1124/dmd.108.024331; Xu G, 2002, CLIN CANCER RES, V8, P2605; Izukawa T, 2009, DRUG METAB DISPOS, V37, P1759, DOI 10.1124/dmd.109.027227; Rowland A, 2008, DRUG METAB DISPOS, V36, P1056, DOI 10.1124/dmd.108.021105; Barter ZE, 2007, CURR DRUG METAB, V8, P33, DOI 10.2174/138920007779315053; JBILO O, 1994, TOXICON, V32, P1445, DOI 10.1016/0041-0101(94)90416-2; Soars MG, 2002, J PHARMACOL EXP THER, V301, P382, DOI 10.1124/jpet.301.1.382; Sugatani J, 2013, DRUG METAB PHARMACOK, V28, P83, DOI 10.2133/dmpk.DMPK-12-RV-096; Kuehl GE, 2005, DRUG METAB DISPOS, V33, P1027, DOI 10.1124/dmd.104.002527; Madan A, 2007, XENOBIOTICA, V37, P736, DOI 10.1080/00498250701433054; BINDA G, 1971, ARZNEI-FORSCHUNG, V21, P1907; Miners JO, 2006, BIOCHEM PHARMACOL, V71, P1531, DOI 10.1016/j.bcp.2005.12.019; Zhang YC, 2012, DRUG METAB DISPOS, V40, P1191, DOI 10.1124/dmd.111.043877; Yueh MF, 2007, J BIOL CHEM, V282, P8749, DOI 10.1074/jbc.M610790200; Nakamura A, 2008, DRUG METAB DISPOS, V36, P1461, DOI 10.1124/dmd.108.021428; Nakajima A, 2011, BIOCHEM PHARMACOL, V82, P1747, DOI 10.1016/j.bcp.2011.08.003; Dong D, 2012, J PHARM SCI-US, V101, P3531, DOI 10.1002/jps.23100; Imai T, 2006, DRUG METAB PHARMACOK, V21, P173, DOI 10.2133/dmpk.21.173; Peer CJ, 2012, CLIN CANCER RES, V18, P2099, DOI 10.1158/1078-0432.CCR-11-2484; Kalthoff S, 2010, GASTROENTEROLOGY, V139, P1699, DOI 10.1053/j.gastro.2010.06.048; Ohtsuki S, 2012, DRUG METAB DISPOS, V40, P83, DOI 10.1124/dmd.111.042259; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Fujino H, 2003, XENOBIOTICA, V33, P27, DOI 10.1080/0049825021000017957; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; Tabata T, 2004, DRUG METAB DISPOS, V32, P1103, DOI 10.1124/dmd.104.000554; Shiratani H, 2008, DRUG METAB DISPOS, V36, P1745, DOI 10.1124/dmd.108.021469; Mizuma T, 2009, INT J PHARMACEUT, V378, P140, DOI 10.1016/j.ijpharm.2009.05.044; Fujiwara R, 2007, DRUG METAB DISPOS, V35, P747, DOI 10.1124/dmd.106.014191; ALDRIDGE WN, 1953, BIOCHEM J, V53, P110; Shimizu M, 2014, DRUG METAB DISPOS, V42, P751, DOI 10.1124/dmd.113.056184; Krishnaswamy S, 2003, DRUG METAB DISPOS, V31, P133, DOI 10.1124/dmd.31.1.133; Li B, 2005, BIOCHEM PHARMACOL, V70, P1673, DOI 10.1016/j.bcp.2005.09.002; Smith NF, 2006, TOXICOL IN VITRO, V20, P163, DOI 10.1016/j.tiv.2005.06.045; Barbier O, 2005, MOL PHARMACOL, V67, P241, DOI 10.1124/mol.104.003863; Owens IS, 2005, METHOD ENZYMOL, V400, P1, DOI 10.1016/S0076-6879(05)00001-7; Oda S, 2014, BIOCHEM PHARMACOL, V87, P660, DOI 10.1016/j.bcp.2013.11.001; COOK DR, 1989, ANESTH ANALG, V68, P452; Quiroga AD, 2011, TRENDS ENDOCRIN MET, V22, P218, DOI 10.1016/j.tem.2011.03.003; Sato Y, 2012, XENOBIOTICA, V42, P823, DOI 10.3109/00498254.2012.665950; Tarkiainen EK, 2012, CLIN PHARMACOL THER, V92, P68, DOI 10.1038/clpt.2012.13; Goda R, 2006, DRUG METAB DISPOS, V34, P828, DOI 10.1124/dmd.105.008623; Brophy VH, 2001, AM J HUM GENET, V68, P1428, DOI 10.1086/320600; Sato Y, 2014, DRUG METAB DISPOS, V42, P885, DOI 10.1124/dmd.113.056291; ARAKI E, 1993, JPN J CANCER RES, V84, P697; Arrowsmith J, 2013, NAT REV DRUG DISCOV, V12, P568, DOI 10.1038/nrd4090; Auyeung DJ, 2003, TOXICOL APPL PHARM, V191, P156, DOI 10.1016/S0041-008X(03)00230-8; Bae SK, 2011, XENOBIOTICA, V41, P437, DOI 10.3109/00498254.2011.551849; Bahar FG, 2012, J PHARM SCI-US, V101, P3979, DOI 10.1002/jps.23258; Basu NK, 2005, P NATL ACAD SCI USA, V102, P6285, DOI 10.1073/pnas.0407872102; Basu NK, 2004, DRUG METAB DISPOS, V32, P768, DOI 10.1124/dmd.32.7.768; Beaulieu M, 1996, J BIOL CHEM, V271, P22855; Bernard O, 2004, DRUG METAB DISPOS, V32, P775, DOI 10.1124/dmd.32.8.775; Bernard P, 1999, MOL PHARMACOL, V56, P526; Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335; Boase S, 2002, BRIT J CLIN PHARMACO, V54, P493, DOI 10.1046/j.1365-2125.2002.01669.x; Bock KW, 2005, METHOD ENZYMOL, V400, P57, DOI 10.1016/S0076-6879(05)00004-2; Bock KW, 1999, BIOCHEM PHARMACOL, V57, P653, DOI 10.1016/S0006-2952(98)00337-2; Bock KW, 2002, BIOCHEM PHARMACOL, V63, P1683, DOI 10.1016/S0006-2952(02)00921-8; Borentain P, 2007, EUR J CANCER, V43, P2479, DOI 10.1016/j.ejca.2007.08.006; CASTUMA CE, 1983, BIOCHIM BIOPHYS ACTA, V729, P9, DOI 10.1016/0005-2736(83)90449-2; CHAN K, 1987, ACTA PHARM SINIC, V8, P555; Chang JH, 2009, MOL PHARMACEUT, V6, P1216, DOI 10.1021/mp900065b; Chang JW, 2011, CHEM BIOL, V18, P476, DOI 10.1016/j.chembiol.2011.02.008; Chen YT, 2012, BIOCHEM PHARMACOL, V84, P864, DOI 10.1016/j.bcp.2012.06.025; Cheng ZQ, 1999, DRUG METAB DISPOS, V27, P1165; Chiaro CR, 2008, MOL PHARMACOL, V74, P1649, DOI 10.1124/mol.108.049379; Coffman BL, 1997, DRUG METAB DISPOS, V25, P1; Court MH, 2003, DRUG METAB DISPOS, V31, P1125, DOI 10.1124/dmd.31.9.1125; Court MH, 2005, METHOD ENZYMOL, V400, P104, DOI 10.1016/S0076-6879(05)00007-8; Crespi CL, 1995, ADV DRUG RES, V26, P179, DOI 10.1016/S0065-2490(05)80006-1; Davies HG, 1996, NAT GENET, V14, P334, DOI 10.1038/ng1196-334; DICKINSON RG, 1994, BIOCHEM PHARMACOL, V47, P469, DOI 10.1016/0006-2952(94)90177-5; DING A, 1995, DRUG METAB DISPOS, V23, P369; Court MH, 2001, J PHARMACOL EXP THER, V299, P998; Durrant AR, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00073; EBNER T, 1993, DRUG METAB DISPOS, V21, P50; Ehmer U, 2010, DRUG METAB DISPOS, V38, P1246, DOI 10.1124/dmd.109.030403; Erichsen TJ, 2008, TOXICOL APPL PHARM, V230, P252, DOI 10.1016/j.taap.2008.02.020; Fisher MB, 2001, DRUG METAB REV, V33, P273, DOI 10.1081/DMR-120000653; Food and Drug Administration (FDA), GUID IND GUID IND DR; Frick C, 2004, J BIOL CHEM, V279, P31131, DOI 10.1074/jbc.M313666200; Fujiwara R, 2008, DRUG METAB DISPOS, V36, P361, DOI 10.1124/dmd.107.018705; Fujiyama N, 2010, DRUG METAB DISPOS, V38, P2210, DOI 10.1124/dmd.110.034249; Fukami T, 2008, PHARMACOGENET GENOM, V18, P911, DOI 10.1097/FPC.0b013e32830b0c5e; Furihata T, 2005, BIOCHEM PHARMACOL, V69, P1287, DOI 10.1016/j.bcp.2005.01.017; Gagnon JF, 2006, CLIN CANCER RES, V12, P1850, DOI 10.1158/1078-0432.CCR-05-2130; Gall WE, 1999, J STEROID BIOCHEM, V70, P101, DOI 10.1016/S0960-0760(99)00088-6; Gardner-Stephen DA, 2007, DRUG METAB DISPOS, V35, P116, DOI 10.1124/dmd.106.012203; Green MD, 1996, DRUG METAB DISPOS, V24, P356; GREEN MD, 1995, DRUG METAB DISPOS, V23, P299; Gregory PA, 2004, TOXICOL APPL PHARM, V199, P354, DOI 10.1016/j.taap.2004.01.008; Gregory PA, 2000, PHARMACOGENETICS, V10, P809, DOI 10.1097/00008571-200012000-00006; Gregory PA, 2004, MOL PHARMACOL, V65, P953, DOI 10.1124/mol.65.4.953; Gregory PA, 2006, PHARMACOGENET GENOM, V16, P527; GUILLERMO FP, 1988, BRIT J ANAESTH, V61, P233; Hanioka N, 2001, J PHARMACEUT BIOMED, V25, P65, DOI 10.1016/S0731-7085(00)00491-X; Hanioka N, 2010, LIFE SCI, V87, P261, DOI 10.1016/j.lfs.2010.07.001; Hatfield MJ, 2010, BRIT J PHARMACOL, V160, P1916, DOI 10.1111/j.1476-5381.2010.00700.x; Higashi E, 2014, BIOPHARM DRUG DISPOS, V35, P313, DOI 10.1002/bdd.1898; Hioki T, 2011, DRUG METAB DISPOS, V39, P1345, DOI 10.1124/dmd.111.038141; Hori T, 2012, XENOBIOTICA, V42, P614, DOI 10.3109/00498254.2011.648670; Hori T, 2010, XENOBIOTICA, V40, P119, DOI 10.3109/00498250903431794; HOSOKAWA M, 1990, ARCH BIOCHEM BIOPHYS, V277, P219, DOI 10.1016/0003-9861(90)90572-G; Hosokawa M, 2008, DRUG METAB PHARMACOK, V23, P73, DOI 10.2133/dmpk.23.73; Hu DG, 2010, MOL PHARMACOL, V78, P714, DOI 10.1124/mol.110.065953; Hu DG, 2010, DRUG METAB DISPOS, V38, P2105, DOI 10.1124/dmd.110.035436; Huang MJ, 2005, WORLD J GASTROENTERO, V11, P797; HUANG YS, 1994, BIOCHEM PHARMACOL, V48, P1273; Ikushiro S, 1997, BIOCHEMISTRY-US, V36, P7154, DOI 10.1021/bi9702344; Ikushiro S, 2006, DRUG METAB PHARMACOK, V21, P70, DOI 10.2133/dmpk.21.70; ILLSLEY NP, 1981, ENDOCRINOLOGY, V108, P1737; INOUE M, 1979, JPN J PHARMACOL, V29, P9, DOI 10.1254/jjp.29.9; Ishii Y, 2000, MOL PHARMACOL, V57, P940; Ishizuka T, 2012, DRUG METAB DISPOS, V40, P374, DOI 10.1124/dmd.111.041475; Ito Y, 2014, DRUG METAB DISPOS, V42, P2109, DOI 10.1124/dmd.114.059485; Jeong EJ, 2005, DRUG METAB DISPOS, V33, P785, DOI 10.1124/dmd.104.001883; Jin CJ, 1997, ARCH BIOCHEM BIOPHYS, V341, P207, DOI 10.1006/abbi.1997.9949; Jones RD, 2013, DRUG METAB DISPOS, V41, P40, DOI 10.1124/dmd.112.048397; Kang SP, 2010, PHARMACOGENET GENOM, V20, P638, DOI 10.1097/FPC.0b013e32833e1b37; Kasai N, 2005, DRUG METAB DISPOS, V33, P102, DOI 10.1124/dmd.104.002303; Kato Y, 2013, DRUG METAB DISPOS, V41, P1389, DOI 10.1124/dmd.113.051565; Khateeb J, 2010, ATHEROSCLEROSIS, V208, P119, DOI 10.1016/j.atherosclerosis.2009.08.051; Koga T, 2011, DRUG METAB DISPOS, V39, P54, DOI 10.1124/dmd.110.035600; Kubota T, 2007, MOL PHARMACOL, V72, P1054, DOI 10.1124/mol.107.037952; Kumon Y, 2003, LIFE SCI, V73, P2807, DOI 10.1016/S0024-3205(03)00704-5; Kuo CL, 1998, DRUG METAB DISPOS, V26, P653; LAMARTINIERE CA, 1986, ENDOCRINOLOGY, V118, P1252; Lewinsky RH, 2005, XENOBIOTICA, V35, P117, DOI 10.1080/00498250400028189; Luan LB, 1997, BIOL PHARM BULL, V20, P71; Luukkanen L, 2005, DRUG METAB DISPOS, V33, P1017, DOI 10.1124/dmd.105.004093; Ma LP, 2012, DRUG METAB DISPOS, V40, P734, DOI 10.1124/dmd.111.043356; Mackenzie P.I., 2010, DRUG METAB REV, V42, P95; Manevski N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054767; Maruichi T, 2010, BIOCHEM PHARMACOL, V79, P288, DOI 10.1016/j.bcp.2009.08.019; Milne AM, 2011, DRUG METAB DISPOS, V39, P2258, DOI 10.1124/dmd.111.041699; MISTRY M, 1987, DRUG METAB DISPOS, V15, P710; Miyake Y, 2013, BIOL PHARM BULL, V36, P452; Miyashita T, 2014, DRUG METAB DISPOS, V42, P1, DOI 10.1124/dmd.113.054478; Morton CL, 1999, CANCER RES, V59, P1458; Munzel PA, 1998, ARCH BIOCHEM BIOPHYS, V350, P72, DOI 10.1006/abbi.1997.0485; Munzel PA, 1999, DRUG METAB DISPOS, V27, P569; Mutoh S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003705; Nakajima M, 2010, BIOCHEM PHARMACOL, V79, P1165, DOI 10.1016/j.bcp.2009.11.020; Nakamura A, 2008, PHARMACOGENET GENOM, V18, P709, DOI 10.1097/FPC.0b013e32830500c9; Nishihara M, 2013, DRUG METAB PHARMACOK, V28, P475, DOI 10.2133/dmpk.DMPK-13-RG-004; Nishimura M, 2002, YAKUGAKU ZASSHI, V122, P339, DOI 10.1248/yakushi.122.339; Nishiyama T, 2002, BIOCHEM PHARMACOL, V63, P1817, DOI 10.1016/S0006-2952(02)00994-2; Oda S, 2012, DRUG METAB DISPOS, V40, P1620, DOI 10.1124/dmd.112.045625; Oda S, 2013, DRUG METAB DISPOS, V41, P1738, DOI 10.1124/dmd.113.051201; Oesch-Bartlomowicz B, 2005, P NATL ACAD SCI USA, V102, P9218, DOI 10.1073/pnas.0503488102; Ohgane J, 2008, PLACENTA, V29, pS29, DOI 10.1016/j.placenta.2007.09.011; Ohura K, 2014, DRUG METAB DISPOS, V42, P264, DOI 10.1124/dmd.113.054551; Okazaki H, 2008, J BIOL CHEM, V283, P33357, DOI 10.1074/jbc.M802686200; Osaki F, 2004, ATHEROSCLEROSIS, V176, P279, DOI 10.1016/j.atherscolerosis.2004.05.029; OSTERGAARD D, 1993, ACTA ANAESTH SCAND, V37, P314; Ozols J, 1999, BIOCHEM J, V338, P265, DOI 10.1042/0264-6021:3380265; PARK YH, 1994, BIOCHEM MOL BIOL INT, V34, P351; PERELMAN A, 1990, J BIOL CHEM, V265, P214; PILLOT T, 1993, J BIOL CHEM, V268, P25636; PROPERT DN, 1976, HUM GENET, V32, P181, DOI 10.1007/BF00291501; Prueksaritanont T, 2002, DRUG METAB DISPOS, V30, P1280, DOI 10.1124/dmd.30.11.1280; Radominska-Pandya A, 2010, DRUG METAB REV, V42, P128; Raungrut P, 2010, J PHARMACOL EXP THER, V334, P609, DOI 10.1124/jpet.110.167916; Reddy ST, 2001, ARTERIOSCL THROM VAS, V21, P542; REYCAMPOS J, 1991, EMBO J, V10, P1445; Ritter JK, 2000, CHEM-BIOL INTERACT, V129, P171, DOI 10.1016/S0009-2797(00)00198-8; Rowland A, 2009, DRUG METAB DISPOS, V37, P1395, DOI 10.1124/dmd.109.027656; Sallustio BC, 1997, DRUG METAB DISPOS, V25, P55; Sallustio BC, 2006, CHEM RES TOXICOL, V19, P683, DOI 10.1021/tx060022k; Sanghani SP, 2002, EUR J BIOCHEM, V269, P4387, DOI 10.1046/j.1432-1033.2002.03121.x; Sato Y, 2012, DRUG METAB DISPOS, V40, P902, DOI 10.1124/dmd.111.043208; Sato Y, 2012, DRUG METAB DISPOS, V40, P1389, DOI 10.1124/dmd.112.045054; Shiner M, 2007, ATHEROSCLEROSIS, V195, P313, DOI 10.1016/j.atherosclerosis.2007.01.007; Soars MG, 2001, DRUG METAB DISPOS, V29, P121; Southwood HT, 2007, CHEM RES TOXICOL, V20, P1520, DOI 10.1021/tx700188x; SPAHNLANGGUTH H, 1992, DRUG METAB REV, V24, P5; STEWART DJ, 1977, LIFE SCI, V20, P1557, DOI 10.1016/0024-3205(77)90448-9; Strassburg CP, 1997, CANCER RES, V57, P2979; Stringer F, 2013, EUR J CLIN PHARMACOL, V69, P423, DOI 10.1007/s00228-012-1382-7; Sun ZJ, 2004, J PHARMACOL EXP THER, V310, P469, DOI 10.1124/jpet.104.067116; Suzuki E, 2010, DRUG METAB DISPOS, V38, P1538, DOI 10.1124/dmd.110.032938; Tabata T, 2004, DRUG METAB DISPOS, V32, P762, DOI 10.1124/dmd.32.7.762; Taketani M, 2007, LIFE SCI, V81, P924, DOI 10.1016/j.lfs.2007.07.026; Tenconi LT, 1970, P EUR SOC DRUG TOXIT, V11, P80; Tougou K, 1998, DRUG METAB DISPOS, V26, P355; Tseng CS, 2005, AM J GASTROENTEROL, V100, P1758, DOI 10.1111/j.1572-0241.2005.41857.x; Tsurkan LG, 2013, CHEM-BIOL INTERACT, V203, P226, DOI 10.1016/j.cbi.2012.10.018; TUNEK A, 1988, BIOCHEM PHARMACOL, V37, P3867, DOI 10.1016/0006-2952(88)90068-8; Turgeon D, 2003, J LIPID RES, V44, P1182, DOI 10.1194/jlr.M300010-JLR200; Uchaipichat V, 2013, DRUG METAB DISPOS, V41, P1273, DOI 10.1124/dmd.113.051656; Vaisi-Raygani A, 2007, CLIN BIOCHEM, V40, P629, DOI 10.1016/j.clinbiochem.2007.01.018; VOLLAND C, 1991, DRUG METAB DISPOS, V19, P1080; Wang Y, 2004, CLIN CANCER RES, V10, P2441, DOI 10.1158/1078-0432.CCR-1187-3; Watanabe Y, 2002, DRUG METAB DISPOS, V30, P1462, DOI 10.1124/dmd.30.12.1462; Wieland E, 2000, CLIN BIOCHEM, V33, P107, DOI 10.1016/S0009-9120(99)00101-0; WILLIAMS AM, 1992, BIOCHEM PHARMACOL, V43, P745, DOI 10.1016/0006-2952(92)90239-F; Wu MH, 2003, PHARMACOGENETICS, V13, P425, DOI 10.1097/01.fpc.0000054103.48725.db; Xiao JF, 2014, EUR J DRUG METAB PH, V39, P335, DOI 10.1007/s13318-013-0163-8; Xie W, 2003, P NATL ACAD SCI USA, V100, P4150, DOI 10.1073/pnas.0438010100; Yan R, 2008, AM J OBSTET GYNECOL, V198, p[229, e1]; Yang J, 2007, TOXICOL SCI, V95, P13, DOI 10.1093/toxsci/kfl120; Yanjiao Xu, 2013, Drug Metab Pharmacokinet, V28, P468; Yasar U, 2013, J PHARM PHARMACOL, V65, P874, DOI 10.1111/jphp.12053; Zhou DS, 2010, DRUG METAB DISPOS, V38, P863, DOI 10.1124/dmd.109.030981; Zhu WZ, 2000, DRUG METAB DISPOS, V28, P186; Zimmer KR, 2012, INT J ENVIRON HEAL R, V22, P279, DOI 10.1080/09603123.2011.634389	321	4	4	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	FEB	2015	30	1					30	51		10.1016/j.dmpk.2014.12.001		22	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VM	WOS:000353285500004		
J	Sanoh, S; Tayama, Y; Sugihara, K; Kitamura, S; Ohta, S				Sanoh, Seigo; Tayama, Yoshitaka; Sugihara, Kazumi; Kitamura, Shigeyuki; Ohta, Shigeru			Significance of aldehyde oxidase during drug development: Effects on drug metabolism, pharmacokinetics, toxicity, and efficacy	DRUG METABOLISM AND PHARMACOKINETICS			English	Review						Aldehyde oxidase; Metabolism; Pharmacokinetics; Efficacy; Toxicity; Species differences; Individual differences; Hepatocytes; Chimeric mice with humanized livers	CRYOPRESERVED HUMAN HEPATOCYTES; SEDATIVE-HYPNOTIC ZALEPLON; AMINO-ACID-RESIDUES; HUMAN LIVER CYTOSOL; XANTHINE-OXIDASE; IN-VITRO; CHIMERIC MICE; MOLYBDENUM HYDROXYLASES; HUMANIZED LIVER; SUBSTRATE-SPECIFICITY	Aldehyde oxidase contributes to drug metabolism and pharmacokinetics (PK), and a few clinical studies were discontinued because of aldehyde oxidase metabolism. Its AOX1, AOX3, AOX3L1, and AOX4 isoforms are expressed in mammals, and species differences in expression profiles reflect differences in drug metabolism and PK between animals and humans. Individual differences in aldehyde oxidase activity also influence drug metabolism in humans. Moreover, the reduced solubility of the aldehyde oxidase metabolites may induce drug toxicity. Because various drugs inhibit aldehyde oxidase, assessments of ensuing drugedrug interactions (DDI) are critical for drug optimization. Although drug metabolism, PK, safety, and DDI are important, drugs such as famciclovir and O6-benzylguanine that affect aldehyde oxidase activity in humans have been reported. Recently, various in vitro approaches have been developed to predict PK in humans. However, in vitro studies on aldehyde oxidase may be hampered because of its instability. In contrast, in vivo studies on chimeric mice with humanized livers have also been focused on to predict aldehyde oxidase-mediated metabolism. Additionally, the ratios of N1-methylnicotinamide to metabolites in urinary excretions may represent useful biomarkers of aldehyde oxidase activity in humans. Thus, assessing the contributions of aldehyde oxidase to drug metabolism in humans is necessary. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Sanoh, Seigo; Ohta, Shigeru] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Tayama, Yoshitaka; Sugihara, Kazumi] Hiroshima Int Univ, Fac Pharmaceut Sci, Hiroshima, Japan; [Kitamura, Shigeyuki] Nihon Pharmaceut Univ, Saitama, Japan	Sanoh, S (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.	sanoh@hiroshima-u.ac.jp					Akabane T, 2012, XENOBIOTICA, V42, P863, DOI 10.3109/00498254.2012.670736; Akabane T, 2012, DRUG METAB PHARMACOK, V27, P181, DOI 10.2133/dmpk.DMPK-11-RG-097; ALKHALID.UA, 1965, BIOCHEM J, V97, P318; Alfaro JF, 2009, DRUG METAB DISPOS, V37, P2393, DOI 10.1124/dmd.109.029520; Al-Salmy HS, 2001, IUBMB LIFE, V51, P249, DOI 10.1080/152165401753311799; Anderson LW, 2005, CANCER CHEMOTH PHARM, V56, P351, DOI 10.1007/s00280-004-0962-3; Ueda O, 2005, DRUG METAB DISPOS, V33, P1312, DOI 10.1124/dmd.105.005306; Strelevitz TJ, 2012, DRUG METAB DISPOS, V40, P1441, DOI 10.1124/dmd.112.045195; Yamasaki C, 2010, DRUG METAB PHARMACOK, V25, P539, DOI 10.2133/dmpk.DMPK-10-RG-047; Garattini Enrico, 2009, Human Genomics, V4, P119; Pryde DC, 2010, J MED CHEM, V53, P8441, DOI 10.1021/jm100888d; Sanoh S, 2012, DRUG METAB DISPOS, V40, P76, DOI 10.1124/dmd.111.041954; Sanoh S, 2012, DRUG METAB DISPOS, V40, P322, DOI 10.1124/dmd.111.040923; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; Kitamura S, 2006, DRUG METAB PHARMACOK, V21, P83, DOI 10.2133/dmpk.21.83; Yamaguchi Y, 2007, J BIOCHEM, V141, P513, DOI 10.1093/jb/mvm053; Tanoue C, 2013, DRUG METAB PHARMACOK, V28, P269, DOI 10.2133/dmpk.DMPK-12-NT-103; Hutzler JM, 2013, EXPERT OPIN DRUG MET, V9, P153, DOI 10.1517/17425255.2013.738668; Hartmann T, 2012, DRUG METAB DISPOS, V40, P856, DOI 10.1124/dmd.111.043828; Garattini E, 2003, BIOCHEM J, V372, P15, DOI 10.1042/BJ20030121; Nauen R, 1998, PESTIC SCI, V52, P53, DOI 10.1002/(SICI)1096-9063(199801)52:1<53::AID-PS621>3.0.CO;2-6; DOLAN ME, 1994, CANCER RES, V54, P5123; Obach RS, 2004, J CLIN PHARMACOL, V44, P7, DOI 10.1177/0091270003260336; Dick RA, 2005, CHEM RES TOXICOL, V18, P317, DOI 10.1021/tx049737i; Akabane T, 2011, XENOBIOTICA, V41, P372, DOI 10.3109/00498254.2010.549970; Di L, 2014, EXPERT OPIN DRUG MET, V10, P379, DOI 10.1517/17425255.2014.876006; Hutzler JM, 2014, DRUG METAB DISPOS, V42, P1090, DOI 10.1124/dmd.114.057984; Garattini E, 2011, DRUG METAB REV, V43, P374, DOI 10.3109/03602532.2011.560606; Kurosaki M, 2013, CELL MOL LIFE SCI, V70, P1807, DOI 10.1007/s00018-012-1229-5; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Coelho C, 2012, J BIOL CHEM, V287, P40690, DOI 10.1074/jbc.M112.390419; Obach RS, 2004, DRUG METAB DISPOS, V32, P89, DOI 10.1124/dmd.32.1.89; Diamond S, 2010, DRUG METAB DISPOS, V38, P1277, DOI 10.1124/dmd.110.032375; Kundu TK, 2012, BIOCHEMISTRY-US, V51, P2930, DOI 10.1021/bi3000879; FILER CW, 1994, XENOBIOTICA, V24, P357; Mahro M, 2011, DRUG METAB DISPOS, V39, P1939, DOI 10.1124/dmd.111.040873; Rashidi MR, 1997, DRUG METAB DISPOS, V25, P805; Garattini E, 2012, EXPERT OPIN DRUG MET, V8, P487, DOI 10.1517/17425255.2012.663352; Linton A, 2011, J MED CHEM, V54, P7705, DOI 10.1021/jm2010942; Vila R, 2004, J BIOL CHEM, V279, P8668, DOI 10.1074/jbc.M308137200; BEEDHAM C, 1987, EUR J DRUG METAB PH, V12, P307; Casida JE, 2011, J AGR FOOD CHEM, V59, P2923, DOI 10.1021/jf102438c; Fu CX, 2013, DRUG METAB DISPOS, V41, P1797, DOI 10.1124/dmd.113.053082; Garattini E, 2008, CELL MOL LIFE SCI, V65, P1019, DOI 10.1007/s00018-007-7398-y; Zhang X, 2011, PHARMACOGENOMICS J, V11, P15, DOI 10.1038/tpj.2010.8; Zientek M, 2010, DRUG METAB DISPOS, V38, P1322, DOI 10.1124/dmd.110.033555; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; Rashidi MR, 2007, DRUG METAB PHARMACOK, V22, P299, DOI 10.2133/dmpk.22.299; Sanoh S, 2014, BIOPHARM DRUG DISPOS, V35, P71, DOI 10.1002/bdd.1864; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Morrison RD, 2012, DRUG METAB DISPOS, V40, P1834, DOI 10.1124/dmd.112.046136; Barr JT, 2013, DRUG METAB DISPOS, V41, P24, DOI 10.1124/dmd.112.048546; Barr JT, 2014, DRUG METAB DISPOS, V42, P695, DOI 10.1124/dmd.113.056374; BEEDHAM C, 1990, BIOCHEM PHARMACOL, V39, P1213, DOI 10.1016/0006-2952(90)90265-M; BEEDHAM C, 1985, DRUG METAB REV, V16, P119, DOI 10.3109/03602538508991432; Choughule KV, 2013, DRUG METAB DISPOS, V41, P1852, DOI 10.1124/dmd.113.052985; Dalvie D, 2012, DRUG METAB DISPOS, V40, P1575, DOI 10.1124/dmd.112.045823; Dalvie D, 2013, XENOBIOTICA, V43, P399, DOI 10.3109/00498254.2012.727499; Dalvie D, 2010, DRUG METAB DISPOS, V38, P641, DOI 10.1124/dmd.109.030783; Dick RA, 2007, CHEM RES TOXICOL, V20, P1942, DOI 10.1021/tx700265r; Dittrich C, 2002, EUR J CANCER, V38, P1072, DOI 10.1016/S0959-8049(02)00020-5; Dolan ME, 1998, J CLIN ONCOL, V16, P1803; DULEY JA, 1985, ALCOHOL CLIN EXP RES, V9, P263, DOI 10.1111/j.1530-0277.1985.tb05747.x; Garattini E, 2013, EXPERT OPIN DRUG DIS, V8, P641, DOI 10.1517/17460441.2013.788497; Honda H, 2006, TOXICOL LETT, V161, P108, DOI 10.1016/j.toxlet.2005.08.004; Hutzler JM, 2012, DRUG METAB DISPOS, V40, P267, DOI 10.1124/dmd.111.042861; Itoh K, 2007, DRUG METAB DISPOS, V35, P1860, DOI 10.1124/dmd.107.015503; JACOBS SA, 1976, J CLIN INVEST, V57, P534, DOI 10.1172/JCI108308; Jones JP, 2013, MOL PHARMACEUT, V10, P1262, DOI 10.1021/mp300568r; Kawashima K, 1999, DRUG METAB DISPOS, V27, P422; KAYE B, 1984, XENOBIOTICA, V14, P935; Kitamura S, 1999, IUBMB LIFE, V48, P607, DOI 10.1080/713803569; Kitamura S, 2014, XENOBIOTICA, V44, P123, DOI 10.3109/00498254.2013.868062; Kitamura S, 2008, DRUG METAB DISPOS, V36, P1202, DOI 10.1124/dmd.107.019075; Klecker RW, 2006, BIOORGAN MED CHEM, V14, P62, DOI 10.1016/j.bmc.2005.07.053; Koshiba T, 1996, PLANT PHYSIOL, V110, P781; KRENITSK.TA, 1974, COMP BIOCHEM PHYSIOL, V49, P687, DOI 10.1016/0305-0491(74)90256-9; KRENITSK.TA, 1972, ARCH BIOCHEM BIOPHYS, V150, P585, DOI 10.1016/0003-9861(72)90078-1; Kundu TK, 2007, ARCH BIOCHEM BIOPHYS, V460, P113, DOI 10.1016/j.abb.2006.12.032; Lake BG, 2002, XENOBIOTICA, V32, P835, DOI 10.1080/00498250210158915; Li YM, 2012, DRUG METAB DISPOS, V40, P1122, DOI 10.1124/dmd.111.044354; Li YM, 2012, DRUG METAB DISPOS, V40, P1130, DOI 10.1124/dmd.111.044362; Maeda K, 2012, GENE, V505, P374, DOI 10.1016/j.gene.2012.06.010; Moriyasu A, 2006, DRUG METAB PHARMACOK, V21, P485, DOI 10.2133/dmpk.21.485; PERRY CM, 1995, DRUGS, V50, P396, DOI 10.2165/00003495-199550020-00011; Pryde DC, 2012, BIOORG MED CHEM LETT, V22, P2856, DOI 10.1016/j.bmcl.2012.02.069; Ramirez J, 2014, PHARMACOGENET GENOM, V24, P129, DOI 10.1097/FPC.0000000000000023; Rivera SP, 2005, TOXICOLOGY, V207, P401, DOI 10.1016/j.tox.2004.10.009; Sahi Jasminder, 2008, Drug Metab Lett, V2, P176, DOI 10.2174/187231208785425818; Schumann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005348; Sharma R, 2012, DRUG METAB DISPOS, V40, P625, DOI 10.1124/dmd.111.042770; Sharma R, 2011, CHEM RES TOXICOL, V24, P2207, DOI 10.1021/tx200329k; Stell JGP, 2012, J PHARM PHARMACOL, V64, P237, DOI 10.1111/j.2042-7158.2011.01408.x; Sugihara K, 2006, DRUG METAB DISPOS, V34, P208, DOI 10.1124/dmd.105.006544; Sugihara K, 1997, BIOCHEM MOL BIOL INT, V41, P1153; Sugihara K, 2001, BIOCHEM BIOPH RES CO, V281, P1093, DOI 10.1006/bbrc.2001.4464; Swenson TL, 2013, TOXICOL SCI, V133, P22, DOI 10.1093/toxsci/kft066; Takasaki W, 2005, CHIRALITY, V17, P135, DOI 10.1002/chir.20124; Tanoue C, 2013, XENOBIOTICA, V43, P956, DOI 10.3109/00498254.2013.788232; TATSUMI K, 1986, CANCER RES, V46, P1089; Tayama Y, 2007, CLIN PHARMACOL THER, V81, P567, DOI 10.1038/sj.clpt.6100078; Tayama Y, 2011, DRUG METAB PHARMACOK, V26, P94, DOI 10.2133/dmpk.DMPK-10-NT-078; Tayama Y, 2012, DRUG METAB PHARMACOK, V27, P543, DOI 10.2133/dmpk.DMPK-11-NT-124; Tayama Y, 2007, DRUG METAB PHARMACOK, V22, P119, DOI 10.2133/dmpk.22.119; Terao M, 2009, MOL CELL BIOL, V29, P357, DOI 10.1128/MCB.01385-08; Tserng KY, 2003, J CLIN PHARMACOL, V43, P881, DOI 10.1177/0091270003256060; Utoh R, 2010, AM J PATHOL, V177, P654, DOI 10.2353/ajpath.2010.090430; VANOVER KE, 1994, DRUG DEVELOP RES, V33, P39, DOI 10.1002/ddr.430330107; Wang Stephen W J, 2013, Drug Metab Lett, V7, P2; Weigert J, 2008, FEBS LETT, V582, P2965, DOI 10.1016/j.febslet.2008.07.034; Yoshihara S, 1997, BIOCHEM PHARMACOL, V53, P1099, DOI 10.1016/S0006-2952(97)00088-9; Zdunek-Zastocka E, 2004, J EXP BOT, V55, P1361, DOI 10.1093/jxb/erh134	112	1	1	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	FEB	2015	30	1					52	63		10.1016/j.dmpk.2014.10.009		12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VM	WOS:000353285500005		
J	Taniguchi-Takizawa, T; Shimizu, M; Kume, T; Yamazaki, H				Taniguchi-Takizawa, Tomomi; Shimizu, Makiko; Kume, Toshiyuki; Yamazaki, Hiroshi			Benzydamine N-oxygenation as an index for flavin-containing monooxygenase activity and benzydamine N-demethylation by cytochrome P450 enzymes in liver microsomes from rats, dogs, monkeys, and humans	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						FMO3; FMO1; CYP2D6; NADPH; Preheating of liver microsomes	ORGANIC-SOLVENTS; L-CARNITINE; METABOLISM; POLYMORPHISMS; OXIDATION; IMPACT; KIDNEY; FMO1	Benzydamine is an anti-inflammatory drug that undergoes flavin-containing monooxygenase (FMO)dependent metabolism to benzydamine N-oxide; however, benzydamine N-demethylation is also catalyzed by liver microsomes. In this study, benzydamine N-oxygenation and N-demethylation mediated by liver microsomes from rats, dogs, monkeys, and humans were characterized comprehensively. Values of the maximum velocity/Michaelis constant ratio for benzydamine N-oxygenation by liver microsomes from dogs and rats were higher than those from monkeys and humans, despite roughly similar rates of N-demethylation in the four species. Benzydamine N-oxygenation by liver microsomes was extensively suppressed by preheating liver microsomes at 45 degrees C for 5 min or at 37 degrees C for 5-10 min without NADPH, and benzydamine N-demethylation was strongly inhibited by 1-aminbobenztriazole. Liver microsomal benzydamine N-oxygenation was inhibited by dimethyl sulfoxide and methimazole, whereas N-demethylation was inhibited by quinidine. High benzydamine N-oxygenation activities of recombinant human FMO1 and FMO3 and human kidney microsomes were observed at pH 8.4, whereas N-demethylation by cytochrome P450 2D6 was faster at pH 7.4. These results suggest that benzydamine N-oxygenation and N-demethylation are mediated by FMO1/3 and P450s, respectively, and that the contribution of FMO to metabolic eliminations of new drug candidates might be underestimated under certain experimental conditions suitable for P450 enzymes. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Taniguchi-Takizawa, Tomomi; Kume, Toshiyuki] Mitsubishi Tanabe Pharma Corp, DMPK Res Labs, Div Res, Toda, Saitama, Japan; [Shimizu, Makiko; Yamazaki, Hiroshi] Showa Pharmaceut Univ, Lab DMPK, Machida, Tokyo 1948543, Japan	Yamazaki, H (reprint author), Showa Pharmaceut Univ, Lab DMPK, 3-3165 Higashi Tamagawa Gakuen, Machida, Tokyo 1948543, Japan.	hyamazak@ac.shoyaku.ac.jp	Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261	Ministry of Education, Culture, Sports, Science and Technology of Japan [25460198]	The authors thank Norie Murayama for her technical assistance and David Smallbones for his English language advice. This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan (25460198, MS, HY).	Hernandez D, 2004, PHARMACOGENETICS, V14, P117, DOI 10.1097/01.fpc.0000054152.92680.ea; Hartiala J, 2014, ARTERIOSCL THROM VAS, V34, P1307, DOI 10.1161/ATVBAHA.114.303252; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Busby WF, 1999, DRUG METAB DISPOS, V27, P246; Cashman JR, 2006, ANNU REV PHARMACOL, V46, P65, DOI 10.1146/annurev.pharmtox.46.120604.141043; Hickman D, 1998, DRUG METAB DISPOS, V26, P207; Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001; Nakamaru Y, 2014, XENOBIOTICA, V44, P242, DOI 10.3109/00498254.2013.816891; Koukouritaki SB, 2002, PEDIATR RES, V51, P236, DOI 10.1203/00006450-200202000-00018; Catucci Gianluca, 2012, Biochem Pharmacol, V83, P551, DOI 10.1016/j.bcp.2011.11.029; Emoto Chie, 2003, Drug Metab Pharmacokinet, V18, P287, DOI 10.2133/dmpk.18.287; Grothusen A, 1996, ARCH TOXICOL, V71, P64, DOI 10.1007/s002040050359; Guo ZY, 1997, DRUG METAB DISPOS, V25, P390; Hamman MA, 2000, BIOCHEM PHARMACOL, V60, P7, DOI 10.1016/S0006-2952(00)00301-4; HUCKER HB, 1967, J PHARMACOL EXP THER, V155, P309; Koukouritaki SB, 2005, PHARMACOGENOMICS, V6, P807, DOI 10.2217/14622416.6.8.807; MORI Y, 1985, MUTAT RES, V142, P153, DOI 10.1016/0165-7992(85)90015-6; Nagashima S, 2009, DRUG METAB PHARMACOK, V24, P218; OTTON SV, 1988, J PHARMACOL EXP THER, V247, P242; Shephard EA, 2012, EUR J HUM GENET, V20, pe1; Shimizu M, 2011, BRIT J CLIN PHARMACO, V71, P585, DOI 10.1111/j.1365-2125.2010.03876.x; Stormer E, 2000, BRIT J CLIN PHARMACO, V50, P553, DOI 10.1046/j.1365-2125.2000.00296.x; Uno Y, 2013, BIOCHEM PHARMACOL, V85, P1837, DOI 10.1016/j.bcp.2013.04.012; Yamazaki M, 2014, BIOCHEM PHARMACOL, V90, P159, DOI 10.1016/j.bcp.2014.04.019; Yeung CK, 2000, DRUG METAB DISPOS, V28, P1107	25	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	FEB	2015	30	1					64	69		10.1016/j.dmpk.2014.09.006		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VM	WOS:000353285500006		
J	Shimizu, M; Shiraishi, A; Sato, A; Nagashima, S; Yamazaki, H				Shimizu, Makiko; Shiraishi, Arisa; Sato, Ayumi; Nagashima, Satomi; Yamazaki, Hiroshi			Potential for drug interactions mediated by polymorphic flavin-containing monooxygenase 3 in human livers	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						FMO3; FMO3 polymorphism; FMO3 activity; Drug oxygenation; Drug interaction	GENETIC POLYMORPHISMS; OXYGENATION ACTIVITIES; FMO3 GENE; METABOLISM; VARIANTS; TRIMETHYLAMINURIA; PERSPECTIVES; POPULATION; MICROSOMES; OXIDATION	Human flavin-containing monooxygenase 3 (FMO3) in the liver catalyzes a variety of oxygenations of nitrogen-and sulfur-containing medicines and xenobiotic substances. Because of growing interest in drug interactions mediated by polymorphic FMO3, benzydamine N-oxygenation by human FMO3 was investigated as a model reaction. Among the 41 compounds tested, trimethylamine, methimazole, itopride, and tozasertib (50 mu M) suppressed benzydamine N-oxygenation at a substrate concentration of 50 mu M by approximately 50% after co-incubation. Suppression of N-oxygenation of benzydamine, trimethylamine, itopride, and tozasertib and S-oxygenation of methimazole and sulindac sulfide after coincubation with the other five of these six substrates was compared using FMO3 proteins recombinantly expressed in bacterial membranes. Apparent competitive inhibition by methimazole (0-50 mu M) of sulindac sulfide S-oxygenation was observed with FMO3 proteins. Sulindac sulfide S-oxygenation activity of Arg205Cys variant FMO3 protein was likely to be suppressed more by methimazole than wild-type or Val257Met variant FMO3 protein was. These results suggest that genetic polymorphism in the human FMO3 gene may lead to changes of drug interactions for N-or S-oxygenations of xenobiotics and endogenous substances and that a probe battery system of benzydamine N-oxygenation and sulindac sulfide S-oxygenation activities is recommended to clarify the drug interactions mediated by FMO3. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Shimizu, Makiko; Shiraishi, Arisa; Sato, Ayumi; Nagashima, Satomi; Yamazaki, Hiroshi] Showa Pharmaceut Univ, Lab DMPK, Machida, Tokyo 1948543, Japan	Yamazaki, H (reprint author), Showa Pharmaceut Univ, Lab DMPK, 3-3165 Higashi Tamagawa Gakuen, Machida, Tokyo 1948543, Japan.	hyamazak@ac.shoyaku.ac.jp	Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261	Ministry of Education, Culture, Sports, Science and Technology of Japan [25460198]	The authors thank John Cashman, Tomomi Taniguchi-Takizawa, Norie Murayama, and Kuniharu Sasaki for their technical assistance and David Smallbones for his English language advice. This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan (25460198).	Ziegler DM, 2002, DRUG METAB REV, V34, P503, DOI 10.1081/DMR-120005650; Hernandez D, 2003, HUM MUTAT, V22, P209, DOI 10.1002/humu.10252; Cashman JR, 2000, DRUG METAB DISPOS, V28, P169; JONES KC, 1986, J BIOL CHEM, V261, P2553; Cashman JR, 2006, ANNU REV PHARMACOL, V46, P65, DOI 10.1146/annurev.pharmtox.46.120604.141043; Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001; Nakamaru Y, 2014, XENOBIOTICA, V44, P242, DOI 10.3109/00498254.2013.816891; Cashman JR, 2002, DRUG METAB DISPOS, V30, P1043, DOI 10.1124/dmd.30.10.1043; Cashman JR, 2008, EXPERT OPIN DRUG MET, V4, P1507, DOI 10.1517/17425250802522188 ; Catucci Gianluca, 2012, Biochem Pharmacol, V83, P551, DOI 10.1016/j.bcp.2011.11.029; Grothusen A, 1996, ARCH TOXICOL, V71, P64, DOI 10.1007/s002040050359; Hamman MA, 2000, BIOCHEM PHARMACOL, V60, P7, DOI 10.1016/S0006-2952(00)00301-4; Hisamuddin IM, 2007, PHARMACOGENOMICS, V8, P635, DOI 10.2217/14622416.8.6.635; Karanam BV, 2004, DRUG METAB DISPOS, V32, P1061, DOI 10.1124/dmd.104.000224; Katchamart S, 2000, DRUG METAB DISPOS, V28, P930; Koukouritaki SB, 2005, PHARMACOGENOMICS, V6, P807, DOI 10.2217/14622416.6.8.807; Koukouritaki SB, 2005, MOL PHARMACOL, V68, P383, DOI 10.1124/mol.105.012062; Mushiroda T, 2000, DRUG METAB DISPOS, V28, P1231; Nagashima S, 2009, DRUG METAB PHARMACOK, V24, P218; Park CS, 2002, PHARMACOGENETICS, V12, P77, DOI 10.1097/00008571-200201000-00011; Ryu SD, 2004, LIFE SCI, V75, P2559, DOI 10.1016/j.lfs.2004.05.018; Shimizu M, 2007, DRUG METAB DISPOS, V35, P328, DOI 10.1124/dmd.106.013094; Shimizu M, 2011, BRIT J CLIN PHARMACO, V71, P585, DOI 10.1111/j.1365-2125.2010.03876.x; Yamazaki H, 2007, MOL GENET METAB, V90, P58, DOI 10.1016/j.ymgme.2006.08.008; Yamazaki M, 2014, BIOCHEM PHARMACOL, V90, P159, DOI 10.1016/j.bcp.2014.04.019; Yamazaki H, 2013, BIOCHEM PHARMACOL, V85, P1588, DOI 10.1016/j.bcp.2013.03.020; Yeung Catherine K, 2006, Methods Mol Biol, V320, P157; Zhou DS, 2011, XENOBIOTICA, V41, P232, DOI 10.3109/00498254.2010.536855; Zhou JH, 2006, MUTAT RES-REV MUTAT, V612, P165, DOI 10.1016/j.mrrev.2005.09.001	29	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	FEB	2015	30	1					70	74		10.1016/j.dmpk.2014.09.008		5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VM	WOS:000353285500007		
J	Purba, ER; Leuhery, EA; Oguro, A; Imaoka, S				Purba, Endang R.; Leuhery, Elsa A.; Oguro, Ami; Imaoka, Susumu			The metabolism of lysophosphatidic acids by allelic variants of human soluble epoxide hydrolase	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Soluble epoxide hydrolase; Allelic variants; Lysophosphatidic acid; Phosphatase activity; Epoxide hydrolase activity; Vascular endothelial growth factor	PHOSPHOLIPASE-D; POLYMORPHISMS; PHOSPHATASE; EPHX2; ASSOCIATION; CHOLESTEROL; MEDIATORS; AUTOTAXIN; DOMAINS; GROWTH	Lysophosphatidic acids (LPAs) are phospholipids which have many physiological and pathophysiological functions. The human soluble epoxide hydrolase (sEH) plays a role in the metabolism of xenobiotics through its metabolism of aromatic hydrocarbon epoxides such as styrene oxide. sEH also has a phosphatase activity, and metabolizes LPAs. In this study, we investigated a purified wild-type (WT) and six allelic variants of sEH to evaluate differences in their activities toward LPAs. We found that the R103C and R287Q showed significantly lower activity than the WT sEH. We also found that the R103C and R287Q had significantly lower activity even when applied to only the N-terminal or C-terminal domain. The kinetic study determined that the R103C and R287Q had a lower Vmax/Km ratio toward stearoyl-LPA than the other variants. In a previous study, we found that WT sEH suppressed vascular endothelial growth factor (VEGF) mRNA in Hep3B cells; in the present experiments, all sEH variants except V442A suppressed VEGF mRNA levels in Hep3B cells. These results suggest that the R103C and R287Q have lower phosphatase activity, but that all the allelic variants have similar effects on VEGF suppression. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Purba, Endang R.; Leuhery, Elsa A.; Oguro, Ami; Imaoka, Susumu] Kwansei Gakuin Univ, Sch Sci & Technol, Res Ctr Environm Biosci, Sanda 6691337, Japan; [Purba, Endang R.; Leuhery, Elsa A.; Oguro, Ami; Imaoka, Susumu] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, Sanda 6691337, Japan	Imaoka, S (reprint author), Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, Gakuen 2-1, Sanda 6691337, Japan.	imaoka@kwansei.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [S1001051]	This work was supported by the Project to Assist Private Universities in Developing Bases for Research of the Ministry of Education, Culture, Sports, Science and Technology, Japan (S1001051).	EnayetAllah AE, 2008, J BIOL CHEM, V283, P36592, DOI 10.1074/jbc.M806315200; Morisseau C, 2014, J LIPID RES, V55, P1131, DOI 10.1194/jlr.M049718; Iliff JJ, 2009, AM J PHYSIOL-HEART C, V296, pH1352, DOI 10.1152/ajpheart.00950.2008; Fornage M, 2004, CIRCULATION, V109, P335, DOI 10.1161/01.CIR.0000109487.46725.02; Morisseau C, 2012, BIOCHEM BIOPH RES CO, V419, P796, DOI 10.1016/j.bbrc.2012.02.108; Fava C, 2010, PHARMACOGENET GENOM, V20, P94, DOI 10.1097/FPC.0b013e3283349ec9; Enayetallah AE, 2004, J HISTOCHEM CYTOCHEM, V52, P447; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Ye XQ, 2008, HUM REPROD UPDATE, V14, P519, DOI 10.1093/humupd/dmn023; GILL SS, 1980, BIOCHEM PHARMACOL, V29, P389, DOI 10.1016/0006-2952(80)90518-3; Watanabe N, 2007, J CLIN GASTROENTEROL, V41, P616, DOI 10.1097/01.mcg.0000225642.90898.0e; Billon-Denis E, 2008, J LIPID RES, V49, P295, DOI 10.1194/jlr.M700171-JLR200; Koerner IP, 2007, J NEUROSCI, V27, P4642, DOI 10.1523/JNEUROSCI.0056-07.2007; Oguro A, 2012, J LIPID RES, V53, P505, DOI 10.1194/jlr.M022319; Rancoule C, 2014, BIOCHIMIE, V96, P140, DOI 10.1016/j.biochi.2013.04.010; Sandberg M, 2000, J BIOL CHEM, V275, P28873, DOI 10.1074/jbc.M001153200; Sato K, 2004, J HUM GENET, V49, P29, DOI 10.1007/s10038-003-0103-6; Campbell WB, 2000, TRENDS PHARMACOL SCI, V21, P125, DOI 10.1016/S0165-6147(00)01472-3; Ohtoshi K, 2005, BIOCHEM BIOPH RES CO, V331, P347, DOI 10.1016/j.bbrc.2005.03.171; IMAMURA F, 1993, BIOCHEM BIOPH RES CO, V193, P497, DOI 10.1006/bbrc.1993.1651; Oguro A, 2009, BIOL PHARM BULL, V32, P1962; Przybyla-Zawislak BD, 2003, MOL PHARMACOL, V64, P482, DOI 10.1124/mol.64.2.482; Purba ER, 2014, BBA-MOL CELL BIOL L, V1841, P954, DOI 10.1016/j.bbalip.2014.03.010; Saito S, 2001, J HUM GENET, V46, P325, DOI 10.1007/s100380170067; Sako A, 2006, J SURG RES, V130, P94, DOI 10.1016/j.jss.2005.08.007; Shen Gui-Fen, 2008, Ai Zheng, V27, P1130; Srivastava PK, 2004, ARCH BIOCHEM BIOPHYS, V427, P164, DOI 10.1016/j.abb.2004.05.003; TOKUMURA A, 1978, LIPIDS, V13, P572, DOI 10.1007/BF02533598; Xie YL, 2009, BIOORG MED CHEM LETT, V19, P2354, DOI 10.1016/j.bmcl.2008.09.066; Zhang ZH, 2006, AM J PHYSIOL-CELL PH, V291, pC1089, DOI 10.1152/ajpcell.00523.2005	31	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	FEB	2015	30	1					75	81		10.1016/j.dmpk.2014.09.002		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VM	WOS:000353285500008		
J	Fujiwara, R; Sumida, K; Kutsuno, Y; Sakamoto, M; Itoh, T				Fujiwara, Ryoichi; Sumida, Kyohei; Kutsuno, Yuki; Sakamoto, Masaya; Itoh, Tomoo			UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Trovafloxacin; UDP-Glucuronosyltransferase; UGT1A1; Acyl-glucuronide; Hepatotoxicity	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ENZYMATIC-ACTIVITIES; ACYL GLUCURONIDES; HUMAN HEPATOCYTES; MESSENGER-RNA; EXPRESSION; SUPERFAMILY; METABOLISM; MECHANISM; HYPERBILIRUBINEMIA	Identification of drug-metabolizing enzyme(s) responsible for the metabolism of drugs is an important step to understand not only interindividual variability in pharmacokinetics but also molecular mechanisms of metabolite-related toxicity. While it was reported that the major metabolic pathway of trovafloxacin, which is an antibiotic, was glucuronidation, the UDP-glucuronosyltransferase (UGT) isoform(s) responsible for the trovafloxacin glucuronidation has not been identified yet. In the present study, among the functional human UGT members, UGT1A1, UGT1A3, and UGT1A9 exhibited higher trovafloxacin acylglucuronidation activities. While other UGT members such as UGT1A8, UGT2B7, and UGT2B15 showed glucuronidation activity toward trovafloxacin, the metabolic velocity was extremely low. In human liver microsomes, trovafloxacin acyl-glucuronidation followed the Hill equation with S50 value of 95 mu M, Vmax value of 243 pmol/min per mg, and a Hill coefficient of 2.0, while the UGT1A1-expressing system displayed Michaelis-Menten kinetics with a substrate inhibition, with K-m value of 759 mu M and V-max value of 1160 mu mol/min per mg. In human liver microsomes prepared from poor metabolizers (UGT1A1*28/*28), significantly reduced trovafloxacin acyl-glucuronide formation activity was observed, indicating that UGT1A1 mainly, while other UGT members such as UGT1A3 and UGT1A9 partially, contributes to the glucuronidation of trovafloxacin. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Fujiwara, Ryoichi; Sumida, Kyohei; Kutsuno, Yuki; Sakamoto, Masaya; Itoh, Tomoo] Kitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan	Fujiwara, R (reprint author), Kitasato Univ, Sch Pharm, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	fujiwarar@pharm.kitasato-u.ac.jp			Kitasato University Research Grant for Young Researchers	Funding for this work was provided in part from a Kitasato University Research Grant for Young Researchers (R.F.).	Lucena MI, 2000, CLIN INFECT DIS, V30, P400, DOI 10.1086/313680; Mackenzie PI, 2008, J BIOL CHEM, V283, P36205, DOI 10.1074/jbc.M807961200; MacKenzie PI, 2011, MOL PHARMACOL, V79, P472, DOI 10.1124/mol.110.069336; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Chang JH, 2013, MOL PHARMACEUT, V10, P3067, DOI 10.1021/mp4001348; Ohno S, 2009, DRUG METAB DISPOS, V37, P32, DOI 10.1124/dmd.108.023598; Sumida K, 2013, MOL PHARMACOL, V84, P679, DOI 10.1124/mol.113.088112; Mathijssen RHJ, 2001, CLIN CANCER RES, V7, P2182; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Meech R, 2012, PHARMACOL THERAPEUT, V134, P200, DOI 10.1016/j.pharmthera.2012.01.009; Izukawa T, 2009, DRUG METAB DISPOS, V37, P1759, DOI 10.1124/dmd.109.027227; Fujiwara R, 2007, DRUG METAB DISPOS, V35, P1781, DOI 10.1124/dmd.107.016402; Nakamura A, 2008, DRUG METAB DISPOS, V36, P1461, DOI 10.1124/dmd.108.021428; Meech R, 2010, DRUG METAB REV, V42, P45, DOI 10.3109/03602530903205823; Kutsuno Y, 2014, DRUG METAB DISPOS, V42, P1146, DOI 10.1124/dmd.114.057083; DING A, 1993, P NATL ACAD SCI USA, V90, P3797, DOI 10.1073/pnas.90.9.3797; Ohtsuki S, 2012, DRUG METAB DISPOS, V40, P83, DOI 10.1124/dmd.111.042259; Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794; Fujiwara R, 2007, DRUG METAB DISPOS, V35, P747, DOI 10.1124/dmd.106.014191; Ando Y, 2000, CANCER RES, V60, P6921; Dalvie DK, 1997, DRUG METAB DISPOS, V25, P423; Dutton G.J., 1980, GLUCURONIDATION DRUG, P69; Gootz TD, 1994, EXPERT OPIN INV DRUG, V3, P93, DOI 10.1517/13543784.3.2.93; Ishii Y, 2010, DRUG METAB REV, V42, P145, DOI 10.3109/03602530903208579; Koga T, 2011, DRUG METAB DISPOS, V39, P54, DOI 10.1124/dmd.110.035600; Liguori MJ, 2005, HEPATOLOGY, V41, P177, DOI 10.1002/hep.20514; Miyashita T, 2014, DRUG METAB DISPOS, V42, P1, DOI 10.1124/dmd.113.054478; Nakajima M, 2002, DRUG METAB DISPOS, V30, P1484, DOI 10.1124/dmd.30.12.1484; Pirmohamed M, 1996, CLIN PHARMACOKINET, V31, P215; PUMFORD NR, 1993, CHEM RES TOXICOL, V6, P147, DOI 10.1021/tx00032a002; Shibuya A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02903; Wang M, 2001, LIFE SCI, V68, P785, DOI 10.1016/S0024-3205(00)00981-4	32	1	1	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	FEB	2015	30	1					82	88		10.1016/j.dmpk.2014.09.003		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VM	WOS:000353285500009		
J	Mimura, H; Kobayashi, K; Xu, LXQ; Hashimoto, M; Ejiri, Y; Hosoda, M; Chiba, K				Mimura, Hanaka; Kobayashi, Kaoru; Xu, Linxiaoqing; Hashimoto, Mari; Ejiri, Yoko; Hosoda, Masaya; Chiba, Kan			Effects of cytokines on CYP3A4 expression and reversal of the effects by anti-cytokine agents in the three-dimensionally cultured human hepatoma cell line FLC-4	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						CYP3A4; Expression; Cytokine; Tocilizumab; IL-1ra	DRUG-METABOLIZING-ENZYMES; ACUTE-PHASE RESPONSE; RHEUMATOID-ARTHRITIS; INTERLEUKIN-6 IL-6; TNF-ALPHA; DISEASE; RECEPTOR; CYTOCHROME-P450; LIVER; SERUM	The expression of hepatic cytochrome P450 (CYP) enzymes is altered under pathological conditions with increased levels of cytokines. In this study, we analyzed the effects of cytokines (interleukin [IL]-1 beta, IL-6 and tumor necrosis factor alpha) on the expression of CYP3A4 using newly introduced three-dimensionally cultured human hepatocarcinoma FLC-4 cells. The mRNA level of CYP3A4 was significantly decreased by IL-1 beta, IL-6 and tumor necrosis factor-alpha. Formation of alpha-hydroxytriazolam catalyzed by CYP3A was decreased by IL-1 beta and IL-6. Pre-treatment with IL-6 enhanced the cytotoxic effects of gefitinib and paclitaxel. In addition, tocilizumab and IL-1 receptor antagonist restored the decreased expression of CYP3A4 mRNA by IL-6 and IL-1 beta, respectively. These results obtained by using three-dimensionally cultured FLC-4 cells are consistent with results obtained by using primary human hepatocytes and results of clinical studies. Therefore, three-dimensionally cultured FLC-4 cell system may be a promising cellular tool to assess the effects of cytokines on CYP3A4 expression. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Mimura, Hanaka; Kobayashi, Kaoru; Xu, Linxiaoqing; Hashimoto, Mari; Chiba, Kan] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Chiba, Japan; [Ejiri, Yoko; Hosoda, Masaya] Kuraray Co Ltd, Tsukuba Res Ctr, Tsukuba, Ibaraki, Japan	Kobayashi, K (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Chiba, Japan.	kaoruk@faculty.chiba-u.jp			Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment); Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported in part by the Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment) and by Special Funds for Education and Research (Development of SPECT Probes for Pharmaceutical Innovation) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Alexandre J, 2007, ANN ONCOL, V18, P168, DOI 10.1093/annonc/mdl321; Alzuherri HM, 1996, VET IMMUNOL IMMUNOP, V49, P331, DOI 10.1016/0165-2427(95)05477-4; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Aitken AE, 2007, DRUG METAB DISPOS, V35, P1687, DOI 10.1124/dmd.107.015511; McKillop D, 2005, XENOBIOTICA, V35, P39, DOI 10.1080/00498250400026464; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; Frye RE, 2002, J CARD FAIL, V8, P315, DOI 10.1054/jcaf.2002.127773; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283; Schmitt C, 2011, CLIN PHARMACOL THER, V89, P735, DOI 10.1038/clpt.2011.35; Dickmann LJ, 2011, DRUG METAB DISPOS, V39, P1415, DOI 10.1124/dmd.111.038679; Rivory LP, 2002, BRIT J CANCER, V87, P277, DOI 10.1038/sj.bjc.6600448; Jover R, 2002, FASEB J, V16, P1799, DOI 10.1096/fj.02-0195fje; Mertens M, 2009, J RHEUMATOL, V36, P1118, DOI 10.3899/jrheum.090074; AREND W P, 1990, Progress in Growth Factor Research, V2, P193, DOI 10.1016/0955-2235(90)90018-F; Beigneux AP, 2002, BIOCHEM BIOPH RES CO, V293, P145, DOI 10.1016/S0006-291X(02)00196-1; CHEN JQ, 1995, MOL PHARMACOL, V47, P940; GEORGE J, 1995, BIOCHEM PHARMACOL, V49, P873, DOI 10.1016/0006-2952(94)00515-N; GrottrupWolfers E, 1996, EUR J CLIN INVEST, V26, P115, DOI 10.1046/j.1365-2362.1996.123262.x; Hidaka T, 2001, J CLIN APHERESIS, V16, P74, DOI 10.1002/jca.1016; Kacevska M, 2011, CLIN CANCER RES, V17, P3170, DOI 10.1158/1078-0432.CCR-10-3289; Kalliolias GD, 2008, EXPERT OPIN INV DRUG, V17, P349, DOI 10.1517/13543784.17.3.349 ; Keskin G, 2010, PROTEIN PEPTIDE LETT, V17, P1258; Kobayashi K, 2012, DRUG METAB PHARMACOK, V27, P478, DOI 10.2133/dmpk.DMPK-12-RG-016; KRAEMER MJ, 1982, PEDIATRICS, V69, P476; Martinez-Jimenez CP, 2005, MOL PHARMACOL, V67, P2088, DOI 10.1124/mol.104.008169; Taniguchi R, 2005, J PHARMACOL SCI, V97, P83, DOI 10.1254/jphs.FP0040603	27	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	FEB	2015	30	1					105	110		10.1016/j.dmpk.2014.09.004		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VM	WOS:000353285500012		
J	Takano, M; Yamamoto, C; Yamaguchi, K; Kawami, M; Yumoto, R				Takano, Mikihisa; Yamamoto, Chieko; Yamaguchi, Koki; Kawami, Masashi; Yumoto, Ryoko			Analysis of TGF-beta 1-and drug-induced epithelial-mesenchymal transition in cultured alveolar epithelial cell line RLE/Abca3	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Pulmonary fibrosis; Alveolar epithelial cells; TGF-beta 1; Bleomycin; Methotrexate; Epithelial-mesenchymal transition	IDIOPATHIC PULMONARY-FIBROSIS; INTERSTITIAL LUNG-DISEASE; ABCA3 MUTATIONS; INSULIN UPTAKE; ALBUMIN UPTAKE; A549 CELLS; IN-VITRO; II CELLS; BLEOMYCIN; EXPRESSION	In this study, we examined the induction of epithelial-mesenchymal transition (EMT) by transforming growth factor (TGF)-beta 1 and drugs in genetically engineered type II alveolar epithelial cell line RLE/Abca3. Treatment of RLE/Abca3 cells with TGF-beta 1 induced marked changes in cell morphology from epithelial-like to elongated fibroblast-like morphology. With these morphological changes, mRNA expression of epithelial markers such as cytokeratin 19 (CK19) decreased, while that of mesenchymal markers such as alpha-smooth muscle actin (alpha-SMA) increased. TGF-beta 1 treatment also decreased the mRNA expression of Abca3, a type II cell marker, and formation of lamellar body structures. Interestingly, the effect of TGF-beta 1 on Abca3 mRNA expression was observed in RLE/Abca3 cells, but not in wild-type RLE-6TN, A549, and H441 cells. Treatment of RLE/Abca3 cells with bleomycin (BLM) and methotrexate (MTX) induced similar morphological and mRNA expression changes. In addition, the increase in alpha-SMA and the decrease in Abca3 mRNA expression by these drugs were observed only in RLE/Abca3 cells. These findings suggest that, like TGF-beta 1, BLM and MTX induce EMT in RLE/Abca3 cells, and RLE/Abca3 cells would be a good model to study drug-induced EMT. The effect of pirfenidone, an antifibrotic and anti-inflammatory drug, on EMT induced by TGF-beta 1 was also discussed. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Takano, Mikihisa; Yamamoto, Chieko; Yamaguchi, Koki; Kawami, Masashi; Yumoto, Ryoko] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmaceut & Therapeut, Minami Ku, Hiroshima 7348553, Japan	Takano, M (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmaceut & Therapeut, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	takanom@hiroshima-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [22390031, 24590195]	This work was supported in part by Grant-in-Aids for Scientific Research (22390031, 24590195) from Japan Society for the Promotion of Science (JSPS).	Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Takano M, 2012, LUNG, V190, P651, DOI 10.1007/s00408-012-9413-9; Salomon JJ, 2014, MOL PHARMACEUT, V11, P995, DOI 10.1021/mp4006535; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Chen JW, 2004, LAB INVEST, V84, P727, DOI 10.1038/labinvest.3700095; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Hartl D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-32; Fehrenbach H, 2001, RESPIR RES, V2, P33, DOI 10.1186/rr36; Kaltenborn E, 2012, HUM MOL GENET, V21, P2793, DOI 10.1093/hmg/dds107; Alipio ZA, 2011, DIFFERENTIATION, V82, P89, DOI 10.1016/j.diff.2011.05.001; Yamano G, 2001, FEBS LETT, V508, P221, DOI 10.1016/S0014-5793(01)03056-3; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Tanjore H, 2011, J BIOL CHEM, V286, P30972, DOI 10.1074/jbc.M110.181164; Sakagami M, 2006, ADV DRUG DELIVER REV, V58, P1030, DOI 10.1016/j.addr.2006.07.012; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Young LR, 2008, CHEST, V134, P192, DOI 10.1378/chest.07-2652; Degryse AL, 2010, AM J PHYSIOL-LUNG C, V299, pL442, DOI 10.1152/ajplung.00026.2010; Cheong N, 2006, J BIOL CHEM, V281, P9791, DOI 10.1074/jbc.M507515200; Yumoto R, 2006, AM J PHYSIOL-LUNG C, V290, pL946, DOI 10.1152/ajplung.00173.2005; Ikehata M, 2008, PHARM RES-DORDR, V25, P913, DOI 10.1007/s11095-007-9426-x; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Yumoto R, 2013, DRUG METAB PHARMACOK, V28, P497, DOI 10.2133/dmpk.DMPK-13-RG-028; Froudarakis M, 2013, CRIT REV ONCOL HEMAT, V87, P90, DOI 10.1016/j.critrevonc.2012.12.003; Takano M, 2013, LIFE SCI, V93, P630, DOI 10.1016/j.lfs.2013.08.008; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; Camus P, 2004, RESPIRATION, V71, P301, DOI 10.1159/000079633; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; BARRERA P, 1994, ANN RHEUM DIS, V53, P434, DOI 10.1136/ard.53.7.434; DRISCOLL KE, 1995, IN VITRO CELL DEV-AN, V31, P516; Foucher P, PNEUMOTOX ONLINE DRU; Hisatomi K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-24; Ikehata M, 2009, BIOL PHARM BULL, V32, P1765; Marmai C, 2011, AM J PHYSIOL-LUNG C, V301, pL71; Oda K, 2011, EUR J PHARMACOL, V672, P62, DOI 10.1016/j.ejphar.2011.10.003; Ohbayashi M, 2014, J TOXICOL SCI, V39, P319; Takano M, 2013, MEMBRANE, V38, P246; VYALOV SL, 1993, AM J PATHOL, V143, P1754; Weichert N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-4; Xu GP, 2007, CELL MOL BIOL LETT, V12, P457, DOI 10.2478/s11658-007-0018-x; Yumoto R, 2012, DRUG METAB PHARMACOK, V27, P336, DOI 10.2133/dmpk.DMPK-11-RG-127	43	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	FEB	2015	30	1					111	118		10.1016/j.dmpk.2014.10.007		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VM	WOS:000353285500013		
J	Saito, T; Honda, M; Takahashi, M; Tsukada, C; Ito, M; Katono, Y; Hosono, H; Saigusa, D; Suzuki, N; Tomioka, Y; Hirasawa, N; Hiratsuka, M				Saito, Takahiro; Honda, Masashi; Takahashi, Masamitsu; Tsukada, Chiharu; Ito, Miyabi; Katono, Yuki; Hosono, Hiroki; Saigusa, Daisuke; Suzuki, Naoto; Tomioka, Yoshihisa; Hirasawa, Noriyasu; Hiratsuka, Masahiro			Functional characterization of 10 CYP4A11 allelic variants to evaluate the effect of genotype on arachidonic acid omega-hydroxylation	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Cytochrome P450; CYP4A11; Genetic polymorphisms; Hypertension; Arachidonic acid; 20-HETE	CORONARY-ARTERY-DISEASE; 20-HYDROXYEICOSATETRAENOIC ACID; ESSENTIAL-HYPERTENSION; T8590C POLYMORPHISM; BLOOD-PRESSURE; GENE; HAPLOTYPE; ASSOCIATION; POPULATION; MEN	Genetic variations in cytochrome P450 4A11 (CYP4A11) contributes to inter-individual variability in the metabolism of fatty acids such as arachidonic acid. CYP4A11 metabolizes arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), which is important for the regulation of blood pressure. Polymorphisms in CYP4A11 are associated with susceptibility to hypertension. In this study, we evaluated the in vitro omega-hydroxylation of arachidonic acid by 10 CYP4A11 allelic variants, which cause amino acid substitutions in the encoded proteins. CYP4A11 variants were heterologously expressed in COS-7 cells and the kinetic parameters of arachidonic acid omega-hydroxylation were estimated. Among 10 CYP4A11 variants, 5 (CYP4A11-v1, CYP4A11-v2, CYP4A11-v3, CYP4A11-v4, and CYP4A11-v7) showed no or markedly lower activity compared to wild-type CYP4A11. This functional analysis of CYP4A11 variants could provide useful information for the effective prevention and treatment of hypertension. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Saito, Takahiro; Honda, Masashi; Takahashi, Masamitsu; Tsukada, Chiharu; Ito, Miyabi; Katono, Yuki; Hosono, Hiroki; Hirasawa, Noriyasu; Hiratsuka, Masahiro] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 980, Japan; [Saigusa, Daisuke] Tohoku Univ, Dept Integrat Genom, Tohoku Med Megabank, Sendai, Miyagi 980, Japan; [Suzuki, Naoto; Tomioka, Yoshihisa] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Oncol Pharm Practice & Sci, Sendai, Miyagi 980, Japan	Hiratsuka, M (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 980, Japan.	mhira@m.tohoku.ac.jp			Ministry of Health, Labour and Welfare, Japan ('Initiative to facilitate development of innovative drug, medical devices, and cellular & tissue-based product'); Smoking Research Foundation; Japan Research Foundation for Clinical Pharmacology	This study was supported in part by a grant from the Ministry of Health, Labour and Welfare, Japan ('Initiative to facilitate development of innovative drug, medical devices, and cellular & tissue-based product'), Smoking Research Foundation, and Japan Research Foundation for Clinical Pharmacology. We thank the Biomedical Research Core of Tohoku University Graduate School of Medicine for technical support.	Williams JS, 2011, J HYPERTENS, V29, P1913, DOI 10.1097/HJH.0b013e32834aa786; Fu ZY, 2013, CLIN APPL THROMB-HEM, V19, P60, DOI 10.1177/1076029611436197; Gainer JV, 2005, CIRCULATION, V111, P63, DOI 10.1161/01.CIR.0000151309.82473.59; Fu ZY, 2013, GENE, V512, P510, DOI 10.1016/j.gene.2012.10.007; Halushka MK, 1999, NAT GENET, V22, P239; Powell PK, 1998, J PHARMACOL EXP THER, V285, P1327; MA YH, 1993, CIRC RES, V72, P126; Cardenas CLL, 2011, GENE, V487, P10, DOI 10.1016/j.gene.2011.07.015; Mayer B, 2005, HYPERTENSION, V46, P766, DOI 10.1161/01.HYP.0000182658.04299.15; Zou AP, 1996, AM J PHYSIOL-REG I, V270, pR228; SCHWARTZMAN M, 1985, NATURE, V314, P620, DOI 10.1038/314620a0; Barri Yousri M, 2006, Curr Cardiol Rep, V8, P411, DOI 10.1007/s11886-006-0098-7; Chang YT, 1999, PROTEINS, V34, P403, DOI 10.1002/(SICI)1097-0134(19990215)34:3<403::AID-PROT12>3.0.CO;2-D; Fu Z, 2008, J HYPERTENS, V26, P453, DOI 10.1097/HJH.0b013e3282f2f10c; Fu ZY, 2012, HEREDITAS, V149, P91, DOI 10.1111/j.1601-5223.2012.02247.x; Gainer JV, 2008, J AM SOC NEPHROL, V19, P1606, DOI 10.1681/ASN.2008010063; Nowicki S, 1997, J CLIN INVEST, V99, P1224, DOI 10.1172/JCI119279; Omura T., 1993, CYTOCHROME P 450; Stokes J, 1989, HYPERTENSION S1, V13, P13; Sugimoto K, 2008, HYPERTENSION, V52, P1142, DOI 10.1161/HYPERTENSIONAHA.108.114082	20	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	FEB	2015	30	1					119	122		10.1016/j.dmpk.2014.09.001		4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VM	WOS:000353285500014		
J	Akai, F; Hosono, H; Hirasawa, N; Hiratsuka, M				Akai, Fumika; Hosono, Hiroki; Hirasawa, Noriyasu; Hiratsuka, Masahiro			Novel single nucleotide polymorphisms of the dihydropyrimidinase gene (DPYS) in Japanese individuals	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Dihydropyrimidinase; DPYS; Genetic polymorphism; SNP; Japanese	5-FLUOROURACIL TOXICITY; DEFICIENCY	Genetic polymorphisms of the dihydropyrimidinase gene (DPYS) may be associated with the development of severe toxicity to 5-fluorouracil, a drug used to treat solid tumors. In this study, we analyzed the nine coding exons and exon-intron junctions of DPYS in 183 Japanese individuals. We detected two novel single nucleotide polymorphisms (SNPs)-285C > T (Thr95Thr) and 349T > C (Trp117Arg)-in exon 2. The nonsynonymous SNP 349T > C was analyzed in 208 Japanese individuals. Although the allele frequency of the SNP in the Japanese population was found to be extremely low (0.13%), the enzymatic activity of the variant protein might be reduced compared with that of the wild-type protein. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Akai, Fumika; Hosono, Hiroki; Hirasawa, Noriyasu; Hiratsuka, Masahiro] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 980, Japan	Hiratsuka, M (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 980, Japan.	mhira@m.tohoku.ac.jp			Smoking Research Foundation	This work was supported in part by a grant from the Smoking Research Foundation.	van Kuilenburg ABP, 2003, CLIN CANCER RES, V9, P4363; Wei XX, 1996, J CLIN INVEST, V98, P610, DOI 10.1172/JCI118830; van Kuilenburg ABP, 2000, CLIN CANCER RES, V6, P4705; van Kuilenburg ABP, 2010, BBA-MOL BASIS DIS, V1802, P639, DOI 10.1016/j.bbadis.2010.03.013; Loganayagam A, 2013, BRIT J CANCER, V108, P2505, DOI 10.1038/bjc.2013.262; DURAN M, 1991, J INHERIT METAB DIS, V14, P367, DOI 10.1007/BF01811705; Fidlerova J, 2010, CANCER CHEMOTH PHARM, V65, P661, DOI 10.1007/s00280-009-1071-0; Hamajima N, 1998, AM J HUM GENET, V63, P717, DOI 10.1086/302022; Hayashi K, 1996, CLIN CANCER RES, V2, P1937; Ohba S, 1995, PURINE PYRIMIDINE ME, V8, P383; vanGennip AH, 1997, J INHERIT METAB DIS, V20, P339, DOI 10.1023/A:1005309423960; van Kuilenburg ABP, 2007, MOL GENET METAB, V91, P157, DOI 10.1016/j.ymgme.2007.02.008; Yeung CW, 2013, HONG KONG MED J, V19, P272, DOI 10.12809/hkmj133598	13	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	FEB	2015	30	1					127	129		10.1016/j.dmpk.2014.09.005		3	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VM	WOS:000353285500016		
J	Uno, Y; Matsushita, A; Murayama, N; Yamazaki, H				Uno, Yasuhiro; Matsushita, Akinori; Murayama, Norie; Yamazaki, Hiroshi			Genetic polymorphism of cynomolgus and rhesus macaque CYP2C9	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Monkey; Cytochrome P450; Genetic polymorphisms; Metabolic activity	CYTOCHROME-P450; VARIANTS; MONKEY; TESTOSTERONE; CYP3A4; LIVER	Cynomolgus and rhesus macaques are non-human primate species widely used in drug metabolism studies. Cynomolgus CYP2C9 (formerly known as CYP2C43) is predominantly expressed in liver and encodes a drug-metabolizing enzyme that metabolizes human CYP2C substrates such as S-mephenytoin and progesterone. In addition, cynomolgus CYP2C9 also metabolizes caffeine, resulting in the formation of the metabolite that is not generated efficiently in humans. Genetic variants of human CYP2C genes account for the inter-individual variability in drug metabolism: however, CYP2C9 variants have not been found in macaques. To see if CYP2C9 is polymorphic in macaques, in this study, CYP2C9 was re-sequenced in 78 cynomolgus and 36 rhesus macaques. A total of 27 non-synonymous variants were found, among which 4 were located in substrate recognition sites, the domain important for protein function. Thirteen and seven variants were unique to cynomolgus and rhesus macaques, respectively. This study revealed the polymorphic nature of cynomolgus and rhesus CYP2C9, similar to human CYP2C genes, by identification of numerous genetic variants including non-synonymous variants. Copyright (C) 2014, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Uno, Yasuhiro; Matsushita, Akinori] Shin Nippon Biomed Labs Ltd, Pharmacokinet & Bioanal Ctr, Kainan, Wakayama, Japan; [Matsushita, Akinori] Shin Nippon Biomed Labs Ltd, Drug Safety Res Ctr, Kagoshima, Japan; [Murayama, Norie; Yamazaki, Hiroshi] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo, Japan	Uno, Y (reprint author), Shin Nippon Biomed Labs Ltd, Pharmacokinet & Bioanal Ctr, 16-1 Minami Akasaka, Kainan, Wakayama, Japan.	uno-yasuhiro@snbl.co.jp	Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261			Kang YS, 2009, CLIN PHARMACOL THER, V85, P312, DOI 10.1038/clpt.2008.215; Dai D, 2001, J PHARMACOL EXP THER, V299, P825; Uno Y, 2011, DRUG METAB REV, V43, P346, DOI 10.3109/03602532.2010.549492; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; JACQZ E, 1988, MOL PHARMACOL, V34, P215; Mitsuda M, 2006, J BIOCHEM, V139, P865, DOI 10.1093/jb/mvj093; Uehara S, 2012, DRUG METAB PHARMACOK, V27, P344, DOI 10.2133/dmpk.DMPK-11-NT-118; Uno Y, 2006, MOL PHARMACOL, V70, P477, DOI 10.1124/mol.106.022673; Uno Y, 2011, DRUG METAB PHARMACOK, V26, P627, DOI 10.2133/dmpk.DMPK-11-NT-026; Uno Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016923; Uno Y, 2010, DRUG METAB DISPOS, V38, P209, DOI 10.1124/dmd.109.029710; Uno Y, 2009, DRUG METAB DISPOS, V37, P14, DOI 10.1124/dmd.108.023622; Uno Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-283; Utoh M, 2013, XENOBIOTICA, V43, P1037, DOI 10.3109/00498254.2013.793874	14	1	1	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	FEB	2015	30	1					130	132		10.1016/j.dmpk.2014.10.002		3	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG4VM	WOS:000353285500017		
J	Uchiyama, S; Tomizawa, T; Tokoro, A; Aoki, M; Hishiki, M; Yamada, T; Tanaka, R; Sakamoto, H; Yoshida, T; Bekki, K; Inaba, Y; Nakagome, H; Kunugita, N				Uchiyama, Shigehisa; Tomizawa, Takuya; Tokoro, Asumo; Aoki, Manami; Hishiki, Mayu; Yamada, Tomomi; Tanaka, Reiko; Sakamoto, Hironari; Yoshida, Tsutomu; Bekki, Kanae; Inaba, Yohei; Nakagome, Hideki; Kunugita, Naoki			Gaseous chemical compounds in indoor and outdoor air of 602 houses throughout Japan in winter and summer	ENVIRONMENTAL RESEARCH			English	Article						Indoor air quality; Nationwide survey; Diffusive sampler; Ozone	SENSITIVE DIFFUSION SAMPLER; 2,4-DINITROPHENYLHYDRAZINE-IMPREGNATED SILICA; KEROSENE HEATERS; AMBIENT AIR; FORMALDEHYDE; HOMES; ACETALDEHYDE; POLLUTION; QUALITY; DEPOSITION	A nationwide survey of indoor air quality in Japan was conducted using four types of diffusive samplers. Gaseous chemical compounds such as carbonyls, volatile organic compounds (VOC), acid gases, basic gases, and ozone were measured in indoor and outdoor air of 602 houses throughout Japan in winter and summer. Four kinds of diffusive samplers were used in this study: DSD-BPE/DNPH packed with 2,4-dinitrophenyl hydrazine and trans-1,2-bis(2-pyridyl)ethylene coated silica for ozone and carbonyls; VOC-SD packed with Carboxen 564 particles for volatile organic compounds; DSD-TEA packed with triethanolamine impregnated silica for acid gases; and DSD-NH3 packed with phosphoric acid impregnated silica for basic gases. These samplers are small and lightweight and do not require a power source, hence, it was possible to obtain a large number of air samples via mail from throughout Japan. Almost all compounds in indoor air were present at higher levels in summer than in winter. In particular, formaldehyde, toluene, and ammonia were strongly dependent on temperature, and their levels increased with temperature. The nitrogen dioxide concentration in indoor air particularly increased only during winter and was well correlated with the formic acid concentration (correlation coefficient=0.959). Ozone concentrations in indoor air were extremely low compared with the outdoor concentrations. Ozone flowing from outdoor air may be decomposed quickly by chemical compounds in indoor air; therefore, it is suggested that the indoor/outdoor ratio of ozone represents the ventilation of the indoor environment. (C) 2014 Elsevier Inc. All rights reserved.	[Uchiyama, Shigehisa; Tomizawa, Takuya; Tokoro, Asumo; Aoki, Manami; Hishiki, Mayu; Yamada, Tomomi; Bekki, Kanae; Inaba, Yohei; Kunugita, Naoki] Natl Inst Publ Hlth, Dept Environm Hlth, Wako, Saitama 3510197, Japan; [Tanaka, Reiko] Yokohama City Inst Hlth, Isogo Ku, Yokohama, Kanagawa 2350012, Japan; [Sakamoto, Hironari] Chiba City Inst Hlth & Environm, Mihama Ku, Chiba, Chiba 2610001, Japan; [Yoshida, Tsutomu] Sapporo City Inst Publ Hlth, Shiroishi Ku, Sapporo, Hokkaido 0038505, Japan; [Nakagome, Hideki] Chiba Univ, Grad Sch Engn, Inage Ku, Chiba, Chiba 2638522, Japan	Uchiyama, S (reprint author), Natl Inst Publ Hlth, Dept Environm Hlth, 2-3-6 Minami, Wako, Saitama 3510197, Japan.	uchiyama@niph.go.jp		Kunugita, Naoki/0000-0002-6516-8379	Ministry of Health, Labour, and Welfare of the Japanese Government	We thank all parties contributed in this nationwide survey. This research was partially supported by Ministry of Health, Labour, and Welfare of the Japanese Government, the Health and Labour Sciences Research Grants (Research on Health Security Control and Third Term Comprehensive Control Research for Cancer). We also gratefully acknowledge Sigma-Aldrich for technical support.	Zuraimi MS, 2007, INDOOR AIR, V17, P317, DOI 10.1111/j.1600-0668.2007.00480.x; WESCHLER CJ, 1994, ENVIRON SCI TECHNOL, V28, P2120, DOI 10.1021/es00061a021; Parthasarathy S, 2011, J AIR WASTE MANAGE, V61, P689, DOI 10.3155/1047-3289.61.6.689; JONES AW, 1995, ALCOHOL ALCOHOLISM, V30, P271; [Anonymous], 2010, WHO GUID IND AIR QUA; Azuma K, 2007, RISK ANAL, V27, P1623, DOI 10.1111/j.1539-6924.2007.00993.x; Osman LM, 2007, AM J RESP CRIT CARE, V176, P465, DOI 10.1164/rccm.200605-589OC; Park JS, 2006, INDOOR AIR, V16, P129, DOI 10.1111/j.1600-0668.2005.00408.x; Bohm M, 2012, J HAZARD MATER, V221, P68, DOI 10.1016/j.jhazmat.2012.04.013; Jia C, 2008, ATMOS ENVIRON, V42, P2083, DOI 10.1016/j.atmosenv.2007.11.055; Kelly TJ, 1999, ENVIRON SCI TECHNOL, V33, P81, DOI 10.1021/es980592+; Dassonville C, 2009, INDOOR AIR, V19, P314, DOI 10.1111/j.1600-0668.2009.00594.x; Harrison RM, 2002, OCCUP ENVIRON MED, V59, P671, DOI 10.1136/oem.59.10.671; Takigawa T, 2010, INT ARCH OCC ENV HEA, V83, P225, DOI 10.1007/s00420-009-0475-9; Ciencewicki J, 2007, INHAL TOXICOL, V19, P1135, DOI 10.1080/08958370701665434; Gomzi M, 2007, ARCH ENVIRON OCCUP H, V62, P147, DOI 10.3200/AEOH.62.3.147-155; KAWAMOTO T, 1997, PERSONAL EXPOSURE IN, V654, P178; McCreddin A, 2013, TOXICS, V1, P60; MELIA RJW, 1990, ATMOS ENVIRON B-URB, V24, P177, DOI 10.1016/0957-1272(90)90023-N; Osawa H, 2009, BUILD ENVIRON, V44, P1330, DOI 10.1016/j.buildenv.2008.06.022; RYAN PB, 1983, ATMOS ENVIRON, V17, P1339, DOI 10.1016/0004-6981(83)90408-0; Salaspuro M, 2009, SCAND J GASTROENTERO, V44, P912, DOI 10.1080/00365520902912563; SHASKAN EG, 1985, PROG NEURO-PSYCHOPH, V9, P267, DOI 10.1016/0278-5846(85)90090-9; Taneja A, 2008, ANN NY ACAD SCI, V1140, P228, DOI 10.1196/annals.1454.033; Tanner PA, 2003, WATER AIR SOIL POLL, V142, P279, DOI 10.1023/A:1022063925972; THATCHER TL, 1995, ATMOS ENVIRON, V29, P1487, DOI 10.1016/1352-2310(95)00016-R; Uchiyama S, 1999, ATMOS ENVIRON, V33, P1913, DOI 10.1016/S1352-2310(98)00208-8; Uchiyama S, 2004, ATMOS ENVIRON, V38, P6319, DOI 10.1016/j.atmosenv.2004.08.008; Uchiyama S, 1999, ATMOS ENVIRON, V33, P1999, DOI 10.1016/S1352-2310(98)00427-0; Uchiyama S, 2011, ANAL CHIM ACTA, V691, P119, DOI 10.1016/j.aca.2011.02.048; Uchiyama S, 2009, ANAL CHEM, V81, P6552, DOI 10.1021/ac9011528; Uchiyama S., 2007, Atmospheric Environment, V41, P8825, DOI 10.1016/j.atmosenv.2007.09.046; Uchiyama S, 2008, ANAL CHEM, V80, P3285, DOI 10.1021/ac702475s; United States Environmental Protection Agency (USEPA), INTR IND AIR QUAL IA; Van Vleet T.R., 2014, ENCY TOXICOLOGY, P22; Yamada T, 2013, BUNSEKI KAGAKU, V62, P603; Yamada T, 2012, ATMOS ENVIRON, V54, P629, DOI 10.1016/j.atmosenv.2012.02.001	37	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0013-9351	1096-0953		ENVIRON RES	Environ. Res.	FEB	2015	137						364	372		10.1016/j.envres.2014.12.005		9	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CF1TO	WOS:000352331000044		
J	Eguchi, A; Nomiyama, K; Tue, NM; Trang, PTK; Viet, PH; Takahashi, S; Tanabe, S				Eguchi, Akifumi; Nomiyama, Kei; Nguyen Minh Tue; Pham Thi Kim Trang; Pham Hung Viet; Takahashi, Shin; Tanabe, Shinsuke			Residue profiles of organohalogen compounds in human serum from e-waste recycling sites in North Vietnam: Association with thyroid hormone levels	ENVIRONMENTAL RESEARCH			English	Article						e-waste; PCBs; PBDEs; Hydroxylated metabolites; Thyroid hormones	POLYBROMINATED DIPHENYL ETHERS; BROMINATED FLAME RETARDANTS; HISTORICAL EMISSION INVENTORY; HYDROXYLATED PCB METABOLITES; TANDEM MASS-SPECTROMETRY; JAPANESE COASTAL WATERS; POLYCHLORINATED-BIPHENYLS; PREGNANT-WOMEN; BALTIC SEA; ORGANOCHLORINE COMPOUNDS	This study demonstrated the contamination levels of polychlorinated biphenyls (PCBs), hydroxylated PCBs (OH-PCBs), polybrominated diphenyl ethers (PBDEs), methoxylated PBDEs (MeO-PBDEs), hydroxylated PBDEs (OH-PBDEs), and bromophenols (BPhs), and their relationships with thyroid hormones (THs), in the serum of human donors from an e-waste recycling site and a rural site in Hung Yen province, Vietnam. Occupationally related exposure was indicated by significantly higher residue levels of PCBs, OH-PCBs, PBDEs, and BPhs in the serum of donors from the e-waste recycling site (median: 420, 160, 290, and 300 pg g(-1) wet wt, respectively) than those in the serum of donors from the rural site (median: 290, 82, 230, and 200 pg g(-1) wet wt, respectively). On the other hand, levels of OH-/MeO-PBDEs were significantly higher in serum of donors from the reference site (median: 160 and 20 pg g(-1) wet wt, respectively) than in those from the e-waste recycling site (median: 43 and 0.52 pg g(-1) wet wt, respectively). In addition, we implemented stepwise generalized linear models to assess the association between the levels of TH and PCBs, PBDEs, and their related compounds. In females, we found positive associations of PCBs and OH-PCB concentrations with total thyroxine, free thyroxine, total triiodothyronine, and free triiodothyronine, and a negative association with thyroid-stimulating hormone concentrations. (C) 2015 Elsevier Inc. All rights reserved.	[Eguchi, Akifumi; Nomiyama, Kei; Nguyen Minh Tue; Tanabe, Shinsuke] Ehime Univ, CMES, Matsuyama, Ehime 7908577, Japan; [Nguyen Minh Tue; Pham Thi Kim Trang; Pham Hung Viet] Hanoi Univ Sci, Ctr Environm Technol & Sustainable Dev, Hanoi, Vietnam; [Takahashi, Shin] Ehime Univ, Fac Agr, Ctr Adv Technol Environm, Matsuyama, Ehime 7908566, Japan	Nomiyama, K (reprint author), Ehime Univ, CMES, Bunkyo Cho 2-5, Matsuyama, Ehime 7908577, Japan.	keinomi@agr.ehime-u.ac.jp	Tanabe, Shinsuke/G-6950-2013		Japan Society for the Promotion of Science (JSPS), Japan [25701014, 25257403, 26881003]; Global Center of Excellence (COE) Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japanese Ministry of the Environment [K2311, 3K133001]; JSPS in Japan [22-6331, 25-6617]	This study was supported by Grants-in-Aid for Young Scientists (A) (No. 25701014), Grants-in-Aid for Scientific Research (A) (No. 25257403) and Grant-in-Aid for Research Activity start-up (No. 26881003) from the Japan Society for the Promotion of Science (JSPS), Japan, the Global Center of Excellence (COE) Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and the Environment Research and Technology Development Fund (K2311 and 3K133001) from the Japanese Ministry of the Environment. We also acknowledge the JSPS Research Fellowships for Young Scientists (DC1 and PD) in Japan that were provided to Dr. A. Eguchi (Nos. 22-6331 and 25-6617).	Abdelouahab N, 2008, ENVIRON RES, V107, P380, DOI 10.1016/j.envres.2008.01.006; Akaike Hirotogu, 1998, INFORM THEORY EXTENS, V1998, P199, DOI DOI 10.1007/978-1-4612-1694-0_; Qiu XH, 2009, ENVIRON HEALTH PERSP, V117, P93, DOI 10.1289/ ehp.11660; KOOPMANESSEBOOM C, 1994, PEDIATR RES, V36, P468, DOI 10.1203/00006450-199410000-00009; Stapleton HM, 2009, ENVIRON HEALTH PERSP, V117, P197, DOI 10.1289/ehp.11807; Mazdai A, 2003, ENVIRON HEALTH PERSP, V111, P1249, DOI 10.1289/ehp.6146; Chevrier J, 2008, AM J EPIDEMIOL, V168, P298, DOI 10.1093/aje/kwn136; Meerts IATM, 2002, TOXICOL SCI, V68, P361, DOI 10.1093/toxsci/68.2.361; Calvert GM, 1999, OCCUP ENVIRON MED, V56, P270; Noguchi T, 2014, J MATER CYCLES WASTE, V16, P46, DOI 10.1007/s10163-013-0159-0; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Nomiyama K, 2011, CHEMOSPHERE, V85, P315, DOI 10.1016/j.chemosphere.2011.06.092; Eguchi A, 2012, ENVIRON INT, V47, P8, DOI 10.1016/j.envint.2012.05.003; Mizukawa H, 2013, ENVIRON POLLUT, V174, P28, DOI 10.1016/j.envpol.2012.11.004; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Valters K, 2005, ENVIRON SCI TECHNOL, V39, P5612, DOI 10.1021/es0506410; Martin L, 2010, TOXICOL SCI, V117, P36, DOI 10.1093/toxsci/kfq187; Lopez-Espinosa MJ, 2009, ENVIRON RES, V109, P479, DOI 10.1016/j.envres.2009.02.003; Sandau CD, 2000, ENVIRON HEALTH PERSP, V108, P611, DOI 10.2307/3434880; Lin SM, 2011, INT J HYG ENVIR HEAL, V214, P115, DOI 10.1016/j.ijheh.2010.10.002; Roze E, 2009, ENVIRON HEALTH PERSP, V117, P1953, DOI 10.1289/ehp.0901015; Malmberg T, 2005, ENVIRON SCI TECHNOL, V39, P5342, DOI 10.1021/es050574+; Meeker JD, 2007, ENVIRON RES, V104, P296, DOI 10.1016/j.envres.2007.11.007; Tue NM, 2013, ENVIRON INT, V51, P160, DOI 10.1016/j.envint.2012.11.006; Breivik K, 2002, SCI TOTAL ENVIRON, V290, P199, DOI 10.1016/S0048-9697(01)01076-2; Alvarez-Pedrerol M, 2009, ENVIRON SCI TECHNOL, V43, P7909, DOI 10.1021/es9007273; Malmvarn A, 2008, CHEMOSPHERE, V72, P910, DOI 10.1016/j.chemosphere.2008.03.036; Wan Y, 2010, ENVIRON SCI TECHNOL, V44, P5233, DOI 10.1021/es1002764; Zota AR, 2011, ENVIRON SCI TECHNOL, V45, P7896, DOI 10.1021/es200422b; Ishikawa Y, 2007, CHEMOSPHERE, V67, P1838, DOI 10.1016/j.chemosphere.2006.05.075; Dohan O, 2007, P NATL ACAD SCI USA, V104, P20250, DOI 10.1073/pnas.0707207104; Jin J, 2009, ENVIRON INT, V35, P1048, DOI 10.1016/j.envint.2009.05.006; Ucan-Marin F, 2010, ENVIRON SCI TECHNOL, V44, P497, DOI 10.1021/es902691u; Tue NM, 2010, ENVIRON SCI TECHNOL, V44, P9195, DOI 10.1021/es102505j; Sjodin A, 2000, ENVIRON HEALTH PERSP, V108, P1035, DOI 10.2307/3434955; Marchesini GR, 2008, TOXICOL APPL PHARM, V232, P150, DOI [10.1016/j.taap.2008.06.014, 10.1016/j.tiap.2008.06.014]; Marsh G, 2004, ENVIRON SCI TECHNOL, V38, P10, DOI 10.1021/es034671j; Hisada A, 2013, ENVIRON HEALTH PREV, V18, P205, DOI 10.1007/s12199-012-0306-6; Nomiyama K, 2011, ENVIRON POLLUT, V159, P3364, DOI 10.1016/j.envpol.2011.08.035; Breivik K, 2002, SCI TOTAL ENVIRON, V290, P181, DOI 10.1016/S0048-9697(01)01075-0; Park HY, 2009, ENVIRON HEALTH PERSP, V117, P1600, DOI 10.1289/ehp.0900611; Qiu XH, 2007, ENVIRON HEALTH PERSP, V115, P1052, DOI 10.1289/ehp.10011; Herbstman JB, 2010, ENVIRON HEALTH PERSP, V118, P712, DOI 10.1289/ehp.0901340; Sala M, 2001, OCCUP ENVIRON MED, V58, P172, DOI 10.1136/oem.58.3.172; Plossl F, 2006, J CHROMATOGR A, V1135, P19, DOI 10.1016/j.chroma.2006.09.033; Hallgren S, 2001, ARCH TOXICOL, V75, P200, DOI 10.1007/s002040000208; Teuten EL, 2005, SCIENCE, V307, P917, DOI 10.1026/science.1106882; Weiss J, 2006, ENVIRON SCI TECHNOL, V40, P6282, DOI 10.1021/es0610941; Soldin OP, 2004, CLIN CHIM ACTA, V349, P181, DOI 10.1016/j.cccn.2004.06.021; BERGMAN A, 1994, ENVIRON HEALTH PERSP, V102, P464, DOI 10.2307/3432042; Tue NM, 2010, SCI TOTAL ENVIRON, V408, P2155, DOI 10.1016/j.scitotenv.2010.01.012; Zhao XR, 2010, CHEMOSPHERE, V78, P659, DOI 10.1016/j.chemosphere.2009.12.013; Wan Y, 2009, ENVIRON SCI TECHNOL, V43, P7536, DOI 10.1021/es901357u; Cheek AO, 1999, ENVIRON HEALTH PERSP, V107, P273, DOI 10.2307/3434593; Suzuki G, 2008, ENVIRON SCI TECHNOL, V42, P1794, DOI 10.1021/es7021895; Longnecker MP, 2003, ENVIRON HEALTH PERSP, V111, P65, DOI 10.1289/ehp.5463; Watanabe I, 2003, ENVIRON INT, V29, P665, DOI 10.1016/S0160-4120(03)00123-5; Tonacchera M, 2004, THYROID, V14, P1012, DOI 10.1089/thy.2004.14.1012; Athanasiadou M, 2008, ENVIRON HEALTH PERSP, V116, P400, DOI 10.1289/ehp.10713; Dirtu AC, 2010, ENVIRON SCI TECHNOL, V44, P2876, DOI 10.1021/es902149b; Eguchi A, 2014, ARCH ENVIRON CON TOX, V67, P29, DOI 10.1007/s00244-014-0021-y; Fangstrom B, 2002, ENVIRON HEALTH PERSP, V110, P895; Freels S, 2007, CHEMOSPHERE, V69, P435, DOI 10.1016/j.chemosphere.2007.04.087; Fujii Y, 2014, ENVIRON POLLUT, V185, P228, DOI 10.1016/j.envpol.2013.11.002; GELFAND RA, 1987, METABOLISM, V36, P562, DOI 10.1016/0026-0495(87)90168-5; Hagmar L, 2001, INT ARCH OCC ENV HEA, V74, P184, DOI 10.1007/s004200000213; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kunisue T, 2011, ENVIRON SCI TECHNOL, V45, P10140, DOI 10.1021/es203002a; Londono M, 2010, J APPL TOXICOL, V30, P334, DOI 10.1002/jat.1501; Morck A, 2003, DRUG METAB DISPOS, V31, P900, DOI 10.1124/dmd.31.7.900; Nomiyama K, 2010, ENVIRON SCI TECHNOL, V44, P2890, DOI 10.1021/es9012432; Park JS, 2009, ENVIRON INT, V35, P937, DOI 10.1016/j.envint.2009.04.002; Persky V, 2001, ENVIRON HEALTH PERSP, V109, P1275, DOI 10.2307/3454751; Roche Diagnostics GmbH, 2008, REF INT CHILDR AD EL; Sjodin A, 1999, ENVIRON HEALTH PERSP, V107, P643, DOI 10.2307/3434456; SVCT, 2002, EXP HARM HIGH TECH T; Takser L, 2005, ENVIRON HEALTH PERSP, V113, P1039, DOI 10.1289/ehp.7685; Tanabe S, 2006, J ENVIRON MONITOR, V8, P782, DOI 10.1039/b602677j; Thuresson K, 2005, ENVIRON SCI TECHNOL, V39, P1980, DOI 10.1021/es048511z; Turyk ME, 2006, ENVIRON RES, V102, P299, DOI 10.1016/j.envres.2006.01.009; UNEP, 2005, E WAST HIDD SID IT E; WOLFF MS, 1992, ENVIRON RES, V59, P202, DOI 10.1016/S0013-9351(05)80240-3; Zoeller RT, 2003, J CLIN INVEST, V111, P954, DOI 10.1172/JCI200318236	83	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0013-9351	1096-0953		ENVIRON RES	Environ. Res.	FEB	2015	137						440	449		10.1016/j.envres.2015.01.007		10	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CF1TO	WOS:000352331000053		
J	Bauer, E; Lampert, N; Mikaelyan, A; Kohler, T; Maekawa, K; Brune, A				Bauer, Eugen; Lampert, Niclas; Mikaelyan, Aram; Koehler, Tim; Maekawa, Kiyoto; Brune, Andreas			Physicochemical conditions, metabolites and community structure of the bacterial microbiota in the gut of wood-feeding cockroaches (Blaberidae: Panesthiinae)	FEMS MICROBIOLOGY ECOLOGY			English	Article						cockroach; gut microbiota; diversity; lignocellulose; hydrogen	TERMITE RETICULITERMES-FLAVIPES; CRIBRATA SAUSSURE; PHYLOGENETIC DIVERSITY; PERIPLANETA-AMERICANA; CELLULOSE DIGESTION; NONPARAMETRIC-ESTIMATION; NASUTITERMES SPP.; CUBITERMES SPP.; GEN. NOV.; HINDGUT	While the gut microbiota of termites and its role in symbiotic digestion have been studied for decades, little is known about the bacteria colonizing the intestinal tract of the distantly related wood-feeding cockroaches (Blaberidae: Panesthiinae). Here, we show that physicochemical gut conditions and microbial fermentation products in the gut of Panesthia angustipennis resemble that of other cockroaches. Microsensor measurements confirmed that all gut compartments were anoxic at the center and had a slightly acidic to neutral pH and a negative redox potential. While acetate dominated in all compartments, lactate and hydrogen accumulated only in the crop. The high, hydrogen-limited rates of methane emission from living cockroaches were in agreement with the restriction of F-420-fluorescent methanogens to the hindgut. The gut microbiota of both P. angustipennis and Salganea esakii differed strongly between compartments, with the highest density and diversity in the hindgut, but similarities between homologous compartments of both cockroaches indicated a specificity of the microbiota for their respective habitats. While some lineages were most closely related to the gut microbiota of omnivorous cockroaches and wood-or litter-feeding termites, others have been encountered also in vertebrates, reinforcing the hypothesis that strong environmental selection drives community structure in the cockroach gut.	[Bauer, Eugen; Lampert, Niclas; Mikaelyan, Aram; Koehler, Tim; Brune, Andreas] Max Planck Inst Terr Microbiol, Dept Biogeochem, D-35043 Marburg, Germany; [Maekawa, Kiyoto] Toyama Univ, Grad Sch Sci & Engn, Toyama 9308555, Japan	Brune, A (reprint author), Max Planck Inst Terr Microbiol, Dept Biogeochem, Karl von Frisch Str 10, D-35043 Marburg, Germany.	brune@mpi-marburg.mpg.de		Mikaelyan, Aram/0000-0002-7276-0194	Max Planck Society	This study was funded by the Max Planck Society.	Akhmanova A, 1998, NATURE, V396, P527, DOI 10.1038/25023; Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0; Brune A, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P439, DOI 10.1007/978-90-481-3977-4_16; Ikeda-Ohtsubo W, 2007, MICROBIOL-SGM, V153, P3458, DOI 10.1099/mic.0.2007/009217-0; Nalepa CA, 2001, INSECT SOC, V48, P194, DOI 10.1007/PL00001767; Ohkuma M, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P413, DOI 10.1007/978-90-481-3977-4_15; Lynn DH, 2013, J EUKARYOT MICROBIOL, V60, P335, DOI 10.1111/jeu.12037; Hongoh Y, 2005, APPL ENVIRON MICROB, V71, P6590, DOI 10.1128/AEM.71.11.6590-6599.2005; BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2681; Tokuda G, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1153; Hongoh Y, 2006, APPL ENVIRON MICROB, V72, P6780, DOI 10.1128/AEM.00891-06; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Dietrich C, 2014, APPL ENVIRON MICROB, V80, P2261, DOI 10.1128/AEM.04206-13; Schmitt-Wagner D, 1999, APPL ENVIRON MICROB, V65, P4490; Lo N, 2003, MOL BIOL EVOL, V20, P907, DOI 10.1093/molbev/msg097; Paul K, 2012, APPL ENVIRON MICROB, V78, P8245, DOI 10.1128/AEM.02193-12; Ikeda-Ohtsubo W, 2009, MOL ECOL, V18, P332, DOI 10.1111/j.1365-294X.2008.04029.x; Otani S, 2014, MOL ECOL, V23, P4631, DOI 10.1111/mec.12874; Pester M, 2007, ISME J, V1, P551, DOI 10.1038/ismej.2007.62; Noda S, 2007, MOL ECOL, V16, P1257, DOI 10.1111/j.1365-294X.2006.03219.x; HACKSTEIN JHP, 1994, P NATL ACAD SCI USA, V91, P5441, DOI 10.1073/pnas.91.12.5441; BIGNELL DE, 1980, J GEN MICROBIOL, V117, P393; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; Schauer C, 2012, APPL ENVIRON MICROB, V78, P2758, DOI 10.1128/AEM.07788-11; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Ebert A, 1997, APPL ENVIRON MICROB, V63, P4039; Schmitt-Wagner D, 2003, APPL ENVIRON MICROB, V69, P6007, DOI 10.1128/AEM.69.10.6007-6017.2003; Hongoh Y, 2006, MOL ECOL, V15, P505, DOI 10.1111/j.1365-294X.2005.02795.x; KANE MD, 1991, APPL ENVIRON MICROB, V57, P2628; Kampfer P, 2011, INT J SYST EVOL MICR, V61, P518, DOI 10.1099/ijs.0.023002-0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCRIVENER AM, 1989, J INSECT PHYSIOL, V35, P935, DOI 10.1016/0022-1910(89)90016-4; Shinzato N, 2007, BIOSCI BIOTECH BIOCH, V71, P906, DOI 10.1271/bbb.60540; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Klass KD, 2008, MOL PHYLOGENET EVOL, V46, P809, DOI 10.1016/j.ympev.2007.11.028; Inward D, 2007, BIOLOGY LETT, V3, P331, DOI 10.1098/rsbl.2007.0102; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Mikaelyan A, 2014, ENVIRON MICROBIOL, V16, P2711, DOI 10.1111/1462-2920.12425; Bertino-Grimaldi D, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-609; BIGNELL DE, 1977, J INVERTEBR PATHOL, V29, P338, DOI 10.1016/S0022-2011(77)80040-2; BRACKE JW, 1979, APPL ENVIRON MICROB, V38, P945; BRACKE JW, 1980, J INSECT PHYSIOL, V26, P85, DOI 10.1016/0022-1910(80)90047-5; Brune A., 2010, HDB HYDROCARBON LIPI, V8, P707; CHAO A, 1984, SCAND J STAT, V11, P265; Charrier M, 2003, CAN J ZOOL, V81, P928, DOI 10.1139/Z03-071; CRUDEN DL, 1984, ARCH MICROBIOL, V138, P131, DOI 10.1007/BF00413013; Day A, 2012, R PACKAGE VERSION 1; GIJZEN HJ, 1991, APPL ENVIRON MICROB, V57, P1630; Hackstein JHP, 2006, INTESTINAL MICROORGA, P162; Hackstein JHP, 1997, ANTON LEEUW INT J G, V72, P63, DOI 10.1023/A:1000321631884; Hara Kurt, 2002, Microbes and Environments, V17, P185, DOI 10.1264/jsme2.17.185; He SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061126; HOGAN ME, 1985, J INSECT PHYSIOL, V31, P587, DOI 10.1016/0022-1910(85)90116-7; KIDDER GEORGE W., 1937, PARASITOLOGY, V29, P163; Lane D. J., 1991, NUCL ACID TECHNIQUES, V4, P115, DOI DOI 10.1002/JOBM.3620310616; Lang K, 2015, APPL ENVIRON MICROB, V81, P1338, DOI 10.1128/AEM.03389-14; Legendre P., 1998, NUMERICAL ECOLOGY; Lemke T, 2001, APPL ENVIRON MICROB, V67, P4657, DOI 10.1128/AEM.67.10.4657-4661.2001; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Maekawa K, 2008, INSECT SOC, V55, P107, DOI 10.1007/s00040-008-0997-2; MARTIN MM, 1991, PHILOS T R SOC B, V333, P281, DOI 10.1098/rstb.1991.0078; Nalepa CA, 2008, ZOOL SCI, V25, P1190, DOI 10.2108/zsj.25.1190; Noda S, 2006, ENVIRON MICROBIOL, V8, P1462; R Development Core Team, 2010, R LANG ENV STAT COMP; Sabree ZL, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-138; Schauer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085861; SCRIVENER AM, 1994, COMP BIOCHEM PHYS B, V107, P309, DOI 10.1016/0305-0491(94)90053-1; Shimada K, 2011, ENTOMOL SCI, V14, P9, DOI 10.1111/j.1479-8298.2010.00406.x; SLAYTOR M, 1992, COMP BIOCHEM PHYS B, V103, P775, DOI 10.1016/0305-0491(92)90194-V; Song YL, 2006, INT J SYST EVOL MICR, V56, P1985, DOI 10.1099/ijs.0.64318-0; Strassert JFH, 2010, MICROBIOL-SGM, V156, P2068, DOI 10.1099/mic.0.037267-0; Tholen A, 2000, ENVIRON MICROBIOL, V2, P436, DOI 10.1046/j.1462-2920.2000.00127.x; Tokuda G, 2005, PHYSIOL ENTOMOL, V30, P372, DOI 10.1111/j.1365-3032.2005.00473.x; van Hoek AHAM, 2000, MOL BIOL EVOL, V17, P251; Westram R, 2011, HDB MOL MICROBIAL EC, P399; Yamasaki M., 1939, Annotationes Zoologicae Japonenses, V18, P65; ZHANG J, 1993, COMP BIOCHEM PHYS A, V104, P155, DOI 10.1016/0300-9629(93)90023-W	81	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0168-6496	1574-6941		FEMS MICROBIOL ECOL	FEMS Microbiol. Ecol.	FEB	2015	91	2								10.1093/femsec/fiu028		14	Microbiology	Microbiology	CF8BX	WOS:000352781400014		
J	Tanaka, TST; Irbis, C; Wang, PY; Inamura, T				Tanaka, Takashi S. T.; Irbis, Chagan; Wang, Pengyun; Inamura, Tatsuya			Impact of plant harvest management on function and community structure of nitrifiers and denitrifiers in a constructed wetland	FEMS MICROBIOLOGY ECOLOGY			English	Article						harvesting reed; PCR-DGGE; nitrification; denitrification	AMMONIA-OXIDIZING ARCHAEA; WASTE-WATER TREATMENT; PHRAGMITES-AUSTRALIS; NICHE DIFFERENTIATION; SPATIAL-PATTERNS; BACTERIA; DIVERSITY; SOIL; SEDIMENT; RHIZOSPHERE	Plant harvest is one of the most important management practices in constructed wetlands. In this study, we evaluated the impact of harvesting Phragmites australis (Cav.) Trin. ex Steudel on the activity and community structure of nitrifiers and denitrifiers in a free-water surface constructed wetland. The nitrifiers were targeted using bacterial and archaeal-amoA that encode ammonia monooxygenase, and the denitrifiers were targeted using nirK and nirS that encode the nitrite reductase. The community structures were evaluated using denaturing gradient gel electrophoresis. The potential nitrification and nitrate reduction rates were shown to be significantly higher in the harvested plant rhizosphere than in a non-harvested control plot. The potential nitrification rate positively correlated with the potential nitrate reduction rate and influenced the community structure of nirK. In addition, plant canopy developed differently after harvest and simultaneously changed the microclimate beneath the plant community. These results suggest that plant harvest management could change subsequent plant development and associated microenvironments, thereby affecting the function and community structure of nitrifiers and denitrifiers. Our study highlights the importance of plant harvest management within constructed wetlands to regulate the functions of nitrification and denitrification.	[Tanaka, Takashi S. T.; Irbis, Chagan] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming 650500, Yunnan, Peoples R China; [Tanaka, Takashi S. T.; Inamura, Tatsuya] Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan; [Wang, Pengyun] Kunming Agrometeorol Stn, Kunming 650228, Yunnan, Peoples R China	Irbis, C (reprint author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, 727 Jingming Rd South, Kunming 650500, Yunnan, Peoples R China.	irbis.chagan@gmail.com			Ministry of education, Culture, Sports, Science and Technology, Japan [21255007]; Kunming Science and Technology Project [2012-02-10-A-S-02-0001];  [26.203]	This work was supported by a Grant-in-Aid for Scientific Research (A) 21255007 from the Ministry of education, Culture, Sports, Science and Technology, Japan. Additional support was provided by the Kunming Science and Technology Project (2012-02-10-A-S-02-0001) and Grant-in-Aid for JSPS Fellows 26.203.	Avrahami S, 2003, ENVIRON MICROBIOL, V5, P691, DOI 10.1046/j.1462-2920.2003.00457.x; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Tanaka T, 2013, J ENVIRON SCI-CHINA, V25, P1107, DOI 10.1016/S1001-0742(12)60206-X; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; TIEDJE JM, 1982, A VAN LEEUW J MICROB, V48, P569; Enwall K, 2010, APPL ENVIRON MICROB, V76, P2243, DOI 10.1128/AEM.02197-09; Philippot L, 2009, ENVIRON MICROBIOL, V11, P1518, DOI 10.1111/j.1462-2920.2009.01879.x; Bollmann A, 2002, APPL ENVIRON MICROB, V68, P4751, DOI 10.1128/AEM.68.10.4751-4757.2002; Urakawa H, 2008, APPL ENVIRON MICROB, V74, P894, DOI 10.1128/AEM.01529-07; Song KY, 2012, ECOL ENG, V38, P130, DOI 10.1016/j.ecoleng.2011.09.008; Sims A, 2012, WATER RES, V46, P4121, DOI 10.1016/j.watres.2012.05.007; Michotey V, 2000, APPL ENVIRON MICROB, V66, P1564, DOI 10.1128/AEM.66.4.1564-1571.2000; Braker G, 2010, FEMS MICROBIOL ECOL, V73, P134, DOI 10.1111/j.1574-6941.2010.00884.x; Herrmann M, 2009, APPL ENVIRON MICROB, V75, P3127, DOI 10.1128/AEM.02806-08; Hallin S, 1999, APPL ENVIRON MICROB, V65, P1652; SAMUELSSON MO, 1985, APPL ENVIRON MICROB, V50, P812; Jahangir MMR, 2012, AGR ECOSYST ENVIRON, V147, P13, DOI 10.1016/j.agee.2011.04.015; Ruiz-Rueda O, 2009, FEMS MICROBIOL ECOL, V67, P308, DOI 10.1111/j.1574-6941.2008.00615.x; Braker G, 2000, APPL ENVIRON MICROB, V66, P2096, DOI 10.1128/AEM.66.5.2096-2104.2000; Vymazal J, 2007, SCI TOTAL ENVIRON, V380, P48, DOI 10.1016/j.scitotenv.2006.09.014; Garcia-Lledo A, 2011, WATER RES, V45, P5621, DOI 10.1016/j.watres.2011.08.025; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; Gorra R, 2007, J APPL MICROBIOL, V103, P1442, DOI 10.1111/j.1365-2672.2007.03357.x; Baneras L, 2012, INT MICROBIOL, V15, P89, DOI 10.2436/20.1501.01.162; BURFORD JR, 1975, SOIL BIOL BIOCHEM, V7, P389, DOI 10.1016/0038-0717(75)90055-3; Nguyen C, 2003, AGRONOMIE, V23, P375, DOI 10.1051/agro:2003011; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704; APHA, 1998, STANDARD METHODS EXA; ARMSTRONG J, 1990, NEW PHYTOL, V114, P121, DOI 10.1111/j.1469-8137.1990.tb00382.x; Averill BA, 2007, BIOL INORGANIC CHEM, P494; Bodelier PLE, 1996, APPL ENVIRON MICROB, V62, P4100; Boyle SA, 2006, SOIL BIOL BIOCHEM, V38, P870, DOI 10.1016/j.soilbio.2005.08.003; Burian K, 1979, MONOG BIOL, V37, P251; CAFFREY JM, 1991, AQUAT BOT, V40, P109, DOI 10.1016/0304-3770(91)90090-R; GRANELI W, 1989, AQUAT BOT, V35, P99, DOI 10.1016/0304-3770(89)90070-3; HANSSON LA, 1984, HYDROBIOLOGIA, V112, P131, DOI 10.1007/BF00006917; Ishii S, 2009, J MICROBIOL METH, V78, P344, DOI 10.1016/j.mimet.2009.07.005; Kindt R., 2005, TREE DIVERSITY ANAL; Monsi M., 1953, JAPANESE J BOTANY, V14, P22; Mulvaney R. L., 1996, SSSA BOOK SER, p[5, 1123]; Muyzer G., 1997, MOL MICROBIAL ECOLOG, V344, P1; Oksanen J., 2008, VEGAN PACKAGE COMMUN; R Development Core Team, 2013, R LANG ENV STAT COMP; Rich JJ, 2004, SOIL BIOL BIOCHEM, V36, P1431, DOI 10.1016/j.soilbio.2004.03.008; RisgaardPetersen N, 1997, LIMNOL OCEANOGR, V42, P529; Sartoris JJ, 2000, ECOL ENG, V14, P49; Thullen JS, 2002, ECOL ENG, V18, P441, DOI 10.1016/S0925-8574(01)00105-7; Woldendorp J. W., 1962, PLANT SOIL, V17, P267, DOI DOI 10.1007/BF01376229	50	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0168-6496	1574-6941		FEMS MICROBIOL ECOL	FEMS Microbiol. Ecol.	FEB	2015	91	2								10.1093/femsec/fiu019		10	Microbiology	Microbiology	CF8BX	WOS:000352781400007		
J	Tanaka, T; Kondo, A				Tanaka, Tsutomu; Kondo, Akihiko			Cell-surface display of enzymes by the yeast Saccharomyces cerevisiae for synthetic biology	FEMS YEAST RESEARCH			English	Review						cell-surface display; yeast; synthetic biology; metabolic engineering; protein secretion	HETEROLOGOUS CELLULASE SECRETION; CELLULOSIC ETHANOL-PRODUCTION; BETA-GLUCOSIDASE; SYSTEMS BIOLOGY; QUANTITATIVE-EVALUATION; DIRECT FERMENTATION; ALPHA-AGGLUTININ; WALL PROTEINS; EXPRESSION; STRAIN	In yeast cell-surface displays, functional proteins, such as cellulases, are genetically fused to an anchor protein and expressed on the cell surface. Saccharomyces cerevisiae, which is often utilized as a cell factory for the production of fuels, chemicals, and proteins, is the most commonly used yeast for cell-surface display. To construct yeast cells with a desired function, such as the ability to utilize cellulose as a substrate for bioethanol production, cell-surface display techniques for the efficient expression of enzymes on the cell membrane need to be combined with metabolic engineering approaches for manipulating target pathways within cells. In this Minireview, we summarize the recent progress of biorefinery fields in the development and application of yeast cell-surface displays from a synthetic biology perspective and discuss approaches for further enhancing cell-surface display efficiency.	[Tanaka, Tsutomu; Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Kondo, A (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodaicho, Kobe, Hyogo 6578501, Japan.	akondo@kobe-u.ac.jp			Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe), MEXT, Japan; MEXT, Japan [24310065]	This work was mainly supported by Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe), MEXT, Japan, and by Grant-in-Aid for Scientific Research (B) (Grant Number: 24310065), MEXT, Japan.	Abe H, 2003, GLYCOBIOLOGY, V13, P87, DOI 10.1093/glycob/cwg014; Hou J, 2012, FEMS YEAST RES, V12, P491, DOI 10.1111/j.1567-1364.2012.00810.x; Van Zyl JHD, 2014, APPL MICROBIOL BIOT, V98, P5567, DOI 10.1007/s00253-014-5647-1; Rakestraw JA, 2009, BIOTECHNOL BIOENG, V103, P1192, DOI 10.1002/bit.22338; Kotaka A, 2008, J BIOSCI BIOENG, V105, P622, DOI 10.1263/jbb.105.622; Matsuoka H, 2014, YEAST, V31, P67, DOI 10.1002/yea.2995; Sun J, 2012, APPL ENVIRON MICROB, V78, P3837, DOI 10.1128/AEM.07679-11; Wang HW, 2013, ANAL CHEM, V85, P6107, DOI 10.1021/ac400979r; Tsai SL, 2013, ACS SYNTH BIOL, V2, P14, DOI 10.1021/sb300047u; Tsai SL, 2010, APPL ENVIRON MICROB, V76, P7514, DOI 10.1128/AEM.01777-10; Fierobe HP, 2001, J BIOL CHEM, V276, P21257, DOI 10.1074/jbc.M102082200; Kim IK, 2012, FEMS YEAST RES, V12, P228, DOI 10.1111/j.1567-1364.2011.00779.x; Yamakawa S, 2010, APPL MICROBIOL BIOT, V87, P109, DOI 10.1007/s00253-010-2487-5; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; Fujita Y, 2004, APPL ENVIRON MICROB, V70, P1207, DOI 10.1128/AEM.70.2.1207-1212.2004; Liang XX, 2013, BIOTECHNOL LETT, V35, P367, DOI 10.1007/s10529-012-1085-2; Yamada R, 2011, ENZYME MICROB TECH, V48, P393, DOI 10.1016/j.enzmictec.2011.01.002; LU CF, 1994, MOL CELL BIOL, V14, P4825; Nielsen J, 2014, NAT CHEM BIOL, V10, P319, DOI 10.1038/nchembio.1519; Hong KK, 2012, CELL MOL LIFE SCI, V69, P2671, DOI 10.1007/s00018-012-0945-1; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Zhang K, 2013, CHEM BIOL, V20, P92, DOI 10.1016/j.chembiol.2012.10.020; Nevoigt E, 2008, MICROBIOL MOL BIOL R, V72, P379, DOI 10.1128/MMBR.00025-07; den Haan R, 2013, PROCESS BIOCHEM, V48, P1, DOI 10.1016/j.procbio.2012.11.015; Kotaka A, 2008, BIOSCI BIOTECH BIOCH, V72, P1376, DOI 10.1271/bbb.70825; Kataeva I, 1997, BIOCHEM J, V326, P617; Andreu C, 2013, APPL MICROBIOL BIOT, V97, P9055, DOI 10.1007/s00253-013-5086-4; Nielsen J, 2008, FEMS YEAST RES, V8, P122, DOI 10.1111/j.1567-1364.2007.00302.x; Tanaka T, 2012, APPL MICROBIOL BIOT, V95, P577, DOI 10.1007/s00253-012-4175-0; Katahira S, 2004, APPL ENVIRON MICROB, V70, P5407, DOI 10.1128/AEM.70.9.5407-5414.2004; Mingardon F, 2007, APPL ENVIRON MICROB, V73, P7138, DOI 10.1128/AEM.01306-07; Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Qiu Z, 2014, MOL BIOTECHNOL, V56, P726, DOI 10.1007/s12033-014-9750-4; Kroukamp H, 2013, APPL ENERG, V102, P150, DOI 10.1016/j.apenergy.2012.05.062; Wen F, 2010, APPL ENVIRON MICROB, V76, P1251, DOI 10.1128/AEM.01687-09; Yi L, 2013, P NATL ACAD SCI USA, V110, P7229, DOI 10.1073/pnas.1215994110; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; Lofblom J, 2011, BIOTECHNOL J, V6, P1115, DOI 10.1002/biot.201100129; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Park JH, 2008, TRENDS BIOTECHNOL, V26, P404, DOI 10.1016/j.tibtech.2008.05.001; Katahira S, 2006, APPL MICROBIOL BIOT, V72, P1136, DOI 10.1007/s00253-006-0402-x; Rudd PM, 2004, TRENDS BIOTECHNOL, V22, P524, DOI 10.1016/j.tibtech.2004.07.012; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; VanderVaart JM, 1997, APPL ENVIRON MICROB, V63, P615; Parthasarathy R, 2006, BIOTECHNOL BIOENG, V93, P159, DOI 10.1002/bit.20684; LU CF, 1995, J CELL BIOL, V128, P333, DOI 10.1083/jcb.128.3.333; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Matsumoto T, 2002, APPL ENVIRON MICROB, V68, P4517, DOI 10.1128/AEM.68.9.4517-4522.2002; Han T, 2011, BIOCHEM BIOPH RES CO, V409, P253, DOI 10.1016/j.bbrc.2011.04.139; Curran KA, 2012, METAB ENG, V14, P289, DOI 10.1016/j.ymben.2012.04.006; Idiris A, 2010, APPL MICROBIOL BIOT, V86, P403, DOI 10.1007/s00253-010-2447-0; Breinig F, 2002, APPL MICROBIOL BIOT, V58, P637, DOI 10.1007/s00253-002-0939-2; Graf A, 2009, FEMS YEAST RES, V9, P335, DOI 10.1111/j.1567-1364.2009.00507.x; Fushimi T, 2013, APPL MICROBIOL BIOT, V97, P4003, DOI 10.1007/s00253-012-4467-4; BAYER EA, 1994, TRENDS BIOTECHNOL, V12, P379, DOI 10.1016/0167-7799(94)90039-6; Ota M, 2013, BIOTECHNOL PROGR, V29, P346, DOI 10.1002/btpr.1700; Nakamura N, 2008, ENZYME MICROB TECH, V43, P233, DOI 10.1016/j.enzmictec.2008.04.003; Sato N, 2002, APPL MICROBIOL BIOT, V60, P469, DOI 10.1007/s00253-002-1121-6; Shigechi H, 2004, APPL ENVIRON MICROB, V70, P5037, DOI 10.1128/AEM.70.8.5037-5040.2004; Elkins JG, 2010, CURR OPIN BIOTECH, V21, P657, DOI 10.1016/j.copbio.2010.05.008; Wilde C, 2012, APPL MICROBIOL BIOT, V95, P647, DOI 10.1007/s00253-011-3788-z; Schwarz WH, 2001, APPL MICROBIOL BIOT, V56, P634, DOI 10.1007/s002530100710; Nakanishi A, 2012, APPL MICROBIOL BIOT, V94, P939, DOI 10.1007/s00253-012-3876-8; Murashima K, 2002, J BACTERIOL, V184, P76, DOI 10.1128/JB.184.1.76-81.2002; Kotaka A, 2010, J BIOSCI BIOENG, V109, P442, DOI 10.1016/j.jbiosc.2009.11.003; Shibasaki S, 2009, ANAL SCI, V25, P41; Kuroda K, 2009, APPL MICROBIOL BIOT, V82, P713, DOI 10.1007/s00253-008-1808-4; Srikrishnan S, 2013, BIOTECHNOL BIOENG, V110, P275, DOI 10.1002/bit.24609; Tyo KE, 2007, TRENDS BIOTECHNOL, V25, P132, DOI 10.1016/j.tibtech.2007.01.003; Fan LH, 2012, P NATL ACAD SCI USA, V109, P13260, DOI 10.1073/pnas.1209856109; Shimoi H, 1998, J BACTERIOL, V180, P3381; Puthenveetil S, 2009, J AM CHEM SOC, V131, P16430, DOI 10.1021/ja904596f; Nielsen J, 2013, CURR OPIN BIOTECH, V24, P398, DOI 10.1016/j.copbio.2013.03.023; Wentz AE, 2007, APPL ENVIRON MICROB, V73, P1189, DOI 10.1128/AEM.02427-06; Ecker M, 2006, J BIOL CHEM, V281, P11523, DOI 10.1074/jbc.M600314200; ZLOTNIK H, 1984, J BACTERIOL, V159, P1018; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Fujita Y, 2002, APPL ENVIRON MICROB, V68, P5136, DOI 10.1128/AEM.68.10.5136-5141.2002; Blazic M, 2013, PROTEIN EXPRES PURIF, V89, P175, DOI 10.1016/j.pep.2013.03.014; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Goyal G, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-89; Idiris A, 2010, APPL MICROBIOL BIOT, V85, P667, DOI 10.1007/s00253-009-2151-0; Kapteyn JC, 1996, GLYCOBIOLOGY, V6, P337, DOI 10.1093/glycob/6.3.337; Kim S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-14; Lee GY, 2011, BIORESOURCE TECHNOL, V102, P9179, DOI 10.1016/j.biortech.2011.06.081; Liu L, 2007, CURR OPIN BIOTECH, V24, P1023; Marshall CJ, 2013, BIOCONJUGATE CHEM, V24, P1634, DOI 10.1021/bc4002618; Nakatani Y, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-66; SCHEKMAN R, 1992, Current Opinion in Cell Biology, V4, P587, DOI 10.1016/0955-0674(92)90076-O; Seong KT, 2006, APPL MICROBIOL BIOT, V73, P60, DOI 10.1007/s00253-006-0454-y; Shibasaki S, 2001, APPL MICROBIOL BIOT, V55, P471; Washida M, 2001, APPL MICROBIOL BIOT, V56, P681, DOI 10.1007/s002530100718	94	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1567-1356	1567-1364		FEMS YEAST RES	FEMS Yeast Res.	FEB	2015	15	1								10.1111/1567-1364.12212		9	Biotechnology & Applied Microbiology; Microbiology; Mycology	Biotechnology & Applied Microbiology; Microbiology; Mycology	CF8CE	WOS:000352782200010		
J	Hiroi, S; Morikawa, S; Nakata, K; Maeda, A; Kanno, T; Irie, S; Ohfuji, S; Hirota, Y; Kase, T				Hiroi, Satoshi; Morikawa, Saeko; Nakata, Keiko; Maeda, Akiko; Kanno, Tsuneji; Irie, Shin; Ohfuji, Satoko; Hirota, Yoshio; Kase, Tetsuo			Trivalent influenza vaccine-induced antibody response to circulating influenza a (H3N2) viruses in 2010/11 and 2011/12 seasons	HUMAN VACCINES & IMMUNOTHERAPEUTICS			English	Article						antibody; circulating viruses; H3N2; influenza; vaccine	IMMUNE-RESPONSE; STRAINS; EFFICACY; IMMUNIZATION; VOLUNTEERS; INFECTION; ADULTS	To evaluate antibody response induced by trivalent inactivated influenza vaccine (TIV) against circulating influenza A (H3N2) strains in healthy adults during the 2010/11 and 2011/12 seasons, a hemagglutination-inhibition (HI) assay was utilized to calculate geometric mean antibody titer (GMT), seroprotection rate (post vaccination HI titers of >= 1:40), and seroresponse rate (4-fold increase in antibody level). In the 2010/11 season, GMT increased 1.8- to 2.0-fold following the first dose of TIV against 3 circulating strains and 2.2-fold following the second compared to before vaccination. The seroresponse rate ranged from 22% to 26% following the first dose of TIV and from 31% to 33% following the second (n = 54). The seroprotection rate increased from a range of 6% to 13% to a range of 26% to 33% following the first dose of TIV and to a range of 37% to 42% following the second (n = 54). In the 2011/12 season, GMT increased 1.4-fold against A/Osaka/110/2011 and 1.8-fold against A/Osaka/5/2012. For A/Osaka/110/2011, the seroresponse rate was 29%, and the seroprotection rate increased from 26% to 55% following vaccination (n = 31). For A/Osaka/5/2012, the seroresponse rate was 26%, and the seroprotection rate increased from 68% to 84% following vaccination (n = 31). HI assays with reference antisera demonstrated that the strains in the 2011/12 season were antigenically distinct from vaccine strain (A/Victoria/210/2009). In conclusion, the vaccination increased the seroprotection rate against circulating H3N2 strains in the 2010/11 and 2011/12 seasons. Vaccination of TIV might have potential to induce reactive antibodies against antigenically distinct circulating H3N2 viruses.	[Hiroi, Satoshi; Morikawa, Saeko; Nakata, Keiko; Kase, Tetsuo] Osaka Prefectural Inst Publ Hlth, Dept Infect Dis, Osaka 537, Japan; [Maeda, Akiko; Ohfuji, Satoko; Hirota, Yoshio] Osaka City Univ, Grad Sch Med, Dept Publ Hlth, Osaka 558, Japan; [Kanno, Tsuneji] Kanno Pediat Clin, Morioka, Iwate, Japan; [Irie, Shin] Med Co LTA, Fukuoka, Japan	Hiroi, S (reprint author), Osaka Prefectural Inst Publ Hlth, Dept Infect Dis, Osaka 537, Japan.	hiroi@iph.pref.osaka.jp			Research on Emerging and Reemerging Infectious Diseases, Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare, Japan [H23-Shinko-Ippan-017]	This study was supported by Research on Emerging and Reemerging Infectious Diseases, Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare, Japan (H23-Shinko-Ippan-017).	Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Treanor JJ, 2012, CLIN INFECT DIS, V55, P951, DOI 10.1093/cid/cis574; Boni MF, 2008, VACCINE, V26, pC8, DOI 10.1016/j.vaccine.2008.04.011; POTTER CW, 1979, BRIT MED BULL, V35, P69; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; de Bruijn IA, 1999, J INFECT DIS, V179, P31, DOI 10.1086/314540; Ansaldi F, 2010, VACCINE, V28, P4123, DOI 10.1016/j.vaccine.2010.04.030; Grohskopf Lisa, 2011, Morbidity and Mortality Weekly Report, V60, P1128; Committee for Proprietary Medicinal Products (CPMP), 1997, NOT GUID HARM REQ IN; deBruijn IA, 1997, VACCINE, V15, P1323, DOI 10.1016/S0264-410X(97)00019-4; de Jong JC, 2000, J MED VIROL, V61, P94; Gardner EM, 2001, VACCINE, V19, P4610, DOI 10.1016/S0264-410X(01)00246-8; Hirota Y, 1997, VACCINE, V15, P962, DOI 10.1016/S0264-410X(96)00302-7; Hirota Y, 1996, VACCINE, V14, P1597, DOI 10.1016/S0264-410X(96)00153-3; HOBSON D, 1973, LANCET, V2, P155; Keitel WA, 1997, VACCINE, V15, P1114, DOI 10.1016/S0264-410X(97)00003-0; Kilbourne ED, 1999, VACCINES, P531; MILLER DL, 1973, J HYG-CAMBRIDGE, V71, P535; Nabeshima S, 2007, J MED VIROL, V79, P320, DOI 10.1002/jmv.20801; Ng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059077; Ohfuji S, 2011, J INFECT DIS, V203, P1301, DOI 10.1093/infdis/jir026; PEREIRA MS, 1972, BRIT MED J, V4, P701; POTTER CW, 1977, J HYG-CAMBRIDGE, V79, P321; PYHALA R, 1994, VACCINE, V12, P947, DOI 10.1016/0264-410X(94)90039-6; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; Wright PF, 2001, FIELDS VIROLOGY, P1533	28	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	2164-5515	2164-554X		HUM VACC IMMUNOTHER	Human Vaccines Immunother.	FEB	2015	11	2					386	390		10.1080/21645515.2015.1009338		5	Biotechnology & Applied Microbiology; Immunology	Biotechnology & Applied Microbiology; Immunology	CF5RR	WOS:000352615200023		
J	Thapa, RB; Watanabe, M; Motohka, T; Shiraishi, T; Shimada, M				Thapa, Rajesh Bahadur; Watanabe, Manabu; Motohka, Takeshi; Shiraishi, Tomohiro; Shimada, Masanobu			Calibration of Aboveground Forest Carbon Stock Models for Major Tropical Forests in Central Sumatra Using Airborne LiDAR and Field Measurement Data	IEEE JOURNAL OF SELECTED TOPICS IN APPLIED EARTH OBSERVATIONS AND REMOTE SENSING			English	Article						Aboveground forest carbon stock (AFCS); biomass modeling; forest carbon; LiDAR; natural forest; plantation forest; REDD	RESOLUTION SATELLITE IMAGERY; SYNTHETIC-APERTURE RADAR; BIOMASS; DYNAMICS; HEIGHT	Despite substantial policy attention, tropical forests in Southeast Asian region are releasing large amount of carbon to the atmosphere due to accelerating deforestation. Accurately determining forest statistics and characterizing aboveground forest carbon stocks (AFCSs) are always challenging in the region. In order to develop more accurate estimates of AFCS, the present study collected airborne LiDAR and field measurements data and calibrated AFCS models to estimate carbon stock in the tropical forests in central Sumatra. The study region consists of natural forests, including peat swamp, dry moist, regrowth, and mangrove, and plantation forests, including rubber, acacia, oil palm, and coconut. To cover the different forest types, 60 field plots of 1 ha in size were inventoried. Eight transects crossing these field plots were acquired to calibrate the LiDAR to AFCS models. The AFCS values for the field plots ranged from 4 to 161 Mg ha(-1). General models were fitted without considering forest types, whereas a specific model was fitted for each specific forest type. Five alternative general models with different LiDAR metrics were calibrated with model performance expressed as R-2 ranging from 0.73 to 0.87 and root-mean-square error (RMSE) values ranging from 17.4 to 25.0 Mg ha(-1). Seven forest-specific AFCS models were calibrated for different forest types, with R-2 values ranging from 0.72 to 0.97 and RMSE values ranging from 1.4 to 10.7 Mg ha(-1). The performance of each model was cross-validated by iteratively removing one data point. While forest-specific models provide better AFCS estimates, the general models are still useful when forest types are ambiguous.	[Thapa, Rajesh Bahadur; Watanabe, Manabu; Motohka, Takeshi; Shiraishi, Tomohiro; Shimada, Masanobu] Japan Aerosp Explorat Agcy JAXA, Earth Observat Res Ctr, Tsukuba, Ibaraki 3058505, Japan	Thapa, RB (reprint author), Japan Aerosp Explorat Agcy JAXA, Earth Observat Res Ctr, Tsukuba, Ibaraki 3058505, Japan.	rajesh.thapa@jaxa.jp		Thapa, Rajesh Bahadur/0000-0003-4467-0148			Adiriono T., 2009, THESIS G MADA U YOGY; Sarker MLR, 2012, ISPRS J PHOTOGRAMM, V69, P146, DOI 10.1016/j.isprsjprs.2012.03.002; Asner GP, 2012, OECOLOGIA, V168, P1147, DOI 10.1007/s00442-011-2165-z; Englhart S, 2013, REMOTE SENS-BASEL, V5, P2368, DOI 10.3390/rs5052368; Koch B, 2010, ISPRS J PHOTOGRAMM, V65, P581, DOI 10.1016/j.isprsjprs.2010.09.001; Wulder MA, 2012, CAN J REMOTE SENS, V38, P600, DOI 10.5589/m12-049; Garcia M, 2010, REMOTE SENS ENVIRON, V114, P816, DOI 10.1016/j.rse.2009.11.021; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Thapa RB, 2013, APPL GEOGR, V41, P168, DOI 10.1016/j.apgeog.2013.04.009; Lim K, 2003, PROG PHYS GEOG, V27, P88, DOI 10.1191/0309133303pp360ra; McInerney DO, 2010, FORESTRY, V83, P195, DOI 10.1093/forestry/cpq001; Mora B, 2013, REMOTE SENS-BASEL, V5, P2308, DOI 10.3390/rs5052308; Mitchard ETA, 2012, BIOGEOSCIENCES, V9, P179, DOI 10.5194/bg-9-179-2012; Schroth G, 2002, FOREST ECOL MANAG, V163, P131, DOI 10.1016/S0378-1127(01)00537-0; Komiyama A, 2005, J TROP ECOL, V21, P471, DOI 10.1017/S0266467405002476; Cawley GC, 2004, NEURAL NETWORKS, V17, P1467, DOI 10.1016/j.neunet.2004.07.002; Naesset E, 2013, REMOTE SENS ENVIRON, V130, P108, DOI 10.1016/j.rse.2012.11.010; FRANGI JL, 1985, ECOL MONOGR, V55, P351, DOI 10.2307/1942582; Brown S., 1997, 134 FAO UN; FAO, 2010, 163 FAO; Hirata Y., 2012, REDD PLUS COOKBOOK M, P1; IPCC, 2006, GUIDELINES NATL GREE; Lefsky M.A., 2010, GEOPHYS RES LETT, V37, P1; Lu D., 2012, INT J FOR RES, V2012, P1, DOI DOI 10.1155/2012/436537; Lucas R, 2010, IEEE J-STARS, V3, P576, DOI 10.1109/JSTARS.2010.2086436; McGaughey RJ, 2013, FUSION LDV SOFTWARE; Ministry of Forestry, 2008, IFCA CONS REP RED EM; Murdiyarso D., 2004, PETUNJUK LAPANGAN PE; Nelson R, 2013, CAN J REMOTE SENS, V39, pS6, DOI 10.5589/m13-011; Pearson T., 2005, SOURCEBOOK LAND USE; Rosenqvist A, 2010, IEEE J-STARS, V3, P551, DOI 10.1109/JSTARS.2010.2086270; Shiraishi T, 2014, IEEE J-STARS, V7, P1186, DOI 10.1109/JSTARS.2014.2313572; Simard M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001708; Tsui OW, 2012, ISPRS J PHOTOGRAMM, V69, P121, DOI 10.1016/j.isprsjprs.2012.02.009; Walker S. M., STANDARD OPERATING P; Watanabe M, 2006, IEEE T GEOSCI REMOTE, V44, P3154, DOI 10.1109/TGRS.2006.880632; Yulianti N., 2009, THESIS BOGOR AGR U B	38	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1939-1404	2151-1535		IEEE J-STARS	IEEE J. Sel. Top. Appl. Earth Observ. Remote Sens.	FEB	2015	8	2					661	673		10.1109/JSTARS.2014.2328656		13	Engineering, Electrical & Electronic; Geography, Physical; Remote Sensing; Imaging Science & Photographic Technology	Engineering; Physical Geography; Remote Sensing; Imaging Science & Photographic Technology	CF1AY	WOS:000352277100020		
J	Azizi, M; Saibi, H				Azizi, Masood; Saibi, Hakim			Integrating Gravity Data With Remotely Sensed Data for Structural Investigation of the Aynak-Logar Valley, Eastern Afghanistan, and the Surrounding Area	IEEE JOURNAL OF SELECTED TOPICS IN APPLIED EARTH OBSERVATIONS AND REMOTE SENSING			English	Article						Afghanistan; analytic signal; aynak-Logar valley; gravity data; horizontal gradient; integration; remote sensing; structure; three-dimensional (3-D) gravity inversion; tilt derivative	POTENTIAL-FIELD DATA; 2-DIMENSIONAL MAGNETIC BODIES; POLYGONAL CROSS-SECTION; LANDSAT-7 ETM+ IMAGERY; ANALYTIC SIGNAL; TILT-ANGLE; AUTOMATIC INTERPRETATION; GEOLOGICAL STRUCTURES; THEMATIC MAPPER; EDGE-DETECTION	This study integrates gravity data with interpreted lineaments from remotely sensed images and geological fault in an effort to understand the geological structure of the Aynak-Logar Valley (ALV) and its surrounding area in eastern Afghanistan. Integrated analysis of Landsat Enhanced Thematic Mapper Plus (ETM+), Shuttle Radar Topography Mission (SRTM), and Digital Elevation Model (DEM) data was applied for lithological mapping and extraction of geological lineaments and landforms. Gravity data were used to delineate a detailed picture of the subsurface structure. Several gravity interpretation techniques such as horizontal gradient (HG), tilt derivative (TD), and analytic signal (AS) were applied to the gravity data with the objective of making geological features such as faults and contacts more visible, and also a three-dimensional (3-D) inversion model of gravity data was developed to show the density distributions in the study area. The combination of these geoscience data provides information about the subsurface structure of ALV. The interpreted faults from remote sensing are striking NE-SW. The faults and contacts from geological map and gravity data analysis are striking mainly in NNE-SSW, which is the direction of the Kabul block trending fault structure.	[Azizi, Masood; Saibi, Hakim] Kyushu Univ, Fac Engn, Dept Earth Resources Engn, Fukuoka 8190395, Japan	Azizi, M (reprint author), Kyushu Univ, Fac Engn, Dept Earth Resources Engn, Fukuoka 8190395, Japan.	saibihakim@mine.kyushu-u.ac.jp					Salem A, 2008, GEOPHYSICS, V73, pL1, DOI 10.1190/1.2799992; Roy IG, 2013, J APPL GEOPHYS, V98, P33, DOI 10.1016/j.jappgeo.2013.07.009; KLINGELE EE, 1991, GEOPHYS PROSPECT, V39, P407, DOI 10.1111/j.1365-2478.1991.tb00319.x; NABIGHIAN MN, 1984, GEOPHYSICS, V49, P780, DOI 10.1190/1.1441706; Solomon S, 2006, J AFR EARTH SCI, V46, P371, DOI 10.1016/j.jafrearsci.2006.06.007; Masoud A, 2006, J AFR EARTH SCI, V45, P467, DOI 10.1016/j.jafrearsci.2006.04.005; Zhang HL, 2014, GEOPHYSICS, V79, pJ43, DOI 10.1190/GEO2013-0218.1; Fedi M, 2001, GEOPHYS PROSPECT, V49, P40, DOI 10.1046/j.1365-2478.2001.00235.x; Uieda L, 2012, GEOPHYSICS, V77, pG55, DOI [10.1190/geo2011-0388.1, 10.1190/GEO2011-0388.1]; Hsu SK, 1998, GEOPHYSICS, V63, P1947, DOI 10.1190/1.1444488; ROEST WR, 1992, GEOPHYSICS, V57, P116, DOI 10.1190/1.1443174; MILLER HG, 1994, J APPL GEOPHYS, V32, P213, DOI 10.1016/0926-9851(94)90022-1; Ali SA, 2004, INT J REMOTE SENS, V25, P4715, DOI 10.1080/01431160410001688295; Li YG, 1998, GEOPHYSICS, V63, P109, DOI 10.1190/1.1444302; Lamontagne M, 2003, CAN J EARTH SCI, V40, P317, DOI 10.1139/E02-104; Cooper GRJ, 2008, GEOPHYSICS, V73, pH1, DOI 10.1190/1.2837309; Jansson KN, 2005, INT J REMOTE SENS, V26, P3931, DOI 10.1080/01431160500106900; TRELOAR PJ, 1993, GEOL SOC SP, V74, P69, DOI 10.1144/GSL.SP.1993.074.01.06; ARISOY MO, 2013, YERBILIMLERI, V34, P73; Arlegui LE, 2003, INT J REMOTE SENS, V24, P457, DOI 10.1080/0143116021000021242; Beamish D, 2011, GEOPHYS J INT, V184, P171, DOI 10.1111/j.1365-246X.2010.04852.x; Chen S, 2005, INT J REMOTE SENS, V26, P2741, DOI 10.1080/01431160500104210; Cooper GRJ, 2011, GEOPHYS PROSPECT, V59, P188, DOI 10.1111/j.1365-2478.2010.00901.x; Cooper GRJ, 2009, GEOPHYS PROSPECT, V57, P1067, DOI 10.1111/j.1365-2478.2009.00791.x; Cordell L, 1985, UTILITY REGIONAL GRA, P181, DOI DOI 10.1190/1.1826915; Cordell L., 1979, P 30 FIELD C NEW MEX, P59; Debeglia N, 1997, GEOPHYSICS, V62, P87, DOI 10.1190/1.1444149; Fairhead J. D., 2008, P SOC EXPL GEOPH ANN, P779; GRAUCH VJS, 1987, GEOPHYSICS, V52, P118, DOI 10.1190/1.1442236; Hinze WJ, 2013, GRAVITY AND MAGNETIC EXPLORATION: PRINCIPLES, PRACTICES, AND APPLICATIONS, P1, DOI 10.1017/CBO9780511843129; Hsu SK, 1996, GEOPHYSICS, V61, P373, DOI 10.1190/1.1443966; Hung L. Q., 2005, P 5 SPIE REM SENS EN, V5983, P182; KAMEL AF, 1994, INT J REMOTE SENS, V15, P1471; Keating P, 2004, GEOPHYS PROSPECT, V52, P165, DOI 10.1111/j.1365-2478.2004.00408.x; Khamies A. A., 2010, EGYPT J REMOTE SENS, V13, P43, DOI DOI 10.1016/J.EJRS.2010.07.006; Lahti Ilkka, 2010, Leading Edge, V29, DOI 10.1190/1.3284049; Li Y., P 2012 ANN M SEG LAS; Lillesand T, 2007, REMOTE SENSING IMAGE; Liu JG, 2006, INT J REMOTE SENS, V27, P4461, DOI 10.1080/01431160600784283; Lunden B, 2001, INT J REMOTE SENS, V22, P517, DOI 10.1080/01431160050505838; Macleod I. N., 1993, EXPLOR GEOPHYS, V24, P679, DOI DOI 10.1071/EG993679; Mather P. M., 2004, COMPUTER PROCESSING, p3rd; McGinnis L. D., 1971, J GEOPHYS RES, V7, P1894; NABIGHIA.MN, 1972, GEOPHYSICS, V37, P507, DOI 10.1190/1.1440276; NABIGHIA.MN, 1974, GEOPHYSICS, V39, P85, DOI 10.1190/1.1440416; Pal SK, 2006, INT J REMOTE SENS, V27, P4513, DOI 10.1080/01431160600658172; Phillips J. D., 2002, 0298 US GEOL SURV; RABIE SI, 1990, INT J REMOTE SENS, V11, P669; Saadi NM, 2008, INT J DIGIT EARTH, V1, P347, DOI 10.1080/17538940802435844; Saadi NM, 2009, IEEE T GEOSCI REMOTE, V47, P3389, DOI 10.1109/TGRS.2009.2020911; Saadi NM, 2008, EARTH PLANETS SPACE, V60, P539; Saibi H, 2006, EARTH PLANETS SPACE, V58, P815; Saibi H, 2008, EARTH PLANETS SPACE, V60, P821; Salem Ahmed, 2007, Leading Edge, V26, DOI 10.1190/1.2821934; Sijmons K., 1987, ITC J, V1, P23; Silverman BW, 1986, DENSITY ESTIMATION S; Tapponnier M., 1981, EARTH PLANET SC LETT, V52, P355; U.S. Geological Survey, 2006, 20061204 US GEOL SUR; U.S. Geological Survey, 2008, 20081089 US GEOL SUR; USGS, 2004, PROJ AFGH; Verduzco B., 2004, LEADING EDGE, V23, P116, DOI DOI 10.1190/1.1651454; Volin M. E., 1950, CHROMITE DEPOSITS LO; Yassaghi A, 2006, INT J REMOTE SENS, V27, P4529, DOI 10.1080/01431160600661283; Zaycev V. N., 1988, AGS ARCH	64	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1939-1404	2151-1535		IEEE J-STARS	IEEE J. Sel. Top. Appl. Earth Observ. Remote Sens.	FEB	2015	8	2					816	824		10.1109/JSTARS.2014.2347375		9	Engineering, Electrical & Electronic; Geography, Physical; Remote Sensing; Imaging Science & Photographic Technology	Engineering; Physical Geography; Remote Sensing; Imaging Science & Photographic Technology	CF1AY	WOS:000352277100031		
J	Fujisawa, Y				Fujisawa, Yusuke			ON SUMS OF GENERALIZED RAMANUJAN SUMS	INDIAN JOURNAL OF PURE & APPLIED MATHEMATICS			English	Article						Ramanujan sums; arithmetical functions		Ramanujan sums have been studied and generalized by several authors. For example, Nowak [8] studied these sums over quadratic number fields, and Grytczuk [4] defined that on semigroups. In this note, we deduce some properties on sums of generalized Ramanujan sums and give examples on number fields. In particular, we have a relational expression between Ramanujan sums and residues of Dedekind zeta functions.	Nagoya Univ, Grad Sch Math, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Fujisawa, Y (reprint author), Nagoya Univ, Grad Sch Math, Chikusa Ku, Furocho, Nagoya, Aichi 4648602, Japan.	fujisawa_gifu@yahoo.co.jp					Apostol T. M., 1972, ACTA ARITH, V41, P281; Chan TH, 2012, ACTA ARITH, V152, P1, DOI 10.4064/aa152-1-1; COHEN H., 2007, GRADUATE TEXTS MATH, V240; Grytczuk A., 1992, TSUKUBA J MATH, V16, P315; Kiuchi I., 2002, PERIOD MATH HUNG, V45, P87, DOI 10.1023/A:1022302114565; Lang S., 1994, GRADUATE TEXTS MATH, V110; Murtv R., 2007, EXPO MATH, V25, P53; Nowak W. G., 2012, ARCH MATH, V99, P433; Titchmarsh B. C., 1986, THEORY RIEMANN ZETA	9	0	0	INDIAN NAT SCI ACAD	NEW DELHI	BAHADUR SHAH ZAFAR MARG, NEW DELHI 110002, INDIA	0019-5588	0975-7465		INDIAN J PURE AP MAT	Indian J. Pure Appl. Math.	FEB	2015	46	1					1	10		10.1007/s13226-015-0103-1		10	Mathematics	Mathematics	CF3YO	WOS:000352485200001		
J	Miyamoto, Y; Iida, A; Sato, K; Muramatsu, SI; Nitta, A				Miyamoto, Yoshiaki; Iida, Asako; Sato, Keiji; Muramatsu, Shin-ichi; Nitta, Atsumi			Knockdown of Dopamine D-2 Receptors in the Nucleus Accumbens Core Suppresses Methamphetamine-Induced Behaviors and Signal Transduction in Mice	INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY			English	Article						adeno-associated virus vectors; dopamine D-2 receptors; nucleus accumbens; methamphetamine	REWARD; INVOLVEMENT; PREFERENCE; MECHANISMS; COCAINE; ROLES	Background: Addictive drugs lead to reinforcing properties by increasing dopamine in the nucleus accumbens, which is composed of a core and shell regions. Neurons in the nucleus accumbens are divided into 2 subtypes based on the differential gene expression of the dopamine D-1 receptors and D-2 receptors. Methods: In the present study, we investigated the role of D-2 receptors in the nucleus accumbens core in behaviors and signal transduction induced by psychostimulant methamphetamine in mice that were microinjected with adeno-associated virus vectors containing a microRNA (miRNA) sequence for D-2 receptor (adeno-associated virus-miD(2)r vectors) in the nucleus accumbens core. The adeno-associated virus vectors containing a miRNA sequence for D-2 receptor-treated mice (miD(2)r mice) were assessed at a reduction in D-2 receptor, but at no change in dopamine D-1 receptor, in the nucleus accumbens core compared with the adeno-associated virus-Mock vectors-treated mice (Mock mice). Results: miD(2)r mice exhibited a reduction in hyperlocomotion that was induced by a single treatment with methamphetamine. The development of locomotor sensitization induced by repeated treatment with methamphetamine exhibited less extension in miD(2)r mice. In a place conditioning paradigm, the preferred effects of methamphetamine were significantly weaker in miD(2)r mice than in Mock mice. Furthermore, the single treatment with methamphetamine-induced phosphorylation of extracellular signal regulated kinase and cyclic adenosine monophosphate response element-binding protein in the nucleus accumbens core of miD2r mice was decreased compared with that in Mock mice. Repeated treatment with methamphetamine-induced delta FBJ murine osteosarcoma viral oncogene homolog B accumulation in the nucleus accumbens core of miD(2)r mice was also attenuated. Conclusions: These findings suggest that a D-2 receptor-mediated neuronal pathway from the nucleus accumbens core plays an inhibitory role in the development of reinforcing properties.	[Miyamoto, Yoshiaki; Sato, Keiji; Nitta, Atsumi] Toyama Univ, Fac Pharmaceut Sci, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut Therapy & Neuropharmacol, Toyama, Toyama 9300194, Japan; [Iida, Asako; Muramatsu, Shin-ichi] Jichi Med Univ, Dept Med, Div Neurol, Shimotsuke, Tochigi, Japan	Nitta, A (reprint author), Toyama Univ, Fac Pharmaceut Sci, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut Therapy & Neuropharmacol, 2630 Sugitani, Toyama, Toyama 9300194, Japan.	nitta@pha.u-toyama.ac.jp			Funding Program for Next Generation World-Leading Researchers (NEXT Program) [LS047]; JSPS [24590183, 23590473]; MEXT [23110515]; Ministry of Health, Labour and Welfare (MHLW); Uehara Memorial Foundation; Smoking Research Foundation Grant for Biomedical Research	This study was supported by the Funding Program for Next Generation World-Leading Researchers (NEXT Program LS047); JSPS Grants-in-aid for Scientific Research (C) (24590183 and 23590473); MEXT Grant-in-Aid for Scientific Research on Innovative Areas "Foundations of Synapse and Neurocircuit Pathology" (23110515); Research on Regulatory Science of Pharmaceuticals, Health and Labour Science Research Grants from the Ministry of Health, Labour and Welfare (MHLW); a grant from the Uehara Memorial Foundation; and a Smoking Research Foundation Grant for Biomedical Research.	Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Stoof JC, 1981, NATURE, V294, P366, DOI 10.1038/294366a0; Kim J, 2011, BIOL PSYCHIAT, V69, P1026, DOI 10.1016/j.biopsych.2011.01.013; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Mizoguchi H, 2004, MOL PHARMACOL, V65, P1293, DOI 10.1124/mol.65.5.1293; Hikida T, 2003, P NATL ACAD SCI USA, V100, P6169, DOI 10.1073/pnas.0631749100; Kelz MB, 1999, NATURE, V401, P272; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Missale C, 1998, PHYSIOL REV, V78, P189; Monahan PE, 2000, GENE THER, V7, P24, DOI 10.1038/sj.gt.3301109; Groenewegen HJ, 1999, ANN NY ACAD SCI, V877, P49, DOI 10.1111/j.1749-6632.1999.tb09260.x; Humphries MD, 2010, PROG NEUROBIOL, V90, P385, DOI 10.1016/j.pneurobio.2009.11.003; Krzyzosiak A, 2010, NEURON, V66, P908, DOI 10.1016/j.neuron.2010.05.004; Carati C, 2011, PHARMACOL BIOCHEM BE, V98, P449, DOI 10.1016/j.pbb.2011.02.010; Kurokawa K, 2012, NEUROSCIENCE, V227, P22, DOI 10.1016/j.neuroscience.2012.09.029; Li XG, 2006, MOL THER, V13, P160, DOI 10.1016/j.ymthe.2005.08.009; Luscher C, 2006, PLOS MED, V3, P2005, DOI 10.1371/journal.pmed.0030437; Miyamoto Y, 2000, BEHAV BRAIN RES, V116, P187, DOI 10.1016/S0166-4328(00)00274-6; Paxinos G, 2008, MOUSE BRAIN STEREOTA	21	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1461-1457	1469-5111		INT J NEUROPSYCHOPH	Int. J. Neuropsychopharmacol.	FEB	2015	18	4								10.1093/ijnp/pyu038		7	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CF4QX	WOS:000352536800004		
J	Zhang, JC; Wu, J; Fujita, Y; Yao, W; Ren, Q; Yang, C; Li, SX; Shirayama, Y; Hashimoto, K				Zhang, Ji-chun; Wu, Jin; Fujita, Yuko; Yao, Wei; Ren, Qian; Yang, Chun; Li, Su-xia; Shirayama, Yukihiko; Hashimoto, Kenji			Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation	INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY			English	Article						BDNF-TrkB signaling; hippocampus; inflammation; nucleus accumbens; prefrontal cortex	NEUROTROPHIC FACTOR EXPRESSION; MOOD DISORDERS; MAJOR DEPRESSION; AGONIST 7,8-DIHYDROXYFLAVONE; SIGNALING PATHWAYS; NUCLEUS-ACCUMBENS; SOCIAL DEFEAT; KINASE-B; BRAIN; RECEPTOR	Background: Brain-derived neurotrophic factor (BDNF) and its receptor, tropomyosin-related kinase B (TrkB), signaling represent potential therapeutic targets for major depressive disorder. The purpose of this study is to examine whether TrkB ligands show antidepressant effects in an inflammation-induced model of depression. Methods: In this study, we examined the effects of TrkB agonist 7,8-dihydroxyflavone (7,8-DHF) and TrkB antagonist ANA-12 on depression-like behavior and morphological changes in mice previously exposed to lipopolysaccharide (LPS). Protein levels of BDNF, phospho-TrkB (p-TrkB), and TrkB in the brain regions were also examined. Results: LPS caused a reduction of BDNF in the CA3 and dentate gyrus (DG) of the hippocampus and prefrontal cortex (PFC), whereas LPS increased BDNF in the nucleus accumbens (NAc). Dexamethason suppression tests showed hyperactivity of the hypothalamic-pituitary-adrenal axis in LPS-treated mice. Intraperitoneal (i.p.) administration of 7,8-DHF showed antidepressant effects on LPS-induced depression-like behavior, and i.p. pretreatment with ANA-12 blocked its antidepressant effects. Surprisingly, ANA-12 alone showed antidepressant-like effects on LPS-induced depression-like behavior. Furthermore, bilateral infusion of ANA-12 into the NAc showed antidepressant effects. Moreover, LPS caused a reduction of spine density in the CA3, DG, and PFC, whereas LPS increased spine density in the NAc. Interestingly, 7,8-DHF significantly attenuated LPS-induced reduction of p-TrkB and spine densities in the CA3, DG, and PFC, whereas ANA-12 significantly attenuated LPS-induced increases of p-TrkB and spine density in the NAc. Conclusions: The results suggest that LPS-induced inflammation may cause depression-like behavior by altering BDNF and spine density in the CA3, DG, PFC, and NAc, which may be involved in the antidepressant effects of 7,8-DHF and ANA-12, respectively.	[Zhang, Ji-chun; Wu, Jin; Fujita, Yuko; Yao, Wei; Ren, Qian; Yang, Chun; Li, Su-xia; Shirayama, Yukihiko; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba 2608670, Japan; [Li, Su-xia] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Shirayama, Yukihiko] Teikyo Univ, Chiba Med Ctr, Dept Psychiat, Chiba, Japan	Hashimoto, K (reprint author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba 2608670, Japan.	hashimoto@faculty.chiba-u.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24116006]; SENSHIN Medical Research Foundation, Japan; JSPS Invitation Fellowship Program for Research in Japan (long-term)	The authors would like to thank Professor Yoshio Kobayashi and Dr Sho Okada (Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine) for the use of a Keyence BZ-9000 Generation II microscope. This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas of the Ministry of Education, Culture, Sports, Science and Technology, Japan (to Dr Hashimoto, #24116006) and the SENSHIN Medical Research Foundation, Japan (to Dr Hashimoto). Dr Li was supported by JSPS Invitation Fellowship Program for Research in Japan (long-term).	Hashimoto K, 2013, PROG NEUROBIOL, V100, P15, DOI 10.1016/j.pneurobio.2012.09.001; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Ren Q, 2013, PHARMACOL BIOCHEM BE, V106, P124, DOI 10.1016/j.pbb.2013.03.016; Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019; Shelton RC, 2011, MOL PSYCHIATR, V16, P751, DOI 10.1038/mp.2010.52; Walsh JJ, 2014, NAT NEUROSCI, V17, P27, DOI 10.1038/nn.3591; Liu X, 2010, J MED CHEM, V53, P8274, DOI 10.1021/jm101206p; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Rantamaki T, 2007, NEUROPSYCHOPHARMACOL, V32, P2152, DOI 10.1038/sj.npp.1301345; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; Shirayama Y, 2002, J NEUROSCI, V22, P3251; Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021; Shirayama Y, 2006, CURR NEUROPHARMACOL, V4, P277, DOI 10.2174/157015906778520773; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; de Paiva VN, 2010, BEHAV BRAIN RES, V215, P146, DOI 10.1016/j.bbr.2010.07.015; Andero R, 2011, AM J PSYCHIAT, V168, P163, DOI 10.1176/appi.ajp.2010.10030326; Ren Q, 2014, PSYCHOPHARMACOLOGY, V231, P159, DOI 10.1007/s00213-013-3221-7; Sun HS, 2013, NEUROPSYCHOPHARMACOL, V38, P124, DOI 10.1038/npp.2012.73; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/S0006-3223(03)00869-2; Guan ZW, 2006, BRAIN BEHAV IMMUN, V20, P64, DOI 10.1016/j.bbi.2005.04.005; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Raison CL, 2010, ARCH GEN PSYCHIAT, V67, P1211, DOI 10.1001/archgenpsychiatry.2010.161; Taliaz D, 2013, BIOL PSYCHIAT, V74, P305, DOI 10.1016/j.biopsych.2012.07.025; Zarate C, 2010, HARVARD REV PSYCHIAT, V18, P293, DOI 10.3109/10673229.2010.511059; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Magarinos AM, 2011, HIPPOCAMPUS, V21, P253, DOI 10.1002/hipo.20744; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Hashimoto K, 2009, BRAIN RES REV, V61, P105, DOI 10.1016/j.brainresrev.2009.05.005; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; Liu X, 2012, J MED CHEM, V55, P8524, DOI 10.1021/jm301099x; Yu H, 2012, J NEUROSCI, V32, P4092, DOI 10.1523/JNEUROSCI.5048-11.2012; Guo J, 2014, NEUROSCIENCE, V263, P1, DOI 10.1016/j.neuroscience.2014.01.008; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Cazorla M, 2011, J CLIN INVEST, V121, P1846, DOI 10.1172/JCI43992; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; Duman RS, 2012, NEUROPHARMACOLOGY, V62, P35, DOI 10.1016/j.neuropharm.2011.08.044; Saarelainen T, 2003, J NEUROSCI, V23, P349; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Krystal JH, 2013, BIOL PSYCHIAT, V73, P1133, DOI 10.1016/j.biopsych.2013.03.026; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Pariante CM, 2001, BIOL PSYCHIAT, V49, P391, DOI 10.1016/S0006-3223(00)01088-X; Hashimoto K, 2010, PSYCHIAT CLIN NEUROS, V64, P341, DOI 10.1111/j.1440-1819.2010.02113.x; Castrén E, 2014, Handb Exp Pharmacol, V220, P461, DOI 10.1007/978-3-642-45106-5_17; Hashimoto K, 2014, BRIT J PSYCHIAT, V205, P410, DOI 10.1192/bjp.205.5.410; Hashimoto K, 2011, EXPERT REV NEUROTHER, V11, P33, DOI [10.1586/ern.10.176, 10.1586/ERN.10.176]; Hashimoto K, 2014, JAMA NEUROL, V71, P653, DOI 10.1001/jamaneurol.2013.6414; Hashimoto K, 2013, EXPERT REV NEUROTHER, V13, P735, DOI 10.1586/14737175.2013.811894; KATHOL RG, 1989, AM J PSYCHIAT, V146, P311; Lindholm JSO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00143; Milatovic D., 2010, CURR PROTOCOLS TOXIC, V12, P1, DOI DOI 10.1002/0471140856.TX1216S43; Ohgi Y, 2013, PHARM BIOCH BEHAV, V103, P856; Paxinos G, 1998, MOUSE BRAIN STEREOTA	65	8	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1461-1457	1469-5111		INT J NEUROPSYCHOPH	Int. J. Neuropsychopharmacol.	FEB	2015	18	4								10.1093/ijnp/pyu077		12	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CF4QX	WOS:000352536800017		
J	Masuda, K				Masuda, Koichi			Fixed investment, liquidity constraint, and monetary policy: Evidence from Japanese manufacturing firm panel data	JAPAN AND THE WORLD ECONOMY			English	Article						Monetary policy shock; Real fixed investment; Net worth	BALANCE-SHEET; TRANSMISSION; CREDIT; FLUCTUATIONS; CHANNEL; CYCLES; ZERO	We empirically analyze the effects of monetary policy shocks on real fixed investment using panel data on Japanese manufacturing firms to examine the existence of a balance sheet channel. We find that contractionary monetary policy statistically significantly increases the firms' liquidity constraint. Especially, the smaller the firm size, the greater the effects of contractionary monetary policy. Therefore, our estimation results support the presence of a balance sheet channel. In addition, the firms' liquidity constraint decreases significantly during quantitative monetary easing policy (QMEP) period. Specifically, QMEP relaxes the liquidity constraint of large firms. Our evidence suggests that QMEP transmission works through the balance sheet channel and affects the real economy. (C) 2015 Elsevier B.V. All rights reserved.	Chuo Univ, Fac Econ, Hachioji, Tokyo 1920393, Japan	Masuda, K (reprint author), Chuo Univ, Fac Econ, 742-1 Higashi Nakano, Hachioji, Tokyo 1920393, Japan.	k-masuda@tamacc.chuo-u.ac.jp					Angelopoulou E, 2009, ECONOMICA, V76, P675, DOI 10.1111/j.1468-0335.2008.00710.x; ROMER CD, 1989, NBER MACROECON ANN, V4, P121, DOI 10.2307/3584969; Oda N, 2007, JPN ECON REV, V58, P303, DOI 10.1111/j.1468-5876.2007.00422.x; Kiyotaki N, 1997, J POLIT ECON, V105, P211, DOI 10.1086/262072; HAYASHI F, 1991, ECONOMETRICA, V59, P731, DOI 10.2307/2938226; GERTLER M, 1992, REV ECON STUD, V59, P455, DOI 10.2307/2297859; BERNANKE BS, 1995, J ECON PERSPECT, V9, P27; BERNANKE B, 1989, AM ECON REV, V79, P14; CALOMIRIS CW, 1990, ECON J, V100, P90, DOI 10.2307/2233596; Fazzari S., 1988, BROOKINGS PAPERS EC, V1, P141, DOI DOI 10.2307/2534426; Fujiwara I, 2006, J JPN INT ECON, V20, P434, DOI 10.1016/j.jjie.2006.02.001; Fukuda S., 2003, NIHON CHOKI KIN YU Y; GERTLER M, 1994, Q J ECON, V109, P309, DOI 10.2307/2118465; Honda Y., 2010, FINANC REV, V99, P59; Honda Y., 2007, 0708 GRAD SCH EC OS; Hoshi T., 1997, JIN YU KENKYU, V16, P105; Hosono K., 2002, KEIZAI KENKYU, V53, P117; Kimura T., 2002, IMES DISCUSSION PA E, VE-22; Kimura T., 2004, FINANCE EC DISCUSSIO; Kuroki Y., 1999, JIN YU SEISAKU YUKOU; Mishkin F., 1995, 5464 NBER; Nagahata T, 2005, JPN WORLD ECON, V17, P345, DOI 10.1016/j.japwor.2004.03.004; Ogawa K, 2002, JPN ECON REV, V53, P425, DOI 10.1111/1468-5876.00030; Ogawa K, 2000, J JPN INT ECON, V14, P385, DOI 10.1006/jjie.2000.0455; Suzuki K., 2001, SETSUBI TOSHI KIN YU; Ugai H, 2006, WORKING PAPER	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0922-1425	1879-2006		JPN WORLD ECON	Jpn. World Econ.	FEB	2015	33						11	19		10.1016/j.japwor.2015.01.001		9	Economics	Business & Economics	CF6IJ	WOS:000352660100002		
J	Nishigami, T; Mibu, A; Osumi, M; Son, K; Yamamoto, S; Kajiwara, S; Tanaka, K; Matsuya, A; Tanabe, A				Nishigami, Tomohiko; Mibu, Akira; Osumi, Michihiro; Son, Kouki; Yamamoto, Shyogo; Kajiwara, Saori; Tanaka, Katsuyoshi; Matsuya, Ayako; Tanabe, Akihito			Are tactile acuity and clinical symptoms related to differences in perceived body image in patients with chronic nonspecific lower back pain?	MANUAL THERAPY			English	Article						Low back pain; Tactile acuity; Body image; Cortical reorganization	PRIMARY SOMATOSENSORY CORTEX; PHANTOM-LIMB PAIN; CORTICAL REORGANIZATION; PERCEPTION DISTURBANCE; CATASTROPHIZING SCALE; SYNDROME CRPS; COMPLEX; DISCRIMINATION; HAND; SELF	Clinically, perceived image of the lower back and the two-point discrimination (TPD) test are used as markers for evaluating alterations of cortical reorganization. The purpose of the present study was to examine whether TPD and selected clinical findings are different in subgroups of individuals with chronic nonspecific lower back pain (CNLBP) based on body image drawings. Forty-two patients with CNLBP and seventeen healthy individuals were recruited. Perceived body image, TPD and clinical profiles was measured. Of the patients with CNLBP, 42.8% had a normal perceived body image, 28.5% an expanded image, and 28.5% a shrunken image. The TPD distance threshold was significantly larger for the expanded subgroup (13.3 +/- 6.8 mm) compared with the control (5.5 +/- 3.8 mm; Difference, 7.8; 95% CI, 1.83 to 13.66; p < 0.05) and normal subgroups (4.5 +/- 5.5 mm; Difference, 8.8; 95% CI, 2.90 to 14.59; p < 0.05). No significant differences in pain intensity, duration of pain, Roland Morris Disability Questionnaire (RDQ), and Pain Catastrophizing Scale (PCS) scores were found between three body image subgroups. Our results suggest that TPD is increased in patients who report an expanded perceived image of the lower back compared with healthy individuals and patients who report a normal image. The effectiveness of new rehabilitation techniques may be evaluated by assessing perceived image of the lower back and TPD values for patients with CNLBP before and after treatment. (C) 2014 Elsevier Ltd. All rights reserved.	[Nishigami, Tomohiko; Matsuya, Ayako] Konan Womans Univ, Dept Nursing & Phys Therapy, Higashinada Ku, Kobe, Hyogo 6580001, Japan; [Mibu, Akira; Son, Kouki; Yamamoto, Shyogo; Kajiwara, Saori; Tanaka, Katsuyoshi; Tanabe, Akihito] Tanabe Orthopaed Clin, Dept Rehabil, Tennouji Ku, Osaka, Japan; [Osumi, Michihiro] Kio Univ, Grad Sch Hlth Sci, Dept Neurorehabil, Kouryou Tyou, Japan	Nishigami, T (reprint author), Konan Womans Univ, Dept Nursing & Phys Therapy, Higashinada Ku, 6-2-23 Morikita Machi, Kobe, Hyogo 6580001, Japan.	t-nishi@konan-wu.ac.jp					Tsao H, 2008, BRAIN, V131, P2161, DOI 10.1093/brain/awn154; Pleger B, 2006, NEUROIMAGE, V32, P503, DOI 10.1016/j.neuroimage.2006.03.045; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Luomajoki H, 2011, BRIT J SPORT MED, V45, P437, DOI 10.1136/bjsm.2009.060731; Maihofner C, 2004, NEUROLOGY, V63, P693; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Wand BM, 2011, PHYS THER, V91, P535, DOI 10.2522/ptj.20100150; Pleger B, 2003, NEURON, V40, P643, DOI 10.1016/S0896-6273(03)00677-9; Lewis JS, 2012, EUR J PAIN, V16, P1320, DOI 10.1002/j.1532-2149.2012.00120.x; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Nelson-Wong E, 2013, J ELECTROMYOGR KINES, V23, P1317, DOI 10.1016/j.jelekin.2013.08.011; McCabe CS, 2003, RHEUMATOLOGY, V42, P97, DOI 10.1093/rheumatology/keg041; McCabe CS, 2005, RHEUMATOLOGY, V44, P509, DOI 10.1093/rheumatology/keh529; Forderreuther S, 2004, PAIN, V110, P756, DOI 10.1016/j.pain.2004.05.019; Moseley GL, 2005, NEUROLOGY, V65, P773, DOI 10.1212/01.wnl.0000174515.07205.11; Lewis JS, 2007, PAIN, V133, P111, DOI 10.1016/j.pain.2007.03.013; Moseley GL, 2008, PAIN, V140, P239, DOI 10.1016/j.pain.2008.08.001; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037//1040-3590.7.4.524; Peltz E, 2011, J PAIN, V12, P1095, DOI 10.1016/j.jpain.2011.05.001; Catley MJ, 2013, RHEUMATOLOGY, V52, P1454, DOI 10.1093/rheumatology/ket140; Ehrsson HH, 2005, PLOS BIOL, V3, P2200, DOI 10.1371/journal.pbio.0030412; Graziano MSA, 2002, ATTENTION PERFORM, V19, P136; Haggard P, 2003, CURR BIOL, V13, pR170, DOI 10.1016/S0960-9822(03)00115-5; Lame IE, 2008, J HEALTH PSYCHOL, V13, P820, DOI 10.1177/1359105308093866; Lotze Martin, 2007, Curr Rheumatol Rep, V9, P488, DOI 10.1007/s11926-007-0079-x; MOBERG E, 1990, SCAND J REHABIL MED, V22, P127; Nishigami T, 2012, J NOV PHYSIOTHER, pS1; Pleger B, 2004, EXP BRAIN RES, V155, P115, DOI 10.1007/s00221-003-1738-4; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Suzukamo Yoshimi, 2003, J Orthop Sci, V8, P543, DOI 10.1007/s00776-003-0679-x; Wand BM, 2014, MANUAL THER, V19, P504, DOI 10.1016/j.math.2014.01.002; Wand BM, 2010, PHYSIOTHERAPY, V96, P317, DOI 10.1016/j.physio.2010.02.005	33	0	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1356-689X	1532-2769		MANUAL THER	Man. Ther.	FEB	2015	20	1					63	67		10.1016/j.math.2014.06.010		5	Rehabilitation	Rehabilitation	CF7WV	WOS:000352768000011		
J	Umegaki, H; Ikezoe, T; Nakamura, M; Nishishita, S; Kobayashi, T; Fujita, K; Tanaka, H; Ichihashi, N				Umegaki, Hiroki; Ikezoe, Tome; Nakamura, Masatoshi; Nishishita, Satoru; Kobayashi, Takuya; Fujita, Kosuke; Tanaka, Hiroki; Ichihashi, Noriaki			The effect of hip rotation on shear elastic modulus of the medial and lateral hamstrings during stretching	MANUAL THERAPY			English	Article						Hamstrings; Ultrasonic shear wave elastography; Stretching; Hip rotation	MUSCLE-TENDON UNIT; WAVE ELASTOGRAPHY; INJURIES; FOOTBALL; PREVENTION; RISK	Regarding hamstring stretching methods, many studies have investigated the effect of stretching duration or frequency on muscle stiffness. However, the most effective stretching positions for hamstrings are unclear because it is impossible to quantify muscle elongation directly and noninvasively in vivo. Recently, a new ultrasound technology, ultrasonic shear wave elastography, has permitted noninvasive and reliable measurement of muscle shear elastic modulus, which has a strong linear relationship to the amount of muscle elongation. This study aimed to investigate the effect of hip internal and external rotation on shear elasticmodulus of the lateral and medial hamstrings, respectively, during stretching in vivo using ultrasonic shearwave elastography. Twenty-three healthy men (age, 23.0 +/- 2.1 years) were recruited for this study. To investigate the effect of hip rotation on the elongation of the medial and lateral hamstrings, shear elastic modulus of the biceps femoris (BF) and semitendinosus (ST) was measured at rest (a supine position with 90 degrees knee flexion, 90 degrees hip flexion, and hip neutral rotation) and in seven stretching positions (with 45 degrees knee flexion and hip internal, external, and neutral rotation) using ultrasonic shearwave elastography. In both BF and ST, the shear elastic modulus in the rest position was significantly lower than that in all stretching positions. However, no significant differences were seen among stretching positions. Our results suggest that adding hip rotation at a stretching position for the hamstrings may not have a significant effect on muscle elongation of the medial and lateral hamstrings. (C) 2014 Elsevier Ltd. All rights reserved.	[Umegaki, Hiroki; Ikezoe, Tome; Nakamura, Masatoshi; Nishishita, Satoru; Kobayashi, Takuya; Fujita, Kosuke; Tanaka, Hiroki; Ichihashi, Noriaki] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto 6068507, Japan; [Nakamura, Masatoshi] Doshisha Univ, Fac Hlth & Sports Sci, Kyoto 602, Japan	Umegaki, H (reprint author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	umegaki.hiroki.86x@st.kyoto-u.ac.jp					Gabbe BJ, 2006, SCAND J MED SCI SPOR, V16, P7, DOI 10.1111/j.1600-0838.2005.00441.x; Brooks JHM, 2006, AM J SPORT MED, V34, P1297, DOI 10.1177/0363546505286022; Witvrouw E, 2003, AM J SPORT MED, V31, P41; Maisetti O, 2012, J BIOMECH, V45, P978, DOI 10.1016/j.jbiomech.2012.01.009; McHugh MP, 2010, SCAND J MED SCI SPOR, V20, P169, DOI 10.1111/j.1600-0838.2009.01058.x; Maganaris CN, 2000, EUR J APPL PHYSIOL, V83, P363, DOI 10.1007/s004210000247; Nakamura M, 2013, MANUAL THER, V18, P211, DOI 10.1016/j.math.2012.09.010; DOSTAL WF, 1986, PHYS THER, V66, P351; Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033; Ben M, 2010, SCAND J MED SCI SPOR, V20, P136, DOI 10.1111/j.1600-0838.2009.00926.x; Bishop GW, 1999, CLIN J SPORT MED, V9, P216, DOI 10.1097/00042752-199910000-00006; Buford W L Jr, 1997, IEEE Trans Rehabil Eng, V5, P367, DOI 10.1109/86.650292; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Feeley BT, 2008, AM J SPORT MED, V36, P1597, DOI 10.1177/0363546508316021; Goldman EF, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006782.pub2; Koo TK, 2014, CLIN BIOMECH, V29, P33, DOI 10.1016/j.clinbiomech.2013.11.009; Leong HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067199; Magnusson SP, 2000, MED SCI SPORT EXER, V32, P1160, DOI 10.1097/00005768-200006000-00020; Mason DL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004575.pub2; Ylinen J, 2009, J REHABIL MED, V41, P80, DOI 10.2340/16501977-0283	20	2	2	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1356-689X	1532-2769		MANUAL THER	Man. Ther.	FEB	2015	20	1					134	137		10.1016/j.math.2014.07.016		4	Rehabilitation	Rehabilitation	CF7WV	WOS:000352768000022		
J	Kato, Y; Moriwaki, T; Funakoshi, M; Zhang-Akiyama, QM				Kato, Yuichi; Moriwaki, Takahito; Funakoshi, Masafumi; Zhang-Akiyama, Qiu-Mei			Caenorhabditis elegans EXO-3 contributes to longevity and reproduction: Differential roles in somatic cells and germ cells	MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS			English	Article						AP site; AP endonuclease; C. elegans; EXO-3; Longevity; Reproduction	BASE EXCISION-REPAIR; URACIL-DNA GLYCOSYLASE; C-ELEGANS; ABASIC SITES; APURINIC/APYRIMIDINIC ENDONUCLEASE-1; BIOLOGICAL CONSEQUENCES; GENE; NEMATODE; DAMAGE; MICE	Apurinic/apyrimidinic (AP) sites are the major DNA damage generated continuously even under normal conditions, and inhibit DNA replication/transcription. AP endonucleases are ubiquitous enzymes required for the repair of AP sites and 3' blocking ends, but their physiological roles in multicellular organisms are not fully understood. In this study, we investigated how an AP endonuclease functions in a multicellular organism (Caenorhabditis elegans (C. elegans)). EXO-3 is one of the AP endonucleases in C. elegans. Using an exo-3 mutant worm, we found that deletion of the exo-3 gene caused shortened lifespan in an ung-1-dependent manner. UNG-1 is a uracil DNA glycosylase in C elegans, and the present finding suggested that UNG-1 is the major producer of AP sites that affects lifespan, and EXO-3 contributes to longevity by completing the repair of uracil. Next we found that the exo-3 gene was abundantly expressed in the gonads, and AP sites in the gonad were efficiently repaired, suggesting that EXO-3 functioned particularly in the gonad. Deletion of the exo-3 gene resulted in a significant decrease in self-brood size. This was rescued by deficiency of NTH-1, which is a bifunctional DNA glycosylase in C. elegans that recognizes oxidative base damage. This result suggested that the major substrate of EXO-3 in the gonad was 3' blocking end generated by NTH-1, and that EXO-3 played an important role in reproduction. A contribution of EXO-3 to reproduction was also suggested by our finding here that the decrease of self-brood size of the exo-3 mutant became more marked when worms were treated with methyl methanesulfonate (MMS) and sodium bisulfite (NaHSO3). This study demonstrated differential roles of EXO-3 in somatic cells and germ cells. (C) 2015 Elsevier B.V. All rights reserved.	[Kato, Yuichi; Moriwaki, Takahito; Funakoshi, Masafumi; Zhang-Akiyama, Qiu-Mei] Kyoto Univ, Grad Sch Sci, Lab Stress Response Biol, Sakyo Ku, Kyoto 6068502, Japan	Zhang-Akiyama, QM (reprint author), Kyoto Univ, Grad Sch Sci, Lab Stress Response Biol, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	qmzhang@kingyo.zool.kyoto-u.ac.jp			NIH Office of Research Infrastructure Programs [P40 OD010440]; Grants for Excellent Graduate Schools, MEXT, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [24510071]; Shiseido Female Research Science Grant	We thank Dr. Elizabeth Nakajima for critically reading the manuscript. We also thank the National Bioresource Project (NBRP) for the Experimental Animal "Nematode C. elegans" of Japan (Mitani laboratory). Some strains were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). This work was financially supported in part by Grants for Excellent Graduate Schools, MEXT, Japan, and by Grants-in-Aid for Scientific Research (#24510071) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We are also grateful to the Shiseido Female Research Science Grant for supporting Q-M. Zhang-Akiyama.	Andux S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000295; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Ludwig DL, 1998, MUTAT RES-DNA REPAIR, V409, P17, DOI 10.1016/S0921-8777(98)00039-1; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Nakamura J, 1999, CANCER RES, V59, P2522; Dalhus B, 2009, FEMS MICROBIOL REV, V33, P1044, DOI 10.1111/j.1574-6976.2009.00188.x; Hodgkin J, 1997, GENETICS, V146, P149; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120; NELSON GA, 1978, DEV BIOL, V66, P386, DOI 10.1016/0012-1606(78)90247-6; Nakamura J, 1998, CANCER RES, V58, P222; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; BARTON MK, 1987, GENETICS, V115, P107; Cabelof DC, 2002, MUTAT RES-FUND MOL M, V500, P135, DOI 10.1016/S0027-5107(02)00003-9; Chastain PD, 2006, FASEB J, V20, P2612, DOI 10.1096/fj.06-6145fje; Chastain P.D. 2nd, 2010, FASEB J, V10, P3674; IDE H, 1993, BIOCHEMISTRY-US, V32, P8276, DOI 10.1021/bi00083a031; Intano GW, 2001, NUCLEIC ACIDS RES, V29, P1366, DOI 10.1093/nar/29.6.1366; KUBO K, 1992, BIOCHEMISTRY-US, V31, P3703, DOI 10.1021/bi00129a020; KUNKEL TA, 1984, P NATL ACAD SCI-BIOL, V81, P1494, DOI 10.1073/pnas.81.5.1494; Li MX, 2014, ANTIOXID REDOX SIGN, V20, P678, DOI 10.1089/ars.2013.5492; Morinaga H, 2009, DNA REPAIR, V8, P844, DOI 10.1016/j.dnarep.2009.04.020; Nakamura N, 2008, MUTAGENESIS, V23, P407, DOI 10.1093/mutage/gen030; Nilsen H, 2003, ONCOGENE, V22, P5381, DOI 10.1038/sj.onc.1206860; Ogawa H, 1998, J BIOL CHEM, V273, P2192, DOI 10.1074/jbc.273.4.2192; Raffoul JJ, 2004, J BIOL CHEM, V279, P18425, DOI 10.1074/jbc.M313983200; RAMOTAR D, 1991, MOL CELL BIOL, V11, P4537; Schlotterer A, 2010, AGING CELL, V9, P420, DOI 10.1111/j.1474-9726.2010.00572.x; SenGupta T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3674; Shatilla A, 2005, DNA REPAIR, V4, P655, DOI 10.1016/j.dnarep.2005.02.005; Shatilla A, 2005, BIOCHEMISTRY-US, V44, P12835, DOI 10.1021/bi050195t; Shatilla A, 2002, BIOCHEM J, V365, P547, DOI 10.1042/BJ20020375; Tan YS, 1996, ACTA MED OKAYAMA, V50, P53; Yang XM, 2012, DNA REPAIR, V11, P811, DOI 10.1016/j.dnarep.2012.06.009; Zakaria C, 2010, DNA REPAIR, V9, P169, DOI 10.1016/j.dnarep.2009.11.007	41	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0027-5107	1873-135X		MUTAT RES-FUND MOL M	Mutat. Res.-Fundam. Mol. Mech. Mutagen.	FEB	2015	772						46	54		10.1016/j.mrfmmm.2015.01.001		9	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	CF6KP	WOS:000352665900009		
J	Kametani, F; Haga, S				Kametani, Fuyuki; Haga, Seiichi			Accumulation of carboxy-terminal fragments of APP increases phosphodiesterase 8B	NEUROBIOLOGY OF AGING			English	Article						Alzheimer's disease; Amyloid; APP; CTF; A beta; Phosphodiesterase; cAMP; Proteomics	AMYLOID PRECURSOR PROTEIN; DEPENDENT TRANSCRIPTIONAL CONTROL; FAMILIAL ALZHEIMERS-DISEASE; DEGRADING ENZYME NEPRILYSIN; A-BETA; GAMMA-SECRETASE; MOUSE MODEL; INTRACELLULAR DOMAINS; COGNITIVE IMPAIRMENT; IMPROVES MEMORY	The long-standing "amyloid hypothesis" that Alzheimer's disease is caused by the production and aggregation of amyloid-beta faces serious challenges by data recently obtained from neuroimaging studies and amyloid-beta amyloid-focused clinical trials. Meanwhile, accumulation of carboxy-terminal fragments (CTFs) of the amyloid precursor protein (APP) may be neurotoxic and may impair synaptic plasticity and long-term memory in Alzheimer's disease, as suggested in murine models. To clarify these issues, we carried out a proteomic analysis of Chinese hamster ovary cells expressing APP CTFs and found that APP-CTF accumulation induced an increase in the level of phosphodiesterase 8B, suggesting that the hydrolysis of cyclic AMP was enhanced. (C) 2015 Elsevier Inc. All rights reserved.	[Kametani, Fuyuki; Haga, Seiichi] Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Tokyo 1568506, Japan	Kametani, F (reprint author), Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	kametani-fy@igakuken.or.jp	Kametani, Fuyuki/G-4752-2011	Kametani, Fuyuki/0000-0001-9125-7001	JSPS KAKENHI [23390093]	This work was supported by JSPS KAKENHI grant number 23390093 (Fuyuki Kametani).	OsterGranite ML, 1996, J NEUROSCI, V16, P6732; Garcia-Barroso C, 2013, NEUROPHARMACOLOGY, V64, P114, DOI 10.1016/j.neuropharm.2012.06.052; Asai M, 2011, FASEB J, V25, P3720, DOI 10.1096/fj.11-182154; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Edison P, 2007, NEUROLOGY, V68, P501, DOI 10.1212/01.wnl.0000244749.20056.d4; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; Cheng YF, 2010, PSYCHOPHARMACOLOGY, V212, P181, DOI 10.1007/s00213-010-1943-3; Bruno O, 2011, BRIT J PHARMACOL, V164, P2054, DOI 10.1111/j.1476-5381.2011.01524.x; Garcia-Osta A, 2012, ACS CHEM NEUROSCI, V3, P832, DOI 10.1021/cn3000907; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Wiley JC, 2005, J NEUROCHEM, V94, P1189, DOI 10.1111/j.1471-4159.2005.03266.x; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Sierksma ASR, 2013, NEUROPHARMACOLOGY, V64, P124, DOI 10.1016/j.neuropharm.2012.06.048; Giacobini E, 2013, NAT REV NEUROL, V9, P677, DOI 10.1038/nrneurol.2013.223; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; Robakis NK, 2011, NEUROBIOL AGING, V32, P372, DOI 10.1016/j.neurobiolaging.2010.05.022; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Pera M, 2013, ACTA NEUROPATHOL, V125, P201, DOI 10.1007/s00401-012-1062-9; Kroker KS, 2014, NEUROBIOL AGING, V35, P2072, DOI 10.1016/j.neurobiolaging.2014.03.023; Tong LQ, 2001, J BIOL CHEM, V276, P17301, DOI 10.1074/jbc.M010450200; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Sierksma ASR, 2014, NEUROPHARMACOLOGY, V77, P120, DOI 10.1016/j.neuropharm.2013.09.015; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; Li Y, 2008, EUR J NUCL MED MOL I, V35, P2169, DOI 10.1007/s00259-008-0833-y; Ohkawara T, 2011, GENE, V475, P1, DOI 10.1016/j.gene.2010.11.014; Chen A. C., 2007, NEURON, V46, P541; Chen A. C., 2007, NEURON, V53, P479; Funamoto S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3529; Kametani F, 2008, CURR ALZHEIMER RES, V5, P165, DOI 10.2174/156720508783954776; Pardossi-Piquard R, 2007, NEURON, V53, P483, DOI 10.1016/j.neuron.2007.01.024; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Peng S, 2014, CELL BIOCHEM BIOPHYS, V70, P83, DOI 10.1007/s12013-014-9930-7; Perez-Gonzalez R, 2013, NEUROBIOL AGING, V34, P2133, DOI 10.1016/j.neurobiolaging.2013.03.011; Perez-Torres S, 2003, EXP NEUROL, V182, P322, DOI 10.1016/S0014-4886(03)00042-6; Robakis NK, 2014, NEURODEGENER DIS, V13, P126, DOI 10.1159/000354241	37	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	FEB	2015	36	2					634	637		10.1016/j.neurobiolaging.2014.09.029		4	Geriatrics & Gerontology; Neurosciences	Geriatrics & Gerontology; Neurosciences & Neurology	CF3MZ	WOS:000352454400010		
J	Doi, T; Shimada, H; Makizako, H; Tsutsumimoto, K; Hotta, R; Nakakubo, S; Suzuki, T				Doi, Takehiko; Shimada, Hiroyuki; Makizako, Hyuma; Tsutsumimoto, Kota; Hotta, Ryo; Nakakubo, Sho; Suzuki, Takao			Association of insulin-like growth factor-1 with mild cognitive impairment and slow gait speed	NEUROBIOLOGY OF AGING			English	Article						IGF-1; MCI; Cognitive function; Gait speed	OLDER-ADULTS; ALZHEIMERS-DISEASE; IGF-I; BINDING PROTEIN-3; VASCULAR DEMENTIA; CONTROLLED-TRIAL; MUSCLE STRENGTH; BRAIN; SERUM; EXERCISE	The decrease in serum insulin-like growth factor-1 (IGF-I) with aging is related to the neurobiological processes in Alzheimer's disease. IGF-1 mediates effects of physical exercise on the brain, and cognition has a common pathophysiology with physical function, particularly with gait. The aim of this study was to examine whether mild cognitive impairment (MCI) and slow gait are associated with the serum IGF-1 level. A population survey was conducted in 3355 participants (mean age, 71.4 years). Cognitive functions (attention, executive function, processing speed, visuospatial skill, and memory), gait speed, and demographic variables were measured. All cognitive functions and gait speed were associated with the IGF-1 level (p < 0.001). The association of IGF-1 with slow gait was weakened by adjustment for covariates, but MCI and the combination of MCI and slow gait were independently related to the IGF-1 level in multivariate analysis (p < 0.05). Our findings support the association of a low IGF-1 level with reduced cognitive function and gait speed, particularly with a combination of MCI and slow gait. (C) 2015 Elsevier Inc. All rights reserved.	[Doi, Takehiko; Shimada, Hiroyuki; Makizako, Hyuma; Tsutsumimoto, Kota; Hotta, Ryo; Nakakubo, Sho] Natl Ctr Geriatr & Gerontol, Dept Functioning Activat, Ctr Gerontol & Social Sci, Obu, Aichi 4748511, Japan; [Doi, Takehiko; Makizako, Hyuma] Japan Soc Promot Sci, Tokyo, Japan; [Doi, Takehiko; Makizako, Hyuma; Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Res Inst, Obu, Aichi 4748511, Japan	Doi, T (reprint author), Natl Ctr Geriatr & Gerontol, Dept Functioning Activat, Ctr Gerontol & Social Sci, 35 Gengo, Obu, Aichi 4748511, Japan.	take-d@ncgg.go.jp			Health and Labor Sciences Research Grants (Comprehensive Research on Aging and Health); National Center for Geriatrics and Gerontology [22-16];  [23300205]	This work was supported by Health and Labor Sciences Research Grants (Comprehensive Research on Aging and Health); a Grant-in-Aid for Scientific Research (B) (grant number 23300205); and Research Funding for Longevity Sciences (22-16) from the National Center for Geriatrics and Gerontology.	ADEM A, 1989, BRAIN RES, V503, P299, DOI 10.1016/0006-8993(89)91678-8; Angelini A, 2009, ARCH GERONTOL GERIAT, V49, P5, DOI 10.1016/j.archger.2009.09.006; Peters DM, 2013, J GERIATR PHYS THER, V36, P24, DOI 10.1519/JPT.0b013e318248e20d; Mielke MM, 2013, J GERONTOL A-BIOL, V68, P929, DOI 10.1093/gerona/gls256; Sanders JL, 2014, J GERONTOL A-BIOL, V69, P174, DOI 10.1093/gerona/glt088; Liu-Ambrose T, 2012, NEUROBIOL AGING, V33, P1690, DOI 10.1016/j.neurobiolaging.2011.05.010; Solfrizzi V, 2013, ALZHEIMERS DEMENT, V9, P113, DOI 10.1016/j.jalz.2011.09.223; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001; Hong M, 1997, J BIOL CHEM, V272, P19547, DOI 10.1074/jbc.272.31.19547; Westwood AJ, 2014, NEUROLOGY, V82, P1613, DOI 10.1212/WNL.0000000000000382; Nishijima T, 2010, NEURON, V67, P834, DOI 10.1016/j.neuron.2010.08.007; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Shimada H, 2013, J AM MED DIR ASSOC, V14, P518, DOI 10.1016/j.jamda.2013.03.010; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Makizako H, 2013, GERIATR GERONTOL INT, V13, P860, DOI 10.1111/ggi.12014; Dik MG, 2003, NEUROBIOL AGING, V24, P573, DOI 10.1016/S0197-4580(02)00136-7; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Verghese J, 2014, NEUROLOGY, V83, P718, DOI 10.1212/WNL.0000000000000717; Johansson P, 2013, PSYCHONEUROENDOCRINO, V38, P1729, DOI 10.1016/j.psyneuen.2013.02.006; Vardy ERLC, 2007, J ALZHEIMERS DIS, V12, P285; Carro E, 2006, NEUROBIOL AGING, V27, P1250, DOI 10.1016/j.neurobiolaging.2005.06.015; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; Buchman AS, 2013, NEUROLOGY, V80, P2055, DOI 10.1212/WNL.0b013e318294b462; Cappola AR, 2001, J CLIN ENDOCR METAB, V86, P4139, DOI 10.1210/jc.86.9.4139; Waite LM, 2005, J NEUROL SCI, V229, P89, DOI 10.1016/j.jns.204.11.009; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Baker LD, 2012, ARCH NEUROL-CHICAGO, V69, P1420, DOI 10.1001/archneurol.2012.1970; Deak F, 2012, J GERONTOL A-BIOL, V67, P611, DOI 10.1093/gerona/gls118; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Lopez-Lopez C, 2004, P NATL ACAD SCI USA, V101, P9833, DOI 10.1073/pnas.0400337101; Sonntag WE, 2005, AGEING RES REV, V4, P195, DOI 10.1016/j.arr.2005.02.001; FLORINI JR, 1991, ANNU REV PHYSIOL, V53, P201, DOI 10.1146/annurev.physiol.53.1.201; van Dam PS, 2000, GROWTH HORM IGF RES, V10, P69; Kaplan RC, 2008, J AM GERIATR SOC, V56, P652, DOI 10.1111/j.1532-5415.2007.01637.x; Duron E, 2012, J CLIN ENDOCR METAB, V97, P4673, DOI 10.1210/jc.2012-2063; Trejo JL, 2001, J NEUROSCI, V21, P1628; Aleman A, 2009, PROG NEUROBIOL, V89, P256, DOI 10.1016/j.pneurobio.2009.07.008; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; Arwert LI, 2005, GROWTH HORM IGF RES, V15, P416, DOI 10.1016/j.ghir.2005.09.001; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V284, pE481, DOI 10.1152/ajpendo.00319.2002; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Jafferali S, 2000, SYNAPSE, V38, P450, DOI 10.1002/1098-2396(20001215)38:4<450::AID-SYN10>3.0.CO;2-J; Kalmijn S, 2000, J CLIN ENDOCR METAB, V85, P4551, DOI 10.1210/jc.85.12.4551; Mikami S, 2008, HYPERTENS RES, V31, P1163, DOI 10.1291/hypres.31.1163; Murase N., 2003, J HLTH WELFARE STAT, V49, P9; Onder G, 2006, AM J PHYSIOL-ENDOC M, V291, pE829, DOI 10.1152/ajpendo.00138.2006; Petersen RC, 2011, NEW ENGL J MED, V364, P2227, DOI 10.1056/NEJMcp0910237; Shimada H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002424; Shum D. H. K., 1990, CLIN NEUROPSYCHOL, V4, P151, DOI 10.1080/13854049008401508; van Exel E., 2014, NEUROBIOL AGING, V35, pe7; Watanabe T, 2005, J AM GERIATR SOC, V53, P1748, DOI 10.1111/j.1532-5415.2005.53524.x	56	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	FEB	2015	36	2					942	947		10.1016/j.neurobiolaging.2014.10.035		6	Geriatrics & Gerontology; Neurosciences	Geriatrics & Gerontology; Neurosciences & Neurology	CF3MZ	WOS:000352454400039		
J	Fujita, K; Kasama, S; Kurabayashi, M				Fujita, Kishu; Kasama, Shu; Kurabayashi, Masahiko			Serial dual single-photon emission computed tomography of thallium-201 and iodine-123 beta-methyliodophenyl pentadecanoic acid scintigraphy can predict functional recovery of patients with coronary artery disease after coronary artery bypass graft surgery	NUCLEAR MEDICINE COMMUNICATIONS			English	Article						coronary artery bypass graft surgery; coronary artery disease; fatty acid; scintigraphy	ACUTE MYOCARDIAL-INFARCTION; SYMPATHETIC-NERVE ACTIVITY; LEFT-VENTRICULAR FUNCTION; BRANCHED FATTY-ACIDS; VIABILITY ASSESSMENT; ISCHEMIC-MYOCARDIUM; NICORANDIL THERAPY; VIABLE MYOCARDIUM; HEART-FAILURE; METABOLISM	Background A mismatch between thallium-201 (Tl-201) and iodine-123 (I-123)-beta-methyl iodophenyl pentadecanoic acid (BMIPP) dual single-photon emission computed tomography (SPECT) reflects a dysfunctional but viable myocardium, such as stunned or hibernating myocardium, in patients with coronary artery disease (CAD). However, the cardiac function does not always improve after revascularization. The present study aimed to determine whether serial Tl-201 and I-123-BMIPP dual SPECT can predict improvements in cardiac function after coronary artery bypass graft surgery (CABG) in patients with CAD. Materials and methods The study included 98 patients with CAD requiring CABG and having a left ventricular ejection fraction (LVEF) less than 50%. The total defect score (TDS) was calculated from Tl-201 and I-123-BMIPP dual-SPECT images acquired before and 3 weeks after CABG. The LVEF, left ventricular end-diastolic volume index, and end-systolic volume index were determined by means of contrast left ventriculography before and 6 months after CABG. Results After 6 months, LVEF improved by 5% or more in 62 patients (group A) but did not improve in the remaining 36 patients (group B). Baseline Tl-TDS was significantly lower (9.1 +/- 4.6 vs. 14.6 +/- 6.5, P < 0.001), and the mismatch score (BMIPP-TDS-Tl-TDS) was significantly higher (6.9 +/- 4.2 vs. 4.2 +/- 3.9, P = 0.002) in group A than in group B. The extent of change in BMIPP-TDS 3 weeks after CABG compared with that before (delta-BMIPP-TDS) was significantly greater in group A than in group B (-5.9 +/- 3.0 vs. 2.8 +/- 4.3, P < 0.001). Stepwise multivariate analysis selected delta-BMIPP-TDS as a significant independent predictor of improvement in LVEF at 6 months after CABG (multivariate beta-coefficient = -0.718, P < 0.001). The degree of change in LVEF 6 months after CABG compared with that before significantly and negatively correlated with delta-BMIPP-TDS (r = -0.631, P < 0.001). Conclusion The delta-BMIPP-TDS evaluated by serial Tl-201 and I-123-BMIPP dual SPECT can predict improvements in cardiac function during the chronic phase of CAD. Nucl Med Commun 36: 148-155 (C) 2015 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Fujita, Kishu; Kasama, Shu; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci Cardiovasc Med, Maebashi, Gunma 3718511, Japan; [Fujita, Kishu] Tsukazaki Hosp, Dept Cardiovasc Surg, Himeji, Hyogo, Japan; [Kasama, Shu] Kitakanto Cardiovasc Hosp, Cardiovasc Hosp Cent Japan, Dept Cardiovasc Med, Gunma, Japan	Kasama, S (reprint author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci Cardiovasc Med, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	s-kasama@bay.wind.ne.jp					Abdulla J, 2007, EUR J HEART FAIL, V9, P129, DOI 10.1016/j.ejheart.2006.05.002; Kasama S, 2007, EUR HEART J, V28, P989, DOI 10.1093/eurheartj/ehm048; DILSIZIAN V, 1990, NEW ENGL J MED, V323, P141, DOI 10.1056/NEJM199007193230301; Haas F, 1997, J AM COLL CARDIOL, V30, P1693, DOI 10.1016/S0735-1097(97)00375-6; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; KNAPP FF, 1986, EUR J NUCL MED, V12, pS39; Lautamaki R, 2009, CIRC-CARDIOVASC IMAG, V2, P299, DOI 10.1161/CIRCIMAGING.108.846253; Taki J, 1997, J NUCL MED, V38, P1503; BLANKE H, 1985, J AM COLL CARDIOL, V5, P827; CULVER CM, 1993, J NUCL MED, V34, P1210; DREYFUS GD, 1994, ANN THORAC SURG, V57, P1402; Dreyfus GD, 1994, ANN THORAC SURG, V57, P1407; Feola M, 2008, NUCL MED COMMUN, V29, P448, DOI 10.1097/MNM.0b013e3282f5d2bc; FRANKEN PR, 1994, J NUCL MED, V35, P1758; Gandhi PS, 2007, CAN J PHYSIOL PHARM, V85, P193, DOI 10.1139/Y07-006; GOODMAN MM, 1984, J MED CHEM, V27, P390, DOI 10.1021/jm00369a027; Hashimoto A, 1996, AM J CARDIOL, V77, P25, DOI 10.1016/S0002-9149(97)89129-1; Ito T, 1996, EUR J NUCL MED, V23, P917, DOI 10.1007/BF01084365; Kasama S, 2007, J AM COLL CARDIOL, V49, P667, DOI 10.1016/j.jacc.2006.09.048; Kasama S, 2007, J NUCL MED, V48, P1676, DOI 10.2967/jnumed.107.043075; Kasama S, 2014, EUR J NUCL MED MOL I, V41, P144, DOI 10.1007/s00259-013-2538-0; Marwick TH, 1999, J AM COLL CARDIOL, V33, P750, DOI 10.1016/S0735-1097(98)00642-1; Marwick TH, 1998, LANCET, V351, P815, DOI 10.1016/S0140-6736(97)08080-X; MATSUNARI I, 1995, J NUCL MED, V36, P1605; Nakata T, 1998, J NUCL MED, V39, P1492; OPIE LH, 1973, EUR J CLIN INVEST, V3, P419, DOI 10.1111/j.1365-2362.1973.tb02210.x; Peluffo RD, 1997, J PHYSIOL-LONDON, V501, P33, DOI 10.1111/j.1469-7793.1997.033bo.x; RAGOSTA M, 1993, CIRCULATION, V87, P1630; SCHELBERT HR, 1983, AM HEART J, V105, P492, DOI 10.1016/0002-8703(83)90368-X; Takeishi Y, 1996, J NUCL MED, V37, P1289; TAMAKI N, 1995, J NUCL MED, V36, P1974; Toyama T, 2004, CIRC J, V68, P348, DOI 10.1253/circj.68.348	32	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0143-3636	1473-5628		NUCL MED COMMUN	Nucl. Med. Commun.	FEB	2015	36	2					148	155		10.1097/MNM.0000000000000228		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CF7IV	WOS:000352730600008		
J	Kim, CW; Morita, T; Oshima, Y; Sugiura, K				Kim, Chul-Woo; Morita, Tomoaki; Oshima, Yoshinobu; Sugiura, Kunitomo			A Bayesian approach for vibration-based long-term bridge monitoring to consider environmental and operational changes	SMART STRUCTURES AND SYSTEMS			English	Article						long-term bridge monitoring; Bayesian regression; temperature; vehicle weight; vibration	DAMAGE DETECTION; TIME-SERIES	This study aims to propose a Bayesian approach to consider changes in temperature and vehicle weight as environmental and operational factors for vibration-based long-term bridge health monitoring. The Bayesian approach consists of three steps: step 1 is to identify damage-sensitive features from coefficients of the auto-regressive model utilizing bridge accelerations; step 2 is to perform a regression analysis of the damage-sensitive features to consider environmental and operational changes by means of the Bayesian regression; and step 3 is to make a decision on the bridge health condition based on residuals, differences between the observed and predicted damage-sensitive features, utilizing 95% confidence interval and the Bayesian hypothesis testing. Feasibility of the proposed approach is examined utilizing monitoring data on an in-service bridge recorded over a one-year period. Observations through the study demonstrated that the Bayesian regression considering environmental and operational changes led to more accurate results than that without considering environmental and operational changes. The Bayesian hypothesis testing utilizing data from the healthy bridge, the damage probability of the bridge was judged as no damage.	[Kim, Chul-Woo; Morita, Tomoaki; Oshima, Yoshinobu; Sugiura, Kunitomo] Kyoto Univ, Dept Civil & Earth Resources Engn, Grad Sch Engn, Nishikyo Ku, Kyoto 6158540, Japan	Kim, CW (reprint author), Kyoto Univ, Dept Civil & Earth Resources Engn, Grad Sch Engn, Nishikyo Ku, Kyoto 6158540, Japan.	kim.chulwoo.5u@kyoto-u.ac.jp; morita.tomoaki.56c@st.kyoto-u.ac.jp; oshima.yoshinobu.3a@kyoto-u.ac.jp; sugiura.kunitomo.4n@kyoto-u.ac.jp			JSPS [24360178]	This study is partly sponsored by JSPS, Grant-in-Aid for Scientific Research (B) under project No. 24360178. Such financial aids are gratefully acknowledged.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Deraemaeker A, 2008, MECH SYST SIGNAL PR, V22, P34, DOI 10.1016/j.ymssp.2007.07.004; Peeters B, 2001, EARTHQUAKE ENG STRUC, V30, P149, DOI 10.1002/1096-9845(200102)30:2<149::AID-EQE1>3.0.CO;2-Z; Nair KK, 2006, J SOUND VIB, V291, P349, DOI 10.1016/j.jsv.2005.06.016; Cunha A, 2013, STRUCT CONTROL HLTH, V20, P853, DOI 10.1002/stc.1516; Dilena M, 2011, MECH SYST SIGNAL PR, V25, P1485, DOI 10.1016/j.ymssp.2010.12.017; Doebling S.W., 1996, LA3070MS LOS AL NAT; Heng S., 2011, P 24 KKCNN S CIV ENG; Jeffreys H, 1998, THEORY PROBABILITY; Jiang XM, 2008, STRUCT CONTROL HLTH, V15, P974, DOI 10.1002/stc.230; Kim C. W., 2013, J JSCE JSCE, V1, P32; Kim C.W., 2011, P 5 INT C STRUCT HLT; Kim CW, 2013, SMART STRUCT SYST, V11, P1; Kim CW, 2012, STRUCT INFRASTRUCT E, V8, P459, DOI 10.1080/15732479.2010.539061; Kim CW, 2007, ENG STRUCT, V29, P576, DOI 10.1016/j.engstruct.2006.05.021; Kim C.W., 2013, P LIF CYCL SUST CIV; KITAGAWA G, 1984, J AM STAT ASSOC, V79, P378, DOI 10.2307/2288279; Moses F., 1979, TRANSPORTATION ENG J, V105, pTE3; Sankararaman S., 2011, STRUCT CONTROL HLTH, V19, P88; Sohn H., 2003, J INTEL MAT SYSTEMS, V13, P153	21	0	0	TECHNO-PRESS	DAEJEON	PO BOX 33, YUSEONG, DAEJEON 305-600, SOUTH KOREA	1738-1584			SMART STRUCT SYST	Smart. Struct. Syst.	FEB	2015	15	2					395	408				14	Engineering, Civil; Engineering, Mechanical; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CF2BN	WOS:000352352400010		
J	Uenaka, K; Higashiyama, H				Uenaka, Kojiro; Higashiyama, Hiroshi			Mechanical characteristics of hollow shear connectors under direct shear force	STEEL AND COMPOSITE STRUCTURES			English	Article						steel-concrete composite deck; hollow shear connector; thickness-to-diameter ratio; web thickness-to-width ratio; shear bond capacity		The steel-concrete composite decks have high fatigue durability and deformability in comparison with ordinary RC slabs. Withal, the steel-concrete composite deck is mostly heavier than the RC slabs. We have proposed herein a new type of steel-concrete composite deck which is lighter than the typical steel-concrete composite decks. This can be achieved by arranging hollow sectional members as shear connectors, namely, half-pipe or channel shear connectors. The present study aims to experimentally investigate mechanical characteristics of the half-pipe shear connectors under the direct shear force. The shear bond capacity and deformability of the half-pipe shear connectors are strongly affected by the thickness-to-diameter ratio. Additionally, the shear strengths of the hollow shear connectors (i.e., the half-pipe and the channel shear connectors) are compared. Furthermore, shear capacities of the hollow shear connectors equivalent to headed stud connectors are also discussed.	[Uenaka, Kojiro] Kobe City Coll Technol, Dept Civil Engn, Nishi Ku, Kobe, Hyogo 6512194, Japan; [Higashiyama, Hiroshi] Kinki Univ, Dept Civil & Environm Engn, Higashiosaka, Osaka 5778502, Japan	Uenaka, K (reprint author), Kobe City Coll Technol, Dept Civil Engn, Nishi Ku, Gakuenhigashimachi 8-3, Kobe, Hyogo 6512194, Japan.	uenaka@kobe-kosen.ac.jp; h-hirosi@civileng.kindai.ac.jp					Baran E, 2012, J CONSTR STEEL RES, V74, P108, DOI 10.1016/j.jcsr.2012.02.015; Costa-Neves LF, 2013, ENG STRUCT, V56, P721, DOI 10.1016/j.engstruct.2013.06.004; Maleki S, 2009, J CONSTR STEEL RES, V65, P1787, DOI 10.1016/j.jcsr.2009.04.008; Ahn JH, 2010, J CONSTR STEEL RES, V66, P1295, DOI 10.1016/j.jcsr.2010.04.008; Candido-Martins JPS, 2010, ENG STRUCT, V32, P1976, DOI 10.1016/j.engstruct.2010.02.031; Higashiyama H., 2010, P 5 CIV ENG C AS REG; Japanese Society of Steel Construction, 1996, RES REP PUSH OUT TES; Smith AL, 2010, J CONSTR STEEL RES, V66, P748, DOI 10.1016/j.jcsr.2010.01.005; Uenaka K., 2010, P 5 CIV ENG C AS REG; Uenaka K., 2013, P 2013 WORLD C ADV S, P2111; Uenaka K., 2009, P JAPAN CONCRETE I, V31, P1117; Xue DY, 2012, J CONSTR STEEL RES, V74, P1, DOI 10.1016/j.jcsr.2011.09.017	12	0	0	TECHNO-PRESS	DAEJEON	PO BOX 33, YUSEONG, DAEJEON 305-600, SOUTH KOREA	1229-9367	1598-6233		STEEL COMPOS STRUCT	Steel Compos. Struct.	FEB	2015	18	2					467	480				14	Construction & Building Technology; Engineering, Civil; Materials Science, Composites	Construction & Building Technology; Engineering; Materials Science	CF2FB	WOS:000352361900011		
J	Katagiri, J; Saomoto, H; Utsuno, M				Katagiri, Jun; Saomoto, Hidetaka; Utsuno, Mori			Quantitative Evaluation of the Effect of Grain Aspect Ratio on Permeability	VADOSE ZONE JOURNAL			English	Article							PARTICLE-SHAPE; KOZENY-CARMAN; GRANULAR ASSEMBLIES; ELEMENT METHOD; PORE-SCALE; FLOW; SOILS	Saturated and unsaturated permeabilities are influenced by the microscopic pore structure of granular porous media. We developed pore flow simulations for grains generated by discrete-element modeling to evaluate the effect of grain shape (aspect ratio) on permeability and other macroscopic properties related to fluid flow. A series of sensitivity analyses was performed for methodological variables, such as the mesh resolution and the size of the simulated soil volume. The simulation results were found to be consistent with the conventional Darcy's law. Consistent with the Kozeny-Carman equation, the results of simulations for grains with various aspect ratios confirmed that permeability depends on the void ratio. We also found that the grain aspect ratio affected the void ratio and the surface area of packed grains. Consequently, the aspect ratio indirectly affected the permeability.	[Katagiri, Jun] Natl Inst Adv Ind Sci & Technol, Methane Hydrate Res Ctr, Tsukuba, Ibaraki 3058569, Japan; [Saomoto, Hidetaka] AIST, Inst Earthquake & Volcano Geol, Tsukuba, Ibaraki 3058567, Japan; [Utsuno, Mori] Kajima Corp, Civil Engn Design Div, Minato Ku, Tokyo 1078502, Japan	Katagiri, J (reprint author), Natl Inst Adv Ind Sci & Technol, Methane Hydrate Res Ctr, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	j-katagiri@aist.go.jp					Andrade JE, 2012, COMPUT METHOD APPL M, V241, P262, DOI 10.1016/j.cma.2012.06.012; ROTHENBURG L, 1992, GEOTECHNIQUE, V42, P79; Bijeljic B, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.013011; Duda A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036319; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47; Carrier WD, 2003, J GEOTECH GEOENVIRON, V129, P1054, DOI 10.1061/(ASCE)1090-0241(2003)129:11(1054); Ghanbarian B, 2013, SOIL SCI SOC AM J, V77, P1461, DOI 10.2136/sssaj2012.0435; Yazdchi K, 2011, INT J MULTIPHAS FLOW, V37, P956, DOI 10.1016/j.ijmultiphaseflow.2011.05.003; Garcia X, 2009, GEOTECHNIQUE, V59, P779, DOI 10.1680/geot.8.T.037; Lu M, 2007, GRANUL MATTER, V9, P69, DOI 10.1007/s10035-006-0021-3; WYLLIE MRJ, 1955, IND ENG CHEM, V47, P1379, DOI 10.1021/ie50547a037; ERGUN S, 1952, CHEM ENG PROG, V48, P89; Matyka M, 2012, AIP CONF PROC, V1453, P17, DOI 10.1063/1.4711147; Zhang DX, 2000, GEOPHYS RES LETT, V27, P1195, DOI 10.1029/1999GL011101; Sun WC, 2013, ACTA GEOTECH, V8, P465, DOI 10.1007/s11440-013-0210-2; Chapuis RP, 2003, CAN GEOTECH J, V40, P616, DOI 10.1139/T03-013; Katagiri J, 2010, GRANUL MATTER, V12, P491, DOI 10.1007/s10035-010-0207-6; ROWE PW, 1962, PROC R SOC LON SER-A, V269, P500, DOI 10.1098/rspa.1962.0193; White JA, 2006, ACTA GEOTECH, V1, P195, DOI 10.1007/s11440-006-0018-4; Matsushima T, 2009, J AEROSPACE ENG, V22, P15, DOI 10.1061/(ASCE)0893-1321(2009)22:1(15); Carman PC, 1939, J AGR SCI, V29, P262; Carman P.C., 1937, T I CHEM ENG-LOND, V15, P150, DOI DOI 10.1016/S0263-8762(97)80003-2; Fredrich J.T., 2006, J GEOPHYS RES-SOL EA, V111, DOI DOI 10.1029/2005JB003774; Garcia X, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021304; Iwashita K., 1999, MECH GRANULAR MAT IN; Jin G., 2009, SOC PETR WELL LOG AN; Katagiri J., 2012, J JSCE, V68, P67; Katagiri J., 2014, J JPN SOC CIV ENG C, V70, P265, DOI [10.2208/jscejge.70.265, DOI 10.2208/JSCEJGE.70.265]; Katagiri J, 2015, J AEROSPACE ENG, V28, DOI 10.1061/(ASCE)AS.1943-5525.0000421; Kutay ME, 2007, INT J PAVEMENT ENG, V8, P29, DOI DOI 10.1080/10298430600819147; Liu X., 2012, P 19 INT C COMP METH; McDowell G, 2011, GEOTECH LETT, V1, P59, DOI 10.1680/geolett.11.00025; Mirghasemi A. A., 1997, SOILS FOUND, V37, P43; Nakano T., 2006, 448 GSJ; Saomoto H., 2002, P NUMGE2002 NUM METH, P239; Sun WC, 2011, INT J NUMER METH ENG, V88, P1260, DOI 10.1002/nme.3220; Terzaghi K., 1996, ENG GEOL, V48; Torskaya T, 2014, TRANSPORT POROUS MED, V102, P71, DOI 10.1007/s11242-013-0262-7; Yazdchi K, 2011, PARTICLE-BASED METHODS II: FUNDAMENTALS AND APPLICATIONS, P264; YOSHIDA T, 1994, LOCALISATION AND BIFURCATION THEORY FOR SOILS AND ROCKS, P165	40	0	0	SOIL SCI SOC AMER	MADISON	677 SOUTH SEGOE ROAD, MADISON, WI 53711 USA	1539-1663			VADOSE ZONE J	Vadose Zone J.	FEB	2015	14	2								10.2136/vzj2014.10.0138		9	Environmental Sciences; Soil Science; Water Resources	Environmental Sciences & Ecology; Agriculture; Water Resources	CF9GZ	WOS:000352873500006		
J	Nozaki, K				Nozaki, Kazuhiko			Aneurysms Associated with Arteriovenous Malformations: Classification and Risk Estimation	WORLD NEUROSURGERY			English	Editorial Material						Cerebral aneurysms; Cerebral arteriovenous malformations; Embolization; Hematoma; Surgery	ARTERIAL ANEURYSMS		Shiga Univ Med Sci, Dept Neurosurg, Otsu, Shiga 52021, Japan	Nozaki, K (reprint author), Shiga Univ Med Sci, Dept Neurosurg, Otsu, Shiga 52021, Japan.	noz@belle.shiga-med.ac.jp					Redekop G, 1998, J NEUROSURG, V89, P539, DOI 10.3171/jns.1998.89.4.0539; Hashimoto N, 2007, NEUROSURGERY, V61, P375, DOI 10.1227/01.NEU.0000255491.95944.EB; Bendjilali N, 2014, J NEUROL NEUROSUR PS, V85, P1280, DOI 10.1136/jnnp-2013-306461; Yasargil MG, 1987, MICRONEUROSURGERY A, VIIIA, P182	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2015	83	2					140	141		10.1016/j.wneu.2014.06.016		2	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CF4CT	WOS:000352496900004		
J	Fukuda, K; Kataoka, H; Nakajima, N; Masuoka, J; Satow, T; Iihara, K				Fukuda, Kenji; Kataoka, Hiroharu; Nakajima, Norio; Masuoka, Jun; Satow, Tetsu; Iihara, Koji			Efficacy of FLOW 800 with Indocyanine Green Videoangiography for the Quantitative Assessment of Flow Dynamics in Cerebral Arteriovenous Malformation Surgery	WORLD NEUROSURGERY			English	Review						Arteriovenous malformation; FLOW 800; Indocyanine green videoangiography; Quantitative assessment	ANEURYSM SURGERY; MOYAMOYA-DISEASE; NORMAL PERFUSION; ANGIOGRAPHY; MANAGEMENT; FISTULAS	OBJECTIVE: To evaluate the quantitative assessment of flow dynamics during surgery for arteriovenous malformations (AVMs) with FLOW 800 with indocyanine green videoangiography. METHODS: Changes in flow dynamics in the superficial AVM components (feeder, nidus, and drainer), the adjacent cortical artery, and the cortical vein surrounding AVM were evaluated. Analysis was performed at predissection, postclipping of the feeders, and postresection of the nidus with the use of quantitative values of the maximum fluorescence intensity, time to half-maximum fluorescence intensity (T-1/2 FI), and the fluorescence intensity rate at T-1/2 FI semiautomatically obtained with the use of FLOW 800 software. RESULTS: FLOW 800 assessments were performed in 7 cases. The time difference between the T-1/2 FI, defined as transit time, in the cortical artery and the drainer was prolonged from 0.08 +/- 0.65 seconds to 2.63 +/- 1.79 seconds (P < 0.0001) at postfeeder clipping phase. The transit time between the cortical artery and the cortical vein was reduced to 3.76 +/- 1.37 seconds at post feeder clipping phase (P = 0.024) and 2.63 +/- 0.80 seconds at final phase (P = 0.005) compared with 4.56 +/- 1.47 seconds at predissection phase. The maximum intensity and the fluorescence intensity rate at T-1/2 FI were not significantly different at these phases, excluding the maximum intensity of the drainer decreasing from 533 +/- 271 to 399 +/- 217 (P = 0.006) at post feeder clipping phase. CONCLUSION: FLOW 800 analysis with indocyanine green videoangiography provides the real-time hemodynamic status of the AVMs and adjacent brain at various stages of resection. This technique is feasible to resect AVMs more safely and convincingly.	[Fukuda, Kenji; Kataoka, Hiroharu; Nakajima, Norio; Masuoka, Jun; Satow, Tetsu; Iihara, Koji] Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, Suita, Osaka, Japan	Iihara, K (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, Suita, Osaka, Japan.	kiihara@ns.med.kyushu-u.ac.jp					Raabe A, 2005, J NEUROSURG, V103, P982, DOI 10.3171/jns.2005.103.6.0982; NORNES H, 1980, J NEUROSURG, V53, P456, DOI 10.3171/jns.1980.53.4.0456; Ng YP, 2013, J CLIN NEUROSCI, V20, P224, DOI 10.1016/j.jocn.2011.12.038; AWAD IA, 1994, STROKE, V25, P611; Chalouhi N, 2012, NEUROSURGERY, V71, P1162, DOI 10.1227/NEU.0b013e318271ebfc; Hashimoto N, 2007, NEUROSURGERY, V61, P375, DOI 10.1227/01.NEU.0000255491.95944.EB; Hanggi D, 2010, NEUROSURGERY, V67, P1094, DOI 10.1227/NEU.0b013e3181eb5049; Faber F, 2011, ACTA NEUROCHIR, V153, P2181, DOI 10.1007/s00701-011-1141-z; Woitzik J, 2006, STROKE, V37, P1549, DOI 10.1161/01.STR.0000221671.94521.51; Killory BD, 2009, NEUROSURGERY, V65, P456, DOI 10.1227/01.NEU.0000346649.48114.3A; Woitzik J, 2005, J NEUROSURG, V102, P692, DOI 10.3171/jns.2005.102.4.0692; SCOTT BB, 1978, SURG NEUROL, V10, P34; Hettige S, 2010, ACTA NEUROCHIR, V152, P533, DOI 10.1007/s00701-009-0445-8; Czabanka M, 2008, STROKE, V39, P1703, DOI 10.1161/STROKEAHA.107.501759; BATJER HH, 1988, NEUROSURGERY, V23, P322; BATJER HH, 1988, NEUROSURGERY, V22, P503; CARTER LP, 1984, NEUROSURGERY, V15, P22; Chen S F, 2011, Surg Neurol Int, V2, P42, DOI 10.4103/2152-7806.78517; de Oliveira JG, 2007, NEUROSURGERY, V61, P63, DOI [10.1227/01.neu.0000333795.21468.d4, 10.1227/01.NEU.0000279982.48426.A1]; Guo WY, 2004, AM J NEURORADIOL, V25, P1636; Holling M, 2013, NEUROSURGERY, V73, P99; Holling M, NEUROSURGERY, V73; Horie N, 2014, ACTA NEUROCHIR, V156, P919, DOI 10.1007/s00701-014-2054-4; Kaminaga T, 1999, J NEURORADIOLOGY, V26, P236; Kamp Marcel A, 2012, Neurosurgery, V70, P65, DOI 10.1227/NEU.0b013e31822f7d7c; Kamp MA, 2012, NEUROSURGERY, V70, P73; Kim DL, 2013, WORLD NEUROSURG, V79; OKABE T, 1983, J NEUROSURG, V59, P21, DOI 10.3171/jns.1983.59.1.0021; Schubert GA, 2012, NEUROSURGERY, V71, P260, DOI 10.1227/NEU.0b013e318265a3fb; Schuette AJ, 2010, NEUROSURGERY, V67, P658, DOI 10.1227/01.NEU.0000374721.84406.7F; Spetzler R F, 1978, Clin Neurosurg, V25, P651; Takagi Y, 2012, NEUROSURGERY, V70, P42; Takagi Yasushi, 2012, Neurosurgery, V70, P34, DOI 10.1227/NEU.0b013e31822d9749; Uchino H, 2013, ACTA NEUROCHIR, V155, P599, DOI 10.1007/s00701-012-1575-y	34	4	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2015	83	2					203	210		10.1016/j.wneu.2014.07.012		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CF4CT	WOS:000352496900022		
J	Izumo, T; Matsuo, T; Morofuji, Y; Hiu, T; Horie, N; Hayashi, K; Nagata, I				Izumo, Tsuyoshi; Matsuo, Takayuki; Morofuji, Yoichi; Hiu, Takeshi; Horie, Nobutaka; Hayashi, Kentaro; Nagata, Izumi			Microsurgical Clipping for Recurrent Aneurysms After Initial Endovascular Coil Embolization	WORLD NEUROSURGERY			English	Review						Aneurysm recurrence; Endovascular coiling; Intracranial aneurysms; Microsurgical clipping; Neurosurgery	RUPTURED INTRACRANIAL ANEURYSMS; STENT-ASSISTED COILING; CEREBRAL ANEURYSMS; ARTERY ANEURYSMS; TRIAL ISAT; RETREATMENT; COMPLICATIONS; PREDICTORS; MANAGEMENT; OCCLUSION	OBJECTIVE: Surgical treatment for recurrent lesions of embolized aneurysms is difficult and challenging for many neurosurgeons because intra-aneurysmal coil masses are sometimes scarred to the wall of the aneurysm or adherent to adjacent vital structures. To assess the efficacy and safety of surgical treatment without coil removal for recurrent aneurysms after previous coil embolization, we retrospectively studied clinical results, angiographic results, and complications in patients treated with additional microsurgical clipping. METHODS: From April 2003 to April 2013, 7 patients with recurrent previous embolized aneurysms underwent microsurgical treatment. RESULTS: This series included 1 man and 6 women receiving endovascular coiling as the first-line treatment. One patient's aneurysm was unruptured, whereas the other 6 were ruptured. The aneurysm locations were posterior communicating (n = 3), anterior communicating (n = 2), ophthalmic (n = 1), and posterior inferior cerebellar (n = 1). The initial sizes ranged from 3-11.5 mm in diameter (mean, 6.6 mm), and the aspect ratios were 1.2 to 3.4 (mean, 1.9). In these aneurysms, the initial coiling result was complete occlusion in 5 patients, and neck remnants in 2 patients. The mechanism underlying aneurysm recurrence was coil compaction in 3 aneurysms, aneurysm regrowth in 3 aneurysms, and fundal migration in 1 aneurysm. The median recurrence latency was 28.8 months (range, 0.7-115 months). Microsurgical clippings without coil removal were used in 6 patients; a parent artery occlusion under bypass protection was done in 1 case with a posterior inferior cerebellar aneurysm. Fenestrated clips in combination with another type of clip were successfully used for 4 of 6 patients who were treated with direct neck clipping. No postoperative morbidity was observed, and postoperative imaging studies revealed complete occlusion of the aneurysms in all cases. There were no recurrences of aneurysms during the follow-up period (mean, 44.7 months; range, 0.5-118 months). CONCLUSIONS: The microsurgical clipping without coil removal for recurrent lesions of embolized aneurysms is effective and safe when it is technically feasible. The tandem clipping in combination with a fenestrated clip is a crucial method for direct neck clipping without coil removal for previously coiled recurrent aneurysms. For unclippable lesions, a parent artery occlusion under bypass protection should be taken into consideration.	[Izumo, Tsuyoshi; Matsuo, Takayuki; Morofuji, Yoichi; Hiu, Takeshi; Horie, Nobutaka; Hayashi, Kentaro; Nagata, Izumi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Neurosurg, Nagasaki 852, Japan	Izumo, T (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Neurosurg, Nagasaki 852, Japan.	go-izumo@hotmail.co.jp					Park HK, 2005, AM J NEURORADIOL, V26, P506; Chalouhi N, 2014, AM J NEURORADIOL, V35, P546, DOI 10.3174/ajnr.A3696; Chalouhi N, 2013, STROKE, V44, P1348, DOI 10.1161/STROKEAHA.111.000641; Sedat J, 2012, INTERV NEURORADIOL, V18, P14; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; Johnston SC, 2008, STROKE, V39, P120, DOI 10.1161/STROKEAHA.107.495747; Anson JA, 1996, J NEUROSURG, V84, P185, DOI 10.3171/jns.1996.84.2.0185; Li YD, 2010, J NEUROL NEUROSUR PS, V81, P74, DOI 10.1136/jnnp.2009.171967; Renowden SA, 2008, AM J NEURORADIOL, V29, P1401, DOI 10.3174/ajnr.A1098; Raymond J, 2002, AM J NEURORADIOL, V23, P1710; Byrne JV, 1999, J NEUROSURG, V90, P656, DOI 10.3171/jns.1999.90.4.0656; Corns R, 2013, BRIT J NEUROSURG, V27, P30, DOI 10.3109/02688697.2012.701676; Sanai N, 2012, NEUROSURGERY, V71, P285, DOI 10.1227/NEU.0b013e318256c3eb; Clatterbuck RE, 2006, NEUROSURGERY, V59, P347, DOI 10.1227/01.NEU.0000222818.42200.BB; Campi A, 2007, STROKE, V38, P1538, DOI 10.1161/STROKEAHA.106.466987; Kadasi LM, 2013, J NEUROINTERV SURG, V5, P201, DOI 10.1136/neurintsurg-2012-010285; Lanzino G, 2006, J NEUROSURG, V104, P344, DOI 10.3171/jns.2006.104.3.344; Chung J, 2010, NEURORADIOLOGY, V52, P1143, DOI 10.1007/s00234-010-0695-4; Civit T, 1999, J NEUROSURG, V90, P807; Davies JM, 2014, NEUROSURGERY, V74, pS7, DOI 10.1227/NEU.0000000000000193; Dorfer C, 2012, NEUROSURGERY, V70, P537, DOI 10.1227/NEU.0b013e3182350da5; Elijovich L, 2008, STROKE, V39, P1501, DOI 10.1161/STROKEAHA.107.504670; Horiuchi T, 2013, NEUROSURG REV, V36, P133, DOI 10.1007/s10143-012-0398-x; Johnston SC, 2006, STROKE, V37, P1437, DOI 10.1161/01.STR.0000221331.01830.ce; Islak C, 2013, EUR J RADIOL, V82, P1659, DOI 10.1016/j.ejrad.2012.12.025; Kadasi LM, 2013, J NEUROSURG, V119, P172, DOI 10.3171/2013.2.JNS12968; Knap D, 2013, NEUROL NEUROCHIR POL, V47, P467, DOI 10.5114/ninp.2013.38226; Lawton MT, 1998, NEUROSURG CLIN N AM, V9, P725; Nakamura M, 2013, CLIN NEUROL NEUROSUR, V115, P1343, DOI 10.1016/j.clineuro.2012.12.030; Ogilvy CS, 2011, J NEUROINTERV SURG, V3, P14, DOI 10.1136/jnis.2010.002303; Raper DMS, 2010, NEUROSURGERY, V66, P1166, DOI 10.1227/01.NEU.0000369613.44834.12; Ringer AJ, 2009, NEUROSURGERY, V65; Ringer AJ, 2009, NEUROSURGERY, V65, P311, DOI 10.1227/01.NEU.0000349922.05350.96; Romani R, 2011, J NEUROSURG SCI, V55, P139; Rubino PA, 2013, WORLD NEUROSURG, V82, pe203; Tirakotai W, 2007, CLIN NEUROL NEUROSUR, V109, P744, DOI 10.1016/j.clineuro.2007.05.024; Waldron JS, 2009, NEUROSURGERY, V64, P301, DOI 10.1227/01.NEU.0000335178.15274.B4; Wang Y, 2013, ACTA NEUROCHIR, V155, P2019, DOI 10.1007/s00701-013-1830-x	39	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2015	83	2					211	218		10.1016/j.wneu.2014.08.013		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CF4CT	WOS:000352496900023		
J	Skowronski, W; Wisniowski, P; Wrona, J; Zywczak, A; Stobiecki, T				Skowronski, W.; Wisniowski, P.; Wrona, J.; Zywczak, A.; Stobiecki, T.			Magnetic Field Sensor Based on Magnetic Tunnel Junction with Voltage-Tunable Magnetic Anisotropy	ACTA PHYSICA POLONICA A			English	Article; Proceedings Paper	14th European Conference on Physics of Magnetism (PM)	JUN 23-27, 2014	Poznan, POLAND	Polish Acad Sci, Inst Mol Phys, Adam Mickiewicz Univ, Fac Phys				We present a submicron magnetic field sensor with voltage-tunable magnetic field sensitivity. The device, based on magnetic tunnel junction, exhibits high tunnelling magnetoresistance ratio of up to 90 %. Perpendicular magnetic anisotropy of thin ferromagnetic sensing layer in combination with an in-plane magnetized reference layer is used to obtain linear change in the sensor resistance in response to the in-plane magnetic field. The perpendicular anisotropy is further controlled by the bias voltage and, thus, the sensitivity of the sensor is changed. In addition, we evaluate the sensor selectivity for the magnetic field direction and present an influence of the temperature on the anisotropy.	[Skowronski, W.; Wisniowski, P.; Wrona, J.; Stobiecki, T.] AGH Univ Sci & Technol, Dept Elect, PL-30059 Krakow, Poland; [Wrona, J.] Singulus Technol, D-63796 Kahl, Germany; [Zywczak, A.] AGH Univ Sci & Technol, Acad Ctr Mat & Nanotechnol, PL-30059 Krakow, Poland	Skowronski, W (reprint author), Natl Inst Adv Ind Sci & Technol, Spintron Res Ctr, Tsukuba, Ibaraki 3058568, Japan.	skowron@agh.edu.pl	Wisniowski, Piotr/E-3288-2010				Almeida J. M., 2009, J APPL PHYS, V103; Skowronski W, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4765350; Alzate JG, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869152; Maruyama T, 2009, NAT NANOTECHNOL, V4, P158, DOI [10.1038/nnano.2008.406, 10.1038/NNANO.2008.406]; Nogues J, 1999, J MAGN MAGN MATER, V192, P203, DOI 10.1016/S0304-8853(98)00266-2; Albon C, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3179241; Skowronski W, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4893463; Shiota Y, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4819199; Barnes SE, 2014, SCI REP-UK, V4, DOI 10.1038/srep04105; Burghoff M, 2004, APPL PHYS LETT, V85, P6278, DOI 10.1063/1.1836869; Chatraphorn S, 2000, APPL PHYS LETT, V76, P2304, DOI 10.1063/1.126327; Djayaprawira DD, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1871344; Wisniowski P, 2008, J APPL PHYS, V103, DOI 10.1063/1.2838626	13	0	0	POLISH ACAD SCIENCES INST PHYSICS	WARSAW	AL LOTNIKOW 32-46, PL-02-668 WARSAW, POLAND	0587-4246	1898-794X		ACTA PHYS POL A	Acta Phys. Pol. A	FEB	2015	127	2					496	498				3	Physics, Multidisciplinary	Physics	CE9BY	WOS:000352139600111		
J	Kaushik, N; Sharma, P; Tanaka, S; Makino, A; Esashi, M				Kaushik, N.; Sharma, P.; Tanaka, S.; Makino, A.; Esashi, M.			Preferentially Oriented Growth of L1(0) Fe Pt on Si Substrate	ACTA PHYSICA POLONICA A			English	Article; Proceedings Paper	14th European Conference on Physics of Magnetism (PM)	JUN 23-27, 2014	Poznan, POLAND	Polish Acad Sci, Inst Mol Phys, Adam Mickiewicz Univ, Fac Phys			MEDIA	Tilting the magnetic easy axis of L1(0) FePt and/or introducing a magnetic buffer layer is most effective in realizing the L1(0) based magnetic recording media. Here we report on preferentially oriented growth of L1(0) FePt with tilted magnetic easy axis. FePt films of thickness up to 170 nm were deposited on Si substrate with a soft magnetic underlayer of glassy FeSiB, FeSiBP and CoFeTaB. Effects of processing conditions on the structural and magnetic properties were studied. A polycrystalline growth of FePt (i.e. mixed orientation) was observed with the underlayer of FeSiB and FeSiBP, but CoFeTaB promotes preferentially oriented growth along (111) crystallographic direction. Compared to FePt films grown on Si substrate, coercivity (H-c) reduces significantly with the introduction of soft magnetic underlayer. The magnetic easy axis of (111) L1(0) FePt is tilted 36 out of plane and it is very promising for tilted magnetic recording media.	[Kaushik, N.; Esashi, M.] Tohoku Univ, WPI AIMR, Sendai, Miyagi 980, Japan; [Sharma, P.; Makino, A.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 980, Japan; [Tanaka, S.] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 980, Japan	Kaushik, N (reprint author), Tohoku Univ, WPI AIMR, Sendai, Miyagi 980, Japan.	neelam@mems.mech.tohoku.ac.jp	MAKINO, AKIHIRO/B-2549-2009; Sharma, Parmanand/C-1518-2011				Utsumiya K, 2011, J APPL PHYS, V110, DOI 10.1063/1.3662901; Dannenberg A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245438; Weller D, 2013, PHYS STATUS SOLIDI A, V210, P1245, DOI 10.1002/pssa.201329106; Dobin AY, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2335590; Ohtake M, 2012, IEEE T MAGN, V48, P3595, DOI 10.1109/TMAG.2012.2198875; Sharma P, 2006, J APPL PHYS, V100, DOI 10.1063/1.2359142; Zou YY, 2003, APPL PHYS LETT, V82, P2473, DOI 10.1063/1.1565503	7	0	0	POLISH ACAD SCIENCES INST PHYSICS	WARSAW	AL LOTNIKOW 32-46, PL-02-668 WARSAW, POLAND	0587-4246	1898-794X		ACTA PHYS POL A	Acta Phys. Pol. A	FEB	2015	127	2					611	613				3	Physics, Multidisciplinary	Physics	CE9BY	WOS:000352139600150		
J	Song, PP; Chen, Y				Song, Peipei; Chen, Yu			Public policy response, aging in place, and big data platforms: Creating an effective collaborative system to cope with aging of the population	BIOSCIENCE TRENDS			English	Article						Older people; public health; institutional care; home-based care; community-based care; information platform	LONG-TERM-CARE; SUB-SAHARAN AFRICA; HEALTH-CARE; OLDER-ADULTS; AGED CARE; INSURANCE; HOME; DEATH; JAPAN; MULTIMORBIDITY	The unprecedented rapid aging of the population is poised to become the next global public health challenge, as is apparent by the fact that 23.1% of the total global burden of disease is attributable to disorders in people aged 60 years and older. Aging of the population is the biggest driver of substantial increases in the prevalence of chronic conditions, and the prevalence of multi-morbidity is much higher in older age groups. This places a large burden on countries' health and long-term care systems. Many behavioral changes and public policy responses to aging of the population have been implemented to cope with these challenges. A system of "aging in place" has been implemented in some high-income countries in order to better provide coordinated and cost-effective health services for the elderly. This approach reduces institutional care while supporting home-or community-based care and other services. Advances in information and communications technology (ICT), assistive devices, medical diagnostics, and interventions offer many ways of more efficiently providing long-term care as part of aging in place. The use of big data on a web services platform in an effective collaborative system should promote systematic data gathering to integrate clinical and public health information systems to provide support across the continuum of care. However, the use of big data in collaborative system is a double-edged sword, as it also bring challenges for information sharing, standardized data gathering, and the security of personal information, that warrant full attention.	[Song, Peipei] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Chen, Yu] Univ Tokyo, Grad Sch Frontier Sci, Dept Human & Engineered Environm Studies, Kashiwa, Chiba, Japan	Chen, Y (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Human & Engineered Environm Studies, 5-1-5 Kashiwanoha, Kashiwa, Chiba, Japan.	chen@k.u-tokyo.ac.jp					Aboderin IAG, 2015, LANCET, V385, pE9, DOI 10.1016/S0140-6736(14)61602-0; Adjuik M, 2006, B WORLD HEALTH ORGAN, V84, P181, DOI 10.2471/BLT.05.026492; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Campbell JC, 2000, HEALTH AFFAIR, V19, P26, DOI 10.1377/hlthaff.19.3.26; Su CJ, 2013, INT J ENV RES PUB HE, V10, P6106, DOI 10.3390/ijerph10116106; [Anonymous], GLOBAL BURDEN DIS; He FJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004549; Chakravarty EF, 2012, AM J MED, V125, P190, DOI 10.1016/j.amjmed.2011.08.006; Kim H, 2013, HEALTH POLICY, V111, P166, DOI 10.1016/j.healthpol.2013.04.009; Fries JF, 2002, B WORLD HEALTH ORGAN, V80, P245; McGrail K, 2000, AGE AGEING, V29, P249, DOI 10.1093/ageing/29.3.249; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; Wilmoth JR, 2000, EXP GERONTOL, V35, P1111, DOI 10.1016/S0531-5565(00)00194-7; Reeder B, 2013, INT J MED INFORM, V82, P565, DOI 10.1016/j.ijmedinf.2013.03.007; Horner B, 2008, AUST HEALTH REV, V32, P356; Banerjee S, 2015, LANCET, V385, P587, DOI 10.1016/S0140-6736(14)61596-8; Beard JR, 2015, LANCET, V385, P658, DOI 10.1016/S0140-6736(14)61461-6; Bloom DE, 2015, LANCET, V385, P649, DOI 10.1016/S0140-6736(14)61464-1; Breslow L, 2006, AM J PUBLIC HEALTH, V96, P17, DOI 10.2105/AJPH.2004.055970; Chatterji S, 2015, LANCET, V385, P563, DOI 10.1016/S0140-6736(14)61462-8; Do R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001106; Doyle Y, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3926; Hsieh HF, 2014, NURS OUTLOOK, V62, P459, DOI 10.1016/j.outlook.2014.05.008; Kubo M, 2014, AUSTRALAS J AGEING, V33, P153, DOI 10.1111/ajag.12038; Ministry of Health Labour and Welfare (MHLW), REP VAR CURR STAT LT; Ouellet MC, 2014, J AM GERIATR SOC, V62, P2130, DOI 10.1111/jgs.13081; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; SArai Y, 2010, BMC GERIATR, V10, P35; Satariano WA, 2014, J AGING HEALTH, V26, P1373, DOI 10.1177/0898264314543470; STULTS BM, 1984, WESTERN J MED, V141, P832; Suzman R, 2015, LANCET, V385, P484, DOI [10.1016/S0140-6736(14)61597-X, 10.1016/S0140-6736(13)61489-0]; The Institute of Gerontology of The University of Tokyo, GUID PROM APPR US IN; TOMASSINI C, 2004, POPULATION TRENDS, V0115; United Nations, 2 WORLD ASS AG; United Nations Department of Economic and Social Affairs, 2013, WORLD POP AG 2013; United Nations Department of Economic and Social Affairs Population Estimates and Projections Section PD, WORLD POP PROSP 2012; Varnfield M, 2011, MED J AUSTRALIA, V194, pS15; WHO, WHO METH LIF EXP HLT; World Health Organization, WORLD HLTH STAT 2014; Yarmo-Roberts D, 2010, J AGING RES, V2010	42	0	0	IRCA-BSSA	TOKYO	PEARL CITY KOISHIKAWA 603, 2-4-5 KASUGA, BUNKYO-KU, TOKYO, 112-0003, JAPAN	1881-7815	1881-7823		BIOSCI TRENDS	BioSci. Trends	FEB	2015	9	1					1	6		10.5582/bst.2015.01025		6	Biology	Life Sciences & Biomedicine - Other Topics	CF0VU	WOS:000352263200001		
J	Oura, F; Yajima, Y; Nakata, M; Taniue, K; Akiyama, T; Nakada, H; Yamamoto, K; Fujita-Yamaguchi, Y				Oura, Fumie; Yajima, Yukiko; Nakata, Munehiro; Taniue, Kenzui; Akiyama, Tetsu; Nakada, Hiroshi; Yamamoto, Kazuo; Fujita-Yamaguchi, Yoko			Susceptibility to proteases of anti-Tn-antigen MLS128 binding glycoproteins expressed in human colon cancer cells	BIOSCIENCE TRENDS			English	Article						Mucin-type O-glycans; N-glycans; limited proteolysis; colon cancer cell lines	GROWTH; LEUKOSIALIN	Anti-Tn antigen MLS128 monoclonal antibody was produced two decades ago by immunizing mice with "cancerous antigens" derived from LS180 colon cancer cells. Previous studies demonstrated that MLS128 bound to 110 kDa glycoprotein (GP) in colon cancer cells, thereby inhibiting cell growth. Extensive attempts have been made towards understanding the inhibitory action of MLS128 on colon cancer cell growth and solving the primary structure of 110 kDa GP. Since limited proteolysis of 110 kDa GP was observed in microdomain fractions that had been kept frozen for several years, susceptibility of 110 kDa GP to trypsin and other proteases as well as N-glycosidase F has been investigated. Furthermore, 110 kDa GP expression was examined in colon cancer cells independently cultured in Akiyama laboratory. In summary, 110 kDa GP contains N-glycans. It does not contain inter-disulfide bonds but appears to have intra-disulfides. It must contain multiple cleavage sites for trypsin and thermolysin since these proteases digested 110 kDa GP to MLS128-undetectable small fragments. It seems to contain cleavage sites for cathepsin D which could cause limited digestion. LS180 cells derived from Akiyama laboratory produced a limited proteolysis product-like 75 kDa GP. This study provides a structural basis for developing cancer diagnostics and therapeutics.	[Oura, Fumie; Yajima, Yukiko; Nakata, Munehiro; Fujita-Yamaguchi, Yoko] Tokai Univ, Sch Engn, Dept Appl Biochem, Kanagawa 2591100, Japan; [Taniue, Kenzui; Akiyama, Tetsu] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Tokyo, Japan; [Nakada, Hiroshi] Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kyoto 603, Japan; [Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan	Fujita-Yamaguchi, Y (reprint author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA 91010 USA.	yyamaguchi@coh.org			Japan Society for the Promotion of Science [17570120, 22570125]	This work was supported by grants (17570120 and 22570125) from Japan Society for the Promotion of Science.	Tuccillo FM, 2014, BIOMED RES INT, DOI 10.1155/2014/742831; CHASIS JA, 1992, BLOOD, V80, P1869; Zamri N, 2012, BIOSCI TRENDS, V6, P303, DOI 10.5582/bst.2012.v6.6.303; NUMATA Y, 1990, BIOCHEM BIOPH RES CO, V170, P981, DOI 10.1016/0006-291X(90)90488-9; CARLSSON SR, 1986, J BIOL CHEM, V261, P2787; de Laurentiis A, 2011, MOL CELL PROTEOMICS, V10; Matsumoto-Takasaki A, 2012, J BIOCHEM, V151, P273, DOI 10.1093/jb/mvr138; Morita N, 2009, BIOSCI TRENDS, V3, P32; NAKADA H, 1991, J BIOL CHEM, V266, P12402; OHSHIO G, 1995, J CANCER RES CLIN, V121, P247, DOI 10.1007/BF01366970; PALLANT A, 1989, P NATL ACAD SCI USA, V86, P1328, DOI 10.1073/pnas.86.4.1328; Robinson BH, 1983, J BIOL CHEM, V247, P6660; Springer GF, 1997, J MOL MED-JMM, V75, P594, DOI 10.1007/s001090050144; Zamri N, 2013, BIOSCI TRENDS, V7, P221, DOI 10.5582/bst.2013.v7.5.221	14	0	0	IRCA-BSSA	TOKYO	PEARL CITY KOISHIKAWA 603, 2-4-5 KASUGA, BUNKYO-KU, TOKYO, 112-0003, JAPAN	1881-7815	1881-7823		BIOSCI TRENDS	BioSci. Trends	FEB	2015	9	1					49	55		10.5582/bst.2014.01127		7	Biology	Life Sciences & Biomedicine - Other Topics	CF0VU	WOS:000352263200006		
J	Kotani, K; Shuumarjav, U; Taniguchi, N; Yamada, T				Kotani, Kazuhiko; Shuumarjav, Uurtuya; Taniguchi, Nobuyuki; Yamada, Toshiyuki			Possible relationship between the heart rates and serum amyloid A in a hyperglycemic population	BIOSCIENCE TRENDS			English	Article						Amyloid A protein; diabetes mellitus; glucose intolerance; heart rhythm; inflammation	AUTONOMIC NEUROPATHY; INFLAMMATION; PROTEIN; PREVENTION; PREDICTOR; OUTCOMES; DISEASE	Hyperglycemia predicts cardiovascular disease (CVD)-related outcomes. The resting heart rates (HRs) and serum amyloid A (SAA), an inflammatory marker, are respectively factors associated with CVD-related outcomes; however, little is known regarding the associations between these two factors. This study aimed to investigate the correlation between the HRs and SAA levels under hyperglycemic conditions. This study included 298 subjects (males, 44%; mean age, 61.1 years) without a history of CVD and/or hypertensive levels. Clinical data, including general laboratory measurements, HRs and SAA, were measured. The analyses were performed after dividing all of the subjects into two groups based on the blood glucose level (< or >= 6.1 mmol/L). There was a higher SAA level in the hyperglycemic group (n = 143; median [interquartile range] 6.1 [4.1-10.6] mu g/mL) than in the counterpart group (n = 155; 6.0 [3.5-8.5] mu g/mL; p < 0.01). There was a trend toward increased HRs in the hyperglycemic group (mean [standard deviation] 65.3 [11.2] bpm) compared to the counterpart group (63.2 [9.4] bpm; p = 0.08). In the hyperglycemic group, there was a significant positive correlation between the HRs and SAA levels (multiple variables-adjusted analysis: beta = 0.21, p = 0.02), while no correlation was found in the counterpart group (beta = 0.06, p = 0.50). In summary, a positive correlation between the HRs and SAA levels can present under hyperglycemic conditions. These findings may provide relevant insights into the CVD-related pathologies associated with hyperglycemia. Further studies are warranted.	[Kotani, Kazuhiko; Shuumarjav, Uurtuya; Taniguchi, Nobuyuki; Yamada, Toshiyuki] Jichi Med Univ, Dept Clin Lab Med, Shimotsuke, Tochigi 3290498, Japan; [Shuumarjav, Uurtuya] Mongolian Natl Univ Med Sci, Dept Pathol, Ulaanbaatar, Mongol Peo Rep	Kotani, K (reprint author), Jichi Med Univ, Dept Clin Lab Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	kazukotani@jichi.ac.jp					Hopper I, 2011, EUR J CARDIOV PREV R, V18, P813, DOI 10.1177/1741826711421687; Vinik AI, 2013, J DIABETES INVEST, V4, P4, DOI 10.1111/jdi.12042; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Sjoholm A, 2006, DIABETES-METAB RES, V22, P4, DOI 10.1002/dmrr.568; Kolb H, 2010, DIABETOLOGIA, V53, P10, DOI 10.1007/s00125-009-1573-7; Spallone V, 2011, DIABETES-METAB RES, V27, P639, DOI 10.1002/dmrr.1239; Kosuge M, 2007, CIRC J, V71, P186, DOI 10.1253/circj.71.186; Vinik AI, 2011, DIABETIC MED, V28, P643, DOI 10.1111/j.1464-5491.2010.03184.x; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Zhang GQ, 2009, AGEING RES REV, V8, P52, DOI 10.1016/j.arr.2008.10.001; Haensel A, 2008, PSYCHONEUROENDOCRINO, V33, P1305, DOI 10.1016/j.psyneuen.2008.08.007; Blendea Mihaela C, 2003, Curr Diab Rep, V3, P223, DOI 10.1007/s11892-003-0068-z; Enkhmaa B, 2005, CLIN CHIM ACTA, V352, P105, DOI 10.1016/j.cccn.2004.08.012; FISCHER KF, 1986, NEW ENGL J MED, V315, P1245, DOI 10.1056/NEJM198611133152002; Hamaad Ali, 2005, Clin Cardiol, V28, P570, DOI 10.1002/clc.4960281207; Hatanaka E, 2007, IMMUNOL LETT, V108, P160, DOI 10.1016/j.imlet.2006.12.005; Kotani K., 2013, BIOMED RES INT, V2013; KUMON Y, 1994, CLIN BIOCHEM, V27, P469, DOI 10.1016/0009-9120(94)00044-V; Suzuki H, 2004, DIABETES RES CLIN PR, V64, P213, DOI 10.1016/j.diabres.2003.11.008; Uurtuya S, 2009, J ATHEROSCLER THROMB, V16, P299	21	0	0	IRCA-BSSA	TOKYO	PEARL CITY KOISHIKAWA 603, 2-4-5 KASUGA, BUNKYO-KU, TOKYO, 112-0003, JAPAN	1881-7815	1881-7823		BIOSCI TRENDS	BioSci. Trends	FEB	2015	9	1					79	81		10.5582/bst.2014.01114		3	Biology	Life Sciences & Biomedicine - Other Topics	CF0VU	WOS:000352263200010		
J	Garg, SK; Admane, K; Freemantle, N; Odawara, M; Pan, CY; Misra, A; Jarek-Martynowa, IR; Abbas-Raza, S; Mirasol, RC; Perfetti, R				Garg, Satish K.; Admane, Karim; Freemantle, Nick; Odawara, Masato; Pan, Chang-Yu; Misra, Anoop; Jarek-Martynowa, Iwona R.; Abbas-Raza, Syed; Mirasol, Roberto C.; Perfetti, Riccardo			PATIENT-LED VERSUS PHYSICIAN-LED TITRATION OF INSULIN GLARGINE IN PATIENTS WITH UNCONTROLLED TYPE 2 DIABETES: A RANDOMIZED MULTINATIONAL ATLAS STUDY	ENDOCRINE PRACTICE			English	Article							GLYCEMIC CONTROL; THERAPY; MANAGEMENT; OBESITY; TRIAL; TREAT; CHINA	Objective: Self-adjustment of insulin dose is commonly practiced in Western patients with type 2 diabetes but is usually not performed in Asian patients. This multinational, 24-week, randomized study compared patient-led with physician-led titration of once-daily insulin glargine in Asian patients with uncontrolled type 2 diabetes who were on 2 oral glucose-lowering agents. Methods: Patient-led (n = 275) or physician-led (n = 277) subjects followed the same dose-titration algorithm guided by self-monitored fasting blood glucose (FBG; target, 110 mg/dL [6.1 mmol/L]). The primary endpoint was change in mean glycated hemoglobin (HbA(1c)) at week 24 in the patient-led versus physician-led titration groups. Results: Patient-led titration resulted in a significantly higher drop in HbA(1c) value at 24 weeks when compared with physician-led titration (-1.40% vs. -1.25%; mean difference, -0.15; 95% confidence interval, -0.29 to 0.00; P =.043). Mean decrease in FBG was greatest in the patientled group (-2.85 mmol/L vs. -2.48 mmol/L; P =.001). The improvements in HbA(1c) and FBG were consistent across countries, with similar improvements in treatment satisfaction in both groups. Mean daily insulin dose was higher in the patient-led group (28.9 units vs. 22.2 units; P<.001). Target HbA(1c) of <7.0% without severe hypoglycemia was achieved in 40.0% and 32.9% in the patient-led and physician-led groups, respectively (P =.086). Severe hypoglycemia was not different in the 2 groups (0.7%), with an increase in nocturnal and symptomatic hypoglycemia in the patient-led arm. Conclusion: Patient-led insulin glargine titration achieved near-target blood glucose levels in Asian patients with uncontrolled type 2 diabetes who were on 2 oral glucose-lowering drugs, demonstrating that Asian patients can self-uptitrate insulin dose effectively when guided.	[Garg, Satish K.] Univ Colorado Denver, Barbara Davis Ctr Diabet, Aurora, CO 80045 USA; [Admane, Karim; Perfetti, Riccardo] Sanofi, Global Diabet Div, Paris, France; [Freemantle, Nick] UCL, Dept Primary Care & Populat Hlth, London, England; [Odawara, Masato] Tokyo Med Univ, Dept Diabetol Metab & Endocrinol, Shinjuku Ku, Tokyo 1608402, Japan; [Pan, Chang-Yu] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing 100853, Peoples R China; [Misra, Anoop] Fortis CDOC Ctr Excellence Diabet Metab Dis & End, New Delhi, India; [Jarek-Martynowa, Iwona R.] Russian Acad Med Sci, Endocrinol Res Ctr, Moscow, Russia; [Abbas-Raza, Syed] Shaukhat Khanum Canc Hosp & Res Ctr, Dept Endocrinol, Lahore, Pakistan; [Mirasol, Roberto C.] St Lukes Med Ctr, Quezon City, Philippines	Garg, SK (reprint author), Univ Colorado Denver, Barbara Davis Ctr Diabet, Med & Pediat, 1775 Aurora Court,Room M20-1323, Aurora, CO 80045 USA.	satish.garg@ucdenver.edu			Sanofi, Paris, France; Joanne Fitz-Gerald at Absolute Healthcare Communications Ltd (Twickenham, UK); Sanofi	The study was sponsored by Sanofi, Paris, France. Medical writing support was provided by Joanne Fitz-Gerald at Absolute Healthcare Communications Ltd (Twickenham, UK) and was funded by Sanofi. We thank Emily G. Moser for assistance in editing and submitting this manuscript. The study is registered at ClinicalTrials. gov under number NCT01169818.	Admane K, 2013, DIABETES, V62, pA654; Anjana RM, 2011, DIABETOLOGIA, V54, P3022, DOI 10.1007/s00125-011-2291-5; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Joshi SR, 2012, CURR DIABETES REP, V12, P204, DOI 10.1007/s11892-012-0260-0; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Misra A, 2011, INT J OBESITY, V35, P167, DOI 10.1038/ijo.2010.135; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Neville SE, 2009, DIABETES-METAB RES, V25, P705, DOI 10.1002/dmrr.1012; Chan JCN, 2009, DIABETES CARE, V32, P227, DOI 10.2337/dc08-0435; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Pan CY, 2009, CURR MED RES OPIN, V25, P39, DOI 10.1185/03007990802586079 ; Davies M, 2005, DIABETES CARE, V28, P1282, DOI 10.2337/diacare.28.6.1282; Odawara M, 2011, DIABETES TECHNOL THE, V13, P67, DOI 10.1089/dia.2010.0170; Bradley C, 1994, HDB PSYCHOL DIABETES, P111; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Eppens MC, 2006, CURR MED RES OPIN, V22, P1013, DOI 10.1185/030079906X104795; EuroQol Group, 1990, Health Policy, V16, P199; Freemantle N, 2013, DIABETES S1, V62, pA588; Howorka K, 2000, QUAL LIFE RES, V9, P915, DOI 10.1023/A:1008921419108; International Diabetes Federation, 2012, GLOB GUID TYP 2 DIAB; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI [10.2337/dc12-0413, 10.2337/dc12-041.3]; Kabadi UM, 2008, INT J DIABETES DEV C, V28, P65, DOI 10.4103/0973-3930.43102; Umezono Tomoya, 2013, Tokai J Exp Clin Med, V38, P28; Wang Z., 2011, THESIS RAND CORPORAT	25	3	3	AMER ASSOC CLINICAL ENDOCRINOLOGISTS	JACKSONVILLE	245 RIVERSIDE AVENUE, STE 200, JACKSONVILLE, FL 32202 USA	1530-891X	1934-2403		ENDOCR PRACT	Endocr. Pract.	FEB	2015	21	2					143	157		10.4158/EP14079.OR		15	Endocrinology & Metabolism	Endocrinology & Metabolism	CE9GO	WOS:000352152300006		
J	Kishi, S; Magalhaes, TA; George, RT; Dewey, M; Laham, RJ; Niinuma, H; Friedman, LA; Cox, C; Tanami, Y; Schuijf, JD; Vavere, AL; Kitagawa, K; Chen, MY; Nomura, CH; Brinker, JA; Rybicki, FJ; Di Carli, MF; Arbab-Zadeh, A; Lima, JAC				Kishi, Satoru; Magalhaes, Tiago A.; George, Richard T.; Dewey, Marc; Laham, Roger J.; Niinuma, Hiroyuki; Friedman, Lisa Aronson; Cox, Christopher; Tanami, Yutaka; Schuijf, Joanne D.; Vavere, Andrea L.; Kitagawa, Kakuya; Chen, Marcus Y.; Nomura, Cesar H.; Brinker, Jeffrey A.; Rybicki, Frank J.; Di Carli, Marcelo F.; Arbab-Zadeh, Armin; Lima, Joao A. C.			Relationship of left ventricular mass to coronary atherosclerosis and myocardial ischaemia: the CORE320 multicenter study	EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING			English	Article						Coronary atherosclerosis; Left ventricular mass; Myocardial ischaemia; Atheroma volume	ROW COMPUTED-TOMOGRAPHY; ARTERY-DISEASE; DIAGNOSTIC PERFORMANCE; HYPERTENSIVE PATIENTS; MAGNETIC-RESONANCE; FLOW RESERVE; HYPERTROPHY; ANGIOGRAPHY; PERFUSION; ECHOCARDIOGRAPHY	Aims The aim of this study was to investigate the association of left ventricular mass (LVM) with coronary atherosclerosis and myocardial infarction (MI). Methods and results Patients (n = 338) underwent 320 x 0.5 mm detector row coronary computed tomography (CT) angiography, invasive coronary angiography (ICA), and single-photon emission CT (SPECT) myocardial perfusion imaging. Quantitative coronary atheroma volume was obtained from the CT images for the entire coronary tree (19-segment model) with an arterial contour detection algorithm. Normalized total atheroma volume (NormTAV) was analysed to reflect quantitative total atheroma volume. LVM was measured on myocardial CT images and indexed to height to the power of 2.7 (LVMi). Patients with obstructive coronary artery disease (CAD) were defined as those with >= 50% diameter stenosis by quantitative ICA. Abnormal perfusion defect was defined as = 1 abnormal myocardial segment by SPECT. The association of LVMi with coronary atherosclerosis and myocardial perfusion defect on SPECT at the patient level was determined with uni-and multivariable linear and logistic regression analyses. Obstructive CAD was present in 60.0% of enrolled patients. LVMi was independently associated with abnormal summed rest score [SRS; odds ratio (OR), 1.07; 95% confidence interval (CI), 1.03-1.09] and summed stress score (OR, 1.04; 95% CI, 1.01-1.07). An increase in LVMi was also independently associated with that in NormTAV (coefficient, 10.44; 95% CI, 1.50-19.39) and SRS = 1 (OR, 1.05; 95% CI, 1.01-1.10), even after adjusting for cardiovascular risk factors in patients without previous MI. Conclusions LVM was independently associated with the presence of coronary artery atherosclerosis and MI.	[Kishi, Satoru; Magalhaes, Tiago A.; George, Richard T.; Vavere, Andrea L.; Brinker, Jeffrey A.; Arbab-Zadeh, Armin; Lima, Joao A. C.] Johns Hopkins Univ, Div Cardiol, Dept Med, Sch Med, Baltimore, MD 21287 USA; [Dewey, Marc] Humboldt Univ, Charite Med Sch, Dept Radiol, D-10099 Berlin, Germany; [Dewey, Marc] Free Univ Berlin, Berlin, Germany; [Laham, Roger J.] Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; [Niinuma, Hiroyuki] St Lukes Int Hosp, Div Cardiol, Tokyo, Japan; [Friedman, Lisa Aronson; Cox, Christopher] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Tanami, Yutaka] Keio Univ, Dept Radiol, Tokyo, Japan; [Schuijf, Joanne D.] Toshiba Med Syst Europe BV, Zoetermeer, Netherlands; [Kitagawa, Kakuya] Mie Univ Hosp, Dept Radiol, Tsu, Mie, Japan; [Chen, Marcus Y.] NHLBI, Adv Cardiovasc Imaging Grp, NIH, Bethesda, MD 20892 USA; [Nomura, Cesar H.] Hosp Israelita Albert Einstein, Radiol Sect, Sao Paulo, Brazil; [Rybicki, Frank J.; Di Carli, Marcelo F.] Harvard Univ, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA	Lima, JAC (reprint author), Johns Hopkins Univ, Div Cardiol, Dept Med, Sch Med, Blalock 524,600 N Wolfe St, Baltimore, MD 21287 USA.	jlima@jhmi.edu		Dewey, Marc/0000-0002-4402-2733	CORE320 study, Toshiba Medical Systems Corporation	The sponsor of the CORE320 study, Toshiba Medical Systems Corporation, was not involved during any stage of the planning, design, data acquisition, data analysis, or manuscript preparation of this study.	Hachamovitch R, 2012, J AM COLL CARDIOL, V59, P462, DOI 10.1016/j.jacc.2011.09.066; Bluemke DA, 2008, J AM COLL CARDIOL, V52, P2148, DOI 10.1016/j.jacc.2008.09.014; Truong QA, 2009, J HYPERTENS, V27, P2472, DOI 10.1097/HJH.0b013e328331054a; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; George RT, 2011, AM J ROENTGENOL, V197, P829, DOI 10.2214/AJR.10.5689; Lin FY, 2008, JACC-CARDIOVASC IMAG, V1, P782, DOI 10.1016/j.jcmg.2008.04.015; LEVY D, 1989, ANN INTERN MED, V110, P101; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; COOPER RS, 1990, AM J CARDIOL, V65, P441, DOI 10.1016/0002-9149(90)90807-D; Vavere AL, 2011, J CARDIOVASC COMPUT, V5, P370, DOI 10.1016/j.jcct.2011.11.001; Sutton MGS, 2000, CIRCULATION, V101, P2981; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; WEBER KT, 1991, CIRCULATION, V83, P1849; Timmer SAJ, 2013, EUR HEART J-CARD IMG, V14, P95, DOI 10.1093/ehjci/jes242; de Graaf MA, 2013, INT J CARDIOVAS IMAG, V29, P1177, DOI 10.1007/s10554-013-0194-x; HOUGHTON JL, 1990, J AM COLL CARDIOL, V15, P43; Rybicki FJ, 2008, INT J CARDIOVAS IMAG, V24, P535, DOI 10.1007/s10554-008-9308-2; Papadopoulou SL, 2012, JACC-CARDIOVASC IMAG, V5, pS28, DOI 10.1016/j.jcmg.2012.01.009; Schafer S, 2002, J HYPERTENS, V20, P1431, DOI 10.1097/00004872-200207000-00031; Cerci RJ, 2012, CIRC-CARDIOVASC IMAG, V5, P587, DOI 10.1161/CIRCIMAGING.111.970608; Armstrong AC, 2012, JACC-CARDIOVASC IMAG, V5, P837, DOI 10.1016/j.jcmg.2012.06.003; Lieb W, 2009, CIRCULATION, V119, P3085, DOI 10.1161/CIRCULATIONAHA.108.824243; Greupner J, 2012, J AM COLL CARDIOL, V59, P1897, DOI 10.1016/j.jacc.2012.01.046; Papadopoulou SL, 2013, INT J CARDIOVAS IMAG, V29, P1095, DOI 10.1007/s10554-012-0167-5; Ghali JK, 1998, J AM COLL CARDIOL, V31, P1635, DOI 10.1016/S0735-1097(98)00131-4; Camici PG, 2012, J MOL CELL CARDIOL, V52, P857, DOI 10.1016/j.yjmcc.2011.08.028; Chin D, 2012, AM J HYPERTENS, V25, P1226, DOI 10.1038/ajh.2012.90; Heupler S, 1997, AM HEART J, V133, P691, DOI 10.1016/S0002-8703(97)70171-6; Lin FY, 2011, J CARDIOVASC COMPUT, V5, P158, DOI 10.1016/j.jcct.2011.01.006; PRINGLE SD, 1992, BRIT HEART J, V67, P377; Rochitte CE, 2013, EUR HEART J, V35, P1120; SALCEDO EE, 1990, EUR HEART J, V11, P72	33	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2047-2404	2047-2412		EUR HEART J-CARD IMG	Eur. Heart J.-Cardiovasc. Imaging	FEB	2015	16	2					166	176		10.1093/ehjci/jeu217		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE8GP	WOS:000352080200006		
J	Maejima, N; Hibi, K; Saka, K; Nakayama, N; Matsuzawa, Y; Endo, M; Iwahashi, N; Okuda, J; Tsukahara, K; Tahara, Y; Kosuge, M; Ebina, T; Umemura, S; Kimura, K				Maejima, Nobuhiko; Hibi, Kiyoshi; Saka, Kenichiro; Nakayama, Naoki; Matsuzawa, Yasushi; Endo, Mitsuaki; Iwahashi, Noriaki; Okuda, Jun; Tsukahara, Kengo; Tahara, Yoshio; Kosuge, Masami; Ebina, Toshiaki; Umemura, Satoshi; Kimura, Kazuo			Morphological features of non-culprit plaques on optical coherence tomography and integrated backscatter intravascular ultrasound in patients with acute coronary syndromes	EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING			English	Article						Optical coherence tomography; Acute coronary syndrome; Plaque vulnerability; Pan-coronary process; Integrated backscatter intravascular ultrasound	RADIOFREQUENCY DATA-ANALYSIS; ACUTE MYOCARDIAL-INFARCTION; ATHEROSCLEROTIC PLAQUE; VULNERABLE PLAQUES; FIBROUS-CAP; CLASSIFICATION; THICKNESS	Aims We sought to compare the morphological features of non-culprit plaques with > 50% diameter stenosis in patients with acute coronary syndromes (ACS) with those of culprit plaques in patients with ACS and stable angina pectoris ( SAP) using optical coherence tomography (OCT) and integrated backscatter intravascular ultrasound (IB-IVUS). Methods and results A total of 150 culprit and non-culprit coronary plaques (non-culprit vessels) in 150 patients with coronary artery disease were interrogated by OCT before percutaneous coronary intervention (PCI). Patients were categorized as follows: 73 culprit plaques in patients with ACS (ACS-C), 32 non-culprit plaques in patients with ACS (ACS-NC), and 45 culprit plaques in patients with SAP. The fibrous cap thickness was thinner in the ACS-C and ACS-NC groups than in the SAP group and was thinnest in the ACS-C group (ACS-C vs. ACS-NC vs. SAP, 60 vs. 82 vs. 114 mm, P < 0.001). IB-IVUS sub-analysis of 95 patients demonstrated that % lipid volume was greater and % fibrous volume was lower in the ACS-NC group than those in the SAP group (ACS-C vs. ACS-NC vs. SAP, 56.3 +/- 11.0 vs. 59.9 +/- 11.2 vs. 50.1 +/- 13.9%, P < 0.05 and 39.5 +/- 9.0 vs. 35.0 +/- 9.0 vs. 43.9 +/- 11.3%, P < 0.01, respectively). Conclusion Plaques of non-culprit vessels in patients with ACS had a thinner fibrous cap and a higher percentage of lipid content than culprit plaques in patients with SAP. However, the fibrous cap thickness was thinner in the culprit lesions in patients with ACS than in the non-culprit lesions in patients with ACS, while plaque compositions were not significantly different between the groups.	[Maejima, Nobuhiko; Hibi, Kiyoshi; Saka, Kenichiro; Nakayama, Naoki; Matsuzawa, Yasushi; Endo, Mitsuaki; Iwahashi, Noriaki; Tsukahara, Kengo; Tahara, Yoshio; Kosuge, Masami; Ebina, Toshiaki; Kimura, Kazuo] Yokohama City Univ, Div Cardiol, Med Ctr, Minami Ku, Yokohama, Kanagawa 2320024, Japan; [Okuda, Jun] Yokosuka City Hosp, Yokosuka, Kanagawa, Japan; [Umemura, Satoshi] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 2320024, Japan	Hibi, K (reprint author), Yokohama City Univ, Div Cardiol, Med Ctr, Minami Ku, 4-57 Urafune Cho, Yokohama, Kanagawa 2320024, Japan.	hibikiyo@urahp.yokohama-cu.ac.jp					Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E; Sawada T, 2008, EUR HEART J, V29, P1136, DOI 10.1093/eurheartj/ehn132; Takarada S, 2009, ATHEROSCLEROSIS, V202, P491, DOI 10.1016/j.atherosclerosis.2008.05.014; Asakura M, 2001, J AM COLL CARDIOL, V37, P1284, DOI 10.1016/S0735-1097(01)01135-4; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Schoenhagen P, 2000, CIRCULATION, V101, P598; Nakayama N, 2013, CIRC J, V77, P424, DOI 10.1253/circj.CJ-12-0630; Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303; Sano K, 2006, J AM COLL CARDIOL, V47, P734, DOI 10.1016/j.jacc.2005.09.061; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Jang IK, 2005, CIRCULATION, V111, P1551, DOI 10.1161/01.CIR.0000159354.43778.69; Amano T, 2011, CIRC J, V75, P157, DOI 10.1253/circj.CJ-10-0612; Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6; Kawasaki M, 2002, CIRCULATION, V105, P2487, DOI 10.1061/01.CIR.0000017200.47342.10; Kubo T, 2007, J AM COLL CARDIOL, V50, P933, DOI 10.1016/j.jacc.2007.04.082; Hibi K, 2005, CATHETER CARDIO INTE, V65, P233, DOI 10.1002/ccd.20366; Libby P, 2001, CIRCULATION, V104, P365; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262; Rioufol G, 2002, CIRCULATION, V106, P804, DOI 10.1161/01.CIR.0000025609.13806.31; Kume T, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.030; Mitsuhashi T, 2011, JACC-CARDIOVASC IMAG, V4, P392, DOI 10.1016/j.jcmg.2011.02.004; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520	22	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2047-2404	2047-2412		EUR HEART J-CARD IMG	Eur. Heart J.-Cardiovasc. Imaging	FEB	2015	16	2					190	197		10.1093/ehjci/jeu173		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE8GP	WOS:000352080200010		
J	Isobe, S; Hakuno, D; Isoda, S; Hayashi, K; Adachi, T				Isobe, Sarasa; Hakuno, Daihiko; Isoda, Susumu; Hayashi, Katsumi; Adachi, Takeshi			Right coronary artery-left ventricle fistula with giant coronary artery aneurysm	EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING			English	Editorial Material									[Isobe, Sarasa; Hakuno, Daihiko; Adachi, Takeshi] Natl Def Med Coll, Dept Cardiol, Tokorozawa, Saitama 359, Japan; [Isoda, Susumu] Natl Def Med Coll, Dept Cardiovasc Surg, Tokorozawa, Saitama 359, Japan; [Hayashi, Katsumi] Natl Def Med Coll, Dept Radiol, Tokorozawa, Saitama 359, Japan	Hakuno, D (reprint author), Kyoto Univ Hosp, Dept Cardiovasc Med, Sakyo Ku, 54 Kawaharacho, Kyoto 6068507, Japan.	daihiko@dg8.so-net.ne.jp						0	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2047-2404	2047-2412		EUR HEART J-CARD IMG	Eur. Heart J.-Cardiovasc. Imaging	FEB	2015	16	2					231	231		10.1093/ehjci/jeu205		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE8GP	WOS:000352080200020		
J	Yamamoto, T; Sakairi, Y; Nakajima, T; Suzuki, H; Tagawa, T; Iwata, T; Mizobuchi, T; Yoshida, S; Nakatani, Y; Yoshino, I				Yamamoto, Takayoshi; Sakairi, Yuichi; Nakajima, Takahiro; Suzuki, Hidemi; Tagawa, Tetsuzo; Iwata, Takekazu; Mizobuchi, Teruaki; Yoshida, Shigetoshi; Nakatani, Yukio; Yoshino, Ichiro			Comparison between endobronchial ultrasound-guided transbronchial needle aspiration and F-18-fluorodeoxyglucose positron emission tomography in the diagnosis of postoperative nodal recurrence in patients with lung cancer	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Lung cancer; Diagnosis; Bronchoscopy/bronchus; Lymph nodes; Metastasis/metastasectomy; Endobronchial ultrasound-guided transbronchial needle aspiration	MANAGEMENT; THERAPY; PET/CT	OBJECTIVES: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has a high diagnostic value for preoperative mediastinal staging in patients with lung cancer. In this study, the utility of EBUS-TBNA for the pathological diagnosis of postoperative lymph node recurrence was investigated and compared with that of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). METHODS: Patients who received both EBUS-TBNA and FDG-PET for the diagnosis of postoperative lymph node recurrence were retrospectively investigated. They underwent routine chest computed tomography (CT) follow-up after thoracotomy, and when hilar or mediastinal lymph nodes showed enlargement on CT compared with the previous chest CT, they were referred for FDG-PET and EBUS-TBNA. We compared the diagnostic performance of these two modalities. In addition, pathological findings of the biopsied sample were evaluated precisely and compared with the results of FDG-PET. Positivity for hypermetabolism on FDG-PET was defined as a standardized uptake value (SUV) greater than 2.5. RESULTS: A total of 40 patients were retrospectively reviewed. The sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy of EBUS-TBNA were 100% for each parameter, whereas those of FDG-PET were 95.8, 12.5, 62.2, 66.7 and 62.5%, respectively. The SUV of true-positive nodes was significantly higher than that of false-positive nodes (P = 0.001). Twenty-two of 24 patients who were confirmed for recurrence by EBUS-TBNA underwent anticancer treatment. The pathological diagnoses of 14 false-positive cases by FDG-PET were chronic inflammation in 12 and non-specific granuloma in 2. CONCLUSIONS: The diagnostic yield of EBUS-TBNA is higher than that of FDG-PET when postoperative lymph node recurrence is suspected.	[Yamamoto, Takayoshi; Sakairi, Yuichi; Nakajima, Takahiro; Suzuki, Hidemi; Tagawa, Tetsuzo; Iwata, Takekazu; Mizobuchi, Teruaki; Yoshida, Shigetoshi; Yoshino, Ichiro] Chiba Univ, Dept Gen Thorac Surg, Chiba 2608670, Japan; [Nakatani, Yukio] Chiba Univ, Dept Diagnost, Grad Sch Med, Chiba 2608670, Japan	Nakajima, T (reprint author), Chiba Univ, Grad Sch Med, Dept Gen Thorac Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	tnakajima76@hotmail.com			Olympus Medical Systems	Dr Nakajima received honoraria and lecture fee for the seminar and hands-on training course of EBUS-TBNA from Olympus Medical Systems.	Nakajima T, 2011, CHEST, V140, P1319, DOI 10.1378/chest.10-3186; Jaklitsch MT, 2013, J THORAC CARDIOV SUR, V146, P9, DOI 10.1016/j.jtcvs.2012.12.069; Silvestri GA, 2013, CHEST, V143, pE211, DOI 10.1378/chest.12-2355; Sakairi Y, 2010, CLIN CANCER RES, V16, P4938, DOI 10.1158/1078-0432.CCR-10-0099; Jimenez-Bonilla JF, 2013, LUNG CANCER, V81, P71, DOI 10.1016/j.lungcan.2013.03.015; Gu P, 2009, EUR J CANCER, V45, P1389, DOI 10.1016/j.ejca.2008.11.043; Yasufuku K, 2006, CHEST, V130, P710, DOI 10.1378/chest.130.3.710; Anraku M, 2011, ANN THORAC SURG, V92, P251, DOI 10.1016/j.athoracsur.2011.03.007; Candela SD, 2010, J THORAC ONCOL, V5, P389, DOI 10.1097/JTO.0b013e3181ce3e5e; Catarino PA, 2006, RESPIRATION, V73, P717, DOI 10.1159/000095901; Cho S, 2010, J THORAC CARDIOV SUR, V139, P1447, DOI 10.1016/j.jtcvs.2009.09.055; Detterbeck FC, 2007, CHEST, V132, p202S, DOI DOI 10.1378/CHEST.07-1362; Fedor D, 2013, SURG ONCOL, V22, P156, DOI 10.1016/j.suronc.2013.04.002; Herth FJF, 2008, J CLIN ONCOL, V26, P3346, DOI 10.1200/JCO.2007.14.9229; Hu M, 2011, CLIN NUCL MED, V36, P429, DOI 10.1097/RLU.0b013e3182173810; Korst RJ, 2006, ANN THORAC SURG, V82, P1009, DOI 10.1016/j.athoracsur.2006.03.062; MEERSSCHAUT D, 1992, ANN THORAC SURG, V53, P120; Mountain CF, 1997, CHEST, V111, P1711; Shingyoji M, 2010, INTERNAL MED, V49, P787, DOI 10.2169/internalmedicine.49.3154; Sobin LH, 2002, TNM CLASSIFICATION M, P97; Szlubowski A, 2014, EUR J CARDIO-THORAC, V46, P262, DOI 10.1093/ejcts/ezt570; Travis WD, 1999, HISTOLOGICAL TYPING; Verhagen AFT, 2004, LUNG CANCER-J IASLC, V44, P175, DOI 10.1016/j.lungcan.2003.11.007; Vueghs P J, 1992, J Cardiothorac Vasc Anesth, V6, P193, DOI 10.1016/1053-0770(92)90197-F; Zielinski M, 2013, J THORAC ONCOL, V8, P630, DOI 10.1097/JTO.0b013e318287c0ce	25	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	FEB	2015	47	2					234	238		10.1093/ejcts/ezu214		5	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CE9YO	WOS:000352199800012		
J	Hattori, A; Suzuki, K; Matsunaga, T; Miyasaka, Y; Takamochi, K; Oh, S				Hattori, Aritoshi; Suzuki, Kenji; Matsunaga, Takeshi; Miyasaka, Yoshikazu; Takamochi, Kazuya; Oh, Shiaki			What is the appropriate operative strategy for radiologically solid tumours in subcentimetre lung cancer patients?	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Sub centimetre; Solid appearance; Prognosis; Lymph node metastasis	POSITRON-EMISSION-TOMOGRAPHY; GROUND GLASS OPACITY; LONG-TERM SURVIVAL; 1 CM; PROGNOSTIC-SIGNIFICANCE; SURGICAL-TREATMENT; LIMITED RESECTION; PULMONARY NODULES; RANDOMIZED-TRIAL; LESS	OBJECTIVES: Solid lung cancers, even subcentimetre lesions, are considered to be invasive pathologically. However, the clinicopathological features and appropriate operative strategies in patients with these small lesions are still controversial, especially for those with a radiologically solid appearance. METHODS: Between 2004 and 2011, 135 patients underwent pulmonary resection for subcentimetre lung cancer with clinical-N0 (c-N0) status. The findings of preoperative thin-section computed tomography (CT) were reviewed, and subcentimetre lung cancer was divided into three groups: pure ground-glass nodule, part-solid and pure-solid lesions. RESULTS: Among the 135 subcentimetre lung cancer patients with c-N0 status, 71 showed a solid appearance on thin-section CT scan. Furthermore, pathological nodal examinations were performed in 49 patients, and nodal involvement was found pathologically in 6 (12.2%) patients. All of them had pure-solid tumours (P = 0.0010). Among the patients with solid subcentimetre lung cancers, the maximum standardized uptake value (SUVmax) was the only significant predictor of nodal involvement by a multivariate analysis (P = 0.0205). With regard to the surgical outcomes, the overall 5-year survival and disease-free survival rates were 100 and 97.8% for part-solid lesions, and 87.3 and 74.8% for pure-solid lesions, respectively. Moreover, there was a significant difference in disease-free survival between a high SUVmax group (60.0%) and a low SUVmax group (94.9%) (P = 0.0013). CONCLUSIONS: There might be a possibility of lymph node metastasis despite subcentimetre lung cancer, especially for radiological pure-solid nodules that show a high SUVmax. If limited surgery is indicated for solid subcentimetre lung cancer, a thorough intraoperative evaluation of lymph nodes is needed to prevent loco-regional failure.	[Hattori, Aritoshi; Suzuki, Kenji; Matsunaga, Takeshi; Miyasaka, Yoshikazu; Takamochi, Kazuya; Oh, Shiaki] Juntendo Univ Sch Med, Dept Gen Thorac Surg, Tokyo 1138431, Japan	Suzuki, K (reprint author), Juntendo Univ Sch Med, Div Gen Thorac Surg, Bunkyo Ku, 1-3 Hongo 3 Chome, Tokyo 1138431, Japan.	kjsuzuki@juntendo.ac.jp			Ministry of Health, Labour and Welfare, Japan; Smoking Research Foundation	This work was supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare, Japan and the Smoking Research Foundation.	Henschke CI, 2006, NEW ENGL J MED, V355, P1763; Suzuki K, 2011, J THORAC ONCOL, V6, P751, DOI 10.1097/JTO.0b013e31821038ab; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Nakamura K, 2010, JPN J CLIN ONCOL, V40, P271, DOI 10.1093/jjco/hyp156; Gould MK, 2001, JAMA-J AM MED ASSOC, V285, P914, DOI 10.1001/jama.285.7.914; Suzuki K, 2000, ANN THORAC SURG, V69, P893, DOI 10.1016/S0003-4975(99)01331-4; Suzuki K, 2002, ANN THORAC SURG, V74, P1635, DOI 10.1016/S0003-4975(02)03895-X; NOGUCHI M, 1995, CANCER, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; Pastorino U, 2009, J THORAC ONCOL, V4, P1352, DOI 10.1097/JTO.0b013e3181bbf1dc; Takamochi K, 2000, J THORAC CARDIOV SUR, V119, P1135, DOI 10.1067/mtc.2000.105830; Darling GE, 2011, J THORAC CARDIOV SUR, V141, P662, DOI 10.1016/j.jtcvs.2010.11.008; Hattori A, 2012, ANN THORAC SURG, V94, P212, DOI 10.1016/j.athoracsur.2012.03.033; Asamura H, 2003, ANN THORAC SURG, V76, P1016, DOI 10.1016/S0003-4975(03)00835-X; ClinicalTrials.gov, COMP DIFF TYP SURG T; Gould MK, 2007, CHEST, V132, p108S, DOI 10.1378/chest.07-1353; Kernstine Kemp H, 2005, Semin Thorac Cardiovasc Surg, V17, P110, DOI 10.1053/j.semtcvs.2005.04.004; Lee PC, 2006, J THORAC CARDIOV SUR, V132, P1382, DOI 10.1016/j.jtcvs.2006.08.053; Miller DL, 2002, ANN THORAC SURG, V73, P1545, DOI 10.1016/S0003-4975(02)03525-7; Feins RH, 2002, ANN THORAC SURG, V73, P1550; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Zhou QJ, 2010, INTERACT CARDIOV TH, V10, P53, DOI 10.1510/icvts.2009.216119	21	4	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	FEB	2015	47	2					244	249		10.1093/ejcts/ezu250		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CE9YO	WOS:000352199800014		
J	Dohi, M; Miyata, H; Doi, K; Okawa, K; Motomura, N; Takamoto, S; Yaku, H				Dohi, Masahiro; Miyata, Hiroaki; Doi, Kiyoshi; Okawa, Kazunari; Motomura, Noboru; Takamoto, Shinichi; Yaku, Hitoshi		Japan Cardiovasc Surg Database	The off-pump technique in redo coronary artery bypass grafting reduces mortality and major morbidities: propensity score analysis of data from the Japan Cardiovascular Surgery Database	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Coronary artery disease; Off-pump; Coronary artery bypass grafting; Reoperation	OPERATIVE MORTALITY; RISK MODELS; THORACIC SURGEONS; BEATING HEART; SINGLE-VESSEL; ON-PUMP; REVASCULARIZATION; REOPERATIONS; EXPERIENCE; OUTCOMES	OBJECTIVES: The benefits of off-pump coronary artery grafting (OPCAB) have been demonstrated. Especially in patients with a high number of comorbidities, redo coronary artery bypass grafting (CABG) remains a difficult entity of CABG, because patients are likely to have multiple risk factors and often have diseased patent grafts with adhesions. The aim of the present study was to evaluate the effects of the OPCAB technique in redo CABG on mortality and morbidity using data from the Japan Cardiovascular Surgery Database (JCVSD). METHODS: We analysed 34 980 patients who underwent isolated CABG between 2008 and 2011, as reported in the JCVSD. Of these, 1.8% of patients (n = 617/34980) had undergone redo CABG, including those who underwent OPCAB (n = 364; 69%) and on-pump CABG (n = 253; 41%). We used propensity score (PS) matching with 13 preoperative risk factors to adjust for differences in baseline characteristics between the redo OPCAB and on-pump redo CABG groups. By one-to-one PS matching, we selected 200 pairs from each group. RESULTS: There were no significant differences in patient background between the redo OPCAB and on-pump redo CABG groups after PS matching. There was no significant difference in the mean number of distal anastomoses after matching (2.41 +/- 1.00 vs 2.21 +/- 1.04, P = 0.074); nevertheless, the mean operation time was significantly shorter in the redo OPCAB than the on-pump redo CABG group (353.7 vs 441.3 min, P < 0.00010). Patients in the redo OPCAB group had a lower 30-day mortality rate (3.5 vs 7.0%, P = 0.18), a significantly lower rate of composite mortality or major morbidities (11.0 vs 21.5%, P = 0.0060), a significantly lower rate of prolonged ventilation (> 24 h) (7.0 vs 15.0%, P = 0.016), a significantly shorter duration of intensive care unit (ICU) stay (ICU stay = 8 days) (7.0 vs 14.5%, P = 0.023) and a significantly decreased need for blood transfusions (71.5 vs 94.0%, P < 0.00010) than patients in the on-pump redo CABG group. CONCLUSION: The off-pump technique reduced early operative mortality and the incidences of major complications in redo CABG.	[Dohi, Masahiro; Doi, Kiyoshi; Okawa, Kazunari; Yaku, Hitoshi] Kyoto Prefectural Univ Med, Dept Cardiovasc Surg, Kyoto 6028566, Japan; [Miyata, Hiroaki; Motomura, Noboru; Takamoto, Shinichi] Japan Cardiovasc Surg Database Org, Tokyo, Japan	Dohi, M (reprint author), Kyoto Prefectural Univ Med, Dept Cardiovasc Surg, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	masad@koto.kpu-m.ac.jp			Japanese Society for Cardiovascular Surgery; Japanese Association for Thoracic Surgery; Japan Heart Foundation	This work was supported by The Japanese Society for Cardiovascular Surgery, The Japanese Association for Thoracic Surgery and Japan Heart Foundation.	Amano Jun, 2013, Gen Thorac Cardiovasc Surg, V61, P578, DOI 10.1007/s11748-013-0289-2; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Puskas JD, 2008, ANN THORAC SURG, V86, P1139, DOI 10.1016/j.athoracsur.2008.05.073; Motomura N, 2008, ANN THORAC SURG, V86, P1866, DOI 10.1016/j.athoracsur.2008.08.001; Zeitani J, 2013, PERFUSION-UK, V28, P298, DOI 10.1177/0267659113478322; Kara I, 2013, ANN THORAC CARDIOVAS, V19, P435, DOI 10.5761/atcs.oa.12.02043; Yau TM, 2000, J THORAC CARDIOV SUR, V120, P156, DOI 10.1067/mtc.2000.106983; Kobayashi J, 2005, CIRCULATION, V112, pI338, DOI 10.1161/CIRCULATIONAHA.104.524504; Emmert MY, 2011, EUR J CARDIO-THORAC, V40, P233, DOI 10.1016/j.ejcts.2010.11.003; Puskas JD, 2003, J THORAC CARDIOV SUR, V125, P797, DOI 10.1067/mtc.2003.324; Griswold ME, 2010, ANN INTERN MED, V152, P393, DOI 10.7326/0003-4819-152-6-201003160-00010; Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841; Yaku H, 2013, ANN THORAC CARDIOVAS, V19, P83, DOI 10.5761/atcs.ra.12.02113; Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6; Czerny M, 2003, ANN THORAC SURG, V75, P847, DOI 10.1016/S0003-4975(02)04652-0; Dewey TM, 2002, HEART SURG FORUM, V5, P301; Di Mauro M, 2005, ANN THORAC SURG, V79, P81, DOI 10.1016/j.athoracsur.2004.06.058; Mack MJ, 2004, J CARDIAC SURG, V19, P313, DOI 10.1111/j.0886-0440.2004.4056_11.x; Mishra YK, 2008, J THORAC CARDIOV SUR, V135, P527, DOI [10.1016/j.jtcvs.2007.10.019, 10.1016/j.jtcvs.2007.10.09]; Miyata H, 2011, EUR J CARDIO-THORAC, V39, P667, DOI 10.1016/j.ejcts.2010.08.050; Morris Cullen D, 2007, Innovations (Phila), V2, P29, DOI 10.1097/01.IMI.0000250499.99341.97; Sabik JF, 2005, ANN THORAC SURG, V80, P1719, DOI 10.1016/j.athoracsur.2005.04.033; Stamou SC, 2000, ANN THORAC SURG, V69, P1383, DOI 10.1016/S0003-4975(00)01177-2; Tugtekin S M, 2006, Clin Res Cardiol, V95, P93, DOI 10.1007/s00392-006-0335-5; Yap CH, 2009, ANN THORAC SURG, V87, P1386, DOI 10.1016/j.athoracsur.2009.02.006	25	2	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	FEB	2015	47	2					299	308		10.1093/ejcts/ezu081		10	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CE9YO	WOS:000352199800021		
J	Marui, A; Kimura, T; Nishiwaki, N; Komiya, T; Hanyu, M; Shiomi, H; Tanaka, S; Sakata, R				Marui, Akira; Kimura, Takeshi; Nishiwaki, Noboru; Komiya, Tatsuhiko; Hanyu, Michiya; Shiomi, Hiroki; Tanaka, Shiro; Sakata, Ryuzo		CREDO-Kyoto PCI CABG Registry	Three-year outcomes after percutaneous coronary intervention and coronary artery bypass grafting in patients with heart failure: from the CREDO-Kyoto percutaneous coronary intervention/coronary artery bypass graft registry cohort-2	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Coronary artery bypass grafting; Percutaneous coronary intervention; SYNTAX score; Heart failure; Left ventricular dysfunction	SURGERY SYNTAX TRIAL; INCOMPLETE REVASCULARIZATION; ELUTING STENTS; RISK-FACTORS; DISEASE; ASSOCIATION; SYNERGY; TAXUS; SCORE; MORTALITY	OBJECTIVES: Ischaemic heart disease is a major risk factor for heart failure. However, long-term benefit of percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in those patients has not been well elucidated. METHODS: Of the 15 939 patients undergoing first myocardial revascularization enrolled in the CREDO-Kyoto PCI/CABG Registry Cohort-2, we identified 1064 patients with multivessel and/or left main disease with a history of heart failure (ACC/AHA Stage C or D). RESULTS: There were 672 patients undergoing PCI and 392 CABG. Preprocedural left ventricular ejection fraction was not different between PCI and CABG (46.6 +/- 15.1 vs 46.6 +/- 14.6%, P = 0.89), but the CABG group included more patients with triple-vessel and left main disease (P <0.01 each). Three-year outcomes revealed that the risk of hospital readmission for heart failure was higher after PCI than after CABG (hazard ratio [95% confidence interval]; 1.90 [1.18-3.05], P = 0.01). More importantly, adjusted mortality after PCI was significantly higher than after CABG (1.79 [1.13-2.82], P = 0.01). The risk of cardiac death after PCI was also higher than after CABG (1.98 [1.10-3.55], P = 0.02). Stratified analysis using the SYNTAX score demonstrated that risk of death was not different between PCI and CABG in patients with low (< 23) and intermediate (23-32) SYNTAX scores (2.10 [0.57-7.68], P = 0.26 and 1.43 [0.63-3.21], P = 0.39, respectively), whereas those with a high (= 33) SYNTAX score, the risk of death was far higher after PCI than after CABG (4.83 [1.46-16.0], P = 0.01). CONCLUSIONS: In patients with heart failure with advanced coronary artery disease, CABG was a better option than PCI because CABG was associated with better survival benefit, particularly in more complex coronary lesions stratified by the SYNTAX score.	[Marui, Akira; Sakata, Ryuzo] Kyoto Univ Grad Sch Med, Dept Cardiovasc Surg, Kyoto 6068507, Japan; [Kimura, Takeshi; Shiomi, Hiroki] Kyoto Univ Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan; [Nishiwaki, Noboru] Nara Hosp Kinki Univ Fac Med, Dept Cardiovasc Surg, Ikoma, Japan; [Komiya, Tatsuhiko] Kurashiki Cent Hosp, Dept Cardiovasc Surg, Kurashiki, Okayama, Japan; [Hanyu, Michiya] Kokura Mem Hosp, Dept Cardiovasc Surg, Kitakyushu, Fukuoka, Japan; [Tanaka, Shiro] Kyoto Univ Grad Sch Med, Dept Pharmacoepidemiol, Kyoto 6068507, Japan	Marui, A (reprint author), Kyoto Univ Grad Sch Med, Dept Cardiovasc Surg, Sakyo Ku, 54 Shogoin Kawahara, Kyoto 6068507, Japan.	marui@kuhp.kyoto-u.ac.jp			Pharmaceuticals and Medical Devices Agency	This work was supported by the Pharmaceuticals and Medical Devices Agency.	Nardi P, 2009, ANN THORAC SURG, V87, P1401, DOI 10.1016/j.athoracsur.2009.02.062; Kimura T, 2008, CIRCULATION, V118, pS199, DOI 10.1161/CIRCULATIONAHA.107.735902; Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Farooq V, 2013, CIRCULATION, V128, P141, DOI 10.1161/CIRCULATIONAHA.113.001803; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Sedlis SP, 2004, AM J CARDIOL, V94, P118, DOI 10.1016/j.amjcard.2004.03.041; Weintraub WS, 2012, NEW ENGL J MED, V366, P1467, DOI 10.1056/NEJMoa1110717; Wu CT, 2013, AM J CARDIOL, V112, P775, DOI 10.1016/j.amjcard.2013.05.003; Weber MB, 2012, ANNU REV NUTR, V32, P417, DOI 10.1146/annurev-nutr-071811-150630; Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211; Farooq V, 2013, J AM COLL CARDIOL, V61, P282, DOI 10.1016/j.jacc.2012.10.017; Hlatky MA, 2013, ANN INTERN MED, V158, P727, DOI 10.7326/0003-4819-158-10-201305210-00639; Shiomi H, 2012, AM J CARDIOL, V110, P924, DOI 10.1016/j.amjcard.2012.05.022; Appoo J, 2004, CIRCULATION S1, V110, pII13, DOI 10.1161/01.CIR.0000138345.69540.ed; Buszman P, 2007, AM J CARDIOL, V99, P36, DOI 10.1016/j.amjcard.2006.07.056; Davoodi Saeed, 2012, Gen Thorac Cardiovasc Surg, V60, P202, DOI 10.1007/s11748-010-0918-y; Farkouh ME, 2012, N ENGL J MED; Filsoufi Farzan, 2008, Interact Cardiovasc Thorac Surg, V7, P90, DOI 10.1510/icvts.2007.164483; Kimura Takeshi, 2011, Cardiovasc Interv Ther, V26, P234, DOI 10.1007/s12928-011-0065-0; Marui A, 2012, EUR J CARDIO-THORAC, V41, P94, DOI 10.1016/j.ejcts.2011.04.004; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Shiomi H, 2011, CIRC J, V75, P1130, DOI 10.1253/circj.CJ-10-1112; Tazaki J, 2013, EUROINTERVENTION, V9, P437, DOI 10.4244/EIJV9I4A72	25	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	FEB	2015	47	2					316	321		10.1093/ejcts/ezu131		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CE9YO	WOS:000352199800023		
J	Katayama, A; Uchida, N; Katayama, K; Arakawa, M; Sueda, T				Katayama, Akira; Uchida, Naomichi; Katayama, Keijiro; Arakawa, Miwa; Sueda, Taijiro			The frozen elephant trunk technique for acute type A aortic dissection: results from 15 years of experience	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Stent graft; Frozen elephant trunk; Acute type A aortic dissection	FALSE LUMEN; I DISSECTION; REPAIR; SURGERY; DISTAL; FATE	OBJECTIVES: We aimed to evaluate the long-term prognosis of prophylactic repair of the descending aorta using the frozen elephant trunk (FET) technique for acute type A aortic dissection (AAAD). METHODS: Between 1997 and 2012, 120 consecutive patients (mean age: 64.4 +/- 10.9 years) underwent total arch replacement with FET for AAAD; 36 patients had an entry at the descending aorta, 68 patients were aged < 70 years and 8 patients had Marfan's syndrome. With regard to preoperative morbidity, 23 patients had stroke, 10 had coronary ischaemia and 9 had visceral ischaemia. During intraoperative measurement, the required size and length of the stent graft were determined and inserted under transoesophageal echographic guidance. RESULTS: Seven patients (6%) died in the hospital. Four (3%) cases of stroke and 2 (2%) with spinal cord injuries were noted. Computed tomography prior to discharge indicated complete thrombosis of the false lumen by the stent graft in 113 patients, with a mean diameter of 26.0 +/- 2.5 mm before discharge and 27.5 +/- 2.5 mm at 1 year postoperatively compared with a mean stent graft diameter of 27.8 +/- 1.7 mm. During the long-term follow-up (mean period: 104.6 +/- 51.9 months), 12 patients died of non-aortic events and 5 distal aortic reoperations were required using endovascular stent grafting of the descending aorta, including 1 case with new tear formation. None of the patients had a patent false lumen on the stent graft at the final follow-up. The 10-year survival rate was 75% and the overall 10-year reoperation-free rate on the thoracic aorta was 93%. CONCLUSIONS: The FET technique results in excellent aortic remodelling of the downstream aorta and can improve the long-term outcomes for AAAD.	[Katayama, Akira; Arakawa, Miwa] Hiroshima City Asa Hosp, Div Cardiovasc Surg, Hiroshima, Japan; [Uchida, Naomichi; Katayama, Keijiro; Sueda, Taijiro] Hiroshima Univ, Div Cardiovasc Surg, Hiroshima, Japan	Katayama, A (reprint author), Hiroshima City Asa Hosp, Div Cardiovasc Surg, Asakita ku, 2-1-1 Kabeminami, Hiroshima, Japan.	katayama@asa-hosp.city.hiroshima.jp					Kimura N, 2008, J THORAC CARDIOV SUR, V136, P1160, DOI 10.1016/j.jtcvs.2008.05.052; Czerny M, 2012, ANN THORAC SURG, V94, P84, DOI 10.1016/j.athoracsur.2012.03.024; Nienaber CA, 2009, CIRCULATION, V120, P2519, DOI 10.1161/CIRCULATIONAHA.109.886408; Sun LZ, 2009, J THORAC CARDIOV SUR, V138, P1358, DOI 10.1016/j.jtcvs.2009.04.017; Fattouch K, 2009, ANN THORAC SURG, V88, P1244, DOI 10.1016/j.athoracsur.2009.06.055; Hoffman A, 2013, J THORAC CARDIOV SUR, V145, P964, DOI 10.1016/j.jtcvs.2012.03.059; Uchida N, 2011, EUR J CARDIO-THORAC, V40, P1066, DOI 10.1016/j.ejcts.2011.02.074; Desai Nimesh D, 2009, Semin Thorac Cardiovasc Surg, V21, P387, DOI 10.1053/j.semtcvs.2009.12.003; Geirsson A, 2007, ANN THORAC SURG, V84, P1955, DOI 10.1016/j.athoracsur.2007.07.017; Halstead JC, 2007, J THORAC CARDIOV SUR, V133, P127, DOI 10.1016/j.jctvs.2006.07.043; Jakob H, 2008, ANN THORAC SURG, V86, P95, DOI 10.1016/j.athoracsur.2008.03.037; Kazui T, 2002, ANN THORAC SURG S, V74, P1844; Kirsch M, 2002, J THORAC CARDIOV SUR, V123, P318, DOI 10.1067/mtc.2002.119702; MILLER DC, 1979, J THORAC CARDIOV SUR, V78, P365; Park KH, 2009, ANN THORAC SURG, V87, P103, DOI 10.1016/j.athoracsur.2008.09.032; Tsagakis K, 2010, J THORAC CARDIOV SUR, V140, pS116, DOI 10.1016/j.jtcvs.2010.07.066; Uchida Naomichi, 2013, Gen Thorac Cardiovasc Surg, V61, P118, DOI 10.1007/s11748-012-0151-y	17	2	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	FEB	2015	47	2					355	360		10.1093/ejcts/ezu173		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CE9YO	WOS:000352199800031		
J	Tanaka, A; Shirasaka, T; Okada, K; Okita, Y				Tanaka, Akiko; Shirasaka, Tomonori; Okada, Kenji; Okita, Yutaka			Aggressive multiple surgical interventions to pulmonary artery sarcoma	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Editorial Material						Primary pulmonary artery sarcoma; Recurrent sarcoma; Lung metastases; Brain metastases		We describe our experience with a patient who had metastasized pulmonary artery sarcoma, but survived 7 years after diagnosis. A 61-year-old man was diagnosed with pulmonary artery intimal sarcoma after resection of metastatic tumours to the bilateral lungs. The primary lesion in the pulmonary artery trunk extending into the bilateral branches was treated by tumour endoarterectomy followed by chemotherapy. He underwent resections of lung metastases two more times before detection of recurrent obstructive pulmonary artery sarcoma 4 years after the tumour endoarterectomy. En bloc resection of the tumour including the pulmonary artery trunk, valve and interventricular septum was performed, and the right ventricular out flow tract was reconstructed with a stentless pulmonary valve and equine pericardium. He died of the disease soon after an operation for metastatic brain tumour 3 years later. Pulmonary artery sarcoma has a dismal prognosis, but aggressively repeated surgical interventions may lengthen survival.	[Tanaka, Akiko; Shirasaka, Tomonori; Okada, Kenji; Okita, Yutaka] Kobe Univ Grad Sch Med, Div Cardiovasc Surg, Dept Surg, Kobe, Hyogo 6500017, Japan	Tanaka, A (reprint author), Kobe Univ Grad Sch Med, Div Cardiovasc Surg, Dept Surg, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	akikotanaka623@gmail.com					Blackmon SH, 2009, ANN THORAC SURG, V87, P977, DOI 10.1016/j.athoracsur.2008.08.018; Attina D, 2013, RADIOL MED, V118, P1259, DOI 10.1007/s11547-013-0943-x; Cox JE, 1997, J COMPUT ASSIST TOMO, V21, P750, DOI 10.1097/00004728-199709000-00018; Mandelstamm M, 1923, VIRCHOWS ARCH A, V245, P43, DOI 10.1007/BF01992097; Maruo A, 2006, ANN THORAC SURG, V82, P2014, DOI 10.1016/j.athoracsur.2006.07.018	5	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	FEB	2015	47	2					384	385		10.1093/ejcts/ezu184		2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CE9YO	WOS:000352199800035		
J	Maeda, S; Numata, S; Nishida, K; Tsutsumi, Y				Maeda, Shusaku; Numata, Satoshi; Nishida, Koichi; Tsutsumi, Yasushi			Late sequela of aortotomy in infancy: supravalvular aortic stenosis and aneurysmal changes of epiaortic branches	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Editorial Material						Aneurysm; Aortic stenosis; Computed tomography			[Maeda, Shusaku; Numata, Satoshi; Tsutsumi, Yasushi] Fukui Cardiovasc Ctr, Dept Cardiovasc Surg, Fukui 9100833, Japan; [Nishida, Koichi] Fukui Cardiovasc Ctr, Dept Pediat, Fukui 9100833, Japan	Numata, S (reprint author), Fukui Cardiovasc Ctr, Dept Cardiovasc Surg, 2-228 Shinpo, Fukui 9100833, Japan.	snumat@yahoo.co.jp						0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	FEB	2015	47	2					386	386		10.1093/ejcts/ezu202		1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CE9YO	WOS:000352199800036		
J	Nishiyama, M; Uchida, K; Abe, N; Nozaki, M				Nishiyama, Maki; Uchida, Katsuhisa; Abe, Nozomi; Nozaki, Masumi			Molecular cloning of cytochrome P450 side-chain cleavage and changes in its mRNA expression during gonadal development of brown hagfish, Paramyxine atami	GENERAL AND COMPARATIVE ENDOCRINOLOGY			English	Article						Hagfish; CYP11A; Gonadotropin; Leydig cell; Theca cell	TROUT ONCORHYNCHUS-MYKISS; ACUTE REGULATORY PROTEIN; EPTATRETUS-STOUTI; PETROMYZON-MARINUS; MYXINE-GLUTINOSA; STEROIDOGENIC ENZYMES; SEX STEROIDS; LOCOMOTOR-ACTIVITY; OVARIAN-FOLLICLES; ATLANTIC HAGFISH	Since hagfishes are considered the most primitive vertebrate known, extant or extinct, studies on their reproduction are indispensable for understanding phylogenetic aspects of vertebrate reproduction. However, little information is available on the endocrine regulation of the gonadal function in the hagfish. Based on EST analysis of the testis of the brown hagfish (Paramyxine atami), P450 side chain cleavage (CYP11A), which is the first and essential enzyme for steroidogenesis in jawed vertebrates, was cloned. The deduced amino acid sequence of hagfish CYP11A shows high identity to other animal forms especially in two functional domains, adrenodoxin binding domain and heme-binding domain. In the phylogenetic analysis, hagfish CYP11A forms a clade with the vertebrate CYP11A. Following the real-time PCR analysis, CYP11A mRNA expression levels were clearly correlated to the developmental stages of gonads in both sexes of the brown hagfish. By in situ hybridization, CYP11A mRNA signals were found in the theca cells of the ovarian follicles and Leydig cells and the tubule-boundary cells of the testis. These molecular and histological evidences are suggesting that CYP11A plays functional roles as a steroidogenic enzyme in gonadal development. Moreover, native GTH purified from hagfish pituitary stimulated the transcriptional levels of CYP11A in the organ-cultured testis in vitro, clearly suggesting that the steroidogenic activity of the hagfish is under the control of the pituitary GTH. It is suggested that vertebrates, during their early evolution, have established the pituitary-gonadal reproductive system. (C) 2015 Elsevier Inc. All rights reserved.	[Nishiyama, Maki; Nozaki, Masumi] Niigata Univ, Fac Sci, Sado Marine Biol Stn, Niigata 9522135, Japan; [Nishiyama, Maki] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata, Niigata 9502181, Japan; [Uchida, Katsuhisa] Miyazaki Univ, Dept Marine Biol & Environm Sci, Fac Agr, Miyazaki 8892192, Japan; [Abe, Nozomi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Nozaki, M (reprint author), Niigata Univ, Fac Sci, Sado Marine Biol Stn, Niigata 9522135, Japan.	nozaki@cc.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology Japan; Japanese Association for Marine Biology (JAMBIO)	We would like to express our gratitude to Dr. S. Awata and Mr. T. Shimotani, Niigata University, for their help in the EST analysis. We also thank Drs. S. Moriyama and H. Amano, Kitasato University, for allowing us to use their laboratories and equipments and for their useful advice. We would also like to thank Dr. H. Ando, Niigata University, for his useful advice. The present study was supported in part by a Grant-in Aid for Basic Research from the Ministry of Education, Culture, Sports, Science and Technology Japan. The present study was also supported in part by the Japanese Association for Marine Biology (JAMBIO).	Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mizuta T, 2007, ENDOCRINOLOGY, V148, P3554, DOI 10.1210/en.2007-0109; Kusakabe M, 2006, J ENDOCRINOL, V189, P541, DOI 10.1677/joe.1.06684; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; FOREY P, 1993, NATURE, V361, P129, DOI 10.1038/361129a0; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Kazeto Y, 2006, J STEROID BIOCHEM, V99, P121, DOI 10.1016/j.jsbmb.2005.12.004; Uchida K, 2010, P NATL ACAD SCI USA, V107, P15832, DOI 10.1073/pnas.1002208107; Nakamoto M, 2010, DEV GROWTH DIFFER, V52, P385, DOI 10.1111/j.1440-169X.2010.01178.x; Nakamura I, 2005, GEN COMP ENDOCR, V144, P224, DOI 10.1016/j.ygcen.2005.06.004; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Bryan MB, 2007, BIOL REPROD, V77, P688, DOI 10.1095/biolreprod.107.061093; Bryan MB, 2008, STEROIDS, V73, P1, DOI 10.1016/j.steroids.2007.08.011; Ijiri S, 2006, GEN COMP ENDOCR, V145, P75, DOI 10.1016/j.ygcen.2005.07.005; CHUNG B, 1986, P NATL ACAD SCI USA, V83, P8962, DOI 10.1073/pnas.83.23.8962; FERNHOLM B, 1972, Acta Zoologica (Stockholm), V53, P235; FOREY P, 1994, AM SCI, V82, P554; GORBMAN A., 1983, FISH PHYSIOL, P1; Gorbman A., 1962, TXB COMP ENDOCRINOLO; Gorbman A., 1978, P49; Gore-Langton R.E., 1998, PHYSL REPROD, V1, P331; Hardisty M. W., 1979, BIOL CYCLOSTOMES; HIROSE K, 1975, COMP BIOCHEM PHYS B, V51, P403, DOI 10.1016/0305-0491(75)90029-2; KABASAWA H, 1991, NIPPON SUISAN GAKK, V57, P1845; KABASAWA H, 1994, FISHERIES SCI, V60, P21; KIME DE, 1980, GEN COMP ENDOCR, V42, P71, DOI 10.1016/0016-6480(80)90258-0; Kobayashi T, 1998, CELL TISSUE RES, V292, P573, DOI 10.1007/s004410051086; Larsen L. O., 1973, THESIS U COPENHAGEN; Lowartz S, 2003, COMP BIOCHEM PHYS A, V134, P365, DOI 10.1016/S1095-6433(02)00285-4; MATTY AJ, 1976, GEN COMP ENDOCR, V30, P500, DOI 10.1016/0016-6480(76)90120-9; Miki M, 2006, GEN COMP ENDOCR, V148, P15, DOI 10.1016/j.ygcen.2006.01.018; Miller Walter L., 2008, V13, P1, DOI 10.1159/000134751; Mime D. E., 1980, GEN COMP ENDOCR, V41, P8; Nagahama Yoshitaka, 1994, P393; Nishiyama M, 2013, ZOOL SCI, V30, P967, DOI 10.2108/zsj.30.967; Nozaki M, 2008, ZOOL SCI, V25, P1028, DOI 10.2108/zsj.25.1028; Nozaki Masumi, 2013, Front Endocrinol (Lausanne), V4, P200, DOI 10.3389/fendo.2013.00200; Nozaki M, 2013, GEN COMP ENDOCR, V189, P111, DOI 10.1016/j.ygcen.2013.04.034; Payne N. H., 2004, ENDOCR REV, V25, P947; Powell ML, 2006, GEN COMP ENDOCR, V148, P95, DOI 10.1016/j.ygcen.2006.01.003; Powell ML, 2004, J EXP ZOOL PART A, V301A, P352, DOI 10.1002/jez.a.20043; SCHUTZINGER S, 1987, ACTA ZOOL-STOCKHOLM, V68, P263; TSUNEKI K, 1977, ACTA ZOOL-STOCKHOLM, V58, P27; TSUNEKI K, 1977, ACTA ZOOL-STOCKHOLM, V58, P17; WEISBART M, 1980, GEN COMP ENDOCR, V41, P506, DOI 10.1016/0016-6480(80)90055-6; Young BA, 2007, GEN COMP ENDOCR, V151, P108, DOI 10.1016/j.ygcen.2006.12.005; YU JYL, 1981, GEN COMP ENDOCR, V43, P492, DOI 10.1016/0016-6480(81)90234-3	47	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0016-6480	1095-6840		GEN COMP ENDOCR	Gen. Comp. Endocrinol.	FEB 1	2015	212						1	9		10.1016/j.ygcen.2015.01.014		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CE9PN	WOS:000352176000001		
J	Bain, PA; Ogino, Y; Miyagawa, S; Iguchi, T; Kumar, A				Bain, Peter A.; Ogino, Yukiko; Miyagawa, Shinichi; Iguchi, Taisen; Kumar, Anupama			Differential ligand selectivity of androgen receptors alpha and beta from Murray-Darling rainbowfish (Melanotaenia fluviatilis)	GENERAL AND COMPARATIVE ENDOCRINOLOGY			English	Article						Androgen receptor; Environmental endocrine disruptors; Anti-androgens; Teleosts; Fish	MINNOW PIMEPHALES-PROMELAS; MALE 3-SPINED STICKLEBACK; FATHEAD MINNOW; GASTEROSTEUS-ACULEATUS; NUCLEAR-LOCALIZATION; ANTIANDROGEN FLUTAMIDE; PROGESTERONE-RECEPTOR; SEX CHARACTERISTICS; GENOME DUPLICATION; ESTROGEN-RECEPTOR	Androgen receptors (ARs) mediate the physiological effects of androgens in vertebrates. In fishes, AR-mediated pathways can be modulated by aquatic contaminants, resulting in the masculinisation of female fish or diminished secondary sex characteristics in males. The Murray-Darling rainbowfish (Melanotaenia fluviatilis) is a small-bodied freshwater teleost used in Australia as a test species for environmental toxicology research. We determined concentration-response profiles for selected agonists and antagonists of rainbowfish AR alpha and AR beta using transient transactivation assays. For both AR alpha and AR beta, the order of potency of natural agonists was 11-ketotestosterone (11-KT) > 5 alpha-dihydrotestosterone > testosterone > androstenedione. Methyltestosterone was a highly potent agonist of both receptors relative to 11-KT. The relative potency of the veterinary growth-promoting androgen, 17 beta-trenbolone, varied by more than a factor of 5 between AR alpha and AR beta. The non-steroidal anti-androgen bicalutamide exhibited high inhibitory potency relative to the structurally related model anti-androgen, flutamide. The inhibitory potency of the agricultural fungicide, vinclozolin, was approximately 1.7-fold relative to flutamide for AR alpha, but over 20-fold in the case of AR beta. Fluorescent protein tagging of ARs showed that the rainbowfish AR alpha subtype is constitutively localised to the nucleus, while AR beta is cytoplasmic in the absence of ligand, an observation which agrees with the reported subcellular localisation of AR subtypes from other teleost species. Collectively, these data suggest that M. fluviatilis AR alpha and AR beta respond differently to environmental AR modulators and that in vivo sensitivity to contaminants may depend on the tissue distribution of the AR subtypes at the time of exposure. (C) 2015 Elsevier Inc. All rights reserved.	[Bain, Peter A.; Kumar, Anupama] CSIRO, Land & Water Flagship, Glen Osmond, SA 5064, Australia; [Ogino, Yukiko; Miyagawa, Shinichi; Iguchi, Taisen] Natl Inst Basic Biol, Div Mol Environm Endocrinol, Okazaki, Aichi 4440867, Japan	Bain, PA (reprint author), CSIRO, Land & Water Flagship, PMB 2, Glen Osmond, SA 5064, Australia.	peter.bain@csiro.au	Kumar, Anu/E-9643-2011; Bain, Peter/A-9067-2013	Bain, Peter/0000-0002-0159-8417	CSIRO (Division of Land and Water Capability Development Theme project) [R-00325-14-012]; UK-Japan Research Collaboration Grants from the Ministry of the Environment (Japan); Japan Society for the Promotion of Science [23254003, 24370029]	This work was supported by funding from CSIRO (Division of Land and Water Capability Development Theme project R-00325-14-012), UK-Japan Research Collaboration Grants from the Ministry of the Environment (Japan), and Grants-in-Aid for Scientific Research (23254003, 24370029) from the Japan Society for the Promotion of Science. We thank A. Gregg and T. Mizutani for technical assistance and A. Papanicolaou for bioinformatics training and advice. We are grateful for early critical reviews of the manuscript provided by V. S. Basheer and S. Hook and to all reviewers for their insightful comments.	Ait-Aissa S, 2010, TOXICOL IN VITRO, V24, P1979, DOI 10.1016/j.tiv.2010.08.014; Martyniuk CJ, 2013, GEN COMP ENDOCR, V194, P264, DOI 10.1016/j.ygcen.2013.09.019; Bayley M, 2002, AQUAT TOXICOL, V56, P227, DOI 10.1016/S0166-445X(01)00210-7; Ankley GT, 2004, ENVIRON SCI TECHNOL, V38, P6322, DOI 10.1021/es040022b; Hager GL, 2000, J STEROID BIOCHEM, V74, P249, DOI 10.1016/S0960-0760(00)00100-X; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Molina-Molina JM, 2006, TOXICOL APPL PHARM, V216, P44, DOI 10.1016/j.taap.2006.04.005; Ni L, 2013, MOL CELL BIOL, V33, P4766, DOI 10.1128/MCB.00647-13; KRUST A, 1986, EMBO J, V5, P891; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; LEITZ T, 1987, GEN COMP ENDOCR, V66, P145, DOI 10.1016/0016-6480(87)90359-5; Lange A, 2012, AQUAT TOXICOL, V109, P250, DOI 10.1016/j.aquatox.2011.09.004; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Ogino Y, 2009, ENDOCRINOLOGY, V150, P5415, DOI 10.1210/en.2009-0523; MacLean HE, 2008, FASEB J, V22, P2676, DOI 10.1096/fj.08-105726; Olsson PE, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-37; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Matsumoto T, 2005, J BIOCHEM, V138, P105, DOI 10.1093/jb/mvi118; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115; Orlando EF, 2004, ENVIRON HEALTH PERSP, V112, P353, DOI 10.1289/ehp.6591; Sebire M, 2009, ECOTOXICOLOGY, V18, P122, DOI 10.1007/s10646-008-0265-2; Harbott LK, 2007, J COMP NEUROL, V504, P57, DOI 10.1002/cne.21435; Bhatia H, 2013, ENVIRON TOXICOL CHEM, V32, P2335, DOI 10.1002/etc.2304; JENSTER G, 1993, BIOCHEM J, V293, P761; Parks LG, 2001, TOXICOL SCI, V62, P257, DOI 10.1093/toxsci/62.2.257; Pollino CA, 2002, ECOTOX ENVIRON SAFE, V52, P180, DOI 10.1006/eesa.2002.2190; GUIOCHONMANTEL A, 1989, CELL, V57, P1147, DOI 10.1016/0092-8674(89)90052-4; Bhatia H, 2014, ENVIRON TOXICOL CHEM, V33, P1098, DOI 10.1002/etc.2524; Braun AM, 2004, BIOL REPROD, V71, P146, DOI 10.1095/biolreprod.103.025825; Jakobsson S, 1999, FISH PHYSIOL BIOCHEM, V20, P79, DOI 10.1023/A:1007776016610; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Bhatia H, 2014, AQUAT TOXICOL, V149, P103, DOI 10.1016/j.aquatox.2014.01.025; Murashima A, 2011, ENDOCRINOLOGY, V152, P1640, DOI 10.1210/en.2010-1121; Zempo B, 2013, J COMP NEUROL, V521, P1760, DOI 10.1002/cne.23255; Woods M, 2011, ENVIRON TOXICOL CHEM, V30, P2620, DOI 10.1002/etc.660; Pollino CA, 2007, ENVIRON TOXICOL CHEM, V26, P2171, DOI 10.1897/06-603R.1; Miyagawa S, 2014, ENVIRON SCI TECHNOL, V48, P5254, DOI 10.1021/es5002659; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wilson VS, 2007, ENVIRON TOXICOL CHEM, V26, P1793, DOI 10.1897/06-593R.1; Filby AL, 2007, AQUAT TOXICOL, V81, P219, DOI 10.1016/j.aquatox.2006.12.003; Pollino CA, 2002, ENVIRON TOXICOL, V17, P138, DOI 10.1002/tox.10043; Papadopoulou N, 2009, IUBMB LIFE, V61, P56, DOI 10.1002/iub.150; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Chiu CH, 2004, GENOME RES, V14, P11, DOI 10.1101/gr.1712904; Crete-Lafreniere A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046662; Douard V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-336; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Hogan NS, 2012, ENVIRON TOXICOL CHEM, V31, P1391, DOI 10.1002/etc.1815; Jolly C, 2009, AQUAT TOXICOL, V92, P228, DOI 10.1016/j.aquatox.2009.02.006; JUKES T H, 1969, P21; Lim CS, 1999, MOL ENDOCRINOL, V13, P366, DOI 10.1210/me.13.3.366; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Margiotta-Casaluci L, 2013, GEN COMP ENDOCR, V191, P202, DOI 10.1016/j.ygcen.2013.06.017; Matsui D, 2002, NUCLEIC ACIDS RES, V30, P1387, DOI 10.1093/nar/30.6.1387; Ogino Y, 2014, ENDOCRINOLOGY, V155, P449, DOI 10.1210/en.2013-1507; Ogino Y, 2004, FEBS LETT, V575, P119, DOI 10.1016/j.febslet.2004.08.046; Ogino Y, 2011, EVOL DEV, V13, P315, DOI 10.1111/j.1525-142X.2011.00482.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; WELSHONS WV, 1984, NATURE, V307, P747, DOI 10.1038/307747a0; Woods M, 2009, MOL CELL ENDOCRINOL, V303, P57, DOI 10.1016/j.mce.2008.12.014	62	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0016-6480	1095-6840		GEN COMP ENDOCR	Gen. Comp. Endocrinol.	FEB 1	2015	212						84	91		10.1016/j.ygcen.2015.01.024		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CE9PN	WOS:000352176000010		
J	Kobayashi, Y; Hamamoto, A; Hirayama, T; Saito, Y				Kobayashi, Yuki; Hamamoto, Akie; Hirayama, Tomo; Saito, Yumiko			Molecular cloning, expression, and signaling pathway of four melanin-concentrating hormone receptors from Xenopus tropicalis	GENERAL AND COMPARATIVE ENDOCRINOLOGY			English	Article						Xenopus tropicalis; Melanin-concentrating hormone (MCH); MCH receptor; Calcium mobilization; Pigment migration	PROTEIN-COUPLED RECEPTORS; FEEDING-BEHAVIOR; BARFIN FLOUNDER; MESSENGER-RNA; HORMONE-RECEPTOR-1; MELANOPHORES; MCH; IDENTIFICATION; ACTIVATION; SLC-1	Melanin-concentrating hormone (MCH) mainly regulates feeding in mammals and pigmentation in teleosts. It acts via two G-protein-coupled receptors, MCH receptor 1 (MCHR1) and MCHR2. Although many studies exploring the MCH system in teleosts and mammals have been carried out, studies on other organisms are limited. In this study, we cloned and characterized four MCHR subtypes from the diploid species Xenopus tropicalis (X-MCHRs; X-MCHR1a, R1b, R2a, and R2b). According to a phylogenetic tree of the X-MCHRs, X-MCHR1a and R2a are close to mammalian MCHRs, while X-MCHR1b and R2b are close to teleostean MCHRs. We previously reported that the G-protein coupling capacity of the MCHR subtypes differed between mammals (R1: G alpha i/o and G alpha q; R2: G alpha q) and teleosts (R1: Gaq; R2: Gai/o and Gaq) in mammalian cell-based assays. By using Ca2+ mobilization assays with pertussis toxin in CHO dhfr(-) cells, we found that X-MCHR1a promiscuously coupled to both Gai/o and Gaq, while X-MCHR1b and R2a exclusively coupled to Gaq. However, no Ca2+ influx was detected in cells transfected with X-MCHR2b. Reverse transcription-PCR showed that the X-MCHR mRNAs were expressed in various tissues. In particular, both X-MCHR1b and R2b were exclusively found in melanophores of the dorsal skin. In skin pigment migration assays, melanophores were weakly aggregated at low concentrations but dispersed at high concentrations of MCH, suggesting possible interactions between X-MCHR1b and R2b for the regulation of body color. These findings demonstrate that X. tropicalis has four characteristic MCHRs and will be useful for elucidating the nature of MCHR evolution among vertebrates. (C) 2014 Elsevier Inc. All rights reserved.	[Kobayashi, Yuki; Hamamoto, Akie; Hirayama, Tomo; Saito, Yumiko] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Hiroshima 7398521, Japan	Saito, Y (reprint author), Hiroshima Univ, Grad Sch Integrated Arts & Sci, 1-7-1 Kagamiyama, Hiroshima 7398521, Japan.	yumist@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [226342]; Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI) [23500449]	This study was supported by a Grant-in-Aid for JSPS Fellows (226342) to Y.K. from the Japan Society for the Promotion of Science and a research grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI 23500449 to Y.S.).	Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Logan DW, 2006, PIGM CELL RES, V19, P206, DOI 10.1111/j.1600-0749.2006.00307.x; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Saito Y, 1999, NATURE, V400, P265; Tan CP, 2002, GENOMICS, V79, P785, DOI 10.1006/geno.2002.6771; An SZ, 2001, P NATL ACAD SCI USA, V98, P7576, DOI 10.1073/pnas.131200698; Saito Y, 2001, J COMP NEUROL, V435, P26, DOI 10.1002/cne.1191; Borowsky B, 2002, NAT MED, V8, P825, DOI 10.1038/nm741; Graham GJ, 2009, EUR J IMMUNOL, V39, P342, DOI 10.1002/eji.200838858; Shimada M, 1998, NATURE, V396, P670; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Hawes BE, 2000, ENDOCRINOLOGY, V141, P4524, DOI 10.1210/en.141.12.4524; Georgescu D, 2005, J NEUROSCI, V25, P2933, DOI 10.1523/JNEUROSCI.1714-04.2005; Verlaet M, 2002, FEBS LETT, V527, P205, DOI 10.1016/S0014-5793(02)03232-5; KAWAUCHI H, 1983, NATURE, V305, P321, DOI 10.1038/305321a0; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Chambers J, 1999, NATURE, V400, P261, DOI 10.1038/22313; Bradley RL, 2002, AM J PHYSIOL-ENDOC M, V283, pE584, DOI 10.1152/ajpendo.00161.2001; CLARK CR, 1987, IN VITRO CELL DEV B, V23, P417; Eberle A.N., 1988, THE MELANOTROPINS, P321; Fan J, 2005, MOL ENDOCRINOL, V19, P2579, DOI 10.1210/me.2004-0301; Fry D, 2006, INT J BIOCHEM CELL B, V38, P1290, DOI 10.1016/j.biocel.2006.01.007; Gao XY, 2004, ANAL BIOCHEM, V328, P187, DOI 10.1016/j.ab.2004.01.017; Gudermann T, 1997, ANNU REV NEUROSCI, V20, P399, DOI 10.1146/annurev.neuro.20.1.399; Hamamoto A., 2012, FRONT ENDOCRINOL LAU, V26, P147; Hamamoto A, 2011, REGUL PEPTIDES, V169, P6, DOI 10.1016/j.regpep.2011.04.001; IDE H, 1985, GEN COMP ENDOCR, V58, P486, DOI 10.1016/0016-6480(85)90123-6; Ji YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-263; Kashiwagi K, 2010, EXP ANIM TOKYO, V59, P395; Kobayashi Y, 2010, GEN COMP ENDOCR, V168, P133, DOI 10.1016/j.ygcen.2010.04.017; Logan DW, 2003, GENOMICS, V81, P184, DOI 10.1016/S0888-7543(02)00037-x; Macdonald D, 2000, MOL PHARMACOL, V58, P217; Mizusawa K, 2009, PEPTIDES, V30, P1990, DOI 10.1016/j.peptides.2009.04.010; Mizusawa K, 2011, GEN COMP ENDOCR, V171, P75, DOI 10.1016/j.ygcen.2010.12.008; Mori M, 2001, BIOCHEM BIOPH RES CO, V283, P1013, DOI 10.1006/bbrc.2001.4893; Oshima N, 2001, COMP BIOCHEM PHYS C, V129, P75, DOI 10.1016/S1532-0456(01)00187-9; Saito Yumiko, 2013, Front Endocrinol (Lausanne), V4, P154, DOI 10.3389/fendo.2013.00154; Saito Y, 2003, FEBS LETT, V533, P29, DOI 10.1016/S0014-5793(02)03744-4; Saito Y, 2001, BIOCHEM BIOPH RES CO, V289, P44, DOI 10.1006/bbrc.2001.5926; Saito Y, 2005, ENDOCRINOLOGY, V146, P3452, DOI 10.1210/en.2005-0115; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Shearman LP, 2003, EUR J PHARMACOL, V475, P37, DOI 10.1016/S0014-2999(03)02146-0; Shimomura Y, 1999, BIOCHEM BIOPH RES CO, V261, P622, DOI 10.1006/bbrc.1999.1104; Siegel S., 1988, NONPARAMETRIC STAT B, P190; Takahashi A, 2007, GEN COMP ENDOCR, V151, P210, DOI 10.1016/j.ygcen.2007.01.011; Takekawa S, 2002, EUR J PHARMACOL, V438, P129, DOI 10.1016/S0014-2999(02)01314-6	47	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0016-6480	1095-6840		GEN COMP ENDOCR	Gen. Comp. Endocrinol.	FEB 1	2015	212						114	123		10.1016/j.ygcen.2014.03.005		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CE9PN	WOS:000352176000014		
J	Nag, K; Sultana, N; Kato, A; Dranik, A; Nakamura, N; Kutsuzawa, K; Hirose, S; Akaike, T				Nag, Kakon; Sultana, Naznin; Kato, Akira; Dranik, Anna; Nakamura, Nobuhiro; Kutsuzawa, Koichi; Hirose, Shigehisa; Akaike, Toshihiro			Ligand-induced internalization, recycling, and resensitization of adrenomedullin receptors depend not on CLR or RAMP alone but on the receptor complex as a whole	GENERAL AND COMPARATIVE ENDOCRINOLOGY			English	Article						Adrenomedullin; CGRP; CLR; RAMP; GPCR; Signaling	ACTIVITY-MODIFYING PROTEINS; CALCITONIN-RECEPTOR; PEPTIDE FAMILY; TRAFFICKING; PHARMACOLOGY; MODULATION; ARRESTIN	Adrenomedullins (AM) is a multifaceted distinct subfamily of peptides that belongs to the calcitonin gene-related peptide (CGRP) superfamily. These peptides exert their functional activities via associations of calcitonin receptor-like receptors (CLRs) and receptor activity-modifying proteins (RAMPs) RAMP2 and RAMP3. Recent studies established that RAMPs and CLRs can modify biochemical properties such as trafficking and glycosylation of each other. However there is very little or no understanding regarding how RAMP or CLR influence ligand-induced events of AM-receptor complex. In this study, using pufferfish homologs of CLR (mfCLR1-3) and RAMP (mfRAMP2 and mfRAMP3), we revealed that all combinations of CLR and RAMP quickly underwent ligand-induced internalization; however, their recycling rates were different as follows: mfCLR1-mfRAMP3 > mfCLR2-mfRAMP3 > mfCLR3-mfRAMP3. Functional receptor assay confirmed that the recycled receptors were resensitized on the plasma membrane. In contrast, a negligible amount of mfCLR1-mfRAMP2 was recycled and reconstituted. Immunocytochemistry results indicated that the lower recovery rate of mfCLR3-mfRAMP3 and mfCLR1-mfRAMP2 was correlated with higher proportion of lysosomal localization of these receptor complexes compared to the other combinations. Collectively our results indicate, for the first time, that the ligand-induced internalization, recycling, and reconstitution properties of RAMP-CLR receptor complexes depend on the receptor-complex as a whole, and not on individual CLR or RAMP alone. (C) 2014 Elsevier Inc. All rights reserved.	[Nag, Kakon; Sultana, Naznin; Kato, Akira; Nakamura, Nobuhiro; Hirose, Shigehisa] Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Nag, Kakon; Dranik, Anna] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; [Nag, Kakon; Kutsuzawa, Koichi; Akaike, Toshihiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Nag, K (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, 4259-B19 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	kakonpoly@yahoo.com	Nakamura, Nobuhiro/C-4265-2015		Ministry of Education, Culture, Sport, Science and Technology of Japan (MEXT) [14104002, 16710145, 18059010, 06F06183]; MEXT; JSPS [P 06183, P 12392]	This work was supported by Grants-in-Aid for Scientific Research (14104002, 16710145, 18059010 and 06F06183) from the Ministry of Education, Culture, Sport, Science and Technology of Japan (MEXT) and the 21st Century and Global COE Programs of MEXT. K.N. and N.S. were supported by JSPS Postdoctoral Fellowship for Foreign Researchers (P 06183 and P 12392, respectively).	Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; McLatchie LM, 1998, NATURE, V393, P333; Padilla BE, 2007, J CELL BIOL, V179, P981, DOI 10.1083/jcb.200704053; Kuwasako K, 2000, J BIOL CHEM, V275, P29602, DOI 10.1074/jbc.M004534200; Bouschet T, 2005, J CELL SCI, V118, P4709, DOI 10.1242/jcs.02598; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Nag K, 2012, BIOCHEM BIOPH RES CO, V418, P824, DOI 10.1016/j.bbrc.2012.01.116; Hay DL, 2006, PHARMACOL THERAPEUT, V109, P173, DOI 10.1016/j.pharmthera.2005.06.015; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Katafuchi T, 2004, PEPTIDES, V25, P2039, DOI 10.1016/j.peptides.2004.08.013; Udawela M, 2004, SEMIN CELL DEV BIOL, V15, P299, DOI 10.1016/j.semcdb.2003.12.019; Bomberger JM, 2005, J BIOL CHEM, V280, P9297, DOI 10.1074/jbc.M13786200; Bomberger JM, 2005, J BIOL CHEM, V280, P23926, DOI 10.1074/jbc.M501751200; da Cruz E. S. O. A., 2004, NEURODEGENER DIS, V1, P196; Nag K, 2006, AM J PHYSIOL-REG I, V290, pR467, DOI 10.1152/ajpregu.00507.2005; Nag K, 2007, GEN COMP ENDOCR, V154, P48, DOI 10.1016/j.ygcen.2007.06.017; Ogoshi M, 2006, PEPTIDES, V27, P3154, DOI 10.1016/j.peptides.2006.09.011; Sexton PM, 2006, ANN NY ACAD SCI, V1070, P90, DOI 10.1196/annals.1317.076; Simaan M, 2005, CELL SIGNAL, V17, P1074, DOI 10.1016/j.cellsig.2004.12.001	22	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0016-6480	1095-6840		GEN COMP ENDOCR	Gen. Comp. Endocrinol.	FEB 1	2015	212						156	162		10.1016/j.ygcen.2014.04.029		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CE9PN	WOS:000352176000018		
J	Umino, S; Kitamura, K; Kanayama, K; Tamura, A; Sakamoto, N; Ishizuka, O; Arai, S				Umino, Susumu; Kitamura, Keitaro; Kanayama, Kyoko; Tamura, Akihiro; Sakamoto, Naoya; Ishizuka, Osamu; Arai, Shoji			Thermal and chemical evolution of the subarc mantle revealed by spinel-hosted melt inclusions in boninite from the Ogasawara (Bonin) Archipelago, Japan	GEOLOGY			English	Article							ISLANDS; ARC; CONSTRAINTS; COMPONENTS; CHICHIJIMA; CHROMITES; VOLCANISM; PETROLOGY; OPHIOLITE; MAGMAS	Primitive melt inclusions in chrome spinel from the Ogasawara Archipelago (Japan) compose two discrete groups of high-SiO2, high-MgO (high-Si) and low-SiO2, low-MgO (low-Si) boninitic suites, with ultra-depleted dish-and V-shaped, and less-depleted flat, rare earth element patterns. The most magnesian melt inclusions of each geochemical type were used to estimate the temperature-pressure conditions for primary boninites, which range from 1345 degrees C at 0.56 GPa to 1421 degrees C at 0.85 GPa for the 48-46 Ma low-Si and high-Si boninites, and 1381 degrees C at 0.85 GPa for the 45 Ma low-Si boninite. The onset of the Pacific slab subduction at 52 Ma forced upwelling of depleted mid-oceanic ridge basalt mantle (DMM) to yield proto-arc basalt (PAB). With the rise of DMM, refractory harzburgite ascended without melting. At 48-46 Ma, introduction of slab fluids induced melting of the PAB residue and high-temperature harzburgite, resulting in the low-Si and high-Si boninites, respectively. Meanwhile, convection within the mantle wedge brought the less-depleted residue of PAB and DMM into the region fluxed by slab fluids, which melted to yield the less-depleted low-Si boninite at 45 Ma, and fertile arc basalts, respectively.	[Umino, Susumu; Kitamura, Keitaro; Kanayama, Kyoko; Tamura, Akihiro; Arai, Shoji] Kanazawa Univ, Div Nat Syst, Kanazawa, Ishikawa 9201192, Japan; [Sakamoto, Naoya] Hokkaido Univ, Creat Res Inst, Sapporo, Hokkaido 0010021, Japan; [Ishizuka, Osamu] Geol Survey Japan, Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058567, Japan	Umino, S (reprint author), Kanazawa Univ, Div Nat Syst, Kanazawa, Ishikawa 9201192, Japan.				Geological Survey of Japan; Japan Ministry of Education, Culture, Sports, Science and Technology Special Budget project [812000009];  [25287133]	This study was supported by the Geological Survey of Japan and Grants-in-Aid for Scientific Research No. 25287133 to Ishizuka, and Japan Ministry of Education, Culture, Sports, Science and Technology Special Budget project no. 812000009 to Arai. We thank N. Yurimoto (Hokkaido University) for the usage of secondary ion mass spectrometry, and N. Chatterjee, A.J. Arculus and F. Sorbadere for their critical reviews.	Schiano P, 2003, EARTH-SCI REV, V63, P121, DOI 10.1016/S0012-8252(03)00034-5; Kelley KA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000435; Kamenetsky VS, 2002, CHEM GEOL, V183, P287, DOI 10.1016/S0009-2541(01)00380-1; Ishizuka O, 2011, EARTH PLANET SC LETT, V306, P229, DOI 10.1016/j.epsl.2011.04.006; Kent AJR, 2008, REV MINERAL GEOCHEM, V69, P273, DOI 10.2138/rmg.2008.69.8; Reagan MK, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002871; Putirka KD, 2008, REV MINERAL GEOCHEM, V69, P61, DOI 10.2138/rmg.2008.69.3; Bedard JH, 1999, J PETROL, V40, P1853, DOI 10.1093/petrology/40.12.1853; Evans KA, 2012, GEOLOGY, V40, P783, DOI 10.1130/G33037.1; Workman RK, 2005, EARTH PLANET SC LETT, V231, P53, DOI 10.1016/j.epsl.2004.12.005; Sobolev AV, 1996, EARTH PLANET SC LETT, V137, P45, DOI 10.1016/0012-821X(95)00203-O; TAYLOR RN, 1994, J PETROL, V35, P577; Yamamoto S, 2009, LITHOS, V109, P314, DOI 10.1016/j.lithos.2008.05.003; Ishizuka O, 2006, EARTH PLANET SC LETT, V250, P385, DOI 10.1016/j.epsl.2006.08.007; Herzberg C, 2009, NATURE, V458, P619, DOI 10.1038/nature07857; SOBOLEV AV, 1994, J PETROL, V35, P1183; Putirka KD, 2007, CHEM GEOL, V241, P177, DOI 10.1016/j.chemgeo.2007.01.014; Crawford A.J., 1989, BONINITES RELATED RO, P1; Herzberg C, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001390; Ishibashi H., 2013, P INT ASS VOLC CHEM; Kanayama K, 2012, ISL ARC, V21, P288, DOI 10.1111/iar.12000; Kanayama K, 2014, J ASIAN EARTH SCI, V85, P1, DOI 10.1016/j.jseaes.2014.01.012; Le Maitre R.W., 2002, IGNEOUS ROCKS CLASSI; Parkinson IJ, 1998, SCIENCE, V281, P2011, DOI 10.1126/science.281.5385.2011; PEARCE JA, 1992, P OCEAN DRILLING PRO, V0125; Shimizu K, 2001, EARTH PLANET SC LETT, V189, P177, DOI 10.1016/S0012-821X(01)00359-4; Shimizu K., 2013, MINERAL MAG, V77, P2200; Shimizu K., 2014, P GOLDSCHM 2014 C 8, p08d; Smith PM, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000816; Suzuki K, 2011, GEOLOGY, V39, P999, DOI 10.1130/G32044.1; UMINO S, 1986, J VOLCANOL GEOTH RES, V29, P125, DOI 10.1016/0377-0273(86)90042-9	31	0	0	GEOLOGICAL SOC AMER, INC	BOULDER	PO BOX 9140, BOULDER, CO 80301-9140 USA	0091-7613	1943-2682		GEOLOGY	Geology	FEB	2015	43	2					151	154		10.1130/G36191.1		4	Geology	Geology	CE8ME	WOS:000352095800014		
J	Kameda, J; Shimizu, M; Ujiie, K; Hirose, T; Ikari, M; Mori, J; Oohashi, K; Kimura, G				Kameda, Jun; Shimizu, Mayuko; Ujiie, Kohtaro; Hirose, Takehiro; Ikari, Matt; Mori, James; Oohashi, Kiyokazu; Kimura, Gaku			Pelagic smectite as an important factor in tsunamigenic slip along the Japan Trench	GEOLOGY			English	Article							TOHOKU-OKI EARTHQUAKE; PLATE-BOUNDARY; ZONE; MINERALOGY; FRICTION; RUPTURE; STRESS; GOUGE; AXIS; CLAY	The very large slip on the shallow portion of the subduction interface during the 2011 Tohoku-oki earthquake (M-w 9.0) caused a huge tsunami along the northeast coast of Honshu, Japan. In order to elucidate the mechanics of such tsunamigenic slip, the Integrated Ocean Drilling Program Expedition 343 (Japan Trench Fast Drilling Project, JFAST), was carried out one year after the earthquake and succeeded in recovering rocks constituting the active plate boundary fault. Our mineralogical analyses using X-ray diffraction reveal that the shallow portion of the fault zone that caused the earthquake is significantly enriched in smectite compared to the surrounding sediments, which may be intimately linked to the tsunamigenic shallow faulting. For comparison, we also analyzed mineralogical features of incoming sediments just prior to subduction, recovered on the outer rise of the Japan Trench (Site 436, Deep Sea Drilling Project Leg 56), and found a characteristic smectite-rich horizon in the uppermost similar to 5 m of the pelagic clay layer. This horizon should be mechanically weak and will become the future plate boundary fault, as observed in the JFAST cores. The smectite-rich deposits are broadly distributed in the northwestern Pacific Ocean, and may therefore potentially enhance conditions for large shallow slip during earthquakes that occur over a broad area of the Japan Trench plate boundary, which would result in large tsunamis for this region.	[Kameda, Jun] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; [Shimizu, Mayuko; Kimura, Gaku] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Ujiie, Kohtaro] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3050006, Japan; [Hirose, Takehiro] Japan Agcy Marine Earth Sci & Technol, Kochi Inst Core Sample Res, Nankoku, Kochi 7838502, Japan; [Ikari, Matt] Univ Bremen, Ctr Marine Environm Sci MARUM, D-28359 Bremen, Germany; [Mori, James] Kyoto Univ, Earthquake Hazards Div Disaster Prevent Res Inst, Uji, Kyoto 6110011, Japan; [Oohashi, Kiyokazu] Chiba Univ, Grad Sch Sci, Dept Earth Sci, Chiba 2638522, Japan	Kameda, J (reprint author), Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, N10 W8, Sapporo, Hokkaido 0600810, Japan.	kameda@mail.sci.hokudai.ac.jp			Japan Society for the Promotion of Science [24740339]; Nanotechnology Platform Project [12024046]; MEXT (Ministry of Education, Culture, Sports, Science and Technology) [21107005]	This research used samples and data provided by the Deep Sea Drilling Project and the Integrated Ocean Drilling Program. We thank Peter Vrolijk, two anonymous reviewers, and editor Bob Hold-sworth for helping us improve the manuscript. This work was supported by Grants-in-Aid for young scientists (24740339) from the Japan Society for the Promotion of Science, the Nanotechnology Platform Project (12024046), and Grants-in-Aid for Scientific Research on Innovative Areas (21107005) from MEXT (Ministry of Education, Culture, Sports, Science and Technology).	Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Fujiwara T, 2011, SCIENCE, V334, P1240, DOI 10.1126/science.1211554; Ujiie K, 2013, SCIENCE, V342, P1211, DOI 10.1126/science.1243485; VROLIJK P, 1990, GEOLOGY, V18, P703, DOI 10.1130/0091-7613(1990)018<0703:OTMROS>2.3.CO;2; Fujii Y, 2011, EARTH PLANETS SPACE, V63, P815, DOI 10.5047/eps.2011.06.010; Rowe CD, 2013, GEOLOGY, V41, P991, DOI 10.1130/G34556.1; BIRD P, 1984, TECTONOPHYSICS, V107, P235, DOI 10.1016/0040-1951(84)90253-1; Fulton PM, 2013, SCIENCE, V342, P1214, DOI 10.1126/science.1243641; Ide S, 2011, SCIENCE, V332, P1426, DOI 10.1126/science.1207020; Tembe S, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006383; Brown KM, 2003, EARTH PLANET SC LETT, V214, P589, DOI 10.1016/S0012-821X(03)00388-1; Kodaira S, 2012, NAT GEOSCI, V5, P646, DOI [10.1038/ngeo1547, 10.1038/NGEO1547]; BISCAYE PE, 1965, GEOL SOC AM BULL, V76, P803, DOI 10.1130/0016-7606(1965)76[803:MASORD]2.0.CO;2; Wang KL, 2013, SCIENCE, V342, P1178, DOI 10.1126/science.1246518; Arthur M.A., 1980, INITIAL REPORTS DEEP, V56, P3, DOI [10.2973/dsdp.proc.5657.101.1980., DOI 10.2973/DSDP.PROC.5657.1980]; Chester FM, 2012, 343343T IODP, DOI [10.2204/ iodp. pr. 343343T, DOI 10.2204/I0DP.PR.343343T]; Chester FM, 2013, SCIENCE, V342, P1208, DOI 10.1126/science.1243719; Collettini C, 2009, NATURE, V462, P907, DOI 10.1038/nature08585; Faulkner DR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048552; Ikari M., 2015, EARTH PLANE IN PRESS; Kurnosov V., 1980, INITIAL REPORTS DE 2, V56, P979, DOI [10.2973/dsdp.proc.5657.134.1980., DOI 10.2973/DSDP.PR0C.5657.134.1980]; Lisitsyna N.A., 1971, LITOLOGIYA POLEZNYS, V4, P3; Mann U., 1980, INIT REPTS DSDP 2, V56, P939, DOI 10.2973/dsdp.proc.5657.133; Moore D. M., 1997, XRAY DIFFRACTION IDE; Moore D.E., 2007, SEISMOGENIC ZONE SUB, V2, P317; Oohashi K., 2013, JAP GEOSC UN M; Sawai M, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/1880-5981-66-65; Ujiies K., 2014, PROG EARTH PLANET SC, V1, P1, DOI DOI 10.1186/2197-4284-1-7; UNDERWOOD MB, 1993, P OCEAN DRILLING PRO, V0131; WU FT, 1978, PURE APPL GEOPHYS, V116, P655, DOI 10.1007/BF00876531	30	6	6	GEOLOGICAL SOC AMER, INC	BOULDER	PO BOX 9140, BOULDER, CO 80301-9140 USA	0091-7613	1943-2682		GEOLOGY	Geology	FEB	2015	43	2					155	158		10.1130/G35948.1		4	Geology	Geology	CE8ME	WOS:000352095800015		
J	Li, HB; Xue, L; Brodsky, EE; Mori, JJ; Fulton, PM; Wang, H; Kano, Y; Yun, K; Harris, RN; Gong, Z; Li, CL; Si, JL; Sun, ZM; Pei, JL; Zheng, Y; Xu, ZQ				Li, Haibing; Xue, Lian; Brodsky, Emily E.; Mori, James J.; Fulton, Patrick M.; Wang, Huan; Kano, Yasuyuki; Yun, Kun; Harris, Robert N.; Gong, Zheng; Li, Chenglong; Si, Jialiang; Sun, Zhiming; Pei, Junling; Zheng, Yong; Xu, Zhiqin			Long-term temperature records following the M-w 7.9 Wenchuan (China) earthquake are consistent with low friction	GEOLOGY			English	Article							SCIENTIFIC DRILLING PROJECT; FAULT ZONE; WFSD-1; ROCKS	Knowledge of the shear stress on a fault during slip is necessary for a physically-based understanding of earthquakes. Borehole temperature measurements inside the fault zone immediately after an earthquake can record the energy dissipated by this stress. In the first Wenchuan Earthquake Fault Zone Scientific Drilling Project hole (Sichuan province, China) we repeatedly measured temperature profiles from 1.3 to 5.3 yr after the 12 May 2008, M-w 7.9 Wenchuan earthquake. The previously identified candidate for the principal slip surface had only a small local temperature increase of at most 0.02 degrees C with no obvious decay. The small amplitude of the temperature increase provides an upper bound for the frictional heat-generated coseismic slip, but is unlikely to be a frictionally generated signal. Two larger temperature anomalies are located above and within the fault zone. However, neither anomaly evolves as expected from a frictional transient. We conclude that the frictional heat from the Wenchuan earthquake remains elusive and the total heat generated at this location is much less than 29 MJ/m(2). Low friction during slip is consistent with the temperature data.	[Li, Haibing; Wang, Huan; Yun, Kun; Gong, Zheng; Li, Chenglong; Si, Jialiang; Zheng, Yong; Xu, Zhiqin] Chinese Acad Geol Sci, Inst Geol, State Key Lab Continental Tecton & Dynam, Beijing, Peoples R China; [Xue, Lian; Brodsky, Emily E.; Fulton, Patrick M.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Mori, James J.; Kano, Yasuyuki] Kyoto Univ, Disaster Prevent Res Inst, Uji, Kyoto, Japan; [Harris, Robert N.] Oregon State Univ, Corvallis, OR 97331 USA; [Sun, Zhiming; Pei, Junling] Chinese Acad Geol Sci, Inst Geomech, Beijing, Peoples R China	Li, HB (reprint author), Chinese Acad Geol Sci, Inst Geol, State Key Lab Continental Tecton & Dynam, Beijing, Peoples R China.	lihaibing06@163.com		Brodsky, Emily/0000-0002-6855-6860	Chinese National Science and Technology Planning Project (Wenchuan Earthquake Fault Zone Scientific Drilling Project, WFSD); National Science Foundation of China [41330211]; U.S. National Science Foundation [EAR-1220642]	This research was supported by the Chinese National Science and Technology Planning Project (Wenchuan Earthquake Fault Zone Scientific Drilling Project, WFSD), National Science Foundation of China grant 41330211 (to Li) and U.S. National Science Foundation grant EAR-1220642 (Brodsky). We thank W. Zhang, G. Yang, R. Guo, and Y. Huang for data collection assistance. Detailed reviews from T. Shimamoto, S. Nielsen and an anonymous reviewer are enormously appreciated.	Kano Y, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026733; Fulton PM, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB007103; Xue L, 2013, SCIENCE, V340, P1555, DOI 10.1126/science.1237237; Zhang L, 2013, TECTONOPHYSICS, V594, P149, DOI 10.1016/j.tecto.2013.03.030; Fulton PM, 2013, SCIENCE, V342, P1214, DOI 10.1126/science.1243641; Li HB, 2014, TECTONOPHYSICS, V619, P86, DOI 10.1016/j.tecto.2013.08.022; Chen JY, 2013, J GEOPHYS RES-SOL EA, V118, P4145, DOI 10.1002/jgrb.50260; Kuo LW, 2014, GEOLOGY, V42, P47, DOI 10.1130/G34862.1; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Di Toro G, 2011, NATURE, V471, P494, DOI 10.1038/nature09838; Li HB, 2013, TECTONOPHYSICS, V584, P23, DOI 10.1016/j.tecto.2012.08.021; Beardsmore G. R, 2001, CRUSTAL HEAT FLOW GU; Harris RN, 2007, GEOPHYSICS, V72, pE119, DOI 10.1190/1.2734382; Jaeger J. C., 1959, CONDUCTION HEAT SOLI; Si JL, 2014, TECTONOPHYSICS, V619, P171, DOI 10.1016/j.tecto.2013.09.022; Tanaka H, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028153; Tanaka H, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026673; Tang LJ, 2014, TECTONOPHYSICS, V619, P70, DOI 10.1016/j.tecto.2013.08.026; Togo Tetsuhiro, 2011, Earthquake Science, V24, DOI 10.1007/s11589-011-0789-z; Togo Tetsuhiro, 2011, Earthquake Science, V24, DOI 10.1007/s11589-011-0790-6; Yao L, 2013, TECTONOPHYSICS, V599, P135, DOI 10.1016/j.tecto.2013.04.011	21	1	1	GEOLOGICAL SOC AMER, INC	BOULDER	PO BOX 9140, BOULDER, CO 80301-9140 USA	0091-7613	1943-2682		GEOLOGY	Geology	FEB	2015	43	2					163	166		10.1130/G35515.1		4	Geology	Geology	CE8ME	WOS:000352095800017		
J	Harris, DL; Webster, JM; Vila-Concejo, A; Hua, Q; Yokoyama, Y; Reimer, PJ				Harris, Daniel L.; Webster, Jody M.; Vila-Concejo, Ana; Hua, Quan; Yokoyama, Yusuke; Reimer, Paula J.			Late Holocene sea-level fall and turn-off of reef flat carbonate production: Rethinking bucket fill and coral reef growth models	GEOLOGY			English	Article							GREAT-BARRIER-REEF; AUSTRALIA; SEDIMENTATION; STATES	Relative sea-level rise has been a major factor driving the evolution of reef systems during the Holocene. Most models of reef evolution suggest that reefs preferentially grow vertically during rising sea level then laterally from windward to leeward, once the reef flat reaches sea level. Continuous lagoonal sedimentation ("bucket fill") and sand apron progradation eventually lead to reef systems with totally filled lagoons. Lagoonal infilling of One Tree Reef (southern Great Barrier Reef) through sand apron accretion was examined in the context of late Holocene relative sea-level change. This analysis was conducted using sedimentological and digital terrain data supported by 50 radiocarbon ages from fossil microatolls, buried patch reefs, foraminifera and shells in sediment cores, and recalibrated previously published radiocarbon ages. This data set challenges the conceptual model of geologically continuous sediment infill during the Holocene through sand apron accretion. Rapid sand apron accretion occurred between 6000 and 3000 calibrated yr before present B.P. (cal. yr B.P.); followed by only small amounts of sedimentation between 3000 cal. yr B.P. and present, with no significant sand apron accretion in the past 2 k.y. This hiatus in sediment infill coincides with a sea-level fall of similar to 1-1.3 m during the late Holocene (ca. 2000 cal. yr B.P.), which would have caused the turn-off of highly productive live coral growth on the reef flats currently dominated by less productive rubble and algal flats, resulting in a reduced sediment input to back-reef environments and the cessation in sand apron accretion. Given that relative sea-level variations of similar to 1 m were common throughout the Holocene, we suggest that this mode of sand apron development and carbonate production is applicable to most reef systems.	[Harris, Daniel L.; Webster, Jody M.; Vila-Concejo, Ana] Univ Sydney, Sch Geosci, Geocoastal Res Grp, Sydney, NSW 2006, Australia; [Harris, Daniel L.] Univ Bremen, ZMT, Leibniz Ctr Trop Marine Ecol, D-28359 Bremen, Germany; [Harris, Daniel L.] Univ Bremen, MARUM, Ctr Marine Environm Res, D-28359 Bremen, Germany; [Hua, Quan] Australian Nucl Sci & Technol Org, Kirrawee Dc, NSW 2232, Australia; [Yokoyama, Yusuke] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan; [Reimer, Paula J.] Queens Univ Belfast, Sch Geog Archaeol & Palaeoecol, Belfast BT9 6AX, Antrim, North Ireland	Harris, DL (reprint author), Univ Sydney, Sch Geosci F09, Sydney, NSW 2006, Australia.	daniel.harris@sydney.edu.au			University of Sydney start-up grant; Australian Institute of Nuclear Science and Engineering (AINSE) Postgraduate award [ALNSTU0910]; German Excellence Initiative at the University of Bremen; Australian Research Council [ARC FT100100215]	This research was funded by a University of Sydney start-up grant to Webster. Harris was funded by an Australian Institute of Nuclear Science and Engineering (AINSE) Postgraduate award (ALNSTU0910) and the German Excellence Initiative at the University of Bremen. Vila-Concejo was supported by a Future Fellowship Award from the Australian Research Council (ARC FT100100215).	Perry CT, 2008, CORAL REEFS, V27, P853, DOI 10.1007/s00338-008-0418-z; Smithers SG, 2000, MAR GEOL, V168, P61, DOI 10.1016/S0025-3227(00)00043-8; Perry CT, 2011, GLOBAL CHANGE BIOL, V17, P76, DOI 10.1111/j.1365-2486.2010.02181.x; Leonard ND, 2013, HOLOCENE, V23, P1841, DOI 10.1177/0959683613508156; Woodroffe CD, 2014, MAR GEOL, V352, P248, DOI 10.1016/j.margeo.2013.12.006; Sloss CR, 2007, HOLOCENE, V17, P999, DOI 10.1177/0959683607082415; Lewis SE, 2013, QUATERNARY SCI REV, V74, P115, DOI 10.1016/j.quascirev.2012.09.006; Barrett SJ, 2012, SEDIMENT GEOL, V265, P56, DOI 10.1016/j.sedgeo.2012.03.015; Harris DL, 2014, GEOMORPHOLOGY, V222, P132, DOI 10.1016/j.geomorph.2014.03.015; Hopley D., 1982, GEOMORPHOLOGY GREAT; Hopley D., 1988, GREENHOUSE PLANNING, P189; Hopley D, 2007, GEOMORPHOLOGY OF THE GREAT BARRIER REEF: DEVELOPMENT, DIVERSITY, AND CHANGE, P1, DOI 10.1017/CBO9780511535543; LADD HS, 1950, AAPG BULL, V34, P203; Marshall J.F., 1982, Coral Reefs, V1, P21, DOI 10.1007/BF00286536; Montaggioni L., 2009, DEV MARINE GEOLOGY S, V5; O'Leary MJ, 2010, GEOLOGY, V38, P855, DOI 10.1130/G31214.1; Purdy EG, 2005, SEDIMENT GEOL, V175, P35, DOI 10.1016/j.sedgeo.2005.01.007; TUDHOPE AW, 1989, J SEDIMENT PETROL, V59, P1036; Yokoyama Y, 2006, GLOBAL PLANET CHANGE, V53, P147, DOI 10.1016/j.gloplacha.2006.01.014	19	2	2	GEOLOGICAL SOC AMER, INC	BOULDER	PO BOX 9140, BOULDER, CO 80301-9140 USA	0091-7613	1943-2682		GEOLOGY	Geology	FEB	2015	43	2					175	178		10.1130/G35977.1		4	Geology	Geology	CE8ME	WOS:000352095800020		
J	Monguchi, Y; Sawama, Y; Sajiki, H				Monguchi, Yasunari; Sawama, Yoshinari; Sajiki, Hironao			SYNTHESIS OF TRIAZOLE, INDOLE, AND FIVE OR SIX-MEMBERED SATURATED HETEROCYCLIC COMPOUNDS	HETEROCYCLES			English	Review						Heterogeneous Catalyst; 1,2,3-Triazole; Indole; Indoline; Saturated Heterocyclic Compound	HETEROGENEOUS PALLADIUM CATALYSTS; HUISGEN 3+2 CYCLOADDITION; MEDIATED INTRAMOLECULAR AMINATION; SUPPORTED COPPER HYDROXIDE; MIYAURA COUPLING REACTION; ONE-STEP SYNTHESIS; CU-I-ZEOLITES; SOLVENT-FREE; LIGAND-FREE; CLICK CHEMISTRY	Heterogeneously-catalyzed synthetic methods for the preparation of 1,2,3-triazoles, indolines, indoles, and saturated heterocyclic compounds, such as piperidine and pyrrolidine, are demonstrated. Triazoles are intermolecularly synthesized by the 1,3-dipolar cycloaddition of alkynes with azides using heterogeneous copper catalysts. Solvent-free triazole syntheses are also described. Inter- and intramolecular annulations as indole syntheses are summarized; e.g., a palladium on carbon (Pd/C)-catalyzed Yamanaka-Larock method affords 2- or 2,3-substituted indoles from 2-iodoaniline derivatives and mono- or di-substituted alkynes; an intramolecular Pd/C-catalyzed Buchwald-Hartwig reaction of 2-bromophenethylamine derivatives temperature-dependently affords indolines or indoles. Pd/C can also catalyze an intermolecular aromatic amination of bromoarenes with indoles to generate the corresponding N-arylindoles. The application of the hydrogenation technology using 10% Pd/C, 10% rhodium on carbon (Rh/C), or 10% ruthenium on carbon (Ru/C) as a catalyst is finally introduced for the synthesis of indole by the intramolecular hydrogenative N-alkylation of 2-cyanomethylaniline and piperidine, pyrrolidine, and tetrahydrofuran derivatives by the arene hydrogenation of pyrridine, pyrrole, and furan derivatives under relatively mild conditions, respectively.	[Monguchi, Yasunari; Sawama, Yoshinari; Sajiki, Hironao] Gifu Pharmaceut Univ, Organ Chem Lab, Gifu 5011196, Japan	Monguchi, Y (reprint author), Gifu Pharmaceut Univ, Organ Chem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	monguchi@gifu-pu.ac.jp; sajiki@gifu-pu.ac.jp					Adachi T, 2002, J CHROMATOGR A, V944, P41, DOI 10.1016/S0021-9673(01)01370-X; Kohler K, 2002, CHEM-EUR J, V8, P622, DOI 10.1002/1521-3765(20020201)8:3<622::AID-CHEM622>3.0.CO;2-0; Lee BS, 2010, CHEM COMMUN, V46, P3935, DOI 10.1039/c001255f; Monguchi Y, 2008, ADV SYNTH CATAL, V350, P2767, DOI 10.1002/adsc.200800417; Yamada YMA, 2012, J AM CHEM SOC, V134, P9285, DOI 10.1021/ja3036543; So MH, 2009, CHEM-ASIAN J, V4, P1551, DOI 10.1002/asia.200900261; Felpin FX, 2006, EUR J ORG CHEM, P2679, DOI 10.1002/ejoc.200501004; Girard C, 2006, ORG LETT, V8, P1689, DOI 10.1021/ol060283l; GURAM AS, 1995, ANGEW CHEM INT EDIT, V34, P1348, DOI 10.1002/anie.199513481; Cacchi S, 2005, CHEM REV, V105, P2873, DOI 10.1021/cr040639b; Su FZ, 2011, ANGEW CHEM INT EDIT, V50, P657, DOI 10.1002/anie.201004365; Sharghi H, 2009, ADV SYNTH CATAL, V351, P207, DOI 10.1002/adsc.200800612; Sajiki H, 2003, TETRAHEDRON LETT, V44, P171, DOI 10.1016/S0040-4039(02)02472-3; Martins MAP, 2009, CHEM REV, V109, P4140, DOI 10.1021/cr9001098; Cavaco SA, 2009, J HAZARD MATER, V169, P516, DOI 10.1016/j.jhazmat.2009.03.129; Varma RS, 2001, PURE APPL CHEM, V73, P193, DOI 10.1351/pac200173010193; Bajwa JS, 2006, TETRAHEDRON LETT, V47, P6425, DOI 10.1016/j.tetlet.2006.06.132; Sajiki H, 2004, ORG LETT, V6, P4977, DOI 10.1021/ol047871o; Monguchi Y, 2006, TETRAHEDRON, V62, P7926, DOI 10.1016/j.tet.2006.05.025; Larock RC, 1998, J ORG CHEM, V63, P7652, DOI 10.1021/jo9803277; Joucla L, 2009, ADV SYNTH CATAL, V351, P673, DOI 10.1002/adsc.200900059; Kwong FY, 2003, ORG LETT, V5, P793, DOI 10.1021/ol0273396; Djakovitch L, 2006, ADV SYNTH CATAL, V348, P715, DOI 10.1002/adsc.200505283; Veerakumar P, 2011, CATAL SCI TECHNOL, V1, P1512, DOI 10.1039/c1cy00300c; Sajiki H, 2002, TETRAHEDRON LETT, V43, P7247, DOI 10.1016/S0040-4039(02)01622-2; Walsh PJ, 2007, CHEM REV, V107, P2503, DOI 10.1021/cr0509556; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Alonso F, 2011, ORG BIOMOL CHEM, V9, P6385, DOI 10.1039/c1ob05735a; Kang H, 2010, TOP CATAL, V53, P523, DOI 10.1007/s11244-010-9481-0; Katayama T, 2009, CHEMSUSCHEM, V2, P59, DOI 10.1002/cssc.200800202; Inman M, 2013, CHEM SCI, V4, P29, DOI 10.1039/c2sc21185h; Omar-Amrani R, 2003, ORG LETT, V5, P2311, DOI 10.1021/ol034659w; Mori S, 2008, CHEM-EUR J, V14, P6994, DOI 10.1002/chem.200800387; Seki M, 2006, SYNTHESIS-STUTTGART, P2975, DOI 10.1055/s-2006-950197; Anderson JC, 2012, J ORG CHEM, V77, P6703, DOI 10.1021/jo3010827; Kolb HC, 2003, DRUG DISCOV TODAY, V8, P1128, DOI 10.1016/S1359-6446(03)02933-7; Monguchi Y, 2011, TETRAHEDRON, V67, P8628, DOI 10.1016/j.tet.2011.09.043; Sajiki H, 2008, CHEM-EUR J, V14, P5109, DOI 10.1002/chem.200800535; Maegawa T, 2009, ADV SYNTH CATAL, V351, P2091, DOI 10.1002/adsc.200900316; Chassaing S, 2008, CHEM-EUR J, V14, P6713, DOI 10.1002/chem.200800479; Lammens M, 2010, CHEM COMMUN, V46, P8719, DOI 10.1039/c0cc01451f; HUISGEN R, 1967, CHEM BER-RECL, V100, P2494, DOI 10.1002/cber.19671000806; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Giffin MJ, 2008, J MED CHEM, V51, P6263, DOI 10.1021/jm800149m; Grasa GA, 2001, J ORG CHEM, V66, P7729, DOI 10.1021/jo010613+; Cacchi S, 2011, CHEM REV, V111, pPR215, DOI 10.1021/cr100403z; Namitharan K, 2009, CHEM-EUR J, V15, P2755, DOI 10.1002/chem.200802384; Chassaing S, 2007, ORG LETT, V9, P883, DOI 10.1021/ol0631152; MARCK G, 1994, TETRAHEDRON LETT, V35, P3277, DOI 10.1016/S0040-4039(00)76884-5; LeBlond CR, 2001, ORG LETT, V3, P1555, DOI 10.1021/ol015850d; Monguchi Y, 2012, CHEMCATCHEM, V4, P546, DOI 10.1002/cctc.201100345; Okano K, 2010, CHEM COMMUN, V46, P2641, DOI 10.1039/b926965g; Yanase T, 2012, RSC ADV, V2, P590, DOI 10.1039/c1ra00776a; Jlalia I, 2009, MOLECULES, V14, P528, DOI 10.3390/molecules14010528; Shafir A, 2006, J AM CHEM SOC, V128, P8742, DOI 10.1021/ja063063b; Sawama Y, 2012, ADV SYNTH CATAL, V354, P777, DOI 10.1002/adsc.201100927; Nomura Y, 2007, HETEROCYCLES, V74, P629; Yamaguchi K, 2003, ANGEW CHEM INT EDIT, V42, P1480, DOI 10.1002/anie.200250779; Yin LX, 2007, CHEM REV, V107, P133, DOI 10.1021/cr0505674; Beneteau V, 2010, TETRAHEDRON LETT, V51, P3673, DOI 10.1016/j.tetlet.2010.05.036; Brown JA, 2000, TETRAHEDRON LETT, V41, P1623, DOI 10.1016/S0040-4039(99)02344-8; Miao T, 2008, SYNTHESIS-STUTTGART, P363, DOI 10.1055/s-2008-1032037; Monguchi Y, 2010, ORG BIOMOL CHEM, V8, P3338, DOI 10.1039/c004939e; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Climent MJ, 2011, CHEM REV, V111, P1072, DOI 10.1021/cr1002084; Maegawa T, 2007, CHEM-EUR J, V13, P5937, DOI 10.1002/chem.200601795; Sajiki H, 2003, TETRAHEDRON LETT, V44, P8437, DOI 10.1016/j.tetlet.2003.09.137; Platon M, 2012, CHEM SOC REV, V41, P3929, DOI 10.1039/c2cs15350e; Taber DF, 2011, TETRAHEDRON, V67, P7195, DOI 10.1016/j.tet.2011.06.040; Tagata T, 2003, J ORG CHEM, V68, P9412, DOI 10.1021/jo034970r; Kitamura Y, 2009, HETEROCYCLES, V77, P521, DOI 10.3987/COM-08-S(F)56; Tanaka K, 2000, CHEM REV, V100, P1025, DOI 10.1021/cr940089p; Zhang H, 2005, J ORG CHEM, V70, P5164, DOI 10.1021/jo0504464; Hara T, 2003, TETRAHEDRON LETT, V44, P6207, DOI 10.1016/S0040-4039(03)01550-8; Kumar A, 2012, GREEN CHEM, V14, P1298, DOI 10.1039/c2gc35070j; Ochiai M, 1997, HETEROCYCLES, V46, P71; Varma RS, 1999, GREEN CHEM, V1, P43, DOI 10.1039/a808223e; Ido A, 2013, CHEMOSPHERE, V90, P57, DOI 10.1016/j.chemosphere.2012.06.074; Miyamura H, 2011, B CHEM SOC JPN, V84, P588, DOI 10.1246/bcsj.20100300; SAKAMOTO T, 1988, CHEM PHARM BULL, V36, P1305; de Lange B, 2011, CHEMCATCHEM, V3, P289, DOI 10.1002/cctc.201000435; Monguchi Y, 2013, GREEN CHEM, V15, P490, DOI 10.1039/c2gc36584g; Yamaguchi K, 2009, CHEM-EUR J, V15, P10464, DOI 10.1002/chem.200901444; Ikawa T, 2005, TETRAHEDRON, V61, P2217, DOI 10.1016/j.tet.2004.11.080; Ikawa T, 2012, ORG BIOMOL CHEM, V10, P293, DOI 10.1039/c1ob06303k; Monguchi Y, 2009, CHEM-EUR J, V15, P834, DOI 10.1002/chem.200801989; Shamim T, 2010, CATAL LETT, V136, P260, DOI 10.1007/s10562-010-0330-3; Xiao RA, 2012, EUR J ORG CHEM, P4178, DOI 10.1002/ejoc.201200359; Mann G, 1998, J AM CHEM SOC, V120, P827, DOI 10.1021/ja973524g; Kitamura Y, 2007, TETRAHEDRON, V63, P10596, DOI 10.1016/j.tet.2007.08.017; Kitamura Y, 2014, HETEROCYCLES, V88, P233, DOI 10.3987/COM-13-S(S)6; Alix A, 2008, TETRAHEDRON, V64, P8922, DOI 10.1016/j.tet.2008.06.086; Moores A, 2006, NEW J CHEM, V30, P1675, DOI 10.1039/b608914c; Huang YB, 2011, J ORG CHEM, V76, P800, DOI 10.1021/jo101917x; Lipshutz BH, 2006, ANGEW CHEM INT EDIT, V45, P8235, DOI 10.1002/anie.200603726; Park IS, 2008, ORG LETT, V10, P497, DOI 10.1021/ol702790w; Takahashi T, 2012, TETRAHEDRON, V68, P8293, DOI 10.1016/j.tet.2012.07.044; Arcadi A, 2003, EUR J ORG CHEM, P4080, DOI 10.1002/ejoc.200300356; Balle T, 2003, J MED CHEM, V46, P265, DOI 10.1021/jm020938y; Batail N, 2009, ADV SYNTH CATAL, V351, P2055, DOI 10.1002/adsc.200900386; Battistuzzi G, 2002, EUR J ORG CHEM, P2671; Bock VD, 2006, EUR J ORG CHEM, P51, DOI 10.1002/ejoc.200500483; Cavaco A., 2007, J HAZARD MATER, V144, P634; Chassaing S, 2010, SYNTHESIS-STUTTGART, P1557, DOI 10.1055/s-0029-1218733; Chi H., 2007, CHEM COMMUN, P745; Chouzier S, 2004, J MOL CATAL A-CHEM, V212, P43, DOI 10.1016/j.molcata.2003.11.027; Cintasa P, 2007, COLLECT CZECH CHEM C, V72, P1014, DOI 10.1135/cccc20071014; Deboves HJC, 2002, J CHEM SOC PERK T 1, P733, DOI 10.1039/b200163b; Dittmer D. C., 1997, CHEM IND, V19, P779; Ennis DS, 1999, ORG PROCESS RES DEV, V3, P248, DOI 10.1021/op980079g; Esaki H, 2007, J SYN ORG CHEM JPN, V65, P1179; Gajare AS, 2004, CHEM COMMUN, P1994, DOI 10.1039/b408232j; Gala D, 1997, ORG PROCESS RES DEV, V1, P163, DOI 10.1021/op960035c; Gando-Ferreira LM, 2011, CHEM ENG J, V172, P277, DOI 10.1016/j.cej.2011.05.105; Gribble GW, 2000, J CHEM SOC PERK T 1, P1045, DOI 10.1039/a909834h; Guo DL, 2010, GREEN CHEM, V12, P276, DOI 10.1039/b917010c; Harada R, 2012, EUR J ORG CHEM, P366, DOI 10.1002/ejoc.201101214; Heidenreich RG, 2002, SYNLETT, P1118; Hong KB, 2004, TETRAHEDRON LETT, V45, P693, DOI 10.1016/j.tetlet.2003.11.075; Hosseinzadeh R, 2012, HETEROATOM CHEM, V23, P415, DOI 10.1002/hc.21031; Huisgen R., 1984, 1 3 DIPOLAR CYCLOADD, P1; Imanishi T, 2012, ADV SYNTH CATAL, V354, P771, DOI 10.1002/adsc.201100778; INADA A, 1980, CHEM LETT, P1287, DOI 10.1246/cl.1980.1287; ISHIHARA S, 2012, HAZARD MAT, V229, P15; Kitamura Y, 2007, CHEM COMMUN, P5069, DOI 10.1039/b712207a; Kitamura Y, 2007, SYNTHETIC COMMUN, V37, P4381, DOI 10.1080/00397910701577612; Kitamura Y, 2010, ADV SYNTH CATAL, V352, P718, DOI 10.1002/adsc.200900638; Kochanowska-Karamyan AJ, 2010, CHEM REV, V110, P4489, DOI 10.1021/cr900211p; Koivula R, 2000, HYDROMETALLURGY, V56, P93, DOI 10.1016/S0304-386X(00)00077-3; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5; Kubo T, 2008, TETRAHEDRON, V64, P11230, DOI 10.1016/j.tet.2008.09.042; Kume A, 2008, APPL CATAL B-ENVIRON, V81, P274, DOI 10.1016/j.apcatb.2007.12.019; LAROCK RC, 1991, J AM CHEM SOC, V113, P6689, DOI 10.1021/ja00017a059; LeBlond C. R., 2000, CHEM-EUR J, V6, P843; Lipshutz B. H., 2006, ANGEW CHEM, V118, P8415, DOI DOI 10.1002/ANGE.200603726; Lysen M, 2005, SYNLETT, P1671, DOI 10.1055/s-2005-869877; Maegawa T, 2009, CHEM-EUR J, V15, P6953, DOI 10.1002/chem.200900361; Maegawa T, 2005, SYNLETT, P845, DOI 10.1055/s-2005-863730; Monguchi Y, 2012, ADV SYNTH CATAL, V354, P2561, DOI 10.1002/adsc.201200179; Monguchi Y, 2008, SYNLETT, P2291, DOI 10.1055/s-2008-1078023; Monguchi Y, 2015, HETEROCYCLES, V90, P186, DOI 10.3987/COM-14-S(K)3; Monguchi Y, 2006, TETRAHEDRON, V62, P8384, DOI 10.1016/j.tet.2006.06.041; Monguchi Y, 2010, ORG PROCESS RES DEV, V14, P1140, DOI 10.1021/op100107r; Monguchi Y, 2014, ADV SYNTH CATAL, V356, P313, DOI 10.1002/adsc.201300710; Monguchi Y, 2014, ADV SYNTH CATAL, V356, P1866, DOI 10.1002/adsc.201301168; Monguchi Y, 2013, SYNTHESIS-STUTTGART, V45, P40, DOI 10.1055/s-0032-1316801; Mori S, 2010, ADV SYNTH CATAL, V352, P1630, DOI 10.1002/adsc.201000173; Mori S, 2009, J MOL CATAL A-CHEM, V307, P77, DOI 10.1016/j.molcata.2009.03.013; Mukaiyama T, 2001, CHEM LETT, P390, DOI 10.1246/cl.2001.390; Nishimura S., 2001, HDB HETEROGENEOUS CA; Novak Z., 2003, J ORG CHEM, V68, P3827; Old DW, 2000, ORG LETT, V2, P1403, DOI 10.1021/ol005728z; Omar-Amrani R, 2004, SYNTHESIS-STUTTGART, P2527; Pal M, 2004, SYNLETT, P1965, DOI 10.1055/s-2004-830861; Sajiki H., 2005, SYNLETT, P619; Sajiki H, 2005, J CHEM RES-S, P344; Sajiki H, 2002, TETRAHEDRON LETT, V43, P7251, DOI 10.1016/S0040-4039(02)01620-9; Sajiki H., 2005, SYNTHESIS-STUTTGART, P537; Sajiki H, 2005, SYNLETT, P1046; Sajiki H, 2005, SYNTHESIS-STUTTGART, P852; Sajiki H., 2004, J CHEM RES, P593; Sawama Y, 2011, EUR J ORG CHEM, P3361, DOI 10.1002/ejoc.201001641; Sawama Y, 2014, TETRAHEDRON, V70, P4540, DOI 10.1016/j.tet.2014.04.098; Sawama Y, 2012, SYNLETT, P959, DOI 10.1055/s-0031-1289696; Seki M, 2006, J SYN ORG CHEM JPN, V64, P853; Sirion U, 2008, SYNLETT, P2326, DOI 10.1055/s-2008-1078245; Suzuka T, 2012, HETEROCYCLES, V85, P615, DOI 10.3987/COM-11-12405; Tanaka K., 2008, SOLVENT FREE ORGANIC; Toda F, 2005, TOP CURR CHEM, V254, P1, DOI 10.1007/b100994; Yabe Y, 2010, TETRAHEDRON, V66, P8654, DOI 10.1016/j.tet.2010.09.027; Yamada K, 2002, SYNLETT, P231; Yanase T, 2011, CHEM LETT, V40, P910, DOI 10.1246/cl.2011.910; Zhang ZF, 2010, ADV SYNTH CATAL, V352, P1600, DOI 10.1002/adsc.201000206	173	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	FEB 1	2015	91	2					239	264				26	Chemistry, Organic	Chemistry	CE7UJ	WOS:000352047000001		
J	Kumagai, K; Tsuda, M; Masuda, A; Fukushi, E; Kawabata, J				Kumagai, Keiko; Tsuda, Masashi; Masuda, Atsunori; Fukushi, Eri; Kawabata, Jun			IRIOMOTEOLIDE-2a, A CYTOTOXIC 23-MEMBERED MACROLIDE FROM MARINE BENTHIC DINOFLAGELLATE AMPHIDINIUM SPECIES	HETEROCYCLES			English	Article						Macrolide; Cytotoxic Acitivity; Marine Dinoflagellate; Amphidinium	NATURAL-PRODUCTS; AMPHIDINOLIDES; CONFIGURATION; NMR	The first 23-membered macrolide, iriomoteolide-2a (1), was isolated from cultivated algal cells of a marine benthic dinoflagellate Amphidinium species. The structure was determined based on detailed analysis of 2D NMR data. The relative stereochemistries were assigned on the basis of coupling constants and ROESY data, and the absolute configurations were elucidated by analyzing the NMR data of the MTPA esters for 1 and its reduced product. Iriomoteolide-2a (1) exhibited potent cytotoxic activities in vitro and in vivo.	[Kumagai, Keiko] Kochi Univ, Ctr Sci Res, Kochi 7838505, Japan; [Tsuda, Masashi] Kochi Univ, Ctr Adv Marine Core Res, Kochi 7838502, Japan; [Masuda, Atsunori] Yanmar Environm Sustainabil Support Assoc, Osaka 5300014, Japan; [Fukushi, Eri; Kawabata, Jun] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan	Kumagai, K (reprint author), Kochi Univ, Ctr Sci Res, Kochi 7838505, Japan.		Kawabata, Jun/A-4495-2012		Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [25860079, 26670045]	We thank R. Iwamoto, Y. Okammoto, Y. Endo, Y. Nagakita, and Y. Fukuda, for dinoflagellate cultivation and measurement of bioactivity and S. Oka and A. Tokumitsu of the Equipment Management Center, Hokkaido University, for ESI-MS measurements. This study was partially supported by a Grant-in-aids for Scientific Research (Nos. 25860079 to K. K. and 26670045 to M. T.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan.	Akakabe M, 2014, TETRAHEDRON, V70, P2962, DOI 10.1016/j.tet.2014.03.025; KINO T, 1987, J ANTIBIOT, V40, P1249; Matsumori N, 1999, J ORG CHEM, V64, P866, DOI 10.1021/jo981810k; Seco JM, 2000, ORG LETT, V2, P3261, DOI 10.1021/ol0062852; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Blunt JW, 2014, NAT PROD REP, V31, P160, DOI 10.1039/c3np70117d; Kalinowski H.-O., 1988, CARBON 13 NMR SPECTR, P533; Tsuda M, 2003, CHEM PHARM BULL, V51, P448; KOBAYASHI J, 1994, J ORG CHEM, V59, P4698, DOI 10.1021/jo00095a058; Kobayashi J, 2004, NAT PROD REP, V21, P77, DOI 10.1039/b310427n; KOBAYASHI J, 1988, J AM CHEM SOC, V110, P490, DOI 10.1021/ja00210a029; Kobayashi J, 2000, ORG LETT, V2, P2805, DOI 10.1021/ol006223b; KOBAYASHI J, 1991, J ANTIBIOT, V44, P1259; Tsuda M., 2006, Japanese Patent, Patent No. [2006-351043 JP, 2006351043]; Tsuda M, 2007, J ORG CHEM, V72, P4469, DOI 10.1021/jo070414b; Usui T, 2004, CHEM BIOL, V11, P1269, DOI 10.1016/j.chembiol.2004.07.014	16	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	FEB 1	2015	91	2					265	274		10.3987/COM-14-13132		10	Chemistry, Organic	Chemistry	CE7UJ	WOS:000352047000002		
J	Usui, K; Nakada, M				Usui, Kenji; Nakada, Masahisa			ENANTIOSELECTIVE TOTAL SYNTHESIS OF (+)-BUCIDARASINS A AND C	HETEROCYCLES			English	Article						Clerodane Diterpene; Diels-Alder Reaction; Enantioselective Synthesis; Natural Product; Total Synthesis	CYTOTOXIC CLERODANE DITERPENOIDS; CASEARIA-SYLVESTRIS SW; CHIRAL BUILDING-BLOCKS; ZUELANIA-GUIDONIA; ANTITUMOR PRINCIPLES; LAETIA-PROCERA; STEM BARK; MEMBRANACEA; LEAVES; FLACOURTIACEAE	In this paper, the first total synthesis of (+)-bucidarasins A and C is described. The chiral starting material was successfully obtained via reduction using a CBS catalyst and selective mono-TBS ether formation of trans-2-benzyloxymethy1-2-methylcyclohexane-1,3-diol, which was crucial to the successful enantioselective total synthesis of (+)-bucidarasins A and C. A synthetic approach towards (+)-bucidarasin C, based on the Barton-McCombie protocol, using V-70 as a radical promoter at low temperature to remove the C6-hydroxy moiety is also described.	[Usui, Kenji; Nakada, Masahisa] Waseda Univ, Fac Sci & Engn, Dept Chem & Biochem, Shinjuku Ku, Tokyo 1698555, Japan	Usui, K (reprint author), Waseda Univ, Fac Sci & Engn, Dept Chem & Biochem, Shinjuku Ku, 3-4-1 Ohkubo, Tokyo 1698555, Japan.	mnakada@waseda.jp			MEXT [25293003]; Waseda University	This work was financially supported in part by the Grant-in-Aid for Scientific Research (B) (25293003) by MEXT, and a Waseda University Grant for Special Research Projects.	Calderon C, 2014, J NAT PROD, V77, P455, DOI 10.1021/np400672g; ITOKAWA H, 1990, CHEM PHARM BULL, V38, P3384; KHAN MR, 1990, PHYTOCHEMISTRY, V29, P3591, DOI 10.1016/0031-9422(90)85282-K; Vieira GM, 2009, J NAT PROD, V72, P1847, DOI 10.1021/np9004079; Chen CY, 2008, CHEM BIODIVERS, V5, P162, DOI 10.1002/cbdv.200890007; Oberlies NH, 2002, J NAT PROD, V65, P95, DOI 10.1021/np010459m; Wang B, 2013, J NAT PROD, V76, P1573, DOI 10.1021/np400212d; Williams RB, 2007, J NAT PROD, V70, P206, DOI 10.1021/np0605034; Kanokmedhakul S, 2005, J NAT PROD, V68, P183, DOI 10.1021/np049757k; Hanson JR, 2003, NAT PROD REP, V20, P70, DOI 10.1039/b108963n; CRABTREE RH, 1982, J AM CHEM SOC, V104, P6994, DOI 10.1021/ja00389a018; Gibbons S, 1996, PHYTOCHEMISTRY, V41, P565, DOI 10.1016/0031-9422(95)00623-0; Uwamori M, 2012, J ORG CHEM, V77, P5098, DOI 10.1021/jo300646j; Ferreira PMP, 2010, CHEM-BIOL INTERACT, V188, P497, DOI 10.1016/j.cbi.2010.08.008; Shen YC, 2004, CHEM PHARM BULL, V52, P108, DOI 10.1248/cpb.52.108; Watanabe H, 2005, J ORG CHEM, V70, P4652, DOI 10.1021/jo050349a; Takano M, 2004, ORG LETT, V6, P4897, DOI 10.1021/ol048010i; Kanokmedhakul S, 2007, J NAT PROD, V70, P1122, DOI 10.1021/np070083y; MORITA H, 1991, CHEM PHARM BULL, V39, P693; Whitson EL, 2010, J NAT PROD, V73, P2013, DOI 10.1021/np1004455; Jullian V, 2005, BIOORG MED CHEM LETT, V15, P5065, DOI 10.1016/j.bmcl.2005.07.090; Shen YC, 2004, J NAT PROD, V67, P316, DOI 10.1021/np0303658; Beutler JA, 2000, J NAT PROD, V63, P657, DOI 10.1021/np990553r; Watanabe H, 2008, J AM CHEM SOC, V130, P1150, DOI 10.1021/ja7102795; Watanabe H, 2007, ORG LETT, V9, P359, DOI 10.1021/ol0628816; Wang W, 2009, PLANTA MED, V75, P1436, DOI 10.1055/s-0029-1185726; Beutler JA, 2000, PHYTOCHEMISTRY, V55, P233, DOI 10.1016/S0031-9422(00)00281-8; de Carvalho PRF, 1998, PHYTOCHEMISTRY, V49, P1659, DOI 10.1016/S0031-9422(98)00249-0; CHEN TB, 1991, J NAT PROD, V54, P1612, DOI 10.1021/np50078a019; Espindola LS, 2004, PLANTA MED, V70, P1093, DOI 10.1055/s-2004-832655; ETSE JT, 1989, PHYTOCHEMISTRY, V28, P2489, DOI 10.1016/S0031-9422(00)98011-7; Frey B, 1999, EUR J ORG CHEM, P1377; Gibbons S, 1996, PHYTOCHEMISTRY, V43, P635, DOI 10.1016/0031-9422(96)00324-X; GUITTET E, 1988, TETRAHEDRON, V44, P2893; Hanson JR, 2004, NAT PROD REP, V21, P312, DOI 10.1039/b300377a; Hanson JR, 2007, NAT PROD REP, V24, P1332, DOI 10.1039/b705951p; Hanson JR, 2011, NAT PROD REP, V28, P1755, DOI 10.1039/c1np90021h; Hayashi K, 2002, BIOORG MED CHEM LETT, V12, P345, DOI 10.1016/S0960-894X(01)00742-9; Huang DM, 2004, EUR J PHARMACOL, V503, P17, DOI 10.1016/j.ejphar.2004.09.040; Hunter MS, 1997, J NAT PROD, V60, P894, DOI 10.1021/np970141n; ITOKAWA H, 1988, CHEM PHARM BULL, V36, P1585; Iwamoto M, 2003, TETRAHEDRON LETT, V44, P7239, DOI 10.1016/j.tetlet.2003.08.009; KHAN MR, 1990, PHYTOCHEMISTRY, V29, P1609, DOI 10.1016/0031-9422(90)80131-Y; KHAN MR, 1990, PHYTOCHEMISTRY, V29, P2939, DOI 10.1016/0031-9422(90)87110-G; Kita Y, 1997, TETRAHEDRON LETT, V38, P3549, DOI 10.1016/S0040-4039(97)00700-4; Liu HJ, 1997, CAN J CHEM, V75, P646, DOI 10.1139/v97-079; MERRITT AT, 1992, NAT PROD REP, V9, P243, DOI 10.1039/np9920900243; Mosaddik M. A., 2006, NAT PROD COMMUN, V1, P601; Mosaddik M. A., 2006, NAT PROD COMMUN, V1, P441; Mosaddik MA, 2007, BIOCHEM SYST ECOL, V35, P631, DOI 10.1016/j.bse.2007.03.003; Nakada M, 2014, CHEM REC, V14, P641, DOI 10.1002/tcr.201402019; Oberlies NH, 2001, J NAT PROD, V64, P497, DOI 10.1021/np0005006; PRAKASH CVS, 2002, NAT PROD, V65, P100; Santos A. G., 2010, CHEM BIODIVERS, V7, P205; Santos AG, 2007, QUIM NOVA, V30, P1100; Shen YC, 2005, J NAT PROD, V68, P1665, DOI 10.1021/np058063o; Shen YC, 2005, J CHIN CHEM SOC-TAIP, V52, P1263; Shen YC, 2005, HELV CHIM ACTA, V88, P68, DOI 10.1002/hlca.200490297; Tokoroyama T, 2000, SYNTHESIS-STUTTGART, P611; Usui K, 2014, ORG LETT, V16, P4734, DOI 10.1021/ol502129u; Vieira-Junior GM, 2011, J NAT PROD, V74, P776, DOI 10.1021/np100840w; Vijayakumar EKS, 2002, INDIAN J CHEM B, V41, P2706	62	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	FEB 1	2015	91	2					332	350		10.3987/COM-14-13161		19	Chemistry, Organic	Chemistry	CE7UJ	WOS:000352047000007		
J	Takeda, N; Taguchi, T; Nakajima, T; Azuma, M				Takeda, Norihiko; Taguchi, Tomoyo; Nakajima, Takeshi; Azuma, Mitsuyoshi			DESIGN, SYNTHESIS, AND BIOLOGICAL ACTIVITY EVALUATION OF THIAZOLIDINONES CONTAINING ALKYNYL AND ALKENYL FURANS FOR DISRUPTING PROTEIN PROTEIN INTERACTIONS BETWEEN HIF-1 alpha AND p300	HETEROCYCLES			English	Article						Hypoxia-inducible Factor Inhibitor; Thiazolidinone	CANCER; HYPOXIA; ANGIOGENESIS; INHIBITOR; HIF	Based on the structure of the potent hypoxia-inducible factor (HIF) inhibitor 1, a novel series of furanylidene-thiazolidinones 6 were designed and synthesized using Sonogashira or Suzuki Miyaura cross-couplings, and subsequent Knoevenagel condensation. In particular, derivatives 6aA, 6cA, 6dA, 6hA, 6iA, and 6cC, bearing an alkynyl or alkenyl group on the furan ring, exhibited four- to five-fold higher activities than 1. These potent compounds will serve as leads for the development of novel small molecules for targeting the HIP-1 alpha/p300 complex.	[Takeda, Norihiko; Taguchi, Tomoyo; Nakajima, Takeshi; Azuma, Mitsuyoshi] Senju Pharmaceut Co Ltd, Senju Lab Ocular Sci, Chuo Ku, Kobe, Hyogo 6500047, Japan	Takeda, N (reprint author), Senju Pharmaceut Co Ltd, Senju Lab Ocular Sci, Chuo Ku, 1-5-5 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	t-nakajima@senju.co.jp					Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Yin SM, 2012, CLIN CANCER RES, V18, P6623, DOI 10.1158/1078-0432.CCR-12-0861; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Jackson AL, 2010, EXPERT OPIN THER TAR, V14, P1047, DOI 10.1517/14728222.2010.511617; Yang YZ, 2013, J CELL BIOCHEM, V114, P967, DOI 10.1002/jcb.24438; Wang YS, 2010, CURR OPIN INVEST DR, V11, P1466; Xia Y, 2012, EUR J MED CHEM, V49, P24, DOI 10.1016/j.ejmech.2012.01.033; Tang CM, 2013, J GASTROEN HEPATOL, V28, P401, DOI 10.1111/jgh.12038; Ban H. S., 2011, EXPERT OPIN THER PAT, P131; Cassin M., 2006, Cell Therapeutics Europe S. R. L., Patent No. [WO 2006/066846, 2006066846]; Cook K. M., 2009, J BIOL CHEM, V284, P26381; Grugni M, 2006, Indole derivatives with antitumor activity, Patent No. [WO/2006/066923, 2006066923]; Hashmi ASK, 2008, SYNTHESIS-STUTTGART, P2707, DOI 10.1055/s-2008-1067227; Kung L., 2004, CANCER CELL, V6, P33; Na Y.-R., 2010, BIOCHEM BIOPH RES CO, V296, P370; Wang SB, 2011, EUR J MED CHEM, V46, P3509, DOI 10.1016/j.ejmech.2011.05.017; Wu DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062014; Zeng JY, 2014, MOL CANCER THER, V13, P37, DOI 10.1158/1535-7163.MCT-13-0242	18	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	FEB 1	2015	91	2					351	362		10.3987/COM-14-13084		12	Chemistry, Organic	Chemistry	CE7UJ	WOS:000352047000008		
J	Shimizu, S; Homma, T; Tsuchiya, H; Ishihara, Y				Shimizu, Shota; Homma, Takumi; Tsuchiya, Hiroki; Ishihara, Yasutoshi			Simulation Study on Iterative Reconstruction Method for Time-Correlation Magnetic Particle Imaging With Continuous Trajectory Scan	IEEE TRANSACTIONS ON MAGNETICS			English	Article						Image reconstruction; iterative algorithm; magnetic particle imaging (MPI); molecular imaging	RESOLUTION	Magnetic particle imaging (MPI) is a medical imaging technology suitable for noninvasive diagnostics. However, in conventional image reconstruction methods, due to either noise or the reconstruction method itself, the reconstructed image quality degrades. In order to suppress this problem, we improved the time-correlation MPI method that we had previously proposed. Specifically, this method iteratively corrects image blurring by reducing the difference between the observed signals from magnetic nanoparticles and the analytically calculated waveforms for the reconstructed image generated with the time-correlation method. Using numerical simulation, we evaluate the effectiveness of this method in conjunction with the continuous scan technique, which makes fast data acquisition possible.	[Shimizu, Shota; Homma, Takumi] Meiji Univ, Grad Sch Sci & Technol, Kawasaki, Kanagawa 2148571, Japan; [Tsuchiya, Hiroki; Ishihara, Yasutoshi] Meiji Univ, Sch Sci & Technol, Kawasaki, Kanagawa 2148571, Japan	Shimizu, S (reprint author), Meiji Univ, Grad Sch Sci & Technol, Kawasaki, Kanagawa 2148571, Japan.	ce32025@meiji.ac.jp			Japan Society for the Promotion of Science [24300184]	This work was supported by a Grant-in-Aid for Scientific Research (B) through the Japan Society for the Promotion of Science under Grant 24300184.	Knopp T, 2010, PHYS MED BIOL, V55, P1577, DOI 10.1088/0031-9155/55/6/003; Goodwill PW, 2011, IEEE T MED IMAGING, V30, P1581, DOI 10.1109/TMI.2011.2125982; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Knopp T, 2010, IEEE T MED IMAGING, V29, P12, DOI 10.1109/TMI.2009.2021612; Rahmer J, 2012, IEEE T MED IMAGING, V31, P1289, DOI 10.1109/TMI.2012.2188639; Weizenecker J, 2007, PHYS MED BIOL, V52, P6363, DOI 10.1088/0031-9155/52/21/001; Goodwill PW, 2010, IEEE T MED IMAGING, V29, P1851, DOI 10.1109/TMI.2010.2052284; Gleich B, 2008, PHYS MED BIOL, V53, pN81, DOI 10.1088/0031-9155/53/6/N01; Ishihara Y, 2013, BMC MED IMAGING, V13, P1; Ishihara Y, 2012, IEICE T INF SYST, VE95D, P872, DOI 10.1587/transinf.E95.D.872; Ishihara Y., 2011, P SOC PHOTO-OPT INS, V7965; Kaczmarz M. S., 1937, B INT ACAD POLONAISE, V35, P355; Knopp T, 2009, PHYS MED BIOL, V54, P385, DOI 10.1088/0031-9155/54/2/014	13	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9464	1941-0069		IEEE T MAGN	IEEE Trans. Magn.	FEB	2015	51	2	1						6501004	10.1109/TMAG.2014.2332096		4	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CF2CT	WOS:000352355700023		
J	Tanaka, S; Murata, H; Oishi, T; Hatsukade, Y; Zhang, Y; Horng, HE; Liao, SH; Yang, HC				Tanaka, Saburo; Murata, Hayaki; Oishi, Tomoya; Hatsukade, Yoshimi; Zhang, Yi; Horng, Herng-Er; Liao, Shu-Hsien; Yang, Hong-Chang			Imaging of Magnetic Nanoparticles Using a Second Harmonic of Magnetization With DC Bias Field	IEEE TRANSACTIONS ON MAGNETICS			English	Article						Magnetic nanoparticles; magnetic particle imaging (MPI); second harmonic; superconducting quantum interference device (SQUID)		We have developed a method to improve the detection sensitivity for the magnetization M of magnetic nanoparticles (MNPs) using a high Tc superconducting quantum interference device magnetometer. The M response of MNP to an applied magnetic field H(M-H characteristics) can be divided into a linear region and a saturation region, which are separated at a transition point H-k. When applying an excitation ac magnetic field (Hac) and an additional dc bias field H-dc = H-k, the second harmonic of M reaches a maximum due to the nonlinearity of its M-H characteristics. This harmonic is stronger than any other harmonics, including a third harmonic. The advantage of using the second harmonic response is that the response can be measured even in a small field Hac. The M response of MNP was systematically analyzed and experimentally demonstrated. For conventional detection using a third harmonic, the amplitude of the Hac must be larger than the threshold level, which is almost the same as H-k. Detection methods using a second harmonic can be applied to magnetic particle imaging. We finally demonstrate the construction of a 1-D image of two separated bottle-shaped MNP samples using the method with a lock-in amplifier.	[Tanaka, Saburo; Murata, Hayaki; Oishi, Tomoya; Hatsukade, Yoshimi] Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan; [Zhang, Yi] Forschungszentrum Julich, Peter Gruenberg Inst, D-52425 Julich, Germany; [Horng, Herng-Er; Liao, Shu-Hsien] Natl Taiwan Normal Univ, Taipei 106, Taiwan; [Yang, Hong-Chang] Kun Shan Univ, Tainan 71003, Taiwan	Tanaka, S (reprint author), Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan.	tanakas@ens.tut.ac.jp					Biederer S, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/20/205007; Goodwill PW, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3694534; Goodwill PW, 2011, IEEE T MED IMAGING, V30, P1581, DOI 10.1109/TMI.2011.2125982; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Yoshida T, 2011, IEEE T MAGN, V47, P2863, DOI 10.1109/TMAG.2011.2157805; Krause HJ, 2007, J MAGN MAGN MATER, V311, P436, DOI 10.1016/j.jmmm.2006.10.1164; Kriz K, 1998, BIOSENS BIOELECTRON, V13, P817, DOI 10.1016/S0956-5663(98)00047-5; Chieh JJ, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2229778; Huang KW, 2012, INT J NANOMED, V7, P2987, DOI 10.2147/IJN.S30061; Zhang Y., 2013, REV SCI INSTRUM, V84	10	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9464	1941-0069		IEEE T MAGN	IEEE Trans. Magn.	FEB	2015	51	2	1						6502504	10.1109/TMAG.2014.2322375		4	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CF2CT	WOS:000352355700038		
J	Tomitaka, A; Ferguson, RM; Khandhar, AP; Kemp, SJ; Ota, S; Nakamura, K; Takemura, Y; Krishnan, KM				Tomitaka, Asahi; Ferguson, Richard Matthew; Khandhar, Amit P.; Kemp, Scott J.; Ota, Satoshi; Nakamura, Kosuke; Takemura, Yasushi; Krishnan, Kannan M.			Variation of Magnetic Particle Imaging Tracer Performance With Amplitude and Frequency of the Applied Magnetic Field	IEEE TRANSACTIONS ON MAGNETICS			English	Article						AC hysteresis; iron oxide nanoparticles; magnetic particle imaging (MPI); magnetic particle spectrometry (MPS); MPI tracers	NANOPARTICLES; SIZE	The magnetic response of magnetic particle imaging (MPI) tracers varies with the slew rate of the applied magnetic field, as well as with the tracer's average magnetic core size. Currently, 25 kHz and 20 mT/mu(0) drive fields are common in MPI, but lower field amplitudes may be necessary for patient safety in future designs. We studied how several different sizes of monodisperse MPI tracers behaved under different drive field amplitude and frequency, using magnetic particle spectrometry and ac hysteresis for drive field conditions at 16, 26, and 40 kHz, with field amplitudes from 5 to 40 mT/mu(0). We observed that both field amplitude and frequency can influence the tracer behavior, but that the magnetic behavior is consistent when the slew rate (the product of field amplitude and frequency) is consistent. However, smaller amplitudes provide a correspondingly smaller field of view, sometimes resulting in excitation of a minor hysteresis loop.	[Tomitaka, Asahi; Krishnan, Kannan M.] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA; [Ferguson, Richard Matthew; Khandhar, Amit P.; Kemp, Scott J.] LodeSpin Labs, Seattle, WA 98145 USA; [Ota, Satoshi; Nakamura, Kosuke; Takemura, Yasushi] Yokohama Natl Univ, Dept Elect & Comp Engn, Yokohama, Kanagawa 2408501, Japan	Krishnan, KM (reprint author), Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA.	kannanmk@uw.edu		Tomitaka, Asahi/0000-0002-1234-6047	NIH [2R42EB013520-02A1, 1RO1EB013689-01/NIBIB]; Japan Society for the Promotion of Science	This work was supported in part by NIH Grant 2R42EB013520-02A1 and Grant 1RO1EB013689-01/NIBIB, and in part by the Japan Society for the Promotion of Science Post-doctoral Fellowship for Research Abroad.	Saritas EU, 2013, IEEE T MED IMAGING, V32, P1600, DOI 10.1109/TMI.2013.2260764; Khandhar AP, 2013, BIOMATERIALS, V34, P3837, DOI 10.1016/j.biomaterials.2013.01.087; Nakamura K, 2013, IEEE T MAGN, V49, P240, DOI 10.1109/TMAG.2012.2226567; CHANTRELL RW, 1978, IEEE T MAGN, V14, P975, DOI 10.1109/TMAG.1978.1059918; Ferguson RM, 2013, BIOMED ENG-BIOMED TE, V58, P493, DOI 10.1515/bmt-2012-0058; Goodwill PW, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3604009; Goodwill PW, 2010, IEEE T MED IMAGING, V29, P1851, DOI 10.1109/TMI.2010.2052284; Arami H, 2013, MED PHYS, V40, DOI 10.1118/1.4810962; Khandhar AP, 2012, J BIOMED MATER RES A, V100A, P728, DOI 10.1002/jbm.a.34011; Ferguson RM, 2011, MED PHYS, V38, P1619, DOI 10.1118/1.3554646; Biederer S., 2010, MAGNETIC NANOPARTICL, P60; Ferguson RM, 2012, J APPL PHYS, V111, DOI 10.1063/1.3676053; Schmale I, 2012, MAGNETIC PARTICLE IM, V140, P287	13	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9464	1941-0069		IEEE T MAGN	IEEE Trans. Magn.	FEB	2015	51	2	1						6100504	10.1109/TMAG.2014.2341570		4	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CF2CT	WOS:000352355700017		
J	Tsuchiya, H; Homma, T; Shimizu, S; Ishihara, Y				Tsuchiya, Hiroki; Homma, Takumi; Shimizu, Shota; Ishihara, Yasutoshi			Experimental Evaluation of an Iterative Reconstruction Method for Time-Correlation Magnetic Particle Imaging	IEEE TRANSACTIONS ON MAGNETICS			English	Article						Image reconstruction; iterative algorithm; magnetic particle imaging (MPI); prototype system		We have previously proposed an image reconstruction method to improve the image resolution in magnetic particle imaging. In that method, the image is reconstructed based on time-correlation information between the observed signal from magnetic nanoparticles and the corresponding system function. However, image blurring and image artifacts were not sufficiently improved under this method. Therefore, we proposed a new iterative image reconstruction method, in which the reconstructed image is iteratively estimated by correcting the difference between the analytically calculated signals from the reconstructed images and the observed signals during iteration. In this paper, to confirm the validity of this new proposed method, we performed experiments using the 3-D prototype system and numerical simulations based on the prototype system setup. The results achieved by the prototype system experiments showed that the image blurring was suppressed and the image quality improved as compared with the previous time-correlation reconstruction method.	[Ishihara, Yasutoshi] Meiji Univ, Sch Sci & Technol, Kawasaki, Kanagawa 2148571, Japan; [Tsuchiya, Hiroki; Homma, Takumi; Shimizu, Shota] Meiji Univ, Grad Sch Sci & Technol, Kawasaki, Kanagawa 2148571, Japan	Tsuchiya, H (reprint author), Meiji Univ, Grad Sch Sci & Technol, Kawasaki, Kanagawa 2148571, Japan.	ee154r@gmail.com			Japan Society for the Promotion of Science [24300184]	The authors would like to thank Dr. Nohara and Dr. Ito from Meito Sangyo Company, Ltd., Aichi, Japan, for providing the magnetic particle sample. This work was supported by a Grant-in-Aid for Scientific Research (B) under Grant 24300184 through the Japan Society for the Promotion of Science in 2012.	Knopp T, 2010, PHYS MED BIOL, V55, P1577, DOI 10.1088/0031-9155/55/6/003; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Homma T., 2013, P IEEE 35 ANN INT C, V3193, P1; Homma T., 2013, P 3 INT WORKSH MAGN; Ishihara Y, 2013, BMC MED IMAGING, V13, P1; Ishihara Y, 2012, IEICE T INF SYST, VE95D, P872, DOI 10.1587/transinf.E95.D.872; Rahmer Jürgen, 2009, BMC Med Imaging, V9, P4, DOI 10.1186/1471-2342-9-4	7	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9464	1941-0069		IEEE T MAGN	IEEE Trans. Magn.	FEB	2015	51	2	1						6502204	10.1109/TMAG.2014.2330874		4	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CF2CT	WOS:000352355700035		
J	Wawrzik, T; Yoshida, T; Schilling, M; Ludwig, F				Wawrzik, Thilo; Yoshida, Takashi; Schilling, Meinhard; Ludwig, Frank			Debye-Based Frequency-Domain Magnetization Model for Magnetic Nanoparticles in Magnetic Particle Spectroscopy	IEEE TRANSACTIONS ON MAGNETICS			English	Article						Magnetic particle spectroscopy (MPS); magnetic particles; modeling; nanoparticles	OPTIMIZATION	Signal generation in magnetic particle imaging and magnetic particle spectroscopy is generally described via the Langevin function of superparamagnetism. To include the magnetization dynamics, the Langevin function is augmented with a frequency-dependent term derived from the linear Debye model. Here, we extend that expression to cover the dynamics of higher harmonics, where each harmonic is multiplied with a complex-valued weighting factor, obtaining a frequency-domain model for application in the context of viscosity-/binding-dependent magnetic particle spectroscopy measurements.	[Wawrzik, Thilo; Schilling, Meinhard; Ludwig, Frank] Tech Univ Carolo Wilhelmina Braunschweig, Inst Fuer Elekt Messtech & Grundlagen Elektrotech, D-38106 Braunschweig, Germany; [Yoshida, Takashi] Kyushu Univ, Dept Elect Engn, Fukuoka 812, Japan	Wawrzik, T (reprint author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Fuer Elekt Messtech & Grundlagen Elektrotech, D-38106 Braunschweig, Germany.	t.wawrzik@tu-bs.de			German Federal Ministry of Economics and Technology [FKZ-KF3061201UW2]	This work was supported by the German Federal Ministry of Economics and Technology under Grant FKZ-KF3061201UW2.	Rauwerdink AM, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3291063; Bedanta S, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/1/013001; Yoshida T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.127002; Deissler RJ, 2014, MED PHYS, V41, DOI 10.1118/1.4837216; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0; Ferguson RM, 2009, J MAGN MAGN MATER, V321, P1548, DOI 10.1016/j.jmmm.2009.02.083; Ludwig F, 2012, IEEE T MAGN, V48, P3780, DOI 10.1109/TMAG.2012.2197601; Biederer S, 2009, J PHYS D, V42; Coffey W., 2004, WORLD SCI SERIES CON, V14; Coffey W. T., 2007, ADV CHEM PHYS, V83; Debye P., 1929, POLAR MOL; Ludwig F., 2010, J APPL PHYS, V108; Martens MA, 2013, MED PHYS, V40, DOI 10.1118/1.4773869; Raikker Y. L., 2007, ADV CHEM PHYS RELAXA, V87; Wawrzik T, 2012, SPRINGER P PHYS, V140, P21; Wawrzik T., 2013, P INT WORKSH MAGN PA, P1; Rauwerdink AM, 2010, J MAGN MAGN MATER, V322, P609, DOI 10.1016/j.jmmm.2009.10.024; Yoshida T., 2012, MAGN PARTICLE IMAG, V140, P3, DOI [10.1007/978-3-642-24133-8_1, DOI 10.1007/978-3-642-24133-8_1]	19	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9464	1941-0069		IEEE T MAGN	IEEE Trans. Magn.	FEB	2015	51	2	1						5300404	10.1109/TMAG.2014.2332371		4	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CF2CT	WOS:000352355700012		
J	Huiskamp, T; Takamura, N; Namihira, T; Pemen, AJM				Huiskamp, T.; Takamura, Norimitsu; Namihira, Takao; Pemen, A. J. M.			Matching a Nanosecond Pulse Source to a Streamer Corona Plasma Reactor With a DC Bias	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						DC voltage; high voltage; nanosecond pulses; pulsed power supply	HIGH-VOLTAGE PULSE; SUBNANOSECOND RISE-TIME; AIR-POLLUTION CONTROL; VARIABLE AMPLITUDE; ENERGY EFFICIENCY; SILENT DISCHARGE; OZONE; DURATION; REMOVAL; GAS	Matching a pulse source to a plasma load is one of the main challenges to overcome to maximize the full potential of pulsed discharges for air purification applications. In this paper, we propose experiments that investigate the matching of a nanosecond pulse source to a corona plasma reactor that is aided by a high voltage on a tertiary electrode. The corona plasma reactor is a wire-cylinder reactor, as is commonly used in pulsed power plasmas. A tertiary electrode is situated on a dielectric layer against the cylinder of the reactor. On this tertiary electrode, we can apply a pulsed RF or dc voltage to provide an additional plasma and bias voltage in the corona plasma reactor. The pulse source that energizes the main corona plasma is the nanosecond pulse source of Kumamoto University, Japan. In this paper, we show the results of experiments with a dc voltage on the tertiary electrode. We varied the amplitude of the pulsed voltage as well as the dc voltage and investigated their effect on the corona plasma with energy and ozone measurements. The results show that the matching to the reactor increases with increasing dc voltages. However, the matching effect decreases with higher repetition rates. Furthermore, ozone measurements confirmed that a better matching also results in a higher ozone production, but in a lower ozone production energy yield.	[Huiskamp, T.; Pemen, A. J. M.] Eindhoven Univ Technol, Elect Energy Syst Grp, NL-5612 AZ Eindhoven, Netherlands; [Takamura, Norimitsu] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8600862, Japan; [Namihira, Takao] Kumamoto Univ, Inst Pulsed Power Sci, Kumamoto 8600862, Japan	Huiskamp, T (reprint author), Eindhoven Univ Technol, Elect Energy Syst Grp, NL-5612 AZ Eindhoven, Netherlands.	t.huiskamp@tue.nl; n.takamura@st.cs.kumamoto-u.ac.jp; namihira@cs.kumamoto-u.ac.jp; a.j.m.pemen@tue.nl			Dutch Technology Foundation STW [10751]; Stichting 3E through the Smit-De Kuiper	This work was supported in part by the Dutch Technology Foundation STW under Contract 10751, and in part by the Stichting 3E through the Smit-De Kuiper.	BRAUN D, 1988, PURE APPL CHEM, V60, P741, DOI 10.1351/pac198860050741; Matsumoto T, 2010, IEEE T PLASMA SCI, V38, P2639, DOI 10.1109/TPS.2010.2045903; Simek M, 2002, J PHYS D APPL PHYS, V35, P1171, DOI 10.1088/0022-3727/35/11/311; Ruan JJ, 2005, CHEMOSPHERE, V59, P327, DOI 10.1016/j.chemosphere.2004.10.025; Wang DY, 2010, J ADV OXID TECHNOL, V13, P71; Rakness K, 1996, OZONE-SCI ENG, V18, P209, DOI 10.1080/01919519608547327; Kim HH, 2004, PLASMA PROCESS POLYM, V1, P91, DOI 10.1002/ppap.200400028; Kitayama J, 1999, J PHYS D APPL PHYS, V32, P3032, DOI 10.1088/0022-3727/32/23/309; CLEMENTS JS, 1989, IEEE T IND APPL, V25, P62, DOI 10.1109/28.18870; Nijdam S, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/45/455201; ELIASSON B, 1991, IEEE T PLASMA SCI, V19, P309, DOI 10.1109/27.106829; Briels TMP, 2006, J PHYS D APPL PHYS, V39, P5201, DOI 10.1088/0022-3727/39/24/016; Hackam R, 2000, IEEE T DIELECT EL IN, V7, P654, DOI 10.1109/94.879361; Hoft H, 2014, IEEE T PLASMA SCI, V42, P2336, DOI 10.1109/TPS.2014.2309595; Huiskamp T, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/16/165202; Huiskamp T, 2014, IEEE T PLASMA SCI, V42, P859, DOI 10.1109/TPS.2014.2300895; Huiskamp T, 2014, IEEE T PLASMA SCI, V42, P127, DOI 10.1109/TPS.2013.2293841; Huiskamp T, 2013, IEEE T PLASMA SCI, V41, P3666, DOI 10.1109/TPS.2013.2286499; Ma HB, 2003, OZONE-SCI ENG, V25, P127; MASUDA S, 1986, IEEE T IND APPL, V22, P886, DOI 10.1109/TIA.1986.4504809; Matsumoto T., 2009, P BIOENG C 2009 IEEE, P1; Matsumoto T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.08JF14; Nijdam S, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/2/025008; Ono R, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/48/485201; Puchkarev V, 1997, APPL PHYS LETT, V71, P3364, DOI 10.1063/1.120338; Samaranayake WJM, 2001, IEEE T DIELECT EL IN, V8, P826, DOI 10.1109/94.959711; van Heesch EJM, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/23/234015; vanVeldhuizen EM, 1996, PLASMA CHEM PLASMA P, V16, P227; Wang DY, 2011, J ADV OXID TECHNOL, V14, P131; Winands GJJ, 2008, IEEE T PLASMA SCI, V36, P243, DOI 10.1109/TPS.2007.914190; Wu Y, 2003, J ELECTROSTAT, V57, P233, DOI 10.1016/S0304-3886(02)00163-8; Yan KP, 1998, J ELECTROSTAT, V44, P17, DOI 10.1016/S0304-3886(98)00019-9	32	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	FEB	2015	43	2					617	624		10.1109/TPS.2015.2388631		8	Physics, Fluids & Plasmas	Physics	CE8IC	WOS:000352084400019		
J	Hsiao, RC; Sung, TL; Liu, CM; Teii, S; Ono, S; Teii, K; Ebihara, K				Hsiao, Ruey-Chang; Sung, Ta-Lun; Liu, Chung-Ming; Teii, Shinriki; Ono, Shigeru; Teii, Kungen; Ebihara, Kenji			Numerical Study on Heat Flow During Catalytic Dissociation of Ozone in a Dielectric Barrier Discharge Ozonizer	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Atmospheric pressure; catalyst; copper; decomposition; dielectric barrier discharge; dissociation; electrode temperature; heat flow; microplasma; ozonizer; stainless steel	STERILIZATION; GENERATION; PLASMA	A simple heat flow model is established for numerical analysis of the effect of catalytic dissociation of ozone on electrode surface temperature in a coaxial cylindrical-type dielectric barrier discharge ozonizer. The amount of heat consumed by the ozone decomposition at the electrode surface is determined from the balance of heat flow among the discharge gas, electrode, and cooling water. Our calculation using the experimental data shows that the ozone decomposition by 1.6% in total ozone reaching the electrode surface is required to explain the observed temperature decrease from about 20 degrees C to 8 degrees C for a stainless steel electrode, while that by 4.5% is needed to explain the temperature decrease from about 20 degrees C to 19 degrees C for a copper electrode. The decomposition rates calculated in the discharge are about two orders of magnitude higher than those measured in gas flow downstream of a similar discharge.	[Hsiao, Ruey-Chang; Sung, Ta-Lun; Liu, Chung-Ming; Teii, Shinriki] Lunghwa Univ Sci & Technol, Dept Chem & Mech Engn, Taoyuan 33306, Taiwan; [Teii, Shinriki] Tokyo City Univ, Tokyo 1600022, Japan; [Ono, Shigeru] Tokyo City Univ, Dept Elect Engn, Tokyo 1600022, Japan; [Teii, Kungen] Kyushu Univ, Dept Appl Sci Elect & Mat, Fukuoka 8168581, Japan; [Ebihara, Kenji] Environm & Energy Lab, Fukuoka 8113134, Japan; [Ebihara, Kenji] Kumamoto Univ, Kumamoto 8600862, Japan	Hsiao, RC (reprint author), Lunghwa Univ Sci & Technol, Dept Chem & Mech Engn, Taoyuan 33306, Taiwan.	hrc@mail.lhu.edu.tw; tlsung@mail.lhu.edu.tw; teii@mail.lhu.edu.tw; s-ono@tcu.ac.jp; teii@ence.kyushu-u.ac.jp; k-shrimp@road.ocn.ne.jp			Japan Society for the Promotion of Science [25390111, 26630368]	This work was supported by the Japan Society for the Promotion of Science through the Grants-in-Aid for Scientific Research under Grant 25390111 and Grant 26630368.	Wei LS, 2014, VACUUM, V104, P61, DOI 10.1016/j.vacuum.2014.01.009; Takayama M, 2006, THIN SOLID FILMS, V506, P396, DOI 10.1016/j.tsf.2005.08.332; Chen LC, 2000, WATER RES, V34, P974, DOI 10.1016/S0043-1354(99)00188-8; Takaki K, 2008, VACUUM, V83, P128, DOI 10.1016/j.vacuum.2008.03.047; Haraki N, 2004, ELECTR ENG JPN, V149, P14, DOI 10.1002/eej.20018; Choi JH, 2006, J ELECTROSTAT, V64, P17, DOI 10.1016/j.elstat.2005.04.001; Patil S, 2012, FOOD SCI TECHNOL-INT, P225, DOI 10.1016/B978-0-12-381470-8.00009-8; Chalmers I. D., 1995, P 10 IEEE INT PULS P, V2, P1249; Eliasson B., 1986, 86E11C KLR; Foller P. C., 1982, U.S. Patent, Patent No. [4 316 782, 4316782]; Hsiao RC, 2014, VACUUM, V101, P345, DOI 10.1016/j.vacuum.2013.10.008; Itoh H, 2011, OZONE-SCI ENG, V33, P106, DOI 10.1080/01919512.2011.548295; Kogoma M, 2001, THIN SOLID FILMS, V386, P200, DOI 10.1016/S0040-6090(00)01643-6; MASUDA S, 1988, IEEE T IND APPL, V24, P223, DOI 10.1109/28.2860; Nomoto Y, 1995, IEEE T IND APPL, V31, P1458, DOI 10.1109/28.475741; Ono S, 2009, THIN SOLID FILMS, V518, P981, DOI 10.1016/j.tsf.2009.07.175; Pelster D. E., 1995, U.S. Patent, Patent No. [5 387 400, 5387400]; Sugimitsu H., 1996, FUNDAMENTALS APPL OZ, P15; Sung TL, 2012, IEEE T PLASMA SCI, V40, P2751, DOI 10.1109/TPS.2012.2210447; Sung T.-L., 2011, P IEE JPN JOINT TECH, P59; Sung TL, 2013, VACUUM, V90, P65, DOI 10.1016/j.vacuum.2012.10.003; Yoshida S., 1999, BASIC HEAT TRANSFER, P66	22	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	FEB	2015	43	2					665	669		10.1109/TPS.2014.2381258		5	Physics, Fluids & Plasmas	Physics	CE8IC	WOS:000352084400025		
J	Ozawa, K				Ozawa, Kazue			Search for the advancement of the International Journal of Clinical Oncology (IJCO)	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Editorial Material									Japan Soc Clin Oncol, Kyoto, Japan	Ozawa, K (reprint author), Japan Soc Clin Oncol, Kyoto, Japan.	office@jsco.or.jp						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					1	2		10.1007/s10147-014-0776-1		2	Oncology	Oncology	CE8OY	WOS:000352104100001		
J	Sobue, T				Sobue, Tomotaka			Cancer registration system: an introduction	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Review							JAPAN		Osaka Univ, Grad Sch Med, Div Environm Med & Populat Sci, Suita, Osaka 5650871, Japan	Sobue, T (reprint author), Osaka Univ, Grad Sch Med, Div Environm Med & Populat Sci, F1,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tsobue@envi.med.osaka-u.ac.jp					[Anonymous], 2000, ENHANCING DATA SYSTE; Okamoto N, 2008, INT J CLIN ONCOL, V13, P90, DOI 10.1007/s10147-008-0759-1; Parkin DM, 2008, INT J CLIN ONCOL, V13, P102, DOI 10.1007/s10147-008-0762-6; Chiang CJ, 2010, JPN J CLIN ONCOL, V40, P897, DOI 10.1093/jjco/hyq057; Sobue T, 2008, INT J CLIN ONCOL, V13, P97, DOI 10.1007/s10147-008-0761-7	5	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					3	4		10.1007/s10147-014-0758-3		2	Oncology	Oncology	CE8OY	WOS:000352104100002		
J	Anazawa, T; Miyata, H; Gotoh, M				Anazawa, Takayuki; Miyata, Hiroaki; Gotoh, Mitsukazu			Cancer registries in Japan: National Clinical Database and site-specific cancer registries	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Review						Cancer registry; Nationwide database; Risk factor; Risk model	REGISTRATION SYSTEM; RISK MODEL; SURGERY	The cancer registry is an essential part of any rational program of evidence-based cancer control. The cancer control program is required to strategize in a systematic and impartial manner and efficiently utilize limited resources. In Japan, the National Clinical Database (NCD) was launched in 2010. It is a nationwide prospective registry linked to various types of board certification systems regarding surgery. The NCD is a nationally validated database using web-based data collection software; it is risk adjusted and outcome based to improve the quality of surgical care. The NCD generalizes site-specific cancer registries by taking advantage of their excellent organizing ability. Some site-specific cancer registries, including pancreatic, breast, and liver cancer registries have already been combined with the NCD. Cooperation between the NCD and site-specific cancer registries can establish a valuable platform to develop a cancer care plan in Japan. Furthermore, the prognosis information of cancer patients arranged using population-based and hospital-based cancer registries can help in efficient data accumulation on the NCD. International collaboration between Japan and the USA has recently started and is expected to provide global benchmarking and to allow a valuable comparison of cancer treatment practices between countries using nationwide cancer registries in the future. Clinical research and evidence-based policy recommendation based on accurate data from the nationwide database may positively impact the public.	[Anazawa, Takayuki; Gotoh, Mitsukazu] Fukushima Med Univ, Dept Regenerat Surg, Fukushima 9601295, Japan; [Miyata, Hiroaki] Univ Tokyo, Grad Sch Med, Dept Healthcare Qual Assessment, Bunkyo Ku, Tokyo 1138655, Japan	Gotoh, M (reprint author), Fukushima Med Univ, Dept Regenerat Surg, 1 Hikarigaoka, Fukushima 9601295, Japan.	mgotoh@fmu.ac.jp					Cohen ME, 2009, J AM COLL SURGEONS, V209, P687, DOI 10.1016/j.jamcollsurg.2009.08.020; Miyata H, 2014, SURG TODAY, V44, P1991, DOI 10.1007/s00595-013-0802-3; Matsubara N, 2014, DIS COLON RECTUM, V57, P1075, DOI 10.1097/DCR.0000000000000176; Konishi T, 2007, GUT, V56, P863, DOI 10.1136/gut.2006.109157; Hall BL, 2009, ANN SURG, V250, P363, DOI 10.1097/SLA.0b013e3181b4148f; [Anonymous], 2014, 69 GEN M JAP SOC GAS; Kobayashi H, 2014, J GASTROENTEROL, V49, P1047, DOI 10.1007/s00535-013-0860-8; Egawa S, 2012, PANCREAS, V41, P985, DOI 10.1097/MPA.0b013e318258055c; Matsuno S, 2004, PANCREAS, V28, P219, DOI 10.1097/00006676-200404000-00002; Kimura W, 2014, ANN SURG, V259, P773, DOI 10.1097/SLA.0000000000000263; Gotoh Mitsukazu, 2014, Nihon Geka Gakkai Zasshi, V115, P8; Ishiguro M, 2014, J AM COLL SURGEONS, V218, P969, DOI 10.1016/j.jamcollsurg.2013.12.046; Kenjo A, 2014, J AM COLL SURGEONS, V218, P412; Miyata H, 2012, J THORAC CARDIOV SUR, V143, P1364, DOI 10.1016/j.jtcvs.2011.07.010; Muir C S, 1985, Conn Med, V49, P713; Nakagoe T, 2014, SURG TODAY; Sobue T, 2008, INT J CLIN ONCOL, V13, P97, DOI 10.1007/s10147-008-0761-7; Suzuki H, 2011, CANCER SCI, V102, P226, DOI 10.1111/j.1349-7006.2010.01749.x; Takeuchi H, 2014, ANN SURG; Watanabe M, 2014, ANN SURG; Yamamoto M, 1998, PANCREAS, V16, P238, DOI 10.1097/00006676-199804000-00006	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					5	10		10.1007/s10147-014-0757-4		6	Oncology	Oncology	CE8OY	WOS:000352104100003		
J	Matsuda, T; Sobue, T				Matsuda, Tomohiro; Sobue, Tomotaka			Recent trends in population-based cancer registries in Japan: the Act on Promotion of Cancer Registries and drastic changes in the historical registry	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Review						Neoplasms; Japan; Registries; Mandatory reporting; Confidentiality; Statistics	SYSTEM	Cancer registration in Japan has a long history spanning over 60 years; the first population-based cancer registry was established in Miyagi prefecture in 1951. The progress made in the regional population-based cancer registries in terms of standardization and quality improvement during the 10 years of the third comprehensive strategy for cancer control was highlighted in the history of cancer registration in Japan. However, there were still weak points regarding local government-oriented cancer registries that remained, e.g., the reporting of cancer cases to the population-based cancer registries was not a mandatory task for medical institutions. After the Cancer Control Act in 2006, the Act on Promotion of Cancer Registries was finally enacted in Japan on December 6, 2013. According to that Act, hospital managers must report information on any primary cancer that was first diagnosed in their institutions from January 1, 2016 to the prefectural governors. Given the increasing number of cases and amount of information recorded, it would have been almost impossible to maintain our cancer registries using the same system, and changes were required to obtain reliable cancer statistics. This was particularly important in Japan, because the country is facing a hyper-aging society, with two to three million cancer patients requiring entry of detailed information. We appreciate the long history of the Japanese cancer registry, but it is necessary to make dramatic changes to bring the registry up to date and to be able to track the increasing amount of information.	[Matsuda, Tomohiro] Natl Canc Ctr, Ctr Control & Informat Serv, Div Surveillance, Task Force Natl Canc Registry,Chuo Ku, Tokyo 1040045, Japan; [Matsuda, Tomohiro] Natl Canc Ctr, Ctr Control & Informat Serv, Div Surveillance, Population Based Canc Registry Sect,Chuo Ku, Tokyo 1040045, Japan; [Sobue, Tomotaka] Osaka Univ, Fac Med, Osaka, Japan	Matsuda, T (reprint author), Natl Canc Ctr, Ctr Control & Informat Serv, Div Surveillance, Task Force Natl Canc Registry,Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tomatsud@ncc.go.jp					Wingo PA, 2003, CANCER CAUSE CONTROL, V14, P175, DOI 10.1023/A:1023002322935; Parkin DM, 2009, EUR J CANCER, V45, P756, DOI 10.1016/j.ejca.2008.11.033; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; Okamoto N, 2008, INT J CLIN ONCOL, V13, P90, DOI 10.1007/s10147-008-0759-1; Matsuda T, 2009, JPN J CLIN ONCOL, V39, P850, DOI 10.1093/jjco/hyp106; Forman D., 2013, CANC INCIDENCE 5 CON; Sobue T, 2008, INT J CLIN ONCOL, V13, P89, DOI 10.1007/s10147-008-0768-0; Sobue T, 2008, INT J CLIN ONCOL, V13, P97, DOI 10.1007/s10147-008-0761-7	8	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					11	20		10.1007/s10147-014-0765-4		10	Oncology	Oncology	CE8OY	WOS:000352104100004		
J	Makino, K; Nakamura, H; Hide, T; Kuroda, J; Yano, S; Kuratsu, J				Makino, Keishi; Nakamura, Hideo; Hide, Taku-ichiro; Kuroda, Jun-ichiro; Yano, Shigetoshi; Kuratsu, Jun-ichi			Prognostic impact of completion of initial high-dose methotrexate therapy on primary central nervous system lymphoma: a single institution experience	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Primary central nervous system lymphoma; High-dose methotrexate; Chemotherapy; Retrospective study; Prognostic impact	PRIMARY CNS LYMPHOMA; LONG-TERM; PHASE-II; CHEMOTHERAPY; RADIOTHERAPY; BRAIN; MULTICENTER; RADIATION; SALVAGE; SURVIVAL	Background This retrospective single-center study assessed the feasibility, outcomes, and side-effects of high-dose methotrexate (HD-MTX) plus procarbazine in the treatment of immunocompetent patients with primary central nervous system lymphoma (PCNSL). Methods Ninety-one patients diagnosed with PCNSL between January 2001 and December 2011 were treated with HD-MTX plus procarbazine. To reduce neurotoxicity in patients aged >= 60 years, only those not responding to chemotherapy and patients with relapse underwent whole-brain irradiation. Results All 91 consecutive patients were scheduled to receive HD-MTX. Their median age was 66 years (range 32-88 years) and their median Karnofsky performance score was 40 (range 20-100). While 56 patients (61.5 %) completed 3 cycles of HD-MTX chemotherapy and 48 (52.7 %) showed a complete response, treatment was stopped in 11 patients (12.1 %) due to toxicity. The median overall survival and progression-free survival were 40.6 and 11.7 months, respectively. Overall survival was significantly improved in patients who completed 3 cycles of chemotherapy compared with those did not (56.4 vs 24.0 months; p = 0.013 by univariate and p = 0.022 by multivariate analysis). Conclusions Initial treatment with HD-MTX plus procarbazine was effective in patients with PCNSL. Completion of 3 cycles of HD-MTX chemotherapy was a significant independent prognostic factor for patient survival.	[Makino, Keishi; Nakamura, Hideo; Hide, Taku-ichiro; Kuroda, Jun-ichiro; Yano, Shigetoshi; Kuratsu, Jun-ichi] Kumamoto Univ, Fac Med, Dept Neurosurg, Chuo Ku, Kumamoto 8608556, Japan	Makino, K (reprint author), Kumamoto Univ, Fac Med, Dept Neurosurg, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	kmakino@fc.kuh.kumamoto-u.ac.jp					Batchelor T, 2003, J CLIN ONCOL, V21, P1044, DOI 10.1200/JCO.2003.03.036; Abrey LE, 2006, J CLIN ONCOL, V24, P5711, DOI 10.1200/JCO.2006.08.2941; Hoang-Xuan K, 2003, J CLIN ONCOL, V21, P2726, DOI 10.1200/JCO.2003.11.036; NELSON DF, 1992, INT J RADIAT ONCOL, V23, P9; Fliessbach K, 2005, NEUROLOGY, V64, P1184; Abrey LE, 2005, J CLIN ONCOL, V23, P5034, DOI 10.1200/JCO.2005.13.524; Correa DD, 2004, NEUROLOGY, V62, P548; DeAngelis LM, 2002, J CLIN ONCOL, V20, P4643, DOI 10.1200/JCO.2002.11.013; Omuro AMP, 2005, ARCH NEUROL-CHICAGO, V62, P1595, DOI 10.1001/archneur.62.10.1595; Nguyen PL, 2005, J CLIN ONCOL, V23, P1507, DOI 10.1200/JCO.2005.01.161; Hottinger AF, 2007, NEUROLOGY, V69, P1178, DOI 10.1212/01.wnl.0000276986.19602.c1; GLASS J, 1994, J NEUROSURG, V81, P188, DOI 10.3171/jns.1994.81.2.0188; Nakamura H, 2011, INT J CLIN ONCOL, V16, P314, DOI 10.1007/s10147-010-0178-y; [Anonymous], 2004, J CLIN ONCOL; Abrey LE, 1998, J CLIN ONCOL, V16, P859; Illerhaus G, 2009, ANN ONCOL, V20, P319, DOI 10.1093/annonc/mdn628; Filley CM, 2001, NEW ENGL J MED, V345, P425, DOI 10.1056/NEJM200108093450606; Guha-Thakurta N, 1999, J NEURO-ONCOL, V43, P259, DOI 10.1023/A:1006210703827; Herrlinger U, 2002, ANN NEUROL, V51, P247, DOI 10.1002/ana.10102; Hiraga S, 1999, J NEUROSURG, V91, P221, DOI 10.3171/jns.1999.91.2.0221; Kiewe P, 2008, CANCER, V112, P1812, DOI 10.1002/cncr.23377; Makino K, 2012, J NEURO-ONCOL, V106, P155, DOI 10.1007/s11060-011-0652-z; Neuwelt EA, 2005, AM J NEURORADIOL, V26, P258; O'Brien P, 2000, J CLIN ONCOL, V18, P519; Reni M, 2004, J CLIN ONCOL, V22, P1165, DOI 10.1200/JCO.2004.99.259	25	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					29	34		10.1007/s10147-014-0692-4		6	Oncology	Oncology	CE8OY	WOS:000352104100006		
J	Masubuchi, T; Tada, Y; Maruya, S; Osamura, Y; Kamata, S; Miura, K; Fushimi, C; Takahashi, H; Kawakita, D; Kishimoto, S; Nagao, T				Masubuchi, Tatsuo; Tada, Yuichiro; Maruya, Shin-ichiro; Osamura, Yoshiyuki; Kamata, Shin-etsu; Miura, Kouki; Fushimi, Chihiro; Takahashi, Hideaki; Kawakita, Daisuke; Kishimoto, Seiji; Nagao, Toshitaka			Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Salivary duct carcinoma; Androgen receptor; HER2; Ki-67; EGFR	BREAST-CANCER SUBTYPES; PROSTATE-CANCER; PHASE-II; BIOLOGIC SIGNIFICANCE; PAROTID-GLAND; THERAPY; TRASTUZUMAB; GEMCITABINE; CETUXIMAB; SURVIVAL	Background Salivary duct carcinoma (SDC) is a highly aggressive disease which often metastasizes to distant sites, and there is no established standard therapy for this systemic disease. Given that SDC is biologically similar to breast and prostate cancer, anti-androgenic receptor (AR) and anti-human epidermal growth factor receptor 2 (HER2) therapies have the potential to exert effects, not only on patients with breast and prostate cancer but also on those with SDC. Methods The expression levels of HER2, epidermal growth factor receptor (EGFR), Ki-67, and AR were assessed in 32 patients with SDC, and their correlations with overall survival (OS) and disease-free survival (DFS) were analyzed retrospectively. SDC was classified into five subtypes using a method similar to that used for breast cancer. Results Anti-AR, HER2, and EGFR were positive in 23 (71.9 %), 14 (43.8 %), and 26 (81.3 %) cases, respectively. One or more of these 3 factors were positive in 30 (93.8 %) cases. The Ki-67 labeling index was greater than 15 % in all cases. While molecular status did not correlate with OS, EGFR and AR positivity were significantly associated with DFS in univariate analysis. Multivariate analysis revealed that EGFR was the only independent predictor of DFS. Conclusions The statuses of some molecules are useful to predict DFS in patients with SDC. Ki-67 overexpression suggests that cytotoxic agents are effective for SDC. Since the majority of SDCs express AR, HER2, and/or EGFR, assessing and targeting these molecules are promising strategies to improve the prognosis of unresectable, metastatic or recurrent SDC, and a classification system according to the molecular expression status may be useful to select appropriate therapy.	[Masubuchi, Tatsuo; Tada, Yuichiro; Maruya, Shin-ichiro; Kamata, Shin-etsu; Miura, Kouki; Fushimi, Chihiro; Takahashi, Hideaki] Int Univ Hlth & Welf, Mita Hosp, Dept Head & Neck Oncol & Surg, Minato Ku, Tokyo 1088239, Japan; [Osamura, Yoshiyuki] Int Univ Hlth & Welf, Mita Hosp, Ctr Diagnost Pathol, Minato Ku, Tokyo 1088239, Japan; [Kawakita, Daisuke] Nagoya City Univ, Grad Sch Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Kishimoto, Seiji] Tokyo Med & Dent Univ, Dept Head & Neck Surg, Bunkyo Ku, Tokyo 1138519, Japan; [Nagao, Toshitaka] Tokyo Med Univ, Dept Anat Pathol, Shinjuku Ku, Tokyo 1600023, Japan	Tada, Y (reprint author), Int Univ Hlth & Welf, Mita Hosp, Dept Head & Neck Oncol & Surg, Minato Ku, 1-4-3 Mita, Tokyo 1088239, Japan.	ytada@iuhw.ac.jp					Adelstein DJ, 2012, SEMIN RADIAT ONCOL, V22, P245, DOI 10.1016/j.semradonc.2012.03.009; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Schlomm T, 2007, CLIN CANCER RES, V13, P6579, DOI 10.1158/1078-0432.CCR-07-1257; Jaspers HCJ, 2011, J CLIN ONCOL, V29, pE473, DOI 10.1200/JCO.2010.32.8351; Hussain MHA, 2007, J CLIN ONCOL, V25, P2218, DOI 10.1200/JCO.2006.08.0994; Locati LD, 2009, ORAL ONCOL, V45, P574, DOI 10.1016/j.oraloncology.2008.07.010; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Dalesio O, 2000, LANCET, V355, P1491; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Lewis JE, 1996, CANCER, V77, P223, DOI 10.1002/(SICI)1097-0142(19960115)77:2<223::AID-CNCR1>3.0.CO;2-N; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Jaehne M, 2005, CANCER, V103, P2526, DOI 10.1002/cncr.21116; Lewis JE, 2001, HUM PATHOL, V32, P596, DOI 10.1053/hupa.2001.25000; Gatzemeier U, 2004, ANN ONCOL, V15, P19, DOI 10.1093/annonc/mdh031; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Nabili V, 2007, HEAD NECK-J SCI SPEC, V29, P907, DOI 10.1002/hed.20614; Guzzo M, 1997, HEAD NECK-J SCI SPEC, V19, P126, DOI 10.1002/(SICI)1097-0347(199703)19:2<126::AID-HED7>3.0.CO;2-6; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Dowsett M, 2011, J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Safran H, 2004, CANCER INVEST, V22, P706, DOI 10.1081/CNV-200032974; Williams MD, 2007, AM J SURG PATHOL, V31, P1645; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Russell PJ, 1998, CLIN CHEM, V44, P705; Nagao T, 2012, ACTA HISTOCHEM CYTOC, V45, P269, DOI 10.1267/ahc.12019; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Prat A, 2008, HEAD NECK-J SCI SPEC, V30, P680, DOI 10.1002/hed.20714; Nashed M, 2009, J LARYNGOL OTOL, V123, P250, DOI 10.1017/S0022215108002314; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Castellano I, 2010, BREAST CANCER RES TR, V124, P607, DOI 10.1007/s10549-010-0761-y; Williams MD, 2010, CLIN CANCER RES, V16, P2266, DOI 10.1158/1078-0432.CCR-09-0238; DEWINTER JAR, 1991, J HISTOCHEM CYTOCHEM, V39, P927; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Barnes L, 2005, WHO CLASSIFICATION T; BATSAKIS JG, 1992, ANN OTO RHINOL LARYN, V101, P102; De Dosso S, 2009, TUMORI, V95, P378; Glisson B, 2005, J CLIN ONCOL, V23, P5532; Hoang MP, 2001, INT J ONCOL, V19, P865; Kaidar-Person O, 2011, MED ONCOL, V29, P704; Kleinsasser O, 1968, Arch Klin Exp Ohren Nasen Kehlkopfheilkd, V192, P100, DOI 10.1007/BF00301495; Lagha A, 2012, HEAD NECK ONCOL, V4, P4; Locati LD, 2003, ANN ONCOL, V14, P1327, DOI 10.1093/annonc/mdg331; Locati LD, 2003, ANN ONCOL         S4, p[14, 126]; Martinez-Barba E, 1997, AM J CLIN PATHOL, V109, P75; Nagao T, 2004, AM J SURG PATHOL, V28, P319, DOI 10.1097/00000478-200403000-00004; Seifert G, 1991, HISTOLOGICAL TYPING; Sharon E, 2010, HEAD NECK ONCOL, V26, P2; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Takeda H, 1996, CANCER, V77, P934, DOI 10.1002/(SICI)1097-0142(19960301)77:5<934::AID-CNCR20>3.0.CO;2-3; Tanei T, 2011, EJSO-EUR J SURG ONC, V37, P155, DOI 10.1016/j.ejso.2010.10.009; Tuefferd M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001138; VANDERHULST RWM, 1994, LANCET, V344, P817, DOI 10.1016/S0140-6736(94)92372-8	53	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					35	44		10.1007/s10147-014-0674-6		10	Oncology	Oncology	CE8OY	WOS:000352104100007		
J	Yamaguchi, S; Ohguri, T; Matsuki, Y; Yahara, K; Oki, H; Imada, H; Narisada, H; Korogi, Y				Yamaguchi, Shinsaku; Ohguri, Takayuki; Matsuki, Yuichi; Yahara, Katsuya; Oki, Hodaka; Imada, Hajime; Narisada, Hiroyuki; Korogi, Yukunori			Radiotherapy for thoracic tumors: association between subclinical interstitial lung disease and fatal radiation pneumonitis	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Thoracic radiotherapy; Interstitial lung disease; Radiation pneumonitis	IDIOPATHIC PULMONARY-FIBROSIS; VOLUME HISTOGRAM PARAMETERS; ACUTE EXACERBATION; DEFINITIVE CHEMORADIOTHERAPY; DOSIMETRIC FACTORS; CANCER; PREDICTION; THERAPY; CHEMORADIATION; DETERIORATION	Background We evaluated the association between subclinical interstitial lung disease (ILD) and fatal radiation pneumonitis (RP) in patients with thoracic tumors treated with thoracic radiotherapy (RT). Methods Sixty-two consecutive patients with thoracic tumors treated with thoracic RT were retrospectively analyzed. According to our protocols, patients with subclinical ILD (untreated and asymptomatic) were considered to be indicated for thoracic RT, while patients with clinical ILD (post-or during treatment) were not considered candidates for thoracic RT. The presence, extent and distribution of subclinical ILD on CT findings at pre-thoracic RT were reviewed and scored by two chest radiologists. The relationships between RP and clinical factors, including subclinical ILD, were investigated. Results Subclinical ILD was recognized in 11 (18 %) of the 62 patients. Grade 2-5 RP was recognized in eight (13 %) of the 62 patients, with Grade 5 in three patients and Grade 2 in five patients. Grade 2-5 RP was observed in four (36 %) of the 11 patients with subclinical ILD. Subclinical ILD was found to be a significant factor influencing the development of Grade 2-5 RP (p = 0.0274). Subclinical ILD tended to be significant for the occurrence of Grade 5 RP (p = 0.0785). Regarding the CT score, more extensive ILD (bilateral fibrosis in multiple lobes) was recognized in two of the three patients with Grade 5 RP. Conclusions In this study, fatal RP tended to be more common in the patients with subclinical ILD. In particular, the presence of extensive fibrosis on CT may be a contraindication for thoracic RT.	[Yamaguchi, Shinsaku; Matsuki, Yuichi] Kitakyushu Gen Hosp, Dept Radiol, Kitakyushu, Fukuoka, Japan; [Ohguri, Takayuki; Yahara, Katsuya; Oki, Hodaka; Korogi, Yukunori] Univ Occupat & Environm Hlth, Dept Radiol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Imada, Hajime; Narisada, Hiroyuki] Tobata Kyoritsu Hosp, Dept Canc Therapy Ctr, Kitakyushu, Fukuoka, Japan	Ohguri, T (reprint author), Univ Occupat & Environm Hlth, Dept Radiol, Yahatanishi Ku, Iseigaoka 1-1, Kitakyushu, Fukuoka 8078555, Japan.	ogurieye@med.uoeh-u.ac.jp					GIBSON PG, 1988, ANN INTERN MED, V109, P288; Kim DS, 2006, EUR RESPIR J, V27, P143, DOI 10.1183/00936.06.00114004; Minegishi Y, 2009, INTERNAL MED, V48, P665, DOI 10.2169/internalmedicine.48.1650; Park J, 2001, EUR RESPIR J, V17, P1216, DOI 10.1183/09031936.01.99055301; Matsuo Y, 2012, INT J RADIAT ONCOL, V83, pE545, DOI 10.1016/j.ijrobp.2012.01.018; Washko GR, 2010, ACAD RADIOL, V17, P48, DOI 10.1016/j.acra.2009.07.016; Wang SL, 2006, INT J RADIAT ONCOL, V64, P692, DOI 10.1016/j.ijrobp.2005.08.002; Mehta V, 2005, INT J RADIAT ONCOL, V63, P5, DOI 10.1016/j.ijrobp.2005.03.047; TURNERWARWICK M, 1980, THORAX, V35, P496, DOI 10.1136/thx.35.7.496; Tsujino K, 2003, INT J RADIAT ONCOL, V55, P110, DOI 10.1016/S0360-3016(02)03807-5; MORGAN GW, 1995, INT J RADIAT ONCOL, V31, P361, DOI 10.1016/0360-3016(94)00477-3; Raghu G, 1999, CHEST, V116, P1168, DOI 10.1378/chest.116.5.1168; KONDOH Y, 1993, CHEST, V103, P1808, DOI 10.1378/chest.103.6.1808; Tanabe S, 2013, J RADIAT RES, V54, P1085, DOI 10.1093/jrr/rrt047; Ishikura S, 2003, J CLIN ONCOL, V21, P2697, DOI 10.1200/JCO.2003.03.055; Seppenwoolde Y, 2001, SEMIN RADIAT ONCOL, V11, P247, DOI 10.1053/srao.2001.23482; PANOS RJ, 1990, AM J MED, V88, P396, DOI 10.1016/0002-9343(90)90495-Y; SMITH JC, 1964, AM REV RESPIR DIS, V89, P264; Washko GR, 2011, NEW ENGL J MED, V364, P897, DOI 10.1056/NEJMoa1007285; Rodrigues G, 2004, RADIOTHER ONCOL, V71, P127, DOI [10.1016/j.radonc.2004.02.015, 10.1016/j.radone.2004.02.015]; Akira M, 1997, AM J ROENTGENOL, V168, P79; ROBERTS CM, 1993, ANN INTERN MED, V118, P696; Kyas I, 2007, INT J RADIAT ONCOL, V67, P768, DOI 10.1016/j.ijrobp.2006.08.066; Sanuki N, 2012, J RADIAT RES, V53, P110, DOI 10.1269/jrr.110142; Baba Yasutaka, 2000, Nippon Acta Radiologica, V60, P23; Chida M, 2008, EUR J CARDIO-THORAC, V34, P878, DOI 10.1016/j.ejcts.2008.07.028; Hanibuchi M, 2001, JPN J LUNG CANC, V41, P281; Kawabata Y, 2001, Nihon Kokyuki Gakkai Zasshi, V39, P316; Kawasaki H, 2001, J SURG ONCOL, V76, P53, DOI 10.1002/1096-9098(200101)76:1<53::AID-JSO1009>3.0.CO;2-T; Marks LB, 2010, INT J RADIAT ONCOL, V76, pS70, DOI 10.1016/j.ijrobp.2009.06.091; Oh D, 2009, JPN J CLIN ONCOL, V39, P151, DOI 10.1093/jjco/hyn158; Takeda A, 2008, RADIAT MED, V26, P504, DOI 10.1007/s11604-008-0261-8; TAKENAKA N, 1988, Neurological Surgery, V16, P529; Tsujino K, 2006, INT J RADIAT ONCOL, V64, P1100, DOI 10.1016/j.ijrobp.2005.09.025	34	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					45	52		10.1007/s10147-014-0679-1		8	Oncology	Oncology	CE8OY	WOS:000352104100008		
J	Yoshitake, T; Nakamura, K; Shioyama, Y; Sasaki, T; Ohga, S; Shinoto, M; Terashima, K; Asai, K; Matsumoto, K; Matsuo, Y; Baba, S; Honda, H				Yoshitake, Tadamasa; Nakamura, Katsumasa; Shioyama, Yoshiyuki; Sasaki, Tomonari; Ohga, Saiji; Shinoto, Makoto; Terashima, Kotaro; Asai, Kaori; Matsumoto, Keiji; Matsuo, Yoshio; Baba, Shingo; Honda, Hiroshi			Stereotactic body radiation therapy for primary lung cancers clinically diagnosed without pathological confirmation: a single-institution experience	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Stereotactic body radiation therapy; Non-small cell lung cancer; Solitary pulmonary nodule	PULMONARY NODULES; RADIOTHERAPY SBRT; TOMOGRAPHY	Background Pathological diagnosis of small lung lesions is sometimes difficult in medically inoperable patients. The purpose of this study was to evaluate the adverse events and the outcomes of stereotactic body radiation therapy (SBRT) for lung lesions which were clinically diagnosed as primary lung cancer without pathological confirmation. Methods Between April 2003 and April 2011, 88 patients with small lung lesions which were clinically diagnosed as primary lung cancer were treated with SBRT. The median tumor size was 19 mm (range 8-40 mm). The radiation dose was 48 Gy in four fractions in all patients. The median follow-up was 23 months (range 6-91 months). Results Recurrence was observed in 13 patients. The local control rate, progression-free survival rate, and overall survival rate at 3 years were 90, 67, and 80 %, respectively. Two patients (2.3 %) had Grade 2 radiation pneumonitis, and six patients (6.8 %) had Grade 2 rib fractures. There were no adverse events of Grade 3 or greater. Conclusions SBRT appears to be a safe and effective treatment option for small lung lesions that are clinically diagnosed as primary lung cancer without pathological confirmation.	[Yoshitake, Tadamasa] Kyushu Univ, Grad Sch Med Sci, Dept Comprehens Clin Oncol, Fukuoka 8128582, Japan; [Nakamura, Katsumasa; Shioyama, Yoshiyuki; Sasaki, Tomonari; Ohga, Saiji; Shinoto, Makoto; Terashima, Kotaro; Asai, Kaori; Matsumoto, Keiji; Matsuo, Yoshio; Baba, Shingo; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka 8128582, Japan	Nakamura, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	nakam@radiol.med.kyushu-u.ac.jp			JSPS KAKENHI [23390302, 23659589, 26461894]; Ministry of Health, Labor and Welfare of Japan	This work was supported in part by JSPS KAKENHI Grant Numbers 23390302, 23659589, 26461894 and also by a grant from the Ministry of Health, Labor and Welfare of Japan.	Allen Tadashi L, 2011, Semin Thorac Cardiovasc Surg, V23, P43, DOI 10.1053/j.semtcvs.2011.05.003; Nagata Y, 2009, INT J RADIAT ONCOL, V75, P343, DOI 10.1016/j.ijrobp.2009.02.087; Kim HK, 2009, J THORAC ONCOL, V4, P1242, DOI 10.1097/JTO.0b013e3181b3fee3; Takeda A, 2012, LUNG CANCER, V77, P77, DOI 10.1016/j.lungcan.2012.01.006; Asai K, 2012, INT J RADIAT ONCOL, V84, P768, DOI 10.1016/j.ijrobp.2012.01.027; Yoshitake T, 2009, PHYS MED BIOL, V54, P7171, DOI 10.1088/0031-9155/54/23/009; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Inoue T, 2009, INT J RADIAT ONCOL, V75, P683, DOI 10.1016/j.ijrobp.2008.11.026; Sieren JC, 2010, J MAGN RESON IMAGING, V32, P1353, DOI 10.1002/jmri.22383; Verstegen NE, 2011, RADIOTHER ONCOL, V101, P250, DOI 10.1016/j.radonc.2011.09.017; van Baardwijk A, 2012, RADIOTHER ONCOL, V105, P145, DOI 10.1016/j.radonc.2012.09.008; Herder GJ, 2005, CHEST, V128, P2490, DOI 10.1378/chest.128.4.2490; Gould MK, 2007, CHEST, V132, p108S, DOI 10.1378/chest.07-1353; Nomori H, 2004, LUNG CANCER-J IASLC, V45, P19, DOI 10.1016/j.lungcan.2004.01.009; Onishi H, 2013, JPN J CLIN ONCOL, V43, P345, DOI 10.1093/jjco/hyt014; Sakanaka K, 2014, INT J CLIN ONCOL, V19, P814, DOI 10.1007/s10147-013-0637-3; Sato Shuichi, 2010, Gen Thorac Cardiovasc Surg, V58, P461, DOI 10.1007/s11748-010-0601-3; Shioyama Y, 2013, J RADIAT RES, V54, P108, DOI 10.1093/jrr/rrs075; Shioyama Yoshiyuki, 2005, Radiat Med, V23, P407	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					53	58		10.1007/s10147-014-0698-y		6	Oncology	Oncology	CE8OY	WOS:000352104100009		
J	Shimizu, C; Kato, T; Tamura, N; Bando, H; Asada, Y; Mizota, Y; Yamamoto, S; Fujiwara, Y				Shimizu, Chikako; Kato, Tomoyasu; Tamura, Nobuko; Bando, Hiroko; Asada, Yoshimasa; Mizota, Yuri; Yamamoto, Seiichiro; Fujiwara, Yasuhiro			Perception and needs of reproductive specialists with regard to fertility preservation of young breast cancer patients	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Fertility preservation; Breast cancer; Reproductive specialist; Needs	WOMEN; RECOMMENDATIONS; LYMPHOMA; CARE	Background Treatment-related infertility is one of the important quality-of-life issues in young breast cancer (YBC) patients. Although existing guidelines recommend supporting fertility preservation (FP) of YBC, the perceptions of reproductive specialists (RS) has not been evaluated. We investigated the perceptions and needs of RS with regard to FP of YBC patients. Methods A cross-sectional survey was sent to 423 certified RS registered to the Japan Society for Reproductive Medicine to self-evaluate their perceptions and needs regarding FP in YBC patients. Results Two hundred RS (47 %) responded to the survey. 99 % responded that RS should be engaged in FP of YBC patients. 88 % responded that they would like to treat YBC patients, while 46 % responded that cancer treatment is more important than childbirth, even when the patient is recurrence-free 5 years after primary treatment. Respondents affiliated to private clinics were more likely to accept both fertilized and unfertilized egg preservation than those affiliated with academic or general hospitals. 70 % responded that they were anxious about treating breast cancer patients: concerns regarding a greater or unknown risk of recurrence (66 %), insufficient knowledge about breast cancer (47 %), and lack of a patient's spouse/partner (24 %) were identified as major barriers in supporting FP for YBC patients. Conclusions RS recognize the need for FP in YBC patients and are willing to participate in their care. Affiliation of RS was related to a positive attitude to egg preservation. Various concerns regarding FP among RS indicate the need for evidence that supports the safety of FP, inter-disciplinary communication, and practice guidelines.	[Shimizu, Chikako; Fujiwara, Yasuhiro] Natl Canc Ctr, Breast & Med Oncol Div, Chuo Ku, Tokyo 1040045, Japan; [Kato, Tomoyasu] Natl Canc Ctr, Dept Gynecol, Tokyo 1040045, Japan; [Tamura, Nobuko] Toranomon Gen Hosp, Dept Surg Oncol, Breast & Endocrine Surg Div, Tokyo, Japan; [Bando, Hiroko] Univ Tsukuba, Grad Sch Comprehens Human Sci, Breast & Endocrine Surg, Tsukuba, Ibaraki, Japan; [Asada, Yoshimasa] Asada Ladies Clin, Nagoya, Aichi, Japan; [Mizota, Yuri; Yamamoto, Seiichiro] Natl Canc Ctr, Ctr Canc Control & Informat Serv, Tokyo 104, Japan	Shimizu, C (reprint author), Natl Canc Ctr, Breast & Med Oncol Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	cshimizu@ncc.go.jp			Health Labor Sciences Research Grant of the Ministry of Health, Labor and Welfare [H21-021]; Third Term Comprehensive 10-year Strategy for Cancer Control [H24-Sanjigan-Ippan-010]	We thank Ms. Masayo Kawamura for her support in data collection and Dr. Richard Theriault of University of Texas, M. D. Anderson Cancer Center for his generous help in editing and reviewing this manuscript. This study was supported by a Health Labor Sciences Research Grant of the Ministry of Health, Labor and Welfare (H21-021) and Third Term Comprehensive 10-year Strategy for Cancer Control (H24-Sanjigan-Ippan-010). The results of this study were partly presented at the 35th Annual San Antonio Breast Cancer Symposium.	Azim HA, 2013, J CLIN ONCOL, V31, P73, DOI 10.1200/JCO.2012.44.2285; Kim SS, 2012, J ASSIST REPROD GEN, V29, P465, DOI 10.1007/s10815-012-9786-y; Thewes B, 2005, J CLIN ONCOL, V23, P5155, DOI 10.1200/JCO.2005.07.773; Azim AA, 2008, J CLIN ONCOL, V26, P2630, DOI 10.1200/JCO.2007.14.8700; Shimizu C, 2013, BREAST CANCER-TOKYO, V20, P230, DOI 10.1007/s12282-011-0328-8; Peate M, 2009, BREAST CANCER RES TR, V116, P215, DOI 10.1007/s10549-009-0401-6; King JW, 2012, ONCOLOGIST, V17, P910, DOI 10.1634/theoncologist.2012-0064; Klemp JR, 2012, J ASSIST REPROD GEN, V29, P469, DOI 10.1007/s10815-012-9791-1; Pagani O, 2011, BREAST CANCER RES TR, V129, P309, DOI 10.1007/s10549-011-1643-7; von Wolff M, 2011, ARCH GYNECOL OBSTET, V284, P427, DOI 10.1007/s00404-011-1874-1; Quinn GP, 2009, J CLIN ONCOL, V27, P5952, DOI 10.1200/JCO.2009.23.0250; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Robertson JA, 2005, FERTIL STERIL, V83, P1622, DOI 10.1016/j.fertnstert.2005.03.013; Gracia CR, 2013, J CLIN ONCOL, V31, P668, DOI 10.1200/JCO.2012.47.5798; Rodriguez S, 2013, J CLIN ONCOL, V31, P665, DOI 10.1200/JCO.2012.44.0990; Sha DK, 2011, INT J GYNECOL OBSTET, V115, P11; Valachis A, 2011, OBSTET GYNECOL SURV, V65, P786	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					82	89		10.1007/s10147-014-0676-4		8	Oncology	Oncology	CE8OY	WOS:000352104100012		
J	Shimada, M; Morine, Y; Nagano, H; Hatano, E; Kaiho, T; Miyazaki, M; Kono, T; Kamiyama, T; Morita, S; Sakamoto, J; Kusano, M; Saji, S; Kanematsu, T; Kitajima, M				Shimada, Mitsuo; Morine, Yuji; Nagano, Hiroaki; Hatano, Etsuro; Kaiho, Takashi; Miyazaki, Masaru; Kono, Toru; Kamiyama, Toshiya; Morita, Satoshi; Sakamoto, Junichi; Kusano, Mitsuo; Saji, Shigetoyo; Kanematsu, Takashi; Kitajima, Masaki			Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001)	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Japanese medicine; Bowel movement; Inflammation; C-reactive protein; Liver damage	DAI-KENCHU-TO; GENE-RELATED PEPTIDE; DELAYED GASTROINTESTINAL TRANSIT; HERBAL MEDICINE; BACTERIAL TRANSLOCATION; POSTOPERATIVE ILEUS; DAIKENCHUTO TU-100; HUMAN PLASMA; DISEASE; RATS	Background This multi-center, phase III trial assesses the efficacy of daikenchuto (TU-100) on gastrointestinal disorders after hepatic resection (UMIN Registration No. 000003103). Materials and methods A total of 231 patients, who underwent hepatic resection at 26 Japanese centers, were enrolled. Patients were randomly assigned to receive either oral doses (15 g/day, three times a day) of TU-100 or placebo control from preoperative day 3 to postoperative day 10, except on the day of surgery. Primary end points were the time from extubation until the first postoperative bowel movement (FBM-T), serum C-reactive protein (CRP) and ammonia levels. Results Finally, 209 patients (TU-100: n = 108, placebo: n = 101) were included in the statistical analysis. The median FBM-T was 88.2 h (95 % CI 74.0-94.1) in the TU-100 group and 93.1 h (95 % CI 83.3-99.4) in the placebo group, demonstrating that TU-100 accelerated the time to first bowel movement significantly more than placebo control. Serum CRP levels did not differ significantly during the study period, although serum CRP levels in the TU-100 group tended to be lower than those in the placebo group in patients with grade B liver damage. Meanwhile, the two groups had similar serum ammonia levels. TU-100-related serious adverse events did not occur during the study. Conclusions TU-100 appears to improve gastrointestinal dysmotility and reduce serum CRP levels in patients with grade B liver damage after hepatectomy. TU-100 is an effective treatment option after hepatic resection in patients with liver cancer.	[Shimada, Mitsuo; Morine, Yuji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Surg, Tokushima 7708503, Japan; [Nagano, Hiroaki] Osaka Univ, Dept Surg, Osaka, Japan; [Hatano, Etsuro] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan; [Kaiho, Takashi] Kimitsu Chuo Hosp, Dept Surg, Chiba, Japan; [Miyazaki, Masaru] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chiba, Japan; [Kono, Toru] Sapporo Higashi Tokushukai Hosp, Sapporo, Hokkaido, Japan; [Kamiyama, Toshiya] Hokkaido Univ, Grad Sch Med, Dept Gen Surg, Sapporo, Hokkaido 060, Japan; [Morita, Satoshi] Yokohama City Univ, Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; [Sakamoto, Junichi; Saji, Shigetoyo] Japanese Fdn Multidisciplinary Treatment Canc, Tokyo, Japan; [Kusano, Mitsuo] Kushiro Rosai Hosp, Kushiro, Hokkaido, Japan; [Kanematsu, Takashi] Nagasaki Municipal Hosp, Nagasaki, Japan; [Kitajima, Masaki] Int Univ Hlth & Welf, Tokyo, Japan	Shimada, M (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Surg, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	mitsuo.shimada@tokushima-u.ac.jp			Japanese Foundation for Multidisciplinary Treatment of Cancer	This work was jointly supported by the Japanese Foundation for Multidisciplinary Treatment of Cancer.	Yoshikawa K, 2012, SURG TODAY, V42, P646, DOI 10.1007/s00595-011-0094-4; Kono T, 2008, J SURG RES, V150, P78, DOI 10.1016/j.jss.2008.02.057; REINSHAGEN M, 1994, GASTROENTEROLOGY, V106, P1208; Kono T, 2011, J GASTROENTEROL, V46, P1187, DOI 10.1007/s00535-011-0438-2; Iwai N, 2007, EUR J PEDIATR SURG, V17, P115, DOI 10.1055/s-2007-965016; Basu S, 2003, TOXICOLOGY, V189, P113, DOI 10.1016/S0300-483X(03)00157-4; Kito Yoshihiko, 2006, Journal of Smooth Muscle Research, V42, P189, DOI 10.1540/jsmr.42.189; Bellot P, 2013, LIVER INT, V33, P31, DOI 10.1111/liv.12021; Itoh T, 2002, J INT MED RES, V30, P428; Endo S, 2006, AM J SURG, V192, P9, DOI 10.1016/j.amjsurg.2006.01.022; Kono T, 2009, SURGERY, V146, P837, DOI 10.1016/j.surg.2009.06.012; Kono T, 2010, J CROHNS COLITIS, V4, P161, DOI 10.1016/j.crohns.2009.09.006; Nagano T, 1999, BIOL PHARM BULL, V22, P1131; Chikakiyo M, 2012, SURG TODAY, V42, P60, DOI 10.1007/s00595-011-0014-7; Fukuda H, 2006, J SURG RES, V131, P290, DOI 10.1016/j.jss.2005.09.018; Furukawa Y, 1999, GASTROENTEROLOGY, V116, pA811; Genesca J, 1999, DIGEST DIS SCI, V44, P372, DOI 10.1023/A:1026618904493; Hayakawa Terumasa, 1999, Journal of Smooth Muscle Research, V35, P47; Kaiho T, 2005, HEPATO-GASTROENTEROL, V52, P161; Kawasaki N, 2007, DIGEST DIS SCI, V52, P2684, DOI 10.1007/s10620-006-9391-y; KINOSHITA Y, 1993, J CLIN GASTROENTEROL, V17, pS27, DOI 10.1097/00004836-199312001-00008; Liver Cancer Study Group of Japan, 1997, CLASS PRIM LIV CANC; Manabe N, 2010, AM J PHYSIOL-GASTR L, V298, pG970, DOI 10.1152/ajpgi.00043.2010; Nakamura T, 2002, JPN J PHARMACOL, V88, P217, DOI 10.1254/jjp.88.217; Narita M, 2009, J GASTROEN HEPATOL, V24, P1051, DOI 10.1111/j.1440-1746.2009.05795.x; Ogasawara T, 2008, HEPATO-GASTROENTEROL, V55, P574; Ohya T, 2003, AM J CHINESE MED, V31, P129, DOI 10.1142/S0192415X03000710; Sakakibara R, 2005, MOVEMENT DISORD, V20, P261, DOI 10.1002/mds.20352; Sato Y, 2004, BIOL PHARM BULL, V27, P1875, DOI 10.1248/bpb.27.1875; Sato Y, 2006, BIOL PHARM BULL, V29, P166, DOI 10.1248/bpb.29.166; Satoh K, 2001, DIGEST DIS SCI, V46, P250, DOI 10.1023/A:1005636412287; Satoh K, 2003, J ETHNOPHARMACOL, V86, P37, DOI 10.1016/S0378-8741(03)00038-2; Satoh K, 2001, BIOL PHARM BULL, V24, P1122, DOI 10.1248/bpb.24.1122; Seo Yeon Seok, 2012, Clin Mol Hepatol, V18, P337, DOI 10.3350/cmh.2012.18.4.337; Shibata C, 1999, SURGERY, V126, P918; Suehiro T, 2005, HEPATO-GASTROENTEROL, V52, P97; Tokita Y, 2007, J PHARMACOL SCI, V104, P303, DOI 10.1254/jphs.FP0070831; Yoshikawa K, 2008, DIGEST DIS SCI, V53, P1824, DOI 10.1007/s10620-008-0281-3	38	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					95	104		10.1007/s10147-014-0678-2		10	Oncology	Oncology	CE8OY	WOS:000352104100014		
J	Akutsu, N; Sasaki, S; Takagi, H; Motoya, M; Shitani, M; Igarashi, M; Hirayama, D; Wakasugi, H; Yamamoto, H; Kaneto, H; Yonezawa, K; Yawata, A; Adachi, T; Hamamoto, Y; Shinomura, Y				Akutsu, Noriyuki; Sasaki, Shigeru; Takagi, Hideyasu; Motoya, Masayo; Shitani, Masahiro; Igarashi, Mai; Hirayama, Daisuke; Wakasugi, Hideki; Yamamoto, Hiroyuki; Kaneto, Hiroyuki; Yonezawa, Kazuhiko; Yawata, Atsushi; Adachi, Takeya; Hamamoto, Yasuo; Shinomura, Yasuhisa			Development of hypertension within 2 weeks of initiation of sorafenib for advanced hepatocellular carcinoma is a predictor of efficacy	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Hepatocellular carcinoma; Hypertension; Sorafenib	COLORECTAL-CANCER PATIENTS; BEVACIZUMAB-INDUCED HYPERTENSION; ANTITUMOR-ACTIVITY; PLUS BEVACIZUMAB; PHASE-II; SUNITINIB; BIOMARKER; PROGRESSION; SURVIVAL; TRIAL	Background Sorafenib is an agent that inhibits vascular endothelial growth factor and is associated with onset or worsening of hypertension in some patients. We conducted a retrospective analysis of whether the development of hypertension during sorafenib treatment of advanced hepatocellular carcinoma could be a predictor of anticancer efficacy. Methods The study included 38 patients with advanced hepatocellular carcinoma who had received sorafenib for at least 1 month between January 2010 and December 2012. A retrospective analysis of the efficacy of sorafenib was conducted by dividing the patients into two groups-a hypertension group, presenting with grade 2 or higher hypertension according to the Common Terminology Criteria for Adverse Events (CTCTE) version 4.0; and a non-hypertension group, which included all other patients. This study evaluated the occurrence of hypertension within 2 weeks of initiation of therapy in order to avoid any treatment duration bias. Images were evaluated using the modified Response Evaluation Criteria in Solid Tumors. The response rate, time to progression, and overall survival were assessed. Results Twenty-two patients (58 %) developed grade 2 or higher hypertension within 2 weeks of initiation of therapy. The response rate was significantly higher in the hypertension group. Median time to progression was 153 days in the hypertension group versus 50.5 days in the non-hypertension group, which was significantly longer in the hypertension group. Moreover, median overall survival was 1,329 days in the hypertension group versus 302 days in the non-hypertension group, which was significantly longer in the hypertension group. Conclusions Hypertension within 2 weeks of initiation of therapy may be a predictor of the anti-cancer efficacy of sorafenib when used for the treatment of advanced hepatocellular carcinoma.	[Akutsu, Noriyuki; Sasaki, Shigeru; Takagi, Hideyasu; Motoya, Masayo; Shitani, Masahiro; Igarashi, Mai; Hirayama, Daisuke; Wakasugi, Hideki; Yamamoto, Hiroyuki; Shinomura, Yasuhisa] Sapporo Med Univ, Dept Gastroenterol Rheumatol & Clin Immunol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan; [Kaneto, Hiroyuki] Muroran City Gen Hosp, Dept Gastroenterol, Muroran, Hokkaido 0518512, Japan; [Yonezawa, Kazuhiko] Kushiro City Gen Hosp, Dept Gastroenterol, Kushiro, Hokkaido 0850822, Japan; [Yawata, Atsushi] Hakodate Goryoukaku Hosp, Dept Gastroenterol, Hakodate, Hokkaido 0408611, Japan; [Adachi, Takeya] Otaru City Gen Hosp, Dept Gastroenterol, Otaru, Hokkaido 0478550, Japan; [Hamamoto, Yasuo] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol,Shinjuku Ku, Tokyo 1608582, Japan	Akutsu, N (reprint author), Sapporo Med Univ, Dept Gastroenterol Rheumatol & Clin Immunol, Chuo Ku, S-1,W-16, Sapporo, Hokkaido 0608543, Japan.	akutsu@sapmed.ac.jp			Bayer Yakuhin Ltd (Osaka, Japan)	Shigeru Sasaki received remuneration for the lecture from Bayer Yakuhin Ltd (Osaka, Japan).	Rini BI, 2011, JNCI-J NATL CANCER I, V103, P763, DOI 10.1093/jnci/djr128; Cheng AL, 2012, EUR J CANCER, V48, P1452, DOI 10.1016/j.ejca.2011.12.006; Funakoshi T, 2013, J HUM HYPERTENS, V27, P601, DOI 10.1038/jhh.2013.30; Spano JP, 2008, LANCET, V371, P2101, DOI 10.1016/S0140-6736(08)60661-3; Mir O, 2011, ONCOLOGIST, V16, P1325, DOI 10.1634/theoncologist.2010-0002; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; Rixe O, 2007, ANN ONCOL, V18, P1117, DOI 10.1093/annonc/mdm184; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Dewdney A, 2012, BRIT J CANCER, V106, P1718, DOI 10.1038/bjc.2012.152; Bono P, 2011, ACTA ONCOL, V50, P569, DOI 10.3109/0284186X.2010.543696; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; George S, 2012, ANN ONCOL, V23, P3180, DOI 10.1093/annonc/mds179; Estfan B, 2013, AM J CLIN ONCOL-CANC, V36, P319, DOI 10.1097/COC.0b013e3182468039; Scartozzi M, 2009, ANN ONCOL, V20, P227, DOI 10.1093/annonc/mdn637; Schneider BP, 2008, J CLIN ONCOL, V26, P4672, DOI 10.1200/JCO.2008.16.1612; Osterlund P, 2011, BRIT J CANCER, V104, P599, DOI 10.1038/bjc.2011.2; Humphreys BD, 2009, CLIN CANCER RES, V15, P5947, DOI 10.1158/1078-0432.CCR-09-1717; Rutkowski P, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-107; Schuster C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038364; Szmit S, 2012, KIDNEY BLOOD PRESS R, V35, P18, DOI 10.1159/000329933; Szmit S, 2012, KIDNEY BLOOD PRESS R, V35, P468, DOI 10.1159/000338175; Tahover E, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0327-4	24	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					105	110		10.1007/s10147-014-0691-5		6	Oncology	Oncology	CE8OY	WOS:000352104100015		
J	Matsumoto, T; Nishina, T; Mizuta, M; Tsuji, A; Watanabe, R; Takahashi, I; Watanabe, Y; Moriwaki, T; Maeba, T; Hyodo, I				Matsumoto, Toshihiko; Nishina, Tomohiro; Mizuta, Minoru; Tsuji, Akihito; Watanabe, Ryouhei; Takahashi, Ikuo; Watanabe, Yuji; Moriwaki, Toshikazu; Maeba, Takashi; Hyodo, Ichinosuke			Phase II study of first-line chemotherapy with uracil-tegafur plus oral leucovorin in elderly (>= 75 years) Japanese patients with metastatic colorectal cancer: SGOSG-CR0501 study	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Chemotherapy; Elderly patients; UFT; Metastatic colorectal cancer	OPEN-LABEL; UFT PLUS; CAPECITABINE; BEVACIZUMAB; TRIAL; URACIL/TEGAFUR; FLUOROURACIL	Background Oral uracil-tegafur and leucovorin (UFT/LV) therapy for elderly patients with metastatic colorectal cancer (mCRC) requires careful handling in Western countries because of a high incidence (>= 20 %) of grade 3 diarrhea. However, its efficacy and safety for elderly Asian patients have not been investigated. Methods In this multicenter cooperative phase II study, the eligibility criteria were: age of 75 years or older, no prior chemotherapy, and histologically confirmed colorectal cancer with one or more measurable lesions. UFT 300 mg/m(2)/day and LV 75 mg/day were administered orally for 28 days followed by a 7-day rest period. Results Twenty-one patients were enrolled in this study (prior to study termination after approval of bevacizumab), and all patients were eligible for efficacy and safety analysis. The median age was 79 years (range, 75-83 years). The majority of patients (95 %) had ECOG Performance Status 0 or 1. The overall response rate was 33 % (95 % confidence interval [CI], 18-53 %). The median progression-free and overall survivals were 5.3 months (95 % CI 4.0-7.9 months) and 18 months (95 % CI 13-21 months), respectively. Grade 3 or greater adverse events included anorexia (10 %), diarrhea (10 %), and leukopenia (5 %). These results were compatible with those seen in Japanese patients in a previous bridging study between Japan and the US, in which patients under 75 years old were evaluated. Conclusions UFT/LV therapy was safe and feasible in elderly Japanese patients with mCRC, and further study of UFT/LV therapy in combination with bevacizumab is warranted.	[Matsumoto, Toshihiko; Nishina, Tomohiro] Shikoku Canc Ctr, Natl Hosp Org, Dept Gastrointestinal Med Oncol, Matsuyama, Ehime 7910280, Japan; [Mizuta, Minoru] Mitoyo Gen Hosp, Kanonji, Kagawa 7691695, Japan; [Tsuji, Akihito] Kochi Hlth Sci Ctr, Kochi 7818555, Japan; [Watanabe, Ryouhei] Matsuyama Shimin Hosp, Matsuyama, Ehime 7900067, Japan; [Takahashi, Ikuo] Matsuyama Red Cross Hosp, Matsuyama, Ehime 7908524, Japan; [Watanabe, Yuji] Ehime Univ, Sch Med, Toon, Ehime 7910295, Japan; [Moriwaki, Toshikazu; Hyodo, Ichinosuke] Univ Tsukuba, Tsukuba, Ibaraki 3050006, Japan; [Maeba, Takashi] Social Insurance Ritsurin Hosp, Takamatsu, Kagawa 760007, Japan	Nishina, T (reprint author), Shikoku Canc Ctr, Natl Hosp Org, Dept Gastrointestinal Med Oncol, Kou 160,Minamiumemotomachi, Matsuyama, Ehime 7910280, Japan.	tnishina@shikoku-cc.go.jp			Taiho Pharmaceutical Co. Ltd.	Ichinosuke Hyodo and Toshikazu Moriwaki received a research grant from Taiho Pharmaceutical Co. Ltd.; Tomohiro Nishina, Minoru Mizuta, Akihito Tsuji, Ryohei Watanabe, Ikuo Takahashi, Yuji Watanabe, Toshikazu Moriwaki, Takashi Maeba and Ichinosuke Hyodo received lecture fees from Taiho Pharmaceutical Co. Ltd.	Gallego R, 2006, EXPERT REV ANTICANC, V6, P795, DOI 10.1586/14737140.6-5.795; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Shirao K, 2004, J CLIN ONCOL, V22, P3466, DOI 10.1200/JCO.2004.05.017; Cunningham D, 2013, LANCET ONCOL, V14, P1077, DOI 10.1016/S1470-2045(13)70154-2; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Seymour MT, 2011, LANCET, V377, P1749, DOI 10.1016/S0140-6736(11)60399-1; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S01053-4296(03)00031-6; Douillard JY, 2002, J CLIN ONCOL, V20, P3605, DOI 10.1200/JCO.2002.04.123; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Price TJ, 2012, ANN ONCOL, V23, P1531, DOI 10.1093/annonc/mdr488; Carmichael J, 2002, J CLIN ONCOL, V20, P3617, DOI 10.1200/JCO.2002.10.129; Feliu J, 2010, BRIT J CANCER, V102, P1468, DOI 10.1038/sj.bjc.6605663; Diaz-Rubio E, 1999, ONCOLOGY-NY, V13, P35; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI DOI 10.1002/IJC.25516; Francois E, 2011, J GERIATR ONCOL, V2, P64, DOI 10.1016/j.jgo.2010.09.005; Hochster HS, 2007, J CLIN ONCOL, V25, P3523; Hyodo I, 2006, JPN J CLIN ONCOL, V36, P410, DOI 10.1093/jjco/hyl058; Kumar R, 2013, CANCER-AM CANCER SOC, V119, P722, DOI 10.1002/cncr.27802; National Comprehensive Cancer Network, 2012, NCCN GUID COL CANC V; Peuguniez C, 2011, J CLIN ONCOL S4, V29; Puthillath A, 2009, CRIT REV ONCOL HEMAT, V71, P242, DOI 10.1016/j.critrevonc.2008.10.012; Van Cutsem E, 2010, ANN ONCOL, V21, pv93	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					111	116		10.1007/s10147-014-0675-5		6	Oncology	Oncology	CE8OY	WOS:000352104100016		
J	Komura, T; Miura, K; Shirasaka, T; Ohnuma, S; Shimada, M; Kajiwara, T; Fujishima, F; Philchenkov, A; Nakagawa, K; Kudoh, K; Haneda, S; Toshima, M; Kohyama, A; Musha, H; Naitoh, T; Shibata, C; Unno, M				Komura, Toshihiro; Miura, Koh; Shirasaka, Tetsuhiko; Ohnuma, Shinobu; Shimada, Miki; Kajiwara, Taiki; Fujishima, Fumiyoshi; Philchenkov, Alex; Nakagawa, Kei; Kudoh, Katsuyoshi; Haneda, Sho; Toshima, Masahide; Kohyama, Atsushi; Musha, Hiroaki; Naitoh, Takeshi; Shibata, Chikashi; Unno, Michiaki			Usefulness of alternate-day administration of S-1 and leucovorin in a xenograft mouse model of colorectal cancer: a shorter drug-free interval leads to more efficient antitumor effects	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						S-1; Leucovorin; Alternate-day administration; Colorectal cancer; In vivo mouse model	ORAL FLUOROPYRIMIDINE S-1; COLON-CARCINOMA; SOLID TUMORS; PHASE-I; FLUORINATED PYRIMIDINES; THYMIDYLATE SYNTHETASE; GASTRIC-CANCER; 5-FLUOROURACIL; INHIBITION; THERAPY	Background A clinical trial of S-1 with leucovorin (S-1/LV) in metastatic colorectal cancer (CRC) patients demonstrated promising efficacy; however, the gastrointestinal toxicities were so severe that it has not been applied in the clinical setting. On the other hand, alternate-day administration of S-1 has been proposed to attenuate the adverse events without reducing its anticancer activity. Our present study was conducted to confirm the feasibility of alternate-day administration of S-1/LV in in vivo xenograft tumor models. Methods Mice were treated with S-1/LV in a daily group (2 weeks of administration followed by 2 weeks of withdrawal) or an alternate-day group (administration on alternate days for 4 weeks), then the mice were killed and the xenograft tumors were resected. We compared body weight changes, condition of feces, mucosal injury and myelosuppression and assessed adverse reactions, tumor volume, tumor growth inhibition (TGI) and expression of Ki67, TUNEL, cIAP2 and XIAP to evaluate the antitumor activity and tumor apoptosis. Results Severe weight loss, diarrhea, mucosal injury and myelosuppression were observed only in the daily group; however, some myelosuppression was also observed in the alternate-day group. The TGI in the alternate-day group was better than in the daily group, possibly resulting from apoptosis due to the suppression of cIAP2 but not XIAP. Conclusion Our findings suggest that alternate-day administration of S-1/LV for CRC treatment can achieve high antitumor activity without severe adverse reactions, and we propose that clinical trials with this regimen should be conducted in CRC patients.	[Komura, Toshihiro; Ohnuma, Shinobu; Kajiwara, Taiki; Nakagawa, Kei; Kudoh, Katsuyoshi; Haneda, Sho; Toshima, Masahide; Kohyama, Atsushi; Musha, Hiroaki; Naitoh, Takeshi; Shibata, Chikashi; Unno, Michiaki] Tohoku Univ, Grad Sch Med, Dept Surg, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Miura, Koh] Miyagi Canc Ctr, Dept Surg, Natori, Miyagi 9811293, Japan; [Shirasaka, Tetsuhiko] Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, Tokyo 1088641, Japan; [Shimada, Miki] Tohoku Univ Hosp, Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Fujishima, Fumiyoshi] Tohoku Univ Hosp, Dept Pathol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Philchenkov, Alex] RE Kavetsky Inst Expt Pathol Oncol & Radiobiol, UA-03022 Kiev, Ukraine	Miura, K (reprint author), Miyagi Canc Ctr, Dept Surg, 47-1 Nodayama, Natori, Miyagi 9811293, Japan.	k-miura@surg1.med.tohoku.ac.jp	Unno, Michiaki/A-8633-2010; Naitoh, Takeshi/K-1693-2014	Unno, Michiaki/0000-0002-2145-6416; Miura, Koh/0000-0001-7303-9430; Naitoh, Takeshi/0000-0003-4169-6334	Setsuro Fujii Memorial Osaka Basic Medical Research Foundation (Osaka, Japan); HIROMI Medical Research Foundation (Sendai, Japan)	This study was financially supported by the Setsuro Fujii Memorial Osaka Basic Medical Research Foundation (Osaka, Japan) and HIROMI Medical Research Foundation (Sendai, Japan).	PIEDBOIS P, 1992, J CLIN ONCOL, V10, P896; QUASTLER H, 1959, EXP CELL RES, V17, P420, DOI 10.1016/0014-4827(59)90063-1; Arai W, 2008, INT J CLIN ONCOL, V13, P515, DOI 10.1007/s10147-008-0780-4; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Hoff PM, 2003, CLIN CANCER RES, V9, P134; Karasawa H, 2009, CANCER SCI, V100, P903, DOI 10.1111/j.1349-7006.2009.01112.x; Miura K, 2012, EXPERT OPIN DRUG DEL, V9, P273, DOI 10.1517/17425247.2012.652945; SHIRASAKA T, 1993, CANCER RES, V53, P4004; WRIGHT JE, 1989, CANCER RES, V49, P2592; HEIDELBERGER C, 1957, NATURE, V179, P663, DOI 10.1038/179663a0; Kim SJ, 2013, CANCER SCI, V104, P116, DOI 10.1111/cas.12044; GILLER SA, 1967, DOKL AKAD NAUK SSSR+, V176, P332; Sakuma K, 2010, INT J CLIN ONCOL, V15, P166, DOI 10.1007/s10147-010-0036-y; Koizumi W, 2010, ANN ONCOL, V21, P766, DOI 10.1093/annonc/mdp371; Miura K, 2011, SURG TODAY, V41, P175, DOI 10.1007/s00595-010-4390-1; Shirasaka T, 1996, CANCER RES, V56, P2602; Arai Wataru, 2004, Int J Clin Oncol, V9, P143; Bruchard M, 2012, NAT MED, V19, P57, DOI DOI 10.1038/NM.2999; Cao SS, 1999, CLIN CANCER RES, V5, P267; Chu QSC, 2004, CLIN CANCER RES, V10, P4913, DOI 10.1158/1078-0432.CCR-04-0469; Deng S, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-128; HARTMANN KU, 1961, J BIOL CHEM, V236, P3006; Hirata K, 1999, CLIN CANCER RES, V5, P2000; Iwasa S, 2011, GASTRIC CANCER, V14, P28, DOI 10.1007/s10120-011-0003-y; Kadota K, 2011, INT J ONCOL, V38, P355, DOI 10.3892/ijo.2010.880; MANSFIELD PF, 1994, NEW ENGL J MED, V331, P1735, DOI 10.1056/NEJM199412293312602; Miura K, 2009, EXPERT OPIN THER TAR, V13, P1333, DOI 10.1517/14728220903277256; NADAL JC, 1988, BIOMED PHARMACOTHER, V42, P387; SAUBERLICH HE, 1948, J BIOL CHEM, V176, P165; Shirasaka T, 2000, INVEST NEW DRUG, V18, P315, DOI 10.1023/A:1006476730671; SKIPPER H E, 1964, Cancer Chemother Rep, V35, P1; SPEARS CP, 1982, CANCER RES, V42, P450; SPEARS CP, 1988, CANCER RES, V48, P5894; Thirion P, 2004, J Clin Oncol, V22, P3766; Tsujimoto Hiroaki, 2007, Gan To Kagaku Ryoho, V34, P413; Tsukioka S, 2009, MOL MED REP, V2, P393, DOI 10.3892/mmr_00000111; van Groeningen CJ, 2000, J CLIN ONCOL, V18, P2772; Xu L, 2012, J CLIN ONCOL S34, V30, P2012	38	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					117	125		10.1007/s10147-014-0699-x		9	Oncology	Oncology	CE8OY	WOS:000352104100017		
J	Iwata, T; Fujii, T; Morii, K; Saito, M; Sugiyama, J; Nishio, H; Morisada, T; Tanaka, K; Yaguchi, T; Kawakami, Y; Aoki, D				Iwata, Takashi; Fujii, Takuma; Morii, Kenji; Saito, Miyuki; Sugiyama, Juri; Nishio, Hiroshi; Morisada, Tohru; Tanaka, Kyoko; Yaguchi, Tomonori; Kawakami, Yutaka; Aoki, Daisuke			Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						CIN; Cytokine; Cytology; HPV; Cigarette smoking	HUMAN-PAPILLOMAVIRUS INFECTION; NATURAL-HISTORY; TOBACCO SMOKING; IMMUNE-RESPONSE; UTERINE CERVIX; T-CELLS; CANCER; WOMEN; EXPRESSION; CLEARANCE	Background Immune responses in the uterine cervix are considered to play an important role in persistent human papillomavirus (HPV) infection and carcinogenesis, but many aspects of the mechanism are still unclear. The goal of this study was to measure cytokines to analyze immune responses in patients with cervical intraepithelial neoplasia (CIN). Materials and methods The levels of 17 cytokines (IL-1 beta, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12, IL-13, IL-17, G-CSF, GM-CSF, INF-gamma, MCP-1, MIP-1 beta, and TNF alpha) in cervical mucus were simultaneously measured using a multiplex immunoassay in 52 high-grade squamous intraepithelial lesion (HSIL) cases and overproduction of IL-1 beta, IL-8, and MIP-1 beta was identified. The levels of these 3 cytokines were measured in 130 patients with or without CIN lesions using enzyme-linked immunosorbent assay. The associations of the cytokine levels with the cytology, infecting HPV type, and status of cigarette smoking were investigated. Results IL-1 beta and IL-8 levels were associated with the cytology, and these levels were higher in HSIL cases than in NILM (negative for intraepithelial lesion and malignancy) and LSIL (low-grade squamous intraepithelial lesion) cases (P = 0.005, P = 0.001, respectively). The MIP-1 beta level was significantly lower in smokers (P = 0.018) and high-risk (HR)-HPV-infected patients (P = 0.021). Conclusions Enhanced expression of IL-1 beta and IL-8 indicates that Th2 inflammatory responses become stronger in the local uterine cervical region with the progression of CIN lesions, and a decrease in the MIP-1 beta level may be advantageous for immunoescape of HPV. Cigarette smoking may further facilitate persistent HPV infection.	[Iwata, Takashi; Fujii, Takuma; Saito, Miyuki; Sugiyama, Juri; Nishio, Hiroshi; Morisada, Tohru; Tanaka, Kyoko; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Tokyo 160, Japan; [Fujii, Takuma] Fujita Hlth Univ, Sch Med, Dept Obstet & Gynecol, Toyoake, Aichi 47011, Japan; [Morii, Kenji; Yaguchi, Tomonori; Kawakami, Yutaka] Keio Univ, Sch Med, Inst Adv Med Res, Div Cellular Signaling, Tokyo, Japan	Iwata, T (reprint author), Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, 35 Shinanomachi, Tokyo 160, Japan.	iwatatakashi@1995.jukuin.keio.ac.jp			Smoking Research Foundation of Japan; Ministry of Education, Culture, Sport and Technology, Japan [23592462]	This work was supported by a grant from the Smoking Research Foundation of Japan. The authors also received a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sport and Technology, Japan (23592462).	Sheu BC, 2001, J IMMUNOL, V167, P2972; Ovestad IT, 2010, MODERN PATHOL, V23, P1231, DOI 10.1038/modpathol.2010.109; Scott ME, 2013, INT J CANCER, V133, P1187, DOI 10.1002/ijc.28119; Bermudez-Morales VH, 2011, MOL MED REP, V4, P369, DOI 10.3892/mmr.2011.429; Meuronen A, 2008, RESPIRATION, V75, P450, DOI 10.1159/000114855; Giuliano AR, 2002, CANCER CAUSE CONTROL, V13, P839, DOI 10.1023/A:1020668232219; Rodriguez AC, 2008, J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Katanoda K, 2008, J EPIDEMIOL, V18, P251, DOI 10.2188/jea.JE2007429; JOHNSON JD, 1990, CRIT REV TOXICOL, V20, P369, DOI 10.3109/10408449009089870; Gritz ER, 2005, CANCER EPIDEM BIOMAR, V14, P2287, DOI 10.1158/1055-9965.EPI-05-0224; Larrubia JR, 2008, WORLD J GASTROENTERO, V14, P7149, DOI 10.3748/wjg.14.7149; Zeidel A, 2002, ACTA ANAESTH SCAND, V46, P959, DOI 10.1034/j.1399-6576.2002.460806.x; Koshiol J, 2006, AM J EPIDEMIOL, V164, P176, DOI 10.1093/aje/kwj165; Gadducci A, 2011, GYNECOL ENDOCRINOL, V27, P597, DOI 10.3109/09513590.2011.558953; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Kobayashi A, 2008, MUCOSAL IMMUNOL, V1, P412, DOI 10.1038/mi.2008.33; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Passmore JAS, 2006, IMMUNOLOGY, V119, P507, DOI 10.1111/j.1365-2567.2006.02465.x; Holowaty P, 1999, J NATL CANCER I, V91, P252, DOI 10.1093/jnci/91.3.252; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Nees M, 2001, J VIROL, V75, P4283, DOI 10.1128/JVI.75.9.4283-4296.2001; Melnikow J, 1998, OBSTET GYNECOL, V92, P727, DOI 10.1016/S0029-7844(98)00245-2; Rajkumar T, 2006, INT J CANCER, V118, P1481; Castle PE, 2002, J NATL CANCER I, V94, P1406; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Collins S, 2010, EUR J CANCER, V46, P405, DOI 10.1016/j.ejca.2009.09.015; Giannini SL, 1998, CLIN EXP IMMUNOL, V113, P183; Guzman-Olea E, 2012, J ONCOLOGY, DOI [10.1155/2012/278312, DOI 10.1155/2012/278312]; zur Hausen H, 1989, Cancer Res, V49, P4677; HELLBERG D, 1988, AM J OBSTET GYNECOL, V158, P910; Herman L, 2010, EUR J IMMUNOL, V40, P3075, DOI 10.1002/eji.201040571; Iancu Iulia Virginia, 2010, Roum Arch Microbiol Immunol, V69, P113; Lieberman JA, 2008, CLIN VACCINE IMMUNOL, V15, P49, DOI 10.1128/CVI.00216-07; Lowe DB, 2011, IMMUNOTHERAPY-UK, V3, P1265, DOI [10.2217/imt.11.113, 10.2217/IMT.11.113]; MCCANN MF, 1992, CANCER EPIDEM BIOMAR, V1, P125; Peralta-Zaragoza O, 2006, VIRAL IMMUNOL, V19, P468, DOI 10.1089/vim.2006.19.468; Samir R, 2010, AM J OBSTET GYNECOL, V202, pe1; Satoh T, 2013, J VIROL METHODS, V188, P83, DOI 10.1016/j.jviromet.2012.10.014; Sharma A, 2007, INT J GYNECOL CANCER, V17, P879, DOI 10.1111/j.1525-1438.2007.00883.x	40	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					126	133		10.1007/s10147-014-0680-8		8	Oncology	Oncology	CE8OY	WOS:000352104100018		
J	Fujii, T; Saito, M; Hasegawa, T; Iwata, T; Kuramoto, H; Kubushiro, K; Ohmura, M; Ochiai, K; Arai, H; Sakamoto, M; Motoyama, T; Aoki, D				Fujii, Takuma; Saito, Miyuki; Hasegawa, Toshihiko; Iwata, Takashi; Kuramoto, Hiroyuki; Kubushiro, Kaneyuki; Ohmura, Mineo; Ochiai, Kazunori; Arai, Hiroharu; Sakamoto, Masaru; Motoyama, Teiichi; Aoki, Daisuke			Performance of p16(INK4a)/Ki-67 immunocytochemistry for identifying CIN2+in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Human papillomavirus; p16 immunocytochemistry; Liquid-based cytology; Cervical cancer screening; Biomarker	HUMAN-PAPILLOMAVIRUS TYPES; LIQUID-BASED CYTOLOGY; CERVICAL-CANCER PRECURSORS; DUAL-STAINED CYTOLOGY; PAP CYTOLOGY; COLPOSCOPY; WOMEN; METAANALYSIS; TERMINOLOGY; WORLDWIDE	Background p16(INK4a) immunohistochemistry has revealed a high rate of positivity in cervical intraepithelial neoplasia grade 2 (CIN2) and more severe conditions (CIN2+). The Lower Anogenital Squamous Terminology Standardization project proposed p16(INK4a) immunohistochemistry as an ancillary test for CIN. Immunocytochemistry involving dual staining for p16(INK4a) and Ki-67 in the triage of atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesions (LSIL) is reported to be useful in the identification of CIN2+. However, it is unclear whether p16(INK4a)/Ki-67 immunocytochemistry is of practical relevance for the triage of ASCUS and LSIL in the Japanese screening system. Methods From 427 women fulfilling the eligibility criteria, 188 ASCUS and 239 LSIL specimens were analyzed. The accuracy of p16(INK4a)/Ki-67 immunocytochemistry and genotyping of high-risk human papillomaviruses (HPVs) in detecting CIN2+ were compared. Results p16(INK4a)/Ki-67 immunocytochemistry was positive in 33.5 % (63/188) of ASCUS, and 36.8 % (88/239) of LSIL specimens. The sensitivity and specificity of p16(INK4a)/Ki-67 immunocytochemistry was 87.3 % (95 % confidence interval 78.0-93.8 %) and 76.4 % (71.6-80.8 %), respectively. The positive and negative predictive values were 45.7 % (37.6-54.0 %) and 96.4 % (93.4-98.3 %), respectively; positive and negative likelihood ratios were 3.71 and 0.17, respectively. Using the McNemar test, p16(INK4a)/Ki-67 immunocytochemistry showed equivalent sensitivity but higher specificity than the HPV genotyping test Conclusions Compared with high-risk HPV genotyping, p16(INK4a)/Ki-67 immunocytochemistry was a more accurate triage test for identifying CIN2+ in ASCUS and LSIL specimens.	[Fujii, Takuma; Saito, Miyuki; Iwata, Takashi; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Tokyo 1608582, Japan; [Fujii, Takuma] Fujita Hlth Univ, Sch Med, Dept Obstet & Gynecol, Toyoake, Aichi 4701192, Japan; [Hasegawa, Toshihiko] Tokyo Hlth Serv Assoc, Dept Gynecol, Shinjuku Ku, Tokyo 1628402, Japan; [Kuramoto, Hiroyuki] Kanagawa Hlth Serv Assoc, Dept Gynecol, Naka Ku, Yokohama, Kanagawa 2310021, Japan; [Kubushiro, Kaneyuki] Toho Univ, Sch Med, Ohashi Med Ctr, Dept Obstet & Gynecol,Megro Ku, Tokyo 1538515, Japan; [Ohmura, Mineo] Dept Gynecol, Chiyoda Ku, Tokyo 1028508, Japan; [Ochiai, Kazunori] Jikei Univ, Sch Med, Dept Obstet & Gynecol, Minato Ku, Tokyo 1058471, Japan; [Arai, Hiroharu] Natl Tokyo Med Ctr, Dept Gynecol, Meguro Ku, Tokyo 1528902, Japan; [Sakamoto, Masaru] Kyoundo Hosp, Dept Gynecol, Sasaki Fdn, Chiyoda Ku, Tokyo 1010062, Japan; [Motoyama, Teiichi] Yamagata Univ, Sch Med, Dept Pathol, Yamagata 9909585, Japan	Fujii, T (reprint author), Fujita Hlth Univ, Sch Med, Dept Obstet & Gynecol, 1-98 Dengakugakubo Kutsukakecho, Toyoake, Aichi 4701192, Japan.	fujiit44@gmail.com			Japanese Gynecologic Oncology Group [JGOG-1073]	We thank Drs. T. Abe and R. Roberts, Center for Clinical Research, Keio University School of Medicine, for conducting biostatistical analysis. We also thank Dr. Tsuda, Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan and Dr. Fukunaga, Department of Pathology, The Jikei University, School of Medicine, Daisan Hospital, Tokyo, Japan for conducting central pathology. The protocol JGOG-1073 was sponsored by the Japanese Gynecologic Oncology Group.	Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Nishio S, 2013, J GYNECOL ONCOL, V24, P215, DOI 10.3802/jgo.2013.24.3.215; Matsumoto K, 2011, INT J CANCER, V128, P2898, DOI 10.1002/ijc.25630; Ikenberg H, 2013, JNCI-J NATL CANCER I, V105, P1550, DOI 10.1093/jnci/djt235; Petry KU, 2011, GYNECOL ONCOL, V121, P505, DOI 10.1016/j.ygyno.2011.02.033; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Denton KJ, 2010, AM J CLIN PATHOL, V134, P12, DOI 10.1309/AJCP3CD9YKYFJDQL; Darragh TM, 2012, J LOW GENIT TRACT DI, V16, P205; Schmidt D, 2011, CANCER CYTOPATHOL, V119, P158, DOI 10.1002/cncy.20140; Wentzensen N, 2012, CLIN CANCER RES, V18, P4154, DOI 10.1158/1078-0432.CCR-12-0270; Ronco G, 2006, J NATL CANCER I, V98, P765, DOI 10.1093/jnci/djj209; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; [Anonymous], 2012, BETHESDA 2001 SYSTEM; Dona MG, 2012, GYNECOL ONCOL, V126, P198, DOI 10.1016/j.ygyno.2012.05.004; Fujii T, 2008, VIRCHOWS ARCH, V453, P545, DOI 10.1007/s00428-008-0687-5; Ishikawa M, 2003, INT J GYNECOL PATHOL, V22, P378, DOI 10.1097/01.pgp.0000092135.88121.1f; Monsonego J, 2007, ACTA CYTOL, V51, P755, DOI 10.1159/000325839; Ronco G, 2005, EUR J CANCER, V41, P297, DOI 10.1016/j.ejca.2004.07.005; zur Hausen H, 1991, Science, V254, P1167, DOI 10.1126/science.1659743	24	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					134	142		10.1007/s10147-014-0688-0		9	Oncology	Oncology	CE8OY	WOS:000352104100019		
J	Iwase, H; Takada, T; Iitsuka, C; Nomura, H; Abe, A; Taniguchi, T; Sakamoto, K; Takizawa, K; Takeshima, N				Iwase, Haruko; Takada, Toshio; Iitsuka, Chiaki; Nomura, Hidetaka; Abe, Akiko; Taniguchi, Tomoko; Sakamoto, Kimihiko; Takizawa, Ken; Takeshima, Nobuhiro			Clinical features of long-term survivors of recurrent epithelial ovarian cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Recurrent epithelial ovarian cancer; Platinum-sensitivity; Disease-free interval; Long-term survival	SECONDARY CYTOREDUCTIVE SURGERY; PEGYLATED LIPOSOMAL DOXORUBICIN; PHASE-III TRIAL; CARCINOMA; CHEMOTHERAPY; CARBOPLATIN; CISPLATIN; SELECTION; THERAPY; GINECO	Background Although recurrent epithelial ovarian cancer (EOC) is generally regarded as an incurable disease, some patients survive more than 5 years after the first recurrence. The aim of this study was to evaluate the clinical features of patients with recurrent EOC who achieve long-term survival. Methods We retrospectively reviewed the medical records of 164 patients with recurrent EOC and analyzed the clinical stage, histologic subtype, primary treatment, disease-free interval (DFI), recurrence site, secondary treatment, and overall survival from the time of the first recurrence (R-OS), using the Kaplan-Meier method and the log-rank test. Results The median R-OS for all 164 patients was 25 months and the 5-year R-OS rate was 25.4 %. There were no significant differences in R-OS according to the disease stage. The median R-OS was significantly shorter in the 6-12-month DFI group (23 months) than in the >= 12-month DFI group (61 months) (p = 0.0002), while there was no significant difference between the 6-12 and 3-6-month DFI groups (20 months) (p = 0.161). Of the 164 patients, only 14 survived >5 years after the first recurrence. Most of them underwent surgery and/or radiotherapy in combination with chemotherapy and underwent >18 cycles of platinum-based chemotherapy throughout their treatments (median 22 cycles; range 4-44). Conclusions If high sensitivity to platinum is maintained, patients with recurrent EOC may have prolonged survival following repeated platinum-based chemotherapy cycles. Moreover, their prognosis improves when chemotherapy is combined with secondary cytoreductive surgery and/or irradiation.	[Iwase, Haruko; Takada, Toshio; Iitsuka, Chiaki; Nomura, Hidetaka; Abe, Akiko; Taniguchi, Tomoko; Sakamoto, Kimihiko; Takizawa, Ken; Takeshima, Nobuhiro] Canc Inst Hosp, Dept Gynecol, Koto Ku, Tokyo 1358550, Japan; [Iwase, Haruko] Kitasato Univ, Sch Med, Dept Obstet & Gynecol, Minami Ku, Sagamihara, Kanagawa 2520374, Japan	Iwase, H (reprint author), Kitasato Univ, Sch Med, Dept Obstet & Gynecol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	haiwase@med.kitasato-u.ac.jp					Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; du Bois A, 2009, CANCER, V115, P1234, DOI 10.1002/cncr.24149; Chi DS, 2006, CANCER, V106, P1933, DOI 10.1002/cncr.21845; Zang RY, 2000, J SURG ONCOL, V75, P24, DOI 10.1002/1096-9098(200009)75:1<24::AID-JSO5>3.0.CO;2-L; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Bristow RE, 2002, CANCER, V95, P791, DOI 10.1002/cncr.10789; Salani R, 2007, CANCER, V109, P685, DOI 10.1002/cncr.22447; Mutch DG, 2007, J CLIN ONCOL, V25, P2811, DOI 10.1200/JCO.2006.09.6735; Santillan A, 2007, GYNECOL ONCOL, V104, P686, DOI 10.1016/j.ygyno.2006.10.020; MARKMAN M, 1991, J CLIN ONCOL, V9, P389; Harter P, 2006, ANN SURG ONCOL, V13, P1702, DOI 10.1245/s10434-006-9058-0; Wagner U, 2012, BRIT J CANCER, V107, P588, DOI 10.1038/bjc.2012.307; Harries M, 2002, LANCET ONCOL, V3, P537, DOI 10.1016/S1470-2045(02)00847-1; Eisenkop SM, 2000, CANCER, V88, P144, DOI 10.1002/(SICI)1097-0142(20000101)88:1<144::AID-CNCR20>3.0.CO;2-X; Pfisterer J, 2006, J CLIN ONCOL, V24, P4699, DOI 10.1200/JCO.2006.06.0913; BLACKLEDGE G, 1989, BRIT J CANCER, V59, P650, DOI 10.1038/bjc.1989.132; Ferrero JM, 2007, ANN ONCOL, V18, P263, DOI 10.1093/annonc/mdl376; EISENKOP SM, 1995, CANCER, V76, P1606, DOI 10.1002/1097-0142(19951101)76:9<1606::AID-CNCR2820760917>3.0.CO;2-H; Gadducci A, 2010, GYNECOL ONCOL, V116, P358, DOI 10.1016/j.ygyno.2009.11.008; GORE ME, 1990, GYNECOL ONCOL, V36, P207, DOI 10.1016/0090-8258(90)90174-J; Kajiyama H, 2012, INT J GYNECOL CANCER, V22, P394, DOI 10.1097/IGC.0b013e31823eed2c; Onda T, 2005, BRIT J CANCER, V92, P1026, DOI 10.1038/sj.bjc.6602466; References Japan Society of Gynecologic Oncology, 2010, OV CANC TREATM GUID; Vergote I, 2009, EUR J CANCER, V45, P2324, DOI 10.1016/j.ejca.2009.05.016	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					143	149		10.1007/s10147-014-0687-1		7	Oncology	Oncology	CE8OY	WOS:000352104100020		
J	Nishikawa, M; Miyake, H; Kitajima, K; Takahashi, S; Sugimura, K; Fujisawa, M				Nishikawa, Masatomo; Miyake, Hideaki; Kitajima, Kazuhiro; Takahashi, Satoru; Sugimura, Kazuro; Fujisawa, Masato			Preoperative differentiation between benign and malignant renal masses smaller than 4 cm treated with partial nephrectomy	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Small renal mass; Enhanced computed tomography; Age; Body mass index	CELL CARCINOMA; PATHOLOGICAL FINDINGS; LESIONS; TUMORS; CT; TOMOGRAPHY; SUBTYPES	Background The aim of this study is to accurately differentiate between benign and malignant small renal masses (SRMs) prior to surgery. Methods The study included 144 patients with SRMs <4 cm suspected to be renal cell carcinoma (RCC) based on several imaging examinations, who subsequently underwent partial nephrectomy. Clinicopathological data were analyzed based on the preoperative findings obtained from enhanced computed tomography (CT) as follows: group 1 showing a typical imaging pattern for clear cell RCC (CCRCC), and group 2 showing an imaging pattern atypical of CCRCC. We then evaluated the association between clinicopathological characteristics and pathological diagnosis in order to identify factors which can predict the pathological diagnosis. Results Based on the criteria, 102 (70.8 %) and 42 (29.2 %) patients were classified into group 1 and group 2, respectively. The only independent factor identified to predict the final pathological diagnosis of the 144 patients was preoperative CT findings. Only 7 (6.9 %) patients were pathologically diagnosed with benign tumors in group 1; however, 13 (31.0 %) of the 42 patients in group 2 appeared to have pathologically confirmed benign tumors. A younger age and lower body mass index (BMI) in group 2 were shown to be independently associated with benign histology on multivariate analysis. Conclusions The proportion of patients with benign tumors was comparatively high in those with CT findings atypical for CCRCC; therefore, other clinical parameters, such as age and BMI, should be considered when determining therapeutic strategies for patients with such SRMs.	[Nishikawa, Masatomo; Miyake, Hideaki; Fujisawa, Masato] Kobe Univ, Grad Sch Med, Div Urol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Kitajima, Kazuhiro; Takahashi, Satoru; Sugimura, Kazuro] Kobe Univ, Grad Sch Med, Div Radiol, Kobe, Hyogo 6500017, Japan	Miyake, H (reprint author), Kobe Univ, Grad Sch Med, Div Urol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hideakimiyake@hotmail.com					Millet I, 2011, AM J ROENTGENOL, V197, P887, DOI 10.2214/AJR.10.6276; Ruppert-Kohlmayr AJ, 2004, AM J ROENTGENOL, V183, P1387; Dechet CB, 2003, J UROLOGY, V169, P71, DOI 10.1097/01.ju.0000042211.18318.ba; Snyder ME, 2006, J UROLOGY, V176, P2391, DOI 10.1016/j.juro.2006.08.013; Jeon HG, 2010, UROLOGY, V76, P574, DOI 10.1016/j.urology.2009.11.082; Kutikov A, 2006, UROLOGY, V68, P737, DOI 10.1016/j.urology.2006.04.011; Pierorazio PM, 2013, UROLOGY, V81, P1265, DOI 10.1016/j.urology.2012.12.049; Kane CJ, 2008, CANCER, V113, P78, DOI 10.1002/cncr.23518; Hollingsworth JM, 2006, J NATL CANCER I, V98, P1331, DOI 10.1093/jnci/djj362; Gill IS, 2003, J UROLOGY, V170, P64, DOI 10.1097/01.ju.0000072272.02322.ff; Kim JK, 2002, AM J ROENTGENOL, V178; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; McKiernan J, 2002, UROLOGY, V60, P1003, DOI 10.1016/S0090-4295(02)01967-2; Murphy AM, 2009, UROLOGY, V73, P1293, DOI 10.1016/j.urology.2008.12.072	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					150	155		10.1007/s10147-014-0673-7		6	Oncology	Oncology	CE8OY	WOS:000352104100021		
J	Fujita, K; Uemura, M; Yamamoto, Y; Tanigawa, G; Nakata, W; Sato, M; Nagahara, A; Kiuchi, H; Nakai, Y; Matsumiya, K; Yamaguchi, S; Nonomura, N				Fujita, Kazutoshi; Uemura, Motohide; Yamamoto, Yoshiyuki; Tanigawa, Go; Nakata, Wataru; Sato, Mototaka; Nagahara, Akira; Kiuchi, Hiroshi; Nakai, Yasutomo; Matsumiya, Kiyomi; Yamaguchi, Seiji; Nonomura, Norio			Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Prognosis; Upper urinary tract urothelial carcinoma; Nephroureterectomy; Sodium; Hemoglobin	RENAL-CELL CARCINOMA; RADICAL NEPHROURETERECTOMY; PROGNOSTIC-FACTORS; HYPONATREMIA; SODIUM; SERUM	Background This study aimed to identify preoperative parameters for predicting cancer-specific survival (CSS) in patients with upper urinary tract urothelial carcinoma (UTUC) who have undergone radical nephroureterectomy (RNU). Methods The preoperative clinical and laboratory records of 357 UTUC patients who underwent RNU at three different institutions were retrospectively reviewed (256, training set; 101, test set). Univariate and multivariate analyses were performed on the training set data to identify preoperative prognostic factors, using which a risk stratification model was developed. The model was validated using test set data. Results In univariate analysis, clinical T stage classification and preoperative concentrations of hemoglobin, C-reactive protein, sodium, and albumin showed significant association with CSS. Multivariate analysis showed that low preoperative sodium and hemoglobin concentrations were significantly associated with a poor prognosis. A risk stratification model was developed using the preoperative sodium (<141 mEq/L) and hemoglobin concentrations (below normal). Three subgroups were formed depending on the presence of no (favorable group), one (intermediate), or two (poor) prognostic factors, and the 5-year CSS estimates were found to be 96.5, 75.5, and 47.0 %, respectively (P < 0.01). The risk model was significantly associated with the adverse pathological findings of stage pT3 or more and lymphovascular invasion (P = 0.005). Conclusion We identified low preoperative sodium and hemoglobin concentrations as prognostic factors for patients with UTUC treated with RNU. Our risk stratification model may help physicians design a therapeutic strategy.	[Fujita, Kazutoshi; Uemura, Motohide; Nakata, Wataru; Sato, Mototaka; Nagahara, Akira; Kiuchi, Hiroshi; Nakai, Yasutomo; Nonomura, Norio] Osaka Univ, Grad Sch Med, Dept Urol, Suita, Osaka 5650871, Japan; [Yamamoto, Yoshiyuki; Matsumiya, Kiyomi] Osaka Police Hosp, Dept Urol, Osaka, Japan; [Tanigawa, Go; Yamaguchi, Seiji] Osaka Gen Med Ctr, Dept Urol, Osaka, Japan	Fujita, K (reprint author), Osaka Univ, Grad Sch Med, Dept Urol, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	kazufujita2@gmail.com			Novartis Pharma; Pfizer Pharmaceutical	Norio Nonomura received lecture fees from Novartis Pharma and Pfizer Pharmaceutical.	Jeppesen AN, 2010, BRIT J CANCER, V102, P867, DOI 10.1038/sj.bjc.6605563; Obata J, 2013, UROL ONCOL-SEMIN ORI, V31, P1725, DOI 10.1016/j.urolonc.2012.05.008; Sakano S, 2013, ANN SURG ONCOL, V20, P4389, DOI 10.1245/s10434-013-3259-0; Kaag MG, 2010, EUR UROL, V58, P581, DOI 10.1016/j.eururo.2010.06.029; Dicato M, 2010, ANN ONCOL, V21, P167, DOI 10.1093/annonc/mdq284; Ng CK, 2011, UROL ONCOL-SEMIN ORI, V29, P27, DOI 10.1016/j.urolonc.2008.10.023; Roupret M, 2013, EUR UROL, V63, P1059, DOI 10.1016/j.eururo.2013.03.032; Swart RM, 2011, NEPHRON PHYSIOL, V118, P45, DOI 10.1159/000322238; Fujita K, 2013, INT J UROL, V20, P594, DOI 10.1111/j.1442-2042.2012.03228.x; Scolieri MJ, 2000, UROLOGY, V56, P930, DOI 10.1016/S0090-4295(00)00800-1; Guthrie GJK, 2013, CANCER TREAT REV, V39, P89, DOI 10.1016/j.ctrv.2012.07.003; Akdogan B, 2006, J UROLOGY, V176, P48, DOI 10.1016/S0022-5347(06)00511-8; Audenet F, 2013, UROL ONCOL-SEMIN ORI, V31, P407, DOI 10.1016/j.urolonc.2010.07.016; SEGUCHI T, 1992, J UROLOGY, V148, P791; Vasudev NS, 2008, CLIN CANCER RES, V14, P1775, DOI 10.1158/1078-0432.CCR-07-1721; Cho KS, 2007, UROLOGY, V70, P662, DOI 10.1016/j.urology.2007.06.1106; Margulis V, 2009, CANCER, V115, P1224, DOI 10.1002/cncr.24135; Huo T, 2008, DIGEST LIVER DIS, V40, P882, DOI 10.1016/j.dld.2008.01.015; Kawashima A, 2012, INT J UROL, V19, P1050, DOI 10.1111/j.1442-2042.2012.03115.x; Mitra AP, 2013, J CLIN ONCOL, V27, P3929	20	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					156	163		10.1007/s10147-014-0695-1		8	Oncology	Oncology	CE8OY	WOS:000352104100022		
J	Inoue, H; Nishimura, K; Yamaguchi, S; Nonomura, N; Hara, T				Inoue, Hitoshi; Nishimura, Kensaku; Yamaguchi, Seiji; Nonomura, Norio; Hara, Tsuneo			Prostate-specific antigen measured 3 months after radical prostatectomy as a new predictor of biochemical recurrence	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Prostate cancer; Prostate-specific antigen; Radical prostatectomy; Predictor; Biochemical recurrence	CANCER-SPECIFIC MORTALITY; RETROPUBIC PROSTATECTOMY; ADJUVANT RADIOTHERAPY; ULTRASENSITIVE PSA; RADIATION-THERAPY; NATURAL-HISTORY; FOLLOW-UP; PROGRESSION; RISK; SURVIVAL	Background This study was undertaken to investigate if the prostate-specific antigen (PSA) level measured 3 months after radical prostatectomy (RP) is a predictor of biochemical recurrence (BCR)-free survival. Methods We retrospectively reviewed the clinicopathologic data of 174 patients with a follow-up of at least 3 years after RP for clinically localized prostate cancer. None of the patients received neoadjuvant/adjuvant therapy. Subjects were categorized according to PSA level 3 months after RP (3M-PSA): <0.010 ng/mL (group 1; n = 119) or 0.010-0.100 ng/mL (group 2; n = 55). BCR was defined as two consecutive rises in PSA level >= 0.2 ng/mL. Results At a median follow-up of 69.5 months (range 36-113 months), 32 (18.4 %) patients experienced BCR. The median time to BCR was 16 months (range 4-98 months) after RP. The 5-year BCR-free survival rate was 92.6 and 57.4 % in groups 1 and 2, respectively. Patients in group 1 had a significantly higher BCR-free survival rate than those in group 2 (log-rank P < 0.001). According to the Cox proportional hazards model, patients with a 3M-PSA level of <0.010 ng/mL were at lower risk for BCR (P < 0.001), along with pathologic Gleason sum 6 (P = 0.028). PSA nadir level after RP was also a risk factor for BCR (log-rank P < 0.001). Area under the receiver operating characteristic curve for 3M-PSA to predict BCR was almost equivalent to that for the PSA nadir level (0.855 vs. 0.849). Conclusions 3M-PSA is an independent predictor of BCR-free survival. Our findings might be used for a risk-adjusted follow-up protocol.	[Inoue, Hitoshi; Nishimura, Kensaku; Hara, Tsuneo] Ikeda Municipal Hosp, Dept Urol, Ikeda, Osaka 5638510, Japan; [Yamaguchi, Seiji] Osaka Gen Med Ctr, Dept Urol, Osaka, Japan; [Nonomura, Norio] Osaka Univ, Grad Sch Med, Dept Urol, Osaka, Japan	Inoue, H (reprint author), Ikeda Municipal Hosp, Dept Urol, 3-1-18 Jonan, Ikeda, Osaka 5638510, Japan.	hiinoue2000@yahoo.co.jp					Antonarakis ES, 2012, BJU INT, V109, P32, DOI 10.1111/j.1464-410X.2011.10422.x; Zhou P, 2005, J CLIN ONCOL, V23, P6992, DOI 10.1200/JCO.2005.01.2906; PARTIN AW, 1994, J UROLOGY, V152, P1358; Ward JF, 2003, J UROLOGY, V170, P1872, DOI 10.1097/01.ju.0000091876.13656.2e; Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433; Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4; Roehl KA, 2004, J UROLOGY, V172, P910, DOI 10.1097/01.ju.0000134888.22332.bb; Bolla M, 2005, LANCET, V366, P572, DOI 10.1016/S0140-6736(05)67101-2; Shen S, 2005, J UROLOGY, V173, P777, DOI 10.1097/01.ju.0000153619.33446.60; Simmons MN, 2007, EUR UROL, V51, P1175, DOI 10.1016/j.eururo.2007.01.015; Boorjian SA, 2011, EUR UROL, V59, P893, DOI 10.1016/j.eururo.2011.02.026; Briganti A, 2012, EUR UROL, V62, P472, DOI 10.1016/j.eururo.2012.04.056; D'Amico AV, 2005, J CLIN ONCOL, V23, P4975, DOI 10.1200/JCO.2005.08.904; Doherty AP, 2000, BRIT J CANCER, V83, P1432, DOI 10.1054/bjoc.2000.1474; Eisenberg ML, 2010, EUR UROL, V57, P622, DOI 10.1016/j.eururo.2009.03.077; Ganswindt U, 2008, EUR UROL, V54, P528, DOI 10.1016/j.eururo.2008.06.059; Haese A, 1999, J UROLOGY, V161, P1206, DOI 10.1016/S0022-5347(01)61635-5; Hong SK, 2010, UROLOGY, V76, P723, DOI 10.1016/j.urology.2010.03.081; Kinoshita H, 2007, INT J UROL, V14, P930, DOI 10.1111/j.1442-2042.2007.01858.x; OESTERLING JE, 1988, J UROLOGY, V139, P766; Roberts SG, 2001, MAYO CLIN PROC, V76, P576; Thompson IM, 2006, JAMA-J AM MED ASSOC, V296, P2329, DOI 10.1001/jama.296.19.2329; Vesely S, 2013, WORLD J UROL, V31, P299, DOI 10.1007/s00345-012-0892-3	23	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					171	175		10.1007/s10147-014-0681-7		5	Oncology	Oncology	CE8OY	WOS:000352104100024		
J	Koie, T; Mitsuzuka, K; Yoneyama, T; Narita, S; Kawamura, S; Kaiho, Y; Tsuchiya, N; Tochigi, T; Habuchi, T; Arai, Y; Ohyama, C; Yoneyama, T; Tobisawa, Y				Koie, Takuya; Mitsuzuka, Koji; Yoneyama, Takahiro; Narita, Shintaro; Kawamura, Sadafumi; Kaiho, Yasuhiro; Tsuchiya, Norihiko; Tochigi, Tatsuo; Habuchi, Tomonori; Arai, Yoichi; Ohyama, Chikara; Yoneyama, Tohru; Tobisawa, Yuki			Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Prostate cancer; High-risk; Prostate-specific antigen density; Advanced prostate cancer; Biochemical recurrence-free survival	PATHOLOGICAL STAGE; GLEASON SUM; SURVIVAL; PSA	Background Patients with advanced local-stage, high-grade prostate cancer (Pca) and high pretreatment prostate-specific antigen (PSA) levels have inferior outcomes compared to their counterparts with more favorable clinical characteristics. However, some patients exhibit favorable pathological features or experience long-term PSA-free survival after radical prostatectomy (RP). We retrospectively examined the ability of preoperative characteristics to predict pathological and oncological outcomes in high-risk Pca patients who underwent RP. Methods We examined data of 1,268 consecutive Pca patients treated with RP alone at 4 hospitals from the Michinoku Urological Cancer Study Group database. Preoperative predictors included age, PSA level, biopsy Gleason score, clinical T stage, and PSA density (PSAD). The outcome measures pathological T stage and PSA-free survival were evaluated by multivariate analysis. Results We identified 380 high-risk Pca patients, of which 44 % patients had extracapsular extension. Logistic regression analysis indicated that PSAD was an independent predictor of adverse pathologic stage. The 5-year PSA-free survival rates were 82.9 % for patients with PSAD <= 0.468 ng mL(-1) cm(-2) and 50.7 % for those with PSAD >0.468 ng mL(-1) cm(-2) (P < 0.0001). Multivariate analyses revealed that PSAD, cT, and the number of preoperative high-risk Pca criteria were independent predictors of PSA-free survival. Conclusions PSAD may be an independent predictor of advanced pathological features and biochemical recurrence in high-risk Pca patients treated with RP alone. PSAD may be used for further risk stratification of high-risk Pca patients.	[Koie, Takuya; Yoneyama, Takahiro; Ohyama, Chikara; Yoneyama, Tohru; Tobisawa, Yuki] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori 0368562, Japan; [Mitsuzuka, Koji; Kaiho, Yasuhiro; Arai, Yoichi] Tohoku Univ, Grad Sch Med, Dept Urol, Sendai, Miyagi 980, Japan; [Narita, Shintaro; Tsuchiya, Norihiko; Habuchi, Tomonori] Akita Univ, Grad Sch Med, Dept Urol, Akita 010, Japan; [Kawamura, Sadafumi; Tochigi, Tatsuo] Miyagi Canc Ctr, Dept Urol, Natori, Miyagi 9811293, Japan	Ohyama, C (reprint author), Hirosaki Univ, Grad Sch Med, Dept Urol, 5 Zaifucho, Hirosaki, Aomori 0368562, Japan.	coyama@cc.hirosaki-u.ac.jp	Tobisawa, Yuki/G-3802-2014	Yoneyama, Tohru/0000-0002-1098-407X; Tobisawa, Yuki/0000-0001-8026-9541			Radwan MH, 2007, UROLOGY, V69, P1121, DOI 10.1016/j.urology.2007.01.087; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Pierorazio PM, 2010, UROLOGY, V76, P715, DOI 10.1016/j.urology.2009.11.085; Koie T, 2011, EJSO-EUR J SURG ONC, V37, P805, DOI 10.1016/j.ejso.2011.06.009; Polascik TJ, 1999, J UROLOGY, V162, P293, DOI 10.1016/S0022-5347(05)68543-6; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Sundi D, 2014, PROSTATE, V74, P628, DOI 10.1002/pros.22780; Loeb S, 2010, UROLOGY, V76, P710, DOI 10.1016/j.urology.2009.09.014; Boorjian SA, 2008, J UROLOGY, V179, P1354, DOI 10.1016/j.juro.2007.11.061; Brassell SA, 2005, UROLOGY, V66, P1229, DOI 10.1016/j.urology.2005.06.106; CORN BW, 1995, J UROLOGY, V153, P1855, DOI 10.1016/S0022-5347(01)67331-2; Edge SB, 2010, AJCC CANC STAGING MA, P457; Gancarczyk KJ, 2003, UROLOGY, V61, P589, DOI 10.1016/S0090-4925(02)02287-2; Giannarini G, 2008, UROL ONCOL-SEMIN ORI, V26, P353, DOI 10.1016/j.urolonc.2007.04.002; Horiguchi A, 2003, PROSTATE, V56, P23, DOI 10.1002/pros.10239; Ishida M, 2009, INT J UROL, V16, P936, DOI 10.1111/j.1442-2042.2009.02399.x; Lee Jun Taik, 2010, Korean J Urol, V51, P745, DOI 10.4111/kju.2010.51.11.745; Perotti M, 1999, UROLOGY, V54, P208; Tsuzuki T, 2005, J UROLOGY, V173, P450, DOI 10.1097/01.ju.0000151370.82099.1a; Yuh B, 2013, EUR UROL, DOI [10.1016/j.eururo.2013.05.026, DOI 10.1016/J.EURURO.2013.05.026]	21	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					176	181		10.1007/s10147-014-0696-0		6	Oncology	Oncology	CE8OY	WOS:000352104100025		
J	Yasuta, M; Sato, S; Kouraba, S; Iino, S; Kiyohara, T				Yasuta, Masato; Sato, Suguru; Kouraba, Sachio; Iino, Shiro; Kiyohara, Takahiro			A statistical study on malignant melanoma over the past 12 years in Fukui University Hospital	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Malignant melanoma; Statistical study; Incisional biopsy; In-transit metastasis; Survival rate	CUTANEOUS MELANOMA	Background The survival rate of patients with malignant melanoma is still low, and there is no established chemotherapeutic method. With the appearance of molecular targeted drugs, improvement in the survival rate can be expected. However, at present, malignant melanoma remains a disease associated with one of the poorest prognoses. Materials and methods We analyzed a total of 51 cases of malignant melanoma who were treated at the Department of Dermatology, University of Fukui from September 2001 to May 2013. Results The survival rate was significantly lower in patients aged >= 65 years. The 5-year survival rate was 100 % for Stage 0/I, 79.59 % for Stage II, and 52 % for Stage III. The incidence of lymph node metastasis was highest in nodular melanoma, and zero in lentigo maligna melanoma. There was a significantly high risk of lymph node metastasis in the presence of ulceration. There was no association between incisional biopsy and lymph node metastasis. Conclusions Although the data were obtained in only one institution and the number of cases was limited in this study, the results are close to previous international data.	[Yasuta, Masato; Sato, Suguru] Univ Fukui, Sch Med, Dept Dermatol, Div Plast & Reconstruct Surg, Fukui 9101193, Japan; [Kouraba, Sachio] Sapporo Wound Care & Antiaging Lab, Sapporo, Hokkaido, Japan; [Iino, Shiro; Kiyohara, Takahiro] Univ Fukui, Dept Dermatol, Fukui 9101193, Japan	Yasuta, M (reprint author), Univ Fukui, Sch Med, Dept Dermatol, Div Plast & Reconstruct Surg, 23-3 Matsuoka Shimoaizuki, Fukui 9101193, Japan.	las@u-fukui.ac.jp					Ishihara K, 2008, INT J CLIN ONCOL, V13, P33, DOI 10.1007/s10147-007-0751-1; Thompson JF, 2011, J CLIN ONCOL, V29, P2199, DOI 10.1200/JCO.2010.31.5812; CASCINELLI N, 1986, EUR J SURG ONCOL, V12, P175; Chi ZH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-85; Fujisawa Y, 2012, SKIN CANC JAPAN, V27, P195; Ishihara K, 2006, SKIN CANC JAPAN, V20, P234; Ishihara K, 2009, SKIN CANC JAPAN, V24, P258; Kretschmer L, 2006, ANN SURG ONCOL, V13, P1105, DOI 10.1245/ASO.2006.07.020; Kumano K, 2012, JAPAN J DERM SURG JA, V16, P156; Kurooka S, 2012, HIHU BYO SHINRYO JAP, V34, P506; Pawlik TM, 2005, ANN SURG ONCOL, V12, P587, DOI 10.1245/ASO.2005.05.025	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					182	187		10.1007/s10147-014-0683-5		6	Oncology	Oncology	CE8OY	WOS:000352104100026		
J	Shibayama, Y; Imafuku, S; Takahashi, A; Nakayama, J				Shibayama, Yoshitsugu; Imafuku, Shinichi; Takahashi, Akira; Nakayama, Juichiro			Role of sentinel lymph node biopsy in patients with Merkel cell carcinoma: statistical analysis of 403 reported cases	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Merkel cell carcinoma; Sentinel lymph node; False negative; Recurrence; Meta-analysis	SINGLE INSTITUTION; CUTANEOUS MELANOMA; LYMPHOSCINTIGRAPHY; EXPERIENCE; SURVIVAL; LYMPHADENECTOMY; LYMPHONODECTOMY; METAANALYSIS; RECURRENCE	Background Merkel cell carcinoma (MCC) is a rare cutaneous malignancy with a high rate of nodal metastasis. Sentinel lymph node biopsy (SLNB) is used in MCC and other cancers to identify regional node micrometastases in patients with clinically negative nodes; however, whether SLN status is associated with recurrence or prognosis in MCC is unclear. Methods A statistical analysis was performed of 397 published cases of MCC with SLNB results from 22 reports and 6 new cases, in order to elucidate any correlation between SLN status and recurrence, and to determine false-negative rates for SLNB. Results Of these 403 cases, 128 (31.8 %) had positive SLNs; 16 of these 128 (12.5 %) developed recurrence (6 nodal, 10 distant). Of 275 patients with negative SLNs, 27 (9.8 %) developed recurrence (19 nodal, 8 distant). Patients with positive SLNs had a greater risk of distant metastasis (OR 2.82; P = 0.037; 95 % CI 1.089-7.347). The false-negative rate for SLNB in all 403 patients was 12.9 %. Use of the immunohistochemical approach to diagnosis of micrometastasis with anti-CK20 antibody did not affect the false-negative rate. Conclusions Patients with positive SLNs had a greater risk of distant metastasis in MCC; positive SLN was an important prognostic factor in MCC. Further studies using standardized, more-sensitive techniques to examine entire SLNs may decrease the false-negative rate, and improve the significance of SLNB in MCC.	[Shibayama, Yoshitsugu; Imafuku, Shinichi; Takahashi, Akira; Nakayama, Juichiro] Fukuoka Univ, Fac Med, Dept Dermatol, Jonan Ku, Fukuoka 8140133, Japan	Shibayama, Y (reprint author), Fukuoka Univ, Fac Med, Dept Dermatol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140133, Japan.	shibayoshi1978@hotmail.com					Allen PJ, 2001, CANCER, V92, P1650, DOI 10.1002/1097-0142(20010915)92:6<1650::AID-CNCR1491>3.0.CO;2-8; Ames SE, 1998, J SURG ONCOL, V67, P251, DOI 10.1002/(SICI)1096-9098(199804)67:4<251::AID-JSO8>3.0.CO;2-7; Fields RC, 2011, ANN SURG ONCOL, V18, P2529, DOI 10.1245/s10434-011-1662-y; Zeitouni NC, 2000, DERMATOL SURG, V26, P12, DOI 10.1046/j.1524-4725.2000.99129.x; Michl C, 2003, BRIT J DERMATOL, V149, P763, DOI 10.1046/j.1365-2133.2003.05578.x; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Allen PJ, 2005, J CLIN ONCOL, V23, P2300, DOI 10.1200/JCO.2005.02.329; Lemos BD, 2010, J AM ACAD DERMATOL, V63, P751, DOI 10.1016/j.jaad.2010.02.056; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Gupta SG, 2006, ARCH DERMATOL, V142, P685, DOI 10.1001/archderm.142.6.685; MORTON DL, 1991, ANN SURG, V214, P491, DOI 10.1097/00000658-199110000-00013; Hill ADK, 1999, BRIT J SURG, V86, P518; Duker I, 2001, DERMATOLOGY, V202, P225, DOI 10.1159/000051641; Messina JL, 1997, ANN SURG ONCOL, V4, P389, DOI 10.1007/BF02305551; Testori A, 2009, ANN SURG ONCOL, V16, P2018, DOI 10.1245/s10434-008-0273-8; Mehrany K, 2002, DERMATOL SURG, V28, P113, DOI 10.1046/j.1524-4725.2002.02901.x; Namikawa K, 2011, EUR J DERMATOL, V21, P184, DOI 10.1684/ejd.2010.1237; Blom A, 2003, ANN DERMATOL VENER, V130, P417; Chao C, 2002, AM J SURG, V184, P520, DOI 10.1016/S0002-9610(02)01102-9; Howle J, 2012, AUSTRALAS J DERMATOL, V53, P26, DOI 10.1111/j.1440-0960.2011.00838.x; Jones EL, 2013, JAMA SURG, V16, P1; Kurul S, 2000, PLAST RECONSTR SURG, V105, P680, DOI 10.1097/00006534-200002000-00030; Maza S, 2006, EUR J NUCL MED MOL I, V33, P433, DOI 10.1007/s00259-005-0014-1; Morton DL, 1991, ANN SURG, V214, P9; Nowecki ZI, 2006, ANN SURG ONCOL, V13, P1655, DOI 10.1245/s10434-006-9066-0; Ortin-Perez J, 2007, EJSO-EUR J SURG ONC, V33, P119, DOI 10.1016/j.ejso.2006.09.004; Pan D, 2002, PLAST RECONSTR SURG, V110, P1259, DOI 10.1097/01.PRS.0000025287.96915.88; Pfeifer T, 1997, J AM ACAD DERMATOL, V37, P650, DOI 10.1016/S0190-9622(97)70189-0; Rodrigues LKE, 2001, J AM ACAD DERMATOL, V45, P303, DOI 10.1067/mjd.2001.114749; Schmalbach CE, 2005, ARCH OTOLARYNGOL, V131, P610, DOI 10.1001/archotol.131.7.610; Sian KU, 1999, ANN PLAS SURG, V42, P679, DOI 10.1097/00000637-199906000-00017; Su LD, 2002, J AM ACAD DERMATOL, V46, P661, DOI 10.1067/mjd.2002.119563; Warner RE, 2008, ANN SURG ONCOL, V15, P2509, DOI 10.1245/s10434-008-9983-1; Wasserberg N, 2000, DERMATOL SURG, V26, P138, DOI 10.1046/j.1524-4725.2000.99213.x	34	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					188	193		10.1007/s10147-014-0685-3		6	Oncology	Oncology	CE8OY	WOS:000352104100027		
J	Tokuda, Y; Arakura, F; Uhara, H				Tokuda, Yasutaka; Arakura, Fuyuko; Uhara, Hisashi			Combination chemotherapy of low-dose 5-fluorouracil and cisplatin for advanced extramammary Paget's disease	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Extramammary Paget's disease; Chemotherapy; 5-Fluorouracil; Cisplatin		Background Extramammary Paget's disease (EPD) is a cutaneous adenocarcinoma. It is usually curable by wide local excision. However, the prognosis for EPD patients with metastases is extremely poor because effective chemotherapy for advanced EPD has not been established. Methods We retrospectively analyzed the efficacy of combination chemotherapy consisting of infusions of 5-fluorouracil (5-FU, 600 mg/m(2)/body, 5 days/week) and cisplatin (5-10 mg/body, 5-7 days/week) administered intravenously for 8-24 h (low-dose FP). Results The patients were 15 males and 7 females and the ages ranged from 54 to 91 years old (median 71). The toxicities of low-dose FP were as follows: hematopoietic dysfunction (n = 4), gastrointestinal dysfunction (4), nephropathy (1), and phlebitis (1). Almost all toxicities were grade 1 or 2 except for 2 cases with grade 3 leukopenia or pancytopenia. Seventeen patients were treated with low-dose FP only, and the clinical results included 10 partial responses (PR), 4 stable disease (SD), and 3 progressive disease (PD). The overall survival ranges (medians) were 5-51 months (12) in all 22 patients, 6-51 months (13) in the 13 patients showing complete response or PR, and 5-12 months (11) in the 6 SD patients. The reported palliative effects of low-dose FP include control of pain and improvement of lymphedema. Conclusion Although the number of cases is limited and there is a bias because cases without clinical effects are less likely to be reported, this regimen might be considered a relatively effective option for advanced EPD.	[Tokuda, Yasutaka; Arakura, Fuyuko] Matsumoto Med Ctr, Div Dermatol, Minami Ku, Matsumoto, Nagano 3998701, Japan; [Uhara, Hisashi] Shinshu Univ, Sch Med, Dept Dermatol, Matsumoto, Nagano 3908621, Japan	Uhara, H (reprint author), Shinshu Univ, Sch Med, Dept Dermatol, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.	uhara@shinshu-u.ac.jp			National Cancer Center Research and Development Fund [23-A-22]	This study was supported in part by a National Cancer Center Research and Development Fund (23-A-22).	Oguchi S, 2002, J DERMATOL, V29, P33; Kariya K, 2004, DERMATOL SURG, V30, P341, DOI 10.1111/j.1524-4725.2004.30093.x; Hatta N, 2008, BRIT J DERMATOL, V158, P313, DOI 10.1111/j.1365-2133.2007.08314.x; Harasima T, 2007, J JPN P R S, V27, P535; Inui S, 2000, J Dermatol, V27, P409; Ishizawa T, 2002, SKIN CANC, V17, P234; Kikuchi Y, 2004, JPN J DERMATOL, V114, P1443; Kurooka S, 2012, JPN J DERMATOL, V122, P2891; Mastuura A, 2002, SKIN CANC, V17, P189; Mkoshiba Y, 2013, J DERMATOL, V40, P664; Morita R, 1999, RINSYO DERMA, V41, P1475; Onishi I, 2002, JPN CANC CHEMOTHER, V29, P1973; Osawa R, 2005, SKIN CANC, V20, P79; Otani T, 2003, J TOKYO WOMEN MED U, V73, P99; Shibuya Y, 2008, SKIN CANC, V23, P375; Tokuda Y, 1997, JPN J DERMATOL, V107, P21; Uemura Motohide, 2002, Acta Urologica Japonica, V48, P311; Uhara H, 2003, SKIN CANC, V18, P92; Yamada N, 2010, JPN J DERMATOL, V120, P728; Yamamoto A, 2010, TOKYO J OBSTET GYNEC, V59, P78; Yamazaki Naoya, 1999, Journal of Dermatology (Tokyo), V26, P311; Yokouchi M, 2007, RINSYO HIFUKA, V61, P554; YOKOYAMA Y, 1990, JPN J CLIN ONCOL, V20, P426	23	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					194	197		10.1007/s10147-014-0686-2		4	Oncology	Oncology	CE8OY	WOS:000352104100028		
J	Shimoyama, N; Gomyo, I; Katakami, N; Okada, M; Yukitoshi, N; Ohta, E; Shimoyama, M				Shimoyama, Naohito; Gomyo, Ikuo; Katakami, Nobuyuki; Okada, Masakuni; Yukitoshi, Nobuyuki; Ohta, Eri; Shimoyama, Megumi			Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined by titration for the treatment of breakthrough pain in Japanese cancer patients: a multicenter, randomized, placebo-controlled, double-blind phase III trial	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Breakthrough pain; Cancer pain; Sublingual fentanyl tablet; Opioid; Dose titration	CITRATE; MANAGEMENT; PHARMACOKINETICS	Background Breakthrough cancer pain typically has a rapid onset and relatively short duration. Due to this temporal profile, it may not be adequately relieved by oral opioid analgesics. The sublingual fentanyl orally disintegrating tablet is a formulation by which fentanyl can be rapidly absorbed across the oral mucosa producing rapid-onset analgesia, and which may be effective for breakthrough pain treatment. Methods A multicenter, randomized, placebo-controlled, double-blind comparative study was conducted to evaluate the efficacy and safety of the sublingual fentanyl tablet at optimized doses for breakthrough pain treatment in cancer patients treated with strong opioid analgesics at fixed intervals. The optimal dose was determined by open-label dose titration. The efficacy and safety of a 12-week extended treatment were also evaluated. Results Eleven of 42 subjects who received the sublingual fentanyl tablet experienced adverse drug reactions. Common reactions were somnolence, constipation, nausea, and vomiting. No serious adverse reactions occurred. Sublingual fentanyl tablets at optimal doses and placebo were administered to 37 subjects in a double-blinded manner. A significant analgesic effect of the sublingual fentanyl tablet was present compared to placebo at 30 min after administration. The sublingual fentanyl tablet was also effective and safe during extended treatment, in which changes in basal opioid doses as well as sublingual fentanyl tablet doses were made as needed. Conclusion Sublingual fentanyl tablets at doses determined by titration were effective and safe for breakthrough pain treatment in cancer patients treated with strong opioid analgesics at fixed intervals. Extended treatment up to 12 weeks was also effective and safe.	[Shimoyama, Naohito] Jikei Univ, Sch Med, Dept Palliat Med, Minato Ku, Tokyo 1058461, Japan; [Gomyo, Ikuo] Saito Yukoukai Hosp, Dept Palliat Med, Osaka 5670085, Japan; [Katakami, Nobuyuki] Inst Biomed Res & Innovat Hosp, Fdn Biomed Res & Innovat, Div Integrated Oncol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Okada, Masakuni] Shakaihoken Kobe Cent Hosp, Dept Internal Med, Kita Ku, Kobe, Hyogo 6511145, Japan; [Yukitoshi, Nobuyuki] Kyowa Hakko Kirin Co Ltd, Clin Dev Dept 2, Dev Div, Chiyoda Ku, Tokyo 1008185, Japan; [Ohta, Eri] Kyowa Hakko Kirin Co Ltd, Clin Data Evaluat Dept, Dev Div, Chiyoda Ku, Tokyo 1008185, Japan; [Shimoyama, Megumi] Teikyo Univ, Chiba Med Ctr, Dept Anesthesiol, Ichihara, Chiba 2990111, Japan	Shimoyama, N (reprint author), Jikei Univ, Sch Med, Dept Palliat Med, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	nshimoya@jikei.ac.jp			Kyowa Hakko Kirin, Co., Ltd.	The sponsor of this clinical trial was Kyowa Hakko Kirin, Co., Ltd.	Streisand JB, 1998, ANESTHESIOLOGY, V88, P305, DOI 10.1097/00000542-199802000-00006; Lennernas B, 2005, BRIT J CLIN PHARMACO, V59, P249, DOI 10.1111/j.1365-2125.2004.02264.x; Christie JM, 1998, J CLIN ONCOL, V16, P3238; Rauck RL, 2009, CURR MED RES OPIN, V25, P2877, DOI 10.1185/03007990903368310; Bennett D, 2005, PHARMACOL THERAPEUT, V30, P354; Bredenberg S, 2003, EUR J PHARM SCI, V20, P327, DOI 10.1016/j.ejps.2003.07.002; CHERNY NI, 1993, CANCER-AM CANCER SOC, V72, P3393, DOI 10.1002/1097-0142(19931201)72:11+<3393::AID-CNCR2820721606>3.0.CO;2-O; England Ruth, 2011, BMJ Support Palliat Care, V1, P349, DOI 10.1136/bmjspcare-2011-000037; Todd KH, 1996, ACAD EMERG MED, V3, P142, DOI 10.1111/j.1553-2712.1996.tb03402.x; Payne R, 2001, J PAIN SYMPTOM MANAG, V22, P575, DOI 10.1016/S0885-3924(01)00306-2; Potenoy RK, 1990, PAIN, V41, P273; Simmonds MA, 1999, ONCOLOGY-NY, V13, P1103; Yamaguchi T, 2013, JPN J CLIN ONCOL, V43, P896, DOI 10.1093/jjco/hyt099	13	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	FEB	2015	20	1					198	206		10.1007/s10147-014-0697-z		9	Oncology	Oncology	CE8OY	WOS:000352104100029		
J	Fujishima, S				Fujishima, Shota			The emergence of cooperation through leadership	INTERNATIONAL JOURNAL OF GAME THEORY			English	Article						Equilibrium selection; Stochastic stability; Asynchronous repeated game; Coordination game; Risk dominance	REPEATED COORDINATION GAMES; EQUILIBRIUM SELECTION; ASYNCHRONOUS CHOICE; DYNAMIC OLIGOPOLY; REPUTATION; EVOLUTION; COMMUNICATION; COMPETITION; ATTRACTION; EXPERIENCE	We study the long-run outcomes of noisy asynchronous repeated games with players that are heterogeneous in their patience. The players repeatedly play a 2 x 2 coordination game with random pair-wise matching. The games are noisy because the players may make mistakes when choosing their actions and are asynchronous because only one player can move in each period. We characterize the long-run outcomes of Markov perfect equilibrium that are robust to the mistakes and show that if one player is sufficiently patient whereas the other players are not so patient, the efficient state can be the unique robust outcome even if it is risk-dominated. Because we need heterogeneity for the result, we argue that it enables the most patient player in effect to be the leader.	Univ Tokyo, Ctr Spatial Informat Sci, Kashiwa, Chiba 2778568, Japan	Fujishima, S (reprint author), Univ Tokyo, Ctr Spatial Informat Sci, 5-1-5 Kashiwa No Ha, Kashiwa, Chiba 2778568, Japan.	sfujishima@csis.u-tokyo.ac.jp					FUDENBERG D, 1989, ECONOMETRICA, V57, P759, DOI 10.2307/1913771; FOSTER D, 1990, THEOR POPUL BIOL, V38, P219, DOI 10.1016/0040-5809(90)90011-J; KANDORI M, 1993, ECONOMETRICA, V61, P29, DOI 10.2307/2951777; Bhaskar V, 2002, J ECON THEORY, V103, P334, DOI 10.1006/jeth.2001.2809; CARLSSON H, 1993, ECONOMETRICA, V61, P989, DOI 10.2307/2951491; MASKIN E, 1988, ECONOMETRICA, V56, P549, DOI 10.2307/1911700; Camerer CF, 2002, J ECON THEORY, V104, P137, DOI 10.1006/jeth.2002.2927; Hyndman K, 2009, EXP ECON, V12, P450, DOI 10.1007/s10683-009-9223-y; MATSUI A, 1995, J ECON THEORY, V65, P415, DOI 10.1006/jeth.1995.1015; Ellison G, 2000, REV ECON STUD, V67, P17, DOI 10.1111/1467-937X.00119; SCHMIDT KM, 1993, ECONOMETRICA, V61, P325, DOI 10.2307/2951554; MORRIS S, 1995, ECONOMETRICA, V63, P145, DOI 10.2307/2951700; FUDENBERG D, 1990, AM ECON REV, V80, P274; Aoyagi M, 1996, J ECON THEORY, V71, P378, DOI 10.1006/jeth.1996.0126; Beggs A, 2005, ECON THEOR, V25, P599, DOI 10.1007/s00199-003-0444-6; Bhaskar V, 1998, J ECON THEORY, V82, P110, DOI 10.1006/jeth.1998.2423; Blume LE, 1997, EC EVOLVING COMPLEX; Blume LE, 2004, EVOLUTIONARY EQUILIB; Celentani M, 1996, ECONOMETRICA, V64, P691, DOI 10.2307/2171867; Cripps MW, 1996, J ECON THEORY, V69, P387, DOI 10.1006/jeth.1996.0060; Dutta Prajit K., 2012, Games and Economic Behavior, V76, DOI 10.1016/j.geb.2012.07.002; Ellison G, 1997, GAME ECON BEHAV, V19, P180, DOI 10.1006/game.1997.0555; Evans R, 1997, ECONOMETRICA, V65, P1153, DOI 10.2307/2171882; Freidlin M. I., 1984, RANDOM PERTURBATIONS; Harsanyi J. C., 1988, GEN THEORY EQUILIBRI; Kajii A, 1997, ECONOMETRICA, V65, P1283, DOI 10.2307/2171737; KIM YG, 1995, ECONOMETRICA, V63, P1181, DOI 10.2307/2171726; Lagunoff R, 1997, ECONOMETRICA, V65, P1467, DOI 10.2307/2171745; Lagunoff R, 2000, INT ECON REV, V41, P273, DOI 10.1111/1468-2354.00064; FUDENBERG D, 1992, REV ECON STUD, V59, P561, DOI 10.2307/2297864; MATSUI A, 1991, J ECON THEORY, V54, P245, DOI 10.1016/0022-0531(91)90122-K; Maynard Smith J., 1982, EVOLUTION THEORY GAM; McCannon BC, 2011, J ECON, V102, P263, DOI 10.1007/s00712-010-0176-6; NOLDEKE G, 1993, GAME ECON BEHAV, V5, P425, DOI 10.1006/game.1993.1024; Norris J., 1998, CAMBRIDGE SERIES STA; Robles J, 2001, GAME ECON BEHAV, V34, P312, DOI 10.1006/game.2000.0809; Sandroni A, 2000, GAME ECON BEHAV, V32, P157, DOI 10.1006/game.1998.0761; SOBEL J, 1993, ECON LETT, V42, P301, DOI 10.1016/0165-1765(93)90077-P; MASKIN E, 1988, ECONOMETRICA, V56, P571, DOI 10.2307/1911701; Weidenholzer S., 2010, GAMES, V1, P551, DOI 10.3390/g1040551; YOUNG HP, 1993, ECONOMETRICA, V61, P57, DOI 10.2307/2951778	41	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0020-7276	1432-1270		INT J GAME THEORY	Int. J. Game Theory	FEB	2015	44	1					17	36		10.1007/s00182-014-0417-y		20	Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods; Statistics & Probability	Business & Economics; Mathematics; Mathematical Methods In Social Sciences	CE8JC	WOS:000352087400002		
J	Kato, M; Ohseto, S; Tamura, S				Kato, Miki; Ohseto, Shinji; Tamura, Shohei			Strategy-proofness versus symmetry in economies with an indivisible good and money	INTERNATIONAL JOURNAL OF GAME THEORY			English	Article						Strategy-proofness; Symmetry; Budget balance; Indivisible good; Monetary transfer	VICKREY ALLOCATION RULE; 2ND PRICE AUCTIONS; PREFERENCE DOMAINS; RESTRICTED DOMAINS; MECHANISMS; CHOICE; MONOTONICITY; OBJECTS; EQUITY	We consider the problem of allocating a single indivisible good among n agents when monetary transfers are allowed. We study the possibility of constructing strategy-proof, symmetric, and budget balanced mechanisms. We show that there is no strategy-proof, symmetric, and budget balanced mechanism (under the weak domain condition that the set of agent's possible valuations includes at least n + 1 common valuations). Moreover, this result implies that there is no strategy-proof, symmetric, and budget balanced mechanism (i) in the model where agents may have non-quasilinear preferences, and/or (ii) in the unit-demand model with n heterogeneous indivisible goods.	[Kato, Miki] Tohoku Seikatsu Bunka Coll, Sendai, Miyagi 9818585, Japan; [Ohseto, Shinji; Tamura, Shohei] Tohoku Univ, Fac Econ, Sendai, Miyagi 9808576, Japan	Ohseto, S (reprint author), Tohoku Univ, Fac Econ, Sendai, Miyagi 9808576, Japan.	ohseto@econ.tohoku.ac.jp			Japan Society for the Promotion of Science	We would like to thank Kazutoshi Ando, an associate editor, and two anonymous referees for helpful suggestions and comments. This research was partially supported by Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science.	Ando K, 2008, MATH SOC SCI, V55, P14, DOI 10.1016/j.mathsocsci.2007.06.002; GIBBARD A, 1973, ECONOMETRICA, V41, P587, DOI 10.2307/1914083; DASGUPTA P, 1979, REV ECON STUD, V46, P185, DOI 10.2307/2297045; Moulin H, 2009, J ECON THEORY, V144, P96, DOI 10.1016/j.jet.2008.03.003; GROVES T, 1973, ECONOMETRICA, V41, P617, DOI 10.2307/1914085; HOLMSTROM B, 1979, ECONOMETRICA, V47, P1137, DOI 10.2307/1911954; MULLER E, 1977, J ECON THEORY, V14, P412, DOI 10.1016/0022-0531(77)90140-5; Barbera S, 2001, SOC CHOICE WELFARE, V18, P619, DOI 10.1007/s003550100151; Sprumont Y, 2013, J ECON THEORY, V148, P1102, DOI 10.1016/j.jet.2012.09.015; Ashlagi I, 2012, SOC CHOICE WELFARE, V38, P531, DOI 10.1007/s00355-011-0535-4; Barbera S, 2012, HDB SOCIAL CHOICE WE, V2, P729; Cavallo R., 2006, P INT C AUT AG MULT, P882, DOI 10.1145/1160633.1160790; Chew SH, 2007, ECON THEOR, V33, P393, DOI 10.1007/s00199-006-0130-6; Foley D.K., 1967, YALE ECON ESSAYS, V7, P45; Fujinaka Y, 2007, ECON LETT, V94, P253, DOI 10.1016/j.econlet.2006.06.038; Hashimoto K, 2010, SOC CHOICE WELFARE, V34, P455, DOI 10.1007/s00355-009-0411-7; Miyagawa E, 2001, J ECON THEORY, V100, P329, DOI 10.1006/jeth.2000.2703; Ohseto S, 2000, INT J GAME THEORY, V29, P365, DOI 10.1007/s001820000046; Ohseto S, 2004, ECON THEOR, V23, P659, DOI 10.1007/s00199-003-0369-0; Ohseto S, 1999, SOC CHOICE WELFARE, V16, P121, DOI 10.1007/s003550050134; Ohseto S, 2006, ECON THEOR, V29, P111, DOI 10.1007/s00199-005-0014-1; Papai S, 2003, SOC CHOICE WELFARE, V20, P371, DOI 10.1007/s003550200185; Porter R, 2004, J ECON THEORY, V118, P209, DOI 10.1016/j.jet.2003.11.005; Saitoh H, 2008, ECON THEOR, V35, P391, DOI 10.1007/s00199-007-0235-6; Sakai T, 2013, INT J ECON THEORY, V9, P255, DOI 10.1111/j.1742-7363.2013.12018.x; Sakai T, 2013, REV ECON DES, V17, P17, DOI 10.1007/s10058-012-0135-5; Sakai T, 2008, ECON THEOR, V37, P347, DOI 10.1007/s00199-007-0311-y; SATTERTHWAITE MA, 1975, J ECON THEORY, V10, P187, DOI 10.1016/0022-0531(75)90050-2; PAZNER EA, 1978, Q J ECON, V92, P671, DOI 10.2307/1883182; Schummer J, 2000, GAME ECON BEHAV, V30, P293, DOI 10.1006/game.1999.0718; SPRUMONT Y, 1995, CAN J ECON, V28, P68, DOI 10.2307/136023; Svensson LG, 2009, ECON THEOR, V40, P227, DOI 10.1007/s00199-008-0366-4; Takamiya K, 2001, MATH SOC SCI, V41, P201, DOI 10.1016/S0165-4896(00)00062-7; VICKREY W, 1961, J FINANC, V16, P8, DOI 10.2307/2977633; Yengin D, 2012, SOC CHOICE WELFARE, V38, P137, DOI 10.1007/s00355-010-0523-0	35	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0020-7276	1432-1270		INT J GAME THEORY	Int. J. Game Theory	FEB	2015	44	1					195	207		10.1007/s00182-014-0425-y		13	Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods; Statistics & Probability	Business & Economics; Mathematics; Mathematical Methods In Social Sciences	CE8JC	WOS:000352087400010		
J	Ishikawa, K; Yoshida, S; Kobayashi, Y; Zhou, Y; Nakama, T; Nakao, S; Sassa, Y; Oshima, Y; Niiro, H; Akashi, K; Kono, T; Ishibashi, T				Ishikawa, Keijiro; Yoshida, Shigeo; Kobayashi, Yoshiyuki; Zhou, Yedi; Nakama, Takahito; Nakao, Shintaro; Sassa, Yukio; Oshima, Yuji; Niiro, Hiroaki; Akashi, Koichi; Kono, Toshihiro; Ishibashi, Tatsuro			Microarray Analysis of Gene Expression in Fibrovascular Membranes Excised From Patients With Proliferative Diabetic Retinopathy	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						proliferative vitreoretinal disease; microarray; fibrosis; angiogenesis; VEGF	OXYGEN-INDUCED RETINOPATHY; EXTRACELLULAR-MATRIX; VITREORETINAL DISEASES; EPIRETINAL MEMBRANES; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; RETINAL DISORDERS; GROWTH-FACTOR; MOUSE MODEL; TENASCIN-C	PURPOSE. We determined the profile of genes expressed in fibrovascular membranes (FVMs). METHODS. Six FVMs were surgically removed from patients with proliferative diabetic retinopathy (PDR) during pars plana vitrectomy with membrane peeling. The FVMs were classified into three active FVMs or three inactive FVMs according to the presence or absence of neovascularization (NV) in the membranes. Total RNA was isolated from the six FVMs and also from three normal human retinas. The DNA microarray analysis was performed to compare the genes expressed in the FVMs to those in normal human retinas, and also between active and inactive FVMs. Ingenuity pathway analysis (IPA) was used to determine the key biological networks related to the genes that were significantly altered. Quantitative RT-PCR and immunohistochemistry were performed to validate the microarray analyses. RESULTS. There were 87 genes expressed at significantly higher levels in FVMs than in normal human retinas. Functional classification of these genes showed that the most clustered genes were those related to extracellular matrix formation. The top biological network generated by the IPA was cellular assembly and organization involving nodes of genes related to extracellular matrix formation. These networks included the collagen family and matricellular proteins, THBS2, POSTN, and TNC. There were 91 genes significantly upregulated in active FVMs, and the most clustered functional category was angiogenesis. In contrast, 89 genes were significantly upregulated in inactive FVMs, and the most clustered functional category was metabolism. The IPA revealed that the top biological network related to the genes that were significantly altered in this comparison was cell-to-cell signaling, and interactions involving the PDGF and TGF beta families. The results of quantitative RT-PCR analyses and immunohistochemistry for several selected molecules were in good agreement with the microarray data. CONCLUSIONS. Our data indicate that extracellular matrix-related molecules such as POSTN, TNC, TGF beta, and angiogenic factors have important roles in promoting the development of FVMs associated with PDR.	[Ishikawa, Keijiro; Yoshida, Shigeo; Kobayashi, Yoshiyuki; Zhou, Yedi; Nakama, Takahito; Nakao, Shintaro; Sassa, Yukio; Oshima, Yuji; Ishibashi, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 8128582, Japan; [Sassa, Yukio; Kono, Toshihiro] Fukuoka Univ, Chikushi Hosp, Chikushino, Japan; [Niiro, Hiroaki; Akashi, Koichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan	Yoshida, S (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 8128582, Japan.	yosida@med.kyushu-u.ac.jp			Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad; JSPS KAKENHI [24249083, 26293374, 26670757]; Takeda Science Foundation	Supported by a fellowship from The Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad (KI), and in part by JSPS KAKENHI Grants 24249083 26293374, 26670757, and Takeda Science Foundation.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Ishikawa K, 2012, LAB INVEST, V92, P91, DOI 10.1038/labinvest.2011.141; Pennock S, 2014, PROG RETIN EYE RES, V40, P16, DOI 10.1016/j.preteyeres.2013.12.006; Buehler A, 2013, FEBS LETT, V587, P1650, DOI 10.1016/j.febslet.2013.04.008; Kasai A, 2010, ARTERIOSCL THROM VAS, V30, P2182, DOI 10.1161/ATVBAHA.110.209775; Ryu JM, 2010, J CELL PHYSIOL, V224, P59, DOI [10.1002/jcp.22091, 10.1002/jcp.2209]; Snead DRJ, 2008, EYE, V22, P1310, DOI 10.1038/eye.2008.36; Kannan R, 2012, PROG RETIN EYE RES, V31, P576, DOI 10.1016/j.preteyeres.2012.06.001; Wei YH, 2013, P NATL ACAD SCI USA, V110, pE3910, DOI 10.1073/pnas.1309276110; Kita T, 2008, P NATL ACAD SCI USA, V105, P17504, DOI 10.1073/pnas.0804054105; Yamaji Y, 2008, INVEST OPHTH VIS SCI, V49, P3151, DOI 10.1167/iovs.07-1249; Ishikawa K, 2010, INVEST OPHTH VIS SCI, V51, P4307, DOI 10.1167/iovs.09-4605; Kita T, 2007, DIABETES, V56, P231, DOI 10.2337/db06-0581; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; Fort PE, 2011, EXP EYE RES, V92, P98, DOI 10.1016/j.exer.2010.11.008; SCHRODER S, 1991, AM J PATHOL, V139, P81; Gravdal K, 2009, CANCER RES, V69, P4708, DOI 10.1158/0008-5472.CAN-08-4417; Nicholson BP, 2010, GRAEF ARCH CLIN EXP, V248, P915, DOI 10.1007/s00417-010-1315-z; Gu CH, 2013, EXP CELL RES, V319, P1306, DOI 10.1016/j.yexcr.2013.02.003; Zhang B, 2014, J CLIN INVEST, V124, P209, DOI 10.1172/JCI71090; Yu WZ, 2013, MOL VIS, V19, P1397; Ishikawa K, 2014, FASEB J, V28, P131, DOI 10.1096/fj.13-229740; Friedlander M, 2007, J CLIN INVEST, V117, P576, DOI 10.1172/JCI31030; Imanaka-Yoshida K, 2012, CIRC J, V76, P2513, DOI 10.1253/circj.CJ-12-1033; Rocha SF, 2014, CIRC RES, V115, P581, DOI 10.1161/CIRCRESAHA.115.304718; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P275, DOI 10.1097/00006982-200603000-00004; Asato R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054191; Cina DP, 2011, AM J PHYSIOL-RENAL, V300, pF488, DOI 10.1152/ajprenal.00214.2010; Coma S, 2011, CELL ADHES MIGR, V5, P266, DOI 10.4161/cam.5.3.16294; Feng YX, 2009, CELL PHYSIOL BIOCHEM, V23, P277, DOI 10.1159/000218174; Gariano RF, 2006, GENE EXPR PATTERNS, V6, P187, DOI 10.1016/j.modgep.2005.06.008; George B, 2009, CURR EYE RES, V34, P134, DOI 10.1080/02713680802585946; Hiscott P, 2002, EYE, V16, P393, DOI 10.1038/sj.eye.6700196; HOSODA Y, 1993, OPHTHALMIC RES, V25, P289; Huang BH, 2011, BLOOD, V118, P2918, DOI 10.1182/blood-2011-03-341214; Ioachim E, 2005, EUR J OPHTHALMOL, V15, P384; Jacot JL, 2011, J OPHTHALMOL, DOI 10.1155/2011/589813; Jorge R, 2003, CURR EYE RES, V26, P107; Link Jenny C, 2013, Adipocyte, V2, P74, DOI 10.4161/adip.23320; Moon SW, 2009, BIOCHEM BIOPH RES CO, V388, P167, DOI 10.1016/j.bbrc.2009.07.144; Nakama T, 2015, GENE THER, V22, P127, DOI 10.1038/gt.2014.112; Nakao S, 2013, RETINA-J RET VIT DIS, V33, P957, DOI 10.1097/IAE.0b013e3182753b41; Pasupuleti N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.3; SCHEIFFARTH OF, 1988, GRAEF ARCH CLIN EXP, V226, P357, DOI 10.1007/BF02172967; Tran AT, 2010, OPHTHAL SURG LAS IM, V41, DOI [10.3928/15428877-20100625-06, DOI 10.3928/15428877-20100625-06]; Veschini L, 2011, FASEB J, V25, P3906, DOI 10.1096/fj.11-182410; Yoshida S, 2011, INVEST OPHTH VIS SCI, V52, P5670, DOI 10.1167/iovs.10-6625; Yoshida S, 2009, BR J OPHTHALMOL, V94, P795; Zhang XY, 2005, CURR EYE RES, V30, P395, DOI 10.1080/02713680590956306	50	0	0	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	FEB	2015	56	2					932	946		10.1167/iovs.14-15589		15	Ophthalmology	Ophthalmology	CE9BC	WOS:000352137300029		
J	Sugita, S; Kamao, H; Iwasaki, Y; Okamoto, S; Hashiguchi, T; Iseki, K; Hayashi, N; Mandai, M; Takahashi, M				Sugita, Sunao; Kamao, Hiroyuki; Iwasaki, Yuko; Okamoto, Satoshi; Hashiguchi, Tomoyo; Iseki, Kyoko; Hayashi, Naoko; Mandai, Michiko; Takahashi, Masayo			Inhibition of T-Cell Activation by Retinal Pigment Epithelial Cells Derived From Induced Pluripotent Stem Cells	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						cytokine; PS cells; TGF beta	GROWTH-FACTOR-BETA; IMMUNE PRIVILEGE; REGULATORY CELLS; INFLAMMATORY CONDITIONS; IPS CELLS; SUPPRESSION; CTLA-2-ALPHA; EXPRESS; EYE	PURPOSE. The purpose of this study was to determine whether human retinal pigment epithelial (RPE) cells from induced pluripotent stem (iPS) cells could inhibit T-cell activation in vitro. METHODS. Cultured iPS-derived RPE (iPS-RPE) cells were established from fresh skin tissues or dental pulp cells obtained from healthy donors or a retinal patient after informed consent was obtained. To confirm expression of the specific markers on iPS and iPS-RPE cells, immunohistochemistry, quantitative RT-PCR (qRT-PCR), and flow cytometry were performed. Target T cells were obtained from peripheral blood mononuclear cells of healthy donors. Target T cells were assessed for proliferation by incorporation of bromodeoxyuridine or carboxyfluorescein succinimidyl ester for production of cytokines such as IFN-alpha. Expression of TGFb beta and other candidate molecules by iPS-RPE cells was evaluated with flow cytometry, ELISA, multiplex cytokine array, immunohistochemistry, and qRT-PCR. RESULTS. The RPE cells we established from iPS cells had many characteristics of mature RPE cells but no characteristics of pluripotent stem cells. Cultured iPS-RPE cells inhibited cell proliferation and production of IFN-alpha by activated CD4(+) T cells. In some bystander T cells, iPS-derived RPE cells induced CD25(+)Foxp3(+) regulatory T cells in vitro. Induced pluripotent stem-RPE cells constitutively expressed TGF beta and suppressed activation of T cells via soluble TGF beta, because TGF beta-downregulated iPS-RPE cells did not inhibit this T-cell activation. CONCLUSIONS. Cultured iPS-derived retinal cells fully suppress T-cell activation. Transplantation of iPS-RPE cells into the eye might be a therapy for retinal disorders.	[Sugita, Sunao; Kamao, Hiroyuki; Iwasaki, Yuko; Okamoto, Satoshi; Hashiguchi, Tomoyo; Iseki, Kyoko; Hayashi, Naoko; Mandai, Michiko; Takahashi, Masayo] RIKEN, Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo 6500047, Japan; [Okamoto, Satoshi] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan	Sugita, S (reprint author), RIKEN, Ctr Dev Biol, Lab Retinal Regenerat, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	sunaoph@cdb.riken.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25293357]; Project for Realization of Regenerative Medicine from the MEXT; Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder	Supported by Scientific Research Grant B, 25293357 from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a grant from the Project for Realization of Regenerative Medicine from the MEXT; and the Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder.	Algvere PV, 1997, ACTA OPHTHALMOL SCAN, V75, P1; LIVERSIDGE J, 1994, IMMUNOLOGY, V83, P404; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Sugita S, 2009, J IMMUNOL, V183, P5013, DOI 10.4049/jimmunol.0901623; Sugita S, 2008, J IMMUNOL, V181, P7525; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Sugita S, 2009, INVEST OPHTH VIS SCI, V50, P2862, DOI 10.1167/iovs.08-2846; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; PEYMAN GA, 1991, OPHTHALMIC SURG LAS, V22, P102; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; Sugita S, 2006, J IMMUNOL, V176, P118; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1172482; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Niederkorn JY, 2002, CRIT REV IMMUNOL, V22, P13; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Horie S, 2010, CLIN IMMUNOL, V136, P83, DOI 10.1016/j.clim.2010.03.001; Kawazoe Y, 2012, EXP EYE RES, V94, P32, DOI 10.1016/j.exer.2011.11.002; Berglin L, 1997, GRAEF ARCH CLIN EXP, V235, P103, DOI 10.1007/BF00941738; COUSINS SW, 1991, INVEST OPHTH VIS SCI, V32, P2201; Futagami Y, 2007, J IMMUNOL, V178, P6994; Grisanti S, 1997, INVEST OPHTH VIS SCI, V38, P1619; Joe AW, 2010, CURR EYE RES, V35, P941, DOI 10.3109/02713683.2010.516466; Sugita S, 2013, INVEST OPHTH VIS SCI, V54, P3240, DOI 10.1167/iovs.12-11483; Sugita S, 2006, EXP EYE RES, V83, P1459, DOI 10.1016/j.exer.2006.08.005; Sugita S, 2009, ARCH IMMUNOL THER EX, V57, P263, DOI 10.1007/s00005-009-0030-0; Sugita S, 2004, J IMMUNOL, V172, P4184; Wallace CA, 2013, INVEST OPHTH VIS SCI, V54, P722, DOI 10.1167/iovs.12-10602; Weisz JM, 1999, RETINA-J RET VIT DIS, V19, P540, DOI 10.1097/00006982-199911000-00011; Wenkel H, 1999, INVEST OPHTH VIS SCI, V40, P3202; Zamiri Parisa, 2007, Chem Immunol Allergy, V92, P86	32	1	1	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	FEB	2015	56	2					1051	1062		10.1167/iovs.14-15619		12	Ophthalmology	Ophthalmology	CE9BC	WOS:000352137300042		
J	Noma, H; Mimura, T; Yasuda, K; Shimura, M				Noma, Hidetaka; Mimura, Tatsuya; Yasuda, Kanako; Shimura, Masahiko			Role of Soluble Vascular Endothelial Growth Factor Receptor Signaling and Other Factors or Cytokines in Central Retinal Vein Occlusion With Macular Edema	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						soluble vascular endothelial growth factor receptor; growth factor; inflammatory factor; central retinal vein occlusion; macular edema	INTRAVITREAL AFLIBERCEPT INJECTION; ISCHEMIA-REPERFUSION INJURY; TYROSINE KINASE; MONOCYTE ACTIVATION; NATURAL-HISTORY; FACTOR VEGF; EXPRESSION; FLT-1; ANGIOGENESIS; RANIBIZUMAB	PURPOSE. The association between aqueous humor levels of various growth/inflammatory factors or cytokines and the severity of macular edema was investigated in patients with central retinal vein occlusion (CRVO). METHODS. Aqueous humor levels of 11 factors or cytokines were measured in CRVO patients with macular edema (n = 38) and in cataract patients (n = 15) as controls. Aqueous humor samples were obtained from the patients during surgery and the levels of VEGF, its receptors, and other factors or cytokines were measured by the suspension array method. The severity of macular edema was determined by measuring the central macular thickness, neurosensory retinal thickness, and subfoveal serous retinal thickness with optical coherence tomography. RESULTS. Aqueous humor levels of growth factors, soluble VEGF receptor 1 (sVEGFR-1), sVEGFR-2, and inflammatory factors or cytokines were significantly higher in the CRVO group than in the control group. The aqueous level of sVEGFR-1 was significantly correlated with the neurosensory retinal thickness, as well as with the levels of growth factors (VEGF, placental growth factor, and platelet-derived growth factor-AA) and inflammatory factors/cytokines (monocyte chemotactic protein-1, interleukin-6, and interleukin-8). Aqueous humor levels of the three growth factors also were significantly correlated with each other, as were levels of the two sVEGFRs. CONCLUSIONS. These findings suggest that growth/inflammatory factors and cytokines have an important role in macular edema associatedwith CRVO. Better understanding of the mechanisms involved may lead to development of new treatments, such as anti-VEGFR-1 therapy.	[Noma, Hidetaka; Yasuda, Kanako; Shimura, Masahiko] Tokyo Med Univ, Dept Ophthalmol, Hachioji Med Ctr, Hachioji, Tokyo 1930998, Japan; [Mimura, Tatsuya] Tokyo Womens Med Univ, Med Ctr East, Dept Ophthalmol, Tokyo, Japan	Noma, H (reprint author), Tokyo Med Univ, Dept Ophthalmol, Hachioji Med Ctr, 1163 Tatemachi, Hachioji, Tokyo 1930998, Japan.	noma-hide@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors alone are responsible for the content and writing of the paper.	Ach T, 2010, GRAEF ARCH CLIN EXP, V248, P155, DOI 10.1007/s00417-009-1167-6; Selvaraj SK, 2003, BLOOD, V102, P1515, DOI 10.1182/blood-2002-11-3423; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Ebos JML, 2008, CANCER RES, V68, P521, DOI 10.1158/0008-5472.CAN-07-3217; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Noma H, 2009, OPHTHALMOLOGY, V116, P87, DOI 10.1016/j.ophtha.2008.09.034; Korobelnik JF, 2014, OPHTHALMOLOGY, V121, P202, DOI 10.1016/j.ophtha.2013.08.012; Campochiaro PA, 2008, MOL THER, V16, P791, DOI 10.1038/mt.2008.10; Brown DM, 2013, AM J OPHTHALMOL, V155, P429, DOI 10.1016/j.ajo.2012.09.026; CLARKSON JG, 1995, OPHTHALMOLOGY, V102, P1425; Kiba A, 2003, BIOCHEM BIOPH RES CO, V301, P371, DOI 10.1016/S0006-291X(02)03033-4; Campochiaro PA, 2011, OPHTHALMOLOGY, V118, P2041, DOI 10.1016/j.ophtha.2011.02.038; Noma H, 2014, INVEST OPHTH VIS SCI, V55, P3878, DOI 10.1167/iovs.14-13961; Ebos JML, 2004, MOL CANCER RES, V2, P315; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Barleon B, 1996, BLOOD, V87, P3336; Funk M, 2009, INVEST OPHTH VIS SCI, V50, P1025, DOI 10.1167/iovs.08-2510; Jo N, 2003, INVEST OPHTH VIS SCI, V44, P4054, DOI 10.1167/iovs.02-1308; De Falco S, 2002, TRENDS CARDIOVAS MED, V12, P241, DOI 10.1016/S1050-1738(02)00168-8; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Murakami M, 2006, BLOOD, V108, P1849, DOI 10.1182/blood-2006-04-016030; Rosenfeld PJ, 2005, OPHTHAL SURG LAS IM, V36, P336; Bottomley MJ, 2000, CLIN EXP IMMUNOL, V119, P182, DOI 10.1046/j.1365-2249.2000.01097.x; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Murakami M, 2008, ARTERIOSCL THROM VAS, V28, P658, DOI 10.1161/ATVBAHA.107.150433; Mallamaci F, 2008, J HYPERTENS, V26, P1875, DOI 10.1097/HJH.0b013e328307c3d2; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; SHIBUYA M, 1990, ONCOGENE, V5, P519; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Clauss M, 1996, J BIOL CHEM, V271, P17629; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Clarkson JC, 1997, ARCH OPHTHALMOL-CHIC, V115, P486; CLARKSON JG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1087; Hornig C, 2000, LAB INVEST, V80, P443; Hossain MZ, 1998, J CELL PHYSIOL, V174, P66; Kernt M, 2012, GROWTH FACTORS, V30, P49, DOI 10.3109/08977194.2011.639300; Kernt M, 2012, RETINA-J RET VIT DIS, V32, P1652, DOI 10.1097/IAE.0b013e318240a558; Kraiss LW, 1996, CIRC RES, V79, P45; Luo L, 2013, ELIFE, V2, DOI 10.7554/eLife.00324; Noma H, 2014, RETINA-J RET VIT DIS, V34, P352, DOI 10.1097/IAE.0b013e3182993d74; Tsujikawa A, 1998, INVEST OPHTH VIS SCI, V39, P793; Yoshimura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008158	45	1	1	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	FEB	2015	56	2					1122	1128		10.1167/iovs.14-15789		7	Ophthalmology	Ophthalmology	CE9BC	WOS:000352137300054		
J	Iwata, T				Iwata, Takeshi			Author Response: Postnatal Overexpression of the Human ARMS2 Gene Does Not Induce Abnormalities in Retina and Choroid in Transgenic Mouse Models	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Letter									Natl Hosp Org Tokyo Med Ctr, Natl Insitute Sensory Organs, Meguro Ku, Tokyo, Japan	Iwata, T (reprint author), Natl Hosp Org Tokyo Med Ctr, Natl Insitute Sensory Organs, Meguro Ku, Tokyo, Japan.	takeshi_iwata@kankakuki.go.jp					Liu J, 2015, INVEST OPHTH VIS SCI, V56, P1387, DOI 10.1167/iovs.14-15914; Nakayama M, 2014, INVEST OPHTH VIS SCI, V55, P6514, DOI 10.1167/iovs.14-14453	2	0	0	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	FEB	2015	56	2					1389	1389		10.1167/iovs.14-16174		1	Ophthalmology	Ophthalmology	CE9BC	WOS:000352137300086		
J	Lin, M; Itoh, M; Maruyama, I				Lin, Mao; Itoh, Mitsuki; Maruyama, Ippei			Mechanism of Change in Splitting Tensile Strength of Concrete during Heating or Drying up to 90 degrees C	JOURNAL OF ADVANCED CONCRETE TECHNOLOGY			English	Article								Changes in temperature and relative humidity affect splitting tensile strength of concrete but the mechanisms are left unknown. This study aimed to clarify the mechanism through experiments using control mortar specimen and concrete specimens with two types of coarse aggregate of different shrinkage behavior mixed with the control mortar. Specimens were shaped in a thin plate for a faster equilibrium with the ambient drying conditions. Dying of different temperatures or relative humidities were maintained till the mass of specimens become constant. Then length changes, mass changes and splitting tensile strength were determined. It was shown that changes in strength of control mortar became more significant as drying conditions became severer while the change was not always monotonic. Compared with existing studies on shrinkage of cement pastes, the shrinkage of mortar specimens was supposed to be affected by the changes in strength of cement paste and by increase in strength as a result of multiple crack formation that occur due to fine aggregates. Changes in strength of concretes were affected by the change in mortar strength particularly at a relative humidity ranging from 0.80 to 0.43, where effects of fine cracks due to restraint of aggregate were imposed and strength reduction became more significant when coarse aggregate with a lower shrinkage was used. The restraining effect of coarse aggregate was confirmed also during heating higher than 40 degrees C resulting in reduction of strength. It was concluded that the changes in strength of concrete during drying were mainly affected by both changes in mortar strength and restraint of coarse aggregate.	[Lin, Mao; Itoh, Mitsuki; Maruyama, Ippei] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Maruyama, I (reprint author), Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, ES Bldg 546,Furo Cho, Nagoya, Aichi 4648603, Japan.	ippei@dali.nuac.nagoya-u.ac.jp			Nuclear Regulation Authority (NRA, Japan); NRA	This research was supported by the Nuclear Regulation Authority (NRA, Japan). We thank the NRA for their sponsorship. The information presented in this paper is the sole opinion of the authors and does not necessarily reflect the views of the sponsoring agencies.	Fujiwara T, 2008, J ADV CONCR TECHNOL, V6, P31, DOI 10.3151/jact.6.31; Maruyama I, 2014, CEMENT CONCRETE RES, V58, P20, DOI 10.1016/j.cemconres.2014.01.007; Maruyama I, 2014, J ADV CONCR TECHNOL, V12, P279, DOI 10.3151/jact.12.279; BAZANT ZP, 1984, J ENG MECH-ASCE, V110, P518; Comite Euro-International du Beton, 1993, CEB FIP MOD COD 90; Hansen J. A., 1968, J ACI, V65, P535; Hasegawa T., 1985, P JAP CONCR I 7 C JU, P309; Japanese Concrete Institute, 2008, GUID CONTR CRACK MAS; Kanda T., 2007, J STRUCTURAL CONSTRU, P15; Kishitani K., 1982, J ADV CONCR TECHNOL, V57, P317; Maruyama I, 2014, CEMENT CONCRETE RES, V66, P48, DOI 10.1016/j.cemconres.2014.07.016; Naus D. J., 2010, NUREGCR7031 US NRC; Tanaka Y., 2008, P JAPAN CONCRETE I, V30, P49; Tanigawa Y., 1977, T ARCHITECTURAL I JA, P13	14	0	0	JAPAN CONCRETE INST	CHIYODA-KU	SOGO HANZOMON BLDG 12F, NO 7, KOJIMACHI 1-CHOME, CHIYODA-KU, TOKYO 102-0083, JAPAN	1346-8014	1347-3913		J ADV CONCR TECHNOL	J. Adv. Concr. Technol.	FEB	2015	13	2					94	102		10.3151/jact.13.94		9	Construction & Building Technology; Engineering, Civil; Materials Science, Multidisciplinary	Construction & Building Technology; Engineering; Materials Science	CF5EA	WOS:000352577600004		
J	Kuratani, N				Kuratani, Norifumi			The cutting edge of neonatal anesthesia: the tide of history is changing	JOURNAL OF ANESTHESIA			English	Editorial Material							REMIFENTANIL; SURGERY; BRAIN		Saitama Childrens Med Ctr, Dept Anesthesia, Saitama 3398551, Japan	Kuratani, N (reprint author), Saitama Childrens Med Ctr, Dept Anesthesia, 2100 Magome, Saitama 3398551, Japan.	nori-kuratani@umin.ac.jp					Ross AK, 2001, ANESTH ANALG, V93, P1393, DOI 10.1097/00000539-200112000-00008; Taddio A, 1997, LANCET, V349, P599, DOI 10.1016/S0140-6736(96)10316-0; [Anonymous], 1987, LANCET; Rizzi S, 2010, ANN NY ACAD SCI, V1199, P43, DOI 10.1111/j.1749-6632.2009.05173.x; Gruber EM, 2001, ANESTH ANALG, V92, P882; Hagen EW, 2008, PEDIATRICS, V122, pE583, DOI 10.1542/peds.2008-1016; Penido MG, 2010, ACTA PAEDIATR, V99, P1454, DOI 10.1111/j.1651-2227.2010.01868.x; Yu DS, 2013, J ANESTH, V27, P750, DOI 10.1007/s00540-013-1609-5	8	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	FEB	2015	29	1					1	3		10.1007/s00540-014-1817-7		3	Anesthesiology	Anesthesiology	CE8QW	WOS:000352110100001		
J	Kajiura, A; Nagata, O; Takizawa, Y; Nakatomi, T; Kodera, S; Murayama, T				Kajiura, Akira; Nagata, Osamu; Takizawa, Yutaka; Nakatomi, Takeshi; Kodera, Shiho; Murayama, Takanori			A large individual variation in both the infusion rate and the blood concentration of rocuronium necessary for obtain adequate surgical muscle relaxation during total intravenous anesthesia with propofol and remifentanil	JOURNAL OF ANESTHESIA			English	Article						Rocuronium; Continuous infusion; Pharmacodynamics; Propofol; Laparoscopic surgery	PHARMACOKINETICS; HALOTHANE	Background Rocuronium (Rb) is ideal for continuous infusion but has a widely variable duration of action. We investigated the distribution of Rb infusion in a steady state of optimal muscle relaxation and the relationship between the measured and predicted blood Rb concentrations in laparoscopic surgery. Methods Seventeen patients were anesthetized with propofol. Continuous Rb infusion was commenced at 7.5 mu g/kg/min from 15 min after an initial Rb injection (0.6 mu g/kg) and adjusted every 15 min to keep T1 within 3-10 %. Blood concentration was measured at the first onset of steady state, predicted concentration was calculated pharmacokinetically, and 25 % recovery time was measured. The distribution of the predicted concentration and infusion rate was plotted by histogram, the median value and 95th percentile were calculated, and the relationship between measured and predicted concentrations was analyzed by regression analysis. Results The rate during the stable state was 7.3 +/- 2.1 mu g/kg/min on average, 4 at minimum, 12 at maximum, and 12 at the 95th percentile. The predicted concentration was 1.7 +/- 0.5 mu g/ml on average, 0.8 at minimum, and 2.9 at maximum. The mean measured concentration was 1.4 +/- 0.4 mu g/ml. The predicted concentration was proportional to the measured concentration (y = 0.91x, r = 0.475; p < 0.001). A significant linear relationship was observed between the measured concentration and infusion rate (y = 0.64 + 0.11x, r = 0.618; p < 0.05). Conclusion The measured blood concentration of Rb was comparable to the predicted value. Anesthesiologists can avoid overdose and attain a reliable muscle relaxant effect by maintaining a continuous dose by titration according to individual differences under muscle relaxant monitoring.	[Kajiura, Akira; Takizawa, Yutaka; Nakatomi, Takeshi; Kodera, Shiho; Murayama, Takanori] Jichi Med Univ, Saitama Med Ctr, Dept Anesthesiol & Crit Care Med, Oomiya Ku, Saitama 3308503, Japan; [Nagata, Osamu] Japanese Fdn Canc Res, Canc Inst Hosp, Div Med Safety Management, Tokyo 1358550, Japan	Kajiura, A (reprint author), Jichi Med Univ, Saitama Med Ctr, Dept Anesthesiol & Crit Care Med, Oomiya Ku, 1-847 Amanuma Cho, Saitama 3308503, Japan.	akiracch1224@yahoo.co.jp					[Anonymous], ESLAX PACK INS; MAGORIAN T, 1993, ANESTHESIOLOGY, V79, P913, DOI 10.1097/00000542-199311000-00007; WIERDA JMKH, 1991, CAN J ANAESTH, V38, P430; [Anonymous], ZEMURON PACK INS; Ito Sachiko, 2010, Masui, V59, P82; McCoy EP, 1996, BRIT J ANAESTH, V76, P29; Takagi Syunichi, 2006, Masui, V55, P963	7	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	FEB	2015	29	1					9	14		10.1007/s00540-014-1879-6		6	Anesthesiology	Anesthesiology	CE8QW	WOS:000352110100003		
J	Saito, J; Kitayama, M; Oishi, M; Kudo, T; Sawada, M; Hashimoto, H; Hirota, K				Saito, Junichi; Kitayama, Masato; Oishi, Masafumi; Kudo, Tomoyuki; Sawada, Masahiro; Hashimoto, Hiroshi; Hirota, Kazuyoshi			The accuracy of non-invasively continuous total hemoglobin measurement by pulse CO-Oximetry undergoing acute normovolemic hemodilution and reinfusion of autologous blood	JOURNAL OF ANESTHESIA			English	Article						Hemoglobin; Hemodilution; Autologous blood transfusion	SPINE SURGERY; MICROCIRCULATION; RHEOLOGY	Background Non-invasively continuous total hemoglobin (SpHb) measurement has not been assessed adequately in acute bleeding and rapid blood transfusion during surgery. Thus, we have assessed the efficacy of SpHb during both acute normovolemic hemodilution (ANH) and autologous blood transfusion (ABT). Methods Twenty-four patients undergoing urological and gynecological surgery were enrolled. ANH was induced by withdrawing blood of 800 g with simultaneous fluid administration. When surgical hemostasis was completed, collected blood was reinfused. Measurement of SpHb, perfusion index (PI) and real total Hb (tHb) were done before and after each 400 ml blood removal (-0, -400, -800 ml) and reinfusion (+0, +400, +800 ml). Results A Bland-Altman analysis for repeated measurements showed a bias (precision) g/dl of 1.12 (1.25), 1.43 (1.24) and 1.10 (1.23) for all data, during ANH and during ABT, respectively. Additionally, a bias (precision) increased with a reduction in tHb (g/dl): >= 10.0; 0.74 (1.30), 8.0-10.0; 1.15 (1.12) and <8.0; 1.60 (1.28). Although the difference between SpHb and tHb was almost zero before anesthesia induction, it became significant just before ANH and did not change further by ANH and ABT. Significant correlations between SpHb and tHb for all data (r = 0.75, n = 228, p < 0.001) were observed. PI slightly correlated with the difference between SpHb and tHb (r = 0.38, n = 216, p < 0.001). Furthermore, before and after induction of anesthesia, PI also correlated with the difference between SpHb and tHb (r = 0.42, n = 23, p = 0.048 and r = 0.51, n = 22, p = 0.016, respectively). Conclusions The present data suggest that SpHb may overestimate tHb during ANH and ABT. In addition, PI and tHb levels had an impact on the accuracy of SpHb measurements.	[Saito, Junichi; Kitayama, Masato; Oishi, Masafumi; Kudo, Tomoyuki; Sawada, Masahiro; Hirota, Kazuyoshi] Hirosaki Univ, Grad Sch Med, Dept Anesthesiol, Hirosaki, Aomori 0368562, Japan; [Hashimoto, Hiroshi] Hirosaki Univ Hosp, Div Surg Ctr, Hirosaki, Aomori, Japan	Saito, J (reprint author), Hirosaki Univ, Grad Sch Med, Dept Anesthesiol, Hirosaki, Aomori 0368562, Japan.	fix-you@hotmail.co.jp; masuika@cc.hirosaki-u.ac.jp; Skdjg633@yahoo.co.jp; kudotomoyuki@yahoo.co.jp; daoyandz@yahoo.co.jp; hasimoto@cc.hirosaki-u.ac.jp; hirotak@cc.hirosaki-u.ac.jp	Saito, Junichi/F-4678-2015		Department of Anaesthesiology, Hirosaki University Graduate School of Medicine	The authors are grateful to Professor Paul Hollister (Medical English Center, Hirosaki University Graduate School of Medicine, Hirosaki, Japan) for his useful suggestions. This work was supported by the Department of Anaesthesiology, Hirosaki University Graduate School of Medicine.	Matot I, 2002, ANESTHESIOLOGY, V97, P794, DOI 10.1097/00000542-200210000-00008; Nguyen BV, 2011, ANESTH ANALG, V113, P1052, DOI 10.1213/ANE.0b013e31822c9679; Ginosar Y, 2009, ACTA ANAESTH SCAND, V53, P1018, DOI 10.1111/j.1399-6576.2009.01968.x; Butwick A, 2012, BRIT J ANAESTH, V108, P271, DOI 10.1093/bja/aer373; Lamhaut L, 2011, ANESTHESIOLOGY, V115, P548, DOI 10.1097/ALN.0b013e3182270c22; Pries AR, 2003, CLIN HEMORHEOL MICRO, V29, P143; Naftalovich R, 2011, MED HYPOTHESES, V77, P665, DOI 10.1016/j.mehy.2011.07.010; Miller RD, 2011, ANESTH ANALG, V112, P858, DOI 10.1213/ANE.0b013e31820eecd1; Sebastiani A, 2012, CAN J ANESTH, V59, P1095, DOI 10.1007/s12630-012-9796-3; Maeda N, 1996, JPN J PHYSIOL, V46, P1, DOI 10.2170/jjphysiol.46.1; Berkow L, 2011, ANESTH ANALG, V113, P1396, DOI 10.1213/ANE.0b013e318230b425; Frasca D, 2011, CRIT CARE MED, V39, P2277, DOI 10.1097/CCM.0b013e3182227e2d; Macknet MR, 2010, ANESTH ANALG, V111, P1424, DOI 10.1213/ANE.0b013e3181fc74b9; Casati V, 2004, ANESTH ANALG, V98, P1217, DOI 10.1213/01.ANE.0000113238.35409.FE; Causey Marlin Wayne, 2011, Am J Surg, V201, P592, DOI 10.1016/j.amjsurg.2011.01.020; Oriani G, 2011, TRANSFUS APHER SCI, V45, P269, DOI 10.1016/j.transci.2011.10.006; Terai A, 2005, UROLOGY, V65, P1152, DOI 10.1016/j.urology.2004.12.034; Vos JJ, 2012, BRIT J ANAESTH, V109, P522, DOI 10.1093/bja/aes234	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	FEB	2015	29	1					29	34		10.1007/s00540-014-1863-1		6	Anesthesiology	Anesthesiology	CE8QW	WOS:000352110100006		
J	Toyoda, D; Fukuda, M; Iwasaki, R; Terada, T; Sato, N; Ochiai, R; Kotake, Y				Toyoda, Daisuke; Fukuda, Mitsue; Iwasaki, Ririko; Terada, Takashi; Sato, Nobukazu; Ochiai, Ryoichi; Kotake, Yoshifumi			The comparison between stroke volume variation and filling pressure as an estimate of right ventricular preload in patients undergoing renal transplantation	JOURNAL OF ANESTHESIA			English	Article						Preload responsiveness; Dynamic parameter; Static parameter; Right ventricular end-diastolic volume; Renal transplantation	MECHANICALLY VENTILATED PATIENTS; CENTRAL VENOUS-PRESSURE; END-DIASTOLIC VOLUME; OF-THE-LITERATURE; FLUID RESPONSIVENESS; LIVER-TRANSPLANTATION; ARTERIAL-PRESSURE; CARDIAC PRELOAD; HEMODYNAMIC-RESPONSE; TRAUMA PATIENTS	Purpose The purpose of this prospective, observational study was to respiratory variation of stroke volume (stroke volume variation, SVV) against central venous pressure (CVP) and pulmonary artery diastolic pressure (PADP) as an estimate of right and left ventricular preload. Methods With IRB approval and informed consent, 31 patients undergoing living related renal transplantation were analyzed. Under general anesthesia with positive pressure ventilation, stroke volume index and SVV were continuously monitored with FloTrac/Vigileo monitor. Right ventricular end-diastolic volume index (RVEDVI) as well as CVP and PADP were continuously monitored with volumetric pulmonary artery catheter. Data of every 30 min interval were used for analysis. The relationship between RVEDVI and CVP, PADP, SVV was analyzed with non-linear regression and the goodness-of-fit was assessed with coefficient of determination (R-2) of each regression curve. The ability of CVP, PADP and SVV to correctly differentiate RVEDVI <100, <120 or >138 ml/m(2), which were used to guide fluid administration, was also assessed with ROC analysis. Results Three hundred forty-eight data sets were obtained and analyzed. The goodness of fit between RVEDVI and SVV (R-2 = 0.48) was better than that between RVEDVI and CVP or PADP (R-2 = 0.19 and 0.33, respectively). The area under the ROC curve of SVV was significantly high compared to CVP or PADP. Conclusions This study confirmed the theoretical framework of right ventricular preload and ventricular filling pressure and respiratory variation of stroke volume. The result also suggests that SVV can correctly predict preload status compared to pressure-based indices.	[Toyoda, Daisuke; Kotake, Yoshifumi] Toho Univ, Ohashi Med Ctr, Dept Anesthesiol, Meguro Ku, Tokyo 1538515, Japan; [Fukuda, Mitsue; Iwasaki, Ririko; Terada, Takashi; Sato, Nobukazu; Ochiai, Ryoichi] Toho Univ, Omori Med Ctr, Dept Anesthesiol, Tokyo 1538515, Japan	Kotake, Y (reprint author), Toho Univ, Ohashi Med Ctr, Dept Anesthesiol, Meguro Ku, 2-17-6 Ohashi, Tokyo 1538515, Japan.	ykotake@med.toho-u.ac.jp			JSPS KAKENHI Grant [24592361]	This work is supported by JSPS KAKENHI Grant Number 24592361.	DIEBEL LN, 1992, ARCH SURG-CHICAGO, V127, P817; Michard F, 2002, CHEST, V121, P2000, DOI 10.1378/chest.121.6.2000; Forget P, 2010, ANESTH ANALG, V111, P910, DOI 10.1213/ANE.0b013e3181eb624f; De Simone R, 2005, EUR J CARDIO-THORAC, V27, P988, DOI 10.1016/j.ejcts.2005.01.022; Wagner JG, 1998, CHEST, V113, P1048, DOI 10.1378/chest.113.4.1048; Cannesson M, 2009, ANESTH ANALG, V108, P513, DOI 10.1213/ane.0b013e318192a36b; Marik PE, 2008, CHEST, V134, P172, DOI 10.1378/chest.07-2331; Biais M, 2008, BRIT J ANAESTH, V101, P761, DOI 10.1093/bja/aen277; Marik PE, 2009, CRIT CARE MED, V37, P2642, DOI 10.1097/CCM.0b013e3181a590da; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Spahn DR, 2006, ANESTH ANALG, V102, P344, DOI 10.1213/01.ane.0000196511.48033.0b; Michard F, 2011, CRIT CARE MED, V39, P402, DOI 10.1097/CCM.0b013e318205c0a6; Zhang ZH, 2011, J ANESTH, V25, P904, DOI 10.1007/s00540-011-1217-1; Biancofiore G, 2011, ANESTH ANALG, V113, P515, DOI 10.1213/ANE.0b013e31822401b2; Taguchi H, 2011, J ANESTH, V25, P563, DOI 10.1007/s00540-011-1175-7; Kumar A, 2004, CRIT CARE MED, V32, P691, DOI 10.1097/01.CCM.0000114996.681110.C9; Osman D, 2007, CRIT CARE MED, V35, P64, DOI 10.1097/01.CCM.0000249851.94101.4F; Arinc H, 2005, AM J NEPHROL, V25, P256, DOI 10.1159/000086080; Biais M, 2012, ANESTHESIOLOGY, V116, P1354, DOI 10.1097/ALN.0b013e318256ee28; Chang MC, 1997, J TRAUMA, V42, P577, DOI 10.1097/00005373-199704000-00001; He ZY, 2011, J ANESTH, V25, P812, DOI 10.1007/s00540-011-1225-1; Hein M, 2009, CRIT CARE MED, V37, P2962, DOI 10.1097/CCM.0b013e3181b027a5; Kincaid EH, 2001, J TRAUMA, V50, P665, DOI 10.1097/00005373-200104000-00011; Michard F, 2005, ANESTHESIOLOGY, V103, P419, DOI 10.1097/00000542-200508000-00026; Miller PR, 1998, J TRAUMA, V44, P107, DOI 10.1097/00005373-199801000-00013; Paneni F, 2010, AM J NEPHROL, V32, P432, DOI 10.1159/000320755; Reuter DA, 2006, ANESTH ANALG, V102, P651, DOI 10.1213/01.ANE.0000190765.48530.5C; Spohr F, 2007, INTENS CARE MED, V33, P1805, DOI 10.1007/s00134-007-0703-2; Sprung J, 2000, Anesthesiol Clin North America, V18, P919, DOI 10.1016/S0889-8537(05)70202-9; Su BC, 2012, TRANSPL P, V44, P429, DOI 10.1016/j.transproceed.2011.12.037; Tsai YF, 2012, TRANSPL P, V44, P433, DOI 10.1016/j.transproceed.2011.12.045; Ytrebo LM, 2011, CRIT CARE MED, V39, P396, DOI 10.1097/CCM.0b013e318205c375; Zink W, 2004, ANAESTHESIA, V59, P1126, DOI 10.1111/j.1365-2044.2004.03876.x	33	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	FEB	2015	29	1					40	46		10.1007/s00540-014-1870-2		7	Anesthesiology	Anesthesiology	CE8QW	WOS:000352110100008		
J	Ajimi, J; Yoshikawa, M; Takahashi, S; Miura, M; Tsukamoto, H; Kawaguchi, M; Kobayashi, H; Suzuki, T				Ajimi, Junko; Yoshikawa, Masanobu; Takahashi, Shigeru; Miura, Masaaki; Tsukamoto, Hideo; Kawaguchi, Mitsuru; Kobayashi, Hiroyuki; Suzuki, Toshiyasu			Effect of three peptidase inhibitors on antinociceptive potential and toxicity with intracerebroventricular administration of dynorphin A (1-17) or (1-13) in the rat	JOURNAL OF ANESTHESIA			English	Article						Dynorphin A; Peptidase; Dynorphin-converting enzyme; Antinociception; Toxicity	KAPPA-OPIOID RECEPTOR; SPINAL-CORD; HEPTADECAPEPTIDE; PHOSPHORAMIDON; COMBINATION; HYDROLYSIS; PROTECTION; CONVERSION; AMASTATIN; CAPTOPRIL	Purpose The N- and C-terminal regions of dynorphin (Dyn) A (1-17) activate opioid and N-methyl-D-aspartate receptors, respectively. Earlier studies demonstrated that Dyn-converting enzyme cleaved Dyn A (1-17) mainly at the Arg(6)-Arg(7) bond, resulting in the production of N- and C-terminal region peptide fragments, and that this enzyme was not inhibited by a mixture of the three peptidase inhibitors (PIs) amastatin (A), captopril (C), and phosphoramidon (P). The purpose of the present study was to evaluate antinociceptive potential and toxicity with intracerebroventricular administration of Dyn A (1-17) or (1-13) under pretreatment with a mixture of A, C, and P and/or Dyn-converting enzyme inhibitor (p-hydroxymercuribenzoate). Methods Peptide fragments from Dyn A (1-17) following incubation with membrane preparation under pretreatment with a mixture of the three PIs was identified by matrix-assisted laser desorption ionization time-of-flight mass spectrometer (MALDI-TOF-MS). Infusion of drugs and peptides into the third ventricle in rats was performed via indwelling cannulae. Induction of antinociception and toxicity by Dyn A (1-17), Dyn A (1-13), Dyn A (1-6), or Dyn A (7-17) were determined by the tail-flick test and induction of barrel rotation, respectively. The effects of the PIs on antinociception and toxicity were evaluated by a dose-response study and a comparison of differences among various combinations of Dyn A (1-17) or Dyn A (1-13) and the three PIs and p-hydroxymercuribenzoate. Results MALDI-TOF-MS analysis identified Dyn A (1-6) and Dyn A (1-10) fragments as products following incubation of Dyn A (1-17) with membrane preparation of rat midbrain under pretreatment with a mixture of the three PIs. Pretreatment with a mixture of the three PIs produced an approximately 30-fold augmentation in antinociception induced by low-dose intracerebroventricular administration of Dyn A (1-17) or (1-13) in a mu-, delta- and kappa-opioid receptor antagonist-reversible manner, but without signs of toxicity such as barrel rotation in the rat. Dyn A (1-17)-induced antinociception and toxicity was greater than that of Dyn A (1-6), Dyn A (1-13), or Dyn A (7-17) at the same dose. Dyn A (1-17)-induced antinociception and toxicity under pretreatment with various combinations of the three PIs and p-hydroxymercuribenzoate was greater than that with a mixture of the three PIs alone. Conclusion These findings suggest that administration of a mixture of the three PIs increases Dyn A (1-17)-or (1-13)-induced antinociception under physiological conditions without toxicity.	[Ajimi, Junko; Miura, Masaaki; Suzuki, Toshiyasu] Tokai Univ, Sch Med, Dept Anesthesiol, Isehara, Kanagawa 2591193, Japan; [Yoshikawa, Masanobu; Takahashi, Shigeru; Kobayashi, Hiroyuki] Tokai Univ, Sch Med, Dept Clin Pharmacol, Isehara, Kanagawa 2591193, Japan; [Yoshikawa, Masanobu; Kawaguchi, Mitsuru] Tokyo Dent Coll, Dept Pharmacol, Chiyoda Ku, Tokyo 1010061, Japan; [Tsukamoto, Hideo] Tokai Univ, Sch Med, Educ & Res Support Ctr, Isehara, Kanagawa 2591193, Japan	Yoshikawa, M (reprint author), Tokai Univ, Sch Med, Dept Clin Pharmacol, Isehara, Kanagawa 2591193, Japan.	yoshikaw@is.icc.u-tokai.ac.jp					Akahori K, 2008, J PHARMACOL SCI, V106, P295, DOI 10.1254/jphs.FP0071318; GOLDSTEIN A, 1981, P NATL ACAD SCI-BIOL, V78, P7219, DOI 10.1073/pnas.78.11.7219; Magnusson K, 2007, PEPTIDES, V28, P851, DOI 10.1016/j.peptides.2006.12.011; CHAVKIN C, 1982, SCIENCE, V215, P413, DOI 10.1126/science.6120570; MANSOUR A, 1995, BRAIN RES, V700, P89, DOI 10.1016/0006-8993(95)00928-J; Pan ZZ, 1998, TRENDS PHARMACOL SCI, V19, P94, DOI 10.1016/S0165-6147(98)01169-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALMBERG AB, 1992, J PHARMACOL EXP THER, V263, P264; Yeomans DC, 1996, PAIN, V68, P141, DOI 10.1016/S0304-3959(96)03177-6; Bandler R, 1991, EMERGING PRINCIPLES; CHAVKIN C, 1981, P NATL ACAD SCI-BIOL, V78, P6543, DOI 10.1073/pnas.78.10.6543; Hauser KF, 2001, EXP NEUROL, V168, P78, DOI 10.1006/exnr.2000.7580; Hauser KF, 2005, FRONT BIOSCI, V10, P216, DOI 10.2741/1522; Hiranuma T, 1998, J PHARMACOL EXP THER, V286, P863; HIRANUMA T, 1986, JPN J PHARMACOL, V41, P437, DOI 10.1254/jjp.41.437; JANSSEN PAJ, 1963, ARZNEIMITTEL-FORSCH, V13, P502; KANEKO T, 1983, LIFE SCI, V33, P661, DOI 10.1016/0024-3205(83)90589-1; Kitamura K, 2000, N-S ARCH PHARMACOL, V361, P273, DOI 10.1007/s002109900182; Lu Y, 2004, ANESTH ANALG, V98, P414, DOI 10.1213/01.ANE.0000094334.12027.06; MARTINKA GP, 1991, EUR J PHARMACOL, V196, P161, DOI 10.1016/0014-2999(91)90423-N; Miura Masaaki, 2013, Tokai J Exp Clin Med, V38, P62; Morgan MM, 2006, J PAIN, V7, P358, DOI 10.1016/j.jpain.2005.12.009; Naqvi T, 1998, PEPTIDES, V19, P1277, DOI 10.1016/S0196-9781(98)00042-4; Oka T, 1986, NIDA Res Monogr, V75, P259; Paxinos G., 1986, RAT BRAIN STEREOTAXI; Reed B, 2003, J NEUROCHEM, V86, P815, DOI 10.1046/j.1471-4159.2003.01859.x; SILBERRING J, 1992, J BIOL CHEM, V267, P21324; Tan-No K, 2001, BRAIN RES, V891, P274, DOI 10.1016/S0006-8993(00)03225-X; Voorn P, 2007, NEUROSCI LETT, V415, P55, DOI 10.1016/j.neulet.2006.12.041; Walker EA, 2006, BRIT J PHARMACOL, V149, P1071, DOI 10.1038/sj.bjp.0706946; Xie H, 2008, ANESTH ANALG, V106, P1873, DOI 10.1213/ane.0b013e31817300be; Yeomans L, 2011, CHEM BIOL DRUG DES, V78, P749, DOI [10.1111/j.1747-0285.2011.01203.x, 10.1111/j.1747-0285.2011.01203]	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	FEB	2015	29	1					65	77		10.1007/s00540-014-1860-4		13	Anesthesiology	Anesthesiology	CE8QW	WOS:000352110100011		
J	Kawasaki, T; Kawasaki, C; Sata, T; Kobayashi, M; Suzuki, F				Kawasaki, Takashi; Kawasaki, Chika; Sata, Takeyoshi; Kobayashi, Makiko; Suzuki, Fujio			Depressed production of beta-defensins from mouse splenic dendritic cells following thermal injury and its influence on susceptibility to infection	JOURNAL OF ANESTHESIA			English	Article						Burn; Defensin; Dendritic cell; Infection; Innate immunity; Host defense	PSEUDOMONAS-AERUGINOSA; HUMAN BETA-DEFENSIN-2; ANTIMICROBIAL PEPTIDES; TISSUE EXPRESSION; HOST-RESISTANCE; MICE; INNATE; BACTEREMIA; MACROPHAGES; EPITHELIA	Purpose Beta-defensins (BDs) and dendritic cells (DC) have been described as major effectors on host antimicrobial innate immunities. In the present study, the ability of DC to produce BDs was explored using DC from normal mice and full-thickness (FT)-burned mice. Methods DCs were isolated from spleens of mice, and 1 x 10(6) cells/ml of them were cultured with LPS or SAC. Culture fluids harvested 24 h after cultivation were assayed for BD1 and BD3 and antibacterial activity (colony-counting, Pseudomonas aeruginosa). Also, DCs were tested for BD mRNAs by RT-PCR. Results Sixty-five percent of the bacterial killing activity was shown by the culture fluids of splenic DC from normal mice, while only 15 % killing activity was shown by the culture fluids of splenic DC from FT-burned mice. X-irradiated NOD SCID IL-2r gamma(null) mice inoculated with splenic DC from FT-burned mice showed increased susceptibility to P. aeruginosa infection compared to those from normal mice. Mice splenic DC expressed BD1 mRNA constitutively and expressed BD3 mRNA after stimulation. These BDs were produced by mice splenic DC. As compared with DC from normal mice, DC from FT-burned mice produced decreased amounts of BD1 and BD3 in their culture fluids. Conclusions These results indicate that (1) DC from spleens of mice have an ability to produce BDs, and (2) the production of BDs by DC is influenced strongly by thermally injured stress. Since FT-burned mice are susceptible to P. aeruginosa infection, BDs produced by DC may play an important role on the host's antibacterial resistance.	[Kawasaki, Takashi; Kawasaki, Chika; Sata, Takeyoshi] Univ Occupat & Environm Hlth, Dept Anesthesiol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Kawasaki, Takashi; Kobayashi, Makiko; Suzuki, Fujio] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA	Kawasaki, T (reprint author), Univ Occupat & Environm Hlth, Dept Anesthesiol, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	takasi-k@med.uoeh-u.ac.jp			Shriners of North American Grant [8610]; Japan Society for the Promotion of Science, Japan [C-25462461]	This work was supported by Shriners of North American Grant (#8610 to MK) and Grant-in-Aid for Scientific Research (C-25462461 to TK) from the Japan Society for the Promotion of Science, Japan.	Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; Presicce P, 2009, J LEUKOCYTE BIOL, V86, P941, DOI 10.1189/jlb.0708412; Kanda N, 2008, EUR J IMMUNOL, V38, P1287, DOI [10.1002/eji.200738051, 10.1002/eji.200738OS1]; Ganz T, 2004, J LEUKOCYTE BIOL, V75, P34, DOI 10.1189/jlb.0403150; Toliver-Kinsky TE, 2005, J IMMUNOL, V174, P404; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Huttner KM, 1997, FEBS LETT, V413, P45, DOI 10.1016/S0014-5793(97)00875-2; LUTERMAN A, 1986, AM J MED, V81, P45, DOI 10.1016/0002-9343(86)90513-9; Zhang GL, 1998, FEBS LETT, V424, P37, DOI 10.1016/S0014-5793(98)00134-3; Duits LA, 2002, IMMUNOLOGY, V106, P517, DOI 10.1046/j.1365-2567.2002.01430.x; Morrison GM, 1998, MAMM GENOME, V9, P453, DOI 10.1007/s003359900795; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; MCMANUS AT, 1985, EUR J CLIN MICROBIOL, V4, P219, DOI 10.1007/BF02013601; Bhat S, 2007, CURR PROTEIN PEPT SC, V8, P506, DOI 10.2174/138920307782411428; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; Bals R, 1999, INFECT IMMUN, V67, P3542; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; Plitas G, 2007, J IMMUNOL, V178, P4411; Ato M, 2006, J IMMUNOL, V176, P5486; Burd RS, 2002, SHOCK, V18, P461, DOI 10.1097/00024382-200211000-00013; Furukawa K, 2002, ANN SURG, V236, P112, DOI 10.1097/01.SLA.0000018661.66027.DD; Harder J, 2000, AM J RESP CELL MOL, V22, P714; Kawasaki T, 2006, J IMMUNOL, V177, P4514; Kawasaki T, 2010, SHOCK, V34, P83, DOI 10.1097/SHK.0b013e3181ce2be8; LISSNER CR, 1983, J IMMUNOL, V131, P3006; MASON AD, 1986, ARCH SURG-CHICAGO, V121, P1027; Milner SM, 2004, BURNS, V30, P649, DOI 10.1016/j.burns.2004.03.001; Milner SM, 1999, BURNS, V25, P411, DOI 10.1016/S0305-4179(98)00192-2; Mitsui H, 2004, J INVEST DERMATOL, V122, P95, DOI 10.1046/j.0022-202X.2003.22116.x; O'Neil DA, 2003, MOL IMMUNOL, V40, P445, DOI 10.1016/S0161-5890(03)00161-5; Shultz LD, 2005, J IMMUNOL, V174, P6477; SITTIG K, 1988, ARCH SURG-CHICAGO, V123, P1367; Steinstraesser L, 2001, SHOCK, V15, P272, DOI 10.1097/00024382-200115040-00004; STIERITZ DD, 1975, J INFECT DIS, V131, P688; Takahashi H, 2004, CRIT CARE MED, V32, P1879, DOI 10.1097/01.CCM.0000139606.34631.61; Wu MH, 2009, J IMMUNOL, V183, P8054, DOI 10.4049/jimmunol.0902140; Yin L, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-37; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200	43	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	FEB	2015	29	1					78	86		10.1007/s00540-014-1882-y		9	Anesthesiology	Anesthesiology	CE8QW	WOS:000352110100012		
J	Dote, K; Yorozuya, T; Ikemune, K; Desaki, Y				Dote, Kentaro; Yorozuya, Tosihiro; Ikemune, Keizo; Desaki, Yoko			Management of patients under general anesthesia with mafutsu-san in Hanaoka-style surgery: comparisons of illustrations from Geka-Kihai-Zufu with descriptions from Mafutsuto-Ron and Yohka-Hiroku	JOURNAL OF ANESTHESIA			English	Article						History; Genndai Kamada; Seisyu Hanaoka; Mafutsutoron; Gekakihaizufu		Introduction Seishu Hanaoka (1760-1835) left behind no books that he himself had written. This is why many aspects of Hanaoka-style general anesthesia using a mixture of herbal extracts, which he called mafutsu-san, remain unknown. We are able to learn about this technique today because there are several descriptions of it in books written by his students, such as Mafutsuto-Ron ("Treatise on Mafutsuto'') by Gendai Kamata (1794-1854) and Yohka-Hiroku ("Secret Records of Surgery'') by Gencho Homma (1804-1872). On the other hand, Geka-Kihai-Zufu ("Illustrations of Surgical Cases''), a surgical textbook, by Gendai Kamata, containing one of the oldest illustrations of general anesthesia published in 1840, was recently rediscovered (2011). For the first time, this book revealed, in the form of a picture image, the actual circumstances of Hanaoka-style general anesthesia. Methods We therefore compared the descriptions of general anesthesia featured in these three documents, and thereby investigated the actual anesthetic management and the procedures used. Results and conclusions We found that the circumstances under which Hanaoka-style general anesthesia, using fabrics and futon mattresses, as well as blindfolding and constraining the patient's body during surgery, were exactly as described in Mafutsuto-Ron and Yohka-Hiroku. In addition, besides a surgeon conducting an operation, there was a physician who observed the patient's general condition. Gendai Kamata, the author of Geka-Kihai-Zufu, is believed to have recognized the importance of anesthetic care of surgical patients.	[Dote, Kentaro; Yorozuya, Tosihiro; Ikemune, Keizo; Desaki, Yoko] Ehime Univ Hosp, Intens Care Unit, Toon, Ehime 7910295, Japan; [Dote, Kentaro; Yorozuya, Tosihiro; Ikemune, Keizo; Desaki, Yoko] Ehime Univ Hosp, Dept Anesthesiol, Toon, Ehime 7910295, Japan	Dote, K (reprint author), Ehime Univ Hosp, Intens Care Unit, Toon, Ehime 7910295, Japan.	dotek@m.ehime-u.ac.jp					Dote K, 2012, EHIMEIGAKU, V31, P69; Dote Kentaro, 2011, Masui, V60 Suppl, pS164; Dote Kentaro, 2013, Masui, V62, P894; Dote K, 2013, ANESTH ANALG, V116, P1391, DOI 10.1213/ANE.0b013e31828e569a; Dote Kentaro, 2010, Masui, V59, P1321; Kamata G., 1840, GEKA KIHAI ZUFU, P1; Matsuoka G, 1839, MAFUTSUTO RON, P1; Nyugan HG., 1847, YOHKA HIROKU, P76; Soda H, 1989, ZUSETSU NIHON IRYO B, P227	9	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	FEB	2015	29	1					96	101		10.1007/s00540-014-1868-9		6	Anesthesiology	Anesthesiology	CE8QW	WOS:000352110100014		
J	Inoue, S; Abe, R; Tanaka, Y; Kawaguchi, M				Inoue, Satoki; Abe, Ryuichi; Tanaka, Yu; Kawaguchi, Masahiko			Is an urban legend true in the teaching hospital that "you will get hurt if you go to hospital at the beginning of the fiscal year''?	JOURNAL OF ANESTHESIA			English	Article						Urban legend; Teaching hospital; Patient satisfaction; Resident physician; Peripheral venous cannulation	PATIENT SATISFACTION; ADVERSE EVENTS	An urban legend that "you will get hurt if you go to hospital at the beginning of the fiscal year'' is in circulation, because people in general suppose that inexperienced newcomers start to work at clinical practice during that time period. We tried to determine whether this urban legend was true or not by using data from our operation management system. We retrospectively conducted a study to investigate whether the number of cannulation failures, which was used as an index of patient disadvantages at clinical practice, could be affected by the volume of residents in clinical participation. The number of insertion trials per case was not prominent in the first month of the fiscal year. However, the number of insertion trials per case increased in proportion to the average number of residents per day. It seems that there was no evidence to support the urban legend that "you will get hurt if you go to hospital at the beginning of the fiscal year.'' However, our results suggest that rather than an urban legend, we are now confronting the fact that patients may suffer from medical disadvantages in the teaching hospitals.	[Inoue, Satoki; Abe, Ryuichi; Tanaka, Yu; Kawaguchi, Masahiko] Nara Med Univ, Div Intens Care, Kashihara, Nara 6348522, Japan; [Inoue, Satoki; Abe, Ryuichi; Tanaka, Yu; Kawaguchi, Masahiko] Nara Med Univ, Dept Anesthesiol, Kashihara, Nara 6348522, Japan	Inoue, S (reprint author), Nara Med Univ, Div Intens Care, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	seninoue@naramed-u.ac.jp; aberyu19761012@mail.goo.ne.jp; tanakayuu717@gmail.com; drjkawa@gmail.com					Boss EF, 2012, LARYNGOSCOPE, V122, P1000, DOI 10.1002/lary.23255; Berwick DM, 2002, HEALTH AFFAIR, V21, P80, DOI 10.1377/hlthaff.21.3.80; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; Weingart SN, 2005, J GEN INTERN MED, V20, P830, DOI 10.1111/j.1525-1497.2005.0180.x; Yancy WS, 2001, J GEN INTERN MED, V16, P755, DOI 10.1111/j.1525-1497.2001.91005.x; Biro P, 1997, Eur J Pain, V1, P37, DOI 10.1016/S1090-3801(97)90051-3; Frank SH, 1997, JAMA-J AM MED ASSOC, V278, P712, DOI 10.1001/jama.278.9.712; OMalley PG, 1997, ACAD MED, V72, P1015, DOI 10.1097/00001888-199711000-00023; Scales K, 2005, Nurs Stand, V19, P48; Sheets K J, 1991, Fam Pract Res J, V11, P421; Taylor BB, 2008, MED CARE, V46, P224, DOI 10.1097/MLR.0b013e3181589ba4	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	FEB	2015	29	1					122	125		10.1007/s00540-014-1867-x		4	Anesthesiology	Anesthesiology	CE8QW	WOS:000352110100017		
J	Tadokoro, T; Tokumine, J; Lefor, AT; Kawabata, T; Yoza, K; Kinjo, T				Tadokoro, Takahiro; Tokumine, Joho; Lefor, Alan T.; Kawabata, Tetsuya; Yoza, Kouji; Kinjo, Tsukasa			The three-step method for ultrasound-guided pediatric internal jugular venous catheterization: a clinical trial	JOURNAL OF ANESTHESIA			English	Article						Internal jugular vein; Ultrasound-guided; Central venous catheterization; Pediatrics; Novice operator	THAN 5 KILOGRAMS; VEIN CATHETERIZATION; INFANTS; ACCESS; CANNULATION	Ultrasound guidance may be a valuable adjunct for pediatric internal jugular vein catheterization. We previously reported a long-axis in plane technique, called the "three-step method'', resulting in high success and a low complication rate by novice operators in adult patients. This is the first report of ultrasound-guided internal jugular vein catheterization (US-IJV) using the three-step method in pediatric patients. Fourteen junior residents underwent simulation training, and then participated in a clinical trial. They performed US-IJV in 14 pediatric patients with congenital heart disease before undergoing cardiac surgery under supervision of an experienced clinician. The overall success rate was 93 %, and all catheterizations were performed within two venipunctures. There were no complications associated with the procedure. The three-step method may facilitate pediatric US-IJV even by a novice operator during their first experience.	[Tadokoro, Takahiro] Okinawa Prefectural Miyako Hosp, Dept Anesthesia, Miyakojima, Okinawa 9060013, Japan; [Tokumine, Joho] Seikei Kai Chiba Med Ctr, Dept Anesthesia, Chiba, Japan; [Lefor, Alan T.] Jichi Med Univ, Dept Surg, Shimotsuke, Japan; [Kawabata, Tetsuya; Yoza, Kouji] Okinawa Prefectural Nanbu Med Ctr & Childrens Med, Dept Anesthesia, Haebaru, Okinawa, Japan; [Kinjo, Tsukasa] Okinawa Prefectural Nanbu Med Ctr & Childrens Med, Dept Pediat Surg, Haebaru, Okinawa, Japan	Tadokoro, T (reprint author), Okinawa Prefectural Miyako Hosp, Dept Anesthesia, 427-1 Hirara Shimozato, Miyakojima, Okinawa 9060013, Japan.	rover2727@yahoo.co.jp		Lefor, Alan/0000-0001-6673-5630			Tokumine J, 2013, BRIT J ANAESTH, V110, P368, DOI 10.1093/bja/aes381; Stone MB, 2010, AM J EMERG MED, V28, P343, DOI 10.1016/j.ajem.2008.11.022; Hosokawa K, 2007, ANESTHESIOLOGY, V107, P720; Schindler E, 2012, PEDIATR ANESTH, V22, P1002, DOI 10.1111/pan.12005; Bruzoni M, 2013, J AM COLL SURGEONS, V216, P939, DOI 10.1016/j.jamcollsurg.2013.01.054; Moureau N, 2013, BRIT J ANAESTH, V110, P347, DOI 10.1093/bja/aes499; Lamperti M, 2012, INTENS CARE MED, V38, P1105, DOI 10.1007/s00134-012-2597-x; Froehlich CD, 2009, CRIT CARE MED, V37, P1090, DOI 10.1097/CCM.0b013e31819b570e; Di Nardo M, 2011, J VASC ACCESS, V12, P321, DOI 10.5301/JVA.2011.8309; ElDaba AA, 2010, ANN PEDIAT SURG, V6, P136; Kayashima K, 2013, PEDIATR ANESTH, V23, P79, DOI 10.1111/pan.12019; Lamperti M, 2010, PEDIATR ANESTH, V20, P373, DOI 10.1111/j.1460-9592.2010.03276.x; Morita M, 2009, ANESTH ANALG, V109, P754, DOI 10.1213/ane.0b013e3181b01ae3	13	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	FEB	2015	29	1					131	133		10.1007/s00540-014-1869-8		3	Anesthesiology	Anesthesiology	CE8QW	WOS:000352110100019		
J	Yamaguchi, K; Koide, Y				Yamaguchi, Kyoko; Koide, Yasuhiro			Role of intraoperative transesophageal echocardiography in detecting masked mitral regurgitation during left atrial myxoma surgery	JOURNAL OF ANESTHESIA			English	Article						Intraoperative transesophageal echocardiography; Myxoma; Mitral regurgitation	SEVERITY	Myxomas are the most common type of cardiac tumor. Mobile or large left atrial (LA) myxomas frequently cause functional mitral stenosis, and can lead to mitral regurgitation (MR). Difficulties have been associated with detecting masked MR jets and evaluating the severity of MR during LA myxoma surgery due to the presence of a prolapsing tumor and changes in blood flow. We herein presented a case of LA myxoma with significant MR diagnosed on intraoperative transesophageal echocardiography (TEE) prior to cardiopulmonary bypass. Repeated careful observations on TEE led to a confident diagnosis of MR and the selection of an additional appropriate procedure. This case study highlighted the importance of intraoperative TEE in supporting clinical decision-making for optimal mitral valve procedures during LA myxoma surgery.	[Yamaguchi, Kyoko; Koide, Yasuhiro] Yokohama City Univ, Med Ctr, Dept Anesthesiol, Yokohama, Kanagawa 2320024, Japan	Yamaguchi, K (reprint author), Kanagawa Children Med Ctr, Yokohama, Kanagawa, Japan.	kyouko-a@df6.so-net.ne.jp					REYNEN K, 1995, NEW ENGL J MED, V333, P1610, DOI 10.1056/NEJM199512143332407; BIASUCCI LM, 1994, CHEST, V105, P315, DOI 10.1378/chest.105.1.315; Formica F, 2006, HEART SURG FORUM, V9, pE849, DOI 10.1532/HSF98.20061077; Germing A, 2006, J HEART VALVE DIS, V15, P830; Lee JH, 2008, J CARDIOVASC ULTRAS, V16, P59; Matsushita T, 2009, HEART LUNG CIRC, V18, P145, DOI 10.1016/j.hlc.2007.10.017; Nardi C, 2000, EUR J CARDIO-THORAC, V17, P338, DOI 10.1016/S1010-7940(99)00369-3; Teng YH, 2010, J HEART VALVE DIS, V19, P806; Vohra HA, 2002, J ROY SOC MED, V95, P252, DOI 10.1258/jrsm.95.5.252; Whitlock R, 2007, J CARDIOTHOR VASC AN, V21, P103, DOI 10.1053/j.jvca.2005.10.015	10	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	FEB	2015	29	1					134	137		10.1007/s00540-014-1885-8		4	Anesthesiology	Anesthesiology	CE8QW	WOS:000352110100020		
J	Tazawa, T; Kamiya, Y; Takamori, M; Ogawa, K; Goto, T				Tazawa, Toshiharu; Kamiya, Yoshinori; Takamori, Mina; Ogawa, Ken-ichi; Goto, Takahisa			Relationship between ventral lumbar disc protrusion and contrast medium leakage during sympathetic nerve block	JOURNAL OF ANESTHESIA			English	Article						Lumbar spinal canal stenosis; Lumbar sympathetic nerve block; Ventral disc protrusion; Leakage of contrast medium		Ventral disc protrusions have been neglected because they are asymptomatic. Lumbar sympathetic nerve block (LSNB) is one of the clinical choices for refractory low back pain treatment. Leakage of the contrast medium may occur and lead to complications, especially when using a neurolytic agent. In this study, we retrospectively reviewed the magnetic resonance images (MRIs) of 52 consecutive patients with refractory low back pain due to lumbar spinal canal stenosis who underwent LSNB, and graded ventral disc protrusion at the L1/2 to L5/S1 vertebral discs on a three-point scale (grade 0 = no protrusion, grade 1 = protrusion without migration, grade 2 = protrusion with migration). We also determined if there was leakage of contrast medium in LSNB. Ventral disc protrusion was observed in all patients, and 75 % (39/52) had grade 2 protrusion in the L1/2-L3/4 vertebral discs. Moreover, the incidence of contrast medium leakage was significantly higher at the vertebrae that had grade 2 protrusion than at those with less protrusion. We revealed a higher incidence of ventral disc protrusion of the lumbar vertebrae than previously reported, and that the incidence of leakage in LSNB increased when ventral disc protrusion was present. To avoid complications, attention should be paid to ventral disc protrusions before performing LSNB.	[Tazawa, Toshiharu; Takamori, Mina; Ogawa, Ken-ichi; Goto, Takahisa] Yokohama City Univ, Grad Sch Med, Dept Anesthesiol & Crit Care Med, Yokohama, Kanagawa 232, Japan; [Kamiya, Yoshinori] Yokohama City Univ, Grad Sch Med, Dept Neuroanat, Yokohama, Kanagawa 232, Japan	Kamiya, Y (reprint author), Niigata Univ, Med & Dent Hosp, Dept Anesthesiol, Chuo Ward, 1-757 Asahimachidori, Niigata, Niigata Prefect 9518510, Japan.	yoshinori.kamiya@gmail.com		Kamiya, Yoshinori/0000-0001-9790-9867			Bonica J., 1990, MANAGEMENT PAIN, P2020; Breivik H, 1988, NEURAL BLOCKADE CLIN, P411; Dirim A, 2008, SCAND J UROL NEPHROL, V42, P395, DOI 10.1080/00365590801966911; HATANGDI VS, 1985, BRIT J ANAESTH, V57, P285, DOI 10.1093/bja/57.3.285; Hong JH, 2010, ANESTH ANALG, V111, P802, DOI 10.1213/ANE.0b013e3181e9eb35; Pennekamp W, 2013, PAIN PHYSICIAN, V16, P391; SCHMIDT RC, 1978, ARCH ORTHOP TRAUM SU, V92, P59, DOI 10.1007/BF00381641; WILSON PR, 1992, ANESTHESIOLOGY, V76, P314, DOI 10.1097/00000542-199202000-00022	8	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	FEB	2015	29	1					138	142		10.1007/s00540-014-1871-1		5	Anesthesiology	Anesthesiology	CE8QW	WOS:000352110100021		
J	Toju, K; Shiraishi, K; Hakozaki, T; Isosu, T; Murakawa, M				Toju, Kazuya; Shiraishi, Katsunori; Hakozaki, Takahiro; Isosu, Tsuyoshi; Murakawa, Masahiro			Plasma ropivacaine concentration following ultrasound-guided subcostal transversus abdominis plane block in adults	JOURNAL OF ANESTHESIA			English	Article						Ultrasound; Transversus abdominis plane block; Ropivacaine	VOLUNTEERS	Ultrasound-guided subcostal transversus abdominis plane block (TAPB) is widely used for abdominal surgery; however, arterial plasma concentration of the anesthetic ropivacaine after the blockade is still unclear. We evaluated ropivacaine concentration after subcostal TAPB in adult patients undergoing upper abdominal surgery. Twelve patients with American Society of Anesthesiologists physical status 1-2 were enrolled. They received ultrasound-guided subcostal TAPB with 0.45 % ropivacaine at 3 mg/kg. Arterial plasma samples were collected at 15, 30, 45, 60, 90, and 120 min after the blockade and analyzed for total ropivacaine concentration using liquid chromatography and mass spectrometry. At every time point, the maximum concentrations (C-max), and time to the C-max (T-max) were recorded. The mean C-max and T-max were 1.87 (0.78) mu g/ml and 31.3 (16.7) min, respectively. No adverse events or clinical symptoms indicating systemic toxicity were observed during this study. The study demonstrated that administration of ropivacaine at 3 mg/kg during subcostal TAPB led to rapid increases in plasma concentration of the anesthetic during the first 2 h after the blockade. C-max nearly reached the threshold for systemic toxicity.	[Toju, Kazuya; Hakozaki, Takahiro; Isosu, Tsuyoshi; Murakawa, Masahiro] Fukushima Med Univ, Sch Med, Dept Anesthesiol, Fukushima, Fukushima 9601295, Japan; [Shiraishi, Katsunori] Fukushima Prefectural Aizu Gen Hosp, Dept Anesthesiol, Fukushima, Japan	Toju, K (reprint author), Fukushima Med Univ, Sch Med, Dept Anesthesiol, Hikarigaoka 1, Fukushima, Fukushima 9601295, Japan.	m00059kt@jichi.ac.jp					Griffiths JD, 2010, BRIT J ANAESTH, V105, P853, DOI 10.1093/bja/aeq255; Paut O, 2004, BRIT J ANAESTH, V92, P416, DOI 10.1093/bja/aeh066; Niraj G, 2011, ANAESTHESIA, V66, P465, DOI 10.1111/j.1365-2044.2011.06700.x; Knudsen K, 1997, BRIT J ANAESTH, V78, P507; Hebbard P, 2008, ANESTH ANALG, V106, P674, DOI 10.1213/ane.0b013e318161a88f; Karmakar MK, 2005, ANESTHESIOLOGY, V103, P704, DOI 10.1097/00000542-200510000-00008; McCartney CJL, 2003, CAN J ANAESTH, V50, P795; Vanterpool S, 2006, REGION ANESTH PAIN M, V31, P417, DOI 10.1016/j.rapm.2006.06.007; Wulf H, 2001, REGION ANESTH PAIN M, V26, P348, DOI 10.1053/rapm.2001.23208	9	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	FEB	2015	29	1					146	148		10.1007/s00540-014-1864-0		3	Anesthesiology	Anesthesiology	CE8QW	WOS:000352110100023		
J	Kasagi, Y; Okutani, R; Oda, Y				Kasagi, Yoshihiro; Okutani, Ryu; Oda, Yutaka			Specialized operating room for cesarean section in the perinatal care unit: a review of the opening process and operating room management	JOURNAL OF ANESTHESIA			English	Article						Cesarean section; Operating room; Perinatal care unit; Occupancy rate	REDESIGN	We have opened an operating room in the perinatal care unit (PNCU), separate from our existing central operating rooms, to be used exclusively for cesarean sections. The purpose is to meet the increasing need for both emergency cesarean sections and non-obstetric surgeries. It is equipped with the same surgical instruments, anesthesia machine, monitoring system, rapid infusion system and airway devices as the central operating rooms. An anesthesiologist and a nurse from the central operating rooms trained the nurses working in the new operating room, and discussed solutions to numerous problems that arose before and after its opening. Currently most of the elective and emergency cesarean sections carried out during the daytime on weekdays are performed in the PNCU operating room. A total of 328 and 347 cesarean sections were performed in our hospital during 2011 and 2012, respectively, of which 192 (55.5 %) and 254 (73.2 %) were performed in the PNCU operating room. The mean occupancy rate of the central operating rooms also increased from 81 % in 2011 to 90 % in 2012. The PNCU operating room was built with the support of motivated personnel and multidisciplinary teamwork, and has been found to be beneficial for both surgeons and anesthesiologists, while it also contributes to hospital revenue.	[Kasagi, Yoshihiro; Okutani, Ryu; Oda, Yutaka] Osaka City Gen Hosp, Dept Anesthesiol, Miyakojima Ku, Osaka 5340021, Japan; [Kasagi, Yoshihiro; Okutani, Ryu; Oda, Yutaka] Childrens Hosp, Miyakojima Ku, Osaka 5340021, Japan	Kasagi, Y (reprint author), Osaka City Gen Hosp, Dept Anesthesiol, Miyakojima Ku, 2-13-22 Miyakojima Hondori, Osaka 5340021, Japan.	yoshihirokasagi@hotmail.com					Harders M, 2006, SURGERY, V140, P509, DOI 10.1016/j.surg.2006.06.018; Marjamaa R, 2008, ACTA ANAESTH SCAND, V52, P596, DOI 10.1111/j.1399-6576.2008.01618.x; Association of Anaesthetists of Great Britain & Ireland Obstetric Anaesthetist' Association, 2013, OAA AAGBI GUID OBST; Cendan JC, 2006, ARCH SURG-CHICAGO, V141, P65, DOI 10.1001/archsurg.141.1.65; Terui K, 2009, SURVEY ANESTHESIA PR, P433	5	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	FEB	2015	29	1					149	151		10.1007/s00540-014-1861-3		3	Anesthesiology	Anesthesiology	CE8QW	WOS:000352110100024		
J	Sugiura, A; Kawamae, K				Sugiura, Asumi; Kawamae, Kaneyuki			Development of a bronchospasm device model	JOURNAL OF ANESTHESIA			English	Article						Asthma; Bronchospasm; Model	ASTHMA	There is no strong evidence to support ventilatory management for critical limitation of expiratory flow, such as bronchospasm during anesthesia or an acute exacerbation of severe asthma and chronic obstructive pulmonary disease (COPD). Animal models cannot be used to develop reproducible experimental models for conducting mechanical ventilation strategy research relating to these etiologies due to the resulting respiratory and hemodynamic instabilities. Therefore, we developed a device model by modifying a positive end-expiratory pressure (PEEP) valve that can simulate the characteristics of airway bronchoconstriction (i.e., limited peak expiratory flow and a prolonged expiratory phase). These characteristics were found to improve upon narrowing the expiratory port. We believe that this device model will facilitate future mechanical ventilation experiments.	[Sugiura, Asumi] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Sugiura, Asumi] Hosp Sick Children, Peter Gilgan Ctr Res & Learning 06 9400, Neurosci & Mental Hlth, Toronto, ON M5G1X8, Canada; [Kawamae, Kaneyuki] Yamagata Univ, Dept Anesthesiol, Yamagata 990, Japan	Sugiura, A (reprint author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning 06 9400, Neurosci & Mental Hlth, 686 Bay St, Toronto, ON M5G1X8, Canada.	asumi_eicmed11@yahoo.co.jp					Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Oddo M, 2006, INTENS CARE MED, V32, P501, DOI 10.1007/s00134-005-0045-x; PERESS L, 1976, AM J MED, V61, P165, DOI 10.1016/0002-9343(76)90165-0; Ranieri VM, 1996, CLIN CHEST MED, V17, P379, DOI 10.1016/S0272-5231(05)70322-1	4	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	FEB	2015	29	1					152	155		10.1007/s00540-014-1872-0		4	Anesthesiology	Anesthesiology	CE8QW	WOS:000352110100025		
J	Sugiyama, S; Kinoshita, H; Shinomiya, I; Kitora, R; Nakagawa, K; Katoh, M; Masumoto, K				Sugiyama, Shigeru; Kinoshita, Haruka; Shinomiya, Ippei; Kitora, Ryuta; Nakagawa, Keizo; Katoh, Masahiro; Masumoto, Kohei			Recovery of the Phosphorus from the Nitric Acid Extract of Powder Collected in a Bag Filter during the Recycling of Used Fluorescence Tubes	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article						Used Fluorescence Tube; Recovery of Phosphate; Enrichment of Rare Earth Elements	IRON-ORE; PHOSPHATE; SLUDGE	During the recovery of phosphorus from the powder collected in a bag filter during the recycling of used fluorescence tubes (bag-powder), the batch method with aqueous HNO3 was used to examine the elution behavior of aqueous phosphate contained in the bag-powder. The main components of the bag-powder included Ca2+, PO43- and Y3+ along with Si4+, Sr2+ and lanthanide cations such as La3+ and Ce4+. Therefore, it seemed possible that, with the selective dissolution of Ca2+ and PO43- from the bag-powder, these lanthanide cations in the residue could be enriched. With the batch method, most of the phosphate in the bag-powder was dissolved within 0.2 min using 1.0 mol/L HNO3. The dissolution behavior of calcium cation was similar to that of the phosphate. In contrast, the dissolution of yttrium, the content of which was the highest among the lanthanide cations in the bag-powder, was increased with the dissolution times, reaching complete dissolution after 24 h. The Sr2+, La3+ and Si4+ in the bag-powder, however, did not dissolve under the same conditions. Although Ca2+, PO43- and Y3+ were the main components in the nitric acid extract, Y3+ was separated as YPO4 at pH = 4.0, while Ca2+ and PO43- were separated as calcium phosphates at pH = 7.0. These results revealed that the separation of calcium phosphates, YPO4 and some residue was possible, and resulted in the enrichment of lanthanide cations along with the recovery of phosphorus from the bag-powder. Using the present technique, 91% of the P in the bag-powder was recovered.	[Sugiyama, Shigeru; Nakagawa, Keizo; Katoh, Masahiro] Univ Tokushima, Inst Sci & Technol, Dept Adv Mat, Tokushima, Tokushima 7708506, Japan; [Sugiyama, Shigeru; Nakagawa, Keizo] Univ Tokushima, Ctr Frontier Res Engn, Dept Resource Circulat Engn, Tokushima, Tokushima 7708506, Japan; [Kinoshita, Haruka; Shinomiya, Ippei; Kitora, Ryuta] Univ Tokushima, Dept Chem Sci & Technol, Tokushima, Tokushima 7708506, Japan; [Masumoto, Kohei] Japan Recycling Light Technol & Syst, Wakamatsu Ku, Kitakyushu, Fukuoka 8080021, Japan	Sugiyama, S (reprint author), Univ Tokushima, Inst Sci & Technol, Dept Adv Mat, Tokushima, Tokushima 7708506, Japan.	sugiyama@tokushima-u.ac.jp					Abelson PH, 1999, SCIENCE, V283, P2015, DOI 10.1126/science.283.5410.2015; Sano A, 2012, CHEMOSPHERE, V89, P1243, DOI 10.1016/j.chemosphere.2012.07.043; ZHANG Y, 1989, HYDROMETALLURGY, V21, P255, DOI 10.1016/0304-386X(89)90001-7; Takahashi M, 2001, CHEMOSPHERE, V44, P23, DOI 10.1016/S0045-6535(00)00380-5; Patrick TRC, 2001, ISIJ INT, V41, P128, DOI 10.2355/isijinternational.41.128; Sugiyama S, 1998, J SOLID STATE CHEM, V135, P86, DOI 10.1006/jssc.1997.7600; Sugiyama Shigeru, 2012, Phosphorus Research Bulletin, V27; Sugiyama S, 2014, J CHEM ENG JPN, V47, P483, DOI 10.1252/jcej.13we065; Sugiyama Shigeru, 2011, Phosphorus Research Bulletin, V25, DOI 10.3363/prb.25.18; Teratoko T, 2012, HIGH TEMP MAT PR-ISR, V31, P329, DOI 10.1515/htmp-2012-0032	10	0	0	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	FEB	2015	48	2					99	103		10.1252/jcej.14we171		5	Engineering, Chemical	Engineering	CF0AY	WOS:000352206100001		
J	Tochigi, K; Ando, S; Suginuma, K; Matsuda, H; Kurihara, K				Tochigi, Katsumi; Ando, Satoru; Suginuma, Kyohei; Matsuda, Hiroyuki; Kurihara, Kiyofumi			Estimation of Critical Temperature and Critical Pressure Using Antoine Constants	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article						Antoine Constant; Critical Temperature; Critical Pressure	IONIC LIQUIDS	Critical temperatures and critical pressures are fundamental properties used widely for discussing the corresponding-state principle. The critical constants are collected in reference books, but at present, experimental critical constant data are rarely measured for new compounds. On the other hand, Antoine constants for new compounds have been determined from vapor pressure data. In this paper, equations for evaluating critical temperature and critical pressure from molecular descriptors are obtained using the polynomial expansion method. The molecular descriptors used are Antoine constants, van der Waals volume and ovality. A genetic algorithm has been used to determine the fit parameters in the polynomial expansion equation. The values obtained using these new equations are more accurate than those obtained using the Joback method.	[Tochigi, Katsumi; Ando, Satoru; Suginuma, Kyohei; Matsuda, Hiroyuki; Kurihara, Kiyofumi] Nihon Univ, Dept Mat & Appl Chem, Chiyoda Ku, Tokyo 1018308, Japan	Tochigi, K (reprint author), Nihon Univ, Dept Mat & Appl Chem, Chiyoda Ku, 1-8 Surugadai, Tokyo 1018308, Japan.	tochigi.katsumi@nihon-u.ac.jp					JOBACK KG, 1987, CHEM ENG COMMUN, V57, P233, DOI 10.1080/00986448708960487; Matsuda H, 2007, FLUID PHASE EQUILIBR, V261, P434, DOI 10.1016/j.fluid.2007.07.018; Tochigi K, 2007, J PHYS CHEM C, V111, P15989, DOI 10.1021/jp073839a; Boublik V., 1984, VAPOUR PRESSURE PURE; Gesteiger J., 2003, CHEMOINFORMATICS, P467; Matsuda H., 2011, J RES I SCI TECH NIH, V129, P1; Poling B.E., 2000, PROPERTIES GASES LIQ; Rowley R. L., 2012, DIPPR 801 DATA COMPI; Sadatomi H., 2006, WINMOSTAR MANUAL; Tochigi K, 2010, FLUID PHASE EQUILIBR, V297, P200, DOI 10.1016/j.fluid.2010.05.011; Yamagishi M, 2010, J CHEM ENG JPN, V43, P727; Yamamoto H., 2006, J COMPUT AIDED CHEM, V7, P168, DOI 10.2751/jcac.7.168; Yamamoto H, 2007, J JPN PETROL INST, V50, P117, DOI 10.1627/jpi.50.117	13	0	0	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	FEB	2015	48	2					104	106		10.1252/jcej.14we106		3	Engineering, Chemical	Engineering	CF0AY	WOS:000352206100002		
J	Kobayashi, Y; Matsudo, H; Kubota, Y; Nakagawa, T; Gonda, K; Ohuchi, N				Kobayashi, Yoshio; Matsudo, Hiromu; Kubota, Yohsuke; Nakagawa, Tomohiko; Gonda, Kohsuke; Ohuchi, Noriaki			Preparation of Silica-Coated Quantum Dot Nanoparticle Colloid Solutions and Their Application in in-vivo Fluorescence Imaging	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article						Quantum Dot; Silica-Coating; Fluorescence Imaging; Core-Shell; Nanoparticle	CELLS; SIZE; CYTOTOXICITY; LUMINESCENT; TOXICITY; DELIVERY; STABILITY; PROBES	This paper describes three findings. The first is a method for producing colloidal solutions of quantum dot (QD) nanoparticles with silica shells (QD/SiO2). QD nanoparticles averaging 10.3 +/- 2.1 nm in size were coated with silica via a sol-gel reaction with tetraethyl orthosilicate using NaOH as a catalyst. The QD/SiO2 particle size could be varied by varying the QD concentration. The average particle sizes were 19.1 +/- 3.0 (S-QD/SiO2) and 47.0 +/- 6.1 nm (L-QD/SiO2) for QD concentrations of 6.4 x 10(-9) M (4.6 x 10(11) particles/L) and 6.4 x 10(-10) M (4.6 x 10(10) particles/L), respectively. The second finding is a method to modify the particle surface with poly(ethylene glycol), which is called PEGylation (QD/SiO2/PEG). S-QD/SiO2 and L-QD/SiO2 were PEGylated using methoxy polyethylene glycol silane (S-QD/SiO2/PEG and L-QD/SiO2/PEG, respectively). The third finding is an in-vivo fluorescence imaging technique using the QD/SiO2/PEG particle colloid solutions. Both QD/SiO2/PEG particle colloid solutions fluoresced with intensities comparable with that of the QD colloid solution. Mouse tissues could be imaged by injecting the QD/SiO2/PEG colloid solution into them and measuring the emitted fluorescence intensity. The L-QD/SiO2/PEG particles did not form aggregates in blood, which allowed the particles to reach the tissues more efficiently than the S-QD/SiO2/PEG particles.	[Kobayashi, Yoshio; Matsudo, Hiromu] Ibaraki Univ, Coll Engn, Dept Biomol Funct Engn, Hitachi, Ibaraki 3168511, Japan; [Kubota, Yohsuke; Nakagawa, Tomohiko; Gonda, Kohsuke; Ohuchi, Noriaki] Tohoku Univ, Grad Sch Med, Div Surg Oncol, Aoba Ku, Sendai, Miyagi 9808574, Japan	Kobayashi, Y (reprint author), Ibaraki Univ, Coll Engn, Dept Biomol Funct Engn, 4-12-1 Naka Narusawa Cho, Hitachi, Ibaraki 3168511, Japan.	ykoba@mx.ibaraki.ac.jp	Kobayashi, Yoshio/N-1451-2015	Kobayashi, Yoshio/0000-0002-8540-3962	JSPS KAKENHI [24310085]; Ministry of Education, Culture, Sports, Science and Technology of Japan [2306]	This is work was supported by JSPS KAKENHI Grant Number 24310085, and by a Grant-in-Aid for Scientific Research on Innovative Areas "Nanomedicine Molecular Science" (No. 2306) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We express our thanks to Prof. T. Noguchi of the College of Science of Ibaraki University, Japan (current affliation: Faculty of Arts and Science of Kyushu University, Japan) for his assistance with the TEM observations.	STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Li JM, 2012, BIOMATERIALS, V33, P2780, DOI 10.1016/j.biomaterials.2011.12.035; Soenen SJ, 2013, ACTA BIOMATER, V9, P9183, DOI 10.1016/j.actbio.2013.04.026; Yang HN, 2014, BIOMATERIALS, V35, P8439, DOI 10.1016/j.biomaterials.2014.06.024; Mondragon R, 2012, POWDER TECHNOL, V224, P138, DOI 10.1016/j.powtec.2012.02.043; Hildebrandt N, 2014, COORDIN CHEM REV, V273, P125, DOI 10.1016/j.ccr.2014.01.020; Ambrosone A, 2012, BIOMATERIALS, V33, P1991, DOI 10.1016/j.biomaterials.2011.11.041; Geszke-Moritz M, 2013, MAT SCI ENG C-MATER, V33, P1008, DOI 10.1016/j.msec.2013.01.003; Probst CE, 2013, ADV DRUG DELIVER REV, V65, P703, DOI 10.1016/j.addr.2012.09.036; Esteve-Turrillas FA, 2013, BIOSENS BIOELECTRON, V41, P12, DOI 10.1016/j.bios.2012.09.025; He XW, 2014, COLLOID SURFACE B, V124, P118, DOI 10.1016/j.colsurfb.2014.06.002; Li CL, 2013, J COLLOID INTERF SCI, V411, P82, DOI 10.1016/j.jcis.2013.08.053; Li Y, 2011, TOXICOL IN VITRO, V25, P1343, DOI 10.1016/j.tiv.2011.05.003; Gholami T, 2013, SUPERLATTICE MICROST, V61, P33, DOI 10.1016/j.spmi.2013.06.004; Pathakoti K, 2013, J ENVIRON SCI-CHINA, V25, P163, DOI 10.1016/S1001-0742(12)60015-1; Plumere N, 2012, J COLLOID INTERF SCI, V368, P208, DOI 10.1016/j.jcis.2011.10.070; Liu YT, 2011, INT J PHARMACEUT, V421, P370, DOI 10.1016/j.ijpharm.2011.10.004; Passagne I, 2012, TOXICOLOGY, V299, P112, DOI 10.1016/j.tox.2012.05.010; Shibu ES, 2014, COORDIN CHEM REV, V263, P2, DOI 10.1016/j.ccr.2013.10.014; Chou KS, 2014, COLLOID SURFACE A, V448, P115, DOI 10.1016/j.colsurfa.2014.02.020; Cywinski PJ, 2014, BIOSENS BIOELECTRON, V52, P288, DOI 10.1016/j.bios.2013.09.002; Darbandi M, 2012, J COLLOID INTERF SCI, V365, P41, DOI 10.1016/j.jcis.2011.09.024; Hennig C, 2013, GEOCHIM COSMOCHIM AC, V103, P197, DOI 10.1016/j.gca.2012.10.051; Isnaeni L. H. Jin, 2013, J COLLOID INTERF SCI, V395, P45; Joshi S, 2014, J COLLOID INTERF SCI, V428, P101, DOI 10.1016/j.jcis.2014.04.041; Kobayashi Y, 2010, J CHEM ENG JPN, V43, P490; Kobayashi Y, 2012, MAT FOCUS, V1, P127; Kobayashi Y., 2013, ISRN NANOMETER, V2013; Kobayashi Y, 2010, J SOL-GEL SCI TECHN, V55, P79, DOI 10.1007/s10971-010-2218-5; Ma-Hock L, 2014, TOXICOL LETT, V225, P20, DOI 10.1016/j.toxlet.2013.11.007; Parpaite T, 2014, POLYMER, V55, P2704, DOI 10.1016/j.polymer.2014.04.016; Yang P, 2012, J NON-CRYST SOLIDS, V358, P3069, DOI 10.1016/j.jnoncrysol.2012.08.031	32	1	1	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	FEB	2015	48	2					112	117		10.1252/jcej.14we218		6	Engineering, Chemical	Engineering	CF0AY	WOS:000352206100004		
J	Takeuchi, K; Amano, Y; Machida, M; Imazeki, F				Takeuchi, Kotaku; Amano, Yoshimasa; Machida, Motoi; Imazeki, Fumio			Batch and Fixed-Bed Column Adsorption of Cd(II) from Aqueous Solution onto Oxidized Bead-Shaped Activated Carbon	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article						Activated Carbon; Bed Column; Heavy Metal Adsorption; Oxidation; Surface Acidic Groups	OXIDATION; PH	Batch and column adsorption of divalent cadmium ions from aqueous solution using oxidized activated carbon (OAC) was investigated. Commercially available bead-shaped activated carbon (BAC) was oxidized with ammonium persulfate, and Cd(II) adsorption experiments were performed in batch and flow systems. The total amount of Cd(II) adsorbed in the flow system was 1.7 mmol/g, which was asymptotically equal to the maximum amount adsorbed in the batch system. Regeneration of the adsorbent was evaluated via Cd(II) desorption from OAC using 0.1 M nitric acid. The total Cd(II) desorbed was approximately 1.9 mmol/g, which was nearly equivalent to the total Cd(II) adsorbed in the flow system. The amount of Cd(II) adsorbed using regenerated OAC in the 2nd-cycle was not significantly different from that adsorbed in the 1st-cycle. These results imply that OAC is prospectively reusable for Cd(II) adsorption applications.	[Takeuchi, Kotaku; Amano, Yoshimasa; Machida, Motoi] Chiba Univ, Grad Sch Engn, Inage Ku, Chiba, Chiba 2638522, Japan; [Amano, Yoshimasa; Machida, Motoi; Imazeki, Fumio] Chiba Univ, Safety & Hlth Org, Inage Ku, Chiba, Chiba 2638522, Japan	Takeuchi, K (reprint author), Chiba Univ, Grad Sch Engn, Inage Ku, 1-33 Yayoi Cho, Chiba, Chiba 2638522, Japan.	k.takeuchi@chiba-u.jp			Japan Society for the Promotion of Science (JSPS) [26340058]	This study was funded in part by the Japan Society for the Promotion of Science (JSPS) through a Grants-in-Aid for Scientific Research (C) (No. 26340058). The authors extend deep gratitude to Prof. Dr. Masami Aikawa, Faculty of Science, Kisarazu National College of Technology, for his advice and guidance.	Rangel-Mendez JR, 2002, WATER RES, V36, P1244, DOI 10.1016/S0043-1354(01)00343-8; Chen XB, 1997, ENVIRON SCI TECHNOL, V31, P624; Keng PS, 2014, ENVIRON CHEM LETT, V12, P15, DOI 10.1007/s10311-013-0427-1; Machida M, 2012, J HAZARD MATER, V221, P220, DOI 10.1016/j.jhazmat.2012.04.039; Beker UG, 2003, CHEM ENG COMMUN, V190, P610, DOI 10.1080/00986440390207297; Boehm H.P., 1966, ADV CATAL, V16, P179, DOI 10.1016/S0360-0564(08)60354-5; Hayashita T, 1996, CHEM LETT, P37, DOI 10.1246/cl.1996.37; Ministry of the Environment, 2011, GOVT JAPAN ENV QUALI	8	1	1	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	FEB	2015	48	2					123	126		10.1252/jcej.14we187		4	Engineering, Chemical	Engineering	CF0AY	WOS:000352206100006		
J	Sugiyama, S; Ehiro, T; Nitta, Y; Itagaki, A; Nakagawa, K; Katoh, M; Katoh, Y; Akihara, S; Yasukawa, T; Ninomiya, W				Sugiyama, Shigeru; Ehiro, Takuya; Nitta, Yoshihisa; Itagaki, Ai; Nakagawa, Keizo; Katoh, Masahiro; Katoh, Yuuki; Akihara, Shuji; Yasukawa, Toshiya; Ninomiya, Wataru			Acidic Properties of Various Silica Catalysts Doped with Chromium for the Oxidative Dehydrogenation of Isobutane to Isobutene	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article						Oxidative Dehydrogenation; Isobutane; Isobutene; FSM-16; Chromium-Doping	ORDERED MESOPOROUS MATERIALS; TEMPLATE-ION EXCHANGE; FSM-16; MCM-41	Although previous researchers have found that FSM-16 (#16 Folded Sheet Mesoporous material) doped with chromium and related Cr-doped silica catalysts has shown great activity for the oxidative dehydrogenation of isobutane to isobutene, information on the nature of these catalysts is insufficient. For this study, three types of Cr-doped silica catalysts were prepared by applying the template ion exchange method. CrOx/FSM-16 and CrOx/SiO2 were used as references. These catalysts were used for oxidative dehydrogenation, which was then characterized via various techniques. The most active catalyst was Cr-doped silica, which did not have the hexagonal structure that is characteristic of mesoporous FSM-16. Various characterizations showed that the catalytic activity of the Cr-species, stemmed from a weak acidic nature and a redox nature that originated from the combination of silicate and a Cr cation, as opposed to the hexagonal structure and strong acidic nature of FSM-16.	[Sugiyama, Shigeru; Nakagawa, Keizo; Katoh, Masahiro] Univ Tokushima, Inst Sci & Technol, Dept Adv Mat, Tokushima, Tokushima 7708506, Japan; [Sugiyama, Shigeru; Nakagawa, Keizo] Univ Tokushima, Ctr Frontier Res Engn, Dept Resource Circulat Engn, Tokushima, Tokushima 7708506, Japan; [Ehiro, Takuya; Nitta, Yoshihisa; Itagaki, Ai] Univ Tokushima, Dept Chem Sci & Technol, Tokushima, Tokushima 7708506, Japan; [Katoh, Yuuki; Akihara, Shuji; Yasukawa, Toshiya; Ninomiya, Wataru] Mitsubishi Rayon Co Ltd, Otake Res Labs, Otake, Hiroshima 7390693, Japan	Sugiyama, S (reprint author), Univ Tokushima, Inst Sci & Technol, Dept Adv Mat, Tokushima, Tokushima 7708506, Japan.	sugiyama@tokushima-u.ac.jp			 [24360328]	This work was funded by a Grant-in-Aid for Scientific Research (B) (KAKENHI 24360328) that was awarded to SS, for which we are grateful. The authors acknowledge Prof. Naonobu Katada (Tottori University, Japan) for his valuable suggestion on NH<INF>3</INF>-TPD and Dr. Shinji Inagaki (Toyota Central Research and Development Laboratories, Japan) and Associate Prof. Takashi Yamamoto (The University of Tokushima, Japan) for their stimulating discussion on FSM-16.	Wang Y, 2003, J CATAL, V220, P347, DOI 10.1016/S0021-9517(03)00278-1; Inagaki S, 1996, B CHEM SOC JPN, V69, P1449, DOI 10.1246/bcsj.69.1449; Iwamoto M, 2003, J AM CHEM SOC, V125, P13032, DOI 10.1021/ja0375129; Sugiyama S, 2010, TOP CATAL, V53, P550, DOI 10.1007/s11244-010-9485-9; Nagai K, 2001, APPL CATAL A-GEN, V221, P367, DOI 10.1016/S0926-860X(01)00810-9; INAGAKI S, 1993, J CHEM SOC CHEM COMM, P680, DOI 10.1039/c39930000680; Wang GZ, 2009, APPL CATAL A-GEN, V355, P192, DOI 10.1016/j.apcata.2008.12.020; Takehira K, 2004, J CATAL, V224, P404, DOI 10.1016/j.jcat.2004.03.014; Grzybowska B, 1998, J CATAL, V178, P687, DOI 10.1006/jcat.1998.2203; Yonemitsu M, 1997, CHEM MATER, V9, P2679, DOI 10.1021/cm970334w; Takita Y, 2005, APPL CATAL A-GEN, V296, P63, DOI 10.1016/j.apcata.2005.07.049; Kung HH, 1994, ADV CATAL, V40, P1, DOI 10.1016/S0360-0564(08)60655-0; Eldarsi HS, 1998, CHEM ENG RES DES, V76, P517, DOI 10.1205/026387698524992; Furukawa Y., 2011, EFFECT PREPARATION C, VPD-19; HAWKE DL, 1954, ANAL CHEM, V26, P1989, DOI 10.1021/ac60096a043; Ito H., 1986, HDB CATALYST EXPT SO, P170; JOHNSON O, 1955, J PHYS CHEM-US, V59, P827, DOI 10.1021/j150531a007; Katoh Masahiro, 2012, International Journal of Modern Physics: Conference Series, V6, DOI 10.1142/S2010194512003571; Kuroda T., 2003, CATALYSTS CATALYSIS, V45, P366; LEBARS J, 1992, APPL CATAL A-GEN, V88, P179, DOI 10.1016/0926-860X(92)80214-W; Matsuzaki I., 1969, CATALYSTS CATALYSIS, V11, P210; Sugiyama S, 2013, J CHEM ENG JPN, V46, P620, DOI 10.1252/jcej.13we059; Sugiyama S., 2013, J CHEM CHEM ENG, V7, P1014; Sulikowski B, 2002, APPL CATAL A-GEN, V232, P189, DOI 10.1016/S0926-860X(02)00102-3; Takita Y, 2005, APPL CATAL A-GEN, V283, P209, DOI 10.1016/j.apcata.2005.01.008; Yamamoto T, 1998, J PHYS CHEM B, V102, P5830, DOI 10.1021/jp980675c	26	1	1	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	FEB	2015	48	2					133	140		10.1252/jcej.14we112		8	Engineering, Chemical	Engineering	CF0AY	WOS:000352206100008		
J	Shiraishi, Y; Hirakawa, H; Hirai, T				Shiraishi, Yasuhiro; Hirakawa, Hiroaki; Hirai, Takayuki			Photocatalytic Hydrogenation of Nitroaromatics to Anilines on Silica-Supported Iron Oxides with Hydrazine Monohydrate as a Reductant	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article						Photocatalysis; Iron Oxides; Nitroaromatics; Hydrazine; Hydrogenation	AROMATIC NITRO-COMPOUNDS; MG-FE HYDROTALCITE; MOLECULAR-OXYGEN; NITROARENES; CATALYSTS; EFFICIENT; HYDRATE; NANOPARTICLES	Photocatalytic hydrogenation of nitroaromatics was carried out with silica-supported iron oxides (FeOx/SiO2) as catalysts and hydrazine monohydrate as a reductant. Photoirradiation of the catalysts at lambda > 300 nm promotes hydrogenation of nitroaromatics to the corresponding anilines with more than 90% selectivity. The FeOx/SiO2 catalysts with lower Fe loadings possess monomeric Fe-III species behaving as the active sites and exhibit higher photocatalytic activity and aniline selectivity. Electron spin resonance (ESR) analysis revealed that photoexcitation of the hydrazine-adsorbed monomeric Fe-III species produces Fe-II species by the reduction with hydrazine. The Fe-II species promote the reduction of nitroaromatics to anilines, along with the Fe-II -> Fe-III oxidation.	[Shiraishi, Yasuhiro] Osaka Univ, Grad Sch Engn Sci, Res Ctr Solar Energy Chem, Toyonaka, Osaka 5608531, Japan; Osaka Univ, Grad Sch Engn Sci, Div Chem Engn, Toyonaka, Osaka 5608531, Japan	Shiraishi, Y (reprint author), Osaka Univ, Grad Sch Engn Sci, Res Ctr Solar Energy Chem, Toyonaka, Osaka 5608531, Japan.	shiraish@cheng.es.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [26289296]	This work was supported by the Grant-in-Aid for Scientific Research (No. 26289296) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Kumbhar PS, 2000, J CATAL, V191, P467, DOI 10.1006/jcat.2000.2827; Shiraishi Y, 2010, ANGEW CHEM INT EDIT, V49, P1656, DOI 10.1002/anie.200906573; DOXSEE KM, 1987, J AM CHEM SOC, V109, P3098, DOI 10.1021/ja00244a037; Yoshida H, 2000, J CATAL, V194, P364, DOI 10.1006/jcat.2000.2952; Shiraishi Y, 2008, J PHOTOCH PHOTOBIO C, V9, P157, DOI 10.1016/j.jphotochemrev.2008.05.001; Cantillo D, 2012, ANGEW CHEM INT EDIT, V51, P10190, DOI 10.1002/anie.201205792; Kumbhar PS, 1998, TETRAHEDRON LETT, V39, P2573, DOI 10.1016/S0040-4039(98)00264-0; Shiraishi Y, 2012, ACS CATAL, V2, P2475, DOI 10.1021/cs300500p; Kim S, 2011, CHEM-ASIAN J, V6, P1921, DOI 10.1002/asia.201100311; Libera JA, 2010, CHEM MATER, V22, P409, DOI 10.1021/cm902825c; Tafesh AM, 1996, CHEM REV, V96, P2035, DOI 10.1021/cr950083f; Kumarraja M, 2004, APPL CATAL A-GEN, V265, P135, DOI 10.1016/j.apacta.2004.01.009; Gu XM, 2013, CHEM COMMUN, V49, P10088, DOI 10.1039/c3cc44523b; Dowing RS, 1997, CATAL TODAY, V37, P121; Kumar M.S., 2006, J CATAL, V239, P173; Moens B, 2007, J CATAL, V247, P86, DOI 10.1016/j.jcat.2007.01.001; Mohapatra SK, 2002, ORG LETT, V4, P4297, DOI 10.1021/ol026926p; SHIN DH, 1985, B KOR CHEM SOC, V6, P247; Shiraishi Y, 2006, J PHYS CHEM B, V110, P6587, DOI 10.1021/jp056624e; Shiraishi Y, 2005, CHEM COMMUN, P4569, DOI 10.1039/b508172f; Shiraishi Y, 2005, J AM CHEM SOC, V127, P8304, DOI 10.1021/ja042707h	21	1	1	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	FEB	2015	48	2					141	146		10.1252/jcej.14we151		6	Engineering, Chemical	Engineering	CF0AY	WOS:000352206100009		
J	Sumino, M; Saito, Y; Ikegami, F; Namiki, T				Sumino, Megumi; Saito, Yuko; Ikegami, Fumio; Namiki, Takao			A Simultaneous Determination of Principal Compounds in Tokishakuyakusan by High-Performance Liquid Chromatography with Diode Array Detector	JOURNAL OF CHROMATOGRAPHIC SCIENCE			English	Article							KAMPO MEDICINES; ALISMATIS RHIZOMA; GLYCYRRHIZIN; ORIENTALE	We developed a simultaneous analysis method using high-performance liquid chromatography coupled with diode-array detector (HPLC-DAD) for six principal compounds (atractylenolide III, alisol A, alisol B, paeoniflorin, ferulic acid and (Z)-ligustilide) in a traditional Japanese (Kampo) medicine, tokishakuyakusan (TSS). The HPLC separation was conducted on a reversed-phase TSK-gel ODS-80TS column (4.6 i.d. x 250 mm, 5 mu m) at 40 degrees C with a 0.1% phosphoric acid-acetonitrile gradient system. The DAD detection wavelength was set at 205, 232 and 330 nm. Calibration curves for the compounds showed linear regressions with correlation coefficients of > 0.999. The intra-and inter-day precision (i.e., the relative standard deviation) were in the range of 0.50-1.55 and 0.70-1.80%, respectively. The average recovery yields of the compounds ranged from 98.3 to 103%. The present results will contribute to shorter analysis times with less organic solvent compared with the individual analysis of each compound for the evaluation of TSS. The application of the established method to TSS will also provide helpful information for the further pharmacological and clinical studies.	[Sumino, Megumi; Saito, Yuko; Namiki, Takao] Chiba Univ, Grad Sch Med, Dept Japanese Oriental Kampo Med, Chuo Ku, Chiba 2608670, Japan; [Ikegami, Fumio] Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba 2770882, Japan	Sumino, M (reprint author), Chiba Univ, Grad Sch Med, Dept Japanese Oriental Kampo Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	sumino@faculty.chiba-u.jp					Okamura N, 1999, J PHARMACEUT BIOMED, V20, P363, DOI 10.1016/S0731-7085(99)00065-5; [Anonymous], 2005, INT C HARM TECHN REQ, P1; Lee JH, 2012, BIOL PHARM BULL, V35, P1581; Islam MN, 2009, CHROMATOGRAPHIA, V70, P1079, DOI 10.1365/s10337-009-1263-0; Shen AY, 2005, AM J CHINESE MED, V33, P747, DOI 10.1142/S0192415X05003351; Chung MiHwa, 2012, Journal of Traditional Medicines, V29, P89; Fujiwara M., 2007, Journal of Traditional Medicines, V24, P149; IMAI Y, 1970, JPN J PHARMACOL, V20, P222, DOI 10.1254/jjp.20.222; Kampo Committee of the Federation of Pharmaceutical Manufacturers' Associations of Japan, 1975, GUID GEN KAMP PRESCR, P196; Kang D., 2011, KAMPO NEWEST THERAPY, V20, P131; Kubo M, 1997, BIOL PHARM BULL, V20, P511; Lee SM, 2004, ARCH PHARM RES, V27, P460, DOI 10.1007/BF02980090; Matsuoka T., 2012, EVID-BASED COMPL ALT, V2012, P5; Ministry of Health Labour and Welfare, 2012, TOK EXTR JAP PHAR S1, P167; Okamura N, 1999, J PHARMACEUT BIOMED, V19, P603, DOI 10.1016/S0731-7085(98)00262-3; Okamura N, 1999, BIOL PHARM BULL, V22, P1015; Okamura N, 2000, CHEM PHARM BULL, V48, P1782; SHIMIZU M, 1991, CHEM PHARM BULL, V39, P2046; TENG CM, 1987, BIOCHIM BIOPHYS ACTA, V924, P375; Toriizuka K., 1987, J MED PHARM SOC WAKA, V4, P20; Ueda J, 2004, YAKUGAKU ZASSHI, V124, P365, DOI 10.1248/yakushi.124.365; Wang Yan, 2012, Journal of Traditional Medicines, V29, P195; Yi L., 2009, J CHROMATOGR A, V1206, P1991; Yu Y, 2011, ANAL BIOANAL CHEM, V399, P1363, DOI 10.1007/s00216-010-4426-9; [郑云枫 ZHENG Yunfeng], 2006, [中草药, Chinese Traditional and Herbal Drugs], V37, P1479	25	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0021-9665	1945-239X		J CHROMATOGR SCI	J. Chromatogr. Sci.	FEB	2015	53	2					320	324		10.1093/chromsci/bmu062		5	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CF1CS	WOS:000352281800017		
J	Kinoshita, H; Maeda, I; Morita, T; Miyashita, M; Yamagishi, A; Shirahige, Y; Takebayashi, T; Yamaguchi, T; Igarashi, A; Eguchi, K				Kinoshita, Hiroya; Maeda, Isseki; Morita, Tatsuya; Miyashita, Mitsunori; Yamagishi, Akemi; Shirahige, Yutaka; Takebayashi, Toru; Yamaguchi, Takuhiro; Igarashi, Ayumi; Eguchi, Kenji			Place of Death and the Differences in Patient Quality of Death and Dying and Caregiver Burden	JOURNAL OF CLINICAL ONCOLOGY			English	Article							OF-LIFE CARE; FAMILY-MEMBERS PERSPECTIVE; CLUSTER RANDOMIZED-TRIAL; PALLIATIVE-CARE; CANCER-PATIENTS; END; PREFERENCES; INTERVENTION; SATISFACTION; PREDICTORS	Purpose To explore the associations between place of death and quality of death and dying and caregiver burden in terminally ill patients with cancer and their families. Methods Two bereavement surveys were conducted in October 2008 and October 2011. A total of 2,247 family caregivers of patients with cancer who were deceased responded to the mail surveys (response rate, 67%). Family members reported patient quality of death and dying and caregiver burden by using the Good Death Inventory and Caregiving Consequences Inventory. Results Patient quality of death and dying was significantly higher at home relative to other places of dying after adjustment for patient and/or family characteristics (adjusted means): 5.0 (95% CI, 4.9 to 5.2) for home, 4.6 (95% CI, 4.5 to 4.7) for palliative care units, and 4.3 (95% CI, 4.2 to 4.4) for hospitals. For all combinations, pairwise P < .001; the size of the difference between home and hospital was moderate (Hedges' g, 0.45). Home was superior to palliative care units or hospitals with respect to "dying in a favorite place," "good relationships with medical staff," "good relationships with family," and "maintaining hope and pleasure" (P < .001 for all combinations of home v palliative care units and home v hospitals). Home death was significantly associated with a lower overall (P = .03) and financial caregiver burden (P = .004) relative to hospital death. Conclusion Dying at home may contribute to achieving good death in terminally ill patients with cancer without causing remarkably increased caregiver burden. Place of death should be regarded as an essential goal in end-of-life care. (C) 2014 by American Society of Clinical Oncology	[Kinoshita, Hiroya] Natl Canc Ctr Hosp East, Chiba, Japan; [Maeda, Isseki] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Shizuoka, Japan; [Yamagishi, Akemi] Hamamatsu Univ Sch Med, Shizuoka, Japan; [Miyashita, Mitsunori; Yamaguchi, Takuhiro] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Shirahige, Yutaka] Shirahige Clin, Nagasaki, Japan; [Takebayashi, Toru] Keio Univ, Sch Med, Tokyo, Japan; [Igarashi, Ayumi] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Eguchi, Kenji] Teikyo Univ, Grad Sch Med, Tokyo 173, Japan	Maeda, I (reprint author), Osaka Univ, Grad Sch Med, Dept Palliat Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	maeda@pm.med.osaka-u.ac.jp	Takebayashi, Toru/K-7526-2013	Takebayashi, Toru/0000-0002-8268-8026	Third Term Comprehensive Control Research for Cancer, Health and Labor Sciences Research Grants of the Ministry of Health, Labour and Welfare of Japan	Supported by a grant from Third Term Comprehensive Control Research for Cancer, Health and Labor Sciences Research Grants of the Ministry of Health, Labour and Welfare of Japan.	Wright AA, 2010, J CLIN ONCOL, V28, P4457, DOI 10.1200/JCO.2009.26.3863; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Jordhoy MS, 2000, LANCET, V356, P888, DOI 10.1016/S0140-6736(00)02678-7; Bell CL, 2010, J PAIN SYMPTOM MANAG, V39, P591, DOI 10.1016/j.jpainsymman.2009.07.007; Ibrahim JG, 2009, TEST-SPAIN, V18, P1, DOI 10.1007/s11749-009-0138-x; Balboni TA, 2007, J CLIN ONCOL, V25, P555, DOI 10.1200/JCO.2006.07.9046; Zhang BH, 2012, ARCH INTERN MED, V172, P1133, DOI 10.1001/archinternmed.2012.2364; Sales E, 2003, QUAL LIFE RES, V12, P33, DOI 10.1023/A:1023513218433; Hirai K, 2006, J PAIN SYMPTOM MANAG, V31, P140, DOI 10.1016/j.jpainsymman.2005.06.012; Patrick DL, 2003, ANN INTERN MED, V139, P410; Mack JW, 2010, J CLIN ONCOL, V28, P1203, DOI 10.1200/JCO.2009.25.4672; Hearn J, 1999, QUAL HEALTH CARE, V8, P219; Gomes B, 2006, BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Jordhoy MS, 2001, J CLIN ONCOL, V19, P3884; Morita T, 2013, LANCET ONCOL, V14, P638, DOI 10.1016/S1470-2045(13)70127-X; Wolff JL, 2007, ARCH INTERN MED, V167, P40, DOI 10.1001/archinte.167.1.40; Mazor KM, 2002, HEALTH SERV RES, V37, P1403, DOI 10.1111/1475-6773.11194; Addington-Hall J, 2001, J PAIN SYMPTOM MANAG, V22, P784, DOI 10.1016/S0885-3924(01)00330-X; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Miyashita M, 2007, ANN ONCOL, V18, P1090, DOI 10.1093/annonc/mom068; Cohen J., 1977, STAT POWER ANAL BEHA; Gomes B, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD007760.PUB2; Gomes B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-400; Miyashita M, 2008, J PAIN SYMPTOM MANAG, V35, P486, DOI [10.1016/j.jpainsymman.2007.07.009, 10.1016/j.jpainsmman.2007.07.009]; Morita T, 2013, CURR OPIN SUPPORT PA, V7, P207, DOI 10.1097/SPC.0b013e3283612241; Morita T, 2012, BMC PALLIAT CARE, V11, DOI 10.1186/1472-684X-11-2; Olkin I., 1985, STAT METHODS METAANA; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Ringdal GI, 2002, J PAIN SYMPTOM MANAG, V24, P53, DOI 10.1016/S0885-3924(02)00417-7; Sanjo M, 2009, PSYCHO-ONCOL, V18, P657, DOI 10.1002/pon.1447; Steinhauser Karen E., 2000, JAMA (Journal of the American Medical Association), V284, P2476, DOI 10.1001/jama.284.19.2476; Tassinari D, 2002, J CLIN ONCOL, V20, P1704; World Health Organization (WHO), 2002, NAT CANC CONTR PROGR	33	4	4	AMER SOC CLINICAL ONCOLOGY	ALEXANDRIA	2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA	0732-183X	1527-7755		J CLIN ONCOL	J. Clin. Oncol.	FEB 1	2015	33	4					357	U105		10.1200/JCO.2014.55.7355		12	Oncology	Oncology	CF3BP	WOS:000352422900014		
J	Habasaki, J; Ngai, KL				Habasaki, J.; Ngai, K. L.			Molecular dynamics study of heterogeneous dynamics in lithium disilicate crystal	JOURNAL OF ELECTROCERAMICS			English	Article						Molecular dynamics simulation; Lithium silicate; Glass; Crystal; Heterogeneity	IONICALLY CONDUCTING GLASSES; NA BETA-ALUMINA; POTASSIUM METASILICATE GLASS; ION DYNAMICS; SILICATE-GLASSES; AC-CONDUCTIVITY; DIELECTRIC LOSS; LI DIFFUSIVITY; ACTIVE REGIONS; OXIDE GLASSES	Molecular dynamics (MD) simulations were performed to study the heterogeneous and anisotropic dynamics of lithium ions in lithium disilicate crystal. Mean squared displacements of Li ions show changing dynamics over several time regions before the terminal diffusive regime is attained. Even near the melting point of the system, simulation of several tens of ns was necessary to obtain the diffusion coefficient. Both localized and diffusive motions of ions were observed in the simulations and the dynamics were found to be dominated by the rare event with a long range motion. This situation is similar to the slow dynamics of the glassy counterpart having the same composition, although the mobility of ions is remarkably small (i.e., the diffusivity of Li ions in the crystal at 1400 K is comparable to that in the glass at a much lower temperature of similar to 650 K) due to longer waiting time of jumps. A kind of zig-zag and long length-scale jump motions were observed along the c-axis, while more localized motions are observed along the a- and b-axes at short time scales. At long times these motions tend to mix and the contribution of the motion along a- and b- axes to the diffusion are not negligible. The heterogeneous dynamics is quite similar to the glass and is apparently a universal property independent of structural disorder and dependent on interaction between the mobile ions. The magnitudes of the non-Gaussanity and non-exponentiality of ion dynamics in the crystal is significantly less than in the glass. However, when defects are introduced in the crystal, mobility and dynamics of ions changed considerably as expected.	[Habasaki, J.] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Innovat & Engn Mat, Yokohama, Kanagawa 2268502, Japan; [Ngai, K. L.] Univ Pisa, Dipartimento Fis, I-56127 Pisa, Italy	Habasaki, J (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Innovat & Engn Mat, Nagatsuta 4259, Yokohama, Kanagawa 2268502, Japan.	habasaki.j.aa@m.titech.ac.jp			Ministry of Education, Science, Sports and Culture, Japan [23540439]; Global Scientific Information and Computing Center, Tokyo Institute of Technology [hp120057]	This research by Junko Habasaki was partly supported by the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Scientific Research, 23540439, 2011-2013. A part of this research was performed using a machine time of HPCI Systems Research Projects (Project ID is hp120057.) using TSUBAME 2.0 at Global Scientific Information and Computing Center, Tokyo Institute of Technology. One of the programs used was accelerated using GPU with an assistence of the center.	Adams S, 2012, APPL ENERG, V90, P323, DOI 10.1016/j.apenergy.2011.04.053; Meyer M, 1996, PHYS REV LETT, V76, P2338, DOI 10.1103/PhysRevLett.76.2338; Du XS, 2007, J PHYS CHEM B, V111, P10064, DOI 10.1021/jp072304e; Rinn B, 1998, PHILOS MAG B, V77, P1283, DOI 10.1080/13642819808205021; CRAMER C, 1995, PHILOS MAG B, V71, P713, DOI 10.1080/01418639508238561; NGAI KL, 1983, PHYS REV B, V27, P6031, DOI 10.1103/PhysRevB.27.6031; De Jong BHWS, 1998, ACTA CRYSTALLOGR B, V54, P568, DOI 10.1107/S0108768198001062; LEE WK, 1991, PHYS REV LETT, V67, P1559, DOI 10.1103/PhysRevLett.67.1559; Todorov IT, 2004, PHILOS T ROY SOC A, V362, P1835, DOI 10.1098/rsta.2004.1419; Habasaki J, 1996, J NON-CRYST SOLIDS, V208, P181, DOI 10.1016/S0022-3093(96)00421-8; GILBERT TL, 1968, J CHEM PHYS, V49, P2640, DOI 10.1063/1.1670463; Dieterich W, 2009, SOLID STATE IONICS, V180, P446, DOI 10.1016/j.ssi.2008.09.027; STROM U, 1991, J NON-CRYST SOLIDS, V131, P1011, DOI 10.1016/0022-3093(91)90716-J; Habasaki J, 2006, J NON-CRYST SOLIDS, V352, P5170, DOI 10.1016/j.jnoncrysol.2006.02.178; MAASS P, 1991, PHYS REV LETT, V66, P52, DOI 10.1103/PhysRevLett.66.52; NGAI KL, 1988, PHYS REV B, V38, P10350, DOI 10.1103/PhysRevB.38.10350; Lammert H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.215901; Yashima M, 2005, J AM CHEM SOC, V127, P3491, DOI 10.1021/ja0449224; CAR R, 1985, PHYS REV LETT, V55, P2471, DOI 10.1103/PhysRevLett.55.2471; SCHMIDT-ROHR K, 1991, PHYS REV LETT, V66, P3020, DOI 10.1103/PhysRevLett.66.3020; Habasaki J, 1998, J PHYS SOC JPN, V67, P2012, DOI 10.1143/JPSJ.67.2012; SHLESINGER MF, 1993, NATURE, V363, P31, DOI 10.1038/363031a0; GLASS AM, 1978, J APPL PHYS, V49, P4808, DOI 10.1063/1.325509; Oda T, 2009, J NUCL MATER, V386-88, P1087, DOI 10.1016/j.jnucmat.2008.12.294; Ngai KL, 1999, J CHEM PHYS, V110, P10576, DOI 10.1063/1.478989; Balbuena C, 2013, J NON-CRYST SOLIDS, V369, P17, DOI 10.1016/j.jnoncrysol.2013.03.017; Horbach J, 1996, PHYS REV E, V54, pR5897; HABASAKI J, 1995, PHYS REV E, V52, P2681, DOI 10.1103/PhysRevE.52.2681; BURNS A, 1989, PHYS CHEM GLASSES, V30, P264; Voigt U, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.064207; Lammert H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.125901; Yildirim H, 2012, PHYS CHEM CHEM PHYS, V14, P4565, DOI 10.1039/c2cp22731b; HIWATARI Y, 1974, PROG THEOR PHYS, V52, P1105, DOI 10.1143/PTP.52.1105; NGAI KL, 1993, SOLID STATE IONICS, V61, P345, DOI 10.1016/0167-2738(93)90402-O; Habasaki J, 2013, AIP CONF PROC, V1518, P170, DOI 10.1063/1.4794564; Habasaki J, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4817544; Leon C, 2009, Z PHYS CHEM, V223, P1311, DOI 10.1524/zpch.2009.6081; Fujii K, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4802768; MUNRO B, 1992, BER BUNSEN PHYS CHEM, V96, P1718; Tracht U, 1998, PHYS REV LETT, V81, P2727, DOI 10.1103/PhysRevLett.81.2727; IDA Y, 1976, PHYS EARTH PLANET IN, V13, P97, DOI 10.1016/0031-9201(76)90074-1; NGAI KL, 1992, PHYS CHEM GLASSES, V33, P109; Berthier L, 2011, DYNAMICAL HETEROGENE; VILLA M, 1980, PHYS REV B, V22, P5033, DOI 10.1103/PhysRevB.22.5033; Campos AA, 2006, J APPL PHYS, V100, DOI 10.1063/1.2345465; Diaz-Guillen MR, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.104304; Ediger MD, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4747326; FRANKE W, 1992, BER BUNSEN PHYS CHEM, V96, P1674; Funke K., 1993, SOLID STATE CHEM, V22, P111; Goncalves L. G. V., ARXIV11070760CONDMAT; HABASAKI J, 1995, J NON-CRYST SOLIDS, V183, P12, DOI 10.1016/0022-3093(94)00529-X; Habasaki J, 2007, PHYS CHEM CHEM PHYS, V9, P4673, DOI 10.1039/b704014h; Habasaki J, 1997, PHYS REV B, V55, P6309, DOI 10.1103/PhysRevB.55.6309; Habasaki J, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021604; HABASAKI J, 1992, MOL SIMULAT, V9, P319, DOI 10.1080/08927029208049124; Habasaki J, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.144207; Habasaki J, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3554378; Habasaki J, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3005372; Heuer A, 2002, PHYS CHEM CHEM PHYS, V4, P3185, DOI 10.1039/b201121b; Horbach J., 2003, NIC SERIES, V20, P215; Hove L. V., 1954, PHYS REV, V95, P249; Kracek FC, 1930, J PHYS CHEM-US, V34, P2641, DOI 10.1021/j150318a001; Kuechler R, 2007, J NON-CRYST SOLIDS, V353, P3940, DOI 10.1016/j.jnoncrysol.2007.04.036; Minami T., 1977, J ELECTROCHEM SCI TE, V1960; Montani RA, 2012, SOLID STATE IONICS, V209, P5, DOI 10.1016/j.ssi.2011.12.009; Muller C, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.014203; Nascimento MLF, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3656696; Ngai KL, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2012-30737-2; Ngai KL, 2005, Z PHYS CHEM, V219, P47, DOI 10.1524/zpch.219.1.47.55017; ODAGAKI T, 1981, PHYS REV B, V24, P5284, DOI 10.1103/PhysRevB.24.5284; Ouyang CY, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.104303; RAHMAN A, 1962, PHYS REV, V126, P986, DOI 10.1103/PhysRev.126.986; Vogel M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.184301; Vogel M, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.094302; Wang ZL, 2012, PHYS CHEM CHEM PHYS, V14, P13535, DOI 10.1039/C2CP42391J	75	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1385-3449	1573-8663		J ELECTROCERAM	J. Electroceram.	FEB	2015	34	1					43	56		10.1007/s10832-014-9897-1		14	Materials Science, Ceramics	Materials Science	CF0NW	WOS:000352241900007		
J	Knauth, P; Engel, J; Bishop, SR; Tuller, HL				Knauth, P.; Engel, J.; Bishop, S. R.; Tuller, H. L.			Study of compaction and sintering of nanosized oxide powders by in situ electrical measurements and dilatometry: Nano CeO2-case study	JOURNAL OF ELECTROCERAMICS			English	Article						Cerium dioxide; Ceria; Electronic conductivity; Defect chemistry; Electrical properties	CEO2 SINGLE-CRYSTALS; DOPED CERIUM OXIDE; NANOCRYSTALLINE CERIA; THIN-FILMS; OXYGEN NONSTOICHIOMETRY; TRANSPORT-PROPERTIES; CHEMICAL EXPANSION; GRAIN-BOUNDARY; CONDUCTIVITY; DEFECT	Densification and sintering of CeO2 nanoparticles and their electrical properties were simultaneously studied as a function of temperature in controlled atmosphere using a modified dilatometer. CeO2 nanoparticles simultaneously shrink and become more resistive upon initial heating, associated with desorption of water. The electrical conductance G at 300-550 A degrees C revealed a pO(2) dependence described by log (G) = A + n x log (pO(2)) with n similar to -1/6, consistent with n-type conduction. The results were analyzed with a defect equilibrium model based on the reduction of ceria and formation of doubly ionized oxygen vacancies and electrons. The activation energy was found equal to (1.3 A +/- 0.1) eV, which results in an enthalpy of reduction of (2.7 A +/- 0.4) eV, considerably lower than that for bulk ceria (similar to 4.5 eV). The coarsening of particles during heat treatment at 800 A degrees C were analysed assuming grain boundary diffusion-limited sintering. Although the coarsened powder shows a similar pO(2) dependence, the activation energy was considerably higher (1.9 A +/- 0.1) eV, leading to a reduction enthalpy of (4.5 A +/- 0.4) eV. The decrease in the enthalpy of reduction with decreasing particle size is consistent with the increasing fraction of oxide ions residing at the surface. Alternate interpretations based on space charge effects and surface adsorption/desorption were considered and found to be less consistent with the experimental results.	[Knauth, P.; Engel, J.; Bishop, S. R.; Tuller, H. L.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Knauth, P.] Aix Marseille Univ, CNRS, Madirel UMR 7246, F-13397 Marseille 20, France; [Bishop, S. R.] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 812, Japan	Knauth, P (reprint author), Aix Marseille Univ, CNRS, Madirel UMR 7246, F-13397 Marseille 20, France.	philippe.knauth@univ-amu.fr	Knauth, Philippe/P-6649-2014	Knauth, Philippe/0000-0001-6335-3194	US-Department of Energy-Basic Energy Sciences [DE-SC0002633]; National Science Foundation [DMR-0819762]; World Premier International Research Initiative (WPI), MEXT Japan	The authors acknowledge the US-Department of Energy-Basic Energy Sciences, Grant No. DE-SC0002633 for financial support. This work made use of the MRSEC Shared Experimental Facilities at MIT, supported by the National Science Foundation under award number DMR-0819762. P. K. wishes to thank H. L. T. for the kind hospitality during his sabbatical at the Massachusetts Institute of Technology. The authors thank Dr. Scott Speakman for assistance with the XRD analysis. SRB thanks I2CNER, supported by the World Premier International Research Initiative (WPI), MEXT Japan, for travel funding.	Rupp JLM, 2006, SOLID STATE IONICS, V177, P2513, DOI 10.1016/j.ssi.2006.07.033; Nigara Y, 1999, J ELECTROCHEM SOC, V146, P2948, DOI 10.1149/1.1392033; Tuller HL, 2000, SOLID STATE IONICS, V131, P143, DOI 10.1016/S0167-2738(00)00629-9; Bishop SR, 2009, ACTA MATER, V57, P3596, DOI 10.1016/j.actamat.2009.04.017; JOHNSON DL, 1969, J APPL PHYS, V40, P192, DOI 10.1063/1.1657030; TULLER HL, 1975, J ELECTROCHEM SOC, V122, P255, DOI 10.1149/1.2134190; Yang SW, 2006, J AM CHEM SOC, V128, P9330, DOI 10.1021/ja063359h; Chueh WC, 2012, CHEM MATER, V24, P1876, DOI 10.1021/cm300574v; Mor GK, 2006, SOL ENERG MAT SOL C, V90, P2011, DOI 10.1016/j.solmat.2006.04.007; YAHIRO H, 1988, J APPL ELECTROCHEM, V18, P527, DOI 10.1007/BF01022246; Sun CW, 2012, ENERG ENVIRON SCI, V5, P8475, DOI 10.1039/c2ee22310d; Hwang JH, 1998, Z PHYS CHEM, V207, P21; Kim S, 2002, J ELECTROCHEM SOC, V149, pJ73, DOI 10.1149/1.1507597; Litzelman SJ, 2009, SOLID STATE IONICS, V180, P1190, DOI 10.1016/j.ssi.2009.05.013; Weibel A, 2005, CHEM MATER, V17, P2378, DOI 10.1021/cm0403762; Djenizian T, 2011, J MATER CHEM, V21, P9925, DOI 10.1039/c0jm04205f; Mai HX, 2005, J PHYS CHEM B, V109, P24380, DOI 10.1021/jp055584b; Mogensen M, 2000, SOLID STATE IONICS, V129, P63, DOI 10.1016/S0167-2738(99)00318-5; Muccillo R, 2013, J EUR CERAM SOC, V33, P515, DOI 10.1016/j.jeurceramsoc.2012.09.020; Kuhn M, 2013, ACTA MATER, V61, P4277, DOI 10.1016/j.actamat.2013.04.001; Marrocchelli D, 2012, ADV FUNCT MATER, V22, P1958, DOI 10.1002/adfm.201102648; Knauth P, 1999, J APPL PHYS, V85, P897, DOI 10.1063/1.369208; HAGFELDT A, 1995, CHEM REV, V95, P49, DOI 10.1021/cr00033a003; Rupp JLM, 2006, ACTA MATER, V54, P1721, DOI 10.1016/j.actamat.2005.11.032; Bishop SR, 2009, ELECTROCHIM ACTA, V54, P1436, DOI 10.1016/j.electacta.2008.09.026; TULLER HL, 1977, J PHYS CHEM SOLIDS, V38, P859, DOI 10.1016/0022-3697(77)90124-X; Wachsman ED, 2011, SCIENCE, V334, P935, DOI 10.1126/science.1204090; Nowick AS, 1998, PHYS REV B, V58, P8398, DOI 10.1103/PhysRevB.58.8398; Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Avila-Paredes HJ, 2010, J MATER CHEM, V20, P6235, DOI 10.1039/c0jm00051e; Chiang YM, 1996, APPL PHYS LETT, V69, P185, DOI 10.1063/1.117366; Engel J, 2014, ADV FUNCT MATER, V24, P4952, DOI 10.1002/adfm.201400203; GOPEL W, 1995, SENSOR ACTUAT B-CHEM, V26, P1, DOI 10.1016/0925-4005(94)01546-T; Hayun S, 2011, J AM CERAM SOC, V94, P3679, DOI 10.1111/j.1551-2916.2011.04843.x; Hwang JH, 1999, J ELECTROCERAM, V3, P7, DOI 10.1023/A:1009998114205; Kim S, 2004, SURF SCI, V549, P196, DOI 10.1016/j.susc.2003.12.002; Knauth P, 2000, SOLID STATE IONICS, V136, P1215, DOI 10.1016/S0167-2738(00)00588-9; Knauth P, 1999, J EUR CERAM SOC, V19, P831, DOI 10.1016/S0955-2219(98)00326-4; Laberty-Robert C., 2006, CHEM MAT, V18; Chiang YM, 1997, J ELECTROCERAM, V1, P7; Lee KR, 2013, PHYS CHEM CHEM PHYS, V15, P15632, DOI 10.1039/c3cp43625j; Macdonald J. R., 1987, IMPEDANCE SPECTROSCO; Maglia F, 2012, J MATER RES, V27, P1975, DOI 10.1557/jmr.2012.158; Maier J., 2002, NANOCRYSTALLINE META, P84; Mazar O., 2013, THESIS ISRAEL I TECH; Neltner B, 2010, ACS NANO, V4, P3227, DOI 10.1021/nn100346h; Perry NH, 2011, J AM CERAM SOC, V94, P508, DOI 10.1111/j.1551-2916.2010.04093.x; Porat O., 1997, NANOPHASE NANOCOMPOS, P99; SAYLE TXT, 1992, J CHEM SOC CHEM COMM, P977, DOI 10.1039/c39920000977; Swaroop S, 2005, ACTA MATER, V53, P4975, DOI 10.1016/j.actamat.2005.05.031; Tschope A, 1996, SENSOR ACTUAT B-CHEM, V31, P111, DOI 10.1016/0925-4005(96)80025-6; Tschope A, 2001, SOLID STATE IONICS, V139, P267, DOI 10.1016/S0167-2738(01)00677-4; TULLER HL, 1979, J ELECTROCHEM SOC, V126, P209, DOI 10.1149/1.2129007; Tuller HL, 2009, PHYS CHEM CHEM PHYS, V11, P3023, DOI 10.1039/b901906e; Varghese OK, 2000, J APPL PHYS, V87, P7457, DOI 10.1063/1.373010; Xiong YP, 2011, SOLID STATE IONICS, V192, P476, DOI 10.1016/j.ssi.2010.07.017	56	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1385-3449	1573-8663		J ELECTROCERAM	J. Electroceram.	FEB	2015	34	1					82	90		10.1007/s10832-014-9946-9		9	Materials Science, Ceramics	Materials Science	CF0NW	WOS:000352241900012		
J	Hirano, D; Kitade, Y; Ohshima, KI; Fukamachi, Y				Hirano, Daisuke; Kitade, Yujiro; Ohshima, Kay I.; Fukamachi, Yasushi			The role of turbulent mixing in the modified Shelf Water overflows that produce Cape Darnley Bottom Water	JOURNAL OF GEOPHYSICAL RESEARCH-OCEANS			English	Article							ANTARCTIC SLOPE FRONT; SOUTHERN-OCEAN; EAST ANTARCTICA; OVERTURNING CIRCULATION; CONTINENTAL-SHELF; CRITICAL LATITUDE; ROSS-SEA; DISSIPATION; MICROSTRUCTURE; VARIABILITY	The mixing process associated with modified Shelf Water (mSW) overflows that eventually mix to form Cape Darnley Bottom Water (CDBW) was investigated by hydrographic and microstructure observations off the Cape Darnley Polynya (CDP), East Antarctica, in January 2009. Closely spaced microstructure observations revealed that mSW properties varied considerably within a distance of similar to 4 km across the shelf edge. Near the bottom, the rate of turbulent kinetic energy dissipation was enhanced to values greater than 1027 W kg(-1), and the vertical scale of the bottom boundary layer (BBL) was on the order of 10 m. The observed BBL around the shelf edge was characterized by strong vertical mixing with turbulent eddy diffusivities of similar to O(102321022) m(2) s(-1). A geostrophically balanced density current, which resulted from the presence of mSW over the continental shelf, is considered the primary energy source for the turbulent mixing in the BBL. This turbulent mixing transforms the overflowing mSW through mixing with ambient water masses, specifically with the overlying modified Circumpolar Deep Water. The BBL is also thought to partly contribute to the gradual descent of mSW down the continental slope through bottom Ekman transport. We conclude that turbulent mixing, primarily caused by a density current, plays an important role in CDBW formation, by modifying the mSW overflowing from the CDP.	[Hirano, Daisuke] Natl Inst Polar Res, Tachikawa, Tokyo, Japan; [Hirano, Daisuke; Kitade, Yujiro] Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Tokyo, Japan; [Ohshima, Kay I.; Fukamachi, Yasushi] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan	Hirano, D (reprint author), Natl Inst Polar Res, Tachikawa, Tokyo, Japan.	hirano.daisuke@nipr.ac.jp	Ohshima, Kay/D-6909-2012; KITADE, Yujiro/O-1912-2014		Ministry of Education, Culture, Sports, Science and Technology, Japan [20221001, 20540419, 23310003, 23340135, 25241001]	All data used in this study were obtained on the 27th cruise of T/RV Umitaka-Maru of Tokyo University of Marine Science and Technology and their metadata are available at the National Institute of Polar Research Science Database (http://scidbase.nipr.ac.jp/modules/metadata/index.php?cat5umitaka). We wish to thank Captain Yoshihiro Kurita and crews of the T/RV Umitaka-maru for their help in carrying out the observations. We express our appreciation to Guy Williams for his useful comments. This work was supported by Grants-in-Aids for Scientific Research (20221001, 20540419, 23310003, 23340135, and 25241001) of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	AINLEY DG, 1981, DEEP-SEA RES, V28, P1173, DOI 10.1016/0198-0149(81)90054-6; Furevik T, 1996, J GEOPHYS RES-OCEANS, V101, P8823, DOI 10.1029/96JC00081; Makinson K, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003062; Padman L, 2002, ANN GLACIOL, V34, P247, DOI 10.3189/172756402781817752; DEWEY RK, 1988, J PHYS OCEANOGR, V18, P1167, DOI 10.1175/1520-0485(1988)018<1167:BSEFVD>2.0.CO;2; Muench R, 2009, J MARINE SYST, V77, P369, DOI 10.1016/j.jmarsys.2008.11.003; Jackett DR, 1997, J PHYS OCEANOGR, V27, P237, DOI 10.1175/1520-0485(1997)027<0237:ANDVFT>2.0.CO;2; Marshall J, 2012, NAT GEOSCI, V5, P171, DOI [10.1038/ngeo1391, 10.1038/NGEO1391]; Orsi AH, 2009, DEEP-SEA RES PT II, V56, P778, DOI 10.1016/j.dsr2.2008.10.033; Meredith MP, 2000, J GEOPHYS RES-OCEANS, V105, P1093, DOI 10.1029/1999JC900263; Tamura T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032903; Orsi AH, 1999, PROG OCEANOGR, V43, P55, DOI 10.1016/S0079-6611(99)00004-X; Rintoul Sr, 1998, ANTARCT RES SER, V75, P151; Sloyan BM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023568; OAKEY NS, 1982, J PHYS OCEANOGR, V12, P256, DOI 10.1175/1520-0485(1982)012<0256:DOTROD>2.0.CO;2; GILL AE, 1973, DEEP-SEA RES, V20, P111, DOI 10.1016/0011-7471(73)90048-X; Gordon AL, 2009, DEEP-SEA RES PT II, V56, P796, DOI 10.1016/j.dsr2.2008.10.037; Whitworth T, 1998, ANTARCT RES SER, V75, P1; JACOBS SS, 1970, DEEP-SEA RES, V17, P935, DOI 10.1016/0011-7471(70)90046-X; Visbeck M, 2002, J ATMOS OCEAN TECH, V19, P794, DOI 10.1175/1520-0426(2002)019<0794:DVPULA>2.0.CO;2; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; Wolk F, 2002, J ATMOS OCEAN TECH, V19, P780, DOI 10.1175/1520-0426(2002)019<0780:ANFFPF>2.0.CO;2; Sheen KL, 2013, J GEOPHYS RES-OCEANS, V118, P2774, DOI 10.1002/jgrc.20217; NOF D, 1983, DEEP-SEA RES, V30, P171, DOI 10.1016/0198-0149(83)90067-5; Ohshima KI, 2013, NAT GEOSCI, V6, P235, DOI 10.1038/NGEO1738; Garabato ACN, 2004, SCIENCE, V303, P210, DOI 10.1126/science.1090929; Ito T, 2008, J PHYS OCEANOGR, V38, P2832, DOI 10.1175/2008JPO3878.1; Wu LX, 2011, NAT GEOSCI, V4, P363, DOI 10.1038/NGEO1156; Johnson GC, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004477; Whitworth T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026357; Baines PG, 1998, ANTARCT RES SER, V75, P29; DEWEY RK, 1988, DYNAM ATMOS OCEANS, V12, P143, DOI 10.1016/0377-0265(88)90023-1; Gordon A. L., 1972, ANTARCTIC OCEANOLOGY, P59; Heywood KJ, 2002, NATURE, V415, P1011, DOI 10.1038/4151011a; Hirano D, 2010, J OCEANOGR, V66, P95; Jacobs S., 1977, DEEP SEA RES       S, V24, P43; Kunze E., 2004, OCEANOGRAPHY, V17, P55, DOI DOI 10.5670/OCEANOG.2004.67; Lien RC, 2001, J GEOPHYS RES-OCEANS, V106, P4575, DOI 10.1029/2000JC000351; Matsumoto K., 2000, J OCEANOGR, V56, P567, DOI DOI 10.1023/A:1011157212596; Matsumura Y, 2011, J PHYS OCEANOGR, V41, P2402, DOI 10.1175/JPO-D-10-05014.1; Meijers AJS, 2010, DEEP-SEA RES PT II, V57, P723, DOI 10.1016/j.dsr2.2009.04.019; Nakayama Y, 2014, J PHYS OCEANOGR, V44, P2921, DOI 10.1175/JPO-D-14-0069.1; Nasmyth P. W., 1970, THESIS U B C VANCOUV; Padman L., 2008, DEEP SEA RES 2, V56, P818; PEDLOSKY J., 1987, GEOPHYS FLUID DYNAMI; Prandle D., 1982, GEOPHYS ASTROPHYS FL, V22, P22; Strickland J. D. H., 1968, PRACTICAL HDB SEAWAT, V167, P71; Thompson AF, 2007, J PHYS OCEANOGR, V37, P572, DOI 10.1175/JPO3021.1; Williams GD, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005812; Wong APS, 2013, GEOPHYS RES LETT, V40, P6186, DOI 10.1002/2013GL058125	50	0	0	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-9275	2169-9291		J GEOPHYS RES-OCEANS	J. Geophys. Res.-Oceans	FEB	2015	120	2					910	922		10.1002/2014JC010059		13	Oceanography	Oceanography	CE9HM	WOS:000352154800020		
J	Doi, T; Behera, SK; Yamagata, T				Doi, Takeshi; Behera, Swadhin K.; Yamagata, Toshio			An interdecadal regime shift in rainfall predictability related to the Ningaloo Nino in the late 1990s	JOURNAL OF GEOPHYSICAL RESEARCH-OCEANS			English	Article							SEA-SURFACE TEMPERATURE; AUSTRALIAN SUMMER MONSOON; GLOBAL PRECIPITATION; ENSO PREDICTION; CLIMATE-CHANGE; INDIAN-OCEAN; VARIABILITY; MODEL; CONVECTION; PACIFIC	The global warming and the Interdecadal Pacific Oscillation (IPO) started influencing the coastal ocean off Western Australia, leading to a dramatic change in the regional climate predictability. The warmer ocean started driving rainfall variability regionally there after the late 1990s. Because of this, rainfall predictability near the coastal region of Western Australia on a seasonal time scale was drastically enhanced in the late 1990s; it is significantly predictable 5 months ahead after the late 1990s. The high prediction skill of the rainfall in recent decades is very encouraging and would help to develop an early warning system of Ningaloo Nino/Nina events to mitigate possible societal as well as agricultural impacts in the granary of Western Australia.	[Doi, Takeshi; Behera, Swadhin K.; Yamagata, Toshio] Applicat Lab JAMSTEC, Yokohama, Kanagawa, Japan	Doi, T (reprint author), Applicat Lab JAMSTEC, Yokohama, Kanagawa, Japan.	takeshi.doi@jamstec.go.jp	Yamagata, Toshio/A-1807-2009; Doi, Takeshi/C-1989-2013		Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [2-1405]	We thank Tomoki Tozuka and Takahito Kataoka for helpful comments and suggestions. The observed and reanalysis data sets for this paper are available at NOAA's Earth System Research Laboratory/Physical Sciences Division (http://www.esrl.noaa.gov/psd/data/). The SINTEX-F1 climate prediction system was produced by the Earth Simulator at JAMSTEC. We are grateful to Jing-Jia Luo, Sebastien Masson, and our European colleagues of INGV/CMCC and L'OCEAN for their contribution to the development of the prototype of the prediction model. This research was supported by the Environment Research and Technology Development Fund (2-1405) of the Ministry of the Environment, Japan.	Behringer DW, 1998, MON WEATHER REV, V126, P1013, DOI 10.1175/1520-0493(1998)126<1013:AICMFE>2.0.CO;2; Han WQ, 2014, CLIM DYNAM, V43, P1357, DOI 10.1007/s00382-013-1951-1; Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Kataoka T, 2014, CLIM DYNAM, V43, P1463, DOI 10.1007/s00382-013-1961-z; Luo JJ, 2010, J CLIMATE, V23, P726, DOI 10.1175/2009JCLI3104.1; Depczynski M, 2013, CORAL REEFS, V32, P233, DOI 10.1007/s00338-012-0974-0; Johnson NC, 2010, NAT GEOSCI, V3, P842, DOI [10.1038/ngeo1008, 10.1038/NGEO1008]; Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; GADGIL S, 1984, NATURE, V312, P141, DOI 10.1038/312141a0; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Hung CW, 2004, Q J ROY METEOR SOC, V130, P739, DOI 10.1256/qj.02.191; Tozuka T, 2014, CLIM DYNAM, V43, P2197, DOI 10.1007/s00382-013-2044-x; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; Feng M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042796; Pearce AF, 2013, J MARINE SYST, V111, P139, DOI 10.1016/j.jmarsys.2012.10.009; Luo JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032793; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Liebmann B, 1996, B AM METEOROL SOC, V77, P1275; GRAHAM NE, 1987, SCIENCE, V238, P657, DOI 10.1126/science.238.4827.657; Luo JJ, 2005, J CLIMATE, V18, P4474, DOI 10.1175/JCLI3526.1; Ashok K, 2009, NATURE, V461, P481, DOI 10.1038/461481a; Arakawa O, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020283; Vecchi GA, 2008, SCIENCE, V322, P687, DOI 10.1126/science.1164396; Luo JJ, 2008, J CLIMATE, V21, P84, DOI 10.1175/2007JCLI1412.1; Lau NC, 2000, J CLIMATE, V13, P4287, DOI 10.1175/1520-0442(2000)013<4287:IOEOTV>2.0.CO;2; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Jin EK, 2008, CLIM DYNAM, V31, P647, DOI 10.1007/s00382-008-0397-3; Luo JJ, 2005, J CLIMATE, V18, P2344, DOI 10.1175/JCLI3404.1; Ashok K, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017926; HENDON HH, 1990, J ATMOS SCI, V47, P2227, DOI 10.1175/1520-0469(1990)047<2227:ACSOOO>2.0.CO;2; Wernberg T, 2013, NAT CLIM CHANGE, V3, P78, DOI [10.1038/nclimate1627, 10.1038/NCLIMATE1627]; Chen JY, 2008, J CLIMATE, V21, P2634, DOI 10.1175/2007JCLI2012.1; Doi T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02892; Feng M, 2015, GEOPHYS RES LETT, V42, P104, DOI 10.1002/2014GL062509; Feng M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01277; Hendon HH, 2010, CLIM DYNAM, V34, P1129, DOI 10.1007/s00382-009-0570-3; Kumar A, 2013, J CLIMATE, V26, P5674, DOI 10.1175/JCLI-D-12-00731.1; Zinke J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4607	39	4	4	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-9275	2169-9291		J GEOPHYS RES-OCEANS	J. Geophys. Res.-Oceans	FEB	2015	120	2					1388	1396		10.1002/2014JC010562		9	Oceanography	Oceanography	CE9HM	WOS:000352154800048		
J	Kato, M; Hanyu, Y				Kato, Mieko; Hanyu, Yoshiro			Potentiation of antigen-specific antibody production by peptides derived from Ag85B of Mycobacterium tuberculosis	JOURNAL OF IMMUNOLOGICAL METHODS			English	Article						Antibody; Immunization; Adjuvant; Peptide-25; MHC-II; Th2	IN-VITRO IMMUNIZATION; HUMAN MONOCLONAL-ANTIBODIES; ADJUVANTS PREPARATION; VACCINE ADJUVANTS; CELL-ACTIVATION; RESPONSES; ELECTROFUSION; FORMULATION; DONORS	To generate high-titer monoclonal antibodies, strong immuno-stimulation must be used for eliciting an intense cellular immune response. Here, we report that antigen-specific antibody production was potentiated by Peptide-25 derived from Ag85B of Mycobacterium tuberculosis, and that the production of antigen-specific IgG1 in particular was markedly potentiated; specifically, this occurred because the use of Peptide-25 resulted in an increase in the number of antigen-specific antibody- producing cells. We studied the activation of T cells by the peptide by examining gene expression. The observed expression pattern of GATA-3 and T-bet suggests that the peptide modulates the Th1/Fh2 balance during immunization. This potentiation, which was remarkably high in BALB/c mice, could be applied in the immunization performed for monoclonal antibody production in vivo and in vitro. (C) 2014 Elsevier B.V. All rights reserved.	[Kato, Mieko] Biopeak Co Ltd, Takasaki, Gumma 3700854, Japan; [Hanyu, Yoshiro] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Mol Composite Med Res Grp, Tsukuba, Ibaraki 3058566, Japan	Hanyu, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Mol Composite Med Res Grp, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	y.hanyu@aist.go.jp					de Titta A, 2013, P NATL ACAD SCI USA, V110, P19902, DOI 10.1073/pnas.1313152110; Yu XC, 2008, J IMMUNOL METHODS, V336, P142, DOI 10.1016/j.jim.2008.04.008; Weeratna RD, 2000, VACCINE, V18, P1755, DOI 10.1016/S0264-410X(99)00526-5; Mizumachi K, 2003, BIOSCI BIOTECH BIOCH, V67, P712; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Tamura T, 2004, INT IMMUNOL, V16, P1691, DOI 10.1093/intimm/dxh170; Stills HF, 2005, ILAR J, V46, P280; Cribbs DH, 2003, INT IMMUNOL, V15, P505, DOI 10.1093/intimm/dxg049; Aguilar JC, 2007, VACCINE, V25, P3752, DOI 10.1016/j.vaccine.2007.01.111; Gupta RK, 1998, DEV BIOLOGICALS, V92, P63; Kato M, 2012, J IMMUNOL METHODS, V386, P60, DOI 10.1016/j.jim.2012.08.019; Ariga H, 2007, IMMUNOLOGY, V122, P210, DOI 10.1111/j.1365-2567.2007.02630.x; Bold TD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002063; CHIN LT, 1995, EUR J IMMUNOL, V25, P657, DOI 10.1002/eji.1830250305; CHIN LT, 1994, IMMUNOLOGY, V81, P428; Crowe JE, 2009, VACCINE, V27, pG47, DOI 10.1016/j.vaccine.2009.10.124; Ge Q, 2002, P NATL ACAD SCI USA, V99, P13729, DOI 10.1073/pnas.212515299; Haensler J, 2010, METHODS MOL BIOL, V626, P73, DOI 10.1007/978-1-60761-585-9_6; Jackson LR., 1995, ILAR J, V37, P141; Kato M, 2011, J IMMUNOL METHODS, V373, P102, DOI 10.1016/j.jim.2011.08.008; KETTLEBOROUGH CA, 1991, PROTEIN ENG, V4, P773, DOI 10.1093/protein/4.7.773; Kikuchi T, 2006, IMMUNOLOGY, V117, P47, DOI 10.1111/j.1365-2567.2005.02262.x; Malyala P, 2010, METHODS MOL BIOL, V626, P91, DOI 10.1007/978-1-60761-585-9_7; Matsumoto S, 2008, J IMMUNOL METHODS, V332, P2, DOI 10.1016/j.jim.2007.12.005; Schmidt CS, 2007, EXPERT REV VACCINES, V6, P391, DOI 10.1586/14760584.6.3.391; Takamura S, 2005, J IMMUNOL, V175, P2541; Takatsu K., 2003, INT IMMUNOPHARMACOL	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-1759	1872-7905		J IMMUNOL METHODS	J. Immunol. Methods	FEB	2015	417						45	51		10.1016/j.jim.2014.12.005		7	Biochemical Research Methods; Immunology	Biochemistry & Molecular Biology; Immunology	CE7UE	WOS:000352046500005		
J	Buck, D; Ishihara, K				Buck, Dorothy; Ishihara, Kai			Coherent band pathways between knots and links	JOURNAL OF KNOT THEORY AND ITS RAMIFICATIONS			English	Article						Coherent band surgery; nullification move; DNA	SITE-SPECIFIC RECOMBINATION; CATENANES; MECHANISM; STEREOSTRUCTURE; NULLIFICATION; INTEGRASE; INVARIANT; SURGERY	We categorize coherent band (aka nullification) pathways between knots and 2-component links. Additionally, we characterize the minimal coherent band pathways (with intermediates) between any two knots or 2-component links with small crossing number. We demonstrate these band surgeries for knots and links with small crossing number. We apply these results to place lower bounds on the minimum number of recombinant events separating DNA configurations, restrict the recombination pathways and determine chirality and/or orientation of the resulting recombinant DNA molecules.	[Buck, Dorothy] Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2AZ, England; [Ishihara, Kai] Yamaguchi Univ, Fac Educ, Yamaguchi 7538511, Japan	Buck, D (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Math, Huxley Bldg, London SW7 2AZ, England.	d.buck@imperial.ac.uk; kisihara@yamaguchi-u.ac.jp			The Leverhulme Trust Research Grant [RP2013-K-017]; EPSRC [G039585/1, H031367/1]; Japan Society for the Promotion of Science KAKENHI [26800081]	The authors would like to thank Claus Ernst, Akio Kawauchi, Taizo Kanenobu and Robert Scharein for their helpful discussions. They also would like to thank the reviewer for the careful reading. This work is partially supported by The Leverhulme Trust Research Grant RP2013-K-017 and EPSRC grants G039585/1 and H031367/1 to Dorothy Buck, and EPSRC grant H031367/1 and the Japan Society for the Promotion of Science KAKENHI 26800081 to Kai Ishihara.	Abe T., 2014, KOBE J MATH, V31, P21; Crisona NJ, 1999, J MOL BIOL, V289, P747, DOI 10.1006/jmbi.1999.2771; Olorunniji FJ, 2012, P NATL ACAD SCI USA, V109, P19661, DOI 10.1073/pnas.1210964109; Kanenobu T, 2012, J KNOT THEOR RAMIF, V21, DOI 10.1142/S0218216512500861; MURASUGI K, 1965, T AM MATH SOC, V117, P387; Buck D, 2007, J MOL BIOL, V374, P1186, DOI 10.1016/j.jmb.2007.10.016; WASSERMAN SA, 1985, SCIENCE, V229, P171, DOI 10.1126/science.2990045; HOESS RH, 1986, NUCLEIC ACIDS RES, V14, P2287, DOI 10.1093/nar/14.5.2287; Shimokawa K, 2013, P NATL ACAD SCI USA, V110, P20906, DOI 10.1073/pnas.1308450110; Grainge I, 2007, EMBO J, V26, P4228, DOI 10.1038/sj.emboj.7601849; SPENGLER SJ, 1985, CELL, V42, P325, DOI 10.1016/S0092-8674(85)80128-8; Kanenobu T, 2010, J KNOT THEOR RAMIF, V19, P1535, DOI 10.1142/S0218216510008522; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; ERNST C, 1990, MATH PROC CAMBRIDGE, V108, P489, DOI 10.1017/S0305004100069383; Baader S, 2006, Q J MATH, V57, P139, DOI 10.1093/qmath/hai010; Buck D., 2011, MATH KNOTS, V4, P182; Cerf C, 1997, J KNOT THEOR RAMIF, V6, P621, DOI 10.1142/S0218216597000340; Colloms SD, 1997, CELL, V88, P855, DOI 10.1016/S0092-8674(00)81931-5; Cox M. M., 1989, MOBILE DNA, P661; Darcy IK, 2012, ALGEBR GEOM TOPOL, V12, P1183, DOI 10.2140/agt.2012.12.1183; Diao YN, 2012, J KNOT THEOR RAMIF, V21, DOI 10.1142/S0218216511009984; Ernst C, 2011, PROG THEOR PHYS SUPP, P66; Fox R. H., 1966, OSAKA J MATH, P257; Ishihara K, 2011, PROG THEOR PHYS SUPP, P245; Kanenobu T., 2013, P RIMS C KOKY INT LO, V1866, P105; Kanenobu T., 2014, B SOC MAT MEX, V20, P467; Kanenobu T, 2011, J KNOT THEOR RAMIF, V20, P813, DOI 10.1142/S0218216511008991; Kanenobu T., 2009, COMMUN MATH RES, V25, P433; Kawauchi A., PREPRINT; Kawauchi A., 2007, LECT KNOT THEORY; ROBERTEL.RA, 1965, COMMUN PUR APPL MATH, V18, P543, DOI 10.1002/cpa.3160180309; Rolfsen D., 2003, KNOTS LINKS; Sola D., 1991, REND SEMIN MAT U PAD, V86, P1; WASSERMAN SA, 1985, P NATL ACAD SCI USA, V82, P1079, DOI 10.1073/pnas.82.4.1079	34	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-2165	1793-6527		J KNOT THEOR RAMIF	J. Knot Theory Ramifications	FEB	2015	24	2							1550006	10.1142/S0218216515500066		21	Mathematics	Mathematics	CF7HU	WOS:000352727900002		
J	Morimoto, K				Morimoto, Kanji			On composite types of tunnel number two knots	JOURNAL OF KNOT THEORY AND ITS RAMIFICATIONS			English	Article						(g, b)-decompositions; tunnel number two knots; connected sum	3-MANIFOLDS	Let K be a tunnel number two knot. Then, by considering the (g, b)-decompositions, K is one of (3, 0), (2, 1), (1, 2) or (0, 3)-knots. In this paper, we analyze the connected sum summands of composite tunnel number two knots and give a complete table of those summands from the point of view of (g, b)-decompositions.	Konan Univ, Dept IS & Math, Higashinada Ku, Kobe, Hyogo 6588501, Japan	Morimoto, K (reprint author), Konan Univ, Dept IS & Math, Higashinada Ku, Okamoto 8-9-1, Kobe, Hyogo 6588501, Japan.	morimoto@konan-u.ac.jp					Hempel J, 2001, TOPOLOGY, V40, P631, DOI 10.1016/S0040-9383(00)00033-1; DOLL H, 1992, MATH ANN, V294, P701, DOI 10.1007/BF01934349; Johnson J, 2011, J KNOT THEOR RAMIF, V20, P609, DOI 10.1142/S0218216511009376; Li T., 2013, ARXIVMATH13105054; Minsky YN, 2007, ALGEBR GEOM TOPOL, V7, P1471, DOI 10.2140/agt.2007.7.1471; MORIMOTO K, 1993, TOPOL APPL, V53, P37, DOI 10.1016/0166-8641(93)90099-Y; MORIMOTO K, 1995, TOPOL APPL, V64, P165, DOI 10.1016/0166-8641(94)00096-L; Morimoto K, 2001, J KNOT THEOR RAMIF, V10, P823, DOI 10.1142/S0218216501001189; NORWOOD FH, 1982, P AM MATH SOC, V86, P143, DOI 10.2307/2044414; OCHIAI M, 1983, OSAKA J MATH, V20, P461; Ozawa M., 1998, P APPL MATH WORKSHOP, V8, P227; Schubert H., 1949, S B HEIDELBERGER MN, V1949, P57; Schubert H, 1954, MATH Z, V61, P245, DOI 10.1007/BF01181346	13	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-2165	1793-6527		J KNOT THEOR RAMIF	J. Knot Theory Ramifications	FEB	2015	24	2							1550013	10.1142/S0218216515500133		10	Mathematics	Mathematics	CF7HU	WOS:000352727900007		
J	Hashimoto, F; Richter, S; Nolte, S; Ozeki, Y; Itoh, K				Hashimoto, F.; Richter, S.; Nolte, S.; Ozeki, Y.; Itoh, K.			Time-resolved Micro-Raman Measurement of Temperature Dynamics during High-Repetition-Rate Ultrafast Laser Microprocessing	JOURNAL OF LASER MICRO NANOENGINEERING			English	Article						femtosecond laser; microprocessing; time-resolved measurement; Raman temperature measurement; thermal process; temperature dynamics; heat accumulation	RATE FEMTOSECOND LASER; TRANSPARENT MATERIALS; HEAT ACCUMULATION; WAVE-GUIDES; PULSES; GLASS	We employed time-resolved micro-Raman spectroscopy to investigate the temperature dynamics inside glass during high-repetition-rate femtosecond laser microprocessing. We measured the temperature evolutions as functions of the distance from the focus of femtosecond laser pulses, although it was difficult to acquire Raman spectra at locations near the focus due to the onset of strong background emissions. The measured temperature data were fitted by, taking the heat accumulation of successive laser pulses into account. We further investigated the dependence of temperature increase on the processing parameters. Our results suggest that the monitoring of thermal process is useful not only for process optimization but also for detailed in situ analysis of thermal process in high-repetition-rate femtosecond laser microprocessing.	[Hashimoto, F.; Ozeki, Y.; Itoh, K.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Richter, S.; Nolte, S.] Univ Jena, Inst Appl Phys, D-07743 Jena, Germany	Hashimoto, F (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	hashimoto@photonics.mls.eng.osaka-u.ac.jp					Shimizu M, 2012, OPT EXPRESS, V20, P934, DOI 10.1364/OE.20.000934; Eaton SM, 2011, J NON-CRYST SOLIDS, V357, P2387, DOI 10.1016/j.jnoncrysol.2010.11.082; Schaffer CB, 2003, APPL PHYS A-MATER, V76, P351, DOI 10.1007/s00339-002-1819-4; Eaton SM, 2005, OPT EXPRESS, V13, P4708, DOI 10.1364/OPEX.13.004708; Itoh K, 2006, MRS BULL, V31, P620, DOI 10.1557/mrs2006.159; Eaton SM, 2008, OPT EXPRESS, V16, P9443, DOI 10.1364/OE.16.009443; Tamaki T, 2005, JPN J APPL PHYS 2, V44, pL687, DOI 10.1143/JJAP.44.L687; Richter S, 2011, APPL PHYS A-MATER, V103, P257, DOI 10.1007/s00339-011-6369-1; Miyamoto I, 2011, OPT EXPRESS, V19, P10714, DOI 10.1364/OE.19.010714; Shimizu M., 2010, J APPL PHYS, V108; Yoshino T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.102403	11	0	0	JAPAN LASER PROCESSING SOC	OSAKA	OSAKA UNIV, 11-1 MIHOGAOKA, IBARAKI C/O KATAYAMA LAB, JOINING & WELDING RES INST, OSAKA, 567-0047, JAPAN	1880-0688			J LASER MICRO NANOEN	J. Laser Micro Nanoeng.	FEB	2015	10	1					29	32		10.2961/jlmn.2015.01.0006		4	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Optics; Physics, Applied	Science & Technology - Other Topics; Materials Science; Optics; Physics	CF1LA	WOS:000352305600006		
J	Yasumaru, N; Sentoku, E; Haga, M; Kiuchi, J				Yasumaru, Naoki; Sentoku, Eisuke; Haga, Masakazu; Kiuchi, Junsuke			Femtosecond-Laser-Induced Nanostructure and High Ablation Rate Observed on Nitrided Alloy Steel	JOURNAL OF LASER MICRO NANOENGINEERING			English	Article						femtosecond-laser ablation; nanostructure; alloy steel; nitriding; tribology	STAINLESS-STEEL; DEPENDENCE; PULSES	Femtosecond (fs)-laser-induced nanostructuring of mainly nitrided die steel (1.5C-12Cr) was experimentally investigated using die steel that was heat-treated and then plasma nitrided. Nitrided stainless steel (18Cr-8Ni) and low-carbon steel (0.1C) were also used to examine the influence of the alloy composition. Periodic nanostructures were formed in the direction perpendicular to the laser polarization and the mean spacing D increased with the fluence F. The minimum D values for alloy steels containing Cr observed at F around the ablation threshold were 250-285 nm, which corresponds to a size of about lambda/3. In contrast, the minimum D for low-carbon steel was larger at 20 to 30% more than those of the alloy steels. In addition, the ablation rate was obtained by analysis of the cross-sectional profiles of craters ablated by superimposed fs-laser pulses. Although the ablation rates for the non-nitrided steels increased linearly with F on a logarithmic scale, it should be noted that the ablation rate for nitrided die or stainless steels increased faster than linearly with F.	[Yasumaru, Naoki; Sentoku, Eisuke; Haga, Masakazu] Fukui Natl Coll Technol, Fukui 9168507, Japan; [Kiuchi, Junsuke] Eyetec Co Ltd, Fukui 9160016, Japan	Yasumaru, N (reprint author), Fukui Natl Coll Technol, Geshi Cho, Fukui 9168507, Japan.	yasuma@fukui-nct.ac.jp			JSPS KAKENHI [24360312]	A part of this work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (B) Grant Number 24360312.	Miyaji G, 2012, OPT EXPRESS, V20, P14848, DOI 10.1364/OE.20.014848; Miyaji G, 2008, OPT EXPRESS, V16, P16265, DOI 10.1364/OE.16.016265; Qi LT, 2009, OPT LETT, V34, P1846, DOI 10.1364/OL.34.001846; Yasumaru N, 1998, MATER T JIM, V39, P1046; Yasumaru N, 2008, APPL SURF SCI, V254, P2364, DOI 10.1016/j.apsusc.2007.09.037; Yasumaru N, 2005, APPL PHYS A-MATER, V81, P933, DOI 10.1007/s00339-005-3218-0; Hashida M, 2002, APPL SURF SCI, V197, P862, DOI 10.1016/S0169-4332(02)00463-4; Hou SS, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/50/505401; Vorobyev AY, 2008, J APPL PHYS, V104, DOI 10.1063/1.2981072; Vorobyev AY, 2007, J APPL PHYS, V101, DOI 10.1063/1.2432288; Yasumaru N, 2013, APPL SURF SCI, V264, P611, DOI 10.1016/j.apsusc.2012.10.076; Golosov EV, 2011, J EXP THEOR PHYS+, V113, P14, DOI 10.1134/S1063776111050025; Chichkov BN, 1996, APPL PHYS A-MATER, V63, P109, DOI 10.1007/BF01567637; HUDIS M, 1973, J APPL PHYS, V44, P1489, DOI 10.1063/1.1662398; Huis in't Veld B., 2008, J MICRO NANOENG, V3, P206; Yasumaru N., 2012, P 13 INT S LAS PREC	16	0	0	JAPAN LASER PROCESSING SOC	OSAKA	OSAKA UNIV, 11-1 MIHOGAOKA, IBARAKI C/O KATAYAMA LAB, JOINING & WELDING RES INST, OSAKA, 567-0047, JAPAN	1880-0688			J LASER MICRO NANOEN	J. Laser Micro Nanoeng.	FEB	2015	10	1					33	37		10.2961/jlmn.2015.01.0007		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Optics; Physics, Applied	Science & Technology - Other Topics; Materials Science; Optics; Physics	CF1LA	WOS:000352305600007		
J	Ishikawa, A; Amemiya, T; Shoji, Y; Hai, PN; Tanaka, M; Mizumoto, T; Arai, S; Tanaka, T				Ishikawa, Atsushi; Amemiya, Tomohiro; Shoji, Yuya; Hai, Pham Nam; Tanaka, Masaaki; Mizumoto, Tetsuya; Arai, Shigehisa; Tanaka, Takuo			Optical and Magnetic Microstructures in YIG Ferrite Fabricated by Femtosecond Laser	JOURNAL OF LASER MICRO NANOENGINEERING			English	Article						Femtosecond laser fabrication; Multi-photon absorption; Three-dimensional structures; Magneto-optical materials; Integrated optics	INTEGRATED-OPTICS; WAVE-GUIDES; METAMATERIALS; REDUCTION; PULSES; GLASS	Optical and magnetic microstructures are directly fabricated inside a film of cerium-substituted yttrium iron garnet (Ce:YIG) by using a direct femtosecond laser writing. The laser irradiation induces local changes in both optical and magnetic properties of Ce:YIG. A quantitative phase imaging technique proves that the refractive index is increased by 0.015 +/- 0.001, which is about 0.7% of Ce:YIG refrative index 2.2 at 632.8 nm. The magneto-optical polar Kerr effect measurement shows that the magnetization property is changed from hard to soft, decreasing the coercivity. Our proposed technique paves the way toward the development of novel three-dimensional magneto-optical devices for optical communication and photonic applications.	[Ishikawa, Atsushi] Okayama Univ, Dept Elect & Elect Engn, Okayama 7008530, Japan; [Ishikawa, Atsushi; Tanaka, Takuo] RIKEN, Metamat Lab, Tokyo, Japan; [Amemiya, Tomohiro; Arai, Shigehisa] Tokyo Inst Technol, Quantum Nanoelect Res Ctr, Tokyo, Japan; [Shoji, Yuya; Mizumoto, Tetsuya; Arai, Shigehisa] Tokyo Inst Technol, Dept Elect & Elect Engn, Tokyo, Japan; [Hai, Pham Nam; Tanaka, Masaaki] Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo 1138654, Japan; [Tanaka, Takuo] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 060, Japan	Ishikawa, A (reprint author), Okayama Univ, Dept Elect & Elect Engn, Okayama 7008530, Japan.	a-ishikawa@okayama-u.ac.jp	Ishikawa, Atsushi/J-3649-2015		Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI [24246061, 24656046, 25420321, 22109006, 23710160, 24760270, 23000010, 24686040]; Strategic Information and Communications R&D Promotion Programme (SCOPE) of the Ministry of Internal Affairs and Communications	The authors acknowledge financial support from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI Grant Nos. 24246061, 24656046, 25420321, 22109006, 23710160, 24760270, 23000010, 24686040, and the Strategic Information and Communications R&D Promotion Programme (SCOPE) of the Ministry of Internal Affairs and Communications.	Amemiya T, 2014, OPT LETT, V39, P212, DOI 10.1364/OL.39.000212; Takei R, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.086204; Tien MC, 2011, OPT EXPRESS, V19, P11740, DOI 10.1364/OE.19.011740; Cao YY, 2009, SMALL, V5, P1144, DOI 10.1002/smll.200801179; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; Schaffer CB, 2001, OPT LETT, V26, P93, DOI 10.1364/OL.26.000093; Iwai H, 2004, OPT LETT, V29, P2399, DOI 10.1364/OL.29.002399; Ishikawa A, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2345601; Chin SL, 2005, CAN J PHYS, V83, P863, DOI 10.1139/P05-048; Nolte S, 2003, APPL PHYS A-MATER, V77, P109, DOI 10.1007/s00339-003-2088-6; Zhou WH, 2002, SCIENCE, V296, P1106, DOI 10.1126/science.296.5570.1106; Tanaka T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2177636; Yamauchi T, 2008, OPT EXPRESS, V16, P12227, DOI 10.1364/OE.16.012227; Ghosh S, 2013, IEEE PHOTONICS J, V5, DOI 10.1109/JPHOT.2013.2264275; Davis KM, 1996, OPT LETT, V21, P1729, DOI 10.1364/OL.21.001729; Mizumoto T, 2012, IEEE J QUANTUM ELECT, V48, P252, DOI 10.1109/JQE.2011.2168194; Wu PW, 2000, ADV MATER, V12, P1438, DOI 10.1002/1521-4095(200010)12:19<1438::AID-ADMA1438>3.0.CO;2-Y; Dotsch H, 2005, J OPT SOC AM B, V22, P240, DOI 10.1364/JOSAB.22.000240; Shoji Y, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2884855; Rill MS, 2008, NAT MATER, V7, P543, DOI 10.1038/nmat2197; Boudiar T, 2004, J MAGN MAGN MATER, V284, P77, DOI 10.1016/j.jmmm.2004.06.046; Lyubchanskii IL, 2003, J PHYS D APPL PHYS, V36, pR277, DOI 10.1088/0022-3727/36/18/R01; Gansel A. J. K., 2009, SCIENCE, V325, P1513; Goppert-Mayer M, 1931, ANN PHYS-BERLIN, V9, P273; Ishikawa A, 2012, J LASER MICRO NANOEN, V7, P11, DOI 10.2961/jlmn.2012.01.0002; Ishikawa A, 2013, IEEE J SEL TOP QUANT, V19, DOI 10.1109/JSTQE.2012.2222019; Ishikawa A, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2785167; Sekhar MC, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3126640; Yokoi H, 2000, APPL OPTICS, V39, P6158, DOI 10.1364/AO.39.006158; Zvezdin A. K., 1997, MODERN MAGNETOOPTICS	30	0	0	JAPAN LASER PROCESSING SOC	OSAKA	OSAKA UNIV, 11-1 MIHOGAOKA, IBARAKI C/O KATAYAMA LAB, JOINING & WELDING RES INST, OSAKA, 567-0047, JAPAN	1880-0688			J LASER MICRO NANOEN	J. Laser Micro Nanoeng.	FEB	2015	10	1					48	52		10.2961/jlmn.2015.01.0010		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Optics; Physics, Applied	Science & Technology - Other Topics; Materials Science; Optics; Physics	CF1LA	WOS:000352305600010		
J	Nakamura, S; Miura, T; Tsuta, M				Nakamura, Susumu; Miura, Takumi; Tsuta, Masaya			Straight Through Hole Drilling in Machinable Ceramics	JOURNAL OF LASER MICRO NANOENGINEERING			English	Article						Machinable ceramics; Straight through hole; Drilling; Nanosecond UV laser; Prove card		This paper presents a unique through hole forming method in machinable ceramics using a flowable backing material during nanosecond pulse UV laser radiation. While processing through holes, the flowable backing material is arranged to be in contact with the back side of machinable ceramics, i.e., surface of laser beam's exit side. The laser beam which penetrated machinable ceramics strikes the flowable backing material and superheated plasma is generated by the laser beam's absorption into the flowable backing material around exit hole. The induced plasma is elevated with the flowable backing material from the back side of machinable ceramics to the front side of that by a capillary phenomenon, and the shape of through holes changed from tapered shape to straight shape by the elevation of plasma. Through this technique, we are able to make substrate for a probe card which has straight shape holes with narrow pitch.	[Nakamura, Susumu] Nagaoka Natl Coll Technol, Dept Elect & Elect Syst Engn, Nagaoka, Niigata 9408532, Japan; [Miura, Takumi; Tsuta, Masaya] Nagaoka Natl Coll Technol, Elect & Mech Syst Engn Adv Course, Nagaoka, Niigata 9408532, Japan	Nakamura, S (reprint author), Nagaoka Natl Coll Technol, Dept Elect & Elect Syst Engn, 888 Nishikatakai, Nagaoka, Niigata 9408532, Japan.	snaka@nagaoka-ct.ac.jp					Locke BR, 2006, IND ENG CHEM RES, V45, P882, DOI 10.1021/ie050981u; Endo H, 2006, INT J MACH TOOL MANU, V46, P575, DOI 10.1016/j.ijmachtools.2005.07.026; Mullan C., 2007, P SOC PHOTO-OPT INS, V6459; Nakamura S, 2014, J LASER MICRO NANOEN, V9, DOI 10.2961/jlmn.2014.01.0015; Nakamura S., 2013, ONLINE P LPM	5	0	0	JAPAN LASER PROCESSING SOC	OSAKA	OSAKA UNIV, 11-1 MIHOGAOKA, IBARAKI C/O KATAYAMA LAB, JOINING & WELDING RES INST, OSAKA, 567-0047, JAPAN	1880-0688			J LASER MICRO NANOEN	J. Laser Micro Nanoeng.	FEB	2015	10	1					101	105		10.2961/jlmn.2015.01.0018		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Optics; Physics, Applied	Science & Technology - Other Topics; Materials Science; Optics; Physics	CF1LA	WOS:000352305600018		
J	Tobase, T; Yoshiasa, A; Wang, L; Hongu, H; Isobe, H; Miyawaki, R				Tobase, Tsubasa; Yoshiasa, Akira; Wang, Ling; Hongu, Hidetomo; Isobe, Hiroshi; Miyawaki, Ritsuro			XAFS study on the Zr local structures in tektites and natural glasses	JOURNAL OF MINERALOGICAL AND PETROLOGICAL SCIENCES			English	Article						Local structure of Zr; Tektites; Impact glasses; EXAFS; XANES	RAY-ABSORPTION-SPECTROSCOPY; COORDINATION CHEMISTRY; SILICATE-GLASSES; MELTS; TEMPERATURE; ENVIRONMENT; STANDARDS; PRESSURE; CRYSTALS; CRATER	The local structures of tektites and natural glasses were studied by Zr K-edge X-ray absorption near edge structure (XANES) and extended X-ray absorption fine structure (EXAFS) measurements in order to obtain quantitative data on the Zr-O (bonding) distances and coordination numbers for the glasses. Zr4+ ions have different coordination environments. The structure of glass (tektite, impact-related glass, fulgurite, and volcanic glasses) is affected by the temperature during the glass-formation process. Differences in the formation processes for natural glasses result in different local structures for the zirconium ions. All tektites can be classified as being of the same type and as having 7-fold coordination Zr ions. The Zr-O distances in tektite glasses are 2.198-2.215 angstrom, and their XANES spectra are similar, too. Impact-related glasses can be classified into different types and are formed under different physical and geological processes at the impact event. Volcanic glasses, impact-related glasses, and fulgurite glasses have several local Zr structures with 6- and 7-fold coordinated Zr ions. It can thus be concluded that local structures of Zr in natural glasses are closely related to the formation temperature and quenching conditions of the glasses. The Zr XAFS spectra of natural glasses can be used to identify the naturalglasses.	[Tobase, Tsubasa; Yoshiasa, Akira; Wang, Ling; Hongu, Hidetomo; Isobe, Hiroshi] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan; [Miyawaki, Ritsuro] Natl Museum Sci, Dept Geol & Paleontol, Tsukuba, Ibaraki 3050005, Japan	Tobase, T (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.	tbs.tobase@gmail.com; yoshiasa@sci.kumamoto-u.ac.jp			Photon Factory Project (PAC) [2012G526]	This study was performed as part of the Photon Factory Project (PAC No. 2012G526).	ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; YARGER JL, 1995, SCIENCE, V270, P1964, DOI 10.1126/science.270.5244.1964; Neuville DR, 2004, CHEM GEOL, V213, P153, DOI 10.1016/j.chemgeo.2004.08.039; Saikia BJ, 2008, B MATER SCI, V31, P155, DOI 10.1007/s12034-008-0027-z; LYTLE FW, 1989, PHYSICA B, V158, P701; Melosh HJ, 1999, ANNU REV EARTH PL SC, V27, P385, DOI 10.1146/annurev.earth.27.1.385; Farges F, 1996, GEOCHIM COSMOCHIM AC, V60, P3023, DOI 10.1016/0016-7037(96)00144-5; REHR JJ, 1991, J AM CHEM SOC, V113, P5135, DOI 10.1021/ja00014a001; STEBBINS JF, 1989, AM MINERAL, V74, P965; Dunlap RA, 1998, J NON-CRYST SOLIDS, V223, P141, DOI 10.1016/S0022-3093(97)00364-5; Farges F, 1997, GEOCHIM COSMOCHIM AC, V61, P1863, DOI 10.1016/S0016-7037(97)00050-1; FUDALI RF, 1979, METEORITICS, V14, P283; ISHII T, 1992, J PHYS-CONDENS MAT, V4, P8029, DOI 10.1088/0953-8984/4/40/015; Koeberl C., 1997, P SIL 96 M; MAEDA H, 1987, J PHYS SOC JPN, V56, P2777, DOI 10.1143/JPSJ.56.2777; Mountjoy G, 2000, PHYS CHEM CHEM PHYS, V2, P2455, DOI 10.1039/a910300g; MYSEN B, 1995, GEOCHIM COSMOCHIM AC, V59, P325, DOI 10.1016/0016-7037(94)00290-3; Osinski GR, 2005, METEORIT PLANET SCI, V40, P1759; Paris E., 1994, PHYS CHEM MINER, V21, P520; Stevenson CM, 1996, J ARCHAEOL SCI, V23, P233, DOI 10.1006/jasc.1996.0020; Tobase T, 2013, J PHYS CONF SER, V430, DOI 10.1088/1742-6596/430/1/012070; UREY HC, 1955, P NATL ACAD SCI USA, V41, P27, DOI 10.1073/pnas.41.1.27; Wang L, 2011, J SYNCHROTRON RADIAT, V18, P885, DOI 10.1107/S0909049511036326; Yoshiasa A, 1997, JPN J APPL PHYS 1, V36, P781, DOI 10.1143/JJAP.36.781	24	1	1	JAPAN ASSOC MINERALOGICAL SCIENCES	SENDAI	C/O GRAD SCH SCIENCES, TOHOKU UNIV, AOBA, SENDAI, 980-8578, JAPAN	1345-6296	1349-3825		J MINER PETROL SCI	J. Mineral. Petrol. Sci.	FEB	2015	110	1					1	7		10.2465/jmps.140317		7	Mineralogy	Mineralogy	CF3CZ	WOS:000352426700001		
J	Endo, S				Endo, Shunsuke			Jadeite-bearing metaigneous rocks from the Northern Chichibu belt, SW Japan: implications for the lowest-grade Sanbagawa metamorphism	JOURNAL OF MINERALOGICAL AND PETROLOGICAL SCIENCES			English	Article						Aegirine; Jadeite; Northern Chichibu belt; Sanbagawa metamorphism; Sodic pyroxene	CENTRAL SHIKOKU; MIXING PROPERTIES; KANTO MOUNTAINS; QUARTZ; PYROXENE; STABILITY; MINERALS; ACMITE; MIKABU; REGION	Multiple generations of Na-Ca and Na pyroxenes (aegirine-augite, aegirine and jadeite) were found in a metamorphosed monzonitic dike from a coherent mafic layer of the Northern Chichibu belt in central Shikoku, Japan. The mafic layer was derived from alkaline basalt magma and its derivatives, and belongs to the Kamiyoshida unit (Middle Jurassic accretionary complex). The earliest-stage sodic pyroxene (jadeite-free Ti-rich aegirine-augite to aegirine) in the dike probably crystallized during a post-magmatic hydrothermal stage. Igneous Ti-rich augite phenocrysts were almost completely pseudomorphed by chlorite + phengite + Al-OH-rich titanite + sodic pyroxene (aegirine-augite with jadeite component) during early stages of subduction metamorphism. The earliest-stage sodic pyroxene and pseudomorphed Ti-rich augite were further overgrown by jadeite/aegirine fringes during high-P/T metamorphism. Jadeite/aegirine pyroxene also occurs as small (similar to 50 mu m long) neoblasts within pseudomorphs (albite + phengite + pumpellyite +/- Ba-rich K-feldspar) after igneous plagioclase. Individual grains of the fringe/neoblastic pyroxene are zoned with a jadeite core (up to 98% jadeite content) and an aegirine rim (down to 25% jadeite content). Jadeite-rich pyroxene (up to 92% jadeite content) was also found in basaltic rock from the mafic layer. The absence of quartz and the alkaline affinity of the protoliths suggest that the jadeite formation can be explained by the reaction analcime = jadeite + H2O. If H2O fluid was present, the decrease in jadeite content in the fringe/neoblastic pyroxene implies decompression from similar to 0.6-0.7 GPa at 300 degrees C to similar to 0.4 GPa at 210-260 degrees C. The formation of the jadeite-to-aegirine pyroxene during exhumation probably resulted from the lowest-grade Sanbagawa metamorphism.	Natl Inst Adv Ind Sci & Technol, Inst Geol & Geoinformat, Tsukuba, Ibaraki 3058567, Japan	Endo, S (reprint author), Natl Inst Adv Ind Sci & Technol, Inst Geol & Geoinformat, Cent 7, Tsukuba, Ibaraki 3058567, Japan.	s-endo@aist.go.jp					Fujinaga K, 2006, RESOUR GEOL, V56, P399, DOI 10.1111/j.1751-3928.2006.tb00293.x; Holland T, 1998, EUR J MINERAL, V10, P395; PLATT JP, 1986, GEOL SOC AM BULL, V97, P1037, DOI 10.1130/0016-7606(1986)97<1037:DOOWAT>2.0.CO;2; ENAMI M, 1994, CONTRIB MINERAL PETR, V116, P182, DOI 10.1007/BF00310699; Whitney DL, 2010, AM MINERAL, V95, P185, DOI 10.2138/am.2010.3371; Green E, 2007, AM MINERAL, V92, P1181, DOI 10.2138/am.2007.2401; White RW, 2007, J METAMORPH GEOL, V25, P511, DOI 10.1111/j.1525-1314.2007.00711.x; Holland TJB, 1998, J METAMORPH GEOL, V16, P309, DOI 10.1111/j.1525-1314.1998.00140.x; LAVERNE C, 1987, LITHOS, V20, P135, DOI 10.1016/0024-4937(87)90003-X; Kouketsu Y, 2014, ISL ARC, V23, P33; White AJR, 2014, J METAMORPH GEOL, V32, P417, DOI 10.1111/jmg.12078; Arai H., 2011, JAPANESE MAGAZINE MI, V40, P177; Banno S., 1959, J GEOL SOC JPN, V65, P652; Connolly JAD, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002540; DALLMEYER RD, 1995, J METAMORPH GEOL, V13, P271, DOI 10.1111/j.1525-1314.1995.tb00218.x; Diener J.F.A., 2012, J METAMORPH GEOL, V30, P113; Endo S, 2013, J METAMORPH GEOL, V31, P647, DOI 10.1111/jmg.12038; Fukuyama M, 2013, J ASIAN EARTH SCI, V63, P206, DOI 10.1016/j.jseaes.2012.10.031; Hirajima T., 1983, J JAPANESE ASS MINER, V78, P77; Itaya T., 1994, ISL ARC, V3, P48, DOI DOI 10.1111/J.1440-1738.1994.TB00004.X; Kawato K., 1991, J GEOLOGICAL SOC JAP, V97, P959; LIU J, 1995, CONTRIB MINERAL PETR, V119, P433, DOI 10.1007/BF00286940; MARUYAMA S, 1985, AM MINERAL, V70, P16; Maruyama S., 1978, J JAPANESE ASS MINER, V73, P300; Matsuoka A., 1998, J GEOLOGICAL SOC JAP, V104, P634; Minakawa T, 2008, J MINER PETROL SCI, V103, P400, DOI 10.2465/jmps.071220; Morimoto M., 1988, MINERAL MAG, V52, P535, DOI DOI 10.1180/MINMAG.1988.052.367.15; Saito M., 2006, B GEOLOGICAL SURVEY, V57, P169; Sakaguchi M, 2008, ISL ARC, V17, P305, DOI 10.1111/j.1440-1738.2008.00620.x; SEKI Y, 1960, AM MINERAL, V45, P668; Suzuki S, 1998, J METAMORPH GEOL, V16, P107, DOI 10.1111/j.1525-1314.1998.00066.x; Suzuki S., 1995, J GEOLOGICAL SOC JAP, V101, P1003; Taguchi T, 2014, J MINER PETROL SCI, V109, P169, DOI 10.2465/jmps.140323; Tsutsumi Y, 2009, J MINER PETROL SCI, V104, P12, DOI 10.2465/jmps.080416; YAGI K, 1953, GEOL SOC AM BULL, V64, P769, DOI 10.1130/0016-7606(1953)64[769:PSOTAR]2.0.CO;2; YAMAKITA S, 1988, Journal of the Faculty of Science University of Tokyo Section II Geology Mineralogy Geography Geophysics, V21, P467	36	0	0	JAPAN ASSOC MINERALOGICAL SCIENCES	SENDAI	C/O GRAD SCH SCIENCES, TOHOKU UNIV, AOBA, SENDAI, 980-8578, JAPAN	1345-6296	1349-3825		J MINER PETROL SCI	J. Mineral. Petrol. Sci.	FEB	2015	110	1					8	19		10.2465/jmps.140724		12	Mineralogy	Mineralogy	CF3CZ	WOS:000352426700002		
J	Naemura, K; Shimizu, I; Svojtka, M; Hirajima, T				Naemura, Kosuke; Shimizu, Ichiko; Svojtka, Martin; Hirajima, Takao			Accessory priderite and burbankite in multiphase solid inclusions in the orogenic garnet peridotite from the Bohemian Massif, Czech Republic	JOURNAL OF MINERALOGICAL AND PETROLOGICAL SCIENCES			English	Article						Garnet peridotite; Variscan orogeny; Multiphase solid inclusion; Priderite; Burbankite	MOLDANUBIAN ZONE; IGNEOUS ROCKS; LITHOSPHERIC MANTLE; MELT INCLUSIONS; LOWER AUSTRIA; GRANULITES; SUBDUCTION; ORIGIN; FLUIDS; METASOMATISM	This paper reports on priderite (potassium titanate) and burbankite (alkali Sr-Ca-REE-Ba carbonate) from an orogenic garnet peridotite body enclosed in high-pressure garnet-kyanite-bearing quartzo-feldspathic Gfohl granulite in the Bohemian Massif of the Variscan belt. The garnet peridotite contains ubiquitous phlogopite and was interpreted to be derived from the mantle wedge formed at the convergent plate margin. The earliest generation of chromian spinel, surrounded by kelyphitized garnet, ubiquitously contains multiphase solid inclusions (MSIs), which are mainly composed of phlogopite, dolomite, calcite, apatite, graphite, monazite, thorianite, and sulfides, and priderite and burbankite are newly identified as rare accessory minerals in such MSIs. Most of these MSIs contained significant amounts of carbonates. The presence of peculiar accessory minerals in MSIs characterizes the nature of parental melts. The formation of priderite requires an ultrapotassic condition, which is usually defined by K2O > 3 wt% and K2O/Na2O >2 in bulk composition, and high Cr2O3 content in priderite (15-18 wt%) suggests that it was formed as a reaction product between a melt inclusion and a host chromite. Burbankite contains significant amounts of Na2O and K2O (similar to 3 wt%) and REE concentration (> 31 wt%). The formation of burbankite requires a per-alkaline condition -K2O + Na2O > Al2O3 in mol-and requires more sodic composition. The presence of priderite and burbankite in MSIs suggests that some of them crystallized from ultrapotassic melts, whereas others crystallized from sodic peralkaline melts. Such alkali-carbonate melts could be present in the mantle wedge peridotite before its' incorporation into the granulite.	[Naemura, Kosuke; Shimizu, Ichiko] Univ Tokyo, Fac Sci, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Svojtka, Martin] Acad Sci ASCR, Inst Geol, Vvi, Prague 16500, Czech Republic; [Hirajima, Takao] Grad Sch Sci, Dept Geol & Mineral, Sakyo Ku, Kyoto 6068502, Japan	Naemura, K (reprint author), Nagoya Univ Museum, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	naemurak@gmail.com			Japan Ministry of Education, Culture, Sports, Science, and Technology [21109005]; Japan Ministry of Education [14403013, 25257208]; Program for the support of International Cooperation Projects AS CR [M100131203]; Scientific Programme of the IG ASCR, v.v.i. [RVO67985831];  [248040]	We thank Koji Ichimura (the University of Tokyo) for his excellent technique in electron microprobe analysis of priderite and burbankite and for his EBSD analysis of burbankite. We are most grateful to Hisao Tutumi (Kyoto University) for making thin sections. We would like to express our appreciation to Prof. A. Giuliani, an anonymous reviewer and Associate Editor Prof. T. Kogiso for their constructive criticism, which helped to improve manuscript. This work was partly supported by a Grant-in-Aid for JSPS Fellows (248040) to KN; a Grant-in-Aid for Scientific Research on Priority Areas (21109005) to IS from the Japan Ministry of Education, Culture, Sports, Science, and Technology; Grants 14403013 and 25257208 to TH from the Japan Ministry of Education; the Program for the support of International Cooperation Projects AS CR - No. M100131203; and the Scientific Programme RVO67985831 of the IG ASCR, v.v.i. to MS.	Korsakov AV, 2006, EARTH PLANET SC LETT, V241, P104, DOI 10.1016/j.epsl.2005.10.037; Naemura K, 2011, ELSEV INSIGHT, P77, DOI 10.1016/B978-0-12-385144-4.00002-3; Ferrando S, 2005, CHEM GEOL, V223, P68, DOI 10.1016/j.chemgeo.2005.01.029; Guzmics T, 2011, CONTRIB MINERAL PETR, V161, P177, DOI 10.1007/s00410-010-0525-z; Giuliani A, 2012, GEOLOGY, V40, P967, DOI 10.1130/G33221.1; Becker H, 1999, J PETROL, V40, P315, DOI 10.1093/petrology/40.2.315; HAGGERTY SE, 1983, AM MINERAL, V68, P494; FOLEY SF, 1987, EARTH-SCI REV, V24, P81, DOI 10.1016/0012-8252(87)90001-8; Tumiati S, 2013, J PETROL, V54, P453, DOI 10.1093/petrology/egs074; CARSWELL DA, 1993, J PETROL, V34, P427; Chakhmouradian AR, 2012, ELEMENTS, V8, P347, DOI 10.2113/gselements.8.5.347; Brueckner HK, 1998, GEOLOGY, V26, P631, DOI 10.1130/0091-7613(1998)026<0631:SIMFTE>2.3.CO;2; Kotkova J, 2011, GEOLOGY, V39, P667, DOI 10.1130/G31971.1; Yamamoto S, 2009, LITHOS, V109, P314, DOI 10.1016/j.lithos.2008.05.003; Gerya TV, 2003, EARTH PLANET SC LETT, V212, P47, DOI 10.1016/S0012-821X(03)00265-6; Malaspina N, 2006, EARTH PLANET SC LETT, V249, P173, DOI 10.1016/j.epsl.2006.07.017; Medaris G, 2005, LITHOS, V82, P1, DOI 10.1016/j.lithos.2004.12.004; Belovitskaya Y. V., 2004, NEW DATA MINERALS, V39, P50; Buhn B, 1999, AM MINERAL, V84, P1117; FOLEY SF, 1990, CHEM GEOL, V85, P1, DOI 10.1016/0009-2541(90)90120-V; Frezzotti M.L., AM MINERALO IN PRESS; Giuliani A, 2014, J PETROL, V55, P831, DOI 10.1093/petrology/egu008; Giuliani A, 2013, CHEM GEOL, V353, P4, DOI 10.1016/j.chemgeo.2012.09.025; Kogure T., 2003, Journal of the Crystallographic Society of Japan, V45; Konzett J, 2013, LITHOS, V182, P165, DOI 10.1016/j.lithos.2013.10.005; Medaris Jr G., 1990, LITHOS, V25, P189; Naemura K, 2009, J PETROL, V50, P1795, DOI 10.1093/petrology/egp052; Nimis P, 2000, J GEODYN, V30, P93, DOI 10.1016/S0264-3707(99)00029-0; Stipska P, 2005, J METAMORPH GEOL, V23, P627, DOI 10.1111/j.1525-1314.2005.00600.x; Svojtka M, 2002, INT J EARTH SCI, V91, P373, DOI 10.1007/s00531-001-0230-2; VRANA S, 1989, CONTRIB MINERAL PETR, V103, P510, DOI 10.1007/BF01041756; Zannetti A., 1999, CONTRIBUTION MINERAL, V134, P107; Zhou H.Y., 1994, ACTA MINERAL SINICA, V14, P234	33	0	0	JAPAN ASSOC MINERALOGICAL SCIENCES	SENDAI	C/O GRAD SCH SCIENCES, TOHOKU UNIV, AOBA, SENDAI, 980-8578, JAPAN	1345-6296	1349-3825		J MINER PETROL SCI	J. Mineral. Petrol. Sci.	FEB	2015	110	1					20	28		10.2465/jmps.140613c		9	Mineralogy	Mineralogy	CF3CZ	WOS:000352426700003		
J	Ando, T; Kanayama, A; Kobayashi, S; Miyawaki, R; Kishi, S; Tanabe, M; Kusachi, I				Ando, Tamami; Kanayama, Akiko; Kobayashi, Shoichi; Miyawaki, Ritsuro; Kishi, Shigetomo; Tanabe, Mitsuo; Kusachi, Isao			Roweite from the Fuka mine, Okayama Prefecture, Japan	JOURNAL OF MINERALOGICAL AND PETROLOGICAL SCIENCES			English	Article						Roweite; Calcium manganese borate; Skarn; Fuka	NEW-JERSEY; FRANKLIN	Roweite occurs as reddish to dark brown granular crystals up to 0.8 mm across in crystalline limestone near gehlenite-spurrite skarns at the Fuka mine, Okayama Prefecture, Japan. It is closely associated with uralborite. Associated minerals include shimazakiite, frolovite, bultfonteinite, fluorite and calcite. An electron microprobe analysis of roweite gave an empirical formula Ca-2.006(Mn1.410Fe0.333Mg0.181Zn0.036Co0.004)(Sigma 1.964)B4.017O6.989 (OH)(6.011) based on O = 13. The unit cell parameters are a = 9.057(2), b = 13.335(3), c = 8.284(3) angstrom. The calculated density is 2.92 g cm(-3). The roweite from the Fuka mine was probably formed as a secondary mineral from calcium borates such as uralborite in a reaction with manganese-bearing late hydrothermal solution.	[Ando, Tamami; Kanayama, Akiko; Kobayashi, Shoichi] Okayama Univ Sci, Fac Sci, Dept Earth Sci, Kita Ku, Okayama 7000005, Japan; [Miyawaki, Ritsuro] Natl Museum Nat & Sci, Dept Geol & Paleontol, Tsukuba, Ibaraki 3050005, Japan	Kobayashi, S (reprint author), Okayama Univ Sci, Fac Sci, Dept Earth Sci, Kita Ku, 1-1 Ridai Cho, Okayama 7000005, Japan.	kobayashi@das.ous.ac.jp			Ministry of Education, Science, Sports and Culture, Japan [24540522]	We would like to thank Mr. Taiji Ohyama of JASCO Corporation and Mr. Kazuaki Nakanishi of Analytical Laboratory, JASCO Engineering CO., LTD for their assistance in the measurement of FT/IR spectra. This work was supported in part by a Grant-in-Aid for the Scientific Research (No. 24540522) from the Ministry of Education, Science, Sports and Culture, Japan.	TORAYA H, 1993, J APPL CRYSTALLOGR, V26, P583, DOI 10.1107/S0021889893001955; ARISTARA.LF, 1974, AM MINERAL, V59, P66; Berman H, 1937, AM MINERAL, V22, P301; Kusachi I., 2000, J MINERALOGICAL PETR, V95, P43, DOI 10.2465/jmps.95.43; Kusachi I, 2013, MINERAL MAG, V77, P93, DOI 10.1180/minmag.2013.077.1.09; Kusachi I., 1995, MINERAL J, V17, P330, DOI 10.2465/minerj.17.330; Malinko S.V., 1972, ZAP VSES MINERAL OBS, V101, P465; Malinko S.V., 1977, INT GEOL REV, V19, P113; MOORE PB, 1974, AM MINERAL, V59, P60; Nakamuta Y., 1999, J MINERALOGICAL SOC, V28, P117	10	0	0	JAPAN ASSOC MINERALOGICAL SCIENCES	SENDAI	C/O GRAD SCH SCIENCES, TOHOKU UNIV, AOBA, SENDAI, 980-8578, JAPAN	1345-6296	1349-3825		J MINER PETROL SCI	J. Mineral. Petrol. Sci.	FEB	2015	110	1					29	34		10.2465/jmps.140729		6	Mineralogy	Mineralogy	CF3CZ	WOS:000352426700004		
J	Ichiyama, Y				Ichiyama, Yuji			Petrogenesis and geotectonics of the Mikame ultramafic body, western Shikoku, Japan	JOURNAL OF MINERALOGICAL AND PETROLOGICAL SCIENCES			English	Article						Mikame ultramafic body; Meta-serpentinite; Cumulate; Forearc; Olivine; Chromian spinel	MARIANA FORE-ARC; CHROMIAN SPINEL; MANTLE WEDGE; OLIVINE; COMPLEX; PERIDOTITES; OPHIOLITE; SERPENTINITE; ZONE; DEHYDRATION	The Mikame ultramafic body, located in westernmost central Shikoku, Japan, forms a nappe accompanied by the Maana Formation and low- to medium-pressure Oshima metamorphic rocks. This body is divided into the Shigiyama and Korotokibana masses. The Shigiyama mass is composed of very fresh dunite, wehrlite and pyroxenite; whereas the Korotokibana mass is composed of antigorite-bearing meta-serpentinite derived from dunite and wehrlite. Estimated equilibrium temperatures are 600-700 degrees C for the Shigiyama mass and 400-500 degrees C for the Kototokibana mass, respectively. The geological and petrological characteristics of the Mikame ultramafic rocks are similar to those of the Higo belt in central Kyushu, rather than those of the Mikabu and Kurosegawa belts, and the Mikame body is possibly equivalent to the Higo belt. The Shigiyama ultramafic rocks are subdivided into Mg- and Fe-rich suites based on their olivine and chromian spinel compositions. The Mg-rich suite is characterized by magnesian olivines (Fo(84-92)) and high-Cr# [= Cr/(Cr + Al) = 0.5-0.8] spinels. On the other hand, the Fe-rich suite contains less magnesian olivines (Fo(74-88)) and low-Cr# (= 0.3-0.4) spinels. The Mg- and Fe-rich suites of the Shigiyama ultramafic rocks are cumulates formed from depleted and less depleted magmas, respectively. The chemistry of the chromian spinels in the Mikame ultramafic rocks indicates that they formed by crystal accumulation from magmas generated in an arc setting. The Korotokibana meta-serpentinites resemble those from the Mariana forearc regarding their mineral assemblage, and olivine and chromian spinel compositions. The Korotokibana meta-serpentinites experienced dehydration at 400-500 degrees C, after serpentinization caused by addition of H2O released from a subducting slab, whereas the Shigiyama ultramafic rocks contain no evidence for dehydration. The Mikame ultramafic body may have been the lower forearc crust produced by magmas with various degrees of depletion, later subjected to diverse hydration and dehydration processes.	JAMSTEC, Kochi Inst Core Sample Res, Nankoku, Kochi 7838502, Japan	Ichiyama, Y (reprint author), JAMSTEC, Kochi Inst Core Sample Res, 200 Monobe Otsu, Nankoku, Kochi 7838502, Japan.	ichiyamay@jamstec.go.jp					AGATA T, 1994, LITHOS, V33, P241, DOI 10.1016/0024-4937(94)90032-9; Ahmed AH, 2008, LITHOS, V104, P85, DOI 10.1016/j.lithos.2007.11.009; FRYER P, 1985, GEOLOGY, V13, P774, DOI 10.1130/0091-7613(1985)13<774:OAEOMF>2.0.CO;2; BREY GP, 1990, J PETROL, V31, P1353; SACK RO, 1991, AM MINERAL, V76, P827; Nozaka T, 2003, AM MINERAL, V88, P1377; Hyndman RD, 2003, EARTH PLANET SC LETT, V212, P417, DOI 10.1016/S0012-821X(03)00263-2; Reagan MK, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002871; Hattori KH, 2003, GEOLOGY, V31, P525, DOI 10.1130/0091-7613(2003)031<0525:VFFAAC>2.0.CO;2; BALLHAUS C, 1991, CONTRIB MINERAL PETR, V107, P27, DOI 10.1007/BF00311183; OBATA M, 1994, LITHOS, V32, P135, DOI 10.1016/0024-4937(94)90026-4; DICK HJB, 1984, CONTRIB MINERAL PETR, V86, P54, DOI 10.1007/BF00373711; Evans BW, 2004, INT GEOL REV, V46, P479, DOI 10.2747/0020-6814.46.6.479; Parkinson IJ, 1998, J PETROL, V39, P1577; Osanai Y, 2006, GONDWANA RES, V9, P152, DOI 10.1016/j.gr.2005.06.008; Murata K, 2009, GEOSPHERE, V5, P90, DOI 10.1130/GES00213.1; Plumper O, 2012, J PETROL, V53, P1943, DOI 10.1093/petrology/egs039; BOUDIER F, 1995, J PETROL, V36, P777; OBATA M, 1974, B SOC FR MINERAL CR, V97, P101; DeBari SM, 2011, FRONT EARTH SCI SER, P121, DOI 10.1007/978-3-540-88558-0_5; ARAI S, 1978, EARTH PLANET SC LETT, V39, P267, DOI 10.1016/0012-821X(78)90202-9; ARAI S, 1992, MINERAL MAG, V56, P173, DOI 10.1180/minmag.1992.056.383.04; Arai S., 1991, J MINERAL PETROL EC, V86, P540; ARAI S, 1994, J VOLCANOL GEOTH RES, V59, P279, DOI 10.1016/0377-0273(94)90083-3; Bloomer S.H., 1983, GEOPHYS MONOGR SER, V27, P274; EALES HV, 1988, MINER DEPOSITA, V23, P150; FABRIES J, 1979, CONTRIB MINERAL PETR, V69, P329, DOI 10.1007/BF00372258; Ichiyama Y, 2014, CONTRIB MINERAL PETR, V168, DOI 10.1007/s00410-014-1019-1; Ishimoto N., 1973, J JAPANESE ASS MINER, V68, P383; ISHIWATARI A, 1991, EPISODES, V14, P274; Ishiwatari A, 2006, ISL ARC, V15, P102, DOI 10.1111/j.1440-1738.2006.00512.x; Isozaki Y., 1990, J GEOLOGICAL SOC JAP, V96, P623; Isozald Y., 2010, J GEOGR, V119, P999; Iwasaki M., 1984, OFIOLITI, V9, P443; Kashima N., 1992, MEMOIRS GEOLOGICAL S, V38, P291; LOFERSKI PJ, 1983, AM MINERAL, V68, P777; MARUYAMA S, 1984, TECTONOPHYSICS, V110, P47, DOI 10.1016/0040-1951(84)90057-X; Masuda T., 1977, J GEOL SOC JAPAN, V83, P821; Mizukami T., 2001, JAPANESE MAGAZINE MI, V31, P87, DOI 10.2465/gkk.31.87; Mizuta T., 1978, J JAPANESE ASS MINER, V73, P202; MORI T, 1973, CONTRIB MINERAL PETR, V41, P301, DOI 10.1007/BF00372169; Morishita T, 2011, GEOLOGY, V39, P411, DOI 10.1130/G31706.1; O'Hanley D.S., 1996, SERPENTINITES RECORD, P277; Osanai Y., 2012, 119 ANN M GEOL SOC J; Ozawa H., 1999, MEM GEOL SOC JAPAN, V52, P217; Research Group of Peridotite Intrusion, 1967, J GEOL SOC JAP, V73, P543; ISHII T, 1992, P OC DRILL PROGR SCI, V0125; Suzuki T., 1977, THE SAMBAGAWA BELT, P23; Takahashi E., 1987, TECHNICAL REPORTS A, P1; Takeda K., 1993, J GEOL SOC JAPAN, V99, P255; Tamura A., 1999, MEMOIRS GEOLOGICAL S, V52, P53; Tamura A, 2005, AM MINERAL, V90, P473, DOI 10.2138/am.2005.1570; Tazaki K., 1974, PAPERS I THERMAL SPR, V43, P1; Uesugi J., 1999, MEMOIRS GEOLOGICAL S, V52, P229; WELLS PRA, 1977, CONTRIB MINERAL PETR, V62, P129, DOI 10.1007/BF00372872; Yamada M., 1961, B GEOLOGICAL SURVEY, V12, P318; Yokoyama K., 1987, J MIN PET EC GEOL, V82, P319	57	0	0	JAPAN ASSOC MINERALOGICAL SCIENCES	SENDAI	C/O GRAD SCH SCIENCES, TOHOKU UNIV, AOBA, SENDAI, 980-8578, JAPAN	1345-6296	1349-3825		J MINER PETROL SCI	J. Mineral. Petrol. Sci.	FEB	2015	110	1					35	46		10.2465/jmps.140625		12	Mineralogy	Mineralogy	CF3CZ	WOS:000352426700005		
J	Kusudo, K; Ino, F; Hagihara, K				Kusudo, Ko; Ino, Fumihiko; Hagihara, Kenichi			A bit-parallel algorithm for searching multiple patterns with various lengths	JOURNAL OF PARALLEL AND DISTRIBUTED COMPUTING			English	Article						String search; Bit-parallel algorithm; Acceleration; AVX	STRING-MATCHING ALGORITHMS; ARCHITECTURE; GRAPHICS	In this paper, we present an Advanced Vector Extensions (AVX) accelerated method for a bit-parallel algorithm that realizes fast string search for maximizing stable search throughput. An advantage of our method is that it accelerates string search by regularizing both control flow and data structures. This regularization facilitates the exploitation of the latest vector instruction set to achieve efficient parallel search of multiple patterns of different lengths. We use AVX instructions to increase search throughput per CPU core and employ OpenMP directives to realize data-parallel search of strings. As a result, we found that our data structure doubled search throughput as compared with a previous bit-parallel approach that used a data structure for patterns of the same length. We also found that our method achieved stable search throughput for arbitrary data if the pattern size is large, but small enough to fit into a word. Some experimental results are provided to understand the advantage and disadvantage of our method with a comparison to Aho-Corasick based methods. We believe that our method is useful for large genome texts with many partial matches. (C) 2014 Elsevier Inc. All rights reserved.	[Kusudo, Ko; Ino, Fumihiko; Hagihara, Kenichi] Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan; [Kusudo, Ko] Fujitsu Ltd, Minato Ku, Tokyo 1057123, Japan	Ino, F (reprint author), Osaka Univ, Grad Sch Informat Sci & Technol, 1-5 Yamada Oka, Suita, Osaka 5650871, Japan.	ino@ist.osaka-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [23300007, 23700057]; Japan Science and Technology Agency CREST program	This study was supported in part by the Japan Society for the Promotion of Science KAKENHI Grant Numbers 23300007 and 23700057 and the Japan Science and Technology Agency CREST program, "An Evolutionary Approach to Construction of a Software Development Environment for Massively-Parallel Computing Systems". We also thank Dr. Takehiko Kashiwagi of NEC Corporation for his insights regarding our research. We are also grateful to the anonymous reviewers for their valuable comments.	AHO AV, 1975, COMMUN ACM, V18, P333, DOI 10.1145/360825.360855; [Anonymous], 2008, IEEE COMPUT; Navarro G, 2001, ACM COMPUT SURV, V33, P31, DOI 10.1145/375360.375365; Faro S, 2012, LECT NOTES COMPUT SC, V7608, P217, DOI 10.1007/978-3-642-34109-0_23; Lindholm E, 2008, IEEE MICRO, V28, P39, DOI 10.1109/MM.2008.31; Vasiliadis G, 2008, LECT NOTES COMPUT SC, V5230, P116, DOI 10.1007/978-3-540-87403-4_7; Arudchutha S., 2013, P 8 IEEE INT C IND I, P231; BAEZAYATES R, 1992, COMMUN ACM, V35, P74, DOI 10.1145/135239.135243; Chandra R., 2000, PARALLEL PROGRAMMING; Cog S., 2012, P 18 INT COMP COMB C, P384; Faro S, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2431211.2431212; Ferragina P., 2005, PIZZA CHILI CORPUS C; Intel Corp, 2007, INT SSE4 PROGR REF; Intel Corporation, 2013, INT ARCH INSTR SET E; Kanani K., 2013, MULTIFAST MULTIPLE S; Kulekci M. O., 2010, MATH COMPUTER SCI, V3, P407; Kulekci MO, 2009, PROCEEDINGS OF THE PRAGUE STRINGOLOGY CONFERENCE 2009, P118; Lin CH, 2013, IEEE T COMPUT, V62, P1906, DOI 10.1109/TC.2012.254; Lin Cui, 2010, Proceedings of the 2010 Asia-Pacific Power and Energy Engineering Conference (APPEEC 2010), DOI [10.1109/APPEEC.2010.5448315, 10.1109/VETECS.2010.5493875]; Lin W, 2008, PROCEEDINGS OF THE 2008 14TH IEEE INTERNATIONAL CONFERENCE ON PARALLEL AND DISTRIBUTED SYSTEMS, P665, DOI 10.1109/ICPADS.2008.47; Michailidis PD, 2007, J PARALLEL DISTR COM, V67, P131, DOI 10.1016/j.jpdc.2006.10.002; NVIDIA Corporation, 2014, CUDA C PROGR GUID VE; Oh D, 2012, COMPUT J, V55, P1331, DOI 10.1093/comjnl/bxs002; Oh Y, 2013, INT J PARALLEL PROG, V41, P526, DOI 10.1007/s10766-012-0234-5; Prasad R., 2010, P INT S BIOC ISB 10, V46, P4; Prasad R., 2011, SCI RES ESSAYS, V6, P876, DOI DOI 10.5897/SRE10.895; Schatz M. C., FAST EXACT STRING MA; Singaraju J, 2008, MICROPROCESS MICROSY, V32, P210, DOI 10.1016/j.micpro.2007.11.001; Tran N.-P., 2013, P IEEE 27 INT S PAR, P1807; Tran T. T., 2011, P 9 INT C PAR PROC 2, P292; Tumeo A., 2010, P IEEE S APPL SPEC P, P71; Tumeo A, 2011, LECT NOTES COMPUT SC, V6566, P26, DOI 10.1007/978-3-642-19137-4_3; Tumeo A., 2010, P 7 ACM INT C COMP F, P87, DOI 10.1145/1787275.1787296; Tumeo A, 2012, IEEE T PARALL DISTR, V23, P436, DOI 10.1109/TPDS.2011.181; Vasiliadis G., 2011, Proceedings of the 2011 IEEE International Symposium on Workload Characterization (IISWC), DOI 10.1109/IISWC.2011.6114181; Villa O., 2009, P 23 IEEE INT PAR DI, P384; WU S, 1992, COMMUN ACM, V35, P83, DOI 10.1145/135239.135244; Xu K., 2013, P 1 INT C INF TECHN, P523; Yadav I, 2009, 2009 INTERNATIONAL CONFERENCE ON ADVANCES IN RECENT TECHNOLOGIES IN COMMUNICATION AND COMPUTING (ARTCOM 2009), P406, DOI 10.1109/ARTCom.2009.211; Yamashita R, 2010, NUCLEIC ACIDS RES, V38, pD98, DOI 10.1093/nar/gkp1017; Zha XY, 2013, IEEE T COMPUT, V62, P1156, DOI 10.1109/TC.2012.61	41	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0743-7315	1096-0848		J PARALLEL DISTR COM	J. Parallel Distrib. Comput.	FEB	2015	76				SI		49	57		10.1016/j.jpdc.2014.11.003		9	Computer Science, Theory & Methods	Computer Science	CE8TU	WOS:000352117800005		
J	Sassa, K; Yin, YP; Canuti, P				Sassa, Kyoji; Yin, Yueping; Canuti, Paolo			The Third World Landslide Forum, Beijing, 2014	LANDSLIDES			English	Article						International Consortium on Landslides (ICL); International Programme on Landslides (IPL); World Landslide Forum (WLF)		The Third World Landslide Forum was held on 2-6 June 2014 at the China National Convention Center, Beijing, China. This article outlines the background and the objectives of the World Landslide Forums and reports on the organized sessions and published books for the Third World Landslide Forum. During this triennial event of ICL, World Centres of Excellence on Landslide Risk Reduction and IPL Awards for Success, Varnes Medal, Best paper awards, and others were conferred. Through the examination in the high-level panel discussion on the first day and the roundtable discussion on the final day, 2014 Beijing Declaration "Landslide Risk Mitigation: Toward a Safer Geo-environment" was adopted. It is a document calling to join the planned Sendai partnerships 2015-2024 as a contribution to post-2015 Framework for Disaster Risk Reduction.	[Sassa, Kyoji; Yin, Yueping; Canuti, Paolo] Int Consortium Landslides, Kyoto, Japan	Sassa, K (reprint author), Int Consortium Landslides, Kyoto, Japan.	sassa@iclhq.org			Ministry of Land and Resources, China; UNESCO; WMO; FAO; UNISDR; UNU; ICSU; WFEO; IUGS	ICL gratefully acknowledges strong supports from all participants, their organizations, and the host organization, Ministry of Land and Resources, China. With supports from ICL supporting organizations (UNESCO, WMO, FAO, UNISDR, UNU, ICSU, WFEO, and IUGS), voluntary efforts by ICL member organizations and worldwide cooperators, ICL has developed, since its foundation in 2002, for research, capacity development and the edition of the journal Landslides. The success of the Third World Landslide Forum and corresponding publications is owed to those long-standing efforts. The authors on behalf of the International Consortium on Landslides would extend their gratitude to those organizations and individuals.	Sassa K, 2012, 2 WORLD LANDSL FOR R, V9, P285	1	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1612-510X	1612-5118		LANDSLIDES	Landslides	FEB	2015	12	1					177	192		10.1007/s10346-015-0555-8		16	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CE9EP	WOS:000352147000013		
J	Margottini, C; Antidze, N; Corominas, J; Crosta, GB; Frattini, P; Gigli, G; Giordan, D; Iwasaky, I; Lollino, G; Manconi, A; Marinos, P; Scavia, C; Sonnessa, A; Spizzichino, D; Vacheishvili, N				Margottini, C.; Antidze, N.; Corominas, J.; Crosta, G. B.; Frattini, P.; Gigli, G.; Giordan, D.; Iwasaky, I.; Lollino, G.; Manconi, A.; Marinos, P.; Scavia, C.; Sonnessa, A.; Spizzichino, D.; Vacheishvili, N.			Landslide hazard, monitoring and conservation strategy for the safeguard of Vardzia Byzantine monastery complex, Georgia	LANDSLIDES			English	Article						Planar slide and wedge failure; Rock fall; Kinematic analysis; Terrestrial laser scanner; Mitigation strategy; Vardzia (Georgia)	ROCK SLOPE STABILITY; PHYSICAL-PROPERTIES; SHEAR-STRENGTH; CAUCASUS; MASSES; METHODOLOGY; IGNIMBRITE	This paper reports preliminary results of a feasibility project developed in cooperation with National Agency for Cultural Heritage Preservation of Georgia, and aimed at envisaging the stability conditions of the Vardzia monastery slope (rupestrian city cave in the south-western Georgia). The aim is the implementation of a low-impact monitoring system together with long-term mitigation/conservation policies. A field analysis was conducted to reconstruct geometry of the rocky cliff, characteristics of discontinuities, main failure modes, and volume of potential unstable blocks and geomechanical parameters. Instability processes are the combination of causative factors such as the following: lithology, frequency and orientation of discontinuities, slope orientation, physical and mechanical characteristics of slope-forming materials, and morphological and hydrological boundary conditions. The combined adoption of different survey techniques (e.g., 3D laser scanner, ground-based radar interferometry) could be the best solution in the interdisciplinary field of cultural heritage preservation policies. The collected data will be the basis for future activities to be completed in collaboration with local authorities for a complete hazard and risk characterization for the monastery site and the development of an early warning system to allow safe exploitation for touristic activities and for historical site preservation.	[Margottini, C.; Spizzichino, D.] ICL Network Landslides & Cultural & Nat Heritage, Italian Inst Environm Protect & Res, ISPRA, Rome, Italy; [Antidze, N.] Natl Agcy Cultural Heritage Preservat Georgia, Tbilisi, Rep of Georgia; [Corominas, J.] Tech Univ Catalonia, Dept Geotech Engn & Geosci, Barcelona, Spain; [Crosta, G. B.; Frattini, P.] Univ Milano Bicocca, Dept Geol Sci & Geotechnol, Milan, Italy; [Gigli, G.] Univ Florence, Dept Earth Sci, Florence, Italy; [Giordan, D.; Lollino, G.; Manconi, A.] CNR, Ist Ric Protez Idrogeol, I-10135 Turin, Italy; [Iwasaky, I.] Geores Inst, Osaka, Japan; [Marinos, P.] Natl Tech Univ Athens, Athens, Greece; [Scavia, C.] Tech Univ Turin, Dept Struct Geotech & Bldg Engn, Turin, Italy; [Sonnessa, A.] Univ Roma La Sapienza, Dept Civil Construct & Environm Engn, SurveyLab, I-00185 Rome, Italy; [Vacheishvili, N.] Agr Univ Georgia, Ctr Dev Georgian Cultural Heritage Resources, GE-0159 Tbilisi, Rep of Georgia	Margottini, C (reprint author), ICL Network Landslides & Cultural & Nat Heritage, Italian Inst Environm Protect & Res, ISPRA, Rome, Italy.	claudio.margottini@gmail.com	Manconi, Andrea/B-8367-2009; 	Manconi, Andrea/0000-0003-2930-4422; Frattini, Paolo/0000-0003-3717-1527; GIGLI, GIOVANNI/0000-0003-4317-5882; GIORDAN, DANIELE/0000-0003-0136-2436			Abellan A, 2010, GEOMORPHOLOGY, V119, P162, DOI 10.1016/j.geomorph.2010.03.016; Frattini P, 2008, GEOMORPHOLOGY, V94, P419, DOI 10.1016/j.geomorph.2006.10.037; Crosta GB, 2004, NAT HAZARD EARTH SYS, V4, P583; del Potro R, 2009, ENG GEOL, V104, P135, DOI 10.1016/j.enggeo.2008.09.005; Gigli G, 2011, INT J ROCK MECH MIN, V48, P187, DOI 10.1016/j.ijrmms.2010.11.009; Pola A, 2012, TECTONOPHYSICS, V566, P67, DOI 10.1016/j.tecto.2012.07.017; Binal A, 2009, Q J ENG GEOL HYDROGE, V42, P107, DOI 10.1144/1470-9326/07-067; Mitchell J, 1999, TECTONOPHYSICS, V304, P157, DOI 10.1016/S0040-1951(99)00027-X; Agliardi F, 2009, NAT HAZARD EARTH SYS, V9, P1059; Agliardi F, 2003, INT J ROCK MECH MIN, V40, P455, DOI 10.1016/S1365-1609(03)00021-2; BARTON N, 1973, ENG GEOL, V7, P287, DOI 10.1016/0013-7952(73)90013-6; Baldo M, 2009, GEOMORPHOLOGY, V105, P193, DOI 10.1016/j.geomorph.2008.09.015; Corominas J, 2013, GEOMORPHOLOGY, V7, P259; Crosta GB, 2003, NAT HAZARD EARTH SYS, V3, P407; Cruden D.M, 1991, B INT ASS ENG GEOLOG, V43, P27, DOI DOI 10.1007/BF02590167; Cruden D.M., 1996, LANDSLIDES INVESTIGA, P36, DOI DOI 10.1007/BF02590167; EINSTEIN HH, 1983, INT J ROCK MECH MIN, V20, P227, DOI 10.1016/0148-9062(83)90003-7; Ershov AV, 1999, TECTONOPHYSICS, V313, P219, DOI 10.1016/S0040-1951(99)00197-3; GAMKRELIDZE IP, 1986, TECTONOPHYSICS, V127, P261, DOI 10.1016/0040-1951(86)90064-8; Gaprindashvili G, 1975, ANCIENT MONUMENTS GE, P7; Gillespie MR, 1999, BRIT GEOLOGICAL SURV, V2nd; Hoek E., 2007, PRACTICAL ROCK ENG; BARTON N, 1978, INT J ROCK MECH MIN, V15, P319; ROCHA M, 1981, INT J ROCK MECH MIN, V18, P85; Jennings JE, 1970, P S THEOR BACKGR PLA, P87; Lembo Fazio A, 1984, 4 INT S LANDSL TOR, V2, P115; Margottini C., 2014, RECONNECTING CITY HI; Margottini C, 2009, GEOIT 2009 SEST FOR; Margottini C, 2009, P 1 INT S DANX LANDF; Mavrouli O, 2009, NAT HAZARD EARTH SYS, V9, P1763; MOON VG, 1993, ENG GEOL, V35, P19, DOI 10.1016/0013-7952(93)90067-M; Nichol SL, 2002, CAN GEOTECH J, V39, P773, DOI 10.1139/T02-027; Rodriguez-Losada JA, 2009, J VOLCANOL GEOTH RES, V182, P67, DOI 10.1016/j.jvolgeores.2009.01.032; Scavia C, 1995, GEOTECHNIQUE, V45, P447; SHRAP, 2009, APRIL PROGR REP 2009; SHRAP, 2010, MAY PROGR REP 2010 S; Spizzichino D, 2009, GEO STRUCTURAL MODEL; Tugrul A, 2004, ENG GEOL, V75, P215, DOI 10.1016/j.enggeo.2004.05.008; Turner AK, 1996, 247 NAT RES COUNC TR, P673; VanDine DF, 1996, 081996 BRIT COL MIN; WP/WLI, 1993, B INT ASS ENG GEOL, V47, P53, DOI DOI 10.1007/BF02639593	41	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1612-510X	1612-5118		LANDSLIDES	Landslides	FEB	2015	12	1					193	204		10.1007/s10346-014-0548-z		12	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CE9EP	WOS:000352147000014		
J	Cloutier, C; Agliardi, F; Crosta, GB; Frattini, P; Froese, C; Jaboyedoff, M; Locat, J; Michoud, C; Marui, H				Cloutier, Catherine; Agliardi, Federico; Crosta, Giovanni Battista; Frattini, Paolo; Froese, Corey; Jaboyedoff, Michel; Locat, Jacques; Michoud, Clement; Marui, Hideaki			The First International Workshop on Warning Criteria for Active Slides: technical issues, problems and solutions for managing early warning systems	LANDSLIDES			English	Article						Warning criteria; Active landslide	LANDSLIDES; RAINFALL; EXPERIENCES; PREDICTION; LAQUILA; FAILURE	Early warning systems (EWSs) rely on the capacity to forecast a dangerous event with a certain amount of advance by defining warning criteria on which the safety of the population will depend. Monitoring of landslides is facilitated by new technologies, decreasing prices and easier data processing. At the same time, predicting the onset of a rapid failure or the sudden transition from slow to rapid failure and subsequent collapse, and its consequences is challenging for scientists that must deal with uncertainties and have limited tools to do so. Furthermore, EWS and warning criteria are becoming more and more a subject of concern between technical experts, researchers, stakeholders and decision makers responsible for the activation, enforcement and approval of civil protection actions. EWSs imply also a sharing of responsibilities which is often averted by technical staff, managers of technical offices and governing institutions. We organized the First International Workshop on Warning Criteria for Active Slides (IWWCAS) to promote sharing and networking among members from specialized institutions and relevant experts of EWS. In this paper, we summarize the event to stimulate discussion and collaboration between organizations dealing with the complex task of managing hazard and risk related to active slides.	[Cloutier, Catherine; Locat, Jacques] Univ Laval, Lab Etud Risques Nat, Dept Geol & Genie Geol, Quebec City, PQ G1V 0A6, Canada; [Agliardi, Federico; Crosta, Giovanni Battista; Frattini, Paolo] Univ Milano Bicocca, Dept Earth & Environm Sci, I-20126 Milan, Italy; [Froese, Corey] Alberta Geol Survey, Edmonton, AB, Canada; [Jaboyedoff, Michel; Michoud, Clement] Univ Lausanne, UNIL Mouline, Fac Geosci & Environm, CRET, CH-1015 Lausanne, Switzerland; [Marui, Hideaki] Niigata Univ, Res Inst Nat Hazards & Disaster Recovery, Div Multihazards, Sect Mech Anal Disasters, Niigata, Japan	Cloutier, C (reprint author), Univ Laval, Lab Etud Risques Nat, Dept Geol & Genie Geol, 1065 Ave Med, Quebec City, PQ G1V 0A6, Canada.	catherine.cloutier.2@ulaval.ca		Frattini, Paolo/0000-0003-3717-1527	Fondazione Montagna Sicura; Courmayeur Municipality; Regione Autonoma Valle d'Aosta	The organizing committee wish to thank the Fondazione Montagna Sicura, the Courmayeur Municipality and the Regione Autonoma Valle d'Aosta for their support in the organization by hosting this workshop, for offering coffee breaks, to allow for the field trip on the landslide and to have overcome the last moment troubles due to the evacuation phase.	Alexander DE, 2014, NAT HAZARDS, V72, P1159, DOI 10.1007/s11069-014-1062-2; Angeli MG, 2000, ENG GEOL, V55, P133, DOI 10.1016/S0013-7952(99)00122-2; KEEFER DK, 1987, SCIENCE, V238, P921, DOI 10.1126/science.238.4829.921; Rose ND, 2007, INT J ROCK MECH MIN, V44, P308, DOI 10.1016/j.ijrmms.2006.07.014; Intrieri E, 2012, ENG GEOL, V147, P124, DOI 10.1016/j.enggeo.2012.07.017; Yin YP, 2010, LANDSLIDES, V7, P339, DOI 10.1007/s10346-010-0220-1; Baum R, 2010, LANDSLIDES, V7, P259, DOI 10.1007/s10346-009-0177-0; Intrieri E, 2013, NAT HAZARD EARTH SYS, V13, P85, DOI 10.5194/nhess-13-85-2013; Pinyol NM, 2010, INT J NUMER ANAL MET, V34, P27, DOI 10.1002/nag.795; Michoud C, 2013, NAT HAZARD EARTH SYS, V13, P2659, DOI 10.5194/nhess-13-2659-2013; Blikra LH, 2008, LANDSLIDES AND ENGINEERED SLOPES: FROM THE PAST TO THE FUTURE, VOLS 1 AND 2, P1089, DOI 10.1201/9780203885284-c143; Aleotti P, 2004, ENG GEOL, V73, P247, DOI 10.1016/j.enggeo.2004.01.007; Casagli N, 2010, LANDSLIDES, V7, P291, DOI 10.1007/s10346-010-0215-y; Blikra L.H., 2012, LANDSLIDES TYPES MEC, P323; Chan RKS, 2003, P 14 SE AS GEOT C BA; Crosta GB, 2014, LANDSLIDES, V11, P747, DOI 10.1007/s10346-013-0433-1; Crosta GB, 2002, PHYS CHEM EARTH, V27, P1557, DOI 10.1016/S1474-7065(02)00177-8; Crosta GB, 2003, CAN GEOTECH J, V40, P176, DOI 10.1139/T02-085; Federico A, 2012, ENVIRON EARTH SCI, V66, P245, DOI 10.1007/s12665-011-1231-5; Froese CR, 2006, 1 SPEC C DIS MIT CAL; Fukuoka H, 2007, PROGR LANDSLIDE SCI, P99, DOI 10.1007/978-3-540-70965-7_7; Fukuzono T, 1985, 4 INT C FIELD WORKSH, P145; Fukuzono T., 1990, LANDSLIDE NEWS, V4, P9; Jakob M, 2012, LANDSLIDES, V9, P165, DOI 10.1007/s10346-011-0282-8; Jordan TH, 2013, SEISMOL RES LETT, V84, P4, DOI 10.1785/0220120167; Kalenchuk KS, 2012, COMPUTAT GEOSCI, V16, P21, DOI 10.1007/s10596-011-9245-3; Mainsant G, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002159; Malone S, 2008, SEISMOL RES LETT, V79, P603, DOI 10.1785/gssrl.79.5.603; Saito M., 1969, P 7 INT C SOIL MECH, P677; UNISDR, 2009, TERM DIS RISK RED; Wilson RC, 2004, LANDSLIDE HAZARD RIS, P493, DOI 10.1002/9780470012659.ch17; Zan L, 2002, INT GEOSCI REMOTE SE, P188; Zvelebil J, 2001, PHYS CHEM EARTH PT B, V26, P159, DOI 10.1016/S1464-1909(00)00234-3	33	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1612-510X	1612-5118		LANDSLIDES	Landslides	FEB	2015	12	1					205	212		10.1007/s10346-014-0530-9		8	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CE9EP	WOS:000352147000015		
J	Chen, F; Li, J; Sugiyama, H; Zhou, DH; Song, HQ; Zhao, GH; Zhu, XQ				Chen, Fen; Li, Juan; Sugiyama, Hiromu; Zhou, Dong-Hui; Song, Hui-Qun; Zhao, Guang-Hui; Zhu, Xing-Quan			Genetic variability among Schistosoma japonicum isolates from the Philippines, Japan and China revealed by sequence analysis of three mitochondrial genes	MITOCHONDRIAL DNA			English	Article						China; cytochrome b (cytb); genetic variation; Japan; mitochondrial DNA (mtDNA); NADH dehydrogenase subunits 2 and 6 (nad2 and nad6); Schistosoma japonicum; The Philippines	MAINLAND CHINA; AMPLIFIED POLYMORPHISM; PHYLOGENETIC ANALYSIS; PARASITIC FLATWORMS; DIFFERENTIATION; GENOMES; MARKERS; TALE	The present study examined sequence variability in the mitochondrial (mt) protein-coding genes cytochrome b (cytb), NADH dehydrogenase subunits 2 and 6 (nad2 and nad6) among 24 isolates of Schistosoma japonicum from different endemic regions in the Philippines, Japan and China. The complete cytb, nad2 and nad6 genes were amplified and sequenced separately from individual schistosome. Sequence variations for isolates from the Philippines were 0-0.5% for cytb, 0-0.6% for nad2, and 0-0.9% for nad6. Variation was 0-0.5%, 0.1-0.8%, 0-0.7% for corresponding genes for schistosome samples from mainland China. For worms in Japan, genetic variations were 0-0.2%, 0.1-0.2% and 0 for the three genes, respectively. Sequence variations were 0-1.0%, 0-1.8% and 0-1.1% for cytb, nad2 and nad6, respectively, among schistosome isolates from different geographical strains in the Philippines, Japan and China. Of the three countries, lowest sequence variations were found between isolates from mainland China and the Philippines and highest were detected between Japan and the Philippines in three mtDNA genes. Phylogenetic analyses based on the combined sequences of cytb, nad2 and nad6 revealed that all isolates in the Philippines clustered together sistered to samples from Yunnan and Zhejiang provinces in China, while isolates from Yamanashi in Japan were in a solitary clade. These results demonstrated the usefulness of the combined three mtDNA sequences for studying genetic diversity and population structure among S. japonicum isolates from the Philippines, China and Japan.	[Chen, Fen; Li, Juan; Zhou, Dong-Hui; Song, Hui-Qun; Zhu, Xing-Quan] Chinese Acad Agr Sci, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou Vet Res Inst, Lanzhou 730046, Gansu, Peoples R China; [Chen, Fen] Xiangnan Univ, Dept Basic Med, Chenzhou, Hunan, Peoples R China; [Li, Juan] Guangdong Acad Agr Sci, Inst Vet Med, Dept Parasitol, Guangzhou, Guangdong, Peoples R China; [Sugiyama, Hiromu] Natl Inst Infect Dis, Dept Parasitol, Tokyo, Japan; [Zhao, Guang-Hui] Northwest A&F Univ, Coll Vet Med, Dept Parasitol, Yangling, Shaanxi, Peoples R China; [Zhu, Xing-Quan] Heilongjiang Bayi Agr Univ, Dept Parasitol, Coll Anim Sci & Vet Med, Daqing, Heilongjiang, Peoples R China	Zhou, DH (reprint author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou 730046, Gansu, Peoples R China.	zhoudonghui@caas.cn; xingquanzhu1@hotmail.com			National S & T Major Program [2012ZX10004-220, ZX01]; Special Funds for Talents in Northwest AF University [Z109021107, 2010BSJJ015]	Project support was provided by the National S & T Major Program (Grant No. 2012ZX10004-220, ZX01) and the Special Funds for Talents in Northwest A&F University (Z109021107 and 2010BSJJ015).	McManus DP, 2010, CLIN MICROBIOL REV, V23, P442, DOI 10.1128/CMR.00044-09; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Zhou XN, 2010, ADV PARASIT, V72, P145, DOI 10.1016/S0065-308X(10)72006-6; CHILTON NB, 1995, INT J PARASITOL, V25, P647, DOI 10.1016/0020-7519(94)00171-J; Strimmer K, 1996, MOL BIOL EVOL, V13, P964; Zhao GH, 2012, INFECT GENET EVOL, V12, P1027, DOI 10.1016/j.meegid.2012.02.020; Le TH, 2000, MOL BIOL EVOL, V17, P1123; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Zhao GH, 2012, PARASITOL RES, V111, P1467, DOI 10.1007/s00436-012-2981-z; Zhao GH, 2009, VET PARASITOL, V162, P67, DOI 10.1016/j.vetpar.2009.02.022; Sugiyama H, 1997, INT J PARASITOL, V27, P811, DOI 10.1016/S0020-7519(97)00028-3; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Shrivastava J, 2005, MOL ECOL, V14, P839, DOI 10.1111/j.1365-294X.2005.02443.x; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005; Littlewood DTJ, 2006, MOL PHYLOGENET EVOL, V39, P452, DOI 10.1016/j.ympev.2005.12.012; McGarvey ST, 1999, PARASITOL TODAY, V15, P214, DOI 10.1016/S0169-4758(99)01409-X; Zhao GH, 2012, BIOTECHNOL ADV, V30, P1381, DOI 10.1016/j.biotechadv.2012.02.008; Burland T G, 2000, Methods Mol Biol, V132, P71; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; Le TH, 2001, MOL BIOCHEM PARASIT, V117, P61, DOI 10.1016/S0166-6851(01)00330-9; Bergquist R, 2010, ADV PARASIT, V72, P109, DOI 10.1016/S0065-308X(10)72005-4; Le TH, 2002, ANN TROP MED PARASIT, V96, P155, DOI 10.1179/000349802125000268; Li J, 2012, ELECTROPHORESIS, V33, P2859, DOI 10.1002/elps.201200110; Li J, 2010, PARASITOL RES, V107, P561, DOI 10.1007/s00436-010-1895-x; Li J, 2011, ELECTROPHORESIS, V32, P1473, DOI 10.1002/elps.201100044; Rudge JW, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000340; Song HQ, 2011, ELECTROPHORESIS, V32, P1364, DOI 10.1002/elps.201000600; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; WOODRUFF DS, 1987, AM J TROP MED HYG, V36, P345; Xiao N, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-13; Zarowlecki MZ, 2007, INT J PARASITOL, V37, P1401, DOI 10.1016/j.ijpara.2007.04.014; Zhao GH, 2011, INFECT GENET EVOL, V11, P610, DOI 10.1016/j.meegid.2011.01.015; Zhao GH, 2011, PARASITOL INT, V60, P170, DOI 10.1016/j.parint.2011.01.008; Zhao GH, 2009, INFECT GENET EVOL, V9, P903, DOI 10.1016/j.meegid.2009.06.006	36	4	4	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1940-1736	1940-1744		MITOCHONDR DNA	Mitochondrial DNA	FEB	2015	26	1					35	40		10.3109/19401736.2013.814110		6	Genetics & Heredity	Genetics & Heredity	CF4JJ	WOS:000352514900010		
J	Li, A; Munehara, H				Li, Ang; Munehara, Hiroyuki			Complete mitochondrial genome of the Antlered sculpin Enophrys diceraus (Scorpaeniformes, Cottidae)	MITOCHONDRIAL DNA			English	Article						Control region; cottidae; Enophrys diceraus; marine sculpin; mitochondrial genome	TELEOSTEI; FISHES	The complete mitochondrial genome (mitogenome) sequence of Enophrys diceraus (Cottidae) was determined for the first time by primer walking methods. It was 16,976 bp in length and contains 13 protein-coding genes, 2 ribosomal RNA genes, 22 transfer RNA genes, and a control region (CR). Within the CR, the extended termination-associated sequence, the central conserved sequence block (CSB-F, CSB-E, CSB-D, CSB-C, CSB-B, CSB-A) and the conserved sequence block (CSB-1, CSB-2, CSB-3) were identified. This first mitogenome information among marine sculpins is expected to enrich the knowledge on phylogenetic studies of this taxon.	[Li, Ang; Munehara, Hiroyuki] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Usujiri Fisheries Lab, Hakodate, Hokkaido 0411613, Japan	Munehara, H (reprint author), Hokkaido Univ, Field Sci Ctr Northern Biosphere, Usujiri Fisheries Lab, Hakodate, Hokkaido 0411613, Japan.	hm@fsc.hokudai.ac.jp			Ministry or Education, Culture, Sports, Science and Technology, Japan [20006885, 23380107]	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry or Education, Culture, Sports, Science and Technology, Japan (Grants-in-Aid 20006885, 23380107). The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the article.	Amaoka K, 2011, FISHES OF HOKKAIDO, P215; Smith WL, 2004, MOL PHYLOGENET EVOL, V32, P627, DOI 10.1016/j.ympev.2004.02.006; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Miya M, 1999, MAR BIOTECHNOL, V1, P416, DOI 10.1007/PL00011798; Knope ML, 2013, MOL PHYLOGENET EVOL, V66, P341, DOI 10.1016/j.ympev.2012.10.008; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Eschmeyer WN, 1983, PETERSON FIELD GUIDE; He Chong-Bo, 2007, Yichuan, V29, P829, DOI 10.1360/yc-007-0829; Hwang DS, 2013, COMPLETE MITOCHONDRI; LEE WJ, 1995, J MOL EVOL, V41, P54; Mecklenburg C. W., 2002, FISHES ALASKA; Nelson JS, 2006, FISHES WORLD; Panchenko VV., 2004, RUSS J MAR BIOL, V31, P273; Ramon ML, 2008, MOL PHYLOGENET EVOL, V46, P475, DOI 10.1016/j.ympev.2007.11.005; YABE M, 1985, Memoirs of the Faculty of Fisheries Hokkaido University, V32, P1; Yokoyama R, 2005, MOL PHYLOGENET EVOL, V36, P654, DOI 10.1016/j.ympev.2005.06.004; Zeng Z, 2012, MITOCHONDR DNA, V23, P435, DOI 10.3109/19401736.2012.710218; Zhou Y, 2009, GENE, V447, P86, DOI 10.1016/j.gene.2009.07.009	18	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1940-1736	1940-1744		MITOCHONDR DNA	Mitochondrial DNA	FEB	2015	26	1					125	126		10.3109/19401736.2013.814114		2	Genetics & Heredity	Genetics & Heredity	CF4JJ	WOS:000352514900027		
J	Baten, MA; Li, MZ; Motohashi, K; Ishiguro, Y; Rahman, MZ; Suga, H; Kageyama, K				Baten, Md Abdul; Li Mingzhu; Motohashi, Keiichi; Ishiguro, Yasushi; Rahman, Mohammad Ziaur; Suga, Haruhisa; Kageyama, Koji			Two new species, Phytopythium iriomotense sp nov and P. aichiense sp nov., isolated from river water and water purification sludge in Japan	MYCOLOGICAL PROGRESS			English	Article						Oomycete; Morphological analysis; Waste water treatment	CYTOCHROME-OXIDASE-II; PHYLOGENETIC-RELATIONSHIPS; GENUS PYTHIUM; SEQUENCE DATA; STEM ROT; REGION; RDNA; HELICOIDES; TAXONOMY	Phytopythium iriomotense sp. nov. was isolated from river water of Iriomote Island, Okinawa Prefecture, Japan. The species can grow at 10-35 degrees C. The optimum temperature was 30 degrees C, with a radial growth of 24.3 mm per day. The species is morphologically characterized by globose to sub-globose sporangia with apical papillae, internally nested and internally extended proliferating sporangia, lateral hyphal swellings, compound sympodia, globose and smooth oogonia, amphigynous or crook-necked antheridial cells, oogonia with double oospores, aplerotic or plerotic oospores, and a chrysanthemum growth pattern on V8A. Phytopythium aichiense sp. nov. was isolated from water purification sludge in Aichi prefecture, Japan. The species can grow at 3-35 degrees C. The optimum temperature was 28 degrees C with a radial growth of 12.3 mm per day. P. aichiense is morphologically characterized by sub-globose, ovoid or limoniform sporangia with apical papillae, internally nested or internally extended proliferating sporangia, filamentous inflated or crook-necked antheridial cells, aplerotic oospores and a stellate growth pattern on V8A. Phylogenetic analyses based on the rDNA ITS region and combined phylogenetic trees based on the nuclear LSU rDNA and beta-tubulin gene, and the mitochondrial coxI and coxII genes, revealed that both species are genetically distinct from each other and from morphologically related species.	[Baten, Md Abdul] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan; [Li Mingzhu; Ishiguro, Yasushi; Rahman, Mohammad Ziaur; Kageyama, Koji] Gifu Univ, River Basin Res Ctr, Gifu 5011193, Japan; [Motohashi, Keiichi] Tokyo Univ Agr, Fac Reg Environm Sci, Tokyo, Japan; [Suga, Haruhisa] Gifu Univ, Life Sci Res Ctr, Gifu 5011193, Japan	Baten, MA (reprint author), Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan.	baten@green.gifu-u.ac.jp					AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633; Broders KD, 2009, MYCOLOGIA, V101, P232, DOI 10.3852/08-133; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Fakhru'l-Razi A, 2007, J HAZARD MATER, V147, P350, DOI 10.1016/j.jhazmat.2007.01.060; Kroon LPNM, 2004, FUNGAL GENET BIOL, V41, P766, DOI 10.1016/j.fgb.2004.03.007; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Vos RA, 2003, SYST BIOL, V52, P368, DOI 10.1080/10635150390196993; Belbahri L, 2006, FEMS MICROBIOL LETT, V255, P209, DOI 10.1111/j.1574-6968.2006.00059.x; Martin FN, 2003, MYCOLOGIA, V95, P269, DOI 10.2307/3762038; Tao YH, 2011, J PHYTOPATHOL, V159, P255, DOI 10.1111/j.1439-0434.2010.01756.x; McLeod A, 2009, MYCOL RES, V113, P933, DOI 10.1016/j.mycres.2009.04.009; Levesque CA, 2004, MYCOL RES, V108, P1363, DOI 10.1017/S0953756204001431; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hulvey J, 2010, PERSOONIA, V25, P109, DOI 10.3767/003158510X551763; Villa NO, 2006, MYCOLOGIA, V98, P410, DOI 10.3852/mycologia.98.3.410; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Bala K, 2010, PERSOONIA, V24, P136; Belbahri L, 2008, FEMS MICROBIOL LETT, V284, P17, DOI 10.1111/j.1574-6968.2008.01168.x; Duan R. L., 1985, Acta Mycologica Sinica, V4, P1; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kageyama K, 2007, MYCOL RES, V111, P416, DOI 10.1016/j.mycres.2007.01.019; Kageyama K, 2010, IFO RES COMMUN, V24, P117; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Matsumoto Chieko, 1999, Mycoscience, V40, P321, DOI 10.1007/BF02463876; Nechwatal J, 2005, FEMS MICROBIOLOGY LE, V255, P96; O'Dannell K, 1993, FUNGAL HOMOMORPH MIO, P225; Paul B, 2004, FEMS MICROBIOL LETT, V234, P269, DOI 10.1016/j.femsle.2004.03.039; Paul B, 2000, FEMS MICROBIOL LETT, V186, P229, DOI 10.1016/S0378-1097(00)00146-4; Subramanian B.S., 2008, WATER ENVIRON RES, V80, P840, DOI DOI 10.2175/106143008X304703; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Swofford D.L, 2002, PHYLOGENETIC ANAL US; VANDERPLAATSNITERINK AJ, 1981, STUD MYCOL, P1; Waterhouse GM, 1967, MYCOL PAP, V109, P1; White TJ, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071; Yang X, 2013, PLANT DIS, V97, P1385, DOI 10.1094/PDIS-05-13-0472-PDN	36	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-416X	1861-8952		MYCOL PROG	Mycol. Prog.	FEB	2015	14	2							2	10.1007/s11557-015-1027-1		12	Mycology	Mycology	CF0TU	WOS:000352257900006		
J	Terashima, A; Ozawa, M				Terashima, Atsunori; Ozawa, Masaki			Numerical analysis on element creation by nuclear transmutation of fission products	NUCLEAR SCIENCE AND TECHNIQUES			English	Article						Nuclear transmutation; Fission products; Element creation; Neutron capture cross section; Apres ORIENT		A burnup calculation was performed to analyze the Apres ORIENT process, which aims to create highly-valuable elements from fission products separated from spent nuclear fuels. The basic idea is to use nuclear transmutation induced by a neutron capture reaction followed by a beta(-) decay, thus changing the atomic number Z of a target element in fission products by 1 unit. LWR (PWR) and FBR (MONJU) were considered as the transmutation devices. High rates of creation were obtained in some cases of platinum group metals (Ru-44 by FBR, Pd-46 by LWR) and rare earth (Gd-64 by LWR, Dy-66 by FBR). Therefore, systems based on LWR and FBR have their own advantages depending on target elements. Furthermore, it was found that creation rates of even Z' (= Z + 1) elements from odd Z ones were higher than the opposite cases. This creation rate of an element was interpreted in terms of "average 1-group neutron capture cross section of the corresponding target element <sigma(cz)>'' defined in this work. General trends of the creation rate of an even (odd) Z' element from the corresponding odd (even) Z one were found to be proportional to the 0.78th (0.63th) power of <sigma(cz)>, however with noticeable dispersion. The difference in the powers in the above analysis was explained by the difference in the number of stable isotopes caused by the even-odd effect of Z.	[Terashima, Atsunori] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Nucl Engn, Meguro Ku, Tokyo 1528550, Japan; [Ozawa, Masaki] Tokyo Inst Technol, Res Lab Nucl Reactors, Tokyo 1528550, Japan	Terashima, A (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Nucl Engn, Meguro Ku, 2-12-1-N1-21 Ookayama, Tokyo 1528550, Japan.	terashima.a.aa@m.titech.ac.jp					Shibata K, 2011, J NUCL SCI TECHNOL, V48, P1, DOI 10.3327/jnst.48.1; Han CY, 2012, SCI CHINA CHEM, V55, P1746, DOI 10.1007/s11426-012-4690-y; Ludwig S., 2002, CCC037117 OAK RIDG N; Ozawa M., 2011, P 17 S SEP SCI TECHN, P38; Ozawa M, 2008, PROG NUCL ENERG, V50, P476, DOI 10.1016/j.pnucene.2007.11.061	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1001-8042	2210-3147		NUCL SCI TECH	Nucl. Sci. Tech.	FEB	2015	26	1					117	124	S10311			8	Nuclear Science & Technology; Physics, Nuclear	Nuclear Science & Technology; Physics	CE9SC	WOS:000352182700020		
J	Yamawaki, M; Yamamoto, T; Arita, Y; Nakamori, F; Ohsawa, K; Konashi, K				Yamawaki, Michio; Yamamoto, Takuya; Arita, Yuji; Nakamori, Fumihiro; Ohsawa, Kazuhito; Konashi, Kenji			Hydriding properties of uranium alloys for purposes of searching for new hydrogen storage materials	NUCLEAR SCIENCE AND TECHNIQUES			English	Article						Depleted uranium; Hydrogen storage material; Uranium alloys; UNiAl intermetallic compound; First principles calculation	ABSORPTION DESORPTION PROPERTIES; CRYSTAL-STRUCTURE; SYSTEM	Hydriding properties of uranium alloys have been studied to search for new hydrogen storage materials to be applied to hydrogen energy systems. Application of uranium-base hydrogen storage materials can be expected to alleviate the risk, as well as to reduce the cost incurred by globally-stored large amounts of depleted uranium left after uranium enrichment. Various uranium alloys have been examined in terms of hydrogen absorption-desorption properties, among which UNiAl intermetallic compound showed promising characteristics, such as lower absorption-desorption temperatures and better anti-powdering strength. First principle calculation has been carried out on UNiAl hydride to predict the change of crystal structure and the lattice constant with increasing hydrogen content, which showed this calculation to be promising in predicting candidates for good hydrogen absorbers.	[Yamawaki, Michio; Yamamoto, Takuya; Arita, Yuji; Nakamori, Fumihiro] Univ Fukui, Res Inst Nucl Engn, Tsuruga, Fukui 9140055, Japan; [Ohsawa, Kazuhito] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan; [Konashi, Kenji] Tohoku Univ, Inst Mat Res, Oarai, Ibaraki 3111313, Japan	Yamawaki, M (reprint author), Univ Fukui, Res Inst Nucl Engn, 1-2-4 Kanawa Cho, Tsuruga, Fukui 9140055, Japan.	yamawaki@u-fukui.ac.jp	Kyushu, RIAM/F-4018-2015		Ministry of Education, Culture, Sports, Science and Technology of Japan [25420903]; Japan Industrial Location Center	Supported by Grants-in-Aid for Scientific Research (No. 25420903) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Japan Industrial Location Center	Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; ANDREEV AV, 1986, PHYS STATUS SOLIDI A, V98, pK47, DOI 10.1002/pssa.2210980148; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; DRULIS H, 1982, J LESS-COMMON MET, V83, P87, DOI 10.1016/0022-5088(82)90172-2; Asada K, 1995, J ALLOY COMPD, V231, P780, DOI 10.1016/0925-8388(95)01717-8; Ito H, 1998, J ALLOY COMPD, V271, P629, DOI 10.1016/S0925-8388(98)00174-1; JACOB I, 1984, J LESS-COMMON MET, V103, P123, DOI 10.1016/0022-5088(84)90366-7; Konashi K, 2012, ADV APPL CERAM, V111, P106, DOI 10.1179/1743676111Y.0000000051; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Maskova S, 2011, J PHYS CONF SER, V303, DOI 10.1088/1742-6596/303/1/012011; Raj P, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.214420; Raj P, 2000, J ALLOY COMPD, V296, P20, DOI 10.1016/S0925-8388(99)00525-3; Tamura H, 1998, HYDROGEN STORAGE ALL, P1; YAMAMOTO T, 1994, J ALLOY COMPD, V213, P533, DOI 10.1016/0925-8388(94)90981-4; YAMAMOTO T, 1991, J LESS-COMMON MET, V172, P71; YAMAMOTO T, 1989, FUSION ENG DES, V7, P363; Yamamoto T, 1998, J ALLOY COMPD, V269, P162, DOI 10.1016/S0925-8388(98)00221-7; YAMAMOTO T, 1988, FUSION TECHNOL, V14, P764; YAMAMOTO T, 1990, J NUCL MATER, V170, P140; Yamanaka S, 1999, J ALLOY COMPD, V293, P52, DOI 10.1016/S0925-8388(99)00300-X; Yamawaki M, 1995, GENSHIRYOKU KOGYO, V41, P27; Yamawaki M, 1999, CIMTEC1999 FIR IT	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1001-8042	2210-3147		NUCL SCI TECH	Nucl. Sci. Tech.	FEB	2015	26	1					125	130	S10312			6	Nuclear Science & Technology; Physics, Nuclear	Nuclear Science & Technology; Physics	CE9SC	WOS:000352182700021		
J	Tsurusawa, M; Gosho, M; Mori, T; Mitsui, T; Sunami, S; Kobayashi, R; Fukano, R; Tanaka, F; Fujita, N; Inada, H; Koh, K; Takimoto, T; Saito, A; Fujimoto, J; Nakazawa, A; Horibe, K				Tsurusawa, Masahito; Gosho, Masahiko; Mori, Tetsuya; Mitsui, Tetsuo; Sunami, Shosuke; Kobayashi, Ryoji; Fukano, Reiji; Tanaka, Fumiko; Fujita, Naoto; Inada, Hiroko; Koh, Katsuyoshi; Takimoto, Tetsuya; Saito, Akiko; Fujimoto, Junichiro; Nakazawa, Atsuko; Horibe, Keizo		Japanese Pediat Leukemia Lymphoma	Statistical Analysis of Relation Between Plasma Methotrexate Concentration and Toxicity in High-Dose Methotrexate Therapy of Childhood NonHodgkin Lymphoma	PEDIATRIC BLOOD & CANCER			English	Article						childhood; HDMTX; nonHodgkin lymphoma; toxicity	ACUTE-LYMPHOBLASTIC-LEUKEMIA; NON-HODGKIN-LYMPHOMA; B-CELL NEOPLASMS; CREATININE CLEARANCE; BFM GROUP; CHILDREN; ADOLESCENTS; IMPACT; FOLATE; TRIAL	Background. Plasma monitoring of Methotrexate (MTX) levels is a standard approach to predict MTX-related toxicities in a high-dose (HD) MTX monotherapy for childhood acute lymphoblastic leukemia. However, it is uncertain whether plasma MTX levels can predict MTX-related toxicity in the HDMTX plus additional chemotherapy for childhood B-cell nonHodgkin lymphoma (B-NHL). Procedures. To statistically analyze the relationship between MTX pharmacokinetic parameters and MTX-related toxicities, we collected data from patients with delayed MTX elimination (>= 1 mu M at 48 hr and/or >= 0.5 mu M at 72 hr) in the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) BNHL 03 study. Blood MTX levels were measured at 24, 48, and 72 hr after 3 or 5 g/m(2) HD-MTX administration for 24 hr. Results. Three hundred and four patients received 2-4 courses of the HDMTX plus additional chemotherapy, and delayed MTX elimination was observed in 165 courses of 127 patients. In those, nephrotoxicity was significantly correlated with plasma MTX levels for each patient (P = 0.03), and also for each course (P = 0.009), but no other toxicities were correlated. Another analysis according to HDMTX courses showed no significant correlation between the first high plasma MTX levels and subsequent MTX levels in later course. It also showed that incidence of liver and gastrointestinal toxicities was most frequent in the first HDMTX course, and then sharply decreased in later courses (P< 0.001). Conclusions. Our results suggest that plasma MTX level is not a reliable predictor for adverse events except for nephrotoxicity in multiple HDMTX therapy courses in childhood B-NHL. (C) 2014 Wiley Periodicals, Inc.	[Tsurusawa, Masahito; Gosho, Masahiko] Aichi Med Univ, Adv Med Res Ctr, Nagakute, Aichi 48011, Japan; [Mori, Tetsuya] Natl Ctr Child Hlth & Dev, Div Pediat Oncol, Tokyo, Japan; [Mitsui, Tetsuo] Yamagata Univ Hosp, Dept Pediat, Yamagata, Japan; [Sunami, Shosuke] Japanese Red Cross Narita Hosp, Dept Pediat, Chiba, Japan; [Kobayashi, Ryoji] Sapporo Hokuyu Hosp, Dept Pediat, Sapporo, Hokkaido, Japan; [Fukano, Reiji] Kushu Canc Ctr, Dept Pediat, Fukuoka, Japan; [Tanaka, Fumiko] Saiseikai Yokohama Nanbu Hosp, Dept Pediat, Yokohama, Kanagawa, Japan; [Fujita, Naoto] Hiroshima Red Cross Hosp, Dept Pediat, Hiroshima, Japan; [Fujita, Naoto] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Inada, Hiroko] Kurume Univ Hosp, Dept Pediat, Kurume, Fukuoka, Japan; [Koh, Katsuyoshi] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan; [Takimoto, Tetsuya; Fujimoto, Junichiro] Natl Ctr Child Hlth & Dev, Clin Res Ctr, Tokyo, Japan; [Saito, Akiko; Horibe, Keizo] Natl Hosp Org, Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [Nakazawa, Atsuko] Natl Ctr Child Hlth & Dev, Dept Pathol, Tokyo, Japan	Tsurusawa, M (reprint author), Aichi Med Univ, Adv Res Ctr, Nagakute, Aichi 48011, Japan.	mtsuru@aichi-med-u.ac.jp			Ministry of Health, Labor and Welfare of Japan [H14-Koka(Gan)-031, H15-Koka(Gan)-024, H16-GanRinsho-004, H17-GanRinsho-004, H20-GanRinsho-Ippan-017, H23-GanRinsho-Ippan-014]	Grant sponsor: Ministry of Health, Labor and Welfare of Japan; Grant numbers: H14-Koka(Gan)-031; H15-Koka(Gan)-024; H16-GanRinsho-004; H17-GanRinsho-004; H20-GanRinsho-Ippan-017; H23-GanRinsho-Ippan-014	LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Reiter A, 1999, BLOOD, V94, P3294; REITER A, 1992, BLOOD, V80, P2471; Patte C, 2001, BLOOD, V97, P3370, DOI 10.1182/blood.V97.11.3370; Woessmann W, 2005, BLOOD, V105, P948, DOI 10.1182/blood-2004-03-0973; Tsurusawa M, 2014, PEDIATR BLOOD CANCER, V61, P1215, DOI [10.1002/pbc.24975, 10.1002/pbc.24968]; Patte C, 2007, BLOOD, V109, P2773, DOI 10.1182/blood-2006-07-036673; Joannon P, 2004, PEDIATR BLOOD CANCER, V43, P17, DOI 10.1002/pbc.20032; Rau T, 2006, CLIN PHARMACOL THER, V80, P468, DOI 10.1016/j.clpt.2006.08.012; Kishi S, 2007, BLOOD, V109, P4151, DOI 10.1182/blood-2006-10-054528; Kodidela S, 2014, EUR J CLIN PHARMACOL, V70, P253, DOI 10.1007/s00228-013-1623-4; Cairo MS, 2007, BLOOD, V109, P2736, DOI 10.1182/blood-2006-07-036665; STOLLER RG, 1977, NEW ENGL J MED, V297, P630, DOI 10.1056/NEJM197709222971203; EVANS WE, 1979, CANCER CHEMOTH PHARM, V3, P161; Hempel L, 2003, MED PEDIATR ONCOL, V40, P348, DOI 10.1002/mpo.10293; Holmboe L, 2011, BR J CLIN PHARM, V73, P106; IVERSEN OH, 1974, EUR J CANCER, V10, P155, DOI 10.1016/0014-2964(74)90148-0; Mao J, 2014, NEOPLASMA, V61, P77, DOI 10.4149/neo_2014_011; Mary V, 1994, J CLIN ONCOL, V12, P1667; May J, 2014, LEUKEMIA LYMPHOMA, V55, P1345, DOI 10.3109/10428194.2013.840780; MURPHY SB, 1979, CANCER RES, V39, P1534; Noha M, 2012, MED ONCOL, V29, P2053; Ramsey LB, 2012, BLOOD, V121, P898; Schmiegelow K, 2009, BRIT J HAEMATOL, V146, P489, DOI 10.1111/j.1365-2141.2009.07765.x; Sterba J, 2006, CLIN CHEM, V52, P692, DOI 10.1373/clinchem.2005.061150; Tsurusawa M, 1995, LEUKEMIA, V11, P1921; Valik D, 2005, ONCOLOGY-BASEL, V69, P269, DOI 10.1159/000088334	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	FEB	2015	62	2					279	284		10.1002/pbc.25305		6	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CF0FN	WOS:000352218600020		
J	Umeda, K; Adachi, S; Tanaka, S; Ogawa, A; Hatakeyama, N; Kudo, K; Sakata, N; Igarashi, S; Ohshima, K; Hyakuna, N; Chin, M; Goto, H; Takahashi, Y; Azuma, E; Koh, K; Sawada, A; Kato, K; Inoue, M; Atsuta, Y; Takami, A; Murata, M				Umeda, Katsutsugu; Adachi, Souichi; Tanaka, Shiro; Ogawa, Atsushi; Hatakeyama, Naoki; Kudo, Kazuko; Sakata, Naoki; Igarashi, Shunji; Ohshima, Kumi; Hyakuna, Nobuyuki; Chin, Motoaki; Goto, Hiroaki; Takahashi, Yoshiyuki; Azuma, Eiichi; Koh, Katsuyoshi; Sawada, Akihisa; Kato, Koji; Inoue, Masami; Atsuta, Yoshiko; Takami, Akiyoshi; Murata, Makoto		Japan Soc Hematopoietic Cell	Comparison of Continuous and Twice-Daily Infusions of Cyclosporine A for Graft-Versus-Host-Disease Prophylaxis in Pediatric Hematopoietic Stem Cell Transplantation	PEDIATRIC BLOOD & CANCER			English	Article						cyclosporine; graft-versus-host disease; hematopoietic stem cell transplantation; pediatric	CONTINUOUS INTRAVENOUS-INFUSION; MARROW TRANSPLANTATION; CALCINEURIN INHIBITION; ACUTE GVHD; NEPHROTOXICITY; RECIPIENTS; BLOOD	Background. Cyclosporine A (CsA) is used widely for graft-versushost disease (GVHD) prophylaxis in hematopoietic stem cell transplantation (HSCT); however, the optimal schedule of its administration has not been established. Although comparative studies of adult patients undergoing HSCT have demonstrated enhanced efficacy and safety of twice-daily infusion (TD) compared with continuous infusion (CIF) of CsA, to our knowledge, similar studies have not yet been performed in pediatric groups. Procedure. A self-administered questionnaire was used to retrospectively compare the clinical outcome and incidence of CsA-associated adverse events of 70 pediatric acute myelogenous leukemia patients who were receiving CsA by TD (n = 36) or CIF (n = 34) as GVHDprophylaxis for their first allogeneic HSCT. Results. The cumulative incidences of grade II-IV acute GVHD and chronic GVHD, as well as the overall survival and event-free survival rates, did not differ significantly between the TD and CIF groups; however, the incidence of severe hypertension was significantly higher in the CIF group than the TD group. Conclusions. The analysis presented here indicates that TDand CIF administration of CsA have similar prophylactic effect on pediatric GVHD and suggest that TD is associated with a lower rate of toxicity than CIF in pediatric patients undergoing HSCT. (C) 2014 Wiley Periodicals, Inc.	[Umeda, Katsutsugu] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto 6068507, Japan; [Adachi, Souichi] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto 6068507, Japan; [Tanaka, Shiro] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto 6068507, Japan; [Ogawa, Atsushi] Niigata Canc Ctr Hosp, Dept Pediat, Niigata, Japan; [Hatakeyama, Naoki] Sapporo Med Univ Hosp, Dept Pediat, Sapporo, Hokkaido, Japan; [Kudo, Kazuko] Shizuoka Childrens Hosp, Div Hematol & Oncol, Shizuoka, Japan; [Sakata, Naoki] Kinki Univ, Fac Med, Dept Pediat, Osaka, Japan; [Igarashi, Shunji] Japanese Red Cross Narita Hosp, Div Pediat, Narita, Japan; [Ohshima, Kumi] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan; [Hyakuna, Nobuyuki] Ryukyu Univ Hosp, Ctr Bone Marrow Transplantat, Okinawa, Japan; [Chin, Motoaki] Nihon Univ, Itabashi Hosp, Dept Pediat & Child Hlth, Tokyo, Japan; [Goto, Hiroaki] Kanagawa Childrens Med Ctr, Div Hematooncol Regenerat Med, Yokohama, Kanagawa, Japan; [Takahashi, Yoshiyuki] Nagoya Univ, Dept Pediat, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Azuma, Eiichi] Mie Univ, Grad Sch Med, Dept Pediat & Cell Transplantat, Tsu, Mie, Japan; [Koh, Katsuyoshi] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan; [Sawada, Akihisa] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Hematol, Osaka, Japan; [Kato, Koji] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Atsuta, Yoshiko] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan; [Atsuta, Yoshiko] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Takami, Akiyoshi] Kanazawa Univ Hosp, Dept Hematol & Oncol, Kanazawa, Ishikawa, Japan; [Murata, Makoto] Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Umeda, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Pediat, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	umeume@kuhp.kyoto-u.ac.jp					Halloran PF, 1999, TRANSPLANTATION, V68, P1356, DOI 10.1097/00007890-199911150-00023; WEISDORF D, 1991, TRANSPLANTATION, V51, P1197, DOI 10.1097/00007890-199106000-00010; Atsuta Y, 2007, INT J HEMATOL, V86, P269, DOI 10.1532/IJH97.06239; Armenian SH, 2010, BIOL BLOOD MARROW TR, V16, P1138, DOI 10.1016/j.bbmt.2010.02.021; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Kimura S, 2010, BONE MARROW TRANSPL, V45, P1088, DOI 10.1038/bmt.2009.316; van Rossum HH, 2010, THER DRUG MONIT, V32, P3, DOI 10.1097/FTD.0b013e3181c0eecb; Furukawa T, 2010, INT J HEMATOL, V92, P144, DOI 10.1007/s12185-010-0610-0; Ruutu T, 1997, BONE MARROW TRANSPL, V19, P759, DOI 10.1038/sj.bmt.1700745; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; STORB R, 1989, BLOOD, V73, P1729; Sindhi R, 2000, TRANSPLANTATION, V69, P432, DOI 10.1097/00007890-200002150-00022; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Ogawa N, 2004, BONE MARROW TRANSPL, V33, P549, DOI 10.1038/sj.bmt.1704374; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Kagawa Y, 2003, BIOL PHARM BULL, V26, P1115; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Majhail NS, 2009, BIOL BLOOD MARROW TR, V15, P1100, DOI 10.1016/j.bbmt.2009.05.010; Oshima K, 2007, AM J HEMATOL, V83, P226	19	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	FEB	2015	62	2					291	298		10.1002/pbc.25243		8	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CF0FN	WOS:000352218600022		
J	Sano, H; Kobayashi, R; Suzuki, D; Kishimoto, K; Yasuda, K; Kobayashi, K				Sano, Hirozumi; Kobayashi, Ryoji; Suzuki, Daisuke; Kishimoto, Kenji; Yasuda, Kazue; Kobayashi, Kunihiko			Comparison Between Piperacillin/Tazobactam and Cefepime Monotherapies as an Empirical Therapy for Febrile Neutropenia in Children With Hematological and Malignant Disorders: A Prospective, Randomized Study	PEDIATRIC BLOOD & CANCER			English	Article						cefepime; empirical therapy; febrile neutropenia; piperacillin/tazobactam	RESISTANT PSEUDOMONAS-AERUGINOSA; PEDIATRIC CANCER-PATIENTS; RISK-FACTORS; PLUS NETILMICIN; FEVER; IMIPENEM; METAANALYSIS; CEFTAZIDIME; TAZOBACTAM; GUIDELINES	To evaluate the efficacy and safety of piperacillin/tazobactam (PIPC/TAZ) or cefepime (CFPM) monotherapy for febrile neutropenia (FN) in children, a total of 53 patients with 213 febrile episodes were randomly treated with either PIPC/TAZ 337.5 mg/kg/day, or CFPM 100 mg/kg/day. No significant differences were observed in the success rates of the PIPC/TAZ and CFPM treatments (62.1% vs. 59.1%, P = 0.650). Furthermore, no differences were noted in the rates of new infection and mortality, and no serious adverse effects occurred in either of groups. Both PIPC/TAZ and CFPM were effective and safe as an empirical therapy for FN in children. Pediatr Blood Cancer 2015;62:356-358. (C) 2014 Wiley Periodicals, Inc.	[Sano, Hirozumi; Kobayashi, Ryoji; Suzuki, Daisuke; Kishimoto, Kenji; Yasuda, Kazue; Kobayashi, Kunihiko] Sapporo Hokuyu Hosp, Dept Pediat, Shiroishi Ku, Sapporo, Hokkaido 0030006, Japan	Sano, H (reprint author), Sapporo Hokuyu Hosp, Dept Pediat, Shiroishi Ku, Higashi Sapporo 6-6, Sapporo, Hokkaido 0030006, Japan.	hirozumi.sano@gmail.com					Agaoglu L, 2001, J CHEMOTHERAPY, V13, P281; Aksoylar S, 2004, PEDIATR HEMAT ONCOL, V21, P115, DOI 10.1080/08880010490277321; Furno P, 2002, LANCET INFECT DIS, V2, P231, DOI 10.1016/S1473-3099(02)00241-4; Paul M, 2003, BRIT MED J, V326, P1111, DOI 10.1136/bmj.326.7399.1111; Cao B, 2004, J HOSP INFECT, V57, P112, DOI 10.1016/j.jhin.2004.03.021; Corapcioglu F, 2006, PEDIATR HEMAT ONCOL, V23, P177, DOI 10.1080/08880010500506370; Freifeld AG, 2011, UPDATE INFECT DIS SO, V52, P427; Ichikawa M, 2011, PEDIATR BLOOD CANCER, V57, P1159, DOI 10.1002/pbc.23106; King A, 1995, J ANTIMICROB CHEMOTH, V36, P1037, DOI 10.1093/jac/36.6.1037; Le Guyader N, 2004, SUPPORT CARE CANCER, V12, P720, DOI 10.1007/s00520-004-0641-2; Ozkurt Z, 2005, BURNS, V31, P870, DOI 10.1016/j.burns.2005.04.015; Paul M, 2010, COCHRANE DB SYST REV, V11; PIZZO PA, 1986, NEW ENGL J MED, V315, P552, DOI 10.1056/NEJM198608283150905; Tamura K, 2005, INT J ANTIMICROB AG, V26, pS123, DOI 10.1016/j.ijantimicag.2005.08.001; Uygun V, 2009, PEDIATR BLOOD CANCER, V53, P610, DOI 10.1002/pbc.22100; Viscoli C, 1998, ONCOLOGY-BASEL, V55, P489, DOI 10.1159/000011901; Zavascki AP, 2005, J HOSP INFECT, V59, P96, DOI 10.1016/j.jhin.2004.09.007	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	FEB	2015	62	2					356	358		10.1002/pbc.25178		3	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CF0FN	WOS:000352218600033		
J	Hosono, H				Hosono, Hideo			A superconducting surprise comes of age	PHYSICS WORLD			English	Article									[Hosono, Hideo] Univ Tokyo, Tokyo 1138654, Japan; Tokyo Inst Technol, Yokohama, Kanagawa 227, Japan	Hosono, H (reprint author), Univ Tokyo, Tokyo 1138654, Japan.	aoki@phys.s.u-tokyo.ac.jp	Hosono, Hideo/J-3489-2013	Hosono, Hideo/0000-0001-9260-6728				0	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-8585			PHYS WORLD	Phys. World	FEB	2015	28	2					31	36				6	Physics, Multidisciplinary	Physics	CF4DT	WOS:000352499600033		
J	Tsubota, T; Okubo-Suzuki, R; Ohashi, Y; Tamura, K; Ogata, K; Yaguchi, M; Matsuyama, M; Inokuchi, K; Miyashita, Y				Tsubota, Tadashi; Okubo-Suzuki, Reiko; Ohashi, Yohei; Tamura, Keita; Ogata, Koshin; Yaguchi, Masae; Matsuyama, Makoto; Inokuchi, Kaoru; Miyashita, Yasushi			Cofilin1 Controls Transcolumnar Plasticity in Dendritic Spines in Adult Barrel Cortex	PLOS BIOLOGY			English	Article							MEDIATED ACTIN DYNAMICS; LONG-TERM DEPRESSION; IN-VIVO; SYNAPTIC PLASTICITY; CORTICAL PLASTICITY; SOMATOSENSORY CORTEX; SENSORY DEPRIVATION; BRAIN PLASTICITY; NEURAL ACTIVITY; MAP PLASTICITY	During sensory deprivation, the barrel cortex undergoes expansion of a functional column representing spared inputs (spared column), into the neighboring deprived columns (representing deprived inputs) which are in turn shrunk. As a result, the neurons in a deprived column simultaneously increase and decrease their responses to spared and deprived inputs, respectively. Previous studies revealed that dendritic spines are remodeled during this barrel map plasticity. Because cofilin1, a predominant regulator of actin filament turnover, governs both the expansion and shrinkage of the dendritic spine structure in vitro, it hypothetically regulates both responses in barrel map plasticity. However, this hypothesis remains untested. Using lentiviral vectors, we knocked down cofilin1 locally within layer 2/3 neurons in a deprived column. Cofilin1-knocked-down neurons were optogenetically labeled using channelrhodopsin-2, and electrophysiological recordings were targeted to these knocked-down neurons. We showed that cofilin1 knockdown impaired response increases to spared inputs but preserved response decreases to deprived inputs, indicating that cofilin1 dependency is dissociated in these two types of barrel map plasticity. To explore the structural basis of this dissociation, we then analyzed spine densities on deprived column dendritic branches, which were supposed to receive dense horizontal transcolumnar projections from the spared column. We found that spine number increased in a cofilin1-dependent manner selectively in the distal part of the supragranular layer, where most of the transcolumnar projections existed. Our findings suggest that cofilin1-mediated actin dynamics regulate functional map plasticity in an input-specific manner through the dendritic spine remodeling that occurs in the horizontal transcolumnar circuits. These new mechanistic insights into transcolumnar plasticity in adult rats may have a general significance for understanding reorganization of neocortical circuits that have more sophisticated columnar organization than the rodent neocortex, such as the primate neocortex.	[Tsubota, Tadashi; Ohashi, Yohei; Tamura, Keita; Ogata, Koshin; Yaguchi, Masae; Matsuyama, Makoto; Miyashita, Yasushi] Univ Tokyo, Sch Med, Dept Physiol, Tokyo 113, Japan; [Okubo-Suzuki, Reiko; Inokuchi, Kaoru] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biochem, Toyama 930, Japan; [Okubo-Suzuki, Reiko; Inokuchi, Kaoru; Miyashita, Yasushi] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan	Tsubota, T (reprint author), Univ Tokyo, Sch Med, Dept Physiol, Tokyo 113, Japan.	yasushi_miyashita@m.u-tokyo.ac.jp			Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); JSPS [23220009, 19002010, 24220008]; MEXT [23700489]; Takeda Science Foundation; Uehara Memorial Fund; JSPS Research Fellowships for Young Scientists [235569]	This work was supported by a grant from Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (KI, YM) (http://www.jst.go.jp/), a grant from Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (http://www.mext.go.jp/) and JSPS (http://www.jsps.go.jp/) (grant number 23220009 to KI, 19002010 to YM, and 24220008 to YM), MEXT Grant-in-Aid Scientific Research on Innovative Areas (KI), a grant from Takeda Science Foundation (KI, YM) (http://www.takeda-sci.or.jp/), a Grant-in-Aid for Young Scientists from MEXT (grant number, 23700489; YO), Uehara Memorial Fund (YO) (http://www.ueharazaidan.or.jp/), and JSPS Research Fellowships for Young Scientists (grant number, 235569; TT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hayama T, 2013, NAT NEUROSCI, V16, P1409, DOI 10.1038/nn.3496; Yaguchi M, 2013, HUM GENE THER METHOD, V24, P333, DOI 10.1089/hgtb.2012.238; Hensch TK, 2014, CELL, V156, P17, DOI 10.1016/j.cell.2013.12.034; Drew PJ, 2009, CEREB CORTEX, V19, P331, DOI 10.1093/cercor/bhn085; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Racz B, 2006, NEUROSCIENCE, V138, P447, DOI 10.1016/j.neuroscience.2005.11.025; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Finnerty GT, 1999, NATURE, V400, P367; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Cauli B, 1997, J NEUROSCI, V17, P3894; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Reyes A, 1999, J NEUROSCI, V19, P3827; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; FOX K, 1994, J NEUROSCI, V14, P7665; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Bosch M, 2014, NEURON, V82, P444, DOI 10.1016/j.neuron.2014.03.021; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Takeuchi D, 2011, SCIENCE, V331, P1443, DOI 10.1126/science.1199967; Davidson BL, 2003, NAT REV NEUROSCI, V4, P353, DOI 10.1038/nrn1104; IZANT JG, 1980, P NATL ACAD SCI-BIOL, V77, P4741, DOI 10.1073/pnas.77.8.4741; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Gilbert CD, 2012, NEURON, V75, P250, DOI 10.1016/j.neuron.2012.06.030; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Paavilainen VO, 2002, J BIOL CHEM, V277, P43089, DOI 10.1074/jbc.M208225200; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Ganguly K, 2013, NEURON, V80, P729, DOI 10.1016/j.neuron.2013.10.028; Margolis DJ, 2012, NAT NEUROSCI, V15, P1539, DOI 10.1038/nn.3240; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Aronoff Rachel, 2007, Front Integr Neurosci, V1, P1, DOI 10.3389/neuro.07.001.2007; Csicsvari J, 1999, J Neurosci, V19, pRC20; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Gorlich A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026789; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Marik SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000395; Ohkawa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045270; Okubo-Suzuki R, 2008, MOL CELL NEUROSCI, V38, P266, DOI 10.1016/j.mcn.2008.03.001; Polley DB, 2004, NATURE, V429, P67, DOI 10.1038/nature02469; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; Tamura K, 2012, J NEUROSCI METH, V211, P49, DOI 10.1016/j.jneumeth.2012.08.004; Tsubota T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022400; Wolf M, 2014, CEREB CORTEX IN PRES	67	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1545-7885			PLOS BIOL	PLoS. Biol.	FEB	2015	13	2							UNSP e1002070	10.1371/journal.pbio.1002070		29	Biochemistry & Molecular Biology; Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	CE8GO	WOS:000352080100017		
J	Furumizu, C; Alvarez, JP; Sakakibara, K; Bowman, JL				Furumizu, Chihiro; Alvarez, John Paul; Sakakibara, Keiko; Bowman, John L.			Antagonistic Roles for KNOX1 and KNOX2 Genes in Patterning the Land Plant Body Plan Following an Ancient Gene Duplication	PLOS GENETICS			English	Article							SHOOT APICAL MERISTEM; BEL1-LIKE HOMEODOMAIN PROTEINS; KNOTTED1-LIKE HOMEOBOX GENES; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTORS; BAYESIAN-INFERENCE; WALL FORMATION; LEAF SHAPE; CELL-FATE; WILD-TYPE	Neofunctionalization following gene duplication is thought to be one of the key drivers in generating evolutionary novelty. A gene duplication in a common ancestor of land plants produced two classes of KNOTTED-like TALE homeobox genes, class I (KNOX1) and class II (KNOX2). KNOX1 genes are linked to tissue proliferation and maintenance of meri-stematic potentials of flowering plant and moss sporophytes, and modulation of KNOX1 activity is implicated in contributing to leaf shape diversity of flowering plants. While KNOX2 function has been shown to repress the gametophytic (haploid) developmental program during moss sporophyte (diploid) development, little is known about KNOX2 function in flowering plants, hindering syntheses regarding the relationship between two classes of KNOX genes in the context of land plant evolution. Arabidopsis plants harboring loss-of-function KNOX2 alleles exhibit impaired differentiation of all aerial organs and have highly complex leaves, phenocopying gain-of-function KNOX1 alleles. Conversely, gain-of-function KNOX2 alleles in conjunction with a presumptive heterodimeric BELL TALE homeobox partner suppressed SAM activity in Arabidopsis and reduced leaf complexity in the Arabidopsis relative Cardamine hirsuta, reminiscent of loss-of-function KNOX1 alleles. Little evidence was found indicative of epistasis or mutual repression between KNOX1 and KNOX2 genes. KNOX proteins heterodimerize with BELL TALE homeobox proteins to form functional complexes, and contrary to earlier reports based on in vitro and heterologous expression, we find high selectivity between KNOX and BELL partners in vivo. Thus, KNOX2 genes confer opposing activities rather than redundant roles with KNOX1 genes, and together they act to direct the development of all above-ground organs of the Arabidopsis sporophyte. We infer that following the KNOX1/KNOX2 gene duplication in an ancestor of land plants, neofunctionalization led to evolution of antagonistic biochemical activity thereby facilitating the evolution of more complex sporophyte transcriptional networks, providing plasticity for the morphological evolution of land plant body plans.	[Furumizu, Chihiro; Alvarez, John Paul; Sakakibara, Keiko; Bowman, John L.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Sakakibara, Keiko] Univ Tokyo, Grad Sch Sci, Tokyo 113, Japan; [Bowman, John L.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA	Furumizu, C (reprint author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	john.bowman@monash.edu		Bowman, John/0000-0001-7347-3691	Australian Research Council [FF0561326, DP110100070, DP130100177]	This study was funded through grants from the Australian Research Council [www.arc.gov.au; FF0561326, DP110100070, DP130100177 (JLB)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Wang S, 2007, PLANT J, V50, P858, DOI 10.1111/j.1365-313X.2007.03096.x; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Shani E, 2009, PLANT CELL, V21, P3078, DOI 10.1105/tpc.109.068148; Lee JH, 2008, CELL, V133, P829, DOI 10.1016/j.cell.2008.04.028; Doyle JA, 1998, ANNU REV ECOL SYST, V29, P567, DOI 10.1146/annurev.ecolsys.29.1.567; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; KUES U, 1992, GENE DEV, V6, P568, DOI 10.1101/gad.6.4.568; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; KERSTETTER R, 1994, PLANT CELL, V6, P1877, DOI 10.1105/tpc.6.12.1877; Liu C, 2009, DEV CELL, V16, P711, DOI 10.1016/j.devcel.2009.03.011; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Ori N, 2000, DEVELOPMENT, V127, P5523; Smith HMS, 2003, PLANT CELL, V15, P1717, DOI 10.1105/tpc.012856; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Sano R, 2005, EVOL DEV, V7, P69, DOI 10.1111/j.1525-142X.2005.05008.x; Hake S, 2004, ANNU REV CELL DEV BI, V20, P125, DOI 10.1146/annurev.cellbio.20.031803.093824; Obayashi T, 2011, PLANT CELL PHYSIOL, V52, P213, DOI 10.1093/pcp/pcq203; Endrizzi K, 1996, PLANT J, V10, P967, DOI 10.1046/j.1365-313X.1996.10060967.x; Vlad D, 2014, SCIENCE, V343, P780, DOI 10.1126/science.1248384; DOCKX J, 1995, PLANT MOL BIOL, V28, P723, DOI 10.1007/BF00021196; Rutjens B, 2009, PLANT J, V58, P641, DOI 10.1111/j.1365-313X.2009.03809.x; Serikawa KA, 1997, PLANT J, V11, P853, DOI 10.1046/j.1365-313X.1997.11040853.x; Kimura S, 2008, CURR BIOL, V18, P672, DOI 10.1016/j.cub.2008.04.008; Efroni I, 2010, PLANT CELL, V22, P1019, DOI 10.1105/tpc.109.073601; Nicotra AB, 2011, FUNCT PLANT BIOL, V38, P535, DOI 10.1071/FP11057; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Truernit E, 2006, PLANT MOL BIOL, V60, P1, DOI 10.1007/s11103-005-1673-9; Byrne ME, 2003, DEVELOPMENT, V130, P3941, DOI 10.1242/dev.00620; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Derelle R, 2007, EVOL DEV, V9, P212; Magnani E, 2008, PLANT CELL, V20, P875, DOI 10.1105/tpc.108.058495; VOLLBRECHT E, 1991, NATURE, V350, P241, DOI 10.1038/350241a0; Hasson A, 2011, PLANT CELL, V23, P54, DOI 10.1105/tpc.110.081448; Hofer J, 1997, CURR BIOL, V7, P581, DOI 10.1016/S0960-9822(06)00257-0; BARTON MK, 1993, DEVELOPMENT, V119, P823; Yanai O, 2005, CURR BIOL, V15, P1566, DOI 10.1016/j.cub.2005.07.060; Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Long JA, 1998, DEVELOPMENT, V125, P3027; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Bertolino E, 1995, J BIOL CHEM, V270, P31178; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Markel H, 2002, NUCLEIC ACIDS RES, V30, P4709, DOI 10.1093/nar/gkf591; Li EY, 2012, NEW PHYTOL, V194, P102, DOI 10.1111/j.1469-8137.2011.04016.x; Harrison CJ, 2005, NATURE, V434, P509, DOI 10.1038/nature03410; Sakakibara K, 2013, SCIENCE, V339, P1067, DOI 10.1126/science.1230082; ROBINSONBEERS K, 1992, PLANT CELL, V4, P1237, DOI 10.1105/tpc.4.10.1237; Alvarez J, 1999, DEVELOPMENT, V126, P2377; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Li EY, 2011, PLANT J, V67, P328, DOI 10.1111/j.1365-313X.2011.04595.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Kim D, 2013, PLANT J, V75, P755, DOI 10.1111/tpj.12236; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Belles-Boix E, 2006, PLANT CELL, V18, P1900, DOI 10.1105/tpc.106.041988; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Ragni L, 2008, PLANT CELL, V20, P888, DOI 10.1105/tpc.108.058230; Wenkel S, 2007, PLANT CELL, V19, P3379, DOI 10.1105/tpc.107.055772; Sakakibara K, 2008, EVOL DEV, V10, P555, DOI 10.1111/j.1525-142X.2008.00271.x; Hay A, 2010, DEVELOPMENT, V137, P3153, DOI 10.1242/dev.030049; Piazza P, 2010, CURR BIOL, V20, P2223, DOI 10.1016/j.cub.2010.11.037; Mitsuda N, 2009, PLANT CELL PHYSIOL, V50, P1232, DOI 10.1093/pcp/pcp075; Bower F.O., 1908, ORIGIN LAND FLORA TH; Cock JM, 2014, CURR OPIN PLANT BIOL, V17, P1, DOI 10.1016/j.pbi.2013.09.004; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Haig D, 2008, BOT REV, V74, P395, DOI 10.1007/s12229-008-9012-x; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Janssen BJ, 1998, PLANT MOL BIOL, V36, P417, DOI 10.1023/A:1005925508579; Kumar R, 2007, PLANT CELL, V19, P2719, DOI 10.1105/tpc.106.048769; Moore I, 1998, P NATL ACAD SCI USA, V95, P376, DOI 10.1073/pnas.95.1.376; Ohno S., 1970, EVOLUTION GENE DUPLI; REISER L, 1995, CELL, V83, P735, DOI 10.1016/0092-8674(95)90186-8; Serikawa KA, 1997, PLANT J, V11, P863, DOI 10.1046/j.1365-313X.1997.11040863.x; Serikawa KA, 1996, PLANT MOL BIOL, V32, P673, DOI 10.1007/BF00020208; Svedelius N, 1927, BOT GAZ, V83, P362, DOI 10.1086/333745; Vasco A, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00544, DOI 10.3389/FPLS.2013.00544]; Viola IL, 2009, BIOCHIMIE, V91, P974, DOI 10.1016/j.biochi.2009.04.021; Winter D, 2007, PLOS ONE, V2, DOI [10.1371/journal.pone.0001317, DOI 10.1371/JOURNAL.PONE.0001317]	81	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7390	1553-7404		PLOS GENET	PLoS Genet.	FEB	2015	11	2							e1004980	10.1371/journal.pgen.1004980		24	Genetics & Heredity	Genetics & Heredity	CE8HF	WOS:000352081800036		
J	Kim, G; Pai, CI; Sato, K; Person, MD; Nakamura, A; Macdonald, PM				Kim, Goheun; Pai, Chin-I; Sato, Keiji; Person, Maria D.; Nakamura, Akira; Macdonald, Paul M.			Region-Specific Activation of oskar mRNA Translation by Inhibition of Bruno-Mediated Repression	PLOS GENETICS			English	Article							POLE CELL-FORMATION; DROSOPHILA OOCYTE; BINDING-PROTEIN; LOCAL TRANSLATION; GENE-EXPRESSION; POSTERIOR POLE; COAT PROTEIN; LOCALIZATION; CUP; PHOSPHORYLATION	A complex program of translational repression, mRNA localization, and translational activation ensures that Oskar (Osk) protein accumulates only at the posterior pole of the Drosophila oocyte. Inappropriate expression of Osk disrupts embryonic axial patterning, and is lethal. A key factor in translational repression is Bruno (Bru), which binds to regulatory elements in the osk mRNA 30 UTR. After posterior localization of osk mRNA, repression by Bru must be alleviated. Here we describe an in vivo assay system to monitor the spatial pattern of Bru-dependent repression, separate from the full complexity of osk regulation. This assay reveals a form of translational activation-region-specific activation-which acts regionally in the oocyte, is not mechanistically coupled to mRNA localization, and functions by inhibiting repression by Bru. We also show that Bru dimerizes and identify mutations that disrupt this interaction to test its role in vivo. Loss of dimerization does not disrupt repression, as might have been expected from an existing model for the mechanism of repression. However, loss of dimerization does impair regional activation of translation, suggesting that dimerization may constrain, not promote, repression. Our work provides new insight into the question of how localized mRNAs become translationally active, showing that repression of osk mRNA is locally inactivated by a mechanism acting independent of mRNA localization.	[Kim, Goheun; Pai, Chin-I; Macdonald, Paul M.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA; [Sato, Keiji] RIKEN, Ctr Dev Biol, Lab Germline Dev, Kobe, Hyogo, Japan; [Person, Maria D.] Univ Texas Austin, Inst Cellular & Mol Biol, Prote Facil, Austin, TX 78712 USA; [Person, Maria D.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Nakamura, Akira] Kumamoto Univ, Inst Mol Embryol & Genet, Div Organogenesis, Dept Germline Dev, Kumamoto, Japan	Kim, G (reprint author), Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA.	pmac@utexas.edu			National Institutes of Health [RO1 GM54409]; Cancer Prevention Research Institute of Texas [RP110782]; MEXT (The Ministry of Education, Culture, Sports, Science and Technology); JST PRESTO project (Precursory Research for Embryonic Science and Technology by Japan Science and Technology Agency)	This work was supported by National Institutes of Health (www.nih.gov) grant RO1 GM54409 (to PMM), Cancer Prevention Research Institute of Texas (www.cprit.state.tx.us) grant RP110782 to MDP, and by Grant-in-Aid from MEXT (The Ministry of Education, Culture, Sports, Science and Technology)(ww.mext.go.jp), and JST PRESTO project (Precursory Research for Embryonic Science and Technology by Japan Science and Technology Agency)(www.jst.go.jp/kisoken/presto) to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Saffman EE, 1998, MOL CELL BIOL, V18, P4855; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Ghosh S, 2012, NAT STRUCT MOL BIOL, V19, P441, DOI 10.1038/nsmb.2257; Vanzo NF, 2002, DEVELOPMENT, V129, P3705; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; Munro TP, 2006, J CELL BIOL, V172, P577, DOI 10.1083/jcb.200510044; Snee MJ, 2009, DEV DYNAM, V238, P918, DOI 10.1002/dvdy.21914; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; RONGO C, 1995, DEVELOPMENT, V121, P2737; Reveal B, 2011, RNA BIOL, V8, P1047, DOI 10.4161/rna.8.6.17542; Paquin N, 2007, MOL CELL, V26, P795, DOI 10.1016/j.molcel.2007.05.016; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Webster PJ, 1997, GENE DEV, V11, P2510, DOI 10.1101/gad.11.19.2510; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; SMITH JL, 1992, CELL, V70, P849, DOI 10.1016/0092-8674(92)90318-7; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Igreja C, 2011, GENE DEV, V25, P1955, DOI 10.1101/gad.17136311; Reveal B, 2010, DEV CELL, V18, P496, DOI 10.1016/j.devcel.2009.12.021; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Haseloff J, 1999, METHOD CELL BIOL, V58, P139; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Chang JS, 1999, DEV BIOL, V215, P91, DOI 10.1006/dbio.1999.9444; SCHUPBACH T, 1989, GENETICS, V121, P101; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Lie YS, 1999, DEVELOPMENT, V126, P4989; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Castagnetti S, 2003, DEVELOPMENT, V130, P835, DOI 10.1242/dev.00309; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088; LECUYER KA, 1995, BIOCHEMISTRY-US, V34, P10600, DOI 10.1021/bi00033a035; Van Doren M, 1998, CURR BIOL, V8, P243; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Wilson JE, 1996, DEVELOPMENT, V122, P1631; Castagnetti S, 2000, DEVELOPMENT, V127, P1063; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; Deng YF, 2008, GENE DEV, V22, P1037, DOI 10.1101/gad.1611308; Filardo P, 2003, MECH DEVELOP, V120, P289, DOI 10.1016/S0925-4773(02)00454-9; Gunkel N, 1998, GENE DEV, V12, P1652, DOI 10.1101/gad.12.11.1652; Jambor H, 2011, RNA, V17, P2049, DOI 10.1261/rna.2686411; Kim-Ha Jeongsil, 1993, Development (Cambridge), V119, P169; LANE ME, 1994, GENE DEV, V8, P2986, DOI 10.1101/gad.8.24.2986; Lasko P., 2012, COLD SPRING HARB PER, V4; Lyon AM, 2009, BIOCHEMISTRY-US, V48, P12202, DOI 10.1021/bi900624j; Reich J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004669; ROMANIUK PJ, 1987, BIOCHEMISTRY-US, V26, P1563, DOI 10.1021/bi00380a011; Snee M, 2008, RNA BIOL, V5, P49; Snee MJ, 2004, J CELL SCI, V117, P2109, DOI 10.1242/jcs.01059; STJOHNSTON D, 1995, CELL, V81, P161, DOI 10.1016/0092-8674(95)90324-0; Verrotti AC, 2000, DEVELOPMENT, V127, P5225; White RR, 1998, J BIOL CHEM, V273, P3166, DOI 10.1074/jbc.273.6.3166; Yoshida S, 2004, DEVELOPMENT, V131, P1401, DOI 10.1242/dev.01034; ZETTERQVIST O, 1990, PEPT PROT PHOSPH, P171	60	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7390	1553-7404		PLOS GENET	PLoS Genet.	FEB	2015	11	2							e1004992	10.1371/journal.pgen.1004992		22	Genetics & Heredity	Genetics & Heredity	CE8HF	WOS:000352081800046		
J	Lim, J; Lachenmayer, ML; Wu, S; Liu, WC; Kundu, M; Wang, R; Komatsu, M; Oh, YJ; Zhao, YX; Yue, ZY				Lim, Junghyun; Lachenmayer, M. Lenard; Wu, Shuai; Liu, Wenchao; Kundu, Mondira; Wang, Rong; Komatsu, Masaaki; Oh, Young J.; Zhao, Yanxiang; Yue, Zhenyu			Proteotoxic Stress Induces Phosphorylation of p62/SQSTM1 by ULK1 to Regulate Selective Autophagic Clearance of Protein Aggregates	PLOS GENETICS			English	Article							UBA DOMAIN; P62; UBIQUITIN; DEGRADATION; COMPLEX; KINASE; MITOPHAGY; PATHWAY; MITOCHONDRIA; RECOGNITION	Disruption of proteostasis, or protein homeostasis, is often associated with aberrant accumulation of misfolded proteins or protein aggregates. Autophagy offers protection to cells by removing toxic protein aggregates and injured organelles in response to proteotoxic stress. However, the exact mechanism whereby autophagy recognizes and degrades misfolded or aggregated proteins has yet to be elucidated. Mounting evidence demonstrates the selectivity of autophagy, which is mediated through autophagy receptor proteins (e.g. p62/SQSTM1) linking autophagy cargos and autophagosomes. Here we report that proteotoxic stress imposed by the proteasome inhibition or expression of polyglutamine expanded huntingtin (polyQ-Htt) induces p62 phosphorylation at its ubiquitin-association (UBA) domain that regulates its binding to ubiquitinated proteins. We find that autophagy-related kinase ULK1 phosphorylates p62 at a novel phosphorylation site S409 in UBA domain. Interestingly, phosphorylation of p62 by ULK1 does not occur upon nutrient starvation, in spite of its role in canonical autophagy signaling. ULK1 also phosphorylates S405, while S409 phosphorylation critically regulates S405 phosphorylation. We find that S409 phosphorylation destabilizes the UBA dimer interface, and increases binding affinity of p62 to ubiquitin. Furthermore, lack of S409 phosphorylation causes accumulation of p62, aberrant localization of autophagy proteins and inhibition of the clearance of ubiquitinated proteins or polyQ-Htt. Therefore, our data provide mechanistic insights into the regulation of selective autophagy by ULK1 and p62 upon proteotoxic stress. Our study suggests a potential novel drug target in developing autophagy-based therapeutics for the treatment of proteinopathies including Huntington's disease.	[Lim, Junghyun; Lachenmayer, M. Lenard; Yue, Zhenyu] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Neurol & Neurosci, New York, NY 10029 USA; [Wu, Shuai; Liu, Wenchao; Zhao, Yanxiang] Hong Kong Polytech Univ, State Key Lab Chirosci, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China; [Kundu, Mondira] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Wang, Rong] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA; [Komatsu, Masaaki] Niigata Univ, Dept Biochem, Niigata, Japan; [Oh, Young J.] Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Lim, J (reprint author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Neurol & Neurosci, New York, NY 10029 USA.	zhenyu.yue@mssm.edu			National Institutes of Health [NIH-R01NS060123]; Deutsche Forschungsgemeinschaft (DFG); American Lebanese Syrian Associated Charities; Research Grants Council [PolyU5644/10M, PolyU 5640/11M, HKUST6/CRF/10, AoE/M-09/12]; Research Committee of the Hong Kong Polytechnic University; NIH [P30 NS061777, S10 RR022415]	This work was supported by National Institutes of Health Grants (NIH-R01NS060123) to ZY, Deutsche Forschungsgemeinschaft (DFG) to MLL, American Lebanese Syrian Associated Charities to MKu, the Research Grants Council grants PolyU5644/10M, PolyU 5640/11M, HKUST6/CRF/10, AoE/M-09/12 and the Research Committee of the Hong Kong Polytechnic University to YZ, NIH P30 NS061777 and S10 RR022415 to RW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Papinski D, 2014, MOL CELL, V53, P471, DOI 10.1016/j.molcel.2013.12.011; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Yan J, 1998, BIOCHEM BIOPH RES CO, V246, P222, DOI 10.1006/bbrc.1998.8546; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Pohl C, 2009, NAT CELL BIOL, V11, P65, DOI 10.1038/ncb1813; Isogai S, 2011, J BIOL CHEM, V286, P31864, DOI 10.1074/jbc.M111.259630; Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11; Loffler AS, 2011, AUTOPHAGY, V7, P696, DOI 10.4161/auto.7.7.15451; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Clausen TH, 2010, AUTOPHAGY, V6, P330; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Pankiv S, 2010, J BIOL CHEM, V285, P5941, DOI 10.1074/jbc.M109.039925; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441; Friedman LG, 2012, J NEUROSCI, V32, P7585, DOI 10.1523/JNEUROSCI.5809-11.2012; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Wu WX, 2014, EMBO REP, V15, P566, DOI 10.1002/embr.201438501; Pike LRG, 2013, BIOCHEM J, V449, P389, DOI 10.1042/BJ20120972; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Doi H, 2013, J NEUROSCI, V33, P7710, DOI 10.1523/JNEUROSCI.3021-12.2013; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; [Anonymous], 2004, MOL CELL BIOL; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; [Anonymous], 2007, J BIOL CHEM; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Moscat J, 2012, TRENDS BIOCHEM SCI, V37, P230, DOI 10.1016/j.tibs.2012.02.008; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Kageyama S, 2014, J BIOL CHEM; Kumari S, 2014, ELIFE, V3; Kurosawa M, 2014, HUM MOL GENET; Long J, 2010, J MOL BIOL, V396, P178, DOI 10.1016/j.jmb.2009.11.032; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Ro SH, 2014, FEBS J; Wong E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2244	55	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7390	1553-7404		PLOS GENET	PLoS Genet.	FEB	2015	11	2							e1004987	10.1371/journal.pgen.1004987		28	Genetics & Heredity	Genetics & Heredity	CE8HF	WOS:000352081800041		
J	Yokoi, S; Okuyama, T; Kamei, Y; Naruse, K; Taniguchi, Y; Ansai, S; Kinoshita, M; Young, LJ; Takemori, N; Kubo, T; Takeuchi, H				Yokoi, Saori; Okuyama, Teruhiro; Kamei, Yasuhiro; Naruse, Kiyoshi; Taniguchi, Yoshihito; Ansai, Satoshi; Kinoshita, Masato; Young, Larry J.; Takemori, Nobuaki; Kubo, Takeo; Takeuchi, Hideaki			An Essential Role of the Arginine Vasotocin System in Mate-Guarding Behaviors in Triadic Relationships of Medaka Fish (Oryzias latipes)	PLOS GENETICS			English	Article							EFFICIENT TARGETED MUTAGENESIS; SOCIAL-BEHAVIOR; TERRITORIAL AGGRESSION; CENTRAL VASOPRESSIN; PARTNER PREFERENCE; EFFECTOR NUCLEASES; MATING PREFERENCES; SEYCHELLES WARBLER; BLUEHEAD WRASSE; PRAIRIE VOLES	To increase individual male fitness, males of various species remain near a (potential) mating partner and repel their rivals (mate-guarding). Mate-guarding is assumed to be mediated by two different types of motivation: sexual motivation toward the opposite sex and competitive motivation toward the same sex. The genetic/molecular mechanisms underlying how mate presence affects male competitive motivation in a triadic relationship has remained largely unknown. Here we showed that male medaka fish prominently exhibit mateguarding behavior. The presence of a female robustly triggers male-male competition for the female in a triadic relationship (2 males and 1 female). The male-male competition resulted in one male occupying a dominant position near the female while interfering with the other male's approach of the female. Paternity testing revealed that the dominant male had a significantly higher mating success rate than the other male in a triadic relationship. We next generated medaka mutants of arginine-vasotocin (avt) and its receptors (V1a1, V1a2) and revealed that two genes, avt and V1a2, are required for normal mate-guarding behavior. In addition, behavioral analysis of courtship behaviors in a dyadic relationship and aggressive behaviors within a male group revealed that avt mutant males displayed decreased sexual motivation but showed normal aggression. In contrast, heterozygote V1a2 mutant males displayed decreased aggression, but normal mate-guarding and courtship behavior. Thus, impaired mate-guarding in avt and V1a2 homozygote mutants may be due to the loss of sexual motivation toward the opposite sex, and not to the loss of competitive motivation toward rival males. The different behavioral phenotypes between avt, V1a2 heterozygote, and V1a2 homozygote mutants suggest that there are redundant systems to activate V1a2 and that endogenous ligands activating the receptor may differ according to the social context.	[Yokoi, Saori; Okuyama, Teruhiro; Kubo, Takeo; Takeuchi, Hideaki] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Okuyama, Teruhiro; Naruse, Kiyoshi] Natl Inst Basic Biol, Lab Bioresources, Okazaki, Aichi 444, Japan; [Kamei, Yasuhiro; Naruse, Kiyoshi] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan; [Kamei, Yasuhiro] Natl Inst Basic Biol, Spectrog & Bioimaging Facil, Okazaki, Aichi 444, Japan; [Naruse, Kiyoshi] Natl Inst Basic Biol, Ctr Interuniv Biobackup Project, Okazaki, Aichi 444, Japan; [Taniguchi, Yoshihito] Kyorin Univ, Sch Med, Dept Publ Hlth & Prevent Med, Mitaka, Tokyo 181, Japan; [Ansai, Satoshi; Kinoshita, Masato] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto, Japan; [Young, Larry J.] Emory Univ, Dept Psychiat & Behav Sci, Yerkes Natl Primate Res Ctr, Ctr Translat Social Neurosci, Atlanta, GA 30322 USA; [Takemori, Nobuaki] Ehime Univ, Proteosci Ctr, Div Prote Res, Toon City, Ehime, Japan	Yokoi, S (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan.	takeuchi@bs.s.u-tokyo.ac.jp		Ansai, Satoshi/0000-0003-2683-0160	National Institute for Basic Biology Priority Collaborative Research Project [10-104]; National Institute for Basic Biology Cooperative Research Project [13-327]; JSPS KAKENHI [26290003, 23300115]; Ministry of Education, Culture, Sports, Science and Technology [26115508]; Cell Science Research Foundation; Comprehensive Brain Science Network	This work was supported by the National Institute for Basic Biology Priority Collaborative Research Project (10-104) and Cooperative Research Project (13-327), JSPS KAKENHI Grant Numbers 26290003 and 23300115, the Grant-in-Aid for Scientific Research on Innovative Areas "Memory dynamism" (26115508) from the Ministry of Education, Culture, Sports, Science and Technology, Grant-in-Aid for a JSPS postdoctoral SPD fellowship (to TO), the Cell Science Research Foundation (to TO), Comprehensive Brain Science Network (to TO), and Grant-in-Aid for JSPS fellows (to SY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancona S, 2010, ANIM BEHAV, V79, P75, DOI 10.1016/j.anbehav.2009.10.005; Santangelo N, 2006, P R SOC B, V273, P3085, DOI 10.1098/rspb.2006.3683; TUTIN CEG, 1979, BEHAV ECOL SOCIOBIOL, V6, P29, DOI 10.1007/BF00293242; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Lema SC, 2004, HORM BEHAV, V46, P628, DOI 10.1016/j.yhbeh.2004.07.003; Huffman LS, 2012, J CHEM NEUROANAT, V44, P86, DOI 10.1016/j.jchemneu.2012.05.002; Takemori N, 2009, PROTEOMICS, V9, P2484, DOI 10.1002/pmic.200800795; Manning M, 2008, PROG BRAIN RES, V170, P473, DOI 10.1016/S0079-6123(08)00437-8; Ansai S, 2013, GENETICS, V193, P739, DOI 10.1534/genetics.112.147645; Tuni C, 2013, J EVOLUTION BIOL, V26, P1261, DOI 10.1111/jeb.12118; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Komdeur J, 2001, P ROY SOC B-BIOL SCI, V268, P2103, DOI 10.1098/rspb.2001.1750; Jonart LM, 2007, ANIM BEHAV, V74, P1675, DOI 10.1016/j.anbehav.2007.03.012; Goodson JL, 1998, HORM BEHAV, V34, P67, DOI 10.1006/hbeh.1998.1467; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Fodor A, 2014, PSYCHONEUROENDOCRINO, V47, P141, DOI 10.1016/j.psyneuen.2014.05.010; Semsar K, 2001, HORM BEHAV, V40, P21, DOI 10.1006/hbeh.2001.1663; PENNA M, 1992, J COMP PHYSIOL A, V170, P73; Goodson JL, 2012, P NATL ACAD SCI USA, V109, P10685, DOI 10.1073/pnas.1203394109; Lema SC, 2010, MOL CELL ENDOCRINOL, V321, P215, DOI 10.1016/j.mce.2010.02.015; Kline RJ, 2011, J CHEM NEUROANAT, V42, P72, DOI 10.1016/j.jchemneu.2011.06.005; Zamudio KR, 2000, P NATL ACAD SCI USA, V97, P14427, DOI 10.1073/pnas.011544998; MAHLMANN S, 1994, P NATL ACAD SCI USA, V91, P1342, DOI 10.1073/pnas.91.4.1342; Kawabata Y, 2012, NEUROSCIENCE, V218, P65, DOI 10.1016/j.neuroscience.2012.05.021; Haller J, 2013, BRAIN RES BULL, V93, P97, DOI 10.1016/j.brainresbull.2012.10.003; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; SHERMAN PW, 1989, NATURE, V338, P418, DOI 10.1038/338418a0; Godwin J, 2012, HORM BEHAV, V61, P230, DOI 10.1016/j.yhbeh.2011.12.016; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Donaldson ZR, 2010, BEHAV NEUROSCI, V124, P159, DOI 10.1037/a0018094; Anderson DJ, 2014, CELL, V157, P187, DOI 10.1016/j.cell.2014.03.003; Oldfield RG, 2011, PHYSIOL BEHAV, V102, P296, DOI 10.1016/j.physbeh.2010.11.022; Kagawa N, 2013, J FISH BIOL, V82, P354, DOI 10.1111/j.1095-8649.2012.03490.x; Paczolt KA, 2010, NATURE, V464, P401, DOI 10.1038/nature08861; Lema SC, 2012, GEN COMP ENDOCR, V179, P451, DOI 10.1016/j.ygcen.2012.10.001; McGraw LA, 2010, TRENDS NEUROSCI, V33, P103, DOI 10.1016/j.tins.2009.11.006; Ansai S, 2014, DEV GROWTH DIFFER, V56, P98, DOI 10.1111/dgd.12104; BEECHER MD, 1979, SCIENCE, V205, P1282, DOI 10.1126/science.205.4412.1282; BIRKHEAD TR, 1988, NATURE, V334, P60, DOI 10.1038/334060a0; Buena LJ, 2008, ANIM BEHAV, V75, P199, DOI 10.1016/j.anbehav.2007.04.027; Buss David M, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P23; Butchart SHM, 1999, ANIM BEHAV, V57, P637, DOI 10.1006/anbe.1998.0985; EWEN KR, 1993, J REPROD FERTIL, V99, P33; Frankino AW, 1994, ANIM BEHAV, V48, P1479; Fukamachi S, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-64; Huffman LS, 2014, GEN COMP ENDOCRINOL, V2014; Imada H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011248; Ishikawa T, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-70; Iwasaki K, 2013, GENE EXPR PATTERNS, V13, P335, DOI 10.1016/j.gep.2013.06.005; Kagawa N, 2014, ZOOL SCI, V31, P116, DOI 10.2108/zsj.31.116; Kobayashi M, 2012, NIPPON SUISAN GAKK, V78, P922, DOI 10.2331/suisan.78.922; Komdeur J, 2007, MOL ECOL, V16, P3679, DOI 10.1111/j.1365-294X.2007.03420.x; Okuyama T, 2014, SCIENCE, V343, P91, DOI 10.1126/science.1244724; Okuyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066597; Ono, 1957, J FAC SC HOKKAIDO UN, V13, P197; Ono Y, 1956, DOBUTSUGAKU ZASSHI, V65, P103; Pinxten R, 1997, ANIM BEHAV, V54, P45, DOI 10.1006/anbe.1996.0432; Santangelo N, 2010, BRAIN BEHAV EVOLUT, V273, P3085; Song ZM, 2014, PSYCHONEUROENDOCRINO, V50, P14, DOI 10.1016/j.psyneuen.2014.08.005; Suehiro Y, 2010, FEBS LETT, V584, P3545, DOI 10.1016/j.febslet.2010.06.047; Suehiro Y, 2009, GEN COMP ENDOCR, V161, P138, DOI 10.1016/j.ygcen.2008.12.001; Takemori N, 2015, MOL BIOSYST, V11, P361, DOI 10.1039/c4mb00556b; Taniguchi Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r116; van Dongen WFD, 2008, NATURWISSENSCHAFTEN, V95, P537, DOI 10.1007/s00114-008-0356-1; Wells SM, 1988, ANIM BEHAV, V36, P321	65	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7390	1553-7404		PLOS GENET	PLoS Genet.	FEB	2015	11	2							e1005009	10.1371/journal.pgen.1005009		25	Genetics & Heredity	Genetics & Heredity	CE8HF	WOS:000352081800060		
J	Abkallo, HM; Tangena, JA; Tang, JX; Kobayashi, N; Inoue, M; Zoungrana, A; Colegrave, N; Culleton, R				Abkallo, Hussein M.; Tangena, Julie-Anne; Tang, Jianxia; Kobayashi, Nobuyuki; Inoue, Megumi; Zoungrana, Augustin; Colegrave, Nick; Culleton, Richard			Within-host Competition Does Not Select for Virulence in Malaria Parasites; Studies with Plasmodium yoelii	PLOS PATHOGENS			English	Article							PAPUA-NEW-GUINEA; MIXED-GENOTYPE INFECTIONS; RODENT MALARIA; SPECIES INFECTIONS; FALCIPARUM-MALARIA; GENETIC DIVERSITY; TRANSMISSION SUCCESS; ANOPHELES-STEPHENSI; MOSQUITOS; CHILDREN	In endemic areas with high transmission intensities, malaria infections are very often composed of multiple genetically distinct strains of malaria parasites. It has been hypothesised that this leads to intra-host competition, in which parasite strains compete for resources such as space and nutrients. This competition may have repercussions for the host, the parasite, and the vector in terms of disease severity, vector fitness, and parasite transmission potential and fitness. It has also been argued that within-host competition could lead to selection for more virulent parasites. Here we use the rodent malaria parasite Plasmodium yoelii to assess the consequences of mixed strain infections on disease severity and parasite fitness. Three isogenic strains with dramatically different growth rates (and hence virulence) were maintained in mice in single infections or in mixed strain infections with a genetically distinct strain. We compared the virulence (defined as harm to the mammalian host) of mixed strain infections with that of single infections, and assessed whether competition impacted on parasite fitness, assessed by transmission potential. We found that mixed infections were associated with a higher degree of disease severity and a prolonged infection time. In the mixed infections, the strain with the slower growth rate was often responsible for the competitive exclusion of the faster growing strain, presumably through host immune-mediated mechanisms. Importantly, and in contrast to previous work conducted with Plasmodium chabaudi, we found no correlation between parasite virulence and transmission potential to mosquitoes, suggesting that within-host competition would not drive the evolution of parasite virulence in P. yoelii.	[Abkallo, Hussein M.; Tangena, Julie-Anne; Tang, Jianxia; Inoue, Megumi; Zoungrana, Augustin; Culleton, Richard] Nagasaki Univ, Malaria Unit, Inst Trop Med, Nagasaki 852, Japan; [Abkallo, Hussein M.; Kobayashi, Nobuyuki] Nagasaki Univ, Grad Sch Biomed Sci, Lab Mol Biol Infect Agents, Nagasaki 852, Japan; [Tangena, Julie-Anne] Wageningen Univ, Entomol Lab, NL-6700 AP Wageningen, Netherlands; [Colegrave, Nick] Univ Edinburgh, Inst Evolutionary Biol, Sch Biol Sci, Edinburgh, Midlothian, Scotland	Abkallo, HM (reprint author), Nagasaki Univ, Malaria Unit, Inst Trop Med, Nagasaki 852, Japan.	richard@nagasaki-u.ac.jp			JSPS [24255009, 25870525]; Naito Foundation Natural Science Scholarship, Japan	This work was supported by the JSPS Grant-in-Aid for Scientific Research Nos. 24255009 and 25870525 (RC), and a Naito Foundation Natural Science Scholarship, Japan (to RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-Elbasit IE, 2007, PARASITOL RES, V102, P29, DOI 10.1007/s00436-007-0716-3; Alifrangis M, 1999, PARASITOLOGY, V119, P337, DOI 10.1017/S0031182099004825; Amodu OK, 2008, ANN TROP MED PARASIT, V102, P95, DOI 10.1179/136485908X252340; Ranjit MR, 2005, T ROY SOC TROP MED H, V99, P389, DOI 10.1016/j.trstmh.2004.09.010; Baker DA, 2010, MOL BIOCHEM PARASIT, V172, P57, DOI 10.1016/j.molbiopara.2010.03.019; Griffiths EC, 2011, J INFECTION, V63, P200, DOI 10.1016/j.jinf.2011.06.005; Taylor LH, 1997, PARASITOLOGY, V115, P121, DOI 10.1017/S0031182097001145; Reece SE, 2008, NATURE, V453, P609, DOI 10.1038/nature06954; Nielsen MA, 2002, J IMMUNOL, V168, P3444; CONWAY DJ, 1991, PARASITOLOGY, V103, P1; Bell AS, 2006, EVOLUTION, V60, P1358, DOI 10.1554/05-611.1; Abkallo HM, 2014, INT J PARASITOL, V44, P467, DOI 10.1016/j.ijpara.2014.03.002; Vezilier J, 2012, P ROY SOC B-BIOL SCI, V279, P4033, DOI 10.1098/rspb.2012.1394; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3; de Roode JC, 2004, P ROY SOC B-BIOL SCI, V271, P1073, DOI 10.1098/rspb.2004.2695; Pollitt LC, 2011, AM NAT, V177, P358, DOI 10.1086/658175; Robert F, 1996, T ROY SOC TROP MED H, V90, P704, DOI 10.1016/S0035-9203(96)90446-0; Kiwuwa MS, 2013, PARASITOL RES, V112, P1691, DOI 10.1007/s00436-013-3325-3; Regev-Rudzki N, 2013, CELL, V153, P1120, DOI 10.1016/j.cell.2013.04.029; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; de Roode JC, 2005, AM NAT, V166, P531, DOI 10.1086/491659; Kun JFJ, 1998, T ROY SOC TROP MED H, V92, P110, DOI 10.1016/S0035-9203(98)90979-8; Arez A. P., 1997, Parassitologia (Rome), V39, P65; BABIKER HA, 1994, PARASITOLOGY, V109, P413; BABIKER HA, 1995, PARASITOLOGY, V111, P433; BEIER MS, 1988, AM J TROP MED HYG, V39, P323; BLACK J, 1994, LANCET, V343, P1095, DOI 10.1016/S0140-6736(94)90203-8; Bruce MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002775; Bruce MC, 2000, PARASITOLOGY, V121, P257, DOI 10.1017/S0031182099006356; Carlton JMR, 1998, MOL BIOCHEM PARASIT, V93, P285, DOI 10.1016/S0166-6851(98)00043-7; Cheesman SJ, 2003, MOL BIOCHEM PARASIT, V131, P83, DOI 10.1016/S0166-6851(03)00195-6; Collins WE, 1999, AM J TROP MED HYG, V61, P36; Culleton R, 2012, EVOLUTION OF VIRULEN, P269; Culleton RL, 2015, PARASITOL INT, V64, P244, DOI 10.1016/j.parint.2014.07.006; Durand R, 2008, TROP MED INT HEALTH, V13, P1392, DOI 10.1111/j.1365-3156.2008.02156.x; Ferguson HM, 2002, TRENDS PARASITOL, V18, P256, DOI 10.1016/S1471-4922(02)02281-X; Ferguson HM, 2003, EVOLUTION, V57, P2792; GAMAGEMENDIS AC, 1993, T ROY SOC TROP MED H, V87, P3, DOI 10.1016/0035-9203(93)90396-8; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; HACKER CS, 1974, J INVERTEBR PATHOL, V23, P101, DOI 10.1016/0022-2011(74)90079-2; Hastings IM, 2010, AM J TROP MED HYG, V83, P489, DOI 10.4269/ajtmh.2010.10-0072; Hogg JC, 1995, PARASITOLOGY, V111, P555; HOGG JC, 1995, MED VET ENTOMOL, V9, P176, DOI 10.1111/j.1365-2915.1995.tb00175.x; Hogg JC, 1997, PARASITOLOGY, V114, P325, DOI 10.1017/S0031182096008542; Huber W, 1998, PARASITOLOGY, V116, P95, DOI 10.1017/S0031182097002138; Hurd H, 2006, PARASITOLOGY, V132, pS33, DOI 10.1017/S0031182006000849; Hurd H, 2005, CURR TOP MICROBIOL, V289, P185; Imwong M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-253; Inoue M, 2012, INT J PARASITOL, V42, P859, DOI 10.1016/j.ijpara.2012.07.001; Mackinnon MJ, 1999, EVOLUTION, V53, P689, DOI 10.2307/2640710; MAIER WA, 1987, PARASITOL TODAY, V3, P216, DOI 10.1016/0169-4758(87)90063-9; Maitland K, 1996, T ROY SOC TROP MED H, V90, P614, DOI 10.1016/S0035-9203(96)90406-X; Mayengue PI, 2007, PARASITOL RES, V100, P487, DOI 10.1007/s00436-006-0287-8; Pattaradilokrat S, 2008, MOL BIOCHEM PARASIT, V157, P244, DOI 10.1016/j.molbiopara.2007.10.011; PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897; Pollitt LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002590; Price RN, 1997, T ROY SOC TROP MED H, V91, P574, DOI 10.1016/S0035-9203(97)90032-8; R Development Core Team, 2014, R LANG ENV STAT COMP; RICHIE TL, 1988, PARASITOLOGY, V96, P607; Rout R, 2009, TROP BIOMED, V26, P165; Schneider P, 2012, P ROY SOC B-BIOL SCI, V279, P4677, DOI 10.1098/rspb.2012.1792; SNOUNOU G, 1993, T ROY SOC TROP MED H, V87, P649, DOI 10.1016/0035-9203(93)90274-T; SNOUNOU G, 1992, PARASITOLOGY, V105, P21; Taylor LH, 1997, P ROY SOC B-BIOL SCI, V264, P927; Vernick KD, 2005, CURR TOP MICROBIOL, V295, P383; Wargo AR, 2007, P R SOC B, V274, P2629, DOI 10.1098/rspb.2007.0873; YOELI M, 1975, ANN TROP MED PARASIT, V69, P173; Zimmerman PA, 2004, TRENDS PARASITOL, V20, P440, DOI 10.1016/j.pt.2004.07.004	69	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7366	1553-7374		PLOS PATHOG	PLoS Pathog.	FEB	2015	11	2							UNSP e1004628	10.1371/journal.ppat.1004628		20	Microbiology; Parasitology; Virology	Microbiology; Parasitology; Virology	CE8HU	WOS:000352083400017		
J	Liu, JL; Park, CH; He, F; Nagano, M; Wang, M; Bellizzi, M; Zhang, K; Zeng, XS; Liu, WD; Ning, YS; Kawano, Y; Wang, GL				Liu, Jinling; Park, Chan Ho; He, Feng; Nagano, Minoru; Wang, Mo; Bellizzi, Maria; Zhang, Kai; Zeng, Xiaoshan; Liu, Wende; Ning, Yuese; Kawano, Yoji; Wang, Guo-Liang			The RhoGAP SPIN6 Associates with SPL11 and OsRac1 and Negatively Regulates Programmed Cell Death and Innate Immunity in Rice	PLOS PATHOGENS			English	Article							GTPASE-ACTIVATING PROTEIN; DISEASE RESISTANCE; FLOWERING TIME; REPEAT PROTEIN; DEFENSE; RECEPTOR; UBIQUITINATION; SYSTEM; FAMILY; ENCODES	The ubiquitin proteasome system in plants plays important roles in plant-microbe interactions and in immune responses to pathogens. We previously demonstrated that the rice U-box E3 ligase SPL11 and its Arabidopsis ortholog PUB13 negatively regulate programmed cell death (PCD) and defense response. However, the components involved in the SPL11/PUB13-mediated PCD and immune signaling pathway remain unknown. In this study, we report that SPL11-interacting Protein 6 (SPIN6) is a Rho GTPase-activating protein (RhoGAP) that interacts with SPL11 in vitro and in vivo. SPL11 ubiquitinates SPIN6 in vitro and degrades SPIN6 in vivo via the 26S proteasome-dependent pathway. Both RNAi silencing in transgenic rice and knockout of Spin6 in a T-DNA insertion mutant lead to PCD and increased resistance to the rice blast pathogen Magnaporthe oryzae and the bacterial blight pathogen Xanthomonas oryzae pv. oryzae. The levels of reactive oxygen species and defense-related gene expression are significantly elevated in both the Spin6 RNAi and mutant plants. Strikingly, SPIN6 interacts with the small GTPase OsRac1, catalyze the GTP-bound OsRac1 into the GDP-bound state in vitro and has GAP activity towards OsRac1 in rice cells. Together, our results demonstrate that the RhoGAP SPIN6 acts as a linkage between a U-box E3 ligase-mediated ubiquitination pathway and a small GTPase-associated defensome system for plant immunity.	[Liu, Jinling; He, Feng; Liu, Wende; Ning, Yuese; Wang, Guo-Liang] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Liu, Jinling; He, Feng; Zeng, Xiaoshan] Hunan Agr Univ, Hunan Prov Key Lab Crop Germplasm Innovat & Utili, Changsha, Hunan, Peoples R China; [Liu, Jinling; He, Feng; Zeng, Xiaoshan] Hunan Agr Univ, Coll Agron, Changsha, Hunan, Peoples R China; [Park, Chan Ho; Wang, Mo; Bellizzi, Maria; Zhang, Kai; Wang, Guo-Liang] Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA; [Nagano, Minoru; Kawano, Yoji] Nara Inst Sci & Technol, Ikoma, Nara, Japan; [Nagano, Minoru] Saitama Univ, Dept Sci & Technol, Sakura Ku, Saitama 3388570, Japan; [Kawano, Yoji] Shanghai Ctr Plant Stress Biol, Signal Transduct & Immun Grp, Shanghai, Peoples R China	Liu, JL (reprint author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	wang.620@osu.edu			973 Project of Ministry of Science and Technology China [2012CB114005]; Program for Innovative Research Team in University [IRT1239]; Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province; U.S. Department of Agriculture-Cooperative State Research, Education, and Extension Service [2007-01667]; USAID-IRRI Linkage Program	This work was supported by the 973 Project (2012CB114005) of Ministry of Science and Technology China; the Program for Innovative Research Team in University (IRT1239); the Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province; the U.S. Department of Agriculture-Cooperative State Research, Education, and Extension Service (grant no. 2007-01667); and the USAID-IRRI Linkage Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171; Jiang SY, 2006, PHYSIOL GENOMICS, V24, P235, DOI 10.1152/physiolgenomics.00210.2005; Vega-Sanchez ME, 2008, PLANT CELL, V20, P1456, DOI 10.1105/tpc.108.058610; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ning YS, 2011, PLANT PHYSIOL, V157, P242, DOI 10.1104/pp.111.180893; Tameling WIL, 2010, PLANT CELL, V22, P4176, DOI 10.1105/tpc.110.077461; Kawano Y, 2010, CELL HOST MICROBE, V7, P362, DOI 10.1016/j.chom.2010.04.010; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Marino D, 2012, PLANT PHYSIOL, V160, P15, DOI 10.1104/pp.112.199281; Chen LT, 2010, CELL HOST MICROBE, V7, P185, DOI 10.1016/j.chom.2010.02.008; Yin ZC, 2000, MOL PLANT MICROBE IN, V13, P869, DOI 10.1094/MPMI.2000.13.8.869; McDowell JM, 2000, TRENDS BIOCHEM SCI, V25, P79, DOI 10.1016/S0968-0004(99)01532-7; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Zago E, 2006, PLANT PHYSIOL, V141, P404, DOI 10.1104/pp.106.078444; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Li W, 2012, PLANT PHYSIOL, V159, P239, DOI 10.1104/pp.111.192617; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Tameling WIL, 2007, PLANT CELL, V19, P1682, DOI 10.1105/tpc.107.050880; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Akamatsu A, 2013, CELL HOST MICROBE, V13, P465, DOI 10.1016/j.chom.2013.03.007; Liu JL, 2012, PLANT PHYSIOL, V160, P28, DOI 10.1104/pp.112.199430; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Van Breusegem F, 2006, PLANT PHYSIOL, V141, P384, DOI 10.1104/pp.106.078295; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Liu LJ, 2010, PLANT J, V61, P893, DOI 10.1111/j.1365-313X.2009.04109.x; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Cheung MY, 2010, J BIOL CHEM, V285, P37359, DOI 10.1074/jbc.M110.172080; Ding B, 2012, PLANT CELL, V24, P3783, DOI 10.1105/tpc.112.101972; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Cheung MY, 2008, NEW PHYTOL, V179, P530, DOI 10.1111/j.1469-8137.2008.02473.x; Hoefle C, 2011, PLANT CELL, V23, P2422, DOI 10.1105/tpc.110.082131; Kawano Y, 2013, CURR OPIN PLANT BIOL, V16, P496, DOI 10.1016/j.pbi.2013.07.004; Kojo K, 2006, PLANT CELL PHYSIOL, V47, P1035, DOI 10.1093/pcp/pcj074; Ning Y, 2011, PLANT SIGNAL BEHAV, V6, DOI [10.4161/psb.6.12.18192, DOI 10.4161/PSB.6.12.18192]; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086	37	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7366	1553-7374		PLOS PATHOG	PLoS Pathog.	FEB	2015	11	2							e1004629	10.1371/journal.ppat.1004629		23	Microbiology; Parasitology; Virology	Microbiology; Parasitology; Virology	CE8HU	WOS:000352083400018		
J	Noda, T; Yoshikawa, T				Noda, Toshihiro; Yoshikawa, Takahiro			Soil water air coupled finite deformation analysis based on a rate-type equation of motion incorporating the SYS Cam-clay model	SOILS AND FOUNDATIONS			English	Article						Soil water air coupled analysis; Unsaturated soil; Finite deformation theory; Dynamic/static; SYS Cam-clay model; Insular air saturation; Back pressure (IGC: D06/ E13)	HYDRAULIC CONDUCTIVITY; POROUS-MEDIA	With the aim of expanding the soil skeleton water coupled finite deformation analysis code, mounted with the SYS Cam-clay model and capable of accommodating inertia forces to deal seatnlessly with soils from the unsaturated to the saturated states, a new soil skeleton water air coupled finite deformation analysis method (u-p(w)-p(a)-s(w) formulation), based on the three-phase mixture theory, was proposed. The following are the main observations obtained through computations performed under simple conditions using this new method. A simulation of constant cell pressure undrained (and unexhausted) triaxial tests on dense sand specimens with a degree of saturation of 99.9%, which in reality could be considered as "saturated soil," was carried out. It was shown that when the back pressure was not sufficiently large, the existence of air caused desaturation to take place due to the effect of volumetric expansion and that no increase in deviator stress was observed. It was confirmed that the results of this simulation agreed with the experimental results. Unlike the conventional method of analysis, in which the degree of saturation is not explicitly made an unknown, the current method of analysis, in which the degree of saturation is explicitly made an unknown (u-p(w)-p(a)-s(w) formulation), was shown to be capable of expressing the increase in the degree of saturation even in the case of insular air saturation when the suction was 0. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier By. All rights reserved.	[Noda, Toshihiro] Nagoya Univ, Disaster Mitigat Res Ctr, Nagoya, Aichi 4648601, Japan; [Yoshikawa, Takahiro] Nagoya Univ, Dept Civil Engn, Nagoya, Aichi 4648601, Japan	Noda, T (reprint author), Nagoya Univ, Disaster Mitigat Res Ctr, Nagoya, Aichi 4648601, Japan.	noda@nagoya-u.jp; yoshikawa.takahiro@b.mbox.nagoya-u.ac.jp			Japan Society for the Promotion of Science [21226012, 25249064]	This research was subsidized by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Grant nos. 21226012 and 25249064). In preparing this paper, the authors obtained valuable advice from Professor Masaki Nakano of Nagoya University regarding the experimental results. We wish to express our grateful thanks to him	Akai K., 1978, P JSCE, V269, P95; Asaoka A, 2002, SOILS FOUND, V42, P47; Uzuoka R, 2012, INT J NUMER ANAL MET, V36, P1535, DOI 10.1002/nag.1061; Noda T, 2008, SOILS FOUND, V48, P771, DOI 10.3208/sandf.48.771; Noda T, 2005, SOILS FOUND, V45, P39; de Boer R, 1998, Z ANGEW MATH MECH, V78, P441, DOI 10.1002/(SICI)1521-4001(199807)78:7<441::AID-ZAMM441>3.0.CO;2-V; MUALEM Y, 1976, WATER RESOUR RES, V12, P513, DOI 10.1029/WR012i003p00513; Noda T, 2009, SOILS FOUND, V49, P739, DOI 10.3208/sandf.49.739; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892; Asaoka A., 1998, SOILS FOUND, V38, P173; Asaoka A., 1994, SOILS FOUND, V34, P91; Asaoka A., 2007, INT WORKSH CONST MOD, P11; Asaoka A., 2003, P 12 AS REG C SOIL M, V2, P1157; Bear J., 1979, HYDRAULICS GROUNDWAT, P190; Christian J.T., 1968, P ASCE, V94, P1333; Green AE, 1965, ARCH RATION MECH AN, V18, P251, DOI DOI 10.1007/BF00251666; Jommi C, 2000, EXPERIMENTAL EVIDENCE AND THEORETICAL APPROACHES IN UNSATURATED SOILS, P139; Kamiya K., 2008, J JSCE C, V64, P650; Kohgo Y, 1993, SOILS FOUND, V33, P49; Muskat M, 1937, FLOW HOMOGENEOUS FLU, P69; Nakano M., 1997, P 9CHUB GEOT S, P19; Nakano M, 2008, SOILS FOUND, V48, P653, DOI 10.3208/sandf.48.653; Nishimura N, 1999, HDB GEOTECHNICAL ENG, P51; Noda T, 2007, SOILS FOUND, V47, P285, DOI 10.3208/sandf.47.285; Roscoe K. H., 1968, ENG PLASTICITY, P535; Schofield A. N., 1968, CRITICAL STATE SOIL; Schrefler B.A., 2002, APPL MECH REV, V55, P351, DOI 10.1115/1.1484107; Schuurman E, 1966, GEOTECHNIQUE, V16, P269; Unno T., 2013, J JSCE C, V69, P386; Wilson E.L., 1973, INT J EARTHQUAKE ENG, V1, P241; Yamada E., 2007, P 13 AS REG C SMGE 1, P787; Yatomi C., 1989, SOILS FOUND, V29, P41; Yoshimi Y, 1989, SOILS FOUND, V3, P157	33	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	FEB	2015	55	1					45	62		10.1016/j.sandf.2014.12.004		18	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CE7HT	WOS:000352010500004		
J	Matsumura, S; Miura, S; Yokohama, S; Kawamura, S				Matsumura, Satoshi; Miura, Seiichi; Yokohama, Shoji; Kawamura, Shima			Cyclic deformation- strength evaluation of compacted volcanic soil subjected to freeze-thaw sequence	SOILS AND FOUNDATIONS			English	Article						Freeze-thaw sequence; Cyclic deformation-strength characteristics; Liquefaction; Crushable volcanic soil; Compaction (IGC: D07/D08/D09)	HYDRAULIC CONDUCTIVITY; TILL	The aim of this paper was to clarify the effect of freeze-thawing on the cyclic shear behavior of a crushable volcanic soil that is widely deposited in Hokkaido, Japan. Using a traxial apparatus, which was newly developed to simulate freeze thaw cycles and cyclic loading, a series of cyclic triaxial tests was performed on compacted volcanic soils subjected to freeze thaw cycles. The experimental results showed that freeze-thawing leads to a significant decrease in the liquefaction strength of densely-compacted volcanic soils. The decrement in liquefaction strength depended strongly on the behavior of the excess pore water pressure during cyclic loading. In addition, according to the variation in cyclic deformation behavior induced by the freeze thaw sequence, it was anticipated that the freeze-thawing would be related to the change in the soil fabric of the specimens. However, the specimens compacted at a lower dry density seemed to be inconsistent with the above; i.e., the liquefaction strength became almost the same regardless of whether or not the specimens were exposed to the freeze-thaw sequence. Thus, it was concluded that the freeze-thaw sequence can degrade the dynamic properties of volcanic soil, but that such influences ought to be incorporated into a correlation with the dry density. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Matsumura, Satoshi] Port & Airport Res Inst, Fdn Grp, Yokosuka, Kanagawa 2390826, Japan; [Miura, Seiichi; Yokohama, Shoji] Hokkaido Univ, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Kawamura, Shima] Muroran Inst Technol, Grad Sch Engn, Muroran, Hokkaido 0508585, Japan; [Matsumura, Satoshi] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido, Japan	Matsumura, S (reprint author), Port & Airport Res Inst, Fdn Grp, 3-1-1 Nagase, Yokosuka, Kanagawa 2390826, Japan.				KAKENHI, Japan Society for the Promotion of Science [23241056]	The authors would like to express their gratitude to Mr. Hiroshi Minami formerly of Hokkaido University who helped us to conduct the experiments. This study was undertaken with the financial supports of KAKENHI (Grant-in-Aid for Scientific Research (A) no. 23241056), Japan Society for the Promotion of Science.	Miura S, 2003, SOILS FOUND, V43, P47; SINGH S, 1982, J GEOTECH ENG-ASCE, V108, P247; Sahaphol T, 2005, SOIL DYN EARTHQ ENG, V25, P157, DOI 10.1016/j.soildyn.2004.10.001; Ishikawa T, 2011, SOILS FOUND, V51, P785, DOI 10.3208/sandf.51.785; Konrad JM, 2010, GEOTECHNIQUE, V60, P679, DOI 10.1680/geot.08.P.020; Goto S., 1993, SOILS FOUND, V33, P148; Ishihara K., 1978, SOILS FOUND, V18, P61; Kawamura S, 2013, SOILS FOUND, V53, P443, DOI 10.1016/j.sandf.2013.04.006; Kawamura S., 2013, J FRONTIERS CONSTRUC, V2, P43; Kazama M., 2006, JGS, V54, P45; KIM WH, 1992, J GEOTECH ENG-ASCE, V118, P1083, DOI 10.1061/(ASCE)0733-9410(1992)118:7(1083); Matsumura S., 2014, LAB INSITU STUDIES M; Miura S., 1984, SOILS FOUND, V24, P69; Miura S., 1996, J GEOTECH ENG JSCE, P257; Miura S., 2005, JGS, V53, P39; Nakata T., 2007, J GEOTECHNICAL ENG, V63, P224; ODA M, 1972, SOILS FOUND, V12, P17; RAD NS, 1984, J GEOTECH ENG-ASCE, V110, P1205; The Japanese Geotechnical Society, 2009, JGS07112009; The Japanese Geotechnical Society, 2009, JGS07112009; The Japanese Geotechnical Society, 2009, JGS05412009; The Japanese Geotechnical Society, 2009, JGS01712009; Viklander P, 1998, CAN GEOTECH J, V35, P471, DOI 10.1139/cgj-35-3-471; Walberg F.C., 1978, P ASCE, V104, P667; Yagi K, 1998, PROBLEMATIC SOILS, VOL 1, P153; Yamaki M., 2009, J GEOTECHNICAL ENG C, V65, P321; Yokohama S, 2014, SOILS FOUND, V54, P731, DOI 10.1016/j.sandf.2014.06.010; Yoshimi Y, 1978, SOILS FOUND, V18, P59	28	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	FEB	2015	55	1					86	98		10.1016/j.sandf.2014.12.007		13	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CE7HT	WOS:000352010500007		
J	Higo, Y; Lee, CW; Doi, T; Kinugawa, T; Kimura, M; Kimoto, S; Oka, F				Higo, Yosuke; Lee, Chung-Won; Doi, Tatsuya; Kinugawa, Teppei; Kimura, Makoto; Kimoto, Sayuri; Oka, Fusao			Study of dynamic stability of unsaturated embankments with different water contents by centrifugal model tests	SOILS AND FOUNDATIONS			English	Article						Unsaturated soil; Embankment; Centrifugal model test; Water content; Dynamic loading	SEISMIC STABILITY	It has been pointed out that the damage to unsaturated embankments caused by earthquakes is attributed to the high water content brought about by the seepage of underground water and/or rainfall infiltration. It is important to study the effects of the water content on the dynamic stability and deformation mode of unsaturated embankments in order to develop a proper design scheme, including effective reinforcements, for preventing severe damage, This paper presents a series of dynamic centrifugal model tests with different water contents to investigate the effect of the water content on the deformation and failure behaviors of unsaturated embankments. By measuring the displacement, the pore water pressure and the acceleration during dynamic loading, as well as the initial suction level, the dynamic behavior of unsaturated embankments with an approximately optimum water content, a higher than optimum water content, and a lower than optimum water content, are discussed. In addition, an image analysis reveals the displacement field and the distribution of strain in the embankment, by which the defortnation mode of the embankment with the higher water content is clarified. It is found that in the case of the higher water content, the settlement of the crown is large mainly due to the volume compression underneath the crown, while the small confining pressure at the toe and near the slope surface induces large shear deformation with volume expansion. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier Boy. All rights reserved.	[Higo, Yosuke] Kyoto Univ, Dept Urban Management, Kyoto, Japan; [Lee, Chung-Won; Doi, Tatsuya; Kinugawa, Teppei; Kimura, Makoto; Kimoto, Sayuri] Kyoto Univ, Dept Civil & Earth Resources Engn, Kyoto, Japan; [Oka, Fusao] Kyoto Univ, Kyoto, Japan	Higo, Y (reprint author), Kyoto Univ, Dept Urban Management, Kyoto, Japan.	higo.yohsuke.5z@kyoto-u.ac.jp			National Institute for Land and Infrastructure Management, MLIT, Japan [21-4]	This research was supported in part by the National Institute for Land and Infrastructure Management, MLIT, Japan (grant for the research and development of technologies for improving the quality of road policies, no. 21-4, 2009-2012).	Central Nippon Expressway Co. Ltd, 2009, 2 M EXPL COMM SEISM; Dewoolker M.M., 1999, GEOTECH TEST J ASTM, V22, P196; Esposito G., 2000, B ENG GEOL ENVIRON, V58, P89, DOI 10.1007/s100640050001; Hayashi H., 2002, P INT C PHYS MOD GEO, P483; Heibrock G., 1998, P INT C CENTR 98 SPE, P964; Higo Y, 2006, PHILOS MAG, V86, P3205, DOI 10.1080/14786430500321203; horel L., 2013, GEOTECHNIQUE, V61, P409; Japan Road Association, 2010, GUID ROAD EARTHW; Ko HY, 1999, PHYSICS AND MECHANICS OF SOIL LIQUEFACTION, P307; Kodaka T., 2001, P 15 ICSMGE IST BALK, V1, P167; Matsuo O, 2002, SOILS FOUND, V42, P89; Nakamura H., 2010, 45 ANN M JAP GEOT SO, VD-06, P1495; National Astronomical Observatory, 2001, CHRON SCI TABL, P375; National Institute for Land and Infrastructure Management and Public Works Research Institute (NILIM and PWRI), 2004, REP DAM INFR 2004 MI, P157; National Institute for Land and Infrastructure Management and Public Works Research Institute (NILIM and PWRI), 2011, QUICK REP DAM INFR 2, P463; National Institute for Land and Infrastructure Management Public Works Research Institute and Building Research Institute (NILIM PWRI and BRI), 2008, REP DAM INFR BUILD 2, P102; Ohkawa H., 2008, 43 ANN M JGS HIR, P1143; Okamura M, 2013, SOILS FOUND, V53, P11, DOI 10.1016/j.sandf.2012.07.015; Okamura M, 2011, INT J PHYS MODEL GEO, V11, P50, DOI 10.1680/ijpmg.2011.11.2.50; Rezzoug A., 2000, J GEOTECH GEOENVIRON, V130, P615; Sakai Y., 2009, J STRUCTURAL CONSTRU, V74, P1531; Sasaki T., 2008, 63 ANN M JSCE SEND S, P67	22	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	FEB	2015	55	1					112	126		10.1016/j.sandf.2014.12.009		15	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CE7HT	WOS:000352010500009		
J	Shinoda, M; Watanabe, K; Sanagawa, T; Abe, K; Nakamura, H; Kawai, T; Nakamura, S				Shinoda, Masahiro; Watanabe, Kenji; Sanagawa, Taisuke; Abe, Keita; Nakamura, Hidetaka; Kawai, Tadashi; Nakamura, Susumu			Dynamic behavior of slope models with various slope inclinations	SOILS AND FOUNDATIONS			English	Article						Slope stability; Shaking table test; Stability analysis; Displacement analysis	INDUCED DEFORMATIONS; EARTHQUAKE; STABILITY; EMBANKMENTS; INTENSITY	The regulatory guide for the seismic design of nuclear power reactor facilities in Japan was revised in 2006. The guide requires the facilities to be designed to withstand earthquakes, taking into consideration slope collapses that can be expected to occur around such facilities. Although these requirements were included in the previous edition of the guide, definite specifications are given in the new edition. This has made the study of the stability of slopes subjected to earthquakes Imre itnportant. This paper describes the dynamic behavior of slope models based on the findings of experimental and analytical investigations. In the experimental investigation, a series of shaking table tests was conducted using slope models with various inclinations. The feature of the present experimental investigation was to use an image processor to precisely measure the dynamic shear strain of the models vhen shaken. In the analytical investigation, Newmark's sliding block analysis was used to assess the validity of the test results. The sliding block analyses of the slope models were based on the results of stability and displacement analyses with the assumption of a circular slip surface. The results of the analyses are used to propose a method for evaluating the stability of rock slopes. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Shinoda, Masahiro; Watanabe, Kenji; Sanagawa, Taisuke; Abe, Keita] Railway Tech Res Inst, Kokubunji, Tokyo 1858540, Japan; [Nakamura, Hidetaka] Japan Nucl Energy Safety Org, Toranomon Towers Off, Minato Ku, Tokyo 1050001, Japan; [Kawai, Tadashi] Tohoku Univ, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Nakamura, Susumu] Nihon Univ, Fukushima 96386420, Japan	Shinoda, M (reprint author), Railway Tech Res Inst, 2-8-38 Hikari Cho, Kokubunji, Tokyo 1858540, Japan.	shinoda.masahiro.97@rtri.or.jp; watanabe.kenji.71@rtri.or.jp; sanagawa.taisuke.39@rtri.or.jp; abe.keita.06@rtri.or.jp; hidetaka-nakamura@jnes.go.jp; t-kawai@civil.tohoku.ac.jp; s-nak@civil.ne.nihon-u.ac.jp					MAKDISI FI, 1978, J GEOTECH ENG-ASCE, V104, P849; Harp EL, 1995, B SEISMOL SOC AM, V85, P1739; Jibson RW, 2007, ENG GEOL, V91, P209, DOI 10.1016/j.enggeo.2007.01.013; [Anonymous], 1987, JEAG46011987; Kayen RE, 1997, J GEOTECH GEOENVIRON, V123, P1162, DOI 10.1061/(ASCE)1090-0241(1997)123:12(1162); [Anonymous], 2006592006 NSC; SPENCER E, 1967, GEOTECHNIQUE, V17, P11; Jibson RW, 2011, ENG GEOL, V122, P43, DOI 10.1016/j.enggeo.2010.09.017; NEWMARK NM, 1965, GEOTECHNIQUE, V15, P139; Arias A., 1970, SEISMIC DESIGN NUCL, P438; Bishop A. W., 1955, GEOTECHNIQUE, V5, P7, DOI [10.1680/geot.1955.5.1.7, DOI 10.1680/GEOT.1955.5.1.7]; Bray JD, 2007, J GEOTECH GEOENVIRON, V133, P381, DOI 10.1061/(ASCE)1090-0241(2007)133:4(381); Duncan CW, 2004, ROCK SLOPE ENG, V4th; Fellenius W., 1927, ERDSTATISCHE BERECHN; Goodman R.E., 1966, ASCE, V92; Hyodo M, 2012, SOILS FOUND, V52, P975, DOI 10.1016/j.sandf.2012.11.015; Ishimaru M., 2011, J JPN SOC CIVIL EN C, V67, P36; Janbu N., 1968, SOIL MECH FDN ENG; Koseki J, 2012, SOILS FOUND, V52, P872, DOI 10.1016/j.sandf.2012.11.009; Kramer S. L., 1996, GEOTECHNICAL EARTHQU; Matasovic N., 1997, P GEOS 97, V97, P989; MORGENST.NR, 1965, GEOTECHNIQUE, V15, P79; Pradel D, 2005, J GEOTECH GEOENVIRON, V131, P1360, DOI 10.1061/(ASCE)1090-0241(2005)131:11(1360); Rocha M., 1957, P 4 INT C SOIL MECH, V1, P183; Shinoda M, 2006, SOILS FOUND, V46, P477, DOI 10.3208/sandf.46.477; Sugawara K., 1983, P INT C ISRM, pC1; Wartman J, 2003, J GEOTECH GEOENVIRON, V129, P673, DOI 10.1061/(ASCE)1090-0241(2003)129:8(673); Wartman J, 2005, J GEOTECH GEOENVIRON, V131, P610, DOI 10.1061/(ASCE)1090-0241(2005)131:4(610); Wasowski J, 2011, ENG GEOL, V122, P1, DOI 10.1016/j.enggeo.2011.06.001; Watanabe K, 2005, GEOTECH TEST J, V28, P423, DOI 10.1520/GTJ12646; WILSON RC, 1983, B SEISMOL SOC AM, V73, P863; YAN LP, 1996, P 11 ASCE ENG MECH C, P1110	32	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	FEB	2015	55	1					127	142		10.1016/j.sandf.2014.12.010		16	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CE7HT	WOS:000352010500010		
J	Matsumoto, T; Phan, LT; Oshima, A; Shimono, S				Matsumoto, Tatsunori; Le Ta Phan; Oshima, Akihiko; Shimono, Shinya			Measurements of driving energy in SPT and various dynamic cone penetration tests	SOILS AND FOUNDATIONS			English	Article						Dosing energy; Driving efficiency; Dynamic cone penetration test; Standard penetration test; Dynamic measurements; Cone resistance; IGC:03; C07	HAMMER	Driving energy was measured in a standard penetration test (SPT) and 12 types of dynamic cone penetration tests (DCPTs) having different configurations for the hammer, driving rod, anvil and cone tip. The driving energy transferred from the free falling hammer to the driving rod was estimated from the measurements of strain and acceleration below the anvil. Basically, the driving energy was estimated for 21 successive blows in order to obtain the mean value, the standard deviation (sigma) and the coefficient of variance (COV) in the SPT and DCPTs. The dynamic cone resistance, q(dyn), vas estimated from the driving energy, the corresponding set per blow, and masses of the hammer and the total rods. Thus, the estimated dynamic cone resistance was compared with the static cone resistance, q(t), from a cone penetration test (CPT). The main objective of this report is to provide information on the driving efficiency in the SPT and each DCPT. The mean values for e(f), in the tests ranged from 52% to 76%. The values of COV for e(f) ranged from 0.024 to 0.265. Even though the test results are limited, the dynamic cone resistance, q(t), estimated from the dynamic measurements were relatively good measures of the cone resistance from the CPT, showing the importance of the dynamic measurement in the SPT and DCPTs. In addition, possible factors influencing the driving efficiency, such as the hammer mass, the configuration of the driving rod (solid or hollow), the ratio of the diameter of the anvil and the diameter of the hammer, and the existence of a cushion or cushions between the anvil and the hammer, are discussed on the basis of the limited test results. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Matsumoto, Tatsunori; Shimono, Shinya] Kanazawa Univ, Kanazawa, Ishikawa, Japan; [Le Ta Phan] Ho Chi Minh City Univ Architecture, Ho Chi Minh City, Vietnam; [Oshima, Akihiko] Osaka City Univ, Osaka 558, Japan	Matsumoto, T (reprint author), Kanazawa Univ, Kanazawa, Ishikawa, Japan.	matsumoto@se.kanazawa-u.ac.jp					Abou-maatar H., 1996, P 5 INT C APPL STRES, P163; [Anonymous], 2005, 224762 ISO; [Anonymous], 2009, 0051 JGS; SKEMPTON AW, 1986, GEOTECHNIQUE, V36, P425; CAVALCANTE EH, 2008, P 8 INT C APPL STRES, P737; Fujita K., 2000, P 6 INT C APPL STRES, P469; Ishihara S., 2004, P 7 INT C APPL STRES, P313; ISO (International Organization for Standardization), 2004, 146882 ISO; KOVACS WD, 1979, J GEOTECH ENG-ASCE, V105, P1; KOVACS WD, 1982, J GEOTECH ENG-ASCE, V108, P599; Matsumoto T., 1992, SOILS FOUND, V32, P67; Michi Y., 2004, P 7 INT C APPL STRES, P333; Morgano C.M., 1992, P 4 INT C APPL STRES, P121; Robertson P.K., 1997, P NCEER WORKSH EV LI, P41; ROBERTSON PK, 1992, CAN GEOTECH J, V29, P551, DOI 10.1139/t92-062; RODRIGUES C, 2008, P 8 INT C APPL STRES, P731; SCHMERTMANN JH, 1979, J GEOTECH ENG-ASCE, V105, P909; SCHMERTMANN JH, 1979, J GEOTECH ENG-ASCE, V105, P655; YOKEL FY, 1982, J GEOTECH ENG-ASCE, V108, P1197; Zarzojus G, 2013, PROCEDIA ENGINEER, V57, P1302, DOI 10.1016/j.proeng.2013.04.164	20	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	FEB	2015	55	1					201	212		10.1016/j.sandf.2014.12.016		12	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CE7HT	WOS:000352010500016		
J	Kaji, I; Iwanaga, T; Watanabe, M; Guth, PH; Engel, E; Kaunitz, JD; Akiba, Y				Kaji, Izumi; Iwanaga, Toshihiko; Watanabe, Masahiko; Guth, Paul H.; Engel, Eli; Kaunitz, Jonathan D.; Akiba, Yasutada			SCFA transport in rat duodenum	AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY			English	Article						acetate; monocarboxylate transporter; sodium-coupled monocarboxylate transporter; short-chain fatty acid	CHAIN FATTY-ACIDS; NA+-COUPLED TRANSPORTER; BICARBONATE SECRETION; ENTEROENDOCRINE CELLS; HEALTHY-SUBJECTS; DISTAL COLON; MONOCARBOXYLATE TRANSPORTERS; GASTROINTESTINAL-TRACT; CELLULAR EXPRESSION; DIGESTIVE-TRACT	Bacterial or ingested food-derived short-chain fatty acids (SCFAs) are present in the duodenal lumen. Acetate, the most abundant SCFA in the foregut lumen, is absorbed immediately after ingestion, although the mechanism by which this absorption occurs is not fully understood. We investigated the distribution and function of candidate SCFA transporters in rat duodenum. The Na+ -coupled monocarboxylate transporter-1 (SMCT1) was localized to the brush border, whereas the pH-dependent monocarboxylate transporter (MCT) 1 and MCT4 were localized to the duodenocyte basolateral membrane. In Ussing chambered duodenal mucosa, luminal acetate dose-dependently increased short-circuit current (I-sc) in the presence of serosal bumetanide and indomethacin by a luminal Na+ -dependent, ouabain-sensitive mechanism. The Isc response was inhibited dose-dependently by the SMCT1 nonsubstrate inhibitor ibuprofen, consistent with net electrogenic absorption of acetate via SMCT1. Other SCFAs and lactate also increased Isc. Furthermore, duodenal loop perfusion of acetate increased portal venous acetate concentration, inhibited by coperfusion of ibuprofen or a MCT inhibitor. Luminal acetate perfusion increased duodenal HCO3 secretion via capsaicin-sensitive afferent nerve activation and cyclooxygenase activity, consistent with absorption-mediated HCO3- secretion. These results suggest that absorption of luminal SCFA via SMCT1 and MCTs increases duodenal HCO3- secretion. In addition to SCFA sensing via free fatty acid receptors, the presence of rapid duodenal SCFA absorption may be important for the suppression of luminal bacterial colonization and implicated in the generation of functional dyspepsia due to bacterial overgrowth.	[Guth, Paul H.; Kaunitz, Jonathan D.; Akiba, Yasutada] Greater Los Angeles Vet Affairs Healthcare Syst, Los Angeles, CA USA; [Kaji, Izumi; Guth, Paul H.; Kaunitz, Jonathan D.; Akiba, Yasutada] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA; [Kaunitz, Jonathan D.] Univ Calif Los Angeles, Sch Med, Dept Surg, Los Angeles, CA 90024 USA; [Engel, Eli] Univ Calif Los Angeles, Sch Med, Dept Biomath, Los Angeles, CA 90024 USA; [Kaji, Izumi; Iwanaga, Toshihiko; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido, Japan; [Kaji, Izumi; Kaunitz, Jonathan D.; Akiba, Yasutada] Brentwood Biomed Res Inst, Los Angeles, CA USA	Kaunitz, JD (reprint author), West Los Angeles VA Med Ctr, Bldg 114,Suite 217,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	jake@ucla.edu	WATANABE, Masahiko/A-4055-2012		Department of Veterans Affairs Merit Review Award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01-DK-54221]; NIDDK [P30-DK-0413];  [24-5317]	This study was supported by a Grant-in-Aid for the Japan Society for the Promotion of Science Fellows to I. Kaji (no. 24-5317), a Department of Veterans Affairs Merit Review Award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (R01-DK-54221 to J. Kaunitz), and the animal core of the NIDDK (P30-DK-0413 to J. E. Rozengurt).	Akiba Y, J PHYSL LON IN PRESS; Akiba Y, 1999, AM J PHYSIOL-GASTR L, V277, pG268; Akiba Y, 2009, AM J PHYSIOL-GASTR L, V297, pG781, DOI 10.1152/ajpgi.90605.2008; RUPPIN H, 1980, GASTROENTEROLOGY, V78, P1500; Wang JH, 2011, J PHARMACOL EXP THER, V339, P464, DOI 10.1124/jpet.111.184788; Akiba Y, 2007, AM J PHYSIOL-GASTR L, V293, pG1223, DOI 10.1152/ajpgi.00313.2007; Powley TL, 2011, J COMP NEUROL, V519, P644, DOI 10.1002/cne.22541; Miyauchi S, 2004, J BIOL CHEM, V279, P13293, DOI 10.1074/jbc.C400059200; Teramae H, 2010, BIOMED RES-TOKYO, V31, P239; EDWARDS CA, 1994, ACTA PAEDIATR, V83, P459, DOI 10.1111/j.1651-2227.1994.tb13059.x; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Borthakur A, 2012, AM J PHYSIOL-GASTR L, V303, pG1126, DOI 10.1152/ajpgi.00308.2012; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; BERGMAN EN, 1990, PHYSIOL REV, V70, P567; BRADEN B, 1995, GASTROENTEROLOGY, V108, P1048, DOI 10.1016/0016-5085(95)90202-3; Akiba Y, 2014, CURR PHARM DESIGN, V20, P2760, DOI 10.2174/13816128113199990565; Ganapathy V, 2008, AAPS J, V10, P193, DOI 10.1208/s12248-008-9022-y; Gill RK, 2005, AM J PHYSIOL-CELL PH, V289, pC846, DOI 10.1152/ajpcell.00112.2005; Takebe K, 2005, BIOMED RES-TOKYO, V26, P213, DOI 10.2220/biomedres.26.213; SKUTCHES CL, 1979, J CLIN INVEST, V64, P708, DOI 10.1172/JCI109513; Parker HE, 2009, DIABETOLOGIA, V52, P289, DOI 10.1007/s00125-008-1202-x; Karaki S, 2006, CELL TISSUE RES, V324, P353, DOI 10.1007/s00441-005-0140-x; Morris ME, 2008, AAPS J, V10, P311, DOI 10.1208/s12248-008-9035-6; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; Coady MJ, 2004, J PHYSIOL-LONDON, V557, P719, DOI 10.1113/jphysiol.2004.063859; Hudson BD, 2012, J BIOL CHEM, V287, P41195, DOI 10.1074/jbc.M112.396259; BERTHOUD HR, 1995, ANAT EMBRYOL, V191, P203; BOTTA GA, 1985, J PERIODONTAL RES, V20, P450, DOI 10.1111/j.1600-0765.1985.tb00827.x; BRAILSFORD MA, 1986, BIOCHEM J, V239, P355; BRIGHENTI F, 1995, EUR J CLIN NUTR, V49, P242; Charney AN, 1998, AM J PHYSIOL-GASTR L, V274, pG518; Feinle-Bisset C, 2004, AM J GASTROENTEROL, V99, P170, DOI 10.1046/j.1572-0241.2003.04003.x; HOVERSTAD T, 1984, SCAND J GASTROENTERO, V19, P1053; ILLMAN RJ, 1986, J NUTR, V116, P1694; Inoue T, 2012, AM J PHYSIOL-GASTR L, V303, pG810, DOI 10.1152/ajpgi.00195.2012; Iwanaga T, 2006, BIOMED RES-TOKYO, V27, P243, DOI 10.2220/biomedres.27.243; Kaji I, 2012, GASTROENTEROLOGY, V142, pS494; Kaunitz J D, 2003, J Physiol Pharmacol, V54 Suppl 4, P19; Kawamata K, 2007, PFLUG ARCH EUR J PHY, V454, P253, DOI 10.1007/s00424-006-0200-4; Lamers J M, 1975, Biochim Biophys Acta, V413, P465; MASCOLO N, 1991, GASTROENTEROLOGY, V101, P331; MCGOWAN PE, 1993, J PHARMACEUT BIOMED, V11, P629, DOI 10.1016/0731-7085(93)80167-Y; Mitsui R, 2005, NEUROGASTROENT MOTIL, V17, P585, DOI 10.1111/j.1365-2982.2005.00669.x; Ostman E, 2005, EUR J CLIN NUTR, V59, P983, DOI 10.1038/sj.ejcn.1602197; Raybould HE, 2003, AM J PHYSIOL-GASTR L, V284, pG367, DOI 10.1152/ajpgi.00292.2001; RAYBOULD HE, 1992, NEUROSCI LETT, V141, P236, DOI 10.1016/0304-3940(92)90902-J; SCHMITT MG, 1977, AM J DIG DIS, V22, P340, DOI 10.1007/BF01072192; Shimotoyodome A, 2000, COMP BIOCHEM PHYS A, V125, P525, DOI 10.1016/S1095-6433(00)00183-5; TAKEUCHI K, 1991, GASTROENTEROLOGY, V101, P954; Tolhurst G., 2012, HDB EXP PHARM, V209, P309; Trinidad TP, 1996, AM J CLIN NUTR, V63, P574; UMESAKI Y, 1980, PFLUG ARCH EUR J PHY, V388, P205, DOI 10.1007/BF00658482; UMESAKI Y, 1979, PFLUG ARCH EUR J PHY, V379, P43, DOI 10.1007/BF00622903; VANNER S, 1995, AM J PHYSIOL-GASTR L, V269, pG203; WALL MJ, 1976, BIOCHIM BIOPHYS ACTA, V433, P654, DOI 10.1016/0005-2736(76)90288-1; SCHMITT MG, 1976, GASTROENTEROLOGY, V70, P211; Yajima T, 2011, J PHYSIOL-LONDON, V589, P953, DOI 10.1113/jphysiol.2010.199976; YAJIMA T, 1985, J PHYSIOL-LONDON, V368, P667; YAJIMA T, 1981, LIFE SCI, V28, P983, DOI 10.1016/0024-3205(81)90743-8	60	2	2	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1857	1522-1547		AM J PHYSIOL-GASTR L	Am. J. Physiol.-Gastroint. Liver Physiol.	FEB 1	2015	308	3					G188	G197		10.1152/ajpgi.00298.2014		10	Gastroenterology & Hepatology; Physiology	Gastroenterology & Hepatology; Physiology	CB6PV	WOS:000349749900004		
J	Kasai, S; Shimizu, Y; Nagasao, T; Ohnishi, F; Minabe, T; Momosawa, A; Kishi, K				Kasai, Shogo; Shimizu, Yusuke; Nagasao, Tomohisa; Ohnishi, Fumio; Minabe, Toshiharu; Momosawa, Akira; Kishi, Kazuo			An Anatomic Study of Nipple Position and Areola Size in Asian Men	AESTHETIC SURGERY JOURNAL			English	Article							TO-MALE TRANSSEXUALS; COMPLEX POSITION; BREAST-CANCER; MALES; RECONSTRUCTION; GYNECOMASTIA	Background: In planning gender-reassignment surgery for biological women and treating men with gynecomastia, surgeons must have a thorough understanding of anatomically correct nipple positions and appropriate areola sizes in men. Objectives: The authors sought to determine whether body height or body mass index (BMI) affects nipple position or areola size in men. Methods: Anatomic measurements of the nipples and areolae of 50 Japanese men were obtained. A relative coordinate system was defined, where the medial-lateral and superior-inferior positions of the nipple were quantitatively indicated by distance ratios between anatomic landmarks. Nipple positions were evaluated for each patient by referring to this coordinate system, and the positions were compared between groups categorized by body height or BMI. Results: Nipple position was not significantly affected by body height. However, the nipple tended to be located more laterally in participants with higher BMI. The vertical nipple position differed between standing and supine positions. Tall men had larger areolae than short men; however, areola size did not differ with respect to BMI. Conclusions: Nipple position and areola size vary by body shape. Consideration of the differences is recommended when performing procedures such as female-to-male gender-reassignment surgery or correction of gynecomastia.	[Kasai, Shogo] Sano Kousei Gen Hosp, Sano City, Tochigi, Japan; [Shimizu, Yusuke; Nagasao, Tomohisa; Kishi, Kazuo] Keio Univ Hosp, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Ohnishi, Fumio; Minabe, Toshiharu] Saitma Med Univ, Saitama Med Ctr, Dept Plast Surg, Saitama, Japan; [Momosawa, Akira] Univ Yamanashi, Fac Med, Dept Plast Reconstruct & Aesthet Surg, Kofu, Yamanashi, Japan	Shimizu, Y (reprint author), Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yyssprs@gmail.com					Harlan LC, 2010, CANCER-AM CANCER SOC, V116, P3558, DOI 10.1002/cncr.25153; Tashkandi M, 2004, ANN PLAS SURG, V53, P17, DOI 10.1097/01.sap.0000112347.30612.f4; Westreich M, 1997, PLAST RECONSTR SURG, V100, P468, DOI 10.1097/00006534-199708000-00032; Hauben DJ, 2003, ANN PLAS SURG, V50, P510, DOI 10.1097/01.SAP.0000044145.34573.F0; Atiyeh BS, 2009, ANN PLAS SURG, V63, P499, DOI 10.1097/SAP.0b013e3181953854; Atiyeh BS, 2009, PLAST RECONSTR SURG, V123, p156E, DOI 10.1097/PRS.0b013e31819e5c3e; Beckenstein MS, 1996, ANN PLAS SURG, V36, P33, DOI 10.1097/00000637-199601000-00007; Beer GM, 2001, PLAST RECONSTR SURG, V108, P1947, DOI 10.1097/00006534-200112000-00015; Buck DW, 2010, BREAST, V19, P521, DOI 10.1016/j.breast.2010.05.017; Cutuli B, 1995, EUR J CANCER, V31A, P1960, DOI 10.1016/0959-8049(95)00366-5; Farhadi J, 2006, J PLAST RECONSTR AES, V59, P40, DOI 10.1016/j.bjps.2005.08.006; HAGE JJ, 1995, ANN PLAS SURG, V34, P59, DOI 10.1097/00000637-199501000-00012; HAGE JJ, 1995, PLAST RECONSTR SURG, V96, P386, DOI 10.1097/00006534-199508000-00019; LETTERMA.G, 1972, PLAST RECONSTR SURG, V49, P259, DOI 10.1097/00006534-197203000-00003; Lindsay W R, 1979, Ann Plast Surg, V3, P39; Monstrey S, 2008, PLAST RECONSTR SURG, V121, P849, DOI 10.1097/01.prs.0000299921.15447.b2; Sanuki J, 2009, AESTHET PLAST SURG, V33, P295, DOI 10.1007/s00266-008-9194-y; Shulman O, 2001, PLAST RECONSTR SURG, V108, P348, DOI 10.1097/00006534-200108000-00010; WRAY RC, 1974, BRIT J PLAST SURG, V27, P39, DOI 10.1016/0007-1226(74)90060-5	19	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1090-820X	1527-330X		AESTHET SURG J	Aesthet. Surg. J.	FEB	2015	35	2					NP20	NP27		10.1093/asj/sju023		8	Surgery	Surgery	CE5ZK	WOS:000351914800001		
J	Shugo, H; Hodo, Y; Yoneshima, M				Shugo, Haruhiko; Hodo, Yuji; Yoneshima, Manabu			Endoscopic Metallic Stent Insertion for Malignant Afferent Loop Obstruction Using Balloon-Assisted Enteroscopy: A Case Report	AMERICAN JOURNAL OF GASTROENTEROLOGY			English	Letter									[Shugo, Haruhiko; Hodo, Yuji; Yoneshima, Manabu] Municipal Tsuruga Hosp, Dept Gastroenterol, Tsuruga, Fukui 9148502, Japan	Shugo, H (reprint author), Municipal Tsuruga Hosp, Dept Gastroenterol, 1-6-60 Mishima Cho, Tsuruga, Fukui 9148502, Japan.	hshugo@m-kanazawa.jp					Aimoto Takayuki, 2006, Journal of Nippon Medical School, V73, P226, DOI 10.1272/jnms.73.226; Han K, 2012, AM J ROENTGENOL, V199, pW761, DOI 10.2214/AJR.12.8575; Hosono S, 2007, J GASTROENTEROL, V42, P283, DOI 10.1007/s00535-006-2003-y; Skinner M, 2014, ENDOSCOPY, V46, P560, DOI 10.1055/s-0034-1365698; Yao NS, 1998, CARDIOVASC INTER RAD, V21, P350, DOI 10.1007/s002709900277	5	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0002-9270	1572-0241		AM J GASTROENTEROL	Am. J. Gastroenterol.	FEB	2015	110	2					355	357		10.1038/ajg.2014.390		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE5ZV	WOS:000351915900024		
J	Higuchi, H; Takagi, S; Zhang, K; Furui, I; Ozaki, M				Higuchi, Hideyuki; Takagi, Shunichi; Zhang, Kan; Furui, Ikue; Ozaki, Makoto			Effect of Lateral Tilt Angle on the Volume of the Abdominal Aorta and Inferior Vena Cava in Pregnant and Nonpregnant Women Determined by Magnetic Resonance Imaging	ANESTHESIOLOGY			English	Article							AORTOCAVAL COMPRESSION; CESAREAN-SECTION; SPINAL-ANESTHESIA; UTERINE DISPLACEMENT; ARTERY PRESSURE; TABLE TILT; UTERUS; HYPOTENSION; POSITIONS; SUPINE	Background: Left-lateral tilt position is used to reduce assumed aortocaval compression by the pregnant uterus. Methods: Magnetic resonance images of 10 singleton parturients at full term and 10 healthy nonpregnant women were obtained for measurement of the abdominal aorta and inferior vena cava volume between the L1-L2 disk and L3-L4 disk levels in both the supine and left-lateral tilt positions (15 degrees, 30 degrees, and 45 degrees) maintained by insertion of a 1.5-m-long polyethylene foam placed under the right side of the parturient's body. Results: Aortic volume did not differ significantly between parturients and nonpregnant women in the supine position (12.7 +/- 2.0 vs. 12.6 +/- 2.1 ml, mean +/- SD; mean difference, -0.1; 95% confidence interval [CI], -2.0 to 1.9; P = 0.95). Inferior vena cava volume in the supine position was significantly lower in parturients than in nonpregnant women (3.2 +/- 3.4 vs. 17.5 +/- 7.8 ml; mean difference, 14.3; 95% CI, 8.3-20.2; P < 0.001). Aortic volume in parturients did not differ among left-lateral tilt positions. Inferior vena cava volume in the parturients was not increased at 15 degrees (3.0 +/- 2.1 ml; mean difference, -0.2; 95% CI, -1.5 to 1.2; P > 0.99), but was significantly increased at 30 degrees (11.5 +/- 8.6 ml; mean difference, 8.3; 95% CI, 2.3-14.2; P = 0.009) and 45 degrees (10.9 +/- 6.8 ml; mean difference, 7.7; 95% CI, 2.2-13.1; P = 0.015). Conclusions: In parturients, the aorta was not compressed, and a 15 degrees left-lateral tilt position did not effectively reduce inferior vena cava compression.	[Higuchi, Hideyuki; Takagi, Shunichi; Zhang, Kan; Furui, Ikue; Ozaki, Makoto] Tokyo Womens Med Univ, Dept Anesthesiol, Tokyo 1628666, Japan	Higuchi, H (reprint author), Tokyo Womens Med Univ, Dept Anesthesiol, Shinjuku Ku, 8-1 Kawadacho, Tokyo 1628666, Japan.	hhiguchi@anes.twmu.ac.jp					Bosio PM, 1999, OBSTET GYNECOL, V94, P978, DOI 10.1016/S0029-7844(99)00430-5; Rees SGO, 2002, ANAESTHESIA, V57, P15, DOI 10.1046/j.1365-2044.2002.02325.x; KINSELLA SM, 1992, BRIT MED J, V305, P539; Sharwood-Smith G, 2009, BRIT J ANAESTH, V102, P291, DOI 10.1093/bja/aep003; SECHER NJ, 1979, SCAND J CLIN LAB INV, V39, P569, DOI 10.3109/00365517909108835; Mendonca C, 2003, ANAESTHESIA, V58, P428, DOI 10.1046/j.1365-2044.2003.03090.x; Jones SJ, 2003, BRIT J ANAESTH, V90, P86, DOI 10.1093/bja/aeg003; HOWARD BK, 1953, OBSTET GYNECOL, V1, P371; BIENIARZ J, 1966, AM J OBSTET GYNECOL, V95, P795; Kinsella SM, 2003, ANAESTHESIA, V58, P835, DOI 10.1046/j.1365-2044.2003.03397.x; CAMANN WR, 1990, INT ANESTHESIOL CLIN, V28, P2, DOI 10.1097/00004311-199002810-00002; REES GAD, 1988, ANAESTHESIA, V43, P347, DOI 10.1111/j.1365-2044.1988.tb09009.x; Steinbrook RA, 2001, ANESTH ANALG, V93, P1570, DOI 10.1097/00000539-200112000-00051; Lee SWY, 2012, BRIT J ANAESTH, V109, P950, DOI 10.1093/bja/aes349; Bamber JH, 2003, ANESTH ANALG, V97, P256, DOI 10.1213/01.ANE.0000067400.79654.30; BIENIARZ J, 1968, AM J OBSTET GYNECOL, V102, P1106; Hirabayashi Y, 1997, BRIT J ANAESTH, V78, P317; Armstrong S, 2011, ANESTH ANALG, V113, P318, DOI 10.1213/ANE.0b013e31821f125c; KERR MG, 1964, BRIT MED J, V1, P532; ANSARI I, 1970, Journal of Obstetrics and Gynaecology of the British Commonwealth, V77, P713; BIENIARZ J, 1969, AM J OBSTET GYNECOL, V103, P19; BIENIARZ J, 1968, AM J OBSTET GYNECOL, V100, P203; COLONMOR.MA, 1970, ANESTH ANAL CURR RES, V49, P223; Coutts WE, 1935, AM J OBSTET GYNECOL, V29, P566; CRAWFORD JS, 1972, BRIT J ANAESTH, V44, P477, DOI 10.1093/bja/44.5.477; ECKSTEIN KL, 1974, ANESTHESIOLOGY, V40, P92, DOI 10.1097/00000542-197401000-00025; Jeon YT, 2010, ANESTH ANALG, V111, P712, DOI 10.1213/ANE.0b013e3181e8137b; Kametas NA, 2001, ULTRASOUND OBST GYN, V18, P467, DOI 10.1046/j.0960-7692.2001.00574.x; KINSELLA SM, 1990, EUR J OBSTET GYN R B, V36, P11, DOI 10.1016/0028-2243(90)90044-2; Lucero JM, 2011, OBSTETRICS BASIC ANE, P514; Matorras R, 1998, J PERINAT MED, V26, P284, DOI 10.1515/jpme.1998.26.4.284; MORGAN DJ, 1984, BRIT J ANAESTH, V56, P349, DOI 10.1093/bja/56.4.349; SCOTT DB, 1968, BRIT J ANAESTH, V40, P120, DOI 10.1093/bja/40.2.120; Vanden Hoek TL, 2010, CIRCULATION, V122, pS829, DOI 10.1161/CIRCULATIONAHA.110.971069; Wong CA, 2010, OBSTETRIC PAIN BONIC, P791	35	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	FEB	2015	122	2					286	293		10.1097/ALN.0000000000000553		8	Anesthesiology	Anesthesiology	CE3NZ	WOS:000351734900008		
J	Herzog, E; Kaspereit, F; Krege, W; Doerr, B; Mueller-Cohrs, J; Pragst, I; Morishima, Y; Dickneite, G				Herzog, Eva; Kaspereit, Franz; Krege, Wilfried; Doerr, Baerbel; Mueller-Cohrs, Jochen; Pragst, Ingo; Morishima, Yoshiyuki; Dickneite, Gerhard			Effective Reversal of Edoxaban-associated Bleeding with Four-factor Prothrombin Complex Concentrate in a Rabbit Model of Acute Hemorrhage	ANESTHESIOLOGY			English	Article							FACTOR XA INHIBITOR; ORAL ANTICOAGULANTS; ATRIAL-FIBRILLATION; IN-VITRO; COAGULATION ASSAYS; BERIPLEX P/N; DABIGATRAN ETEXILATE; HEALTHY-VOLUNTEERS; EX-VIVO; RIVAROXABAN	Background: Edoxaban is an oral, selective direct factor Xa inhibitor approved in Japan for venous thromboembolism prevention after orthopedic surgery. Data are lacking regarding reversal strategies for edoxaban; this study assessed whether four-factor prothrombin complex concentrate (Beriplex (R)/Kcentra (R); CSL Behring GmbH, Marburg, Germany) can effectively reverse its effects on hemostasis using a previously described rabbit model. Methods: The study comprised assessments of thrombin generation in vitro, pharmacokinetic parameters, and edoxaban reversal in vivo. In a blinded in vivo stage, a standardized kidney incision was performed in animals (n = 11 per group) randomized to receive vehicle + saline, edoxaban (1,200 mu g/kg) + saline, or edoxaban (1,200 mu g/kg) + four-factor prothrombin complex concentrate (50 IU/kg). Animals were monitored for treatment impact on hemostasis and coagulation parameters. Data are median (range). Statistical tests were adjusted for multiple testing. Results: Edoxaban administration increased blood loss (30 [2 to 44] ml) and time to hemostasis (23 [8.5 to 30.0] min) compared with the control group (3 [1 to 8] ml and 3 [2.0 to 5.0] min, respectively). Biomarkers of coagulation (prothrombin time, activated partial thromboplastin time, whole blood clotting time) and thrombin generation parameters (e.g., peak thrombin, endogenous thrombin potential, lag time) were also affected by edoxaban. Administration of four-factor prothrombin complex concentrate significantly reduced time to hemostasis (to 8 [6.5 to 14.0] min, observed P < 0.0001) and total blood loss (to 9 [4 to 22] ml, observed P = 0.0050) compared with the edoxaban + saline group. Of the biomarkers tested, prothrombin time, whole blood clotting time, and endogenous thrombin potential correlated best with clinical parameters. Conclusion: In a rabbit model of hemostasis, four-factor prothrombin complex concentrate administration significantly decreased edoxaban-associated hemorrhage.	[Herzog, Eva; Kaspereit, Franz; Krege, Wilfried; Doerr, Baerbel; Mueller-Cohrs, Jochen; Pragst, Ingo; Dickneite, Gerhard] CSL Behring GmbH, Preclin Res & Dev, D-35002 Marburg, Germany; [Morishima, Yoshiyuki] Daiichi Sankyo Co Ltd, Biol Res Labs, R&D Div, Tokyo, Japan	Herzog, E (reprint author), CSL Behring GmbH, Preclin Res & Dev, POB 1230, D-35002 Marburg, Germany.	eva.herzog@cslbehring.com			CSL Behring GmbH, Marburg, Germany	This study was supported by CSL Behring GmbH, Marburg, Germany.	Ageno W, 2012, CHEST S, V141, pe44S, DOI DOI 10.1378/CHEST.11-2292; Ahrens I, 2012, DISCOV MED, V73, P433; Dickneite G, 2014, THROMB HAEMOSTASIS, V111, P189, DOI 10.1160/TH13-05-0431; Samama MM, 2010, THROMB HAEMOSTASIS, V103, P815, DOI 10.1160/TH09-03-0176; Levy JH, 2013, ANESTHESIOLOGY, V118, P1466, DOI 10.1097/ALN.0b013e318289bcba; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Heidbuchel H, 2013, EUROPACE, V15, P625, DOI 10.1093/europace/eut083; HARA T, 1995, THROMB RES, V80, P99, DOI 10.1016/0049-3848(95)00155-K; Dinkelaar J, 2013, J THROMB HAEMOST, V11, P1111, DOI 10.1111/jth.12236; Wong PC, 2008, J THROMB HAEMOST, V6, P820, DOI 10.1111/j.1538-7836.2008.02939.x; Grottke O, 2014, CRIT CARE, V18, DOI 10.1186/cc13717; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Hillarp A, 2011, J THROMB HAEMOST, V9, P133, DOI 10.1111/j.1538-7836.2010.04098.x; Lu GM, 2013, NAT MED, V19, P446, DOI 10.1038/nm.3102; Leissinger CA, 2008, AM J HEMATOL, V83, P137, DOI 10.1002/ajh.21046; Ogata K, 2010, J CLIN PHARMACOL, V50, P743, DOI 10.1177/0091270009351883; Eriksson BI, 2011, ANNU REV MED, V62, P41, DOI 10.1146/annurev-med-062209-095159; Pabinger I, 2008, J THROMB HAEMOST, V6, P622, DOI 10.1111/j.1538-7836.2008.02904.x; Pengo V, 2011, THROMB HAEMOSTASIS, V106, P868, DOI 10.1160/TH11-05-0358; Grottke O, 2011, BLOOD, V118, P1943, DOI 10.1182/blood-2011-03-343046; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Huisman MV, 2012, THROMB HAEMOSTASIS, V107, P838, DOI 10.1160/TH11-10-0718; van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758; Marlu R, 2012, THROMB HAEMOSTASIS, V108, P217, DOI 10.1160/TH12-03-0179; Lindahl TL, 2011, THROMB HAEMOSTASIS, V105, P371, DOI 10.1160/TH10-06-0342; MENACHE D, 1990, BLOOD, V75, P33; Turpie AGG, 2012, THROMB HAEMOSTASIS, V108, P876, DOI 10.1160/TH12-03-0209; Fukuda T, 2012, THROMB HAEMOSTASIS, V107, P253, DOI 10.1160/TH11-09-0668; Zafar MU, 2007, THROMB HAEMOSTASIS, V98, P883, DOI 10.1160/TH07-04-0312; Mitterlechner T, 2011, J THROMB HAEMOST, V9, P729, DOI 10.1111/j.1538-7836.2011.04211.x; Pragst I, 2012, J THROMB HAEMOST, V10, P1841, DOI 10.1111/j.1538-7836.2012.04859.x; Herzog E, 2014, THROMB RES, V134, P729, DOI 10.1016/j.thromres.2014.07.003; Miesbach W, 2012, THROMB HAEMOSTASIS, V108, P625, DOI 10.1160/TH12-05-0319; Baglin T, 2013, J THROMB HAEMOST, V11, P756, DOI DOI 10.1111/JTH.12149; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Dickneite G, 2008, BIOPHARM DRUG DISPOS, V29, P356, DOI 10.1002/bdd.623; Fuji T., 2011, BLOOD, V118, P208; Furugohri T, 2008, J THROMB HAEMOST, V6, P1542, DOI 10.1111/j.1538-7836.2008.03064.x; Hanke AA, 2013, BRIT J ANAESTH, V110, P764, DOI 10.1093/bja/aes501; Hirsh J, 2001, CHEST S, V119, P64; Hirsh J, 2008, CHEST, V133, p141S; Hoffman MR, 2012, BLOOD, V120; Levi M, 2014, J THROMB HAEMOST, V12, P1428, DOI 10.1111/jth.12599; Samama MM, 2010, THROMB RES, V126, pE286, DOI 10.1016/j.thromres.2010.07.015; van Ryn J., 2011, BLOOD, V118, P2316; Van Ryn J, 2011, J THROMB HAEMOST, V9, P110; Wong PC, 2002, CARDIOVASC DRUG REV, V20, P137; Zhang DL, 2010, J THROMB THROMBOLYS, V29, P70, DOI 10.1007/s11239-009-0401-8	48	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	FEB	2015	122	2					387	398		10.1097/ALN.0000000000000520		12	Anesthesiology	Anesthesiology	CE3NZ	WOS:000351734900018		
J	Voronina, S; Collier, D; Chvanov, M; Middlehurst, B; Beckett, AJ; Prior, IA; Criddle, DN; Begg, M; Mikoshiba, K; Sutton, R; Tepikin, AV				Voronina, Svetlana; Collier, David; Chvanov, Michael; Middlehurst, Ben; Beckett, Alison J.; Prior, Ian A.; Criddle, David N.; Begg, Malcolm; Mikoshiba, Katsuhiko; Sutton, Robert; Tepikin, Alexei V.			The role of Ca2+ influx in endocytic vacuole formation in pancreatic acinar cells	BIOCHEMICAL JOURNAL			English	Article						acute pancreatitis; calpain; GSK-7975A; store-operated Ca2+ entry; stromal interaction molecule	CHANNEL BLOCKERS; CALCIUM; ACTIVATION; RAT; MECHANISM; MOUSE; OSCILLATIONS; TOXICITY; CERULEIN; WAVES	The inducers of acute pancreatitis trigger a prolonged increase in the cytosolic Ca2+ concentration ([Ca2+](c)), which is responsible for the damage to and eventual death of pancreatic acinar cells. Vacuolization is an important indicator of pancreatic acinar cell damage. Furthermore, activation of trypsinogen occurs in the endocytic vacuoles; therefore the vacuoles can be considered as 'initiating' organelles in the development of the cell injury. In the present study, we investigated the relationship between the formation of endocytic vacuoles and Ca2+ influx developed in response to the inducers of acute pancreatitis [bile acid taurolithocholic acid 3-sulfate (TLC-S) and supramaximal concentration of cholecystokinin-8 (CCK)]. We found that the inhibitor of STIM (stromal interaction molecule)/Orai channels, GSK-7975A, effectively suppressed both the Ca2+ influx (stimulated by inducers of pancreatitis) and the formation of endocytic vacuoles. Cell death induced by TLCS or CCK was also inhibited by GSK-7975A. We documented the formation of endocytic vacuoles in response to store-operated Ca2+ entry (SOCE) induced by thapsigargin [TG; inhibitor of sarcoplasmic/endoplasmic reticulum (ER) Ca2+ pumps] and observed strong inhibition of TG-induced vacuole formation by GSK-7975A. Finally, we found that structurally-unrelated inhibitors of calpain suppress formation of endocytic vacuoles, suggesting that this Ca2+-dependent protease is a mediator between Ca2+ elevation and endocytic vacuole formation.	[Voronina, Svetlana; Collier, David; Chvanov, Michael; Middlehurst, Ben; Beckett, Alison J.; Prior, Ian A.; Criddle, David N.; Tepikin, Alexei V.] Univ Liverpool, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Collier, David; Mikoshiba, Katsuhiko] Riken Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Begg, Malcolm] GlaxoSmithKline, Med Res Ctr, Resp Therapy Area Unit, Stevenage SG1 2NY, Herts, England; [Sutton, Robert] Univ Liverpool, NIHR Liverpool Pancreas Biomed Res Unit, Liverpool L69 3BX, Merseyside, England	Tepikin, AV (reprint author), Univ Liverpool, Dept Cellular & Mol Physiol, Crown St, Liverpool L69 3BX, Merseyside, England.	a.tepikin@liv.ac.uk			Medical Research Council [MR/K012967/1]; National Institute for Health Research	This work was supported by the Medical Research Council [grant number MR/K012967/1]; and the National Institute for Health Research (to the NIHR Liverpool Pancreas Biomedical Research Unit).	Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; Rice LV, 2013, EUR J PHARMACOL, V704, P49, DOI 10.1016/j.ejphar.2013.02.022; Straub SV, 2000, J GEN PHYSIOL, V116, P547, DOI 10.1085/jgp.116.4.547; SALUJA A, 1985, AM J PHYSIOL, V249, pG702; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Gerasimenko JV, 2013, P NATL ACAD SCI USA, V110, P13186, DOI 10.1073/pnas.1300910110; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Putney JW, 2007, CELL CALCIUM, V42, P103, DOI 10.1016/j.ceca.2007.01.011; Husain SZ, 2005, P NATL ACAD SCI USA, V102, P14386, DOI 10.1073/pnas.0503215102; Kim MS, 2011, GASTROENTEROLOGY, V140, P2107, DOI 10.1053/j.gastro.2011.02.052; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Neoptolemos JP, 1998, GUT, V42, P886; Derler I, 2013, CELL CALCIUM, V53, P139, DOI 10.1016/j.ceca.2012.11.005; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1093/jcb.200502019; van Acker GJD, 2006, WORLD J GASTROENTERO, V12, P1985; Voronina SG, 2007, AM J PHYSIOL-GASTR L, V293, pG1333, DOI 10.1152/ajpgi.00275.2007; Otani T, 1998, AM J PHYSIOL-GASTR L, V275, pG999; Sutton R, 2003, PANCREATOLOGY, V3, P497, DOI 10.1159/000075581; Sutton R, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e3181675010; TEPIKIN AV, 1992, J BIOL CHEM, V267, P3569; Voronina S, 2002, J PHYSIOL-LONDON, V540, P49, DOI 10.1113/jphysiol.2002.017525; Weber H, 2009, INT J EXP PATHOL, V90, P387, DOI 10.1111/j.1365-2613.2009.00638.x; Yule DI, 1996, AM J PHYSIOL-CELL PH, V271, pC1285	32	3	3	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0264-6021	1470-8728		BIOCHEM J	Biochem. J.	FEB 1	2015	465		3				405	412		10.1042/BJ20140398		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CE2XV	WOS:000351686200005		
J	Ohtomo, K; Ueta, T; Nagahara, M				Ohtomo, Kazuyoshi; Ueta, Takashi; Nagahara, Miyuki			Congenital nasolacrimal duct obstruction with fungal dacryoliths	CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE			English	Letter									[Ohtomo, Kazuyoshi; Ueta, Takashi; Nagahara, Miyuki] Tokyo Univ Hosp, Bunkyo Ku, Tokyo 113, Japan	Ohtomo, K (reprint author), Tokyo Univ Hosp, Bunkyo Ku, Tokyo 113, Japan.	hhrpfb@yahoo.co.jp					LINBERG JV, 1986, OPHTHALMOLOGY, V93, P1055; BERLIN AJ, 1980, OPHTHALMIC SURG LAS, V11, P435; Iliadelis E, 1999, EUR J OPHTHALMOL, V9, P266; Kubo M, 2013, ISRN OPHTHALMOL, V2013; Sasaki T, 2009, JPN J OPHTHALMOL, V53, P145, DOI 10.1007/s10384-008-0624-9; Takahashi Yasuhiro, 2013, Orbit, V32, P338, DOI 10.3109/01676830.2013.815228; WILKINS RB, 1980, OPHTHALMIC SURG LAS, V11, P787; Yazici B, 2001, OPHTHALMOLOGY, V108, P1308, DOI 10.1016/S0161-6420(01)00596-6; Young JDH, 1997, BRIT MED J, V315, P293	9	0	0	CANADIAN OPHTHAL SOC	OTTAWA	1525 CARLING AVE SUITE 610, OTTAWA, ONTARIO K1Z 8R9, CANADA	0008-4182	1715-3360		CAN J OPHTHALMOL	Can. J. Opthalmol.-J. Can. Opthalmol.	FEB	2015	50	1					E7	E8		10.1016/j.jcjo.2014.10.012		3	Ophthalmology	Ophthalmology	CE6MP	WOS:000351951400004		
J	Mashiko, S; Kitatani, K; Toyoshima, M; Ichimura, A; Dan, T; Usui, T; Ishibashi, M; Shigeta, S; Nagase, S; Miyata, T; Yaegashi, N				Mashiko, Satsuki; Kitatani, Kazuyuki; Toyoshima, Masafumi; Ichimura, Atsuhiko; Dan, Takashi; Usui, Toshinori; Ishibashi, Masumi; Shigeta, Shogo; Nagase, Satoru; Miyata, Toshio; Yaegashi, Nobuo			Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer	CANCER BIOLOGY & THERAPY			English	Article						cancer therapeutics; clear cell carcinoma of the ovary; ovarian cancer; plasminogen activator inhibitor-1; plasminogen activator inhibitor-1 inhibitor; TM5275	BREAST-CANCER; PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; CYTOCHROME-C; PAI-1; APOPTOSIS; TYPE-1; SURVIVAL; SYSTEM; TPA	Plasminogen activator inhibitor (PAI)-1 is predictive of poor outcome in several types of cancer. The present study investigated the biological role for PAI-1 in ovarian cancer and potential of targeted pharmacotherapeutics. In patients with ovarian cancer, PAI-1 mRNA expression in tumor tissues was positively correlated with poor prognosis. To determine the role of PAI-1 in cell proliferation in ovarian cancer, the effects of PAI-1 inhibition were examined in PAI-1-expressing ovarian cancer cells. PAI-1 knockdown by small interfering RNA resulted in significant suppression of cell growth accompanied with G2/M cell cycle arrest and intrinsic apoptosis. Similarly, treatment with the small molecule PAI-1 inhibitor TM5275 effectively blocked cell proliferation of ovarian cancer cells that highly express PAI-1. Together these results suggest that PAI-1 promotes cell growth in ovarian cancer. Interestingly, expression of PAI-1 was increased in ovarian clear cell carcinoma compared with that in serous tumors. Our results suggest that PAI-1 inhibition promotes cell cycle arrest and apoptosis in ovarian cancer and that PAI-1 inhibitors potentially represent a novel class of anti-tumor agents.	[Mashiko, Satsuki; Kitatani, Kazuyuki; Toyoshima, Masafumi; Usui, Toshinori; Ishibashi, Masumi; Nagase, Satoru; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Educ, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Kitatani, Kazuyuki; Usui, Toshinori] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Ichimura, Atsuhiko; Dan, Takashi; Miyata, Toshio] Tohoku Univ, Grad Sch Educ, United Ctr Adv Res, Div Mol Med & Therapy, Sendai, Miyagi 980, Japan; [Ichimura, Atsuhiko; Dan, Takashi; Miyata, Toshio] Tohoku Univ, Grad Sch Educ, United Ctr Translat Med, Div Mol Med & Therapy, Sendai, Miyagi 980, Japan; [Shigeta, Shogo] Yamagata Univ, Dept Obstet & Gynecol, Fac Med, Yamagata 990, Japan	Kitatani, K (reprint author), Tohoku Univ, Grad Sch Educ, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan.	kitatani@med.tohoku.ac.jp; m-toyo@med.tohoku.ac.jp	Miyata, Toshio/A-4872-2010; 	Kitatani, Kazuyuki/0000-0002-8516-6135	JSPS KAKENHI [23790366, 24390375, 23791801]; Health Labor Sciences Research Grant [201221019A]; Kurokawa Cancer Research Foundation; Japan Society of Gynecologic Oncology; Foundation for Promotion of Cancer Research; Tohoku University Graduate School of Medicine United Center for Advanced Research and Translational Medicine	This study was supported in part by JSPS KAKENHI Grants (23790366, to K.K., 24390375 to N.Y. and 23791801 to M.T), a Health Labor Sciences Research Grant (201221019A to N.Y.), the Kurokawa Cancer Research Foundation (M.T.), the Japan Society of Gynecologic Oncology (M.T.), the Foundation for Promotion of Cancer Research (M.T.), and Tohoku University Graduate School of Medicine United Center for Advanced Research and Translational Medicine (M.T.).	Boe AE, 2013, CIRCULATION, V128, P2318, DOI 10.1161/CIRCULATIONAHA.113.003192; Allgayer H, 1997, BRIT J SURG, V84, P1651, DOI 10.1002/bjs.1800841206; Duska LR, 2010, GYNECOL ONCOL, V116, P374, DOI [10.1016/j.ygyno.2009.10.069, 10.1016/j,ygyno.2009.10.069]; Raigoso P, 2000, INT J BIOL MARKER, V15, P44; Izuhara Y, 2010, J CEREBR BLOOD F MET, V30, P904, DOI 10.1038/jcbfm.2009.272; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Schuliga M, 2013, CURR OPIN PHARMACOL, V13, P386, DOI 10.1016/j.coph.2013.05.014; Zhang W, 2013, ONCOL REP, V29, P637, DOI 10.3892/or.2012.2148; Yamamoto S, 2011, MODERN PATHOL, V24, P1146, DOI 10.1038/modpathol.2011.70; Fang H, 2012, J NATL CANCER I, V104, P1470, DOI 10.1093/jnci/djs377; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Goldstein JC, 2000, NAT CELL BIOL, V2, P156; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Liu JJ, 2005, CANCER BIOL THER, V4, P885; Harbeck N, 1999, BREAST CANCER RES TR, V54, P147, DOI 10.1023/A:1006118828278; Balsara RD, 2008, THROMB HAEMOSTASIS, V100, P1029, DOI 10.1160/TH08-07-0427; Kuhn W, 1999, BRIT J CANCER, V79, P1746, DOI 10.1038/sj.bjc.6690278; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Alberti C, 2012, ONCOGENE, V31, P4139, DOI 10.1038/onc.2011.572; DiPaola RS, 2002, CLIN CANCER RES, V8, P3311; Berger DH, 2002, WORLD J SURG, V26, P767, DOI 10.1007/s00268-002-4050-8; AYY Lee, 2003, CIRCULATION, V107, P17; Bajou K, 2008, CANCER CELL, V14, P324, DOI 10.1016/j.ccr.2008.08.012; Baron JA, 1998, LANCET, V351, P1077, DOI 10.1016/S0140-6736(97)10018-6; Boccaccio C, 2005, NATURE, V434, P396, DOI 10.1038/nature03357; Borgfeldt C, 2003, GYNECOL ONCOL, V91, P112, DOI 10.1016/S0090-8258(03)00493-1; Chambers SK, 1998, INT J CANCER, V79, P449; Dass Kathleen, 2008, Cancer Treat Rev, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; de Witte JH, 1999, BRIT J CANCER, V80, P286; FOEKENS JA, 1995, J NATL CANCER I, V87, P751, DOI 10.1093/jnci/87.10.751; Ichimura A, 2013, ARTERIOSCL THROM VAS, V33, P935, DOI 10.1161/ATVBAHA.113.301224; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Kohler HP, 2000, NEW ENGL J MED, V342, P1792; Offersen BV, 2008, ACTA ONCOL, V47, P618, DOI 10.1080/02841860801958295; Rickles FR, 2009, THROMB RES, V123, pS16, DOI 10.1016/S0049-3848(09)70004-0; Webb DJ, 2001, J CELL BIOL, V152, P741, DOI 10.1083/jcb.152.4.741; WU K, 1995, BLOOD, V86, P1056; Yamashita Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057724; Zekanowska Ewa, 2004, Pneumonol Alergol Pol, V72, P409; Zubac DP, 2010, BMC UROL, V10, DOI 10.1186/1471-2490-10-20	40	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-4047	1555-8576		CANCER BIOL THER	Cancer Biol. Ther.	FEB	2015	16	2					253	260		10.1080/15384047.2014.1001271		8	Oncology	Oncology	CE2FZ	WOS:000351631200013		
J	Ishiguro, S; Yoshimura, K; Tsunedomi, R; Oka, M; Takao, S; Inui, M; Kawabata, A; Wall, T; Magafa, V; Cordopatis, P; Tzakos, AG; Tamura, M				Ishiguro, Susumu; Yoshimura, Kiyoshi; Tsunedomi, Ryouichi; Oka, Masaaki; Takao, Sonshin; Inui, Makoto; Kawabata, Atsushi; Wall, Terrahn; Magafa, Vassiliki; Cordopatis, Paul; Tzakos, Andreas G.; Tamura, Masaaki			Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice	CANCER BIOLOGY & THERAPY			English	Article						angiotensin II type 2 receptor (AT2R); apoptosis; pancreatic ductal adenocarcinoma; selective AT2R agonist	SMOOTH-MUSCLE-CELLS; TUMOR ANGIOGENESIS; GENE-EXPRESSION; CANCER CELLS; SYSTEM; INHIBITION; INDUCTION; SURVIVAL; CLONING; PATHWAY	We have recently discovered the potential involvement of angiotensin II type 2 receptor (AT2R) signaling in pancreatic cancer using AT2R deficient mice. To examine the involvement of AT2R expression in human PDAC, expressions of AT2R as well as the major angiotensin II receptor (type 1 receptor, AT1R) in human PDAC and adjacent normal tissue was evaluated by immunohistochemistry and real time PCR using surgically dissected human PDAC specimens. In immunohistochemical analysis, relatively strong AT1R expression was detected consistently in both normal pancreas and PDAC areas, whereas moderate AT2R expression was detected in 78.5% of PDAC specimens and 100% of normal area of the pancreas. AT1R, but not AT2R, mRNA levels were significantly higher in the PDAC area than in the normal pancreas. AT2R mRNA levels showed a negative correlation trend with overall survival. In cell cultures, treatment with a novel AT2R agonist significantly attenuated both murine and human PDAC cell growth with negligible cytotoxicity in normal epithelial cells. In a mouse study, administrations of the AT2R agonist in tumor surrounding connective tissue markedly attenuated growth of only AT2R expressing PAN02 murine PDAC grafts in syngeneic mice. The AT2R agonist treatment induced apoptosis primarily in tumor cells but not in stromal cells. Taken together, our findings offer clinical and preclinical evidence for the involvement of AT2R signaling in PDAC development and pinpoint that the novel AT2R agonist could serve as an effective therapeutic for PDAC treatment.	[Ishiguro, Susumu; Kawabata, Atsushi; Wall, Terrahn; Tamura, Masaaki] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Yoshimura, Kiyoshi; Tsunedomi, Ryouichi; Oka, Masaaki] Yamaguchi Univ, Dept Surg Oncol Surg 2, Grad Sch Med, Yamaguchi, Japan; [Takao, Sonshin] Kagoshima Univ, Ctr Biomed Sci & Swine Res, Kagoshima 890, Japan; [Inui, Makoto] Yamaguchi Univ, Dept Pharmacol, Grad Sch Med, Yamaguchi, Japan; [Magafa, Vassiliki; Cordopatis, Paul] Univ Patras, Dept Pharm, Patras, Greece; [Tzakos, Andreas G.] Univ Ioannina, Dept Chem, Sect Organ Chem & Biochem, Ioannina, Greece	Tamura, M (reprint author), Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA.	mtamura@vet.ksu.edu			Kansas State University (KSU) Johnson Cancer Research Center; KSU College of Veterinary Medicine Dean's fund; NIH [P20 RR017686, P20 RR016475, 5P20RR015563]; Kansas Bioscience Authority Collaborative Cancer Research grant; Japanese Ministry of Education, Culture, Sports, Science and Technology [25293288]; European Union (European Social Fund-ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)	This work was supported in part by Kansas State University (KSU) Johnson Cancer Research Center, KSU College of Veterinary Medicine Dean's fund, NIH grants P20 RR017686, P20 RR016475, 5P20RR015563 and Kansas Bioscience Authority Collaborative Cancer Research grant. In addition, this work was supported by the Grant-in-Aid for Scientific Research (B) 25293288 from the Japanese Ministry of Education, Culture, Sports, Science and Technology (ST), and the European Union (European Social Fund-ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: ARISTEIA II. Investing in knowledge society through the European Social Fund (AGT).	Anandanadesan R, 2008, J GASTROINTEST SURG, V12, P57, DOI 10.1007/s11605-007-0403-9; Fujita M, 2005, CARCINOGENESIS, V26, P271, DOI 10.1093/carcin/bgh324; Miura SI, 2000, EMBO J, V19, P4026, DOI 10.1093/emboj/19.15.4026; Arrieta O, 2008, BRIT J CANCER, V99, P160, DOI 10.1038/sj.bjc.6604431; Rocken C, 2007, CANCER EPIDEM BIOMAR, V16, P1206, DOI 10.1158/1055-9965.EPI-05-0934; KAMBAYASHI Y, 1993, J BIOL CHEM, V268, P24543; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; Egami K, 2003, J CLIN INVEST, V112, P67, DOI 10.1172/JCI200316645; Miyajima A, 2002, CANCER RES, V62, P4176; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Yamada T, 1996, P NATL ACAD SCI USA, V93, P156, DOI 10.1073/pnas.93.1.156; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Lam KY, 2002, EUR J ENDOCRINOL, V146, P567, DOI 10.1530/eje.0.1460567; Nakai Y, 2010, BRIT J CANCER, V103, P1644, DOI 10.1038/sj.bjc.6605955; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Fujimoto Y, 2001, FEBS LETT, V495, P197, DOI 10.1016/S0014-5793(01)02377-8; Fujiyama S, 2001, CIRC RES, V88, P22; Johnstone MT, 2004, CIRCULATION, V110, P2060, DOI 10.1161/01.CIR.0000143627.55926.4C; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; FERNANDEZ LA, 1985, J LAB CLIN MED, V105, P141; Jones ES, 2008, PHARMACOL THERAPEUT, V120, P292, DOI 10.1016/j.pharmthera.2008.08.009; SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0; leNoble FAC, 1996, J VASC RES, V33, P480; Senbonmatsu T, 2003, EMBO J, V22, P6471, DOI 10.1093/emboj/cdg637; MUKOYAMA M, 1993, J BIOL CHEM, V268, P24539; Miura S, 2005, J BIOL CHEM, V280, P18237, DOI 10.1074/jbc.M500639200; STOLL M, 1995, J CLIN INVEST, V95, P651, DOI 10.1172/JCI117710; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Richard DE, 2000, J BIOL CHEM, V275, P26765; Arafat HA, 2007, J AM COLL SURGEONS, V204, P996, DOI 10.1016/j.jamcollsurg.2007.01.067; Berry C, 2001, AM J PHYSIOL-HEART C, V281, pH2337; CHAPPELL MC, 1992, PEPTIDES, V13, P313, DOI 10.1016/0196-9781(92)90114-I; CUBILLA AL, 1978, J SURG ONCOL, V10, P465, DOI 10.1002/jso.2930100602; Doi C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-67; Fujino Y, 2003, HEPATO-GASTROENTEROL, V50, P250; Ino K, 2006, BRIT J CANCER, V94, P552, DOI 10.1038/sj.bjc.6602961; Lee FTH, 2004, J AM SOC NEPHROL, V15, P2139, DOI 10.1097/01.ASN.0000135055.61833.A8; Leung PS, 1997, J ENDOCRINOL, V153, P269, DOI 10.1677/joe.0.1530269; Leung PS, 1999, J ENDOCRINOL, V160, P13, DOI 10.1677/joe.0.1600013; LYALL F, 1992, J HYPERTENS, V10, P1463, DOI 10.1097/00004872-199210120-00005; Magnani F, 2014, ACS CHEM BIOL, V9, P1420, DOI 10.1021/cb500063y; Matsuzuka T, 2010, LUNG CANCER, V70, P28, DOI 10.1016/j.lungcan.2010.01.003; McGhee A, 2011, SURGERY, V150, P284, DOI 10.1016/j.surg.2011.06.002; NEYSES L, 1993, J HYPERTENS, V11, P927, DOI 10.1097/00004872-199309000-00006; Puolakkainen PA, 2004, MOL CANCER RES, V2, P215; SADOSHIMA J, 1993, CIRC RES, V73, P424; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Shirotake S, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.11.002; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tamura Masaaki, 1999, Hypertension (Baltimore), V33, P626; Teicher BA, 2002, TUMOR MODELS CANC RE; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706	52	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-4047	1555-8576		CANCER BIOL THER	Cancer Biol. Ther.	FEB	2015	16	2					307	316		10.1080/15384047.2014.1002357		10	Oncology	Oncology	CE2FZ	WOS:000351631200019		
J	Takai, M; Nakagawa, T; Tanabe, A; Terai, Y; Ohmichi, M; Asahi, M				Takai, Masaaki; Nakagawa, Takatoshi; Tanabe, Akiko; Terai, Yoshito; Ohmichi, Masahide; Asahi, Michio			Crosstalk between PI3K and Ras pathways via protein phosphatase 2A in human ovarian clear cell carcinoma	CANCER BIOLOGY & THERAPY			English	Article						HIF-1; mTOR; MEK inhibitor; ovarian clear cell carcinoma; PI3K pathway; PP2A; Ras pathway	MAMMALIAN TARGET; CANCER-THERAPY; SIGNALING PATHWAYS; GENE ALTERATIONS; AKT; INHIBITION; RAPAMYCIN; MTOR; ACTIVATION; HIF-1	Hypoxia-inducible factor-1 (HIF-1) is one of the most promising pharmacological targets for all types of cancer, including ovarian cancer. Ovarian clear cell carcinoma (OCCC) has poor prognosis because of its insensitivity to chemotherapy. To elucidate the characteristics of this troublesome cancer, we examined HIF-1 expression under normoxia or hypoxia in various ovarian cancer cell lines. HIF-1 was highly expressed under normoxia only in RMG-1, an OCCC cell line. To examine whether HIF-1 is involved in the tumorigenesis of RMG-1 cells, we established HIF-1-silenced cells, RMG-1HKD. The proliferation rate of RMG-1HKD cells was faster than that of RMG-1 cells. Furthermore, the activity of MEK/ERK in the Ras pathway increased in RMG-1HKD cells, whereas that of mTOR in the PI3K pathway did not change. Activation of the Ras pathway was attributable to the increase in phosphorylated MEK via PP2A inactivation. To confirm the crosstalk between the PI3K and Ras pathways in vivo, RMG-1 or RMG-1HKD cells were transplanted into the skin of nude mice with rapamycin (an inhibitor of mTOR), PD98059 (an inhibitor of MEK), or both. RMG-1HKD cells showed higher sensitivity to PD98059 than that observed in RMD-1 cells, whereas the combination therapy resulted in synergistic inhibition of both cells. These findings suggest that inhibition of HIF-1, a downstream target of mTOR in the PI3K pathway, activates the Ras pathway on account of the increase in MEK phosphorylation via PP2A inactivation, and the crosstalk between the 2 pathways could be applied in the combination therapy for HIF-1-overexpressing cancers such as OCCC.	[Takai, Masaaki; Tanabe, Akiko; Terai, Yoshito; Ohmichi, Masahide] Osaka Med Coll, Fac Med, Dept Obstet & Gynecol, Osaka, Japan; [Nakagawa, Takatoshi; Asahi, Michio] Osaka Med Coll, Fac Med, Dept Pharmacol, Osaka, Japan	Asahi, M (reprint author), Osaka Med Coll, Fac Med, Dept Pharmacol, Osaka, Japan.	masahi@art.osaka-med.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [24390384, 25670709, 22590297]	This work was supported by Grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology [24390384 and 25670709 to M.O. and 22590297 to M.A.].	Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/JCI34739, 10.1172/jCI34739]; Nakagawa T, 2013, J MEMBRANE BIOL, V246, P571, DOI 10.1007/s00232-013-9571-6; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/mrc839; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Tanaka Y, 2011, CANCER BIOL THER, V11, P50, DOI 10.4161/cbt.11.1.13877; Agani F, 2013, CURR CANCER DRUG TAR, V13, P245; Wang XR, 2008, CANCER RES, V68, P7409, DOI 10.1158/0008-5472.CAN-08-1522; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Li W, 2010, CANCER SCI, V101, P1226, DOI 10.1111/j.1349-7006.2010.01523.x; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; Huang SL, 2003, CANCER BIOL THER, V2, P222; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Hisamatsu T, 2013, MOL CANCER THER, V12, P1367, DOI 10.1158/1535-7163.MCT-12-1185; Mabuchi S, 2009, CLIN CANCER RES, V15, P5404, DOI 10.1158/1078-0432.CCR-09-0365; Matsumura N, 2010, CANCER SCI, V101, P2658, DOI 10.1111/j.1349-7006.2010.01736.x; Bae D, 2009, BIOCHEM BIOPH RES CO, V385, P523, DOI 10.1016/j.bbrc.2009.05.082; Fujisue Y, 2013, ONCOL LETT, V5, P1765, DOI 10.3892/ol.2013.1283; Fukukawa C, 2005, CANCER LETT, V226, P155, DOI 10.1016/j.canlet.2004.11.026; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Tsunetoh S, 2010, CANCER BIOL THER, V10, P1138, DOI 10.4161/cbt.10.11.13443; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200	35	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-4047	1555-8576		CANCER BIOL THER	Cancer Biol. Ther.	FEB	2015	16	2					325	335		10.1080/15384047.2014.1002362		11	Oncology	Oncology	CE2FZ	WOS:000351631200021		
J	Ono, K; Horie, T; Nishino, T; Baba, O; Kuwabara, Y; Yokode, M; Kita, T; Kimura, T				Ono, Koh; Horie, Takahiro; Nishino, Tomohiro; Baba, Osamu; Kuwabara, Yasuhide; Yokode, Masayuki; Kita, Toru; Kimura, Takeshi			MicroRNA-33a/b in Lipid Metabolism - Novel "Thrifty" Models	CIRCULATION JOURNAL			English	Review						High-density lipoprotein cholesterol; Lipid homeostasis; MicroRNA	ELEMENT-BINDING PROTEIN-1; DENSITY-LIPOPROTEIN; CHOLESTEROL HOMEOSTASIS; CIRCULATING MICRORNAS; EXPRESSION PROFILE; C-ELEGANS; MIR-33; ATHEROSCLEROSIS; DISEASE; LIVER	MicroRNAs (miRNAs; miRs) are small non-protein-coding RNAs that negatively regulate gene expression. They bind to the 3' UTR of specific mRNAs and either inhibit translation or promote mRNA degradation. There is emerging evidence linking miR-33a/b to lipid homoeostasis, targeting ABCA1, SREBF1, etc and it would appear that they have acted as "thrifty genes" during evolution to maintain cholesterol levels both at the cellular and whole body level. As we are now living in a period of "satiation", miR-33a/b no longer seem to be useful and could be potential therapeutic targets for lipid disorders and/or atherosclerosis. In this review, we describe the current understanding of the function of miR-33a/b in lipid homeostasis, focusing on the "thrifty" aspect.	[Ono, Koh; Horie, Takahiro; Nishino, Tomohiro; Baba, Osamu; Kuwabara, Yasuhide; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Inst Adv Clin & Translat Sci, Dept Cardiovasc Med, Kyoto 6068507, Japan; [Yokode, Masayuki] Kyoto Univ, Grad Sch Med, Inst Adv Clin & Translat Sci, Dept Clin Innovat Med, Kyoto 6068507, Japan; [Kita, Toru] Gen Hosp, Kobe City Med Ctr, Dept Cardiovasc Med, Kobe, Hyogo, Japan	Ono, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, 54 Shogoinkawahara Cho, Kyoto 6068507, Japan.	kohono@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Otsuka Pharmaceutical Co, Ltd. Kyoto University SRP Program; Banyu Life Science Foundation International; Takeda Memorial Foundation; Suzuken Memorial Foundation; Sakakibara Memorial Foundation; Japan Foundation of Applied Enzymology; SENSHIN Medical Research Foundation; Kowa Life Science Foundation; ONO Medical Research Foundation; Cell Science Research Foundation; Daiichi-Sankyo Foundation of Life Science	This work was supported in part by grants from the Japan Society for the Promotion of Science; by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. Kimura, T. Kita, K.H., T.H., and K.O.); by a Grant-in-Aid for Scientific Research on Innovative Areas "Crosstalk between transcriptional control and energy pathways, mediated by hub metabolites" (3307) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K.O.); by Otsuka Pharmaceutical Co, Ltd. Kyoto University SRP Program (to T. Kimura, T. Kita, M.Y., T.H., and K.O.); by grants from Banyu Life Science Foundation International, Takeda Memorial Foundation, Suzuken Memorial Foundation, Sakakibara Memorial Foundation, Japan Foundation of Applied Enzymology, SENSHIN Medical Research Foundation, Kowa Life Science Foundation, and ONO Medical Research Foundation (to T.H.); and by grants from ONO Medical Research Foundation, the Cell Science Research Foundation, Daiichi-Sankyo Foundation of Life Science, and Takeda Memorial Foundation (to K.O.).	Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Horie T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3883; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Rotllan N, 2013, ARTERIOSCL THROM VAS, V33, P1973, DOI 10.1161/ATVBAHA.113.301732; Munehira Y, 2004, J BIOL CHEM, V279, P15091, DOI 10.1074/jbc.M313436200; Marquart TJ, 2013, ARTERIOSCL THROM VAS, V33, P455, DOI 10.1161/ATVBAHA.112.300639; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Zhang B, 2013, CIRC J, V77, P2651, DOI 10.1253/circj.CJ-12-1584; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Moore KJ, 2010, TRENDS ENDOCRIN MET, V21, P699, DOI 10.1016/j.tem.2010.08.008; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Gerin I, 2010, J BIOL CHEM, V285, P33652, DOI 10.1074/jbc.M110.152090; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; Kuwabara Y, 2011, CIRC-CARDIOVASC GENE, V4, P446, DOI 10.1161/CIRCGENETICS.110.958975; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Widera C, 2011, J MOL CELL CARDIOL, V51, P872, DOI 10.1016/j.yjmcc.2011.07.011; Allen RM, 2012, EMBO MOL MED, V4, P882, DOI 10.1002/emmm.201201228; Brown MS, 2010, SCIENCE, V328, P1495, DOI 10.1126/science.1192409; Cheng AYY, 2006, CURR OPIN CARDIOL, V21, P400; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Hirayama A, 2014, CIRC J, V78, P1073, DOI 10.1253/circj.CJ-14-0130; Horie T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05312; Horie T, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003376; Horton JD, 1999, CURR OPIN LIPIDOL, V10, P143, DOI 10.1097/00041433-199904000-00008; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Matsue Y, 2013, CIRC J, V77, P1791, DOI 10.1253/circj.CJ-13-0033; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Norata GD, 2013, ATHEROSCLEROSIS, V227, P209, DOI 10.1016/j.atherosclerosis.2012.11.019; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rottiers V, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006840; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Zhang B, 2012, CIRC J, V76, P2241, DOI 10.1253/circj.CJ-12-0381	49	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					278	284		10.1253/circj.CJ-14-1252		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700008		
J	Nakazato, Y				Nakazato, Yuji			Reliability of Detecting High-Risk Patients With Fatal Ventricular Arrhythmias via Methods Using Cardiac Electrical Signals	CIRCULATION JOURNAL			English	Editorial Material							WAVE AMPLITUDE VARIABILITY; MYOCARDIAL-INFARCTION		Juntedo Univ, Urayasu Hosp, Dept Cardiol, Ctr Heart, Urayasu 2790021, Japan	Nakazato, Y (reprint author), Juntedo Univ, Urayasu Hosp, Dept Cardiol, Ctr Heart, 2-1-1 Tomioka, Urayasu 2790021, Japan.	ynkzt@juntendo-urayasu.jp					Yoshioka K, 2013, CIRC J, V77, P610, DOI 10.1253/circj.CJ-12-0932; MALIK M, 1990, CLIN CARDIOL, V13, P570; Bloomfield DM, 2002, J CARDIOVASC ELECTR, V13, P502, DOI 10.1046/j.1540-8167.2002.00502.x; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Hohnloser SF, 1988, J CARDIOVASC ELECTR, V9, P1258; Levitt K, 2014, J ELECTROCARDIOL, V47, P251, DOI 10.1016/j.jelectrocard.2013.12.007; Nakazato Y., 2000, Annals of Noninvasive Electrocardiology, V5, DOI 10.1111/j.1542-474X.2000.tb00379.x; SIMSON MB, 1981, CIRCULATION, V64, P235; Stojkovic S, 2015, CIRC J, V79, P318, DOI 10.1253/circj.CJ-14-1028; Tasic J, 2009, PACE, V32, pS155, DOI 10.1111/j.1540-8159.2008.02274.x; Zizek D, 2012, EUROPACE, V14, P1646, DOI 10.1093/europace/eus055	11	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					285	286		10.1253/circj.CJ-14-1366		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700009		
J	Goto, S; Goto, S				Goto, Shinichi; Goto, Shinya			How Can We Bridge the Results of Global Clinical Trials and Region/Country Specific Clinical Practice by Region/Country Specific Registry Data?	CIRCULATION JOURNAL			English	Editorial Material							NONVALVULAR ATRIAL-FIBRILLATION; JAPANESE PATIENTS; WARFARIN; ATHEROTHROMBOSIS; RIVAROXABAN; GUIDELINES; DABIGATRAN; DISEASE		[Goto, Shinichi; Goto, Shinya] Tokai Univ, Sch Med, Dept Med Cardiol, Isehara, Kanagawa 2591143, Japan	Goto, S (reprint author), Tokai Univ, Sch Med, Dept Med Cardiol, 143 Shimokasuya, Isehara, Kanagawa 2591143, Japan.	shinichi@is.icc.u-tokai.ac.jp					Ruff CT, 2014, INT J CARDIOL, V170, P413, DOI 10.1016/j.ijcard.2013.11.030; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Goto S, 2008, THROMB HAEMOSTASIS, V100, P611, DOI 10.1160/TH08-06-0388; Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.05.007; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI 10.1093/eurheartj/ehq278; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Roldan V, 2013, CHEST, V143, P179, DOI 10.1378/chest.12-0608; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615; Inoue H, 2013, CIRC J, V77, P2264, DOI 10.1253/circj.CJ-13-0290; FLEMING HA, 1971, POSTGRAD MED J, V47, P599; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022; Inoue H, 2014, CIRC J, V78, P1997, DOI 10.1253/circj.CJ-66-0092; Kodani E, 2015, CIRC J, V79, P325, DOI 10.1253/circj.CJ-14-1057; Levine GN, 2014, NAT REV CARDIOL, V11, P597, DOI 10.1038/nrcardio.2014.104	18	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					287	288		10.1253/circj.CJ-14-1319		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700010		
J	Mukoyama, M; Nakayama, Y; Adachi, M				Mukoyama, Masashi; Nakayama, Yushi; Adachi, Masataka			Renal Angioplasty for Atherosclerotic Renal Artery Stenosis Revisited - Efficacy and Safety of Renal Artery Stenting in the J-RAS Study	CIRCULATION JOURNAL			English	Editorial Material							PRACTICE GUIDELINES; TASK-FORCE; DISEASE; MANAGEMENT		[Mukoyama, Masashi; Nakayama, Yushi; Adachi, Masataka] Kumamoto Univ, Grad Sch Med Sci, Dept Nephrol, Kumamoto 8608556, Japan	Mukoyama, M (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Nephrol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	mmuko@kumamoto-u.ac.jp					Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Caielli P, 2015, NEPHROL DIAL TRANSPL, V30, P541, DOI 10.1093/ndt/gfu072; Anderson JL, 2013, CIRCULATION, V127, P1425, DOI 10.1161/CIR.0b013e31828b82aa; Safian RD, 2001, NEW ENGL J MED, V344, P431, DOI 10.1056/NEJM200102083440607; Bax L, 2009, ANN INTERN MED, V150, P840; Cooper CJ, 2014, NEW ENGL J MED, V370, P13, DOI 10.1056/NEJMoa1310753; Fujihara M, 2015, CIRC J, V79, P351, DOI 10.1253/circj.CJ-14-0908; Fujiwara H, 2013, CIRC J, V77, P1590, DOI 10.1253/circj.CJ-66-0065; Ogawa S, 2013, CIRC J, V77, P2816, DOI 10.1253/circj.CJ-13-0269; Preston RA, 1997, J HYPERTENS, V15, P1365, DOI 10.1097/00004872-199715120-00001; Rooke Thom W, 2013, J Am Coll Cardiol, V61, P1555, DOI 10.1016/j.jacc.2013.01.004; Shimamoto K, 2014, HYPERTENS RES, V37, P349; Textor SC, 2015, J HUM HYPERTENS, V29, P141, DOI 10.1038/jhh.2014.51; The ASTRAL Investigators, 2009, ANN ENGL J MED, V361, P1953	14	0	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					295	296		10.1253/circj.CJ-14-1361		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700013		
J	Kuga, K				Kuga, Keisuke			Prophylactic Implantation of Implantable Cardioverter-Defibrillator for Japanese Patients With Heart Failure - Problem of "Underuse"	CIRCULATION JOURNAL			English	Editorial Material							SUDDEN CARDIAC DEATH; PERCUTANEOUS CORONARY INTERVENTION; VENTRICULAR EJECTION FRACTION; ASSOCIATION TASK-FORCE; TERM-FOLLOW-UP; MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; AMERICAN-COLLEGE; REGISTRY; THERAPY		Univ Tsukuba, Dept Cardiol, Tsukuba, Ibaraki 3058575, Japan	Kuga, K (reprint author), Univ Tsukuba, Dept Cardiol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	kuga.keisuke.gp@u.tsukuba.ac.jp					Albert CM, 2013, CIRCULATION, V128, P1721, DOI 10.1161/CIRCULATIONAHA.113.005832; Chugh SS, 2004, J AM COLL CARDIOL, V44, P1268, DOI 10.1016/j.jacc.2004.06.029; Bonow RO, 2012, CIRCULATION, V125, P2382, DOI 10.1161/CIR.0b013e3182507bec; Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938; Hernandez AF, 2007, JAMA-J AM MED ASSOC, V298, P1525, DOI 10.1001/jama.298.13.1525; Narayanan K, 2013, CIRCULATION, V128, P1733, DOI 10.1161/CIRCULATIONAHA.113.002539; Fonarow GC, 2010, CIRCULATION, V122, P585, DOI 10.1161/CIRCULATIONAHA.109.934471; Myerburg RJ, 2001, J CARDIOVASC ELECTR, V12, P369, DOI 10.1046/j.1540-8167.2001.00369.x; Al-Khatib SM, 2012, CIRCULATION, V125, P1094, DOI 10.1161/CIRCULATIONAHA.111.066605; Zipes DP, 2006, EUROPACE, V8, P746, DOI 10.1093/europace/eul108; Ottervanger JP, 2007, AM J CARDIOL, V100, P793, DOI 10.1016/j.amjcard.2007.03.101; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Shiga T, 2009, HEART, V95, P216, DOI 10.1136/hrt.2008.145243; Hamaguchi S, 2009, CIRC J, V73, P2084; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Hohnloser SH, 1999, J AM COLL CARDIOL, V33, P1895, DOI 10.1016/S0735-1097(99)00108-4; JCS Joint Working Group, 2013, CIRC J, V77, P249; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Kuga K, 2014, CIRC J, V78, P2483, DOI 10.1253/circj.CJ-14-0301; Parkash R, 2012, CIRC-ARRHYTHMIA ELEC, V5, P706, DOI 10.1161/CIRCEP.112.970798; Reinier K, 2004, J AM COLL CARDIOL HE, V2, P221; Satake H, 2015, CIRC J, V79, P381, DOI 10.1253/circj.CJ-14-0925; Tanno K, 2005, CIRC J, V69, P19, DOI 10.1253/circj.69.19; Voigt A, 2004, J AM COLL CARDIOL, V44, P855, DOI 10.1016/j.jacc.2004.05.053	26	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					297	299		10.1253/circj.CJ-14-1394		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700014		
J	Izawa, H; Amano, T				Izawa, Hideo; Amano, Tetsuya			Plasma MicroRNA-100 as a Biomarker of Coronary Plaque Vulnerability - A New Generation of Biomarker for Developing Acute Coronary Syndrome	CIRCULATION JOURNAL			English	Editorial Material							BACKSCATTER INTRAVASCULAR ULTRASOUND; ARTERY-DISEASE		[Izawa, Hideo] Fujita Hlth Univ, Banbuntane Hotokukai Hosp, Dept Cardiol, Nagoya, Aichi, Japan; [Amano, Tetsuya] Aichi Med Univ, Dept Cardiol, Nagakute, Aichi 4801195, Japan	Amano, T (reprint author), Aichi Med Univ, Dept Cardiol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	amanot@aichi-med-u.ac.jp					Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Amano T, 2007, J AM COLL CARDIOL, V49, P1149, DOI 10.1016/j.jacc.2006.12.028; Guo M, 2010, IMMUNOL CELL BIOL, V88, P555, DOI 10.1038/icb.2010.16; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sano K, 2006, J AM COLL CARDIOL, V47, P734, DOI 10.1016/j.jacc.2005.09.061; Varnava AM, 2002, CIRCULATION, V105, P939, DOI 10.1161/hc0802.104327; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JC133099; De Rosa S, 2014, CIRC J, V78, P567, DOI 10.1253/circj.CJ-14-0086; Amano T, 2008, JACC-CARDIOVASC IMAG, V1, P39, DOI 10.1016/j.jcmg.2007.09.003; Funahashi H, 2011, J CARDIOL, V57, P338, DOI 10.1016/j.jjcc.2011.01.009; FUSTER V, 1992, NEW ENGL J MED, V326, P242; Long GW, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-178; Soeki T, 2015, CIRC J, V79, P413, DOI 10.1253/circj.CJ-14-0958	15	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					303	304		10.1253/circj.CJ-14-1295		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700016		
J	Takahashi, Y				Takahashi, Yoshihide			Perspectives on Catheter Ablation of Atrial Fibrillation	CIRCULATION JOURNAL			English	Editorial Material							CONGESTIVE-HEART-FAILURE; HYPERTROPHIC CARDIOMYOPATHY; EFFICACY; OUTCOMES; IMPACT; SAFETY		Disaster Med Ctr, Dept Cardiovasc Med, Tachikawa, Tokyo 1900014, Japan	Takahashi, Y (reprint author), Disaster Med Ctr, Dept Cardiovasc Med, 3256 Midoricho, Tachikawa, Tokyo 1900014, Japan.	yoshihide_takahashi@oboe.ocn.ne.jp					Aizawa Y, 2010, CIRC J, V74, P71, DOI 10.1253/circj.CJ-09-0367; Jones DG, 2013, J AM COLL CARDIOL, V61, P1894, DOI 10.1016/j.jacc.2013.01.069; Bunch TJ, 2008, J CARDIOVASC ELECTR, V19, P1009, DOI 10.1111/j.1540-8167.2008.01192.x; Machino-Ohtsuka T, 2013, J AM COLL CARDIOL, V62, P1857, DOI 10.1016/j.jacc.2013.07.020; Santangeli P, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1089, DOI 10.1161/CIRCEP.113.000339; Di Donna P, 2010, EUROPACE, V12, P347, DOI 10.1093/europace/euq013; Olivotto I, 2001, CIRCULATION, V104, P2517, DOI 10.1161/hc4601.097997; Fukuda T, 2007, CIRC J, V71, P308, DOI 10.1253/circj.71.308; Hsu LF, 2004, NEW ENGL J MED, V351, P2373, DOI 10.1056/NEJMoa041018; Okamatsu H, 2015, CIRC J, V79, P419, DOI 10.1253/circj.CJ-14-0823; Sherrid MV, 2005, J AM COLL CARDIOL, V45, P1251, DOI 10.1016/j.jacc.2005.01.012; Yasaka M, 2014, CIRC J, V78, P2367, DOI 10.1253/circj.CJ-14-0720	12	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					305	306		10.1253/circj.CJ-14-1363		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700017		
J	Toyoda, K				Toyoda, Kazunori			Is Anticoagulant Therapy Unnecessary for Lower-Risk Japanese Patients With Atrial Fibrillation? - Lessons From the SAMURAI-NVAF and BAT Studies	CIRCULATION JOURNAL			English	Editorial Material							FUSHIMI AF REGISTRY; J-RHYTHM REGISTRY; ANTITHROMBOTIC THERAPY; PREDICTING STROKE; BLEEDING EVENTS; CHA(2)DS(2)-VASC; THROMBOEMBOLISM; VALIDATION; SCORES		Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan	Toyoda, K (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	toyoda@ncvc.go.jp	Toyoda, Kazunori/J-3828-2015	Toyoda, Kazunori/0000-0002-8346-9845			Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Toyoda K, 2008, STROKE, V39, P1740, DOI 10.1161/STROKEAHA.107.504993; Okumura K, 2014, CIRC J, V78, P1593, DOI 10.1253/circj.CJ-14-0144; Akao M, 2013, J CARDIOL, V61, P260, DOI 10.1016/j.jjcc.2012.12.002; Toyoda K, 2010, STROKE, V41, P1440, DOI 10.1161/STROKEAHA.110.580506; Inoue H, 2013, CIRC J, V77, P2264, DOI 10.1253/circj.CJ-13-0290; Akao M, 2014, CIRC J, V78, P2166, DOI 10.1253/circj.CJ-14-0344; Inoue H, 2006, CIRC J, V70, P651, DOI 10.1253/circj.70.651; Suzuki S, 2011, J CARDIOL, V58, P116, DOI 10.1016/j.jjcc.2011.06.006; Olesen JB, 2012, CHEST, V141, P147, DOI 10.1378/chest.11-0862; Suzuki S, 2015, CIRC J, V79, P432, DOI 10.1253/circj.CJ-14-1131; Toyoda K, 2015, INT J STROKE, DOI [10.1111/ijs.12452, DOI 10.1111/IJS.12452]; Toyoda K, 2014, HYPERTENS RES, V37, P463, DOI 10.1038/hr.2013.150	14	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					307	309		10.1253/circj.CJ-14-1350		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700018		
J	Okamura, H; Kamakura, T; Morita, H; Tokioka, K; Nakajima, I; Wada, M; Ishibashi, K; Miyamoto, K; Noda, T; Aiba, T; Nishii, N; Nagase, S; Shimizu, W; Yasuda, S; Ogawa, H; Kamakura, S; Ito, H; Ohe, T; Kusano, KF				Okamura, Hideo; Kamakura, Tsukasa; Morita, Hiroshi; Tokioka, Koji; Nakajima, Ikutaro; Wada, Mitsuru; Ishibashi, Kohei; Miyamoto, Koji; Noda, Takashi; Aiba, Takeshi; Nishii, Nobuhiro; Nagase, Satoshi; Shimizu, Wataru; Yasuda, Satoshi; Ogawa, Hisao; Kamakura, Shiro; Ito, Hiroshi; Ohe, Tohru; Kusano, Kengo F.			Risk Stratification in Patients With Brugada Syndrome Without Previous Cardiac Arrest - Prognostic Value of Combined Risk Factors -	CIRCULATION JOURNAL			English	Article						Brugada syndrome; Electrophysiological study; Primary prevention; Risk stratification; Syncope	ST-SEGMENT ELEVATION; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; PROGRAMMED ELECTRICAL-STIMULATION; HEART-RHYTHM-SOCIETY; LONG-TERM PROGNOSIS; BUNDLE-BRANCH BLOCK; FOLLOW-UP; MULTICENTER; ELECTROCARDIOGRAM; INDIVIDUALS	Background: Risk stratification in patients with Brugada syndrome for primary prevention of sudden cardiac death is still an unsettled issue. A recent consensus statement suggested the indication of implantable cardioverter defibrillator (ICD) depending on the clinical risk factors present (spontaneous type 1 Brugada electrocardiogram (ECG) [Sp1], history of syncope [syncope], and ventricular fibrillation during programmed electrical stimulation [PES+]). The indication of ICD for the majority of patients, however, remains unclear. Methods and Results: A total of 218 consecutive patients (211 male; aged 46 +/- 13 years) with a type 1 Brugada ECG without a history of cardiac arrest who underwent evaluation for ICD including electrophysiological testing were examined retrospectively. During a mean follow-up period of 78 months, 26 patients (12%) developed arrhythmic events. On Kaplan-Meier analysis patients with each of Sp1, syncope, or PES+ suffered arrhythmic events more frequently (P=0.018, P<0.001, and P=0.003, respectively). On multivariate analysis Sp1 and syncope were independent predictors of arrhythmic events. When dividing patients according to the number of these 3 risk factors present, patients with 2 or 3 risk factors experienced arrhythmic events more frequently than those with 0 or 1 risk factor (23/93 vs. 3/125; P<0.001). Conclusions: Syncope, Sp1, and PES+ are important risk factors and the combination of these risks well stratify the risk of later arrhythmic events.	[Okamura, Hideo; Kamakura, Tsukasa; Nakajima, Ikutaro; Wada, Mitsuru; Ishibashi, Kohei; Miyamoto, Koji; Noda, Takashi; Aiba, Takeshi; Yasuda, Satoshi; Ogawa, Hisao; Kamakura, Shiro; Kusano, Kengo F.] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan; [Okamura, Hideo; Miyamoto, Koji; Shimizu, Wataru; Yasuda, Satoshi; Kusano, Kengo F.] Kumamoto Univ, Dept Adv Cardiovasc Med, Grad Sch Med Sci, Kumamoto, Japan; [Ogawa, Hisao] Kumamoto Univ, Dept Cardiovasc Med, Grad Sch Med Sci, Kumamoto, Japan; [Morita, Hiroshi; Tokioka, Koji; Nishii, Nobuhiro; Nagase, Satoshi; Ito, Hiroshi; Ohe, Tohru; Kusano, Kengo F.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama 7008530, Japan; [Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo 113, Japan	Kusano, KF (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	kusanokengo@hotmail.com			Ministry of Health, Labor, and Welfare [H24-033]	This work was supported by a research grant for the cardiovascular diseases (grant number H24-033) from the Ministry of Health, Labor, and Welfare.	Priori SG, 2012, J AM COLL CARDIOL, V59, P37, DOI 10.1016/j.jacc.2011.08.064; Probst V, 2010, CIRCULATION, V121, P635, DOI 10.1161/CIRCULATIONAHA.109.887026; Fauchier L, 2013, INT J CARDIOL, V168, P3027, DOI 10.1016/j.ijcard.2013.04.146; Shimizu W, 2000, J CARDIOVASC ELECTR, V11, P396, DOI 10.1111/j.1540-8167.2000.tb00334.x; Priori SG, 2002, CIRCULATION, V105, P1342, DOI 10.1161/hc1102.105288; Yamawake N, 2014, CIRC J, V78, P360, DOI 10.1253/circj.CJ-13-0576; Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Kum LCC, 2002, PACE, V25, P1660, DOI 10.1046/j.1460-9592.2002.01660.x; Brugada J, 2002, CIRCULATION, V105, P73, DOI 10.1161/hc0102.101354; Takigawa M, 2008, HEART RHYTHM, V5, P1523, DOI 10.1016/j.hrthm.2008.08.022; Delise P, 2011, EUR HEART J, V32, P169, DOI 10.1093/eurheartj/ehq381; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391; Sarkozy A, 2007, EUR HEART J, V28, P334, DOI 10.1093/eurheartj/ehl450; Makimoto H, 2012, HEART RHYTHM, V9, P242, DOI 10.1016/j.hrthm.2011.09.053; Sacher F, 2013, CIRCULATION, V128, P1739, DOI 10.1161/CIRCULATIONAHA.113.001941; Epstein AE, 2013, CIRCULATION, V127, pE283, DOI 10.1161/CIR.0b013e318276ce9b; Kamakura S, 2009, CIRC-ARRHYTHMIA ELEC, V2, P495, DOI 10.1161/CIRCEP.108.816892; Takagi M, 2014, HEART RHYTHM, V11, P1716, DOI [10.1016/j.hrthm.2014.06.033, 10.1016/j.hrthm2014.06033]; Ariyarajah V, 2008, J ELECTROCARDIOL, V41, P302, DOI 10.1016/j.jelectrocard.2007.11.003; JCS Joint Working Group, 2013, CIRC J, V77, P249; Nademanee Koonlawee, 1997, American Journal of Cardiology, V79, P10, DOI 10.1016/S0002-9149(97)00113-6; Porres JM, 2002, PACE, V25, P1646, DOI 10.1046/j.1460-9592.2002.01646.x; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014	23	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					310	+		10.1253/circj.CJ-14-1059		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700019		
J	Kodani, E; Atarashi, H; Inoue, H; Okumura, K; Yamashita, T				Kodani, Eitaro; Atarashi, Hirotsugu; Inoue, Hiroshi; Okumura, Ken; Yamashita, Takeshi		J-RHYTHM Registry Investigators	Target Intensity of Anticoagulation With Warfarin in Japanese Patients With Valvular Atrial Fibrillation - Subanalysis of the J-RHYTHM Registry -	CIRCULATION JOURNAL			English	Article						Anticoagulation; Atrial fibrillation; International normalized ratio; Valvular disease; Warfarin	HEART-VALVE PROSTHESES; RISK-FACTORS; THERAPY; PREVENTION; GUIDELINES; MANAGEMENT; EVENTS; STROKE	Background: Warfarin is widely used for prevention of thromboembolism in patients with valvular atrial fibrillation (AF), and an international normalized ratio (INR) of prothrombin time between 2.0 and 3.0 is recommended. Optimal intensity of anticoagulation with warfarin in Japanese patients with valvular AF, however, has not been clarified thoroughly as yet. Methods and Results: We evaluated the status of anti-thrombotic therapy and incidence rates of events in 410 patients with mitral stenosis and/or mechanical valve replacement (valvular AF) among 7,816 patients with AF followed in the J-RHYTHM Registry. Patients were divided into 5 groups based on INR (<1.6, 1.6-1.99, 2.0-2.59, 2.6-2.99, and >= 3.0) at the time of event or at the end of follow-up in order to determine the target INR for patients with valvular AF. Warfarin was prescribed in 407 (99.3%) of valvular AF patients. During a 2-year follow-up period, thromboembolism and major hemorrhage occurred in 12 (2.9%) and in 15 (3.7%) patients, respectively. Among patients receiving warfarin, 2-year incidence rates of thromboembolism were 10.3%, 1.6%, 0.6%, 3.0%, and 0.0% (P=0.003 for trend), and those of major hemorrhage were 1.5%, 1.6%, 3.2%, 6.1%, and 21.1% (P<0.001 for trend), respectively. Conclusions: INR between 1.6 and 2.6 could be optimal to prevent thromboembolism without increasing major hemorrhage in Japanese patients with valvular AF. INR 2.6-2.99 would also be effective, but is associated with a modestly increased risk of major hemorrhage.	[Kodani, Eitaro; Atarashi, Hirotsugu] Tama Nagayama Hosp, Nippon Med Sch, Dept Internal Med & Cardiol, Tama Ku, Tokyo 2068512, Japan; [Inoue, Hiroshi] Toyama Univ, Grad Sch Med, Dept Internal Med 2, Toyama 930, Japan; [Okumura, Ken] Hirosaki Univ, Grad Sch Med, Dept Cardiol Respira Med & Nephrol, Aomori, Japan; [Yamashita, Takeshi] Cardiovasc Inst, Tokyo, Japan	Kodani, E (reprint author), Tama Nagayama Hosp, Nippon Med Sch, Dept Internal Med & Cardiol, Tama Ku, 1-7-1 Nagayama, Tokyo 2068512, Japan.	kodani@nms.ac.jp			Japan Heart Foundation; Boehringer Ingelheim; Bayer Healthcare; Daiichi-Sankyo; Pfizer; Bristol-Myers Squibb; Eisai	The J-RHYTHM registry was supported by a grant from Japan Heart Foundation. Co-authors have potential conflict of interest: Dr Atarashi received research funding from Boehringer Ingelheim, and remuneration from Bayer Healthcare, Boehringer Ingelheim, and Daiichi-Sankyo; Dr Inoue received research funding from Boehringer Ingelheim and Daiichi-Sankyo, and remuneration from Daiichi-Sankyo, Bayer Healthcare, and Boehringer Ingelheim; Dr Okumura received research funding from Boehringer Ingelheim and Daiichi-Sankyo, and remuneration from Boehringer Ingelheim, Bayer Healthcare, Daiichi-Sankyo, and Pfizer; Dr Yamashita received research funding from Boehringer Ingelheim and Daiichi-Sankyo, and remuneration from Boehringer Ingelheim, Daiichi-Sankyo, Bayer Healthcare, Pfizer, Bristol-Myers Squibb, and Eisai.	Atarashi H, 2011, CIRC J, V75, P1328, DOI 10.1253/circj.CJ-10-1119; CANNEGIETER SC, 1994, CIRCULATION, V89, P635; Johnson JA, 2008, CIRCULATION, V118, P1383, DOI 10.1161/CIRCULATIONAHA.107.704023; Sun JCJ, 2009, LANCET, V374, P565, DOI 10.1016/S0140-6736(09)60780-7; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Matsuyama K, 2002, CIRC J, V66, P668, DOI 10.1253/circj.66.668; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Inoue H, 2013, CIRC J, V77, P2264, DOI 10.1253/circj.CJ-13-0290; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Akao M, 2014, CIRC J, V78, P2166, DOI 10.1253/circj.CJ-14-0344; Inoue H, 2006, CIRC J, V70, P651, DOI 10.1253/circj.70.651; Suzuki S, 2007, CIRC J, V71, P761, DOI 10.1253/circj.71.761; Atarashi H, 2011, J CARDIOL, V57, P95, DOI 10.1016/j.jjcc.2010.09.002; WOLF PA, 1991, STROKE, V22, P983; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Ogawa S, 2010, CIRC J, V74, P2479, DOI 10.1253/circj.CJ-88-0001; Inoue H, 2011, CIRC J, V75, P2357, DOI 10.1253/circj.CJ-11-0427; Mori Takanobu, 2002, Ann Thorac Cardiovasc Surg, V8, P83; Stassano P, 2009, J AM COLL CARDIOL, V54, P1862, DOI 10.1016/j.jacc.2009.07.032; Torn M, 2009, ARCH INTERN MED, V169, P1203, DOI 10.1001/archinternmed.2009.176	22	3	3	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					325	+		10.1253/circj.CJ-14-1057		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700021		
J	Senoo, K; Lau, YC; Dzeshka, M; Lane, D; Okumura, K; Lip, GYH				Senoo, Keitaro; Lau, Yee Cheng; Dzeshka, Mikhail; Lane, Deirdre; Okumura, Ken; Lip, Gregory Y. H.			Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation - Meta-Analysis -	CIRCULATION JOURNAL			English	Article						Atrial fibrillation; Japanese; Meta-analysis; Non-vitamin K antagonist oral anticoagulant; Stroke prevention	J-RHYTHM REGISTRY; DABIGATRAN; RISK; RIVAROXABAN; THERAPY; TRIALS; AF	Background: Non-vitamin K antagonist oral anticoagulants (NOAC) have been developed as alternatives to warfarin. Until recently, the latter was the standard oral anticoagulant for patients with non-valvular atrial fibrillation (NVAF). The efficacy and safety of NOAC in Japanese patients with NVAF has been investigated in small trials or subgroups from global randomized control trials (RCT). Methods and Results: We conducted a systematic review and meta-analysis of RCT, to compare the efficacy and safety of NOAC to those of warfarin in Japanese patients with NVAF. Published research was systematically searched for RCT that compared NOAC to warfarin in Japanese patients with NVAF. Random-effects models were used to pool efficacy and safety data across RCT. Three studies, involving 1,940 patients, were identified. Patients randomized to NOAC had a decreased risk for stroke and systemic thromboembolism (relative risk [RR], 0.45; 95% CI: 0.24-0.85), with a non-significant trend for lower major bleeding (RR, 0.66; 95% CI: 0.29-1.47), intracranial bleeding (RR, 0.46; 95% CI: 0.18-1.16) and gastrointestinal bleeding (RR, 0.52; 95% CI: 0.25-1.08). Conclusions: NOAC are more efficacious than warfarin for the prevention of stroke and systemic embolism in Japanese patients with NVAF. The present findings offer clinicians a more comprehensive picture of NOAC as a therapeutic option to reduce the risk of stroke in Japanese NVAF patients.	[Senoo, Keitaro; Lau, Yee Cheng; Dzeshka, Mikhail; Lane, Deirdre; Lip, Gregory Y. H.] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham B18 7QH, W Midlands, England; [Dzeshka, Mikhail] Grodno State Med Univ, Grodno, Byelarus; [Okumura, Ken] Hirosaki Univ, Grad Sch Med, Dept Cardiol, Hirosaki, Aomori, Japan; [Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark	Lip, GYH (reprint author), Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham B18 7QH, W Midlands, England.	g.y.h.lip@bham.ac.uk			Boehringer Ingelheim; Bayer Healthcare; Daiichi-Sankyo; Bristol-Myers-Squibb	Grant: None. Conflict of Interest: Keitaro Senoo, grantee of NIHON KOHDEN/St. Jude Medical Arrhythmia Fellowship; Yee Cheng Lau, nothing to disclose; Mikhail Dzeshka, grantee of EHRA Academic Fellowship programme; Deirdre A Lane, investigator-initiated educational grant from Boehringer Ingelheim and honoraria from Boehringer Ingelheim, Bristol-Myers-Squibb/Pfizer and Bayer for lectures at educational meetings (Dr Lane is also on the Steering Committee of a Phase IV clinical trial sponsored by Bristol-Myers-Squibb); Ken Okumura, research funding from Boehringer Ingelheim, Bayer Healthcare, and Daiichi-Sankyo; speakers' bureau/honorarium from Boehringer Ingelheim, Bayer Healthcare, Bristol-Myers Squibb, Pfizer, and Eisai; Gregory Y.H. Lip, consultant for Bayer, Astellas, Merck, AstraZeneca, Sanofi Aventis, Biotronik, BMS/Pfizer, Daiichi-Sankyo, Medtronic and Boehringher Ingelheim; speakers' bureau for Bayer, BMS/Pfizer, Boehringher Ingelheim, Daiichi-Sankyo, Medtronic and Sanofi Aventis.	Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Atarashi H, 2011, CIRC J, V75, P1328, DOI 10.1253/circj.CJ-10-1119; Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454; Okumura K, 2011, CIRC J, V75, P2087, DOI 10.1253/circj.CJ-11-0350; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hori M, 2011, CIRC J, V75, P800, DOI 10.1253/circj.CJ-11-0191; Chiang CE, 2014, THROMB HAEMOSTASIS, V111, P789, DOI 10.1160/TH13-11-0948; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Inoue H, 2013, CIRC J, V77, P2264, DOI 10.1253/circj.CJ-13-0290; Akao M, 2014, CIRC J, V78, P2166, DOI 10.1253/circj.CJ-14-0344; Naganuma M, 2012, THROMB RES, V130, P21, DOI 10.1016/j.thromres.2011.11.005; Hori M, 2013, STROKE, V44, P1891, DOI 10.1161/STROKEAHA.113.000990; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Bristol-Myers K.K, COMMON TECHNICAL DOC; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; JCS Joint Working Group, 2013, GUID PHARM ATR FIBR; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006	23	4	5	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					339	345		10.1253/circj.CJ-14-1042		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700023		
J	Ichihara, N; Miyazaki, S; Taniguchi, H; Usui, E; Takagi, T; Iwasawa, J; Kuroi, A; Nakamura, H; Hachiya, H; Iesaka, Y				Ichihara, Noboru; Miyazaki, Shinsuke; Taniguchi, Hiroshi; Usui, Eisuke; Takagi, Takamitsu; Iwasawa, Jin; Kuroi, Akio; Nakamura, Hiroaki; Hachiya, Hitoshi; Iesaka, Yoshito			Simple Minimal Sedation for Catheter Ablation of Atrial Fibrillation	CIRCULATION JOURNAL			English	Article						Atrial fibrillation; Catheter ablation; Sedation	CONSECUTIVE PATIENTS; CONSCIOUS SEDATION; PULMONARY VEINS; FOLLOW-UP; ANESTHESIA	Background: Deep sedation or general anesthesia is generally used during atrial fibrillation (AF) ablation. The aim of this study was to report the safety and feasibility of minimal sedation during AF ablation. Methods and Results: One thousand and fifty-two AF ablation procedures in 819 patients (62 +/- 11 years, 621 men, 506 paroxysmal) were included. Boluses of intravenous hydroxyzine pamoate and pentazocine were administered, with a maximal dose of 100 mg of hydroxyzine and 60 mg of pentazocine in response to pain. If the pain was intolerable or patients requested deeper sedation, moderate sedation using dexmedetomidine or propofol was introduced. Among 819 consecutive first procedures, the procedure was completed under minimal sedation in 795 (97.1%) patients without inotropic drugs or respiratory support, whereas in 20 (2.4%) patients, anesthesia was switched to moderate sedation due to pain. Patients requiring a switch to moderate sedation were significantly younger than those without (53.6 +/- 2.3 vs. 62.6 +/- 10.4, P<0.01). No procedures were abandoned due to adverse effects of sedation. Significant intra-procedural blood pressure decreases requiring inotropic drugs were not observed in any patients. Among 233 patients who underwent repeat procedures, 6 (2.6%) requested moderate sedation before the procedure. The mean procedure time was 151 +/- 54 min. Cardiac tamponade, unrelated to sedation, was observed in 7 (0.66%) procedures. Conclusions: Minimal sedation might be acceptable anesthesia in the vast majority of AF ablation procedures performed in electrophysiological laboratories.	[Ichihara, Noboru; Miyazaki, Shinsuke; Taniguchi, Hiroshi; Usui, Eisuke; Takagi, Takamitsu; Iwasawa, Jin; Kuroi, Akio; Nakamura, Hiroaki; Hachiya, Hitoshi; Iesaka, Yoshito] Tsuchiura Kyodo Gen Hosp, Cardiovasc Ctr, Tsuchiura, Ibaraki 3000053, Japan	Miyazaki, S (reprint author), Tsuchiura Kyodo Gen Hosp, Cardiovasc Ctr, Div Cardiol, 11-7 Manabeshin Machi, Tsuchiura, Ibaraki 3000053, Japan.	mshinsuke@k3.dion.ne.jp					American Society of Anesthesiologists Committee on Quality Management and Departmental Administration, 2009, CONT DEPTH SED DEF G; Lu F, 2013, J CARDIOVASC ELECTR, V24, P237, DOI 10.1111/jce.12001; Kottkamp H, 2011, J CARDIOVASC ELECTR, V22, P1339, DOI 10.1111/j.1540-8167.2011.02120.x; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Miyazaki S, 2013, CIRC J, V77, P352, DOI 10.1253/circj.CJ-12-0951; Di Biase L, 2009, CIRC-ARRHYTHMIA ELEC, V2, P108, DOI 10.1161/CIRCEP.108.815266; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Miyazaki S, 2011, HEART, V97, P668, DOI 10.1136/hrt.2009.186874; Cervigon R, 2013, PACE, V36, P1176, DOI 10.1111/pace.12137; Hachiya H, 2007, J CARDIOVASC ELECTR, V18, P1; Miyazaki S, 2013, HEART RHYTHM, V10, P338, DOI 10.1016/j.hrthm.2012.11.025; Miyazaki S, 2013, CIRC J, V78, P78; Nakagawa H, 2007, HEART RHYTHM, V14, pS61; Powell CG, 1998, ANAESTH INTENS CARE, V26, P107; Salukhe TV, 2012, EUROPACE, V14, P325, DOI 10.1093/europace/eur328; Takagi T, 2014, CIRC J, V78, P2637, DOI 10.1253/circj.CJ-14-0610; Takahashi A, 2002, CIRCULATION, V105, P2998, DOI 10.1161/01.CIR.0000019585.91146.AB; Uchiyama T, 2013, CIRC J, V77, P2722, DOI 10.1253/circj.CJ-13-0468	18	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					346	350		10.1253/circj.CJ-14-1106		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700024		
J	Fujihara, M; Yokoi, Y; Abe, T; Soga, Y; Yamashita, T; Miyashita, Y; Nakamura, M; Yokoi, H; Ito, S				Fujihara, Masahiko; Yokoi, Yoshiaki; Abe, Takaaki; Soga, Yoshimitsu; Yamashita, Takehiro; Miyashita, Yusuke; Nakamura, Masato; Yokoi, Hiroyoshi; Ito, Sadayoshi		J-RAS Study Investigators	Clinical Outcome of Renal Artery Stenting for Hypertension and Chronic Kidney Disease up to 12 Months in the J-RAS Study - Prospective, Single-Arm, Multicenter Clinical Study -	CIRCULATION JOURNAL			English	Article						Atherosclerotic renal artery stenosis; Chronic kidney disease; Hypertension; Renal artery stenting	DUPLEX ULTRASOUND PARAMETERS; BLOOD-PRESSURE RESPONSE; FRACTIONAL FLOW RESERVE; MEDICAL THERAPY; STENOSIS; TRIAL; ANGIOGRAPHY; PLACEMENT; SOCIETY; REVASCULARIZATION	Background: Atherosclerotic renal artery stenosis (ARAS) causes renovascular hypertension (HTN) and impairs renal function, leading to chronic kidney disease (CKD). The J-RAS study was a prospective, multicenter study to assess the clinical outcome of renal artery stenting for up to 1 year in Japanese patients with ARAS. Methods and Results: One hundred and forty-nine patients were enrolled between November 2010 and January 2013. The patients were classified into an HTN (n=121) group and a CKD (n=108) group in the primary analysis. The primary efficacy endpoints were change in blood pressure for the HTN group and change in estimated glomerular filtration rate (eGFR) for the CKD group at 1 months. The primary safety endpoint was freedom from major cardiovascular or renal events at 12 months. In the HTN group, the mean systolic blood pressure (SBP) significantly decreased from 161.6 +/- 21 mmHg at baseline to 137.0 +/- 21 mmHg (P<0.0001). In the CKD group, there was no significant difference in eGFR from 40.7 +/- 10 ml.min(-1).1.73 m(-2) at baseline to 40.8 +/- 13 ml.min(-1).1.73 m(-2) (P=0.32). The primary safety endpoint was 89.4% at 12 months. Conclusions: In the J-RAS trial, significant SBP reduction was seen in the HTN group, and stabilization of renal function in the CKD group. Renal artery stenting for ARAS is safe and effective in Japanese patients.	[Fujihara, Masahiko; Yokoi, Yoshiaki] Kishiwada Tokushukai Hosp, Cardiovasc Ctr, Kishiwada 5968522, Japan; [Abe, Takaaki; Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Soga, Yoshimitsu] Kokura Mem Hosp, Kitakyushu, Fukuoka, Japan; [Yamashita, Takehiro] Hokkaido Ohno Hosp, Cardiovasc Ctr, Sapporo, Hokkaido, Japan; [Miyashita, Yusuke] Shinshu Univ Hosp, Matsumoto, Nagano, Japan; [Nakamura, Masato] Toho Univ, Ohashi Med Ctr, Tokyo, Japan; [Yokoi, Hiroyoshi] Fukuoka Sanno Hosp, Fukuoka, Japan	Fujihara, M (reprint author), Kishiwada Tokushukai Hosp, Dept Cardiol, 4-27-1 Kamori Cho, Kishiwada 5968522, Japan.	masahiko-fujihara@themis.ocn.ne.jp			Cordis Japan; Johnson and Johnson Company	Conflict of Interest: The authors have no commercial, proprietary, or financial interest in any products or companies described in this article. Grant Sponsor: Cordis Japan, Johnson and Johnson Company.	AbuRahma AF, 2012, J VASC SURG, V56, P1052, DOI 10.1016/j.jvs.2012.03.036; Hansen K, 2012, J VASC SURG, V56, P1059; AbuRahma AF, 2012, J VASC SURG, V56, pe1; AbuRahma AF, 2012, J VASC SURG, V56, P1060; Ando Yasuhiro, 2009, Clin Exp Nephrol, V13, P191, DOI 10.1007/s10157-009-0163-9; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Jaff MR, 2012, CATHETER CARDIO INTE, V80, P343, DOI 10.1002/ccd.24449; Drieghe B, 2008, EUR HEART J, V29, P517, DOI 10.1093/eurheartj/ehm631; Leertouwer TC, 2000, RADIOLOGY, V216, P78; Radermacher J, 2001, NEW ENGL J MED, V344, P410, DOI 10.1056/NEJM200102083440603; Leesar MA, 2009, J AM COLL CARDIOL, V53, P2363, DOI 10.1016/j.jacc.2009.03.031; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; OLIN JW, 1995, ANN INTERN MED, V122, P833; Cianci R, 2013, EUR REV MED PHARMACO, V17, P507; Safian RD, 2001, NEW ENGL J MED, V344, P431, DOI 10.1056/NEJM200102083440607; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Bax L, 2009, ANN INTERN MED, V150, P840; Bax L, 2009, ANN INTERN MED, V150, pW150; Cooper CJ, 2014, NEW ENGL J MED, V370, P13, DOI 10.1056/NEJMoa1310753; Dworkin LD, 2009, NEW ENGL J MED, V361, P1972, DOI 10.1056/NEJMcp0809200; Wheatley K, 2009, NEW ENGL J MED, V361, P1953; Kadziela J, 2013, CARDIOL J, V20, P418, DOI 10.5603/CJ.2013.0101; Levin A, 2007, AM J NEPHROL, V27, P212, DOI 10.1159/000101000; Mitchell JA, 2007, CATHETER CARDIO INTE, V69, P685, DOI 10.1002/ccd.21095; Miura T, 2013, CIRC J, V77, P89, DOI 10.1253/circj.CJ-12-0535; Ogawa S, 2013, CIRC J, V77, P2816, DOI 10.1253/circj.CJ-13-0269; Rocha-Singh K, 2008, CATHETER CARDIO INTE, V72, P853, DOI 10.1002/ccd.21749; Rocha-Singh KJ, 2011, CATHETER CARDIO INTE, V78, P779, DOI 10.1002/ccd.23055; Sapoval M, 2010, CARDIOVASC INTER RAD, V33, P475, DOI 10.1007/s00270-009-9733-1; Sapoval M, 2005, J VASC INTERV RADIOL, V16, P1195, DOI 10.1097/01.RVI.0000171765.67665.D3; Schwarzwalder U, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-60; Silva JA, 2005, CIRCULATION, V111, P328, DOI 10.1161/01.CIR.0000153271.77341.9F; Staub D, 2010, EUR J VASC ENDOVASC, V40, P599, DOI 10.1016/j.ejvs.2010.07.013	33	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					351	359		10.1253/circj.CJ-14-0908		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700025		
J	Martin, ST; Kato, TS; Farr, M; McKeen, JT; Cheema, F; Ji, MX; Ross, A; Yerebakan, H; Naka, Y; Takayama, H; Restaino, S; Mancini, D; Schulze, C				Martin, Spencer T.; Kato, Tomoko S.; Farr, Maryjane; McKeen, Jaclyn T.; Cheema, Faisal; Ji, Mengxi; Ross, Alexandra; Yerebakan, Halit; Naka, Yoshifumi; Takayama, Hiroo; Restaino, Susan; Mancini, Donna; Schulze, Christian			Similar Survival in Patients Following Heart Transplantation Receiving Induction Therapy Using Daclizumab vs. Basiliximab	CIRCULATION JOURNAL			English	Article						Heart transplantation; Immunosuppressant; Induction therapy; Prognosis	RENAL-TRANSPLANTATION; INTERNATIONAL SOCIETY; CARDIAC TRANSPLANTATION; IMMUNOSUPPRESSIVE DRUGS; REJECTION; REGISTRY; INTERLEUKIN-2-RECEPTOR; RECIPIENTS; BLOCKADE	Background: Induction therapy with interleukin-2 receptor antagonists has been established as an effective immunosuppressive strategy in the management of heart transplant (HTx) recipients. We compared outcomes following HTx in patients receiving basiliximab, daclizumab, or no induction therapy. Methods and Results: We investigated post-transplant prognosis of patients receiving basiliximab (n=67), daclizumab (n=98) or no induction therapy (n=70). Patients treated with daclizumab (50.3 +/- 14.7 years) were younger than those receiving basiliximab (55.8 +/- 11.2 years) or no induction therapy (54.9 +/- 14.1 years; both P<0.05). Patients receiving either induction therapy showed better survival 1 year after HTx (95%) than those without induction therapy (82%; P<0.001). Survival was similar between patients receiving basiliximab and daclizumab. The incidence of acute cellular or antibody-mediated rejections did not differ among the groups. The main reason that patients did not receive induction therapy was ongoing infection (65.7%), which was more common in patients on ventricular assist device (VAD) support than those without VAD (76.1% vs. 45.8%; P=0.004). The VAD-related infection rate in the entire study cohort was 29.7% (35/118 VAD recipients). Conclusions: Survival following HTx was worse in patients not receiving induction therapy. No differences were noted in survival or the incidence of rejection between the daclizumab- and basiliximab-treated groups. Induction therapy was less used in patients with infection, which was related to prior VAD support.	[Martin, Spencer T.] Hartford Hosp, Dept Pharm, Hartford, CT 06115 USA; [Kato, Tomoko S.] Juntendo Univ, Sch Med, Tokyo 113, Japan; [Kato, Tomoko S.; Farr, Maryjane; Ji, Mengxi; Ross, Alexandra; Restaino, Susan; Mancini, Donna; Schulze, Christian] Columbia Univ, Dept Med, Div Cardiol, Med Ctr, New York, NY USA; [Cheema, Faisal; Yerebakan, Halit; Naka, Yoshifumi; Takayama, Hiroo] Columbia Univ, Dept Surg, Div Cardiothorac Surg, Med Ctr, New York, NY USA; [McKeen, Jaclyn T.] Hackensack Med Ctr, Dept Pharm, Hackensack, NJ 07604 USA	Kato, TS (reprint author), Juntendo Univ, Sch Med, Bunkyo Ku, Bldg 9,1F Room124A,2-1-1 Hongo, Tokyo 1138431, Japan.	rinnko@sannet.ne.jp			National Institutes of Health (NIH) [K23HL095742-01, P30HL101272-01]; Irving Institute of Clinical and Translational Research of Columbia University; National Center for Advancing Translational Sciences through NIH [UL1 TR000040]	Dr Schulze was supported by grants from the National Institutes of Health (NIH; K23HL095742-01, P30HL101272-01) and the Irving Institute of Clinical and Translational Research of Columbia University. Dr Kato was supported by the National Center for Advancing Translational Sciences, through the NIH (UL1 TR000040). All other authors have no disclosures to report.	Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Gabardi S, 2011, AM J HEALTH-SYST PH, V68, P211, DOI 10.2146/ajhp090636; Kato TS, 2010, EUR J CARDIO-THORAC, V37, P1104, DOI 10.1016/j.ejcts.2009.11.037; Toyoda Y, 2013, CIRC J, V77, P1097, DOI 10.1253/circj.CJ-13-0296; Dipchand AI, 2013, J HEART LUNG TRANSPL, V32, P979, DOI 10.1016/j.healun.2013.08.005; Lin MZ, 2006, CLIN TRANSPLANT, V20, P325, DOI 10.1111/j.1399-0012.2005.00488.x; Hershberger RE, 2005, NEW ENGL J MED, V352, P2705, DOI 10.1056/NEJMoa032953; Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034; Beniaminovitz A, 2000, NEW ENGL J MED, V342, P613, DOI 10.1056/NEJM200003023420902; Nair MP, 2001, TRANSPLANT P, V33, P2767, DOI 10.1016/S0041-1345(01)02184-4; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Cha MJ, 2013, CIRC J, V77, P2056, DOI 10.1253/circj.CJ-12-1269; Vincenti F, 1998, NEW ENGL J MED, V338, P161, DOI 10.1056/NEJM199801153380304; Stehlik J, 2011, J HEART LUNG TRANSPL, V30, P1078, DOI 10.1016/j.healun.2011.08.003; Baran DA, 2011, CIRC-HEART FAIL, V4, P129, DOI 10.1161/CIRCHEARTFAILURE.110.958520; Mehra MR, 2005, J HEART LUNG TRANSPL, V24, P1297, DOI 10.1016/j.healun.2004.09.010; Ensor CR, 2009, PROG TRANSPLANT, V19, P333; Kandus A, 2010, TRANSPLANTATION, V89, P1022, DOI 10.1097/TP.0b013e3181d02496; Kobashigawa J, 2005, TRANSPLANT P, V37, P1333, DOI 10.1016/j.transproceed.2004.12.135; Lindenfeld JA, 2004, CIRCULATION, V110, P3734, DOI 10.1161/01.CIR.0000149745.83186.89; Ueno T, 2012, CIRC J, V76, P752, DOI 10.1253/circj.CJ-11-1001	21	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					368	374		10.1253/circj.CJ-14-0718		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700027		
J	Satake, H; Fukuda, K; Sakata, Y; Miyata, S; Nakano, M; Kondo, M; Hasebe, Y; Segawa, M; Shimokawa, H				Satake, Hiroyuki; Fukuda, Koji; Sakata, Yasuhiko; Miyata, Satoshi; Nakano, Makoto; Kondo, Masateru; Hasebe, Yuhi; Segawa, Masato; Shimokawa, Hiroaki		Chart-2 Investigators	Current Status of Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter Defibrillator in Patients With Chronic Heart Failure - A Report From the CHART-2 Study -	CIRCULATION JOURNAL			English	Article						Heart failure; Implantable cardioverter defibrillator; Sudden cardiac death	VENTRICULAR EJECTION FRACTION; ACUTE MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; RISK STRATIFICATION; CLINICAL CHARACTERISTICS; DILATED CARDIOMYOPATHY; CARDIOVASCULAR DEATH; PRACTICE GUIDELINES; AMERICAN-COLLEGE; RANDOMIZED-TRIAL	Background: The current status of primary prevention of sudden cardiac death (SCD) with implantable cardioverter defibrillator (ICD) in patients with heart failure with reduced ejection fraction remains to be fully elucidated in Japan. Methods and Results: In the chronic heart failure (CHF) cohort study, the CHART-2 Study, we enrolled 2,778 consecutive patients with NYHA class II-III. According to the Japanese Circulation Society guideline of prophylactic ICD, we divided them into 3 groups: group A, class I indication; B, class IIa; and C, no indication. During the (median) 3.2-year follow-up, 79 fatal arrhythmic events (FAE), defined as composite of sudden cardiac/arrhythmic death, ventricular tachycardia/fibrillation and appropriate ICD therapy, occurred. In the groups A, B and C, the prevalence of FAE was 16.1%, 8.9% and 1.9%, respectively; the use of prophylactic ICD among those with FAE, however, was only 44%, 9% and 6%, respectively. In the groups A and B combined, chronic atrial fibrillation (cAF) and left ventricular end-diastolic dimension (LVDd) >= 65 mm were independent predictors of FAE, and, when combined, their prognostic impact was highly significant (hazard ratio, 7.01; P<0.001). Conclusions: Primary prevention of SCD with ICD in CHF patients is validated but is still underused in Japan, and the combination of cAF and LVDd >= 65 mm may be a useful indication of prophylactic ICD implantation.	[Satake, Hiroyuki; Fukuda, Koji; Sakata, Yasuhiko; Nakano, Makoto; Kondo, Masateru; Hasebe, Yuhi; Segawa, Masato; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan; [Miyata, Satoshi; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Evidenced Based Cardiovasc Med, Sendai, Miyagi 9808574, Japan	Shimokawa, H (reprint author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Aoba Ku, Seiryo Machi, Sendai, Miyagi 9808574, Japan.	shimo@cardio.med.tohoku.ac.jp			Ministry of Health, Labour, and Welfare; Daiichi Sankyo (Tokyo, Japan); Bayer Yakuhin (Osaka, Japan); Kyowa Hakko Kirin (Tokyo, Japan); Kowa Pharmaceutical (Tokyo, Japan); Novartis Pharma (Tokyo, Japan); Dainippon Sumitomo Pharma (Osaka, Japan); Nippon Boehringer Ingelheim (Tokyo, Japan)	We thank all members of the Tohoku Heart Failure Society and staff of the Department of Evidence-based Cardiovascular medicine for their kind contributions (Appendix S1). This study was supported by Grants-in-Aid from a Research Grant from the Ministry of Health, Labour, and Welfare (H. Shimokawa). The Department of Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine, is supported in part by the unrestricted research grants from Daiichi Sankyo (Tokyo, Japan), Bayer Yakuhin (Osaka, Japan), Kyowa Hakko Kirin (Tokyo, Japan), Kowa Pharmaceutical (Tokyo, Japan), Novartis Pharma (Tokyo, Japan), Dainippon Sumitomo Pharma (Osaka, Japan), and Nippon Boehringer Ingelheim (Tokyo, Japan). H. Shimokawa has received lecture fees from Bayer Yakuhin (Osaka, Japan), Daiichi Sankyo (Tokyo, Japan) and Novartis Pharma (Tokyo, Japan).	Abildstrom SZ, 2005, INT J CARDIOL, V104, P184, DOI 10.1016/j.ijcard.2004.12.014; Greenberg H, 2004, J AM COLL CARDIOL, V43, P1459, DOI 10.1016/j.jacc.2003.11.038; Dagres N, 2013, EUR HEART J, V34, P1964, DOI 10.1093/eurheartj/eht109; Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938; Hernandez AF, 2007, JAMA-J AM MED ASSOC, V298, P1525, DOI 10.1001/jama.298.13.1525; Sakata Y, 2014, CIRC J, V78, P428, DOI 10.1253/circj.CJ-13-1009; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; Hoang A, 2014, HEART RHYTHM, V11, P849, DOI 10.1016/j.hrthm.2014.02.019; Nochioka K, 2013, CIRC J, V77, P2318, DOI 10.1253/circj.CJ-13-0127; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pitt B, 1997, LANCET, V349, P747, DOI 10.1016/S0140-6736(97)01187-2; Shiba N, 2011, CIRC J, V75, P823, DOI 10.1253/circj.CJ-11-0135; Desai AS, 2004, JAMA-J AM MED ASSOC, V292, P2874, DOI 10.1001/jama.292.23.2874; Watanabe J, 2006, EUR J HEART FAIL, V8, P237, DOI 10.1016/j.ejheart.2005.08.003; Carson P, 2005, J AM COLL CARDIOL, V46, P2329, DOI 10.1016/j.jacc.2005.09.016; Borleffs CJW, 2010, J AM COLL CARDIOL, V55, P879, DOI 10.1016/j.jacc.2009.09.053; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Zipes DP, 2006, EUROPACE, V8, P746, DOI 10.1093/europace/eul108; Strickberger SA, 2003, J AM COLL CARDIOL, V41, P1707, DOI 10.1016/S0735-1097(03)00297-3; Uretsky BF, 2000, CIRCULATION, V102, P611; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P288, DOI 10.1016/j.jacc.2007.08.058; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Pedersen OD, 2006, EUR HEART J, V27, P290, DOI 10.1093/eurheartj/ehi629; Shiga T, 2009, HEART, V95, P216, DOI 10.1136/hrt.2008.145243; Kearney MT, 2004, HEART, V90, P1137, DOI 10.1136/hrt.2003.021733; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Birnie DH, 2007, CAN MED ASSOC J, V177, P41, DOI 10.1503/cmaj.060730; CIBIS-II Investigators and Committees, 1999, LANCET, V352, P9; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Epstein AE, 2012, CIRCULATION, V127, pe283, DOI DOI 10.1161/CIR.0B013E318276CE9B; Gravelin LM, 2011, CIRC-CARDIOVASC QUAL, V4, P152, DOI [10.1161/CIRCOUTCOMES.110.956987, 10.1161/CIRCOUTCOMES.111.956987]; Grimm W, 2000, AM HEART J, V140, P43, DOI 10.1067/mhj.2000.107178; JCS Joint Working Group, 2013, CIRC J, V77, P249; Kadlish A, 2004, NEW ENGL J MED, V350, P2151; Kober L, 1995, NEW ENGL J MED, V80, P257; Miura M, 2013, CIRC J, V77, P2954, DOI 10.1253/circj.CJ-13-0725; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Olgin AE, 2005, HEART DIS, P841; Parkash R, 2012, CIRC-ARRHYTHMIA ELEC, V5, P706, DOI 10.1161/CIRCEP.112.970798; Sadarmin PP, 2014, EUROPACE, V16, P1575, DOI 10.1093/europace/euu054; Shiba Nobuyuki, 2008, Vasc Health Risk Manag, V4, P103, DOI 10.2147/vhrm.2008.04.01.103; Tanno K, 2005, CIRC J, V69, P19, DOI 10.1253/circj.69.19; Ushigome R, 2014, CIRC J S, V78, P549	43	5	5	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					381	+		10.1253/circj.CJ-14-0925		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700029		
J	Nishi, H; Toda, K; Miyagawa, S; Yoshikawa, Y; Fukushima, S; Kawamura, M; Saito, T; Yoshioka, D; Daimon, T; Sawa, Y				Nishi, Hiroyuki; Toda, Koichi; Miyagawa, Shigeru; Yoshikawa, Yasushi; Fukushima, Satsuki; Kawamura, Masashi; Saito, Tetsuya; Yoshioka, Daisuke; Daimon, Takashi; Sawa, Yoshiki			Novel Method of Evaluating Liver Stiffness Using Transient Elastography to Evaluate Perioperative Status in Severe Heart Failure	CIRCULATION JOURNAL			English	Article						Heart failure; Liver; Ventricular assist device	VENTRICULAR ASSIST DEVICE; FUNCTION ABNORMALITIES; NONINVASIVE ASSESSMENT; FIBROSIS; DYSFUNCTION; MORTALITY; PRESSURE; VALUES	Background: The aim of the present study was to assess the efficacy of a non-invasive method, transient elastography (FibroScan), in measuring liver stiffness (LS), and whether LS can be used as a marker of cardiac - and hence perioperative -status. Methods and Results: Perioperative LS was prospectively measured using a FibroScan in 30 patients (21 male; 42.2 +/- 13.3 years old) who underwent left ventricular assist device (LVAD) implantation. LS was checked pre- and postoperatively, then analyzed in regard to perioperative status. Preoperative LS was 13.3 +/- 13.0 kPa (normal, <5.5 kPa), and was abnormal in 77% of patients. Four required bilateral VAD. LS in patients with bilateral VAD tended to be higher than in LVAD patients (25.1 +/- 22.7 vs. 11.5 +/- 10.5 kPa, P=0.051). No patient with LS <= 7.0 kPa required a right VAD. The incidence of major adverse events was lower in patients with LS <= 12.5 kPa (25% vs. 80%, P<0.05). There were also no mortalities among patients with LS <= 12.5 kPa. Conclusions: LS was correlated with preoperative severity in patients with severe heart failure and reflected liver congestion, and may be useful to predict the requirement of right VAD, as well as postoperative complications in patients with LVAD implantation. This novel modality may be a useful non-invasive assessment method for management of severe heart failure.	[Nishi, Hiroyuki; Toda, Koichi; Miyagawa, Shigeru; Yoshikawa, Yasushi; Fukushima, Satsuki; Kawamura, Masashi; Saito, Tetsuya; Yoshioka, Daisuke; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan; [Daimon, Takashi] Hyogo Coll Med, Dept Biostat, Nishinomiya, Hyogo 6638501, Japan	Sawa, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	sawa-p@surg1.osaka-u.med.ac.jp					Alegre F, 2013, ACTA GASTRO-ENT BELG, V76, P246; Alisi A, 2009, HEPATOLOGY, V50, P2048, DOI 10.1002/hep.23345; Shiga T, 2012, CIRC J, V76, P2785, DOI 10.1253/circj.CJ-12-0231; Masai T, 2002, ANN THORAC SURG, V73, P549, DOI 10.1016/S0003-4975(01)03510-X; Poelzl G, 2012, EUR J CLIN INVEST, V42, P153, DOI 10.1111/j.1365-2362.2011.02573.x; KUBO SH, 1987, ARCH INTERN MED, V147, P1227, DOI 10.1001/archinte.147.7.1227; Lau GT, 2002, AM J CARDIOL, V90, P1405, DOI 10.1016/S0002-9149(02)02886-2; Nishi H, 2012, CARDIOLOGY, V122, P12, DOI 10.1159/000338142; Colli A, 2010, RADIOLOGY, V257, P872, DOI 10.1148/radiol.10100013; Aaronson KD, 2012, CIRCULATION, V125, P3191, DOI 10.1161/CIRCULATIONAHA.111.058412; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; RICHMAN SM, 1961, AM J MED, V30, P211, DOI 10.1016/0002-9343(61)90093-6; Millonig G, 2008, HEPATOLOGY, V48, P1718, DOI 10.1002/hep.22577; Van Deursen VM, 2010, J CARD FAIL, V16, P84, DOI 10.1016/j.cardfail.2009.08.002; Imamura T, 2013, CIRC J, V77, P96, DOI 10.1253/circj.CJ-12-0686; Saito S, 2010, CIRC J, V74, P715, DOI 10.1253/circj.CJ-09-0747; Millonig G, 2010, J HEPATOL, V52, P206, DOI 10.1016/j.jhep.2009.11.018; Friedrich-Rust M, 2008, J THORAC CARDIOV SUR, V135, P560, DOI 10.1016/j.jtcvs.2007.09.039; Yoshioka D, 2012, CIRC J, V76, P1631, DOI 10.1253/circj.CJ-11-1452; Sakaguchi T, 2013, CIRC J, V77, P1736, DOI 10.1253/circj.CJ-12-1410; Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; Lindvig K, 2012, EUR J CLIN INVEST, V42, P146, DOI 10.1111/j.1365-2362.2011.02571.x; Craig Michael L, 2011, Curr Heart Fail Rep, V8, P65, DOI 10.1007/s11897-010-0043-3; Fujita Yasuki, 2005, J Artif Organs, V8, P28, DOI 10.1007/s10047-004-0276-6; Fukushima N, 2013, CIRC J, V77, P45, DOI 10.1253/circj.CJ-12-1398; Hopper I, 2012, EUR J HEART FAIL, V14, P621, DOI 10.1093/eurjhf/hfs044; Martinez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013; Taniguchi T, 2014, AM J CARDIOL, V113, P552, DOI 10.1016/j.amjcard.2013.10.018	30	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					391	397		10.1253/circj.CJ-14-0929		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700030		
J	Miyoshi, T; Osawa, K; Ito, H; Kanazawa, S; Kimura, T; Shiomi, H; Kuribayashi, S; Jinzaki, M; Kawamura, A; Bezerra, H; Achenbach, S; Norgaard, BL				Miyoshi, Toru; Osawa, Kazuhiro; Ito, Hiroshi; Kanazawa, Susumu; Kimura, Takeshi; Shiomi, Hiroki; Kuribayashi, Sachio; Jinzaki, Masahiro; Kawamura, Akio; Bezerra, Hiram; Achenbach, Stephan; Norgaard, Bjarne L.			Non-Invasive Computed Fractional Flow Reserve From Computed Tomography (CT) for Diagnosing Coronary Artery Disease - Japanese Results From NXT Trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps)	CIRCULATION JOURNAL			English	Article						Computed tomography; Coronary artery disease; Fractional flow reserve	DISCOVER-FLOW; DE-FACTO; PERFORMANCE; INTERVENTION; ACCURACY; STENOSES; ASSOCIATION; RATIONALE; DESIGN	Background: Recently, a non-invasive method using computational fluid dynamics to calculate vessel-specific fractional flow reserve (FFRCT) from routinely acquired coronary computed tomography angiography (CTA) was described. The Analysis of Coronary Blood Flow Using CT Angiography: Next Steps (NXT) trial, which was a prospective, multicenter trial including 254 patients with suspected coronary artery disease, noted high diagnostic performance of FFRCT compared with invasive FFR. The aim of this post-hoc analysis was to assess the diagnostic performance of non-invasive FFRCT vs. standard stenosis quantification on coronary CTA in the Japanese subset of the NXT trial. Methods and Results: A total of 57 Japanese participants were included from Okayama University (n=36), Kyoto University (n=17), and Keio University (n=4) Hospitals. Per-patient diagnostic accuracy of FFRCT (74%; 95% confidence interval [CI]: 60-85%) was higher than for coronary CTA (47%; 95% CI: 34-61%, P<0.001) arising from improved specificity (63% vs. 27%, P<0.001). FFRCT correctly reclassified 53% of patients and 63% of vessels with coronary CTA false positives as true negatives. When patients with Agatston score >1,000 were excluded, per-patient accuracy of FFRCT was 83% with a high specificity of 76%, similar to the overall NXT trial findings. Conclusions: FFRCT has high diagnostic performance compared with invasive FFR in the Japanese subset of patients in the NXT trial.	[Miyoshi, Toru; Osawa, Kazuhiro; Ito, Hiroshi] Okayama Univ Hosp, Dept Cardiovasc Med, Okayama, Japan; [Kanazawa, Susumu] Okayama Univ Hosp, Dept Radiol, Okayama, Japan; [Kimura, Takeshi; Shiomi, Hiroki] Kyoto Univ Hosp, Dept Cardiovasc Med, Kyoto 606, Japan; [Kuribayashi, Sachio; Jinzaki, Masahiro] Keio Univ Hosp, Dept Radiol, Tokyo, Japan; [Kawamura, Akio] Keio Univ Hosp, Dept Cardiovasc Med, Tokyo, Japan; [Bezerra, Hiram] Univ Hosp Cleveland, Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA; [Achenbach, Stephan] Erlangen Univ Hosp, Dept Cardiol, Nurnberg, Germany; [Norgaard, Bjarne L.] Aarhus Univ, Hosp Skejby, Dept Cardiol, Aarhus, Denmark	Miyoshi, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	miyoshit@cc.okayama-u.ac.jp			HeartFlow, Inc.	This study was supported by HeartFlow, Inc.	Abbara Suhny, 2009, J Cardiovasc Comput Tomogr, V3, P190, DOI 10.1016/j.jcct.2009.03.004; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P636, DOI 10.1016/j.jacc.2008.05.024; Naidu SS, 2012, CATHETER CARDIO INTE, V80, P456, DOI 10.1002/ccd.24311; Genders TSS, 2011, EUR HEART J, V32, P1316, DOI 10.1093/eurheartj/ehr014; Leipsic J, 2014, AM J ROENTGENOL, V202, P989, DOI 10.2214/AJR.13.11441; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Min JK, 2012, JAMA-J AM MED ASSOC, V308, P1237, DOI 10.1001/2012.jama.11274; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Urabe Y, 2013, CIRC J, V77, P2578, DOI 10.1253/circj.CJ-13-0257; Min JK, 2012, J CARDIOVASC COMPUT, V6, P191, DOI 10.1016/j.jcct.2012.04.010; Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083; Hoffmann MHK, 2005, JAMA-J AM MED ASSOC, V293, P2471, DOI 10.1001/jama.293.20.2471; Hulten EA, 2011, J AM COLL CARDIOL, V57, P1237, DOI 10.1016/j.jacc.2010.10.011; Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096; Koo BK, 2011, J AM COLL CARDIOL, V58, P1989, DOI 10.1016/j.jacc.2011.06.066; Gaur S, 2013, J CARDIOVASC COMPUT, V7, P279, DOI 10.1016/j.jcct.2013.09.003; Hlatky MA, 2013, CLIN CARDIOL, V36, P743, DOI 10.1002/clc.22205; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Japanese Circulation Society, 2014, JAP REG ALL CARD VAS; Kim KH, 2014, JACC-CARDIOVASC INTE, V7, P72, DOI 10.1016/j.jcin.2013.05.024; Kim YH, 2013, CIRC J, V77, P1967, DOI 10.1253/circj.CJ-13-0376; Kimura Takeshi, 2015, Cardiovasc Interv Ther, V30, P38, DOI 10.1007/s12928-014-0285-1; Min JK, 2011, J CARDIOVASC COMPUT, V5, P301, DOI 10.1016/j.jcct.2011.08.003; Motoyama S, 2013, CIRC J, V77, P411, DOI 10.1253/circj.CJ-12-0688; Nishio M, 2014, CIRC J, V78, P2203, DOI 10.1253/circj.CJ-14-0103; Norgaard BL, 2014, J AM COLL CARDIOL, V63, P1145, DOI 10.1016/j.jacc.2013.11.043; Osawa K, 2013, CIRC J, V77, P146, DOI 10.1253/circj.CJ-12-0663; Schuijf JD, 2008, HEART, V94, P255, DOI 10.1136/hrt.2006.105833	29	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					406	412		10.1253/circj.CJ-14-1051		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700032		
J	Soeki, T; Yamaguchi, K; Niki, T; Uematsu, E; Bando, S; Matsuura, T; Ise, T; Kusunose, K; Hotchi, J; Tobiume, T; Yagi, S; Fukuda, D; Taketani, Y; Iwase, T; Yamada, H; Wakatsuki, T; Shimabukuro, M; Sata, M				Soeki, Takeshi; Yamaguchi, Koji; Niki, Toshiyuki; Uematsu, Etsuko; Bando, Sachiko; Matsuura, Tomomi; Ise, Takayuki; Kusunose, Kenya; Hotchi, Junko; Tobiume, Takeshi; Yagi, Shusuke; Fukuda, Daiju; Taketani, Yoshio; Iwase, Takashi; Yamada, Hirotsugu; Wakatsuki, Tetsuzo; Shimabukuro, Michio; Sata, Masataka			Plasma MicroRNA-100 Is Associated With Coronary Plaque Vulnerability	CIRCULATION JOURNAL			English	Article						Coronary artery disease; Coronary circulation; Intravascular ultrasound; MicroRNA	BACKSCATTER INTRAVASCULAR ULTRASOUND; CIRCULATING MICRORNAS; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; ATHEROSCLEROSIS; BIOMARKERS; EXPRESSION; HUMANS; CANCER	Background: Although numerous studies have reported altered plasma levels of various microRNAs (miRNAs) in patients with cardiovascular disease, there are no data on the relationship between plasma miRNAs and vulnerable coronary plaque. In this study, we investigated whether plasma miRNAs might be a sensitive marker of coronary plaque vulnerability. Methods and Results: Integrated backscatter intravascular ultrasound (IB-IVUS) was performed in 32 consecutive patients with angina pectoris who underwent percutaneous coronary intervention. Three-dimensional analysis of IB-IVUS was performed to determine the percentage of lipid volume (%LV) and fibrous volume (%FV). Circulating miRNAs were measured in EDTA-plasma simultaneously obtained from the aorta and the coronary sinus (CS). Muscle-enriched (miR-133a, miR-208a, miR-499), vascular-enriched (miR-92a, miR-100, miR-126, miR-127, miR145), and myeloid cell-enriched miRNAs (miR-155, miR-223) were measured. Plasma miR-100 was higher in the CS than in the aorta, but there were no significant differences in the levels of other miRNAs between the aorta and CS. Plasma miR-100 in the aorta was positively correlated with %LV (r=0.48, P<0.01) and negatively correlated with % FV (r=-0.41, P<0.05). Importantly, transcoronary concentration gradient of circulating miR-100 was more strongly correlated with % LV (r=0.53, P<0.01) and % FV (r=-0.56, P<0.01). Conclusions: miR-100 might be released into the coronary circulation from vulnerable coronary plaques. This study provides insights into the role of miRNAs in coronary atherosclerotic disease.	[Soeki, Takeshi; Yamaguchi, Koji; Uematsu, Etsuko; Bando, Sachiko; Matsuura, Tomomi; Ise, Takayuki; Kusunose, Kenya; Hotchi, Junko; Tobiume, Takeshi; Yagi, Shusuke; Iwase, Takashi; Yamada, Hirotsugu; Wakatsuki, Tetsuzo; Sata, Masataka] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Cardiovasc Med, Tokushima 7708503, Japan; [Fukuda, Daiju; Shimabukuro, Michio] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Cardiodiabet Med, Tokushima 7708503, Japan; [Niki, Toshiyuki; Taketani, Yoshio] Shikoku Med Ctr Children & Adults, Dept Cardiovasc Med, Zentsuji, Japan	Soeki, T (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Cardiovasc Med, 2-50-1 Kuramoto, Tokushima 7708503, Japan.	soeki@tokushima-u.ac.jp			JSPS Kakenhi [25670390, 25293184]	This work was partially supported by JSPS Kakenhi Grants (Number 25670390 and 25293184 to M. Sata).	Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Santovito D, 2012, NUTR METAB CARDIOVAS, V22, P937, DOI 10.1016/j.numecd.2012.03.007; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Zile MR, 2011, CIRC-CARDIOVASC GENE, V4, P614, DOI 10.1161/CIRCGENETICS.111.959841; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Amano T, 2007, J AM COLL CARDIOL, V49, P1149, DOI 10.1016/j.jacc.2006.12.028; Cipollone F, 2011, STROKE, V42, P2556, DOI 10.1161/STROKEAHA.110.597575; Nakayama N, 2013, CIRC J, V77, P424, DOI 10.1253/circj.CJ-12-0630; Sano K, 2006, J AM COLL CARDIOL, V47, P734, DOI 10.1016/j.jacc.2005.09.061; Inoue K, 2007, ARTERIOSCL THROM VAS, V27, P161, DOI 10.1161/01.ATV.0000252126.48375.d5; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Grundmann S, 2011, CIRCULATION, V123, P999, DOI 10.1161/CIRCULATIONAHA.110.000323; Amano T, 2011, CIRC J, V75, P157, DOI 10.1253/circj.CJ-10-0612; Soeki T, 2011, J CARDIOL, V58, P151, DOI 10.1016/j.jjcc.2011.04.005; Kawasaki M, 2002, CIRCULATION, V105, P2487, DOI 10.1061/01.CIR.0000017200.47342.10; Li J, 2009, ANAL CHEM, V81, P5446, DOI 10.1021/ac900598d; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JC133099; De Rosa S, 2011, CIRCULATION, V124, P1936, DOI 10.1161/CIRCULATIONAHA.111.037572; Ma KL, 2013, CARDIOVASC RES, V100, P450, DOI 10.1093/cvr/cvt203; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Sternberg Z, 2013, ATHEROSCLEROSIS, V229, P338, DOI 10.1016/j.atherosclerosis.2013.04.035; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Chen LJ, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-79; Libby P, 2003, AM J CARDIOL, V91, p3A; Ohota M, 2012, CIRC J, V76, P1678, DOI 10.1253/circj.CJ-11-1157; Shi W, 2010, INT J CANCER, V126, P2036, DOI 10.1002/ijc.24880; Wang XC, 2013, INT J MOL MED, V32, P1215, DOI 10.3892/ijmm.2013.1494; Yamaguchi K, 2013, CIRC J, V78, P240; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zernecke A, 2012, THROMB HAEMOSTASIS, V107, P626, DOI 10.1160/TH11-08-0603	33	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					413	418		10.1253/circj.CJ-14-0958		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700033		
J	Okamatsu, H; Ohara, T; Kanzaki, H; Nakajima, I; Miyamoto, K; Okamura, H; Noda, T; Aiba, T; Kusano, K; Kamakura, S; Shimizu, W; Satomi, K				Okamatsu, Hideharu; Ohara, Takahiro; Kanzaki, Hideaki; Nakajima, Ikutaro; Miyamoto, Koji; Okamura, Hideo; Noda, Takashi; Aiba, Takeshi; Kusano, Kengo; Kamakura, Shiro; Shimizu, Wataru; Satomi, Kazuhiro			Impact of Left Ventricular Diastolic Dysfunction on Outcome of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy	CIRCULATION JOURNAL			English	Article						Atrial fibrillation; Diastolic dysfunction; Hypertrophic cardiomyopathy; Radiofrequency catheter ablation	FILLING PRESSURES; OF-CARDIOLOGY; HEART-ASSOCIATION; EUROPEAN-SOCIETY; TISSUE DOPPLER; TASK-FORCE; ECHOCARDIOGRAPHY; RECOMMENDATIONS; RELAXATION; GUIDELINES	Background: The relationship between outcome of radiofrequency catheter ablation (RFCA) for atrial fibrillation (AF) and the severity of left ventricular (LV) diastolic dysfunction in patients with hypertrophic cardiomyopathy (HCM) remains unknown. Methods and Results: Twenty-two HCM patients (12 female, aged 65 +/- 11 years) with paroxysmal (n=5; 23%) or persistent (n=17; 77%) AF were enrolled. LV diastolic function was evaluated according to the ratio of the mitral inflow early filling velocity to the velocity of the early medial mitral annular ascent (E/e') measured on pulsed wave and tissue Doppler assessments in all patients. Pulmonary vein isolation was performed in all patients. A second procedure was performed in 3 patients. During a follow-up of 21 +/- 12 months, sinus rhythm was maintained in 13 of 22 patients (59%). E/e' was significantly higher in the patients with AF recurrence than in those without (18 +/- 7 vs. 11 +/- 3; P<0.01). On Kaplan-Meier analysis the prevalence of AF recurrence was significantly higher in patients with E/e' >= 15 (n=6) than in those with E/e' <15 (n=16; P<0.01). On multivariate Cox regression analysis the only significant and independent predictor for AF recurrence was E/e' (hazard ratio, 1.16; 95% confidence interval: 1.01-1.37, P=0.03). Conclusions: LV diastolic dysfunction evaluated using E/e' was associated with difficulty of rhythm control after RFCA in patients with HCM and AF.	[Okamatsu, Hideharu; Nakajima, Ikutaro; Miyamoto, Koji; Okamura, Hideo; Noda, Takashi; Aiba, Takeshi; Kusano, Kengo; Kamakura, Shiro; Shimizu, Wataru; Satomi, Kazuhiro] Natl Cerebral & Cardiovasc Ctr, Div Arrhythmia & Electrophysiol, Suita, Osaka, Japan; [Ohara, Takahiro; Kanzaki, Hideaki] Natl Cerebral & Cardiovasc Ctr, Div Heart Failure, Suita, Osaka, Japan; [Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo 113, Japan; [Satomi, Kazuhiro] Tokyo Med Univ, Hachioji Med Ctr, Dept Cardiol, Tokyo 1930944, Japan	Satomi, K (reprint author), Tokyo Med Univ, Hachioji Med Ctr, Dept Cardiol, 1163 Tatemachi, Tokyo 1930944, Japan.	ksatomi@tokyo-med.ac.jp					Bunch TJ, 2008, J CARDIOVASC ELECTR, V19, P1009, DOI 10.1111/j.1540-8167.2008.01192.x; Tsang TSM, 2002, J AM COLL CARDIOL, V40, P1636, DOI 10.1016/S0735-1097(02)02373-2; Ommen SR, 2000, CIRCULATION, V102, P1788; Nagueh SF, 1999, CIRCULATION, V99, P254; Lee JS, 2013, CIRC J, V77, P697, DOI 10.1253/circj.CJ-12-1009; Cha YM, 2011, CIRC-ARRHYTHMIA ELEC, V4, P724, DOI 10.1161/CIRCEP.110.960690; Hu YF, 2010, CIRC J, V74, P2074, DOI 10.1253/circj.CJ-10-0175; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI 10.1093/eurheartj/ehq278; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Sohn DW, 1999, J AM SOC ECHOCARDIOG, V12, P927, DOI 10.1016/S0894-7317(99)70145-8; Jais P, 2000, J CARDIOVASC ELECTR, V11, P623, DOI 10.1111/j.1540-8167.2000.tb00023.x; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Tsang TSM, 2004, AM J CARDIOL, V93, P54, DOI 10.1016/j.amjcard.2003.09.012; Di Donna P, 2010, EUROPACE, V12, P347, DOI 10.1093/europace/euq013; Maron BJ, 2000, CIRCULATION, V102, P858; Olivotto I, 2001, CIRCULATION, V104, P2517, DOI 10.1161/hc4601.097997; Gaita F, 2007, AM J CARDIOL, V99, P1575, DOI 10.1016/j.amjcard.2006.12.087; ROBINSON K, 1990, J AM COLL CARDIOL, V15, P1279; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Gersh BJ, 2011, CIRCULATION, V124, pE783, DOI 10.1161/CIR.0b013e318223e2bd; Kilicaslan Fethi, 2006, Heart Rhythm, V3, P275, DOI 10.1016/j.hrthm.2005.11.013; Melek M, 2007, ECHOCARDIOGR-J CARD, V24, P34, DOI 10.1111/j.1540-8175.2007.00347.x; Nishimura RA, 1996, J AM COLL CARDIOL, V28, P1226, DOI 10.1016/S0735-1097(96)00315-4; Wada Y, 2012, CIRC J, V76, P675, DOI 10.1253/circj.CJ-11-0703	25	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					419	424		10.1253/circj.CJ-14-0823		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700034		
J	Suzuki, S; Yamashita, T; Okumura, K; Atarashi, H; Akao, M; Ogawa, H; Inoue, H				Suzuki, Shinya; Yamashita, Takeshi; Okumura, Ken; Atarashi, Hirotsugu; Akao, Masaharu; Ogawa, Hisashi; Inoue, Hiroshi			Incidence of Ischemic Stroke in Japanese Patients With Atrial Fibrillation Not Receiving Anticoagulation Therapy - Pooled Analysis of the Shinken Database, J-RHYTHM Registry, and Fushimi AF Registry	CIRCULATION JOURNAL			English	Article						Atrial fibrillation; Epidemiologic method; Ischemic stroke; Prognosis	RISK STRATIFICATION; ORAL ANTICOAGULANTS; PREDICTING STROKE; GUIDELINES; MORTALITY; EVENTS; THROMBOEMBOLISM; HYPERTENSION; PREVALENCE; VALIDATION	Background: The incidence rate of ischemic stroke in Japanese non-valvular atrial fibrillation (NVAF) patients without anticoagulation therapy remains unclear. Methods and Results: We performed a pooled analysis of 3,588 patients from the Shinken Database (n=1,099), J-RHYTHM Registry (n=1,002), and Fushimi AF Registry (n=1,487) to determine the incidence rate of ischemic stroke in Japanese NVAF patients without anticoagulation therapy. Average patient age was 68.1 years. During the follow-up period (total, 5,188 person-years; average, 1.4 years), 69 patients suffered from ischemic stroke (13.3 per 1,000 person-years; 95% confidence intervals [CI]: 10.5-16.8). The incidence rates of ischemic stroke were 5.4, 9.3, and 24.7 per 1,000 person-years and 5.3, 5.5, and 18.4 per 1,000 person-years in patients with low (0), intermediate (1), and high (>= 2) CHADS2 and CHA2DS2-VASc scores, respectively. History of ischemic stroke or transient ischemic attack (hazard ratio [HR], 3.25; 95% CI: 1.86-5.67), age >= 75 years (HR, 2.31; 95% CI: 1.18-4.52), and hypertension (HR, 1.69; 95% CI: 1.01-2.86) were independent risk factors for ischemic stroke. Conclusions: A low incidence rate of ischemic stroke was observed in Japanese NVAF patients except for those with CHADS2 score >= 2. In this pooled analysis, history of ischemic stroke or transient ischemic attack, advanced age, and hypertension were identified as independent risk factors for ischemic stroke.	[Suzuki, Shinya; Yamashita, Takeshi] Cardiovasc Inst, Dept Cardiovasc Med, Minato Ku, Tokyo 1060031, Japan; [Okumura, Ken] Hirosaki Univ, Grad Sch Med, Dept Cardiol Resp Med & Nephrol, Hirosaki, Aomori, Japan; [Atarashi, Hirotsugu] Tama Nagayama Hosp, Nippon Med Sch, Dept Internal Med, Tokyo, Japan; [Akao, Masaharu; Ogawa, Hisashi] Natl Hosp Org, Kyoto Med Ctr, Dept Cardiol, Kyoto, Japan; [Inoue, Hiroshi] Toyama Univ, Dept Internal Med 2, Grad Sch Med, Toyama 930, Japan	Suzuki, S (reprint author), Cardiovasc Inst, Dept Cardiovasc Med, Minato Ku, 3-2-19 Nishiazabu, Tokyo 1060031, Japan.	sinsuz-tky@umin.ac.jp			Boehringer Ingelheim; Daiichi-Sankyo; Bayer Healthcare; Pfizer; Bristol-Myers Squibb; Eisai; Ono Pharmaceutical; Mitsubishi Tanabe Pharma; Sumitomo Dainippon Pharma; Otsuka Pharmaceutical; Astellas Pharma; AstraZeneca; Novartis Pharma; MSD; Sanofi-Aventis; Takeda Pharmaceutical	Dr Suzuki has no conflict of interest; Dr Yamashita received research funding from Boehringer Ingelheim and Daiichi-Sankyo and remuneration from Boehringer Ingelheim, Daiichi-Sankyo, Bayer Healthcare, Pfizer, Bristol-Myers Squibb, Eisai, and Ono Pharmaceutical; Dr Okumura received research funding from Boehringer Ingelheim, Bayer Healthcare, and Daiichi-Sankyo and remuneration from Boehringer Ingelheim, Bayer Healthcare, Bristol-Myers Squibb, Pfizer, and Eisai; Dr Atarashi received research funding from Daiichi-Sankyo and Boehringer Ingelheim and lecture fees from Bayer Healthcare and Boehringer Ingelheim; Dr Akao received lecture fees from Pfizer, Bristol-Myers Squibb, Boehringer Ingelheim, Bayer Healthcare, and Daiichi-Sankyo; Dr Ogawa has no conflict of interest; Dr Inoue received research funding from Boehringer Ingelheim, Daiichi-Sankyo, Mitsubishi Tanabe Pharma, and Sumitomo Dainippon Pharma and remuneration from Otsuka Pharmaceutical, Daiichi-Sankyo, Sumitomo Dainippon Pharma, Boehringer Ingelheim, and Bayer Healthcare; the Fushimi AF Registry is supported by research funding from Boehringer Ingelheim, Bayer Healthcare, Pfizer, Bristol-Myers Squibb, Astellas Pharma, AstraZeneca, Daiichi-Sankyo, Novartis Pharma, MSD, Sanofi-Aventis, and Takeda Pharmaceutical.	Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Atarashi H, 2011, CIRC J, V75, P1328, DOI 10.1253/circj.CJ-10-1119; Miyasaka Y, 2005, STROKE, V36, P2362, DOI 10.1161/01.STR.0000185927.63746.23; Hart RG, 2007, ANN INTERN MED, V146, P857; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Chalmers J, 1999, J HYPERTENS, V17, P151; Ohsawa M, 2005, J EPIDEMIOL, V15, P194, DOI 10.2188/jea.15.194; Lip GYH, 2007, EUR HEART J, V28, P752, DOI 10.1093/eurheartj/ehl504; Inoue H, 2014, AM J CARDIOL, V113, P957, DOI 10.1016/j.amjcard.2013.11.057; Okumura K, 2014, CIRC J, V78, P1593, DOI 10.1253/circj.CJ-14-0144; Hughes M, 2008, THROMB HAEMOSTASIS, V99, P295, DOI 10.1160/TH07-08-0508; Akao M, 2013, J CARDIOL, V61, P260, DOI 10.1016/j.jjcc.2012.12.002; Suzuki S, 2008, CIRC J, V72, P914, DOI 10.1253/circj.72.914; Camm AJ, 2010, EUROPACE, V12, P1360, DOI 10.1093/europace/euq350; Inoue H, 2013, CIRC J, V77, P2264, DOI 10.1253/circj.CJ-13-0290; Akao M, 2014, CIRC J, V78, P2166, DOI 10.1253/circj.CJ-14-0344; Inoue H, 2006, CIRC J, V70, P651, DOI 10.1253/circj.70.651; Inoue H, 2009, INT J CARDIOL, V137, P102, DOI 10.1016/j.ijcard.2008.06.029; Suzuki S, 2011, J CARDIOL, V58, P116, DOI 10.1016/j.jjcc.2011.06.006; Atarashi H, 2011, J CARDIOL, V57, P95, DOI 10.1016/j.jjcc.2010.09.002; Hart RG, 2008, STROKE, V39, P1901, DOI 10.1161/STROKEAHA.107.501825; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Arima H, 2005, STROKE, V36, P2164, DOI 10.1161/01.STR.0000181115.59173.42; Frost L, 2007, AM J MED, V120, P47, DOI 10.1016/j.amjmed.2005.12.027; Inoue H, 2004, INTERNAL MED, V43, P529, DOI 10.2169/internalmedicine.43.529; Ogawa S, 2010, CIRC J, V74, P2479, DOI 10.1253/circj.CJ-88-0001	26	7	7	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					432	438		10.1253/circj.CJ-14-1131		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700036		
J	Tamada, T; Okura, H; Yoshida, K				Tamada, Tomoko; Okura, Hiroyuki; Yoshida, Kiyoshi			New Echo Window to Quantify Eccentric Mitral Regurgitation Using a Transgastric Approach on Transesophageal Echocardiography	CIRCULATION JOURNAL			English	Editorial Material							3-DIMENSIONAL ECHOCARDIOGRAPHY; HEART-DISEASE; ORIFICE AREA; VALVE; COAPTATION		[Tamada, Tomoko; Okura, Hiroyuki] Kawasaki Med Univ, Div Cardiol, Kurashiki, Okayama 7010192, Japan; [Yoshida, Kiyoshi] Sakakibara Heart Inst Okayama, Div Cardiol, Okayama, Japan	Okura, H (reprint author), Kawasaki Med Univ, Div Cardiol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	hokura@fides.dti.ne.jp					Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Saito K, 2012, JACC-CARDIOVASC IMAG, V5, P337, DOI 10.1016/j.jcmg.2011.10.004; ENRIQUEZSARANO M, 1995, J AM COLL CARDIOL, V25, P703, DOI 10.1016/0735-1097(94)00434-R; Okura H, 2008, J AM SOC ECHOCARDIOG, V21, P355, DOI 10.1016/j.echo.2007.06.002; Enriquez-Sarano M, 2005, NEW ENGL J MED, V352, P875, DOI 10.1056/NEJMoa041451; ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V23, P443; Murashita T, 2013, CIRC J, V77, P2050, DOI 10.1253/circj.CJ-13-0089; Obase K, 2012, J THORAC CARDIOV SUR, V143, DOI 10.1016/j.jtcvs.2012.01.064; Obase K, 2013, ECHOCARDIOGR-J CARD, V30, P945, DOI 10.1111/echo.12154; Tsukiji M, 2008, J AM SOC ECHOCARDIOG, V21, P43, DOI 10.1016/j.echo.2007.05.023; Vecera J, 2014, CIRC J, V78, P2741, DOI 10.1253/circj.CJ-14-0183	12	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					439	440		10.1253/circj.CJ-14-1103		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700037		
J	Sakamoto, S; Kawarada, O; Kanaya, T; Otsuka, F; Harada, K; Ogawa, H; Yasuda, S				Sakamoto, Shingo; Kawarada, Osami; Kanaya, Tomoaki; Otsuka, Fumiyuki; Harada, Koichiro; Ogawa, Hisao; Yasuda, Satoshi			Vascular Response to Bare Metal Stents in the Superficial Femoral Artery as Assessed on Optical Coherence Tomography	CIRCULATION JOURNAL			English	Editorial Material							CORONARY STENT; IMPLANTATION; INTIMA		[Sakamoto, Shingo; Kawarada, Osami; Kanaya, Tomoaki; Otsuka, Fumiyuki; Harada, Koichiro; Ogawa, Hisao; Yasuda, Satoshi] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan; [Sakamoto, Shingo; Yasuda, Satoshi] Tohoku Univ, Grad Sch Med, Dept Adv Cardiovasc Med, Sendai, Miyagi 980, Japan; [Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan	Yasuda, S (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	yasuda.satoshi.hp@mail.ncvc.go.jp					Nakano M, 2012, JACC-CARDIOVASC IMAG, V5, P71, DOI 10.1016/j.jcmg.2011.09.015; Herisson F, 2011, ATHEROSCLEROSIS, V216, P348, DOI 10.1016/j.atherosclerosis.2011.02.004; Yonetsu T, 2013, CIRC J, V77, P1933, DOI 10.1253/circj.CJ-13-0643.1; Habara M, 2013, EUR HEART J-CARD IMG, V14, P276, DOI 10.1093/ehjci/jes183; Takano M, 2009, J AM COLL CARDIOL, V55, P26, DOI 10.1016/j.jacc.2009.08.032; Teramoto T, 2010, CIRC J, V74, P1257, DOI 10.1253/circj.CJ-10-0189; Dalager S, 2007, STROKE, V38, P2698, DOI 10.1161/STROKEAHA.107.486480; Kobayashi Y, 2001, J AM COLL CARDIOL, V37, P1329, DOI 10.1016/S0735-1097(01)01162-7; Mosseri Morris, 2005, Cardiovasc Revasc Med, V6, P147, DOI 10.1016/j.carrev.2005.08.008; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Otake H, 2012, INT J CARDIOL, V157, P38, DOI 10.1016/j.ijcard.2010.11.006	11	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					441	+		10.1253/circj.CJ-14-1069		4	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700038		
J	Takigawa, M; Takahashi, A; Kuwahara, T; Hirao, K; Isobe, M				Takigawa, Masateru; Takahashi, Atsushi; Kuwahara, Taishi; Hirao, Kenzo; Isobe, Mitsuaki			Catheter Ablation of Atrial Fibrillation and Thromboembolic Risk - Reply	CIRCULATION JOURNAL			English	Letter							CARDIOMYOPATHY		[Takigawa, Masateru; Takahashi, Atsushi; Kuwahara, Taishi] Yokosuka Kyosai Hosp, Cardiovasc Ctr, Yokosuka, Kanagawa, Japan; [Hirao, Kenzo] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Tokyo, Japan; [Takigawa, Masateru; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan	Takigawa, M (reprint author), Yokosuka Kyosai Hosp, Cardiovasc Ctr, Yokosuka, Kanagawa, Japan.						Potpara TS, 2012, CIRC-ARRHYTHMIA ELEC, V5, P319, DOI 10.1161/CIRCEP.111.966713; YAMAMOTO K, 1995, J AM COLL CARDIOL, V25, P1634, DOI 10.1016/0735-1097(95)00049-A; Camm AJ, 2010, EUROPACE, V12, P1360, DOI 10.1093/europace/euq350; Feng D, 2007, CIRCULATION, V116, P2420, DOI 10.1161/CIRCULATIONAHA.107.697763; Fuster V, 2006, CIRCULATION, V114, P700, DOI DOI 10.1161/CIRCULATI0NAHA.106.177031; Hohnloser SH, 2014, EUR HEART J, V35, P3323, DOI 10.1093/eurheartj/ehu386; Kornej J, 2013, CIRC-ARRHYTHMIA ELEC, V6, P868, DOI 10.1161/CIRCEP.113.000869; Lowe BS, 2014, J AM SOC ECHOCARDIOG, V27, P1176, DOI 10.1016/j.echo.2014.08.016; Takigawa M, 2014, CIRC J, V78, P2394, DOI 10.1253/circj.CJ-14-0525; Tuluce SY, 2010, J AM SOC ECHOCARDIOG, V23, P1207, DOI 10.1016/j.echo.2010.08.016	10	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	FEB	2015	79	2					445	445				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PJ	WOS:000351739700040		
J	Fujita, S; Sugimoto, K; Izu, A; Takemura, T				Fujita, Shinsuke; Sugimoto, Keisuke; Izu, Akane; Takemura, Tsukasa			A boy with IgA nephropathy complicated by tubulointerstitial nephritis and uveitis (TINU) syndrome	CLINICAL NEPHROLOGY			English	Article						IgA nephritis; uveitis tubulointerstitial injury; human leukocyte antigen; cellular immunity	PROGNOSIS	Background: Abnormal cellular and humoral immunity underlie both immunoglobulin A (IgA) nephropathy and tubulointerstitial nephritis and uveitis (TINU) syndrome. We encountered a teenage boy who developed TINU syndrome during the course of IgA nephropathy. Case Report: 1 year after onset of IgA nephropathy following acute enteritis, a 14-year-old boy again experienced acute enteritis caused by Campylobacter jejuni, which was followed by TINU syndrome with prominent low-molecular- weight proteinuria. Renal histologic examination showed T-cell-dominant tubulointerstitial infiltration of marked immune cells including CD54-positive cells. Steroid therapy improved renal function, reversing aggravation of IgA nephropathy by TINU syndrome. Conclusions: The boy's human leukocyte antigen profile suggested predisposition to these two diseases, triggered by which were intestinal infections. The enteritis probably induced abnormalities in cellular and humoral immunity. Low-molecular- weight proteinuria, which reflected our patient's tubulointerstitial lesions, should call for consideration of TINU syndrome, including ophthalmologic assessment for possible uveitis.	[Fujita, Shinsuke; Sugimoto, Keisuke; Izu, Akane; Takemura, Tsukasa] Kinki Univ, Fac Med, Dept Pediat, Osaka 5898511, Japan	Takemura, T (reprint author), Kinki Univ, Sch Med, Dept Pediat, 377-2 Ohno Higashi, Osaka 5898511, Japan.	tsukasa@med.kindai.ac.jp					Mackensen F, 2009, CURR OPIN OPHTHALMOL, V20, P525, DOI 10.1097/ICU.0b013e3283318f9a; Boyd JK, 2012, KIDNEY INT, V81, P833, DOI 10.1038/ki.2011.501; Du LP, 2009, OCUL IMMUNOL INFLAMM, V17, P249, DOI 10.1080/09273940902999356; CARTER JE, 1991, NEPHRON, V58, P101; Daniel L, 2000, AM J KIDNEY DIS, V35, P13, DOI 10.1016/S0272-6386(00)70295-2; Gorrono-Echebarria MB, 2001, BRIT J OPHTHALMOL, V85, P1010; HIKI Y, 1990, NEPHRON, V54, P264; Izzedine H, 2008, NEPHROL DIAL TRANSPL, V23, P1095, DOI 10.1093/ndt/gfm940; Onyekpe I, 2011, NEPHROL DIAL TRANSPL, V26, P3060, DOI 10.1093/ndt/gfr352; PASCUAL J, 1991, J RHEUMATOL, V18, P942; Roman E, 2004, NEFROLOGIA, V24, P489; Takemura T, 1999, AM J KIDNEY DIS, V34, P1016, DOI 10.1016/S0272-6386(99)70006-5; Tan Y, 2011, CLIN J AM SOC NEPHRO, V6, P93, DOI 10.2215/CJN.09051209	13	0	0	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0301-0430			CLIN NEPHROL	Clin. Nephrol.	FEB	2015	83	2					117	120		10.5414/CN108139		4	Urology & Nephrology	Urology & Nephrology	CF0LF	WOS:000352234800008		
J	Gibbs, AJ; Nguyen, HD; Ohshima, K				Gibbs, Adrian J.; Huy Duc Nguyen; Ohshima, Kazusato			The 'emergence' of turnip mosaic virus was probably a 'gene-for-quasi-gene' event	CURRENT OPINION IN VIROLOGY			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; YELLOW-STRIPE-VIRUS; NBS-LRR GENES; HOST; RNA; COEVOLUTION; POPULATIONS; NARCISSUS; POTYVIRUS; INFECTION	Turnip mosaic potyvirus is a virus of brassicas that emerged from a lineage of monocotyledon-infecting potyviruses about 1000 years ago. In vivo and in silica studies all indicate that sites, primarily in its protein 3 (P3) and cylindrical inclusion protein (Cl) genes, but also its small 6 kDa 2 protein (6K2) and genome-linked viral protein (VPg) genes, control host specificity in a dynamic way. It is most likely that non-unique combinations of transient viral genomic single nucleotide polymorphisms (SNPs), not all of them non-synonymous, allowed the host switch to occur. These SNPs were probably ephemeral and replaced over time by other combinations as the population subsequently diverged within, and adapted to, the brassica host population.	[Gibbs, Adrian J.] Australian Natl Univ, Emeritus Fac, Canberra, ACT 2601, Australia; [Huy Duc Nguyen; Ohshima, Kazusato] Saga Univ, Fac Agr, Lab Plant Virol, Saga 840, Japan; [Huy Duc Nguyen] Vietnam Natl Univ Agr, Fac Agron, Dept Plant Pathol, Hanoi, Vietnam	Gibbs, AJ (reprint author), Australian Natl Univ, Emeritus Fac, Canberra, ACT 2601, Australia.	adrian_j_gibbs@hotmail.com			Saga University; JSPS KAKENHI [18405022, 24405026]	We thank Mark Gibbs for helpful discussions. This work was in part funded by Saga University and supported by JSPS KAKENHI Grant Numbers 18405022 and 24405026 to KO.	Ivanov KI, 2014, J GEN VIROL, V95, P1415, DOI 10.1099/vir.0.064220-0; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Yue JX, 2012, NEW PHYTOL, V193, P1049, DOI 10.1111/j.1469-8137.2011.04006.x; de Vienne DM, 2013, NEW PHYTOL, V198, P347, DOI 10.1111/nph.12150; Ohshima K, 2007, J GEN VIROL, V88, P298, DOI 10.1099/vir.0.82335-0; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Flor HH, 1942, PHYTOPATHOLOGY, V32, P653; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; Ohshima K, 2010, J GEN VIROL, V91, P788, DOI 10.1099/vir.0.016055-0; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114; Magallon S, 2013, AM J BOT, V100, P556, DOI 10.3732/ajb.1200416; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Elena SF, 2011, MOL PLANT MICROBE IN, V24, P287, DOI 10.1094/MPMI-09-10-0214; Jenner CE, 2002, VIROLOGY, V300, P50, DOI 10.1006/viro.2002.1519; Betts MJ, 2003, BIOINFORMATICS GENET; Che J, 2002, Arch Virol, V147, P683; Chen J, 2006, ARCH VIROL, V151, P1673, DOI 10.1007/s00705-006-0788-x; Fuji S, 2000, ARCH VIROL, V145, P635, DOI 10.1007/s007050050052; Gibbs AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002523; Hughes AL, 2009, VIROLOGY, V393, P127, DOI 10.1016/j.virol.2009.07.016; Ivanov KI, 2012, CURR OPIN VIROL, V2, P712, DOI 10.1016/j.coviro.2012.10.001; Knip M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004602; Lin SQ, 2012, ARCH VIROL, V157, P1821, DOI 10.1007/s00705-012-1328-5; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nguyen HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055336; Obbard DJ, 2014, CURR OPIN VIROL, V8, P73, DOI 10.1016/j.coviro.2014.07.002; Tomlinson JA, 1970, CMI AAB DESCRIPTIONS, V8; Tran PT, 2014, J VIROL METHODS, V201, P57, DOI 10.1016/j.jviromet.2014.02.003; Villarreal Luis P, 2013, World J Biol Chem, V4, P79, DOI 10.4331/wjbc.v4.i4.79; Wilke CO, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-44; Wylie SJ, 2013, VIRUS RES, V171, P22, DOI 10.1016/j.virusres.2012.10.003; Wylie SJ, 2014, ARCH VIROL, V159, P1521, DOI 10.1007/s00705-013-1969-z; Wylie SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079587	35	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1879-6257			CURR OPIN VIROL	Curr. Opin. Virol.	FEB	2015	10						20	26		10.1016/j.coviro.2014.12.004		7	Virology	Virology	CE4HY	WOS:000351792900005		
J	Horii, Y; Nakakita, Y; Fujisaki, Y; Kaneda, H; Shigyo, T; Nagai, K				Horii, Yuko; Nakakita, Yasukazu; Fujisaki, Yoshiyuki; Kaneda, Hirotaka; Shigyo, Tatsuro; Nagai, Katsuya			INTRADUODENAL INJECTION OF HEAT-KILLED LACTOBACILLUS BREVIS SBC8803 MODULATES AUTONOMIC NEUROTRANSMISSION IN THE GUT: INVOLVEMENT OF VAGAL AFFERENTS AND SEROTONIN RECEPTORS	CURRENT TOPICS IN NUTRACEUTICAL RESEARCH			English	Article						Gastric vagal nerve; Granisetron; Intestinal vagal nerve; Ketanserin; Lactobacillus brevis SBC8803; Serotonin	BLOOD-PRESSURE; VAGUS NERVE; L-CARNOSINE; RATS; MECHANISMS; APPETITE; RELEASE; NUCLEUS; STRAIN	Previously, we found that intraduodenal administration of heat-killed Lactobacillus brevis SBC8803 (SBC8803) elevates both the efferent gastric vagal nerve activity (efferent GVNA) and the afferent intestinal vagal nerve activity (afferent IVNA) in rats. In this study, the effects of vagotomy and serotonin (5-HT) receptor antagonists on the above changes due to SBC8803 were examined in rats to clarify the mechanism. It was found that the elevation of efferent GVNA induced by SBC8803 was eliminated by subdiaphragmatic vagotomy, and inhibited by intracerebroventricular but not intravenous administration of ketanserin (5-HT2 antagonist), Moreover, both the efferent GVNA and the afferent IVNA elevations were suppressed by intracerebroventricular administration of granisetron (5-HT3 antagonist). Combining this with our previous findings that granisetron can produce the same effects intravenously, these findings suggest the following: I) the efferent GVNA enhancement requires afferent vagal nerves, central but not peripheral 5-HT2 receptors, and both central and peripheral 5-HT3 receptors, and 2) the afferent IVNA enhancement requires central and peripheral 5-HT3 receptors. Moreover, these results implicate the afferent IVNA in the mechanism of the SBC8803-induced increase in efferent GVNA.	[Horii, Yuko; Fujisaki, Yoshiyuki; Nagai, Katsuya] ANBAS Corp, Kita Ku, Osaka 5310072, Japan; [Nakakita, Yasukazu; Shigyo, Tatsuro] Sapporo Breweries Ltd, Frontier Labs Value Creat, Shizuoka 4250013, Japan; [Kaneda, Hirotaka] Sapporo Holdings Ltd, Corporate Planning Dept, Shibuya Ku, Tokyo 1508522, Japan; [Nagai, Katsuya] Osaka Univ, Suita, Osaka 5650871, Japan	Horii, Y (reprint author), ANBAS Corp, Kita Ku, 4-12-10 Toyosaki, Osaka 5310072, Japan.	yhorii@anbas.co.jp					AHLMAN H, 1983, J AUTONOM NERV SYST, V9, P119, DOI 10.1016/0165-1838(83)90136-4; ALTSCHULER SM, 1993, GASTROENTEROLOGY, V104, P502; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Koda S, 2005, ENDOCRINOLOGY, V146, P2369, DOI 10.1210/en.2004-1266; Ahrne S, 1998, J APPL MICROBIOL, V85, P88; GORDON HA, 1971, BACTERIOL REV, V35, P390; Nagai K, 2003, EXP BIOL MED, V228, P1138; GEHLERT DR, 1991, BRAIN RES, V553, P149, DOI 10.1016/0006-8993(91)90242-N; Jordan D, 2005, EXP PHYSIOL, V90, P175, DOI 10.1113/expphysiol.2004.029058; Fukumoto S, 2003, AM J PHYSIOL-REG I, V284, pR1269, DOI 10.1152/ajpregu.00442.2002; Ueno N, 2011, INFLAMM BOWEL DIS, V17, P2235, DOI 10.1002/ibd.21597; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Gershon Michael D, 2003, Rev Gastroenterol Disord, V3 Suppl 2, pS25; Hirata T, 2008, NEUROGASTROENT MOTIL, V20, P557, DOI 10.1111/j.1365-2982.2007.01069.x; Horii Y, 2013, NEUROSCI LETT, V539, P32, DOI 10.1016/j.neulet.2013.01.037; Huang C, 1998, J CHROMATOGR B, V716, P251, DOI 10.1016/S0378-4347(98)00274-6; Nagai N, 1996, ENDOCRINOLOGY, V137, P504, DOI 10.1210/en.137.2.504; Nakaita Y., 2013, Food and Nutrition Sciences, V4, P767, DOI 10.4236/fns.2013.48099; Niijima A, 1998, J AUTONOM NERV SYST, V73, P19, DOI 10.1016/S0165-1838(98)00109-X; PRATT GD, 1989, NEUROPHARMACOLOGY, V28, P1367, DOI 10.1016/0028-3908(89)90012-9; SAWCHENKO PE, 1981, SCIENCE, V214, P685, DOI 10.1126/science.7292008; Tanida M, 2007, CURR TOP NUTRACEUT R, V5, P157; Tanida M, 2005, AM J PHYSIOL-REG I, V288, pR447, DOI 10.1152/ajpregu.00275.2004	24	0	0	NEW CENTURY HEALTH PUBLISHERS, LLC	COPPELL	PO BOX 175, COPPELL, TX 75019 USA	1540-7535			CURR TOP NUTRACEUT R	Curr. Top. Nutraceutical Res.	FEB	2015	13	1					47	54				8	Nutrition & Dietetics; Pharmacology & Pharmacy	Nutrition & Dietetics; Pharmacology & Pharmacy	CE8UT	WOS:000352120300006		
J	Numata, S; Ishii, K; Tajima, A; Iga, J; Kinoshita, M; Watanabe, S; Umehara, H; Fuchikami, M; Okada, S; Boku, S; Hishimoto, A; Shimodera, S; Imoto, I; Morinobu, S; Ohmori, T				Numata, Shusuke; Ishii, Kazuo; Tajima, Atsushi; Iga, Jun-ichi; Kinoshita, Makoto; Watanabe, Shinya; Umehara, Hidehiro; Fuchikami, Manabu; Okada, Satoshi; Boku, Shuken; Hishimoto, Akitoyo; Shimodera, Shinji; Imoto, Issei; Morinobu, Shigeru; Ohmori, Tetsuro			Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles: discovery and validation	EPIGENETICS			English	Article						biomarkers; multiplex; blood; DNA methylation; epigenetic; major depressive disorder; microarray	SYNTHASE KINASE 3-BETA; BIPOLAR-DISORDER; ANTIDEPRESSANT TREATMENT; GENES; BDNF; STRESS; BRAIN; SGK1; LIFE; REPLICATION	Aberrant DNA methylation in the blood of patients with major depressive disorder (MDD) has been reported in several previous studies. However, no comprehensive studies using medication-free subjects with MDD have been conducted. Furthermore, the majority of these previous studies has been limited to the analysis of the CpG sites in CpG islands (CGIs) in the gene promoter regions. The main aim of the present study is to identify DNA methylation markers that distinguish patients with MDD from non-psychiatric controls. Genome-wide DNA methylation profiling of peripheral leukocytes was conducted in two set of samples, a discovery set (20 medication-free patients with MDD and 19 controls) and a replication set (12 medication-free patients with MDD and 12 controls), using Infinium HumanMethylation450 BeadChips. Significant diagnostic differences in DNA methylation were observed at 363 CpG sites in the discovery set. All of these loci demonstrated lower DNA methylation in patients with MDD than in the controls, and most of them (85.7%) were located in the CGIs in the gene promoter regions. We were able to distinguish patients with MDD from the control subjects with high accuracy in the discriminant analysis using the top DNA methylation markers. We also validated these selected DNA methylation markers in the replication set. Our results indicate that multiplex DNA methylation markers may be useful for distinguishing patients with MDD from non-psychiatric controls.	[Numata, Shusuke; Iga, Jun-ichi; Kinoshita, Makoto; Watanabe, Shinya; Umehara, Hidehiro; Ohmori, Tetsuro] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Psychiat,Course Integrated Brain Sci,Med Inf, Tokushima 770, Japan; [Ishii, Kazuo] Tokyo Univ Agr & Technol, Fac Agr, Dept Appl Biol Sci, Saiwai Ku, Fuchu, Tokyo 183, Japan; [Tajima, Atsushi; Imoto, Issei] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Human Genet, Tokushima 770, Japan; [Tajima, Atsushi] Kanazawa Univ, Grad Sch Med Sci, Dept Bionformat & Genom, Kanazawa, Ishikawa 9201192, Japan; [Fuchikami, Manabu; Okada, Satoshi; Morinobu, Shigeru] Hiroshima Univ, Appl Life Sci Inst Biomed & Hlth Sci, Dept Psychiat & Neurosci, Hiroshima, Japan; [Boku, Shuken; Hishimoto, Akitoyo] Kobe Univ, Grad Sch Med, Dept Psychiat, Kobe, Hyogo 657, Japan; [Shimodera, Shinji; Morinobu, Shigeru] Kochi Univ, Kochi Med Sch, Dept Neuropsychiat, Kochi 780, Japan	Numata, S (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Psychiat,Course Integrated Brain Sci,Med Inf, Tokushima 770, Japan.	shu-numata@umin.ac.jp	Tajima, Atsushi/C-1053-2008	Tajima, Atsushi/0000-0001-6808-5491	Health and Labor Science Research Grant from the Japanese Ministry of Health, Labor and welfare; SENSHIN Medical Research Foundation	This work was supported by a Health and Labor Science Research Grant from the Japanese Ministry of Health, Labor and welfare, and SENSHIN Medical Research Foundation. The all authors report no biomedical financial interests or potential conflicts of interest.	Melas PA, 2012, INT J NEUROPSYCHOPH, V15, P669, DOI 10.1017/S1461145711000940; Schniepp R, 2004, INVEST OPHTH VIS SCI, V45, P1442, DOI 10.1167/iovs.03-0062; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lang F, 2010, J PHYSIOL-LONDON, V588, P3349, DOI 10.1113/jphysiol.2010.190926; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Manji HK, 1999, BIOL PSYCHIAT, V46, P1328, DOI 10.1016/S0006-3223(99)00235-8; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Li XH, 2004, NEUROPSYCHOPHARMACOL, V29, P1426, DOI 10.1038/sj.npp.1300439; Anacker C, 2011, PSYCHONEUROENDOCRINO, V36, P415, DOI 10.1016/j.psyneuen.2010.03.007; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Savitz J, 2013, BRAIN BEHAV IMMUN, V31, P161, DOI 10.1016/j.bbi.2012.10.007; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Papakostas GI, 2013, MOL PSYCHIATR, V18, P332, DOI 10.1038/mp.2011.166; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Park SW, 2009, EUR NEUROPSYCHOPHARM, V19, P356, DOI 10.1016/j.euroneuro.2008.12.012; Park SW, 2011, NEUROSCI RES, V71, P335, DOI 10.1016/j.neures.2011.08.010; D'Addario C, 2012, NEUROPSYCHOPHARMACOL, V37, P1647, DOI 10.1038/npp.2012.10; Anacker C, 2013, P NATL ACAD SCI USA, V110, P8708, DOI 10.1073/pnas.1300886110; Kinoshita M, 2013, NEUROMOL MED, V15, P95, DOI 10.1007/s12017-012-8198-6; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Inkster B, 2009, ARCH GEN PSYCHIAT, V66, P721, DOI 10.1001/archgenpsychiatry.2009.70; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Weber H, 2011, NEUROPSYCHOPHARMACOL, V36, P2076, DOI 10.1038/npp.2011.98; Jiang C, 2013, TRANSL NEUROSCI, V4, P46, DOI 10.2478/s13380-013-0103-8; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Zheng P, 2012, J PROTEOME RES, V11, P1741, DOI 10.1021/pr2010082; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Asai T, 2013, INT J NEUROPSYCHOPH, V16, P2285, DOI 10.1017/S1461145713000710; BERRIDGE MJ, 1989, JAMA-J AM MED ASSOC, V262, P1834; Byrne EM, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.45; Dick KJ, 2014, LANCET, P62674; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Fuchikami M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023881; Na KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085425; Oh DH, 2010, PSYCHIAT INVEST, V7, P202, DOI 10.4306/pi.2010.7.3.202; Petronis A, 2000, MOL PSYCHIATR, V5, P342, DOI 10.1038/sj.mp.4000750; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Saus E, 2010, GENES BRAIN BEHAV, V9, P799, DOI 10.1111/j.1601-183X.2010.00617.x; Spijker S, 2010, BIOL PSYCHIAT, V68, P179, DOI 10.1016/j.biopsych.2010.03.017; Tsai SJ, 2008, PHARMACOGENOMICS J, V8, P384, DOI 10.1038/sj.tpj.6500486; Zhang KR, 2010, J NEURAL TRANSM, V117, P393, DOI 10.1007/s00702-009-0360-4; Zill P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040479	45	3	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1559-2294	1559-2308		EPIGENETICS-US	Epigenetics	FEB	2015	10	2					135	141		10.1080/15592294.2014.1003743		7	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CE1XR	WOS:000351606700004		
J	Iwata, K; Yoo, CM				Iwata, Kengo; Yoo, Chul-Moon			Impact of small-scale inhomogeneities on observations of standard candles	EPL			English	Article							INTERGALACTIC MEDIUM; UNIVERSES	We investigate the effect of small-scale inhomogeneities on standard candle observations, such as type-Ia supernovae (SNe) observations. The existence of the small-scale inhomogeneities may cause a tension between SNe observations and other observations with larger-diameter sources, such as the cosmic microwave background (CMB) observation. To clarify the impact of the small-scale inhomogeneities, we use the Dyer-Roeder approach. We determined the smoothness parameter a(z) as a function of the redshift z so as to compensate the deviation of cosmological parameters for SNe from those for CMB. The range of the deviation which can be compensated by the smoothness parameter a(z) satisfying 0 <= a(z) <= 1 is reported. Our result suggests that the tension may give us the information of the small-scale inhomogeneities through the smoothness parameter. Copyright (C) EPLA, 2015	[Iwata, Kengo; Yoo, Chul-Moon] Nagoya Univ, Grad Sch Sci, Grav & Particle Cosmol Grp, Div Particle & Astrophys Sci, Nagoya, Aichi 4648602, Japan	Iwata, K (reprint author), Nagoya Univ, Grad Sch Sci, Grav & Particle Cosmol Grp, Div Particle & Astrophys Sci, Nagoya, Aichi 4648602, Japan.	iwata@gravity.phys.nagoya-u.ac.jp; yoo@gravity.phys.nagoya-u.ac.jp					Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; DYER CC, 1972, ASTROPHYS J, V174, pL115, DOI 10.1086/180961; SASAKI M, 1993, PROG THEOR PHYS, V90, P753; Linder EV, 1998, ASTROPHYS J, V497, P28, DOI 10.1086/305468; Fleury P, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.123526; Lima JAS, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.067301; Clarkson C, 2012, MON NOT R ASTRON SOC, V426, P1121, DOI 10.1111/j.1365-2966.2012.21750.x; DYER CC, 1973, ASTROPHYS J, V180, pL31, DOI 10.1086/181146; LINDER EV, 1988, ASTRON ASTROPHYS, V206, P190; Mattsson T, 2010, GEN RELAT GRAVIT, V42, P567, DOI 10.1007/s10714-009-0873-z; Fleury P, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.091302; Busti VC, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.103503; Busti VC, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/11/020; Busti VC, 2012, MON NOT R ASTRON SOC, V426, pL41, DOI 10.1111/j.1745-3933.2012.01319.x; Conley A, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/1/1; Fleury P, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/06/054; SACHS R, 1961, PROC R SOC LON SER-A, V264, P309, DOI 10.1098/rspa.1961.0202; Schneider P., 1992, GRAVITATIONAL LENSES	18	0	0	EPL ASSOCIATION, EUROPEAN PHYSICAL SOCIETY	MULHOUSE	6 RUE DES FRERES LUMIERE, MULHOUSE, 68200, FRANCE	0295-5075	1286-4854		EPL-EUROPHYS LETT	EPL	FEB	2015	109	3							39001	10.1209/0295-5075/109/39001		6	Physics, Multidisciplinary	Physics	CE2QJ	WOS:000351660100035		
J	Romano, AE; Vallejo, SA				Romano, Antonio Enea; Vallejo, Sergio Andres			Directional dependence of the local estimation of H-0 and the nonperturbative effects of primordial curvature perturbations	EPL			English	Article							HUBBLE CONSTANT; UNIVERSE; MODELS	Recent measurements of the cosmic microwave background (CMB) radiation have shown an apparent tension with the present value of the Hubble parameter inferred from local observations of supernovae, which look closer, i.e. brighter, than what is expected in a homogeneous model with a value of H-0 equal to the one estimated from CMB observations. We examine the possibility that such a discrepancy is the consequence of the presence of a local inhomogeneity seeded by primordial curvature perturbations, finding that a negative peak of the order of less than two standard deviations could allow to fit low-redshift supernovae observations without the need of using a value of the Hubble parameter different from H-0(CMB). The type of inhomogeneity we consider does not modify the distance to the last scattering, making it compatible with the constraints of the PLANCK mission data. The effect on the luminosity distance is in fact localized around the region in space where the transition between different values of the curvature perturbations occurs, producing a local decrease, while the distance outside the inhomogeneity is not affected. Our calculation is fully relativistic and nonperturbative, and for this reason shows important effects which were missed in the previous investigations using relativistic perturbations or Newtonian approximations, because the structures seeded by primordial curvature perturbations can be today highly nonlinear, and relativist Doppler terms cannot be neglected. Because of these effects the correction to the luminosity distance necessary to explain observations is associated to a compensated structure which involves both an underdense central region and an overdense outer shell, ensuring that the distance to the last scattering surface is unaffected. Comparison with studies of local structure based on galaxy surveys analysis reveals that the density profile we find could in fact be compatible with the one obtained for the same region of sky where most of the supernovae used for the local H-0 estimation are located, suggesting a possible directional dependence which could be partially attributed to the presence of the Sloan Great Wall and hinting to the need of a more careful investigation, including a wider set of low-redshift supernovae in different regions of the sky. Copyright (C) EPLA, 2015	[Romano, Antonio Enea] Kyoto Univ, Yukawa Inst Theoret Phys, Kyoto 6068502, Japan; [Romano, Antonio Enea; Vallejo, Sergio Andres] Univ Crete, Dept Phys, Iraklion 71110, Greece; [Romano, Antonio Enea; Vallejo, Sergio Andres] Univ Crete, CCTP, Iraklion 71110, Greece; [Romano, Antonio Enea] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Romano, Antonio Enea; Vallejo, Sergio Andres] Univ Antioquia, Inst Fis, Medellin, Colombia	Romano, AE (reprint author), Kyoto Univ, Yukawa Inst Theoret Phys, Kyoto 6068502, Japan.				European Union (European Social Fund, ESF); Greek national funds under the "ARISTEIA II" Action; Dedicacion exclusiva and Sostenibilidad programs at UDEA; UDEA CODI project [IN10219CE]	AER thanks RYAN KEENAN and LICIA VERDE for useful comments and discussions, the Department of Physics of Heidelberg University for the kind hospitality, and LUCA AMENDOLA, VALERIA PETTORINO and MIGUEL ZUMALACARREGUI for insightful discussions. This work was supported by the European Union (European Social Fund, ESF) and Greek national funds under the "ARISTEIA II" Action, the Dedicacion exclusiva and Sostenibilidad programs at UDEA, the UDEA CODI project IN10219CE. The authors thank the anonymous referee for useful comments to improve the manuscript.	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Tolman RC, 1934, P NATL ACAD SCI USA, V20, P169, DOI 10.1073/pnas.20.3.169; BARDEEN JM, 1986, ASTROPHYS J, V304, P15, DOI 10.1086/164143; Wang Y, 1998, ASTROPHYS J, V498, P1, DOI 10.1086/305539; Romano AE, 2012, EUR PHYS J C, V72, DOI 10.1140/epjc/s10052-012-2242-4; Shi XD, 1998, ASTROPHYS J, V493, P519, DOI 10.1086/305169; Bolejko K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.021302; Verde L, 2013, PHYS DARK UNIVERSE, V2, P166, DOI 10.1016/j.dark.2013.09.002; BONDI H, 1947, MON NOT R ASTRON SOC, V107, P410; Ben-Dayan I, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.221301; Gott JR, 2005, ASTROPHYS J, V624, P463, DOI 10.1086/428890; Keenan RC, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/62; Lemaitre G, 1997, GEN RELAT GRAVIT, V29, P641; Marra V, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.241305; Riess AG, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/119; Romano A. E., 2013, ARXIV13111476; Romano A. E., 2012, ARXIV12040866; Romano A. E., 2012, ARXIV12075572; Romano AE, 2011, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2011/10/016; Wojtak R., 2013, ARXIV13120276	20	0	0	EPL ASSOCIATION, EUROPEAN PHYSICAL SOCIETY	MULHOUSE	6 RUE DES FRERES LUMIERE, MULHOUSE, 68200, FRANCE	0295-5075	1286-4854		EPL-EUROPHYS LETT	EPL	FEB	2015	109	3							39002	10.1209/0295-5075/109/39002		6	Physics, Multidisciplinary	Physics	CE2QJ	WOS:000351660100036		
J	Yamamoto, T; Kuroda, M; Sano, M				Yamamoto, T.; Kuroda, M.; Sano, M.			Three-dimensional analysis of thermo-mechanically rotating cholesteric liquid crystal droplets under a temperature gradient	EPL			English	Article							POLARIZING MICROSCOPY; CHIRALITY; ORDER	We studied the rotational motion of cholesteric liquid crystal droplets under a temperature gradient (the Lehmann effect). We found that different surface treatments, planar and homeotropic anchoring, provided three types of droplets with different textures and geometries. The rotational velocity of these droplets depends differently on their size. Determining the three-dimensional structures of these droplets by the fluorescence confocal polarizing microscopy, we propose a phenomenological equation to explain the rotational behavior of these droplets. This result shows that the description by the Ericksen-Leslie theory should be valid in the bulk of the droplet, but we need to take into account the surface torque induced by temperature gradient to fully understand the Lehmann effect. Copyright (C) EPLA, 2015	[Yamamoto, T.; Kuroda, M.; Sano, M.] Univ Tokyo, Grad Sch Sci, Dept Phys, Tokyo 1130033, Japan	Yamamoto, T (reprint author), Univ Tokyo, Grad Sch Sci, Dept Phys, Tokyo 1130033, Japan.	tyamamoto@daisy.phys.s.u-tokyo.ac.jp			JSPS; MEXT KAKENHI [24244063, 25103004];  [26.9814]	We thank H. R. Brand, K. Kawaguchi, Y. Nakayama and K. A. Takeuchi for fruitful discussions. This work is supported by the JSPS Core-to-Core Program "Non-equilibrium dynamics of soft matter and information", Grant-in-Aid for JSPS Fellows (Grant No. 26.9814), and MEXT KAKENHI Grant Nos. 24244063 and 25103004.	Akopyan R. S., 1984, SOV PHYS JETP, V59, P953; Yoshioka J, 2014, SOFT MATTER, V10, P5869, DOI 10.1039/c4sm00670d; Yang SY, 2012, CHEM COMMUN, V48, P2861, DOI 10.1039/c2cc17861c; Cherstvy AG, 2008, J PHYS CHEM B, V112, P12585, DOI 10.1021/jp801220p; Lee T, 2010, OPT LETT, V35, P3447, DOI 10.1364/OL.35.003447; Marinelli M, 1998, PHYS REV E, V58, P5860, DOI 10.1103/PhysRevE.58.5860; Dogic Z, 2000, LANGMUIR, V16, P7820, DOI 10.1021/la000446t; Smalyukh II, 2001, CHEM PHYS LETT, V336, P88, DOI 10.1016/S0009-2614(00)01471-8; Humar M, 2010, OPT EXPRESS, V18, P26995, DOI 10.1364/OE.18.026995; Bernardino NR, 2014, SOFT MATTER, V10, P9399, DOI 10.1039/c4sm01857e; BRAND HR, 1988, PHYS REV A, V37, P2736, DOI 10.1103/PhysRevA.37.2736; de Gennes P. G., 1993, PHYS LIQUID CRYSTALS; de Groot S.R, 1984, NONEQUILIBRIUM THERM; Lamb H., 1945, HYDRODYNAMICS; LAVRENTOVICH OD, 1987, UKR FIZ ZH+, V32, P710; Lehmann O, 1900, ANN PHYS-BERLIN, V2, P649; Oswald P, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061703; Oswald P, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022509; Oswald P, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12010-5; Oswald P, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.217802; Sarman S, 1999, J CHEM PHYS, V110, P12218, DOI 10.1063/1.479159; Svensek D, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.021703; Tkachenko G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4577; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005; Zola RS, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.057801	25	0	0	EPL ASSOCIATION, EUROPEAN PHYSICAL SOCIETY	MULHOUSE	6 RUE DES FRERES LUMIERE, MULHOUSE, 68200, FRANCE	0295-5075	1286-4854		EPL-EUROPHYS LETT	EPL	FEB	2015	109	4							46001	10.1209/0295-5075/109/46001		6	Physics, Multidisciplinary	Physics	CE6NS	WOS:000351955600020		
J	Miyazaki, S; Taniguchi, H; Kusa, S; Komatsu, Y; Ichihara, N; Takagi, T; Iwasawa, J; Kuroi, A; Nakamura, H; Hachiya, H; Hirao, K; Iesaka, Y				Miyazaki, Shinsuke; Taniguchi, Hiroshi; Kusa, Shigeki; Komatsu, Yuki; Ichihara, Noboru; Takagi, Takamitsu; Iwasawa, Jin; Kuroi, Akio; Nakamura, Hiroaki; Hachiya, Hitoshi; Hirao, Kenzo; Iesaka, Yoshito			Catheter ablation of atrial tachyarrhythmias causing inappropriate implantable cardioverter-defibrillator shocks	EUROPACE			English	Article						Implantable cardioverter-defibrillator; Inappropriate shock; Catheter ablation; Atrial tachyarrhythmias	QUALITY-OF-LIFE; DUAL-CHAMBER; SUPRAVENTRICULAR TACHYCARDIA; RANDOMIZED-TRIAL; PULMONARY VEINS; BETA-BLOCKERS; FIBRILLATION; THERAPY; PREVENTION; SINGLE	Aims Inappropriate shocks have been an important issue post-implantable cardioverter-defibrillator (ICD) implantation. Moreover, inappropriate ICD shocks are associated with increased mortality. The objective of this study was to evaluate the feasibility of catheter ablation therapy for atrial tachyarrhythmias (ATa) responsible for inappropriate ICD shocks. Methods and results Among 108 consecutive patients who underwent ICD implantations, 22, 5, and 3 experienced inappropriate ICD shocks due to ATa, sinus tachycardia, and T-wave oversensing, respectively. Among the 22 patients with ATa, 18 patients (55 +/- 10 years, 15 men, structural heart disease in 9) underwent catheter ablation of ATa causing inappropriate shocks. The median duration between the ICD implantation and first inappropriate shock was 10.0 (3.0-24.5) months. The ATa were atrial fibrillation (AF), atrial flutter (AFL), and atrioventricular nodal reentrant tachycardia in 14, 2, and 2 patients, respectively. One patient underwent an atrioventricular nodal ablation for persistent AF associated with a venous anomaly. Among 13 patients who underwent pulmonary vein antrum isolation, 10 (76.9%) were free from AF for a median of 21.0 (13-37.3) months after an average of 1.3 +/- 0.5 procedures. In four patients with AFL or a supraventricular tachycardia, none had any arrhythmia recurrence for a median of 6.0 (3.3-93.5) months after a cavotricuspid isthmus or slow pathway ablation, respectively. There were no procedural complications. During the median follow-up of 19.0 (9.5-37.3) months after the last procedure, no patients experienced any inappropriate shocks. Conclusion Catheter ablation is a feasible therapeutic option for treating ATa responsible for inappropriate shock(s) in patients with ICD.	[Miyazaki, Shinsuke; Taniguchi, Hiroshi; Kusa, Shigeki; Komatsu, Yuki; Ichihara, Noboru; Takagi, Takamitsu; Iwasawa, Jin; Kuroi, Akio; Nakamura, Hiroaki; Hachiya, Hitoshi; Iesaka, Yoshito] Tsuchiura Kyodo Gen Hosp, Cardiovasc Ctr, Cardiol Div, Tsuchiura, Ibaraki 3000053, Japan; [Hirao, Kenzo] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Tokyo 1138510, Japan	Miyazaki, S (reprint author), Tsuchiura Kyodo Gen Hosp, Cardiovasc Ctr, Cardiol Div, 11-7 Manabeshin Machi, Tsuchiura, Ibaraki 3000053, Japan.	mshinsuke@k3.dion.ne.jp					van Rees JB, 2011, J AM COLL CARDIOL, V57, P556, DOI 10.1016/j.jacc.2010.06.059; Arentz T, 2007, CIRCULATION, V115, P3057, DOI 10.1161/CIRCULATIONAHA.107.690578; Theuns DAMJ, 2004, J AM COLL CARDIOL, V44, P2362, DOI 10.1016/j.jacc.2004.09.039; Sweeney MO, 2005, CIRCULATION, V111, P2898, DOI 10.1161/CIRCULATIONAHA.104.526673; Connolly SJ, 2006, JAMA-J AM MED ASSOC, V295, P165, DOI 10.1001/jama.295.2.165; Rosenqvist M, 1998, CIRCULATION, V98, P663; Deisenhofer I, 2001, J CARDIOVASC ELECTR, V12, P134, DOI 10.1046/j.1540-8167.2001.00134.x; Shah D, 2000, CIRCULATION, V102, P1517; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Epstein AE, 2013, CIRCULATION, V127, pE283, DOI 10.1161/CIR.0b013e318276ce9b; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Brodine WN, 2005, AM J CARDIOL, V96, P691, DOI 10.1016/j.amjcard.2005.04.046; Friedman PA, 2006, CIRCULATION, V113, P2871, DOI 10.1161/CIRCULATIONAHA.105.594531; Nault I, 2010, EUR HEART J, V31, P1046, DOI 10.1093/eurheartj/ehq079; Sacher F, 2006, CIRCULATION, V114, P2317, DOI 10.1161/CIRCULATIONAHA.106.628537; Schron EB, 2002, CIRCULATION, V105, P589, DOI 10.1161/hc0502.103330; Daubert JP, 2008, J AM COLL CARDIOL, V51, P1357, DOI 10.1016/j.jacc.2007.09.073; Miyazaki S, 2011, HEART, V97, P668, DOI 10.1136/hrt.2009.186874; Friedman PA, 2014, EUROPACE, V16, P1460, DOI 10.1093/europace/euu022; Jais P, 2009, J CARDIOVASC ELECTR, V20, P480, DOI 10.1111/j.1540-8167.2008.01373.x; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Korte T, 2001, PACE, V24, P1061, DOI 10.1046/j.1460-9592.2001.01061.x; Kosiuk J, 2014, EUROPACE, V16, P1322, DOI 10.1093/europace/euu018; Mainigi SK, 2012, AM J CARDIOL, V109, P231, DOI 10.1016/j.amjcard.2011.08.035; Vollmann D, 2005, HEART RHYTHM, V2, P307, DOI 10.1016/j.hrthm.2004.11.019	25	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1099-5129	1532-2092		EUROPACE	Europace	FEB 1	2015	17	2					289	294		10.1093/europace/euu185		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE1VU	WOS:000351601600021		
J	Takada, J; Miyamoto, JJ; Yokota, T; Ono, T; Moriyama, K				Takada, Jun-ichi; Miyamoto, Jun J.; Yokota, Toshiaki; Ono, Takashi; Moriyama, Keiji			Comparison of the mandibular hinge axis in adult patients with facial asymmetry with and without posterior unilateral crossbite	EUROPEAN JOURNAL OF ORTHODONTICS			English	Article							CLASS-III MALOCCLUSION; CEPHALOMETRIC NORMS; MAXILLARY IMPACTION; SKELETAL ASYMMETRY; BITE PATIENTS; AUTOROTATION; CADIAX(R); PATH	Background/Objectives: Although it has been suggested that adult patients with facial asymmetry with posterior unilateral crossbite (PUXB) may have a more tilted mandibular hinge axis (MHA) than those without PUXB, whether craniofacial morphology is associated with the MHA remains unclear. The purpose of this study was to compare the craniofacial morphology and MHA in adult subjects with post-growth facial asymmetry with and without PUXB. Subjects/Methods: Thirty pre-orthodontic patients (PUXB and non-PUXB groups, n = 15 each, 9 females and 6 males, mean age: 23.2 years) participated in the study. The MHA was measured by computerized axiography and duplicated on posteroanterior and submentovertex cephalometric radiographs. Morphological asymmetry was evaluated for both skeletal and dental components and positional deviation of the mandible by cephalometric analysis. The Mann-Whitney U-test and Spearman's correlation coefficient by rank were used for statistical analysis. The level of statistical significance was set at P < 0.05. Results: Significant differences in both skeletal and dental components were found between the PUXB and non-PUXB groups. In both the frontal and horizontal dimensions, the inclination of the MHA towards the mandibular shifted side was greater in the PUXB group than in the non-PUXB group. Conclusions/Implications: The present findings suggest that facially asymmetric adult subjects with malocclusions associated with PUXB exhibit not only mandibular asymmetry but also remodelling of the condylar head and glenoid fossa that accompanies the three-dimensional shifting of the MHA.	[Takada, Jun-ichi; Miyamoto, Jun J.; Yokota, Toshiaki; Moriyama, Keiji] Tokyo Med & Dent Univ, Grad Sch, Maxillofacial Orthognath, Tokyo 1138549, Japan; [Ono, Takashi] Tokyo Med & Dent Univ, Grad Sch, Orthodont Sci, Tokyo 1138549, Japan	Miyamoto, JJ (reprint author), Tokyo Med & Dent Univ, Grad Sch, Maxillofacial Orthognath, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	mjmort@tmd.ac.jp			Japan Society for the Promotion of Science [22792036, 25862001]; 'International Research Center for Molecular Science in Tooth and Bone Diseases', part of the Japanese Ministry of Education, Global Center of Excellence Program	Grants-in-Aid for Scientific Research Projects from the Japan Society for the Promotion of Science (#22792036, 25862001) and the 'International Research Center for Molecular Science in Tooth and Bone Diseases', part of the Japanese Ministry of Education, Global Center of Excellence Program.	Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; SCHMID W, 1991, AM J ORTHOD DENTOFAC, V100, P19, DOI 10.1016/0889-5406(91)70045-X; Baek SH, 2007, ORAL SURG ORAL MED O, V104, P628, DOI 10.1016/j.tripleo.2007.03.002; FORSBERG CT, 1984, AM J ORTHOD DENTOFAC, V85, P224, DOI 10.1016/0002-9416(84)90062-9; LETZER GM, 1967, ANGLE ORTHOD, V37, P205, DOI 10.1043/0003-3219(1967)037&lt;0205:APCEOC&gt;2.0.CO;2; Kecik D, 2007, AM J ORTHOD DENTOFAC, V131, P202, DOI 10.1016/j.ajodo.2005.03.030; PIRTTINIEMI P, 1990, EUR J ORTHODONT, V12, P408; Kusayama M, 2003, AM J ORTHOD DENTOFAC, V123, P329, DOI 10.1067/mod.2003.41; Al-Azemi R, 2012, EUR J ORTHODONT, V34, P312, DOI 10.1093/ejo/cjr007; THILANDER B, 1984, EUR J ORTHODONT, V6, P25; Baccetti T, 2005, SEMIN ORTHOD, V11, P119, DOI DOI 10.1053/J.SODO.2005.04.005; Brian L.O., 1995, AM J ORTHOD DENTOFAC, V107, P394; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cook J T, 1980, Br J Orthod, V7, P33; Gsellmann B, 1998, J ORAL REHABIL, V25, P146, DOI 10.1046/j.1365-2842.1998.00198.x; Guilherme R.P.J., 2001, AM J ORTHOD DENTOFAC, V107, P397; Han BJ, 2010, INT J ORAL SCI, V2, P208, DOI 10.4248/IJOS10071; Hashimoto K, 2008, ORTHOD CRANIOFAC RES, V11, P74, DOI 10.1111/j.1601-6343.2007.00412.x; Jamilian A, 2009, J CRANIOFAC SURG, V20, P841, DOI 10.1097/SCS.0b013e3181a14d8b; Kanomi R, 2004, J DENT RES, V83, P109; Kim HO, 2013, KOREAN J ORTHOD, V43, P209, DOI 10.4041/kjod.2013.43.5.209; KUROL J, 1992, European Journal of Orthodontics, V14, P173; Langberg BJ, 2005, AM J ORTHOD DENTOFAC, V127, P6, DOI 10.1016/j.ajodo.2004.10.044; Mantout B., 2008, INT J STOMAT OCC MED, V1, P45; MIMURA H, 1994, CRANIO, V12, P161; Nadjmi N, 1998, J ORAL MAXIL SURG, V56, P1241, DOI 10.1016/S0278-2391(98)90599-7; Okeson J.P., 2007, MANAGEMENT TEMPOROMA, P81; Pinto A.S., 2001, AM J ORTHOD DENTOFAC, V120, P13; REKOW ED, 1993, AM J ORTHOD DENTOFAC, V103, P530; Severt T R, 1997, Int J Adult Orthodon Orthognath Surg, V12, P171; Shigefuji R., 2001, JAPANESE J JAW DEFOR, V11, P11; Slavicek R, 1988, J Clin Orthod, V22, P776; Slavicek R, 1989, J Clin Orthod, V23, P42; Takada J, 2011, EUR J ORTHODONT, V33, P243, DOI 10.1093/ejo/cjq060; Uysal T, 2005, AM J ORTHOD DENTOFAC, V128, P724, DOI 10.1016/j.ajodo.2004.09.027; Wang YC, 2006, J CRANIOFAC SURG, V17, P898, DOI 10.1097/01.scs.0000234985.99863.97	36	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0141-5387	1460-2210		EUR J ORTHODONT	Eur. J. Orthodont.	FEB	2015	37	1					22	27		10.1093/ejo/cju009		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE7HV	WOS:000352010700003		
J	Hakami, Z; Kitaura, H; Kimura, K; Ishida, M; Sugisawa, H; Ida, H; Jafari, S; Takano-Yamamoto, T				Hakami, Zaki; Kitaura, Hideki; Kimura, Keisuke; Ishida, Masahiko; Sugisawa, Haruki; Ida, Hiroto; Jafari, Saeed; Takano-Yamamoto, Teruko			Effect of interleukin-4 on orthodontic tooth movement and associated root resorption	EUROPEAN JOURNAL OF ORTHODONTICS			English	Article							MEDIATED OSTEOCLAST FORMATION; IN-VIVO; PROINFLAMMATORY CYTOKINES; PERIODONTAL-DISEASE; MECHANICAL-STRESS; BONE-RESORPTION; DEFICIENT MICE; STROMAL CELLS; GENE-THERAPY; TISSUE	Objectives: Interleukin-4 (IL-4) is a recognized immunomodulatory cytokine that regulates bone homeostasis. However, the influence of IL-4 on orthodontic tooth movement (OTM) and subsequent root resorption is still unknown. Therefore, the purpose of this study was to investigate the effect of IL-4 on tooth movement and its associated root resorption in a mouse model. Materials and methods: The maxillary first molars of four male mice for each experimental group were subjected to mesial force by a nickel titanium coil spring for 12 days. Control mice were not given appliances and injections. Varying doses of IL-4 were injected locally, adjacent to the first molar. Two sets of experiments were designed. The first set was composed of three groups: the control, treatment with phosphate-buffered saline (PBS), or 1.5 mu g/day of IL-4. The second set was composed of five groups: the control, treatment with 0 (PBS only), 0.015, 0.15, or 1.5 mu g/day of IL-4. The distance of OTM was measured and tartrate-resistant acid phosphatase positive cells along the loaded alveolar bone and root surface were identified. The root resorption associated with OTM was evaluated by a scanning electron microscope. Results: The amount of OTM and the number of osteoclasts were significantly decreased in the IL-4-treated mice. Moreover, IL-4 significantly suppressed force-induced odontoclasts and root resorption. Conclusion: IL-4 inhibits tooth movement and prevents root resorption in the mouse model. These results suggest that IL-4 could be used as a useful adjunct to regulate the extent of OTM and also to control root resorption.	[Hakami, Zaki; Kitaura, Hideki; Kimura, Keisuke; Ishida, Masahiko; Sugisawa, Haruki; Ida, Hiroto; Jafari, Saeed; Takano-Yamamoto, Teruko] Tohoku Univ, Grad Sch Dent, Dept Translat Med, Div Orthodont & Dentofacial Orthopaed,Aoba Ku, Sendai, Miyagi 9808575, Japan	Takano-Yamamoto, T (reprint author), Tohoku Univ, Grad Sch Dent, Dept Translat Med, Div Orthodont & Dentofacial Orthopaed,Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	t-yamamo@m.tohoku.ac.jp			Japan Society for the Promotion of Science [23249085, 24593075]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science (23249085 and 24593075); The Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alhashimi N, 2001, AM J ORTHOD DENTOFAC, V119, P307, DOI 10.1067/mod.2001.110809; Andrade I., 2012, SEMINARS ORTHODONTIC, V18, P257; Yoshimatsu M, 2006, J BONE MINER METAB, V24, P20, DOI 10.1007/s00774-005-0641-4; Fuller K, 2002, ENDOCRINOLOGY, V143, P1108, DOI 10.1210/en.143.3.1108; Harris DA, 2006, AM J ORTHOD DENTOFAC, V130, P639, DOI 10.1016/j.ajodo.2005.01.029; Kitaura H, 2005, J CLIN INVEST, V115, P3418, DOI 10.1172/JCI26132; Gonzales C, 2008, ANGLE ORTHOD, V78, P502, DOI 10.2319/052007-240.1; MUNDY GR, 1993, J CELL BIOCHEM, V53, P296, DOI 10.1002/jcb.240530405; Andrade I, 2007, J DENT RES, V86, P1089; Wei S, 2002, J BIOL CHEM, V277, P6622, DOI 10.1074/jbc.M104957200; Fujii T, 2012, BONE, V51, P771, DOI 10.1016/j.bone.2012.06.024; Kitaura H, 2003, IMMUNOL LETT, V88, P193, DOI 10.1016/S0165-2478(03)00082-8; Grant M, 2013, EUR J ORTHODONT, V35, P644, DOI 10.1093/ejo/cjs057; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Fujimura Y, 2009, EUR J ORTHODONT, V31, P572, DOI 10.1093/ejo/cjp068; Kitaura H, 2004, J IMMUNOL, V173, P4838; Meikle MC, 2006, EUR J ORTHODONT, V28, P221, DOI 10.1093/ejo/cj1001; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Oshiro T, 2002, ANAT REC, V266, P218, DOI 10.1002/ar.10061; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Sasaki T, 2003, MICROSC RES TECHNIQ, V61, P483, DOI 10.1002/jemt.10370; Giannopoulou C, 2003, J CLIN PERIODONTOL, V30, P145, DOI 10.1034/j.1600-051X.2003.300201.x; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Krishnan V, 2009, J DENT RES, V88, P597, DOI 10.1177/0022034509338914; Casa MA, 2006, ANGLE ORTHOD, V76, P1015, DOI 10.2319/071505-233; BRUDVIK P, 1994, EUR J ORTHODONT, V16, P249; Brudvik P, 1993, Eur J Orthod, V15, P467; BRUDVIK P, 1994, EUR J ORTHODONT, V16, P265; Chung CJ, 2008, J CELL PHYSIOL, V214, P614, DOI 10.1002/jcp.21250; Giannopoulou C, 2008, ACTA ODONTOL SCAND, V66, P169, DOI 10.1080/00016350802123126; Harokopakis-Hajishengallis Evlambia, 2007, J Oral Sci, V49, P1, DOI 10.2334/josnusd.49.1; Kitaura H, 2008, J DENT RES, V87, P396; Kitaura H, 2009, ANGLE ORTHOD, V79, P835, DOI 10.2319/080708-412.1; Lubberts E, 2000, J CLIN INVEST, V105, P1697, DOI 10.1172/JCI7739; Masella RS, 2006, AM J ORTHOD DENTOFAC, V129, P458, DOI 10.1016/j.ajoda.2005.12.013; NAGASAKI K, 1991, BIOCHEM BIOPH RES CO, V178, P694, DOI 10.1016/0006-291X(91)90163-2; NAKANO Y, 1994, J BONE MINER RES, V9, P1533; Pradeep AR, 2008, J PERIODONTAL RES, V43, P712, DOI 10.1111/j.1600-0765.2007.01079.x; SHAPIRA L, 1992, MED HYPOTHESES, V39, P319, DOI 10.1016/0306-9877(92)90056-I; Terai K, 1999, J BONE MINER RES, V14, P839, DOI 10.1359/jbmr.1999.14.6.839; Woods JM, 2001, J IMMUNOL, V166, P1214; Yoshimatsu M, 2012, ARCH ORAL BIOL, V57, P36, DOI 10.1016/j.archoralbio.2011.07.006	42	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0141-5387	1460-2210		EUR J ORTHODONT	Eur. J. Orthodont.	FEB	2015	37	1					87	94		10.1093/ejo/cju016		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE7HV	WOS:000352010700013		
J	Nihara, J; Gielo-Perczak, K; Cardinal, L; Saito, I; Nanda, R; Uribe, F				Nihara, Jun; Gielo-Perczak, Krystyna; Cardinal, Lucas; Saito, Isao; Nanda, Ravindra; Uribe, Flavio			Finite element analysis of mandibular molar protraction mechanics using miniscrews	EUROPEAN JOURNAL OF ORTHODONTICS			English	Article							ORTHODONTIC TOOTH MOVEMENT; PERIODONTAL-LIGAMENT; FEM ANALYSIS; ANCHORAGE; RETRACTION; RESISTANCE; SPACE; 2ND	Background/Objectives: The aim of this study was to determine the most desirable force system to achieve molar protraction from an interdental miniscrew minimizing side-effects. Several iterations of force delivery were simulated through variations in the height of a miniscrew, length of a molar extension arm, and incorporation of a lingual force. Materials/Methods: A three-dimensional mesh model of the right posterior segment of the mandible was developed from cone beam computed tomography data from a patient missing a first molar. Protraction appliances were constructed using computer-aided design software and integrated with finite element software. After mesh generation, a total of 80 loading conditions were simulated by altering the extension arm length (2-10 mm), miniscrew height (0-8 mm), and magnitude of protraction force from the lingual side (0-1.5 N). A constant labial force of 1 N was used in all models. Results: As the length of the extension arm increased, mesial tipping decreased, rotation decreased, and buccolingual inclination remained the same without lingual traction force. Lingual traction reduced rotation but increased tipping. Similar trends were observed in all situations despite of the height of the miniscrew. Conclusions: The height of the miniscrew is not as critical in affecting tooth movement during mandibular second molar protraction as the length of the extension arm. The most ideal force system in the model appeared to be the longest extension arm (10 mm) with the addition of a lingual force of half or equal magnitude of the labial force.	[Nihara, Jun; Cardinal, Lucas; Uribe, Flavio] Univ Connecticut, Ctr Hlth, Dept Craniofacial Sci, Div Orthodont, Farmington, CT USA; [Nihara, Jun; Saito, Isao] Niigata Univ, Dept Oral Biol Sci, Div Orthodont, Niigata 9518514, Japan; [Gielo-Perczak, Krystyna] Univ Connecticut, Dept Biomed Engn, Sch Engn, Storrs, CT USA; [Nanda, Ravindra] Univ Connecticut, Sch Dent Med, Dept Craniofacial Sci, Farmington, CT 06032 USA	Nihara, J (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral & Biol Sci, Div Orthodont,Chuo Ku, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.	ni-hara@dent.niigata-u.ac.jp			JSPS Institutional Program for Young Researcher Overseas Visits	This work was supported by the JSPS Institutional Program for Young Researcher Overseas Visits.	Ammar HH, 2011, AM J ORTHOD DENTOFAC, V139, DOI 10.1016/j.ajodo.2010.09.020; Viecilli RF, 2013, J DENT RES, V92, P346, DOI 10.1177/0022034513480794; Van Schepdael A, 2013, MED ENG PHYS, V35, P403, DOI 10.1016/j.medengphy.2012.09.008; Toms SR, 2002, J BIOMECH, V35, P1411, DOI 10.1016/S0021-9290(02)00166-5; Singh S, 2012, AM J ORTHOD DENTOFAC, V141, P327, DOI 10.1016/j.ajodo.2011.07.022; BURSTONE CJ, 1981, J DENT RES, V60, P515; SMITH RJ, 1984, AM J ORTHOD DENTOFAC, V85, P294, DOI 10.1016/0002-9416(84)90187-8; Freudenthaler JW, 2001, CLIN ORAL IMPLAN RES, V12, P358, DOI 10.1034/j.1600-0501.2001.012004358.x; Fill TS, 2012, J BIOMECH, V45, P9, DOI 10.1016/j.jbiomech.2011.09.020; Viecilli RF, 2013, AM J ORTHOD DENTOFAC, V143, P163, DOI 10.1016/j.ajodo.2012.09.010; Baik UB, 2012, AM J ORTHOD DENTOFAC, V141, P783, DOI 10.1016/j.ajodo.2010.07.031; Geramy A, 2011, AUST ORTHOD J, V27, P125; Geramy A, 2013, ACTA ODONTOL SCAND, V71, P570, DOI 10.3109/00016357.2012.700059; Geramy A, 2008, AUST ORTHOD J, V24, P96; Holberg C, 2013, CLIN ORAL INVEST, V17, P1821, DOI 10.1007/s00784-012-0872-4; Holberg C, 2014, CLIN ORAL INVEST, V18, P327, DOI 10.1007/s00784-013-0969-4; Jayade V, 2007, ANGLE ORTHOD, V77, P214, DOI 10.2319/030106-83; Kojima Y, 2012, EUR J ORTHODONT, V34, P10, DOI 10.1093/ejo/cjq164; Kojima Y, 2012, AM J ORTHOD DENTOFAC, V142, P501, DOI 10.1016/j.ajodo.2012.05.014; Kojima Y, 2007, AM J ORTHOD DENTOFAC, V132, P630, DOI 10.1016/j.ajodo.2005.07.035; Kravitz Neal D, 2008, J Clin Orthod, V42, P351; Lombardo Luca, 2012, Prog Orthod, V13, P154, DOI 10.1016/j.pio.2011.10.005; Marcé-Nogué Jordi, 2013, Int J Oral Maxillofac Implants, V28, pe177, DOI 10.11607/jomi.2447; Nagaraj K, 2008, AM J ORTHOD DENTOFAC, V134, P583, DOI 10.1016/j.ajodo.2006.09.055; Sung SJ, 2010, AM J ORTHOD DENTOFAC, V137, P648, DOI 10.1016/j.ajodo.2008.06.036; Uribe F, 2013, ANGLE ORTHOD, V83, P1083, DOI 10.2319/122612-968.1	26	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0141-5387	1460-2210		EUR J ORTHODONT	Eur. J. Orthodont.	FEB	2015	37	1					95	100		10.1093/ejo/cju017		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE7HV	WOS:000352010700014		
J	Motokawa, M; Kaku, M; Matsuda, Y; Oki, N; Sugino, H; Sumi, C; Darendeliler, MA; Tanimoto, K				Motokawa, Masahide; Kaku, Masato; Matsuda, Yayoi; Oki, Nanae; Sugino, Hirotaka; Sumi, Chikako; Darendeliler, M. Ali; Tanimoto, Kotaro			Open bite as a risk factor for orthodontic root resorption Reply	EUROPEAN JOURNAL OF ORTHODONTICS			English	Letter							TOMOGRAPHY		[Motokawa, Masahide; Kaku, Masato; Matsuda, Yayoi; Oki, Nanae; Sugino, Hirotaka; Sumi, Chikako; Tanimoto, Kotaro] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthodont & Craniofacial Dev Biol, Hiroshima 730, Japan; [Darendeliler, M. Ali] Univ Sydney, Dept Orthodont, Sydney, NSW 2006, Australia	Motokawa, M (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthodont & Craniofacial Dev Biol, Hiroshima 730, Japan.						Wang Y, 2013, ORTHOD CRANIOFAC RES, V16, P169, DOI 10.1111/ocr.12016; Aras B, 2012, AM J ORTHOD DENTOFAC, V141, pE29, DOI 10.1016/j.ajodo.2011.07.018	2	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0141-5387	1460-2210		EUR J ORTHODONT	Eur. J. Orthodont.	FEB	2015	37	1					119	120		10.1093/ejo/cju022		3	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE7HV	WOS:000352010700020		
J	Domon, K; Kitamura, Y				Domon, Koji; Kitamura, Yoshihiro			A Survey on Characteristics of Japanese Academic Job Market and Evaluation	EVALUATION REVIEW			English	Article						economic evaluation; design and evaluation of programs and policies; education; content area		Background: During the Meiji era, at the end of the 19th century, Japan introduced western systems into many fields, economically developing later than other industrially developed countries. Japan introduced a higher education system modeled on the German system, focusing not on education but on research. The historical background has shaped contemporary Japanese academia differently from that of the United States and the European Union. In addition, because of geographical and linguistic barriers in Asia, intercommunication with researchers in other developed countries has been much less than that between the United States and the European Union, leaving Japanese academia relatively isolated. Method: We survey the characteristics of the Japanese academic system in higher education, using the latest published data. Result: This article indicates a concentration of research at former imperial universities and a rigidity of movement among universities both internationally and domestically. Furthermore, small differences in salary levels have provided little incentive to perform research. However, while most universities in Japan have not introduced evaluation systems for promotion and salary that are heavily dependent on journal rankings, as in the European Union and United States, Japanese academic performance has not declined. Conclusion: This article suggests that in Japan, salary incentives, the impact factor, and so on have had little influence on academic performance. Even though cultural and historical differences between countries affect academic behaviors, we hope that this article might trigger consideration of other possible evaluation schemes for the future.	[Domon, Koji; Kitamura, Yoshihiro] Waseda Univ, Sch Social Sci, Tokyo 1698050, Japan	Domon, K (reprint author), Waseda Univ, Sch Social Sci, 1-6-1 Nishi Waseda, Tokyo 1698050, Japan.	domon-5stars@waseda.jp			Waseda University [2013C-349]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This paper was partly supported by a Waseda University grant for special research project (2013C-349).	Department of Business Innovation and Skills, 2013, INT COMP PERF UK RES; Ebara T., 2004, KYOTO U RES STUDIES, V50, P22; Flora P., 1995, STATE EC SOC W EUROP; Hata I., 2003, STORY GOVT HIGH SCH; Hosotsubo M., 2010, 60 NAT I SCI TECHN P; Kato M., 2011, 78 NAT I SCI TECHN; Ministry of Education Culture Sports Science and Technology, 2009, COMP AN R D INP OUTP; Ministry of Education Science and Culture, 1972, HIST ED SYST; Ministry of Education Science and Culture, 1962, JAP GROWTH ED; Ministry of Education Science and Culture, 1972, INQ ED AB JAP CONSCR; Muller-Camen M, 2005, ORGAN STUD, V26, P271, DOI 10.1177/0170840605049802; Nishimoto A., 1994, 38 NAT I SCI TECHN P; Rubinger R., 2007, POPULAR LIT EARLY MO; Tsutsui K., 2004, CORRUPTION ACAD ABIL	14	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0193-841X	1552-3926		EVALUATION REV	Eval. Rev.	FEB	2015	39	1			SI		82	101		10.1177/0193841X14565176		20	Social Sciences, Interdisciplinary	Social Sciences - Other Topics	CE3AX	WOS:000351697500004		
J	Anan, M; Shinkoda, K; Suzuki, K; Yagi, M; Ibara, T; Kito, N				Anan, Masaya; Shinkoda, Koichi; Suzuki, Kentaro; Yagi, Masahide; Ibara, Takuya; Kito, Nobuhiro			Do patients with knee osteoarthritis perform sit-to-stand motion efficiently?	GAIT & POSTURE			English	Article						Knee osteoarthritis; Sit-to-stand; Mechanical energy transfer; Power; Energy	ENERGY-TRANSFER; WALKING; STRENGTH; STRATEGIES; MECHANICS; WOMEN; GAIT	The sit-to-stand motion (STS) is a frequently executed activity that is affected by weakness in the quadriceps femoris muscle and knee joint pain in patients with knee osteoarthritis (OA). We investigated whether patients with knee OA can efficiently perform STS through mechanical energy transfer assessments. Participants were 20 women with knee OA and 17 age-matched asymptomatic controls. The center of mass (COM), segment angles, joint moments, and powers during STS were measured. The negative mechanical work in the proximal portion of the shank, negative mean powers in the distal portion of the pelvis and proximal portion of the shank, and the positive mean power in the proximal and distal portions of the thigh were significantly lower in the knee OA group than in the control group. Patients with knee OA primarily performed thoracic forward lean movement, shifting their COM closer to the base of support provided by the feet alone, in an attempt to achieve stability at and after buttocks-off. However, control ability, which generates and absorbs kinetic energy quickly, was not enhanced in these patients, and their motion was unable to increase absorption of the mechanical energy in hip extensors and reduce the load on knee extensors. Furthermore, STS in patients with knee OA had reduced energy absorption in the knee extensors from the shank forward lean movement after buttocks-off, had reduced knee extensor efficiency, and made greater use of physiological energy. These findings suggest that, from the standpoint of mechanical energy transfer, patients with knee OA do not perform STS efficiently. (C) 2014 Elsevier B.V. All rights reserved.	[Anan, Masaya; Shinkoda, Koichi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biomech, Minami Ku, Hiroshima 7348553, Japan; [Suzuki, Kentaro] Nagoya Univ Hosp, Showa Ku, Nagoya, Aichi 4668550, Japan; [Yagi, Masahide] Midorii Orthopaed Joint Reconstruct & Arthroscopy, Asaminami Ku, Hiroshima 7310103, Japan; [Ibara, Takuya] Kawashima Orthopaed Hosp, Nakatsu, Oita 8710012, Japan; [Kito, Nobuhiro] Hiroshima Int Univ, Higashihiroshima, Hiroshima 7370112, Japan	Anan, M (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biomech, Minami Ku, 2-3 Kasumi 1-Chome, Hiroshima 7348553, Japan.	anan@hiroshima-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [21700532]	This study was supported by a Grant-in-Aid 21700532 from the Japan Society for the Promotion of Science (JSPS). We hereby express our sincere appreciation to Dr. Yoshihiro Ehara at Niigata University of Health and Welfare for his advice and guidance throughout this study.	ALTMAN RD, 1987, J RHEUMATOL, V14, P3; Anan M, 2012, J PHYS THER SCI, V24, P231; HUGHES MA, 1994, CLIN BIOMECH, V9, P187, DOI 10.1016/0268-0033(94)90020-5; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Bean JF, 2003, J GERONTOL A-BIOL, V58, P728; Siegel KL, 2004, GAIT POSTURE, V19, P69, DOI 10.1016/S0966-6362(03)00010-9; Hubley-Kozey C, 2008, CLIN BIOMECH, V23, P71, DOI 10.1016/j.clinbiomech.2007.08.019; Andriacchi TP, 2009, J BONE JOINT SURG AM, V91A, P95, DOI 10.2106/JBJS.H.01408; WILLIAMS KR, 1987, J APPL PHYSIOL, V63, P1236; Ploutz-Snyder LL, 2002, J GERONTOL A-BIOL, V57, pB144; ANDRIACCHI TP, 1982, J BONE JOINT SURG AM, V64, P1328; Palmieri-Smith RM, 2010, AM J PHYS MED REHAB, V89, P541, DOI 10.1097/PHM.0b013e3181ddd5c3; DOORENBOSCH CAM, 1994, J BIOMECH, V27, P1299, DOI 10.1016/0021-9290(94)90039-6; Mills K, 2013, CLIN BIOMECH, V28, P713, DOI 10.1016/j.clinbiomech.2013.07.008; Okada H, 1996, BIOMECHANISMS, V13, P125; Patsika G, 2011, J ELECTROMYOGR KINES, V21, P689, DOI 10.1016/j.jelekin.2011.05.006; Robertson D., 2004, RES METHODS BIOMECHA; ROBERTSON DGE, 1980, J BIOMECH, V13, P845; Shum GL, 2009, ARCH PHYS MED REHAB, V90, P127, DOI 10.1016/j.apmr.2008.06.028; Turcot K, 2012, GAIT POSTURE, V36, P68, DOI 10.1016/j.gaitpost.2012.01.005; Winter D. A., 2009, BIOMECHANICS MOTOR C	21	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	FEB	2015	41	2					488	492		10.1016/j.gaitpost.2014.11.015		5	Neurosciences; Orthopedics; Sport Sciences	Neurosciences & Neurology; Orthopedics; Sport Sciences	CE6GC	WOS:000351933700023		
J	Tateuchi, H; Shiratori, S; Ichihashi, N				Tateuchi, Hiroshige; Shiratori, Sakiko; Ichihashi, Noriaki			The effect of angle and moment of the hip and knee joint on iliotibial band hardness	GAIT & POSTURE			English	Article						Posture; Iliotibial band; Hip joint; External joint moment	SHEAR-WAVE ELASTOGRAPHY; BIOMECHANICAL FACTORS; GASTROCNEMIUS-MUSCLE; RUNNING BIOMECHANICS; RUNNERS; VIVO; MECHANICS; ANATOMY; TISSUE; TRACT	Although several studies have described kinematic deviations such as excessive hip adduction in patients with iliotibial band (ITB) syndrome, the factors contributing to increased ITB hardness remains undetermined, owing to lack of direct in vivo measurement. The purpose of this study was to clarify the factors contributing to an increase in ITB hardness by comparing the ITB hardness between the conditions in which the angle, moment, and muscle activity of the hip and knee joint are changed. Sixteen healthy individuals performed the one-leg standing under five conditions in which the pelvic and trunk inclination were changed in the frontal plane. The shear elastic modulus in the ITB was measured as an indicator of the ITB hardness using shear wave elastography. The three-dimensional joint angle and external joint moment in the hip and knee joints, and muscle activities of the gluteus maximus, gluteus medius, tensor fasciae latae, and vastus lateralis, which anatomically connect to the ITB, were also measured. ITB hardness was significantly increased in the posture with pelvic and trunk inclination toward the contralateral side of the standing leg compared with that in all other conditions (increase of approximately 32% compared with that during normal one-leg standing). This posture increased both the hip adduction angle and external adduction moment at the hip and knee joint, although muscle activities were not increased. Our findings suggest that coexistence of an increased adduction moment at the hip and knee joints with an excessive hip adduction angle lead to an increase in ITB hardness. (C) 2014 Elsevier B.V. All rights reserved.	[Tateuchi, Hiroshige; Ichihashi, Noriaki] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan; [Shiratori, Sakiko] Shiga Univ, Med Sci Hosp, Div Phys Therapy, Rehabil Units, Shiga, Japan	Tateuchi, H (reprint author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan.	tateuchi.hiroshige.8x@kyoto-u.ac.jp					Botanlioglu H, 2013, SKELETAL RADIOL, V42, P659, DOI 10.1007/s00256-012-1520-4; Hamill J, 2008, CLIN BIOMECH, V23, P1018, DOI 10.1016/j.clinbiomech.2008.04.017; Baker RL, 2011, PM&R, V3, P550, DOI 10.1016/j.pmrj.2011.01.002; Akagi R, 2013, MED SCI SPORT EXER, V45, P1348, DOI 10.1249/MSS.0b013e3182850e17; Grau S, 2011, SCAND J MED SCI SPOR, V21, P184, DOI 10.1111/j.1600-0838.2009.01045.x; Kito N, 2010, CLIN BIOMECH, V25, P914, DOI 10.1016/j.clinbiomech.2010.06.008; Maisetti O, 2012, J BIOMECH, V45, P978, DOI 10.1016/j.jbiomech.2012.01.009; Vieira ELC, 2007, ARTHROSCOPY, V23, P269, DOI 10.1016/j.arthro.2006.11.019; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; TERRY GC, 1986, AM J SPORT MED, V14, P39, DOI 10.1177/036354658601400108; Kouzaki M, 2008, EXP BRAIN RES, V188, P153, DOI 10.1007/s00221-008-1426-5; Hug F, 2013, J BIOMECH, V46, P2534, DOI 10.1016/j.jbiomech.2013.07.015; Aubry S, 2013, SKELETAL RADIOL, V42, P1143, DOI 10.1007/s00256-013-1649-9; Foch E, 2014, J BIOMECH, V47, P81, DOI 10.1016/j.jbiomech.2013.10.008; Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033; Koo TK, 2013, J BIOMECH, V46, P2053, DOI 10.1016/j.jbiomech.2013.05.016; Becker I, 2010, CLIN ANAT, V23, P575, DOI 10.1002/ca.20974; Fairclough J, 2007, J SCI MED SPORT, V10, P74, DOI 10.1016/j.jsams.2006.05.017; Fairclough J, 2006, J ANAT, V208, P309, DOI 10.1111/j.1469-7580.2006.00531.x; Feber R, 2010, J ORTHOP SPORT PHYS, V40, P52; Foch E, 2014, J APPL BIOMECH, V30, P58, DOI 10.1123/jab.2013-0051; Goh LA, 2003, J CLIN ULTRASOUND, V31, P239, DOI 10.1002/jcu.10168; Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348; Louw M, 2014, PHYS THER SPORT, V15, P64, DOI 10.1016/j.ptsp.2013.07.002; Miller RH, 2007, GAIT POSTURE, V26, P407, DOI 10.1016/j.gaitpost.2006.10.007; Noehren B, 2007, CLIN BIOMECH, V22, P951, DOI 10.1016/j.clinbiomech.2007.07.001; Noehren B, 2014, J ORTHOP SPORT PHYS, V44, P217, DOI 10.2519/jospt.2014.4991; Potvin JR, 1998, SPINE, V23, P774, DOI 10.1097/00007632-199804010-00006; van der Worp MP, 2012, SPORTS MED, V42, P969, DOI 10.2165/11635400-000000000-00000; Wang HK, 2008, MANUAL THER, V13, P334, DOI 10.1016/j.math.2007.03.002; YOON YS, 1982, J BIOMECH, V15, P905, DOI 10.1016/0021-9290(82)90008-2	31	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	FEB	2015	41	2					522	528		10.1016/j.gaitpost.2014.12.006		7	Neurosciences; Orthopedics; Sport Sciences	Neurosciences & Neurology; Orthopedics; Sport Sciences	CE6GC	WOS:000351933700029		
J	Sakaguchi, M; Shimizu, N; Yanai, T; Stefanyshyn, DJ; Kawakami, Y				Sakaguchi, Masanori; Shimizu, Norifumi; Yanai, Toshimasa; Stefanyshyn, Darren J.; Kawakami, Yasuo			Hip rotation angle is associated with frontal plane knee joint mechanics during running	GAIT & POSTURE			English	Article						Running injury; Patellofemoral pain; Knee abduction; Toe-out	PATELLOFEMORAL PAIN; ADDUCTION MOMENT; STANCE PHASE; KINEMATICS; RUNNERS; FEMALES; OSTEOARTHRITIS; STRENGTH; GAIT	Inability to control lower extremity segments in the frontal and transverse planes resulting in large knee abduction angle and increased internal knee abduction impulse has been associated with patellofemoral pain (PFP). However, the influence of hip rotation angles on frontal plane knee joint kinematics and kinetics remains unclear. The purpose of this study was to explore how hip rotation angles are related to frontal plane knee joint kinematics and kinetics during running. Seventy runners participated in this study. Three-dimensional marker positions and ground reaction forces were recorded with an 8-camera motion analysis system and a force plate while subjects ran along a 25-m runway at a speed of 4 m/s. Knee abduction, hip rotation and toe-out angles, frontal plane lever arm at the knee, internal knee abduction moment and impulse, ground reaction forces and the medio-lateral distance from the ankle joint center to the center of pressure (AJC-CoP) were quantified. The findings of this study indicate that greater hip external rotation angles were associated with greater toe-out angles, longer AJC-CoP distances, smaller internal knee abduction impulses with shorter frontal plane lever arms and greater knee abduction angles. Thus, there appears to exist a conflict between kinematic and kinetic risk factors of PFP, and hip external rotation angle may be a key factor to control frontal plane knee joint kinematics and kinetics. These results may help provide an appropriate manipulation and/or intervention on running style to reduce the risk of PFP. (C) 2014 Elsevier B.V. All rights reserved.	[Sakaguchi, Masanori; Shimizu, Norifumi] Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Saitama 3591192, Japan; [Sakaguchi, Masanori; Stefanyshyn, Darren J.] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada; [Yanai, Toshimasa; Kawakami, Yasuo] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama 3591192, Japan	Kawakami, Y (reprint author), Waseda Univ, Fac Sport Sci, 2-579-15 Mikajima, Tokorozawa, Saitama 3591192, Japan.	ykawa@waseda.jp			Waseda University Global COE Program "Sport Sciences for the Promotion of Active Life''	This study was partly supported by Waseda University Global COE Program "Sport Sciences for the Promotion of Active Life'' and the research partnership with adidas Japan K.K.	Ae M, 1992, BIOMECHANISMS, V11, P23; Andrews M, 1996, J ORTHOPAED RES, V14, P289, DOI 10.1002/jor.1100140218; Myer GD, 2010, CLIN BIOMECH, V25, P700, DOI 10.1016/j.clinbiomech.2010.04.001; SODERKVIST I, 1993, J BIOMECH, V26, P1473, DOI 10.1016/0021-9290(93)90098-Y; Dierks TA, 2008, J ORTHOP SPORT PHYS, V38, P448, DOI 10.2519/jospt.2008.2490; Souza RB, 2009, AM J SPORT MED, V37, P579, DOI 10.1177/0363546508326711; Stefanyshyn DJ, 2006, AM J SPORT MED, V34, P1844, DOI 10.1177/0363546506288753; Willson JD, 2008, CLIN BIOMECH, V23, P203, DOI 10.1016/j.clinbiomech.2007.08.025; Ireland ML, 2003, J ORTHOP SPORT PHYS, V33, P671; Noehren B, 2013, MED SCI SPORT EXER, V45, P1120, DOI 10.1249/MSS.0b013e31828249d2; HUBERTI HH, 1984, J BONE JOINT SURG AM, V66A, P715; Willy RW, 2012, MED SCI SPORT EXER, V44, P2165, DOI 10.1249/MSS.0b013e3182629215; Willson JD, 2008, J ORTHOP SPORT PHYS, V38, P606, DOI 10.2519/jospt.2008.2706; Park SK, 2011, CLIN BIOMECH, V26, P392, DOI 10.1016/j.clinbiomech.2010.11.015; Hunt MA, 2006, J BIOMECH, V39, P2213, DOI 10.1016/j.jbiomech.2005.07.002; AREBLAD M, 1990, J BIOMECH, V23, P933, DOI 10.1016/0021-9290(90)90358-A; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136; Jenkyn TR, 2008, J BIOMECH, V41, P276, DOI 10.1016/j.jbiomech.2007.09.015; Powers CM, 2003, J ORTHOP SPORT PHYS, V33, P639; Sakaguchi M, 2014, EUR J SPORT SCI, V14, pS302, DOI 10.1080/17461391.2012.693953; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; TIBERIO D, 1987, Journal of Orthopaedic and Sports Physical Therapy, V9, P160; Vaughan C., 1992, DYNAMICS HUMAN GAIT	23	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	FEB	2015	41	2					557	561		10.1016/j.gaitpost.2014.12.014		5	Neurosciences; Orthopedics; Sport Sciences	Neurosciences & Neurology; Orthopedics; Sport Sciences	CE6GC	WOS:000351933700035		
J	Saito, M; Yano, Y; Hirano, H; Momose, K; Yoshida, M; Azuma, T				Saito, Masaya; Yano, Yoshihiko; Hirano, Hirotaka; Momose, Kenji; Yoshida, Masaru; Azuma, Takeshi			Serum NX-DCP as a New Noninvasive Model to Predict Significant Liver Fibrosis in Chronic Hepatitis C	HEPATITIS MONTHLY			English	Article						Hepatitis C; Chronic; Biopsy; Liver Fibrosis; des-Gamma-Carboxy Prothrombin	EPITHELIAL-MESENCHYMAL TRANSITION; GAMMA-CARBOXY PROTHROMBIN; PLATELET RATIO INDEX; HEPATOCELLULAR-CARCINOMA; VIRUS-INFECTION; CIRRHOSIS; BIOPSY; TESTS; IDENTIFICATION; FIBROGENESIS	Background: Finding a noninvasive method to predict liver fibrosis using inexpensive and easy-to-use markers is important. Objectives: We aimed to clarify whether NX-des-gamma-carboxyprothrombin (NX-DCP) could become a new noninvasive model to predict liver fibrosis in hepatitis C virus (HCV) related liver disease. Patients and Methods: We performed a prospective cohort study on a consecutive group of 101 patients who underwent liver biopsy for HCV-related liver disease at Kobe University Hospital. Laboratory measurements were performed on the same day as the biopsy. Factors associated with significant fibrosis (F3-4) were assessed by multivariate analyses. A comparison of predictive ability between multivariate factors and abovementioned noninvasive models was also performed. Results: Increase in serum NX-DCP was significantly related to increase in fibrosis stage (P = 0.006). Moreover, NX-DCP was a multivariate factor associated with the presence of significant fibrosis F 3-4 (median 21 of F0-2 group vs. median 22 of F3-4 group with P = 0.002). The AUC of NX-DCP showed no significant differences compared with those of the AST-to-platelet ratio index (APRI), modified-APRI, the Goteborg University Cirrhosis Index (GUCI), the Lok index, the Hui score, cirrhosis discriminating score (CDS) and the Pohl score (P > 0.05). Conclusions: NX-DCP correlated positively with fibrosis stage and could discriminate well between HCV-related patients with or without significant fibrosis. Moreover, NX-DCP had a similar predictive ability to the abovementioned models, and thereby could be a new noninvasive prediction tool for fibrosis.	[Saito, Masaya; Yano, Yoshihiko; Hirano, Hirotaka; Momose, Kenji; Yoshida, Masaru; Azuma, Takeshi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Hyogo 657, Japan; [Yano, Yoshihiko] Kobe Univ, Grad Sch Med, Ctr Infect Dis, Kobe, Hyogo 657, Japan; [Yoshida, Masaru] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Metabol Res, Kobe, Hyogo 657, Japan	Saito, M (reprint author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Hyogo 657, Japan.	masaya@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was supported by a Grant-in-Aid for Young Scientists (B) [M.S.], and was also supported by grants for the Global COE Program, Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [M.Y. and T.A.].	Adler M, 2008, HEPATOLOGY, V47, P762, DOI 10.1002/hep.22085; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Murata K, 2009, INT J ONCOL, V35, P1005, DOI 10.3892/ijo_00000415; Regev A, 2002, AM J GASTROENTEROL, V97, P2614; Pohl A, 2001, AM J GASTROENTEROL, V96, P3142, DOI 10.1111/j.1572-0241.2001.05268.x; Lackner C, 2005, HEPATOLOGY, V41, P1376, DOI 10.1002/hep.20717; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; Copple BL, 2010, LIVER INT, V30, P669, DOI 10.1111/j.1478-3231.2010.02205.x; Hui AY, 2005, AM J GASTROENTEROL, V100, P616, DOI 10.1111/j.1572-0241.2005.41289.x; Pinzani M, 2011, J HEPATOL, V55, P459, DOI 10.1016/j.jhep.2011.02.001; Islam S, 2005, SCAND J GASTROENTERO, V40, P867, DOI 10.1080/00365520510015674; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Dai CY, 2010, J HEPATOL, V52, P160, DOI 10.1016/j.jhep.2009.11.017; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Liu CH, 2006, LIVER INT, V26, P1087, DOI 10.1111/j.1478-3231.2006.01355.x; Sheth SG, 1998, AM J GASTROENTEROL, V93, P44; Lok ASF, 2005, HEPATOLOGY, V42, P282, DOI 10.1002/hep.20772; Shaheen AAM, 2007, HEPATOLOGY, V46, P912, DOI 10.1002/hep.21835; Nitta T, 2008, HEPATOLOGY, V48, P909, DOI 10.1002/hep.22397; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; de Torres Mercedes, 2003, Ann Hepatol, V2, P5; Ehsan N, 2008, ARAB J GASTROENTEROL, V9, P7; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; ICHINO N, 2010, AM J GASTROENTEROL, V16, P4809; Khairy M, 2012, HEPAT MON, V12; Le Couteur DG, 1999, J PHARMACOL EXP THER, V289, P1553; Loaeza-del-Castillo A, 2008, ANN HEPATOL, V7, P350; Peck-Radosavljevic M, 2001, EUR J GASTROEN HEPAT, V13, P317, DOI 10.1097/00042737-200104000-00004; Pradat P, 2007, LIVER INT, V27, P335, DOI 10.1111/j.1478-3231.2006.01430.x; Rosner B, 2012, FUNDAMENTALS BIOSTAT; Tanaka T, 2013, J GASTROEN HEPATOL, V28, P1348, DOI 10.1111/jgh.12166; Toyoda H, 2012, CANCER SCI, V103, P921, DOI 10.1111/j.1349-7006.2012.02232.x	36	0	0	KOWSAR PUBL	HOENSBROEK	PATERSWEG 22,, HOENSBROEK, LIMBURG 6431 GC, NETHERLANDS	1735-143X	1735-3408		HEPAT MON	Hepat. Mon.	FEB	2015	15	2							e22978	10.5812/hepatmon.22978		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE3IG	WOS:000351719300003		
J	You, DY; Gao, XD; Katayama, S				You, Deyong; Gao, Xiangdong; Katayama, Seiji			A Novel Stability Quantification for Disk Laser Welding by Using Frequency Correlation Coefficient Between Multiple-Optics Signals	IEEE-ASME TRANSACTIONS ON MECHATRONICS			English	Article						Correlation coefficient; disk laser welding; low-frequency component; multiple-optics sensing; stability quantification	SEAM TRACKING; STAINLESS-STEEL; POWER; PLASMA; SENSOR; FUSION; OSCILLATION; SYSTEM; METAL	This paper presents a multioptics sensing system consisting of two photodiode sensors and two visual sensors for multisignals extraction. Five welding features, including visible light (V), laser reflection (R), keyhole size (K), metallic vapor on top of the material (PT) and at the bottom (PB), were obtained by way of signal processing and image processing. A new correlation coefficient of low-frequency component has been designed to quantify the stability of laser welding process. Under the same welding conditions, the frequency correlation between different features was analyzed. Also, with the same features, the frequency correlation between different conditions was then researched. A three-phase welding experiment was devised to present the practical application of frequency-domain correlation to welding monitoring. Experimental results showed that welding status was well reflected by the correlation of frequency-domain component that is within the range of 11-1000 Hz. The welding process remained stable when frequency-domain correlation was low. However, when welding process turned unstable the correlation would increase. The current research has devised an approach of analyzing frequency-domain correlation that could effectively quantify the stability of laser welding process.	[You, Deyong; Gao, Xiangdong] Guangdong Univ Technol, Sch Electromech Engn, Guangzhou 510006, Guangdong, Peoples R China; [Katayama, Seiji] Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan	Gao, XD (reprint author), Guangdong Univ Technol, Sch Electromech Engn, Guangzhou 510006, Guangdong, Peoples R China.	ongyou@gmail.com; gaoxd666@126.com; katayama@jwri.osaka-u.ac.jp			National Natural Science Foundation of China [51175095]; Guangdong Provincial Natural Science Foundation of China [10251009001000001]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20104420110001]; State Scholarship Fund from the China Scholarship Council [2011844250]	This work was supported in part by the National Natural Science Foundation of China (51175095), in part by the Guangdong Provincial Natural Science Foundation of China (10251009001000001), in part by the Specialized Research Fund for the Doctoral Program of Higher Education of China (20104420110001), and in part by the State Scholarship Fund from the China Scholarship Council (2011844250).	Celik O, 2013, IEEE-ASME T MECH, V18, P812, DOI 10.1109/TMECH.2012.2195326; Baek YM, 2014, IEEE-ASME T MECH, V19, P278, DOI 10.1109/TMECH.2012.2230402; Ancona A, 2001, APPL OPTICS, V40, P6019, DOI 10.1364/AO.40.006019; Bi GJ, 2007, INT J MACH TOOL MANU, V47, P555, DOI 10.1016/j.ijmachtools.2006.05.010; Scintilla LD, 2013, INT J MACH TOOL MANU, V69, P30, DOI 10.1016/j.ijmachtools.2013.02.008; Kawahito Y, 2011, J MATER PROCESS TECH, V211, P1563, DOI 10.1016/j.jmatprotec.2011.04.002; Sibillano T, 2009, SENSORS-BASEL, V9, P3376, DOI 10.3390/s90503376; Kawahito Y, 2008, SCI TECHNOL WELD JOI, V13, P744, DOI 10.1179/136217108X329313; Gao XD, 2012, IEEE T IND ELECTRON, V59, P4315, DOI 10.1109/TIE.2012.2193854; Schmidt M, 2008, CIRP ANN-MANUF TECHN, V57, P213, DOI 10.1016/j.cirp.2008.03.043; Dubey AK, 2008, INT J MACH TOOL MANU, V48, P609, DOI 10.1016/j.ijmachtools.2007.10.017; Luo RC, 2013, IEEE-ASME T MECH, V18, P845, DOI 10.1109/TMECH.2012.2188300; Fang ZJ, 2011, IEEE-ASME T MECH, V16, P540, DOI 10.1109/TMECH.2010.2045766; Sibillano T, 2007, J MATER PROCESS TECH, V191, P364, DOI 10.1016/j.jmatprotec.2007.03.075; Rodil SS, 2010, INT J ADV MANUF TECH, V49, P133, DOI 10.1007/s00170-009-2395-y; Naso D, 2005, IEEE T IND INFORM, V1, P259, DOI 10.1109/TII.2005.857617; Gao XD, 2012, MECHATRONICS, V22, P370, DOI 10.1016/j.mechatronics.2011.09.005; Bardin F, 2005, APPL OPTICS, V44, P3869, DOI 10.1364/AO.44.003869; Bardin F, 2005, APPL OPTICS, V44, P13, DOI 10.1364/AO.44.000013; Bingul Z, 2006, IEEE-ASME T MECH, V11, P47, DOI 10.1109/TMECH.2005.863366; Colombo D, 2010, INT J MATER FORM, V3, P1123, DOI 10.1007/s12289-010-0969-8; Davis TA, 2011, IEEE-ASME T MECH, V16, P1032, DOI 10.1109/TMECH.2010.2071417; De Keuster J, 2007, INT J ADV MANUF TECH, V35, P115, DOI 10.1007/s00170-006-0695-z; Eriksson I., 2010, MEAS SCI TECHNOL, V21; Gao X., 2012, ACTA PHYS SINICA, V61; Geiger M., 2008, PRODUCTION ENG RES D, V2, P235, DOI 10.1007/s11740-008-0109-1; Ghaffari A, 2013, IEEE-ASME T MECH, V18, P922, DOI 10.1109/TMECH.2012.2195670; Katayama S, 2008, SCRIPTA MATER, V59, P1247, DOI 10.1016/j.scriptamat.2008.08.026; Kawahito Y., 2009, J PHYS D, V42, P607; Mazzoni M, 2012, NDT&E INT, V45, P63, DOI 10.1016/j.ndteint.2011.09.009; Molino A, 2009, MICROPROCESS MICROSY, V33, P179, DOI 10.1016/j.micpro.2008.11.001; Na XD, 2010, IEEE T CONTR SYST T, V18, P927, DOI 10.1109/TCST.2009.2026163; Norman P., 2008, J PHYS D, V41; Ohnishi T, 2013, SCI TECHNOL WELD JOI, V18, P314, DOI 10.1179/1362171813Y.0000000108; Oiwa S., 2011, J LASER APPL, V23; Olsson R, 2011, OPT LASER ENG, V49, P188, DOI 10.1016/j.optlaseng.2010.08.018; Park H, 1999, OPT LASER TECHNOL, V31, P119, DOI 10.1016/S0030-3992(99)00013-4; Park S, 2012, IEEE-ASME T MECH, V17, P1009, DOI 10.1109/TMECH.2011.2157352; Sibillano T, 2006, OPT LASER ENG, V44, P1324, DOI 10.1016/j.optlaseng.2005.12.002; Sibillano T, 2007, OPT LASER ENG, V45, P1005, DOI 10.1016/j.optlaseng.2007.04.002; Sibillano T, 2005, OPT COMMUN, V251, P139, DOI [10.1016/j.optcom.2005.02.076, 10.1016/j.eptcom.2005.02.076]; Speka M, 2008, NDT&E INT, V41, P178, DOI 10.1016/j.ndteint.2007.10.005; Wang T, 2012, PLASMA SCI TECHNOL, V14, P245, DOI 10.1088/1009-0630/14/3/11; You D., MECH SYST S IN PRESS; Zeng J. X., 2012, J PHYS D, V45, P3376; Zhou K, 2014, IEEE-ASME T MECH, V19, P559, DOI 10.1109/TMECH.2013.2251351	46	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1083-4435	1941-014X		IEEE-ASME T MECH	IEEE-ASME Trans. Mechatron.	FEB	2015	20	1					327	337		10.1109/TMECH.2014.2311097		11	Automation & Control Systems; Engineering, Manufacturing; Engineering, Electrical & Electronic; Engineering, Mechanical	Automation & Control Systems; Engineering	CE7ZO	WOS:000352060700033		
J	Tomkos, I; Miyamoto, Y; Wellbrock, G; Winzer, PJ				Tomkos, Ioannis; Miyamoto, Yutaka; Wellbrock, Glenn; Winzer, Peter J.			SPATIALLY AND SPECTRALLY FLEXIBLE ELASTIC OPTICAL NETWORKING	IEEE COMMUNICATIONS MAGAZINE			English	Editorial Material									[Tomkos, Ioannis] AIT, Researching Next Generat Opt Commun Syst & Networ, Pune, Maharashtra, India; [Tomkos, Ioannis] IEEE Commun Soc, New York, NY USA; [Miyamoto, Yutaka] NTT Network Innovat Labs, Innovat Photon Network Res Ctr IPC, Tokyo, Japan; [Winzer, Peter J.] Alcatel Lucent, Bell Labs, Opt Transmiss Syst Res Dept, Murray Hill, NJ USA; [Winzer, Peter J.] Bell Labs, Murray Hill, NJ USA	Tomkos, I (reprint author), AIT, Researching Next Generat Opt Commun Syst & Networ, Pune, Maharashtra, India.	itom@ait.gr; miyamoto.yutaka@lab.ntt.co.jp; glenn.wellbrock@verizon.com; peter.winzer@bell-labs.com						0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0163-6804	1558-1896		IEEE COMMUN MAG	IEEE Commun. Mag.	FEB	2015	53	2					20	22				3	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CE3NH	WOS:000351732700007		
J	Nakajima, K; Sillard, P; Richardson, D; Li, MJ; Essiambre, RJ; Matsuo, S				Nakajima, Kazuhide; Sillard, Pierre; Richardson, David; Li, Ming-Jun; Essiambre, Rene-Jean; Matsuo, Shoichiro			Transmission Media for an SDM-Based Optical Communication System	IEEE COMMUNICATIONS MAGAZINE			English	Article							FIBERS	Space-division multiplexing technology is an attractive candidate for overcoming a potential future "capacity crunch" in optical networks based on conventional single-mode fiber. Transmission media for SDM optical communication systems can be designed based on both single- and multi-core concepts. This article investigates the potential of various SDM transmission media.	[Nakajima, Kazuhide] NTT Corp, Tokyo, Japan; [Sillard, Pierre] Prysmian Grp, Milan, Italy; [Richardson, David] Univ Southampton, ORC, Southampton SO9 5NH, Hants, England; [Li, Ming-Jun] Corning Inc, Corning, NY USA; [Essiambre, Rene-Jean] Alcatel Lucent, Bell Labs, Boulogne Billancourt, France; [Matsuo, Shoichiro] Fujikura Ltd, Opt & Elect Lab, Chiba, Japan	Nakajima, K (reprint author), NTT Corp, Tokyo, Japan.						Egorova ON, 2014, OPT LETT, V39, P2168, DOI 10.1364/OL.39.002168; Arik SO, 2013, IEEE PHOTONIC TECH L, V25, P2054, DOI 10.1109/LPT.2013.2280897; Koshiba M, 2012, IEEE PHOTONICS J, V4, P1987, DOI 10.1109/JPHOT.2012.2221085; Winzer PJ, 2011, OPT EXPRESS, V19, P16680, DOI 10.1364/OE.19.016680; Essiambre RJ, 2013, IEEE PHOTONICS J, V5, DOI 10.1109/JPHOT.2013.2253091; Gruner-Nielsen L, 2012, J LIGHTWAVE TECHNOL, V30, P3693, DOI 10.1109/JLT.2012.2227243; Sillard P, 2014, J LIGHTWAVE TECHNOL, V32, P2824, DOI 10.1109/JLT.2014.2312845; Poletti F, 2013, NANOPHOTONICS-BERLIN, V2, P315, DOI 10.1515/nanoph-2013-0042; Poletti F, 2013, NAT PHOTONICS, V7, P279, DOI [10.1038/nphoton.2013.45, 10.1038/NPHOTON.2013.45]; Jain S., 2013, P ECOC 13, V4.A.2; Mumtaz S., 2012, OPT SOC AM FRONTIERS; Ryf R., 2012, P ECOC 12; Sakamoto T., 2014, P ECOC 14; Sasaki Y., 2014, P ECOC 14; Sleiffer VAJM, 2014, J LIGHTWAVE TECHNOL, V32, P854, DOI 10.1109/JLT.2013.2274194	15	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0163-6804	1558-1896		IEEE COMMUN MAG	IEEE Commun. Mag.	FEB	2015	53	2					44	51				8	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CE3NH	WOS:000351732700010		
J	Klonidis, D; Cugini, F; Gerstel, O; Jinno, M; Lopez, V; Palkopoulou, E; Sekiya, M; Siracusa, D; Thouenon, G; Betoule, C				Klonidis, Dimitrios; Cugini, Filippo; Gerstel, Ori; Jinno, Masahiko; Lopez, Victor; Palkopoulou, Eleni; Sekiya, Motoyoshi; Siracusa, Domenico; Thouenon, Gilles; Betoule, Christophe			Spectrally and Spatially Flexible Optical Network Planning and Operations	IEEE COMMUNICATIONS MAGAZINE			English	Article								The advent of spectrally flexible (a.k.a. elastic) optical networking is widely identified as the next generation optical network solution that permits varying bandwidth demands to be dynamically assigned over flexible spectral containers, targeting optimum use of the available network resources. Additionally, the adoption of the space dimension is identified as a promising solution for the capacity expansion of future networks, while novel spatial-spectral switching solutions show that the flexible networking concept can be further expanded over both the spatial and spectral dimensions. This article provides an overview of the latest developments and possible approaches with respect to flexible optical networking and the emerging benefits that spatially flexible networking approaches can offer. The focus is on the network planning and resource optimization functions, the main network operations related to fragmentation and IP/optical layer integration, and the control plane solutions.	[Klonidis, Dimitrios] Athens Informat Technol, Athens, Greece; [Cugini, Filippo] CNIT, Natl Lab Photon Networks, Pisa, Italy; [Jinno, Masahiko] Kagawa Univ, Elect & Informat Engn, Takamatsu, Kagawa 760, Japan; [Lopez, Victor] Telefonica, Madrid, Spain; [Sekiya, Motoyoshi] Fujitsu Labs Amer, Sunnyvale, CA USA	Klonidis, D (reprint author), Athens Informat Technol, Athens, Greece.	dikl@ait.gr; filippo.cugini@cnit.it; ori@ieee.org; jinno.masahiko@lab.ntt.co.jp; victor.lopezalvarez@telefonica.com; epalkopo@cisco.com; sekiya.motoyosh@jp.fujitsu.com; domenico.siracusa@create-net.org; gilles.thouenon@orange.com; christophe.betoule@orange.com			European Community [318415, 317999, 619732]	The work presented here has received partially funding from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreements no. 318415 FOX-C, no. 317999 IDEALIST, and no. 619732 INSPACE projects.	Cvijetic M, 2012, OPT EXPRESS, V20, P9144, DOI 10.1364/OE.20.009144; Gerstel O, 2012, IEEE COMMUN MAG, V50, pS12, DOI 10.1109/MCOM.2012.6146481; Amaya N, 2014, OPT EXPRESS, V22, P3638, DOI 10.1364/OE.22.003638; Tomkos I, 2014, P IEEE, V102, P1317, DOI 10.1109/JPROC.2014.2324652; Sambo N, 2014, J LIGHTWAVE TECHNOL, V32, P2079, DOI 10.1109/JLT.2014.2319859; Stiakogiannakis I, 2014, J OPT COMMUN NETW, V6, P259, DOI 10.1364/JOCN.6.000259; Fujii S, 2014, J OPT COMMUN NETW, V6, P1059, DOI 10.1364/JOCN.6.001059; King D., IETF IN PRESS; Muhammad A., 2014, P INT C OPT NETW DES, P192; Nelson E., 2014, IEEE JLT, V32, P783; Rudnick R., 2014, P OFC NFOEC 14 MAR; Sasaki Y, 2012, OPT EXPRESS, V20, pB77, DOI 10.1364/OE.20.000B77; Sygletos S., 2014, P ECOC 14 SEPT; 王晓蕙, 2012, [药学服务与研究, Pharmaceutical Care and Research], V12, P5; Winzer P. J., 2013, P ECOC 13 SEPT	15	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0163-6804	1558-1896		IEEE COMMUN MAG	IEEE Commun. Mag.	FEB	2015	53	2					69	78				10	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CE3NH	WOS:000351732700013		
J	Shen, WY; Yoshida, M; Minato, K; Imajuku, W				Shen, Wenyu; Yoshida, Masahiro; Minato, Kenji; Imajuku, Wataru			vConductor: An Enabler for Achieving Virtual Network Integration as a Service	IEEE COMMUNICATIONS MAGAZINE			English	Article								Network function virtualization is regarded as a promising candidate for future networks. Although many advantages are expected, there is still a lack of services that directly link to increased revenue for telecom operators. Therefore, we propose a new NFV-based service, virtual network integration as a service (VNIaaS). The service allows enterprise network administrators to construct and monitor virtual enterprise networks as necessary. As a key enabler, we further propose vConductor, an innovative technology due to its automatic network provisioning, multi-objective resource scheduling, and NFV-oriented inventory management characteristics. Finally, we show the feasibility through implementation of a prototype system. We believe that this contribution will be a catalyst to accelerate the industrialization of NFV.	[Shen, Wenyu; Yoshida, Masahiro; Minato, Kenji; Imajuku, Wataru] NTT Network Innovat Labs, Yokosuka, Kanagawa, Japan		wenyu.shen@ntt.com					[Anonymous], 2000, GEN FUNCT ARCH TRANS; McKeown N, 2008, ACM SIGCOMM COMP COM, V38, P69, DOI 10.1145/1355734.1355746; Chiosi M., 2012, SDN OPENFLOW WORLD C; Esposito F., 2013, NSDIV 13 LOMB IL APR; Mitchel M., 1996, INTRO GENETIC ALGORI; Monteleone G., 2013, P IEEE SDN4FNS TRENT; Mosharaf N., 2009, IEEE COMMUN MAG, V47, P20; Quittek J., 2014, ESTI NFV NOV; Shen W., 2014, P APNOMS 14 TS2 2 HS; Strassner J. C., 2004, POLICY BASED NETWORK; Yoshida M., 2014, P APNOMS 14 TS4 2 HS; Yu M, 2008, COMPUT COMMUN REV, V38, P17, DOI DOI 10.1145/1355734.1355737; Zhu Y., 2006, P IEEE INFOCOM	13	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0163-6804	1558-1896		IEEE COMMUN MAG	IEEE Commun. Mag.	FEB	2015	53	2					116	124				9	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CE3NH	WOS:000351732700019		
J	Ishibuchi, H				Ishibuchi, Hisao			Top Three News Stories on IEEE CIM in 2014	IEEE COMPUTATIONAL INTELLIGENCE MAGAZINE			English	Editorial Material									Osaka Prefecture Univ, Sakai, Osaka, Japan	Ishibuchi, H (reprint author), Osaka Prefecture Univ, Sakai, Osaka, Japan.		Ishibuchi, Hisao/B-3599-2009	Ishibuchi, Hisao/0000-0001-9186-6472				0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1556-603X	1556-6048		IEEE COMPUT INTELL M	IEEE Comput. Intell. Mag.	FEB	2015	10	1					2	2		10.1109/MCI.2014.2369874		1	Computer Science, Artificial Intelligence	Computer Science	CE7MO	WOS:000352025600001		
J	Ichino, M; Yamazaki, Y; Yoshiura, H				Ichino, Masatsugu; Yamazaki, Yasushi; Yoshiura, Hiroshi			Speaker Verification Method for Operation System of Consumer Electronic Devices	IEEE TRANSACTIONS ON CONSUMER ELECTRONICS			English	Article						consumer electronic device; mobile phone; CELP; LSP; speaker verification	HOME AUTOMATION; SPEECH; RECOGNITION; SECURITY	A system is proposed that can remotely operate consumer electronic devices by voice. It uses the mobile phone as a controller. And it uses the CELP(code excited linear prediction) parameters that are used for speech coding in mobile phones. A speaker verification function protects private information and separates the user's voice from that of people nearby who are also speaking. A CELP-based speaker verification method is used to match the audio stream by comparing the trajectories of continuous phonemes. Experimental evaluation of the speaker verification method demonstrated the effectiveness of the proposed verification method.(1).	[Ichino, Masatsugu; Yoshiura, Hiroshi] Univ Electrocommun, Grad Sch Informat & Engn, Dept Informat, Tokyo 1828585, Japan; [Yamazaki, Yasushi] Univ Kitakyushu, Fac Environm Engn, Fukuoka 8080135, Japan	Ichino, M (reprint author), Univ Electrocommun, Grad Sch Informat & Engn, Dept Informat, Tokyo 1828585, Japan.	ichino@inf.uec.ac.jp; y-yamazaki@kitakyu-u.ac.jp; yoshiura@hc.uec.ac.jp			JSPS KAKENHI [25820155]	This work was supported in part by JSPS KAKENHI Grant Number 25820155.	Balasubramanian K, 2009, IEEE T CONSUM ELECTR, V55, P1401, DOI 10.1109/TCE.2009.5278006; Kim T, 2010, IEEE T CONSUM ELECTR, V56, P2537, DOI 10.1109/TCE.2010.5681138; [Anonymous], 1996, G729 ITUT; Papp II, 2011, IEEE T CONSUM ELECTR, V57, P606, DOI 10.1109/TCE.2011.5955198; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; Chatelin F, 1988, VELEURS PROPRES MATR; Chuang YR, 2013, I SYMP CONSUM ELECTR, P79; Damper RI, 1996, INT J HUM-COMPUT ST, V45, P337, DOI 10.1006/ijhc.1996.0055; Decuir J., 2014, IEEE CONSUMER ELECT, P25; Han J, 2010, IEEE T CONSUM ELECTR, V56, P1843, DOI 10.1109/TCE.2010.5606335; Ichino M., 2007, IEICE T INF SYST, VJ90-D, P2168; ITAHASHI S, 1991, IEICE TRANS COMMUN, V74, P1906; Lee KM, 2005, INT J HUM-COMPUT INT, V19, P343, DOI 10.1207/s15327590ijhc1903_4; Maeda K., 1985, IEICE T INF SYST, V68, P345; Park JS, 2013, IEEE T CONSUM ELECTR, V59, P244; QUATIERI TF, 2000, ACOUST SPEECH SIG PR, P1089; Sakano H, 2005, ELECTRON COMM JPN 2, V88, P45, DOI 10.1002/ecjb.20190; Yamaguchi O., 1998, IEEE INT C AUT FAC G, P318; Yamazaki Y., 2004, ICARCV2004, P408; Yuan Y., 2012, IEEE CONSUMER ELECT, P23	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0098-3063	1558-4127		IEEE T CONSUM ELECTR	IEEE Trans. Consum. Electron.	FEB	2015	61	1					96	102				7	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CE3VU	WOS:000351758600013		
J	Sagara, A; Uedono, A; Shibata, S				Sagara, Akihiko; Uedono, Akira; Shibata, Satoshi			Thermal Behavior of Residual Defects in Low-Dose Arsenic- and Boron-Implanted Silicon After High-Temperature Rapid Thermal Annealing	IEEE TRANSACTIONS ON SEMICONDUCTOR MANUFACTURING			English	Article						Residual damage; ion implantation; rapid thermal annealing (RTA); silicon	LUMINESCENCE; BAND	We investigated the thermal behavior of defects remaining in low-dose (<10(13) cm(-2)) arsenic-and boron-implanted Si after high-temperature (1100 degrees C) rapid thermal annealing (RTA). The defects remaining after RTA were characterized as vacancy-type defects, and confirmed to be created by nonequilibrium states that occur during the extremely rapid cooling step of the RTA sequence. They were gradually removed by applying additional furnace annealing (FA) (i.e., thermal equilibrium heating process) at 300-400 degrees C. At the range of 500-600 degrees C, however, carbon-and oxygen-related point defects were newly created. These defects were confirmed to be eliminated at 700 degrees C, and the crystal quality was significantly improved. When using a rapid thermal process for heat treatment after low-dose impurity implantation, it is necessary to apply an equilibrium thermal treatment at > 700 degrees C to remove residual damage as well as to activate impurities.	[Sagara, Akihiko; Uedono, Akira; Shibata, Satoshi] Panasonic Corp, Div Res & Dev, Device Solut Ctr, Osaka 5708501, Japan	Sagara, A (reprint author), Panasonic Corp, Div Res & Dev, Device Solut Ctr, Osaka 5708501, Japan.	sagara.akihiko@jp.panasonic.com					DAVIES G, 1989, PHYS REP, V176, P83, DOI 10.1016/0370-1573(89)90064-1; Uedono A, 2003, J APPL PHYS, V93, P3228, DOI 10.1063/1.1542923; PUSKA MJ, 1994, REV MOD PHYS, V66, P841, DOI 10.1103/RevModPhys.66.841; Sameshima T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.021204; Giri PK, 2005, SEMICOND SCI TECH, V20, P638, DOI 10.1088/0268-1242/20/6/027; DAVIES G, 1987, J PHYS C SOLID STATE, V20, P191, DOI 10.1088/0022-3719/20/2/003; Faifer VN, 2006, J VAC SCI TECHNOL B, V24, P414, DOI 10.1116/1.2137334; Fuse G., 2014, ECS Transactions, V60, DOI 10.1149/06001.0675ecst; Giri PK, 2001, APPL PHYS LETT, V78, P291, DOI 10.1063/1.1339253; JONES CE, 1973, J APPL PHYS, V44, P5402, DOI 10.1063/1.1662165; Kanazaki E., 2009, P 9 INT WORKSH JUNCT, P106; Parish CM, 2007, ADV IMAG ELECT PHYS, V147, P1, DOI 10.1016/S1076-5670(07)47001-X; Sagara A, 2010, AIP CONF PROC, V1321, P225; Sagara A., 2012, P 12 INT WORKSH JUNC, P81; Sagara A, 2014, NUCL INSTRUM METH B, V321, P54, DOI 10.1016/j.nimb.2013.12.026; Sameshima T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.03CA02; Sameshima T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.03CA04; Sze S. M., 2002, SEMICONDUCTOR DEVICE; Uedono A, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.051301; Yacobi B. G., 1990, CATHODOLUMINESCENCE	20	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0894-6507	1558-2345		IEEE T SEMICONDUCT M	IEEE Trans. Semicond. Manuf.	FEB	2015	28	1					92	95		10.1109/TSM.2014.2373636		4	Engineering, Manufacturing; Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CE7YS	WOS:000352058500010		
J	Mahboob, U; Evans, P				Mahboob, Usman; Evans, Phillip			Key Steps for Managing Changes in the Curriculum	JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN			English	Editorial Material							PROFESSIONALISM		[Mahboob, Usman] Khyber Med Univ, Inst Hlth Profess Educ & Res, Peshawar, Pakistan; [Evans, Phillip] Gifu Univ, Collaborat Ctr Med Educ, Med Educ Dev Ctr, Gifu, Japan	Mahboob, U (reprint author), Khyber Med Univ, Inst Hlth Profess Educ & Res, Peshawar, Pakistan.	usman.mahboob@kmu.edu.pk					Bland CJ, 2000, ACAD MED, V75, P575, DOI 10.1097/00001888-200006000-00006; Jones R, 2001, LANCET, V357, P699, DOI 10.1016/S0140-6736(00)04134-9; Roff S, 1997, MED TEACH, V19, P295; O'Sullivan H, 2012, MED TEACH, V34, pE64, DOI 10.3109/0142159X.2012.655610; Steinert Y, 2005, MED EDUC, V39, P127, DOI 10.1111/j.1365-2929.2004.02069.x; [Elearn Elearn], 2007, CHANGE MANAGEMENT, P89; MILLER GE, 1990, ACAD MED, V65, pS63, DOI 10.1097/00001888-199009000-00045; Nilakant SR, 2006, CHANGE MANAGEMENT AL; van der Vleuten CPM, 2010, BEST PRACT RES CL OB, V24, P703, DOI 10.1016/j.bpobgyn.2010.04.001	9	0	0	COLL PHYSICIANS & SURGEONS PAKISTAN	KARACHI	SEVENTH CENTRAL ST, DEFENCE HOUSING AUTHORITY, KARACHI, 75500, PAKISTAN	1022-386X	1681-7168		JCPSP-J COLL PHYSICI	JCPSP-J. Coll. Physicians Surg.	FEB	2015	25	2					85	86				2	Medicine, General & Internal	General & Internal Medicine	CE3SQ	WOS:000351749300001		
J	Kim, KM; Lee, JI; Ryu, JH				Kim, Kang Min; Lee, Jung-Il; Ryu, Jeong Ho			Thermal annealing effect on nitrogen related defects of GaInNAs semiconductors	JOURNAL OF CERAMIC PROCESSING RESEARCH			English	Article						GaInNAs; Thermal annealing; N-induced defect	MOLECULAR-BEAM EPITAXY; QUANTUM-WELLS; SPECTROSCOPY; TEMPERATURE; RESONANCE; SURFACES; BEHAVIOR; ALLOYS; GROWTH	Nitrogen related defects of GaInNAs epilayers grown by molecular beam epitaxy were investigated before and after rapid thermal annealing using X-ray photoelectron spectroscopy (XPS). XPS analysis revealed that the N-induced defect configurations are most likely attributed to the N-As spilt interstitials and (N-As-As-Ga) complex. Comparison of as-grown and annealed samples showed that the nearest N-bonding configuration of GaInNAs changes from Ga3In1N to Ga1In3N after annealing, which can lead to reduction of the local strain. Annealed sample demonstrated a reduced the defect concentration, which could be due to the transformation of nearest N-bonding configuration after annealing.	[Kim, Kang Min; Ryu, Jeong Ho] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Lee, Jung-Il] Korea Natl Univ Transportat, Dept Mat Sci & Engn, Chungju 380702, Chungbuk, South Korea	Ryu, JH (reprint author), Natl Inst Adv Ind Sci & Technol, 1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	jhryu@ut.ac.kr			"Energy Efficiency & Resources" of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) - Korea government Ministry of Knowledge Economy [20125010100030-11-2-400]	This work was supported by the "Energy Efficiency & Resources" of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant funded by the Korea government Ministry of Knowledge Economy. (No. 20125010100030-11-2-400).	Kim K, 2001, PHYS REV LETT, V86, P2609, DOI 10.1103/PhysRevLett.86.2609; Friedman DJ, 1998, J CRYST GROWTH, V195, P409, DOI 10.1016/S0022-0248(98)00561-2; Li W, 2001, APPL PHYS LETT, V79, P1094, DOI 10.1063/1.1396316; Carrier P, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.165212; Zhang SB, 2001, PHYS REV LETT, V86, P1789, DOI 10.1103/PhysRevLett.86.1789; Xin HP, 1999, APPL PHYS LETT, V74, P2337, DOI 10.1063/1.123843; Veal TD, 2004, APPL PHYS LETT, V85, P1550, DOI 10.1063/1.1784886; Kondow M, 1996, JPN J APPL PHYS 1, V35, P1273, DOI 10.1143/JJAP.35.1273; Khan A, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2747664; Berkovits VL, 2002, APPL PHYS LETT, V80, P3739, DOI 10.1063/1.1479212; EASTMAN DE, 1980, PHYS REV LETT, V45, P656, DOI 10.1103/PhysRevLett.45.656; Gwo S, 1997, APPL PHYS LETT, V71, P362, DOI 10.1063/1.119538; Harrison W. A., 1989, ELECT STRUCTURE PROP, P175; INGREY S, 1986, J VAC SCI TECHNOL A, V4, P984, DOI 10.1116/1.573770; Ishikawa F, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3573789; Iwata K, 1996, JPN J APPL PHYS 2, V35, pL289, DOI 10.1143/JJAP.35.L289; Karirinne S, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/192; Liu HY, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2202744; Pinault MA, 2001, APPL PHYS LETT, V79, P3404, DOI 10.1063/1.1418263; Thinh NQ, 2001, APPL PHYS LETT, V79, P3089, DOI 10.1063/1.1416155; Traub MC, 2008, J PHYS CHEM C, V112, P18467, DOI 10.1021/jp803992h	21	0	0	KOREAN ASSOC CRYSTAL GROWTH, INC	SEOUL	SUNGDONG POST OFFICE, P O BOX 27, SEOUL 133-600, SOUTH KOREA	1229-9162			J CERAM PROCESS RES	J. Ceram. Process. Res.	FEB	2015	16	1					45	48				4	Materials Science, Ceramics	Materials Science	CE3XE	WOS:000351762600009		
J	Empizo, MJF; Yamanoi, K; Fukuda, K; Arita, R; Minami, Y; Shimizu, T; Sarukura, N; Fukuda, T; Santos-Putungan, AB; Vargas, RM; Salvador, AA; Sarmago, RV				Empizo, Melvin John F.; Yamanoi, Kohei; Fukuda, Kazuhito; Arita, Ren; Minami, Yuki; Shimizu, Toshihiko; Sarukura, Nobuhiko; Fukuda, Tsuguo; Santos-Putungan, Alexandra B.; Vargas, Ray M.; Salvador, Arnel A.; Sarmago, Roland V.			Photoluminescence investigations of bulk and microstructured ZnO crystals for scintillator applications	JOURNAL OF CERAMIC PROCESSING RESEARCH			English	Article						ZnO; Oxides; Microstructures; Photoluminescence; Scintillators	TIME-RESOLVED PHOTOLUMINESCENCE; ZINC-OXIDE; EXCITON SPECTRUM; THIN-FILMS; NANOSTRUCTURES; EMISSION; GAP	Photoluminescence properties of bulk and microstructured ZnO crystals are investigated for potential scintillator applications. A bulk crystal is prepared by hydrothermal method, while hexagonal micron-sized crystals are prepared by aqueous chemical growth and carbothermal reduction methods. The bulk sample exhibits UV emission only, while the microstructured samples exhibit both UV and visible emissions. The ZnO microstructures have faster near-band edge emission lifetimes of 100 to 800 ps compared to 440 ps and 2 ns of bulk ZnO. No direct correlation between the defect-related emissions and the near-band edge emission has been observed. ZnO microstructures with fast luminescence lifetimes have promising applications as EUV lithography and XFELs scintillators.	[Empizo, Melvin John F.; Yamanoi, Kohei; Fukuda, Kazuhito; Arita, Ren; Minami, Yuki; Shimizu, Toshihiko; Sarukura, Nobuhiko] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Fukuda, Tsuguo] Fukuda Crystal Lab Co Ltd, Aoba Ku, Sendai, Miyagi 9893204, Japan; [Santos-Putungan, Alexandra B.] Univ Philippines Los Banos, Inst Math Sci & Phys, College Los Banos 4031, Laguna, Philippines; [Santos-Putungan, Alexandra B.; Vargas, Ray M.; Salvador, Arnel A.; Sarmago, Roland V.] Univ Philippines Diliman, Natl Inst Phys, Quezon City 1101, Philippines	Empizo, MJF (reprint author), Osaka Univ, Inst Laser Engn, 2-6 Yamadaoka, Suita, Osaka 5650871, Japan.	mjfempizo@ile.osaka-u.ac.jp	Sarukura, Nobuhiko/F-3276-2015; Shimizu, Toshihiko/F-5079-2015; Yamanoi, Kohei/B-2150-2013	Sarukura, Nobuhiko/0000-0003-2353-645X; Shimizu, Toshihiko/0000-0001-6712-3804; Yamanoi, Kohei/0000-0003-4492-4099			Koida T, 2003, APPL PHYS LETT, V82, P532, DOI 10.1063/1.1540220; Ozgur U, 2004, APPL PHYS LETT, V84, P3223, DOI 10.1063/1.1713034; Empizo MJF, 2014, OPT MATER, V38, P256, DOI 10.1016/j.optmat.2014.10.044; Johnson JC, 2003, J PHYS CHEM B, V107, P8816, DOI 10.1021/jp034482n; Vayssieres L, 2003, ADV MATER, V15, P464, DOI 10.1002/adma.200390108; Nakazato T, 2009, J CRYST GROWTH, V311, P875, DOI 10.1016/j.jcrysgro.2008.09.106; Xu S, 2011, NANO RES, V4, P1013, DOI 10.1007/s12274-011-0160-7; Kwok WM, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2137456; Wang ZL, 2004, MATER TODAY, V7, P26, DOI 10.1016/S1369-7021(04)00286-X; Tanaka M, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2815920; Hauschild R, 2006, PHYS STATUS SOLIDI C, V3, P976, DOI 10.1002/pssc.200564643; PARK YS, 1966, PHYS REV, V143, P512, DOI 10.1103/PhysRev.143.512; Yamanoi K, 2013, J CRYST GROWTH, V362, P264, DOI 10.1016/j.jcrysgro.2012.01.008; Wilkinson J, 2004, RADIAT MEAS, V38, P501, DOI 10.1016/j.radmeas.2004.01.022; Furukawa Y, 2008, J OPT SOC AM B, V25, pB118, DOI 10.1364/JOSAB.25.00B118; Magdaluyo ER, 2008, ADV MAT RES, V31, P92; Morkoc H, 2009, ZINC OXIDE FUNDAMENT, P365; Morkoc Hadis, 2009, ZINC OXIDE FUNDAMENT, P131; Mosquera AA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01714; Ozgur U, 2005, J APPL PHYS, V98, DOI 10.1063/1.1992666; Santos A. B., 2011, P 5 INT C HUM NAN IN; THOMAS DG, 1960, J PHYS CHEM SOLIDS, V15, P86, DOI 10.1016/0022-3697(60)90104-9	22	1	1	KOREAN ASSOC CRYSTAL GROWTH, INC	SEOUL	SUNGDONG POST OFFICE, P O BOX 27, SEOUL 133-600, SOUTH KOREA	1229-9162			J CERAM PROCESS RES	J. Ceram. Process. Res.	FEB	2015	16	1					98	101				4	Materials Science, Ceramics	Materials Science	CE3XE	WOS:000351762600019		
J	Yokotani, A; Kihara, R; Nakayoshi, K				Yokotani, Atsushi; Kihara, Ryota; Nakayoshi, Kohei			STM observation of initial stage of growth of Si-Mn films on Si(111)7 x 7 surface	JOURNAL OF CERAMIC PROCESSING RESEARCH			English	Article						STM; PLD; Diluted magnetic semiconductor; Adsorption; Mn		Recently, it has become very important to obtain knowledge about interactions between substrates and deposited materials in an atomic scale. In this study, we focused on the initial stage of Si-Mn films adsorbed on to a Si(111) substrate. A sample were prepared by depositing the Mn particles onto a cleaned Si(111) substrate by the pulsed laser deposition (PLD) method and the observation was performed with a scanning tunneling microscope (STM). First, we have observed adsorption site, size and shape of the particles at room temperature. Next, the change of the STM image at elevated temperature up to 200 degrees C was observed. In this paper, we have discussed about the structure of clustered Mn particles on Si(111) substrate by comparing the result with particles of other kinds.	[Yokotani, Atsushi; Kihara, Ryota; Nakayoshi, Kohei] Miyazaki Univ, Fac Engn, Miyazaki, Japan	Yokotani, A (reprint author), Miyazaki Univ, Fac Engn, Miyazaki, Japan.	a-yokotani@opt.miyazaki-u.ac.jp					Dietl Tomasz, SPINTRONICS FERROMAG	1	0	0	KOREAN ASSOC CRYSTAL GROWTH, INC	SEOUL	SUNGDONG POST OFFICE, P O BOX 27, SEOUL 133-600, SOUTH KOREA	1229-9162			J CERAM PROCESS RES	J. Ceram. Process. Res.	FEB	2015	16	1					107	110				4	Materials Science, Ceramics	Materials Science	CE3XE	WOS:000351762600021		
J	Ahn, TH; Kishi, T				Ahn, Tae-Ho; Kishi, Toshiharu			Effect of self-healing agents on inorganic crack repair materials for concrete infrastructures	JOURNAL OF CERAMIC PROCESSING RESEARCH			English	Article						Crack; Water leakage; Repair; Self-healing capability		In this study, innovative repair methods based on crack self-healing technologies using cementitious materials were suggested in order to prevent water leakage in concrete infrastructures such as slab, tunnel and water-retaining structure. Especially, this study aims to develop new inorganic repair materials as needed to follow the crack and its repair methods. Crack repair methods such as Coating Method (CM), Drilling & Filling Method (DFM) and Coating and DF Method (CDFM) for the practical industrial application were examined in comparison with normal crack repair method without self-healing capability. From these results, it was confirmed that the sealing effects of water leakage through the penetrating cracks from field tests could be improved by cementitious composite materials with self-healing capability.	[Ahn, Tae-Ho] Hanyang Univ, Int Sustainable Engn Mat ISEM Ctr, Ceram Mat Inst, Seoul 133791, South Korea; [Ahn, Tae-Ho] Hanyang Univ, Div Adv Mat Sci Engn, Seoul 133791, South Korea; [Kishi, Toshiharu] Univ Tokyo, Inst Ind Sci, Dept Human & Social Syst, Tokyo, Japan	Ahn, TH (reprint author), Hanyang Univ, Int Sustainable Engn Mat ISEM Ctr, Ceram Mat Inst, Seoul 133791, South Korea.	thahn@hanyang.ac.kr			JSPS (Japan Society for the Promotion of Science)	The author would like to thank for the advice provide by Dr. Y. Matsuda at East Japan Railway Company (JR), Mr. Kamada at the University of Tokyo and Dr. T. Koide at Sumitomo Osaka Cement Co. in JAPAN. The experimental work in this paper was carried out with the financial support by Grants-in-Aid for Young Scientists (A) from JSPS (Japan Society for the Promotion of Science).	AHN T.H., 2011, 3 INT C SELF HEAL MA, P40; AHN T.H., 2010, CEMENT SCI CONCRETE, P477; AHN T.H., 2010, P 4 ACF AS CONCR FED; AHN T.H., 2010, 64 JAP CEM S TOKY MA, P158; AHN T.H., 2011, P 11 JSMS S CONCR ST; Ahn TH, 2010, J ADV CONCR TECHNOL, V8, P171; Kishi T, 2011, 3 INT C SELF HEAL MA, P297; Naaman A.E., 2005, CONCR CRACK WORKSH A	8	0	0	KOREAN ASSOC CRYSTAL GROWTH, INC	SEOUL	SUNGDONG POST OFFICE, P O BOX 27, SEOUL 133-600, SOUTH KOREA	1229-9162			J CERAM PROCESS RES	J. Ceram. Process. Res.	FEB	2015	16	1					117	123				7	Materials Science, Ceramics	Materials Science	CE3XE	WOS:000351762600023		
J	Ahn, TH; Henry, M				Ahn, Tae-Ho; Henry, Michael			Relationship between degradation and self-healing behavior in high strength mortar exposed to high temperatures (up to 500 degrees C)	JOURNAL OF CERAMIC PROCESSING RESEARCH			English	Article						Self-healing; Degradation; Pore pressure; Fire-damaged concrete	FIRE-DAMAGED CONCRETE	High-strength concrete exposed to fire is prone to strength reduction and possible explosive spalling due to thermo-mechanical and thermo-hydral processes; however, recovery is possible under water re-curing depending on the degree of fire damage. This research investigated the relationship between degradation and self-healing capability by examining the surface microstructure of high-strength mortar after fire in order to explore re-curing as a new repair method. Morphology properties and the shape of external and inner pores in the specimens were examined by microscopy, SEM-EDS, TG-DTA, and MIP after heating. The results show that degradation is driven by the interaction of the dehydrated zones at the surface, and spalling at the microstructure level can be attributed to build up of vapor pressure in entrained air pores. Self-healing capability was clearly observed in the dry/dehydrating and quasi-saturated zones, but is limited in dry/dehydrated, sintered areas. From these results, utilization of the dry/dehydrating and quasi-saturated zones may have high potential for a new repair method for fire-damaged concrete.	[Ahn, Tae-Ho] Hanyang Univ, Int Sustainable Engn Mat ISEM Ctr, Ceram Mat Inst, Seoul 133791, South Korea; [Ahn, Tae-Ho] Hanyang Univ, Div Adv Mat Sci Engn, Seoul 133791, South Korea; [Henry, Michael] Univ Tokyo, Int Ctr Urban Safety Engn ICUS, Tokyo 1138654, Japan	Ahn, TH (reprint author), Hanyang Univ, Int Sustainable Engn Mat ISEM Ctr, Ceram Mat Inst, Seoul 133791, South Korea.	thahn@hanyang.ac.kr			SERIC (Sustainable Engineering Research Innovative Consultant) Co., Ltd. in Korea	The author would like to thank the SERIC (Sustainable Engineering Research Innovative Consultant) Co., Ltd. in Korea for their advice and financial support (www.seric.co.kr).	Ahn T.H., 2008, THESIS U TOKYO TOKYO; Ahn TH, 2010, J ADV CONCR TECHNOL, V8, P171; SARSHAR R, 1993, MAG CONCRETE RES, V45, P51; Kalifa P, 2000, CEMENT CONCRETE RES, V30, P1915, DOI 10.1016/S0008-8846(00)00384-7; CROOK DN, 1970, MAG CONCRETE RES, V22, P149; Lin WM, 1996, ACI MATER J, V93, P199; Poon CS, 2001, CEMENT CONCRETE RES, V31, P1307, DOI 10.1016/S0008-8846(01)00582-8; Bazant Z. P., 1997, NIST INT WORKSH FIR, P155; Consolazio GR, 1998, ACI MATER J, V95, P525; Henry M., 2008, P JAPAN CONCRETE I, V30, P435; Kishi T, 2007, 1 INT C SELF HEAL MA; Kodur V., 2003, AM CONCRETE I, P221; Korea Concrete Institute, 2005, KCI; Tovey A. K., 1986, ACI, P47	14	0	0	KOREAN ASSOC CRYSTAL GROWTH, INC	SEOUL	SUNGDONG POST OFFICE, P O BOX 27, SEOUL 133-600, SOUTH KOREA	1229-9162			J CERAM PROCESS RES	J. Ceram. Process. Res.	FEB	2015	16	1					156	161				6	Materials Science, Ceramics	Materials Science	CE3XE	WOS:000351762600029		
J	DasGupta, R; Shaw, R				DasGupta, Rajarshi; Shaw, Rajib			An indicator based approach to assess coastal communities' resilience against climate related disasters in Indian Sundarbans	JOURNAL OF COASTAL CONSERVATION			English	Article						Community resilience; Climate related disasters; Resilience indicators; Indian Sundarbans	ECOLOGICAL RESILIENCE; SAGAR ISLAND; MANAGEMENT; VULNERABILITY; ADAPTATION; ZONES; SYSTEMS; TSUNAMI; BENGAL	The article attempts to develop a five dimensional community resilience assessment framework and a composite resilience index against climate related disasters with special applications to the coastal rural communities' in the developing world. Consequently, it narrates the case study of Indian Sundarbans, which serves as a typical example of a complex & dynamic 'socio-ecological' system characterized by dense mangrove forests, high population density and recurrent climate related disasters. In the present study, 'community resilience' of 19 coastal administrative blocks of Indian Sundarbans were assessed through a systematic questionnaire survey of administrative officials and the composite resilience scores were found to vary between 2.51 and 3.63 in a five point scale. Out of the 19 coastal blocks only one could be classified as high resilient block and the rest were found to be in low to moderate resilience categories. In general, the extreme coastal blocks were found to be less resilient due to their high exposure & developmental deficit, however, at the same time, the study finds strong correlation of institutional interventions & effective coastal zone management in enhancing the overall resilience scores. The study concludes with broad recommendation of integrated planning for disaster & climate resilience in this eco-fragile region where low impact economic development remains at the central.	[DasGupta, Rajarshi; Shaw, Rajib] Kyoto Univ, Grad Sch Global Environm Studies, Int Environm & Disaster Management Res Grp, Sakyo Ku, Kyoto 6068501, Japan	DasGupta, R (reprint author), Kyoto Univ, Grad Sch Global Environm Studies, Int Environm & Disaster Management Res Grp, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	rajarshidg1@yahoo.co.in			MEXT (MONBUKAGAKUSHO) scholarship by the Japanese Government; Kyoto University	The first author greatly acknowledges the MEXT (MONBUKAGAKUSHO) scholarship provided by the Japanese Government for conducting research in the Graduate School of Global Environmental Studies of Kyoto University. The authors would also like to thank the district administrative officials for their administrative support during the field survey at Indian Sundarbans. In this regard, the continuous support of GCOE-ARS program and CoHHO program (Studies on the Connectivity of Hilltop, Human and Ocean) of Kyoto University is thankfully acknowledged.	Adger WN, 2000, PROG HUM GEOG, V24, P347, DOI 10.1191/030913200701540465; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; McDaniels T, 2008, GLOBAL ENVIRON CHANG, V18, P310, DOI 10.1016/j.gloenvcha.2008.03.001; Small C, 2003, J COASTAL RES, V19, P584; Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Costanza R, 2007, ECOL ECON, V63, P249, DOI 10.1016/j.ecolecon.2007.03.002; Gopal B, 2006, AQUAT SCI, V68, P338, DOI 10.1007/s00027-006-0868-8; Danielsen F, 2005, SCIENCE, V310, P643, DOI 10.1126/science.1118387; Thomalla F, 2006, DISASTERS, V30, P39, DOI 10.1111/j.1467-9523.2006.00305.x; Mitra A, 2009, CURR SCI INDIA, V97, P1445; Gopinath G, 2005, ENVIRON GEOL, V48, P1058, DOI 10.1007/s00254-005-0044-9; Murphy BL, 2007, NAT HAZARDS, V41, P297, DOI 10.1007/s11069-006-9037-6; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Kathiresan K, 2005, ESTUAR COAST SHELF S, V65, P601, DOI 10.1016/j.ecss.2005.06.022; Cutter SL, 2008, GLOBAL ENVIRON CHANG, V18, P598, DOI 10.1016/j.gloenvcha.2008.07.013; Gopinath G, 2010, ENVIRON MONIT ASSESS, V160, P555, DOI 10.1007/s10661-008-0718-3; Auld H, 2008, WMO B, V57, P118; Bandyopadhyay S, 1997, SINGAPORE J TROP GEO, V18, P20, DOI 10.1111/1467-9493.00003; Banerjee A, 1998, ENV POPULATION HUMAN; Bene C., 2012, IDS WORK PAP, V2012, P1; Cutter S, 2008, FRAMEWORK MEASURING; Cutter SL, 2010, J HOMEL SECUR EMERG, V7; DasGupta R, 2013, OCEAN COAST MANAGE, V80, P107, DOI 10.1016/j.ocecoaman.2013.04.010; de Bruijn K. M., 2004, INT J RIVER BASIN MA, V2, P199; Edward JP, 2010, RECENT RES SCI TECHN, V2; Field CB, 2012, MANAGING RISKS EXTRE, P1, DOI DOI 10.1017/CBO9781139177245; Forest Survey of India, 2011, STAT FOR REP 2011; INCCA, 2010, CLIM CHANG IND A 4 X; Joerin J, 2011, COMM ENV DISAST RISK, V6, P47, DOI 10.1108/S2040-7262(2011)0000006009; Joerin J, 2012, ENVIRON HAZARDS-UK, V11, P226, DOI 10.1080/17477891.2012.689248; Klein RJT, 1998, GEOGR J, V164, P259, DOI 10.2307/3060615; Mandal RN, 2010, SCI CULT, V76, P275; Mimura N, 2007, CLIMATE CHANGE 2007, P687; Mukhopadhyay A, 2009, CYCLONE AILA SUNDARB; Nakagawa Yuko, 2004, INT J MASS EMERGENCI, V22, P5; Nicholls RJ, 1998, GEOGR J, V164, P255, DOI 10.2307/3060614; Peacock W.G., 2010, ADV RESILIENCE COAST; Miller F, 2010, ECOL SOC, V15; Teo M, 2013, P 9 ANN INT C INT I; United States Indian Ocean Tsunami Warning System Program (USIOTWSP), 2007, RES IS YOUR COAST CO; Uy N, 2011, ENVIRON HAZARDS-UK, V10, P139, DOI 10.1080/17477891.2011.579338; Vandermeulen H, 1998, OCEAN COAST MANAGE, V39, P63, DOI 10.1016/S0964-5691(98)00014-3; WONG P. P, 2007, CLIMATE CHANGE, P315	46	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1400-0350	1874-7841		J COAST CONSERV	J. Coast. Conserv.	FEB	2015	19	1					85	101		10.1007/s11852-014-0369-1		17	Biodiversity Conservation; Environmental Sciences; Marine & Freshwater Biology; Water Resources	Biodiversity & Conservation; Environmental Sciences & Ecology; Marine & Freshwater Biology; Water Resources	CE8RI	WOS:000352111400009		
J	Yang, N; Luo, TF; Esfarjani, K; Henry, A; Tian, ZT; Shiomi, J; Chalopin, Y; Li, BW; Chen, G				Yang, Nuo; Luo, Tengfei; Esfarjani, Keivan; Henry, Asegun; Tian, Zhiting; Shiomi, Junichiro; Chalopin, Yann; Li, Baowen; Chen, Gang			Thermal Interface Conductance Between Aluminum and Silicon by Molecular Dynamics Simulations	JOURNAL OF COMPUTATIONAL AND THEORETICAL NANOSCIENCE			English	Article						Molecular Dynamics; Phonons; Electron Phonon Couplings; Thermal Interface Conductance; Aluminum and Silicon; Atomic Level Disorder	BOUNDARY RESISTANCE; NANOSCALE; CONDUCTIVITY; TRANSPORT; METAL; HEAT; DISPERSION	The thermal interface conductance between Al and Si was simulated by a non-equilibrium molecular dynamics method. In the simulations, the coupling between electrons and phonons in Al are considered by using a stochastic force. The results show the size dependence of the interface thermal conductance and the effect of electron phonon coupling on the interface thermal conductance. To understand the mechanism of interface resistance, the vibration power spectra are calculated. We find that the atomic level disorder near the interface is an important aspect of interfacial phonon transport, which leads to a modification of the phonon states near the interface. There, the vibrational spectrum near the interface greatly differs from the bulk. This change in the vibrational spectrum affects the results predicted by AMM and DMM theories and indicates new physics is involved with phonon transport across interfaces.	[Yang, Nuo; Li, Baowen] Tongji Univ, Sch Phys Sci & Engn, Ctr Phonon & Thermal Energy Sci, Shanghai 200092, Peoples R China; [Yang, Nuo; Tian, Zhiting; Chen, Gang] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Luo, Tengfei] Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN 46556 USA; [Esfarjani, Keivan] Rutgers State Univ, Dept Mech Engn, Piscataway, NJ 08854 USA; [Henry, Asegun] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Henry, Asegun] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; [Shiomi, Junichiro] Univ Tokyo, Dept Mech Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Chalopin, Yann] Ecole Cent Paris, CNRS UPR 288, Lab Energet Mol & Macroscop, F-92295 Chatenay Malabry, France; [Li, Baowen] Natl Univ Singapore, Dept Phys, Singapore 117456, Singapore; [Li, Baowen] Natl Univ Singapore, Ctr Computat Sci & Engn, Singapore 117456, Singapore; [Li, Baowen] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore	Li, BW (reprint author), Tongji Univ, Sch Phys Sci & Engn, Ctr Phonon & Thermal Energy Sci, Shanghai 200092, Peoples R China.		Li, Baowen/G-3003-2011; Chen, Gang/J-1325-2014	Chen, Gang/0000-0002-3968-8530	Solid State Solar-Thermal Energy Conversion Center (S3TEC), an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001299/DE-FG02-09ER46577]; National University of Singapore [R-144-000-300-112]; Tongji University; Natural Science Foundation of China [11334007, 11204216]; Shanghai Pujiang program	This work was supported in part by the "Solid State Solar-Thermal Energy Conversion Center (S<SUP>3</SUP>TEC), an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Award Number: DE-SC0001299/DE-FG02-09ER46577 (Gang Chen). This work was supported in part by the R-144-000-300-112 from the National University of Singapore (Baowen Li). This work is supported in part by the startup fund from Tongji University, Natural Science Foundation of China "11334007" (Nuo Yang and Baowen Li) and "11204216" (Nuo Yang). Nuo Yang is sponsored by Shanghai Pujiang program.	Feng B, 2009, THIN SOLID FILMS, V517, P2803, DOI 10.1016/j.tsf.2008.10.116; Lee CM, 2009, SCRIPTA MATER, V61, P911, DOI 10.1016/j.scriptamat.2009.07.032; Cahill DG, 2003, J APPL PHYS, V93, P793, DOI 10.1063/1.1524305; Hu L, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195423; Tian ZT, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.235304; Schelling PK, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144306; Majumdar A, 2004, APPL PHYS LETT, V84, P4768, DOI 10.1063/1.1758301; Lin Z, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075133; STILLINGER FH, 1985, PHYS REV B, V31, P5262, DOI 10.1103/PhysRevB.31.5262; Collins KC, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3480413; Hu L, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.235427; Komarov PL, 2003, MICROELECTRON J, V34, P1115, DOI 10.1016/S0026-2692(03)00201-5; Schmidt AJ, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3006335; Lee BJ, 2010, CALPHAD, V34, P510, DOI 10.1016/j.calphad.2010.10.007; Chalopin Y, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195302; Hopkins PE, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.035438; Reddy P, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2133890; Yang N, 2012, AIP ADV, V2, DOI 10.1063/1.4773462; Luo TF, 2013, PHYS CHEM CHEM PHYS, V15, P3389, DOI 10.1039/c2cp43771f; Wang Y, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.205311; SWARTZ ET, 1989, REV MOD PHYS, V61, P605, DOI 10.1103/RevModPhys.61.605; Henry AS, 2008, J COMPUT THEOR NANOS, V5, P141; Zhang LF, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.064303; Minnich AJ, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.095901; Jiang JW, 2013, NANO LETT, V13, P1670, DOI 10.1021/nl400127q; Duffy DM, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/1/016207; Bartkowiak M, 2001, SEMICONDUCT SEMIMET, V70, P245; CHEN YF, 2008, J COMPUT THEOR NANOS, V5, P157; Cruz C. A. D., 2011, ASME C P; Esfarjani K, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.085204; Heino P, 2007, J COMPUT THEOR NANOS, V4, P896; Heino P, 2007, EUR PHYS J B, V60, P171, DOI 10.1140/epjb/e2007-00342-9; Landry ES, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165304; Mahan GD, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.075408; MATSUMOTO DS, 1977, PHYS REV B, V16, P3303, DOI 10.1103/PhysRevB.16.3303; Sergeev AV, 1998, PHYS REV B, V58, P10199; Termentzidis K., 2011, NANOSCALE RES LETT, V6, P1; Zhang CW, 2013, CARBON, V64, P61, DOI 10.1016/j.carbon.2013.07.021; Zhou Y, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2802366; Zimbovskaya N. A., 2014, REV THEOR SCI, V2, P1	40	1	1	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1546-1955	1546-1963		J COMPUT THEOR NANOS	J. Comput. Theor. Nanosci.	FEB	2015	12	2					168	174		10.1166/jctn.2015.3710		7	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CE5RE	WOS:000351892500002		
J	Gumrukcuoglu, AE; Heisenberg, L; Mukohyama, S				Guemruekcueoglu, A. Emir; Heisenberg, Lavinia; Mukohyama, Shinji			Cosmological perturbations in massive gravity with doubly coupled matter	JOURNAL OF COSMOLOGY AND ASTROPARTICLE PHYSICS			English	Article						modified gravity; cosmological perturbation theory; gravity	BORN-INFELD; SUPERNOVAE; BIGRAVITY; CONSTANT; UNIVERSE	We investigate the cosmological perturbations around FLRW solutions to nonlinear massive gravity with a new effective coupling to matter proposed recently. Unlike the case with minimal matter coupling, all five degrees of freedom in the gravity sector propagate on generic self-accelerating FLRW backgrounds. We study the stability of the cosmological solutions and put constraints on the parameters of the theory by demanding the correct sign for the kinetic terms for scalar, vector and tensor perturbations.	[Guemruekcueoglu, A. Emir] Univ Nottingham, Sch Math Sci, Nottingham NG7 2RD, England; [Heisenberg, Lavinia] KTH Royal Inst Technol, NORDITA, S-10691 Stockholm, Sweden; [Heisenberg, Lavinia] Stockholm Univ, S-10691 Stockholm, Sweden; [Heisenberg, Lavinia] AlbaNova Univ Ctr, Dept Phys, S-10691 Stockholm, Sweden; [Mukohyama, Shinji] AlbaNova Univ Ctr, Oskar Klein Ctr, S-10691 Stockholm, Sweden; [Mukohyama, Shinji] Univ Tokyo WPI, Todai Inst Adv Study, Kavli Inst Phys & Math Universe, Kashiwa, Chiba 2778583, Japan; [Mukohyama, Shinji] Kyoto Univ, Yukawa Inst Theoret Phys, Kyoto 6068502, Japan	Gumrukcuoglu, AE (reprint author), Univ Nottingham, Sch Math Sci, Univ Pk, Nottingham NG7 2RD, England.	Emir.Gumrukcuoglu@nottingham.ac.uk; Lavinia.Heisenberg@unige.ch; shinji.mukohyama@ipmu.jp			European Research Council under the European Union's Seventh Framework Programme (FP7) / ERC Grant [306425]; WPI Initiative, MEXT, Japan;  [24540256]	We would like to thank N. Tanahashi for very useful discussions. AEG acknowledges financial support from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) / ERC Grant Agreement n. 306425 "Challenging General Relativity". This work was supported in part by WPI Initiative, MEXT, Japan and Grant-in-Aid for Scientific Research 24540256.	Akrami Y, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/10/46; Akrami Y, 2015, GEN RELAT GRAVIT, V47, DOI 10.1007/s10714-014-1838-4; Akrami Y, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2013)099; Vollick DN, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.084026; Hassan SF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.041101; Tonry JL, 2003, ASTROPHYS J, V594, P1, DOI 10.1086/376865; Perlmutter S, 1998, NATURE, V391, P51, DOI 10.1038/34124; Blas D, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.181302; Nicolis A, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.064036; de Rham C, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.084058; de Rham C, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.085017; de Rham C, 2014, LIVING REV RELATIV, V17, DOI 10.12942/lrr-2014-7; Mirbabayi M, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.084006; Comelli D, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.101502; D'Amico G, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.124046; Gratia P, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.061504; WEISBERG JM, 1981, SCI AM, V245, P74; Hassan SF, 2012, PHYS LETT B, V715, P335, DOI 10.1016/j.physletb.2012.07.018; Khosravi N, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.024049; de Rham C, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.043503; Mukohyama S, 2009, PHYS LETT B, V679, P6, DOI 10.1016/j.physletb.2009.07.005; Vakili B, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.083529; BOULWARE DG, 1972, PHYS REV D, V6, P3368, DOI 10.1103/PhysRevD.6.3368; Horava P, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.084008; Pani P, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.084020; de Rham C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.231101; Tasinato G, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.064029; Volkov MS, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.104022; Nojiri S, 2011, PHYS REP, V505, P59, DOI 10.1016/j.physrep.2011.04.001; Hinterbichler K, 2012, REV MOD PHYS, V84, P671, DOI 10.1103/RevModPhys.84.671; Kobayashi T, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.061505; Soloviev VO, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.084026; Kluson J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.044024; Pani P, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.251102; De Felice A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.171101; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; De Felice A, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/18/184004; Chamseddine AH, 2011, PHYS LETT B, V704, P652, DOI 10.1016/j.physletb.2011.09.085; Blas D, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2011)018; Blas D, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/10/029; Brouzakis N, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.125017; Buchbinder IL, 2012, PHYS LETT B, V712, P104, DOI 10.1016/j.physletb.2012.04.045; Comelli D, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/05/036; D'Amico G, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.124019; de Rham C, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/11/016; de Rham C, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.103516; de Rham C, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2011)093; de Rham Claudia, 2012, Physics Letters B, V711, DOI 10.1016/j.physletb.2012.03.081; de Rham C, 2015, CLASSICAL QUANT GRAV, V32, DOI 10.1088/0264-9381/32/3/035022; de Rham C, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.044020; Deffayet C, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2013)086; Deser S, 1998, CLASSICAL QUANT GRAV, V15, pL35, DOI 10.1088/0264-9381/15/5/001; Gumrukcuoglu AE, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/23/235026; Enander J, 2015, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2015/01/006; Fasiello M, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/12/002; Fasiello M, 2012, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2012/11/035; Fierz M, 1939, PROC R SOC LON SER-A, V173, P0211, DOI 10.1098/rspa.1939.0140; Golovnev A, 2012, PHYS LETT B, V707, P404, DOI 10.1016/j.physletb.2011.12.064; Gumrukcuoglu AE, 2012, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2012/03/006; Gumrukcuoglu AE, 2011, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2011/11/030; Hassan SF, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2011)009; Hassan S. F., ARXIV14091909; Hassan SF, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP02(2012)126; de Rham C, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.124042; Heisenberg L, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.064005; Heisenberg L., ARXIV14104239; Heisenberg L, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.103008; Hinterbichler K, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2012)047; Ketov S. V., HEPTH0108189; Komada M., ARXIV14091663; Koyama K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.131101; Koyama K, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP12(2011)065; Motloch P., 2011, PHYS REV D, VD 90; Mukohyama S, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/12/011; Mukohyama S, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/22/223101; Noller J, 2015, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2015/01/003; Odintsov SD, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.044003; Olmo GJ, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-2804-8; Jimenez JB, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/11/004; Ondo NA, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2013)059; Park M, 2011, CLASSICAL QUANT GRAV, V28, DOI 10.1088/0264-9381/28/10/105012; Hassan SF, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2012)123; Scargill JHC, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.103533; Schmidt-May A, ARXIV14093146; Soloviev VO, 2013, THEOR MATH PHYS+, V176, P1163, DOI 10.1007/s11232-013-0097-y; Tamanini N, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/02/015; VANNIEUW.P, 1973, NUCL PHYS B, VB 60, P478, DOI 10.1016/0550-3213(73)90194-6; WEINBERG S, 1989, REV MOD PHYS, V61, P1, DOI 10.1103/RevModPhys.61.1; Wohlfarth MNR, 2004, CLASSICAL QUANT GRAV, V21, P5297, DOI 10.1088/0264-9381/21/22/C01; Wohlfarth MNR, 2004, CLASSICAL QUANT GRAV, V21, P1927, DOI 10.1088/0264-9381/21/8/001; Yamashita Y, ARXIV14080487	91	19	19	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1475-7516			J COSMOL ASTROPART P	J. Cosmol. Astropart. Phys.	FEB	2015		2							022	10.1088/1475-7516/2015/02/022		19	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	CE0NY	WOS:000351502100023		
J	Kohri, K; Matsuda, T				Kohri, Kazunori; Matsuda, Tomohiro			Ambiguity in running spectral index with an extra light field during inflation	JOURNAL OF COSMOLOGY AND ASTROPARTICLE PHYSICS			English	Article						inflation; particle physics - cosmology connection; CMBR theory	MODELS	At the beginning of inflation there could be extra dynamical scalar fields that will soon disappear (become static) before the end of inflation. In the light of multi-field inflation, those extra degrees of freedom may alter the time-dependence of the original spectrum of the curvature perturbation. It is possible to remove such fields introducing extra number of e-foldings prior to N-epsilon similar to 60, however such extra e-foldings may make the trans-Planckian problem worse due to the Lyth bound. We show that such extra scalar fields can change the running of the spectral index to give correction of +/- 0.01 without adding significant contribution to the spectral index. The corrections to the spectral index (and the amplitude) could be important in considering global behavior of the corrected spectrum, although they can be neglected in the estimation of the spectrum and its spectral index at the pivot scale. The ambiguity in the running of the spectral index, which could be due to such fields, can be used to nullify tension between BICEP2 and Planck experiments.	[Kohri, Kazunori] KEK, Ctr Theory, Cosmophys Grp, Tsukuba, Ibaraki 3050801, Japan; [Kohri, Kazunori] Grad Univ Adv Study Sokendai, Tsukuba, Ibaraki 3050801, Japan; [Matsuda, Tomohiro] Saitama Inst Technol, Phys Lab, Saitama 3690293, Japan	Kohri, K (reprint author), KEK, Ctr Theory, Cosmophys Grp, Tsukuba, Ibaraki 3050801, Japan.	kohri@post.kek.jp; matsuda@sit.ac.jp			Ministry of Education, Science, Sports, and Culture (MEXT), Japan [21111006, 23540327, 26105520]; Center for the Promotion of Integrated Science (CPIS) of Sokendai [1HB5804100]	K.K. is supported in part by Grant-in-Aid for Scientific research from the Ministry of Education, Science, Sports, and Culture (MEXT), Japan, Nos. 21111006, 23540327, 26105520 (K.K.). The work of K.K. is also supported by the Center for the Promotion of Integrated Science (CPIS) of Sokendai (1HB5804100).	Ade P.A.R., 2014, PHYS REV LETT, V112; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321569; Bassett BA, 2006, REV MOD PHYS, V78, P537, DOI 10.1103/RevModPhys.78.537; Damour T, 1998, PHYS REV LETT, V80, P3440, DOI 10.1103/PhysRevLett.80.3440; OLIVE KA, 1990, PHYS REP, V190, P307, DOI 10.1016/0370-1573(90)90144-Q; POLARSKI D, 1992, NUCL PHYS B, V385, P623, DOI 10.1016/0550-3213(92)90062-G; Lyth DH, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.103515; Ashoorioon A, 2014, PHYS LETT B, V737, P98, DOI 10.1016/j.physletb.2014.08.038; Easther R, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.161302; Contaldi CR, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/07/014; Czerny M., 2011, PHYS LETT B, V735, P176; Dimopoulos K, 2005, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2005/06/008; Dimopoulos K, 2012, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2012/03/022; Dimopoulos K, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.123541; Enomoto S, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.123520; Frazer J, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/01/028; Gerbino M, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.047301; Gong JO, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/07/022; Hazra D.K., 2014, PHYS REV LETT, V113; Hinshaw G, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/19; Kaiser DI, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.011302; Kallosh R, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/07/002; Kawasaki M, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.023508; Kobayashi T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.231101; Kobayashi T, 2012, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2012/06/004; Kobayashi T., ARXIV14043102; Kohri K, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/10/065; Liddle AR, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.083508; Lyth DH, 1999, PHYS REP, V314, P1, DOI 10.1016/S0370-1573(98)00128-8; Lyth DH, 2005, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2005/05/004; Matsuda T, 2008, J HIGH ENERGY PHYS; Matsuda T., 2012, JCAP, V04, P020; Matsuda T, 2006, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2006/09/003; McDonald J., 2014, JCAP, V11, P012; Mortonson M.J., 2014, JCAP, V10, P035; Seto O, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.103504; Sloth MS, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.063511; Takamizu Y, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.043504; Taruya A, 1999, PHYS REV D, V59; Vernizzi F, 2006, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2006/05/019; Wands D, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.043527; Yokoyama J, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.107303	42	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1475-7516			J COSMOL ASTROPART P	J. Cosmol. Astropart. Phys.	FEB	2015		2							019	10.1088/1475-7516/2015/02/019		11	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	CE0NY	WOS:000351502100020		
J	Kuroyanagi, S; Takahashi, T; Yokoyama, S				Kuroyanagi, Sachiko; Takahashi, Tomo; Yokoyama, Shuichiro			Blue-tilted tensor spectrum and thermal history of the Universe	JOURNAL OF COSMOLOGY AND ASTROPARTICLE PHYSICS			English	Article						primordial gravitational waves (theory); physics of the early universe; gravitational waves and CMBR polarization	COLLIDING VACUUM BUBBLES; GRAVITATIONAL-WAVES; LIMITS; RADIATION; PERTURBATIONS; INFLATION; COSMOLOGY; PLANCK; MODELS; STATE	We investigate constraints on the spectral index of primordial gravitational waves (GWs), paying particular attention to a blue-tilted spectrum. Such constraints can be used to test a certain class of models of the early Universe. We investigate observational bounds from LIGO+Virgo, pulsar timing and big bang nucleosynthesis, taking into account the suppression of the amplitude at high frequencies due to reheating after inflation and also late-time entropy production. Constraints on the spectral index are presented by changing values of parameters such as reheating temperatures and the amount of entropy produced at late time. We also consider constraints under the general modeling approach which can approximately describe various scenarios of the early Universe. We show that the constraints on the blue spectral tilt strongly depend on the underlying assumption and, in some cases, a highly blue-tilted spectrum can still be allowed.	[Kuroyanagi, Sachiko] Tokyo Univ Sci, Fac Sci, Dept Phys, Shinjuku Ku, Tokyo 1628601, Japan; [Takahashi, Tomo] Saga Univ, Dept Phys, Saga 8408502, Japan; [Yokoyama, Shuichiro] Rikkyo Univ, Dept Phys, Toshima Ku, Tokyo 1718501, Japan	Kuroyanagi, S (reprint author), Tokyo Univ Sci, Fac Sci, Dept Phys, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	skuro@rs.tus.ac.jp; tomot@cc.saga-u.ac.jp; shuichiro@rikkyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [24-2775, 23740195]	The authors thank K. Nakayama and J. Yokoyama for helpful discussions. The work is supported by Grant-in-Aid for Scientific Research Nos. 24-2775 (SY) and 23740195 (TT) from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Aasi J., ARXIV14064556; Abadie J, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.122001; Ade PAR, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/62; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321569; Akutsu T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.101101; Allen B., 1997, HOUCHES SCH ASTROPHY, P373; Amaro-Seoane P., 2013, GW NOTES, V6, P4; Sendra I, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.123002; Steigman G, 2012, ADV HIGH ENERGY PHYS, DOI 10.1155/2012/268321; Liu H, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/2/L29; Kobayashi T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.231302; Cook JL, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.023534; Kosowsky A, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.024030; Brandenberger RH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.231302; Lyth DH, 2002, PHYS LETT B, V524, P5, DOI 10.1016/S0370-2693(01)01366-1; Nakayama K, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.124001; Easther R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.221301; Baldi M, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.083504; Zhao W, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.124012; Khlebnikov S, 1997, PHYS REV D, V56, P653, DOI 10.1103/PhysRevD.56.653; KOSOWSKY A, 1993, PHYS REV D, V47, P4372, DOI 10.1103/PhysRevD.47.4372; Moroi T, 2002, PHYS LETT B, V539, P303, DOI 10.1016/S0370-2693(02)02070-1; Grojean C, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.043507; Jenet FA, 2006, ASTROPHYS J, V653, P1571, DOI 10.1086/508702; Ashoorioon A, 2014, PHYS LETT B, V737, P98, DOI 10.1016/j.physletb.2014.08.038; Dufaux JF, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.123517; Ade PAR, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.241101; Caprini C, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.063511; KOSOWSKY A, 1992, PHYS REV D, V45, P4514, DOI 10.1103/PhysRevD.45.4514; Caprini C, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.063521; Kahniashvili T, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.043003; Wu FQ, 2014, SCI CHINA PHYS MECH, V57, P1449, DOI 10.1007/s11433-014-5516-z; Calcagni G, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.103514; Amaro-Seoane P, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/12/124016; Seto N, 2003, J PHYS SOC JPN, V72, P3082, DOI 10.1143/JPSJ.72.3082; Shoda A, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.027101; Caprini C, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.083519; van Haasteren R, 2011, MON NOT R ASTRON SOC, V414, P3117, DOI 10.1111/j.1365-2966.2011.18613.x; Boyle LA, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.043531; KAMIONKOWSKI M, 1994, PHYS REV D, V49, P2837, DOI 10.1103/PhysRevD.49.2837; Smith TL, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.021301; Aoyama S., ARXIV14024521; Armstrong JW, 2003, ASTROPHYS J, V599, P806, DOI 10.1086/379505; Astone P, 1999, ASTRON ASTROPHYS, V351, P811; Biagetti M, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.103518; Brandenberger RH, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.067301; Calcagni G, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/03/052; Camerini R, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.101301; Caprini C, 2009, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2009/12/024; Chluba J., ARXIV14073653; Chongchitnan S, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.083511; Cook J.L., 2012, PHYS REV D, V86; Copeland EJ, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.023508; Coughlin M., 2011, PHYS REV LETT, V112; Demorest PB, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/94; Easther R, 2006, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2006/04/010; Enqvist K, 2002, NUCL PHYS B, V626, P395, DOI 10.1016/S0550-3213(02)00043-3; Felder GN, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.043518; Flauger R, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/08/039; Garcia-Bellido J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.061302; Garcia-Bellido J., 2008, PHYS REV D, V77; Gerbino M, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.047301; Gong JO, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/07/022; Harry G.M., 2006, CLASSICAL QUANT GRAV, V23, P7361, DOI 10.1088/0264-9381/23/24/C01; Harry GM, 2006, CLASSICAL QUANT GRAV, V23, P4887, DOI 10.1088/0264-9381/23/15/008; Hu B, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.023544; Hui L, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.084009; Kawamura S, 2011, CLASSICAL QUANT GRAV, V28, DOI 10.1088/0264-9381/28/9/094011; Kuroyanagi S, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.069901; Kuroyanagi S, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.103501; Kuroyanagi S, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.083502; Kuroyanagi S, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.083524; Kuroyanagi S, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.123513; Maggiore M., 2000, Physics Reports, V331, DOI 10.1016/S0370-1573(99)00102-7; Mendes L.E., GRQC9811040; Mohanty S., ARXIV14042222; Moroi T, 2001, PHYS LETT B, V522, P215, DOI 10.1016/S0370-2693(01)01295-3; Mortonson MJ, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/10/035; Mukohyama S, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/08/036; Nakayama K, 2008, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2008/06/020; Nakayama K, 2010, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2010/01/010; Ota A., ARXIV14060451; Piao YS, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.063513; Seto N, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.063001; Siegel DM, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/2/88; Stewart A, 2008, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2008/08/012; Tashiro H, 2004, CLASSICAL QUANT GRAV, V21, P1761, DOI 10.1088/0264-9381/21/7/004; TURNER MS, 1993, PHYS REV D, V48, P4613, DOI 10.1103/PhysRevD.48.4613; Wang Y, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/10/075; Watanabe Y, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.123515	90	3	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1475-7516			J COSMOL ASTROPART P	J. Cosmol. Astropart. Phys.	FEB	2015		2							003	10.1088/1475-7516/2015/02/003		23	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	CE0NY	WOS:000351502100004		
J	Wagatsuma, T; Khan, MSH; Watanabe, T; Maejima, E; Sekimoto, H; Yokota, T; Nakano, T; Toyomasu, T; Tawaraya, K; Koyama, H; Uemura, M; Ishikawa, S; Ikka, T; Ishikawa, A; Kawamura, T; Murakami, S; Ueki, N; Umetsu, A; Kannari, T				Wagatsuma, Tadao; Khan, Md. Shahadat Hossain; Watanabe, Toshihiro; Maejima, Eriko; Sekimoto, Hitoshi; Yokota, Takao; Nakano, Takeshi; Toyomasu, Tomonobu; Tawaraya, Keitaro; Koyama, Hiroyuki; Uemura, Matsuo; Ishikawa, Satoru; Ikka, Takashi; Ishikawa, Akifumi; Kawamura, Takeshi; Murakami, Satoshi; Ueki, Nozomi; Umetsu, Asami; Kannari, Takayuki			Higher sterol content regulated by CYP51 with concomitant lower phospholipid content in membranes is a common strategy for aluminium tolerance in several plant species	JOURNAL OF EXPERIMENTAL BOTANY			English	Article						Aluminium (Al) tolerance; CYP51; phospholipid; plasma membrane; sterol; uniconazole-P	ROOT-TIP CELLS; PHOTOBLASTIC LETTUCE SEEDS; EXTRUSION MATE FAMILY; ARABIDOPSIS-THALIANA; ACID SOILS; GIBBERELLIN BIOSYNTHESIS; MALATE TRANSPORTER; MULTIPLE GENES; LIPID TRANSFER; ORYZA-SATIVA	Several studies have shown that differences in lipid composition and in the lipid biosynthetic pathway affect the aluminium (Al) tolerance of plants, but little is known about the molecular mechanisms underlying these differences. Phospholipids create a negative charge at the surface of the plasma membrane and enhance Al sensitivity as a result of the accumulation of positively charged Al3+ ions. The phospholipids will be balanced by other electrically neutral lipids, such as sterols. In the present research, Al tolerance was compared among pea (Pisum sativum) genotypes. Compared with Al-tolerant genotypes, the Al-sensitive genotype accumulated more Al in the root tip, had a less intact plasma membrane, and showed a lower expression level of PsCYP51, which encodes obtusifoliol-14 alpha-demethylase (OBT 14DM), a key sterol biosynthetic enzyme. The ratio of phospholipids to sterols was higher in the sensitive genotype than in the tolerant genotypes, suggesting that the sterol biosynthetic pathway plays an important role in Al tolerance. Consistent with this idea, a transgenic Arabidopsis thaliana line with knocked-down AtCYP51 expression showed an Al-sensitive phenotype. Uniconazole-P, an inhibitor of OBT 14DM, suppressed the Al tolerance of Al-tolerant genotypes of maize (Zea mays), sorghum (Sorghum bicolor), rice (Oryza sativa), wheat (Triticum aestivum), and triticale (xTriticosecale Wittmark cv. Currency). These results suggest that increased sterol content, regulated by CYP51, with concomitant lower phospholipid content in the root tip, results in lower negativity of the plasma membrane. This appears to be a common strategy for Al tolerance among several plant species.	[Wagatsuma, Tadao; Toyomasu, Tomonobu; Tawaraya, Keitaro; Ishikawa, Akifumi; Kawamura, Takeshi; Ueki, Nozomi; Umetsu, Asami; Kannari, Takayuki] Yamagata Univ, Fac Agr, Tsuruoka, Yamagata 9978555, Japan; [Khan, Md. Shahadat Hossain] HMD Sci & Technol Univ, Dinajpur, Bangladesh; [Watanabe, Toshihiro; Maejima, Eriko] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan; [Sekimoto, Hitoshi] Utsunomiya Univ, Fac Agr, Utsunomiya, Tochigi 3218505, Japan; [Yokota, Takao] Teikyo Univ, Dept Biosci, Utsunomiya, Tochigi 3208551, Japan; [Nakano, Takeshi] RIKEN, Antibiot Lab, Wako, Saitama 3510198, Japan; [Nakano, Takeshi] RIKEN, Ctr Sustainable Resource Sci, Wako, Saitama 3510198, Japan; [Nakano, Takeshi] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan; [Koyama, Hiroyuki; Murakami, Satoshi] Gifu Univ, Fac Appl Biol Sci, Gifu 5011193, Japan; [Uemura, Matsuo] Iwate Univ, Cryobiosyst Res Ctr, Fac Agr, Morioka, Iwate 0208550, Japan; [Ishikawa, Akifumi] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan; [Ikka, Takashi] Shizuoka Univ, Fac Agr, Shizuoka 4228529, Japan	Wagatsuma, T (reprint author), Yamagata Univ, Fac Agr, Tsuruoka, Yamagata 9978555, Japan.	wagatuma@tds1.tr.yamagata-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [18208008, 23380041]	This work was supported by Grants-in-Aid for Scientific Research (A) and (B) (Nos 18208008, 23380041) from the Japan Society for the Promotion of Science (JSPS).	Magalhaes JV, 2010, ANN BOT-LONDON, V106, P199, DOI 10.1093/aob/mcq115; Hoekenga OA, 2006, P NATL ACAD SCI USA, V103, P9738, DOI 10.1073/pnas.0602868103; Ohyama Y, 2013, PLANT PHYSIOL, V162, P1937, DOI 10.1104/pp.113.218958; Hartmann MA, 1998, TRENDS PLANT SCI, V3, P170, DOI 10.1016/S1360-1385(98)01233-3; Lynch DV, 2004, NEW PHYTOL, V161, P677, DOI 10.1111/j.1469-8137.2004.00992.x; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Chen ZC, 2012, PLANT PHYSIOL, V159, P1624, DOI 10.1104/pp.112.199778; Akhter A, 2009, SOIL SCI PLANT NUTR, V55, P394, DOI 10.1111/j.1747-0765.2009.00372.x; Ryan PR, 2011, J EXP BOT, V62, P9, DOI 10.1093/jxb/erq272; Kim HB, 2005, PLANT PHYSIOL, V138, P2033, DOI 10.1104/pp.105.061598; Iuchi S, 2007, P NATL ACAD SCI USA, V104, P9900, DOI 10.1073/pnas.0700117104; Wang P, 2011, PLANT PHYSIOL, V155, P808, DOI 10.1104/pp.110.165985; POLLE E, 1978, CROP SCI, V18, P823; Sawada Y, 2008, PLANT PHYSIOL, V146, P1386, DOI 10.1104/pp.107.115162; Shaff JE, 2010, PLANT SOIL, V330, P207, DOI 10.1007/s11104-009-0193-9; Toyomasu T, 1998, PLANT PHYSIOL, V118, P1517, DOI 10.1104/pp.118.4.1517; Cheng HC, 2004, PROTEIN SCI, V13, P2304, DOI 10.1110/ps.04799704; Kinraide TB, 2010, J EXP BOT, V61, P2507, DOI 10.1093/jxb/erq082; Davidson SE, 2004, PLANT PHYSIOL, V134, P1123, DOI 10.1104/pp.103.032706; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; Horst WJ, 2010, ANN BOT-LONDON, V106, P185, DOI 10.1093/aob/mcq053; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; Suzuki M, 2006, PLANT CELL PHYSIOL, V47, P565, DOI 10.1093/pcp/pcj031; FUJIWARA T, 1992, PLANT PHYSIOL, V99, P263, DOI 10.1104/pp.99.1.263; Magalhaes JV, 2007, NAT GENET, V39, P1156, DOI 10.1038/ng2074; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Khan MSH, 2009, PHYSIOL PLANTARUM, V135, P73, DOI 10.1111/j.1399-3054.2008.01175.x; Ryan PR, 2007, PLANT PHYSIOL, V144, P1968, DOI 10.1104/pp.107.100446; Ishikawa S, 1998, PLANT CELL PHYSIOL, V39, P516; Sawaki Y, 2009, PLANT PHYSIOL, V150, P281, DOI 10.1104/pp.108.134700; Yamaji N, 2009, PLANT CELL, V21, P3339, DOI 10.1105/tpc.109.070771; Liu JP, 2009, PLANT J, V57, P389, DOI 10.1111/j.1365-313X.2008.03696.x; Jouhet J, 2007, PROG LIPID RES, V46, P37, DOI 10.1016/j.plipres.2006.06.002; Kobayashi Y, 2007, PLANT PHYSIOL, V145, P843, DOI 10.1104/pp.107.102335; Ikka T, 2007, THEOR APPL GENET, V115, P709, DOI 10.1007/s00122-007-0602-5; BENVENISTE P, 1986, ANNU REV PLANT PHYS, V37, P275, DOI 10.1146/annurev.pp.37.060186.001423; BURDEN RS, 1987, PESTIC BIOCHEM PHYS, V27, P289, DOI 10.1016/0048-3575(87)90058-7; DELEERS M, 1985, BIOCHIM BIOPHYS ACTA, V813, P195, DOI 10.1016/0005-2736(85)90233-0; Fisher R. A., 1958, STAT METHODS RES WOR; Garcia-Oliveira AL, 2014, PHYSIOL PLANTARUM, DOI [10.1111/ppl12179, DOI 10.1111/PPL12179]; HAMPP R, 1984, PLANT PHYSIOL, V75, P1017, DOI 10.1104/pp.75.4.1017; HARTMANN MA, 1987, METHOD ENZYMOL, V148, P632; Ishikawa S, 2001, SOIL SCI PLANT NUTR, V47, P489; Ishikawa S, 1996, SOIL SCI PLANT NUTR, V42, P613; Kobayashi Y, 2005, PLANT CELL ENVIRON, V28, P1516, DOI 10.1111/j.1365-3040.2005.01388.x; Kobayashi Y, 2013, PLANT PHYSIOL, V163, P180, DOI 10.1104/pp.113.222893; Kolesnikova MD, 2006, ARCH BIOCHEM BIOPHYS, V447, P87, DOI 10.1016/j.abb.2005.12.010; Kushiro M, 2001, BIOCHEM BIOPH RES CO, V285, P98, DOI 10.1006/bbrc.2001.5122; Maejima E, 2014, J PLANT PHYSIOL, V171, P9, DOI 10.1016/j.jplph.2013.09.012; Nezames CD, 2013, FUNCT PLANT BIOL, V40, P67, DOI 10.1071/FP12234; Suzuki Y, 2004, BIOTECHNIQUES, V37, P542; Tanimoto E, 2002, PLANT ROOTS HIDDEN H, P405; Toda T, 1999, BIOSCI BIOTECH BIOCH, V63, P210, DOI 10.1271/bbb.63.210; UEMURA M, 1984, PLANT PHYSIOL, V75, P818, DOI 10.1104/pp.75.3.818; WAGATSUMA T, 1989, SOIL SCI PLANT NUTR, V35, P443; Wagatsuma T, 2005, SOIL SCI PLANT NUTR, V51, P701, DOI 10.1111/j.1747-0765.2005.tb00095.x; Xia JX, 2013, PLANT J, V76, P345, DOI 10.1111/tpj.12296; Yang ZB, 2010, J EXP BOT, V61, P3245, DOI 10.1093/jxb/erq146; Yaxley JR, 2001, PLANT PHYSIOL, V125, P627, DOI 10.1104/pp.125.2.627; Zhang GC, 1996, PHYSIOL PLANTARUM, V96, P683; ZLATKIS A, 1969, ANAL BIOCHEM, V29, P143, DOI 10.1016/0003-2697(69)90017-7	61	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	FEB	2015	66	3					907	918		10.1093/jxb/eru455		12	Plant Sciences	Plant Sciences	CE2RD	WOS:000351662300024		
J	Hisanaga, T; Kawade, K; Tsukaya, H				Hisanaga, Tetsuya; Kawade, Kensuke; Tsukaya, Hirokazu			Compensation: a key to clarifying the organ-level regulation of lateral organ size in plants	JOURNAL OF EXPERIMENTAL BOTANY			English	Review						Cell proliferation; cell size; cell-to-cell communication; compensation; leaf size; organ size	ARABIDOPSIS LEAF DEVELOPMENT; DNA TOPOISOMERASE-VI; ENHANCED CELL EXPANSION; CHLOROPLAST DIVISION; FUNCTIONAL-ANALYSIS; DEVELOPING LEAVES; PLASTID DIVISION; THALIANA; GROWTH; PROLIFERATION	Leaves are ideal model systems to study the organ size regulation of multicellular plants. Leaf cell number and cell size are determinant factors of leaf size which is controlled through cell proliferation and post-mitotic cell expansion, respectively. To achieve a proper leaf size, cell proliferation and post-mitotic cell expansion should be co-ordinated during leaf morphogenesis. Compensation, which is enhanced post-mitotic cell expansion associated with a decrease in cell number during lateral organ development, is suggestive of such co-ordination. Genetic and kinematic studies revealed at least three classes of modes of compensation, indicating that compensation is a heterogeneous phenomenon. Recent studies have increased our understanding about the molecular basis of compensation by identifying the causal genes of each compensation-exhibiting mutant. Furthermore, analyses using chimeric leaves revealed that a type of compensated cell expansion requires cell-to-cell communication. Information from recent advances in molecular and genetic studies on compensation has been integrated here and its role in organ size regulation is discussed.	[Hisanaga, Tetsuya] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan; [Kawade, Kensuke] Hokkaido Univ, Fac Sci, Dept Biol Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Tsukaya, Hirokazu] Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	Tsukaya, H (reprint author), Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan.	tsukaya@bs.s.u-tokyo.ac.jp	Tsukaya, Hirokazu/A-2614-2013	Tsukaya, Hirokazu/0000-0002-4430-4538	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan; Mitsubishi Foundation	This work was supported by the Japan Society for the Promotion of Science [Grants-in-Aid for Creative Scientific Research and Scientific Research A and JSPS Fellows], the Ministry of Education, Culture, Sports, Science and Technology, Japan (Scientific Research on Priority Areas and Scientific Research on Innovative Areas), and the Mitsubishi Foundation.	Taylor NG, 1999, PLANT CELL, V11, P769, DOI 10.1105/tpc.11.5.769; Kerstetter RA, 1998, ANNU REV CELL DEV BI, V14, P373, DOI 10.1146/annurev.cellbio.14.1.373; De Veylder L, 2001, PLANT CELL, V13, P1653, DOI 10.1105/tpc.13.7.1653; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Ferjani A, 2007, PLANT PHYSIOL, V144, P988, DOI 10.1104/PP.107.099325; Usami T, 2009, DEVELOPMENT, V136, P955, DOI 10.1242/dev.028613; Sugimoto-Shirasu K, 2005, P NATL ACAD SCI USA, V102, P18736, DOI 10.1073/pnas.0505883102; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; White DWR, 2006, P NATL ACAD SCI USA, V103, P13238, DOI 10.1073/pnas.0604349103; Hisanaga T, 2013, PLANT PHYSIOL, V162, P831, DOI 10.1104/pp.113.216796; Kawade K, 2010, DEVELOPMENT, V137, P4221, DOI 10.1242/dev.057117; Vercruyssen L, 2014, PLANT CELL, V26, P210, DOI 10.1105/tpc.113.115907; Horiguchi G, 2006, PLANT J, V48, P638, DOI 10.1111/j.1365-313X.2006.02896.x; Simpson C, 2009, PLANT CELL, V21, P581, DOI 10.1105/tpc.108.060145; Mizukami Y, 2000, P NATL ACAD SCI USA, V97, P942, DOI 10.1073/pnas.97.2.942; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; PYKE KA, 1992, PLANT PHYSIOL, V99, P1005, DOI 10.1104/pp.99.3.1005; Beemster GTS, 2003, TRENDS PLANT SCI, V8, P154, DOI 10.1016/S1360-1385(03)00046-3; PYKE KA, 1994, PLANT PHYSIOL, V104, P201; Disch S, 2006, CURR BIOL, V16, P272, DOI 10.1016/j.cub.2005.12.026; Kim JH, 2004, P NATL ACAD SCI USA, V101, P13374, DOI 10.1073/pnas.0405450101; Tsukaya H, 2002, INT REV CYTOL, V217, P1; Verkest A, 2005, PLANT CELL, V17, P1723, DOI 10.1105/tpc.105.032383; Day SJ, 2000, DEVELOPMENT, V127, P2977; Ichihashi Y, 2010, PLANT CELL PHYSIOL, V51, P252, DOI 10.1093/pcp/pcp184; HEMERLY A, 1995, EMBO J, V14, P3925; Wilmoth JC, 2005, PLANT J, V43, P118, DOI 10.1111/j.1365-313X.2005.02432.x; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Horiguchi G, 2009, PLANT J, V60, P122, DOI 10.1111/j.1365-313X.2009.03940.x; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Andriankaja M, 2012, DEV CELL, V22, P64, DOI 10.1016/j.devcel.2011.11.011; Breuer C, 2007, PLANT CELL, V19, P3655, DOI 10.1105/tpc.107.054833; Fujikura U, 2009, PLANT J, V59, P499, DOI 10.1111/j.1365-313X.2009.03886.x; Autran D, 2002, EMBO J, V21, P6036, DOI 10.1093/emboj/cdf614; Barroco RM, 2006, PLANT PHYSIOL, V142, P1053, DOI 10.1104/pp.106.087056; Li YH, 2008, GENE DEV, V22, P1331, DOI 10.1101/gad.463608; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; Narita NN, 2004, PLANT J, V38, P699, DOI 10.1111/j.1365-313X.2004.02078.x; Ferjani A, 2013, PLANT CELL PHYSIOL, V54, P1989, DOI 10.1093/pcp/pct138; HABER AH, 1962, AM J BOT, V49, P583, DOI 10.2307/2439715; Fukao Y, 2011, PLANT PHYSIOL, V155, P1893, DOI 10.1104/pp.110.169730; Barow M, 2003, PLANT CELL ENVIRON, V26, P571, DOI 10.1046/j.1365-3040.2003.00988.x; Anastasiou E, 2007, DEV CELL, V13, P843, DOI 10.1016/j.devcel.2007.10.001; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Okazaki K, 2009, PLANT CELL, V21, P1769, DOI 10.1105/tpc.109.067785; Miyagishima SY, 2006, PLANT CELL, V18, P2517, DOI 10.1105/tpc.106.045484; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Sonoda Y, 2009, PLANT J, V60, P68, DOI 10.1111/j.1365-313X.2009.03932.x; Kazama T, 2010, PLANT CELL PHYSIOL, V51, P1046, DOI 10.1093/pcp/pcq051; Ichihashi Y, 2011, PLANT PHYSIOL, V157, P1151, DOI 10.1104/pp.111.185066; Ferjani Ali, 2013, Plant Signal Behav, V8, pe27204, DOI 10.4161/psb.27204; Foster AS, 1936, BOT REV, V2, P349, DOI 10.1007/BF02870152; Fujikura U, 2007, PLANT CELL PHYSIOL, V48, P278, DOI 10.1093/pcp/pcm002; Fujikura Ushio, 2007, Plant Signal Behav, V2, P378, DOI 10.4161/psb.2.5.4525; Fukao Yoichiro, 2011, Plant Signal Behav, V6, P1253; Hanstein J., 1868, NATUR HEILKUNDE, P109; Hirakawa Y, 2010, CURR OPIN PLANT BIOL, V14, P1; Horiguchi G, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00024; Hu YX, 2003, PLANT CELL, V15, P1951, DOI 10.1105/tpc.013557; Kalve S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00362; Kawade K, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-143; Kurepa J, 2009, PLANT PHYSIOL, V150, P178, DOI 10.1104/pp.109.135970; Leevers SJ, 2005, CURR OPIN CELL BIOL, V17, P604, DOI 10.1016/j.ceb.2005.09.008; Okazaki Kumiko, 2010, Plant Signal Behav, V5, P164, DOI 10.4161/psb.5.2.10461; Potter CJ, 2001, CURR OPIN GENET DEV, V11, P279, DOI 10.1016/S0959-437X(00)00191-X; Raynaud C, 2005, P NATL ACAD SCI USA, V102, P8216, DOI 10.1073/pnas.0502564102; Roeder AHK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000367; Sugimoto-Shirasu K, 2002, CURR BIOL, V12, P1782, DOI 10.1016/S0960-9822(02)01198-3; Tsukaya H, 2000, PLANTA, V210, P536, DOI 10.1007/s004250050042; Tsukaya Hirokazu, 2013, Arabidopsis Book, V11, pe0163, DOI 10.1199/tab.0163; Tsukaya H, 2008, PLOS BIOL, V6, P1373, DOI 10.1371/journal.pbio.0060174; Tsukaya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083729	72	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	FEB	2015	66	4			SI		1055	1063		10.1093/jxb/erv028		9	Plant Sciences	Plant Sciences	CE2RG	WOS:000351662800003		
J	Kim, M				Kim, Miji			Association between Objectively Measured Sleep Quality and Obesity in Community-dwelling Adults Aged 80 Years or Older: A Cross-sectional Study	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						Sleep Quality; Motor Activity; Obesity; Aged; 80 and over; Accelerometer	METABOLIC CONSEQUENCES; FUNCTIONAL LIMITATIONS; EPIDEMIOLOGIC EVIDENCE; WAKE IDENTIFICATION; ELDERLY PERSONS; POOR SLEEP; DURATION; WOMEN; POPULATION; FRAGMENTATION	The purpose of this study was to examine the association between objective measures of sleep quality and obesity in older community-dwelling people. This cross-sectional study included 189 community-dwelling adults aged >= 80 yr (83.4 +/- 2.5 yr [age range, 80-95 yr]). Participants wore an accelerometer (ActiGraph GT3X(+)) on their non-dominant wrist 24 hr per day for 7 consecutive nights. Sleep parameters measured included total sleep time, sleep efficiency, and wake after sleep onset (WASO) during the night. Associations between sleep parameters and obesity were investigated by using multivariate logistic regression analysis. In multivariate models, those with sleep efficiency lower than 85% had a 2.85-fold increased odds of obesity, compared with those with sleep efficiency of 85% or higher. Similarly, those with WASO of >= 60 min (compared with < 60 min) had a 3.13-fold increased odds of obesity. However, there were no significant associations between total sleep time or self-reported napping duration and obesity. We found that poor sleep quality was an independent risk factor for obesity in community-dwelling Japanese adults aged >= 80 yr, even after controlling for potential confounding factors, including daily physical activity.	[Kim, Miji] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo 1730015, Japan; [Kim, Miji] Inst Gerontol, Tokyo, Japan	Kim, M (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	mijiak@tmig.or.jp			Japan Society for the Promotion of Science [23700820, 26750349]	This work was supported by a Grant-in-Aid for Young Scientists ([B] No. 23700820 and No. 26750349) awarded to Miji Kim by the Japan Society for the Promotion of Science.	Kim HK, 2012, J AM GERIATR SOC, V60, P16, DOI 10.1111/j.1532-5415.2011.03776.x; Ancoli-Israel S, 2003, SLEEP, V26, P342; Van Cauter E, 2000, JAMA-J AM MED ASSOC, V284, P861, DOI 10.1001/jama.284.7.861; Al Snih S, 2007, ARCH INTERN MED, V167, P774, DOI 10.1001/archinte.167.8.774; Patel SR, 2008, INT J OBESITY, V32, P1825, DOI 10.1038/ijo.2008.198; Houston DK, 2009, J AM DIET ASSOC, V109, P1886, DOI 10.1016/j.jada.2009.08.014; Villareal DT, 2005, OBES RES, V13, P1849, DOI 10.1038/oby.2005.228; Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; van den Berg JF, 2009, SLEEP, V32, P1367; Cellini N, 2013, CHRONOBIOL INT, V30, P691, DOI 10.3109/07420528.2013.782312; Goldman SE, 2007, SLEEP, V30, P1317; Strath SJ, 2012, MED SCI SPORT EXER, V44, pS77, DOI 10.1249/MSS.0b013e3182399eb1; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; Van Den Berg JF, 2008, J SLEEP RES, V17, P295, DOI 10.1111/j.1365-2869.2008.00638.x; Ohayon MM, 2004, SLEEP, V27, P1255; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; AKERSTEDT T, 1994, PERCEPT MOTOR SKILL, V79, P287; Kim M, 2013, EUR J CLIN NUTR, V67, P395, DOI 10.1038/ejcn.2013.9; Unruh ML, 2008, J AM GERIATR SOC, V56, P1218, DOI 10.1111/j.1532-5415.2008.01755.x; Marshall NS, 2008, SLEEP MED REV, V12, P289, DOI 10.1016/j.smrv.2008.03.001; Nielsen LS, 2011, OBES REV, V12, P78, DOI 10.1111/j.1467-789X.2010.00724.x; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Hung HC, 2013, OBESITY, V21, P486, DOI [10.1002/oby.20259, 10.1002/oby.2012.169]; Gangwisch JE, 2005, SLEEP, V28, P1289; COLE RJ, 1992, SLEEP, V15, P461; Jennings JR, 2007, SLEEP, V30, P219; Kim JH, 2013, J KOREAN MED SCI, V28, P1041, DOI 10.3346/jkms.2013.28.7.1041; Bassett J, 2000, ASIA PACIFIC PERSPEC; Butte NF, 2012, MED SCI SPORT EXER, V44, pS5, DOI 10.1249/MSS.0b013e3182399c0e; Fogelholm M, 2007, INT J OBESITY, V31, P1713, DOI 10.1038/sj.ijo.0803663; Kojima N, 2014, GERIATR GERONTOL INT, V14, P674, DOI 10.1111/ggi.12158; Matsuzawa Y, 2000, J JAPAN SOC STUDY OB, V6, P18; SADEH A, 1994, SLEEP, V17, P201; Spira AP, 2012, J AM GERIATR SOC, V60, P1092, DOI 10.1111/j.1532-5415.2012.03968.x; van den Berg JF, 2008, INT J OBESITY, V32, P1083, DOI 10.1038/ijo.2008.57; Yan Zhou, 2012, Age (Dordr), V34, P527, DOI 10.1007/s11357-011-9251-3	37	1	1	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934	1598-6357		J KOREAN MED SCI	J. Korean Med. Sci.	FEB	2015	30	2					199	206		10.3346/jkms.2015.30.2.199		8	Medicine, General & Internal	General & Internal Medicine	CE3XK	WOS:000351763200013		
J	Tokiwa, T; Taira, K; Une, Y				Tokiwa, T.; Taira, K.; Une, Y.			Experimental Infection of Mongolian Gerbils with Baylisascaris potosis	JOURNAL OF PARASITOLOGY			English	Article							KINKAJOU; FLAVUS	The present study evaluated the pathogenicity of Baylisascaris potosis, a newly described ascarid nematode, in Mongolian gerbils. Gerbils were infected with varying doses of either B. potosis or Baylisascaris transfuga embryonated eggs (100, 1,000, and 4,000) for 30 days postinfection (pi). Baylisascaris potosis-infected gerbils showed no clinical signs of disease; however, gerbils exposed to 1,000 and 4,000 B. transfuga eggs showed severe neurologic signs at 22-29 days and 14-15 days pi, respectively. Histopathologic examination revealed larvae and lesions in the intestine, lung, liver, and muscles of B. potosis-infected gerbils, but not in the brain, whereas B. transfuga larvae were found only in the brain and muscle. These results indicate that B. potosis larvae migrate through numerous organs and are associated with visceral larva migrans in gerbils, but less frequently migrate to the nervous system in gerbils than does B. transfuga.	[Tokiwa, T.; Une, Y.] Azabu Univ, Sch Vet Med, Pathol Lab, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Taira, K.] Azabu Univ, Sch Vet Med, Parasitol Lab, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan	Une, Y (reprint author), Azabu Univ, Sch Vet Med, Pathol Lab, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	une@azabu-u.ac.jp	Tokiwa, Toshihiro/B-4664-2015	Une, Yumi/0000-0002-2112-1894; Tokiwa, Toshihiro/0000-0003-1943-5146	Ministry of Health, Labor and Welfare of Japan [H24-Shinko-Ippan-06]; Azabu University	This work was supported by a Grant-in-Aid for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor and Welfare of Japan (H24-Shinko-Ippan-06) and a research project grant awarded by the Azabu University.	Sato H, 2004, J PARASITOL, V90, P774, DOI 10.1645/GE-3330; Cho S, 2007, J HELMINTHOL, V81, P43, DOI 10.1017/S0022149X07212118; Akao N., 2003, Journal of Parasitology, V89, P174, DOI 10.1645/0022-3395(2003)089[0174:DRDTBP]2.0.CO;2; Kazacos K. R., 2011, Morbidity and Mortality Weekly Report, V60, P302; Taira K, 2013, HELMINTHOLOGIA, V50, P238, DOI 10.2478/s11687-013-0136-0; Tokiwa T, 2014, PARASITOL INT, V63, P591, DOI 10.1016/j.parint.2014.03.003	6	1	1	AMER SOC PARASITOLOGISTS	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	0022-3395	1937-2345		J PARASITOL	J. Parasitol.	FEB	2015	101	1					114	115		10.1645/14-541.1		2	Parasitology	Parasitology	CE1HN	WOS:000351562800021		
J	Uchiyama, M				Uchiyama, Masanobu			New Reactions, New Materials, and New Functions based on Integration of Theoretical Calculation and Synthetic Chemistry	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Review						ate complex; heteroleptic complex; zinc	CROSS-COUPLING REACTION; NEAR-INFRARED DYE; ARYL CHLORIDES; REACTION PATHWAY; CATALYZED BORYLATION; TMP-ZINCATE; BIS(IODOZINCIO)METHANE; ACTIVATION; GENERATION; REACTIVITY	Our main research aims include development of innovative chemical reactions, and design and creation of new functional molecules. We are conducting fundamental and applied research in these areas not only by means of experimental approaches based on synthetic organic chemistry, elements chemistry, and spectroscopy, but also from a theoretical viewpoint based on computational chemistry. We understand that rational and accurate designs of new reactions and novel materials based only on past experiences are often difficult because excellent estimates of transition state structures, reactive intermediates and functions by means of experimental techniques are almost impossible. For example, catalytic reactions and multicomponent reactions (MCRs) that chemically combine three or more molecules into a new product are faster and generate less waste, making them invaluable in efforts to improve efficiency and sustainability; however, a full understanding of those processes has eluded researchers because its multipart workings are difficult to detect experimentally. We believes a dual approach combining the benefits of theoretical and experimental chemistry should be encouraged: an approach that will result in breakthrough synthetic processes and functional molecules, use fewer chemicals and be more cost effective.	[Uchiyama, Masanobu] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Uchiyama, Masanobu] RIKEN, Ctr Sustainable Resource Sci, Adv Elements Chem Res Team, Wako, Saitama 3510198, Japan; [Uchiyama, Masanobu] RIKEN, Elements Chem Lab, Wako, Saitama 3510198, Japan	Uchiyama, M (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	uchiyama@mol.f.u-tokyo.ac.jp	Uchiyama, Masanobu/B-7181-2015				Kleeberg C, 2009, ANGEW CHEM INT EDIT, V48, P5350, DOI 10.1002/anie.200901879; Muranaka A, 2012, J AM CHEM SOC, V134, P190, DOI 10.1021/ja210410c; Nagashima Y, 2014, J AM CHEM SOC, V136, P8532, DOI 10.1021/ja5036754; Cid J, 2012, CHEM SOC REV, V41, P3558, DOI 10.1039/c2cs15291f; Uchiyama M, 2004, J AM CHEM SOC, V126, P10897, DOI 10.1021/ja048663u; Billingsley KL, 2007, ANGEW CHEM INT EDIT, V46, P5359, DOI 10.1002/anie.200701551; Ishiyama T, 1997, TETRAHEDRON LETT, V38, P3447, DOI 10.1016/S0040-4039(97)00642-4; Kawamorita S, 2011, ANGEW CHEM INT EDIT, V50, P8363, DOI 10.1002/anie.201103224; Shoji Y, 2014, NAT CHEM, V6, P498, DOI [10.1038/nchem.1948, 10.1038/NCHEM.1948]; Furstner A, 2002, ORG LETT, V4, P541, DOI 10.1021/ol0171463; Yamamoto T, 2011, ORG LETT, V13, P5766, DOI 10.1021/ol202267t; ISHIYAMA T, 1995, J ORG CHEM, V60, P7508, DOI 10.1021/jo00128a024; Miyaura N, 2008, B CHEM SOC JPN, V81, P1535, DOI 10.1246/bcsj.81.1535; Takaya J, 2012, ACS CATAL, V2, P1993, DOI 10.1021/cs300320u; Tang WJ, 2011, ORG LETT, V13, P1366, DOI 10.1021/ol2000556; Sada M, 2010, J AM CHEM SOC, V132, P17452, DOI 10.1021/ja104439w; BLOOR JE, 1964, CAN J CHEM, V42, P2201, DOI 10.1139/v64-325; Naka H, 2007, J AM CHEM SOC, V129, P1921, DOI 10.1021/ja064601n; Baker SJ, 2009, FUTURE MED CHEM, V1, P1275, DOI [10.4155/fmc.09.71, 10.4155/FMC.09.71]; Nagashima Y, 2013, J AM CHEM SOC, V135, P18730, DOI 10.1021/ja409748m; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Uchiyama M, 2006, J AM CHEM SOC, V128, P8748, DOI 10.1021/ja060489h; Sada M, 2010, CHEM-EUR J, V16, P10474, DOI 10.1002/chem.201000738; Muranaka A, 2010, J AM CHEM SOC, V132, P7844, DOI 10.1021/ja101818g; Huang K, 2011, CHEM-EUR J, V17, P786, DOI 10.1002/chem.201001943; Asano Y, 2007, J AM CHEM SOC, V129, P4516, DOI 10.1021/ja068528c; Iwai Y, 2013, CHEM SCI, V4, P1111, DOI 10.1039/c2sc22045h; Kim RH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4583; Komagawa S, 2008, J SYN ORG CHEM JPN, V66, P974; Komagawa S, 2012, ANGEW CHEM INT EDIT, V51, P12081, DOI 10.1002/anie.201204923; Komagawa S, 2013, J AM CHEM SOC, V135, P14508, DOI 10.1021/ja4068468; Kondo Y, 2007, J AM CHEM SOC, V129, P12734, DOI 10.1021/ja072118m; Maeda S, 2011, ANGEW CHEM INT EDIT, V50, P644, DOI 10.1002/anie.201005336; Maeda S, 2014, J SYN ORG CHEM JPN, V72, P567; Matsusita O., 2012, J AM CHEM SOC, V134, P3411; Muranaka A, 2014, J PHYS CHEM A, V118, P4415, DOI 10.1021/jp5001557; Passerini M., 1921, GAZZ CHIM ITAL, V51, P181; Smoum R., 2012, CHEM REV, V122, P4156; Toriumi N, 2014, ANGEW CHEM INT EDIT, V53, P7814, DOI 10.1002/anie.201404020; Molander GA, 2010, J AM CHEM SOC, V132, P17701, DOI 10.1021/ja1089759; Uchiyama M, 2007, ANGEW CHEM INT EDIT, V46, P926, DOI 10.1002/anie.200602664; Uchiyama M, 2008, J AM CHEM SOC, V130, P472, DOI 10.1021/ja071268u; Uchiyama M, 2007, J AM CHEM SOC, V129, P13360, DOI 10.1021/ja070123k; Yamashita M., 2012, ANGEW CHEM INT EDIT, V49, P2474; Yamashita M, 2010, J SYN ORG CHEM JPN, V68, P359	45	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	FEB	2015	73	2					119	130				12	Chemistry, Organic	Chemistry	CE5PG	WOS:000351887000002		
J	Kobayashi, S				Kobayashi, Shoji			Divergent Total Synthesis of Bioactive Molecules Derived from the Fruiting Bodies of Hericium erinaceum	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Review						Hericium erinaceum; geranyl resorcylates; hericenone; hericerin; hericenol; hericene; erinacerin; total synthesis; structure revision	CROSS-COUPLING REACTIONS; AROMATIC-COMPOUNDS; SELECTIVE OXIDATION; HERICENONE-A; MUSHROOM; ALCOHOLS; HERICERIN; MILD; INHIBITOR; REAGENTS	Geranyl resorcylates isolated from the fruiting bodies of Hericium erinaceum exhibit a variety of biological activities including stimulation of nerve growth factor (NGF) synthesis, inhibition of collagen-induced platelet aggregation, suppression of endoplasmic reticulum (ER) stress-dependent cell death, plant growth regulation, and so on. This paper describes the divergent total synthesis of the members of geranyl resorcylates with the intention to clarify the structure-activity relationship (SAR) and to supply compounds for further research. The synthesis commenced with preparation of the phthalide core by the newly-developed CuBr2-mediated one-pot multi-functionalization reaction. The C5'-oxidized side chain was synthesized via alkylation with the protected cyanohydrin. Two fragments were assembled by the modified Stille coupling reactions, which were followed by functional group manipulations to furnish the target molecules. From the common intermediates, eleven natural products including hericenones A, B, J and I, hericene A, hericerin, hericenols B-D, and erinacerins A and B were synthesized. Among them, the structures of hericerin and hericenone B were revised as the carbonyl regioisomers of the original assignments. Futhermore, it was suggested that hericenols C and D were artifacts resulting from degradation of hericenol B. This study affords not only the natural product library for SAR study but information to deduce the biosynthetic pathways of geranyl resorcylates.	Osaka Inst Technol, Fac Engn, Dept Appl Chem, Asahi Ku, Osaka 5358585, Japan	Kobayashi, S (reprint author), Osaka Inst Technol, Fac Engn, Dept Appl Chem, Asahi Ku, 5-16-1 Ohmiya, Osaka 5358585, Japan.	shoji.kobayashi@oit.ac.jp					Cordes J, 2012, J ORG CHEM, V77, P652, DOI 10.1021/jo202354j; KIMURA Y, 1991, AGR BIOL CHEM TOKYO, V55, P2673; KING LC, 1964, J ORG CHEM, V29, P3459, DOI 10.1021/jo01035a003; DESS DB, 1991, J AM CHEM SOC, V113, P7277, DOI 10.1021/ja00019a027; Mori K, 2009, PHYTOTHER RES, V23, P367, DOI 10.1002/ptr.2634; Kobayashi S, 2011, TETRAHEDRON, V67, P9087, DOI 10.1016/j.tet.2011.09.104; KAWAGISHI H, 1990, TETRAHEDRON LETT, V31, P373, DOI 10.1016/S0040-4039(00)94558-1; Li W, 2015, FOOD CHEM, V170, P336, DOI 10.1016/j.foodchem.2014.08.078; KAWAGISHI H, 1993, PHYTOCHEMISTRY, V32, P175, DOI 10.1016/0031-9422(92)80127-Z; Suga S, 2010, CHEM LETT, V39, P404, DOI 10.1246/cl.2010.404; Littke AF, 2002, J AM CHEM SOC, V124, P6343, DOI 10.1021/ja020012f; Ueda K, 2008, BIOORGAN MED CHEM, V16, P9467, DOI 10.1016/j.bmc.2008.09.044; Nguyen TB, 2012, ORG LETT, V14, P3202, DOI 10.1021/ol301308c; Treadwell EM, 1999, J ORG CHEM, V64, P8718, DOI 10.1021/jo9908795; Bentley R, 2000, CHEM REV, V100, P3801, DOI 10.1021/cr990097b; Shibuya M, 2006, J AM CHEM SOC, V128, P8412, DOI 10.1021/ja0620336; Mori K, 2010, PHYTOMEDICINE, V17, P1082, DOI 10.1016/j.phymed.2010.05.004; Miyazawa M, 2012, TETRAHEDRON, V68, P2007, DOI 10.1016/j.tet.2011.11.068; Shinozuka T, 2008, TETRAHEDRON LETT, V49, P1619, DOI 10.1016/j.tetlet.2008.01.031; KAWAGISHI H, 1991, TETRAHEDRON LETT, V32, P4561, DOI 10.1016/0040-4039(91)80039-9; ARNONE A, 1994, J NAT PROD, V57, P602, DOI 10.1021/np50107a006; Kim KH, 2012, J ANTIBIOT, V65, P575, DOI 10.1038/ja.2012.65; BASHA A, 1977, TETRAHEDRON LETT, P4171; CLEAVER L, 1976, AUST J CHEM, V29, P1989; Doi N., 2002, EP, Patent No. [1231197A1, 1231197, EP1231197A1]; Falck JR, 1997, TETRAHEDRON LETT, V38, P5245, DOI 10.1016/S0040-4039(97)01146-5; FETIZON M, 1968, CR ACAD SCI C CHIM, V267, P900; Gomez-Prado RA, 2013, TETRAHEDRON LETT, V54, P2131, DOI 10.1016/j.tetlet.2013.02.027; GUINDON Y, 1984, J ORG CHEM, V49, P3912, DOI 10.1021/jo00195a007; Kawagishi H, 2010, J SYN ORG CHEM JPN, V68, P514; Kawagishi H, 2007, HETEROCYCLES, V72, P45; Kende A. S., 1986, ORG SYNTH, V64, P221; Kobayashi S, 2014, J ORG CHEM, V79, P5227, DOI 10.1021/jo500795z; Kobayashi S, 2012, J ORG CHEM, V77, P5819, DOI 10.1021/jo300719m; Lemire A, 2004, ORG LETT, V6, P3517, DOI 10.1021/ol048624n; Li W, 2014, TETRAHEDRON LETT, V55, P4086, DOI 10.1016/j.tetlet.2014.05.117; Ma BingJi, 2010, Mycology - An International Journal on Fungal Biology, V1, P92; MCKILLOP A, 1979, SYNTHESIS-STUTTGART, P401; Miyazawa M, 2012, TETRAHEDRON, V68, P3786, DOI 10.1016/j.tet.2012.03.046; Omolo O., 2002, PHYTOCHEMISTRY, V60, P431; RAO AVR, 1992, TETRAHEDRON LETT, V33, P4061; SAA JM, 1992, J ORG CHEM, V57, P678, DOI 10.1021/jo00028a051; SAIMOTO H, 1995, B CHEM SOC JPN, V68, P2727, DOI 10.1246/bcsj.68.2727; STILLE JK, 1986, ANGEW CHEM INT EDIT, V25, P508, DOI 10.1002/anie.198605081; Weigand S, 1996, SYNTHESIS-STUTTGART, P475; Yaoita Y, 2005, CHEM PHARM BULL, V53, P1202, DOI 10.1248/cpb.53.1202	46	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	FEB	2015	73	2					131	139				9	Chemistry, Organic	Chemistry	CE5PG	WOS:000351887000003		
J	Ohmatsu, K; Ooi, T				Ohmatsu, Kohsuke; Ooi, Takashi			Development of Ion-Paired Chiral Ligands for Asymmetric Transition-Metal Catalysis	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Review						ligand design; chiral ligand; ion pair; supramolecular ligand; phosphine; palladium; asymmetric allylic alkylation; combinatorial screening	CARBON QUATERNARY STEREOCENTERS; ENANTIOSELECTIVE ALLYLATION; SUPRAMOLECULAR CATALYSIS; ALLYLIC ALKYLATIONS; BIDENTATE LIGANDS; HYDROGENATION; CONSTRUCTION; CYCLOPROPANATION; BENZOFURANONES; INHIBITOR	A new strategy for the design of a chiral ligand for asymmetric transition-metal catalysis has been developed. Our strategy is based on the development of achiral cationic ammonium-phosphine hybrid ligands paired with readily available chiral anions. These ion-paired chiral ligands impart a remarkable stereocontrolling ability to their palladium complexes, which catalyze highly enantioselective allylic alkylations of prochiral carbon nucleophiles. Moreover, the exploitation of ion-paired chiral ligands in combinatorial screening has enabled the rapid identification of the optimal ligand for the palladium-catalyzed new asymmetric allylation reaction. We also developed a highly enantio- and diastereoselective [3+2] annulation reaction of 5-vinyloxazolidinones and activated trisubstituted alkenes catalyzed by a palladium complex bearing a different type of ion-paired ligand, which allows for the single-step construction of three contiguous stereo-centers, including vicinal all-carbon quaternary stereocenters.	[Ohmatsu, Kohsuke; Ooi, Takashi] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Ohmatsu, Kohsuke; Ooi, Takashi] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Ohmatsu, K (reprint author), Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	ohmatsu@apchem.nagoya-u.ac.jp; tooi@apchem.nagoya-u.ac.jp					Mohr JT, 2007, CHEM-ASIAN J, V2, P1476, DOI 10.1002/asia.200700183; Trost BM, 2003, J AM CHEM SOC, V125, P3090, DOI 10.1021/ja020988s; Ohmatsu K, 2014, NAT CHEM, V6, P47, DOI [10.1038/nchem.1796, 10.1038/NCHEM.1796]; Wieland J, 2010, NAT CHEM, V2, P832, DOI [10.1038/nchem.800, 10.1038/NCHEM.800]; Ohmatsu K, 2013, J AM CHEM SOC, V135, P18706, DOI 10.1021/ja411647x; Gao LZ, 2011, J AM CHEM SOC, V133, P20708, DOI 10.1021/ja209270e; Lu Z, 2008, ANGEW CHEM INT EDIT, V47, P258, DOI 10.1002/anie.200605113; Ge HM, 2008, CHEM-EUR J, V14, P376, DOI 10.1002/chem.200700960; van Leeuwen PWNM, 2011, J AM CHEM SOC, V133, P18562, DOI 10.1021/ja207912d; Adediran SA, 2001, BIOORGAN MED CHEM, V9, P1175, DOI 10.1016/S0968-0896(00)00345-X; Passreiter CM, 2002, TETRAHEDRON, V58, P279, DOI 10.1016/S0040-4020(01)01139-5; Payette JN, 2007, J AM CHEM SOC, V129, P9536, DOI 10.1021/ja0735958; Wu B, 2007, HELV CHIM ACTA, V90, P1586, DOI 10.1002/hlca.200790166; Trost BM, 2007, J AM CHEM SOC, V129, P12396, DOI 10.1021/ja075335w; Kwon YJ, 2007, ORG LETT, V9, P2449, DOI 10.1021/ol0703231; Phipps RJ, 2012, NAT CHEM, V4, P603, DOI [10.1038/nchem.1405, 10.1038/NCHEM.1405]; Gadzikwa T, 2012, J AM CHEM SOC, V134, P2860, DOI 10.1021/ja211455j; Takacs JM, 2004, J AM CHEM SOC, V126, P4494, DOI 10.1021/ja049873; Uyeda C, 2010, ANGEW CHEM INT EDIT, V49, P9753, DOI 10.1002/anie.201005183; Brak K, 2013, ANGEW CHEM INT EDIT, V52, P534, DOI 10.1002/anie.201205449; Trost BM, 1996, CHEM REV, V96, P395, DOI 10.1021/cr9409804; Mahlau M, 2013, ANGEW CHEM INT EDIT, V52, P518, DOI 10.1002/anie.201205343; Gais HJ, 2005, TETRAHEDRON LETT, V46, P6279, DOI 10.1016/j.tetlet.2005.07.044; Slagt VF, 2004, J AM CHEM SOC, V126, P4056, DOI 10.1021/ja038955f; Cao ZY, 2013, J AM CHEM SOC, V135, P8197, DOI 10.1021/ja4040895; Ohmatsu K, 2014, CHEM SCI, V5, P3645, DOI 10.1039/c4sc01032a; Ohmatsu K, 2013, J AM CHEM SOC, V135, P590, DOI 10.1021/ja312125a; Yoon TP, 2003, SCIENCE, V299, P1691, DOI 10.1126/science.1083622; Hatano M, 2011, ANGEW CHEM INT EDIT, V50, P12189, DOI 10.1002/anie.201106497; GUILLANEUX D, 1994, J AM CHEM SOC, V116, P9430, DOI 10.1021/ja00100a004; LINDQUIST N, 1991, J AM CHEM SOC, V113, P2303, DOI 10.1021/ja00006a060; Meeuwissen J, 2010, NAT CHEM, V2, P615, DOI [10.1038/nchem.744, 10.1038/NCHEM.744]; Nakoji M, 2001, ORG LETT, V3, P3329, DOI 10.1021/ol016567h; Weis M, 2006, J AM CHEM SOC, V128, P4188, DOI 10.1021/ja058202o; Zhang HL, 2013, J AM CHEM SOC, V135, P14098, DOI 10.1021/ja408336v; Ohmatsu K, 2012, NAT CHEM, V4, P473, DOI [10.1038/nchem.1311, 10.1038/NCHEM.1311]; Wiester MJ, 2011, ANGEW CHEM INT EDIT, V50, P114, DOI 10.1002/anie.201000380; Knight JG, 2008, TETRAHEDRON, V64, P3744, DOI 10.1016/j.tet.2008.02.019; Trost BM, 2003, CHEM REV, V103, P2921, DOI 10.1021/cr020027w; Liu Y, 2006, J AM CHEM SOC, V128, P14212, DOI 10.1021/ja063350f; Pignataro L, 2012, CHEM-EUR J, V18, P10368, DOI 10.1002/chem.201201032; Bellini R, 2012, EUR J INORG CHEM, P4684, DOI 10.1002/ejic.201200549; Durini M, 2012, EUR J ORG CHEM, P5451, DOI 10.1002/ejoc.201200516; Girard C., 1998, ANGEW CHEM INT EDIT, V37, P2922, DOI 10.1002/(SICI)1521-3773(19981116)37:21<2922::AID-ANIE2922>3.0.CO;2-1; Kitamura M, 1998, J AM CHEM SOC, V120, P9800, DOI 10.1021/ja981740z; Nemoto T, 2005, ADV SYNTH CATAL, V347, P1504, DOI 10.1002/adsc.200505149; Ohmatsu K, 2014, CHEM COMMUN, V50, P4554, DOI 10.1039/c3cc49338e; Panisheva E. K., 2007, PHARM CHEM J, V41, P549, DOI 10.1007/s11094-008-0011-3; Reetz MT, 2008, ANGEW CHEM INT EDIT, V47, P2556, DOI 10.1002/anie.200704327; Sasson Y., 1997, HDB PHASE TRANSFER C; Sawamura M, 1996, J ORG CHEM, V61, P9090, DOI 10.1021/jo961343b; SHIPCHANDLER MT, 1979, SYNTHESIS-STUTTGART, P666; Sontag B, 2006, EUR J ORG CHEM, P1023, DOI 10.1002/ejoc.200500714; Trost BM, 2004, CHEM-EUR J, V10, P2237, DOI 10.1002/chem.200305634; van Leeuwen P. W. N. M., 2008, SUPRAMOLECULAR CATAL	55	1	1	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	FEB	2015	73	2					140	150				11	Chemistry, Organic	Chemistry	CE5PG	WOS:000351887000004		
J	Kita, M; Kigoshi, H				Kita, Masaki; Kigoshi, Hideo			Target Identification and Mode of Action Studies of an Antitumor Compound Aplyronine A by Using Photoaffinity Derivatives	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Review						antitumor macrolide; photoaffinity probe; target identification; cytoskeletal protein; protein-protein interaction	MARINE ORIGIN; ARP2/3 COMPLEX; MACROLIDE APLYRONINE; NATURAL-PRODUCTS; DEPOLYMERIZING ACTIVITY; ARTIFICIAL ANALOGS; CROSS-LINKING; KABIRAMIDE-C; SEA HARES; BINDING	Actin is an essential cytoskeletal protein for the regulation of various cellular functions. A number of actin-stabilizing and depolymerizing agents have been discovered in marine invertebrates, and they show potent cytotoxicity. Among them, a polyketide macrolide aplyronine A has antitumor effects against xenograft in mice. However, the potent cytotoxicity and apoptogenic effect of aplyronine A was not entirely accounted for by its actin filament-severing properties, and its molecular targets and mechanisms of action remained unclear. We developed aplyronine A acetylene or biotin derivatives that bear an aryldiazirine group at the C34 terminus, which formed a covalent bond with actin. By using these chemical probes, we have showed that aplyronine A synergistically binds to tubulin in association with actin, and prevents spindle formation and mitosis in tumor cells. Our findings of aplyronine A will provide further insights into the molecular mechanisms of structurally diverse natural products that regulate cytoskeletal dynamics.	[Kita, Masaki; Kigoshi, Hideo] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058501, Japan	Kita, M (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058501, Japan.	mkita@chem.tsukuba.ac.jp; kigoshi@chem.tsukuba.ac.jp					Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Allingham JS, 2006, CELL MOL LIFE SCI, V63, P2119, DOI 10.1007/s00018-006-6157-9; Kingston DGI, 2009, J NAT PROD, V72, P507, DOI 10.1021/np800568j; Kita M, 2012, J AM CHEM SOC, V134, P20314, DOI 10.1021/ja310495p; Kita M, 2011, ANGEW CHEM INT EDIT, V50, P9871, DOI 10.1002/anie.201103802; Kalia J, 2008, ANGEW CHEM INT EDIT, V47, P7523, DOI 10.1002/anie.200802651; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Gomes AF, 2010, J MASS SPECTROM, V45, P892, DOI 10.1002/jms.1776; Ojika M, 2007, TETRAHEDRON, V63, P3138, DOI 10.1016/j.tet.2007.02.011; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Kita M, 2012, CHEMBIOCHEM, V13, P1754, DOI 10.1002/cbic.201200385; Chan TR, 2004, ORG LETT, V6, P2853, DOI 10.1021/ol0493094; KIGOSHI H, 1994, J AM CHEM SOC, V116, P7443, DOI 10.1021/ja00095a072; Kita M, 2012, B CHEM SOC JPN, V85, P1175, DOI 10.1246/bcsj.20120198; Milroy LG, 2012, J AM CHEM SOC, V134, P8480, DOI 10.1021/ja211708z; Saito SY, 1996, J BIOCHEM-TOKYO, V120, P552; Yeung KS, 2002, ANGEW CHEM INT EDIT, V41, P4632, DOI 10.1002/anie.200290057; Hirata K, 2006, J MOL BIOL, V356, P945, DOI 10.1016/j.jmb.2005.12.031; YAMADA K, 1993, J AM CHEM SOC, V115, P11020, DOI 10.1021/ja00076a082; Blanchoin L, 2000, NATURE, V404, P1007; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Yamada K, 2009, NAT PROD REP, V26, P27, DOI 10.1039/b800263k; Peterson JR, 2002, CHEM BIOL, V9, P1275, DOI 10.1016/S1074-5521(02)00284-3; Kita M, 2013, J AM CHEM SOC, V135, P18089, DOI 10.1021/ja406580w; Fenteany G, 2003, CURR TOP MED CHEM, V3, P593, DOI 10.2174/1568026033452348; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nr1317; CHEN Y, 1994, SCIENCE, V265, P90, DOI 10.1126/science.8016656; Kigoshi H, 1996, J SYN ORG CHEM JPN, V54, P1076; Kigoshi H, 2002, TETRAHEDRON, V58, P1075, DOI 10.1016/S0040-4020(01)01206-6; Kigoshi H, 1996, J ORG CHEM, V61, P5326, DOI 10.1021/jo9606113; Kita M., 2015, HDB ANTICANCER DRUGS, P701; Kits M., NAT PROD RE IN PRESS; Klenchin VA, 2003, NAT STRUCT BIOL, V10, P1058, DOI 10.1038/nsb1006; Kuroda T, 2006, BIOCONJUGATE CHEM, V17, P524, DOI 10.1021/bc050324i; MATSUNAGA S, 1986, J AM CHEM SOC, V108, P847, DOI 10.1021/ja00264a053; Morimoto S, 2013, CHEM COMMUN, V49, P1811, DOI 10.1039/c3cc38594a; Nassal M., 1993, LIEBIGS ANN CHEM, P1510; Ohno O., 2013, BIOORG MED CHEM LETT, V23, P1467; Petchprayoon C, 2005, BIOCONJUGATE CHEM, V16, P1382, DOI 10.1021/bc050006j; Suenaga K, 1997, BIOORG MED CHEM LETT, V7, P269, DOI 10.1016/S0960-894X(96)00620-8; Suenaga K, 2006, J SYN ORG CHEM JPN, V64, P1273; Tanaka J, 2003, P NATL ACAD SCI USA, V100, P13851, DOI 10.1073/pnas.2233339100; Wada S, 1998, J BIOCHEM-TOKYO, V123, P946; Yamada K, 2010, P JPN ACAD B-PHYS, V86, P176, DOI 10.2183/pjab.86.176; Yamada K, 1997, B CHEM SOC JPN, V70, P1479, DOI 10.1246/bcsj.70.1479; Yamada Kiyoyuki, 2000, P59, DOI 10.1159/000062489; ZABRISKIE TM, 1986, J AM CHEM SOC, V108, P3123, DOI 10.1021/ja00271a062	48	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	FEB	2015	73	2					151	160				10	Chemistry, Organic	Chemistry	CE5PG	WOS:000351887000005		
J	Yamano, Y; Tode, C; Wada, A; Ito, M				Yamano, Yumiko; Tode, Chisato; Wada, Akimori; Ito, Masayoshi			Biomimetic Type Total Syntheses of Carotenoids via Regiocontrolled Oxirane-Ring Cleavage	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Review						total synthesis; carotenoid; regioselective oxirane-ring cleavage; 5,6-epoxide; tetrasubstituted olefin; cyclopentyl ketone; 3,6-epoxide	PAPRIKA CAPSICUM-ANNUUM; STEREOCONTROLLED TOTAL-SYNTHESIS; STRUCTURALLY RELATED-COMPOUNDS; ACTIVE NATURAL CAROTENOIDS; STEREOSELECTIVE REARRANGEMENT; RED PAPRIKA; ACETYLENIC CAROTENOIDS; PERIDININ-CHLOROPHYLL; CRASSOSTREAXANTHIN-B; MARINE CAROTENOIDS	We achieved biomimetic type total syntheses of various carotenoids by using oxirane-ring cleavage as a key reaction. The fascinating point of this strategy is as follows; selective preparation of tetrasubstituted olefinic compounds, cyclopentyl ketones, or 3,6-epoxides could be attained by optimization of side chain lengths and the terminal functional groups at the C-6-position of 5,6-epoxides as a result of regioselective oxirane-ring cleavage and subsequent reactions. In particular, Lewis acid-treatment of epoxide carrying an acetoxypropyl group at C-6 preferably provided tetrasubstituted olefinic compound. On the other hand, Lewis acid or aminium salt-treatment of epoxides carrying an acetoxyethyl or a siloxymethyl group at C-6, and epoxy dienal preferentially afforded cyclopentyl ketones. Treatment of epoxy dienoate and epoxy dienonitrile, possessing a free hydroxy group at the C-3-position with aminium salt preferentially afforded 3,6-epoxides. These resulting compounds were successfully utilized for the total syntheses of crassostreaxanthin B, mytiloxanthin, capsanthin, capsorubin, cucurbitaxanthin A, and cycloviolaxanthin, respectively. Total syntheses of amarouciaxanthin A and B, salmoxanthin, and deepoxysalmoxanthin utilizing oxirane-ring cleavage are also described.	[Yamano, Yumiko] Kobe Pharmaceut Univ, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Yamano, Y (reprint author), Kobe Pharmaceut Univ, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	y-yamano@kobepharma-u.ac.jp; c-tode@kobepharma-u.ac.jp; a-wada@kobepharma-u.ac.jp; masayoshi_ito1008@yahoo.co.jp					SONG PS, 1976, BIOCHEMISTRY-US, V15, P4422, DOI 10.1021/bi00665a012; PAULING H, 1976, HELV CHIM ACTA, V59, P1233, DOI 10.1002/hlca.19760590426; Yim MJ, 2011, J AGR FOOD CHEM, V59, P1646, DOI 10.1021/jf103290f; Latowski D, 2011, REDOX REP, V16, P78, DOI 10.1179/174329211X13020951739938; MATSUNO T, 1986, PHYTOCHEMISTRY, V25, P2837, DOI 10.1016/S0031-9422(00)83753-X; LEUENBERGER HGW, 1976, HELV CHIM ACTA, V59, P1832, DOI 10.1002/hlca.19760590541; DAVIS FA, 1995, J ORG CHEM, V60, P6148, DOI 10.1021/jo00124a030; Matsufuji H, 1998, J AGR FOOD CHEM, V46, P3468, DOI 10.1021/jf980200i; LOPEZ L, 1994, TETRAHEDRON, V50, P9097, DOI 10.1016/S0040-4020(01)85375-8; PARKES KEB, 1986, TETRAHEDRON LETT, V27, P2535, DOI 10.1016/S0040-4039(00)84578-5; MIWA K, 1994, SYNLETT, P107, DOI 10.1055/s-1994-22755; Bautista JA, 1999, J PHYS CHEM A, V103, P2267, DOI 10.1021/jp983943f; BERNHARD K, 1980, HELV CHIM ACTA, V63, P1473, DOI 10.1002/hlca.19800630618; Britton G., 2004, CAROTENOIDS HDB; CHOPRA AK, 1988, J CHEM SOC PERK T 1, P1383, DOI 10.1039/p19880001383; Deli J, 1996, HELV CHIM ACTA, V79, P1435, DOI 10.1002/hlca.19960790516; DELI J, 1991, HELV CHIM ACTA, V74, P819, DOI 10.1002/hlca.19910740416; FISCHLI A, 1976, HELV CHIM ACTA, V59, P397, DOI 10.1002/hlca.19760590208; FUJIWARA Y, 1992, TETRAHEDRON LETT, V33, P4941, DOI 10.1016/S0040-4039(00)61240-6; Furuichi N, 2004, J ORG CHEM, V69, P7949, DOI 10.1021/jo048852v; Furuichi N, 2002, ANGEW CHEM INT EDIT, V41, P1023, DOI 10.1002/1521-3773(20020315)41:6<1023::AID-ANIE1023>3.0.CO;2-A; HIRAYAMA O, 1994, LIPIDS, V29, P149, DOI 10.1007/BF02537155; KHARE A, 1973, TETRAHEDRON LETT, P3921; Maoka T., 1996, J JPN OIL CHEM SOC, V45, P667; MATSUNO T, 1985, J NAT PROD, V48, P606, DOI 10.1021/np50040a015; Matsuno T, 2001, J NAT PROD, V64, P507, DOI 10.1021/np0004294; MIMURO M, 1993, CHEM PHYS LETT, V213, P576, DOI 10.1016/0009-2614(93)89163-C; SHEER B. T., 1940, Journal of Biological Chemistry, V136, P275; Tode C, 2001, J CHEM SOC PERK T 1, P3338; Tode C, 2002, J CHEM SOC PERK T 1, P1581, DOI 10.1039/b201228f; WIDMER E, 1990, HELV CHIM ACTA, V73, P861, DOI 10.1002/hlca.19900730411; YAMANO Y, 1993, J CHEM SOC PERK T 1, P1599, DOI 10.1039/p19930001599; Yamano Y, 2013, ORG LETT, V15, P5310, DOI [10.1021/ol402540g, 10.1021/oI402540g]; Yamano Y, 2012, ORG BIOMOL CHEM, V10, P4103, DOI 10.1039/c2ob25321f; Yamano Y, 1999, J NUTR SCI VITAMINOL, V45, P49; Yamano Y, 1998, J CHEM SOC PERK T 1, P2569, DOI 10.1039/a803116i; YAMANO Y, 1995, J CHEM SOC PERK T 1, P1895, DOI 10.1039/p19950001895; Yamano Y, 1997, J CHEM SOC PERK T 1, P2713, DOI 10.1039/a702815f; Yarnano Y., 2007, ORG BIOMOL CHEM, V5, P3207	39	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	FEB	2015	73	2					161	170				10	Chemistry, Organic	Chemistry	CE5PG	WOS:000351887000006		
J	Mitsudo, K; Tanaka, H; Suga, S				Mitsudo, Koichi; Tanaka, Hideo; Suga, Seiji			Development of Cross-Coupling Reactions Including Electro-oxidative Processes and Their Applications to the Synthesis of pi-Extended Compounds	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Review						homo-coupling; cross-coupling; electrochemistry; electro-oxidation; palladium; silver; silver acetylide; catalytic reaction	ARYLBORONIC ACIDS; TERMINAL ALKYNES; HOMOCOUPLING REACTION; NATURAL-PRODUCTS; BORONIC ACIDS; LIGAND; ELECTROCHEMISTRY; ALKYNYLATION; ACETYLIDES; CATALYSTS	An electrochemical method to synthesize cationic palladium complexes has been developed. Their counter anions could be changed readily by the electrolyte. The reaction could be incorporated into electro-oxidative palladium catalyzed reactions, such as Wacker-type reaction, homo-coupling of arylboronic acids, oxidative Sonogashira-type coupling, and Glaser-type coupling of terminal alkynes. These reactions exhibited a wide scope and a variety of products were obtained in high yields due to high activity of electrogenerated palladium species. We also developed site-selective sequential reactions by the integration of the electro-oxidative coupling reactions with non-electrochemical reactions. The reaction site could be controlled completely by the on/off application of electricity.	[Mitsudo, Koichi] Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, Okayama 7008530, Japan	Mitsudo, K (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	mitsudo@oc.okayama-u.ac.jp; tanaka95@cc.okayama-u.ac.jp; suga@cc.okayama-u.ac.jp	Mitsudo, Koichi/B-2570-2011	Mitsudo, Koichi/0000-0002-6744-7136			Albert BJ, 2008, J ORG CHEM, V73, P1093, DOI 10.1021/jo702306k; Amatore C, 2008, EUR J ORG CHEM, P4567, DOI 10.1002/ejoc.200800631; Zou G, 2003, TETRAHEDRON LETT, V44, P8709, DOI 10.1016/j.tetlet.2003.09.173; Kabalka GW, 2002, TETRAHEDRON LETT, V43, P3067, DOI 10.1016/S0040-4039(02)00437-9; Zhang SL, 2011, ADV SYNTH CATAL, V353, P1463, DOI 10.1002/adsc.201100035; Mitsudo K, 2012, ORG BIOMOL CHEM, V10, P9562, DOI 10.1039/c2ob26567b; Suga S, 2002, J AM CHEM SOC, V124, P14824, DOI 10.1021/ja028663z; Sperry JB, 2006, CHEM SOC REV, V35, P605, DOI 10.1039/b512308a; Moeller KD, 2000, TETRAHEDRON, V56, P9527, DOI 10.1016/S0040-4020(00)00840-1; Lei AW, 2002, TETRAHEDRON LETT, V43, P2525, DOI 10.1016/S0040-4039(02)00328-3; Lund H, 2002, J ELECTROCHEM SOC, V149, pS21, DOI 10.1149/1.1462037; Yoshida J, 2008, CHEM REV, V108, P2265, DOI 10.1021/cr0680843; Wong MS, 2001, TETRAHEDRON LETT, V42, P4087, DOI 10.1016/S0040-4039(01)00637-2; Xu Z, 2008, CATAL COMMUN, V9, P97, DOI 10.1016/j.catcom.2007.05.008; Bruyere D, 2004, TETRAHEDRON, V60, P4007, DOI 10.1016/j.tet.2004.03.023; Suga S, 2010, CHEM LETT, V39, P404, DOI 10.1246/cl.2010.404; Halbes-Letinois U, 2007, CHEM SOC REV, V36, P759, DOI 10.1039/b602151b; Kajiyama D, 2013, ELECTROCHEMISTRY, V81, P319, DOI 10.5796/electrochemistry.81.319; Yoshida H, 2003, TETRAHEDRON LETT, V44, P1541, DOI 10.1016/S0040-4039(03)00023-6; Aramendia MA, 1999, J ORG CHEM, V64, P3592, DOI 10.1021/jo982210o; Aiso H, 2012, J ORG CHEM, V77, P7718, DOI 10.1021/jo3012286; Rosen BR, 2014, J AM CHEM SOC, V136, P5571, DOI 10.1021/ja5013323; Backvall J.-E., 1987, J CHEM SOC CHEM COMM, P1236; Bard A. J., 1994, INTEGRATED CHEM SYST; Hammerich O., 2001, ORGANIC ELECTROCHEMI; Inokuchi T., 1994, CHEM LETT, P441; Kim S, 2009, SYNTHESIS-STUTTGART, P1963, DOI 10.1055/s-0029-1216788; Koza DJ, 2002, SYNTHESIS-STUTTGART, P2183, DOI 10.1055/s-2002-34855; Mitsudo K, 2007, J AM CHEM SOC, V129, P2246, DOI 10.1021/ja069043r; Mitsudo K, 2010, CHEM COMMUN, V46, P9256, DOI 10.1039/c0cc02633f; Mitsudo K, 2008, TETRAHEDRON LETT, V49, P6593, DOI 10.1016/j.tetlet.2008.09.022; Pan CD, 2009, TETRAHEDRON LETT, V50, P5044, DOI 10.1016/j.tetlet.2009.06.093; Pouwer RH, 2005, ORG LETT, V7, P1323, DOI 10.1021/ol050121+; Saitoh T, 2014, J SYN ORG CHEM JPN, V72, P1120; Shahi SP, 2004, ANGEW CHEM INT EDIT, V43, P2525, DOI 10.1002/anie.200353400; Smith K. A., 1997, SYNLETT, P13; TSUJI J, 1987, TETRAHEDRON LETT, V28, P3683, DOI 10.1016/S0040-4039(00)96354-8; Tuji J., 2004, PALLADIM REAGENTS CA; Yamamura S, 2002, SYNLETT, P533; Yoshida J, 2002, CHEM-EUR J, V8, P2651; Yoshida J, 2011, SYNLETT, P1189, DOI 10.1055/s-0030-1259946; Zhou L, 2007, CHINESE CHEM LETT, V18, P1043, DOI 10.1016/j.cclet.2007.06.023	42	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	FEB	2015	73	2					171	180				10	Chemistry, Organic	Chemistry	CE5PG	WOS:000351887000007		
J	Takei, R; Hayashi, M; Umene, S; Narita, K; Kobayashi, Y; Masunaga, H				Takei, Ryo; Hayashi, Masahiro; Umene, Shingo; Narita, Kazuyoshi; Kobayashi, Yasunori; Masunaga, Hiroaki			CHANGES IN PHYSICAL PROPERTIES OF ENZYME-TREATED BEEF BEFORE AND AFTER MASTICATION	JOURNAL OF TEXTURE STUDIES			English	Article						Beef; enzyme; firmness; protein; rheological properties	FOOD; RHEOLOGY; TEXTURE	This study was conducted to determine whether enzymatically softened beef is more easily ingested by individuals with decreased masticatory function while retaining the original appearance and palatability using a homogeneous enzyme permeation (HEP) method. The number of mastication cycles required to induce the first swallow of normally cooked beef (NB) and HEP-treated beef (HEPB) was investigated. Pre- and post-mastication samples were also tested for firmness, viscoelastic properties, compression stress and disintegrability. Compared with NB, HEPB was shown to require less than one-third the number of mastication cycles while retaining approximately 1/15 the firmness. HEP treatment reduced the coefficient of viscosity to less than 1/20 of NB. Stress increased abruptly with compression of post-mastication NB samples, while a lower increase was observed for HEPB. Disintegration tests revealed fewer residues for HEPB. HEPB demonstrated sufficient softness, good deformability and quick water dispersibility while retaining the same shape as NB. Practical ApplicationWith these features, beef made using the homogeneous enzyme permeation method is expected to expand the applicability of oral nutrition and help establish a new approach to nutritional management for people with difficulty masticating. This technology has already been used for food products named iEat (EN Otsuka Pharmaceutical Co., Ltd., Japan), which are produced for patients with masticatory difficulties.	[Takei, Ryo; Hayashi, Masahiro; Umene, Shingo; Narita, Kazuyoshi; Kobayashi, Yasunori; Masunaga, Hiroaki] EN Otsuka Pharmaceut Co Ltd, Tokyo Lab, Sumida Ku, Tokyo 1300013, Japan	Takei, R (reprint author), EN Otsuka Pharmaceut Co Ltd, Tokyo Lab, Sumida Ku, 1-11-10 Kinshi, Tokyo 1300013, Japan.	r-takei@enotsuka.co.jp					Higashiguchi T, 2013, NUTRITION, V29, P858, DOI 10.1016/j.nut.2012.12.016; Onder G, 2007, J AM GERIATR SOC, V55, P1961, DOI 10.1111/j.1532-5415.2007.01453.x; Xu YL, 2008, J FOOD ENG, V86, P10, DOI 10.1016/j.jfoodeng.2007.09.002; Nishinari K, 2004, J TEXTURE STUD, V35, P113, DOI 10.1111/j.1745-4603.2004.tb00828.x; Hiiemae KM, 1999, DYSPHAGIA, V14, P31, DOI 10.1007/PL00009582; Mioche L, 2002, FOOD QUAL PREFER, V13, P583, DOI 10.1016/S0950-3293(02)00056-3; Tabilo-Munizaga G, 2005, J FOOD ENG, V67, P147, DOI 10.1016/j.jfoodeng.2004.05.062; Association of Official Analytical Chemists, 1980, OFF METH AN AOAC; Association of Official Analytical Chemists, 2002, OFF METH AN AOAC; Boles JA, 2001, MEAT SCI, V59, P259, DOI 10.1016/S0309-1740(01)00078-X; Committee for Editing of the Commentaries on Japan Pharmacopoeia, 2006, PHARM JAP; Food Safety Commission of Japan, 2010, RISK ASS REP CHOK AC; Fujishima I., 2014, DEGLUTITION, V3, P110; Hernandez-Estrada ZJ, 2014, J FOOD ENG, V143, P62, DOI 10.1016/j.jfoodeng.2014.06.034; Jones D. P., 2008, AM J CLIN NUTR, V87, p1562S; Kjeldahl J, 1883, Z ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; Kohyama K., 2001, Food Science and Technology Research, V7, P290, DOI 10.3136/fstr.7.290; Kuwa M, 2003, Japanese Unexamined Patent Application Publication, Patent No. [2003-174850, 20120308684, US2012/0308684 A1]; Mioche L, 2004, NUTR RES REV, V17, P43, DOI 10.1079/NRR200375; Saitoh E., 2008, CLIN NEUROL, V48, P875; Shibata M, 2008, FOOD SCI TECHNOL RES, V14, P367, DOI 10.3136/fstr.14.367; Shiozawa K., 2003, JPN J ORAL BIOL, V45, P59; Svanberg E, 1996, AM J PHYSIOL-ENDOC M, V271, pE718; Tanaka H., 2006, DIGESTION ABSORPTION, V28, P54; The Japanese Ministry of Health Labor and Welfare, 2009, PHARM FOOD SAF; Tsai CL, 2012, BIOSCI BIOTECH BIOCH, V76, P331, DOI 10.1271/bbb.110722	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4901	1745-4603		J TEXTURE STUD	J. Texture Stud.	FEB	2015	46	1					3	11		10.1111/jtxs.12103		9	Food Science & Technology	Food Science & Technology	CE7IJ	WOS:000352012300003		
J	Kato, S; Yamada, K; Nishide, T				Kato, Sadaaki; Yamada, Kyohei; Nishide, Toshikazu			Water harvesting capability of petal-effect hafnia films and hydrophilic-hydrophobic patterned films	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Water harvesting; Hydrophilicity; Hydrophobicity; Patterned film; Petal effect; Screen printing	SURFACE-STRUCTURE; DESERT BEETLE; MONOLAYERS	Two types of petal-effect hafnia films and hydrophilic-hydrophobic stripe-patterned films consisting of 1-mm-wide lines and spaces were fabricated and their water harvesting capability was investigated. Petal-effect hafnia films containing glycine and glycolic acid were prepared by a sol-gel technique. Hydrophilic-hydrophobic stripe-patterned films were fabricated by screen printing a hydrophobic hafnia sol as a paste onto a superhydrophilic alumina film substrate. The water harvesting capability of the films was evaluated using a custom-built water collecting apparatus. The mass of water both on the sample surface and in a petri dish set under the sample was measured to evaluate the water collecting capability. When a vapor covered the petal-effect film, small dew droplets formed on the surface and grew to large hemispheric ones, but most of the water remained on the sample surface without falling into the petri dish. When a vapor covered the patterned film surface, small droplets and large, long ones formed on the hydrophobic and hydrophilic patterns, respectively. The large droplets that grew on the hydrophilic patterns fell into the petri dish. The total amount of water that collected on the petal-effect films and the patterned films was ca. 1.6 times larger than the respective amount collected with a superhydrophilic alumina film, a hydrophobic hafnia film and a glass substrate as a control reference. The patterned films collected a larger amount of water in the petri dish than the petal-effect films did because the hydrophilic molecules of organic acids on the surface of the latter films retained a larger amount of droplets. It is concluded that both the petal-effect films and the patterned films have superior water harvesting capability from a vapor in the ambient atmosphere. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Kato, Sadaaki; Yamada, Kyohei; Nishide, Toshikazu] Nihon Univ, Coll Engn, Dept Chem Biol & Appl Chem, Koriyama, Fukushima 9638642, Japan	Nishide, T (reprint author), Nihon Univ, Coll Engn, Dept Chem Biol & Appl Chem, Koriyama, Fukushima 9638642, Japan.	nishide@ce.nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology	This research was financially supported by a Grant- in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology.	Zhai L, 2006, NANO LETT, V6, P1213, DOI 10.1021/nl060644q; Dorrer C, 2008, LANGMUIR, V24, P6154, DOI 10.1021/la800226e; Parker AR, 2001, NATURE, V414, P33, DOI 10.1038/35102108; Yoshimitsu Z, 2002, LANGMUIR, V18, P5818, DOI 10.1021/la020088p; Morita M, 2005, LANGMUIR, V21, P911, DOI 10.1021/la0485172; Feng L, 2008, LANGMUIR, V24, P4114, DOI 10.1021/la703821h; Her EK, 2012, NANOSCALE, V4, P2900, DOI 10.1039/c2nr11934j; Hong D, 2010, LANGMUIR, V26, P15080, DOI 10.1021/la102379s; Kato S., J CERAM SOC JA UNPUB; Koga T, 2002, INT J NANOSCI SER, V1, P419, DOI 10.1142/S0219581X02000437; Lee A., 2008, LANGMUIR, V28, P10183; Lide D. R., 2000, CRC HDB CHEM PHYS, P9; Malik F. T., 2014, BIOINSPIR BIOMIM, V9, P1; Nakamoto K., 2009, INFRARED RAMAN SPE B, P68; Norgaard T., 2012, PLOS ONE, V7, P1; Schiermeier Q, 2014, NATURE, V510, P326, DOI 10.1038/510326a; Tonosaki A, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.125801; Xia YN, 2004, ADV MATER, V16, P1245, DOI 10.1002/adma.200400834	18	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	FEB	2015	123	1434					73	78		10.2109/jcersj2.123.73		6	Materials Science, Ceramics	Materials Science	CE9DM	WOS:000352143800002		
J	Suzuki, A; Yamaguchi, H; Kageyama, H; Oaki, Y; Imai, H				Suzuki, Ayami; Yamaguchi, Hideki; Kageyama, Hiroyuki; Oaki, Yuya; Imai, Hiroaki			Microwave-assisted rapid synthesis of anatase TiO2 nanosized particles in an ionic liquid-water system	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Nanoparticle; IL; Titanium dioxide; Size control	PHOTOCATALYTIC ACTIVITY; HYDROTHERMAL SYNTHESIS; TITANIUM-DIOXIDE; TEMPERATURE; FILMS; NANOCRYSTALS; PHASE; DEPOSITION; NANORODS	Nanosized anatase TiO2 crystals were rapidly prepared in a mixture of an ionic liquid (1-butyl-3-methylimidazolium chloride) and water under microwave irradiation for 5 min. The crystal size in the c axis was varied in the range from similar to 5 to similar to 17 nm with prolongation of the irradiation time. A high susceptibility of the ionic liquid to microwave and a catalytic property of the imidazolium cation are effective for the rapid synthesis of the highly crystalline nanosized particles. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Suzuki, Ayami; Kageyama, Hiroyuki; Oaki, Yuya; Imai, Hiroaki] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Suzuki, Ayami; Yamaguchi, Hideki] KRI Inc, Shimogyo Ku, Kyoto 6008813, Japan	Imai, H (reprint author), Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	hiroaki@applc.keio.ac.jp	Imai, Hiroaki/F-8459-2014				FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Zhu J, 2007, APPL CATAL B-ENVIRON, V76, P82, DOI 10.1016/j.apcatb.2007.05.017; Limmer SJ, 2003, ADV MATER, V15, P427, DOI 10.1002/adma.200390099; Wang G, 2007, J MOL CATAL A-CHEM, V274, P185, DOI 10.1016/j.molcata.2007.05.009; Bach U, 1998, NATURE, V395, P583; Aloui F, 2007, APPL SURF SCI, V253, P3737, DOI 10.1016/j.apsusc.2006.08.029; Yang HY, 2004, J APPL POLYM SCI, V92, P3201, DOI 10.1002/app.20327; Anpo M, 2003, J CATAL, V216, P505, DOI 10.1016/S0021-9517(02)00104-5; Kavan L, 1996, J AM CHEM SOC, V118, P6716, DOI 10.1021/ja954172l; Nakashima T, 2003, J AM CHEM SOC, V125, P6386, DOI 10.1021/ja034954b; Barnard AS, 2005, NANO LETT, V5, P1261, DOI 10.1021/nl050355m; Yamabi S, 2002, CHEM MATER, V14, P609, DOI 10.1021/cm010559d; Miao Z, 2002, NANO LETT, V2, P717, DOI 10.1021/nl025541w; Alammar T, 2013, NANOSCALE, V5, P8045, DOI 10.1039/c3nr00824j; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Ding KL, 2007, J AM CHEM SOC, V129, P6362, DOI 10.1021/ja070809c; Chen YJ, 2006, J MOL CATAL A-CHEM, V244, P73, DOI 10.1016/j.molcata.2005.08.056; Cozzoli PD, 2003, J AM CHEM SOC, V125, P14539, DOI 10.1021/ja036505h; Zhou Y, 2003, J AM CHEM SOC, V125, P14960, DOI 10.1021/ja0380998; Jun YW, 2003, J AM CHEM SOC, V125, P15981, DOI 10.1021/ja0369515; Puddu V, 2007, CHEM COMMUN, P4749, DOI 10.1039/b711559h; Dufour F., 2012, EUR J INORG CHEM, V16, P2707; KIYAMA M, 1972, CHEM LETT, P21, DOI 10.1246/cl.1972.21; Liu YH, 2011, J MATER SCI, V46, P4826, DOI 10.1007/s10853-011-5394-y; Melghit K, 2008, CERAM INT, V34, P479, DOI 10.1016/j.ceramint.2006.11.011; Sheng QR, 2006, MICROPOR MESOPOR MAT, V95, P220, DOI 10.1016/j.micromeso.2006.05.033; Yang HG, 2004, J PHYS CHEM B, V108, P819, DOI 10.1021/jp036760o	27	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	FEB	2015	123	1434					79	82		10.2109/jcersj2.123.79		4	Materials Science, Ceramics	Materials Science	CE9DM	WOS:000352143800003		
J	Kawashima, T; Suzuki, Y				Kawashima, Tasuku; Suzuki, Yoshikazu			High-temperature X-ray diffraction analysis and reactive sintering of BaTiO3 piezoelectric ceramics	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						BaTiO3; High-temperature X-ray diffraction; Reactive sintering; Piezoelectric material; Curie temperature; Dielectric constant	BARIUM-TITANATE; MICROSTRUCTURE; PARTICLES; HISTORY	Barium titanate is a potential lead-free piezoelectric ceramic with high dielectric and piezoelectric constants. In this study, the reaction behavior of a mixed powder of BaCO3 and anatase TiO2 was investigated by using high-temperature X-ray diffraction analysis. Frequency and temperature dependences of the dielectric constant were studied for the reactively-sintered BaTiO3 ceramics. Relatively high piezoelectric constant (d(33) similar to 120 pC/N) was obtained for BaTiO3 reactively-sintered at 1300 degrees C for 2 h, even with a density only of 3 similar to 85%, which implies the future improvement for reactively-sintered BaTiO3. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Kawashima, Tasuku; Suzuki, Yoshikazu] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Suzuki, Yoshikazu] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan	Suzuki, Y (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan.	suzuki@ims.tsukuba.ac.jp	Suzuki, Yoshikazu/N-3525-2015				Zheng P, 2012, ACTA MATER, V60, P5022, DOI 10.1016/j.actamat.2012.06.015; Wang LQ, 2007, J ALLOY COMPD, V440, P78, DOI 10.1016/j.jallcom.2006.09.023; Ciftci E, 2001, J MATER SCI, V36, P4875, DOI 10.1023/A:1011828018247; Shvartsman VV, 2012, J AM CERAM SOC, V95, P1, DOI 10.1111/j.1551-2916.2011.04952.x; Zhao Z, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.024107; Karaki T, 2007, JPN J APPL PHYS 1, V46, P7035, DOI 10.1143/JJAP.46.7035; Huan Y, 2013, J AM CERAM SOC, V96, P3369, DOI 10.1111/jace.12601; Liou YC, 2006, MATER RES BULL, V41, P455, DOI 10.1016/j.materresbull.2005.09.021; Ctibor P, 2010, CERAM INT, V36, P2155, DOI 10.1016/j.ceramint.2010.05.016; Arvanitidis I, 1996, METALL MATER TRANS B, V27, P409, DOI 10.1007/BF02914905; Haertling GH, 1999, J AM CERAM SOC, V82, P797; Hoshina T, 2013, J CERAM SOC JPN, V121, P156, DOI 10.2109/jcersj2.121.156; Kong LB, 2001, MATER LETT, V51, P95, DOI 10.1016/S0167-577X(01)00272-5; Guo D., 2013, J ASIAN CERAM SOC, V1, P197; Liou YC, 2008, CERAM INT, V34, P517, DOI 10.1016/j.ceramint.2006.11.005; Liou YC, 2007, J MATER SCI, V42, P3580, DOI 10.1007/s10853-006-0399-7; Potdar HS, 1999, MATER CHEM PHYS, V58, P121, DOI 10.1016/S0254-0584(98)00262-4; Stojanovic BD, 2005, J EUR CERAM SOC, V25, P1985, DOI 10.1016/j.jeurceramsoc.2005.03.003; Vijatovic MM, 2008, SCI SINTER, V40, P155, DOI 10.2298/SOS0802155V	19	1	1	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	FEB	2015	123	1434					83	85		10.2109/jcersj2.123.83		3	Materials Science, Ceramics	Materials Science	CE9DM	WOS:000352143800004		
J	Hu, CF; Kim, BN; Park, YJ; Estili, M; Grasso, S; Morita, K; Yoshida, H; Nishimura, T; Guo, SQ; Sakka, Y				Hu, Chun-Feng; Kim, Byung-Nam; Park, Young-Jo; Estili, Mehdi; Grasso, Salvatore; Morita, Koji; Yoshida, Hidehiro; Nishimura, Toshiyuki; Guo, Shu-Qi; Sakka, Yoshio			Nano ZrO2-TiN composites with high strength and conductivity	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Composite; ZrO2; TiN; Microstructure; Properties	MECHANICAL-PROPERTIES; TRIBOLOGICAL BEHAVIOR; ZIRCONIA; ALUMINA	Nano ZrO2-TiN (10-40 vol.%) composites were successfully fabricated by spark plasma sintering (SPS) at 1200 degrees C under 80 MPa. The as-obtained composites remained nanosized grains of ZrO2 and TiN below 200 nm. The physical and mechanical properties of composites were systemically investigated. It was found that above 20 vol.% TiN the composites were electrically conductive. 30 and 40 vol.% TiN reinforced composites possessed the highest flexural strength of 1459.7MPa and maximum electrical conductivity of 17081.7 S.m(-1) respectively. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Hu, Chun-Feng; Kim, Byung-Nam; Estili, Mehdi; Morita, Koji; Yoshida, Hidehiro; Nishimura, Toshiyuki; Guo, Shu-Qi; Sakka, Yoshio] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Hu, Chun-Feng] Drexel Univ, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Park, Young-Jo] Korea Inst Mat Sci, Chang Won 642831, South Korea; [Grasso, Salvatore] Queen Mary Univ London, Sch Mat Sci & Engn, London E1 4NS, England	Hu, CF (reprint author), Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.	chfhu@live.cn; Kim.Byung-nam@nims.go.jp			Fundamental Research Program of Korean Institute of Materials Science (KIMS); Ningbo Natural Science Foundation [2013A610128]; National Natural Science Foundation of China [U1232136]; Japan Society for the Promotion Science [23350104]; UK EPSRC (XMat) [EP/K008749/1]	This work is supported by the Fundamental Research Program of Korean Institute of Materials Science (KIMS), Ningbo Natural Science Foundation (2013A610128), National Natural Science Foundation of China (U1232136), and Grant-in-Aid for Scientific Research B (No. 23350104) from Japan Society for the Promotion Science. S.G. is supported by UK EPSRC (EP/K008749/1, XMat).	Anne G, 2005, J EUR CERAM SOC, V25, P55, DOI 10.1016/j.jeurceramsoc.2004.01.015; Grasso S, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/5/053001; Zhang XH, 2008, MAT SCI ENG A-STRUCT, V497, P195, DOI 10.1016/j.msea.2008.06.038; Bonny K, 2008, J MATER PROCESS TECH, V208, P423, DOI 10.1016/j.jmatprotec.2008.01.020; Vanmeensel K, 2007, J EUR CERAM SOC, V27, P979, DOI 10.1016/j.jeurceramsoc.2006.04.142; Hayashi H, 2005, SOLID STATE IONICS, V176, P613, DOI 10.1016/j.ssi.2004.08.021; Vanmeensel K, 2007, ACTA MATER, V55, P1801, DOI 10.1016/j.actamat.2006.10.042; Ghosh S, 2014, SCRIPTA MATER, V86, P13, DOI 10.1016/j.scriptamat.2014.04.014; Basu B, 2005, J EUR CERAM SOC, V25, P3629, DOI 10.1016/j.jeurceramsoc.2004.09.017; Bonny K, 2008, WEAR, V265, P1884, DOI 10.1016/j.wear.2008.04.033; Chakravarty D, 2005, B MATER SCI, V28, P227, DOI 10.1007/BF02711252; Desmaison-Brut M., 1989, EURO CERAMICS, V3, P258; Estili M, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/1/014201; Hvizdos P, 2010, SCRIPTA MATER, V63, P254, DOI 10.1016/j.scriptamat.2010.03.069; Kern F, 2012, SCRIPTA MATER, V67, P301, DOI 10.1016/j.scriptamat.2012.05.009; Kern F, 2012, SCRIPTA MATER, V67, P1007, DOI 10.1016/j.scriptamat.2012.09.019; Salehi S, 2006, J EUR CERAM SOC, V26, P3173, DOI 10.1016/j.jeurceramsoc.2005.10.010; Shibata K, 1997, J MATER SCI, V32, P583, DOI 10.1023/A:1018515213895; Su PJ, 2013, THIN SOLID FILMS, V529, P317, DOI 10.1016/j.tsf.2012.07.066	19	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	FEB	2015	123	1434					86	89		10.2109/jcersj2.123.86		4	Materials Science, Ceramics	Materials Science	CE9DM	WOS:000352143800005		
J	Yaowakulpattana, P; Kondo, S; Kadono, K; Wakasugi, T				Yaowakulpattana, Panitpicha; Kondo, Shinya; Kadono, Kohei; Wakasugi, Takashi			Effect of B2O3 on crystallization behavior of ZnO-Al2O3-SiO2 glasses	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						ZAS glass-ceramics; B2O3 addition; Nucleating agent; Crystal size; Gahnite	CERAMICS	The effects of B2O3 on the crystallization behavior of ZnO-Al2O3-SiO2 glasses were investigated by DTA and XRD measurements after nucleation heat-treatment (NHT) at various temperatures for 24 h. The addition of B2O3 also decreased T-c of glasses. According to XRD measurements, gahnite precipitated as main phase in every composition. Precipitation of quartz or willemite was observed for the glass in which little nucleation occurred because of low NHT temperature. Addition of B2O3 promoted the precipitation of willemite instead of quartz. However, the precipitation of these phases was not observed when the nucleation was enough. Crystal sizes became smaller with the increase of the number density of nuclei. On the other hand, they became larger by the addition of B2O3. It was found that B2O3 addition decreases the nucleation rate and increases the crystal growth rate.	[Yaowakulpattana, Panitpicha; Kondo, Shinya; Kadono, Kohei; Wakasugi, Takashi] Kyoto Inst Technol, Fac Engn & Design, Dept Mat & Life Sci, Sakyou Ku, Kyoto 6068585, Japan	Yaowakulpattana, P (reprint author), Kyoto Inst Technol, Fac Engn & Design, Dept Mat & Life Sci, Sakyou Ku, Kyoto 6068585, Japan.	y.panitpicha@gmail.com					Kurama S, 2006, J EUR CERAM SOC, V26, P755, DOI 10.1016/j.jeurceramsoc.2005.07.039; BEALL GH, 1969, J MATER SCI, V4, P340, DOI 10.1007/BF00550404; Pinckney LR, 2006, PHYS CHEM GLASSES-B, V47, P127; Chunhui S., 2006, J WUHAN UNIV TECHNOL, V21, P110; GIELISSE PJ, 1962, NATURE, V195, P69, DOI 10.1038/195069a0; Levin E. M., 1964, AM CERAMICS SOC, V87, P258; Liying T., 2013, J WUHAN UNIV TECHNOL, V28, P69; RAO BB, 1989, B MATER SCI, V12, P137; Rezvani M., 2011, J MAT SCI ENG, V8, P41; Wakasugi Takashi, 2008, Journal of the Society of Materials Science, Japan, V57, DOI 10.2472/jsms.57.552; Wakasugi T., 2010, J SOC MATER SCI JPN, V59, P430; Wakasugi T, 1999, J NON-CRYST SOLIDS, V244, P63, DOI 10.1016/S0022-3093(98)00841-2	12	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	FEB	2015	123	1434					96	99		10.2109/jcersj2.123.96		4	Materials Science, Ceramics	Materials Science	CE9DM	WOS:000352143800007		
J	Somekawa, H; Osawa, Y; Singh, A; Washio, K; Kato, A; Mukai, T				Somekawa, Hidetoshi; Osawa, Yoshiaki; Singh, Alok; Washio, Kota; Kato, Akira; Mukai, Toshiji			Effect of Micro-Alloying Elements on Deformation Behavior in Mg-Y Binary Alloys	JOURNAL OF THE JAPAN INSTITUTE OF METALS			Japanese	Article						magnesium; solute atom; electron backscatter diffraction observation; deformation twin	GRAINED MAGNESIUM ALLOYS; ROOM-TEMPERATURE; ZN ALLOY; MECHANISMS; CREEP; MICROSTRUCTURES; PLASTICITY; EXTRUSION; POWDER; SIZE	The effect of minor yttrium atom addition on deformation behavior was investigated using Mg-X at %Y (X = 0.01, 0.02, 0.03, 0.04 and 0.05) dilute alloys and pure magnesium with an average grain size of about 50 mu m. The stress and strain curves in all the alloys showed a sigmoidal shape in the compression tests, which suggested the formation of {10 (1) over bar2}-type twinning due to the lack of slip system. On the other hand, yttrium atom addition of more than 0.03 at% was effective to affect the deformation behavior: a large compressive strain of 0.5 was possible to obtain, and the sub-grained and fine-grained structures were formed even at room temperature in three kinds of alloys. The dominant deformation mechanism in these alloys was the twinning at the beginning of the state and the dislocation slip with further imposed strain.	[Somekawa, Hidetoshi; Osawa, Yoshiaki; Singh, Alok] Natl Inst Mat Sci, Res Ctr Strateg Mat, Tsukuba, Ibaraki 3050047, Japan; [Somekawa, Hidetoshi; Washio, Kota; Kato, Akira] Toyota Motor Co Ltd, Adv Mat Engn Div, Susono 4101193, Japan; [Mukai, Toshiji] Kobe Univ, Dept Mech Engn, Kobe, Hyogo 6578501, Japan	Somekawa, H (reprint author), Natl Inst Mat Sci, Res Ctr Strateg Mat, Tsukuba, Ibaraki 3050047, Japan.	SOMEKAWA.Hidetoshi@nims.go.jp	Mukai, Toshiji/F-9570-2014; SINGH, Alok/H-2916-2011	Mukai, Toshiji/0000-0002-9628-5762; SINGH, Alok/0000-0001-5515-8305			Suzuki M, 1998, MAT SCI ENG A-STRUCT, V252, P248, DOI 10.1016/S0921-5093(98)00662-5; STOHR JF, 1972, PHILOS MAG, V25, P1313, DOI 10.1080/14786437208223856; Sandlobes S, 2012, ACTA MATER, V60, P3011, DOI 10.1016/j.actamat.2012.02.006; Bohlen J, 2007, ACTA MATER, V55, P2101, DOI 10.1016/j.actamat.2006.11.013; Meyers MA, 2001, ACTA MATER, V49, P4025, DOI 10.1016/S1359-6454(01)00300-7; Barnett MR, 2004, ACTA MATER, V52, P5093, DOI 10.1016/j.actamat.2004.07.015; Oberson PG, 2009, INT J PLASTICITY, V25, P881, DOI 10.1016/j.ijplas.2008.06.002; Koike J, 2005, METALL MATER TRANS A, V36A, P1689, DOI 10.1007/s11661-005-0032-4; Somekawa H, 2011, ACTA MATER, V59, P7554, DOI 10.1016/j.actamat.2011.08.047; Miura S, 2008, MATER TRANS, V49, P952, DOI 10.2320/matertrans.MC2007109; [Anonymous], 1999, ASM SPECIALTY HDB MA; Zhu SM, 2010, SCRIPTA MATER, V63, P698, DOI 10.1016/j.scriptamat.2010.02.005; Watanabe H, 2011, PHILOS MAG, V91, P4158, DOI 10.1080/14786435.2011.603370; Chino Y, 2009, MAT SCI ENG A-STRUCT, V513-14, P394, DOI 10.1016/j.msea.2009.01.074; Sandlobes S, 2011, ACTA MATER, V59, P429, DOI 10.1016/j.actamat.2010.08.031; Mendis CL, 2007, SCRIPTA MATER, V57, P485, DOI 10.1016/j.scriptamat.2007.05.031; KAIBYSHEV R, 1994, Z METALLKD, V85, P738; Somekawa H, 2013, SCRIPTA MATER, V68, P416, DOI 10.1016/j.scriptamat.2012.11.010; Elsayed FR, 2013, SCRIPTA MATER, V68, P797, DOI 10.1016/j.scriptamat.2013.01.032; Kawamura Y, 2001, MATER TRANS, V42, P1172, DOI 10.2320/matertrans.42.1172; Armstrong R. W., 1960, METALL MATER TRANS A, V1, P1169; Ashby M.F., 1982, DEFORMATION MECH MAP; Beetles C. J., 2004, SCRIPTA MATER, V51, P193; Chino Y, 2008, MAT SCI ENG A-STRUCT, V486, P481, DOI 10.1016/j.msea.2007.09.058; Geng J, 2011, MAT SCI ENG A-STRUCT, V528, P3659, DOI 10.1016/j.msea.2011.01.024; Halada K., 2004, MAT JAPAN, V43, P264; Jain A, 2008, MAT SCI ENG A-STRUCT, V486, P545, DOI 10.1016/j.msea.2007.09.069; KATO A, 1994, MATER T JIM, V35, P125; Kimura H., 2002, ZAIRYOKYODO NO KANGA; Mohri M., 1998, MAT SCI ENG A-STRUCT, V257, P287; Mordike BL, 2002, MAT SCI ENG A-STRUCT, V324, P103, DOI 10.1016/S0921-5093(01)01290-4; Somekawa H, 2013, MAT SCI ENG A-STRUCT, V561, P378, DOI 10.1016/j.msea.2012.10.040; Somekawa H, 2009, PHIL MAG LETT, V89, P2, DOI 10.1080/09500830802537718; Song SX, 2007, SCRIPTA MATER, V56, P393, DOI 10.1016/j.scriptamat.2006.10.040; Stanford N, 2013, METALL MATER TRANS A, V44A, P2466, DOI 10.1007/s11661-013-1712-0; Syed B, 2012, SCRIPTA MATER, V67, P700, DOI 10.1016/j.scriptamat.2012.06.036; Thompson A. W., 1972, Metallography, V5, DOI 10.1016/0026-0800(72)90018-3; Tsuru T, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/2/022202; Uesugi T., 2004, J JAPAN I LIGHT META, V54, P82; Watanabe H, 2003, MATER TRANS, V44, P463, DOI 10.2320/matertrans.44.463; Yashi J. A., 2010, ACTA MAT, V58, P5704	41	0	0	JAPAN INST METALS	SENDAI	1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN	0021-4876	1880-6880		J JPN I MET	J. Jpn. Inst. Met.	FEB	2015	79	2					35	40		10.2320/jinstmet.J2014044		6	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CE2MR	WOS:000351650200001		
J	Yoshimura, A; Umehara, K; Takai, M; Matsuno, Y				Yoshimura, Akihiro; Umehara, Kana; Takai, Madoka; Matsuno, Yasunari			Development of Recycling System of Precious Metals and Rare Metals Using DMSO Solvent Containing CuBr2	JOURNAL OF THE JAPAN INSTITUTE OF METALS			Japanese	Article						copper dibromide; dimethylsulfoxide; electrochemical measurement; recycling	ACETONITRILE; WATER; GOLD	We have presented a novel process for recycling gold from secondary sources: Leaching of gold by dimethyl sulfoxide solutions containing copper bromide and precipitation with water, which could offer a number of advantages, including eco-friendliness, ease of operation and low cost. In this work, we applied this process to other metals which are contained in secondary sources, e.g. printed wired board. The mechanism of dissolution was investigated by electrochemical measurements. Metal wires were dissolved in a DMSO solution with 0.2 M of CuBr2 and 0.2 M of KBr at 343 K. The precipitation of dissolved metals were performed by the addition of water, during which the effects of the amount of water and pH on the recovery rate were investigated. The results of the electrochemical measurements indicate that the anodic dissolution of sample metals in DMSO containing CuBr2 occurs at relatively negative potentials and is paired with the cathodic reduction of Cu2+ to Cu+ It was found that gold, silver, copper, tin, cobalt, nickel and zinc were able to be dissolved, all of which can be effectively precipitated by the addition of water with appropriate pH.	[Yoshimura, Akihiro; Umehara, Kana; Takai, Madoka; Matsuno, Yasunari] Univ Tokyo, Grad Sch Engn, Tokyo 1138656, Japan	Yoshimura, A (reprint author), Univ Tokyo, Tokyo 1138654, Japan.						Lin W, 2010, ANGEW CHEM INT EDIT, V49, P7929, DOI 10.1002/anie.201001244; CHAUDHRY M, 1994, J CHEM SOC FARADAY T, V90, P2243, DOI 10.1039/ft9949002243; Gromov A, 2005, SCRIPTA MATER, V52, P375, DOI 10.1016/j.scriptamat.2004.10.029; Iguchi Y., 1999, EXTRACTIVE METALLURG, P166; Imai H., 1993, KINZOKUSAKUTAI KAGAK, P8; Matsumoto K., 2014, NANYOUSEI BUSSHITSU; Nakao Y, 1996, CHEM COMMUN, P897, DOI 10.1039/cc9960000897; National institute for Materials Science, 2014, RAR MET TOK; National Institute for Materials Science, 2014, EST C02 EM EN CONS E; Sauer D. T., 1982, ANAL CHEM, V54, P1720; Shibata J., 2002, J MMIJ, V118, P1; Shiratori T., 2007, J MMIJ, V123, P171; Yoshimura A, 2014, HYDROMETALLURGY, V149, P177, DOI 10.1016/j.hydromet.2014.08.003	13	1	1	JAPAN INST METALS	SENDAI	1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN	0021-4876	1880-6880		J JPN I MET	J. Jpn. Inst. Met.	FEB	2015	79	2					41	48		10.2320/jinstmet.J2014047		8	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CE2MR	WOS:000351650200002		
J	Nemoto, K; Kikugawa, H; Moriyama, H; Kasuya, H				Nemoto, Keiichi; Kikugawa, Hisao; Moriyama, Hiroyuki; Kasuya, Hirakazu			Effect of Lamination Constitution on Post Buckling Behavior of Symmetrically Laminated Plates with Initial Deflection	JOURNAL OF THE JAPAN INSTITUTE OF METALS			Japanese	Article						structural analysis; composite materials; carbon fiber reinforced plastic (CFRP); secondary buckling; initial deflection; symmetrically laminated plates		Advanced fiber-reinforced composite materials are used as structural members in various fields because of their high strength and high stiffness-to-weight ratios, and hence analysis of thin laminated structures is important. Post-buckling behaviors of thin laminated plates under uniaxial compression have been discussed by many researchers. However, little research has been performed on the secondary buckling phenomenon for thin laminated plate which occurs with further increase of load. In this paper, the stability condition of carbon-epoxy symmetrically laminated plates with initial deflections under uniaxial compression which are simply supported along four edges is determined, using the second variation of total potential energy. The necessity of secondary buckling is proven analytically, and the effects of various factors, such as initial deflection, lamination constitution, and number of layers, are clarified.	[Nemoto, Keiichi] Yokohama Rubber Co Ltd, Dept Aerosp Engn, Hiratsuka, Kanagawa 2548601, Japan; [Kikugawa, Hisao] Tokai Univ, Sch Engn, Dept Biomed Engn, Hiratsuka, Kanagawa 2591292, Japan; [Moriyama, Hiroyuki; Kasuya, Hirakazu] Tokai Univ, Sch Engn, Dept Prime Mover Engn, Hiratsuka, Kanagawa 2591292, Japan	Nemoto, K (reprint author), Yokohama Rubber Co Ltd, Dept Aerosp Engn, Hiratsuka, Kanagawa 2548601, Japan.						Fukunaga H., 1993, T JPN SOC MECH ENG, V59, P2343; Jones R. M., 1975, MECH COMPOS MATER; Kasuya H., 1993, Journal of the Society of Materials Science, Japan, V42; Kasuya H., 1985, T JAPAN SOC MECH E A, V51, P393; Kasuya H., 1992, T JPN SOC MECH ENG, V58, P1544; Kasuya H., 2011, KIKUGAWA J SCO DESIG, V46, P454; NEMETH MP, 1986, AIAA J, V24, P1831, DOI 10.2514/3.9531; Sato M., 1994, T JPN SOC MECH ENG, V60, P853; Terada Y., 2000, T JPN SOC MECH ENG, V66, P714; Turvey G.J., 1995, BUCKLING POSTBUCKLIN; Uemura M., 1977, T JPN SOC MECH ENG, V43, P2818; Uemura M., 1975, Journal of the Society of Materials Science, Japan, V24	12	0	0	JAPAN INST METALS	SENDAI	1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN	0021-4876	1880-6880		J JPN I MET	J. Jpn. Inst. Met.	FEB	2015	79	2					49	56		10.2320/jinstmet.J2014041		8	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CE2MR	WOS:000351650200003		
J	Kirino, F; Kitada, M				Kirino, Fumiyoshi; Kitada, Masahiro			Microstructures of Surface Corrosion Layer of the Japanese Oldest Coin: Wadoukaichin Made in the Nara Era	JOURNAL OF THE JAPAN INSTITUTE OF METALS			Japanese	Article						Wadoukaichin; corrosion; transmission electron microscope (TEM); microstructure; malachite; azurite; copper oxide		The microstructures of a corrosion layer formed on the surface of two Japanese oldest coins, Wadoukaichin (surface color: dark brown and green) were studied. Compositions of these coins are that main element is Cu and Sn and traces are Pb, Fe and As. X-ray diffraction patterns show that copper di-hydroxide (Cu(OH)(2) 2H(2)O), Cu-1 S-81 and Cu2O are detected on the surface corrosion layer of dark brown sample, and Cu-2 (CO3) (OH)(2) (malachite), Cu-3(CO3)(2)(OH)(2) (azurite) and Cu2O are detected on the surface corrosion layer of green sample. Optical microscope images show that the surface corrosion layer of dark brown sample is porous, and blue and green grains on the brown layer are existed on that of green sample. From spectrographs of these grains, the peak wavelength of green grains is matched to that of malachite, but this of blue grains is shifted to long wavelength side of about 40 nm at azurite on an influence of trace contaminations. The corrosion layer has two layers, surface layer is plate-like texture, and under layer is aggregation microstructure from TEM observation. The crystal structure of these two layers is matched to azurite from the electron beam diffraction patterns.	[Kirino, Fumiyoshi] Tokyo Univ Arts, Grad Sch Fine Arts, Tokyo 1108714, Japan; [Kitada, Masahiro] Nara Natl Res Inst Cultural Properties, Ctr Archaeol Operat, Nara 6308577, Japan	Kirino, F (reprint author), Tokyo Univ Arts, Grad Sch Fine Arts, Tokyo 1108714, Japan.						Ashida T., 1912, GELDWESEN JAPANS ENT; Hansen M., 1985, CONSTITUTION BINARY, P160; Hansen M., 1985, CONSTITUTION BINARY, P633; Hashimoto T., 2007, P 24 JAP SOC SCI STU, P110; Hashimoto T., 2006, P 23 JAP SOC SCI STU, P27; Hashimoto T., 2005, P 10 JAP SOC SCI STU, P39; Hayakawa Y., 2001, BUNKAZAI HOZON SHUUF, V45, P44; Honjyou E., 1939, DAINIHONKAHEISHI; Imamura H., 2001, FUHONNSENN NAZONOGIN; Itou H., 2003, KOUZAN KINZOKU BUNKA, P90; Koga N., 1919, KOUKOGAKUZASSHI, V9, P35; Mabuchi H., 2000, KOUKOGAKU KAGAKU WO, P243; Matsubara S., 2003, NIHON NO KOUBUTSU, P101; Taguchi I., 1993, P 10 JAP SOC SCI STU, P56; Takizawa T., 1999, NIHONSHISHOUHYAKKA K, P172; Tsukamoto T., 1925, NIHONKAHEISHI; Uhlig H. H., 1989, CORROSION CORROSION, P177; Yutaka T., 1996, KOUBUTSU GANSEKI, P150	18	1	1	JAPAN INST METALS	SENDAI	1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN	0021-4876	1880-6880		J JPN I MET	J. Jpn. Inst. Met.	FEB	2015	79	2					57	63		10.2320/jinstmet.J2014040		7	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CE2MR	WOS:000351650200004		
J	Kitada, M; Kohzuma, Y; Koezuka, T; Tateishi, T				Kitada, Masahiro; Kohzuma, Yohsei; Koezuka, Takayasu; Tateishi, Toru			Microstructure of Red Pigment Layer Painted on the Takamatsuzuka Tumulus Wall	JOURNAL OF THE JAPAN INSTITUTE OF METALS			Japanese	Article						Takamatsuzuka tumulus; mural; pigment; cinnabar; calcite; albite		The Takamatsuzuka tumulus was constructed in the 7-8th centuries at Asuka in Nara prefecture (the Kinki region in Japan). The tumulus was excavated by village Asuka proprietor in 1972 and a beautiful mural of human figures and other subjects were discovered. However, the mural is deteriorating as a result of rainwater, mold, and other unknown causes. The purpose of this investigation is to clarify the composition, crystal structure, and other material factors of the red pigment layer of the mural as basic research to identify the materials used in the mural. An optical microscope, a scanning electron microscope, and a transmission electron microscope are utilized to examine the microstructure. The red particles on the white stucco base are observed with the optical microscope. Mercury and sulfur are detected from the red pigment by EDS, and hexagonal HgS is confirmed by electron diffraction pattern analysis. Therefore, the red pigment is cinnabar (HgS). The HgS particle size is 0.2 to 5 mu m and the surface is in a cloven condition. This shows that the particles have been crushed mechanically. Calcite and albite exist as the base matter and impurity particle, respectively.	[Kitada, Masahiro; Kohzuma, Yohsei; Koezuka, Takayasu] Nara Natl Res Inst Cultural Properties, Ctr Archaeol Operat, Nara 6308577, Japan; [Tateishi, Toru] Agcy Cultural Affairs, Cultural Properties Dept, Tokyo 1108914, Japan	Kitada, M (reprint author), Tokyo Univ Arts, Tokyo, Japan.						Agency for Cultural Affairs, 2010, RES REP CAUS DEGR TA, P14; Hayakawa Y., 2004, CONSERVATION SCI, V43, P63; Kikawa R., 2010, CULTURAL PROPERTIES, P29; Kitada M., 2001, B FACULTY FINE ARTS, P5; Kitada M., 2013, BEAUTY ARTS MAT SCI, P138; Kitada M., 2013, COMMITTEE REPORT RES, P1; Kitada M., 2012, COMMITTEE REPORT RES, P1; Koezuka T., 2010, CULTURAL PROPERTIES, P34; Nagai Y., 2010, CULTURAL PROPERTIES, P4; Nagakura S., 1998, RIKAGAKU JITEN, P675; Nara National Research Institute for Cultural Properties, 2009, PUBL HIST MAT, P9; Sano T., 2010, CONSERVATION SCI, V49, P119; Takatori K., 2007, BOHKIN BOHBAI, V35, P655; Yoshida N., 2010, CONSERVATION SCI, V49, P197	14	2	2	JAPAN INST METALS	SENDAI	1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN	0021-4876	1880-6880		J JPN I MET	J. Jpn. Inst. Met.	FEB	2015	79	2					64	70		10.2320/jinstmet.J2014050		7	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CE2MR	WOS:000351650200005		
J	Kitada, M; Kohzuma, Y; Koezuka, T; Tateishi, T				Kitada, Masahiro; Kohzuma, Yohsei; Koezuka, Takayasu; Tateishi, Toru			Microstructure of Black Pigment Painted on the Takamatsuzuka Tumulas Wall	JOURNAL OF THE JAPAN INSTITUTE OF METALS			Japanese	Article						Takamatsuzuka tumulus; mural; black pigment; magnetite; ilmenite; zirconium		The mural of the Takamatsuzuka tumulus in Asuka, Nara prefecture, was painted in the 7-8th centuries. Red, green, blue, yellow, and black pigments are used in the mural. The microstructure of one of them, the red pigment, was described in the previous paper. In this study, the black pigment observed within the red pigment area has been investigated. An optical microscope, a scanning electron microscope, and a transmission electron microscope are utilized to examine the microstructure. Among the black particles, two different Fe compounds are observed. One is magnetite (Fe3O4) comprising small amounts of Ti, Al, and Mg, and the other is ilmenite (FeTiO3) containing a small amount of Mg. In addition to the above compounds, an oxide particle containing Zr is also observed.	[Kitada, Masahiro; Kohzuma, Yohsei; Koezuka, Takayasu] Nara Natl Res Inst Cultural Properties, Ctr Archaeol Operat, Nara 6308577, Japan; [Tateishi, Toru] Agcy Cultural Affairs, Cultural Properties Dept, Tokyo 1108914, Japan	Kitada, M (reprint author), Tokyo Univ Arts, Tokyo, Japan.						[Anonymous], JCPDS NO 01 075 1230; [Anonymous], JCPDS NO 01 071 6336; Kitada M, 2015, J JPN I MET, V79, P64, DOI 10.2320/jinstmet.J2014050; KITADA M, 1980, J MATER SCI, V15, P1684, DOI 10.1007/BF00550585; Kitada M., 2008, MUROMACHI NIHONTOU B, P36; Nagakura S., 1998, RIKAGAKU JITEN, P91; Nagakura S., 1998, RIKAGAKU JITEN, P1168; Nagakura S., 1998, RIKAGAKU JITEN, P598; Rusakov A., 1950, NAUK USSR, V77, P411; Sano T., 2009, CONSERVATION SCI, V48, P119	10	1	1	JAPAN INST METALS	SENDAI	1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN	0021-4876	1880-6880		J JPN I MET	J. Jpn. Inst. Met.	FEB	2015	79	2					71	75		10.2320/jinstmet.J2014051		5	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CE2MR	WOS:000351650200006		
J	Chiba, S; Funato, S; Horiuchi, N; Matsumoto, K; Inokuma, H; Furuoka, H; Kobayashi, Y				Chiba, Shiori; Funato, Shingo; Horiuchi, Noriyuki; Matsumoto, Kotaro; Inokuma, Hisashi; Furuoka, Hidefumi; Kobayashi, Yoshiyasu			Optic pathway degeneration in Japanese black cattle	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						axonal degeneration; gliosis; Japanese black cattle; optic pathway degeneration	HYPOVITAMINOSIS-A; RETINAL DEGENERATION; WISTAR RATS; DEFICIENCY; NERVE; CALVES; EXPRESSION; INJURY; SLC	Degeneration of the optic pathway has been reported in various animal species including cattle. We experienced a case of bilateral optic tract degeneration characterized by severe gliosis in a Japanese black cattle without any obvious visual defects. To evaluate the significance, pathological nature and pathogenesis of the lesions, we examined the optic pathway in 60 cattle (41 Japanese black, 13 Holstein and 6 crossbreed) with or without ocular abnormalities. None of these animals had optic canal stenosis. Degenerative changes with severe gliosis in the optic pathway, which includes the optic nerve, optic chiasm and optic tract, were only observed in 8 Japanese black cattle with or without ocular abnormalities. Furthermore, strong immunoreactivity of glial fibrillary acidic protein was observed in the retinal stratum opticum and ganglion cell layer in all 5 cattle in which the optic pathway lesions could be examined. As etiological research, we also examined whether the concentrations of vitamin A and vitamin B12 or bovine viral diarrhea virus (BVDV) infection was associated with optic pathway degeneration. However, our results suggested that the observed optic pathway degeneration was probably not caused by these factors. These facts indicate the presence of optic pathway degeneration characterized by severe gliosis that has never been reported in cattle without bilateral compressive lesions in the optic pathway or bilateral severe retinal atrophy.	[Chiba, Shiori; Funato, Shingo; Horiuchi, Noriyuki; Furuoka, Hidefumi; Kobayashi, Yoshiyasu] Obihiro Univ Agr & Vet Med, Dept Basic Vet Med, Lab Vet Pathol, Obihiro, Hokkaido 0808555, Japan; [Matsumoto, Kotaro; Inokuma, Hisashi] Obihiro Univ Agr & Vet Med, Dept Clin Vet Med, Lab Vet Internal Med, Obihiro, Hokkaido 0808555, Japan	Kobayashi, Y (reprint author), Obihiro Univ Agr & Vet Med, Dept Basic Vet Med, Lab Vet Pathol, Nishi 2-11,Inada Cho, Obihiro, Hokkaido 0808555, Japan.	kyoshi@obihiro.ac.jp			Japan Society for the Promotion of Science (JSPS) [25450420]	This work was supported in part by a Grant-in-Aid for Scientific Research (no. 25450420) from the Japan Society for the Promotion of Science (JSPS).	DOWLING JE, 1958, P NATL ACAD SCI USA, V44, P648, DOI 10.1073/pnas.44.7.648; Briani C, 2013, NUTRIENTS, V5, P4521, DOI 10.3390/nu5114521; HAYES KC, 1968, ARCH OPHTHALMOL-CHIC, V80, P777; BOOTH A, 1987, J AM VET MED ASSOC, V190, P1305; Zhang SD, 2009, BRAIN RES, V1303, P131, DOI 10.1016/j.brainres.2009.09.029; Luna G, 2010, MOL VIS, V16, P2511; Ito Y, 2009, EXP EYE RES, V89, P246, DOI 10.1016/j.exer.2009.03.013; LEWIS GP, 1995, INVEST OPHTH VIS SCI, V36, P2404; Dyer MA, 2000, NAT NEUROSCI, V3, P873; Dikeman ME, 2007, MEAT SCI, V77, P121, DOI 10.1016/j.meatsci.2007.04.011; Behbehani Raed, 2007, Clin Ophthalmol, V1, P233; Cullen C. L., 2013, VET OPHTHALMOLOGY, V2, P2071; de Lahunta A., 2009, VET NEUROANATOMY CLI, P407; Dubielzig R. R., 2010, VET OCULAR PATHOLOGY, P32; Gin P. E., 2007, PATHOLOGY DOMESTIC A, V1, P628; Grahn B, 2013, VET OPHTHALMOL, V16, P1, DOI 10.1111/vop.12067; Hardman J. M., 1991, TXB NEUROPATHOLOGY, P986; Hind V M, 1970, Trans Ophthalmol Soc U K, V90, P839; HOLMES JM, 1956, BRIT MED J, V2, P1394; Kesler Anat, 2003, Curr Neurol Neurosci Rep, V3, P410, DOI 10.1007/s11910-003-0024-y; LEE EW, 1990, VET PATHOL, V27, P439; Martins B. C., 2013, VET OPHTHALOMOLOGY, V2, P1463; Mason CS, 2003, VET REC, V153, P213; Maxie M. G., 2007, JUBB KENNEDY PALMERS, V1, P281; Miller PE, 2013, SLATTERS FUNDAMENTAL, P247; Myers R. K., 2012, PATHOLOGIC BASIS VET, V1, P29; Ofri R., 2013, SLATTERS FUNDAMENTAL, P299; Pandey S, 2004, CLIN NEUROPHYSIOL, V115, P914, DOI 10.1016/j.clinph.2003.11.013; Schochet Jr S. S., 1991, TXB NEUROPATHOLOGY, P455; SHIBUYA K, 1989, VET PATHOL, V26, P518; SHIBUYA K, 1993, J VET MED SCI, V55, P905; SPRATLIN.FR, 1965, VET REC, V77, P1532; Thompson K., 2007, PATHOLOGY DOMESTIC A, VI, P55; VanderLugt JJ, 1996, VET PATHOL, V33, P495; Weinstock D, 2001, J CLIN MICROBIOL, V39, P343, DOI 10.1128/JCM.39.1.343-346.2001; Wilcock B.P., 2007, JUBB KENNEDY PALMERS, V1, P459	36	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	FEB	2015	77	2					147	154		10.1292/jvms.14-0299		8	Veterinary Sciences	Veterinary Sciences	CE7PL	WOS:000352033700003		
J	Ito, Y; Maehara, S; Itoh, Y; Hayashi, M; Kubo, A; Itami, T; Ishizuka, T; Tamura, J; Yamashita, K				Ito, Yosuke; Maehara, Seiya; Itoh, Yoshiki; Hayashi, Miri; Kubo, Akira; Itami, Takaharu; Ishizuka, Tomohito; Tamura, Jun; Yamashita, Kazuto			Effect of sevoflurane concentration on visual evoked potentials with pattern stimulation in dogs	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						canine; minimum alveolar concentration; P100 implicit time; pattern stimulated visual evoked potentials; sevoflurane	MINIMAL ALVEOLAR CONCENTRATION; BISPECTRAL INDEX; ISOFLURANE; ANESTHESIA; SUPPRESSION; SEDATION; PROPOFOL; DISEASE	The purpose of this study was to investigate the effects of sevoflurane concentration on canine visual evoked potentials with pattern stimulation (P-VEPs). Six clinically normal laboratory-beagle dogs were used. The minimum alveolar concentration (MAC) of sevoflurane was detected from all subjects by tail clamp method. The refractive power of the right eyes of all subjects was corrected to 2 diopters after skiascopy. For P-VEP recording, the recording and reference electrode were positioned at inion and nasion, respectively, and the earth electrode was positioned on the inner surface. To grasp the state of CNS suppression objectively, the bispectral index (BIS) value was used. The stimulus pattern size and distance for VEP recording were constant, 50.3 arc-min and 50 cm, respectively. P-VEPs and BIS values were recorded under sevoflurane in oxygen inhalational anesthesia at 0.5, 1.0, 1.5, 2.0, 2.5 and 2.75 sevoflurane MAC. For analysis of P-VEP, the P100 implicit time and N75-P100 amplitude were estimated. P-VEPs were detected at 0.5 to 1.5 MAC in all dogs, and disappeared at 2.0 MAC in four dogs and at 2.5 and 2.75 MAC in one dog each. The BIS value decreased with increasing sevoflurane MAC, and burst suppression began to appear from 1.5 MAC. There was no significant change in P100 implicit time and N75-P100 amplitude with any concentration of sevoflurane. At concentrations around 1.5 MAC, which are used routinely to immobilize dogs, sevoflurane showed no effect on P-VEP.	[Ito, Yosuke; Maehara, Seiya; Hayashi, Miri; Kubo, Akira; Itami, Takaharu; Ishizuka, Tomohito; Tamura, Jun; Yamashita, Kazuto] Rakuno Gakuen Univ, Sch Vet Med, Dept Small Anim Clin Sci, Ebetsu, Hokkaido 0698501, Japan; [Itoh, Yoshiki] Yamaguchi Univ, Joint Fac Vet Med, Dept Vet Radiol, Yamaguchi 7538515, Japan	Maehara, S (reprint author), Rakuno Gakuen Univ, Sch Vet Med, Dept Small Anim Clin Sci, 582 Bunkyodai Midorimachi, Ebetsu, Hokkaido 0698501, Japan.	seiya-m@rakuno.ac.jp					Greene SA, 2002, COMPARATIVE MED, V52, P424; SEBEL PS, 1986, BRIT J ANAESTH, V58, P580, DOI 10.1093/bja/58.6.580; Katoh T, 1998, ANESTHESIOLOGY, V88, P642, DOI 10.1097/00000542-199803000-00014; Besch G, 2011, BRIT J ANAESTH, V107, P749, DOI 10.1093/bja/aer235; Makela K, 1996, EVOKED POTENTIAL, V100, P269, DOI 10.1016/0168-5597(96)00321-8; SOKOL S, 1981, VISION RES, V21, P1279, DOI 10.1016/0042-6989(81)90232-7; OKUDA B, 1995, ALZ DIS ASSOC DIS, V9, P68, DOI 10.1097/00002093-199509020-00002; Denman WT, 2000, ANESTH ANALG, V90, P872; Glass PS, 1997, ANESTHESIOLOGY, V86, P836, DOI 10.1097/00000542-199704000-00014; BRIGELL M. G., 2001, ELECTROPHYSIOLOGIC T, P237; CHI OZ, 1986, ANESTHESIOLOGY, V65, P328; Ekesten B, 2007, VET OPHTHALMOLOGY, V1, P520; Fahle M., 2006, PRINCIPLES PRACTICE, P207; Hamaguchi Kaoru, 2005, Masui, V54, P998; HAUPT WF, 1994, INT J NEUROSCI, V79, P59; Itoh Y, 2010, J VET MED SCI, V72, P1449, DOI 10.1292/jvms.10-0073; Kameyama Y, 1994, Masui, V43, P657; Ko JCH, 2000, J AM VET MED ASSOC, V217, P1025, DOI 10.2460/javma.2000.217.1025; Nakagawa Itsuo, 2006, Masui, V55, P692; Nakayama N., 1996, ANIM EYE RES, V15, P148; Nakayama N., 1995, ANIM EYE RES, V14, P141; Sasaki Tatsuya, 2006, Masui, V55, P302; Sebel PS, 1997, ANESTH ANALG, V84, P891, DOI 10.1097/00000539-199704000-00035; SOKOL S, 1983, BRIT J OPHTHALMOL, V67, P310, DOI 10.1136/bjo.67.5.310; Tufano R, 2000, Minerva Anestesiol, V66, P389; Yamashita K, 2009, J VET MED SCI, V71, P1509, DOI 10.1292/jvms.001509	26	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	FEB	2015	77	2					155	160		10.1292/jvms.14-0345		6	Veterinary Sciences	Veterinary Sciences	CE7PL	WOS:000352033700004		
J	Fukushima, S; Niimi, K; Takahashi, E				Fukushima, Sanae; Niimi, Kimie; Takahashi, Eiki			Piebald mutation on a C57BL/6J background	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						aganglionic rectum; Ednrb gene; genetic background; piebald mutation	ENTERIC NERVOUS-SYSTEM; HIRSCHSPRUNGS-DISEASE; MOUSE; MICE; RAT	The classic piebald mutation in the endothelin receptor type B (Ednrb) gene was found on rolling Nagoya genetic background (PROD-s/s) mice with white coat spotting. To examine whether genetic background influenced the phenotype in the piebald mutant mice, we generated a congenic strain (B6.PROD-s/s), produced by repeated backcrosses to the C57BL/6J (B6) strain. Although B6.PROD-s/s mice showed white coat spotting, 7% of B6.PROD-s/s mice died between 2 and 5 weeks after birth due to megacolon. The PROD-s/s, s/s and Japanese fancy mouse I (JFI) strains, which also have piebald mutations on different genetic backgrounds with B6, showed only pigmentation defects without megacolon. In expression analyses, rectums of B6.PROD-s/s with megacolon mice showed similar to 5% of the level of Ednrb gene expression versus B6 mice. In histological analyses, aganglionosis was detected in the rectum of megacolon animals. The aganglionic rectum was thought to lead to severe constipation and intestinal blockage, resulting in megacolon. We also observed an abnormal intestinal flora, including a marked increase in Bacteroidaceae and Erysipelotrichaceae and a marked decrease in Lactobacillus and Clostridiales, likely inducing endotoxin production and a failure of the mucosal barrier system, leading ultimately to death. These results indicate that the genetic background plays a key role in the development of enteric ganglion neurons, controlled by the Ednrb gene, and that B6 has modifier gene (s) regarding aganglionosis.	[Fukushima, Sanae; Niimi, Kimie; Takahashi, Eiki] RIKEN, Brain Sci Inst, Res Resources Ctr, Wako, Saitama 3510198, Japan	Takahashi, E (reprint author), RIKEN, Brain Sci Inst, Res Resources Ctr, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	etakahashi@brain.riken.jp					Mori Y, 2000, J NEUROSCI, V20, P5654; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Horinouchi T, 2013, J PHARMACOL SCI, V123, P85, DOI 10.1254/jphs.13R02CR; Takahashi E, 2011, NEUROBIOL AGING, V32, P486, DOI 10.1016/j.neurobiolaging.2009.03.001; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Borrego S, 2013, HISTOL HISTOPATHOL, V28, P1117; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Cheng Z, 2011, PEDIATR SURG INT, V27, P145, DOI 10.1007/s00383-010-2787-y; Dang RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024086; Dang RH, 2012, J VET MED SCI, V74, P391, DOI 10.1292/jvms.11-0447; Dang RH, 2012, BIOMED RES-TOKYO, V33, P249; Dunn LC, 1920, GENETICS, V5, P344; Koide T, 1998, MAMM GENOME, V9, P15, DOI 10.1007/s003359900672; Kumagai T, 1998, EXP ANIM TOKYO, V47, P265, DOI 10.1538/expanim.47.265; Oda S, 1973, Jikken Dobutsu, V22, P281; Sakuraoka Y, 2012, WORLD J GASTROENTERO, V18, P3727, DOI 10.3748/wjg.v18.i28.3727; Suzuki T, 2004, AM J PHYSIOL-GASTR L, V287, pG638, DOI 10.1152/ajpgi.00077.2004; Takahashi E, 2011, BEHAV BRAIN RES, V218, P353, DOI 10.1016/j.bbr.2010.12.019; Yoshimoto T, 2014, J VET MED SCI, V76, P1093, DOI 10.1292/jvms.14-0096	22	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	FEB	2015	77	2					161	166		10.1292/jvms.14-0408		6	Veterinary Sciences	Veterinary Sciences	CE7PL	WOS:000352033700005		
J	Yamaue, Y; Hosaka, YZ; Uehara, M				Yamaue, Yasuhiro; Hosaka, Yoshinao Z.; Uehara, Masato			Spatial relationships among the cellular tapetum, visual streak and rod density in dogs	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						eye; ganglion cell; rod; tapetum; visual streak	RETINAL GANGLION-CELLS; HORSE; PHOTORECEPTORS; TOPOGRAPHY; VISION; ACUITY; SHEEP; AREA; CAT; EYE	The dog visual system is well suited to dim light conditions due to rod-dominated retina and the reflective tapetum. The topographical distributions of rods and thickness of the tapetum of the dog were quantified in retinal whole mounts stained with thionine, and spatial relationships among the tapetum, rod density and visual streak of high ganglion cell density were elucidated. The relationship between the retina and tapetum was analyzed in parasagittal sections stained with thionine or hematoxylin-eosin. The tapetum was thick in its center, and the thickest part consisted of 9 to 12 tapetal cell layers. Rod density ranged from 200,000 to 540,000/mm(2). Maximum rod density was found in the area dorsal to the visual streak, and the density in that area was significantly higher than the rod density in the visual streak and accorded spatially with the thickest part of the tapetum. The horizontal visual streak was found over the horizontal line through the optic disc in the temporal half and extended slightly into the nasal half. The central area of the highest density of ganglion cells was approximately located midway between the nasal and temporal ends of the visual streak. The visual streak was located within the tapetal area, but ventrally to the thick part of the tapetum.	[Yamaue, Yasuhiro; Hosaka, Yoshinao Z.; Uehara, Masato] Tottori Univ, Fac Agr, Dept Vet Anat, Tottori 6808553, Japan; [Yamaue, Yasuhiro] Yamaguchi Univ, United Grad Sch Vet Sci, Dept Basic Vet Sci, Yamaguchi 7538515, Japan	Uehara, M (reprint author), Tottori Univ, Fac Agr, Dept Vet Anat, Tottori 6808553, Japan.	muehara@muses.tottori-u.ac.jp					Miller PE, 1995, J AM VET MED ASSOC, V207, P1623; Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; Mowat FM, 2008, MOL VIS, V14, P2518; Calderone JB, 2003, BRAIN BEHAV EVOLUT, V62, P182, DOI 10.1159/000073270; PEICHL L, 1992, J COMP NEUROL, V324, P603, DOI 10.1002/cne.903240412; Gianfranceschi L, 1999, VISION RES, V39, P569, DOI 10.1016/S0042-6989(98)00169-2; Chandler Matthew J., 1999, Veterinary Ophthalmology, V2, P179; GONZALEZSORIANO J, 1995, ANAT HISTOL EMBRYOL, V24, P61, DOI 10.1111/j.1439-0264.1995.tb00010.x; Granar MIKS, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-13; Hall C, 2007, BEHAV PROCESS, V76, P29, DOI 10.1016/j.beproc.2006.09.017; HEBEL R, 1976, ANAT EMBRYOL, V150, P45; JACOBS GH, 1993, VISUAL NEUROSCI, V10, P173; Janssens G. H. R. R., 2011, ACTA VET SCAND, V53, P193; KRINKE A, 1981, ZBL VET MED C, V10, P26; Ollivier FJ, 2004, VET OPHTHALMOL, V7, P11, DOI 10.1111/j.1463-5224.2004.00318.x; SAMUELSON D.A, 2007, VET OPHTHALMOLOGY, P37; Shinozaki A, 2010, J VET MED SCI, V72, P211, DOI 10.1292/jvms.09-0413; Shinozaki A, 2013, J ANAT, V223, P509, DOI 10.1111/joa.12100; STEINBER.RH, 1973, J COMP NEUROL, V148, P229, DOI 10.1002/cne.901480209; TIMNEY B, 1992, VISION RES, V32, P2289, DOI 10.1016/0042-6989(92)90092-W; WEN GY, 1985, LAB ANIM SCI, V35, P200; Yamaue Y, 2014, J VET MED SCI, V76, P1099, DOI 10.1292/jvms.14-0132	22	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	FEB	2015	77	2					175	179		10.1292/jvms.14-0447		5	Veterinary Sciences	Veterinary Sciences	CE7PL	WOS:000352033700007		
J	Matsui, H; Isshiki, Y; Eguchi, M; Ogawa, Y; Shimoji, Y				Matsui, Hidenori; Isshiki, Yasunori; Eguchi, Masahiro; Ogawa, Yohsuke; Shimoji, Yoshihiro			Evaluation of the live vaccine efficacy of virulence plasmid-cured, and phoP- or aroA-deficient Salmonella enterica serovar Typhimurium in mice	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						aroA; BALB/c mouse; oral vaccine; phoP; Salmonella enterica serovar Typhimurium	ORAL IMMUNIZATION; GROWTH-RATE; SYSTEM; GENES; CELLS; PROLIFERATION; ENTERITIDIS; MACROPHAGES; CHALLENGE; REGULATOR	We evaluated the protective efficacy of 94-kb virulence plasmid-cured, and phoP- or aroA-deficient strains of Salmonella enterica serovar Typhimurium (Delta phoP or Delta aroA S. Typhimurium) as oral vaccine candidates in BALB/c mice. Two weeks after the completion of 3 oral immunizations with 1 x 10(8) colony-forming units (CFU) of virulence plasmid-cured, and Delta phoP or Delta aroA S Typhimurium at 10-day intervals, S. Typhimurium lipopolysaccharide (LPS)-specific mucosal secretory immunoglobulin A (s-IgA) antibody titers were detected in the cecal homogenate, bile and lung lavage fluid, but not in the intestinal lavage fluid. In addition, the increases in S. Typhimurium LPS-specific immunoglobulin G (IgG) and IgA antibody titers in the serum were also observed 2 weeks after completing 3 oral immunizations with virulence plasmid-cured, and Delta phoP or Delta aroA S. Typhimurium. The series of 3 oral immunizations protected the mice against an oral challenge with 5 x 108 CFU of the virulent strain of S. Typhimurium, suggesting that both the virulence plasmid-cured, and Delta phoP and Delta aroA S. Typhimurium strains are promising candidates for safe and effective live S. Typhimurium vaccines.	[Matsui, Hidenori] Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, Tokyo 1088641, Japan; [Matsui, Hidenori] Kitasato Univ, Grad Sch Infect Control Sci, Tokyo 1088641, Japan; [Isshiki, Yasunori] Josai Univ, Sch Pharmaceut Sci, Dept Microbiol, Sakado, Saitama 3500295, Japan; [Eguchi, Masahiro; Ogawa, Yohsuke; Shimoji, Yoshihiro] Natl Agr & Food Res Org, Nat Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan	Matsui, H (reprint author), Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	hmatsui@lisci.kitasato-u.ac.jp					VanCott JL, 1998, NAT MED, V4, P1247, DOI 10.1038/3227; Matsui H, 2001, J BACTERIOL, V183, P4652, DOI 10.1128/JB.183.15.4652-4658.2001; Kodama C, 2004, INFECT IMMUN, V72, P2449, DOI 10.1128/IAI.72.4.2449-2451.2004; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; GROISMAN EA, 1989, P NATL ACAD SCI USA, V86, P7077, DOI 10.1073/pnas.86.18.7077; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Gulig PA, 1998, INFECT IMMUN, V66, P2471; HORMAECHE CE, 1991, MICROB PATHOGENESIS, V10, P149, DOI 10.1016/0882-4010(91)90075-L; Simon R, 2011, VACCINE, V29, P5094, DOI 10.1016/j.vaccine.2011.05.022; Matsui H, 2003, INFECT IMMUN, V71, P30, DOI 10.1128/IAI.71.1.30-39.2003; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; GULIG PA, 1993, INFECT IMMUN, V61, P504; Sano G, 2007, J BACTERIOL, V189, P8224, DOI 10.1128/JB.00898-07; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Rychlik I, 2006, VET MICROBIOL, V112, P1, DOI 10.1016/j.vetmic.2005.10.030; BARROW PA, 1990, RES MICROBIOL, V141, P851, DOI 10.1016/0923-2508(90)90120-F; Bijlsma Jetta J. E., 2003, Trends in Microbiology, V11, P359, DOI 10.1016/S0966-842X(03)00176-8; Boyle EC, 2007, J BACTERIOL, V189, P1489, DOI 10.1128/JB.01730-06; COOPER GL, 1990, MICROB PATHOGENESIS, V9, P255, DOI 10.1016/0882-4010(90)90014-H; Sebkova A, 2008, J BACTERIOL, V190, P3155, DOI 10.1128/JB.00053-08; Detweiler CS, 2001, P NATL ACAD SCI USA, V98, P5850, DOI 10.1073/pnas.091110098; Eguchi M, 2007, FEMS IMMUNOL MED MIC, V50, P411, DOI 10.1111/j.1574-695X.2007.00275.x; Eguchi M, 2007, FEMS IMMUNOL MED MIC, V50, P300, DOI 10.1111/j.1574-695X.2007.00240.x; Eguchi M, 2010, J INFECT DIS, V201, P62, DOI 10.1086/648615; Eisenstein TK, 1999, INTRACELLULAR BACTERIAL VACCINE VECTORS, P51; Gulig P. A., 1996, ESCHERICHIA COLI SAL, P2774; Gulig PA, 1997, INFECT IMMUN, V65, P5191; GULIG PA, 1993, MOL MICROBIOL, V7, P825, DOI 10.1111/j.1365-2958.1993.tb01172.x; Kodama C, 2005, MICROBIOL IMMUNOL, V49, P1035; Matsui H, 2000, MICROBIOL IMMUNOL, V44, P447; Matsui H, 2001, MICROBIOL IMMUNOL, V45, P79; Matsui H, 2005, ANTIMICROB AGENTS CH, V49, P3396, DOI 10.1128/AAC.49.8.3396-3403.2005; Matsui H, 2000, MICROB PATHOGENESIS, V29, P53, DOI 10.1006/mpat.2000.0370; Scherer C. A., 2001, PRINCIPLES BACTERIAL, P265, DOI 10.1016/B978-012304220-0/50008-X	34	1	1	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	FEB	2015	77	2					181	186		10.1292/jvms.14-0013		6	Veterinary Sciences	Veterinary Sciences	CE7PL	WOS:000352033700008		
J	Takano, H; Isogai, T; Aoki, T; Wakao, Y; Fujii, Y				Takano, Hiroshi; Isogai, Tomomi; Aoki, Takuma; Wakao, Yoshito; Fujii, Yoko			Feasibility of radial and circumferential strain analysis using 2D speckle tracking echocardiography in cats	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						feline hypertrophic cardiomyopathy; left ventricle	FELINE HYPERTROPHIC CARDIOMYOPATHY; LEFT-VENTRICULAR CONTRACTION; NORMAL EJECTION FRACTION; HEALTHY CATS; 2-DIMENSIONAL STRAIN; HEART-FAILURE; MYOCARDIAL DEFORMATION; FILLING PRESSURES; HYPERTHYROIDISM; RELAXATION	The purpose of the present study is to investigate the feasibility of strain analysis using speckle tracking echocardiography (STE) in cats and to evaluate STE variables in cats with hypertrophic cardiomyopathy (HCM). Sixteen clinically healthy cats and 17 cats with HCM were used. Radial and circumferential strain and strain rate variables in healthy cats were measured using STE to assess the feasibility. Comparisons of global strain and strain variables between healthy cats and cats with HCM were performed. Segmental assessments of left ventricle (LV) wall for strain and strain rate variables in cats with HCM were also performed. As a result, technically adequate images were obtained in 97.6% of the segments for STE analysis. Sedation using buprenorphine and acepromazine did not affect any global strain nor strain rate variable. In LV segments of cats with HCM, reduced segmental radial strain and strain rate variables had significantly related with segmental LV hypertrophy. It is concluded that STE analysis using short axis images of LV appeared to be clinically feasible in cats, having the possibility to be useful for detecting myocardial dysfunctions in cats with diseased heart.	[Takano, Hiroshi; Isogai, Tomomi; Aoki, Takuma; Wakao, Yoshito; Fujii, Yoko] Azabu Univ, Sch Vet Med, Dept Surg 1, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Takano, Hiroshi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan	Takano, H (reprint author), Japan Anim Specialty Med Inst Inc JASMINE, 2-7-3 Nakagawa, Yokohama, Kanagawa 0240001, Japan.	h.takano@cardiovets.jp					Adamu U, 2009, EUR J ECHOCARDIOGR, V10, P303, DOI 10.1093/ejechocard/jen238; Abbott JA, 2006, J VET INTERN MED, V20, P111, DOI 10.1892/0891-6640(2006)20[111:TEAOTF]2.0.CO;2; Koffas H, 2006, J VET INTERN MED, V20, P65, DOI 10.1892/0891-6640(2006)20[65:PTDIIN]2.0.CO;2; Simpson KE, 2009, J FELINE MED SURG, V11, P293, DOI 10.1016/j.jfms.2008.08.003; Mizuguchi Y, 2008, J AM SOC ECHOCARDIOG, V21, P1138, DOI 10.1016/j.echo.2008.07.016; Amundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040; Martinez DA, 2003, DIABETES RES CLIN PR, V59, P1, DOI 10.1016/S0168-8227(02)00178-X; Serri K, 2006, J AM COLL CARDIOL, V47, P1175, DOI 10.1016/j.jacc.2005.10.061; Wang J, 2008, EUR HEART J, V29, P1283, DOI 10.1093/eurheartj/ehn141; Abbott JA, 2010, VET CLIN N AM-SMALL, V40, P685, DOI 10.1016/j.cvsm.2010.04.004; Garceau P, 2012, ECHOCARDIOGR-J CARD, V29, P934, DOI 10.1111/j.1540-8175.2012.01708.x; Palmieri V, 2009, EUR J ECHOCARDIOGR, V10, P745, DOI 10.1093/ejechocard/jep055; Chetboul V, 2003, J VET INTERN MED, V17, P89, DOI 10.1892/0891-6640(2003)017<0089:SFHCAE>2.3.CO;2; Okura H, 2009, CIRC-CARDIOVASC IMAG, V2, P41, DOI 10.1161/CIRCIMAGING.108.809087; Tapp RJ, 2010, J AM COLL CARDIOL, V55, P1875, DOI 10.1016/j.jacc.2009.11.084; Carasso S, 2008, J AM SOC ECHOCARDIOG, V21, P675, DOI 10.1016/j.echo.2007.10.021; Wess G, 2010, J VET INTERN MED, V24, P1375, DOI 10.1111/j.1939-1676.2010.0586.x; Popovic ZB, 2008, J AM SOC ECHOCARDIOG, V21, P1299, DOI 10.1016/j.echo.2008.09.011; Nishimura RA, 2004, NEW ENGL J MED, V350, P1320, DOI 10.1056/NEJMcp030779; Becker M, 2006, HEART, V92, P1102, DOI 10.1136/hrt.2005.077107; Chang SA, 2012, INT J CARDIOVAS IMAG, V28, P133, DOI 10.1007/s10554-012-0141-2; Phan TT, 2009, EUR J ECHOCARDIOGR, V10, P793, DOI 10.1093/ejechocard/jep072; Kim HK, 2007, J AM SOC ECHOCARDIOG, V20, P45, DOI 10.1016/j.echo.2006.07.007; Brown S, 2007, J VET INTERN MED, V21, P542, DOI 10.1892/0891-6640(2007)21[542:GFTIEA]2.0.CO;2; Paige CF, 2009, JAVMA-J AM VET MED A, V234, P1398, DOI 10.2460/javma.234.11.1398; BOND BR, 1988, J AM VET MED ASSOC, V192, P1546; Brizard D, 2009, SCHWEIZ ARCH TIERH, V151, P529, DOI 10.1024/0036-7281.151.11.529; BROUSSARD JD, 1995, J AM VET MED ASSOC, V206, P302; Cheng A, 2008, CIRCULATION, V118, P713, DOI 10.1161/CIRCULATIONAHA.107.744623; Edvardsen T, 2006, PROG CARDIOVASC DIS, V49, P207, DOI 10.1016/j.pcad.2006.08.008; Hurlburt HM, 2007, ECHOCARDIOGR-J CARD, V24, P723, DOI 10.1111/j.1540-8175.2007.00460.x; Hurty CA, 2005, J AM ANIM HOSP ASSOC, V41, P292; Kimura K, 2011, ECHOCARDIOGR-J CARD, V28, P1148, DOI 10.1111/j.1540-8175.2011.01517.x; MacDonald KA, 2006, J VET INTERN MED, V20, P627, DOI 10.1892/0891-6640(2006)20[627:TDIAGE]2.0.CO;2; Meluzin J, 2009, J AM SOC ECHOCARDIOG, V22, P486, DOI 10.1016/j.echo.2009.02.022; Meluzin J, 2011, EUR J ECHOCARDIOGR, V12, P11, DOI 10.1093/ejechocard/jeq088; Milner RJ, 2006, JAVMA-J AM VET MED A, V228, P559, DOI 10.2460/javma.228.4.559; PETERSON ME, 1990, J VET INTERN MED, V4, P192; Riesen SC, 2012, AM J VET RES, V73, P202, DOI 10.2460/ajvr.73.2.202; Riesen SC, 2012, J VET CARDIOL, V14, P323, DOI 10.1016/j.jvc.2011.11.007; Riesen SC, 2011, J VET INTERN MED, V25, P469, DOI 10.1111/j.1939-1676.2011.0705.x; Takano H, 2010, AM J VET RES, V71, P421, DOI 10.2460/ajvr.71.4.421; Takano H, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-23	43	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	FEB	2015	77	2					193	201		10.1292/jvms.13-0241		9	Veterinary Sciences	Veterinary Sciences	CE7PL	WOS:000352033700010		
J	Suto, J; Satou, K				Suto, Jun-ichi; Satou, Kunio			Further characterization of diabetes mellitus and body weight loss in males of the congenic mouse strain DDD.Cg-A(y)	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						A(y) allele; beta-cell loss; DDD.Cg-A(y) mouse; quantitative trait locus (QTL); reduced insulin level	QUANTITATIVE TRAIT LOCI; AGOUTI LOCUS; YELLOW MICE; A(Y) ALLELE; RECEPTOR; PROTEIN; MUTATIONS; OBESITY; GENE; DISRUPTION	The A(y) allele at the agouti locus causes obesity and promotes linear growth in mice. However, body weight gain stops between 16 and 17 weeks after birth, and then, body weight decreases gradually in DDD.Cg-A(y) male mice. Body weight loss is a consequence of diabetes mellitus, which is genetically controlled mainly by a quantitative trait locus (QTL) on chromosome 4. This study aimed to further characterize diabetes mellitus and body weight loss in DDD.Cg-A(y) males. The number of-cells was markedly reduced, and plasma insulin levels were very low in the DDD.Cg-4(y) males. Using a backcross progeny of DDD x (B6 x DDD.Cg-A(y)) F-1-A(y), we identified one significant QTL for plasma insulin levels on distal chromosome 4, which was coincidental with QTL for hyperglycemia and lower body weight. The DDD allele was associated with decreased plasma insulin levels. When the DDD.Cg-A(y) males were housed under three different housing conditions [group housing (4 or 5 DDD.Cg-A(y) and DDD males), individual housing (single DDD.Cg-A(y) male) and single male housing with females (single DDD.Cg-A(y) male with DDD.Cg-A(y) or DDD females)], diabetes mellitus and body weight loss were most severely expressed in individually housed mice. Thus, the severity of diabetes and body weight loss in the DDD.Cg-A(y) males was strongly influenced by the housing conditions. These results demonstrate that both genetic and nongenetic environmental factors are involved in the development of diabetes mellitus and body weight loss in the DDD.Cg-A(y) males.	[Suto, Jun-ichi] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Tsukuba, Ibaraki 3058634, Japan; [Satou, Kunio] Natl Inst Anim Hlth, Ctr Anim Dis Control & Prevent, Tsukuba, Ibaraki 3050856, Japan	Suto, J (reprint author), Natl Inst Agrobiol Sci, Agrogen Res Ctr, Tsukuba, Ibaraki 3058634, Japan.	jsuto@affrc.go.jp			NIAS	This study was supported in part by an institutional grant from NIAS.	Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; HUMMEL KP, 1972, BIOCHEM GENET, V7, P1, DOI 10.1007/BF00487005; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; COLEMAN DL, 1973, DIABETOLOGIA, V9, P287, DOI 10.1007/BF01221856; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Homo-Delarche F, 2006, DIABETES, V55, P1625, DOI 10.2337/db05-1526; Leibel RL, 1997, J BIOL CHEM, V272, P31937, DOI 10.1074/jbc.272.51.31937; MICHAUD EJ, 1994, P NATL ACAD SCI USA, V91, P2562, DOI 10.1073/pnas.91.7.2562; MICHAUD EJ, 1993, GENE DEV, V7, P1203, DOI 10.1101/gad.7.7a.1203; Suto J, 2011, J VET MED SCI, V73, P907, DOI 10.1292/jvms.10-0573; Suto J, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-35; Suto J, 2009, P JPN ACAD B-PHYS, V85, P248, DOI 10.2183/pjab.85.248	21	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	FEB	2015	77	2					203	210		10.1292/jvms.14-0351		8	Veterinary Sciences	Veterinary Sciences	CE7PL	WOS:000352033700011		
J	Hakim, H; Thammakarn, C; Suguro, A; Ishida, Y; Kawamura, A; Tamura, M; Satoh, K; Tsujimura, M; Hasegawa, T; Takehara, K				Hakim, Hakimullah; Thammakarn, Chanathip; Suguro, Atsushi; Ishida, Yuki; Kawamura, Akinobu; Tamura, Miho; Satoh, Keisuke; Tsujimura, Misato; Hasegawa, Tomomi; Takehara, Kazuaki			Evaluation of sprayed hypochlorous acid solutions for their virucidal activity against avian influenza virus through in vitro experiments	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						aerosol disinfection; avian influenza; biosecurity; hypochlorous acid solution; spray	ELECTROLYZED WATER; H5N1; SURVIVAL; INACTIVATION; INFECTION; SURFACES; BIRDS; HOUSE	Hypochlorous acid (HOCI) solutions were evaluated for their virucidal ability against a low pathogenic avian influenza virus (AIV), H7N1 HOCI solutions containing 50, 100 and 200 ppm chlorine (pH 6) or their sprayed solutions (harvested in dishes placed at 1 or 30 cm distance between the spray nozzle and dish) were mixed with the virus with or without organic materials (5% fetal bovine serum: FBS). Under plain diluent conditions (without FBS), harvested solutions of HOCI after spraying could decrease the AIV titer by more than 1,000 times, to an undetectable level (<2.5 log10TCID(50)/m/) within 5 sec, with the exception of the 50 ppm solution harvested after spraying at the distance of 30 cm. Under the dirty conditions (in the presence of 5% FBS), they lost their virucidal activity. When HOCI solutions were sprayed directly on the virus on rayon sheets for 10 sec, the solutions of 100 and 200 ppm could inactivate AIV immediately after spraying, while 50 ppm solution required at least 3 min of contact time. In the indirect spray form, after 10 sec of spraying, the lids of the dishes were opened to expose the virus on rayon sheets to HOC. In this form, the 200 ppm solution inactivated AIV within 10 min of contact, while 50 and 100 ppm could not inactivate it. These data suggest that HOCI can be used in spray form to inactivate AIV at the farm level.	[Hakim, Hakimullah; Thammakarn, Chanathip; Suguro, Atsushi; Ishida, Yuki; Kawamura, Akinobu; Tamura, Miho; Satoh, Keisuke; Tsujimura, Misato; Hasegawa, Tomomi; Takehara, Kazuaki] Tokyo Univ Agr & Technol, Fac Agr, Dept Vet Med, Hlth Anim Lab, Fuchu, Tokyo 1838509, Japan; [Hakim, Hakimullah; Thammakarn, Chanathip; Takehara, Kazuaki] Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan	Takehara, K (reprint author), Tokyo Univ Agr & Technol, Fac Agr, Dept Vet Med, Hlth Anim Lab, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	takehara@cc.tuat.ac.jp	TAKEHARA, Kazuaki/C-2361-2013	TAKEHARA, Kazuaki/0000-0001-7205-7186			Achenbach JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017643; BEAN B, 1982, J INFECT DIS, V146, P47; Zhao Y, 2014, ANN AGR ENV MED, V21, P249, DOI 10.5604/1232-1966.1108585; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; Suarez DL, 2012, AVIAN DIS, V56, P836, DOI 10.1637/10207-041512-Review.1; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650; Huang YR, 2008, FOOD CONTROL, V19, P329, DOI 10.1016/j.foodcont.2007.08.012; Jahangir A, 2010, VIRUS GENES, V40, P94, DOI 10.1007/s11262-009-0423-5; Yao ML, 2011, BERL MUNCH TIERARZTL, V124, P136, DOI 10.2376/0005-9366-124-136; Lombardi ME, 2008, AVIAN DIS, V52, P118, DOI 10.1637/8055-070907-Reg; Avellaneda G, 2010, AVIAN DIS, V54, P278, DOI 10.1637/8644-020409-Reg.1; Bieker J. M., 2005, INACTIVATION VARIOUS; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Dychdala G. R., 2001, DISINFECTION STERILI, P135; Hao XX, 2013, POULTRY SCI, V92, P2560, DOI 10.3382/ps.2013-03117; Hao XX, 2013, J APPL MICROBIOL, V115, P703, DOI 10.1111/jam.12274; HARPER G. J., 1958, JOUR HYGIENE, V56, P364; Hinds W. C., 1999, PROPERTIES BEHAV MEA; Maillard J.-Y., 1997, Science Progress, V80, P287; MATUMOTO M., 1949, JAP JOUR EXPTL MED, V20, P175; Quinn P. J., 1992, DISINFECTION STERILI, P1069; Rice EW, 2007, EMERG INFECT DIS, V13, P1568, DOI 10.3201/eid1310.070323; Sattar A. S., 1999, PRINCIPLES PRACTICE, P109; Shahid MA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-38; Shahzad MI, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-144; Shoham D, 2012, INFLUENZA RES TREAT, V2012, DOI [10.1155/2012/912326, DOI 10.1155/2012/912326]; Spickler AR, 2008, AVIAN PATHOL, V37, P555, DOI 10.1080/03079450802499118; Tiwari A, 2006, AVIAN DIS, V50, P284, DOI 10.1637/7453-101205R.1	28	1	1	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	FEB	2015	77	2					211	215		10.1292/jvms.14-0413		5	Veterinary Sciences	Veterinary Sciences	CE7PL	WOS:000352033700012		
J	Nguyen, TT; Motsiri, MS; Taioe, MO; Mtshali, MS; Goto, Y; Kawazu, SI; Thekisoe, OMM; Inoue, N				Thu-Thuy Nguyen; Motsiri, Mono Sophie; Taioe, Moeti Oriel; Mtshali, Moses Sibusiso; Goto, Yasuyuki; Kawazu, Shin-Ichiro; Thekisoe, Oriel Matlhahane Molifi; Inoue, Noboru			Application of crude and recombinant ELISAs and immunochromatographic test for serodiagnosis of animal trypanosomosis in the Umkhanyakude district of KwaZulu-Natal province, South Africa	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						animal African trypanosomosis; ELISA; immunochromatographic test; serodiagnosis; South Africa	BLOOD-STREAM FORMS; WATER-BUFFALOS; TSETSE-FLIES; CONGOLENSE; INFECTION; EVANSI; CULTIVATION; ANTIGEN; REGION; CATTLE	A total of 231 serum samples were collected from sheep (n=9), goats (n=99) and cattle (n=123) in northeastern KwaZuluNatal, South Africa. Trypanosome infection was detected using Trypanosoma brucei brucei crude antigen (TbbCA) and T congolense crude antigen (TcoCA) ELISA assays. Recombinant antigen (T evansi GM6 which consisted of 4 repeat domains, TeGM6-4r) ELISA and immunochromatographic test (ICT) were also used. Crude antigen ELISA, TeGM6-4r-ELISA and ICT detected 27.3%, 29% and 19.9% of trypanosome seropositive samples, respectively. Trypanosome infection prevalence in cattle and goats was 35.8-46.3% and 0-9.1%, respectively. Out of 9 sheep serum samples, 2-4 sera (22.2-44.4%) were positive. The detection performance of crude and recombinant antigen ELISAs was relatively similar (K=0.6-0.7); both are recommended for reference diagnosis and large scale epidemiological surveys. There is potential application for ICT in on-site diagnosis, but its sensitivity should be improved.	[Thu-Thuy Nguyen; Kawazu, Shin-Ichiro; Inoue, Noboru] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, OIE Collaborating Ctr, OIE Reference Lab Surra, Obihiro, Hokkaido 0808555, Japan; [Motsiri, Mono Sophie; Taioe, Moeti Oriel; Mtshali, Moses Sibusiso; Thekisoe, Oriel Matlhahane Molifi] Univ Orange Free State, Dept Zool & Entomol, Parasitol Res Program, ZA-9866 Phuthaditjhaba, South Africa; [Mtshali, Moses Sibusiso] Natl Zool Gardens South Africa, Res & Sci Serv Dept, Vet Parasitol Unit, ZA-0001 Pretoria, South Africa; [Goto, Yasuyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Mol Immunol, Bunkyo Ku, Tokyo 1138657, Japan	Inoue, N (reprint author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, OIE Collaborating Ctr, OIE Reference Lab Surra, Obihiro, Hokkaido 0808555, Japan.	ircpmi@obihiro.ac.jp	Goto, Yasuyuki/E-9028-2011	Goto, Yasuyuki/0000-0002-8654-7888	Japan Society for the Promotion of Science (JSPS); JST/JICA, SATREPS	This study was financially supported by the Japan Society for the Promotion of Science (JSPS), Grants-in-Aid for Scientific Research for the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and JST/JICA, SATREPS.	Viera AJ, 2005, FAM MED, V37, P360; Sow A, 2013, RES VET SCI, V94, P573, DOI 10.1016/j.rvsc.2012.12.011; Nguyen TT, 2014, VET PARASITOL, V201, P18, DOI 10.1016/j.vetpar.2014.01.009; Namangala B, 2013, AM J TROP MED HYG, V89, P116, DOI 10.4269/ajtmh.13-0078; Gillingwater K, 2010, J S AFR VET ASSOC, V81, P219; Thuy N, 2012, PARASITOL RES, V110, P733, DOI 10.1007/s00436-011-2632-9; Simo G, 2013, INFECT GENET EVOL, V18, P66, DOI 10.1016/j.meegid.2013.04.019; Goto Y, 2011, PARASITOL INT, V60, P538, DOI 10.1016/j.parint.2011.09.003; Bruce D, 1895, PRELIMINARY REPORT T; Gutierrez C, 2006, ANN NY ACAD SCI, V1081, P300, DOI 10.1196/annals.1373.040; HIRUMI H, 1991, PARASITOLOGY, V102, P225; Hirumi H, 1997, TROP MED INT HEALTH, V2, P240, DOI 10.1046/j.1365-3156.1997.d01-268.x; Kappmeier K, 1998, ONDERSTEPOORT J VET, V65, P195; Latif A., 2005, J S AFR VET ASSOC, V80, P126; Li FJ, 2005, MOL CELL PROBE, V19, P400, DOI 10.1016/j.mcp.2005.07.002; Luckins A. G., 2004, The trypanosomiases, P269, DOI 10.1079/9780851994758.0269; Mamabolo MV, 2009, PARASITOLOGY, V136, P425, DOI 10.1017/S0031182009005587; Motloang Makhosazana, 2012, Onderstepoort J Vet Res, V79, pE1, DOI 10.4102/ojvr.v79i1.353; OIE, 2012, MAN DIAGN TESTS VACC, P809; Pillay D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078565; van den Bossche P, 2006, ONDERSTEPOORT J VET, V73, P77; Verloo D, 2000, VET PARASITOL, V92, P87, DOI 10.1016/S0304-4017(00)00284-3	22	2	2	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	FEB	2015	77	2					217	220		10.1292/jvms.14-0330		4	Veterinary Sciences	Veterinary Sciences	CE7PL	WOS:000352033700013		
J	Mitake, H; Ito, N; Okadera, K; Okada, K; Nakagawa, K; Tanaka, T; Katsuragi, K; Kasahara, K; Nihongi, T; Tsunemitsu, H; Sugiyama, M				Mitake, Hiromichi; Ito, Naoto; Okadera, Kota; Okada, Kazuma; Nakagawa, Kento; Tanaka, Tomomi; Katsuragi, Kiyohito; Kasahara, Kasumi; Nihongi, Toshihide; Tsunemitsu, Hiroshi; Sugiyama, Makoto			Detection of avian-like rotavirus A VP4 from a calf in Japan	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						avian-like; cattle; rotavirus A; VP4	GROUP-A ROTAVIRUS; MAMMALIAN ROTAVIRUSES; NUCLEOTIDE-SEQUENCE; STRAINS; PORCINE; IDENTIFICATION; TRANSMISSION; GENOTYPE; DIARRHEA; BEARING	A total of 568 normal feces from calves on a beef farm in Fukui Prefecture, Japan, in 2011-2012 were examined by RT-semi-nested PCR for rotavirus A (RVA) VP4 genes. Through partial sequencing and BLAST analyses of 84 VP4-positive specimens, we identified an avian-like RVA strain, N2342, which shares highest nucleotide identity (80.0%) with known avian-like bovine strain 993/83, in one specimen. Phylogenetic analysis also revealed a close genetic relationship between N2342 and avian RVAs, suggesting bird-to-cattle transmission. We observed frequent contact of wild birds with calves in the farm, suggesting that these birds were the source of the virus.	[Mitake, Hiromichi; Ito, Naoto; Okadera, Kota; Okada, Kazuma; Nakagawa, Kento; Tsunemitsu, Hiroshi; Sugiyama, Makoto] Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan; [Ito, Naoto; Sugiyama, Makoto] Gifu Univ, Fac Appl Biol Sci, Lab Zoonot Dis, Gifu 5011193, Japan; [Tanaka, Tomomi; Katsuragi, Kiyohito; Kasahara, Kasumi; Nihongi, Toshihide] Fukui Prefectural Livestock Hyg Serv Ctr, Fukui 9188226, Japan; [Tsunemitsu, Hiroshi] Natl Inst Anim Hlth, Dairy Hyg Res Div, Sapporo, Hokkaido 0620045, Japan	Sugiyama, M (reprint author), Gifu Univ, Fac Appl Biol Sci, Lab Zoonot Dis, 1-1 Yanagido, Gifu 5011193, Japan.	sugiyama@gifu-u.ac.jp			Japan Society for the Promotion of Science [26292148]	This study was supported in part by Grant-in-Aids for Scientific Research (B) from Japan Society for the Promotion of Science (no. 26292148).	De Grazia S, 2011, INFECT GENET EVOL, V11, P1449, DOI 10.1016/j.meegid.2011.05.015; Abe M, 2009, VIRUS RES, V144, P250, DOI 10.1016/j.virusres.2009.05.005; Matthijnssens J, 2009, J VIROL, V83, P2917, DOI 10.1128/JVI.02246-08; Ito H, 2001, VIRUS RES, V75, P123, DOI 10.1016/S0168-1702(01)00234-9; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Martella V, 2006, VIROLOGY, V344, P509, DOI 10.1016/j.virol.2005.08.029; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Abe M, 2011, J GEN VIROL, V92, P952, DOI 10.1099/vir.0.028175-0; BRUSSOW H, 1992, J CLIN MICROBIOL, V30, P67; Mukherjee A, 2011, CLIN MICROBIOL INFEC, V17, P1343, DOI 10.1111/j.1469-0691.2010.03383.x; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; BRUSSOW H, 1992, J GEN VIROL, V73, P1873, DOI 10.1099/0022-1317-73-7-1873; Estes MK, 2013, FIELDS VIROLOGY, V2, P1347; Ghosh S, 2007, J CLIN MICROBIOL, V45, P2751, DOI 10.1128/JCM.00230-07; Miyazaki A, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-112; Mori Y, 2001, VIROLOGY, V288, P63, DOI 10.1006/viro.2001.1051; Rohwedder A, 1997, VIRUS GENES, V14, P147, DOI 10.1023/A:1007921418679; ROHWEDDER A, 1993, VIROLOGY, V195, P820, DOI 10.1006/viro.1993.1437; ROHWEDDER A, 1995, VIROLOGY, V210, P231, DOI 10.1006/viro.1995.1338	20	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	FEB	2015	77	2					221	224		10.1292/jvms.14-0379		4	Veterinary Sciences	Veterinary Sciences	CE7PL	WOS:000352033700014		
J	Inoue, S; Yonemaru, K; Yanai, T; Sakai, H				Inoue, Saki; Yonemaru, Kayoko; Yanai, Tosuma; Sakai, Hiroki			Mixed germ cell-sex cord-stromal tumor with a concurrent interstitial cell tumor in a ferret	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						ferret; immunohistochemistry; interstitial cell tumor; mixed germ cell-sex cord-stromal tumor; testis	GONADOBLASTOMA; DISEASES; STALLION; TESTIS; DOGS	A 5-year-old male ferret presented with an enlarged canalicular testis in the left inguinal region. Microscopically, the enlarged testis consisted of a diffuse intimately admixed proliferation of c-kit-positive germ cell-like and Wilms tumor-1 protein-positive Sertoli cell-like components, but no Call-Exner body was detected. In addition, the compact proliferation of steroidogenic acute regulatory protein-intense positive interstitial cells was identified in a separate peripheral area of the mass. Based on histopathological and immunohistochemical findings, the tumor was diagnosed as a mixed germ cell-sex cord-stromal tumor with a concurrent interstitial cell tumor.	[Inoue, Saki; Yonemaru, Kayoko; Yanai, Tosuma; Sakai, Hiroki] Gifu Univ, Fac Appl Biol Sci, Lab Vet Pathol, Gifu 5011193, Japan; [Yonemaru, Kayoko; Sakai, Hiroki] Gifu Univ, Fac Appl Biol Sci, Comparat Canc Ctr, Gifu 5011193, Japan	Sakai, H (reprint author), Gifu Univ, Fac Appl Biol Sci, Lab Vet Pathol, 1-1 Yanagido, Gifu 5011193, Japan.	shiroki@gifu-u.ac.jp					SCULLY RE, 1970, CANCER, V25, P1340, DOI 10.1002/1097-0142(197006)25:6<1340::AID-CNCR2820250612>3.0.CO;2-N; Owston MA, 2007, VET PATHOL, V44, P936, DOI 10.1354/vp.44-6-936; Li XT, 1998, J AM VET MED ASSOC, V212, P1402; CARPENTER JW, 1977, J AM VET MED ASSOC, V171, P890; Batista-Arteaga M, 2011, REPROD DOMEST ANIM, V46, P177, DOI 10.1111/j.1439-0531.2009.01567.x; Brito LFC, 2009, REPROD DOMEST ANIM, V44, P846, DOI 10.1111/j.1439-0531.2008.01090.x; CULLEN JM, 1987, VET PATHOL, V24, P575; DILLBERGER JE, 1989, J COMP PATHOL, V100, P161, DOI 10.1016/0021-9975(89)90127-8; Gentil M, 2012, CELL TISSUE RES, V350, P513, DOI 10.1007/s00441-012-1506-5; Irizarry Royira A. R., 2012, J COMP PATHOL, p[147, 204]; Kennedy P.C., 1998, HISTOLOGICAL CLASSIF; MESCHTER CL, 1989, LAB ANIM SCI, V39, P353; Miwa Y, 2009, J VET MED SCI, V71, P397, DOI 10.1292/jvms.71.397; PATNAIK AK, 1993, VET PATHOL, V30, P287; Pollack SE, 1997, J CLIN ENDOCR METAB, V82, P4243, DOI 10.1210/jc.82.12.4243; Suzuki M, 2011, J VET DIAGN INVEST, V23, P1028, DOI 10.1177/1040638711406975; Ulbright T. M., 2004, PATHOLOGY GENETICS T, P261	17	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	FEB	2015	77	2					225	228		10.1292/jvms.14-0435		4	Veterinary Sciences	Veterinary Sciences	CE7PL	WOS:000352033700015		
J	Usui, R; Okada, Y; Fukui, E; Hasegawa, A				Usui, Reiko; Okada, Yuki; Fukui, Emiko; Hasegawa, Atsuhiko			A canine case of otitis media examined and cured using a video otoscope	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						complex ceruminous adenoma; diode laser; otitis media; pseudomonas; video otoscope	EXTERNA	Otitis media of the left ear was diagnosed by video otoscopic examination in a 7-year-old, intact male Shih-tzu dog (weight, 5.1 kg), that also had three complex ceruminous adenomas and a Pseudomonas aeruginosa infection in the left ear canal. In such cases, total ear canal ablation is usually required. However, a complete cure was achieved in the present case without total ear canal ablation. The complex ceruminous adenomas were excised using a diode laser, and repeated cleansing of the tympanic cavity and ear canal was implemented using a video otoscope. As a result, the ear canal was closed in a U-form, and the otitis media was cured.	[Usui, Reiko] Usui Anim Hosp, Utsunomiya, Tochigi 3210136, Japan; [Usui, Reiko; Okada, Yuki] Nippon Vet & Life Sci Univ, Tokyo 1808602, Japan; [Fukui, Emiko] Utsunomiya Univ, Fac Agr, Lab Anim Breeding Reprod, Utsunomiya, Tochigi 3218505, Japan; [Hasegawa, Atsuhiko] Teikyo Univ Inst Med Mycol, Hachioji, Tokyo 1920395, Japan	Usui, R (reprint author), Usui Anim Hosp, 4-5 Midori No, Utsunomiya, Tochigi 3210136, Japan.	rei@u-a-h.com					Usui R, 2011, J VET MED SCI, V73, P1249, DOI 10.1292/jvms.10-0488; Smeak DD, 2011, VET CLIN N AM-SMALL, V41, P981, DOI 10.1016/j.cvsm.2011.05.011; Morris DO, 2004, VET CLIN N AM-SMALL, V34, P541, DOI 10.1016/j.cvsm.2003.10.009; Angus JC, 2001, VET CLIN N AM-SMALL, V31, P809; Cole LK, 2004, VET CLIN N AM-SMALL, V34, P397, DOI 10.1016/j.cvsm.2003.10.004; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P1003; Medleau L., 2006, SMALL ANIMAL DERMATO, P376; Papich G. M., 2011, SAUNDERS HDB VET DRU, P24; Scott D. W., 2001, MULLER KIRKS SMALL A, P127, DOI 10.1017/CBO9780511546020.010; Selimoglu E, 2007, CURR PHARM DESIGN, V13, P119, DOI 10.2174/138161207779313731; Usui R., 2009, Japanese Journal of Veterinary Dermatology, V15, P207, DOI 10.2736/jjvd.15.207	11	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	FEB	2015	77	2					237	239		10.1292/jvms.14-0072		3	Veterinary Sciences	Veterinary Sciences	CE7PL	WOS:000352033700018		
J	Ibrahim, D; Abdel-Maksoud, F; Taniguchi, K; Yamamoto, Y; Taniguchi, K; Nakamuta, N				Ibrahim, Dalia; Abdel-Maksoud, Fatma; Taniguchi, Kazumi; Yamamoto, Yoshio; Taniguchi, Kazuyuki; Nakamuta, Nobuaki			Immunohistochemical studies for the neuronal elements in the vomeronasal organ of the one-humped camel	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						olfactory system; OMP; PGP 9.5; PLC beta 2; SCCs	CHEMOSENSORY CELLS; MOUSE; COMMUNICATION; PHEROMONES; IRRITANTS; BEHAVIOR; SIGNALS; BITTER; GENES	The neuronal elements of the vomeronasal organ (VNO) of camel were investigated immunohistochemically. PGP 9.5 labeled the receptor cells in the vomeronasal sensory epithelium, but not the supporting or basal cells. OMP stained some receptor cells, but no immunoreactive signals for OMP were detected in the non-sensory epithelium. PLC beta 2 labeled scattered cells in the sensory epithelium and a larger number of cells in the non-sensory epithelium. Double labeling immunohistochemistry revealed that the PLC beta 2-positive cells were surrounded by substance P-positive nerve fibers. Collectively, these data suggest that the camel VNO bears, in addition to the mature vomeronasal receptor cells, trigeminally-innervated solitary chemosensory cells which are expected to play a substantial role in the control of stimulus access to the VNO.	[Ibrahim, Dalia; Yamamoto, Yoshio; Nakamuta, Nobuaki] Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan; [Ibrahim, Dalia] South Valley Univ, Fac Vet Med, Dept Histol, Qena 83523, Egypt; [Abdel-Maksoud, Fatma] Assiut Univ, Fac Vet Med, Dept Anat & Histol, Assiut, Egypt; [Taniguchi, Kazumi] Kitasato Univ, Sch Vet Med, Lab Vet Anat, Towada, Aomori 0348628, Japan; [Yamamoto, Yoshio; Nakamuta, Nobuaki] Iwate Univ, Fac Agr, Lab Vet Anat, Morioka, Iwate 0208550, Japan; [Taniguchi, Kazuyuki] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan	Nakamuta, N (reprint author), Iwate Univ, Fac Agr, Lab Vet Anat, 3-18-8 Ueda, Morioka, Iwate 0208550, Japan.	nakamuta@iwate-u.ac.jp					Amautovic I., 1970, ACTA ANAT, V77, P144; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; Yokosuka M, 2012, EXP ANIM TOKYO, V61, P13; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Swaney WT, 2009, BEHAV BRAIN RES, V200, P239, DOI 10.1016/j.bbr.2008.09.039; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; Gulbransen BD, 2008, J NEUROPHYSIOL, V99, P2929, DOI 10.1152/jn.00066.2008; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; He J, 2008, SCIENCE, V320, P535, DOI 10.1126/science.1154476; Zancanaro C, 1999, EUR J NEUROSCI, V11, P4473, DOI 10.1046/j.1460-9568.1999.00912.x; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; BUIAKOVA OI, 1994, GENOMICS, V20, P452, DOI 10.1006/geno.1994.1200; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Lin WH, 2008, J NEUROPHYSIOL, V99, P1451, DOI 10.1152/jn.01195.2007; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Dennis JC, 2003, J ANAT, V202, P515; JOHNSON EW, 1994, DEV BRAIN RES, V78, P259, DOI 10.1016/0165-3806(94)90034-5; Karimi H., 2013, ANAT HISTOL EMBRYOL; Kaske S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2201-8-49; Matsuda H, 1996, BRAIN RES, V712, P35; MEREDITH M, 1979, J PHYSIOL-LONDON, V286, P301; Ogura T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011924; Oikawa T, 2001, J VET MED SCI, V63, P759, DOI 10.1292/jvms.63.759; TAKAMI S, 1993, NEUROREPORT, V4, P375, DOI 10.1097/00001756-199304000-00008; Takami S, 2002, MICROSC RES TECHNIQ, V58, P228, DOI 10.1002/jemt.10094; Tizzano M, 2013, PHYSIOLOGY, V28, P51, DOI 10.1152/physiol.00035.2012; Touhara K, 2008, CURR OPIN PHARMACOL, V8, P759, DOI 10.1016/j.coph.2008.09.001	29	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	FEB	2015	77	2					241	245		10.1292/jvms.14-0424		5	Veterinary Sciences	Veterinary Sciences	CE7PL	WOS:000352033700019		
J	Suto, A; Suto, Y; Onohara, N; Tomizawa, Y; Yamamoto-Sugawara, Y; Okayama, T; Masuda, K				Suto, Akemi; Suto, Yukinori; Onohara, Nozomi; Tomizawa, Yu; Yamamoto-Sugawara, Yukiko; Okayama, Taro; Masuda, Kenichi			Food allergens inducing a lymphocyte-mediated immunological reaction in canine atopic-like dermatitis	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						canine; canine atopic-like dermatitis; food allergen; food allergy; lymphocyte	PROLIFERATIVE RESPONSES; CROSS-REACTIVITY; DOGS; HYPERSENSITIVITY; PREVALENCE	Canine atopic-like dermatitis (ALD) is suspected to be associated with food allergies, particularly those mediated by lymphocytes. In this study, 54 cases were included as ALD dogs, based on the negative IgE test results. In the dogs, the percentage of activated cells in helper-T lymphocytes was measured by flow cytometry using cultured peripheral lymphocytes under food allergen stimulation. We observed that 49 of the 54 ALD dogs (90.7%) had positive lymphocyte reactions against one or more food allergens. The most common food allergen was soybean, showing positive results in 21 dogs (42.9%), while the allergen to cause the lowest number of reactions was catfish (only 5 dogs, 10.2%). These results may be useful in considering elimination diets for ALD dogs.	[Suto, Akemi; Suto, Yukinori; Onohara, Nozomi; Tomizawa, Yu] Suto Anim Hosp, Urayasu, Chiba 2790041, Japan; [Yamamoto-Sugawara, Yukiko; Okayama, Taro; Masuda, Kenichi] Anim Allergy Clin Lab Inc, Midori Ku, Sagamihara, Kanagawa 2520131, Japan	Masuda, K (reprint author), Anim Allergy Clin Lab Inc, Midori Ku, SIC-2 301,5-4-30 Nishihashimoto, Sagamihara, Kanagawa 2520131, Japan.	masuda@aacl.co.jp					Halliwell R, 2006, VET IMMUNOL IMMUNOP, V114, P207, DOI 10.1016/j.vetimm.2006.08.013; DeBoer DJ, 2001, VET IMMUNOL IMMUNOP, V81, P271, DOI 10.1016/S0165-2427(01)00312-9; Fujimura M, 2011, J VET MED SCI, V73, P1309, DOI 10.1292/jvms.10-0410; Ishida R, 2004, J VET INTERN MED, V18, P25, DOI 10.1892/0891-6640(2004)18<25:LBRTIF>2.0.CO;2; Jahn-Schmid B, 2005, J ALLERGY CLIN IMMUN, V116, P213, DOI 10.1016/j.jaci.2005.04.019; Kawano K, 2013, POL J VET SCI, V16, P735, DOI 10.2478/pjvs-2013-0104; MCCRORY WW, 1986, KIDNEY INT, V30, P592, DOI 10.1038/ki.1986.226; Okayama T, 2011, VET IMMUNOL IMMUNOP, V139, P99, DOI 10.1016/j.vetimm.2010.09.002; Olivry T, 2010, VET DERMATOL, V21, P123, DOI 10.1111/j.1365-3164.2009.00776.x; Olivry T, 2007, J VET MED SCI, V69, P1025, DOI 10.1292/jvms.69.1025; Perez-Gordo M, 2011, CLIN EXP ALLERGY, V41, P750, DOI 10.1111/j.1365-2222.2011.03721.x; Proverbio D, 2010, J SMALL ANIM PRACT, V51, P370, DOI 10.1111/j.1748-5827.2010.00951.x; Salzmann CA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-37	13	1	1	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	FEB	2015	77	2					251	254		10.1292/jvms.14-0406		4	Veterinary Sciences	Veterinary Sciences	CE7PL	WOS:000352033700021		
J	Hirose, N; Uchida, K; Matsunaga, S; Chambers, JK; Nakayama, H				Hirose, Naoki; Uchida, Kazuyuki; Matsunaga, Satoru; Chambers, James Kenn; Nakayama, Hiroyuki			Expression of cell adhesion molecules in canine choroid plexus tumors	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						beta-catenin; cadherin; canine; choroid plexus tumor; immunohistochemistry	PRIMARY BRAIN-TUMORS; E-CADHERIN; MENINGEAL CARCINOMATOSIS; CYTOPLASMIC DOMAIN; BETA-CATENIN; DOG; PAPILLOMA; PROTEIN; SIGNS	Choroid plexus tumor (CPT) is a primary intracranial neoplasm of the choroid plexus epithelium in the central nervous system. In the current World Health Organization classification, CPT is classified into two categories; choroid plexus papilloma (CPP) and carcinoma (CPC). In the present study, we investigated immunohistochemical expressions of N-cadherin, E-cadherin and beta-catenin in 5 canine CPT cases (I disseminated CPC, 2 CPCs and 2 CPPs). One CPP case was positive for N-cadherin and beta-catenin, but negative for E-cadherin. The disseminated CPC case was positive for E-cadherin and beta-catenin, but negative for N-cadherin. The other cases were positive for the three molecules examined. These results suggest that loss of the N-cadherin expression might associate with the spreading of CPC cells. KEY WORDS: beta-catenin, cadherin, canine, choroid plexus tumor, immunohistochemistry	[Hirose, Naoki; Uchida, Kazuyuki; Chambers, James Kenn; Nakayama, Hiroyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Tokyo 1138657, Japan; [Matsunaga, Satoru] Japan Anim Referral Med Ctr, Takatsu Ku, Kawasaki, Kanagawa 2130032, Japan	Uchida, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Tokyo 1138657, Japan.	auchidak@mail.ece.u-tokyo.ac.jp					Thomas WB, 1996, VET RADIOL ULTRASOUN, V37, P20, DOI 10.1111/j.1740-8261.1996.tb00807.x; CHENIER M, 1983, J AM VET MED ASSOC, V182, P66; Ide T, 2010, VET PATHOL, V47, P741, DOI 10.1177/0300985810363486; WILSON RB, 1989, J COMP PATHOL, V100, P323, DOI 10.1016/0021-9975(89)90110-2; Cantile C, 2002, J COMP PATHOL, V126, P183, DOI 10.1053/jcpa.2002.0544; RIBAS JL, 1989, VET PATHOL, V26, P55; TURREL JM, 1986, J AM VET MED ASSOC, V188, P851; Pastorello A, 2010, VET CLIN PATH, V39, P505, DOI 10.1111/j.1939-165X.2010.00270.x; KURTZ HJ, 1971, VET PATHOL, V8, P91; Snyder JM, 2006, J VET INTERN MED, V20, P669, DOI 10.1892/0891-6640(2006)20[669:CIPNC]2.0.CO;2; Lipsitz D, 1999, VET RADIOL ULTRASOUN, V40, P246, DOI 10.1111/j.1740-8261.1999.tb00356.x; OHASHI F, 1993, J VET MED SCI, V55, P875; Westworth DR, 2008, J VET INTERN MED, V22, P1157, DOI 10.1111/j.1939-1676.2008.0170.x; OZAWA M, 1989, EMBO J, V8, P1711; Kraft SL, 1997, J VET INTERN MED, V11, P218; Buendia AJ, 2013, VET PATHOL, V51, P755; COTCHIN E, 1953, J PATHOL BACTERIOL, V65, P257, DOI 10.1002/path.1700650128; HAMMER AS, 1990, J SMALL ANIM PRACT, V31, P341, DOI 10.1111/j.1748-5827.1990.tb00826.x; HATTA K, 1985, P NATL ACAD SCI USA, V82, P2789, DOI 10.1073/pnas.82.9.2789; Ide T, 2011, VET PATHOL, V48, P292, DOI 10.1177/0300985810389312; INDRIERI RJ, 1980, J AM ANIM HOSP ASSOC, V16, P263; Koestner A., 2002, TUMORS DOMESTIC ANIM, P709; Koestner A., 1999, HISTOLOGICAL CLASSIF, P23; LOOMIS LN, 1964, BRIT VET J, V120, P336; MILKS H. J., 1936, Cornell Veterinarian, V26, P159; NAGAFUCHI A, 1989, CELL REGUL, V1, P37; NASHOLD BS, 1961, J NEUROSURG, V18, P250, DOI 10.3171/jns.1961.18.2.0250; Nentwig A, 2012, J VET DIAGN INVEST, V24, P14, DOI 10.1177/1040638711425940; PALMER AC, 1974, J SMALL ANIM PRACT, V15, P359, DOI 10.1111/j.1748-5827.1974.tb06512.x; PATNAIK AK, 1980, VET PATHOL, V17, P381; Restucci B, 2009, ANTICANCER RES, V29, P2919; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; YOSHIDA C, 1982, CELL, V28, P217, DOI 10.1016/0092-8674(82)90339-7; ZAKI FA, 1974, J AM VET MED ASSOC, V164, P1195; ZAKI FA, 1980, J AM VET MED ASSOC, V176, P328	35	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	FEB	2015	77	2					255	259		10.1292/jvms.14-0381		5	Veterinary Sciences	Veterinary Sciences	CE7PL	WOS:000352033700022		
J	Takayasu, M; Hamamoto, K; Satoh, H; Ichijo, T; Takahashi, T; Furuhama, K				Takayasu, Mariko; Hamamoto, Kouko; Satoh, Hiroshi; Ichijo, Toshihiro; Takahashi, Toru; Furuhama, Kazuhisa			Pharmacokinetics of metoclopramide in calves with renal dysfunction	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						calf; glomerular filtration rate; metoclopramide; renal dysfunction	GLOMERULAR-FILTRATION-RATE; CATTLE; IODIXANOL; MOTILITY	To clarify the effect of renal dysfunction on pharmacokinetics of the prokinetic agent metoclopramide (MCP), we administered intravenously 0.4 mg/kg MCP to healthy calves and calves subjected to right kidney vessel ligation (ligation) without or with a subsequent left nephrectomy (ligation plus removal). Plasma MCP concentration, glomerular filtration rate (GFR) and plasma prolactin level were measured by liquid chromatography-tandem mass spectrometry, simplified equation using iodixanol and enzyme-linked immunosorbent assay, respectively. Only in calves with ligation plus removal, plasma MCP concentrations were increased significantly 6, 8 and 12 hr after injection, showing that a negative correlation was observed between the plasma MCP concentrations and GFR value. A tendency to increase in plasma PRL concentration was noted also in these calves. In conclusions, plasma MCP concentrations depend on the GFR mode in calves, and its critical GFR value was estimated.	[Takayasu, Mariko; Satoh, Hiroshi; Ichijo, Toshihiro; Takahashi, Toru; Furuhama, Kazuhisa] Iwate Univ, Cooperat Dept Vet Med, Morioka, Iwate 0208550, Japan; [Hamamoto, Kouko] Minist Agr Forestry & Fisheries, Natl Vet Assay Lab, Kokubunji, Tokyo 1858511, Japan	Furuhama, K (reprint author), Iwate Univ, Cooperat Dept Vet Med, 3-18-8 Ueda, Morioka, Iwate 0208550, Japan.	furuhama@iwate-u.ac.jp					Ahmadzadeh A, 2006, J DAIRY SCI, V89, P2051; Katayama R, 2010, J PHARMACOL TOX MET, V61, P59, DOI 10.1016/j.vascn.2009.10.002; Briejer MR, 1995, PHARMACOL REV, V47, P631; Hamamoto K, 2013, J VET MED SCI, V75, P509, DOI 10.1292/jvms.12-0220; Imai K, 2012, VET J, V193, P174, DOI 10.1016/j.tvjl.2011.10.002; Imai K, 2011, J VET MED SCI, V73, P1625, DOI 10.1292/jvms.11-0252; JONES RD, 1994, J VET PHARMACOL THER, V17, P141, DOI 10.1111/j.1365-2885.1994.tb00224.x; LIPHAM LB, 1992, J VET PHARMACOL THER, V15, P78, DOI 10.1111/j.1365-2885.1992.tb00989.x; National Kidney Foundation, 2002, AM J KIDNEY DIS, V39, pS76; Pasricha PJ, 2006, GOODMAN GILMANS PHAR, P983; ROUSSEL AJ, 1994, AM J VET RES, V55, P111	11	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	FEB	2015	77	2					261	263		10.1292/jvms.14-0301		3	Veterinary Sciences	Veterinary Sciences	CE7PL	WOS:000352033700023		
J	Fryer, LK				Fryer, Luke K.			Predicting self-concept, interest and achievement for first-year students: The seeds of lifelong learning	LEARNING AND INDIVIDUAL DIFFERENCES			English	Article						Reciprocal modeling; Interest; Self-concept	GOAL CONTENTS; ACADEMIC-ACHIEVEMENT; INTRINSIC GOAL; MOTIVATION; PERFORMANCE; AUTONOMY; MODEL; INSTRUMENTALITY; EFFICACY; FUTURE	After achievement, academic self-concept and interest are essential learning outcomes in the transition to higher education and then lifelong learning. The current study examines self-concept, instrumental goals, interest and three types of achievement in the context of English language learning at one Japanese university. First-year students (n = 381) from seven departments participated in a yearlong study, completing surveys at three time points. Course grade, pre-post standardized English language proficiency tests and a final vocabulary test were also included in modeling. The self-concept and proficiency students come to university with play a substantial role in their future motivation and achievement. Distal internally regulated goals had the overall largest predictive effect on future personal interest A small/moderate predictive gender effect on self-concept, prior ability and distal internally regulated goals was also observed, Male students are entering university at a distinct disadvantage to female students, a trend widely observed throughout formal education. Implications for practice are discussed. (C) 2015 Elsevier Inc. All rights reserved.	Kyushu Sangyo Univ, Language Educ & Res Ctr, Higashi Ku, Fukuoka 8138503, Japan	Fryer, LK (reprint author), Kyushu Sangyo Univ, Language Educ & Res Ctr, Higashi Ku, 3-1 Matsukadai 2 Chome, Fukuoka 8138503, Japan.	lukefryer@yahoo.com					Brophy J, 1999, EDUC PSYCHOL, V34, P75, DOI 10.1207/s15326985ep3402_1; Vansteenkiste M, 2004, J EDUC PSYCHOL, V96, P755, DOI 10.1037/0022-0663.96.4.755; SHAVELSON RJ, 1976, REV EDUC RES, V46, P407, DOI 10.3102/00346543046003407; Murayama K, 2009, J EDUC PSYCHOL, V101, P432, DOI 10.1037/a0014221; MCDONALD RP, 1990, PSYCHOL BULL, V107, P247, DOI 10.1037//0033-2909.107.2.247; Marsh HW, 2008, PERS SOC PSYCHOL B, V34, P542, DOI 10.1177/0146167207312313; ZIMMERMAN BJ, 1992, AM EDUC RES J, V29, P663, DOI 10.3102/00028312029003663; HIDI S, 1990, REV EDUC RES, V60, P549, DOI 10.3102/00346543060004549; Simons J, 2004, BRIT J EDUC PSYCHOL, V74, P343, DOI 10.1348/0007099041552314; Koller O, 2001, J RES MATH EDUC, V32, P448, DOI 10.2307/749801; Brophy J, 2008, EDUC PSYCHOL-US, V43, P132, DOI 10.1080/00461520701756511; Hidi S, 2006, EDUC PSYCHOL, V41, P111, DOI 10.1207/s15326985ep4102_4; Husman J, 1999, EDUC PSYCHOL, V34, P113, DOI 10.1207/s15326985ep3402_4; Zimmerman BJ, 2000, CONTEMP EDUC PSYCHOL, V25, P82, DOI 10.1006/ceps.1999.1016; Pascarella ET, 2004, J HIGH EDUC, V75, P249, DOI 10.1353/jhe.2004.0016; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037//0003-066X.55.1.68; Peterson RA, 2005, J APPL PSYCHOL, V90, P175, DOI 10.1037/0021-9010.90.1.175; Vansteenkiste M, 2004, J PERS SOC PSYCHOL, V87, P246, DOI 10.1037/0022-3514.87.2.246; Lens W, 2002, ADOLESCENCE EDUC, P221; Marsh HW, 2011, BRIT J EDUC PSYCHOL, V81, P59, DOI 10.1348/000709910X503501; Sheldon KM, 2004, PERS SOC PSYCHOL B, V30, P475, DOI 10.1177/0146167203261883; Meece JL, 2006, J SCHOOL PSYCHOL, V44, P351, DOI 10.1016/j.jsp.2006.04.004; Vansteenkiste M, 2006, EDUC PSYCHOL, V41, P19, DOI 10.1207/s15326985ep4101_4; Marsh HW, 1997, AM EDUC RES J, V34, P691; Worthington RL, 2006, COUNS PSYCHOL, V34, P806, DOI 10.1177/001100006288127; Luftenegger M, 2012, LEARN INSTR, V22, P27, DOI 10.1016/j.learninstruc.2011.06.001; AMES C, 1992, J EDUC PSYCHOL, V84, P261, DOI 10.1037//0022-0663.84.3.261; Denissen JJA, 2007, CHILD DEV, V78, P430, DOI 10.1111/j.1467-8624.2007.01007.x; Marsh HW, 2005, CHILD DEV, V76, P397, DOI 10.1111/j.1467-8624.2005.00853.x; Marsh HW, 2006, PERSPECT PSYCHOL SCI, V1, P133, DOI 10.1111/j.1745-6916.2006.00010.x; Briggs A. R. J., 2012, QUALITY HIGHER ED, V18, P3; BROWNE MW, 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Cohen J., 1988, STAT POWER ANAL BEHA; Deci E. L., 1985, INTRINSIC MOTIVATION; DeVellis R. F., 2012, SCALE DEV THEORY APP; Fryer L. K, 2014, BRIT J ED PSYCHOL; Fryer L. K., 2010, JAP ASS LANG TEACH N; Fryer L. K., 2013, INNOVATION LANGUAGE; Fryer L. K, 2013, MOTIVATED STUDY LEAR; HANSFORD BC, 1982, REV EDUC RES, V52, P123, DOI 10.3102/00346543052001123; Hattie JAC, 2009, VISIBLE LEARNING: A SYNTHESIS OF OVER 800 META-ANALYSES RELATING TO ACHIEVEMENT, P1; Ichihara M., 2004, TSUKUBA PSYCHOL RES, V27, P43; KASSER T, 1993, J PERS SOC PSYCHOL, V65, P410, DOI 10.1037//0022-3514.65.2.410; Marsh H. W., 1996, HDB SELF CONCEPT, P38; Mau W.-C., 2001, EDUC PSYCHOL, V21, P133, DOI [10.1080/01443410020043832, DOI 10.1080/01443410020043832]; Musser T., 2012, ARE MEN NEW AT RISK; Muthen L., 1998, MPLUS USERS GUIDE; Rosenberg M., 1965, SOC ADOLESCENT SELF; Ryan R. M., 1996, PSYCHOL ACTION LINKI, P7; SAS, 2007, JMP VERS 9 01; SCHUNK DH, 1991, EDUC PSYCHOL, V26, P207, DOI 10.1207/s15326985ep2603&4_2; Simons J, 2000, BRIT J PSYCHOL, V91, P335, DOI 10.1348/000712600161862; Stewart J., 2013, JACET J, V51, P51; Stewart J., 2012, SHIKEN RES B, V16; Vansteenkiste M., 2009, THEORY RES ED, V7, P155, DOI [10.1177/1477878509104320, DOI 10.1177/1477878509104320]; Vansteenkiste M, 2004, J SPORT EXERCISE PSY, V26, P232; Vansteenkiste M, 2005, CHILD DEV, V76, P483, DOI 10.1111/j.1467-8624.2005.00858.x; Voyer D, 2014, PSYCHOL BULL, V140, P1174, DOI 10.1037/a0036620	58	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1041-6080	1873-3425		LEARN INDIVID DIFFER	Learn. Individ. Differ.	FEB	2015	38						107	114		10.1016/j.lindif.2015.01.007		8	Psychology, Educational	Psychology	CE7SB	WOS:000352041000014		
J	Smith, KF; Abbott, CL; Saito, Y; Fidler, AE				Smith, Kirsty F.; Abbott, Cathryn L.; Saito, Yasunori; Fidler, Andrew E.			Comparison of whole mitochondrial genome sequences from two clades of the invasive ascidian, Didemnum vexillum	MARINE GENOMICS			English	Article						Functional genes; Mitochondrial protein-coding genes; Divergence; Speciation; Invasive species; Mitogenome	CYTOCHROME-C-OXIDASE; TRANSFER-RNA GENES; DROSOPHILA-SIMULANS; MOLECULAR EVOLUTION; POPULATION-GENETICS; THERMAL SENSITIVITY; DNA-SEQUENCE; ADAPTATION; SELECTION; MITOGENOMICS	The mitochondria are the main source of cellular energy production and have an important role in development, fertility, and thermal limitations. Adaptive mitochondrial DNA mutations have the potential to be of great importance in determining aspects of the life history of an organism. Phylogenetic analyses of the globally invasive marine ascidian Didemnum vexillum using the mitochondrial cytochrome c oxidase 1 (COX1) coding region, revealed two distinct clades. Representatives of one clade (denoted by 'B') are geographically restricted to D. vexillum's native region (north-west Pacific Ocean, including Japan), whereas members of the other clade (denoted by 'A') have been introduced and become invasive in temperate coastal areas around the world. Persistence of clade B's restricted distribution may reflect it being inherently less invasive than clade A. To investigate this we sought to determine if the two clades differ significantly in other mitochondrial genes of functional significance, specifically, alterations in amino acids encoded in mitochondrial enzyme subunits. Differences in functional mitochondrial genes could indicate an increased ability for clade A colonies to tolerate a wider range of environmental temperature. Full mitochondrial genomic sequences from D. vexillum clades A and B were obtained and they predict significant sequence differences in genes encoding for enzymes involved in oxidative phosphorylation. Diversity levels were relatively high and showed divergence across almost all genes, with p-distance values between the two clades indicating recent divergence. Both clades showed an excess of rare variants, which is consistent with balancing selection or a recent population expansion. Results presented here will inform future research focusing on examining the functional properties of the corresponding mitochondria( respiration enzymes, of A and B clade enzymes. By comparing closely related taxa that have differing distributions it is possible to identify genes and phenotypes suited to particular environments. The examination of mitochondrial genotypes, and associated enzyme functioning, across populations may aid in our understanding of thermal tolerance and environmental adaptation. (C) 2014 Elsevier B.V. All rights reserved.	[Smith, Kirsty F.; Saito, Yasunori] Univ Tsukuba, Shimoda Marine Res Ctr, Shimoda City, Shizuoka 4150025, Japan; [Smith, Kirsty F.; Fidler, Andrew E.] Cawthron Inst, Nelson 7042, New Zealand; [Abbott, Cathryn L.] Fisheries & Oceans Canada, Biol Stn, Nanaimo, BC V9T 6N7, Canada; [Fidler, Andrew E.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand; [Fidler, Andrew E.] Univ Auckland, Inst Marine Sci, Auckland 1142, New Zealand	Smith, KF (reprint author), Cawthron Inst, Private Bag 2, Nelson 7042, New Zealand.	kirsty.smith@cawthron.org.nz	Abbott, Cathryn/O-2066-2015		Japan Society for the Promotion of Science; New Zealand Ministry of Business, Innovation and Employment (MBIE) [CAWX0802]; National Institute of Water and Atmospheric Research (NIWA) Coasts and Oceans Research Programme 4 - Marine Biosecurity [2012/13 SCI]	The authors would like to thank the staff at the Shimoda Marine Research Center (University of Tsukuba), the Shizugawa Nature Center, Misaki Marine Biological Station (University of Tokyo), the Sugashima Marine Biological Laboratory (Nagoya University), and the Asamushi Research Center for Marine Biology (Tohoku University) for their assistance with the sample collection in Japan. This research was funded by a Japan Society for the Promotion of Science post-doctoral fellowship to KFS, the New Zealand Ministry of Business, Innovation and Employment (MBIE) (contract CAWX0802), and the National Institute of Water and Atmospheric Research (NIWA) Coasts and Oceans Research Programme 4 - Marine Biosecurity (2012/13 SCI).	Abbott CL, 2011, CONSERV GENET RESOUR, V3, P79, DOI 10.1007/s12686-010-9294-2; Lee CE, 2011, EVOLUTION, V65, P2229, DOI 10.1111/j.1558-5646.2011.01308.x; Balloux F, 2009, P R SOC B, V276, P3447, DOI 10.1098/rspb.2009.0752; Ballard JWO, 2010, MOL ECOL, V19, P1523, DOI 10.1111/j.1365-294X.2010.04594.x; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Pichaud N, 2011, AM J PHYSIOL-REG I, V301, pR48, DOI 10.1152/ajpregu.00542.2010; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1035, DOI 10.1038/nbt0804-1035; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Foote AD, 2011, BIOL LETTERS, V7, P116, DOI 10.1098/rsbl.2010.0638; Rand DM, 2001, ANNU REV ECOL SYST, V32, P415, DOI 10.1146/annurev.ecolsys.32.081501.114109; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Pichaud N, 2012, EVOLUTION, V66, P3189, DOI 10.1111/j.1558-5646.2012.01683.x; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Ballard JWO, 2014, FUNCT ECOL, V28, P218, DOI 10.1111/1365-2435.12177; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Stefaniak L, 2012, J EXP MAR BIOL ECOL, V422, P64, DOI 10.1016/j.jembe.2012.04.012; Ballard JWO, 2007, EVOLUTION, V61, P1735, DOI 10.1111/j.1558-5646.2007.00133.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Dalziel AC, 2006, J MOL EVOL, V62, P319, DOI 10.1007/s00239-005-0110-7; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Lee CE, 2000, EVOLUTION, V54, P2014, DOI 10.1111/j.0014-3820.2000.tb01245.x; Ballard JWO, 2005, ANNU REV ECOL EVOL S, V36, P621, DOI 10.1146/annurev.ecolsys.36.091704.175513; TAJIMA F, 1989, GENETICS, V123, P585; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Pichaud N, 2010, J EXP BIOL, V213, P1665, DOI 10.1242/jeb.040261; Bock DG, 2012, P ROY SOC B-BIOL SCI, V279, P2377, DOI 10.1098/rspb.2011.2610; Lee CE, 2008, EVOL APPL, V1, P427, DOI 10.1111/j.1752-4571.2008.00039.x; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Jacobsen MW, 2012, MOL ECOL, V21, P2727, DOI 10.1111/j.1365-294X.2012.05561.x; Griggio F, 2014, GENOME BIOL EVOL, V6, P591, DOI 10.1093/gbe/evu041; Fields PA, 2012, J EXP BIOL, V215, P1106, DOI 10.1242/jeb.062273; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo YJ, 2008, MITOCHONDRION, V8, P352, DOI 10.1016/j.mito.2008.07.005; Bar-Yaacov D, 2012, BBA-GENE REGUL MECH, V1819, P1107, DOI 10.1016/j.bbagrm.2011.10.008; Shamblin BM, 2012, MOL ECOL, V21, P2330, DOI 10.1111/j.1365-294X.2012.05530.x; Mishmar D, 2006, GENE, V378, P11, DOI 10.1016/j.gene.2006.03.015; Valentine PC, 2007, J EXP MAR BIOL ECOL, V342, P179, DOI 10.1016/j.jembe.2006.10.038; Ferretti L, 2013, MOL ECOL, V22, P5561, DOI 10.1111/mec.12522; Rubinstein ND, 2013, GENOME BIOL EVOL, V5, P1185, DOI 10.1093/gbe/evt081; Tsutsui ND, 2001, EVOLUTION, V55, P976, DOI 10.1554/0014-3820(2001)055[0976:PGACSO]2.0.CO;2; Gershoni M, 2009, BIOESSAYS, V31, P642, DOI 10.1002/bies.200800139; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Scott GR, 2011, MOL BIOL EVOL, V28, P351, DOI 10.1093/molbev/msq205; Cheviron ZA, 2012, HEREDITY, V108, P354, DOI 10.1038/hdy.2011.85; Somero GN, 2012, ANNU REV MAR SCI, V4, P39, DOI 10.1146/annurev-marine-120710-100935; Bennett A.F., 1996, ANIMALS TEMPERATURE; Boore JL, 2008, PHILOS T R SOC B, V363, P1445, DOI 10.1098/rstb.2007.2234; Denny CM, 2008, ICES J MAR SCI, V65, P805, DOI 10.1093/icesjms/fsn039; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Drummond A.J., 2011, GENEIOUS V5 4; DURRHEIM GA, 1993, NUCLEIC ACIDS RES, V21, P3587, DOI 10.1093/nar/21.15.3587; Evans ML, 2012, J EVOLUTION BIOL, V25, P1823, DOI 10.1111/j.1420-9101.2012.02570.x; Gissi C, 2010, MOL BIOL EVOL, V27, P211, DOI 10.1093/molbev/msp234; Heller R, 2012, MOL ECOL, V21, P3947, DOI 10.1111/j.1365-294X.2012.05671.x; Iannelli F., 2007, TRENDS GENET, V23, P419; Kofler R., 2011, BIOINFORMATICS, V27, P3435; Kofler R., 2011, PLOS ONE, V6; Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012; Lambert Gretchen, 2009, Aquatic Invasions, V4, P5, DOI 10.3391/ai.2009.4.1.2; Lee CE, 2012, J EVOLUTION BIOL, V25, P625, DOI 10.1111/j.1420-9101.2012.02459.x; Martinez-Fernandez M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-356; Minchin Dan, 2006, Aquatic Invasions, V1, P143; Singh TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-534; Smith KF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030473; Smith K.F., 2012, USE GENETIC METHODS; Sorte C.J.B., 2011, PLOS ONE, V6; Stach T, 2010, MOL PHYLOGENET EVOL, V55, P860, DOI 10.1016/j.ympev.2010.03.011; Stefaniak Lauren, 2009, Aquatic Invasions, V4, P29, DOI 10.3391/ai.2009.4.1.3; Stern RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013991; Tsagkogeorga G, 2012, GENOME BIOL EVOL, V4, P852, DOI 10.1093/gbe/evs054; Watanabe Yoh-ichi, 2014, Frontiers in Genetics, V5, DOI 10.3389/fgene.2014.00109; Winkler G, 2008, MOL ECOL, V17, P415, DOI 10.1111/j.1365-294X.2007.03480.x; Yokobori S, 1999, GENETICS, V153, P1851; YOKOBORI S, 1993, J MOL EVOL, V36, P1, DOI 10.1007/BF02407301; Zhang ZY, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2758	83	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-7787	1876-7478		MAR GENOM	Mar. Genom.	FEB	2015	19						75	83		10.1016/j.margen.2014.11.007		9	Genetics & Heredity; Marine & Freshwater Biology	Genetics & Heredity; Marine & Freshwater Biology	CE2OT	WOS:000351655600014		
J	Wei, QS; Mukaida, M; Kirihara, K; Naitoh, Y; Ishida, T				Wei, Qingshuo; Mukaida, Masakazu; Kirihara, Kazuhiro; Naitoh, Yasuhisa; Ishida, Takao			Recent Progress on PEDOT-Based Thermoelectric Materials	MATERIALS			English	Review							SEEBECK COEFFICIENT; THIN-FILMS; THERMAL-CONDUCTIVITY; POLYMER COMPOSITES; POWER FACTORS; POLY(3,4-ETHYLENEDIOXYTHIOPHENE); ENHANCEMENT; PSS; PERFORMANCE; REDUCTION	The thermoelectric properties of poly(3,4-ethylenedioxythiophene) (PEDOT)-based materials have attracted attention recently because of their remarkable electrical conductivity, power factor, and figure of merit. In this review, we summarize recent efforts toward improving the thermoelectric properties of PEDOT-based materials. We also discuss thermoelectric measurement techniques and several unsolved problems with the PEDOT system such as the effect of water absorption from the air and the anisotropic thermoelectric properties. In the last part, we describe our work on improving the power output of thermoelectric modules by using PEDOT, and we outline the potential applications of polymer thermoelectric generators.	[Wei, Qingshuo; Mukaida, Masakazu; Kirihara, Kazuhiro; Naitoh, Yasuhisa; Ishida, Takao] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki 3058564, Japan	Ishida, T (reprint author), Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, 1-2-1 Namiki, Tsukuba, Ibaraki 3058564, Japan.	qingshuo.wei@aist.go.jp; mskz.mukaida@aist.go.jp; kz-kirihara@aist.go.jp; ys-naitou@aist.go.jp; t-ishida@aist.go.jp	Wei, Qingshuo/A-1916-2010		TherMAT, Future Pioneering Projects of the Ministry of Economy, Trade and Industry, Japan; MEXT, Japan [25888025]	Our work presented in this review was supported by TherMAT, Future Pioneering Projects of the Ministry of Economy, Trade and Industry, Japan. Some of our work was also supported by a Grant-in-Aid for Research Activity Start-up 25888025 from MEXT, Japan.	Liu CC, 2011, J ELECTRON MATER, V40, P948, DOI 10.1007/s11664-010-1465-0; Culebras M, 2014, J MATER CHEM A, V2, P10109, DOI 10.1039/c4ta01012d; PARKER WJ, 1961, J APPL PHYS, V32, P1679, DOI 10.1063/1.1728417; Matiko JW, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/1/012002; Fabretto M, 2008, MACROMOL RAPID COMM, V29, P1403, DOI 10.1002/marc.200800270; Wang YY, 2011, ACS APPL MATER INTER, V3, P1163, DOI 10.1021/am101287w; Park T, 2013, ENERG ENVIRON SCI, V6, P788, DOI 10.1039/c3ee23729j; Aich RB, 2009, CHEM MATER, V21, P751, DOI 10.1021/cm8031175; Park GO, 2014, THIN SOLID FILMS, V566, P14, DOI 10.1016/j.tsf.2014.07.011; Yoshida A, 2014, J ELECTRON MATER, V43, P1492, DOI 10.1007/s11664-013-2745-2; Bubnova O, 2011, NAT MATER, V10, P429, DOI [10.1038/nmat3012, 10.1038/NMAT3012]; Mua Y, 1996, J ELECTROCHEM SOC, V143, P2558, DOI 10.1149/1.1837047; Chang KC, 2009, J ELECTRON MATER, V38, P1182, DOI 10.1007/s11664-009-0821-4; Xia YJ, 2012, ADV MATER, V24, P2436, DOI 10.1002/adma.201104795; Cho B, 2014, NANO LETT, V14, P3321, DOI 10.1021/nl500748y; Wei QS, 2013, ADV MATER, V25, P2831, DOI 10.1002/adma.201205158; POHL HA, 1962, J PHYS CHEM-US, V66, P2085, DOI 10.1021/j100817a004; Zhang B, 2010, ACS APPL MATER INTER, V2, P3170, DOI 10.1021/am100654p; McGrail BT, 2015, ANGEW CHEM INT EDIT, V54, P1710, DOI 10.1002/anie.201408431; Jiang QL, 2014, J POLYM SCI POL PHYS, V52, P737, DOI 10.1002/polb.23482; Kim GH, 2013, NAT MATER, V12, P719, DOI [10.1038/nmat3635, 10.1038/NMAT3635]; Bubnova O, 2014, NAT MATER, V13, P190, DOI [10.1038/nmat3824, 10.1038/NMAT3824]; HEYWANG G, 1992, ADV MATER, V4, P116, DOI 10.1002/adma.19920040213; Fabretto M, 2011, POLYMER, V52, P1725, DOI 10.1016/j.polymer.2011.02.028; Yamashita M, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3647574; Crispin X, 2006, CHEM MATER, V18, P4354, DOI 10.1021/cm061032+; Yee SK, 2013, PHYS CHEM CHEM PHYS, V15, P4024, DOI 10.1039/c3cp44558e; Burkov AT, 2001, MEAS SCI TECHNOL, V12, P264, DOI 10.1088/0957-0233/12/3/304; Kim N, 2014, ADV MATER, V26, P2268, DOI 10.1002/adma.201304611; Mateeva N, 1998, J APPL PHYS, V83, P3111, DOI 10.1063/1.367119; Park H, 2014, J MATER CHEM A, V2, P6532, DOI 10.1039/c3ta14960a; Massonnet N, 2014, J MATER CHEM C, V2, P1278, DOI 10.1039/c3tc31674b; Wei QS, 2014, RSC ADV, V4, P28802, DOI 10.1039/c4ra04946b; Jiang FX, 2008, CHINESE PHYS LETT, V25, P2202, DOI 10.1088/0256-307X/25/6/076; Bernards DA, 2007, ADV FUNCT MATER, V17, P3538, DOI 10.1002/adfm.200601239; Kim JY, 2007, ADV MATER, V19, P3501, DOI 10.1002/adma.200602163; Winther-Jensen B, 2008, SCIENCE, V321, P671, DOI 10.1126/science.1159267; Lee SM, 1997, J APPL PHYS, V81, P2590, DOI 10.1063/1.363923; CAHILL DG, 1987, PHYS REV B, V35, P4067, DOI 10.1103/PhysRevB.35.4067; Snyder GJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.148301; Okuzaki H, 2003, SYNTHETIC MET, V137, P947, DOI 10.1016/S0379-6779(02)00943-8; Takano T, 2012, MACROMOLECULES, V45, P3859, DOI 10.1021/ma300120g; See KC, 2010, NANO LETT, V10, P4664, DOI 10.1021/nl102880k; Ashizawa S, 2005, SYNTHETIC MET, V153, P5, DOI 10.1016/j.synthmet.2005.07.214; QUICKENDEN TI, 1995, J ELECTROCHEM SOC, V142, P3985, DOI 10.1149/1.2048446; Zebarjadi M, 2012, ENERG ENVIRON SCI, V5, P5147, DOI 10.1039/c1ee02497c; Lee SH, 2014, J MATER CHEM A, V2, P13380, DOI 10.1039/c4ta01839g; Hiroshige Y, 2006, SYNTHETIC MET, V156, P1341, DOI 10.1016/j.synthmet.2006.10.004; Moriarty GP, 2013, ENERGY TECHNOL-GER, V1, P265, DOI 10.1002/ente.201300018; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Forrest SR, 2007, CHEM REV, V107, P923, DOI 10.1021/cr0501590; Massonnet N, 2015, CHEM SCI, V6, P412, DOI 10.1039/c4sc02463j; Kim D, 2010, ACS NANO, V4, P513, DOI 10.1021/nn9013577; Bilal BA, 1998, J APPL ELECTROCHEM, V28, P1073, DOI 10.1023/A:1003455219932; DELEEUW DM, 1994, SYNTHETIC MET, V66, P263, DOI 10.1016/0379-6779(94)90076-0; Elschner A., 2010, PEDOT PRINCIPLES APP; Hiroshige Y, 2007, SYNTHETIC MET, V157, P467, DOI 10.1016/j.synthmet.2007.05.003; Hokazono M, 2014, J ELECTRON MATER, V43, P2196, DOI 10.1007/s11664-014-3003-y; Hsu FC, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.235219; Jonas F., 1988, (Bayer AG) DE, Patent No. [38 13 589 A1, 3813589]; Kemp NT, 1999, J POLYM SCI POL PHYS, V37, P953, DOI 10.1002/(SICI)1099-0488(19990501)37:9<953::AID-POLB7>3.0.CO;2-L; Kim JY, 2002, SYNTHETIC MET, V126, P311, DOI 10.1016/S0379-6779(01)00576-8; Lee S, 2014, ADV FUNCT MATER, V24, P7187, DOI 10.1002/adfm.201401282; REYNOLDS JR, 1985, J ELECTROCHEM SOC, V132, P1131, DOI 10.1149/1.2114027; Sakai A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06089; Toshima N, 2013, J ELECTRON MATER, V42, P1882, DOI 10.1007/s11664-012-2458-y; van Reenen S, 2014, ORG ELECTRON, V15, P2250, DOI 10.1016/j.orgel.2014.06.018; Wei Q, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.031601; Wei QS, 2014, ACS MACRO LETT, V3, P948, DOI 10.1021/mz500446z; Yoshino H, 2009, SYNTHETIC MET, V159, P2387, DOI 10.1016/j.synthmet.2009.08.030	70	2	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1996-1944			MATERIALS	Materials	FEB	2015	8	2					732	750		10.3390/ma8020732		19	Materials Science, Multidisciplinary	Materials Science	CE7WM	WOS:000352052600025		
J	Shioura, A				Shioura, Akiyoshi			Polynomial-Time Approximation Schemes for Maximizing Gross Substitutes Utility Under Budget Constraints	MATHEMATICS OF OPERATIONS RESEARCH			English	Article						discrete concave function; submodular function; budget constraints; gross substitutes utility; polynomial-time approximation scheme	SET FUNCTION SUBJECT; MATROID CONSTRAINT; CONVEX-FUNCTIONS; EQUILIBRIUM; RELAXATION	We consider the maximization of a gross substitutes utility function under budget constraints. This problem naturally arises in applications such as exchange economies in mathematical economics and combinatorial auctions in (algorithmic) game theory. We show that this problem admits a polynomial-time approximation scheme (PTAS). More generally, we present a PTAS for maximizing a discrete concave function called an M-right angle-concave function under budget constraints. Our PTAS is based on rounding an optimal solution of a continuous relaxation problem, which is shown to be solvable in polynomial time by the ellipsoid method. We also consider the maximization of the sum of two M-right angle-concave functions under a single budget constraint. This problem is a generalization of the budgeted max-weight matroid intersection problem to the one with certain nonlinear objective functions. We show that this problem also admits a PTAS.	Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 9808579, Japan	Shioura, A (reprint author), Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 9808579, Japan.	shioura@dais.is.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21740060]	An extended abstract of this paper appeared in Proceedings of the 19th Annual European Symposium on Algorithms (ESA 2011), Lecture Notes in Computer Science, Vol. 6942, (Springer). The author thanks Satoru Iwata and Kazuo Murota for discussions and valuable comments on the preliminary version of the manuscript, and the two anonymous referees for their valuable comments on the presentation of the manuscript. This work is supported by Grant-in-Aid of the Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant 21740060].	KELSO AS, 1982, ECONOMETRICA, V50, P1483, DOI 10.2307/1913392; Gul F, 1999, J ECON THEORY, V87, P95, DOI 10.1006/jeth.1999.2531; Murota K, 1999, MATH OPER RES, V24, P95, DOI 10.1287/moor.24.1.95; LIN S, 1973, OPER RES, V21, P498, DOI 10.1287/opre.21.2.498; WOLSEY LA, 1982, MATH OPER RES, V7, P410, DOI 10.1287/moor.7.3.410; Feige U, 1998, J ACM, V45, P634, DOI 10.1145/285055.285059; Lee J, 2010, SIAM J DISCRETE MATH, V23, P2053, DOI 10.1137/090750020; Kulik A, 2009, PROCEEDINGS OF THE TWENTIETH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P545; Sviridenko M, 2004, OPER RES LETT, V32, P41, DOI 10.1016/S0167-6377(03)00062-2; Berger A, 2011, MATH PROGRAM, V128, P355, DOI 10.1007/s10107-009-0307-4; Feige U, 2009, SIAM J COMPUT, V39, P122, DOI 10.1137/070680977; Chekuri C, 2011, ACM S THEORY COMPUT, P783; DRESS AWM, 1992, ADV MATH, V93, P214, DOI 10.1016/0001-8708(92)90028-J; Lehmann B, 2006, GAME ECON BEHAV, V55, P270, DOI 10.1016/j.geb.2005.02.006; Kulik A, 2013, MATH OPER RES, V38, P729, DOI 10.1287/moor.2013.0592; Chekuri C, 2011, PROCEEDINGS OF THE TWENTY-SECOND ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1080; Ausubel L.M., 2002, FRONTIERS THEORETICA, V1, P1; Bertelsen A, 2005, THESIS HEBREW U JERU; Bing Meir, 2004, P EC 2004, P238, DOI 10.1145/988772.988812; Blumrosen L, 2007, ALGORITHMIC GAME THEORY, P267; Calinescu G, 2007, LECT NOTES COMPUT SC, V4513, P182; Calinescu G, 2011, SIAM J COMPUT, V40, P1740, DOI 10.1137/080733991; Cramton P., 2006, COMBINATORIAL AUCTIO; Feldman M, 2011, P 52 ANN IEEE S FDN, P580; FRANK A, 1988, MATH PROGRAM, V42, P489, DOI 10.1007/BF01589418; Fujishige S, 2005, ANN DISCR MATH, V58, P1; Fujishige S, 2003, MATH OPER RES, V28, P463, DOI 10.1287/moor.28.3.463.16393; Grandoni F, 2010, LECT NOTES COMPUT SC, V6346, P536, DOI 10.1007/978-3-642-15775-2_46; Grotschel M., 1993, GEOMETRIC ALGORITHMS; Megiddo N., 1979, Mathematics of Operations Research, V4, DOI 10.1287/moor.4.4.414; Moriguchi S, 2009, PAC J OPTIM, V5, P227; Murota K, 2003, JPN J IND APPL MATH, V20, P257; Murota K, 2003, DISCRETE APPL MATH, V131, P495, DOI 10.1016/S0166-218X(02)00469-9; Murota K, 2000, ADV APPL MATH, V25, P352, DOI 10.1006/aama.2000.0702; Murota K, 1996, SIAM J DISCRETE MATH, V9, P545, DOI 10.1137/S0895480195279994; Murota K, 1998, MATH PROGRAM, V83, P313, DOI 10.1007/BF02680565; Murota K., 2003, DISCRETE CONVEX ANAL; Murota K, 2009, RESEARCH TRENDS IN COMBINATORIAL OPTIMIZATION, P219, DOI 10.1007/978-3-540-76796-1_11; Murota K, 1996, ADV MATH, V124, P272, DOI 10.1006/aima.1996.0084; OXLEY J. G., 1992, MATROID THEORY; Ravi R., 1996, P SCAND WORKSH ALG T, V1097, P66; Rockafellar R T, 1970, CONVEX ANAL; Schrijver A., 2003, COMBINATORIAL OPTIMI; Shioura A., 2009, DISCRET MATH ALGORIT, V1, P1	44	0	0	INFORMS	CATONSVILLE	5521 RESEARCH PARK DR, SUITE 200, CATONSVILLE, MD 21228 USA	0364-765X	1526-5471		MATH OPER RES	Math. Oper. Res.	FEB	2015	40	1					192	225		10.1287/moor.2014.0668		34	Operations Research & Management Science; Mathematics, Applied	Operations Research & Management Science; Mathematics	CE6CA	WOS:000351922200009		
J	Jaeger, A; Nugroho, SB; Zusman, E; Nakano, R; Daggy, R				Jaeger, Andreas; Nugroho, Sudarmanto Budi; Zusman, Eric; Nakano, Ryoko; Daggy, Rachel			Governing sustainable low-carbon transport in Indonesia: An assessment of provincial transport plans	NATURAL RESOURCES FORUM			English	Article						Sustainable low carbon transport; multi-level governance; nationally appropriate mitigation actions (NAMAs)	CLIMATE-CHANGE MITIGATION; MULTILEVEL GOVERNANCE; PERSPECTIVE	Over the past three years, Indonesia has tasked provincial governments with defining sub-national actions to help implement the nationally appropriate mitigation action (NAMA) it pledged to the United Nations Framework Convention (UNFCCC) in 2009. This paper assesses provincial plans in Indonesia's Sustainable Urban Transport Initiative (SUTI) a set of transport plans that developed in parallel to its NAMA focusing on three key questions distilled from sustainable low carbon transport and multi-level governance literature. The questions seek to shed light into whether provincial governments: (1) prioritize actions that avoid unnecessary travel and shift passengers to more efficient modes; (2) carefully consider funding and costs estimates; and (3) clearly define institutional roles and responsibilities. The assessment suggests that most provincial governments prioritize measures designed to improve vehicle efficiencies and shift to more efficient modes (rather than avoid and shift). Furthermore, there is little evidence of due diligence being performed in relation to estimating costs and seeking creative financing. Lastly, observations point toward low levels of cross-agency collaboration and weakly defined institutional responsibilities at sub-provincial levels. The results imply that Indonesia may encounter some of the same problems confronting developed countries such as the United Kingdom as they translate national climate targets into local transport actions. Three focused case studies suggest that provinces with greater population density, economic diversity, and experience with international organizations outperform other provinces. They may therefore serve as a useful model for sharing with other provinces that are further behind the learning curve.	[Jaeger, Andreas; Nugroho, Sudarmanto Budi; Zusman, Eric; Nakano, Ryoko] IGES, Hayama, Kanagawa 2400115, Japan; [Daggy, Rachel] Univ Texas Austin, Lyndon B Johnson Sch Publ Affairs, Austin, TX 78712 USA	Jaeger, A (reprint author), IGES, 2108-11 Kamiyamaguchi, Hayama, Kanagawa 2400115, Japan.	Jaeger@iges.or.jp; nugroho@iges.or.jp; zusman@iges.or.jp; r-nakano@iges.or.jp; rachel.daggy@utexas.edu					ADS (Asian Development Bank), 2010, SUST TRANSP IN OP PL; Anggraini S. D., 2011, STUDY CARBON GOVERNA; Bakker S, 2010, NAT RESOUR FORUM, V34, P314, DOI 10.1111/j.1477-8947.2010.01315.x; Chapman L, 2007, J TRANSP GEOGR, V15, P354, DOI 10.1016/j.jtrangeo.2006.11.008; Andersson KP, 2008, POLICY SCI, V41, P71, DOI 10.1007/s11077-007-9055-6; Betsill MM, 2006, GLOBAL GOV, V12, P141; Wright L, 2005, TRANSPORT REV, V25, P691, DOI 10.1080/01441640500360951; Anguelovski I, 2011, CURR OPIN ENV SUST, V3, P169, DOI 10.1016/j.cosust.2010.12.017; Asian Development Bank (ADB), 2009, TRANSP CARB DIOX EM; Asian Development Bank (ADB), 2010, SPEC EV STUD AS DEV; Bache I, 2015, BRIT J POLIT INT REL, V17, P64, DOI 10.1111/1467-856X.12040; Marsden G, 2014, CLIM POLICY, V14, P617, DOI 10.1080/14693062.2014.905823; Bakker S, 2014, TRANSPORT REV, V34, P335, DOI 10.1080/01441647.2014.903531; BAPPENAS, 2011, GUID DEV LOC ACT PLA; BAPPENAS, 2010, IND CLIM CHANG SECT; Berger G, 2014, J ENVIRON POL PLAN, V16, P303, DOI 10.1080/1523908X.2014.954077; Bulkeley H., 2012, T I BRIT GEOGR, V38, P361, DOI 10.1111/j.1475-5661.2012.00535.x; Dalkmann H, 2007, TRANSPORT CLIMATE CH; Edenhofer O., 2014, CLIMATE CHANGE 2014; Gota S, 2014, WORKING PAPER; Hanaoka S, 2013, TRANSPORT ENV ASIAN; Harrison N., 2013, SUBNATIONAL INVOLVEM; Huizenga H., 2012, CARS AND CARBON, P371, DOI [10.1007/978-94-007-2123-4_16, DOI 10.1007/978-94-007-2123-4_16]; ICCTF, 2014, ICCTF BUS PLAN 2014; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SYNT; IPCC, 2014, 5 IPCC; Lutken SE, 2013, GUIDANCE NAMA DESIGN; Maps of Net, 2013, IND MAPS; Marks L., 2001, MULTILEVEL GOVERNANC; Marsden G, 2010, J TRANSP GEOGR, V18, P669, DOI 10.1016/j.jtrangeo.2009.09.014; OECD, 2013, 56 OECD; Ramani TL, 2011, TRANSPORT RES REC, P9, DOI 10.3141/2242-02; Sakamoto K., 2010, PARADIGM SHIFT SUST; Schipper L., 2000, FLEXING LINK CARBON; Silva de Harran D., 2012, LOW CARBON TRANSPORT, P21; Simon GL, 2014, AREA, V46, P268, DOI 10.1111/area.12110; Suzuki H., 2013, TRANSFORMING CITIES, DOI [10.1596/978-0-8213-9745-9, DOI 10.1596/978-0-8213-9745-9]; Thamrin S., 2011, GUIDELINE IMPLEMENTI; UITP, 2001, MILL CIT DAT; UNDP, 2009, PROV GOV STRENGTH PR; UNFCCC, 2014, MIT NAMAS NAT APPR; Wilkes A, 2013, NATL INTEGRATED MITI; World Bank, 2014, IND DAT POL EC RES D; Zusman E., 2012, LOW CARBON TRANSPORT	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0165-0203	1477-8947		NAT RESOUR FORUM	Nat. Resour. Forum	FEB	2015	39	1			SI		27	40		10.1111/1477-8947.12066		14	Environmental Sciences; Environmental Studies	Environmental Sciences & Ecology	CE4BK	WOS:000351775600004		
J	Nugroho, SB; Zusman, E				Nugroho, Sudarmanto Budi; Zusman, Eric			Estimating greenhouse gas (GHG) emissions from paratransit in Bandung, Indonesia: Reducing the transaction costs of generating conservative emissions baselines	NATURAL RESOURCES FORUM			English	Article						Paratransit; fuel consumption; GHG emission baselines; Bandung; Indonesia	TRANSPORT	In developing countries, paratransit often meets essential mobility needs with older, inefficient vehicles that degrade air quality and emit greenhouse gases (GHGs). International climate change finance mechanisms such as the Clean Development Mechanism (CDM) or Green Climate Fund (GCF) could help fund cleaner vehicles. However, these mechanisms require generating a credible business-as-usual GHG baseline to compare against actual emissions. For paratransit, irregular scheduling and erratic driving behaviour add to a well-documented list of factors that make the transaction costs prohibitively expensive for constructing robust transport baselines. This paper compares the relative accuracy and affordability of constructing five baselines for motorcycle taxis or ojeks in Bandung, Indonesia. The baselines that were constructed incorporate data that was gathered from one day and one week studies using revealed preference surveys as well as using real time global positioning systems (GPS) over one week into fuel efficiency and fuel consumption-based emissions calculation techniques. The calculations show that the week-long fuel consumption survey data generated the lowest fuel efficiency and highest GHG estimates. Driver survey data may therefore help construct a relatively low cost conservative baseline, especially when triangulated by GPS-verified distance travelled data. The study concludes with several promising future research areas, including expanding the period of estimation for paratransit; examining the relationship between self-reported distance and fuel consumption data; optimizing survey administration; and promoting climate finance mechanisms that engage stakeholders to lower the transaction costs of data gathering.	[Nugroho, Sudarmanto Budi; Zusman, Eric] IGES, Hayama, Kanagawa 2400115, Japan	Nugroho, SB (reprint author), IGES, 2108-11 Kamiyamaguchi, Hayama, Kanagawa 2400115, Japan.	nugroho@iges.or.jp; zusman@iges.or.jp			Global Environmental Leadership Program at the Graduate School of International Development and Cooperation, Hiroshima University, Japan	This research is partially supported by the Global Environmental Leadership Program at the Graduate School of International Development and Cooperation, Hiroshima University, Japan.	Anh K., 2008, TRANSPORT RES D-TR E, V13, P151; Bakker S, 2010, NAT RESOUR FORUM, V34, P314, DOI 10.1111/j.1477-8947.2010.01315.x; Olsen KH, 2008, ENERG POLICY, V36, P2819, DOI 10.1016/j.enpol.2008.02.039; Ericsson E, 2006, TRANSPORT RES C-EMER, V14, P369, DOI 10.1016/j.trc.2006.10.001; Karathodorou N, 2010, ENERG ECON, V32, P86, DOI 10.1016/j.eneco.2009.05.005; Bakker S, 2014, TRANSPORT REV, V34, P335, DOI 10.1080/01441647.2014.903531; Bappeda Jabarprov, 2010, W JAV FIG 2010; Carvero R., 2007, TRANSPORT POLICY, V14, P445; Center for Clean Air Policy, 2010, TRANSP NAMAS PROP FR; Eichhorst U., 2010, EXPLORING STANDARDIS; Gang L. I., 2011, J E ASIA SOC TRANSPO, V9, P1144; Global Environmental Centre Foundation (GEC), 2012, MRV DEM STUD DS US M; Grutter J. M., 2007, CDM TRANSPORT SECTOR; Huizenga C, 2012, LOW CARBON TRANSPORT, P225; Huizenga C., 2012, CARS CARBON AUTOMOBI, P371; Joewono TB, 2007, J PUBLIC TRANSPORT, V10, P99; Kaltheier R.M., 2002, URBAN TRANSPORT POVE; Millard-Ball A, 2010, ENERG POLICY, V38, P533, DOI 10.1016/j.enpol.2009.10.005; Nugroho S. B., 2011, P INFR PLANN; Pang-Ning T., 2006, CLUSTER ANAL BASIC C, P487; Roser F., 2012, ANN STATUS REPORT NA; Rouhani O. M., 2013, P 92 ANN M TRANSP RE, P1; Rouhani OM, 2014, TRANSPORT RES D-TR E, V31, P48, DOI 10.1016/j.trd.2014.05.018; Saboohi Y, 2009, APPL ENERG, V86, P1925, DOI 10.1016/j.apenergy.2008.12.017; Salon D., 2001, INITIAL VIEW METHODO; Satiennam T., 2006, J INT ASS TRAFFIC SA, V30, P59; Schipper L, 2000, FLEXING LINK TRANSPO; Tolouei R, 2009, TRANSPORT RES D-TR E, V14, P385, DOI 10.1016/j.trd.2009.01.005; Transport Research Foundation (TRF), 2010, SUBM MOD PROC DEV ST; Zegras C., 2007, ENERG POLICY, V35, P5136; Zegras P. C., 2009, P 88 ANN M TRANSP RE; Zusman E., 2012, LOW CARBON TRANSPORT	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0165-0203	1477-8947		NAT RESOUR FORUM	Nat. Resour. Forum	FEB	2015	39	1			SI		53	63		10.1111/1477-8947.12065		11	Environmental Sciences; Environmental Studies	Environmental Sciences & Ecology	CE4BK	WOS:000351775600006		
J	Mederacke, I; Dapito, DH; Affo, S; Uchinami, H; Schwabe, RF				Mederacke, Ingmar; Dapito, Dianne H.; Affo, Silvia; Uchinami, Hiroshi; Schwabe, Robert F.			High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers	NATURE PROTOCOLS			English	Article							FAT-STORING CELLS; RAT-LIVER; GROWTH-FACTOR; FIBROSIS; PATHOGENESIS; PURIFICATION; CULTURE	Hepatic stellate cells (HSCs) have been identified as the main fibrogenic cell type in the liver. Hence, efforts to understand hepatic fibrogenesis and to develop treatment strategies have focused on this cell type. HSC isolation, originally developed in rats, has subsequently been adapted to mice, thus allowing the study of fibrogenesis by genetic approaches in transgenic mice. However, mouse HSC isolation is commonly hampered by low yield and purity. Here we present an easy-to-perform protocol for high-purity and high-yield isolation of quiescent and activated HSCs in mice, based on retrograde pronase-collagenase perfusion of the liver and subsequent density-gradient centrifugation. We describe an optional add-on protocol for ultrapure HSC isolation from normal and fibrotic livers via subsequent flow cytometric sorting, thus providing a validated method to determine gene expression changes during HSC activation devoid of cell culture artifacts or contamination with other cells. The described isolation procedure takes similar to 4 h to complete.	[Mederacke, Ingmar; Affo, Silvia; Schwabe, Robert F.] Columbia Univ, Dept Med, New York, NY 10027 USA; [Dapito, Dianne H.; Schwabe, Robert F.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA; [Uchinami, Hiroshi] Akita Univ, Sch Med, Dept Surg Gastroenterol, Akita 010, Japan	Schwabe, RF (reprint author), Columbia Univ, Dept Med, New York, NY 10027 USA.	rfs2102@cumc.columbia.edu			German Research Foundation [ME 3723/1-1]; American Liver Foundation; Spanish Association for the Study of the Liver (AEEH);  [5R01AA020211];  [1U01AA021912];  [5R01DK076920];  [F31DK091980]	R.F.S. was supported by grants 5R01AA020211, 1U01AA021912 and 5R01DK076920. D.H.D. was supported by grant F31DK091980. I.M. was supported by grant from the German Research Foundation (ME 3723/1-1) and the American Liver Foundation. S.A. was supported by a grant from the Spanish Association for the Study of the Liver (AEEH).	Pradere JP, 2013, HEPATOLOGY, V58, P1461, DOI 10.1002/hep.26429; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Mehal WZ, 2011, NAT MED, V17, P552, DOI 10.1038/nm0511-552; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; KNOOK DL, 1982, EXP CELL RES, V139, P468, DOI 10.1016/0014-4827(82)90283-X; PINZANI M, 1989, J CLIN INVEST, V84, P1786, DOI 10.1172/JCI114363; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Sancho-Bru P, 2005, J HEPATOL, V43, P272, DOI 10.1016/j.jhep.2005.02.035; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Brenner David A, 2012, Fibrogenesis Tissue Repair, V5, pS17, DOI 10.1186/1755-1536-5-S1-S17; DAVIS BH, 1988, J CELL PHYSIOL, V136, P547, DOI 10.1002/jcp.1041360323; Geerts A, 1998, HEPATOLOGY, V27, P590, DOI 10.1002/hep.510270238; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kluwe J, 2011, GUT, V60, P1260, DOI 10.1136/gut.2010.209551; Luedde T., 2014, GASTROENTEROLOGY, V147; MATSUOKA M, 1989, LIVER, V9, P71; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Seki E., 2014, HEPATOLOGY; Troeger J.S., 2012, GASTROENTEROLOGY, V143	25	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1754-2189	1750-2799		NAT PROTOC	Nat. Protoc.	FEB	2015	10	2					305	315		10.1038/nprot.2015.017		11	Biochemical Research Methods	Biochemistry & Molecular Biology	CE6ET	WOS:000351930100006		
J	Hayashi, T; Murata, T				Hayashi, Takuma; Murata, Toshinori			Physiological significance of Rag1 in retinal ganglion cell death	NEURAL REGENERATION RESEARCH			English	Editorial Material							RECOMBINATION-ACTIVATING GENE-1; B/REL TRANSCRIPTION FACTORS; OPTIC NEUROPATHY; KAPPA-B; MICE		[Hayashi, Takuma] Shinshu Univ, Grad Sch Med, Dept Immunol & Infect Dis, Matsumoto, Nagano 3908621, Japan; [Murata, Toshinori] Shinshu Univ, Grad Sch Med, Dept Ophthalmol, Matsumoto, Nagano 3908621, Japan	Hayashi, T (reprint author), Shinshu Univ, Grad Sch Med, Dept Immunol & Infect Dis, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	takumah@shinshu-u.ac.jp					MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S; Fang MR, 2013, BEHAV BRAIN RES, V236, P200, DOI 10.1016/j.bbr.2012.09.002; Hirano T, 2015, FEBS J, V282, P129, DOI 10.1111/febs.13109; Takahashi Y, 2007, NEUROPATH APPL NEURO, V33, P692, DOI 10.1111/j.1365-2990.2007.00862.x; Verkoczy L, 2005, IMMUNITY, V22, P519, DOI 10.1016/j.immuni.2005.03.006	10	0	0	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	FEB	2015	10	2					192	194		10.4103/1673-5374.152365		3	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	CE4EG	WOS:000351783300007		
J	Yamato, M; Kataoka, Y				Yamato, Masanori; Kataoka, Yosky			Fatigue sensation following peripheral viral infection is triggered by neuroinflaimnation: who will answer these questions?	NEURAL REGENERATION RESEARCH			English	Editorial Material							MINOCYCLINE		[Yamato, Masanori; Kataoka, Yosky] RIKEN Ctr Life Sci Technol, Cellular Funct Imaging Team, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kataoka, Y (reprint author), RIKEN Ctr Life Sci Technol, Cellular Funct Imaging Team, Chuo Ku, 6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	kataokay@riken.jp					Kohler E, 2013, STROKE, V44, P2493, DOI 10.1161/STROKEAHA.113.000780; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Yasui M, 2014, GLIA, V62, P1407, DOI 10.1002/glia.22687; Katafuchi T, 2005, EUR J NEUROSCI, V22, P2817, DOI 10.1111/j.1460-9568.2005.04478.x; Song C, 2011, PROG NEURO-PSYCHOPH, V35, P760, DOI 10.1016/j.pnpbp.2010.06.020; Nakatomi Y, 2014, J NUCL MED, V55, P945, DOI 10.2967/jnumed.113.131045; Fan Z, 2014, ALZHEIMERS DEMENT, DOI [10. 1016/j. jalz. 2014. 06. 016, DOI 10.1016/J.JALZ.2014.06.016]; Kataoka Y, 2013, ADV NEUROIMMUNE BIOL, V4, P237; Loddick SA, 1997, BIOCHEM BIOPH RES CO, V234, P211, DOI 10.1006/bbrc.1997.6436; Yamato M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090950	10	0	0	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	FEB	2015	10	2					203	204		10.4103/1673-5374.152369		2	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	CE4EG	WOS:000351783300011		
J	Jiang, DX; Lu, ZS; Li, GB; Sun, SY; Mu, X; Lee, P; Chen, W				Jiang, Dai-xun; Lu, Zhi-song; Li, Ge-bin; Sun, Sheng-yong; Mu, Xiang; Lee, Peter; Chen, Wu			Electroacupuncture improves microcirculation and neuronal morphology in the spinal cord of a rat model of intervertebral disc extrusion	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; electroacupuncture; intervertebral disc; blood circulation; inflammation; neuroprotection; motor function; neurons; NSFC grants; neural regeneration	MICROVASCULAR ENDOTHELIAL-CELLS; INJURY; RECOVERY; STIMULATION; DOG	Most studies on spinal cord neuronal injury have focused on spinal cord tissue histology and the expression of nerve cell damage and repair-related genes. The importance of the microcirculation is often ignored in spinal cord injury and repair research. Therefore, in this study, we established a rat model of intervertebral disc extrusion by inserting a silica gel pad into the left ventral surface of T. Electroacupuncture was used to stimulate the bilateral Zusanli point (ST36) and Neiting point (ST44) for 14 days. Compared with control animals, blood flow in the first lumbar vertebra (L-1) was noticeably increased in rats given electroacupuncture. Microvessel density in the T-13 segment of the spinal cord was increased significantly as well. The number of normal neurons was higher in the ventral horn of the spinal cord. In addition, vacuolation in the white matter was lessened. No obvious glial cell proliferation was visible. Furthermore, hindlimb motor function was improved significantly. Collectively, our results suggest that electroacupuncture can improve neuronal morphology and microcirculation, and promote the recovery of neurological functions in a rat model of intervertebral disc extrusion.	[Jiang, Dai-xun; Lu, Zhi-song; Li, Ge-bin; Sun, Sheng-yong; Mu, Xiang; Chen, Wu] Beijing Agr Univ, Beijing Key Lab Tradit Chinese Vet Med, Beijing 100094, Peoples R China; [Li, Ge-bin; Lee, Peter] Nippon Vet & Life Sci Univ, Dept Vet Biochem, Musashino, Tokyo, Japan	Chen, W (reprint author), Beijing Agr Univ, Beijing Key Lab Tradit Chinese Vet Med, Beijing 100094, Peoples R China.	tcvmchenwu@hotmail.com			National Natural Science Foundation of China [31372473, 30871886]; Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality of China [PHR201107134]; Scientific Research Quality Raising Funds of Beijing University of Agriculture of China [PXM2012_014207_000010]	This study was supported by the National Natural Science Foundation of China, No. 31372473, 30871886; the Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality of China, No. PHR201107134; the 2012 Scientific Research Quality Raising Funds of Beijing University of Agriculture of China, No. PXM2012_014207_000010.	Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Han HJ, 2010, AM J CHINESE MED, V38, P1015, DOI 10.1142/S0192415X10008433; Sharma HS, 2011, J NEURAL TRANSM, V118, P155, DOI 10.1007/s00702-010-0514-4; Hayashi AM, 2007, J VET SCI, V8, P95; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Tsuchiya M, 2007, ANESTH ANALG, V104, P301, DOI 10.1213/01.ane.0000230622.16367.fb; Kato S, 2008, SPINE, V33, P1533, DOI 10.1097/BRS.0b013e318178e5af; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Benton RL, 2008, J CEREBR BLOOD F MET, V28, P1771, DOI 10.1038/jcbfm.2008.76; Bartsch T, 2002, BRAIN, V125, P1496, DOI 10.1093/brain/awf166; Benton EL, 2009, CURR NEUROVASC RES, V6; Butcher J, 2000, LANCET, V356, P405; Crystal GJ, 2002, ANESTH ANALG, V95, P851, DOI 10.1213/01.ANE.0000025619.91086.E8; Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106; Hamamoto Y, 2009, SPINAL CORD, V48, P149; Jiang JT, 2005, GANSU ZHONGYI XUEYUA, V22, P16; Li WH, 2009, BRAIN RES, V1287, P28, DOI 10.1016/j.brainres.2009.06.057; Li Z. R., 2007, EXPT ACUPUNCTURE SCI; Lim JH, 2007, J VET SCI, V8, P89; Sharp KG, 2012, EXP NEUROL, V235, P345, DOI 10.1016/j.expneurol.2012.02.016; Song Le, 2006, Zhongguo Zhen Jiu, V26, P362; Su H, 2009, HUAZHONG KEJI DAXUE, V38, P106; Wu YG, 1995, ZHONGGUO ZHONGYIYAO, V2, P14; Yang Jung-whan, 2003, J Vet Sci, V4, P97; Zhu YD, 2012, ZHEJIANG ZHONGYIYAO, V36, P565	25	0	0	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	FEB	2015	10	2					237	243		10.4103/1673-5374.152377		7	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	CE4EG	WOS:000351783300019		
J	Nishimura, T; Hoshi, H; Hotta, A				Nishimura, Takeshi; Hoshi, Harutaka; Hotta, Akitoshi			CURRENT RESEARCH AND DEVELOPMENT ACTIVITIES ON FISSION PRODUCTS AND HYDROGEN RISK AFTER THE ACCIDENT AT FUKUSHIMA DAIICHI NUCLEAR POWER STATION	NUCLEAR ENGINEERING AND TECHNOLOGY			English	Article						Fission product; Fukushima; Hydrogen; Iodine; Severe accident; Venting	MODEL	After the Fukushima Daiichi nuclear power plant (NPP) accident, new regulatory requirements were enforced in July 2013 and a backfit was required for all existing nuclear power plants. It is required to take measures to prevent severe accidents and mitigate their radiological consequences. The Regulatory Standard and Research Department, Secretariat of Nuclear Regulation Authority (S/NRA/R) has been conducting numerical studies and experimental studies on relevant severe accident phenomena and countermeasures. This article highlights fission product (FP) release and hydrogen risk as two major areas. Relevant activities in the S/NRA/R are briefly introduced, as follows: 1. For FP release: Identifying the source terms and leak mechanisms is a key issue from the viewpoint of understanding the progression of accident phenomena and planning effective countermeasures that take into account vulnerabilities of containment under severe accident conditions. To resolve these issues, the activities focus on wet well venting, pool scrubbing, iodine chemistry (in-vessel and ex-vessel), containment failure mode, and treatment of radioactive liquid effluent. 2. For hydrogen risk: because of three incidents of hydrogen explosion in reactor buildings, a comprehensive reinforcement of the hydrogen risk management has been a high priority topic. Therefore, the activities in evaluation methods focus on hydrogen generation, hydrogen distribution, and hydrogen combustion. Copyright (C) 2015, Published by Elsevier Korea LLC on behalf of Korean Nuclear Society.	[Nishimura, Takeshi; Hoshi, Harutaka; Hotta, Akitoshi] S NRA R, Secretariat Nucl Regulat Author, Regulatory Standard & Res Dept, Minato Ku, Tokyo 1068450, Japan	Hoshi, H (reprint author), S NRA R, Secretariat Nucl Regulat Author, Regulatory Standard & Res Dept, Minato Ku, 1-9-9 Ropponghi, Tokyo 1068450, Japan.	harutaka_hoshi@nsr.go.jp					[Anonymous], 2011, IAEATECDOC1661; Wren JC, 2001, RADIAT PHYS CHEM, V60, P577, DOI 10.1016/S0969-806X(00)00385-6; Bentaib A., 2010, 8 ISHPMIE SEPT 5 10; Clement B., 2007, NEACSNIR20071 ORG EC; Computer Soft Design Co, 1993, AN SUPP VER EXP REAC; Dorofeev S., 1997, SARJ WORKSH YOK JAP; Glowa G., 2011, NEACSNIR201111 ORG E; Hoshi H., 2013, 15 INT TOP M NUCL RE; Hoshi H., 2012, SID EV UPD ACT TEPCO; IAEA, 2009, SEV ACC MAN PROGR NU; Ishikawa J., 2014, J NUCL SCI TECHNOL; KANZLEITER TF, 1994, NUCL ENG DES, V146, P417, DOI 10.1016/0029-5493(94)90347-6; Katata G., 2014, ATOMS CHEM PHYS DISC, P14725; Ministry of Education, 2012, RES AIRB MON MIN ED; Moriyama K., 2011, KICHE SIMULATION TOO; Nishimura T., 2014, CFD SIMULATION STRAT; Nuclear Emergency Response Headquarters Government of Japan, 2011, JAP GOV IAEA MIN C N; Nuclear Regulation Authority, 2013, OUTL NEW REG REQ LIG; NUPEC, 1995, VER EXP REACT CONT R; OECD/NEA, 2012, NEACSNIR20125 OECD; OECD/NEA, 2010, 1501326FR1 OECDNEA; OECD/NEA, 2004, NEACSNIR200424 OECD; OECD/NEA, 2001, NEACSNIR200115 OECD; OECD/NEA, 2013, OECD NEA HYDR MIT EX; Organisation for Economic Cooperation and Development Nuclear Energy Agency (OECD/NEA), 1993, NEACSNIR934 OECD; Organisation for Economic Cooperation and Development Nuclear Energy Agency (OECD/NEA), 1994, ISP35 OECDNEA; Organisation for Economic Cooperation and Development/Nuclear Energy Agency (OECD/NEA), 2014, NEACSNIR20148 OECD; Owczarski P.C., 1991, NUREGCR5765; Powers D.A., 1986, VANESA MECH MODEL RA; Sehgal B.R., 2012, NUCL SAFETY LIGHT WA, P193; Sehgal B.R., 2012, LIGHT WATER REACTORS, P369; TEPCO, 2012, FUK NUCL ACC AN REP; Thompson R.T., 1998, NP3878 EPRI, V1; Tokyo Electric Power Co (TEPCO), 2011, PLANT DAT FUK DAIICH; Tokyo Electric Power Co. (TEPCO), 2011, PROGR COLL TREATM RA; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2014, LEV EFF RAD EXP NUCL; Voelsing K., 2014, GOTHIC THERMAL HYDRA	37	0	0	KOREAN NUCLEAR SOC	DAEJEON	NUTOPIA BLDG, 342-1 JANGDAE-DONG, DAEJEON, 305-308, SOUTH KOREA	1738-5733			NUCL ENG TECHNOL	Nucl. Eng. Technol.	FEB	2015	47	1					1	10		10.1016/j.net.2014.12.002		10	Nuclear Science & Technology	Nuclear Science & Technology	CE2OE	WOS:000351654100001		
J	Kato, H; Ochiai-Shino, H; Onodera, S; Saito, A; Shibahara, T; Azuma, T				Kato, Hiroshi; Ochiai-Shino, Hiromi; Onodera, Shoko; Saito, Akiko; Shibahara, Takahiko; Azuma, Toshifumi			Promoting effect of 1,25(OH)(2) vitamin D-3 in osteogenic differentiation from induced pluripotent stem cells to osteocyte-like cells	OPEN BIOLOGY			English	Article						induced pluripotent stem cells; vitamin D; osteoblasts; osteocytes; drug assessment	OSTEOBLAST DIFFERENTIATION; POSTMENOPAUSAL WOMEN; BIOCHEMICAL MARKERS; BONE TURNOVER; OSTEOPOROSIS; ALENDRONATE; MECHANISMS; EXPRESSION; FRACTURES; DISEASE	We recently reported a new method to purify the induced pluripotent stem (iPS)-derived osteoprogenitors (iPSop). In this paper, we optimized the procedure and characterized cells at each process step. We observed that 10 days of treatment with FGF-2, IGF-1 and TGF-beta (FIT) resulted in early-phase osteoblasts and 14 days of treatment resulted in late-phase osteoblasts. We found that treatment with 1,25(OH)(2) vitamin D-3 increased expression of osteocalcin and decreased expression of tissue-non-specific alkaline phosphatase and runt-related transcription factor 2 (RUNX2) in iPSop-day14 cells (cells treated with FIT for 14 days). Therefore, iPSop-day14 cells were promoted to mature osteoblasts by 1,25(OH)(2) vitamin D-3 treatment. In addition, we found that 1,25(OH)(2) vitamin D-3 treatment for 14 days enhanced not only mineralization but also expression of osteocyte markers, including dentin matrix protein-1 and fibroblast growth factor-23, in iPSop cells. Therefore, 1,25(OH)(2) vitamin D-3 is a potent promoter of osteoblast-osteocyte transition. The results of this study suggest that it is possible to evaluate both early-and late-phase osteoblasts and to apply cells to drug screening for anabolic drugs that stimulate bone formation.	[Kato, Hiroshi; Shibahara, Takahiko] Tokyo Dent Coll, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Ochiai-Shino, Hiromi; Onodera, Shoko; Saito, Akiko; Azuma, Toshifumi] Tokyo Dent Coll, Dept Biochem, Tokyo, Japan	Azuma, T (reprint author), Tokyo Dent Coll, Dept Biochem, Tokyo, Japan.	tazuma@tdc.ac.jp			JSPS KAKENHI [25462900, 25861761, 26861686, 26861560]	This work was supported by JSPS KAKENHI (C) grant no. 25462900 and by JSPS KAKENHI for young scientist (B) grant nos. 25861761, 26861686 and 26861560.	Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Black DM, 2000, J CLIN ENDOCR METAB, V85, P4118, DOI 10.1210/jc.85.11.4118; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Nordin BEC, 2004, AM J CLIN NUTR, V80, P998; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Geng S, 2013, METABOLISM, V62, P768, DOI 10.1016/j.metabol.2013.01.003; Li F, 2010, J CELL BIOCHEM, V109, P643, DOI 10.1002/jcb.22440; Bilousova G, 2011, STEM CELLS, V29, P206, DOI 10.1002/stem.566; Inoue H, 2011, CLIN PHARMACOL THER, V89, P655, DOI 10.1038/clpt.2011.38; Ochiai H, 2012, J BIOL CHEM, V287, P22654, DOI 10.1074/jbc.M111.279091; van Driel M, 2004, CURR PHARM DESIGN, V10, P2535; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Yoshimura N, 2010, INT J EPIDEMIOL, V39, P988, DOI 10.1093/ije/dyp276; Das S, 2013, DRUG DES DEV THER, V7, P435, DOI 10.2147/DDDT.S31504; Tashiro K, 2009, STEM CELLS, V27, P1802, DOI 10.1002/stem.108; Zhou SH, 2010, ENDOCRINOLOGY, V151, P14, DOI 10.1210/en.2009-0969; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Ebert Allison D, 2010, Nat Rev Drug Discov, V9, P367, DOI 10.1038/nrd3000; Evenepoel P, 2014, NEW ENGL J MED, V370, P1664, DOI [10.1056/NEJMc1402396#SA1, 10.1056/NEJMc1402396]; Fleisch H, 1998, ENDOCR REV, V19, P80, DOI 10.1210/er.19.1.80; Gupta Swati, 2013, Natl J Maxillofac Surg, V4, P151, DOI 10.4103/0975-5950.127643; Iki M, 2004, OSTEOPOROSIS INT, V15, P981, DOI 10.1007/s00198-004-1634-1; Inoue H, 2014, EMBO J, V33, P409, DOI 10.1002/embj.201387098; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Ochiai-Shino H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099534; Pajevic Paola Divieti, 2013, Endocrinology and Metabolism, V28, P255; Saito A, 2013, FASEB J, V27, P2165, DOI 10.1096/fj.12-221432; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Sharma Dileep, 2013, Vasc Cell, V5, P1, DOI 10.1186/2045-824X-5-1; van Dinther M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062295; Woeckel VJ, 2013, GENE, V512, P438, DOI [10.1016/j.gene.2012.07.051, 10.1016/j.gene2012.07.051]; Yahata N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025788; Yoshimura N, 1999, CALCIFIED TISSUE INT, V65, P198	36	1	1	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	2046-2441			OPEN BIOL	Open Biol	FEB	2015	5	2							140201	10.1098/rsob.140201		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CE6BV	WOS:000351921700003		
J	Conca, A; Murai, S				Conca, Aldo; Murai, Satoshi			REGULARITY BOUNDS FOR KOSZUL CYCLES	PROCEEDINGS OF THE AMERICAN MATHEMATICAL SOCIETY			English	Article						Castelnuovo-Mumford regularity; Koszul cycles; Koszul homology		We study the Castelnuovo-Mumford regularity of the module of Koszul cycles Z(t)(I, M) of a homogeneous ideal I in a polynomial ring S with respect to a graded module M in the homological position t is an element of N. Under mild assumptions on the base field we prove that reg Z(t)(I, S) is a subadditive function of t when dim S/I = 0. For Borel-fixed ideals I, J we prove that reg Z(t)(I, S/J) <= t(1 + reg I) + reg S/J, a result already announced by Bruns, Conca and Romer.	[Conca, Aldo] Univ Genoa, Dipartimento Matemat, I-16146 Genoa, Italy; [Murai, Satoshi] Osaka Univ, Dept Pure & Appl Math, Grad Sch Informat Sci & Technol, Toyonaka, Osaka 5600043, Japan	Conca, A (reprint author), Univ Genoa, Dipartimento Matemat, Via Dodecaneso 35, I-16146 Genoa, Italy.	conca@dima.unige.it; s-murai@ist.osaka-u.ac.jp		CONCA, ALDO/0000-0001-5897-9985	KAKENHI [22740018]	The research of the second author was partially supported by KAKENHI 22740018.	Bruns W, 2011, ABEL SYMP, V6, P17, DOI 10.1007/978-3-642-19492-4_2; Bruns W, 2011, MATH ANN, V351, P761, DOI 10.1007/s00208-010-0616-1; Bruns Winfried, 1993, CAMBRIDGE STUDIES AD, V39; Caviglia G, 2007, P AM MATH SOC, V135, P1949, DOI 10.1090/S0002-9939-07-08222-6; Cox David A., 2005, GRADUATE TEXTS MATH, V185; Eisenbud D, 2006, AM J MATH, V128, P573, DOI 10.1353/ajm.2006.0022; ELIAHOU S, 1990, J ALGEBRA, V129, P1, DOI 10.1016/0021-8693(90)90237-I; GREEN ML, 1984, J DIFFER GEOM, V20, P279	8	0	0	AMER MATHEMATICAL SOC	PROVIDENCE	201 CHARLES ST, PROVIDENCE, RI 02940-2213 USA	0002-9939	1088-6826		P AM MATH SOC	Proc. Amer. Math. Soc.	FEB	2015	143	2					493	503	PII S0002-9939(2014)12292-1			11	Mathematics, Applied; Mathematics	Mathematics	CE1GM	WOS:000351560100004		
J	Nakamura, T				Nakamura, Takashi			A MODIFIED RIEMANN ZETA DISTRIBUTION IN THE CRITICAL STRIP	PROCEEDINGS OF THE AMERICAN MATHEMATICAL SOCIETY			English	Article						Characteristic function; infinite divisibility; zeros of zeta functions		Let sigma, t is an element of R, s = sigma + it and sigma(s) be the Riemann zeta function. Put f(sigma)(t) := sigma(sigma - it)/(sigma - it) and F-sigma(t) := f(sigma)(t) /f sigma (0). We show that F-sigma(t) is a characteristic function of a probability measure for any 0 < sigma not equal by giving the probability density function. By using this fact, we show that for any C is an element of C satisfying broken vertical bar C broken vertical bar > 10 and -19/2 <= RC <= 17/2, the function sigma(s) + Cs does not vanish in the half-plane sigma > 1/18. Moreover, we prove that F-sigma(t) is an infinitely divisible characteristic function for any F-sigma > 1. Furthermore, rse show that the Biernann hypothesis is true if cacti F-sigma(t) is an in characteristic function for each 1/2 < sigma < 1.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Nakamura, T (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	takashin@ms.u-tokyo.ac.jp					Jessen B, 1935, T AM MATH SOC, V38, P48, DOI 10.2307/1989728; Lagarias JC, 2006, J NUMBER THEORY, V118, P98, DOI 10.1016/j.jnt.2005.08.010; Aoyama T., 2012, ARXIVORGABS12044041; Apostol Tom M., 1976, UNDERGRADUATE TEXTS; Biane P, 2001, B AM MATH SOC, V38, P435, DOI 10.1090/S0273-0979-01-00912-0; Bohr H, 1932, ACTA MATH-DJURSHOLM, V58, P1, DOI 10.1007/BF02547773; Gnedenko B. V., 1968, LIMIT DISTRIBUTIONS; Gut A, 2006, REV ROUMAINE MATH PU, V51, P205; HEJHAL DA, 1990, J ANAL MATH, V55, P59, DOI 10.1007/BF02789198; Ivic Aleksandar, 2003, RIEMANN ZETA FUNCTIO; Khintchine A. Ya., 1938, LIMITS THEOREM SUMS; Lagarias JC, 2003, ANN I FOURIER, V53, P1; Laurincikas Antanas, 1996, MATH APPL, V352; Lin GD, 2001, BERNOULLI, V7, P817, DOI 10.2307/3318543; Matsumoto K., 2004, SUGAKU EXPOSITIONS, V53, p[279, 51], DOI DOI 10.1007/S10625-005-0242-Y; Nakamura T., 2012, ARXIV12125890; Sato K.-i., 1999, CAMBRIDGE STUDIES AD, V68; Steuding Jorn, 2007, LECT NOTES MATH, V1877; Taylor P. R., 1945, Q J MATH OXFORD SER, V16, P1, DOI 10.1093/qmath/os-16.1.1; Titchmarsh E. C., 1986, THEORY RIEMANN ZETA	20	0	0	AMER MATHEMATICAL SOC	PROVIDENCE	201 CHARLES ST, PROVIDENCE, RI 02940-2213 USA	0002-9939	1088-6826		P AM MATH SOC	Proc. Amer. Math. Soc.	FEB	2015	143	2					897	905	PII S 0002-9939(2014)12279-9			9	Mathematics, Applied; Mathematics	Mathematics	CE1GM	WOS:000351560100041		
J	Nakamura, H; Tazaki, L; Kanoh, D; Sato, S				Nakamura, Hiroyuki; Tazaki, Lisa; Kanoh, Daisuke; Sato, Shinichi			Diaryl-substituted carboranes as inhibitors of hypoxia inducible factor-1 transcriptional activity	PURE AND APPLIED CHEMISTRY			English	Article; Proceedings Paper	15th International Conference on Boron Chemistry (IMEBORON)	AUG 24-28, 2014	Prague, CZECH REPUBLIC			cancer therapy; diaryl-substituted carboranes; hypoxia inducible factor-1 (HIF-1); IMEBORON XV	HIF-ALPHA; CANCER; DISCOVERY; HYDROXYLATION; STRATEGIES; COMPLEXES; RUTHENIUM; CHEMISTRY; THERAPY; CELLS	Diaryl-substituted carboranes, as a new class of HIF-1 alpha inhibitors, were synthesized from the corresponding diaryl-substituted alkynes by decaborane coupling. The microwave-irradiated conditions with a combination of N, N-dimethylaniline and chlorobenzene were effective to obtain the diaryl-substituted carboranes in good to high yields. Among the compounds synthesized, compounds 1a and 1d showed significant inhibition of HIF-1 mediated transcriptional activity under hypoxia. Both compounds similarly suppressed hypoxia-induced HIF-1 alpha accumulation in a concentration-dependent manner without affecting HIF-1 alpha mRNA expression.	[Nakamura, Hiroyuki; Sato, Shinichi] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Nakamura, Hiroyuki; Tazaki, Lisa; Kanoh, Daisuke] Gakushuin Univ, Fac Sci, Dept Chem, Tokyo 1718588, Japan	Nakamura, H (reprint author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	hiro@res.titech.ac.jp	Nakamura, Hiroyuki/E-8627-2014; Sato, Shinichi/E-7536-2014	Nakamura, Hiroyuki/0000-0002-4511-2984; 			Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; BREGADZE VI, 1992, CHEM REV, V92, P209, DOI 10.1021/cr00010a002; Barry NPE, 2012, CHEM SOC REV, V41, P3264, DOI 10.1039/c2cs15300a; Ban HS, 2010, J AM CHEM SOC, V132, P11870, DOI 10.1021/ja104739t; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Nakamura H, 2014, DALTON T, V43, P4941, DOI 10.1039/c3dt52828f; Jiang BH, 1996, J BIOL CHEM, V271, P17771; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Minegishi H, 2013, CHEMMEDCHEM, V8, P265, DOI 10.1002/cmdc.201200502; Dowlati A, 2002, CANCER RES, V62, P3408; Scholz M, 2011, CHEM REV, V111, P7035, DOI 10.1021/cr200038x; Fujii S, 2011, J AM CHEM SOC, V133, P20933, DOI 10.1021/ja208797n; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Chun YS, 2001, BIOCHEM PHARMACOL, V61, P947, DOI 10.1016/S0006-2952(01)00564-0; Endo Y, 2001, CHEM BIOL, V8, P341, DOI 10.1016/S1074-5521(01)00016-3; Maxwell PH, 1999, NATURE, V399, P271; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Semenza GL, 2001, J CLIN INVEST, V108, P39, DOI 10.1172/JCI13374; Minegishi H, 2013, ACS MED CHEM LETT, V4, P297, DOI 10.1021/ml3004632; Armstrong AF, 2007, DALTON T, P4240, DOI 10.1039/b709843j; Ban H. S., 2012, PURE APPL CHEM, V84, P13; Ban HS, 2010, CHEMMEDCHEM, V5, P1236, DOI 10.1002/cmdc.201000112; Dachs GU, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-280; HILL WE, 1975, INORG CHEM, V14, P1244, DOI 10.1021/ic50148a008; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; Lawrence NJ, 1999, SYNTHESIS-STUTTGART, P1656; Takeuchi A, 2012, MEDCHEMCOMM, V3, P1455, DOI 10.1039/c2md20134h; Wu DH, 2009, DALTON T, P285, DOI 10.1039/b810831e; Zhang G, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-6	30	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0033-4545	1365-3075		PURE APPL CHEM	Pure Appl. Chem.	FEB	2015	87	2					143	154		10.1515/pac-2014-0911		12	Chemistry, Multidisciplinary	Chemistry	CE6KZ	WOS:000351946600004		
J	Fahrenbach, AC				Fahrenbach, Albert C.			Template-directed nonenzymatic oligonucleotide synthesis: lessons from synthetic chemistry	PURE AND APPLIED CHEMISTRY			English	Article						IUPAC-SOLVAY International Award for Young Chemists; kinetic template effect; mechanically interlocked molecules; origins of life; RNA replication; supramolecular chemistry	RNA WORLD; TETRATHIAFULVALENE UNIT; MOLECULAR RECOGNITION; BINDING-SITES; CROWN ETHERS; CYCLOBIS(PARAQUAT-P-PHENYLENE); COMPLEXES; CATENANES; CATALYSIS; SELECTION	The nonenzymatic synthesis of nucleic acids, in particular, RNA, and the template-directed synthesis of artificial organic molecules, such as macrocycles, catenanes and rotaxanes, have both undergone significant development since the last half of the 20th century. The intersection of these two fields affords insights into how template effects can lead to information copying and storage at the molecular level. Mechanistic examples of model template-directed RNA replication experiments as well as those for totally artificial organic template-directed syntheses will be discussed. The fact that templates typically bind to their reacted products more tightly than their unreacted substrates may be a mechanistic feature necessary to store information in the form of nucleic acids. Understanding the mechanisms of nonenzymatic RNA synthesis is not only essential for testing the RNA world hypothesis in the context of the origin of life on Earth and other planetary bodies, but may one day afford chemists the insights to construct their own artificial molecular replicators.	[Fahrenbach, Albert C.] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, Tokyo 1528551, Japan; [Fahrenbach, Albert C.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, Boston, MA 02114 USA; [Fahrenbach, Albert C.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	Fahrenbach, AC (reprint author), Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528551, Japan.	fahrenbach@molbio.mgh.harvard.edu			NSF Graduate Research Fellowship; Earth-Life Science Institute (ELSI)	I would like to first of all thank IUPAC for providing me with the opportunity to write this review. A special thank you goes out to my PhD advisor Professor Fraser Stoddart for his constant support and encouragement that he continues to provide past my graduate career. I would like to acknowledge my current advisor, Professor jack Szostak, for his very valuable input, advice and encouragement. Financial support during my PhD was provided by an NSF Graduate Research Fellowship. I would like to thank the Earth-Life Science Institute (ELSI) for the award of a postdoctoral fellowship and Aaron T. Larsen, Nicholas Guttenberg and Nathaniel Virgo for useful discussions.	Kervio E, 2014, NUCLEIC ACIDS RES, V42, P7409, DOI 10.1093/nar/gku314; Fahrenbach AC, 2013, ADV MATER, V25, P331, DOI 10.1002/adma.201201912; SCHNEIDER HJ, 1991, ANGEW CHEM INT EDIT, V30, P1417, DOI 10.1002/anie.199114171; Engelhart AE, 2013, NAT CHEM, V5, P390, DOI 10.1038/nchem.1623; Barnes JC, 2013, SCIENCE, V339, P429, DOI 10.1126/science.1228429; Mansy SS, 2008, NATURE, V454, P122, DOI 10.1038/nature07018; Kool ET, 1997, CHEM REV, V97, P1473, DOI 10.1021/cr9603791; PEDERSEN CJ, 1967, J AM CHEM SOC, V89, P7017, DOI 10.1021/ja01002a035; Barin G, 2012, CHEMPLUSCHEM, V77, P159, DOI 10.1002/cplu.201100075; Krupkin M, 2011, PHILOS T R SOC B, V366, P2972, DOI 10.1098/rstb.2011.0146; ANDERSON S, 1993, ACCOUNTS CHEM RES, V26, P469, DOI 10.1021/ar00033a003; Stoddart JF, 2009, CHEM SOC REV, V38, P1802, DOI 10.1039/b819333a; Schalley CA, 2004, TOP CURR CHEM, V248, P141, DOI 10.1007/b99913; NAGEL B, 1992, PURE APPL CHEM, V64, P143, DOI 10.1351/pac199264010143; Coskun A, 2012, CHEM SOC REV, V41, P19, DOI 10.1039/c1cs15262a; Beves JE, 2011, ANGEW CHEM INT EDIT, V50, P9260, DOI 10.1002/anie.201007963; THOMPSON MC, 1964, J AM CHEM SOC, V86, P213, DOI 10.1021/ja01056a021; Balzani V, 2000, J ORG CHEM, V65, P1924, DOI 10.1021/jo991781t; Spruell JM, 2010, PURE APPL CHEM, V82, P2281, DOI 10.1351/PAC-CON-10-08-03; Zhang DY, 2011, NAT CHEM, V3, P103, DOI [10.1038/nchem.957, 10.1038/NCHEM.957]; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Leigh DA, 2003, NATURE, V424, P174, DOI 10.1038/nature01758; Arduini A, 2012, CHEM-EUR J, V18, P16203, DOI 10.1002/chem.201201625; JOYCE GF, 1989, NATURE, V338, P217, DOI 10.1038/338217a0; Lewandowski B, 2013, SCIENCE, V339, P189, DOI 10.1126/science.1229753; Coskun A, 2012, CHEM SOC REV, V41, P4827, DOI 10.1039/c2cs35053j; Kay ER, 2007, ANGEW CHEM INT EDIT, V46, P72, DOI 10.1002/anie.200504313; Li H, 2013, J AM CHEM SOC, V135, P18609, DOI 10.1021/ja4094204; Zhu TF, 2009, J AM CHEM SOC, V131, P5705, DOI 10.1021/ja900919c; Asakawa M, 1998, ANGEW CHEM INT EDIT, V37, P333, DOI 10.1002/(SICI)1521-3773(19980216)37:3<333::AID-ANIE333>3.0.CO;2-P; VONKIEDROWSKI G, 1989, ANGEW CHEM INT EDIT, V28, P1235, DOI 10.1002/anie.198912351; Corbett PT, 2006, CHEM REV, V106, P3652, DOI 10.1021/cr020452p; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; PAULING L, 1948, NATURE, V161, P707, DOI 10.1038/161707a0; Zaher HS, 2007, RNA, V13, P1017, DOI 10.1261/rna.548807; Joyce GF, 2006, COLD SPRING HARB MON, V43, P23; BUSCH DH, 1990, COORDIN CHEM REV, V100, P119, DOI 10.1016/0010-8545(90)85007-F; Arias-Gonzalez JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042272; Berger J, 2010, CHEM BIODIVERS, V7, P2581, DOI 10.1002/cbdv.201000108; Brudno Y, 2009, CHEM BIOL, V16, P265, DOI 10.1016/j.chembiol.2009.02.004; BUSCH DH, 1992, J INCLUS PHENOM MOL, V12, P389, DOI 10.1007/BF01053876; CACCIAPAGLIA R, 1993, CHEM SOC REV, V22, P221, DOI 10.1039/cs9932200221; Capobianchi S, 1997, J ORG CHEM, V62, P7015, DOI 10.1021/jo970702f; Capobianchi S, 1998, J ORG CHEM, V63, P8088, DOI 10.1021/jo981390z; Choi JA, 2006, OPERA NEWS, V71, P12; CRAM DJ, 1986, ANGEW CHEM INT EDIT, V25, P1039, DOI 10.1002/anie.198610393; D'Acerno C, 2004, J ORG CHEM, V69, P1393, DOI 10.1021/jo035483e; D'Acerno C, 2000, CHEM-EUR J, V6, P3540, DOI 10.1002/1521-3765(20001002)6:19<3540::AID-CHEM3540>3.0.CO;2-Z; DALE J, 1972, ACTA CHEM SCAND, V26, P1471, DOI 10.3891/acta.chem.scand.26-1471; Doddi G, 2007, J ORG CHEM, V72, P1503, DOI 10.1021/jo062115c; Doddi G, 2001, J ORG CHEM, V66, P4950, DOI 10.1021/jo015684n; Doddi G, 2005, J ORG CHEM, V70, P3761, DOI 10.1021/jo050263h; GOKEL GW, 1976, SYNTHESIS-STUTTGART, P168; GRAY RT, 1976, RECL TRAV CHIM PAY B, V95, P258; GREENE RN, 1972, TETRAHEDRON LETT, P1793; Hazen RM, 2007, P NATL ACAD SCI USA, V104, P8574, DOI 10.1073/pnas.0701744104; Howard A. W., 2012, ASTROPHYS J SUPPL S, V201, P1; ILLUMINATI G, 1983, J AM CHEM SOC, V105, P555, DOI 10.1021/ja00341a041; IUPAC, 2014, COMP CHEM TERM GOLD; Joyce GF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001323; Kanavarioti A, 1999, J ORG CHEM, V64, P8323, DOI 10.1021/jo991216q; Kay ER, 2005, TOP CURR CHEM, V262, P133, DOI 10.1007/128_011; Kozlov IA, 2000, MOL BIOL+, V34, P781, DOI 10.1023/A:1026663422976; MADAN K, 1975, J CHEM SOC CHEM COMM, P427, DOI 10.1039/c39750000427; MANDOLINI L, 1977, J AM CHEM SOC, V99, P7709, DOI 10.1021/ja00465a052; NAYLOR R, 1966, BIOCHEMISTRY-US, V5, P2722, DOI 10.1021/bi00872a032; ODELL B, 1988, ANGEW CHEM INT EDIT, V27, P1547, DOI 10.1002/anie.198815471; Olsen J.-C., 2011, NONCOVALENT ASSEMBLI, P65; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; PAGE MI, 1973, CHEM SOC REV, V2, P295, DOI 10.1039/cs9730200295; Pedersen C. J., 1972, ORG SYNTH, V52, P66; Raymo F. M., 2000, TEMPLATED ORGANIC SY, P75; REINHOUDT DN, 1976, TETRAHEDRON, V32, P1161, DOI 10.1016/0040-4020(76)85040-5; Robertson MP, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003608; Sasselov DD, 2008, NATURE, V451, P29, DOI 10.1038/451029a; Smith E, 2008, J THEOR BIOL, V252, P185, DOI 10.1016/j.jtbi.2008.02.010; Stoddart J. F., 1991, FRONTIERS SUPRAMOLEC, P251; Sue CH, 2010, CHEM SCI, V1, P119, DOI 10.1039/c0sc00176g; Szostak J. W., 2012, J SYS CHEM, V3, P1; VONKIEDROWSKI G, 1986, ANGEW CHEM INT EDIT, V25, P932, DOI 10.1002/anie.198609322; Wintner EA, 1996, ACTA CHEM SCAND, V50, P469, DOI 10.3891/acta.chem.scand.50-0469	81	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0033-4545	1365-3075		PURE APPL CHEM	Pure Appl. Chem.	FEB	2015	87	2					205	218		10.1515/pac-2014-1004		14	Chemistry, Multidisciplinary	Chemistry	CE6KZ	WOS:000351946600010		
J	Takahashi, K; Igel, J; Preetz, H; Sato, M				Takahashi, Kazunori; Igel, Jan; Preetz, Holger; Sato, Motoyuki			Sensitivity analysis of soil heterogeneity for ground-penetrating radar measurements by means of a simple modeling	RADIO SCIENCE			English	Article							LANDMINE DETECTION	Higher-frequency ground-penetrating radar (GPR) is becoming more common for various applications. While it can achieve a higher resolution than low-frequency measurements, it also becomes more sensitive to heterogeneous soils. The increased sensitivity in small-scale measurements often creates the problem of unwanted scattering in the data. Unwanted scattering is commonly called clutter. If clutter contaminates the data significantly, data analysis and interpretation become difficult. Our study analyzes the sensitivity of soil heterogeneity by evaluating the amount of clutter caused by soils. Clutter is calculated by simple modeling that takes into account soil heterogeneity. The method constructs a dielectric sphere model that uses statistical properties of permittivity distribution and calculates backscattering power from the sphere that emulates the backscattering observed from heterogeneous soil. The modeling was carried out for a range of heterogeneities. The results show that the level of permittivity variation of soil mostly dominates the clutter power. However, the influence of correlation length becomes greater when the correlation length of soil permittivity distribution is a multiple of wavelength. Therefore, to observe the influence of heterogeneous soils on GPR measurements, the spatial distribution of soil permittivity must be taken into account in addition to the variation.	[Takahashi, Kazunori; Sato, Motoyuki] Tohoku Univ, Ctr Northeast Asian Studies, Sendai, Miyagi 980, Japan; [Igel, Jan] Leibniz Inst Appl Geophys, Hannover, Germany; [Preetz, Holger] Fed Competence Ctr Soil & Groundwater Protect UXO, Hannover, Germany	Takahashi, K (reprint author), Tohoku Univ, Ctr Northeast Asian Studies, Sendai, Miyagi 980, Japan.	kazunori.takahashi@cneas.tohoku.ac.jp			JSPS [24612001]; Federal Office of Defense Technology and Procurement, Germany	The data for this paper are available upon request to the corresponding author. This work was supported in part by the JSPS Grant-in-Aid for Scientific Research (C) 24612001 and the Federal Office of Defense Technology and Procurement, Germany.	Rea J, 1998, WATER RESOUR RES, V34, P329, DOI 10.1029/97WR03070; MCBRATNEY AB, 1986, J SOIL SCI, V37, P617; Preetz H, 2008, SOIL SCI SOC AM J, V72, P151, DOI 10.2136/sssaj2007.0065; TOPP GC, 1980, WATER RESOUR RES, V16, P574, DOI 10.1029/WR016i003p00574; Bohren C. F., 1983, ABSORPTION SCATTERIN; Duetsch C. V., 1992, GSLIB GEOSTATISTICAL; Goovaerts P., 1997, GEOSTATISTICS NATURA; Igel J., 2008, 12 INT C GPR BIRM UK; Isaaks E.H., 1989, INTRO APPL GEOSTATIS; Jol HM, 2009, GROUND PENETRATING RADAR THEORY AND APPLICATIONS, P1; Lampe B, 2003, GEOPHYSICS, V68, P1934, DOI 10.1190/1.1635047; SIQUEIRA PR, 1995, RADIO SCI, V30, P1325, DOI 10.1029/95RS01760; Takahashi K, 2011, IEEE J-STARS, V4, P739, DOI 10.1109/JSTARS.2011.2106481; Takahashi K, 2014, IEEE T GEOSCI REMOTE, V52, P3464, DOI 10.1109/TGRS.2013.2273082; Takahashi K, 2011, J APPL GEOPHYS, V73, P368, DOI 10.1016/j.jappgeo.2011.02.008; Takahashi K, 2012, INT J ANTENN PROPAG, DOI 10.1155/2012/643430; Tsang L., 1985, THEORY MICROWAVE REM	17	1	1	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	0048-6604	1944-799X		RADIO SCI	Radio Sci.	FEB	2015	50	2					79	86		10.1002/2014RS005499		8	Astronomy & Astrophysics; Geochemistry & Geophysics; Meteorology & Atmospheric Sciences; Remote Sensing; Telecommunications	Astronomy & Astrophysics; Geochemistry & Geophysics; Meteorology & Atmospheric Sciences; Remote Sensing; Telecommunications	CE8IB	WOS:000352084300001		
J	Kayano, Y; Inoue, H				Kayano, Yoshiki; Inoue, Hiroshi			Dominant factors of electromagnetic interference problems of asymmetrical and equi-distance differential-paired lines	RADIO SCIENCE			English	Article							BEND DISCONTINUITIES; TRANSMISSION-LINES; SUPPRESSION; NOISE; BAND	Multichannel differential signaling scheme is one of the key technologies for modern electronics systems. For actual system, the ideal balance or symmetrical topology cannot be established, and hence, an imbalance component is excited. To provide the basic considerations for electromagnetic (EM) radiation from practical asymmetrical differential-paired lines structure with equi-distance routing, in which the same-length paired lines are used in high-speed board/LSI layout design, in this paper we newly attempt to clarify the characteristics and to identify dominant imbalance and EM radiation factor from asymmetrical differential-paired lines, by a physics-based model. The frequency response of EM radiation from asymmetrical differential-paired lines can be identified using the physics-based model. The physics-based model is constructed with an equivalent circuit model to calculate current distribution, and radiation model based on Hertzian dipole antenna. It is validated by comparing the predicted results with finite difference time domain simulation. This paper reported the basic characteristics of imbalance component of differential-paired lines with asymmetrical equi-distance routing and demonstrates the dominant factor of imbalance component and EM radiation successfully.	[Kayano, Yoshiki] Akita Univ, Dept Elect & Elect Engn, Akita 010, Japan; [Inoue, Hiroshi] Open Univ Japan, Akita Study Ctr, Akita, Japan	Kayano, Y (reprint author), Akita Univ, Dept Elect & Elect Engn, Akita 010, Japan.	kayano@gipc.akita-u.ac.jp			JSPS KAKENHI [26820091]	Data supporting all figures are available as in supporting information. The authors sincerely thank to Yasunori Tsuda and Akita Industrial Technology Center, for their support of measurements, and Cyberscience Center, Tohoku University, for their support with computer resources. This research was supported by JSPS KAKENHI (grant-in-aid for Young Scientists (B), grant 26820091).	Sejima K, 2012, IEEE INT SYMP ELEC, P492, DOI 10.1109/ISEMC.2012.6351682; Chang CH, 2012, IEEE T COMP PACK MAN, V2, P1518, DOI 10.1109/TCPMT.2012.2192439; LUEBBERS RJ, 1991, IEEE T ANTENN PROPAG, V39, P429, DOI 10.1109/8.81453; Shiue GH, 2006, IEEE T ADV PACKAGING, V29, P560, DOI 10.1109/TADVP.2006.875413; Gazda C, 2010, IEEE T ADV PACKAGING, V33, P969, DOI 10.1109/TADVP.2010.2077287; Shiue GH, 2012, IEEE T ELECTROMAGN C, V54, P655, DOI 10.1109/TEMC.2011.2173765; Grassi F, 2013, IEEE T ELECTROMAGN C, V55, P1346, DOI 10.1109/TEMC.2013.2261302; Caorsi S, 2001, RADIO SCI, V36, P1363, DOI 10.1029/2000RS002625; Culhaoglu AE, 2014, RADIO SCI, V49, P68, DOI 10.1002/2013RS005242; DAZEY MH, 1982, RADIO SCI, V17, P589, DOI 10.1029/RS017i003p00589; Graham Martin, 2003, HIGH SPEED SIGNAL PR; Hall S. H., 2000, HIGH SPEED DIGITAL S; Kayano Y., 2011, T JIEP, V4, P6; Kayano Y, 2013, URSI INT SYM ELECT, P218; Kayano Y, 2012, IEEE INT SYMP ELEC, P311, DOI 10.1109/ISEMC.2012.6351830; Kayano Y, 2004, IEEE T ELECTROMAGN C, V46, P46, DOI 10.1109/TEMC.2004.823609; Kayano Y, 2011, RADIO SCI, V46, DOI 10.1029/2011RS004735; Kayano Y., 2010, T JIEP, V3, P24; Kraus J. D., 1988, ANTENNAS; Wu TL, 2005, IEEE T MICROW THEORY, V53, P2935, DOI 10.1109/TMTT.2005.845248; Xiao F., 2004, INT S EL COMP EMC SE, P29; Yamaguchi M, 1996, IEEE T MAGN, V32, P4941, DOI 10.1109/20.539295	22	0	0	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	0048-6604	1944-799X		RADIO SCI	Radio Sci.	FEB	2015	50	2					111	121		10.1002/2014RS005507		11	Astronomy & Astrophysics; Geochemistry & Geophysics; Meteorology & Atmospheric Sciences; Remote Sensing; Telecommunications	Astronomy & Astrophysics; Geochemistry & Geophysics; Meteorology & Atmospheric Sciences; Remote Sensing; Telecommunications	CE8IB	WOS:000352084300004		
J	Duan, YL; Shao, XW; Shi, Y; Miyazaki, H; Iwao, K; Shibasaki, R				Duan, Yulin; Shao, Xiaowei; Shi, Yun; Miyazaki, Hiroyuki; Iwao, Koki; Shibasaki, Ryosuke			Unsupervised Global Urban Area Mapping via Automatic Labeling from ASTER and PALSAR Satellite Images	REMOTE SENSING			English	Article							LAND-COVER CLASSIFICATION; SPECTRAL MIXTURE ANALYSIS; DIFFERENCE WATER INDEX; REMOTELY-SENSED DATA; IMPERVIOUS SURFACES; SCALE; VEGETATION; CITIES; ENVIRONMENT; ACCURACY	In this study, a novel unsupervised method for global urban area mapping is proposed. Different from traditional clustering-based unsupervised methods, in our approach a labeler is designed, which is able to automatically select training samples from satellite images by propagating common urban/non-urban knowledge through the unlabeled data. Two kinds of satellite images, captured by the Advanced Spaceborne Thermal Emission and Reflection Radiometer (ASTER) and the Phased Array L-band Synthetic Aperture Radar (PALSAR), are exploited here. In this method, spectral features are first extracted from the original dataset, followed by coarse prediction of urban/non-urban areas via weak classifiers. By developing an improved belief-propagation based clustering algorithm, a confidence map is obtained and training data are selected via weighted sampling. Finally, the urban area map is obtained by employing the Support Vector Machine (SVM) classifier. The proposed method can generate urban area maps at a resolution of 15 m, while the same settings are used for all test cases. Experimental results involving 75 scenes from different climate zones show that our proposed method achieves an overall accuracy of 84.4% and a kappa coefficient of 0.628, which is competitive relative to the supervised SVM method.	[Duan, Yulin; Shibasaki, Ryosuke] Univ Tokyo, Ctr Spatial Informat Sci, Kashiwa, Chiba 2778568, Japan; [Shao, Xiaowei; Miyazaki, Hiroyuki] Univ Tokyo, Earth Observat Data Integrat & Fus Res Initiat, Tokyo 1538505, Japan; [Shi, Yun] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100081, Peoples R China; [Iwao, Koki] Geol Survey Japan, Natl Inst Adv Ind Sci & Technol, Tokyo 1008921, Japan	Shao, XW (reprint author), Univ Tokyo, Earth Observat Data Integrat & Fus Res Initiat, Tokyo 1538505, Japan.	shaoxw@iis.u-tokyo.ac.jp			GRENE Program (Green Network of Excellence) - Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan; National Natural Science Foundation of China [41301365]	This work was supported in part by the GRENE Program (Green Network of Excellence, 2011-2016) funded by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan, and by the National Natural Science Foundation of China under Grant 41301365.	Angel S., 2005, DYNAMICS GLOBAL URBA; Nemmour H, 2006, ISPRS J PHOTOGRAMM, V61, P125, DOI 10.1016/j.isprsjprs.2006.09.004; Sanderson D, 2000, ENVIRON URBAN, V12, P93, DOI 10.1177/095624780001200208; Small C, 2003, REMOTE SENS ENVIRON, V88, P170, DOI 10.1016/j.rse.2003.04.008; Huang X, 2009, INT J REMOTE SENS, V30, P3205, DOI 10.1080/01431160802559046; Loveland TR, 1999, PHOTOGRAMM ENG REM S, V65, P1021; Arino O, 2007, INT GEOSCI REMOTE SE, P2412, DOI 10.1109/IGARSS.2007.4423328; Clarke KC, 1997, ENVIRON PLANN B, V24, P247, DOI 10.1068/b240247; Mas JF, 2008, INT J REMOTE SENS, V29, P617, DOI 10.1080/01431160701352154; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425; Thapa RB, 2009, APPL GEOGR, V29, P135, DOI 10.1016/j.apgeog.2008.08.001; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Potere D, 2009, INT J REMOTE SENS, V30, P6531, DOI 10.1080/01431160903121134; Seto KC, 2010, CURR OPIN SUST, V2, P127; Fan JF, 2014, REMOTE SENS-BASEL, V6, P7840, DOI 10.3390/rs6087840; Fensholt R, 2006, IEEE T GEOSCI REMOTE, V44, P1774, DOI 10.1109/TGRS.2006.875940; Luo Y, 2013, IEEE T IMAGE PROCESS, V22, P523, DOI 10.1109/TIP.2012.2218825; Schneider A, 2010, REMOTE SENS ENVIRON, V114, P1733, DOI 10.1016/j.rse.2010.03.003; Ji L, 2009, PHOTOGRAMM ENG REM S, V75, P1307; Blaschke T, 2011, REMOTE SENS-BASEL, V3, P1743, DOI 10.3390/rs3081743; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Cao X, 2009, REMOTE SENS ENVIRON, V113, P2205, DOI 10.1016/j.rse.2009.06.001; Neteler M, 2012, ENVIRON MODELL SOFTW, V31, P124, DOI 10.1016/j.envsoft.2011.11.014; Stefanov WL, 2005, REMOTE SENS ENVIRON, V99, P31, DOI 10.1016/j.rse.2005.04.024; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; Montgomery MR, 2008, SCIENCE, V319, P761, DOI 10.1126/science.1153012; Kajimoto M, 2013, IEEE GEOSCI REMOTE S, V10, P337, DOI 10.1109/LGRS.2012.2207085; Weng QH, 2012, REMOTE SENS ENVIRON, V117, P34, DOI 10.1016/j.rse.2011.02.030; Belkin M, 2006, J MACH LEARN RES, V7, P2399; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; Yamaguchi Y, 1998, IEEE T GEOSCI REMOTE, V36, P1062, DOI 10.1109/36.700991; Zhou DY, 2004, ADV NEUR IN, V16, P321; Schneider A, 2003, PHOTOGRAMM ENG REM S, V69, P1377; Bontemps S., GLOBCOVER 2009 PRODU; Chang C-C, 2011, ACM T INTEL SYST TEC, V2, P3, DOI DOI 10.1145/1961189.1961199; Chen Y, 2007, INT J REMOTE SENS, V28, P4645; CIESIN (Center for International Earth Science Information Network), GLOB RUR URB MAPP PR; Cristianini N, 2000, INTRO SUPPORT VECTOR; Department for Economic and Social Affairs United Nations, 2013, WORLD POP PROSP; Doocy Shannon, 2007, Am J Public Health, V97 Suppl 1, pS146, DOI 10.2105/AJPH.2006.095240; Eddins S.L., 2004, DIGITAL IMAGE PROCES; Esch T, 2012, J APPL REMOTE SENS, V6, DOI 10.1117/1.JRS.6.061702; Galletti CS, 2014, REMOTE SENS-BASEL, V6, P6089, DOI 10.3390/rs6076089; Gao F, 2012, INT J REMOTE SENS, V33, P7609, DOI 10.1080/01431161.2012.700424; Itabashi K., 2011, P AS C REM SENS TAIP, P432; Kellndorfer JM, 1998, IEEE T GEOSCI REMOTE, V36, P1396, DOI 10.1109/36.718844; LP DAAC (Land Processes Distributed Active Archive Center) U.S. Department of the Interior, LAND COV TYP YEARL L; MathWorks, DOC ENTR; Mountrakis G, 2011, ISPRS J PHOTOGRAMM, V66, P247, DOI 10.1016/j.isprsjprs.2010.11.001; Orenstein DE, 2011, INT J REMOTE SENS, V32, P2621, DOI 10.1080/01431161003713036; Pu RL, 2008, REMOTE SENS ENVIRON, V112, P939, DOI 10.1016/j.rse.2007.07.005; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; Rosenqvist A, 2007, IEEE T GEOSCI REMOTE, V45, P3307, DOI 10.1109/TGRS.2007.901027; Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003; Sekiguchi S, 2008, IEEE SYST J, V2, P374, DOI 10.1109/JSYST.2008.925976; Serra J., 1982, IMAGE ANAL MATH MORP; Triguero I., 2013, KNOWL INF SYST, V42, P1; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; TURK G, 1979, REMOTE SENS ENVIRON, V8, P65, DOI 10.1016/0034-4257(79)90024-5; Weng Q, 2014, GLOBAL URBAN MONITOR; Weng QH, 2008, IEEE T GEOSCI REMOTE, V46, P2397, DOI 10.1109/TGRS.2008.917601; Yamamoto N., 2006, P 6 IEEE INT C COMP, P75	64	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-4292			REMOTE SENS-BASEL	Remote Sens.	FEB	2015	7	2					2171	2192		10.3390/rs70202171		22	Remote Sensing	Remote Sensing	CF1BZ	WOS:000352279900001		
J	Kose, R; Yamaguchi, K; Okayama, T				Kose, Ryota; Yamaguchi, Kouki; Okayama, Takayuki			Influence of Addition of Fine Cellulose Fibers on Physical Properties and Structure of Paper	SEN-I GAKKAISHI			English	Article								Recently, various fine cellulose fibers (CFs) such as cellulose nanofiber and microfibrillated cellulose have been developed. However, it is not clear how the addition of these fine CFs influences the physical properties and structure of paper. This study examines the benefits of adding fine CFs, including nano- and submicron-sized CFs, to paper by mixing them into unbeaten pulp, and discusses CF size differences between the micron and smaller scales. Two types of CFs were used in this study. One consists of micro-, submicron-, and nano-sized CFs (CF1) and another consists of nano- and submicron-sized CFs (CF2). The results show that both CF1 and CF2 enhance the tensile index, stretch at break, and tensile energy absorption of a handsheet. To explain these results, the fiber strength index and bond strength index were calculated using the Page's equation, and the tensile index for the handsheets with CF1 and CF2 showed a strong correlation with the bond strength index, thus suggesting that CF1 and CF2 were deposited in locations where there was interfiber bonding. However, differences were observed in the internal structures of the paper samples, indicating that CF2 did not change the pore volume and pore size of the resulting samples.	[Kose, Ryota; Okayama, Takayuki] Tokyo Univ Agr & Technol, Inst Agr, Div Nat Resources & Ecomat, Fuchu, Tokyo 1838509, Japan; [Yamaguchi, Kouki] Tokyo Univ Agr & Technol, Fac Agr, Dept Environm & Nat Resource Sci, Fuchu, Tokyo 1838509, Japan	Okayama, T (reprint author), Tokyo Univ Agr & Technol, Inst Agr, Div Nat Resources & Ecomat, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	okayama@cc.tuat.ac.jp	Okayama, Takayuki/E-1120-2013				PAGE DH, 1969, TAPPI, V52, P674; Abe K, 2009, CELLULOSE, V16, P1017, DOI 10.1007/s10570-009-9334-9; Wagberg L, 2008, LANGMUIR, V24, P784, DOI 10.1021/la702481v; Arbatan T, 2012, CHEM ENG J, V210, P74, DOI 10.1016/j.cej.2012.08.074; [Anonymous], TAPP TEST METH; Saito T, 2006, BIOMACROMOLECULES, V7, P1687, DOI 10.1021/bm060154s; Isogai A, 2013, J WOOD SCI, V59, P449, DOI 10.1007/s10086-013-1365-z; Kose R, 2011, BIOMACROMOLECULES, V12, P716, DOI 10.1021/bm1013469; Taipale T, 2010, CELLULOSE, V17, P1005, DOI 10.1007/s10570-010-9431-9; Nogi M., 2013, APPL PHYS LETT, V102; Onogi Y., 1974, J TAPPI, V28, P99; Retulainen E., 1998, PAPER PHYS, P63; Suzuki K., 1979, JAPAN TAPPI J, V33, P347; Turbak A. F., 1983, J APPL POLYM SCI APP, V37, P815; White R. E., 1962, TAPPI, V45, P279	15	0	0	SOC FIBER SCIENCE TECHNOLOGY	TOKYO	KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN	0037-9875			SEN-I GAKKAISHI	Sen-I Gakkaishi	FEB	2015	71	2					85	90				6	Materials Science, Textiles; Polymer Science	Materials Science; Polymer Science	CE5MY	WOS:000351881000009		
J	Kanmuri, S; Kobayashi, K; Kimura, Y; Masutani, K				Kanmuri, Shuhei; Kobayashi, Koji; Kimura, Yoshiharu; Masutani, Kazunari			Preparation of Chain-Extended Poly(hexamethylene/pentamethylene carbonate)s and Their Block Copolymerization with Poly-L-lactide into Partly Biobased Thermoplastic Elastomers	SEN-I GAKKAISHI			English	Article							ALIPHATIC POLYCARBONATE; MECHANICAL-PROPERTIES; COPOLYCARBONATES	A commercially available carbonate oligomer, poly(hexamethylene/pentamethylene carbonate) (PHPC), was found to involve various minor units that had been formed during the ester-exchanging polycondensation of ethylene carbonate and a mixture of 1,6-hexanediol and 1,5-pentanediol. This PHPC oligomer was chain-extended by using diphenyl carbonate as chain extender and then subjected to tin-catalyzed ring-opening polymerization of L-lactide to prepare ABA in-block copolymers consisting of poly-L-lactide (PLLA) and PHPC as the hard A and soft B blocks, respectively. With the chain-extended PHPC as the macro-initiators, the molecular weights of the resultant copolymers became significantly higher even at increased contents of PHPC. The in-block copolymers obtained were fabricated into polymer films by solution casting, and their properties were analyzed. It was revealed that the in-block copolymers PLLA-PHPC-PLLA can be novel thermoplastic elastomers that are environmentally friendly in terms of utilization of carbon dioxide as feedstock.	[Kanmuri, Shuhei; Kimura, Yoshiharu] Kyoto Inst Technol, Dept Biobased Mat Sci, Sakyo Ku, Kyoto 6068585, Japan; [Kobayashi, Koji] TOYOBO Co Ltd, Res Ctr, Otsu, Shiga 5200292, Japan; [Masutani, Kazunari] Kyoto Inst Technol, Ctr Fiber & Text Sci, Sakyo Ku, Kyoto 6068585, Japan	Masutani, K (reprint author), Kyoto Inst Technol, Ctr Fiber & Text Sci, Sakyo Ku, Kyoto 6068585, Japan.						Fenouillot F, 2010, PROG POLYM SCI, V35, P578, DOI 10.1016/j.progpolymsci.2009.10.001; Kiran S, 2012, J BIOMED MATER RES A, V100A, P3472, DOI 10.1002/jbm.a.34295; Tian DW, 2012, ACS CATAL, V2, P2029, DOI 10.1021/cs300462r; Lu LB, 2005, POLYM INT, V54, P870, DOI 10.1002/pi.1765; Jiang ZZ, 2008, MACROMOLECULES, V41, P4671, DOI 10.1021/ma702868a; Song QW, 2013, GREEN CHEM, V15, P110, DOI 10.1039/c2gc36210d; Li Q, 2013, J POLYM SCI POL CHEM, V51, P1387, DOI 10.1002/pola.26507; Saralegi A, 2013, POLYM BULL, V70, P2193, DOI 10.1007/s00289-013-0930-3; Kricheldorf HR, 1997, J MACROMOL SCI R M C, VC37, P599; Chatti S, 2006, MACROMOLECULES, V39, P9064, DOI 10.1021/ma0606051; Pego AP, 2003, POLYMER, V44, P6495, DOI 10.1016/S0032-3861(03)00668-2; Lee CH, 2013, J APPL POLYM SCI, V127, P530, DOI 10.1002/app.37838; Hrdlicka Z, 2014, CHEM PAP, V68, P233, DOI 10.2478/s11696-013-0439-0; Kobayashi K, 2014, MACROMOL MATER ENG, V299, P1384, DOI 10.1002/mame.201400098; Lee CH, 2011, J MATER CHEM, V21, P6844, DOI 10.1039/c1jm10087d; Rokicki A., 1981, J MACROMOL CHEM C, V21, P123; Yu T, 2009, POLYM INT, V58, P1058, DOI 10.1002/pi.2633	17	0	0	SOC FIBER SCIENCE TECHNOLOGY	TOKYO	KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN	0037-9875			SEN-I GAKKAISHI	Sen-I Gakkaishi	FEB	2015	71	2					91	104				14	Materials Science, Textiles; Polymer Science	Materials Science; Polymer Science	CE5MY	WOS:000351881000010		
J	Kitagawa, T; Sugihara, H; Tsutsumi, M				Kitagawa, Tooru; Sugihara, Hideki; Tsutsumi, Masayuki			The Effect of Non-Aqueous Coagulation in the Structure of Poly-p-phenylenebenzobisoxazole (PBO) Fibers	SEN-I GAKKAISHI			English	Article							POLY(P-PHENYLENE BENZOBISOXAZOLE) FIBERS; VIBRATIONAL SPECTROSCOPIC MEASUREMENT; RAMAN BAND SHIFTS; X-RAY-SCATTERING; STRESS-DISTRIBUTION; TENSION; CRYSTAL	This article concerns surface roughness of PBO fibers. Atomic force microscopy is applied to measuring the surface roughness of the PBO AS, HM and HM+ fibers. Also linear thermal expansion was measured. The reason that the surface roughness is decreased as fiber modulus increases is discussed from the viewpoint of microscopic fiber surface structure. There is a discussion in that the smoothness of fiber surface has relation with fiber modulus, molecular orientation and crystallinity of the fibers. The coefficient of thermal expansion is also measured. The PBO HM+ fiber shows a lower value (-8.7 x 10(-6) K-1) of coefficient of thermal expansion than that of the PBO HM.	[Kitagawa, Tooru; Sugihara, Hideki; Tsutsumi, Masayuki] TOYOBO CO LTD, Res Ctr, Membrane Struct Dev Grp, Otsu, Shiga 5200292, Japan	Kitagawa, T (reprint author), TOYOBO CO LTD, Res Ctr, Membrane Struct Dev Grp, 2-1-1 Katata, Otsu, Shiga 5200292, Japan.	Tooru_Kitagawa@toyobo.jp					BAI SJ, 1992, POLYMER, V33, P2136, DOI 10.1016/0032-3861(92)90880-6; Kitagawa T, 1998, J POLYM SCI POL PHYS, V36, P39, DOI 10.1002/(SICI)1099-0488(19980115)36:1<39::AID-POLB5>3.3.CO;2-5; ROITMAN DB, 1993, MACROMOLECULES, V26, P5174, DOI 10.1021/ma00071a030; ROITMAN DB, 1993, MACROMOLECULES, V26, P4381, DOI 10.1021/ma00068a050; MARTIN DC, 1991, MACROMOLECULES, V24, P2450, DOI 10.1021/ma00009a049; Tashiro K, 1998, MACROMOLECULES, V31, P5430, DOI 10.1021/ma980113r; Kitagawa T, 2002, J POLYM SCI POL PHYS, V40, P1281, DOI 10.1002/polb.10185; Kitagawa T, 2002, J MACROMOL SCI PHYS, VB41, P61, DOI 10.1081/MB-120002346; Kitagawa T, 2002, J POLYM SCI POL PHYS, V40, P1269, DOI 10.1002/polb.10186; WIERSCHKE SG, 1992, POLYMER, V33, P3357, DOI 10.1016/0032-3861(92)91092-G; Davies RJ, 2005, POLYMER, V46, P1935, DOI 10.1016/j.polymer.2004.12.031; YOUNG RJ, 1990, J MATER SCI, V25, P127, DOI 10.1007/BF00544197; Fratini AV, 1989, MATER RES SOC S P, V134, P431; HARAGUCHI K, 1979, J APPL POLYM SCI, V23, P903, DOI 10.1002/app.1979.070230325; HUNSAKER ME, 1992, POLYMER, V33, P2128, DOI 10.1016/0032-3861(92)90879-2; Kitagawa T, 2014, J MATER SCI, V49, P6467, DOI 10.1007/s10853-014-8377-y; Kitagawa T, 2001, POLYMER, V42, P2101, DOI 10.1016/S0032-3861(00)00571-1; Kitagawa T, 2000, J POLYM SCI POL PHYS, V38, P2901, DOI 10.1002/1099-0488(20001115)38:22<2901::AID-POLB50>3.3.CO;2-R; Kitagawa T, 2000, J POLYM SCI POL PHYS, V38, P1605, DOI 10.1002/(SICI)1099-0488(20000615)38:12<1605::AID-POLB50>3.3.CO;2-Q; Kitagawa T., UNPUB; KRAUSE SJ, 1988, POLYMER, V29, P1354, DOI 10.1016/0032-3861(88)90297-2; KUMAR S, 1994, POLYMER, V35, P5408, DOI 10.1016/S0032-3861(05)80003-5; Ledbetter H. D., 1989, MATER RES SOC S P, V134, P253; WOLFE JF, 1988, ENCY POLYM SCI ENG, V11, P601; Yabuki K., 1975, SEN-I GAKKAISHI, V31, pT524	25	3	3	SOC FIBER SCIENCE TECHNOLOGY	TOKYO	KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN	0037-9875			SEN-I GAKKAISHI	Sen-I Gakkaishi	FEB	2015	71	2					105	111				7	Materials Science, Textiles; Polymer Science	Materials Science; Polymer Science	CE5MY	WOS:000351881000011		
J	Suzuta, K; Hamada, K; Arai, K				Suzuta, Kazuyuki; Hamada, Kunihiro; Arai, Kozo			Reproduction Mechanism of SS Cross-Links in Permed Hair by the Washing after Reduction with Thioglycolic Acid	SEN-I GAKKAISHI			Japanese	Article							PERMANENT WAVING PERFORMANCE; BENDING RELAXATION PROPERTIES; REDUCING AGENTS; KERATIN FIBERS; ALPHA-KERATIN; WOOL; NUMBER; PROTEIN; DESORPTION; COMPONENTS	Permanent waving is important process to set hair configuration for the maintenance of wanted hairstyle. This process consists of scission of disulfide (SS) cross-links in hair keratin by reduction, washing with water to remove reductants, and subsequent reformation by oxidation. It is important to assess the type, number and location of SS cross-links to understand setting mechanism which has been still unknown. Even though the reduction of SS bonds with thiol is equilibrium reaction, there are few researches focusing on washing step which may decrease drastically the concentration of reductants inside or on the surface of the hair fiber. In a permanent waving system consisting of three step processes of reduction with thioglycolic acid (TGA), washing with water and oxidation by sodium bromate, we attempted to quantify the amount of reformation of SS cross-links during washing, and clarify the effect of washing time on the reproduction of the SS cross-links in microstructures of hair. In order to estimate the change in the cross-link density of hair, the force-extension curve for rubber-like swollen hair fibers treated in a specific diluents mixture was analyzed by using a rubber elasticity theory derived from a two-phase model comprising of the globular matrix of keratin-associated proteins (KAP) dispersed in a swollen network of the intermediate filament (IF) proteins. It was found that the integrity of the SS cross-linked structure of IF is retained, while the intermolecular SS cross-links between KAP molecules cleaved by the reduction are regenerated by the reverse reaction of the equilibrium reactions occurring during washing, and this leads to increase of the extension modulus and breaking stress of the hair fibers in water.	[Suzuta, Kazuyuki] Milbon Co Ltd, Cent Res Inst, Osaka 5340015, Japan; [Suzuta, Kazuyuki; Hamada, Kunihiro] Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 3868567, Japan; [Arai, Kozo] KRA Wool Res Lab, Kiryu, Gunma 3760011, Japan	Suzuta, K (reprint author), Milbon Co Ltd, Cent Res Inst, 2-3-35 Zengenji, Osaka 5340015, Japan.						FLORY PJ, 1956, J AM CHEM SOC, V78, P5222, DOI 10.1021/ja01601a025; ARAI K, 1993, J APPL POLYM SCI, V47, P1973, DOI 10.1002/app.1993.070471107; Kon R, 1998, J COSMET SCI, V49, P13; Naito S, 1996, J APPL POLYM SCI, V61, P1913, DOI 10.1002/(SICI)1097-4628(19960912)61:11<1913::AID-APP6>3.0.CO;2-M; Arai K, 1996, J APPL POLYM SCI, V60, P169, DOI 10.1002/(SICI)1097-4628(19960411)60:2<169::AID-APP4>3.0.CO;2-Q; Langbein L, 2001, J BIOL CHEM, V276, P35123, DOI 10.1074/jbc.M103305200; ARAI K, 1989, J APPL POLYM SCI, V38, P1159, DOI 10.1002/app.1989.070380613; Ogawa S, 2008, SEN-I GAKKAISHI, V64, P137; Nishikawa N, 1998, POLYMER, V39, P3835, DOI 10.1016/S0032-3861(97)10299-3; PARRY DAD, 1985, INT J BIOL MACROMOL, V7, P203, DOI 10.1016/0141-8130(85)90003-0; ARAI K, 1991, J APPL POLYM SCI, V42, P1125, DOI 10.1002/app.1991.070420426; Suzuta K, 2012, J COSMET SCI, V63, P177; DOWLING LM, 1986, BIOCHEM J, V236, P705; Arai K., 1980, P 6 INT WOOL TEXT RE, V2, P285; Crewther W. G., 1980, FIBROUS PROTEINS SCI, V2, P151; FEUGHELMAN M, 1990, J SOC COSMET CHEM, V41, P209; FEUGHELMAN M, 1991, J SOC COSMET CHEM, V42, P129; HAMADA K, 1987, POLYM J, V19, P701, DOI 10.1295/polymj.19.701; JACKSON JHE, 1952, J SOC DYERS COLOUR, V68, P345; Joko K, 2013, SEN-I GAKKAISHI, V69, P8; Joko K, 2013, SEN-I GAKKAISHI, V69, P19; Joko K, 2014, SEN-I GAKKAISHI, V70, P152; Kuzuhara A, 2013, J MOL STRUCT, V1037, P85, DOI 10.1016/j.molstruc.2012.12.040; Leonard Jr W. J., 1976, J POLYM SCI POLYM  C, V54, P237; Naito S, 1996, J APPL POLYM SCI, V61, P2113; NICHOLLS CH, 1956, J SOC DYERS COLOUR, V72, P479; Ogawa S, 2009, SEN-I GAKKAISHI, V65, P15; Okano M., 1998, J SOC COSMET CHEM JA, V32, P43; Sakurai K, 2010, SEN-I GAKKAISHI, V66, P272; Shin H, 1999, SEN-I GAKKAISHI, V55, P155; Treloar L. R. G., 1975, PHYS RUBBER ELASTICI; Weigmann D., 1966, TEXT RES J, V36, P535; Wickett R. R., 1991, COSMET TOILETRIES, V106, P37; WORTMANN FJ, 1990, J SOC COSMET CHEM, V41, P123	34	1	1	SOC FIBER SCIENCE TECHNOLOGY	TOKYO	KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN	0037-9875			SEN-I GAKKAISHI	Sen-I Gakkaishi	FEB	2015	71	2					112	120				9	Materials Science, Textiles; Polymer Science	Materials Science; Polymer Science	CE5MY	WOS:000351881000012		
J	Jackson, BV; Odstrcil, D; Yu, HS; Hick, PP; Buffington, A; Mejia-Ambriz, JC; Kim, J; Hong, S; Kim, Y; Han, J; Tokumaru, M				Jackson, B. V.; Odstrcil, D.; Yu, H. -S.; Hick, P. P.; Buffington, A.; Mejia-Ambriz, J. C.; Kim, J.; Hong, S.; Kim, Y.; Han, J.; Tokumaru, M.			The UCSD kinematic IPS solar wind boundary and its use in the ENLIL 3-D MHD prediction model	SPACE WEATHER-THE INTERNATIONAL JOURNAL OF RESEARCH AND APPLICATIONS			English	Article							REMOTE-SENSING OBSERVATIONS; INTERPLANETARY SCINTILLATION OBSERVATIONS; TIME-DEPENDENT TOMOGRAPHY; ADVANCED COMPOSITION EXPLORER; CORONAL MASS EJECTIONS; HELIOSPHERIC TOMOGRAPHY; RECONSTRUCTION; DISTURBANCES; CME; STREAMS	The University of California, San Diego interplanetary scintillation (IPS) time-dependent kinematic 3-D reconstruction technique has been used and expanded upon for over a decade to provide predictions of heliospheric solar wind parameters. These parameters include global reconstructions of velocity, density, and (through potential field modeling and extrapolation upward from the solar surface) radial and tangential interplanetary magnetic fields. Time-dependent results can be extracted at any solar distance within the reconstructed volume and are now being exploited as inner boundary values to drive the ENLIL 3-D MHD model in near real time. The advantage of this coupled system is that it uses the more complete physics of 3-D MHD modeling to provide an automatic prediction of coronal mass ejections and solar wind stream structures several days prior to their arrival at Earth without employing coronagraph observations. Here we explore, with several examples, the current differences between the IPS real-time kinematic analyses and those from the ENLIL 3-D MHD modeling using IPS-derived real-time boundaries. Future possibilities for this system include incorporating many different worldwide IPS stations as input to the remote sensing analysis using ENLIL as a kernel in the iterative 3-D reconstructions.	[Jackson, B. V.; Yu, H. -S.; Hick, P. P.; Buffington, A.; Mejia-Ambriz, J. C.] Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA; [Odstrcil, D.] George Mason Univ, Sch Phys Astron & Computat Sci, Fairfax, VA 22030 USA; [Odstrcil, D.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Mejia-Ambriz, J. C.] Univ Nacl Autonoma Mexico, Unidad Michoacan, Inst Geofis, SCiESMEX, Morelia, Michoacan, Mexico; [Kim, J.; Hong, S.; Kim, Y.; Han, J.] Natl Radio Res Agcy, Korean Space Weather Ctr, Jeju Si, South Korea; [Tokumaru, M.] Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Jackson, BV (reprint author), Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA.	bvjackson@ucsd.edu			AFOSR [FA9550-11-1-0324]; NSF [AGS-1053766, AGS-1358399]; UC MEXUS CONACyT program while at UCSD; NASA/NSF LWS Partnership for Collaborative Space Weather Modeling program Collaborative Space Weather [11-LWSCSW11-0034]	The KSWC initiated and have supported this project from its onset with partial funding to B.V. Jackson and D. Odstrcil. In addition, B.V. Jackson, H.-S. Yu., and A. Buffington have been partially funded by AFOSR contract FA9550-11-1-0324 and NSF contracts AGS-1053766 and AGS-1358399 to the University of California, San Diego. J. Mejia-Ambriz thanks and acknowledges his support from the UC MEXUS CONACyT program while at UCSD. D. Odstrcil also acknowledges support from the NASA/NSF LWS Partnership for Collaborative Space Weather Modeling program Collaborative Space Weather 11-LWSCSW11-0034 project for this effort. The SWIFT IPS observations were carried out under the solar wind program of the Solar-Terrestrial Environment Laboratory (STELab) of Nagoya University. The STELab near-real-time IPS observations used in these analyses are available online at . We are grateful for the SOHO LASCO team and especially K. Schenk for providing alerts (e-mail: email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Soho-halo-alert@grace.nascom.nasa.gov">Soho-halo-alert@grace.nascom.nasa.gov) and for making available the LASCO C2 and C3 observations at used in these analyses. We thank the ACE spacecraft group for making their data available in real time for use at UCSD through the Space Weather Prediction Center, NOAA, Boulder, and for Figure rid="#swe20202-fig-0004" at and to the Wind spacecraft group for making their data available for Figures rid="#swe20202-fig-0006" and rid="#swe20202-fig-0007" at . A special thanks is warranted for the SOHO/CELIAS data made available to UCSD in near real time by the Proton Monitor group at the University of Maryland, College Park, USA at ftp://space.umd.edu/pm/houraverages.txt.	ANANTHAKRISHNAN S, 1980, J GEOPHYS RES-SPACE, V85, P6025, DOI 10.1029/JA085iA11p06025; Hovestadt D, 1995, SOL PHYS, V162, P441, DOI 10.1007/BF00733436; Jackson BV, 2003, AIP CONF PROC, V679, P75; Jackson BV, 2004, ASTROPHYS SPACE SC L, V314, P355; HEWISH A, 1964, NATURE, V203, P1214, DOI 10.1038/2031214a0; Jackson BV, 2013, SOL PHYS, V285, P151, DOI 10.1007/s11207-012-0102-x; Jackson BV, 2011, J ATMOS SOL-TERR PHY, V73, P1214, DOI 10.1016/j.jastp.2010.10.007; Toth G, 2012, J COMPUT PHYS, V231, P870, DOI 10.1016/j.jcp.2011.02.006; Odstrcil D, 2003, ADV SPACE RES, V32, P497, DOI 10.1016/S0273-1177(03)00332-6; Mejia-Ambriz JC, 2010, SOL PHYS, V265, P309, DOI 10.1007/s11207-010-9562-z; Kim TK, 2014, J GEOPHYS RES-SPACE, V119, P7981, DOI 10.1002/2013JA019755; Kojima M, 1998, J GEOPHYS RES-SPACE, V103, P1981, DOI 10.1029/97JA02162; HEWISH A, 1986, SOL PHYS, V106, P185, DOI 10.1007/BF00161362; Arge CN, 2000, J GEOPHYS RES-SPACE, V105, P10465, DOI 10.1029/1999JA000262; KOJIMA M, 1987, J GEOPHYS RES, V92, P7269, DOI 10.1029/JA092iA07p07269; Jackson BV, 1998, J GEOPHYS RES-SPACE, V103, P12049, DOI 10.1029/97JA02528; Chashei IV, 2013, SOL PHYS, V285, P141, DOI 10.1007/s11207-012-9952-5; Odstrcil D, 1999, J GEOPHYS RES-SPACE, V104, P483, DOI 10.1029/1998JA900019; Stone EC, 1998, SPACE SCI REV, V86, P1, DOI 10.1023/A:1005082526237; Scherrer PH, 2012, SOL PHYS, V275, P207, DOI 10.1007/s11207-011-9834-2; Brueckner GE, 1995, SOL PHYS, V162, P357, DOI 10.1007/BF00733434; Odstrcil D, 2008, ASTR SOC P, V385, P167; Yu HS, 2012, AIP CONF PROC, V1500, P147, DOI 10.1063/1.4768758; McComas DJ, 1998, SPACE SCI REV, V86, P563, DOI 10.1023/A:1005040232597; GAPPER GR, 1982, NATURE, V296, P633, DOI 10.1038/296633a0; Hick PP, 2004, P SOC PHOTO-OPT INS, V5171, P287, DOI 10.1117/12.513122; Bisi MM, 2009, ANN GEOPHYS-GERMANY, V27, P4479, DOI 10.5194/angeo-27-4479-2009; DOMINGO V, 1995, SPACE SCI REV, V72, P81, DOI 10.1007/BF00768758; Manoharan PK, 2010, SOL PHYS, V265, P137, DOI 10.1007/s11207-010-9593-5; Dunn T, 2005, SOL PHYS, V227, P339, DOI 10.1007/s11207-005-2759-x; Jackson BV, 2010, SOL PHYS, V265, P245, DOI 10.1007/s11207-010-9529-0; BEHANNON KW, 1991, J GEOPHYS RES, V96, P21213, DOI 10.1029/91JA02267; Bisi M. M., 2014, COMMUNICATION   0728; Bisi M. M., 2007, ADV GEOSCI, V14, P161; Bisi M. M., 2008, ADV GEOSCI, V21, P1; Hayashi K, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009567; Hayashi M., 2012, J GEOPHYS RES, V117, DOI [10.1029/2011JA017490, DOI 10.1029/2011JA017490]; HOUMINER Z, 1971, NATURE-PHYS SCI, V231, P165; Jackson B. V., 2012, ADV GEOSCI, V30, P93; Jackson B. V., 2014, COMMUNICATION   0423; Jackson B. V., 2008, ADV GEOSCI, V21, P339; Jackson BV, 2007, SOL PHYS, V241, P385, DOI 10.1007/s11207-007-0276-9; Jackson BV, 2010, ASTROPHYS J, V724, P829, DOI 10.1088/0004-637X/724/2/829; Kim J.-H., 2013, 2013 STELAB IPS WORK; Kim TK, 2012, AIP CONF PROC, V1500, P140, DOI 10.1063/1.4768757; Kojima M, 2003, P SOC PHOTO-OPT INS, V4853, P121, DOI 10.1117/12.460271; Lugaz N, 2011, ADV SPACE RES, V48, P292, DOI 10.1016/j.asr.2011.03.015; MacNeice P. J., 2011, AGU FALL M PROGR SAN; MacNeice P. J., 2012, SHINE 12 WORKSH MAUI; Meng X., 2013, CONNECTING REMOTE SE; Oberoi D, 2012, RADIO SCI, V47, DOI 10.1029/2012RS004992; Odstrcil D., 2005, SPIE 50 ANN M OPT PH; Odstrcil D., 2012, CCMC WORKSH KEY LARG; Odstrcil D., 2007, CCMC WORKSH AR PUERT; Schenk K., 2014, 18 APRIL SOHO HALO A; Shibata K., 2007, SPACE WEATHER, V5, DOI [10.1029/2006SW000306, DOI 10.1029/2006SW000306]; Tatarski V. I., 1961, WAVE PROPAGATION TUR; Tokumaru M, 2013, P JPN ACAD B-PHYS, V89, P67, DOI 10.2183/pjab.89.67; Tokumaru M, 2011, RADIO SCI, V46, DOI 10.1029/2011RS004694; Wu CC, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA012211; Wu CC, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016947; Yu H.-S., 2013, SPAC WEATH WEEK BOUL; ZHAO XP, 1995, J GEOPHYS RES, V100, P19, DOI 10.1029/94JA02266	63	2	2	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	1542-7390			SPACE WEATHER	Space Weather	FEB	2015	13	2					104	115		10.1002/2014SW001130		12	Astronomy & Astrophysics; Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	Astronomy & Astrophysics; Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	CE0ZP	WOS:000351541000003		
J	Bocherer, S; Das, S				Boecherer, Siegfried; Das, Soumya			LINEAR INDEPENDENCE OF POINCARE SERIES OF EXPONENTIAL TYPE VIA NON-ANALYTIC METHODS	TRANSACTIONS OF THE AMERICAN MATHEMATICAL SOCIETY			English	Article						Congruences; Siegel modular forms; Fourier coefficients; Poincare series	SIEGEL MODULAR-FORMS; THETA-SERIES; ZETA-FUNCTIONS; MOD-P; OPERATOR	Given a finite set {T} of symmetric, positive definite, half-integral n by n matrices over Z which are inequivalent under the action of GL(n, Z), we show that the corresponding set of Poincare series {P-k(n) (T)} attached to them are linearly independent for weights k in infinitely many arithmetic progressions. We also give a quite explicit description of those arithmetic progressions for all even degrees, when the matrices T have no improper automorphisms and their level is an odd prime. Our main tools are theta series with simple harmonic polynomials as coefficients and techniques familiar from the theory of modular forms mod p.	[Boecherer, Siegfried] Univ Tokyo, Grad Sch Math Sci, Komaba, Tokyo 1538914, Japan; [Das, Soumya] Tata Inst Fundamental Res, Sch Math, Bombay 400005, Maharashtra, India	Bocherer, S (reprint author), Univ Tokyo, Grad Sch Math Sci, Komaba, Tokyo 1538914, Japan.	boecherer@t-online.de; somu@math.tifr.res.in			Graduate School of Mathematical Sciences at the University of Tokyo	We thank the Tata Institute of Fundamental Research, Mumbai, where a first draft of this work was done, for providing excellent working conditions. During the preparation of the final version, the first author was supported by the Graduate School of Mathematical Sciences at the University of Tokyo, and he wishes to thank in particular Professor T. Oda for arranging this stay. We thank the anonymous referee for comments on the paper.	Ahlgren S, 2008, MATH COMPUT, V77, P1725, DOI 10.1090/S0025-5718-08-02078-4; Andrianov A. N., 1995, TRANSLATIONS MATH MO, V145; Andrianov AN, 2008, ST PETERSB MATH J, V19, P675, DOI 10.1090/S1061-0022-08-01015-7; Andrianov Anatolij N., 1987, GRUND MATH WISS, V286; Das S, 2012, MATH Z, V272, P869, DOI 10.1007/s00209-011-0961-0; Choie Y, 2005, B LOND MATH SOC, V37, P335, DOI 10.1112/S0024609305004285; Bocherer S, 2007, MATH ANN, V338, P421, DOI 10.1007/s00208-007-0081-7; SHIMURA G, 1973, ANN MATH, V97, P440, DOI 10.2307/1970831; Bauer R., 1988, THESIS DIPLOMARBEIT; Bocherer S, 2005, J MATH KYOTO U, V45, P807; Bocherer S., ARXIV13052813MATHNT; Bocherer S, 2010, MANUSCRIPTA MATH, V132, P501, DOI 10.1007/s00229-010-0357-1; Bocherer S, 1999, J NUMBER THEORY, V78, P119, DOI 10.1006/jnth.1999.2404; CHRISTIAN U, 1962, MATH ANN, V148, P257, DOI 10.1007/BF01451138; Das S, 2012, ACTA ARITH, V156, P75, DOI 10.4064/aa156-1-6; Das S, 2012, B LOND MATH SOC, V44, P988, DOI 10.1112/blms/bds028; Evdokimov A., 1977, J SOVIET MATH, V38, P141; Horn Roger A., 1985, MATRIX ANAL; Iwaniec Henryk, 1997, GRADUATE STUDIES MAT, V17; KITAOKA Y, 1976, NAGOYA MATH J, V63, P153; KLINGEN H, 1960, MATH ANN, V140, P76, DOI 10.1007/BF01359987; KLINGEN H, 1978, MATH ANN, V234, P145, DOI 10.1007/BF01420965; Klingen H., 1990, INTRODUCTORY LECT SI; LI WW, 1975, MATH ANN, V212, P285, DOI 10.1007/BF01344466; MAASS H, 1977, MATH ANN, V226, P275, DOI 10.1007/BF01362431; Maass Hans, 1951, MATH ANN, V123, P125, DOI 10.1007/BF02054945; Petersson Hans, 1973, ACTA ARITH, V24, P411; RANKIN RA, 1980, P EDINBURGH MATH SOC, V23, P151; Serre Jean-Pierre, 1973, LECT NOTES MATH, V350, P191; Shimura Goro, 1975, NACHR AKAD WISS GOTT, V17, P261; Swinnerton-Dyer H. P. F., 1973, LECT NOTES MATH, V350, P1; Wilton J. R., P LOND MATH SOC, VS2-31, P1, DOI [10.1112/plms/s2-31.1.1.MR1577449, DOI 10.1112/PLMS/S2-31.1.1]	32	1	1	AMER MATHEMATICAL SOC	PROVIDENCE	201 CHARLES ST, PROVIDENCE, RI 02940-2213 USA	0002-9947	1088-6850		T AM MATH SOC	Trans. Am. Math. Soc.	FEB	2015	367	2					1329	1345	PII S0002-9947(2014)06204-1			17	Mathematics	Mathematics	CE5FM	WOS:000351856400021		
J	Ono, K				Ono, Kyosuke			Diffusion Equation for Spreading and Replenishment in Submonolayer Lubricant Film	TRIBOLOGY LETTERS			English	Article						Thin film; Submonolayer liquid film; Continuum mechanics; Diffusion equation; Spreading; Replenishment; Head-disk interface	SLIDER-DISK INTERFACES; HEAD/DISK INTERFACE; MOLECULAR-DYNAMICS; PFPE LUBRICANTS; SURFACE; SIMULATION; PRESSURE; DRIVES; DEFORMATION; PROFILES	In the field of head-disk interface technology, evaluating the effects of lubrication of a submonolayer lubricant film is becoming increasingly important as the thickness of the mobile lubricant film is reduced to <0.3 nm. Although the spreading and replenishment speed of a submonolayer lubricant can be evaluated by conventional diffusion theory if a large effective viscosity value is selected, it is commonly considered inappropriate to use the conventional diffusion equation based on continuum mechanics for a submonolayer liquid film. This paper presents a new diffusion equation that formulates the averaged flow of a submonolayer liquid film with a reduced density compared to the bulk density. The Hamaker constant for disjoining pressure in the submonolayer liquid film is also modified to be proportional to the film thickness. The difference between the viscosity in the submonolayer film and the bulk viscosity is also taken into account. From the derived diffusion equation for a submonolayer film, the spreading of a lubricant boundary and replenishment process of a depleted lubricant surface are studied in comparison with the results obtained using the conventional diffusion equation. The replenishment process of submonolayer lubricant profiles in a depleted groove for the Z-tetraol lubricant with a 0.24-nm-thick mobile layer can be calculated from submonolayer diffusion theory by using a low viscosity value consistent with that measured by a blow-off experiment.	Tokyo Inst Technol, Tokyo 1670022, Japan	Ono, K (reprint author), Tokyo Inst Technol, 10-4-1 Suginami Ku, Tokyo 1670022, Japan.	ono_kyosuke@nifty.com			JSPS [24560154]	This study was supported by the JSPS Grant-in-Aid for Scientific Research (C) No. 24560154. The author acknowledges M. C. Mate in HGST/WD for his valuable discussion in this study.	Mate CM, 2013, TRIBOL LETT, V51, P385, DOI 10.1007/s11249-013-0171-5; Itoh S, 2008, TRIBOL LETT, V30, P177, DOI 10.1007/s11249-008-9325-2; Wu L, 2008, J APPL PHYS, V104, DOI 10.1063/1.2951616; Canchi SV, 2012, MICROSYST TECHNOL, V18, P1517, DOI 10.1007/s00542-012-1582-1; MATE CM, 1992, J APPL PHYS, V72, P3084, DOI 10.1063/1.351467; Tagaya Y, 2007, IEEE T MAGN, V43, P2229, DOI 10.1109/TMAG.2007.893413; Tani H, 2009, IEEE T MAGN, V45, P5050, DOI 10.1109/TMAG.2009.2029602; Xu JG, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2013.2286619; Itoh S, 2009, IEEE T MAGN, V45, P5055, DOI 10.1109/TMAG.2009.2029605; Canchi S. V., 2012, IEEE T MAGN, V47, P1842; Dai Q, 2004, J APPL PHYS, V96, P696, DOI 10.1063/1.1739527; Dai Q, 2007, TRIBOL LETT, V26, P1, DOI 10.1007/s11249-006-9174-9; Fukui S, 2007, MICROSYST TECHNOL, V13, P1339, DOI 10.1007/s00542-006-0359-9; Guo Q, 2006, IEEE T MAGN, V42, P2528, DOI 10.1109/TMAG.2006.878645; Israelachvili J. N., 1991, INTERMOLECULAR SURFA; Karis TE, 1999, J NON-NEWTON FLUID, V82, P287, DOI 10.1016/S0377-0257(98)00167-0; Katano T, 2003, IEEE T MAGN, V39, P2489, DOI 10.1109/TMAG.2003.816449; Kawaguchi M, 2003, IEEE T MAGN, V39, P2483, DOI 10.1109/TMAG.2003.816447; Kim SH, 2011, IEEE T MAGN, V47, P239, DOI 10.1109/TMAG.2010.2090537; Kobayashi N, 2014, TRIBOL LETT, V53, P43, DOI 10.1007/s11249-013-0242-7; Kubotera H, 2007, J APPL PHYS, V102, DOI 10.1063/1.2777139; Ma X., 1999, PHYS REV E, V59, P723; Ma XD, 1999, TRIBOL LETT, V6, P9, DOI 10.1023/A:1019143103204; Marchon B, 2009, IEEE T MAGN, V45, P872, DOI 10.1109/TMAG.2008.2010661; Marchon H., 2006, EPL-EUROPHYS LETT, V74, P294; Mate CM, 2011, IEEE T MAGN, V47, P124, DOI 10.1109/TMAG.2010.2073691; Mate CM, 2010, TRIBOL LETT, V37, P581, DOI 10.1007/s11249-009-9555-y; Matsuoka H, 2005, MICROSYST TECHNOL, V11, P824, DOI 10.1007/s00542-005-0541-5; Matthes L., 2013, P ASME 2013 C INF ST; Ono K, 2012, J TRIBOL-T ASME, V134, DOI 10.1115/1.4005643; Ono K., 2013, TRIBOL LETT, V52, P123; Saeki F, 2009, IEEE T MAGN, V45, P5061, DOI 10.1109/TMAG.2009.2029606; Saito Y., 2010, P JAST TRIB C TOK MA, P139; Scarpulla MA, 2003, J CHEM PHYS, V118, P3368, DOI 10.1063/1.1536953; Tyndall GW, 1999, TRIBOL T, V42, P463, DOI 10.1080/10402009908982242; Waltman RJ, 2010, TRIBOL LETT, V39, P211, DOI 10.1007/s11249-010-9638-9; Wu L, 2006, IEEE T MAGN, V42, P2480, DOI 10.1109/TMAG.2006.880471; Wu L, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/21/215702; Wu L, 2006, J APPL PHYS, V100, DOI 10.1063/1.2220489	39	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1023-8883	1573-2711		TRIBOL LETT	Tribol. Lett.	FEB	2015	57	2							13	10.1007/s11249-014-0455-4		14	Engineering, Chemical; Engineering, Mechanical	Engineering	CE9LV	WOS:000352166400003		
J	Mochida, K; Zhang, WY; Toda, M				Mochida, Koji; Zhang, Wan-Yu; Toda, Mamoru			The function of body coloration of the hai coral snake Sinomicrurus japonicus boettgeri	ZOOLOGICAL STUDIES			English	Article						Aposematism; Disruptive coloration; Background matching; Coral snake mimicry	RANGING AVIAN PREDATORS; PROTECTIVE COLORATION; DISRUPTIVE COLORATION; PIGMENTATION PATTERN; BUTTERFLY LARVA; CONTRAST; APOSEMATISM; AVOIDANCE; EVOLUTION; ELAPIDAE	Background: Prey animals often protect themselves from visual hunting predators via their body coloration, which encompasses various visual effects. When a prey animal displays a certain color pattern on its body surface, its protective function and effect are largely dependent on how a predator would encounter and perceive the prey animal. Asian coral snakes of the genus Sinomicrurus, which are venomous, display black bands and stripes on their orange body coloration. The banded pattern has been characterized as an aposematic signal in the New World coral snakes, but the stripes generally occur in cryptic snakes. We investigated the function of this complex color pattern, which might be interpreted as aposematic and cryptic, in Sinomicrurus japonicus boettgeri. Results: First, plasticine replica experiments were conducted to assess whether natural avian predators avoid the color pattern of S. japonicus boettgeri; the results showed that they attacked the coral snake replicas and the control replicas with coloration similar to another prey snake, suggesting that the body coloration of S. japonicus boettgeri did not function aposematically in the wild. Second, we evaluated the chromatic contrast of the snake coloration with backgrounds from their natural habitats based on the avian predator visual systems. The body coloration of S. japonicus boettgeri showed the same, or lower, contrast levels with natural backgrounds than those of sympatric cryptic snakes, suggesting that the coloration was ineffective as an aposematic signal. Conclusions: These results imply that the body coloration of S. japonicus boettgeri would work as crypsis through background matching or disruptive camouflage rather than aposematism.	[Mochida, Koji; Toda, Mamoru] Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 9030213, Japan; [Zhang, Wan-Yu] Univ Ryukyus, Grad Sch Engn & Sci, Nishihara, Okinawa 9030213, Japan	Mochida, K (reprint author), Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 9030213, Japan.	kj.mochida@gmail.com			JSPS Research Fellowship for Young Scientists;  [228700159]	We thank the Environmental Forest Yona Field, University of Ryukyus for support of this research. We are grateful for helps to collect the reflectance spectral data of snakes to T. Jono, Y. Kadota, T. Kaito, T. Otani, K. Terada, and A. Mori. T. Jono and T. Kaito also gave us good photographs. This study was financially supported by a JSPS Research Fellowship for Young Scientists and a Grant-in-Aid for Research Activity Start-up (228700159) to KM.	Stevens M, 2009, PHILOS T R SOC B, V364, P481, DOI 10.1098/rstb.2008.0216; Bohlin T, 2008, ANIM BEHAV, V76, P577, DOI 10.1016/j.anbehav.2008.02.012; GREENE HW, 1981, SCIENCE, V213, P1207, DOI 10.1126/science.213.4513.1207; Allen WL, 2013, BEHAV ECOL, V24, P1237, DOI 10.1093/beheco/art058; SMITH SM, 1975, SCIENCE, V187, P759, DOI 10.1126/science.187.4178.759; Mochida K, 2011, EVOL ECOL, V25, P1017, DOI 10.1007/s10682-011-9471-0; BRODIE ED, 1993, EVOLUTION, V47, P227; Tullberg BS, 2005, P ROY SOC B-BIOL SCI, V272, P1315, DOI 10.1098/rspb.2005.3079; Wilson D, 2007, BIOL LETT-UK, V3, P40, DOI 10.1098/rsbl.2006.0574; Stevens M, 2007, P R SOC B, V274, P1457, DOI 10.1098/rspb.2007.0220; Valkonen J, 2011, EVOL ECOL, V25, P1047, DOI 10.1007/s10682-011-9463-0; Gamberale-Stille G, 2001, BEHAV ECOL, V12, P768, DOI 10.1093/beheco/12.6.768; Mappes J, 2005, TRENDS ECOL EVOL, V20, P598, DOI 10.1016/j.tree.2005.07.011; Stevens M, 2006, P R SOC B, V273, P2433, DOI 10.1098/rspb.2006.3614; Stobbe N, 2008, P ROY SOC B-BIOL SCI, V275, P1535, DOI 10.1098/rspb.2008.0209; Valkonen JK, 2012, ECOL EVOL, V2, P1971, DOI 10.1002/ece3.315; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; BRODIE ED, 1995, FUNCT ECOL, V9, P186; Stoddard MC, 2008, AM NAT, V171, P755, DOI 10.1086/587526; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; BRATTSTROM BH, 1955, EVOLUTION, V9, P217, DOI 10.2307/2405591; Castoe TA, 2007, ZOOL J LINN SOC-LOND, V151, P809; Cott H. B., 1940, ADAPTIVE COLORATION; Edmunds M, 1974, DEFENCE ANIMALS SURV; Exnerova A, 2003, BIOL J LINN SOC, V78, P517, DOI 10.1046/j.0024-4066.2002.00161.x; Hailman JP, 1977, OPTICAL SIGNALS; Honma M, 1967, NIPPON NETTAI IGAKU, V8, P65; JACKSON JF, 1976, AM NAT, V110, P1029, DOI 10.1086/283125; MURRAY JD, 1991, J THEOR BIOL, V149, P339, DOI 10.1016/S0022-5193(05)80310-8; Obara Y, 2013, AKAMATA, V24, P1; POUGH F H, 1988, American Naturalist, V131, pS67, DOI 10.1086/284767; Ratcliffe JM, 2008, NATURE, V455, P96, DOI 10.1038/nature07087; Ruxton G. D., 2004, AVOIDING ATTACK EVOL; Slowinski JB, 2001, HERPETOLOGICA, V57, P233; Tanaka Koji, 2000, Current Herpetology, V19, P97	35	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1021-5506	1810-522X		ZOOL STUD	Zool. Stud.	FEB	2015	54								33	10.1186/s40555-015-0110-2		6	Zoology	Zoology	CE5WP	WOS:000351906800010		
J	Nomura, N; Tsuyuzaki, S				Nomura, Nanae; Tsuyuzaki, Shiro			Hares promote seed dispersal and seedling establishment after volcanic eruptions	ACTA OECOLOGICA-INTERNATIONAL JOURNAL OF ECOLOGY			English	Article						Endozoochory; Gaultheria miqueliana; Lepus timidus ainu; Pellet; Seed immigration and germination	DELAYED GERMINATION; SPATIAL-PATTERNS; LEPUS-TIMIDUS; BOREAL FOREST; JAPAN; RECRUITMENT; SURVIVAL; SWEDEN; TREE	Although seed dispersal through animal guts (endozoochory) is a process that determines plant establishment, the behaviour of carriers mean that the seeds are not always dispersed to suitable habitats for germination. The germinable seeds of Gaultheria miqueliana were stored in the pellets of a hare (Lepus timidus ainu) on Mount Koma in northern Japan. To clarify the roles of hares in seed dispersal and germination, field censuses and laboratory experiments were conducted. The field observations were conducted on pellets and seeds in four habitats (bare ground, G. miqueliana shrub patch, Salix reinii patch, and Larix kaempferi understory), and the laboratory experiments were conducted on seed germination with different light, water potential and cold stratification treatments. The laboratory experiments confirmed that seed germination began a few weeks after the sowing of seeds, independent of cold stratification, when light was sufficient and the water potential was low. The seeds did not germinate at high water potential. The pellets were gradually degraded in situ. More seeds germinated from crushed than from intact pellets. Therefore, over the long term, seeds germinated when exposed to light due to the degradation of pellets. The pellets were proportionally dispersed among the four studied habitats. More seeds sown in the field germinated more in shaded habitats, such as in the Gaultheria patch and the Larix understory, and seeds did not germinate on bare ground, where drought often occurred. Thus, the hares had two roles in the dispersal and germination of seeds: (1) the expansion of G. miqueliana populations through seed dispersal to various habitats and (2) the facilitation of delayed seed germination to avoid risks of hazards such as drought. The relationships between small mammals represented by the hare and the shrubs that produce berries are likely to be more mutually evolved than was previously thought. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Nomura, Nanae] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan; [Tsuyuzaki, Shiro] Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 06008W, Japan	Tsuyuzaki, S (reprint author), Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 06008W, Japan.	tsuyu@ees.hokudai.ac.jp			MEXT; JSPS	T.S. Kohyama, G. Kudo, T. Kubo and C. Egawa provided comments and suggestions to improve the manuscript. Thanks are also due to T. Kwon for his cooperation on the field survey, to all members in the laboratory for support, and to the staff members of the Forest Office of Oshima District and Mori Town Office for permission and support to conduct the research. This work was supported in part by MEXT and JSPS.	Akasaka M, 2009, PLANT ECOL, V202, P235, DOI 10.1007/s11258-008-9464-4; Wenny DG, 2001, EVOL ECOL RES, V3, P51; Ronnegard L, 2010, R J, V2, P20; VENABLE DL, 1980, OECOLOGIA, V46, P272, DOI 10.1007/BF00540137; MICHEL BE, 1973, PLANT PHYSIOL, V51, P914, DOI 10.1104/pp.51.5.914; Bruun HH, 2008, OECOLOGIA, V155, P101, DOI 10.1007/s00442-007-0892-y; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Chang ER, 2005, FUNCT ECOL, V19, P665, DOI 10.1111/j.1365-2435.2005.01011.x; MASUDA M, 1992, OECOLOGIA, V89, P42, DOI 10.1007/BF00319013; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Uesaka S, 2004, PLANT ECOL, V175, P165; Hirsch BT, 2012, ECOL LETT, V15, P1423, DOI 10.1111/ele.12000; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Calvino-Cancela M, 2002, J ECOL, V90, P775, DOI 10.1046/j.1365-2745.2002.00711.x; Dahl F, 2005, WILDLIFE BIOL, V11, P309, DOI 10.2981/0909-6396(2005)11[309:NDAHRA]2.0.CO;2; Dahl F, 2005, EUR J WILDLIFE RES, V51, P163, DOI 10.1007/s10344-005-0095-y; Godinez-Alvarez H, 2002, ECOLOGY, V83, P2617, DOI 10.2307/3071819; Green K, 2013, PLANT ECOL DIVERS, V6, P511, DOI 10.1080/17550874.2013.787466; Izhaki I, 1997, J ARID ENVIRON, V37, P343, DOI 10.1006/jare.1997.0273; Kondo Toshihiro, 1999, Diversity and Distributions, V5, P223, DOI 10.1046/j.1472-4642.1999.00056.x; Koyama A., 2013, J VEG SCI, V24, P478; Nakashima Y, 2010, OECOLOGIA, V164, P721, DOI 10.1007/s00442-010-1714-1; Nishi H, 2004, ECOGRAPHY, V27, P311, DOI 10.1111/j.0906-7590.2004.03737.x; Pico FX, 2012, J ECOL, V100, P1009, DOI 10.1111/j.1365-2745.2012.01979.x; Rice KJ, 2001, PLANT ECOL, V155, P237, DOI 10.1023/A:1013257407909; Tsuyuzaki S, 2009, PLANT BIOLOGY, V11, P369, DOI 10.1111/j.1438-8677.2008.00136.x; Tsuyuzaki S, 2012, CLIM RES, V51, P1, DOI 10.3354/cr01047; Tsuyuzaki S, 1997, J VEG SCI, V8, P727, DOI 10.2307/3237378	28	0	0	GAUTHIER-VILLARS/EDITIONS ELSEVIER	PARIS	23 RUE LINOIS, 75015 PARIS, FRANCE	1146-609X	1873-6238		ACTA OECOL	Acta Oecol.-Int. J. Ecol.	FEB	2015	63						22	27		10.1016/j.actao.2015.02.003		6	Ecology	Environmental Sciences & Ecology	CE2NR	WOS:000351652800004		
J	Thongyen, T; Hata, M; Toriba, A; Ikeda, T; Koyama, H; Otani, Y; Furuuchi, M				Thongyen, Thunyapat; Hata, Mitsuhiko; Toriba, Akira; Ikeda, Takuji; Koyama, Hiromi; Otani, Yoshio; Furuuchi, Masami			Development of PM0.1 Personal Sampler for Evaluation of Personal Exposure to Aerosol Nanoparticles	AEROSOL AND AIR QUALITY RESEARCH			English	Article						PM0.1; Nanoparticles; Personal exposure; Inertial filter	AIRBORNE PARTICULATE MATTER; HUMAN HEALTH; ULTRAFINE PARTICLES; AMBIENT; PM2.5; WORKPLACES; SMOKE	A PM0.1 sampler for the evaluation of the personal exposure to nanoparticles was designed based on a novel approach to a layered mesh inertial filter. Applications to practical environments would include roadsides and highly contaminated workplaces. The separation performances of PM0.1 sampler consisting of a layered mesh inertial filter and pre-separators for the removal of coarse particles were evaluated. The influence of particle loading on the pressure drop and separation performance, which is important from a practical standpoint, was also discussed. The novel personal sampler recorded a cutoff size of 100 nm with a small pressure drop of similar to 5 kPa. Through the combination of a layered mesh inertial filter for the PM0.1 and pre-cut impactors for the removal of huge or coagulated particles (PM1.4-TSP) along with a pre-cut inertial filter using webbed SUS fibers for the removal of fine particles (PM0.5-PM1.4), the present PM0.1 inlet for the personal sampler was practical for the chemical analysis of collected particles. This sampler was proven effective even under the limitations of a small-capacity portable battery pump, which was rated at less than the minimum change for separation performance. The novel PM0.1 personal sampler is compact and lightweight (under 1 kg including a portable battery pump), which is important for the practical application of a personal sampler.	[Thongyen, Thunyapat; Hata, Mitsuhiko; Toriba, Akira; Otani, Yoshio; Furuuchi, Masami] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Ikeda, Takuji] Nitta Cooperat, Yamato Koriyama, Nara 6391085, Japan; [Koyama, Hiromi] Shibata Sci Technol, Tokyo 1130034, Japan	Furuuchi, M (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan.	mfuruch@staff.kanazawa-u.ac.jp	TORIBA, Akira/D-8415-2015; OTANI, Yoshio/L-3581-2015	TORIBA, Akira/0000-0002-6411-4088; OTANI, Yoshio/0000-0002-5751-6898	Japan Society for the Promotion of Science (JSPS) [23651024]; Smoking Research Foundation; Environment Research and Technology Development Fund of the Minis-ay of the Environment, Japan [5RF-1302]	The authors gratefully acknowledge The Japan Society for the Promotion of Science (JSPS) for their support (grant No. 23651024) and The Smoking Research Foundation and also the Environment Research and Technology Development Fund (5RF-1302) of the Minis-ay of the Environment, Japan.	Davidson CI, 2005, AEROSOL SCI TECH, V39, P737, DOI 10.1080/02786820500191348; Donaldson K, 2002, J AEROSOL MED, V15, P213, DOI 10.1089/089426802320282338; Jahn HJ, 2013, ATMOS ENVIRON, V74, P402, DOI 10.1016/j.atmosenv.2013.04.011; [Anonymous], SCI TOTAL ENV, V472, P947; Lim S, 2012, ATMOS ENVIRON, V47, P407, DOI 10.1016/j.atmosenv.2011.10.043; Herner JD, 2005, J AIR WASTE MANAGE, V55, P30; Du XA, 2010, J ENVIRON SCI-CHINA, V22, P1757, DOI 10.1016/S1001-0742(09)60316-8; Bolch WE, 2001, HEALTH PHYS, V81, P378, DOI 10.1097/00004032-200110000-00003; Tsai CJ, 2012, ENVIRON SCI TECHNOL, V46, P4546, DOI 10.1021/es204580f; Granum B, 2002, TOXICOL SCI, V65, P7, DOI 10.1093/toxsci/65.1.7; Warheit DB, 2004, MATER TODAY, V7, P32, DOI 10.1016/S1369-7021(04)00081-1; Borm PJA, 2004, J NANOSCI NANOTECHNO, V4, P521, DOI 10.1166/jnn.2004.081; Borgini A, 2011, ATMOS ENVIRON, V45, P4147, DOI 10.1016/j.atmosenv.2011.05.026; Morawska L, 2008, ATMOS ENVIRON, V42, P8113, DOI 10.1016/j.atmosenv.2008.07.050; Behera SN, 2014, SCI TOTAL ENVIRON, V472, P947, DOI 10.1016/j.scitotenv.2013.11.063; Eryu K., 2009, J AEROSOL RES, V24, P24; Furuuchi M, 2010, AEROSOL AIR QUAL RES, V10, P30, DOI 10.4209/aaqr.2009.06.0040; Hinds WC, 1999, AEROSOL TECHNOLOGY; Hussain M., 2011, TheHealth, V2, P51; Kuhlbusch TAJ, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-22; Ngo MA, 2010, CALIF AGR, V64, P12, DOI 10.3733/ca.v064n01p12; Otani Y., 2007, AEROSOL AIR QUAL RES, V7, P343; Phillips K, 2001, ENVIRON INT, V27, P69, DOI 10.1016/S0160-4120(01)00057-5; Takebayashi M, 2012, THESIS KANAZAWA U; Young LH, 2013, AEROSOL AIR QUAL RES, V13, P849, DOI 10.4209/aaqr.2012.10.0270	25	0	0	TAIWAN ASSOC AEROSOL RES-TAAR	TAICHUNG COUNTY	CHAOYANG UNIV TECH, DEPT ENV ENG & MGMT, PROD CTR AAQR, NO 168, JIFONG E RD, WUFONG TOWNSHIP, TAICHUNG COUNTY, 41349, TAIWAN	1680-8584	2071-1409		AEROSOL AIR QUAL RES	Aerosol Air Qual. Res.	FEB	2015	15	1					180	187		10.4209/aaqr.2014.05.0102		8	Environmental Sciences	Environmental Sciences & Ecology	CD8ND	WOS:000351351000015		
J	Araki, S; Yamamoto, K; Kondo, A				Araki, Shin; Yamamoto, Kouhei; Kondo, Akira			Application of Regression Kriging to Air Pollutant Concentrations in Japan with High Spatial Resolution	AEROSOL AND AIR QUALITY RESEARCH			English	Article						Spatial distribution; Geostatistics; Air quality; Ozone; NO2	PARTICULATE MATTER; VARIABILITY	The application of regression kriging to air pollutants in Japan was examined for the purpose of providing a practical method to obtain a spatial distribution with sufficient accuracy and a high spatial resolution of 1 x 1 km. We used regulatory air monitoring data from the years 2009 and 2010. Predictor variables at 1 x 1 km resolution were prepared from various datasets to perform regression kriging. The prediction performance was assessed by indicators, including root mean squared error (RMSE) and R-2, calculated from the leave-one-out cross validation results, and was compared to the results obtained from a linear regression method, often referred to as land use regression (LUR). Regression kriging well-explained the spatial variability of NO2, with R-2 values of 0.77 and 0.78. Ozone (O-3) was moderately explained, with R-2 values of 0.52 and 0.66. The reason for this difference in performance between NO2 and O-3 might be the characteristics of these pollutants - primary or secondary. Regression kriging outperformed the linear regression method with regard to RMSE and R-2. The performance of regression kriging in this work was comparable to that found in previous studies. The results indicate that regression kriging is a practical procedure that can be applied for the prediction of the spatial distribution of air pollutants in Japan, with sufficient accuracy and a high spatial resolution.	[Araki, Shin] Otsu City Publ Hlth Ctr, Otsu, Shiga 5208575, Japan; [Araki, Shin; Kondo, Akira] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Yamamoto, Kouhei] Kyoto Univ, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan	Araki, S (reprint author), Otsu City Publ Hlth Ctr, Goryocho 3-1, Otsu, Shiga 5208575, Japan.	araki@ea.see.eng.osaka-u.ac.jp		Araki, Shin/0000-0002-6149-621X			Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; Briggs DJ, 2000, SCI TOTAL ENVIRON, V253, P151, DOI 10.1016/S0048-9697(00)00429-0; Pearce JL, 2009, ATMOS ENVIRON, V43, P2060, DOI 10.1016/j.atmosenv.2008.10.060; Marshall JD, 2008, ATMOS ENVIRON, V42, P1359, DOI 10.1016/j.atmosenv.2007.08.012; Beelen R, 2009, SCI TOTAL ENVIRON, V407, P1852, DOI 10.1016/j.scitotenv.2008.11.048; Kannari A, 2007, ATMOS ENVIRON, V41, P3428, DOI 10.1016/j.atmosenv.2006.12.015; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI [10.1016/j.cageo.2004.03.012, 10.1016/j.cargo.2004.03.012]; Hoek G, 2008, ATMOS ENVIRON, V42, P7561, DOI 10.1016/j.atmosenv.2008.05.057; Ross Z, 2007, ATMOS ENVIRON, V41, P2255, DOI 10.1016/j.atmosenv.2006.11.012; Cyrys J, 2005, ENVIRON HEALTH PERSP, V113, P987, DOI 10.1289/ehp.7662; De Smet P., 2010, EUROPEAN AIR QUALITY; De Smet P., 2011, EUROPEAN AIR QUALITY; Hengl T., 2007, 229404 EUR EN OFF OF; HENGL T, 2003, TECHNICAL REPORT; Hijmans R. J., 2012, RASTER GEOGRAPHIC AN; Kannari A., 2006, J JAPAN SOC ATMOSPHE, V41, P220; Mercer L.D., 2011, ATMOS ENVIRON, V45, P4414; R Core Team, 2012, R LANG ENV STAT COMP	18	0	0	TAIWAN ASSOC AEROSOL RES-TAAR	TAICHUNG COUNTY	CHAOYANG UNIV TECH, DEPT ENV ENG & MGMT, PROD CTR AAQR, NO 168, JIFONG E RD, WUFONG TOWNSHIP, TAICHUNG COUNTY, 41349, TAIWAN	1680-8584	2071-1409		AEROSOL AIR QUAL RES	Aerosol Air Qual. Res.	FEB	2015	15	1					234	241		10.4209/aaqr.2014.01.0011		8	Environmental Sciences	Environmental Sciences & Ecology	CD8ND	WOS:000351351000019		
J	Tsushima, A; Ochi, A; Takaishi, T				Tsushima, Akira; Ochi, Akira; Takaishi, Tetsuo			Immediate effects of varying cadence in bicycle ergometry on characteristics of gait and lower extremity motor activity in frail older adults	AGING CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						Gait speed; Cadence; Gait functions; Activities of daily living; Pedaling exercise	MUSCLE STRENGTH; WALKING SPEED; ELDERLY WOMEN; INTERLIMB COORDINATION; BALANCE PERFORMANCE; HUMAN MOVEMENT; HEART-FAILURE; EXERCISE; LOCOMOTION; YOUNG	Aim This study examined the immediate effects of a 5-min pedaling period with varying cadence (VC) on various dimensions of gait function in frail older adults. Methods Twenty frail older adults (mean age 77.2 years) were randomly assigned to one of two groups: the VC group or the constant cadence (CC) group. Each group performed bicycle ergometry for 5 min at 20 W. The CC group pedaled continuously at a CC of 50 rpm, while the VC group pedaled continuously at cadences of 45, 55, 65, 55, and 45 rpm, in this order, changing cadence every 60 s. Immediately before and after bicycle ergometry, the following measurements were carried out: gait performance, muscle activity (electromyographic analysis), and knee motion analysis. Results CC did not significantly affect any of the measured parameters. In contrast, the VC group showed improvement in all three parameters: an increase in normal gait speed and cadence (p < 0.01), a reduction in the activation period (p < 0.04) and CI-THIGH (antagonistic coactivation time between knee flexor and extensor muscles, p < 0.05), and an increase in maximum knee extension angular velocity (p < 0.01). Conclusion A short period of VC bicycle ergometry with low work intensity was effective in immediately improving gait function in frail older adults.	[Tsushima, Akira; Takaishi, Tetsuo] Nagoya City Univ, Grad Sch Nat Sci, Mizuho Ku, Nagoya, Aichi 4678501, Japan; [Tsushima, Akira] Chubu Univ, Coll Life & Hlth Sci, Dept Phys Therapy, Kasugai, Aichi 4878501, Japan; [Ochi, Akira] Seijoh Univ, Fac Care & Rehabil, Div Phys Therapy, Tokai, Ibaraki 4768588, Japan	Tsushima, A (reprint author), Nagoya City Univ, Grad Sch Nat Sci, Mizuho Ku, 1 Yamanohata Mizuho Cho, Nagoya, Aichi 4678501, Japan.	tsushima@isc.chubu.ac.jp					Bini RR, 2010, J ELECTROMYOGR KINES, V20, P102, DOI 10.1016/j.jelekin.2008.10.003; MacKay-Lyons M, 2002, PHYS THER, V82, P69; Scardovi AB, 2007, J CARDIOVASC MED, V8, P608; Macaluso A, 2004, EUR J APPL PHYSIOL, V91, P450, DOI 10.1007/s00421-003-0991-3; Hortobagyi T, 2000, J PHYSIOL-LONDON, V524, P293, DOI 10.1111/j.1469-7793.2000.00293.x; Macaluso A, 2003, EUR J APPL PHYSIOL, V90, P458, DOI 10.1007/s00421-003-0866-7; Bertucci W, 2005, J BIOMECH, V38, P1003, DOI 10.1016/j.jbiomech.2004.05.037; Macaluso A, 2003, J APPL PHYSIOL, V95, P2544, DOI 10.1152/japplphysiol.00416.2003; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; Sipila S, 1996, ACTA PHYSIOL SCAND, V156, P457, DOI 10.1046/j.1365-201X.1996.461177000.x; Kerrigan DC, 2001, ARCH PHYS MED REHAB, V82, P26, DOI 10.1053/apmr.2001.18584; Samson MM, 2001, AGING-CLIN EXP RES, V13, P16; Lindemann U, 2008, GAIT POSTURE, V27, P91, DOI 10.1016/j.gaitpost.2007.02.005; Schwenk M, 2014, GERONTOLOGY, V60, P79, DOI 10.1159/000354211; FORSSBERG H, 1979, J NEUROPHYSIOL, V42, P936; Christensen LOD, 2000, EXP BRAIN RES, V135, P66, DOI 10.1007/s002210000493; YANAGIHARA D, 1993, NEUROSCI RES, V18, P241, DOI 10.1016/0168-0102(93)90060-4; Della Croce U, 2005, GAIT POSTURE, V21, P226, DOI 10.1016/j.gaitpost.2004.05.003; BRANCH LG, 1985, AM J PUBLIC HEALTH, V75, P1436, DOI 10.2105/AJPH.75.12.1436; Izquierdo M, 1999, EUR J APPL PHYSIOL O, V79, P260, DOI 10.1007/s004210050504; Kerrigan DC, 1998, ARCH PHYS MED REHAB, V79, P317, DOI 10.1016/S0003-9993(98)90013-2; Peterson MD, 2010, AGEING RES REV, V9, P226, DOI 10.1016/j.arr.2010.03.004; Hortobagyi T, 2006, EXP BRAIN RES, V171, P322, DOI 10.1007/s00221-005-0274-9; Raasch CC, 1999, J NEUROPHYSIOL, V82, P515; Mian OS, 2006, ACTA PHYSIOL, V186, P127, DOI 10.1111/j.1748-1716.2006.01522.x; Shinkai S, 2000, AGE AGEING, V29, P441, DOI 10.1093/ageing/29.5.441; DiPietro L, 2001, J GERONTOL A-BIOL, V56, P13; Castagno P, 1995, GAIT POSTURE, V3, P87, DOI 10.1016/0966-6362(95)93466-P; Castronovo AM, 2012, IEEE ENG MED BIO, P3612, DOI 10.1109/EMBC.2012.6346748; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; ENGLISH AW, 1989, AM ZOOL, V29, P255; Gabell A, 1984, J GERONTOL, V39, P62; HAGEMAN PA, 1986, PHYS THER, V66, P1382; Heath John M, 2002, J Am Board Fam Pract, V15, P218; HIMANN JE, 1988, MED SCI SPORT EXER, V20, P161; Judge JO, 1996, J GERONTOL A-BIOL, V51, pM303; KADABA MP, 1990, J ORTHOPAED RES, V8, P383, DOI 10.1002/jor.1100080310; KANEKO M, 1991, CAN J SPORT SCI, V16, P223; Laudani L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074227; Liu H, 2010, J GERIATR PHYS THER, V33, P103, DOI 10.1097/JPT.0b013e3181eda1c4; Miller KL, 2010, J GERIATR PHYS THER, V33, P85, DOI 10.1097/JPT.0b013e3181df0035; Murray M P, 1966, Am J Phys Med, V45, P8; Puntawangkoon C, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-48; Quintana M, 2004, CLIN SCI, V106, P451, DOI 10.1042/CS20030259; Seidler-Dobrin R D, 1998, Motor Control, V2, P314; Zehr EP, 2005, EXERC SPORT SCI REV, V33, P54	46	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1594-0667	1720-8319		AGING CLIN EXP RES	Aging Clin. Exp. Res.	FEB	2015	27	1					43	51		10.1007/s40520-014-0245-8		9	Geriatrics & Gerontology	Geriatrics & Gerontology	CE0WN	WOS:000351530600007		
J	Fukutani, N; Yamada, M; Nishiguchi, S; Yukutake, T; Kayama, H; Tanigawa, T; Adachi, D; Hotta, T; Morino, S; Tashiro, Y; Aoyama, T; Tsuboyama, T				Fukutani, Naoto; Yamada, Minoru; Nishiguchi, Shu; Yukutake, Taiki; Kayama, Hiroki; Tanigawa, Takanori; Adachi, Daiki; Hotta, Takayuki; Morino, Saori; Tashiro, Yuto; Aoyama, Tomoki; Tsuboyama, Tadao			The physiological characteristics of community-dwelling elderly Japanese with airflow limitation: a cross-sectional study	AGING CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						Airflow limitation; Pulmonary function; Skeletal muscle mass index; Community-dwelling elderly; Japanese	OBSTRUCTIVE PULMONARY-DISEASE; FAT-FREE MASS; SYSTEMIC INFLAMMATION; TISSUE DEPLETION; COPD; PERFORMANCE; SMOKING; LIFE	Background and aims The aim of this study was to investigate the physiological characteristics of community-dwelling elderly subjects, aged >= 65 years, with airflow limitation in the Japanese community. Methods Subjects were recruited through local press advertisement, and 180 individuals were enrolled. Data on age, body mass index (BMI), gender, smoking history, and past medical history were obtained, as were pulmonary function parameters, skeletal muscle mass index, and physical activity. Results The final study population comprised 161 participants from whom we obtained valid spirometry results. The mean age of this population was 73.4 +/- 4.4 years, and 78 participants (48.4 %) were men. The prevalence of airflow limitation was 29.2 % (n = 47). Subjects with airflow limitation were significantly older (P = 0.01) and had poorer pulmonary function (P < 0.01), lower BMI (P < 0.01), and lower skeletal muscle mass index (P = 0.03) than healthy elderly subjects. Furthermore, skeletal muscle mass index was significantly correlated with the percentage of predicted forced vital capacity r = 0.45, P < 0.05) and forced expiratory volume in 1 s (r = 0.50, P < 0.05) only in men with airflow limitation. Conclusions We found that the skeletal muscle mass index was significantly reduced in community-dwelling elderly with airflow limitation, and the skeletal muscle mass index was correlated with pulmonary function only in men with airflow limitation.	[Fukutani, Naoto; Yamada, Minoru; Nishiguchi, Shu; Yukutake, Taiki; Kayama, Hiroki; Tanigawa, Takanori; Adachi, Daiki; Hotta, Takayuki; Morino, Saori; Tashiro, Yuto; Aoyama, Tomoki; Tsuboyama, Tadao] Kyoto Univ, Grad Sch Med, Dept Phys Therapy, Human Hlth SciSakyo Ku, Kyoto 6068507, Japan; [Nishiguchi, Shu] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan	Fukutani, N (reprint author), Kyoto Univ, Grad Sch Med, Dept Phys Therapy, Human Hlth SciSakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	fukutani.naoto.36x@st.kyoto-u.ac.jp					Abbatecola AM, 2013, BODY COMPOSITION MAR; Akamatsu K, 2008, COPD, V5, P269, DOI 10.1080/15412550802363303; Alfagemel L, 2010, CHRONIC RESP DIS, V7, P135; Allen S, 2012, CHRONIC OBSTRUCTIVE, P1; Pitta F, 2005, AM J RESP CRIT CARE, V171, P972, DOI 10.1164/rccm.200407-855OC; Thorleifsson SJ, 2009, RESP MED, V103, P1548, DOI 10.1016/j.rmed.2009.04.005; Fabbri LM, 2003, EUR RESPIR J, V22, P1, DOI 10.1183/09031936.03.00063703; Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x; Shrikrishna D, 2012, EUR RESPIR J, V40, P1115, DOI 10.1183/09031936.00170111; Ischaki E, 2007, CHEST, V132, P164, DOI 10.1378/chest.06-2789; Fogarty AW, 2007, THORAX, V62, P515, DOI 10.1136/thx.2006.066969; Agusti AGN, 2002, AM J RESP CRIT CARE, V166, P485, DOI 10.1164/rccm.2108013; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Ju CR, 2012, RESP MED, V106, P102, DOI 10.1016/j.rmed.2011.07.016; Kojima S, 2005, J EPIDEMIOL, V15, P113, DOI 10.2188/jea.15.113; Bellia V, 2000, AM J RESP CRIT CARE, V161, P1094; Sevenoaks MJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-70; Agusti A, 2008, COPD, V5, P133, DOI 10.1080/15412550801941349; PRIGNOT J, 1987, EUR J RESPIR DIS, V70, P1; Mostert R, 2000, RESP MED, V94, P859, DOI 10.1053/rmed.2000.0829; Anstey KJ, 2004, GERONTOLOGY, V50, P230, DOI 10.1159/000078352; Asero V, 2005, CHEST, V128, P3772, DOI 10.1378/chest.128.5.3772; Baarends EM, 1997, EUR RESPIR J, V10, P2807, DOI 10.1183/09031936.97.10122807; Cevenini E CC, 2010, CURR PHARM DESIGN, V16, P609; Hillman CM, 2012, INTERN MED J, V42, P578, DOI 10.1111/j.1445-5994.2012.02771.x; Holbrook EA, 2009, MED SCI SPORT EXER, V41, P669, DOI 10.1249/MSS.0b013e3181886095; Janssen L, 2004, AM J EPIDEMIOL, V159, P413; Kalhan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011431; Kimura K, 2011, INTERNAL MED, V50, P2135, DOI 10.2169/internalmedicine.50.5517; Kobayashi A, 2000, LUNG, V178, P119, DOI 10.1007/s004080000014; Marc D, 2013, GLOBAL STRATEGY DIAG; McDonald CF, 2013, INTERN MED J, V43, P854; Olafsdóttir Inga Sif, 2007, Int J Chron Obstruct Pulmon Dis, V2, P635; SCHOLS AMWJ, 1991, AM J CLIN NUTR, V54, P983; The Committee of Pulmonary Physiology JRS, 2004, GUID  PULM FUNCT TES; Tojo Naoko, 2005, Rinsho Byori, V53, P77; Ulrik CS, 2011, INT J CHRONIC OBSTR, V6, P123, DOI 10.2147/COPD.S16929; World Health Organization, 2010, CHR RES DIS CHR OBST	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1594-0667	1720-8319		AGING CLIN EXP RES	Aging Clin. Exp. Res.	FEB	2015	27	1					69	74		10.1007/s40520-014-0248-5		6	Geriatrics & Gerontology	Geriatrics & Gerontology	CE0WN	WOS:000351530600010		
J	Frisoni, GB; Jack, CR; Bocchetta, M; Bauer, C; Frederiksen, KS; Liu, YW; Preboske, G; Swihart, T; Blair, M; Cavedo, E; Grothe, MJ; Lanfredi, M; Martinez, O; Nishikawa, M; Portegies, M; Stoub, T; Ward, C; Apostolova, LG; Ganzola, R; Wolf, D; Barkhof, F; Bartzokis, G; DeCarli, C; Csernansky, JG; DeToledo-Morrell, L; Geerlings, MI; Kaye, J; Killiany, RJ; Lehericy, S; Matsuda, H; O'Brien, J; Silbert, LC; Scheltens, P; Soininen, H; Teipel, S; Waldemar, G; Fellgiebel, A; Barnes, J; Firbank, M; Gerritsen, L; Henneman, W; Malykhin, N; Pruessner, JC; Wang, L; Watson, C; Wolf, H; deLeon, M; Pantel, J; Ferrari, C; Bosco, P; Pasqualetti, P; Duchesne, S; Duvernoy, H; Boccardi, M				Frisoni, Giovanni B.; Jack, Clifford R., Jr.; Bocchetta, Martina; Bauer, Corinna; Frederiksen, Kristian S.; Liu, Yawu; Preboske, Gregory; Swihart, Tim; Blair, Melanie; Cavedo, Enrica; Grothe, Michel J.; Lanfredi, Mariangela; Martinez, Oliver; Nishikawa, Masami; Portegies, Marileen; Stoub, Travis; Ward, Chadwich; Apostolova, Liana G.; Ganzola, Rossana; Wolf, Dominik; Barkhof, Frederik; Bartzokis, George; DeCarli, Charles; Csernansky, John G.; deToledo-Morrell, Leyla; Geerlings, Mirjam I.; Kaye, Jeffrey; Killiany, Ronald J.; Lehericy, Stephane; Matsuda, Hiroshi; O'Brien, John; Silbert, Lisa C.; Scheltens, Philip; Soininen, Hilkka; Teipel, Stefan; Waldemar, Gunhild; Fellgiebel, Andreas; Barnes, Josephine; Firbank, Michael; Gerritsen, Lotte; Henneman, Wouter; Malykhin, Nikolai; Pruessner, Jens C.; Wang, Lei; Watson, Craig; Wolf, Henrike; deLeon, Mony; Pantel, Johannes; Ferrari, Clarissa; Bosco, Paolo; Pasqualetti, Patrizio; Duchesne, Simon; Duvernoy, Henri; Boccardi, Marina		EADC-ADNI Working Grp Harmonized P; Alzheimers Dis Neuroimaging Initia	The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity	ALZHEIMERS & DEMENTIA			English	Article						Hippocampal volumetry; Magnetic resonance; Alzheimer's disease; Biomarkers; Diagnostic criteria; Enrichment; Clinical trials; Validation; Harmonized protocol; Standard operating procedures; Manual segmentation	FAMILIAL ALZHEIMERS-DISEASE; TEMPORAL-LOBE EPILEPSY; CEREBROSPINAL-FLUID; VOLUME MEASUREMENTS; BRAIN VOLUME; CLINICAL-USE; MRI; ATROPHY; AMYGDALA; RELIABILITY	Background: An international Delphi panel has defined a harmonized protocol (HarP) for the manual segmentation of the hippocampus on MR. The aim of this study is to study the concurrent validity of the HarP toward local protocols, and its major sources of variance. Methods: Fourteen tracers segmented 10 Alzheimer's Disease Neuroimaging Initiative (ADNI) cases scanned at 1.5 T and 3T following local protocols, qualified for segmentation based on the HarP through a standard web-platform and resegmented following the HarP. The five most accurate tracers followed the HarP to segment 15 ADNI cases acquired at three time points on both 1.5 T and 3T. Results: The agreement among tracers was relatively low with the local protocols (absolute left/right ICC 0.44/0.43) and much higher with the HarP (absolute left/right ICC 0.88/0.89). On the larger set of 15 cases, the HarP agreement within (left/right ICC range: 0.94/0.95 to 0.99/0.99) and among tracers (left/right ICC range: 0.89/0.90) was very high. The volume variance due to different tracers was 0.9% of the total, comparing favorably to variance due to scanner manufacturer (1.2), atrophy rates (3.5), hemispheric asymmetry (3.7), field strength (4.4), and significantly smaller than the variance due to atrophy (33.5%, P < .001), and physiological variability (49.2%, P < .001). Conclusions: The HarP has high measurement stability compared with local segmentation protocols, and good reproducibility within and among human tracers. Hippocampi segmented with the HarP can be used as a reference for the qualification of human tracers and automated segmentation algorithms. (C) 2015 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.	[Frisoni, Giovanni B.; Bocchetta, Martina; Cavedo, Enrica; Bosco, Paolo; Boccardi, Marina] IRCCS Ist Ctr S Giovanni Dio Fatebenefratelli, LENITEM Lab Epidemiol Neuroimaging & Telemed, Brescia, Italy; [Frisoni, Giovanni B.] Univ Hosp, Memory Clin, Geneva, Switzerland; [Frisoni, Giovanni B.] Univ Hosp, LANVIE Lab Neuroimaging Aging, Geneva, Switzerland; [Frisoni, Giovanni B.] Univ Geneva, Geneva, Switzerland; [Jack, Clifford R., Jr.; Preboske, Gregory; Ward, Chadwich] Mayo Clin & Mayo Fdn, Dept Diagnost Radiol, Rochester, MN USA; [Bocchetta, Martina] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Bauer, Corinna; Killiany, Ronald J.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Frederiksen, Kristian S.; Waldemar, Gunhild] Rigshosp, Dept Neurol, Memory Disorders Res Grp, DK-2100 Copenhagen, Denmark; [Liu, Yawu; Soininen, Hilkka] Univ Eastern Finland, Dept Neurol, Kuopio, Finland; [Liu, Yawu; Soininen, Hilkka] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Swihart, Tim; Kaye, Jeffrey; Silbert, Lisa C.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Blair, Melanie] Natl Hosp Neurol & Neurosurg, UCL Inst Neurol, Dept Neurodegenerat Dis, Dementia Res Ctr, London WC1N 3BG, England; [Grothe, Michel J.; Teipel, Stefan] German Ctr Neurodegenerat Dis DZNE, Rostock, Germany; [Lanfredi, Mariangela; Ferrari, Clarissa] IRCCS Ctr S Giovanni Dio Fatebenefratelli, Unit Psychiat, Brescia, Italy; [Martinez, Oliver; DeCarli, Charles; Barnes, Josephine; Watson, Craig] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; [Nishikawa, Masami; Matsuda, Hiroshi] Kawamura Gakuen Womans Univ, Abiko, Chiba, Japan; [Portegies, Marileen; Geerlings, Mirjam I.; Gerritsen, Lotte] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Stoub, Travis; deToledo-Morrell, Leyla] Rush Univ, Dept Neurol Sci, Chicago, IL 60612 USA; [Apostolova, Liana G.] Univ Calif Los Angeles, David Geffen Sch Med, Mary S Easton Ctr Alzheimers Dis Res, Los Angeles, CA 90095 USA; [Apostolova, Liana G.] Univ Calif Los Angeles, David Geffen Sch Med, Lab NeuroImaging, Los Angeles, CA 90095 USA; [Ganzola, Rossana; Duchesne, Simon] Univ Laval, Dept Radiol, Quebec City, PQ, Canada; [Ganzola, Rossana; Duchesne, Simon] Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada; [Wolf, Dominik; Fellgiebel, Andreas] Johannes Gutenberg Univ Mainz, Klin Psychiat & Psychotherapie, D-55122 Mainz, Germany; [Barkhof, Frederik; Henneman, Wouter] Vrije Univ Amsterdam, Med Ctr, Image Anal Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Bartzokis, George] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Csernansky, John G.] Northwestern Univ, Washington Univ, Chicago, IL 60611 USA; [Lehericy, Stephane] Hop La Pitie Salpetriere, Serv Neuroradiol, Paris, France; [O'Brien, John; Firbank, Michael] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Scheltens, Philip] VU Univ Med Cente, Dept Neurol & Alzheimer Ctr, Amsterdam, Netherlands; [Scheltens, Philip] Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Teipel, Stefan] Univ Rostock, Dept Psychosomat Med, D-18055 Rostock, Germany; [Gerritsen, Lotte] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Malykhin, Nikolai] Univ Alberta, Ctr Neurosci, Dept Biomed Engn, Edmonton, AB, Canada; [Pruessner, Jens C.] McGill Univ, McGill Ctr Studies Aging, Dept Psychiat, Montreal, PQ, Canada; [Wang, Lei] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Wolf, Henrike] Univ Zurich, Psychiat Univ Hosp, Dept Psychiat Res & Geriatr Psychiat, Zurich, Switzerland; [Wolf, Henrike] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [deLeon, Mony] NYU, Sch Med, Ctr Brain Hlth, New York, NY USA; [Pantel, Johannes] Goethe Univ Frankfurt, Inst Gen Practice, D-60054 Frankfurt, Germany; [Pasqualetti, Patrizio] Fatebenefratelli Hosp, AFaR Fatebenefratelli Assoc Res, SeSMIT Serv Med Stat & Informat Technol, Rome, Italy; [Pasqualetti, Patrizio] IRCCS San Raffaele Pisana, Unit Clin & Mol Epidemiol, Rome, Italy	Boccardi, M (reprint author), IRCCS Ist Ctr S Giovanni Dio Fatebenefratelli, LENITEM Lab Epidemiol Neuroimaging & Telemed, Brescia, Italy.	mboccardifbf@gmail.com	Visser, Pieter/C-8541-2015; Bocchetta, Martina/B-6331-2013; Simmons, Andrew/B-8848-2008; Jack, Clifford/F-2508-2010; Barnes, Josesphine/P-5698-2014; Bosco, Paolo/F-2195-2014; Maller, Jerome/H-4963-2014; Marina, Boccardi/B-2733-2010; Sachdev, Perminder/H-3968-2015	Visser, Pieter/0000-0001-8008-9727; Bocchetta, Martina/0000-0003-1814-5024; Simmons, Andrew/0000-0003-2306-5811; Jack, Clifford/0000-0001-7916-622X; Maller, Jerome/0000-0003-4685-1508; Marina, Boccardi/0000-0001-6744-8246; Sachdev, Perminder/0000-0002-9595-3220	Alzheimer's Association [IIRG-10-174022]; Lilly International; Wyeth International; Ministere du Developpement Economique, de l'Innovation et de l'Exportation of Quebec; Alzheimer's Research UK; Brain Research Trust; NIHR Queen Square Dementia BRU; NIH/NIA ADC P30 grant [P30 AG008017]; Investissements d' avenir [ANR-10-IAIHU-06]; Alzheimer's Disease Neuroimaging Initiative (ADM) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; ADNI clinical sites in Canada; NM grants [P30 AG010129, K01 AG030514]	The "Harmonized Protocol For Manual Hippocampal Segmentation: An EADC-ADNI Effort" has been funded thanks to an unrestricted grant from the Alzheimer's Association (grant number IIRG-10-174022). The project PI is Giovanni B Frisoni, IRCCS Fatebenefratelli, Brescia, Italy; the co-PI is Clifford R. Jack, Mayo Clinic, Rochester, MN; the Statistical Working Group is led by Simon Duchesne, Laval University, Quebec City, Canada; project Coordinator is Marina Boccardi, IRCCS Fatebenefratelli, Brescia, Italy. EADC Centres (local P.I.) are: lRCCS Fatebenefratelli, Brescia, Ray (GB Frisoni); University of Kuopio and Kuopio University Hospital, Kuopio, Finland (H Soininen); Hopital Salpetriere, Paris, France (B Dubois and S Lehericy); University of Frankfurt, Frankfurt, Germany (H Hampel); University Rostock and DZNE, Rostock, Germany (S Teipel); Karolinska institutet, Stockholm, Sweden (L-O Wahlund); Department of Psychiatry Research, Zurich, Switzerland (C Hock); Alzheimer Centre, Vrije Univ Medical Centre, Amsterdam, The Netherlands (F Barkhof and P Scheltens); Dementia Research Group Institute of Neurology, London, United Kingdom (N Fox); Dep. of Psychiatry and Psychotherapy, University Medical Center, Mainz (A. Fellgiebel); NEUROMED, Department of Neuroimaging, King's College London, London, United Kingdom (A Simmons). ADNI Centres are: Mayo Clinic, Rochester, MN (CR Jack); University of California Davis, CA (C DeCarli and C Watson); University of California, Los Angeles (UCLA), CA (G Bartzokis); University of California San Francisco (UCSF), CA (M Weiner and S Mueller); University of California, Los Angeles (UCLA), CA (LG Apostolova); Laboratory of NeuroImaging (LoNI), University of Southern California, Los Angeles, CA (PM Thompson); Rush University Medical Center, Chicago, IL (L deToledo-Morrell); Rush Alzheimer's Disease Center, Chicago, IL (D Bennet); Northwestern University, IL (JG Csernansky); Boston University School of Medicine, MA (R Killiany); John Hopkins University, Baltimore, MD (M Albert); Center for Brain Health, New York, NY (M De Leon); Oregon Health & Science University, Portland, OR (J Kaye). Other Centres are: McGill University, Montreal, Quebec, Canada (J Pruessner); University of Alberta, Edmonton, AB, Canada (R Camicioli and N Malykhin); Department of Psychiatry, Psychosomatic, Medicine & Psychotherapy, Johann-, Wolfgang GoetheUniversity, Frankfurt, Germany (J Pantel); Institute for Ageing and Health, Wolfson Research Centre, Newcastle General Hospital, Newcastle, United Kingdom (J O'Brien). Population based Studies: PATH through life, Australia (P Sachdev and JJ Mailer); SMART-Medea Study, University Medical Center Utrecht, The Netherlands (MI Geerlings); Rotterdam Scan Study, The Netherlands (T denHeijer). Statistical Working Group: AFAR (Fatebenefratelli Association for Biomedical Research) San Giovanni Calibita - Fatebenefratelli Hospital Rome, Italy (P Pasqualetti); Laval University, Quebec City, Canada (S Duchesne); MM, McGill University, Montreal, Canada (L Collins) Advisors: Clinical issues: PJ Visser, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands; EADC PIs: B Winbald, Karolinska Institute, Sweden and L Froelich, Central Institute of Mental Health, Mannheim, Germany; Dissemination & Education: G Waldemar, Copenhagen University Hospital, Copenhagen, Denmark; ADNI PI: M Weiner, University of California San Francisco (UCSF), CA; Population Studies: L Launer, National Institute on Aging (NIA), Bethesda and W Jagust, University of California, Berkeley, CA.; Preparatory work (reported in Boccardi et al:, J Alzheimers Dis, 2011; 26:61-75 and in Boccardi et al, Alzheimer's and Dementia 2013, doi:pii: S1552-5260(13)00078-2) was funded by unrestricted grants from Lilly International and Wyeth International (a part of the Pfizer group).; The Statistical Working Group is co-funded through an international collaborative grant from the Ministere du Developpement Economique, de l'Innovation et de l'Exportation of Quebec.; Josephine Barnes is an Alzheimer's Research UK senior research fellow based at the Dementia Research Centre, Department of Neurodegenerative Disease, UCL, Institute of Neurology. The Dementia Research Centre is an Alzheimer's Research UK Coordinating Centre and has also received equipment funded by Alzheimer's Research UK and Brain Research Trust. Part of this work was supported by the NIHR Queen Square Dementia BRU.; Contribution by Tim Swihart, Lisa C Silbert and Jeffiey Kaye was supported by NIH/NIA ADC P30 grant (P30 AG008017). Contribution by Stephane Lehericy was supported by the grant: "Investissements d' avenir" (grant number ANR-10-IAIHU-06).; Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADM) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; E Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.Y.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health Rev March 26, 2012 (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NM grants P30 AG010129 and K01 AG030514.	Frisoni GB, 2011, ALZHEIMERS DEMENT, V7, P171, DOI 10.1016/j.jalz.2010.06.007; Mattsson N, 2011, ALZHEIMERS DEMENT, V7, P386, DOI 10.1016/j.jalz.2011.05.2243; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037//0033-2909.86.2.420; Hoglund K, 2012, J ALZHEIMERS DIS, V32, P939, DOI 10.3233/JAD-2012-120976; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Geuze E, 2005, MOL PSYCHIATR, V10, P147, DOI 10.1038/sj.mp.4001580; Chetelat G, 2003, NEUROIMAGE, V18, P525, DOI 10.1016/S1053-8119(02)00026-5; Watson C, 1997, ARCH NEUROL-CHICAGO, V54, P1521; SOININEN HS, 1994, NEUROLOGY, V44, P1660; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Noga JT, 2001, PSYCHIAT RES-NEUROIM, V106, P25, DOI 10.1016/S0925-4927(00)00084-6; COOK MJ, 1992, BRAIN, V115, P1001, DOI 10.1093/brain/115.4.1001; Ridha BH, 2006, LANCET NEUROL, V5, P828, DOI 10.1016/S1474-4422(06)70550-6; Schott JM, 2003, ANN NEUROL, V53, P181, DOI 10.1002/ana.10424; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P474, DOI 10.1016/j.jalz.2011.04.007; Kaye JA, 1997, NEUROLOGY, V48, P1297; deToledo-Morrell L, 2004, NEUROBIOL AGING, V25, P1197, DOI 10.1016/j.neurobiolaging.2003.12.007; Jack CR, 2004, NEUROLOGY, V62, P591; Boccardi M, 2011, J ALZHEIMERS DIS, V26, P61, DOI 10.3233/JAD-2011-0004; Knoops AJG, 2012, PSYCHIAT RES-NEUROIM, V203, P31, DOI 10.1016/j.pscychresns.2011.12.002; Convit A, 1997, NEUROBIOL AGING, V18, P131, DOI 10.1016/S0197-4580(97)00001-8; Chupin M, 2007, NEUROIMAGE, V34, P996, DOI 10.1016/j.neuroimage.2006.10.035; Haller JW, 1997, RADIOLOGY, V202, P504; Bartzokis G, 1998, PSYCHIAT RES-NEUROIM, V82, P11, DOI 10.1016/S0925-4927(98)00007-9; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P175, DOI 10.1016/j.jalz.2014.12.002; Boccardi M, 2014, J NEUROIMAGING, V24, P509, DOI 10.1111/jon.12065; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P184, DOI 10.1016/j.jalz.2013.03.001; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P126, DOI 10.1016/j.jalz.2014.02.009; Bocchetta M, 2015, ALZHEIMERS DEMENT, V11, P151, DOI 10.1016/j.jalz.2013.12.019; Bosscher L, 2002, EVIDENCE BASED DEMEN, P154; Committee for Medicinal Products for Human Use (CHMP), 2011, EMACHMPSAWP809208201; Duchesne S, 2015, ALZHEIMERS DEMENT, V11, P161, DOI 10.1016/j.jalz.2015.01.002; JACK CR, 1994, EPILEPSIA, V35, pS21, DOI 10.1111/j.1528-1157.1994.tb05986.x; KILLIANY RJ, 1993, ARCH NEUROL-CHICAGO, V50, P949; van de Pol LA, 2007, NEUROLOGY, V69, P1491, DOI 10.1212/01.wnl.0000277458.26846.96	38	11	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	FEB	2015	11	2					111	125		10.1016/j.jalz.2014.05.1756		15	Clinical Neurology	Neurosciences & Neurology	CD7FB	WOS:000351255100002		
J	Boccardi, M; Bocchetta, M; Morency, FC; Collins, DL; Nishikawa, M; Ganzola, R; Grothe, MJ; Wolf, D; Redolfi, A; Pievani, M; Antelmi, L; Fellgiebel, A; Matsuda, H; Teipel, S; Duchesne, S; Jack, CR; Frisoni, GB				Boccardi, Marina; Bocchetta, Martina; Morency, Felix C.; Collins, D. Louis; Nishikawa, Masami; Ganzola, Rossana; Grothe, Michel J.; Wolf, Dominik; Redolfi, Alberto; Pievani, Michela; Antelmi, Luigi; Fellgiebel, Andreas; Matsuda, Hiroshi; Teipel, Stefan; Duchesne, Simon; Jack, Clifford R., Jr.; Frisoni, Giovanni B.		Eadc Adni Working Grp Harmonized P	Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol	ALZHEIMERS & DEMENTIA			English	Article						Harmonized protocol; Benchmark images; Automated segmentation algorithms; Algorithm training; MRI; Hippocampus; Hippocampal segmentation	CEREBROSPINAL-FLUID; BIOMARKERS; DISEASE	Background: The European Alzheimer's Disease Consortium and Alzheimer's Disease Neuroimaging Initiative (ADNI) Harmonized Protocol (HarP) is a Delphi definition of manual hippocampal segmentation from magnetic resonance imaging (MRI) that can be used as the standard of truth to train new tracers, and to validate automated segmentation algorithms. Training requires large and representative data sets of segmented hippocampi. This work aims to produce a set of HarP labels for the proper training and certification of tracers and algorithms. Methods: Sixty-eight 1.5 T and 67 3 T volumetric structural ADNI scans from different subjects, balanced by age, medial temporal atrophy, and scanner manufacturer, were segmented by five qualified HarP tracers whose absolute interrater intraclass correlation coefficients were 0.953 and 0.975 (left and right). Labels were validated as HarP compliant through centralized quality check and correction. Results: Hippocampal volumes (mm(3)) were as follows: controls: left = 3060 (standard deviation [SD], 502), right = 3120 (SD, 897); mild cognitive impairment (MCI): left = 2596 (SD, 447), right = 2686 (SD, 473); and Alzheimer's disease (AD): left = 2301 (SD, 492), right = 2445 (SD, 525). Volumes significantly correlated with atrophy severity at Scheltens' scale (Spearman's rho = < -0.468, P = <.0005). Cerebrospinal fluid spaces (mm(3)) were as follows: controls: left = 23 (32), right = 25 (25); MCI: left = 15 (13), right = 22 (16); and AD: left = 11(13), right = 20 (25). Five subjects (3.7%) presented with unusual anatomy. Conclusions: This work provides reference hippocampal labels for the training and certification of automated segmentation algorithms. The publicly released labels will allow the widespread implementation of the standard segmentation protocol. (C) 2015 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.	[Boccardi, Marina; Bocchetta, Martina; Redolfi, Alberto; Pievani, Michela; Antelmi, Luigi; Frisoni, Giovanni B.] IRCCS Ctr S Giovanni de Dio Fatebenefratelli, LENITEM, Brescia, Italy; [Bocchetta, Martina] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Morency, Felix C.; Ganzola, Rossana; Duchesne, Simon] Univ Laval, Dept Radiol, Quebec City, PQ, Canada; [Morency, Felix C.; Ganzola, Rossana; Duchesne, Simon] Univ Sante Mentale Quebec, Ctr Rech Inst, Quebec City, PQ, Canada; [Morency, Felix C.] Imeka, Sherbrooke, PQ, Canada; [Collins, D. Louis] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Nishikawa, Masami] Kawamura Gakuen Womans Univ, Abiko, Chiba, Japan; [Grothe, Michel J.; Teipel, Stefan] German Ctr Neurodegenerat Dis DZNE, Rostock, Germany; [Wolf, Dominik; Fellgiebel, Andreas] Johannes Gutenberg Univ Mainz, Klin Psychiat & Psychotherapie, D-55122 Mainz, Germany; [Antelmi, Luigi; Frisoni, Giovanni B.] HUG Belle Idee, Dept Psychiat, Lab Neuroimaging Aging, Geneva, Switzerland; [Matsuda, Hiroshi; Teipel, Stefan] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Tokyo, Japan; [Jack, Clifford R., Jr.] Mayo Clin & Mayo Fdn, Dept Diagnost Radiol, Rochester, MN USA; [Frisoni, Giovanni B.] Univ Geneva, Fac Med, Geneva, Switzerland	Boccardi, M (reprint author), IRCCS Ctr S Giovanni de Dio Fatebenefratelli, LENITEM, Brescia, Italy.	mboccardifbf@gmail.com	Bocchetta, Martina/B-6331-2013; Jack, Clifford/F-2508-2010; Marina, Boccardi/B-2733-2010	Bocchetta, Martina/0000-0003-1814-5024; Jack, Clifford/0000-0001-7916-622X; Marina, Boccardi/0000-0001-6744-8246	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec; Bristol-Myers Squibb Company; Eisai; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd, company Genentech, Inc.; GE Healthcare; Innogenetics N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer; Piramal Imaging; Servier; Synarc; Takeda Pharmaceutical Company; Canadian Institutes of Health Research; Ministere du Developpement Economique, de l'Innovation et de l'Exportation du Quebec [PSR-SIIRI 631]; Alzheimer's Society of Canada [13 32]	The MR images used in this paper belong to the ADNI dataset. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec; Bristol-Myers Squibb Company; Eisai; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer; Piramal Imaging; Servier; Synarc; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.; SD, FV, AV, and NR have received funding support from the Ministere du Developpement Economique, de l'Innovation et de l'Exportation du Quebec (PSR-SIIRI 631), and the Alzheimer's Society of Canada (#13 32). S.D. is a Junior 1 Research Scholar from the Fonds de Recherche Quebec-Sante (#22424).	DeCarli C, 2007, ARCH NEUROL-CHICAGO, V64, P108, DOI 10.1001/archneur.64.1.108; Mattsson N, 2011, ALZHEIMERS DEMENT, V7, P386, DOI 10.1016/j.jalz.2011.05.2243; Hoglund K, 2012, J ALZHEIMERS DIS, V32, P939, DOI 10.3233/JAD-2012-120976; Geuze E, 2005, MOL PSYCHIATR, V10, P147, DOI 10.1038/sj.mp.4001580; Boccardi M, 2011, J ALZHEIMERS DIS, V26, P61, DOI 10.3233/JAD-2011-0004; Apostolova LG, 2015, ALZHEIMERS DEMENT, V11, P139, DOI 10.1016/j.jalz.2015.01.001; Boccardi M, 2014, J NEUROIMAGING, V24, P509, DOI 10.1111/jon.12065; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P184, DOI 10.1016/j.jalz.2013.03.001; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P126, DOI 10.1016/j.jalz.2014.02.009; Bocchetta M, 2015, ALZHEIMERS DEMENT, V11, P151, DOI 10.1016/j.jalz.2013.12.019; Duchesne S, 2013, MED MEAS APPL P MEME, P35; Duchesne S, 2015, ALZHEIMERS DEMENT, V11, P161, DOI 10.1016/j.jalz.2015.01.002; Frisoni GB, 2015, ALZHEIMERS DEMENT, V11, P111, DOI 10.1016/j.jalz.2014.05.1756; Li Y, 2006, AM J NEURORADIOL, V27, P912; Scheltens P, 1992, J NEUROL NEUROSUR PS, V55, P967	15	5	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	FEB	2015	11	2					175	183		10.1016/j.jalz.2014.12.002		9	Clinical Neurology	Neurosciences & Neurology	CD7FB	WOS:000351255100007		
J	Abdulkadiroglu, A; Che, YK; Yasuda, Y				Abdulkadiroglu, Atila; Che, Yeon-Koo; Yasuda, Yosuke			Expanding "Choice" in School Choice	AMERICAN ECONOMIC JOURNAL-MICROECONOMICS			English	Article							2-SIDED MATCHING MARKETS; ASSIGNMENT PROBLEM; BOSTON MECHANISM; STABILITY; INCENTIVES; ALLOCATION; EFFICIENCY; DESIGN; GALE	Gale-Shapley's deferred acceptance (henceforth DA) mechanism has emerged as a prominent candidate for placing students to public schools. While DA has desirable fairness and incentive properties, it limits the applicants' abilities to communicate their preference intensities, which entails ex ante inefficiency when ties at school preferences are broken randomly. We propose a variant of deferred acceptance mechanism that allows students to influence how they are treated in ties. It inherits much of the desirable properties of DA but performs better in ex ante efficiency.	[Abdulkadiroglu, Atila] Duke Univ, Dept Econ, Durham, NC 27708 USA; [Che, Yeon-Koo] Columbia Univ, Dept Econ, New York, NY 10027 USA; [Yasuda, Yosuke] Osaka Univ, Econ, Toyonaka, Osaka 5600043, Japan	Abdulkadiroglu, A (reprint author), Duke Univ, Dept Econ, 213 Social Sci Bldg, Durham, NC 27708 USA.	atila.abdulkadiroglu@duke.edu; yeonkooche@gmail.com; yyasuda@econ.osaka-u.ac.jp			NSF-CAREER; National Research Foundation in Korea through its Global Research Network Grant [NRF-2013S1A2A2035408];  [20830024]	We are grateful to Eduardo Azevedo, Francis Bloch, Guilherme Carmona, Olivier Compte, Haluk Ergin, Matt Jackson, Navin Kartik, Fuhito Kojima, David Levine, Paul Milgrom, Al Roth, Ilya Segal, Ron Siegel, Olivier Tercieux, and other seminar participants at Brown University, Caltech, Duke University, GREQAM, GRIPS, Harvard Market Design Workshop, Hong Kong University, National University of Singapore, New York University, Nihon University (ARISH), Northwestern University, Okayama University, Osaka Workshop on Economics of Institution and Organizations, Oxford University, Paris School of Economics, Princeton University (IAS), Stanford University, Tokyo Institute of Technology, Toyama University, Tsukuba University, Waseda University, Washington University, Yonsei University, and Universities of California-LA and -SD, Leicester, Pompeu Fabra, and Rochester. Abdulkadiroglu acknowledges an NSF-CAREER grant. Che acknowledges the financial support from the National Research Foundation in Korea through its Global Research Network Grant (NRF-2013S1A2A2035408).; Yasuda acknowledges research support from Grant-in-Aid for Scientific Research, 20830024, administered by the Japanese Ministry of Education.	Abdulkadiroglu Atila, 2008, 080909 PER COL U; Abdulkadiroglu Atila, 2006, CHANGING BOSTON SCH; Sonmez T, 2010, INT ECON REV, V51, P99; Abdulkadiroglu A, 2009, AM ECON REV, V99, P1954, DOI 10.1257/aer.99.5.1954; Kojima F, 2009, AM ECON REV, V99, P608, DOI 10.1257/aer.99.3.608; Coles P, 2013, AM ECON J-MICROECON, V5, P99, DOI 10.1257/mic.5.2.99; Budish E, 2013, AM ECON REV, V103, P585, DOI 10.1257/aer.103.2.585; Erdil A, 2008, AM ECON REV, V98, P669, DOI 10.1257/aer.98.3.669; GALE D, 1962, AM MATH MON, V69, P9, DOI 10.2307/2312726; HYLLAND A, 1979, J POLIT ECON, V87, P293, DOI 10.1086/260757; Bogomolnaia A, 2001, J ECON THEORY, V100, P295, DOI 10.1006/jeth.2000.2710; Ergin H, 2006, J PUBLIC ECON, V90, P215, DOI 10.1016/j.jpubeco.2005.02.002; Abdulkadiroglu A, 2003, AM ECON REV, V93, P729, DOI 10.1257/000282803322157061; Budish E, 2012, AM ECON REV, V102, P2237, DOI 10.1257/aer.102.5.2237; Roth AE, 2008, INT J GAME THEORY, V36, P537, DOI 10.1007/s00182-008-0117-6; Jackson MO, 2007, ECONOMETRICA, V75, P241, DOI 10.1111/j.1468-0262.2007.00737.x; Abdulkadiroglu A, 2011, AM ECON REV, V101, P399, DOI 10.1257/aer.101.1.399; Roth AE, 1999, AM ECON REV, V89, P748, DOI 10.1257/aer.89.4.748; Che YK, 2010, ECONOMETRICA, V78, P1625, DOI 10.3982/ECTA8354; Arrow Kenneth J., 2009, COMMUNICATION   0103; Azevedo Eduardo M., 2013, SUPPLY DEMAND FRAMEW; Azevedo EM, 2014, GAME ECON BEHAV, V83, P207, DOI 10.1016/j.geb.2013.11.009; Balinski M, 1999, J ECON THEORY, V84, P73, DOI 10.1006/jeth.1998.2469; Bodoh-Creed Aaron, J EC THEORY IN PRESS; Casella A, 2005, GAME ECON BEHAV, V51, P391, DOI 10.1016/j.geb.2004.09.009; DUBINS LE, 1981, AM MATH MON, V88, P485, DOI 10.2307/2321753; Inunorlica Nicole, 2005, P 16 ANN ACM SIAM S, P53; MASCOLELL A, 1984, J MATH ECON, V13, P201, DOI 10.1016/0304-4068(84)90029-6; McLennan Andrew, 2011, COMPUTATIONAL COMPLE; Miralles Antonio, 2008, SCH CHOICE CASE BOST; Pathak Parag A., 2008, AM ECON REV, V98, P1636; Kojima F, 2013, Q J ECON, V128, P1585, DOI 10.1093/qje/qjt019; ROTH AE, 1982, MATH OPER RES, V7, P617, DOI 10.1287/moor.7.4.617; Sandholm T., 2006, COMBINATORIAL AUCTIO, P233; Uhlig H, 1996, ECON THEORY, V8, P41, DOI 10.1007/s001990050076; ZHOU L, 1990, J ECON THEORY, V52, P123, DOI 10.1016/0022-0531(90)90070-Z	36	0	0	AMER ECONOMIC ASSOC	NASHVILLE	2014 BROADWAY, STE 305, NASHVILLE, TN 37203 USA	1945-7669	1945-7685		AM ECON J-MICROECON	Am. Econ. J.-Microecon.	FEB	2015	7	1					1	42		10.1257/mic.20120027		42	Economics	Business & Economics	CE0PS	WOS:000351507200001		
J	Vol'vach, AE; Larionov, MG; Vol'vach, LN; Lahteenmaki, A; Tornikoski, M; Aller, MF; Aller, HD; Sasada, M				Vol'vach, A. E.; Larionov, M. G.; Vol'vach, L. N.; Lahteenmaki, A.; Tornikoski, M.; Aller, M. F.; Aller, H. D.; Sasada, M.			Physical Characteristics of the Blazar AO 0235+164	ASTRONOMY REPORTS			English	Article							BL-LACERTAE OBJECT; EXTRAGALACTIC RADIO-SOURCES; ACTIVE GALACTIC NUCLEI; X-RAY-SPECTRA; 3C 454.3; WEBT CAMPAIGN; LOUD BLAZARS; XMM-NEWTON; LAC OBJECT; AO-0235+164	Long series of multi-frequency monitoring data of the active galactic nucleus (AGN) AO 0235+164 from the radio to the gamma-ray are analyzed. AO 0235+164 may be a close binary system comprised of two supermassive black holes (SMBHs). A harmonic analysis has established the presence of orbital and precessional periods of two and eight years, respectively. These values are close to the analogous periods found in other AGNs that have been proposed to be close SMBH binary systems in a stage of their evolution close to coalescence. A cross-correlation analysis is used to find the time delay between corresponding flares occurring in different wavebands. The empirical dependence found earlier for a number of other AGNS relating the delay in the flux variations with the frequency is observed for this object, and has the form of an inverse logarithmic dependence, providing evidence that the flux variability of AGNs at centimeter and shorter wavelengths is intrinsic. The standard picture of jet activity of AGNs supposes plasma formations that move from the central regions along outflows, becoming optically thin at longer and longer wavelengths as they do so. The physical and dynamical characteristics of AO 0235+164 suggest it is a close binary with SMBHs with similar masses of the order of 10(10)M(circle dot). This is one of the most massive systems of two SMBHs. The velocities of the companion and central black hole about their common center of mass are estimated to be 10(4) and 5 x 10(3) km/s. The results obtained suggest that observed bright AGNs form a relatiavely rare population among massive elliptical galaxies, due to their narrowly directed emission and their short lifetimes.	[Vol'vach, A. E.; Vol'vach, L. N.] Crimean Astrophys Observ, Jalta, Crimean Republi, Russia; [Larionov, M. G.] Russian Acad Sci, Astro Space Ctr, PN Lebedev Phys Inst, Moscow, Russia; [Lahteenmaki, A.; Tornikoski, M.] Aalto Univ, Metsahovi Radio Observ, Helsinki, Finland; [Aller, M. F.; Aller, H. D.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Sasada, M.] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan	Vol'vach, AE (reprint author), Crimean Astrophys Observ, Jalta, Crimean Republi, Russia.	volvach@meta.ua	Lahteenmaki, Anne/L-5987-2013; Larionov, Mikhail/N-2668-2015		Ukrainian-Indian grant	We thank the staff of the 22-m CrAO radio telescope for their help with carrying out the observations. This work was supported by a Ukrainian-Indian grant.	ABRAHAM RG, 1993, ASTROPHYS J, V415, P101, DOI 10.1086/173147; Ackermann M, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/159; Aller M. F., 2001, B AM ASTRON SOC, V33, P1516; Atwood WB, 2009, ASTROPHYS J, V697, P1071, DOI 10.1088/0004-637X/697/2/1071; SCHMIDT GD, 1992, ASTRON J, V104, P1563, DOI 10.1086/116341; Raiteri CM, 2001, ASTRON ASTROPHYS, V377, P396, DOI 10.1051/0004-6361:20011112; Jorstad SG, 2010, ASTROPHYS J, V715, P362, DOI 10.1088/0004-637X/715/1/362; Ostorero L, 2004, ASTRON ASTROPHYS, V419, P913, DOI 10.1051/0004-6361:20035813; Jorstad SG, 2001, ASTROPHYS J SUPPL S, V134, P181, DOI 10.1086/320858; Bychkova VS, 2011, J ASTROPHYS ASTRON, V32, P105, DOI 10.1007/s12036-011-9015-6; Chen YJ, 1999, ASTROPHYS SPACE SCI, V266, P495, DOI 10.1023/A:1002028601799; COHEN RD, 1987, ASTROPHYS J, V318, P577, DOI 10.1086/165393; Comastri A, 1997, ASTROPHYS J, V480, P534, DOI 10.1086/303986; Frey S, 2000, PUBL ASTRON SOC JPN, V52, P975; Fujisawa K, 1999, PUBL ASTRON SOC JPN, V51, P537; GHOSH KK, 1995, ASTROPHYS J SUPPL S, V100, P37, DOI 10.1086/192207; Nesterov NS, 2000, ASTRON LETT+, V26, P204, DOI 10.1134/1.20383; Noble J. C., 1996, Astronomical Society of the Pacific Conference Series, V110; Padovani P, 2004, MON NOT R ASTRON SOC, V347, P1282, DOI 10.1111/j.1365-2966.2004.07313.x; Raiteri CM, 2006, ASTRON ASTROPHYS, V459, P731, DOI 10.1051/0004-6361:20065744; Raiteri CM, 2008, ASTRON ASTROPHYS, V480, P339, DOI 10.1051/0004-6361:20079044; Raiteri CM, 2005, ASTRON ASTROPHYS, V438, P39, DOI 10.1051/0004-6361:20042567; Raiteri CM, 2007, ASTRON ASTROPHYS, V464, P871, DOI 10.1051/0004-6361:20066599; Raiteri CM, 2006, ASTRON ASTROPHYS, V452, P845, DOI 10.1051/0004-6361:20054409; RIEKE GH, 1976, NATURE, V260, P754, DOI 10.1038/260754a0; Romero GE, 2003, CHINESE J ASTRON AST, V3, P513; Romero GE, 2000, ASTRON ASTROPHYS, V360, pL47; Sadler EM, 2006, MON NOT R ASTRON SOC, V371, P898, DOI [10.1111/j.1365-2966.2006.10729.x, 10.1111/j.1365-2966.10729.x]; Sasada M, 2012, PUBL ASTRON SOC JPN, V64; Shvartsman V. F., 1970, SOV ASTRON, V14, P662; SMITH PS, 1985, ASTRON J, V90, P1184, DOI 10.1086/113824; SPINRAD H, 1975, ASTROPHYS J, V201, P275, DOI 10.1086/153883; STICKEL M, 1988, ASTRON ASTROPHYS, V198, pL13; Tokalo L. O., 1992, ASTRON J, V104, P40; Volvach AE, 2006, ASTR SOC P, V360, P133; Volvach A. E., 2014, ASTRON REP, V58, P78; Vol'vach AE, 2010, ASTRON REP+, V54, P28, DOI 10.1134/S106377291001004X; Volvach AE, 2007, ASTRON REP+, V51, P450, DOI 10.1134/S1063772907060030; Volvach AE, 2012, ASTRON REP+, V56, P275, DOI 10.1134/S1063772912030079; Vol'vach AE, 2013, ASTRON REP+, V57, P46, DOI 10.1134/S1063772912120098; Webb JR, 2000, ASTRON J, V120, P41, DOI 10.1086/301432; WORRALL DM, 1990, ASTROPHYS J, V360, P396, DOI 10.1086/169130; YANNY B, 1989, ASTROPHYS J, V338, P735, DOI 10.1086/167231	43	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1063-7729	1562-6881		ASTRON REP+	Astron. Rep.	FEB	2015	59	2					145	155		10.1134/S1063772914120117		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CD7QA	WOS:000351284400006		
J	Yamanaka, N; Iino, Y; Uno, Y; Kudo, F; Kurono, Y; Suzaki, H; Haruna, S; Hotomi, M; Horiguchi, S; Mashima, Y; Matsubara, S; Nakayama, T; Hirakawa, K; Okamoto, Y				Yamanaka, Noboru; Iino, Yukiko; Uno, Yoshifumi; Kudo, Fumiyo; Kurono, Yuichi; Suzaki, Harumi; Haruna, Shinichi; Hotomi, Muneki; Horiguchi, Shigetoshi; Mashima, Yuichi; Matsubara, Shigenori; Nakayama, Takeo; Hirakawa, Katsuhiro; Okamoto, Yoshitaka		Japanese Rhinologic Soc	Practical guideline for management of acute rhinosinusitis in Japan	AURIS NASUS LARYNX			English	Article							ACUTE BACTERIAL SINUSITIS; TEBIPENEM PIVOXIL; LEVOFLOXACIN; ADULTS; MULTICENTER; FORMULATION; PATHOGENS; CHILDREN; TRIAL		[Yamanaka, Noboru; Hotomi, Muneki] Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Wakayama 6418509, Japan; [Iino, Yukiko] Jichi Med Univ, Saitama Med Ctr, Dept Otolaryngol, Saitama, Japan; [Uno, Yoshifumi] Uno ENT Clin, Okayama, Japan; [Kudo, Fumiyo] Chiba Prefectural Univ Hlth Sci, Fac Hlth Sci, Dept Nutr, Chiba, Japan; [Kurono, Yuichi] Kagoshima Univ, Fac Med, Dept Otolaryngol, Kagoshima 890, Japan; [Suzaki, Harumi] Showa Univ, Sch Med, Dept Otorhinolaryngol, Tokyo 142, Japan; [Haruna, Shinichi] Dokkyo Med Univ, Dept Otorhinolaryngol & Head & Neck Surg, Mibu, Tochigi, Japan; [Horiguchi, Shigetoshi; Okamoto, Yoshitaka] Chiba Univ, Sch Med, Dept Otorhinolaryngol, Chiba 280, Japan; [Mashima, Yuichi] Ise Municipal Gen Hosp, Ise, Japan; [Matsubara, Shigenori] Matsubara ENT Clin, Gifu, Japan; [Nakayama, Takeo] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan; [Hirakawa, Katsuhiro] Hiroshima Univ, Fac Med, Dept Otorhinolaryngol, Hiroshima, Japan	Yamanaka, N (reprint author), Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, 811-1 Kimiidera, Wakayama 6418509, Japan.	ynobi@wakayama-med.ac.jp			Takahashi Otolaryngological Research Foundation	The Japanese Rhinologic Society covered the cost of developing this guideline, including travel expenses of all panel members, in full, and the scholarship of Takahashi Otolaryngological Research Foundation covered the cost of preparing this manuscript in part. The Japanese Rhinologic Society is not supported by any particular organization or business firm, and no funding from business firms, such as pharmaceutical companies, was used for the preparation of these guidelines.	Adelglass J, 1999, OTOLARYNG HEAD NECK, V120, P320, DOI 10.1016/S0194-5998(99)70269-X; Brook I, 2005, J CLIN MICROBIOL, V43, P3479, DOI 10.1128/JCM.43.7.3479-3480.2005; Anon JB, 2004, OTOLARYNG HEAD NECK, V130, P1, DOI 10.1016/j.otohns.2003.12.003; Lund VJ, 1997, OTOLARYNG HEAD NECK, V117, pS35, DOI 10.1016/S0194-5998(97)70005-6; BABA S, 2009, JPN J CHEMOTHER S1, V57, P151; Baba S, 2000, J JPN SOC INFECT DIS, V18, P48; Brook I, 2007, INFECT DIS CLIN N AM, V21, P427, DOI 10.1016/j.idc.2007.02.001; Brook I, 2005, INT J ANTIMICROB AG, V26, P416, DOI 10.1016/j.ijantimicag.2005.08.012; Casiano R R, 2000, Semin Respir Infect, V15, P216; Clinical and Laboratory Standards Institute, 2008, CLSI DOCUMENT M100 S; FIREMAN P, 1992, J ALLERGY CLIN IMMUN, V90, P433, DOI 10.1016/0091-6749(92)90164-W; Hotomi M, 2012, PLOS ONE, V7, P1; HOTOMI M, 2008, JPN J CHEMOTHER, V56, P7; Japan Rhinologic Society, 2007, GUIDE FOR THE DIAGNO, V5, P38; Japan Rhinologic Society, 2007, GUIDE FOR THE DIAGNO, V5, P37; Karageorgopoulos DE, 2008, CAN MED ASSOC J, V178, P845, DOI 10.1503/cmaj.071157; Kudo F, 2008, THE 37TH FORUM ON CL; Kudo F, 2008, J JPN RHINOL SOC, V47, P115; Lau J, 2000, EVID REP TECHNOL ASS, V9, P1; Lund VJ., 1997, ENT-EAR NOSE THROAT, V12, P1; Lund V J, 1995, Ann Otol Rhinol Laryngol Suppl, V167, P17; Marple BF, 2007, CLIN THER, V29, P2690, DOI 10.1016/j.clinthera.2007.12.030; Matsubara S, 2000, PRACT-OTO-RHINO-LARY, V93, P283; Murray JJ, 2005, OTOLARYNG HEAD NECK, V133, P194, DOI 10.1016/j.otohns.2005.04.020; Niki Y., 2008, Journal of Infection and Chemotherapy, V14, P279, DOI 10.1007/s10156-008-0623-2; Nishimura T, 2004, J JPN SOC INFECT DIS, V22, P12; SAIKA T, 2009, JPN J CHEMOTHER, V57, P203; Sande MA, 2004, CLIN INFECT DIS, V39, pS151, DOI 10.1086/421353; Sher LD, 2002, CLIN THER, V24, P269, DOI 10.1016/S0149-2918(02)85023-8; Slavin Raymond G, 2005, J Allergy Clin Immunol, V116, pS13, DOI 10.1016/j.jaci.2005.09.048; SUNAKAWA K, 2009, JPN J CHEMOTHER, V57, P279; Suzuki K, 2008, J JPN SOC INFECT DIS, V26, P15; Uchizono A, 2012, J JPN SOC INFECT DIS, V30, P31; Yamanaka N, 2011, PRACT OTORHINOLARYNG, V104, P591; YAMANAKA N, 2009, JPN J CHEMOTHER S1, V57, P125; Yamanaka N, 2011, PRACT OTORHINOLARYNG, V104, P741; YAMANAKA N, 2008, JPN J CHEMOTHER, V56, P525	37	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	FEB	2015	42	1					1	7		10.1016/j.anl.2014.05.022		7	Otorhinolaryngology	Otorhinolaryngology	CD7EP	WOS:000351253900001		
J	Nishimura, T; Hosoi, H; Saito, O; Miyamae, R; Shimokura, R; Matsui, T; Yamanaka, T; Kitahara, T; Levitt, H				Nishimura, Tadashi; Hosoi, Hiroshi; Saito, Osamu; Miyamae, Ryosuke; Shimokura, Ryota; Matsui, Toshie; Yamanaka, Toshiaki; Kitahara, Tadashi; Levitt, Harry			Cartilage conduction efficiently generates airborne sound in the ear canal	AURIS NASUS LARYNX			English	Article						Air conduction; Bone conduction; Occlusion effect; Aural cartilage; Cartilage-air; Cartilage-bone; Direct-air; Tragus	BONE-CONDUCTION	Objective: By attaching a transducer to the aural cartilage, a relatively loud sound is audible even with a negligibly small fixation force. Previous study has identified several pathways for sound transmission by means of cartilage conduction. This investigation focused on the relative contribution of direct vibration of the aural cartilage to sound transmission in an open and in an occluded ear. Methods: Thresholds with and without an earplug were compared for three experimental conditions: the transducer being placed on the tragus, pretragus, and mastoid. Eight volunteers with normal hearing participated. Results: The thresholds increased with distance of the transducer from the ear canal (tragus, pretragus, mastoid, in that order). The differences were statistically significant for all conditions except for the occluded ear at 4 kHz. With the earplug inserted, the thresholds for the tragus condition were most sensitive below 2 kHz, indicating a significant contribution of direct vibration of the aural cartilage. Conclusion: Direct vibration of the aural cartilage can enhance sound transmission. At low frequencies, cartilage conduction can deliver sound efficiently across a blockage in the ear canal. Stray airborne sound radiating from the transducer dominates cartilage conduction in the open ear at high frequencies. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Nishimura, Tadashi; Saito, Osamu; Miyamae, Ryosuke; Shimokura, Ryota; Yamanaka, Toshiaki; Kitahara, Tadashi] Nara Med Univ, Dept Otolaryngol Head & Neck Surg, Kashihara, Nara 6348522, Japan; [Hosoi, Hiroshi] Nara Med Univ, Kashihara, Nara 6348522, Japan; [Matsui, Toshie] Univ Tsukuba, Dept Life Sci, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaragi 3058577, Japan; [Levitt, Harry] CUNY, New York, NY USA	Nishimura, T (reprint author), Nara Med Univ, Dept Otolaryngol Head & Neck Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	t-nishim@naramed-u.ac.jp			Health and Labour Science Research Grants for the Sensory and Communicative Disorders from the Ministry of Health, Labour and Welfare, Japan; JSPS KAKENHI [23791924]; Adaptable and Seamless Technology Transfer Program through target-driven RD, JST Grant [AS251Z00168P]	This research was supported by a Health and Labour Science Research Grants for the Sensory and Communicative Disorders from the Ministry of Health, Labour and Welfare, Japan. This research was also supported by JSPS KAKENHI Grant Number 23791924. This research was also supported by Adaptable and Seamless Technology Transfer Program through target-driven R&D, JST Grant Number AS251Z00168P. We thank Mr. Takashi lwakura and Mr. Kyoji Yoshikawa (Rion Co., Ltd.) for development of the cartilage conduction experiment device.	Stenfelt S, 2003, J ACOUST SOC AM, V113, P902, DOI 10.1121/1.1534606; Stenfelt S, 2005, OTOL NEUROTOL, V26, P1245, DOI 10.1097/01.mao.0000187236.10842.d5; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Baun J., 2004, PHYS PRINCIPLES GEN; Dillon H, 2001, HEARING AIDS; Hosoi H, Japanese patent, Patent No. 4541111; Hosoi H., 2010, ARCH MAT SCI ENG, V42, P104; Hosoi H, Japanese patent application, Patent No. 166644; Lightfoot G R, 1979, Br J Audiol, V13, P53, DOI 10.3109/03005367909078877; Morimoto C, 2014, J REHABIL RES DEV, V51, P325, DOI 10.1682/JRRD.2013.05.0128; Nishimura T, 2013, AURIS NASUS LARYNX, V40, P440, DOI 10.1016/j.anl.2012.12.003; Nishimura T, 2014, LARYNGOSCOPE, V124, P1214, DOI 10.1002/lary.24485; Shimokura R, 2013, APPL ACOUST, V74, P1234, DOI 10.1016/j.apacoust.2013.04.013; Shipton M S, 1980, Br J Audiol, V14, P86, DOI 10.3109/03005368009078908	14	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	FEB	2015	42	1					15	19		10.1016/j.anl.2014.08.001		5	Otorhinolaryngology	Otorhinolaryngology	CD7EP	WOS:000351253900003		
J	Fukuhara, T; Fujiwara, K; Fujii, T; Takeda, K; Matsuda, E; Hasegawa, K; Nomura, K; Kitano, H				Fukuhara, Takahiro; Fujiwara, Kazunori; Fujii, Taihei; Takeda, Kenichi; Matsuda, Eriko; Hasegawa, Kensaku; Nomura, Kenichi; Kitano, Hiroya			Usefulness of chest CT scan for head and neck cancer	AURIS NASUS LARYNX			English	Article						Chest CT; Head and neck cancer; Lung metastases; Small lung nodules	SQUAMOUS-CELL CARCINOMA; SMALL PULMONARY NODULES; NEWLY-DIAGNOSED HEAD; DISTANT METASTASES; COMPUTED-TOMOGRAPHY; MANAGEMENT; TUMORS; RISK; LUNG	Objective: Chest computed tomography (CT) is not performed routinely or worldwide as the initial diagnostic procedure for patients with head and neck cancer (HNC). The significance of the chest CT scan for HNC diagnosis has not been thoroughly defined. The present study reports findings in an effort to broaden the acceptance and application of CT for HNC. Methods: Using medical records, we assessed initial chest CT scans of the patients with new-onset HNC between April 2004 and March 2010. The results were classified into three groups: nodules >= 1 cm, small nodules (<1 cm) that were indeterminate and normal lungs without nodules. Lung nodules that increased in size and/or number at follow-up were regarded as malignant. First, the sensitivity of X-ray and CT for detection of lung nodules in patients with HNC was compared. Second, the nodules were estimated to be malignant or not malignant by follow-up chest CT. Third, statistical analyses were performed to determine the association between variables and distant lung metastases in patients with head and neck squamous cell carcinoma. Results: In total, 332 patients underwent a chest CT scan as part of the initial examination. Lung nodules were detected on the initial chest CT in 77 patients: in contrast, lung nodules were detected on the initial chest X-ray in only five patients. On initial chest CT scans, lung nodules >= 1 cm were observed in 10 patients, small solitary lung nodules were observed in 67 patients, and lungs without nodules were observed in 255 patients. Lung nodules were detected in 77 (23.2%) patients, 25 (32.5%) of whom had malignant lung nodules. Moreover, in 18/67 patients (26.9%), small lung nodules initially classified as indeterminate were determined as malignant at follow-up. However, 30/255 patients (11.8%) without nodules at initial diagnosis developed lung nodules at follow-up. 13 or T4 disease (P = 0.006), N2 or N3 disease (P < 0.001) and stage 3 or 4 disease (P = 0.001) individually and significantly correlated with the development of lung metastases. In addition, lung nodules in initial CT scans (P = 0.004) and other distant metastases (P < 0.001) were significant predictors for the development of lung metastases at follow-up. Conclusion: Initial chest CT scan is recommended for patients with advanced HNC. Further, patients with advanced HNC with or without lung nodules, as detected on initial chest CT scans, should be followed up with additional scanning. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Fukuhara, Takahiro; Fujiwara, Kazunori; Fujii, Taihei; Matsuda, Eriko; Hasegawa, Kensaku; Kitano, Hiroya] Tottori Univ, Fac Med, Dept Otolaryngol Head & Neck Surg, Yonago, Tottori 6838504, Japan; [Takeda, Kenichi] Tottori Univ, Fac Med, Dept Multidisciplinary Internal Med, Div Med Oncol & Mol Respirol, Yonago, Tottori 6838504, Japan; [Nomura, Kenichi] Niigata Coll Nursing, Dept Nursing, Div Biol & Med, Joetsu 9430147, Japan	Fukuhara, T (reprint author), Tottori Univ, Fac Med, Dept Otolaryngol Head & Neck Surg, 36-1 Nishicho, Yonago, Tottori 6838504, Japan.	tfukuhara3387@med.tottori-u.ac.jp					Hashibe M, 2013, HEAD NECK-J SCI SPEC, V35, P914, DOI 10.1002/hed.23052; Leon X, 2000, HEAD NECK-J SCI SPEC, V22, P680, DOI 10.1002/1097-0347(200010)22:7<680::AID-HED7>3.0.CO;2-J; Benjamin MS, 2003, RADIOLOGY, V226, P489, DOI 10.1148/radiol.2262010556; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Shah SI, 2000, LARYNGOSCOPE, V110, P2033, DOI 10.1097/00005537-200012000-00010; REMYJARDIN M, 1993, RADIOLOGY, V187, P513; de Bree R, 2000, LARYNGOSCOPE, V110, P397, DOI 10.1097/00005537-200003000-00012; HSAIRI M, 1989, HEAD NECK-J SCI SPEC, V11, P426, DOI 10.1002/hed.2880110508; Beech TJ, 2010, CLIN OTOLARYNGOL, V35, P474, DOI 10.1111/j.1749-4486.2010.02198.x; Brouwer J, 2005, LARYNGOSCOPE, V115, P1813, DOI 10.1097/01.mlg.0000174954.51541.b7; Ghosh SK, 2009, HEAD NECK-J SCI SPEC, V31, P1563, DOI 10.1002/hed.21124; Houghton DJ, 1998, HEAD NECK-J SCI SPEC, V20, P614; Hsu YB, 2008, ARCH OTOLARYNGOL, V134, P1050, DOI 10.1001/archotol.134.10.1050; Ishikawa M, 2011, AURIS NASUS LARYNX, V38, P426, DOI 10.1016/j.anl.2010.11.009; Jackel MC, 2007, LARYNGOSCOPE, V117, P242, DOI 10.1097/01.mlg.0000248232.27668.57; Johnson JT, 2001, ORL J OTO-RHINO-LARY, V63, P256, DOI 10.1159/000055752; JONES AS, 1995, CANCER, V75, P1343, DOI 10.1002/1097-0142(19950315)75:6<1343::AID-CNCR2820750617>3.0.CO;2-T; Keski-Santti HT, 2005, HEAD NECK-J SCI SPEC, V27, P909, DOI 10.1002/hed.20259; Libby DM, 2004, CHEST, V125, P1522, DOI 10.1378/chest.125.4.1522; Loh KS, 2005, HEAD NECK-J SCI SPEC, V27, P990, DOI 10.1002/hed.20261; MCGARRY GW, 1992, CLIN OTOLARYNGOL, V17, P558, DOI 10.1111/j.1365-2273.1992.tb01718.x; McLeod NMH, 2009, HEAD NECK-J SCI SPEC, V31, P548, DOI 10.1002/hed.21004; Mesurolle B, 2003, HEAD NECK-J SCI SPEC, V25, P889, DOI 10.1002/hed.10303; Ong TK, 1999, J CRANIO MAXILL SURG, V27, P339, DOI 10.1054/jcms.2000.0094; Tan LKS, 1999, OTOLARYNG HEAD NECK, V120, P689, DOI 10.1053/hn.1999.v120.a91767; ZBAREN P, 1987, ARCH OTOLARYNGOL, V113, P762	26	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	FEB	2015	42	1					49	52		10.1016/j.anl.2014.08.013		4	Otorhinolaryngology	Otorhinolaryngology	CD7EP	WOS:000351253900010		
J	Ohki, M; Komiyama, S; Tayama, N				Ohki, Masafumi; Komiyama, Sakurako; Tayama, Niro			Pharyngolaryngeal paralysis in a patient with pharyngeal tuberculosis	AURIS NASUS LARYNX			English	Article						Tuberculosis; Pharyngeal paralysis; Nasal; Recurrent laryngeal nerve paralysis; Pharyngeal tuberculosis; Dysphagia	VOCAL CORD PARALYSIS; HORNERS-SYNDROME; LYMPHADENOPATHY	Pharyngeal tuberculosis is a rare disease, and its commonly reported symptoms include sore throat, dysphagia, and throat discomfort. The dysphagia in pharyngeal tuberculosis cases is not due to pharyngolaryngeal paralysis but due to odynophagia. Herein, we describe the first case of dysphagia caused by pharyngolaryngeal paralysis secondary to pharyngeal tuberculosis. An irregular mass at the right nasopharynx was detected in a 57-year-old female patient, along with dysphagia and hoarseness. She had poor right soft palate elevation, inadequate right velopharyngeal closure, poor constrictor pharyngus muscle contraction, and an immobilized right vocal cord, which collectively indicate right pharyngolaryngeal paralysis. Pathological examination and, culture testing revealed pharyngeal tuberculosis. She was diagnosed with pharyngolaryngeal paralysis secondary to pharyngeal tuberculosis. The pharyngolaryngeal paralysis resolved after beginning anti-tuberculous treatment. Right pharyngolaryngeal paralysis was attributed to glossopharyngeal and vagus nerve impairment in the parapharyngeal space. Prior reports indicate that peripheral nerve paralysis, including recurrent laryngeal nerve paralysis caused by tuberculous lymphadenitis, often recovers after anti-tuberculous treatment. Pharyngeal tuberculosis rarely causes dysphagia and hoarseness attributable to pharyngolaryngeal paralysis. The neuropathy may recover after anti-tuberculous treatment. Pharyngeal tuberculosis is a new potential differential diagnosis in pharyngolaryngeal paralysis. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Ohki, Masafumi] Saitama Med Univ, Saitama Med Ctr, Dept Otolaryngol, Kawagoe, Saitama 3508550, Japan; [Komiyama, Sakurako] Teikyo Univ, Sch Med, Univ Hosp, Dept Otolaryngol,Takatsu Ku, Kawasaki, Kanagawa 2138507, Japan; [Tayama, Niro] Natl Ctr Global Hlth & Med, Dept Otolaryngol, Shinjuku Ku, Tokyo 1628655, Japan	Ohki, M (reprint author), Saitama Med Univ, Saitama Med Ctr, Dept Otolaryngol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	m-ohki@umin.ac.jp					AlSoub H, 1996, TUBERCLE LUNG DIS, V77, P563, DOI 10.1016/S0962-8479(96)90057-X; Al-Serhani AM, 2001, AM J OTOLARYNG, V22, P236, DOI 10.1053/ajot.2001.24818; Rathinam S, 2006, EUR J CARDIO-THORAC, V30, P833, DOI 10.1016/j.ejcts.2006.09.025; Hosoglu S, 2002, INT J TUBERC LUNG D, V6, P64; Rafay MA, 2000, ANN THORAC SURG, V70, P2142, DOI 10.1016/S0003-4975(00)01193-0; FOWLER RW, 1983, BRIT MED J, V286, P1562; Freercks R, 2011, SAMJ S AFR MED J, V101, P381; Goussard P, 2009, PEDIATR PULM, V44, P345, DOI 10.1002/ppul.21007; GUPTA S K, 1960, J Laryngol Otol, V74, P106, DOI 10.1017/S0022215100056309; ISMAIL MHA, 1988, S AFR MED J, V74, P586; Jain SK, 2002, AM J GASTROENTEROL, V97, P287; Misra UK, 2004, CLIN NEUROPHYSIOL, V115, P2267, DOI 10.1016/j.clinph.2004.05.013; Nagai Kenta, 2011, Case Rep Gastroenterol, V5, P540, DOI 10.1159/000331662; National Collaborating Centre for Chronic Conditions, 2006, TUB CLIN DIAGN MAN T, P1; VYRAVANATHAN S, 1983, J LARYNGOL OTOL, V97, P523, DOI 10.1017/S0022215100094494	15	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	FEB	2015	42	1					63	67		10.1016/j.anl.2014.08.020		5	Otorhinolaryngology	Otorhinolaryngology	CD7EP	WOS:000351253900014		
J	Kishimoto, I; Kikuchi, M; Shinohara, S; Fujiwara, K; Kanazawa, Y; Tona, R; Harada, H; Usami, Y; Naito, Y				Kishimoto, Ippei; Kikuchi, Masahiro; Shinohara, Shogo; Fujiwara, Keizo; Kanazawa, Yuji; Tona, Risa; Harada, Hiroyuki; Usami, Yu; Naito, Yasushi			A case of angiosarcoma arising from internal jugular vein	AURIS NASUS LARYNX			English	Article						Angiosarcoma; Deep neck; Jugular vein; Surgery; Postoperative radiotherapy	PAZOPANIB	Primary angiosarcoma is a rare disease with a poor prognosis. It most commonly arises in the head and neck region; localization in the deep soft tissue of the neck is extremely rare. We herein present a case of angiosarcoma derived from the right internal jugular vein. A 79-year-old man presented with a 1-month history of a growing right neck mass. Computed tomography, magnetic resonance imaging, positron emission tomography-computed tomography, and fine-needle aspiration cytology revealed a malignant tumor of unknown origin. Right neck dissection was performed for both diagnosis and therapy. Immunostaining of the resected tumor cells revealed positivity for CD31, CD34, factor VIII-related antigen, and D2-40, which allowed for a definitive diagnosis of angiosarcoma. Postoperative radiotherapy (66 Gy) was performed on the right neck, including the surgical bed and upper mediastinum. The patient was followed up for 10 months with no recurrence. Only six cases of angiosarcoma arising in the deep soft tissue of the neck have been reported in the English-language literature. The present report is the first to describe angiosarcoma arising from the internal jugular vein. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kishimoto, Ippei; Kikuchi, Masahiro; Shinohara, Shogo; Fujiwara, Keizo; Harada, Hiroyuki; Naito, Yasushi] Kobe City Med Ctr Gen Hosp, Dept Otolaryngol Head & Neck Surg, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kanazawa, Yuji] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sakyo Ku, Kyoto 6068507, Japan; [Tona, Risa] Inst Biomed Res & Innovat, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Usami, Yu] Kobe City Med Ctr Gen Hosp, Dept Clin Pathol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kishimoto, I (reprint author), Kobe City Med Ctr Gen Hosp, Dept Otolaryngol Head & Neck Surg, Chuo Ku, 2-1-1 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	ippei5756jp@yahoo.co.jp					Naka N, 1996, J SURG ONCOL, V61, P170, DOI 10.1002/(SICI)1096-9098(199603)61:3<170::AID-JSO2>3.0.CO;2-8; Young RJ, 2010, LANCET ONCOL, V11, P983, DOI 10.1016/S1470-2045(10)70023-1; Tomita H, 2014, J AM ACAD DERMATOL, V70, pE19, DOI 10.1016/j.jaad.2013.08.055; Goldblum JR, 2014, ENZINGER WEISSS SOFT; Heudel Pierre, 2012, Clin Pharmacol, V4, P65, DOI 10.2147/CPAA.S33195; McIntosh BC, 2005, J CRANIOFAC SURG, V16, P699, DOI 10.1097/01.SCS.0000159941.70498.B9; MIETTINEN M., 2010, MODERN SOFT TISSUE P; Ong P, 2012, CIRCULATION, V126, pE279, DOI 10.1161/CIRCULATIONAHA.112.128348; Ruckert RI, 2000, CANCER, V89, P1577	9	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	FEB	2015	42	1					68	71		10.1016/j.anl.2014.08.018		4	Otorhinolaryngology	Otorhinolaryngology	CD7EP	WOS:000351253900015		
J	Kusano, J; Iguchi, F; Takahashi, Y; Terada, Y; Murai, N				Kusano, Junko; Iguchi, Fukuichiro; Takahashi, Yuka; Terada, Yasuji; Murai, Norihiko			Neck and superior mediastinal granular cell tumor excised via a combined approach	AURIS NASUS LARYNX			English	Article						Granular cell tumor; Neurogenic tumor; Neck; Mediastinum; Neck incision; Video-assisted thoracoscopic surgery		Granular cell tumor (GCT) is an uncommon tumor of Schwann cell origin. GCT occurs in various sites throughout the body, but mediastinal GCT is very rare. We present an extremely rare case of GCT of the neck and superior mediastinum. A 36-year-old man with a 3-month history of cough was investigated at our hospital. CT and MRI revealed a spindle-shaped mass in the left neck and superior mediastinum, with features suggesting a neurogenic tumor. The tumor was successfully excised via combined neck incision and video-assisted thoracoscopic surgery. Histopathological examination showed proliferation of polygonal and spindled cells with eosinophilic granule-rich cytoplasm. These cells were S-100 protein positive, and the cytoplasmic granules were periodic acid-Schiff positive. Based on these histopathological and immunohistochemical findings, a diagnosis of GCT was established. The patient developed hoarseness immediately after the operation, and laryngoscopy revealed the left vocal cord palsy in the paramedian position, which resolved after about 3 months. The tumor did not recur during the following 10 months. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kusano, Junko; Iguchi, Fukuichiro; Takahashi, Yuka; Murai, Norihiko] Kyoto Katsura Hosp, Dept Otolaryngol, Nishikyou Ku, Kyoto 6158256, Japan; [Terada, Yasuji] Kyoto Katsura Hosp, Dept Thorac Surg, Nishikyou Ku, Kyoto 6158256, Japan	Murai, N (reprint author), Kyoto Katsura Hosp, Dept Otolaryngol, Nishikyou Ku, Yamada Hirao Cho 17, Kyoto 6158256, Japan.	murai@ent.kuhp.kyoto-u.ac.jp					Al-Mufarrej Faisal, 2010, Gen Thorac Cardiovasc Surg, V58, P636, DOI 10.1007/s11748-009-0542-x; Angeles RM, 2005, ARCH PATHOL LAB MED, P129; Becelli R, 2001, J CRANIOFAC SURG, V12, P78, DOI 10.1097/00001665-200101000-00013; Abrikossoff A, 1926, VIRCHOWS ARCH A, V260, P215, DOI 10.1007/BF02078314; Ponce FA, 2011, J NEUROSURG-SPINE, V14, P377, DOI 10.3171/2010.11.SPINE09718; Fanburg-Smith JC, 1998, AM J SURG PATHOL, V22, P779, DOI 10.1097/00000478-199807000-00001; Machida E, 2003, INTERNAL MED, V42, P178, DOI 10.2169/internalmedicine.42.178; De Luca G, 2013, J THORAC ONCOL, V8, P1107, DOI 10.1097/JTO.0b013e318299ad62; BURTON DM, 1992, LARYNGOSCOPE, V102, P807, DOI 10.1288/00005537-199207000-00010; Curtis BV, 1997, HEAD NECK-J SCI SPEC, V19, P634, DOI 10.1002/(SICI)1097-0347(199710)19:7<634::AID-HED12>3.0.CO;2-2; Fumagalli I, 2012, ACTA ONCOL, V51, P133, DOI 10.3109/0284186X.2011.587449; Kanat O, 2008, CLIN ONCOL-UK, V20, P93, DOI 10.1016/j.clon.2007.09.002; Nakao Masayuki, 2012, Asian Cardiovasc Thorac Ann, V20, P71, DOI 10.1177/0218492311421453; ROSENTHAL SA, 1990, CANCER, V65, P897, DOI 10.1002/1097-0142(19900215)65:4<897::AID-CNCR2820650413>3.0.CO;2-1; Yamaguchi Masafumi, 2006, Ann Thorac Cardiovasc Surg, V12, P194	15	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	FEB	2015	42	1					72	76		10.1016/j.anl.2014.09.001		5	Otorhinolaryngology	Otorhinolaryngology	CD7EP	WOS:000351253900016		
J	Nakamura, T				Nakamura, Takashi			A complete Riemann zeta distribution and the Riemann hypothesis	BERNOULLI			English	Article						characteristic function; Levy-Khintchine representation; Riemann hypothesis; zeta distribution		Let a, t is an element of IR, s = sigma + it, Gamma(s) be the Gamma function, zeta(s) be the Riemann zeta function and xi(s) := s(s - 1)pi(-s/2)Gamma(s/2)zeta(s) be the complete Riemann zeta function. We show that Xi(sigma)(t) := xi(sigma -it)/xi(sigma) is a characteristic function for any a E Ilk by giving the probability density function. Next we prove that the Riemann hypothesis is true if and only if each Xi(sigma)(t) is a pretended-infinitely divisible characteristic function, which is defined in this paper, for each 1/2 < sigma <1. Moreover, we show that Xi(sigma)(t) is a pretended-infinitely divisible characteristic function when sigma = 1. Finally we prove that the characteristic function Xi(sigma)(t) is not infinitely divisible but quasi-infinitely divisible for any sigma > 1.	Tokyo Univ Sci, Fac Sci & Technol, Dept Math, Noda, Chiba 2788510, Japan	Nakamura, T (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Math, Noda, Chiba 2788510, Japan.	nakamura_takashi@ma.noda.tus.ac.jp					Aoyama T., 2012, PREPRINT; Biane P, 2001, B AM MATH SOC, V38, P435, DOI 10.1090/S0273-0979-01-00912-0; GNEDENKO B.V., 1968, LIMIT DISTRIBUTIONS; Gut A, 2006, REV ROUMAINE MATH PU, V51, P205; Khintchine A. Ya., 1938, LIMITS THEOREM SUMS; Lagarias JC, 2003, ANN I FOURIER, V53, P1; Lin GD, 2001, BERNOULLI, V7, P817, DOI 10.2307/3318543; Lindner A, 2011, MATH NACHR, V284, P2225, DOI 10.1002/mana.200910223; Nakamura T., P AM MATH S IN PRESS; Niedbalska-Rajba T., 1981, C MATH, V44, P347; Nikeghbali A, 2009, ELECTRON COMMUN PROB, V14, P396; Patterson S.J., 1988, CAMBRIDGE STUDIES AD, V14; Sato K, SUGAKU EXPO IN PRESS; Sato Ken-iti, 1999, CAMBRIDGE STUDIES AD, V68; Titchmarsh E. C., 1986, THEORY RIEMANN ZETA; Whittaker E. T., 1996, COURSE MODERN ANAL	16	0	0	INT STATISTICAL INST	VOORBURG	428 PRINSES BEATRIXLAAN, 2270 AZ VOORBURG, NETHERLANDS	1350-7265	1573-9759		BERNOULLI	Bernoulli	FEB	2015	21	1					604	617		10.3150/13-BEJ581		14	Statistics & Probability	Mathematics	CD5IB	WOS:000351120100022		
J	Tatsuzawa, F; Hatakeyama, N; Takehara, A; Nakajo, S; Muraoka, H; Ogawa, S; Takahata, Y; Kato, K				Tatsuzawa, Fumi; Hatakeyama, Nanako; Takehara, Akihide; Nakajo, Shiduko; Muraoka, Hiroki; Ogawa, Satoshi; Takahata, Yoshihito; Kato, Kazuhisa			Acylated anthocyanins in flowers of Moricandia DC. (Brassicaceae)	BIOCHEMICAL SYSTEMATICS AND ECOLOGY			English	Article						Moricandia arvensis; Moricandia bactico; Moricandia clabata; Moricandia foetida; Moricandia nitens; Moricandia ramburii; Acylated anthocyanin; Brassicaceae	PURPLE-VIOLET FLOWERS; INCLUDING ANTHOCYANINS; GLYCOSIDES; FLAVONOIDS		[Tatsuzawa, Fumi; Hatakeyama, Nanako; Takahata, Yoshihito; Kato, Kazuhisa] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; [Takehara, Akihide] Iwate Univ, Fac Humanities & Social Sci, Morioka, Iwate 0208550, Japan; [Nakajo, Shiduko] Iwate Univ, Tech Div, Morioka, Iwate 0208551, Japan; [Muraoka, Hiroki; Ogawa, Satoshi] Iwate Univ, Fac Engn, Morioka, Iwate 0208551, Japan	Tatsuzawa, F (reprint author), Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan.	fumi@iwate-u.ac.jp			Japan Society for the Promotion of Science [25450037]	We thank Prof.T.Nishio (Tohoku University) for the donation of Moricandia seeds (accession numbers: MOR-ARV-3, MOR-ARV-4, MOR-ARV-5, MOR-ARV-8, MOR-ARV-9, MOR-ARV-10, MOR-ARV-12, MOR-ARV-13, MOR-ARV-15, MOR-FOE-2, MOR-CLA-3, MOR-NIT-1, MOR-RAM-1, and MOR-BAC-1: Tohoku University Brassica Seed Bank). This work was supported in part by a Grant-in-Aid for Science Research (C) [No.25450037, to F.T.] from the Japan Society for the Promotion of Science.	Andersen O. M., 2006, FLAVONOIDS CHEM BIOC, P471; Veitch NC, 2008, NAT PROD REP, V25, P555, DOI 10.1039/b718040n; Veitch NC, 2011, NAT PROD REP, V28, P1626, DOI 10.1039/c1np00044f; SAITO N, 1995, PHYTOCHEMISTRY, V40, P1283, DOI 10.1016/0031-9422(95)00369-I; Harborne J. B., 1999, HDB NATURAL FLAVONOI, V2; Harborne JB, 1984, PHYTOCHEMICAL METHOD; Tatsuzawa E, 2014, NAT PRODUCT IN PRESS; Tatsuzawa F, 2012, PHYTOCHEMISTRY, V76, P73, DOI 10.1016/j.phytochem.2011.12.019; Tatsuzawa F, 2013, PHYTOCHEM LETT, V6, P170, DOI 10.1016/j.phytol.2012.12.007; Tatsuzawa F, 2014, PHYTOCHEM LETT, V9, P17, DOI 10.1016/j.phytol.2014.03.011	10	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0305-1978	1873-2925		BIOCHEM SYST ECOL	Biochem. Syst. Ecol.	FEB	2015	58						38	42		10.1016/j.bse.2014.10.010		5	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	CD8BK	WOS:000351320000007		
